PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bicknell, LS; Walker, S; Klingseisen, A; Stiff, T; Leitch, A; Kerzendorfer, C; Martin, CA; Yeyati, P; Al Sanna, N; Bober, M; Johnson, D; Wise, C; Jackson, AP; O'Driscoll, M; Jeggo, PA				Bicknell, Louise S.; Walker, Sarah; Klingseisen, Anna; Stiff, Tom; Leitch, Andrea; Kerzendorfer, Claudia; Martin, Carol-Anne; Yeyati, Patricia; Al Sanna, Nouriya; Bober, Michael; Johnson, Diana; Wise, Carol; Jackson, Andrew P.; O'Driscoll, Mark; Jeggo, Penny A.			Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome	NATURE GENETICS			English	Article							II MOPD-II; SECKEL-SYNDROME; CELL-CYCLE; REPLICATION; PERICENTRIN; PROTEIN; DNA; CHECKPOINT; DEFECT; PCNT	Studies into disorders of extreme growth failure (for example, Seckel syndrome and Majewski osteodysplastic primordial dwarfism type II) have implicated fundamental cellular processes of DNA damage response signaling and centrosome function in the regulation of human growth. Here we report that mutations in ORC1, encoding a subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. We establish that these mutations disrupt known ORC1 functions including pre-replicative complex formation and origin activation. ORC1 deficiency perturbs S-phase entry and S-phase progression. Additionally, we show that Orc1 depletion in zebrafish is sufficient to markedly reduce body size during rapid embryonic growth. Our data suggest a model in which ORC1 mutations impair replication licensing, slowing cell cycle progression and consequently impeding growth during development, particularly at times of rapid proliferation. These findings establish a novel mechanism for the pathogenesis of microcephalic dwarfism and show a surprising but important developmental impact of impaired origin licensing.	[Kerzendorfer, Claudia; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Human DNA Damage Response Disorders Grp, Brighton, E Sussex, England; [Bicknell, Louise S.; Klingseisen, Anna; Leitch, Andrea; Martin, Carol-Anne; Yeyati, Patricia; Jackson, Andrew P.] Western Gen Hosp, Inst Genet & Mol Med, HGU, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Walker, Sarah; Stiff, Tom] Univ Sussex, Genome Damage & Stabil Ctr, DNA Double Strand Break Repair Lab, Brighton, E Sussex, England; [Al Sanna, Nouriya] Dhahran Hlth Ctr, Pediat Serv Div, Dhahran, Saudi Arabia; [Bober, Michael] Alfred I DuPont Hosp Children, Dept Pediat, Div Genet, Wilmington, DE USA; [Johnson, Diana] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; [Wise, Carol] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA	University of Sussex; University of Edinburgh; University of Sussex; Nemours Alfred I. duPont Hospital for Children; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Texas Scottish Rite Hospital for Children	O'Driscoll, M (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Human DNA Damage Response Disorders Grp, Brighton, E Sussex, England.	andrew.jackson@hgu.mrc.ac.uk; m.o-driscoll@sussex.ac.uk	Bicknell, Louise/AAL-8003-2020; Bober, Michael/AAH-4553-2021; Bicknell, Louise/GLR-4215-2022; Jackson, Andrew P/D-3442-2009	Bicknell, Louise/0000-0001-6899-9322; Jackson, Andrew P/0000-0002-8739-2646; O'Driscoll, Mark/0000-0003-2765-316X; Bober, Michael/0000-0002-6178-1264; Martin, Carol-Anne/0000-0001-5914-2757; Mason, Sarah/0000-0002-0065-1503; Wise, Carol/0000-0002-6790-2194	MRC; Lister Insitute for Preventive Medicine; Cancer Research UK; Association for International Cancer Research; Wellcome Research Trust; MRC [MC_U127580972, G0500897, G0700733] Funding Source: UKRI; Medical Research Council [G0700733, G0801130B, G0500897, MC_U127580972] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Insitute for Preventive Medicine; Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Wellcome Research Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families and clinicians for their involvement; S. McKay, K. Erskine and the MRC HGU core sequencing service for advice and technical support; D. Fitzpatrick, J. Blow, E. Patton, V. van Heyningen, N. Hastie and T. Carr for discussions and comments; A. Sinclair for p294(oriP); A. Oliver for structural modeling; and S. Devroy for subject enrollment and sample collection. The A.P.J. laboratory is funded by the MRC and the Lister Insitute for Preventive Medicine, the M.O'D. laboratory is funded by Cancer Research UK and the MRC, and the P.A.J. laboratory is funded by the MRC, Association for International Cancer Research and the Wellcome Research Trust. A.P.J. is an MRC Senior Clinical Fellow and Lister Institute Prize fellow. M.O'D. is a CRUK Senior Cancer Research Fellow.	Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Ge XQ, 2009, CELL CYCLE, V8, P2320; GORLIN RJ, 1992, J MED GENET, V29, P516; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Teer JK, 2006, J BIOL CHEM, V281, P6253, DOI 10.1074/jbc.M507150200; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298	23	148	153	4	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2011	43	4					350	U103		10.1038/ng.776	http://dx.doi.org/10.1038/ng.776			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21358633				2022-12-17	WOS:000288903700016
J	Stefansson, H; Steinberg, S; Petursson, H; Gustafsson, O; Gudjonsdottir, IH; Jonsdottir, GA; Palsson, ST; Jonsson, T; Saemundsdottir, J; Bjornsdottir, G; Bottcher, Y; Thorlacius, T; Haubenberger, D; Zimprich, A; Auff, E; Hotzy, C; Testa, CM; Miyatake, LA; Rosen, AR; Kristleifsson, K; Rye, D; Asmus, F; Schols, L; Dichgans, M; Jakobsson, F; Benedikz, J; Thorsteinsdottir, U; Gulcher, J; Kong, A; Stefansson, K				Stefansson, Hreinn; Steinberg, Stacy; Petursson, Hjorvar; Gustafsson, Omar; Gudjonsdottir, Iris H.; Jonsdottir, Gudrun A.; Palsson, Stefan T.; Jonsson, Thorlakur; Saemundsdottir, Jona; Bjornsdottir, Gyda; Boettcher, Yvonne; Thorlacius, Theodora; Haubenberger, Dietrich; Zimprich, Alexander; Auff, Eduard; Hotzy, Christoph; Testa, Claudia M.; Miyatake, Lisa A.; Rosen, Ami R.; Kristleifsson, Kristleifur; Rye, David; Asmus, Friedrich; Schoels, Ludger; Dichgans, Martin; Jakobsson, Finnbogi; Benedikz, John; Thorsteinsdottir, Unnur; Gulcher, Jeffrey; Kong, Augustine; Stefansson, Kari			Variant in the sequence of the LINGO1 gene confers risk of essential tremor	NATURE GENETICS			English	Article							DISORDERS; MOUSE	We identified a marker in LINGO1 showing genome-wide significant association (P = 1.2 x 10(-9), odds ratio = 1.55) with essential tremor. LINGO1 has potent, negative regulatory influences on neuronal survival and is also important in regulating both central-nervous-system axon regeneration and oligodendrocyte maturation. An increase in the number of fusiform swellings of Purkinje cell axons in LINGO1 knockout models highlights the potential role of LINGO1 in essential tremor pathophysiology.	[Stefansson, Hreinn; Steinberg, Stacy; Petursson, Hjorvar; Gustafsson, Omar; Gudjonsdottir, Iris H.; Jonsdottir, Gudrun A.; Palsson, Stefan T.; Jonsson, Thorlakur; Saemundsdottir, Jona; Bjornsdottir, Gyda; Boettcher, Yvonne; Thorlacius, Theodora; Kristleifsson, Kristleifur; Thorsteinsdottir, Unnur; Gulcher, Jeffrey; Kong, Augustine; Stefansson, Kari] DeCODE Genet, IS-101 Reykjavik, Iceland; [Haubenberger, Dietrich; Zimprich, Alexander; Auff, Eduard; Hotzy, Christoph] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; [Testa, Claudia M.] Emory Dept Neurol, Atlanta, GA 30322 USA; [Testa, Claudia M.] Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Miyatake, Lisa A.; Rosen, Ami R.; Rye, David] Wesley Woods Hlth Ctr, Emory Dept Neurol, Atlanta, GA 30329 USA; [Asmus, Friedrich] Univ Tubingen, Ctr Neurol, Dystonia Genet Unit, Inst Clin Brain Res, Tubingen, Germany; [Schoels, Ludger] Univ Tubingen, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Jakobsson, Finnbogi] Landspitalinn Univ Hosp, Dept Neurol, IS-108 Reykjavik, Iceland; [Benedikz, John] Landspitalinn Univ Hosp, Dept Neurol, IS-101 Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland	Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland	Stefansson, K (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Schöls, Ludger/ABB-2482-2021; Dichgans, Martin/HCH-3247-2022; Stefansson, Kari/AAE-7187-2019; Zimprich, Alexander/A-5232-2017	Schöls, Ludger/0000-0001-7774-5025; Dichgans, Martin/0000-0002-0654-387X; Zimprich, Alexander/0000-0002-1668-5177; Stefansson, Hreinn/0000-0002-9331-6666; Haubenberger, Dietrich/0000-0002-6233-8168; Gudjonsdottir, Iris Hronn/0000-0001-6013-9520; Kong, Augustine/0000-0001-8193-5438; Bjornsdottir, Gyda/0000-0002-8100-0306	Emory General Clinical Research Center [NIH/NCRR M01 RR00039]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	Emory General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals taking part in this study whose contribution made this work possible. We also thank the Nurses at Krokhals (deCODE's recruitment center) and the personnel at the deCODE core facilities. The US sample was recruited through support from Emory General Clinical Research Center NIH/NCRR M01 RR00039 (CRIN Infra-structure support).	BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Deuschl G, 2000, BRAIN, V123, P1568, DOI 10.1093/brain/123.8.1568; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Laursen LS, 2007, NEURON GLIA BIOL, V3, P367, DOI 10.1017/S1740925X08000161; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; Louis ED, 2005, LANCET NEUROL, V4, P100, DOI 10.1016/S1474-4422(05)00991-9; Louis ED, 2007, BRAIN, V130, P3297, DOI 10.1093/brain/awm266; Louis ED, 2007, NEUROEPIDEMIOLOGY, V29, P208, DOI 10.1159/000111584; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mi S, 2008, INT J BIOCHEM CELL B, V40, P1971, DOI 10.1016/j.biocel.2008.03.018; MOGHAL S, 1994, NEUROEPIDEMIOLOGY, V13, P175, DOI 10.1159/000110376; Oliver PL, 2005, CLIN SCI, V108, P385, DOI 10.1042/CS20050041; Shill HA, 2008, NEUROLOGY, V70, P1452, DOI 10.1212/01.wnl.0000310425.76205.02; Zhao XH, 2008, CELL MOL NEUROBIOL, V28, P727, DOI 10.1007/s10571-007-9258-6	15	148	156	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					277	279		10.1038/ng.299	http://dx.doi.org/10.1038/ng.299			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19182806	Green Accepted			2022-12-17	WOS:000263640200005
J	Cizkova, A; Stranecky, V; Mayr, JA; Tesarova, M; Havlickova, V; Paul, J; Ivanek, R; Kuss, AW; Hansikova, H; Kaplanova, V; Vrbacky, M; Hartmannova, H; Noskova, L; Honzik, T; Drahota, Z; Magner, M; Hejzlarova, K; Sperl, W; Zeman, J; Houstek, J; Kmoch, S				Cizkova, Alena; Stranecky, Viktor; Mayr, Johannes A.; Tesarova, Marketa; Havlickova, Vendula; Paul, Jan; Ivanek, Robert; Kuss, Andreas W.; Hansikova, Hana; Kaplanova, Vilma; Vrbacky, Marek; Hartmannova, Hana; Noskova, Lenka; Honzik, Tomas; Drahota, Zdenek; Magner, Martin; Hejzlarova, Katerina; Sperl, Wolfgang; Zeman, Jiri; Houstek, Josef; Kmoch, Stanislav			TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy	NATURE GENETICS			English	Article							ASSEMBLY FACTORS; DEFECTS; COMPLEX	We carried out whole-genome homozygosity mapping, gene expression analysis and DNA sequencing in individuals with isolated mitochondrial ATP synthase deficiency and identified disease-causing mutations in TMEM70. Complementation of the cell lines of these individuals with wild-type TMEM70 restored biogenesis and metabolic function of the enzyme complex. Our results show that TMEM70 is involved in mitochondrial ATP synthase biogenesis in higher eukaryotes.	[Cizkova, Alena; Havlickova, Vendula; Paul, Jan; Kaplanova, Vilma; Vrbacky, Marek; Drahota, Zdenek; Hejzlarova, Katerina; Houstek, Josef] Acad Sci Czech Republ, Inst Physiol, Dept Bioenerget, CR-14220 Prague, Czech Republic; [Cizkova, Alena; Stranecky, Viktor; Ivanek, Robert; Hartmannova, Hana; Noskova, Lenka; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12808, Czech Republic; [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria; [Tesarova, Marketa; Hansikova, Hana; Honzik, Tomas; Magner, Martin; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 12808, Czech Republic; [Kuss, Andreas W.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Paracelsus Private Medical University; Charles University Prague; Max Planck Society	Houstek, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Bioenerget, CR-14220 Prague, Czech Republic.	houstek@biomed.cas.cz; skmoch@lf1.cuni.cz	Tesarova, Marketa/I-1531-2016; /F-8296-2014; Vrbacky, Marek/A-1044-2010; Hansikova, Hana/E-9350-2017; Kmoch, Stanislav/C-1575-2010; Houstek, Josef/C-5019-2012; Kaplanova, Vilma/C-7960-2012; Cizkova Vrbacka, Alena/F-4100-2011; Noskova, Lenka/F-6564-2017; Ivanek, Robert/A-8852-2008; Tauchmannova, Katerina/G-1023-2014; Magner, Martin/J-3553-2017; Honzik, Tomas/N-7509-2017; Karbanova, Vendula/I-6851-2013; Hartmannova, Hana/H-4735-2017; Stranecky, Viktor/I-8524-2017; Zeman, Jiri/K-2691-2017	Tesarova, Marketa/0000-0002-5141-2289; /0000-0003-2117-6809; Vrbacky, Marek/0000-0001-7218-8370; Hansikova, Hana/0000-0002-2734-225X; Kmoch, Stanislav/0000-0002-6239-707X; Houstek, Josef/0000-0002-8413-4772; Cizkova Vrbacka, Alena/0000-0003-4640-1646; Noskova, Lenka/0000-0001-7011-4327; Tauchmannova, Katerina/0000-0002-3745-8790; Magner, Martin/0000-0002-5883-9509; Honzik, Tomas/0000-0003-4300-2519; Hartmannova, Hana/0000-0001-7787-832X; Stranecky, Viktor/0000-0002-2599-6479; Zeman, Jiri/0000-0002-2678-7919; Kuss, Andreas/0000-0002-9401-4627; Ivanek, Robert/0000-0002-8403-056X; Mayr, Johannes/0000-0001-6970-336X	Ministry of Education of Czech Republic [1M6837805002, AV0Z 50110509, MSM0021620806, 14/2006]; GACR [305/08/H037]; OeNB [12568]; Pad. Forschungsverein and PMU Salzburg [06/04/022]	Ministry of Education of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); GACR(Grant Agency of the Czech Republic); OeNB; Pad. Forschungsverein and PMU Salzburg	This study was supported by grants from Ministry of Education of Czech Republic (1M6837805002, AV0Z 50110509, MSM0021620806, Kontakt 14/2006), GACR (305/08/H037), OeNB 12568, Pad. Forschungsverein and PMU Salzburg (06/04/022). We thank R. Gallyova, S.. Rosipal, V. Smolka, A. Hlavata, P. Freisinger, M. Huemer and O. Bodamer, who provided samples from affected individuals for this study, and D. Seelow for bioinformatic support.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Cizkova A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-38; Collinson IR, 1996, BIOCHEMISTRY-US, V35, P12640, DOI 10.1021/bi960969t; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Houstek J, 1999, HUM MOL GENET, V8, P1967; Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Pickova A, 2005, PROTEINS, V59, P393, DOI 10.1002/prot.20452; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	14	148	155	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1288	1290		10.1038/ng.246	http://dx.doi.org/10.1038/ng.246			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953340				2022-12-17	WOS:000260501500019
J	Pennington, JM; Rosenberg, SM				Pennington, Jeanine M.; Rosenberg, Susan M.			Spontaneous DNA breakage in single living Escherichia coli cells	NATURE GENETICS			English	Article							STALLED REPLICATION FORKS; RECOMBINATIONAL REPAIR; CHROMOSOME; FIDELITY; MUTANTS; CANCER; DAMAGE; AMPLIFICATION; DYNAMICS; BACTERIA	Spontaneous DNA breakage is predicted to be a frequent, inevitable consequence of DNA replication and is thought to underlie much of the genomic change that fuels cancer and evolution(1-3). Despite its importance, there has been little direct measurement of the amounts, types, sources and fates of spontaneous DNA lesions in living cells. We present a direct, sensitive flow cytometric assay in single living Escherichia coli cells for DNA lesions capable of inducing the SOS DNA damage response, and we report its use in quantification of spontaneous DNA double-strand breaks (DSBs). We report efficient detection of single chromosomal DSBs and rates of spontaneous breakage similar to 20- to 100-fold lower than predicted. In addition, we implicate DNA replication in the origin of spontaneous DSBs with the finding of fewer spontaneous DSBs in a mutant with altered DNA polymerase III. The data imply that spontaneous DSBs induce genomic changes and instability 20-100 times more potently than previously appreciated. Finally, FACS demonstrated two main cell fates after spontaneous DNA damage: viability with or without resumption of proliferation.	Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	smr@bcm.tmc.edu		Rosenberg, Susan M./0000-0003-1444-473X	NCI NIH HHS [R01-CA85777, R01 CA085777] Funding Source: Medline; NIGMS NIH HHS [R01 GM053158-11A1, R01 GM053158-10, R01 GM053158, R01-GM53158] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; FRAME R, 1971, BIOCHEM J, V121, P93, DOI 10.1042/bj1210093; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Nystrom T, 2002, CURR OPIN MICROBIOL, V5, P596, DOI 10.1016/S1369-5274(02)00367-3; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rothstein R, 2000, GENE DEV, V14, P1; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998	30	148	150	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					797	802		10.1038/ng2051	http://dx.doi.org/10.1038/ng2051			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529976	Green Accepted			2022-12-17	WOS:000246859100026
J	Manak, JR; Dike, S; Sementchenko, V; Kapranov, P; Biemar, F; Long, J; Cheng, J; Bell, I; Ghosh, S; Piccolboni, A; Gingeras, TR				Manak, J. Robert; Dike, Sujit; Sementchenko, Victor; Kapranov, Philipp; Biemar, Frederic; Long, Jeff; Cheng, Jill; Bell, Ian; Ghosh, Srinka; Piccolboni, Antonio; Gingeras, Thomas R.			Biological function of unannotated transcription during the early development of Drosophila melanogaster	NATURE GENETICS			English	Article							GENE-EXPRESSION; SERIAL ANALYSIS; GENOME; IDENTIFICATION	Many animal and plant genomes are transcribed much more extensively than current annotations predict. However, the biological function of these unannotated transcribed regions is largely unknown. Approximately 7% and 23% of the detected transcribed nucleotides during D. melanogaster embryogenesis map to unannotated intergenic and intronic regions, respectively. Based on computational analysis of coordinated transcription, we conservatively estimate that 29% of all unannotated transcribed sequences function as missed or alternative exons of well-characterized protein-coding genes. We estimate that 15.6% of intergenic transcribed regions function as missed or alternative transcription start sites (TSS) used by 11.4% of the expressed protein-coding genes. Identification of P element mutations within or near newly identified 5' exons provides a strategy for mapping previously uncharacterized mutations to their respective genes. Collectively, these data indicate that at least 85% of the fly genome is transcribed and processed into mature transcripts representing at least 30% of the fly genome.	Affymetrix Inc, Santa Clara, CA 95051 USA; Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Affymetrix; University of California System; University of California Berkeley	Manak, JR (corresponding author), Affymetrix Inc, Santa Clara, CA 95051 USA.	John_Manak@affymetrix.com		Manak, John/0000-0002-6562-7694; Kapranov, Philipp/0000-0003-2647-4856; Gingeras, Thomas/0000-0001-9106-3573	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NHGRI NIH HHS [U01 HG003147] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Denholm B, 2005, DEVELOPMENT, V132, P2389, DOI 10.1242/dev.01829; FOE VE, 1989, DEVELOPMENT, V107, P1; Hild M, 2004, GENOME BIOL, V5; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [10.1186/gb-2002-3-12-research0083, DOI 10.1186/GB-2002-3-12-RESEARCH0083]; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Shamloula HK, 2002, GENETICS, V161, P693; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Strapps WR, 2001, DEVELOPMENT, V128, P4829; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101	26	148	154	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1151	1158		10.1038/ng1875	http://dx.doi.org/10.1038/ng1875			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951679				2022-12-17	WOS:000241251100014
J	Zhang, JZ				Zhang, Jianzhi			Parallel adaptive origins of digestive RNases in Asian and African leaf monkeys	NATURE GENETICS			English	Article							POSITIVE DARWINIAN SELECTION; AMINO-ACID-SEQUENCES; PANCREATIC RIBONUCLEASE; CONVERGENT EVOLUTION; GENE; LYSOZYMES; TESTS	Similar morphological or physiological changes occurring in multiple evolutionary lineages are not uncommon. Such parallel changes are believed to be adaptive, because a complex character is unlikely to originate more than once by chance. However, the occurrence of adaptive parallel amino acid substitutions is debated(1-3). Here I propose four requirements for establishing adaptive parallel evolution at the protein sequence level and use these criteria to demonstrate such a case. I report that the gene encoding pancreatic ribonuclease was duplicated independently in Asian and African leaf-eating monkeys. Statistical analyses of DNA sequences, functional assays of reconstructed ancestral proteins and site-directed mutagenesis show that the new genes acquired enhanced digestive efficiencies through parallel amino acid replacements driven by darwinian selection. They also lost a non-digestive function independently, under a relaxed selective constraint. These results demonstrate that despite the overall stochasticity, even molecular evolution has a certain degree of repeatability and predictability under the pressures of natural selection.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhang, JZ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 1075 Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	jianzhi@umich.edu						BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; BEINTEMA JJ, 1990, MOL BIOL EVOL, V7, P470; Bull JJ, 1997, GENETICS, V147, P1497; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Delson Eric, 1994, P11; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Guyton AC, 1996, TXB MED PHYSL, V9th; HANG J, 2000, J MOL EVOL, V50, P56; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kay Robin N. B., 1994, P229; Li W.H., 1997, MOL EVOLUTION; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Monod J., 1972, CHANCE NECESSITY; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; TAJIMA F, 1993, GENETICS, V135, P599; Tang H, 2004, MOL BIOL EVOL, V21, P1548, DOI 10.1093/molbev/msh158; YANG ZH, 1995, GENETICS, V141, P1641; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2003, MOL BIOL EVOL, V20, P1310, DOI 10.1093/molbev/msg143; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789	30	148	158	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					819	823		10.1038/ng1812	http://dx.doi.org/10.1038/ng1812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16767103				2022-12-17	WOS:000238669300019
J	Schonberger, J; Wang, L; Shin, TJ; Kim, SD; Depreux, FFS; Zhu, H; Zon, L; Pizard, A; Kim, JB; MacRae, CA; Mungall, AJ; Seidman, JG; Seidman, CE				Schonberger, J; Wang, L; Shin, TJ; Kim, SD; Depreux, FFS; Zhu, H; Zon, L; Pizard, A; Kim, JB; MacRae, CA; Mungall, AJ; Seidman, JG; Seidman, CE			Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss	NATURE GENETICS			English	Article							DROSOPHILA-EYES-ABSENT; PROTEIN; GENE; PHOSPHATASE; HOMOLOGS; REVEALS; DFNA10	We identified a human mutation that causes dilated cardiomyopathy and heart failure preceded by sensorineural hearing loss (SNHL). Unlike previously described mutations causing dilated cardiomyopathy that affect structural proteins, this mutation deletes 4,846 bp of the human transcriptional coactivator gene EYA4. To elucidate the roles of eya4 in heart function, we studied zebrafish embryos injected with antisense morpholino oligonucleotides. Attenuated eya4 transcript levels produced morphologic and hemodynamic features of heart failure. To determine why previously described mutated EYA4 alleles(1,2) cause SNHL without heart disease, we examined biochemical interactions of mutant Eya4 peptides. Eya4 peptides associated with SNHL, but not the shortened 193 amino acid peptide associated with dilated cardiomyopathy and SNHL, bound wild-type Eya4 and associated with Six proteins. These data define unrecognized and crucial roles for Eya4-Six-mediated transcriptional regulation in normal heart function.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Wurzburg, Dept Med, D-97080 Wurzburg, Germany; Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; Massachusetts Gen Hosp, Dev Biol Lab, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Childrens Hosp, Div Pulm Med, Boston, MA 02115 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Wurzburg; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Wellcome Trust Sanger Institute	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Mungall, Andrew J./U-7067-2018; Zhu, Hao/L-5114-2013; Pizard, Anne CM/P-4754-2016	Mungall, Andrew J./0000-0002-0905-2742; Zhu, Hao/0000-0002-8417-9698; Pizard, Anne CM/0000-0003-2705-6365				BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Bui QT, 2000, GENETICS, V155, P709; Hanson IM, 2001, SEMIN CELL DEV BIOL, V12, P475, DOI 10.1006/scdb.2001.0271; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pfister M, 2002, MOL MED, V8, P607, DOI 10.1007/BF03402171; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Schonberger J, 2000, CIRCULATION, V101, P1812, DOI 10.1161/01.CIR.101.15.1812; Schwerte T, 2000, J EXP BIOL, V203, P1659; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816	16	148	162	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					418	422		10.1038/ng1527	http://dx.doi.org/10.1038/ng1527			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735644				2022-12-17	WOS:000228040000026
J	Zhang, JK; Gray, J; Wu, LZ; Leone, G; Rowan, S; Cepko, CL; Zhu, XM; Craft, CM; Dyer, MA				Zhang, JK; Gray, J; Wu, LZ; Leone, G; Rowan, S; Cepko, CL; Zhu, XM; Craft, CM; Dyer, MA			Rb regulates proliferation and rod photoreceptor development in the mouse retina	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; RAT RETINA; CELL-DIFFERENTIATION; HISTONE ACETYLATION; RETINOBLASTOMA GENE; CHIMERIC MICE; LOCALIZATION; NEUROGENESIS; EXPRESSION; DEFICIENT	The retinoblastoma protein (Rb) regulates proliferation, cell fate specification and differentiation in the developing central nervous system (CNS), but the role of Rb in the developing mouse retina has not been studied, because Rb-deficient embryos die before the retinas are fully formed. We combined several genetic approaches to explore the role of Rb in the mouse retina. During postnatal development, Rb is expressed in proliferating retinal progenitor cells and differentiating rod photoreceptors. In the absence of Rb, progenitor cells continue to divide, and rods do not mature. To determine whether Rb functions in these processes in a cell-autonomous manner, we used a replication-incompetent retrovirus encoding Cre recombinase to inactivate the Rb1(lox) allele in individual retinal progenitor cells in vivo. Combined with data from studies of conditional inactivation of Rb1 using a combination of Cre transgenic mouse lines, these results show that Rb is required in a cell-autonomous manner for appropriate exit from the cell cycle of retinal progenitor cells and for rod development.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Southern California	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Rowan, Sheldon/AAA-3271-2019; Dyer, Michael/N-8134-2018	Rowan, Sheldon/0000-0002-1123-6743; 				Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DiCiommo D, 2000, SEMIN CANCER BIOL, V10, P255, DOI 10.1006/scbi.2000.0326; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Dyer MA, 2001, J COMP NEUROL, V429, P601; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Ferguson KL, 2001, NEUROREPORT, V12, pA55, DOI 10.1097/00001756-200107030-00001; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Greenlee MHW, 2002, SEMIN CELL DEV BIOL, V13, P99, DOI 10.1016/S1084-9521(02)00015-0; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Koulen P, 1999, EUR J NEUROSCI, V11, P2007, DOI 10.1046/j.1460-9568.1999.00622.x; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LIOU GI, 1991, BIOCHEM BIOPH RES CO, V181, P159, DOI 10.1016/S0006-291X(05)81395-6; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Schubeler D, 2000, GENE DEV, V14, P940; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	41	148	153	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2004	36	4					351	360		10.1038/ng1318	http://dx.doi.org/10.1038/ng1318			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	14991054	Bronze			2022-12-17	WOS:000220647200018
J	McMurray, CT; Tainer, JA				McMurray, CT; Tainer, JA			Cancer, cadmium and genome integrity	NATURE GENETICS			English	Editorial Material							DNA-DAMAGE; MAINTENANCE; PROTEINS; METALS	The direct inhibition of DNA mismatch repair by cadmium provides a molecular mechanism for cadmium toxicity with profound implications for human health, risk assessment and biological understanding of environmental mutagens. Alteration of key DNA damage response pathways may prove even more important than direct DNA damage by mutagens.	Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Mayo Clinic; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	McMurray, CT (corresponding author), Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	mcmurray.cynthia@mayo.edu; jat@scripps.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429				Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Drotschmann K, 2002, BIOL CHEM, V383, P969, DOI 10.1515/BC.2002.103; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Hayes RB, 1997, CANCER CAUSE CONTROL, V8, P371, DOI 10.1023/A:1018457305212; Hengstler JG, 2003, CARCINOGENESIS, V24, P63, DOI 10.1093/carcin/24.1.63; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; McMurray CT, 2001, LANCET, pS37; McMurray CT, 2001, TRENDS NEUROSCI, V24, pS32, DOI 10.1016/S0166-2236(00)01997-4; Thilly WG, 2003, NAT GENET, V34, P255, DOI 10.1038/ng1205	15	148	157	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					239	241		10.1038/ng0703-239	http://dx.doi.org/10.1038/ng0703-239			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12833042				2022-12-17	WOS:000183815300004
J	Cheung, VG; Spielman, RS				Cheung, VG; Spielman, RS			The genetics of variation in gene expression	NATURE GENETICS			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; BLOCKS; ATM	The genetic basis of variation in gene expression lends itself to investigation by microarrays. For genetic analysis, we view the expression level of a gene as a quantitative or 'complex' trait, analogous to an individual's height or cholesterol level, and, therefore, as an inherited phenotype. Several genetic analyses of 'gene expression phenotypes' have been carried out in experimental organisms, and initial steps have been taken toward similar studies in humans-although these present challenging technical and statistical problems. Further advances in the genetic analysis of variation in gene expression will contribute to our understanding of transcriptional regulation and will provide models for studying other quantitative and complex traits.	Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020					Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Chen XN, 1999, GENOME RES, V9, P492; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P347, DOI 10.1093/nar/25.2.347; Concannon P, 2002, NAT GENET, V32, P89, DOI 10.1038/ng0902-89; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ewens WJ, 2001, THEOR POPUL BIOL, V60, P135, DOI 10.1006/tpbi.2001.1547; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Griffin TJ, 1999, P NATL ACAD SCI USA, V96, P6301, DOI 10.1073/pnas.96.11.6301; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Oliphant A, 2002, BIOTECHNIQUES, P56; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; THOMSON G, 1995, AM J HUM GENET, V57, P487; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Watts JA, 2002, AM J HUM GENET, V71, P791, DOI 10.1086/342974	32	148	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			522	525		10.1038/ng1036	http://dx.doi.org/10.1038/ng1036			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454648				2022-12-17	WOS:000179742900013
J	Zou, YR; Sunshine, MJ; Taniuchi, I; Hatam, F; Killeen, N; Littman, DR				Zou, YR; Sunshine, MJ; Taniuchi, I; Hatam, F; Killeen, N; Littman, DR			Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage	NATURE GENETICS			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; METHYLATION; REPRESSION; SELECTION; PROLIFERATION; TRANSCRIPTION; INACTIVATION; INHERITANCE; THYMOCYTES	The process of thymocyte development culminates in the maturation of helper (CD4(+)) and cytotoxic (CD8(+)) T cells from their common precursors, the CD4(+)CD8(+) double-positive cells(1,2). A crucial step during lineage specification is the termination of expression of either the CD4 or the CD8 coreceptor(3,4). A silencer element within the first intron of the CD4 gene is sufficient for CD4 transcriptional repression in cells of the cytotoxic lineage, as well as in thymocytes at earlier stages of differentiation(5,6). Here we show that the function of the CD4 silencer is required only at distinct stages of development. Its deletion before the initiation of lineage specification resulted in CD4 derepression throughout thymocyte differentiation. By contrast, once cells committed to the cytotoxic CD8(+) lineage, the CD4 locus remained silent through subsequent mitoses, even when the silencer element was excised. The epigenetic inheritance of the silenced CD4 locus was not affected by the inhibition of DNA methylation or histone deacetylation, and may thus involve other mechanisms that ensure a stable state of gene expression.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	New York University; Howard Hughes Medical Institute; New York University; University of California System; University of California San Francisco	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA.	yz2001@columbia.edu; littman@saturn.med.nyu.edu	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; Sunshine, Mary Jean/0000-0002-2188-7881				Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clerc P, 2000, SCIENCE, V290, P1518, DOI 10.1126/science.290.5496.1518; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; von Boehmer H, 2000, CURR BIOL, V10, pR642, DOI 10.1016/S0960-9822(00)00665-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481	33	148	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					332	336		10.1038/ng750	http://dx.doi.org/10.1038/ng750			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687799				2022-12-17	WOS:000171911000022
J	Lafreniere, RG; Rochefort, DL; Chretien, N; Rommens, JM; Cochius, JI; Kalviainen, R; Nousiainen, U; Patry, G; Farrell, K; Soderfeldt, B; Federico, A; Hale, BR; Cossio, OH; Sorensen, T; Pouliot, MA; Kmiec, T; Uldall, P; Janszky, J; Pranzatelli, MR; Andermann, F; Andermann, E; Rouleau, GA				Lafreniere, RG; Rochefort, DL; Chretien, N; Rommens, JM; Cochius, JI; Kalviainen, R; Nousiainen, U; Patry, G; Farrell, K; Soderfeldt, B; Federico, A; Hale, BR; Cossio, OH; Sorensen, T; Pouliot, MA; Kmiec, T; Uldall, P; Janszky, J; Pranzatelli, MR; Andermann, F; Andermann, E; Rouleau, GA			Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1	NATURE GENETICS			English	Article							RAMSAY-HUNT-SYNDROME; FRAGILE-X-SYNDROME; DINUCLEOTIDE REPEAT; HUMAN CHROMOSOME-21; RESTRICTION MAP; CGG REPEAT; LONG ARM; INSTABILITY; HUMAN-CHROMOSOME-21; POLYMORPHISM	Progressive myoclonus epilepsy type 1 (EPM1, also known as Unverricht-Lundborg disease) is an autosomal recessive disorder characterized by progressively worsening myoclonic jerks, frequent generalized tonic-clonic seizures, and a slowly progressive decline in cognition(1). Recently, two mutations in the cystatin B gene (also known as stefin B, STFB) mapping to 21q22.3 have been implicated in the EPM1 phenotype: a G-->C substitution in the last nucleotide of intron 1 that was predicted to cause a splicing defect in one family, and a C-->T substitution that would change an Arg codon (CGA) to a stop codon (TCA) at amino acid position 68, resulting in a truncated cystatin B protein in two other families(2). A fourth family showed undetectable amounts of STFB mRNA by northern blot analysis in an affected individual. We present haplotype and mutational analyses of our collection of 20 unrelated EPM1 patients and families from different ethnic groups. We identify four different mutations, the most common of which consists of an unstable similar to 600-900 bp insertion which is resistant to PCR amplification. This insertion maps to a 12-bp polymorphic tandem repeat located in the 5' flanking region of the STFB gene, in the region of the promoter. The size of the insertion varies between different EPM1 chromosomes sharing a common haplotype and a common origin, suggesting some level of meiotic instability over the course of many generations. This dynamic mutation, which appears distinct from conventional trinucleotide repeat expansions, may arise via a novel mechanism related to the instability of tandemly repeated sequences.	MONTREAL GEN HOSP, RES INST, DEPT NEUROL, MONTREAL, PQ H3G 1A4, CANADA; UNIV TORONTO, HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5S 1A1, CANADA; NORFOLK & NORWICH HOSP, DEPT NEUROL, NORWICH, NORFOLK, ENGLAND; KUOPIO UNIV HOSP, DEPT NEUROL, SF-70210 KUOPIO, FINLAND; UNIV KUOPIO, VAAJASALO HOSP, DEPT CLIN NEUROPHYSIOL, FIN-70211 KUOPIO, FINLAND; UNIV LAVAL, DEPT NEUROL, QUEBEC CITY, PQ, CANADA; UNIV BRITISH COLUMBIA, DEPT PAEDIAT, VANCOUVER, BC V5Z 1M9, CANADA; LINKOPING UNIV HOSP, DEPT NEUROL, S-58185 LINKOPING, SWEDEN; UNIV SIENA, INST NEUROL SCI, DEPT NEUROL, I-53100 SIENA, ITALY; DEPT PEDIAT NEUROL, INDIANAPOLIS, IN USA; HOSP SANTA CASA MISERICORDIA, CTR NEUROL & NEUROCIRUGIA, CURITIBA, PARANA, BRAZIL; UNIV COPENHAGEN, HVIDOVRE HOSP, DEPT NEUROL, DK-2650 HVIDOVRE, DENMARK; CHILDRENS MEM HLTH INST, DEPT NEUROL, WARSAW, POLAND; DIANALUND EPILEPSY HOSP, CHILD DEPT, DIANALUND, DENMARK; ORSZAGOS NEUROL & PSICHIAT INTEZET, DEPT NEUROL, BUDAPEST, HUNGARY; GEORGE WASHINGTON UNIV, DEPT NEUROL, WASHINGTON, DC 20052 USA; GEORGE WASHINGTON UNIV, DEPT PAEDIAT, WASHINGTON, DC 20052 USA; GEORGE WASHINGTON UNIV, DEPT PHARMACOL, WASHINGTON, DC 20052 USA; MCGILL UNIV, DEPT NEUROL & NEUROSURG, MONTREAL, PQ H3A 2T5, CANADA; MCGILL UNIV, DEPT PEDIAT, MONTREAL, PQ H3A 2T5, CANADA; MONTREAL NEUROL HOSP & INST, EPILEPSY SERV, MONTREAL, PQ H3A 2B4, CANADA; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ, CANADA; MONTREAL NEUROL HOSP & INST, NEUROGENET UNIT, MONTREAL, PQ H3A 2B4, CANADA	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Laval University; University of British Columbia; Linkoping University; University of Siena; University of Copenhagen; Children's Memorial Health Institute; George Washington University; George Washington University; George Washington University; McGill University; McGill University; McGill University; McGill University; McGill University	Lafreniere, RG (corresponding author), MCGILL UNIV, CTR RES NEUROSCI, ROOM L12-144, 1650 CEDAR AVE, MONTREAL, PQ H3G 1A4, CANADA.			Kmiec, Tomasz/0000-0001-6958-6239; federico, antonio/0000-0002-5246-1621				ANDERMANN F, 1989, MOVEMENT DISORD, V4, P13, DOI 10.1002/mds.870040104; [Anonymous], 1990, Ann Neurol, V28, P113; AVRAMOPOULOS D, 1993, HUM GENET, V90, P566; CHENG JF, 1994, GENOMICS, V23, P75, DOI 10.1006/geno.1994.1461; COCHIUS JI, 1993, ANN NEUROL, V34, P739, DOI 10.1002/ana.410340519; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GENTON P, 1990, ACTA NEUROL SCAND, V81, P8; ICHIKAWA H, 1993, NAT GENET, V4, P361, DOI 10.1038/ng0893-361; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAFRENIERE RG, 1995, GENOMICS, V29, P288, DOI 10.1006/geno.1995.1248; MUNKE M, 1988, AM J HUM GENET, V42, P542; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEDERSEN E, 1982, J NEUROL SCI, V53, P305, DOI 10.1016/0022-510X(82)90015-6; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; PETERSEN MB, 1991, HUM GENET, V87, P401; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P2517, DOI 10.1093/nar/19.9.2517; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291	20	148	151	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					298	302		10.1038/ng0397-298	http://dx.doi.org/10.1038/ng0397-298			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054946				2022-12-17	WOS:A1997WK38600023
J	Levanat, S; Gorlin, RJ; Fallet, S; Johnson, DR; Fantasia, JE; Bale, AE				Levanat, S; Gorlin, RJ; Fallet, S; Johnson, DR; Fantasia, JE; Bale, AE			A two-hit model for developmental defects in Gorlin syndrome	NATURE GENETICS			English	Letter							MUTATION; TUMOR		YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520; UNIV MINNESOTA,SCH DENT,DEPT ORAL PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH DENT,DEPT GENET,MINNEAPOLIS,MN 55455; ALBERT EINSTEIN COLL MED,LONG ISL JEWISH MED CTR,SCHNEIDER CHILDRENS HOSP,DEPT DENT MED,NEW HYDE PK,NY 11042	Yale University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yeshiva University					NATIONAL CANCER INSTITUTE [R01CA057605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007439] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA57605] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07439] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLFORS E, 1984, J ORAL MAXIL SURG, V42, P10, DOI 10.1016/0278-2391(84)90390-2; BALE SJ, 1991, AM J MED GENET, V40, P206, DOI 10.1002/ajmg.1320400217; BROWNE R M, 1975, Journal of Oral Pathology, V4, P31, DOI 10.1111/j.1600-0714.1975.tb01738.x; CROSBY JL, 1993, AM J HUM GENET, V52, P866; FRASER FC, 1980, AM J HUM GENET, V32, P796; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GALE AE, 1994, J INVEST DERMATOL, V103, pS126; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JOHNSON DR, 1995, BIOTECHNIQUES, V19, P190; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LI CC, 1987, AM J HUM GENET, V41, P517; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; Moore KL, 1993, DEV HUMAN, V5thed.; PANDERS AK, 1969, J ORAL SURG, V27, P931; PERICAKVANCE MA, IN PRESS ANN HUM GEN; REGEZI JA, 1981, HEAD NECK SURG, V4, P48, DOI 10.1002/hed.2890040110; Sambrook J., 1989, MOL CLONING LAB MANU; Soskolne W A, 1967, Br Dent J, V123, P321; STOELINGA PJW, 1975, J ORAL SURG, V33, P659; TOLLER PAUL, 1967, ANN ROY COLL SURG ENGL, V40, P306; TOVELL KE, 1972, J CAN DENT ASSOC, V4, P145; VANHEYNINGEN V, 1994, NATURE, V367, P319, DOI 10.1038/367319a0; VEDTOFTE P, 1982, SCAND J DENT RES, V90, P306	26	148	155	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					85	87		10.1038/ng0196-85	http://dx.doi.org/10.1038/ng0196-85			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528259				2022-12-17	WOS:A1996TM55500020
J	MELTZER, PS; GUAN, XY; TRENT, JM				MELTZER, PS; GUAN, XY; TRENT, JM			TELOMERE CAPTURE STABILIZES CHROMOSOME BREAKAGE	NATURE GENETICS			English	Article							DICENTRIC CHROMOSOMES; INSITU HYBRIDIZATION; ALPHA-THALASSEMIA; TRANSLOCATIONS; DELETIONS; (TTAGGG)N; ENDS	Terminal deletions are found frequently in both malignancies and clinically recognizable deletion syndromes in man. Little is known, particularly in cancer, of the specific mechanisms which lead to the generation of deleted chromosomes or the process by which these broken chromosomes are stabilized. We demonstrate that several examples of apparent terminal deletions are, in fact, subtelomeric translocations which were not detectable using conventional cytogenetics. The unexpectedly high frequency of this phenomenon and the diversity of partner chromosomes involved in the subtelomeric translocations is consistent with a model in which telomere capture can stabilize chromosome breakage in man.	UNIV MICHIGAN,DEPT RADIAT ONCOL,MED SCI RES BLDG 2,ROOM C560,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805	NATIONAL CANCER INSTITUTE [R37CA029476] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA-29476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; BLACKBURN EH, 1986, ANNU REV GENET, V20, P501; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bridges CB, 1917, GENETICS, V2, P445; BRIDGES CB, 1923, 2ND INT C EUG, V1, P76; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DOWDY SF, 1990, GENE CHROMOSOME CANC, V2, P318, DOI 10.1002/gcc.2870020410; GUAN XY, 1992, GENOMICS, V14, P680, DOI 10.1016/S0888-7543(05)80168-5; HABER JE, 1984, GENETICS, V106, P207; HEIM S, 1987, CANCER CYTOGENETICS; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; KAMPER J, 1989, MOL CELL BIOL, V9, P3931; KUWANO A, 1991, AM J HUM GENET, V49, P707; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; McClintock B, 1938, GENETICS, V23, P315; McClintock B., 1931, U MISSOURI AGR RES S, V163, P3; MEESE EU, 1992, GENOMICS, V12, P542, DOI 10.1016/0888-7543(92)90446-Y; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; MITELMAN F, 1991, CATALOG CHROMOSOME A; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; Muller H, 1938, COLLECTING NET, V13, P181; Muller H.J., 1938, COLLECTING NET, V13, P181; MURANE JP, 1993, MOL CELL BIOL, V13, P977; Painter TS, 1929, J HERED, V20, P287, DOI 10.1093/oxfordjournals.jhered.a103199; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0	30	148	154	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					252	255		10.1038/ng0793-252	http://dx.doi.org/10.1038/ng0793-252			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358433				2022-12-17	WOS:A1993LJ84200012
J	Drier, Y; Cotton, MJ; Williamson, KE; Gillespie, SM; Ryan, RJH; Kluk, MJ; Carey, CD; Rodig, SJ; Sholl, LM; Afrogheh, AH; Faquin, WC; Queimado, L; Qi, J; Wick, MJ; El-Naggar, AK; Bradner, JE; Moskaluk, CA; Asters, JC; Knoechel, B; Bernstein, BE				Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Kluk, Michael J.; Carey, Christopher D.; Rodig, Scott J.; Sholl, Lynette M.; Afrogheh, Amir H.; Faquin, William C.; Queimado, Lurdes; Qi, Jun; Wick, Michael J.; El-Naggar, Adel K.; Bradner, James E.; Moskaluk, Christopher A.; Asters, Jon C.; Knoechel, Birgit; Bernstein, Bradley E.			An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GENES; SELECTIVE-INHIBITION; RECURRENT FUSION; SUPER-ENHANCERS; BREAST-CANCER; TARGET GENES; EXPRESSION; P63; LEUKEMIA; NOTCH	Translocation events are frequent in cancer and may create chimeric fusions or 'regulatory rearrangements' that drive oncogene overexpression. Here we identify super-enhancer translocations that drive overexpression of the oncogenic transcription factor MYB as a recurrent theme in adenoid cystic carcinoma (ACC). Whole-genome sequencing data and chromatin maps highlight distinct chromosomal rearrangements that juxtapose super-enhancers to the MYB locus. Chromosome conformation capture confirms that the translocated enhancers interact with the MYB promoter. Remarkably, MYB protein binds to the translocated enhancers, creating a positive feedback loop that sustains its expression. MYB also binds enhancers that drive different regulatory programs in alternate cell lineages in ACC, cooperating with TP63 in myoepithelial cells and a Notch program in lumina! epithelial cells. Bromodomain inhibitors slow tumor growth in ACC primagraft models in vivo. Thus, our study identifies super-enhancer translocations that drive MYB expression and provides insight into downstream MYB functions in alternate ACC lineages.	[Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Knoechel, Birgit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Kluk, Michael J.; Carey, Christopher D.; Rodig, Scott J.; Sholl, Lynette M.; Asters, Jon C.; Knoechel, Birgit; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Bradner, James E.; Knoechel, Birgit; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kluk, Michael J.; Carey, Christopher D.; Rodig, Scott J.; Sholl, Lynette M.; Asters, Jon C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Otorhinolaryngol, Oklahoma City, OK USA; [Qi, Jun] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wick, Michael J.] South Texas Accelerated Res Therapeut, San Antonio, TX USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Moskaluk, Christopher A.] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA USA; [Knoechel, Birgit] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Knoechel, Birgit] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Virginia; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Knoechel, B; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Knoechel, B; Bernstein, BE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Knoechel, B; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Knoechel, B; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.; Knoechel, B (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA.; Knoechel, B (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	birgit_knoechel@dfci.harvard.edu; bernstein.bradley@mgh.harvard.edu	Queimado, Lurdes/AAY-2545-2021; Queimado, Lurdes/L-7465-2013; Drier, Yotam/K-5208-2012; Rodig, Scott/Y-3889-2019	Queimado, Lurdes/0000-0002-1106-4873; Queimado, Lurdes/0000-0002-1106-4873; Drier, Yotam/0000-0003-1725-2995; Ryan, Russell/0000-0001-8174-3962; Carey, Christopher/0000-0002-4293-3920; Gillespie, Shawn/0000-0003-1913-0860; Williamson, Kaylyn/0000-0002-3252-5050	National Institute of Dental and Craniofacial Research (NIDCR) [HHSN268200900039C 04]; Adenoid Cystic Carcinoma Research Foundation; Temares Family Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Adenoid Cystic Carcinoma Research Foundation; Temares Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Rivera, N. Riggi, S. Puram, P. van Galen, J. Lohr and J. Kaufman for helpful discussions and critical comments on the manuscript; J. Voisine, R. Isenhart, R. Issner, H. Whitton, A. Spooner, M. Uziel, C. Epstein and N. Shoresh for technical assistance; T. Chan and V. Makarov for help with wholegenome sequencing data access; and the Salivary Gland Tumor Biorepository for providing the primary tumors (National Institute of Dental and Craniofacial Research (NIDCR) award reference HHSN268200900039C 04). This work was supported by the Adenoid Cystic Carcinoma Research Foundation (B.E.B. and B.K.), the Temares Family Foundation and the Howard Hughes Medical Institute. B.E.B. is an American Cancer Society Research Professor.	Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Bell D, 2012, CANCER-AM CANCER SOC, V118, P1288, DOI 10.1002/cncr.26412; Bell D, 2011, CANCER BIOL THER, V12, P569, DOI 10.4161/cbt.12.7.17008; Brill LB, 2011, MODERN PATHOL, V24, P1169, DOI 10.1038/modpathol.2011.86; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Haydu JE, 2012, BLOOD, V119, P5211, DOI 10.1182/blood-2011-10-388504; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mitani Y, 2011, AM J PATHOL, V179, P391, DOI 10.1016/j.ajpath.2011.03.037; Mitani Y, 2010, CLIN CANCER RES, V16, P4722, DOI 10.1158/1078-0432.CCR-10-0463; Moll UM, 2004, MOL CANCER RES, V2, P371; Moskaluk CA, 2011, LAB INVEST, V91, P1480, DOI 10.1038/labinvest.2011.105; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; NOMURA T, 1993, J BIOL CHEM, V268, P21914; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; OHNO H, 1990, P NATL ACAD SCI USA, V87, P628, DOI 10.1073/pnas.87.2.628; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Queimado L, 1999, INT J CANCER, V81, P793, DOI 10.1002/(SICI)1097-0215(19990531)81:5<793::AID-IJC21>3.0.CO;2-4; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Sato K, 2006, VIRCHOWS ARCH, V448, P204, DOI 10.1007/s00428-005-0054-8; Stephens PJ, 2013, J CLIN INVEST, V123, P2965, DOI 10.1172/JCI67201; Stoeck A, 2014, CANCER DISCOV, V4, P1154, DOI 10.1158/2159-8290.CD-13-0830; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; YAMAMOTO Y, 1992, J LARYNGOL OTOL, V106, P1016, DOI 10.1017/S0022215100121656; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024	38	147	154	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					265	272		10.1038/ng.3502	http://dx.doi.org/10.1038/ng.3502			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829750	Green Accepted, Green Submitted			2022-12-17	WOS:000370902600010
J	Reynolds, A; Qiao, HY; Yang, Y; Chen, JK; Jackson, N; Biswas, K; Holloway, JK; Baudat, F; de Massy, B; Wang, J; Hoog, C; Cohen, PE; Hunter, N				Reynolds, April; Qiao, Huanyu; Yang, Ye; Chen, Jefferson K.; Jackson, Neil; Biswas, Kajal; Holloway, J. Kim; Baudat, Frederic; de Massy, Bernard; Wang, Jeremy; Hoog, Christer; Cohen, Paula E.; Hunter, Neil			RNF212 is a dosage-sensitive regulator of crossing-over during mammalian meiosis	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; SYNAPTONEMAL COMPLEX-FORMATION; MEIOTIC RECOMBINATION; CHROMOSOME SYNAPSIS; MOUSE SPERMATOCYTES; HOLLIDAY JUNCTIONS; HUMAN ANEUPLOIDY; MICE LACKING; FEMALE MICE; CROSSOVER	Crossing-over ensures accurate chromosome segregation during meiosis, and every pair of chromosomes obtains at least one crossover, even though the majority of recombination sites yield non-crossovers. A putative regulator of crossing-over is RNF212, which is associated with variation in crossover rates in humans. We show that mouse RNF212 is essential for crossing-over, functioning to couple chromosome synapsis to the formation of crossover-specific recombination complexes. Selective localization of RNF212 to a subset of recombination sites is shown to be a key early step in the crossover designation process. RNF212 acts at these sites to stabilize meiosis-specific recombination factors, including the MutS gamma complex (MSH4-MSH5). We infer that selective stabilization of key recombination proteins is a fundamental feature of meiotic crossover control. Haploinsufficiency indicates that RNF212 is a limiting factor for crossover control and raises the possibility that human alleles may alter the amount or stability of RNF212 and be risk factors for aneuploid conditions.	[Reynolds, April; Qiao, Huanyu; Yang, Ye; Chen, Jefferson K.; Jackson, Neil; Biswas, Kajal; Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Reynolds, April; Qiao, Huanyu; Yang, Ye; Chen, Jefferson K.; Jackson, Neil; Biswas, Kajal; Hunter, Neil] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Holloway, J. Kim; Cohen, Paula E.] Cornell Univ, Dept Biomed Sci, Ctr Reprod Genom, Ithaca, NY USA; [Baudat, Frederic; de Massy, Bernard] CNRS, Inst Genet Humaine, Montpellier, France; [Wang, Jeremy] Univ Penn, Dept Anim Biol, Ctr Anim Transgenesis & Germ Cell Res, Philadelphia, PA 19104 USA; [Hoog, Christer] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; Cornell University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Pennsylvania; Karolinska Institutet; University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA.	nhunter@ucdavis.edu	Yang, Ye/C-8397-2011	Qiao, Huanyu/0000-0003-0966-8077; Baudat, Frederic/0000-0003-2415-8366; Biswas, Kajal/0000-0003-2645-9349	CNRS; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche [ANR-09-BLAN-0269-01]; US National Institutes of Health (NIH) [R01GM084955]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041012] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD041012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084955] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Heyting (Wageningen University) for antibodies to SYCP1 and SYCP3, S. Keeney and M. Jasin (Memorial Sloan-Kettering Cancer Center) for Spo11 knockout mice, M. Paddy for help with SIM imaging, J. Trimmer for help with imaging tissue sections and G. Coop for discussions. Knockout mice were generated in collaboration with the University of California, Davis, Mouse Biology Program (MBP). B.d.M. is supported by grants from the CNRS, Association pour la Recherche sur le Cancer and Agence Nationale de la Recherche (ANR-09-BLAN-0269-01). This work was supported by US National Institutes of Health (NIH) grant R01GM084955 to N.H. N.H. is an Early Career Scientist of the Howard Hughes Medical Institute.	Adelman CA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000042; Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 2005, CYTOGENET GENOME RES, V109, P198, DOI 10.1159/000082400; Anderson LK, 1999, GENETICS, V151, P1569; Ashley T, 2001, J CELL SCI, V114, P685; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; Chelysheva L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002799; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Cobb J, 1999, DEV BIOL, V205, P49, DOI 10.1006/dbio.1998.9101; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hirose Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001329; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2007, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kan R, 2008, BIOL REPROD, V78, P462, DOI 10.1095/biolreprod.107.065771; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; Marcon E, 2003, GENETICS, V165, P2283; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Otto SP, 2011, TRENDS GENET, V27, P358, DOI 10.1016/j.tig.2011.05.001; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Sakuno T, 2011, DEV CELL, V21, P534, DOI 10.1016/j.devcel.2011.08.012; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Singh MK, 2007, ONCOGENE, V26, P4825, DOI 10.1038/sj.onc.1210282; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Strong ER, 2010, GENES-BASEL, V1, P440, DOI 10.3390/genes1030440; Terribas E, 2010, J ANDROL, V31, P346, DOI 10.2164/jandrol.109.008805; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Xu KQ, 2010, CLIN CHIM ACTA, V411, P49, DOI 10.1016/j.cca.2009.09.038; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	81	147	150	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					269	278		10.1038/ng.2541	http://dx.doi.org/10.1038/ng.2541			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23396135	Green Accepted			2022-12-17	WOS:000315664800010
J	Sun, L; Rommens, JM; Corvol, H; Li, WL; Li, X; Chiang, TA; Lin, F; Dorfman, R; Busson, PF; Parekh, RV; Zelenika, D; Blackman, SM; Corey, M; Doshi, VK; Henderson, L; Naughton, KM; O'Neal, WK; Pace, RG; Stonebraker, JR; Wood, SD; Wright, FA; Zielenski, J; Clement, A; Drumm, ML; Boelle, PY; Cutting, GR; Knowles, MR; Durie, PR; Strug, LJ				Sun, Lei; Rommens, Johanna M.; Corvol, Harriet; Li, Weili; Li, Xin; Chiang, Theodore A.; Lin, Fan; Dorfman, Ruslan; Busson, Pierre-Francois; Parekh, Rashmi V.; Zelenika, Diana; Blackman, Scott M.; Corey, Mary; Doshi, Vishal K.; Henderson, Lindsay; Naughton, Kathleen M.; O'Neal, Wanda K.; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Wood, Sally D.; Wright, Fred A.; Zielenski, Julian; Clement, Annick; Drumm, Mitchell L.; Boelle, Pierre-Yves; Cutting, Garry R.; Knowles, Michael R.; Durie, Peter R.; Strug, Lisa J.			Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis	NATURE GENETICS			English	Article							GENOME; LINKAGE; IDENTIFICATION; GENE; ONTOLOGY; CFTR; TOOL	Variants associated with meconium ileus in cystic fibrosis were identified in 3,763 affected individuals by genome-wide association study (GWAS). Five SNPs at two loci near SLC6A14 at Xq23-24 (minimum P = 1.28 x 10(-12) at rs3788766) and SLC26A9 at 1q32.1 (minimum P = 9.88 x 10(-9) at rs4077468) accounted for similar to 5% of phenotypic variability and were replicated in an independent sample of affected individuals (n = 2,372; P = 0.001 and 0.0001, respectively). By incorporating the knowledge that disease-causing mutations in CFTR alter electrolyte and fluid flux across surface epithelium into a hypothesis-driven GWAS (GWAS-HD), we identified associations with the same SNPs in SLC6A14 and SLC26A9 and established evidence for the involvement of SNPs in a third solute carrier gene, SLC9A3. In addition, GWAS-HD provided evidence of association between meconium ileus and multiple genes encoding constituents of the apical plasma membrane where CFTR resides (P = 0.0002; testing of 155 apical membrane genes jointly and in replication, P = 0.022). These findings suggest that modulating activities of apical membrane constituents could complement current therapeutic paradigms for cystic fibrosis.	[Sun, Lei; Li, Weili; Strug, Lisa J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Sun, Lei] Univ Toronto, Dept Stat, Toronto, ON, Canada; [Rommens, Johanna M.; Lin, Fan; Dorfman, Ruslan; Parekh, Rashmi V.; Zielenski, Julian] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Corvol, Harriet; Clement, Annick] Hosp Trousseau, AP HP, Pediat Pulm Dept, INSERM,U938, Paris, France; [Corvol, Harriet; Clement, Annick; Boelle, Pierre-Yves] Univ Paris 06, Paris, France; [Li, Weili; Li, Xin; Chiang, Theodore A.; Corey, Mary; Strug, Lisa J.] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Busson, Pierre-Francois; Boelle, Pierre-Yves] Hop St Antoine, AP HP, Dept Biostat, INSERM,UMR S707, F-75571 Paris, France; [Zelenika, Diana] CEA, CNG, Evry, France; [Blackman, Scott M.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Doshi, Vishal K.; Henderson, Lindsay; Naughton, Kathleen M.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [O'Neal, Wanda K.; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Wood, Sally D.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Durie, Peter R.] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Durie, Peter R.] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Case Western Reserve University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Strug, LJ (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada.	lisa.strug@utoronto.ca	Corvol, Harriet/N-5922-2018; Rommens, Johanna/AAT-7465-2021; Busson, Pierre-François/D-3589-2015	Corvol, Harriet/0000-0002-7026-7523; Strug, Lisa/0000-0003-0503-9740; Dorfman, Ruslan/0000-0002-3421-5582; Boelle, Pierre-Yves/0000-0002-5367-8232; Blackman, Scott/0000-0002-4532-6421; Li, Xin/0000-0002-7414-5734; Pace, Rhonda/0000-0001-8606-0327	Genome Canada, through the Ontario Genomics Institute [2004-OGI-3-05]; Ontario Research Fund, Research Excellence Program; University of Toronto McLaughlin Centre; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council; Cystic Fibrosis Canada (CFC); Natural Sciences and Engineering Research Council (NSERC) [F250053-2008]; Canadian Institutes of Health Research (CIHR) [MOP 84287, MOP 258916]; Lloyd Carr-Harris Foundation; US National Institutes of Health [R01 HL68927, K23 DK083551, R01 HL068890, R01 DK066368, R01 HL095396, HG-0004314]; US CFF [CUTTIN06P0, R025-CR07, KNOWLE00A0, RDP-R026-CR07, DRUMM0A00]; Flight Attendant Medical Research Institute [FAMRI2006]; Lawson Wilkins Pediatric Endocrine Society; INSERM; AP-HP; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche [R09186DS]; Direction Generale de la Sante; Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares; US CFF; CIHR; Ontario Women's Health Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927, R01HL095396, R01HL068890] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG004314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK083551, R01DK066368, P30DK027651] Funding Source: NIH RePORTER	Genome Canada, through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund, Research Excellence Program; University of Toronto McLaughlin Centre; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada (CFC); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lloyd Carr-Harris Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US CFF; Flight Attendant Medical Research Institute; Lawson Wilkins Pediatric Endocrine Society; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche(French National Research Agency (ANR)); Direction Generale de la Sante(General Electric); Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares; US CFF; CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank the study particpiants, the Cystic Fibrosis Foundation (CFF) Patient Registry, the University of North Carolina DNA Laboratory and the Genome Quebec and McGill University Innovation Centre. We thank I. Wong for technical help with the replication genotyping, the computer specialists from the French study J.-F. Vibert and M. Mahloul and clinical research assistants Michon, A. Blondel and P. Touche involved in the study design and subject recruitment of the French sample, E. Hawbaker and A. Dang for data coordination in the Gene Modifier Study, Y. Berthiaume, A. Sandford and P. Pare for ascertainment of Canadian phenotype data and DNA, J. Breaton, M. Christofi, N. Anderson, K. Keenan, C. Taylor and J. Avolio for coordinating and verifying the Canadian data collection, E. Crowdy for database development and management in Canada, S. Norris, A. Kohl, P. Miller, L. Charnin, W. Hannah and S. Adams for recruitment, phenotyping and data entry at the University of North Carolina, W. Wolf for DNA analysis and H. Kelkar, T. Randall and A. Xu for bioinformatics at the University of North Carolina, and N. Wang, K. Kaniecki, J. Bonner and C. Watson for technical assistance at Johns Hopkins University. This work was supported in part by Genome Canada, through the Ontario Genomics Institute per research agreement 2004-OGI-3-05 (to P. R. D.), with the Ontario Research Fund, Research Excellence Program; the University of Toronto McLaughlin Centre (to L. S.); the Ontario Ministry of Research and Innovation Early Researcher award and the Natural Sciences and Engineering Research Council (to L. J. S.); Cystic Fibrosis Canada (CFC; to P. R. D., J.Z. and L. J. S.); the Natural Sciences and Engineering Research Council (NSERC; F250053-2008 to L. S.); the Canadian Institutes of Health Research (CIHR; MOP 84287 to L. S. and MOP 258916 to L. J. S.); the Lloyd Carr-Harris Foundation; the US National Institutes of Health (R01 HL68927 (G. R. C.), K23 DK083551 (S. M. B.), R01 HL068890 (M. R. K.), R01 DK066368 (M. R. K.), R01 HL095396 (M. R. K.) and HG-0004314 (L. J. S.)); the US CFF (CUTTIN06P0, R025-CR07, KNOWLE00A0, RDP-R026-CR07 and DRUMM0A00); the Flight Attendant Medical Research Institute (FAMRI2006 to G. R. C.); the Lawson Wilkins Pediatric Endocrine Society Clinical Scholar Award (to S. M. B.); INSERM; AP-HP; Universite Pierre et Marie Curie Paris; Agence Nationale de la Recherche (R09186DS to H. C.), Direction Generale de la Sante; Association Vaincre la Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose; and Groupement d'Interet Scientifique (GIS)-Institut des Maladies Rares. Funds for genome-wide genotyping of North American participants were generously provided by the US CFF. R. D. received a Joint Fellowship from the CIHR and Ontario Women's Health Council.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Bradford EM, 2009, AM J PHYSIOL-GASTR L, V296, pG886, DOI 10.1152/ajpgi.90520.2008; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Dorfman R, 2011, PEDIATR PULM, V46, P385, DOI 10.1002/ppul.21372; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fraga S, 2002, J NUTR, V132, P733, DOI 10.1093/jn/132.4.733; Hodges CA, 2011, AM J PHYSIOL-GASTR L, V301, pG528, DOI 10.1152/ajpgi.00052.2011; Hoglund PJ, 2005, BIOCHEM BIOPH RES CO, V336, P175, DOI 10.1016/j.bbrc.2005.08.048; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Li W, 2011, CLIN GENET, V79, P136, DOI 10.1111/j.1399-0004.2010.01502.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedroso I., 2009, GENETICS COMPLEX HUM, P194; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Thomas Duncan C., 2009, Human Genomics, V4, P21; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Yoo YJ, 2010, GENET EPIDEMIOL, V34, P107, DOI 10.1002/gepi.20438; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	37	147	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					562	+		10.1038/ng.2221	http://dx.doi.org/10.1038/ng.2221			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22466613	Green Submitted, Green Accepted			2022-12-17	WOS:000303416300017
J	Szappanos, B; Kovacs, K; Szamecz, B; Honti, F; Costanzo, M; Baryshnikova, A; Gelius-Dietrich, G; Lercher, MJ; Jelasity, M; Myers, CL; Andrews, BJ; Boone, C; Oliver, SG; Pal, C; Papp, B				Szappanos, Balazs; Kovacs, Karoly; Szamecz, Bela; Honti, Frantisek; Costanzo, Michael; Baryshnikova, Anastasia; Gelius-Dietrich, Gabriel; Lercher, Martin J.; Jelasity, Mark; Myers, Chad L.; Andrews, Brenda J.; Boone, Charles; Oliver, Stephen G.; Pal, Csaba; Papp, Balazs			An integrated approach to characterize genetic interaction networks in yeast metabolism	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENOME; BIOLOGY; DELETION; LANDSCAPE; EPISTASIS; DATABASE; FITNESS; CELLS	Although experimental and theoretical efforts have been applied to globally map genetic interactions, we still do not understand how gene-gene interactions arise from the operation of biomolecular networks. To bridge the gap between empirical and computational studies, we i, quantitatively measured genetic interactions between similar to 185,000 metabolic gene pairs in Saccharomyces cerevisiae, ii, superposed the data on a detailed systems biology model of metabolism and iii, introduced a machine-learning method to reconcile empirical interaction data with model predictions. We systematically investigated the relative impacts of functional modularity and metabolic flux coupling on the distribution of negative and positive genetic interactions. We also provide a mechanistic explanation for the link between the degree of genetic interaction, pleiotropy and gene dispensability. Last, we show the feasibility of automated metabolic model refinement by correcting misannotations in NAD biosynthesis and confirming them by in vivo experiments.	[Szappanos, Balazs; Kovacs, Karoly; Szamecz, Bela; Honti, Frantisek; Pal, Csaba; Papp, Balazs] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Honti, Frantisek] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Costanzo, Michael; Baryshnikova, Anastasia; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Costanzo, Michael; Baryshnikova, Anastasia; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Dept Mol Genet, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Gelius-Dietrich, Gabriel; Lercher, Martin J.] Univ Dusseldorf, Dept Comp Sci, Dusseldorf, Germany; [Jelasity, Mark] Univ Szeged, Res Grp Artificial Intelligence, Szeged, Hungary; [Jelasity, Mark] HAS, Szeged, Hungary; [Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Oliver, Stephen G.; Papp, Balazs] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Papp, Balazs] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Bath; University of Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Szeged University; University of Minnesota System; University of Minnesota Twin Cities; University of Cambridge; University of Cambridge; University of Cambridge	Papp, B (corresponding author), Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	pappb@brc.hu	Lercher, Martin/K-7939-2013; Szappanos, Balázs/D-1937-2013; Oliver, Stephen/AAQ-5992-2021; jelasity, mark/F-3798-2011	Lercher, Martin/0000-0003-3940-1621; Oliver, Stephen/0000-0003-3410-6439; jelasity, mark/0000-0001-9363-1482; Papp, Balazs/0000-0003-3093-8852; Baryshnikova, Anastasia/0000-0002-0123-2052; Szappanos, Balazs/0000-0002-5075-1799	The International Human Frontier Science Program Organization; Hungarian Scientific Research Fund [OTKA PD 75261]; Hungarian Academy of Sciences; European Research Council [202591]; Wellcome Trust; FEBS; Biotechnology & Biological Sciences Research Council [BB/C505140/1]; European Commission [201142]; US National Institutes of Health [1R01HG005084-01A1, 1R01HG005853-01]; University of Minnesota; Canadian Institutes of Health Research [MOP-102629]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005084, R01HG005853] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C505140/2, BB/C505140/1] Funding Source: researchfish	The International Human Frontier Science Program Organization(Human Frontier Science Program); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); FEBS; Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from The International Human Frontier Science Program Organization, the Hungarian Scientific Research Fund (OTKA PD 75261) and the 'Lendulet Program' of the Hungarian Academy of Sciences (B.P.), European Research Council (202591), Wellcome Trust and Hungarian Scientific Research Fund (C.P.), FEBS Long-Term Fellowship (B. Szamecz), Biotechnology & Biological Sciences Research Council (Grant BB/C505140/1) and the UNICELLSYS Collaborative Project (No. 201142) of the European Commission (S.G.O.), the US National Institutes of Health (1R01HG005084-01A1) and a seed grant from the University of Minnesota Biomedical Informatics and Computational Biology program (C.L.M.), the Canadian Institutes of Health Research (MOP-102629) (C.B. and B.J.A.) and the US National Institutes of Health (1R01HG005853-01) (C.B., B.J.A. and C.L.M.).	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI [10.1038/nmeth.1534, 10.1038/NMETH.1534]; Bouwman J, 2011, YEAST, V28, P43, DOI 10.1002/yea.1819; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; FLACHMANN R, 1988, EUR J BIOCHEM, V175, P221, DOI 10.1111/j.1432-1033.1988.tb14187.x; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Notebaart RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040026; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Shlomi T, 2007, GENOME RES, V17, P1626, DOI 10.1101/gr.6678707; Snitkin ES, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r140; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Ulitsky I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r140; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101	51	147	159	2	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					656	U182		10.1038/ng.846	http://dx.doi.org/10.1038/ng.846			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21623372	Green Accepted			2022-12-17	WOS:000292184600009
J	Vassiliou, GS; Cooper, JL; Rad, R; Li, J; Rice, S; Uren, A; Rad, L; Ellis, P; Andrews, R; Banerjee, R; Grove, C; Wang, W; Liu, PT; Wright, P; Arends, M; Bradley, A				Vassiliou, George S.; Cooper, Jonathan L.; Rad, Roland; Li, Juan; Rice, Stephen; Uren, Anthony; Rad, Lena; Ellis, Peter; Andrews, Rob; Banerjee, Ruby; Grove, Carolyn; Wang, Wei; Liu, Pentao; Wright, Penny; Arends, Mark; Bradley, Allan			Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER GENE DISCOVERY; CYTOPLASMIC NUCLEOPHOSMIN; MUTAGENESIS; NPM1; MUTATIONS; TRANSFORMATION; ABNORMALITIES; BEARING; GROWTH	Acute myeloid leukemia (AML) is a molecularly diverse malignancy with a poor prognosis whose largest subgroup is characterized by somatic mutations in NPM1, which encodes nucleophosmin(1). These mutations, termed NPM1c, result in cytoplasmic dislocation of nucleophosmin1 and are associated with distinctive transcriptional signatures(2), yet their role in leukemogenesis remains obscure. Here we report that activation of a humanized Npm1c knock-in allele in mouse hemopoietic stem cells causes Hox gene overexpression, enhanced self renewal and expanded myelopoiesis. One third of mice developed delayed-onset AML, suggesting a requirement for cooperating mutations. We identified such mutations using a Sleeping Beauty(3,4) transposon, which caused rapid-onset AML in 80% of mice with Npm1c, associated with mutually exclusive integrations in Csf2, Flt3 or Rasgrp1 in 55 of 70 leukemias. We also identified recurrent integrations in known and newly discovered leukemia genes including Nf1, Bach2, Dleu2 and Nup98. Our results provide new pathogenetic insights and identify possible therapeutic targets in NPM1c+AML.	[Vassiliou, George S.; Cooper, Jonathan L.; Rad, Roland; Rice, Stephen; Rad, Lena; Ellis, Peter; Andrews, Rob; Banerjee, Ruby; Grove, Carolyn; Wang, Wei; Liu, Pentao; Bradley, Allan] Wellcome Trust Sanger Inst, Mouse Genom Team, Cambridge, England; [Li, Juan] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Uren, Anthony] Netherlands Canc Inst, Amsterdam, Netherlands; [Wright, Penny; Arends, Mark] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; Netherlands Cancer Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Vassiliou, GS (corresponding author), Wellcome Trust Sanger Inst, Mouse Genom Team, Wellcome Trust Genome Campus, Cambridge, England.	gsv20@sanger.ac.uk; abradley@sanger.ac.uk	Uren, Anthony G/A-5784-2009	Uren, Anthony G/0000-0002-6019-7111; Bradley, Allan/0000-0002-2349-8839; Vassiliou, George/0000-0003-4337-8022	Cancer Research UK; MRC [MC_UP_A652_1001] Funding Source: UKRI; Medical Research Council [MC_UP_A652_1001, 1116184] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the use of the Research Support Facility at the Wellcome Trust Sanger Institute, the Department of Pathology Tissue Bank and the Cambridge National Institute of Health Research (NIHR) Biomedical Research Centre, University of Cambridge. We thank F. Law and J. Gadiot for assistance in generating the Npm1<SUP>flox-CA</SUP> and Rosa<SUP>flox-SB</SUP> mice; F. Foyer and B. Graham for help with fluorescent microscopy; B. Ling, W. Cheng, R. Macintyre and P. Chan for help with flow cytometry; R. Bautista for help with gene expression images; C. Hale and A. Nyzhnyk for help with ELISAs; B. Huntly, D. Adams, J. Cadinanos, H. Prosser, N. Conte, K. Yusa and Q. Liang for helpful discussions during the project; and P. Campbell and A. Green for critical reading of the manuscript. This work was supported by a Clinician Scientist Fellowship from Cancer Research UK (G.S.V.).	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; DUHRSEN U, 1990, EMBO J, V9, P1087, DOI 10.1002/j.1460-2075.1990.tb08214.x; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2008, HAEMATOLOGICA, V93, P439, DOI 10.3324/haematol.12153; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; ROGERS SY, 1994, EXP HEMATOL, V22, P593; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Voisin W, 2006, J VIROL, V80, P4026, DOI 10.1128/JVI.80.8.4026-4037.2006; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YOUNG DC, 1986, BLOOD, V68, P1178	40	147	155	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					470	+		10.1038/ng.796	http://dx.doi.org/10.1038/ng.796			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21441929	Green Submitted, Green Accepted			2022-12-17	WOS:000289972600019
J	Franke, A; Balschun, T; Sina, C; Ellinghaus, D; Hasler, R; Mayr, G; Albrecht, M; Wittig, M; Buchert, E; Nikolaus, S; Gieger, C; Wichmann, HE; Sventoraityte, J; Kupcinskas, L; Onnie, CM; Gazouli, M; Anagnou, NP; Strachan, D; McArdle, WL; Mathew, CG; Rutgeerts, P; Vermeire, S; Vatn, MH; Krawczak, M; Rosenstiel, P; Karlsen, TH; Schreiber, S				Franke, Andre; Balschun, Tobias; Sina, Christian; Ellinghaus, David; Haesler, Robert; Mayr, Gabriele; Albrecht, Mario; Wittig, Michael; Buchert, Eva; Nikolaus, Susanna; Gieger, Christian; Wichmann, H. Erich; Sventoraityte, Jurgita; Kupcinskas, Limas; Onnie, Clive M.; Gazouli, Maria; Anagnou, Nicholas P.; Strachan, David; McArdle, Wendy L.; Mathew, Christopher G.; Rutgeerts, Paul; Vermeire, Severine; Vatn, Morten H.; Krawczak, Michael; Rosenstiel, Philip; Karlsen, Tom H.; Schreiber, Stefan		IBSEN Study Grp	Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY; BTNL2	We performed a genome-wide association analysis of 1,897,764 SNPs in 1,043 German ulcerative colitis (UC) cases and 1,703 controls. We discovered new associations at chromosome 7q22 (rs7809799) and at chromosome 22q13 in IL17REL (rs5771069) and confirmed these associations in six replication panels (2,539 UC cases and 5,428 controls) from different regions of Europe (overall study sample P(rs7809799) = 8.81 x 10(-11) and P(rs5771069) = 4.21 x 10(-8), respectively).	[Franke, Andre; Balschun, Tobias; Ellinghaus, David; Haesler, Robert; Wittig, Michael; Buchert, Eva; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, Kiel, Germany; [Sina, Christian; Nikolaus, Susanna] Univ Kiel, PopGen Biobank, Univ Hosp Schleswig Holstein, Kiel, Germany; [Sina, Christian; Nikolaus, Susanna; Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Univ Hosp Schleswig Holstein, Kiel, Germany; [Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Saarbrucken, Germany; [Gieger, Christian; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Sventoraityte, Jurgita; Kupcinskas, Limas] Kaunas Univ Med, Dept Gastroenterol, Kaunas, Lithuania; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Gazouli, Maria; Anagnou, Nicholas P.] Univ Athens, Sch Med, Dept Biol, GR-11527 Athens, Greece; [Strachan, David] St Georges Univ, Div Community Hlth Sci, London, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; [Rutgeerts, Paul; Vermeire, Severine] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Leuven, Belgium; [Vatn, Morten H.] Akershus Univ Hosp, Fac Med, Oslo, Norway; [Vatn, Morten H.; Karlsen, Tom H.] Univ Hosp, Rikshosp, Dept Med, Oslo, Norway; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Lithuanian University of Health Sciences; University of London; King's College London; Athens Medical School; National & Kapodistrian University of Athens; St Georges University London; University of Bristol; KU Leuven; University Hospital Leuven; University of Oslo; University of Oslo; National Hospital Norway; University of Kiel	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, Kiel, Germany.	a.franke@mucosa.de	Albrecht, Mario/B-6694-2008; Gazouli, Maria/I-2572-2018; Ellinghaus, David/G-4467-2012; Krawczak, Michael/A-8964-2010; Wichmann, Heinz Erich/AAA-5695-2022; Ellinghaus, David/ABC-3610-2020; Ellinghaus, Eva/E-6490-2012; Anagnou, Nicholas/GLR-3609-2022; Mathew, Christopher G/G-3434-2015; Rosenstiel, Philip/A-5137-2009; Sina, Christian/D-5348-2014; Balschun, Tobias/B-2356-2010; Häsler, Robert/A-4908-2009; Franke, Andre/B-2151-2010; Gazouli, Maria/W-6245-2019	Albrecht, Mario/0000-0002-3103-9624; Gazouli, Maria/0000-0002-3295-6811; Krawczak, Michael/0000-0003-2603-1502; Ellinghaus, David/0000-0002-4332-6110; Ellinghaus, Eva/0000-0003-2914-3382; Mathew, Christopher G/0000-0003-4178-1838; Rosenstiel, Philip/0000-0002-9692-8828; Häsler, Robert/0000-0003-4174-8229; Franke, Andre/0000-0003-1530-5811; Gazouli, Maria/0000-0002-3295-6811; Gieger, Christian/0000-0001-6986-9554; Vermeire, Severine/0000-0001-9942-3019	BMBF through the National Genome Research Network (NGFN); PopGen Biobank; Cooperative Research in the Region of Augsburg (KORA); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Sciences (MC Health); UK Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934, MC_qA137934] Funding Source: UKRI; Medical Research Council [MC_qA137934, G0000934] Funding Source: researchfish	BMBF through the National Genome Research Network (NGFN); PopGen Biobank; Cooperative Research in the Region of Augsburg (KORA); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; Munich Center of Health Sciences (MC Health); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all individuals with UC and CD studied here, their families and physicians for their cooperation. We acknowledge the cooperation of the German Crohn and Colitis Foundation (Deutsche Morbus Crohn und Colitis Vereingung e. V.), the German Ministry of Education and Research (BMBF) competence network "IBD" and the contributing gastroenterologists. We thank E. Melum and K. Holm for discussion and support; T. Wesse, T. Henke, C. Furstenau, S. Ehlers and R. Vogler for expert technical help; T. Wienker and M. Steffens (Institut fur Medizinische Biometrie, Informatik und Epidemiologie, University of Bonn) for performing the quality control of the GWAS datasets; B. A. Lie and the Norwegian Bone Marrow Donor Registry at Rikshospitalet University Hospital, Oslo, for contributing the healthy Norwegian control population; and the following individuals for their invaluable participation in the collection of the Baltic (Lithuanian and Latvian) patient panel: G. Kiudelis, L. Jonaitis, A. Zvirbliene, G. Denapiene, A. Irnius, J. Valantinas, V. Svalbonas, D. Krukas, G. Simulionis, Z. Sukys, M. Leja and A. Derovs. This study was supported by the BMBF through the National Genome Research Network (NGFN), the PopGen Biobank and the Cooperative Research in the Region of Augsburg (KORA) research platform. KORA was initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria and the Munich Center of Health Sciences (MC Health) as part of the LMUinnovativ initiative. The project received infrastructure support through the Deutsche Forschungsgemeinschaft clusters of excellence Multimodal Computing and Interaction, Future Ocean, and Inflammation and Interfaces. We acknowledge use of DNA from the 1958 British Birth Cohort collection (courtesy of R. Jones, S. Ring, W. McArdle and M. Pembrey), funded by the UK Medical Research Council (grant G0000934) and the Wellcome Trust (grant 068545/Z/02). C. G. M. and C.M.O. were supported by The Wellcome Trust and Core (UK).	Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hommes DW, 1996, CLIN EXP IMMUNOL, V106, P529, DOI 10.1046/j.1365-2249.1996.d01-863.x; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Pathan S, 2009, TISSUE ANTIGENS, V74, P322, DOI 10.1111/j.1399-0039.2009.01314.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406	15	147	150	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2010	42	4					292	294		10.1038/ng.553	http://dx.doi.org/10.1038/ng.553			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20228798				2022-12-17	WOS:000276150500007
J	Mu, JB; Myers, RA; Jiang, HY; Liu, SF; Ricklefs, S; Waisberg, M; Chotivanich, K; Wilairatana, P; Krudsood, S; White, NJ; Udomsangpetch, R; Cui, LW; Ho, M; Ou, FZ; Li, HB; Song, JP; Li, GQ; Wang, XH; Seila, S; Sokunthea, S; Socheat, D; Sturdevant, DE; Porcella, SF; Fairhurst, RM; Wellems, TE; Awadalla, P; Su, XZ				Mu, Jianbing; Myers, Rachel A.; Jiang, Hongying; Liu, Shengfa; Ricklefs, Stacy; Waisberg, Michael; Chotivanich, Kesinee; Wilairatana, Polrat; Krudsood, Srivicha; White, Nicholas J.; Udomsangpetch, Rachanee; Cui, Liwang; Ho, May; Ou, Fengzhen; Li, Haibo; Song, Jianping; Li, Guoqiao; Wang, Xinhua; Seila, Suon; Sokunthea, Sreng; Socheat, Duong; Sturdevant, Daniel E.; Porcella, Stephen F.; Fairhurst, Rick M.; Wellems, Thomas E.; Awadalla, Philip; Su, Xin-zhuan			Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; QUININE RESISTANCE; MALARIA; CHLOROQUINE; MUTATIONS; MEFLOQUINE; THAILAND; PROTEIN	Antimalarial drugs impose strong selective pressure on Plasmodium falciparum parasites and leave signatures of selection in the parasite genome(1,2); screening for genes under selection may suggest potential drug or immune targets(3). Genome-wide association studies (GWAS) of parasite traits have been hampered by the lack of high-throughput genotyping methods, inadequate knowledge of parasite population history and time-consuming adaptations of parasites to in vitro culture. Here we report the first Plasmodium GWAS, which included 189 culture-adapted P. falciparum parasites genotyped using a custom-built Affymetrix molecular inversion probe 3K malaria panel array with a coverage of similar to 1 SNP per 7 kb. Population structure, variation in recombination rate and loci under recent positive selection were detected. Parasite half-maximum inhibitory concentrations for seven antimalarial drugs were obtained and used in GWAS to identify genes associated with drug responses. This study provides valuable tools and insight into the P. falciparum genome.	[Mu, Jianbing; Jiang, Hongying; Liu, Shengfa; Fairhurst, Rick M.; Wellems, Thomas E.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Myers, Rachel A.; Awadalla, Philip] Univ Montreal, Dept Pediat, Fac Med, St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada; [Myers, Rachel A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Liu, Shengfa] Xiamen Univ, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Ricklefs, Stacy; Sturdevant, Daniel E.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Res Technol Branch,Rocky Mt Labs,NIH, Hamilton, MT USA; [Waisberg, Michael] NIAID, Immunogenet Lab, NIH, Bethesda, MD 20892 USA; [Chotivanich, Kesinee; Wilairatana, Polrat] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Krudsood, Srivicha] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [White, Nicholas J.] Mahidol Univ, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Ho, May] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Ou, Fengzhen; Li, Haibo; Song, Jianping; Li, Guoqiao] Res Ctr Qinghao, Guangzhou, Guangdong, Peoples R China; [Wang, Xinhua] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China; [Seila, Suon; Sokunthea, Sreng; Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of North Carolina; North Carolina State University; Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; Mahidol University; Mahidol University; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Calgary; Guangzhou University of Chinese Medicine; National Center Parasitology, Entomology & Malaria Control	Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmu@niaid.nih.gov; philip.awadalla@umontreal.ca; xsu@niaid.nih.gov	Awadalla, Philip/AAC-4896-2021; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Su, Xinzhuan/0000-0003-3246-3248	Division of Intramural Research, NIAID, NIH (USA); Canadian Institute of Health Research [11284, 200183]; US National Academies Keck Genome Initiative; Human Frontiers in Science Program [RGP54/2006]; Wellcome Trust; 973 National Basic Research Program of China [2007CB513103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI000483, ZIAAI000892, ZIAAI001066, ZICAI001052] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); US National Academies Keck Genome Initiative; Human Frontiers in Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); 973 National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, NIAID, NIH (USA), funds from the Canadian Institute of Health Research #11284 and #200183, the US National Academies Keck Genome Initiative, and the Human Frontiers in Science Program #RGP54/2006 for P. A. K. C. and N.J.W. are supported by the Wellcome Trust. S. L. was supported by the 973 National Basic Research Program of China, #2007CB513103. We also thank J. Sattabongkot for help in parasite shipping, J. Dunn and L. Zhang for assistance in parasite culture and NIAID intramural editor B. R. Marshall for assistance.	BASCO LK, 1993, AM J TROP MED HYG, V49, P301, DOI 10.4269/ajtmh.1993.49.301; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Escalante AA, 1998, GENETICS, V149, P189; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Liu SF, 2008, AM J TROP MED HYG, V79, P178, DOI 10.4269/ajtmh.2008.79.178; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zalis MG, 1998, AM J TROP MED HYG, V58, P630, DOI 10.4269/ajtmh.1998.58.630	31	147	152	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					268	U113		10.1038/ng.528	http://dx.doi.org/10.1038/ng.528			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101240	Green Accepted			2022-12-17	WOS:000274912400019
J	Shukla, V; Coumoul, X; Wang, RH; Kim, HS; Deng, CX				Shukla, Vivek; Coumoul, Xavier; Wang, Rui-Hong; Kim, Hyun-Seok; Deng, Chu-Xia			RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis	NATURE GENETICS			English	Article							MUTATIONS; FGFR2; ACTIVATION; EXPRESSION; RECEPTORS; PATHWAY; ROLES; CELLS; FGF-2	Premature fusion of one or more of the cranial sutures ( craniosynostosis) in humans causes over 100 skeletal diseases, which occur in 1 of approximate to 2,500 live births(1-3). Among them is Apert syndrome, one of the most severe forms of craniosynostosis, primarily caused by missense mutations leading to amino acid changes S252W or P253R in fibroblast growth factor receptor 2 ( FGFR2)(4-6). Here we show that a small hairpin RNA targeting the dominant mutant form of Fgfr2 ( Fgfr2(S252W)) completely prevents Apert- like syndrome in mice. Restoration of normal FGFR2 signaling is manifested by an alteration of the activity of extracellular signal- regulated kinases 1 and 2 ( ERK1/ 2), implicating the gene encoding ERK and the genes downstream of it in disease expressivity. Furthermore, treatment of the mutant mice with U0126, an inhibitor of mitogen- activated protein ( MAP) kinase kinase 1 and 2 ( MEK1/ 2) that blocks phosphorylation and activation of ERK1/ 2, significantly inhibits craniosynostosis. These results illustrate a pathogenic role for ERK activation in craniosynostosis resulting from FGFR2 with the S252W substitution and introduce a new concept of small- molecule inhibitor - mediated prevention and therapy for diseases caused by gain- of- function mutations in the human genome.	NIDDKD, US Natl Inst Hlth, Genet Dev & Dis Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deng, CX (corresponding author), NIDDKD, US Natl Inst Hlth, Genet Dev & Dis Branch, 10 Ctr Dr, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	COUMOUL, Xavier/AAR-3649-2020; deng, chuxia/N-6713-2016	COUMOUL, Xavier/0000-0003-2928-9648; 	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056004, Z01DK056004] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cabrita MA, 2003, THROMB HAEMOSTASIS, V90, P586, DOI 10.1160/TH03-04-0217; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Coumoul X, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh083; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Eswarakumar VP, 2006, P NATL ACAD SCI USA, V103, P18603, DOI 10.1073/pnas.0609157103; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Ibrahimi OA, 2005, PLAST RECONSTR SURG, V115, P264, DOI 10.1097/01.PRS.0000146703.08958.95; Katzen JT, 2000, OTOLARYNG CLIN N AM, V33, P1257, DOI 10.1016/S0030-6665(05)70280-2; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Ornitz DM, 2001, GENOME BIOL, V2; PARK WJ, 1995, AM J HUM GENET, V57, P321; Perlyn CA, 2006, NEUROSURGERY, V59, P210, DOI 10.1227/01.NEU.0000224323.53866.1E; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Renier D, 2000, CHILD NERV SYST, V16, P645, DOI 10.1007/s003810000320; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Spector JA, 2005, PLAST RECONSTR SURG, V115, P838, DOI 10.1097/01.PRS.0000153035.73507.7B; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	30	147	163	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1145	1150		10.1038/ng2096	http://dx.doi.org/10.1038/ng2096			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694057				2022-12-17	WOS:000249122400026
J	Williamson, CM; Turner, MD; Ball, ST; Nottingham, WT; Glenister, P; Fray, M; Tymowska-Lalanne, Z; Plagge, A; Powles-Glover, N; Kelsey, G; Maconochie, M; Peters, J				Williamson, CM; Turner, MD; Ball, ST; Nottingham, WT; Glenister, P; Fray, M; Tymowska-Lalanne, Z; Plagge, A; Powles-Glover, N; Kelsey, G; Maconochie, M; Peters, J			Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster	NATURE GENETICS			English	Article							XL-ALPHA-S; G-PROTEIN; ANTISENSE; NESP; SUBUNIT; MICE; MARK	Genomic imprinting results in allele-specific silencing according to parental origin(1). Silencing is brought about by imprinting control regions (ICRs) that are differentially marked in gametogenesis(2). The group of imprinted transcripts in the mouse Gnas cluster (Nesp, Nespas, Gnasxl, Exon1A and Gnas) provides a model for analyzing the mechanisms of imprint regulation. We previously identified an ICR that specifically regulates the tissue-specific imprinted expression of the Gnas gene(3). Here we identify a second ICR at the Gnas cluster. We show that a paternally derived targeted deletion of the germline differentially methylated region (DMR) associated with the antisense Nespas transcript unexpectedly affects both the expression of all transcripts in the cluster and methylation of two DMRs. Our results establish that the Nespas DMR is the principal ICR at the Gnas cluster and functions bidirectionally as a switch for modulating expression of the antagonistically acting genes Gnasxl and Gnas. Uniquely, the Nespas DMR acts on the downstream ICR at exon 1A to regulate tissue-specific imprinting of the Gnas gene.	MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England; Babraham Inst, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Peters, J (corresponding author), MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England.	j.peters@har.mrc.ac.uk	Williamson, Christine/GSE-3696-2022; Plagge, Antonius/AAH-3877-2019; Turner, Martin/N-9976-2014	Plagge, Antonius/0000-0001-6592-1343; Turner, Martin/0000-0002-3801-9896; Kelsey, Gavin/0000-0002-9762-5634	Medical Research Council [MC_UP_1502/1, MC_U142636336] Funding Source: Medline; MRC [MC_UP_1502/1, MC_U142636336] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Ischia R, 1997, J BIOL CHEM, V272, P11657; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; KEHLENBACH RH, 1994, NATURE, V372, P804; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Li T, 2000, GENOMICS, V69, P295, DOI 10.1006/geno.2000.6337; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Williamson CM, 2002, MAMM GENOME, V13, P74, DOI 10.1007/s00335-001-2102-2; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	30	147	162	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					350	355		10.1038/ng1731	http://dx.doi.org/10.1038/ng1731			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462745				2022-12-17	WOS:000235589600018
J	Yu, L; Liu, CH; Vandeusen, J; Becknell, B; Dai, ZY; Wu, YZ; Raval, A; Liu, TH; Ding, W; Mao, C; Liu, SJ; Smith, LT; Lee, S; Rassenti, L; Marcucci, G; Byrd, J; Caligiuri, MA; Plass, C				Yu, L; Liu, CH; Vandeusen, J; Becknell, B; Dai, ZY; Wu, YZ; Raval, A; Liu, TH; Ding, W; Mao, C; Liu, SJ; Smith, LT; Lee, S; Rassenti, L; Marcucci, G; Byrd, J; Caligiuri, MA; Plass, C			Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; EPIGENETIC ALTERATIONS; TRANSGENIC MICE; LIVER-TUMORS; CPG ISLANDS; SLIT2 GENE; EXPRESSION; CELLS; APOPTOSIS; PROTEINS	DNA methylation is associated with malignant transformation, but limitations imposed by genetic variability, tumor heterogeneity, availability of paired normal tissues and methodologies for global assessment of DNA methylation have limited progress in understanding the extent of epigenetic events in the initiation and progression of human cancer and in identifying genes that undergo methylation during cancer. We developed a mouse model of T/natural killer acute lymphoblastic leukemia that is always preceded by polyclonal lymphocyte expansion to determine how aberrant promoter DNA methylation and consequent gene silencing might be contributing to leukemic transformation. We used restriction landmark genomic scanning with this mouse model of preleukemia reproducibly progressing to leukemia to show that specific genomic methylation is associated with only the leukemic phase and is not random. We also identified Idb4 as a putative tumor-suppressor gene that is methylated in most mouse and human leukemias but in only a minority of other human cancers.	Ohio State Univ, Div Human Canc Genet, Tzagournis Med Res Facil 464A, Columbus, OH 43210 USA; Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA; Gen Hosp PLA 301, Dept Hematol, Beijing, Peoples R China; Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Canc Leukemia Grp B, Chicago, IL USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Plass, C (corresponding author), Ohio State Univ, Div Human Canc Genet, Tzagournis Med Res Facil 464A, 420 W 12th Ave, Columbus, OH 43210 USA.	plass-1@medctr.osu.edu	Reever, Larson/H-9685-2019; Plass, Christoph/H-7192-2014; Xiao, Yang/B-5668-2012	Reever, Larson/0000-0002-5692-4793; Yu, Li/0000-0001-6872-2665				Akama TO, 1997, CANCER RES, V57, P3294; Andres-Barquin PJ, 1999, EXP CELL RES, V247, P347, DOI 10.1006/excr.1998.4360; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Bellido M, 2003, HAEMATOLOGICA, V88, P994; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Costello JF, 2002, METHODS, V27, P144, DOI 10.1016/S1046-2023(02)00067-1; Dai ZY, 2002, GENOME RES, V12, P1591, DOI 10.1101/gr.197402; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Filmus J, 2001, GLYCOBIOLOGY, V11, p19R, DOI 10.1093/glycob/11.3.19R; FREUND RJ, 1997, STAT METHODS; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jen Y, 1996, DEV DYNAM, V207, P235; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kee Y, 2001, MECH DEVELOP, V109, P341, DOI 10.1016/S0925-4773(01)00576-7; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Paine-Saunders S, 1999, GENOMICS, V57, P455, DOI 10.1006/geno.1999.5793; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Rush LJ, 2001, BLOOD, V97, P3226, DOI 10.1182/blood.V97.10.3226; SHOJI W, 1994, J BIOL CHEM, V269, P5078; Smiraglia DJ, 1999, GENOMICS, V58, P254, DOI 10.1006/geno.1999.5840; Tateno M, 2001, CANCER RES, V61, P1144; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; WENDELHANSEN V, 1994, LEUKEMIA, V8, P476; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970; Zhu WG, 2001, CANCER RES, V61, P1327	45	147	188	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					265	274		10.1038/ng1521	http://dx.doi.org/10.1038/ng1521			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15723065				2022-12-17	WOS:000227297800017
J	Baxendale, S; Davison, C; Muxworthy, C; Wolff, C; Ingham, PW; Roy, S				Baxendale, S; Davison, C; Muxworthy, C; Wolff, C; Ingham, PW; Roy, S			The B-cell maturation factor Blimp-1 specifies vertebrate slow-twitch muscle fiber identity in response to Hedgehog signaling	NATURE GENETICS			English	Article							ZEBRAFISH EMBRYO; SOMITE FORMATION; SONIC HEDGEHOG; PLASMA-CELLS; EXPRESSION; REPRESSION; DIFFERENTIATION; PROTEIN; IDENTIFICATION; INDUCTION	Vertebrate skeletal muscles comprise distinct fiber types that differ in their morphology, contractile function, mitochondrial content and metabolic properties. Recent studies identified the transcriptional coactivator PGC-1 as a key mediator of the physiological stimuli that modulate fiber-type plasticity in postembryonic development(1). Although myoblasts become fated to differentiate into distinct kinds of fibers early in development, the identities of regulatory proteins that determine embryonic fiber-type specification are still obscure. Here we show that the gene u-boot (ubo), a mutation in which disrupts the induction of embryonic slow-twitch fibers(2), encodes the zebrafish homolog of Blimp-1, a SET domain containing transcription factor that promotes the terminal differentiation of B lymphocytes in mammals(3). Expression of ubo is induced by Hedgehog (Hh) signaling in prospective slow muscle precursors, and its activity alone is sufficient to direct slow-twitch fiber specific development by naive myoblasts. Our data provide the first molecular insight into the mechanism by which a specific group of muscle precursors is driven along a distinct pathway of fiber-type differentiation in response to positional cues in the vertebrate embryo.	Univ Sheffield, Sch Med & Biomed Sci, Ctr Dev Genet, MRC Intecellular Signaling Grp, Sheffield S10 2TN, S Yorkshire, England; Inst Mol & Cell Biol, Singapore 117609, Singapore	University of Sheffield; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ingham, PW (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Ctr Dev Genet, MRC Intecellular Signaling Grp, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.		Ingham, Philip W/G-9903-2011; Ingham, Philip William/AAH-5884-2020; Ingham, Philip W/E-6710-2010	Ingham, Philip W/0000-0001-8224-9958; Ingham, Philip William/0000-0001-8224-9958; Baxendale, Sarah/0000-0002-6760-9457	MRC [G0100151] Funding Source: UKRI; Medical Research Council [G0100151] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Borycki AG, 1998, DEVELOPMENT, V125, P777; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; de Souza FSJ, 1999, EMBO J, V18, P6062, DOI 10.1093/emboj/18.21.6062; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Talbot WS, 1999, METHOD CELL BIOL, V60, P259; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	29	147	150	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					88	93		10.1038/ng1280	http://dx.doi.org/10.1038/ng1280			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702044	Bronze			2022-12-17	WOS:000187666800019
J	Sellar, GC; Watt, KP; Rabiasz, GJ; Stronach, EA; Li, L; Miller, EP; Massie, CE; Miller, J; Contreras-Moreira, B; Scott, D; Brown, I; Williams, AR; Bates, PA; Smyth, JF; Gabra, H				Sellar, GC; Watt, KP; Rabiasz, GJ; Stronach, EA; Li, L; Miller, EP; Massie, CE; Miller, J; Contreras-Moreira, B; Scott, D; Brown, I; Williams, AR; Bates, PA; Smyth, JF; Gabra, H			OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer	NATURE GENETICS			English	Article							ADHESION MOLECULE OBCAM; CELL-ADHESION; HETEROPHILIC INTERACTIONS; NEURITE OUTGROWTH; RAT-BRAIN; EXPRESSION; HETEROZYGOSITY; PROTEIN; FAMILY; GENES	Epithelial ovarian cancer (EOC), the leading cause of death from gynecological malignancy, is a poorly understood disease. The typically advanced presentation of EOC with loco-regional dissemination in the peritoneal cavity and the rare incidence of visceral metastases are hallmarks of the disease. These features relate to the biology of the disease, which is a principal determinant of outcome(1,2). EOC arises as a result of genetic alterations sustained by the ovarian surface epithelium (OSE; ref. 3). The causes of these changes are unknown but are manifest by activation of oncogenes and inactivation of tumor-suppressor genes (TSGs). Our analysis of loss of heterozygosity at 11q25 identified OPCML (also called OBCAM), a member of the IgLON family of immunoglobulin (Ig) domain containing glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecules, as a candidate TSG in EOC. OPCML is frequently somatically inactivated in EOC by allele loss and by CpG island methylation. OPCML has functional characteristics consistent with TSG properties both in vitro and in vivo. A somatic missense mutation from an individual with EOC shows clear evidence of loss of function. These findings suggest that OPCML is an excellent candidate for the 11q25 ovarian cancer TSG. This is the first description to our knowledge of the involvement of the IgLON family in cancer.	Univ Edinburgh, Canc Res UK Edinburgh Oncol Unit, Ctr Canc Res, Edinburgh EH4 2XR, Midlothian, Scotland; Imperial Canc Res Fund, Biomol Modelling Lab, Canc Res UK London Res Inst, London WC2A 3PX, England; Univ Aberdeen, Dept Surg, Aberdeen AB25 2ZD, Scotland; Univ Edinburgh, Dept Pathol, Sch Med, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh; Cancer Research UK; University of Aberdeen; University of Edinburgh	Gabra, H (corresponding author), Univ Edinburgh, Canc Res UK Edinburgh Oncol Unit, Ctr Canc Res, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	grant.sellar@cancer.org.uk; hani.gabra@cancer.org.uk	Contreras-Moreira, Bruno/G-4334-2011; Williams, Alistair/A-3531-2008; Bates, Paul/A-1651-2011; Bates, Paul A/AAF-8561-2020	Bates, Paul A/0000-0003-0621-0925; Contreras Moreira, Bruno/0000-0002-5462-907X; Massie, Charlie/0000-0003-2314-4843; Scott, Derek Anthony/0000-0002-2029-6174; Gabra, Hani/0000-0002-3322-4399				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Axton RA, 1997, MOL CELL PROBE, V11, P287, DOI 10.1006/mcpr.1997.0117; Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Bates PA, 2001, PROTEINS, P39; Chi DS, 2001, GYNECOL ONCOL, V82, P532, DOI 10.1006/gyno.2001.6328; Davis M, 1996, CANCER RES, V56, P741; FOULKES WD, 1993, BRIT J CANCER, V67, P268, DOI 10.1038/bjc.1993.51; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Gabra H, 1996, CANCER RES, V56, P950; GABRA H, 1995, BRIT J CANCER, V72, P367, DOI 10.1038/bjc.1995.340; Gil OD, 1998, J NEUROSCI, V18, P9312; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Hachisuka A, 2000, DEV BRAIN RES, V122, P183, DOI 10.1016/S0165-3806(00)00072-9; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hoskins WJ, 1995, J CELL BIOCHEM, P189; Ji L, 2002, CANCER RES, V62, P2715; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Launonen V, 1998, GYNECOL ONCOL, V71, P299, DOI 10.1006/gyno.1998.5186; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Miyata S, 2000, J COMP NEUROL, V424, P74, DOI 10.1002/1096-9861(20000814)424:1<74::AID-CNE6>3.0.CO;2-5; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Sellar GC, 2001, CANCER RES, V61, P6977; SHARK KB, 1995, GENE, V155, P213, DOI 10.1016/0378-1119(94)00830-L; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson DJA, 1996, J CELL SCI, V109, P3129	30	147	161	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					337	343		10.1038/ng1183	http://dx.doi.org/10.1038/ng1183			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12819783				2022-12-17	WOS:000183815300024
J	Chapman, KL; Mortier, GR; Chapman, K; Loughlin, J; Grant, ME; Briggs, MD				Chapman, KL; Mortier, GR; Chapman, K; Loughlin, J; Grant, ME; Briggs, MD			Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia	NATURE GENETICS			English	Article							OLIGOMERIC MATRIX PROTEIN; IX COLLAGEN; PSEUDOACHONDROPLASIA; GENE; IDENTIFICATION; CHAIN; COMP; STATURE; COL9A2; FAMILY	Multiple epiphyseal dysplasia (MED) is a relatively mild and clinically variable osteochondrodysplasia, primarily characterized by delayed and irregular ossification of the epiphyses and early-onset osteoarthritis(1-3). Mutations in the genes encoding cartilage oligomeric matrix protein (COMP) and type IX collagen (COL9A2 and COL9A3) have previously been shown to cause different forms of MED (refs. 4-13). These dominant forms of MED (EDM1-3) are caused by mutations in the genes encoding structural proteins of the cartilage extracellular matrix (ECM); these proteins interact with high affinity in vitro(14,15). A recessive form of MED (EDM4) has also been reported; it is caused by a mutation in the diastrophic dysplasia sulfate transporter gene(16) (SLC26A). A genomewide screen of family with autosomal-dominant MED not linked to the EDM1-3 genes(17) provides significant genetic evidence for a MED locus on the short arm of chromosome 2 (2p24-p23), and a search for candidate genes identified MATN3 (ref. 18), encoding matrilin-3, within the critical region. Matrilin-3 is an oligomeric protein that is present in the cartilage ECM. We have identified two different missense mutations in the exon encoding the von Willebrand factor A (vWFA) domain of matrilin-3 in two unrelated families with MED (EDM5). These are the first mutations to be identified in any of the genes encoding the matrilin family of proteins and confirm a role for matrilin-3 in the development and homeostasis of cartilage and bone.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Univ Oxford, Inst Mol Med, Oxford, England	University of Manchester; Ghent University; Ghent University Hospital; University of Oxford	Briggs, MD (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	mike.briggs@man.ac.uk	Mortier, Geert/D-2542-2012	Mortier, Geert/0000-0001-9871-4578; Loughlin, John/0000-0003-2018-3361				Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Belluoccio D, 1998, GENOMICS, V53, P391, DOI 10.1006/geno.1998.5519; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; Briggs MD, 2000, METH MOL B, V139, P133; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; Delot E, 1998, J BIOL CHEM, V273, P26692, DOI 10.1074/jbc.273.41.26692; Haga N, 1998, J PEDIATR ORTHOPED, V18, P394, DOI 10.1097/00004694-199805000-00023; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Ikegawa S, 1998, HUM GENET, V103, P633, DOI 10.1007/s004390050883; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Loughlin J, 1998, HUM MUTAT, pS10; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; MORTIER GR, IN PRESS EUR J HUM G; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; Rimoin DL, 1998, AM J MED GENET, V79, P376; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; Spayde EC, 2000, MATRIX BIOL, V19, P121, DOI 10.1016/S0945-053X(00)00055-X; Superti-Furga A, 1999, J MED GENET, V36, P621; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TREBLE NJ, 1990, J BONE JOINT SURG BR, V72, P1061, DOI 10.1302/0301-620X.72B6.2246289; Unger SL, 2001, PEDIATR RADIOL, V31, P10, DOI 10.1007/s002470000362; Wagener R, 2000, MAMM GENOME, V11, P85, DOI 10.1007/s003350010018	28	147	150	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					393	396		10.1038/ng573	http://dx.doi.org/10.1038/ng573			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479597				2022-12-17	WOS:000170174800024
J	Pearce, DA; Ferea, T; Nosel, SA; Das, B; Sherman, F				Pearce, DA; Ferea, T; Nosel, SA; Das, B; Sherman, F			Action of BTN1, the yeast orthologue of the gene mutated in Batten disease	NATURE GENETICS			English	Article							MITOCHONDRIAL ATP SYNTHASE; NEURONAL CEROID-LIPOFUSCINOSIS; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; SUBUNIT-C; MEMBRANE; PROTEIN; EXPRESSION; STORAGE; MUTANTS	Neuronal ceroid-lipofuscinoses (NCL) are autosomal recessive disorders that form the most common group of progressive neurodegenerative diseases in children, with an incidence as high as 1 in 12,500 live births, and with approximately 440,000 carriers in the United States(1,2). Disease progression is characterized by a decline in mental abilities, increased severity of untreatable seizures, blindness, loss of motor skills and premature death. The CLN3 gene, which is responsible for Batten disease, has been positionally cloned(3). The yeast gene, denoted BTN1, encodes a non-essential protein that is 39% identical and 59% similar to human CLN3 (ref. 4). Strains lacking Btn1p, btn1-Delta, are resistant to D-(-)-threo-2-amino-1-[p-nitrophenyl]-1,3-propanediol (ANP) in a pH-dependent manner(5). This phenotype was complemented by expression of human CLN3, demonstrating that yeast Btn1p and human CLN3 share the same function(5). Here, we report that btn1-Delta yeast strains have an abnormally acidic vacuolar pH in the early phases of growth. Furthermore, DNA microarray analysis of BTN1 and btn1-Delta strains revealed differential expression of two genes, with at least one, HSP30, involved in pH control. Because Btn1p is located in the vacuole, we suggest that Batten disease is caused by a defect in vacuolar (lysosomal) pH control. Our findings draw parallels between fundamental biological processes in yeast and previously observed characteristics of neurodegeneration in humans.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Rochester; Stanford University	Pearce, DA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.		Das, Biswadip/AAN-6505-2021	Das, Biswadip/0000-0002-2839-2048	NCI NIH HHS [CA 36856] Funding Source: Medline; NINDS NIH HHS [R01 NS36610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANERJEE P, 1992, AM J MED GENET, V42, P549, DOI 10.1002/ajmg.1320420426; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Croopnick JB, 1998, BIOCHEM BIOPH RES CO, V250, P335, DOI 10.1006/bbrc.1998.9272; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; GOEBEL HH, 1995, J CHILD NEUROL, V10, P424, DOI 10.1177/088307389501000602; HALL NA, 1991, BIOCHEM J, V275, P269, DOI 10.1042/bj2750269; HALTIA M, 1973, J NEUROL SCI, V18, P269, DOI 10.1016/0022-510X(73)90076-2; HEMENWAY CS, 1995, GENETICS, V141, P833; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; KOENIG H, 1964, J NEUROPATH EXP NEUR, V23, P191; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MORANO KA, 1994, J CELL SCI, V107, P2813; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.0.CO;2-L; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pearce DA, 1998, P NATL ACAD SCI USA, V95, P6915, DOI 10.1073/pnas.95.12.6915; Pearce DA, 1997, YEAST, V13, P691, DOI 10.1002/(SICI)1097-0061(19970630)13:8<691::AID-YEA123>3.0.CO;2-D; Pearce DA, 1999, MOL GENET METAB, V66, P320, DOI 10.1006/mgme.1999.2819; Pearce DA, 1999, MOL GENET METAB, V66, P314, DOI 10.1006/mgme.1999.2820; Piper PW, 1997, CELL STRESS CHAPERON, V2, P12, DOI 10.1379/1466-1268(1997)002<0012:HTIPMH>2.3.CO;2; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; Sambrook J, 1989, MOL CLONING LAB MANU; SERRANO R, 1978, MOL CELL BIOCHEM, V22, P51; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	26	147	152	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					55	58		10.1038/8861	http://dx.doi.org/10.1038/8861			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319861				2022-12-17	WOS:000080096300022
J	Malter, HE; Iber, JC; Willemsen, R; deGraaff, E; Tarleton, JC; Leisti, J; Warren, ST; Oostra, BA				Malter, HE; Iber, JC; Willemsen, R; deGraaff, E; Tarleton, JC; Leisti, J; Warren, ST; Oostra, BA			Characterization of the full fragile X syndrome mutation in fetal gametes	NATURE GENETICS			English	Article							CAG REPEAT LENGTH; MENTAL-RETARDATION; DNA METHYLATION; TRINUCLEOTIDE REPEAT; CGG REPEAT; ABNORMAL METHYLATION; HUNTINGTONS-DISEASE; FMR-1 GENE; GERM-CELLS; INSTABILITY	Fragile X syndrome results from the expansion of the CGG repeat in the FMR1 gene. Expansion has been suggested to be a postzygotic event with the germline protected. From an analysis of intact ovaries of full mutation fetuses, we now show that only full expansion alleles can be detected in oocytes (but in the unmethylated state). Similarly, the testes of a 13-week full mutation fetus show no evidence of premutations while a 17-week full mutation fetus exhibits some germ cells with attributes of premutations. These data discount the hypothesis that the germline is protected from full expansion and suggest full mutation contraction in the immature testis. Thus, full expansion may already exist in the maternal oocyte, or postzygotic expansion, if it occurs, arises quite early in development prior to germline segregation.	EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,NL-3000 DR ROTTERDAM,NETHERLANDS; GREENWOOD GENET CTR,GREENWOOD,SC 29646; UNIV OULU,OULU,FINLAND	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Erasmus University Rotterdam; Greenwood Genetic Center; University of Oulu			de Graaff, Esther/D-3287-2011; Warren, Stephen T/A-2498-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521] Funding Source: NIH RePORTER; NICHD NIH HHS [R37HD20521] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASHLEY AE, 1995, AM J HUM GENET, V57, P1414; BACHNER D, 1993, NAT GENET, V4, P115, DOI 10.1038/ng0693-115; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BAKKER CE, 1994, CELL, V78, P23; BEAUMONT HM, 1963, J EMBRYOL EXP MORPH, V11, P715; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Byskov A. G., 1982, GERM CELLS FERTILIZA, P1; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DEGRAAFF E, 1995, AM J HUM GENET, V57, P609; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; FISCH GS, 1995, AM J HUM GENET, V56, P1147; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1995, NAT GENET, V6, P9; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAIRD CD, 1987, GENETICS, V117, P587; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LUO SY, 1993, SOMAT CELL MOLEC GEN, V19, P393, DOI 10.1007/BF01232750; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; MIGEON BR, 1991, SOMAT CELL MOLEC GEN, V17, P159, DOI 10.1007/BF01232973; MONK M, 1987, DEVELOPMENT, V99, P371; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1994, HUM MOL GENET, V3, P927, DOI 10.1093/hmg/3.6.927; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SNOW K, 1993, AM J HUM GENET, V53, P1217; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1995, ANNU REV NEUROSCI, V18, P77, DOI 10.1146/annurev.neuro.18.1.77; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140	42	147	149	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					165	169		10.1038/ng0297-165	http://dx.doi.org/10.1038/ng0297-165			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020841				2022-12-17	WOS:A1997WF08700015
J	JACOBSON, SG; CIDECIYAN, AV; REGUNATH, G; RODRIGUEZ, FJ; VANDENBURGH, K; SHEFFIELD, VC; STONE, EM				JACOBSON, SG; CIDECIYAN, AV; REGUNATH, G; RODRIGUEZ, FJ; VANDENBURGH, K; SHEFFIELD, VC; STONE, EM			NIGHT BLINDNESS IN SORSBYS-FUNDUS-DYSTROPHY REVERSED BY VITAMIN-A	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; RHODOPSIN LEVELS; A-DEFICIENCY; MACULAR DYSTROPHY; RETINAL FUNCTION; RECOVERY	Sorsby's fundus dystrophy (SFD) is an autosomal dominant retinal degeneration caused by mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) gene, Mechanisms of the visual loss in SFD, however, remain unknown. In a SFD family with a novel TIMP3 point mutation, we tested a hypothesis that their night blindness is due to a chronic deprivation of vitamin A at the level of the photoreceptors caused by a thickened membrane barrier between the photoreceptor layer and its blood supply. Vitamin A at 50,000 IU/d was administered orally. Within a week, the night blindness disappeared in patients at early stages of disease. Nutritional night blindness is thus part of the pathophysiology of this genetic disease and vitamin A supplementation can lead to dramatic restoration of photoreceptor function.	UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,DEPT OPHTHALMOL,MIAMI,FL 33136; UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242	Bascom Palmer Eye Institute; University of Miami; University of Iowa; University of Iowa			Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Stone, Edwin M./0000-0003-3343-4414; Jacobson, Samuel/0000-0003-2122-169X	NEI NIH HHS [EY05627, EY10539, EY10564] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010539, R01EY010564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CAPON MRC, 1988, EYE, V2, P114, DOI 10.1038/eye.1988.23; CAPON MRC, 1989, OPHTHALMOLOGY, V96, P1760; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; FRENCH J, 1971, MATH STATISTICS; GOURAS P, 1971, INVEST OPHTH VISUAL, V10, P784; HAMILTON WK, 1989, OPHTHALMOLOGY, V96, P1755; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2477; HOSKIN A, 1981, BRIT J OPHTHALMOL, V65, P859, DOI 10.1136/bjo.65.12.859; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; JACOBSON SG, 1994, INVEST OPHTH VIS SCI, V35, P2521; JACOBSON SG, 1991, HDB CLIN VISION TEST, P475; KATZ ML, 1993, EXP EYE RES, V56, P671, DOI 10.1006/exer.1993.1084; KEMP CM, 1994, INVEST OPHTH VIS SCI, V35, P3154; KEMP CM, 1988, EXP EYE RES, V46, P185, DOI 10.1016/S0014-4835(88)80076-9; KEMP CM, 1989, EXP EYE RES, V49, P49; NICHOLS BE, 1994, AM J HUM GENET, V54, P95; POLKINGHORNE PJ, 1989, OPHTHALMOLOGY, V96, P1763; PULIDO JS, 1990, EYE SYSTEMIC DISEASE, P344; SAARI JC, 1990, PROGR RETINAL RES, P368; SANDBERG MA, 1977, AM J OPHTHALMOL, V84, P658, DOI 10.1016/0002-9394(77)90381-6; SEARLE SR, 1992, VARIANCE COMPONENTS, P78; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; STEINMETZ RL, 1993, BRIT J OPHTHALMOL, V77, P549, DOI 10.1136/bjo.77.9.549; STEINMETZ RL, 1995, INVEST OPHTH VIS SCI, V33, P633; WALT RP, 1984, BRIT MED J, V288, P1030, DOI 10.1136/bmj.288.6423.1030; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WU G, 1991, AM J OPHTHALMOL, V111, P294, DOI 10.1016/S0002-9394(14)72312-8	30	147	156	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					27	32		10.1038/ng0995-27	http://dx.doi.org/10.1038/ng0995-27			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550309				2022-12-17	WOS:A1995RR72800011
J	SABOURI, LA; MAHADEVAN, MS; NARANG, M; LEE, DSC; SURH, LC; KORNELUK, RG				SABOURI, LA; MAHADEVAN, MS; NARANG, M; LEE, DSC; SURH, LC; KORNELUK, RG			EFFECT OF THE MYOTONIC-DYSTROPHY (DM) MUTATION ON MESSENGER-RNA LEVELS OF THE DM GENE	NATURE GENETICS			English	Article							FRAGILE-X SYNDROME; EXPRESSION; EXTRACTION; STABILITY; FRAGMENTS; ARREST; MUSCLE	Myotonic dystrophy (DM) results from the amplification of an unstable CTG repeat in the 3' untranslated region of a transcript encoding a putative serine/threonine kinase. We have analysed the amplification of the repeat and the steady state levels of the DM kinase (DMK) mRNA in tissues and cell lines from normal and congenital DM individuals. Southern blot analysis of DNA samples from a severely affected neonate shows somatic heterogeneity of the repeat in all tissues studied. RNA analyses on these tissues show a marked increase in DMK steady state mRNA levels. We demonstrate that the mutant DMK allele is expressed regardless of the number of CTG repeats and that the increase in DMK mRNA levels is due to elevated mutant mRNA levels. We postulate that elevated DMK levels explains the dominant inheritance pattern of DM.	UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA K1H 8M5,ONTARIO,CANADA; CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ON,CANADA; UNIV WESTERN ONTARIO,ST JOSEPHS HLTH CTR,LONDON NGA 6V2,ON,CANADA	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Western University (University of Western Ontario)								ANNEMIEKE J, 1991, CELL, V65, P905; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARCELONA JM, IN PRESS HUM MOL GEN; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; DRETZEN G, 1981, ANAL BIOCHEM, V112, P295, DOI 10.1016/0003-2697(81)90296-7; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GILILAND G, 1990, P NATL ACAD SCI USA, V87, P2725; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; KASPAR RL, 1992, J BIOL CHEM, V267, P508; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LI L, 1992, MOL CELL BIOL, V12, P4478, DOI 10.1128/MCB.12.10.4478; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN M, IN PRESS HUM MOL GEN; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SABOURIN LA, 1990, J CELL PHYSIOL, V145, P564, DOI 10.1002/jcp.1041450325; Sambrook J., 1989, MOL CLONING LAB MANU; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P466, DOI 10.1001/archneur.1976.00500070008002; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SOUSSIYANICOSTA.N, 1992, NEUROMUSCULAR DISORD, V1, P103; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.biochem.59.1.971; TSLIFIDIS C, 1992, NAT GENET, V1, P192; VANIER TM, 1960, BRIT MED J, V2, P1285; WISDOM R, 1990, J BIOL CHEM, V265, P19015; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133; 1993, CELL, V72, P971	48	147	149	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					233	238		10.1038/ng0793-233	http://dx.doi.org/10.1038/ng0793-233			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358430				2022-12-17	WOS:A1993LJ84200009
J	PARKINSON, DB; THAKKER, RV				PARKINSON, DB; THAKKER, RV			A DONOR SPLICE SITE MUTATION IN THE PARATHYROID-HORMONE GENE IS ASSOCIATED WITH AUTOSOMAL RECESSIVE HYPOPARATHYROIDISM	NATURE GENETICS			English	Article							FAMILIAL ISOLATED HYPOPARATHYROIDISM; MESSENGER-RNA; IDIOPATHIC HYPOPARATHYROIDISM; TRANSCRIPTION; SEQUENCE; DNA; INTRON	Investigation of one kindred with autosomal recessive isolated hypoparathyroidism, which had resulted from a consanguineous marriage, has identified a g to c substitution in the first nucleotide of intron 2 of the parathyroid hormone (PTH) gene. This donor splice mutation could be detected by restriction enzyme cleavage with Ddel, and this revealed that the patients were homozygous for the mutant alleles, the unaffected relatives were heterozygous, and unrelated normals were homozygous for the wild type alleles. Defects in messenger RNA splicing were investigated by the detection of illegitimate transcription of the PTH gene in lymphoblastoid cells. The mutation resulted in exon skipping with a loss of exon 2, which encodes the initiation codon and the signal peptide, thereby causing parathyroid hormone deficiency.	MRC,CLIN RES CTR,DIV MOLEC MED,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND	Medical Research Council Clinical Trials Unit				Thakker, Rajesh/0000-0002-1438-3220				AHN TG, 1986, MEDICINE, V65, P73, DOI 10.1097/00005792-198603000-00001; ARNOLD A, 1990, J CLIN INVEST, V86, P1084, DOI 10.1172/JCI114811; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARR DGD, 1971, HELV PAEDIATR ACTA, V26, P507; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; BRG LP, 1990, HUM GENET, V85, P655; BRONSKY D, 1968, J CLIN ENDOCR METAB, V28, P61, DOI 10.1210/jcem-28-1-61; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; EMR SD, 1980, J CELL BIOL, V86, P701, DOI 10.1083/jcb.86.3.701; KEUTMANN HT, 1978, BIOCHEMISTRY-US, V12, P5723; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LOVELLBADGE RH, 1987, TERATOCARCINOMAS EMB, P153; MCKUSICK VA, 1988, MENDELIAN INHERITANC; NAYLOR SL, 1983, SOMAT CELL GENET, V9, P609, DOI 10.1007/BF01574261; NICHOLLS AC, 1991, HUM GENET, V87, P193, DOI 10.1007/BF00204180; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; OHNO K, 1988, J BIOL CHEM, V263, P18563; ROELEN DL, 1989, EUR J CLIN INVEST, V19, P311, DOI 10.1111/j.1365-2362.1989.tb00235.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SCHMIDTKE J, 1984, HUM GENET, V67, P427; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; THAKKER RV, 1990, J CLIN INVEST, V86, P40, DOI 10.1172/JCI114712; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; VASICEK TJ, 1983, P NATL ACAD SCI-BIOL, V80, P2127, DOI 10.1073/pnas.80.8.2127; WHYTE MP, 1981, J PEDIATR-US, V99, P608, DOI 10.1016/S0022-3476(81)80272-7	28	147	150	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1992	1	2					149	152		10.1038/ng0592-149	http://dx.doi.org/10.1038/ng0592-149			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302009				2022-12-17	WOS:A1992JC98000015
J	Ishiura, H; Doi, K; Mitsui, J; Yoshimura, J; Matsukawa, MK; Fujiyama, A; Toyoshima, Y; Kakita, A; Takahashi, H; Suzuki, Y; Sugano, S; Qu, W; Ichikawa, K; Yurino, H; Higasa, K; Shibata, S; Mitsue, A; Tanaka, M; Ichikawa, Y; Takahashi, Y; Date, H; Matsukawa, T; Kanda, J; Nakamoto, FK; Higashihara, M; Abe, K; Koike, R; Sasagawa, M; Kuroha, Y; Hasegawa, N; Kanesawa, N; Kondo, T; Hitomi, T; Tada, M; Takano, H; Saito, Y; Sanpei, K; Onodera, O; Nishizawa, M; Nakamura, M; Yasuda, T; Sakiyama, Y; Otsuka, M; Ueki, A; Kaida, K; Shimizu, J; Hanajima, R; Hayashi, T; Terao, Y; Inomata-Terada, S; Hamada, M; Shirota, Y; Kubota, A; Ugawa, Y; Koh, K; Takiyama, Y; Ohsawa-Yoshida, N; Ishiura, S; Yamasaki, R; Tamaoka, A; Akiyama, H; Otsuki, T; Sano, A; Ikeda, A; Goto, J; Morishita, S; Tsuji, S				Ishiura, Hiroyuki; Doi, Koichiro; Mitsui, Jun; Yoshimura, Jun; Matsukawa, Miho Kawabe; Fujiyama, Asao; Toyoshima, Yasuko; Kakita, Akiyoshi; Takahashi, Hitoshi; Suzuki, Yutaka; Sugano, Sumio; Qu, Wei; Ichikawa, Kazuki; Yurino, Hideaki; Higasa, Koichiro; Shibata, Shota; Mitsue, Aki; Tanaka, Masaki; Ichikawa, Yaeko; Takahashi, Yuji; Date, Hidetoshi; Matsukawa, Takashi; Kanda, Junko; Nakamoto, Fumiko Kusunoki; Higashihara, Mana; Abe, Koji; Koike, Ryoko; Sasagawa, Mutsuo; Kuroha, Yasuko; Hasegawa, Naoya; Kanesawa, Norio; Kondo, Takayuki; Hitomi, Takefumi; Tada, Masayoshi; Takano, Hiroki; Saito, Yutaka; Sanpei, Kazuhiro; Onodera, Osamu; Nishizawa, Masatoyo; Nakamura, Masayuki; Yasuda, Takeshi; Sakiyama, Yoshio; Otsuka, Mieko; Ueki, Akira; Kaida, Ken-Ichi; Shimizu, Jun; Hanajima, Ritsuko; Hayashi, Toshihiro; Terao, Yasuo; Inomata-Terada, Satomi; Hamada, Masashi; Shirota, Yuichiro; Kubota, Akatsuki; Ugawa, Yoshikazu; Koh, Kishin; Takiyama, Yoshihisa; Ohsawa-Yoshida, Natsumi; Ishiura, Shoichi; Yamasaki, Ryo; Tamaoka, Akira; Akiyama, Hiroshi; Otsuki, Taisuke; Sano, Akira; Ikeda, Akio; Goto, Jun; Morishita, Shinichi; Tsuji, Shoji			Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy	NATURE GENETICS			English	Article							HEXANUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY; CLINICAL ANTICIPATION; CHLORIDE CHANNEL; TANDEM REPEATS; C9ORF72; TREMOR; GENE; RNA; HYPEREXCITABILITY	Epilepsy is a common neurological disorder, and mutations in genes encoding ion channels or neurotransmitter receptors are frequent causes of monogenic forms of epilepsy. Here we show that abnormal expansions of TTTCA and TTTTA repeats in intron 4 of SAMD12 cause benign adult familial myoclonic epilepsy (BAFME). Single-molecule, real-time sequencing of BAC clones and nanopore sequencing of genomic DNA identified two repeat configurations in SAMD12. Intriguingly, in two families with a clinical diagnosis of BAFME in which no repeat expansions in SAMD12 were observed, we identified similar expansions of TTTCA and TTTTA repeats in introns of TNRC6A and RAPGEF2, indicating that expansions of the same repeat motifs are involved in the pathogenesis of BAFME regardless of the genes in which the expanded repeats are located. This discovery that expansions of noncoding repeats lead to neuronal dysfunction responsible for myoclonic tremor and epilepsy extends the understanding of diseases with such repeat expansion.	[Ishiura, Hiroyuki; Mitsui, Jun; Matsukawa, Miho Kawabe; Shibata, Shota; Mitsue, Aki; Tanaka, Masaki; Date, Hidetoshi; Matsukawa, Takashi; Kanda, Junko; Nakamoto, Fumiko Kusunoki; Shimizu, Jun; Hayashi, Toshihiro; Inomata-Terada, Satomi; Hamada, Masashi; Shirota, Yuichiro; Kubota, Akatsuki; Tsuji, Shoji] Univ Tokyo Hosp, Dept Neurol, Tokyo, Japan; [Doi, Koichiro; Yoshimura, Jun; Suzuki, Yutaka; Qu, Wei; Ichikawa, Kazuki; Morishita, Shinichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan; [Fujiyama, Asao] Natl Inst Genet, Adv Genom Ctr, Shizuoka, Japan; [Toyoshima, Yasuko; Kakita, Akiyoshi; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo, Japan; [Yurino, Hideaki] Kanazawa Univ, Grad Sch Med Sci, Dept Lab Med, Kanazawa, Ishikawa, Japan; [Higasa, Koichiro] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Human Dis Genom, Kyoto, Japan; [Ichikawa, Yaeko] Kyorin Univ, Dept Neurol, Tokyo, Japan; [Takahashi, Yuji] Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan; [Higashihara, Mana] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo, Japan; [Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama, Japan; [Koike, Ryoko; Kuroha, Yasuko] Nishi Niigata Chuo Natl Hosp, Dept Neurol, Niigata, Japan; [Sasagawa, Mutsuo] Toyosato Hosp, Dept Psychiat, Ibaraki, Japan; [Hasegawa, Naoya] Nishi Niigata Chuo Natl Hosp, Dept Epilepsy, Niigata, Japan; [Kanesawa, Norio] Natl Hosp Org Takasaki, Gen Med Ctr, Div Cardiol, Gunma, Japan; [Kondo, Takayuki; Hitomi, Takefumi] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Hitomi, Takefumi] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Kyoto, Japan; [Tada, Masayoshi; Onodera, Osamu] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata, Japan; [Takano, Hiroki] Tachikawa Gen Hosp, Dept Neurol, Niigata, Japan; [Saito, Yutaka] Sannocho Hosp, Dept Neurol, Niigata, Japan; [Sanpei, Kazuhiro] Sado Gen Hosp, Dept Neurol, Niigata, Japan; [Nishizawa, Masatoyo] Niigata Med Ctr, Dept Neurol, Niigata, Japan; [Nakamura, Masayuki; Sano, Akira] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Kagoshima, Japan; [Yasuda, Takeshi] Kurashikikinen Hosp, Dept Neurol, Okayama, Japan; [Sakiyama, Yoshio] Jichi Med Univ, Saitama Med Ctr, Dept Neurol, Saitama, Japan; [Otsuka, Mieko] Int Univ Hlth & Welf, Dept Neurol, Otawara, Tochigi, Japan; [Kaida, Ken-Ichi] Natl Def Med Coll, Dept Internal Med 3, Saitama, Japan; [Hanajima, Ritsuko] Kitasato Univ, Sch Med, Dept Neurol, Tokyo, Kanagawa, Japan; [Terao, Yasuo] Kyorin Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan; [Ugawa, Yoshikazu] Fukushima Med Univ, Dept Neurol, Fukushima, Japan; [Koh, Kishin; Takiyama, Yoshihisa] Univ Yamanashi, Dept Neurol, Yamanashi, Japan; [Ohsawa-Yoshida, Natsumi; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Ishiura, Shoichi] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan; [Yamasaki, Ryo] Kyushu Univ, Grad Sch Med Sci, Fac Med, Dept Neurol,Neurol Inst, Fukuoka, Japan; [Tamaoka, Akira] Univ Tsukuba, Fac Med, Dept Neurol, Ibaraki, Japan; [Akiyama, Hiroshi] Hiratsuka Hosp, Hiratsuka, Kanagawa, Japan; [Otsuki, Taisuke] Epilepsy Hosp Bethel Japan, Tokyo, Miyagi, Japan; [Ikeda, Akio] Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Kyoto, Japan; [Goto, Jun] Int Univ Hlth & Welf, Mita Hosp, Dept Neurol, Tokyo, Japan; [Tsuji, Shoji] Tokyo Univ Hosp, Med Genome Ctr, Tokyo, Japan; [Tsuji, Shoji] Int Univ Hlth & Welf, Chiba, Japan	University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Niigata University; University of Tokyo; Kanazawa University; Kyoto University; Kyorin University; National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology; Okayama University; Kyoto University; Kyoto University; Niigata University; Tachikawa Hospital; Kagoshima University; Jichi Medical University; International University of Health & Welfare; National Defense Medical College - Japan; Kitasato University; Kyorin University; Fukushima Medical University; University of Yamanashi; University of Tokyo; Doshisha University; Kyushu University; University of Tsukuba; Kyoto University; International University of Health & Welfare; University of Tokyo; International University of Health & Welfare	Tsuji, S (corresponding author), Univ Tokyo Hosp, Dept Neurol, Tokyo, Japan.; Tsuji, S (corresponding author), Tokyo Univ Hosp, Med Genome Ctr, Tokyo, Japan.; Tsuji, S (corresponding author), Int Univ Hlth & Welf, Chiba, Japan.	tsuji@m.u-tokyo.ac.jp	Ugawa, Yoshikazu/AAM-2052-2020; Yamasaki, Ryo/AAQ-6245-2021; Hamada, Masashi/AAB-5563-2020; Hayashi, Toshihiro/A-6028-2008; Hamada, Masashi/GLT-1279-2022; Onodera, Osamu/K-7327-2013	Ugawa, Yoshikazu/0000-0002-8016-152X; Yamasaki, Ryo/0000-0003-2071-7861; Hayashi, Toshihiro/0000-0003-4362-7439; Hamada, Masashi/0000-0002-2866-8067; Onodera, Osamu/0000-0003-3354-5472; Morishita, Shinichi/0000-0002-6201-8885; Kubota, Akatsuki/0000-0001-5623-3602; Shibata, Shota/0000-0002-9131-5408; , Yuichiro/0000-0001-7205-0814; Sano, Akira/0000-0001-5843-9786; Yoshimura, Jun/0000-0003-2988-1123	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [22129001, 22129002]; Ministry of Health, Welfare and Labour, Japan [H23-Jitsuyoka (Nanbyo)-Ippan-004, H26-Jitsuyoka (Nanbyo)-Ippan-080]; Japan Agency for Medical Research and Development (AMED) [15ek0109065h0002, 16kk0205001h0001, 17kk0205001h0002, 17ek0109279h0001]; KAKENHI from the Japan Society for the Promotion of Science [17H05085]; Grants-in-Aid for Scientific Research [15H06161, 15H05871] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Welfare and Labour, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the patients and family members for participating in the study. We thank T. Sekiya (Department of Neurology, Sumitomo Hospital, Osaka, Japan), M. Kinoshita (Department of Neurology, Utano National Hospital, National Hospital Organization, Kyoto, Japan), M. Kanda (Department of Neurology, Ijinkai Takeda General Hospital, Kyoto, Japan), K. Hokkoku (Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan) and others for kindly collecting and providing clinical information, and K. Hirayama, Zhenghong Wu, M. Takeyama, K. Wakabayashi, N. Maruyama, T. Sugai, and Y. Tsukamoto for technical support. This work was supported in part by KAKENHI (Grants-in-Aid for Scientific Research on Innovative Areas 22129001 and 22129002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Grants-in-Aid (H23-Jitsuyoka (Nanbyo)-Ippan-004 and H26-Jitsuyoka (Nanbyo)-Ippan-080) from the Ministry of Health, Welfare and Labour, Japan, and grants (15ek0109065h0002, 16kk0205001h0001, 17kk0205001h0002 and 17ek0109279h0001) from the Japan Agency for Medical Research and Development (AMED) to S.T. This work was also supported by KAKENHI (Grant-in-Aid for Young Scientists 17H05085) from the Japan Society for the Promotion of Science for H.I.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Cen ZD, 2015, AM J MED GENET B, V168, P595, DOI 10.1002/ajmg.b.32337; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Depienne C, 2010, NEUROLOGY, V74, P2000, DOI 10.1212/WNL.0b013e3181e396a8; Doi K, 2014, BIOINFORMATICS, V30, P815, DOI 10.1093/bioinformatics/btt647; Fukuda Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-121; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Guerrini R, 2001, BRAIN, V124, P2459, DOI 10.1093/brain/124.12.2459; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Henden L, 2016, HUM GENET, V135, P1117, DOI 10.1007/s00439-016-1700-8; Hitomi T, 2013, EPILEPTIC DISORD, V15, P428, DOI 10.1684/epd.2013.0608; Hitomi T, 2012, EPILEPSIA, V53, pe33, DOI 10.1111/j.1528-1167.2011.03349.x; Hitomi T, 2011, MOVEMENT DISORD, V26, P1509, DOI 10.1002/mds.23653; IKEDA A, 1990, NEUROLOGY, V40, P1561, DOI 10.1212/WNL.40.10.1561; Inazuki G, 1990, Seishin Shinkeigaku Zasshi, V92, P1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurosaki T, 2009, MOL BIOL EVOL, V26, P2573, DOI 10.1093/molbev/msp172; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Mikami M, 1999, AM J HUM GENET, V65, P745, DOI 10.1086/302535; Miyake N, 2016, AM J HUM GENET, V99, P950, DOI 10.1016/j.ajhg.2016.08.005; Mori S, 2011, J HUM GENET, V56, P742, DOI 10.1038/jhg.2011.93; Plaster NM, 1999, NEUROLOGY, V53, P1180, DOI 10.1212/WNL.53.6.1180; Ptacek L. J., 1995, ADV NEUROL, V95, P281; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Suzuki T., 2002, NIIGATA IGAKKAI ZASS, V116, P535; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; YASUDA T, 1991, Kawasaki Medical Journal, V17, P1; Yeetong P, 2013, EUR J HUM GENET, V21, P225, DOI 10.1038/ejhg.2012.133; Yoshida K, 2014, NEUROPATHOLOGY, V34, P261, DOI 10.1111/neup.12090; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	45	146	149	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					581	+		10.1038/s41588-018-0067-2	http://dx.doi.org/10.1038/s41588-018-0067-2			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	29507423				2022-12-17	WOS:000429529300018
J	Shin, HY; Willi, M; Yoo, KH; Zeng, XK; Wang, CC; Metser, G; Hennighausen, L				Shin, Ha Youn; Willi, Michaela; Yoo, Kyung Hyun; Zeng, Xianke; Wang, Chaochen; Metser, Gil; Hennighausen, Lothar			Hierarchy within the mammary STAT5-driven Wap super-enhancer	NATURE GENETICS			English	Article							WHEY ACIDIC PROTEIN; DISTAL REGULATORY ELEMENTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SIGNAL TRANSDUCER; GLAND DEVELOPMENT; CELL IDENTITY; STAT5; PREGNANCY; PROMOTER	Super-enhancers comprise dense transcription factor platforms highly enriched for active chromatin marks. A paucity of functional data led us to investigate the role of super-enhancers in the mammary gland, an organ characterized by exceptional gene regulatory dynamics during pregnancy. ChIP-seq analysis for the master regulator STAT5A, the glucocorticoid receptor, H3K27ac and MED1 identified 440 mammary-specific super-enhancers, half of which were associated with genes activated during pregnancy. We interrogated the Wap super-enhancer, generating mice carrying mutations in STAT5-binding sites within its constituent enhancers. Individually, the most distal site displayed the greatest enhancer activity. However, combinatorial mutation analysis showed that the 1,000-fold induction in gene expression during pregnancy relied on all enhancers. Disabling the binding sites of STAT5, NFIB and ELF5 in the proximal enhancer incapacitated the entire super-enhancer. Altogether, these data suggest a temporal and functional enhancer hierarchy. The identification of mammary-specific super-enhancers and the mechanistic exploration of the Wap locus provide insights into the regulation of cell-type-specific expression of hormone-sensing genes.	[Shin, Ha Youn; Willi, Michaela; Yoo, Kyung Hyun; Zeng, Xianke; Wang, Chaochen; Metser, Gil; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Willi, Michaela] Med Univ Innsbruck, Div Bioinformat, Bioctr, Innsbruck, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Medical University of Innsbruck	Hennighausen, L (corresponding author), NIDDK, Lab Genet & Physiol, US Natl Inst Hlth, Bethesda, MD 20892 USA.	lotharh@mail.nih.gov	Shin, Ha Youn/B-1751-2017; Wang, Chaochen/AAE-6657-2022; Wang, Chaochen/AAO-2998-2021	Wang, Chaochen/0000-0003-2346-2884; Hennighausen, Lothar/0000-0001-8319-9841; Shin, Ha Youn/0000-0002-8553-2107; Willi, Michaela/0000-0002-2248-1998	IPR of the NIDDK/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK071001, ZIADK061000] Funding Source: NIH RePORTER	IPR of the NIDDK/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Smith from the NIDDK genomics core for never-ending help with next-generation sequencing and C. Liu from the NHLBI transgenic core for generating the CRISPR/Cas9-based mouse mutants. M.W. is a graduate student of the Individual Graduate Partnership Program (GPP) between NIH/NIDDK and the Medical University of Innsbruck. This work was performed in partial fulfillment of the graduation requirements for M.W. We thank K. Kang and S. Oh for discussions in the early stage of this project and Z. Trajanoski for advising M.W. during her graduate studies. This research was funded by the IPR of the NIDDK/NIH.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; BAYNA EM, 1990, NUCLEIC ACIDS RES, V18, P2977, DOI 10.1093/nar/18.10.2977; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; BURDON T, 1991, J BIOL CHEM, V266, P6909; BURDON TG, 1994, MOL ENDOCRINOL, V8, P1528, DOI 10.1210/me.8.11.1528; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fang Z, 2015, EUR J IMMUNOL, V45, P3150, DOI 10.1002/eji.201545713; Gonzalez AJ, 2015, NAT GENET, V47, P1249, DOI 10.1038/ng.3402; Gordon K, 1992, Biotechnology, V24, P425; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; GREENBERG NM, 1991, MOL ENDOCRINOL, V5, P1504, DOI 10.1210/mend-5-10-1504; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; HENNIGHAUSEN LG, 1982, EUR J BIOCHEM, V125, P131, DOI 10.1111/j.1432-1033.1982.tb06660.x; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Kang K, 2014, MOL CELL BIOL, V34, P464, DOI 10.1128/MCB.00988-13; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lefebvre V., NUCL ACIDS RES; Li P, 2014, IMMUNOL REV, V261, P141, DOI 10.1111/imr.12199; LI S, 1995, MOL CELL BIOL, V15, P2063; LI S, 1994, J BIOL CHEM, V269, P14235; LI S, 1994, MOL ENDOCRINOL, V8, P1328, DOI 10.1210/me.8.10.1328; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; MCKNIGHT RA, 1995, TRANSGENIC RES, V4, P39, DOI 10.1007/BF01976500; McKnight RA, 1996, MOL REPROD DEV, V44, P179, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;179::AID-MRD6&gt;3.0.CO;2-K; MCKNIGHT RA, 1995, MOL ENDOCRINOL, V9, P717, DOI 10.1210/me.9.6.717; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Ong CT, 2012, EMBO REP, V13, P423, DOI 10.1038/embor.2012.52; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904; Pinz S, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0063-y; PITTIUS CW, 1988, MOL ENDOCRINOL, V2, P1027, DOI 10.1210/mend-2-11-1027; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; RICHARDS DA, 1981, J BIOL CHEM, V256, P526; Robinson GW, 2014, MOL ENDOCRINOL, V28, P758, DOI 10.1210/me.2012-1387; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Thakurela S, 2015, GENOME RES, V25, P1309, DOI 10.1101/gr.190926.115; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Witte S, 2015, TRENDS IMMUNOL, V36, P519, DOI 10.1016/j.it.2015.07.005; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou HF, 2015, CELL HOST MICROBE, V17, P205, DOI 10.1016/j.chom.2014.12.013; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538	78	146	150	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					904	+		10.1038/ng.3606	http://dx.doi.org/10.1038/ng.3606			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27376239	Green Accepted			2022-12-17	WOS:000380755100014
J	Rockett, KA; Clarke, GM; Fitzpatrick, K; Hubbart, C; Jeffreys, AE; Rowlands, K; Craik, R; Jallow, M; Conway, DJ; Bojang, KA; Pinder, M; Usen, S; Sisay-Joof, F; Sirugo, G; Toure, O; Thera, MA; Konate, S; Sissoko, S; Niangaly, A; Poudiougou, B; Mangano, VD; Bougouma, EC; Sirima, SB; Modiano, D; Amenga-Etego, LN; Ghansah, A; Koram, KA; Wilson, MD; Enimil, A; Evans, J; Amodu, O; Olaniyan, S; Apinjoh, T; Mugri, R; Ndi, A; Ndila, CM; Uyoga, S; Macharia, A; Peshu, N; Williams, TN; Manjurano, A; Riley, E; Drakeley, C; Reyburn, H; Nyirongo, V; Kachala, D; Molyneux, M; Dunstan, SJ; Phu, NH; Quyen, NTN; Thai, CQ; Hien, TT; Manning, L; Laman, M; Siba, P; Karunajeewa, H; Allen, S; Allen, A; Davis, TME; Michon, P; Mueller, I; Green, A; Molloy, S; Johnson, KJ; Kerasidou, A; Cornelius, V; Hart, L; Vanderwal, A; SanJoaquin, M; Band, G; Le, SQ; Pirinen, M; Sepulveda, N; Spencer, CCA; Clark, TG; Agbenyega, T; Achidi, E; Doumbo, O; Farrar, J; Marsh, K; Taylor, T; Kwiatkowski, DP				Rockett, Kirk A.; Clarke, Geraldine M.; Fitzpatrick, Kathryn; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Craik, Rachel; Jallow, Muminatou; Conway, David J.; Bojang, Kalifa A.; Pinder, Margaret; Usen, Stanley; Sisay-Joof, Fatoumatta; Sirugo, Giorgio; Toure, Ousmane; Thera, Mahamadou A.; Konate, Salimata; Sissoko, Sibiry; Niangaly, Amadou; Poudiougou, Belco; Mangano, Valentina D.; Bougouma, Edith C.; Sirima, Sodiomon B.; Modiano, David; Amenga-Etego, Lucas N.; Ghansah, Anita; Koram, Kwadwo A.; Wilson, Michael D.; Enimil, Anthony; Evans, Jennifer; Amodu, Olukemi; Olaniyan, Subulade; Apinjoh, Tobias; Mugri, Regina; Ndi, Andre; Ndila, Carolyne M.; Uyoga, Sophie; Macharia, Alexander; Peshu, Norbert; Williams, Thomas N.; Manjurano, Alphaxard; Riley, Eleanor; Drakeley, Chris; Reyburn, Hugh; Nyirongo, Vysaul; Kachala, David; Molyneux, Malcolm; Dunstan, Sarah J.; Nguyen Hoan Phu; Nguyen Thi Ngoc Quyen; Cao Quang Thai; Tran Tinh Hien; Manning, Laurens; Laman, Moses; Siba, Peter; Karunajeewa, Harin; Allen, Steve; Allen, Angela; Davis, Timothy M. E.; Michon, Pascal; Mueller, Ivo; Green, Angie; Molloy, Sile; Johnson, Kimberly J.; Kerasidou, Angeliki; Cornelius, Victoria; Hart, Lee; Vanderwal, Aaron; SanJoaquin, Miguel; Band, Gavin; Le, Si Quang; Pirinen, Matti; Sepulveda, Nuno; Spencer, Chris C. A.; Clark, Taane G.; Agbenyega, Tsiri; Achidi, Eric; Doumbo, Ogobara; Farrar, Jeremy; Marsh, Kevin; Taylor, Terrie; Kwiatkowski, Dominic P.		Malaria Genomic Epidemiology Netwo	Reappraisal of known malaria resistance loci in a large multicenter study	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; PLASMODIUM-FALCIPARUM; G6PD DEFICIENCY; NATURAL-SELECTION; VIVAX; TRANSMISSION; PROTECTION; GENETICS; CHILDREN; VARIANT	Many human genetic associations with resistance to malaria have been reported, but few have been reliably replicated. We collected data on 11,890 cases of severe malaria due to Plasmodium falciparum and 17,441 controls from 12 locations in Africa, Asia and Oceania. We tested 55 SNPs in 27 loci previously reported to associate with severe malaria. There was evidence of association at P < 1 x 10(-4) with the HBB, ABO, ATP2B4, G6PD and CD40LG loci, but previously reported associations at 22 other loci did not replicate in the multicenter analysis. The large sample size made it possible to identify authentic genetic effects that are heterogeneous across populations or phenotypes, with a striking example being the main African form of G6PD deficiency, which reduced the risk of cerebral malaria but increased the risk of severe malarial anemia. The finding that G6PD deficiency has opposing effects on different fatal complications of P. falciparum infection indicates that the evolutionary origins of this common human genetic disorder are more complex than previously supposed.	[Rockett, Kirk A.; Clarke, Geraldine M.; Fitzpatrick, Kathryn; Hubbart, Christina; Jeffreys, Anna E.; Rowlands, Kate; Craik, Rachel; Green, Angie; Molloy, Sile; Johnson, Kimberly J.; Kerasidou, Angeliki; Cornelius, Victoria; Hart, Lee; Vanderwal, Aaron; SanJoaquin, Miguel; Band, Gavin; Le, Si Quang; Pirinen, Matti; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Rockett, Kirk A.; Clarke, Geraldine M.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Rockett, Kirk A.; Clarke, Geraldine M.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England; [Jallow, Muminatou; Conway, David J.; Bojang, Kalifa A.; Pinder, Margaret; Usen, Stanley; Sisay-Joof, Fatoumatta; Sirugo, Giorgio] MRC Unit, Serrekunda, Gambia; [Jallow, Muminatou] Royal Victoria Teaching Hosp, Banjul, Gambia; [Conway, David J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Toure, Ousmane; Thera, Mahamadou A.; Konate, Salimata; Sissoko, Sibiry; Niangaly, Amadou; Poudiougou, Belco; Doumbo, Ogobara] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali; [Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, Dipartimento Sanita Publ & Malattie Infett, I-00185 Rome, Italy; [Bougouma, Edith C.; Sirima, Sodiomon B.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Amenga-Etego, Lucas N.] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Ghansah, Anita; Koram, Kwadwo A.; Wilson, Michael D.] Noguchi Mem Inst Med Res, Accra, Ghana; [Enimil, Anthony; Agbenyega, Tsiri] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Evans, Jennifer] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Evans, Jennifer] Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Amodu, Olukemi; Olaniyan, Subulade] Univ Ibadan, Coll Med, Inst Child Hlth, Ibadan, Nigeria; [Apinjoh, Tobias] Univ Buea, Dept Biochem & Mol Biol, Buea, Cameroon; [Mugri, Regina; Ndi, Andre; Achidi, Eric] Univ Buea, Dept Med Lab Sci, Buea, Cameroon; [Ndila, Carolyne M.; Uyoga, Sophie; Macharia, Alexander; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Fac Med, London, England; [Manjurano, Alphaxard; Drakeley, Chris; Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Manjurano, Alphaxard; Riley, Eleanor; Drakeley, Chris; Reyburn, Hugh] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Nyirongo, Vysaul] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Kachala, David; Dunstan, Sarah J.; Nguyen Hoan Phu; Nguyen Thi Ngoc Quyen; Cao Quang Thai; Tran Tinh Hien; Farrar, Jeremy] Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Molyneux, Malcolm; Dunstan, Sarah J.; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Dunstan, Sarah J.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Nguyen Hoan Phu; Cao Quang Thai; Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Manning, Laurens; Laman, Moses; Siba, Peter; Michon, Pascal; Mueller, Ivo] Papua New Guinea Inst Med Res, Garoka, Papua N Guinea; [Manning, Laurens; Karunajeewa, Harin; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp Unit, Sch Med & Pharmacol, Fremantle, WA, Australia; [Allen, Steve] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Allen, Angela] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Michon, Pascal] Divine Word Univ, Fac Hlth Sci, Madang, Papua N Guinea; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Mueller, Ivo] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Kerasidou, Angeliki] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England; [Sepulveda, Nuno; Clark, Taane G.] London Sch Hyg & Trop Med, London WC1, England; [Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Taylor, Terrie] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Bamako; Sapienza University Rome; Navrongo Health Research Center; University of Ghana; Kwame Nkrumah University Science & Technology; Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; University of Ibadan; Imperial College London; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of Oxford; University of Melbourne; University of Oxford; PNG Institute Of Medical Research; University of Western Australia; Swansea University; University of Oxford; Walter & Eliza Hall Institute; ISGlobal; CRESIB; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Kwame Nkrumah University Science & Technology; University of Malawi	Rockett, KA (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	kirk.rockett@well.ox.ac.uk; dominic.kwiatkowski@well.ox.ac.uk	Ademola, Subulade Abigail/O-2452-2017; Sirugo, Giorgio/N-9056-2019; Clark, Taane G./AAM-2570-2020; Enimil, Anthony/AAV-2595-2021; Riley, Eleanor/AAL-1382-2020; Sirugo, Giorgio/L-1628-2016; Farrar, Jeremy J./HGA-7610-2022; Manning, Laurens A/H-5360-2014; Riley, Eleanor M/C-8960-2013; Dunstan, Sarah/AAO-9597-2020; Sepulveda, Nuno/AAA-5544-2021; Pinder, Margaret/AAQ-7129-2020; Le, Quang/A-4861-2012	Ademola, Subulade Abigail/0000-0002-9372-0183; Clark, Taane G./0000-0001-8985-9265; Riley, Eleanor/0000-0003-3447-3570; Manning, Laurens A/0000-0003-4334-5351; Riley, Eleanor M/0000-0003-3447-3570; Thera, Mahamadou A/0000-0002-2679-035X; Farrar, Jeremy/0000-0002-2700-623X; Apinjoh, Tobias/0000-0001-9889-7271; Mangano, Valentina D/0000-0002-2021-6162; Conway, David/0000-0002-8711-3037; Johnson, Kimberly J/0000-0002-6365-906X; Pirinen, Matti/0000-0002-1664-1350; Spencer, Christopher/0000-0002-8508-456X; Bojang, Kalifa/0000-0001-7506-0938; Laman, Moses/0000-0003-0964-805X; Molloy, Sile/0000-0001-8847-2325; Amodu, Olukemi/0000-0003-1477-4229; Hart, Lee/0000-0002-6473-0964; Kwiatkowski, Dominic/0000-0002-5023-0176; Allen, Stephen/0000-0001-6675-249X; Sepulveda, Nuno/0000-0002-8542-1706; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Davis, Timothy/0000-0003-0749-7411; Uyoga, Sophie/0000-0003-1746-7873; Dunstan, Sarah/0000-0001-7873-933X; Le, Quang/0000-0002-3715-210X	Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 090532/Z/09/Z, 098051/Z/05/Z, 076934/Z/05/Z, 091758/Z/10/Z]; Bill and Melinda Gates Foundation through The Foundation for the National Institutes of Health (FNIH, USA), Grand Challenges in Global Health Initiative [566]; Interagency Committee on Disability Research (ICDR) grant from the National Institute of Allergy and Infectious Diseases/US National Institutes of Health (NIAID/NIH); University of Bamako (USTTB); Mali-NIAID/NIH International Centers for Excellence in Research (ICER) at USTTB; BioMalPar European Network of Excellence [LSHP-CT-2004-503578]; European Community's Seventh Framework Programme [242095-EVIMalaR]; Central African Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM); European and Developing Countries Clinical Trials Partnership (EDCTP); Fogarty Foundation Scholarship; NHMRC; FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; MRC [MC_UP_A900_1118, G0600230, G19/9, G0600718] Funding Source: UKRI; Medical Research Council [G19/9, G0600718, G0600230] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation through The Foundation for the National Institutes of Health (FNIH, USA), Grand Challenges in Global Health Initiative; Interagency Committee on Disability Research (ICDR) grant from the National Institute of Allergy and Infectious Diseases/US National Institutes of Health (NIAID/NIH); University of Bamako (USTTB); Mali-NIAID/NIH International Centers for Excellence in Research (ICER) at USTTB; BioMalPar European Network of Excellence; European Community's Seventh Framework Programme(European Commission); Central African Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM); European and Developing Countries Clinical Trials Partnership (EDCTP); Fogarty Foundation Scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and the Bill and Melinda Gates Foundation through The Foundation for the National Institutes of Health (FNIH, USA) (566) as part of the Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported-by the UK Medical Research Council (G0600718 and G0600230) and by the Wellcome Trust Biomedical Ethics Enhancement Award (087285) and Strategic Award (096527). D.P.K. receives support from the UK Medical Research Council (G19/9). C.C.A.S. was supported by a Wellcome Trust Career Development Fellowship (097364/Z/11/Z). The Wellcome Trust also provides core awards to the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and the Wellcome Trust Sanger Institute (098051/Z/05/Z). The Malaria Research and Training Center-Bandiagara Malaria Project (MRTC-BMP) in Mali group is supported by an Interagency Committee on Disability Research (ICDR) grant from the National Institute of Allergy and Infectious Diseases/US National Institutes of Health (NIAID/NIH) to the University of Maryland and the University of Bamako (USTTB) and by the Mali-NIAID/NIH International Centers for Excellence in Research (ICER) at USTTB. Contributions from Nigeria to CP1 were supported financially by a grant within the BioMalPar European Network of Excellence (LSHP-CT-2004-503578). E.A. received partial funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095-EVIMalaR and the Central African Network for Tuberculosis, HIV/AIDS and Malaria (CANTAM) funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). T.N.W. is funded by Senior Fellowship awards from the Wellcome Trust (076934/Z/05/Z and 091758/Z/10/Z) and through the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095-EVIMalaR. The Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme is funded through core support from the Wellcome Trust. This paper is published with the permission of the director of KEMRI. C.M.N. is supported through a strategic award to the KEMRI-Wellcome Trust Programme from the Wellcome Trust (084538). The Joint Malaria Programme, Kilimanjaro Christian Medical Centre in Tanzania received funding from a UK MRC grant (G9901439). We would like to thank all the Vietnamese individuals who agreed to provide samples for this study. We acknowledge the work of the clinical staff from the Hospital of Tropical Diseases, HCMC and Phuoc Long and Dong Xoai District Hospitals in Binh Phuoc province, Vietnam, who initially diagnosed and studied the individuals with severe malaria. We would like to thank N.T. Hieu and his staff from Hung Vuong Obstetric Hospital for the collection of the cord blood controls. The clinical component of this study was funded through the Wellcome Trust Major Overseas Program in Vietnam (089276/Z/09/Z). L.M. was supported through Basser (Royal Australasian College of Physicians) and National Health and Medical Research Council (NHMRC) scholarships. M.L. was supported through a Fogarty Foundation Scholarship. T.M.E.D. was supported through an NHMRC practitioner fellowship.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; Atkinson SH, 2014, BLOOD, V123, P2008, DOI 10.1182/blood-2013-10-533489; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BIENZLE U, 1972, LANCET, V1, P107; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Chokshi DA, 2007, PLOS MED, V4, P636, DOI 10.1371/journal.pmed.0040095; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Jallow M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045645; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Liu WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4346; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Luzzatto L, 2012, HEREDITY, V108, P456, DOI 10.1038/hdy.2011.90; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Ogasawara K, 1996, BLOOD, V88, P2732, DOI 10.1182/blood.V88.7.2732.bloodjournal8872732; Parker M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000143; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; STEINBERG MH, 1978, BRIT J HAEMATOL, V40, P533, DOI 10.1111/j.1365-2141.1978.tb05829.x; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; Weatherall DJ, 2002, PEDIATR CLIN N AM, V49, P1149, DOI 10.1016/S0031-3955(02)00087-1; WHO, 2010, GUID TREATM MAL, V2nd; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	49	146	146	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1197	1204		10.1038/ng.3107	http://dx.doi.org/10.1038/ng.3107			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25261933	Green Accepted, Bronze			2022-12-17	WOS:000344131900010
J	Worley, KC; Warren, WC; Rogers, J; Locke, D; Muzny, DM; Mardis, ER; Weinstock, GM; Tardif, SD; Aagaard, KM; Archidiacono, N; Rayan, NA; Batzer, MA; Beal, K; Brejova, B; Capozzi, O; Capuano, SB; Casola, C; Chandrabose, MM; Cree, A; Dao, MD; de Jong, PJ; del Rosario, RCH; Delehaunty, KD; Dinh, HH; Eichler, EE; Fitzgerald, S; Flicek, P; Fontenot, CC; Fowler, RG; Fronick, C; Fulton, LA; Fulton, RS; Gabisi, RA; Gerlach, D; Graves, TA; Gunaratne, PH; Hahn, MW; Haig, D; Han, Y; Harris, RA; Herrero, J; Hillier, LW; Hubley, R; Hughes, JF; Hume, J; Jhangiani, SN; Jorde, LB; Joshi, V; Karakor, E; Konkel, MK; Kosiol, C; Kovar, CL; Kriventseva, EV; Lee, SL; Lewis, LR; Liu, YS; Lopez, J; Lopez-Otin, C; Lorente-Galdos, B; Mansfield, KG; Marques-Bonet, T; Minx, P; Misceo, D; Moncrieff, JS; Morgan, MB; Nazareth, LV; Newsham, I; Nguyen, NB; Okwuonu, G; Prabhakar, S; Perales, L; Pu, LL; Puente, XS; Quesada, V; Ranck, MC; Raney, BJ; Raveendran, M; Deiros, DR; Rocchi, M; Rodriguez, D; Ross, C; Ruffier, M; Ruiz, SJ; Sajjadian, S; Santibanez, J; Schrider, DR; Searle, S; Skaletsky, H; Soibam, B; Smit, AFA; Tennakoon, JB; Tomaska, L; Ullmer, B; Vejnar, CE; Ventura, M; Vilella, AJ; Vinar, T; Vogel, JH; Walker, JA; Wang, Q; Warner, CM; Wildman, DE; Witherspoon, DJ; Wright, RA; Wu, YQ; Xiao, WM; Xing, JC; Zdobnov, EM; Zhu, BL; Gibbs, RA; Wilson, RK				Worley, Kim C.; Warren, Wesley C.; Rogers, Jeffrey; Locke, Devin; Muzny, Donna M.; Mardis, Elaine R.; Weinstock, George M.; Tardif, Suzette D.; Aagaard, Kjersti M.; Archidiacono, Nicoletta; Rayan, Nirmala Arul; Batzer, Mark A.; Beal, Kathryn; Brejova, Brona; Capozzi, Oronzo; Capuano, Saverio B.; Casola, Claudio; Chandrabose, Mimi M.; Cree, Andrew; Dao, Marvin Diep; de Jong, Pieter J.; del Rosario, Ricardo Cruz-Herrera; Delehaunty, Kim D.; Dinh, Huyen H.; Eichler, Evan E.; Fitzgerald, Stephen; Flicek, Paul; Fontenot, Catherine C.; Fowler, R. Gerald; Fronick, Catrina; Fulton, Lucinda A.; Fulton, Robert S.; Gabisi, Ramatu Ayiesha; Gerlach, Daniel; Graves, Tina A.; Gunaratne, Preethi H.; Hahn, Matthew W.; Haig, David; Han, Yi; Harris, R. Alan; Herrero, Javier; Hillier, LaDeana W.; Hubley, Robert; Hughes, Jennifer F.; Hume, Jennifer; Jhangiani, Shalini N.; Jorde, Lynn B.; Joshi, Vandita; Karakor, Emre; Konkel, Miriam K.; Kosiol, Carolin; Kovar, Christie L.; Kriventseva, Evgenia V.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yih-shin; Lopez, John; Lopez-Otin, Carlos; Lorente-Galdos, Belen; Mansfield, Keith G.; Marques-Bonet, Tomas; Minx, Patrick; Misceo, Doriana; Moncrieff, J. Scott; Morgan, Margaret B.; Nazareth, Lynne V.; Newsham, Irene; Ngoc Bich Nguyen; Okwuonu, Geoffrey; Prabhakar, Shyam; Perales, Lora; Pu, Ling-Ling; Puente, Xose S.; Quesada, Victor; Ranck, Megan C.; Raney, Brian J.; Raveendran, Muthuswamy; Deiros, David Rio; Rocchi, Mariano; Rodriguez, David; Ross, Corinna; Ruffier, Magali; Ruiz, San Juana; Sajjadian, Saba; Santibanez, Jireh; Schrider, Daniel R.; Searle, Steve; Skaletsky, Helen; Soibam, Benjamin; Smit, Arian F. A.; Tennakoon, Jayantha B.; Tomaska, Lubomir; Ullmer, Brygg; Vejnar, Charles E.; Ventura, Mario; Vilella, Albert J.; Vinar, Tomas; Vogel, Jan-Hinnerk; Walker, Jerilyn A.; Wang, Qing; Warner, Crystal M.; Wildman, Derek E.; Witherspoon, David J.; Wright, Rita A.; Wu, Yuanqing; Xiao, Weimin; Xing, Jinchuan; Zdobnov, Evgeny M.; Zhu, Baoli; Gibbs, Richard A.; Wilson, Richard K.		Marmoset Genome Sequencing Anal Co	The common marmoset genome provides insight into primate biology and evolution	NATURE GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; INCREASED OVULATION RATE; SEGMENTAL DUPLICATIONS; GENE; GROWTH; MUTATIONS; VARIANTS; VERTEBRATES; CHIMPANZEE; CHIMERISM	We report the whole-genome sequence of the common marmoset (Callithrix jacchus). The 2.26-Gb genome of a female marmoset was assembled using Sanger read data (6x) and a whole-genome shotgun strategy. A first analysis has permitted comparison with the genomes of apes and Old World monkeys and the identification of specific features that might contribute to the unique biology of this diminutive primate, including genetic changes that may influence body size, frequent twinning and chimerism. We observed positive selection in growth hormone/insulin-like growth factor genes (growth pathways), respiratory complex I genes (metabolic pathways), and genes encoding immunobiological factors and proteases (reproductive and immunity pathways). In addition, both protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution. This genome sequence for a New World monkey enables increased power for comparative analyses among available primate genomes and facilitates biomedical research application.	[Worley, Kim C.; Rogers, Jeffrey; Muzny, Donna M.; Weinstock, George M.; Chandrabose, Mimi M.; Cree, Andrew; Dao, Marvin Diep; Dinh, Huyen H.; Fowler, R. Gerald; Gabisi, Ramatu Ayiesha; Gunaratne, Preethi H.; Han, Yi; Harris, R. Alan; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yih-shin; Lopez, John; Morgan, Margaret B.; Nazareth, Lynne V.; Newsham, Irene; Ngoc Bich Nguyen; Okwuonu, Geoffrey; Perales, Lora; Pu, Ling-Ling; Raveendran, Muthuswamy; Deiros, David Rio; Ruiz, San Juana; Santibanez, Jireh; Warner, Crystal M.; Wright, Rita A.; Wu, Yuanqing; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Worley, Kim C.; Rogers, Jeffrey; Muzny, Donna M.; Weinstock, George M.; Chandrabose, Mimi M.; Cree, Andrew; Dao, Marvin Diep; Dinh, Huyen H.; Fowler, R. Gerald; Gabisi, Ramatu Ayiesha; Gunaratne, Preethi H.; Han, Yi; Harris, R. Alan; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Liu, Yih-shin; Lopez, John; Morgan, Margaret B.; Nazareth, Lynne V.; Newsham, Irene; Ngoc Bich Nguyen; Okwuonu, Geoffrey; Perales, Lora; Pu, Ling-Ling; Raveendran, Muthuswamy; Deiros, David Rio; Ruiz, San Juana; Santibanez, Jireh; Warner, Crystal M.; Wright, Rita A.; Wu, Yuanqing; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Warren, Wesley C.; Locke, Devin; Mardis, Elaine R.; Weinstock, George M.; Delehaunty, Kim D.; Fronick, Catrina; Fulton, Lucinda A.; Fulton, Robert S.; Graves, Tina A.; Hillier, LaDeana W.; Minx, Patrick; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Tardif, Suzette D.; Ross, Corinna] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Aagaard, Kjersti M.; Harris, R. Alan] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Archidiacono, Nicoletta; Capozzi, Oronzo; Misceo, Doriana; Rocchi, Mariano] Univ Bari, Dept Biol, Bari, Italy; [Rayan, Nirmala Arul; del Rosario, Ricardo Cruz-Herrera; Prabhakar, Shyam] Genome Inst Singapore, Singapore, Singapore; [Batzer, Mark A.; Fontenot, Catherine C.; Ranck, Megan C.; Walker, Jerilyn A.; Wang, Qing] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Beal, Kathryn; Fitzgerald, Stephen; Flicek, Paul; Herrero, Javier; Ruffier, Magali; Vilella, Albert J.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, Cambs, England; [Brejova, Brona; Vinar, Tomas] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia; [Capuano, Saverio B.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Casola, Claudio; Hahn, Matthew W.; Schrider, Daniel R.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Casola, Claudio; Hahn, Matthew W.; Schrider, Daniel R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [de Jong, Pieter J.; Misceo, Doriana; Zhu, Baoli] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Eichler, Evan E.; Karakor, Emre; Sajjadian, Saba; Ventura, Mario] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Flicek, Paul; Kriventseva, Evgenia V.; Ruffier, Magali; Searle, Steve; Vogel, Jan-Hinnerk] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Gerlach, Daniel; Moncrieff, J. Scott; Vejnar, Charles E.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gunaratne, Preethi H.; Konkel, Miriam K.; Soibam, Benjamin; Tennakoon, Jayantha B.; Xiao, Weimin] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hubley, Robert; Smit, Arian F. A.] Inst Syst Biol, Seattle, WA USA; [Hughes, Jennifer F.; Skaletsky, Helen] Whitehead Inst, Cambridge, MA 02142 USA; [Jorde, Lynn B.; Witherspoon, David J.; Xing, Jinchuan] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Kosiol, Carolin] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria; [Lopez-Otin, Carlos; Puente, Xose S.; Quesada, Victor; Rodriguez, David] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, Oviedo, Spain; [Lorente-Galdos, Belen] Spanish Natl Bioinformat Inst INB, Barcelona, Spain; [Lorente-Galdos, Belen; Marques-Bonet, Tomas] Univ Pompeu Fabra, Inst Biol Evolut, Consejo Super Invest Cient, Inst Catalana Recerca & Estudis Avangats, Barcelona, Spain; [Mansfield, Keith G.] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Comparat Pathol, Southborough, MA 01772 USA; [Marques-Bonet, Tomas] CNAG, Barcelona, Spain; [Raney, Brian J.] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Skaletsky, Helen] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Tomaska, Lubomir] Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava, Slovakia; [Ullmer, Brygg] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; [Ullmer, Brygg] Louisiana State Univ, Dept Comp Sci, Baton Rouge, LA 70803 USA; [Wildman, Derek E.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Zdobnov, Evgeny M.] Swiss Inst Bioinformat, Geneva, Switzerland; [Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Universita degli Studi di Bari Aldo Moro; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Louisiana State University System; Louisiana State University; European Molecular Biology Laboratory (EMBL); Comenius University Bratislava; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; University of Geneva; University of Houston System; University of Houston; Baylor College of Medicine; Harvard University; Institute for Systems Biology (ISB); Massachusetts Institute of Technology (MIT); Whitehead Institute; Utah System of Higher Education; University of Utah; University of Veterinary Medicine Vienna; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); ICREA; Pompeu Fabra University; Harvard University; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Comenius University Bratislava; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Wayne State University; Swiss Institute of Bioinformatics; Imperial College London	Worley, KC (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	kworley@bcm.edu	Vinar, Tomas/I-3695-2014; Wilson, Richard K./AAF-4139-2019; Zdobnov, Evgeny/AAB-2745-2022; Tomaska, Lubomir/I-3071-2014; Marques-Bonet, Tomas/ABF-3734-2020; Puente, Xosé S./ADB-0672-2022; Misceo, Doriana/AAR-9085-2020; Quesada, Víctor/B-6557-2014; Raney, Brian/ABE-6267-2020; Mardis, Elaine/W-2202-2019; López-Otín, Carlos/AAB-2106-2020; Harris, R. Alan/AAI-2784-2020; Rodríguez, David/K-3872-2017; Brejova, Brona/I-3718-2014; Herrero, Javier/H-6971-2019; Zdobnov, Evgeny M/K-1133-2012; Vogel, Jan-Hinnerk/C-4582-2013; Weinstock, George M/C-6314-2013; Ventura, Mario/E-6420-2011	Vinar, Tomas/0000-0003-3898-3447; Wilson, Richard K./0000-0002-1992-1358; Zdobnov, Evgeny/0000-0002-5178-1498; Tomaska, Lubomir/0000-0003-4886-1910; Marques-Bonet, Tomas/0000-0002-5597-3075; Puente, Xosé S./0000-0001-9525-1483; Misceo, Doriana/0000-0002-6594-5801; Quesada, Víctor/0000-0002-8398-3457; López-Otín, Carlos/0000-0001-6964-1904; Harris, R. Alan/0000-0002-7333-4752; Rodríguez, David/0000-0002-7530-2770; Brejova, Brona/0000-0002-9483-1766; Herrero, Javier/0000-0001-7313-717X; Weinstock, George M/0000-0002-2997-4592; Ruffier, Magali/0000-0002-8386-1580; archidiacono, nicoletta/0000-0002-1439-9521; Casola, Claudio/0000-0003-4853-1866; Hahn, Matthew/0000-0002-5731-8808; Flicek, Paul/0000-0002-3897-7955; Gerlach, Daniel/0000-0001-9338-3765; CAPOZZI, Oronzo/0000-0002-7443-6777; Locke, Devin/0000-0002-2527-0475; Worley, Kim/0000-0002-0282-1000; Rocchi, Mariano/0000-0002-9451-5616; del Rosario, Ricardo/0000-0002-7038-9598; Lorente-Galdos, Belen/0000-0001-5390-2452; Ventura, Mario/0000-0001-7762-8777; Wildman, Derek/0000-0002-6374-5136; Vilella, Albert/0000-0002-2005-2516	National Human Genome Research Institute (NHGRI) [U54 HG003273, U54 HG003079]; US National Institutes of Health (NIH) [R01 DK077639, R01 GM59290, HG002385, P51-OD011133]; National Science Foundation [NSF BCS-0751508]; VEGA grant agency [1/0719/14, 1/1085/12]; Howard Hughes Medical Institute grant; NHGRI [K99 HG005846]; Cullen Foundation; European Research Council Starting Grant [260372]; MICINN (Spain) [BFU2011-28549]; Spanish National Institute of Bioinformatics; Austrian Science Fund (FWF) [P 24551] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, K99HG005846, R01HG002385, U54HG003079, U41HG002371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER; Direct For Biological Sciences [0845494] Funding Source: National Science Foundation; ICREA Funding Source: Custom	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); VEGA grant agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Howard Hughes Medical Institute grant(Howard Hughes Medical Institute); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cullen Foundation; European Research Council Starting Grant(European Research Council (ERC)); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute of Bioinformatics; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ICREA(ICREA)	The authors acknowledge the contributions of the sequence production staff of the Human Genome Sequencing Center: K. Abraham, C. Adams, C. Allen, U. Anosike, T. Attaway, D. Bandaranaike, A. Bell, S.N. Bell, B. Beltran, C. Bickham, J. Chacko, A. Chavez, H.-S. Chu, M. Coyle, M.L. Davila, L. Davy-Carroll, S. Denson, Y. Ding, S. Dugan, V. Ebong, S. Fernandez, P. Fernando, A. Ferrer, J. Ganer, R. Garcia III, T. Garrett, E. Hawkins, S. Hines, M. Holder, B. Hollins, H. Jiang, B. Johnson, H. Kisamo, L. Lago, M. Lago, C.-Y. Lai, T.-K. Le, F. Legal III, S. Lemon, R. Madu, E. Martinez, I. Mercado, C. Mercado, M. Munidasa, D. Ngo, P. Nguyen, O. Nwaokelemeh, M. Obregon, C. Onwere, A. Parra, H. Paul, A. Perez, Y. Perez, E. Primus, J. Quiroz, B. Schneider, I. Sisson, X.-Z. Song, A. Svatek, T. Taylor, R. Thelus, N. Thomas, R. Thornton, Z. Trejos, K. Usmani, S. Vattathil, D. Villasana, D. Walker, K. Wang, S. Wang, C. White, A. Williams, J. Williams, J. Woodworth and L. Zhang. The Washington University Genome Sequencing Center acknowledges the many people who contributed to the sequencing and analysis in this project who are not named here individually. We thank J. Steitz for mRNA data used to annotate the 3' UTRs of genes. The miRNA analysis group acknowledges the contributions of D. Rajapakshe, C. Athulathmudali, H. Jiang and A. Moehring. We gratefully acknowledge the assistance of D. Opheim with the figures. The marmoset genome project was funded by the National Human Genome Research Institute (NHGRI), including from grants U54 HG003273 (R.A. Gibbs) and U54 HG003079 (R.K.W.), with additional support from the US National Institutes of Health (NIH), including from grants R01 DK077639 (S.D.T.), R01 GM59290 (L.B.J. and M.A.B.), HG002385 (E.E.E.) and P51-OD011133 (Southwest NPRC), and support from the National Science Foundation (NSF BCS-0751508 to DEW.) and the VEGA grant agency: 1/0719/14 (TV.) and 1/1085/12 (B.B.). C.C.F. and M.C.R. were supported in part by a Howard Hughes Medical Institute grant to Louisiana State University through the Undergraduate Biological Sciences Education program. J.X. was supported by NHGRI grant K99 HG005846. P.H.G. was supported by the Cullen Foundation. T.M.-B. was supported by European Research Council Starting Grant (260372) and MICINN (Spain) grant BFU2011-28549. B.L.-G. was supported by the Spanish National Institute of Bioinformatics (see URLs). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Cheung VG, 2010, SCIENCE, V327, P791, DOI 10.1126/science.1187155; Choi JH, 2011, J CLIN ENDOCR METAB, V96, pE130, DOI 10.1210/jc.2010-1789; del Rosario R. C. H., GENOME RES; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Falush D, 2003, GENETICS, V164, P1567; Fang P, 2012, J CLIN ENDOCR METAB, V97, pE243, DOI 10.1210/jc.2011-2142; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; GENGOZIAN N, 1964, CYTOGENETICS, V3, P384, DOI 10.1159/000129828; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; GOLDIZEN AW, 1988, TRENDS ECOL EVOL, V3, P36, DOI 10.1016/0169-5347(88)90045-6; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Kingsley CB, 2011, METHODS MOL BIOL, V700, P37, DOI 10.1007/978-1-61737-954-3_3; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEUTENEGGER W, 1973, FOLIA PRIMATOL, V20, P280, DOI 10.1159/000155580; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Marroig G, 2010, EVOLUTION, V64, P1470, DOI 10.1111/j.1558-5646.2009.00920.x; McNerney ME, 2005, BLOOD, V106, P1337, DOI 10.1182/blood-2005-01-0357; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Palmer JS, 2006, J CLIN ENDOCR METAB, V91, P4713, DOI 10.1210/jc.2006-0970; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Pritchard JK, 2000, GENETICS, V155, P945; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sharma N, 2008, MOL REPROD DEV, V75, P1136, DOI 10.1002/mrd.20855; TARDIF SD, 1994, ANN NY ACAD SCI, V709, P214, DOI 10.1111/j.1749-6632.1994.tb30405.x; Trivedi NN, 2007, J IMMUNOL, V179, P6072, DOI 10.4049/jimmunol.179.9.6072; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Wang QF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r68; Wang QF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r1; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	50	146	154	0	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					850	857		10.1038/ng.3042	http://dx.doi.org/10.1038/ng.3042			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038751	Green Published, hybrid, Green Accepted			2022-12-17	WOS:000339704400013
J	Huang, QL; Whitington, T; Gao, P; Lindberg, JF; Yang, YH; Sun, JL; Vaisanen, MR; Szulkin, R; Annala, M; Yan, J; Egevad, LA; Zhang, K; Lin, RZ; Jolma, A; Nykter, M; Manninen, A; Wiklund, F; Vaarala, MH; Visakorpi, T; Xu, JF; Taipale, J; Wei, GH				Huang, Qilai; Whitington, Thomas; Gao, Ping; Lindberg, Johan F.; Yang, Yuehong; Sun, Jielin; Vaisanen, Marja-Riitta; Szulkin, Robert; Annala, Matti; Yan, Jian; Egevad, Lars A.; Zhang, Kai; Lin, Ruizhu; Jolma, Arttu; Nykter, Matti; Manninen, Aki; Wiklund, Fredrik; Vaarala, Markku H.; Visakorpi, Tapio; Xu, Jianfeng; Taipale, Jussi; Wei, Gong-Hong			A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; G84E MUTATION; RISK; GENE; LOCI; ENHANCERS; REPLICATION; CONSORTIUM; SIGNATURES; LANDSCAPE	Genome-wide association studies have identified thousands of SNPs associated with predisposition to various diseases, including prostate cancer. However, the mechanistic roles of these SNPs remain poorly defined, particularly for noncoding polymorphisms. Here we find that the prostate cancer risk-associated SNP rs339331 at 6q22 lies within a functional HOXB13-binding site. The risk-associated T allele at rs339331 increases binding of HOXB13 to a transcriptional enhancer, conferring allele-specific upregulation of the rs339331-associated gene RFX6. Suppression of RFX6 diminishes prostate cancer cell proliferation, migration and invasion. Clinical data indicate that RFX6 upregulation in human prostate cancers correlates with tumor progression, metastasis and risk of biochemical relapse. Finally, we observe a significant association between the risk-associated T allele at rs339331 and increased RFX6 mRNA levels in human prostate tumors. Together, our results suggest that rs339331 affects prostate cancer risk by altering RFX6 expression through a functional interaction with the prostate cancer susceptibility gene HOXB13.	[Huang, Qilai; Gao, Ping; Yang, Yuehong; Zhang, Kai; Lin, Ruizhu; Manninen, Aki; Wei, Gong-Hong] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Huang, Qilai; Gao, Ping; Yang, Yuehong; Zhang, Kai; Lin, Ruizhu; Manninen, Aki; Wei, Gong-Hong] Univ Oulu, Inst Biomed, Dept Med Biochem & Mol Biol, Oulu, Finland; [Whitington, Thomas; Yan, Jian; Jolma, Arttu; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Sun, Jielin; Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Vaisanen, Marja-Riitta; Vaarala, Markku H.] Oulu Univ Hosp, Dept Pathol, Oulu, Finland; [Annala, Matti; Nykter, Matti; Visakorpi, Tapio] Univ Tampere, Inst Biomed Technol & BioMediTech, Prostate Canc Res Ctr, FIN-33101 Tampere, Finland; [Annala, Matti; Nykter, Matti; Visakorpi, Tapio] Tampere Univ Hosp, Tampere, Finland; [Egevad, Lars A.] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Jolma, Arttu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland; [Vaarala, Markku H.] Univ Oulu, Med Res Ctr, Oulu, Finland	University of Oulu; University of Oulu; Karolinska Institutet; Fudan University; University of Oulu; Tampere University; Tampere University; Tampere University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Oulu	Wei, GH (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.	jussi.taipale@ki.se; gonghong.wei@oulu.fi	Zhang, Kai/M-9831-2017; Jolma, Arttu/AAK-9649-2021; Vaarala, Markku/B-4116-2013; Manninen, Aki/AAC-8067-2019; Wei, Gonghong/C-6263-2014; Huang, Qilai/B-4725-2015; Yan, Jian/B-2631-2018	Zhang, Kai/0000-0003-2962-3976; Vaarala, Markku/0000-0003-4735-815X; Manninen, Aki/0000-0002-6263-8101; Huang, Qilai/0000-0002-4252-3980; Yan, Jian/0000-0002-1267-2870; Jolma, Arttu/0000-0002-2543-7490; Visakorpi, Tapio/0000-0002-5004-0364; Wei, Gong-Hong/0000-0001-6546-9334; Nykter, Matti/0000-0001-6956-2843; gao, ping/0000-0003-1383-3290; Lindberg, Johan/0000-0003-3610-6774	Academy of Finland [135560, 251314]; Chinese National Key Basic Research Program Grant 973 [2012CB518301]; Biocenter Oulu; University of Oulu; Biocenter Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; China Scholarship Council fellowship via Northwest Agriculture and Forestry University [201206300074]; Cancer Foundation Finland sr [130133] Funding Source: researchfish	Academy of Finland(Academy of Finland); Chinese National Key Basic Research Program Grant 973(National Basic Research Program of China); Biocenter Oulu; University of Oulu; Biocenter Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; China Scholarship Council fellowship via Northwest Agriculture and Forestry University; Cancer Foundation Finland sr	We thank P. Vuokila, S. Lahdesmaki, J. Traskelin and A. Viklund for technical service, M. Mannikko for DNA sequencing, M. Taipale and L. Hu for massively parallel sequencing, P. Karppinen for critically reading the manuscript and A. Juffer for providing the Linux High-Performance Computing server. We also thank the TCGA Research Network for generating the TCGA data sets for prostate adenocarcinoma. A.M. and K.Z. are funded by the Academy of Finland (135560 and 251314). J.X. is funded by Chinese National Key Basic Research Program Grant 973 (2012CB518301). This work was supported by Strategic Funds from Biocenter Oulu and the University of Oulu, Biocenter Finland, the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation and a China Scholarship Council fellowship, 201206300074, via Northwest Agriculture and Forestry University.	Akbari MR, 2012, J NATL CANCER I, V104, P1260, DOI 10.1093/jnci/djs288; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kim Y.R., 2013, ONCOGENE, DOI [10.1038/onc.2013.404, DOI 10.1038/0NC.2013.404]; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Laitinen VH, 2013, CANCER EPIDEM BIOMAR, V22, P452, DOI 10.1158/1055-9965.EPI-12-1000-T; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P212, DOI 10.1158/1055-9965.EPI-11-0870-T; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Long QZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037866; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Szulkin R, 2012, PROSTATE, V72, P30, DOI 10.1002/pros.21403; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang ML, 2012, CARCINOGENESIS, V33, P356, DOI 10.1093/carcin/bgr279; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu JF, 2013, HUM GENET, V132, P5, DOI 10.1007/s00439-012-1229-4; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang XY, 2012, GENOME RES, V22, P1437, DOI 10.1101/gr.135665.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	146	149	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					126	+		10.1038/ng.2862	http://dx.doi.org/10.1038/ng.2862			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24390282				2022-12-17	WOS:000331208300008
J	Goriely, A; Hansen, RMS; Taylor, IB; Olesen, IA; Jacobsen, GK; McGowan, SJ; Pfeifer, SP; McVean, GAT; Rajpert-De Meyts, E; Wilkie, AOM				Goriely, Anne; Hansen, Ruth M. S.; Taylor, Indira B.; Olesen, Inge A.; Jacobsen, Grete Krag; McGowan, Simon J.; Pfeifer, Susanne P.; McVean, Gilean A. T.; Rajpert-De Meyts, Ewa; Wilkie, Andrew O. M.			Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; GERM-CELL TUMORS; THANATOPHORIC DYSPLASIA; PATERNAL AGE; SPERMATOCYTIC SEMINOMA; ACANTHOSIS NIGRICANS; SELECTIVE ADVANTAGE; COSTELLO-SYNDROME; NOONAN-SYNDROME; BLADDER-CANCER	Genes mutated in congenital malformation syndromes are frequently implicated in oncogenesis(1,2), but the causative germline and somatic mutations occur in separate cells at different times of an organism's life. Here we unify these processes to a single cellular event for mutations arising in male germ cells that show a paternal age effect(3). Screening of 30 spermatocytic seminomas(4,5) for oncogenic mutations in 17 genes identified 2 mutations in FGFR3 (both 1948A>G, encoding K650E, which causes thanatophoric dysplasia in the germline)(6) and 5 mutations in HRAS. Massively parallel sequencing of sperm DNA showed that levels of the FGFR3 mutation increase with paternal age and that the mutation spectrum at the Lys650 codon is similar to that observed in bladder cancer(7,8). Most spermatocytic seminomas show increased immunoreactivity for FGFR3 and/or HRAS. We propose that paternal age-effect mutations activate a common 'selfish' pathway supporting proliferation in the testis, leading to diverse phenotypes in the next generation including fetal lethality, congenital syndromes and cancer predisposition.	[Goriely, Anne; Hansen, Ruth M. S.; Taylor, Indira B.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Olesen, Inge A.; Rajpert-De Meyts, Ewa] Univ Copenhagen Hosp, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Jacobsen, Grete Krag] Univ Copenhagen Hosp, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [McGowan, Simon J.] Univ Oxford, Computat Biol Res Grp, Oxford, England; [Pfeifer, Susanne P.; McVean, Gilean A. T.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oxford; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	awilkie@hammer.imm.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020; Olesen, Inge/B-7812-2014; Rajpert-De Meyts, Ewa/H-6526-2019; Goriely, Anne/AAR-1133-2020	Wilkie, Andrew/0000-0002-2972-5481; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Goriely, Anne/0000-0001-9229-7216; Pfeifer, Susanne/0000-0003-1378-2913; McGowan, Simon/0000-0001-9720-1914	Danish Cancer Society [DP08147]; Wellcome Trust [078666]	Danish Cancer Society(Danish Cancer Society); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the Oxford Fertility Clinic and anonymous sperm donors for help with obtaining samples; L. Andersen, T. Chin-A-Woeng, K. Clark, K. Cook, A. Fenwick, A. Herlihy, H. Kistrup, J. Lim, J.-E. Nielsen, L. Thompson and N. Ward for expert technical support and advice; associates of the Rajpert-De Meyts and Wilkie labs for discussions; staff in numerous pathology departments in Denmark and Lund (Sweden), and G. Turner and I. Roberts, for histopathological support and samples; L. Legeai-Mallet for providing control genomic samples; G. Spagnoli for the MAGE-A4 antibody; M. de Gobbi for information on TaqMan primers for DNA quantification; and S. Robertson for comments on the manuscript. This work was funded by the Danish Cancer Society (DP08147 to E. R.-D. M.) and the Wellcome Trust (078666 to A. O. M. W.).	Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bohm J, 2006, AM J MED GENET A, V140A, P1904, DOI 10.1002/ajmg.a.31383; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Castro-Feijoo L, 2008, EUR J ENDOCRINOL, V159, P243, DOI 10.1530/EJE-08-0393; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Dym M, 2009, BIRTH DEFECTS RES C, V87, P27, DOI 10.1002/bdrc.20141; EBLE JN, 1994, HUM PATHOL, V25, P1035, DOI 10.1016/0046-8177(94)90062-0; Friedman JM, 1997, AM J HUM GENET, V60, P469; Giudicelli MD, 2008, FERTIL STERIL, V89, P1651, DOI 10.1016/j.fertnstert.2007.04.037; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Hafner C, 2007, J INVEST DERMATOL, V127, P1883, DOI 10.1038/sj.jid.5700804; Hansen RM, 2005, J PATHOL, V207, P27, DOI 10.1002/path.1816; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Iwata T, 2001, HUM MOL GENET, V10, P1255, DOI 10.1093/hmg/10.12.1255; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Juul A, 2007, HUM REPROD, V22, P1907, DOI 10.1093/humrep/dem126; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Nachman MW, 2000, GENETICS, V156, P297; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; ORIOLI IM, 1995, AM J MED GENET, V59, P209, DOI 10.1002/ajmg.1320590218; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Rajpert-De Meyts E, 2003, HISTOPATHOLOGY, V42, P217, DOI 10.1046/j.1365-2559.2003.01587.x; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Sol-Church K, 2006, HUM MUTAT, V27, P736, DOI 10.1002/humu.20381; SRIVASTAVA SK, 1985, P NATL ACAD SCI USA, V82, P38, DOI 10.1073/pnas.82.1.38; Tartaglia M, 2004, AM J HUM GENET, V75, P492, DOI 10.1086/423493; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Waller DK, 2008, AM J MED GENET A, V146A, P2385, DOI 10.1002/ajmg.a.32485; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558; Zampino G, 2007, HUM MUTAT, V28, P265, DOI 10.1002/humu.20431; Zankl A, 2008, AM J MED GENET A, V146A, P212, DOI 10.1002/ajmg.a.32085	60	146	152	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1247	U119		10.1038/ng.470	http://dx.doi.org/10.1038/ng.470			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19855393	Green Accepted			2022-12-17	WOS:000271247600020
J	Phalke, S; Nickel, O; Walluscheck, D; Hortig, F; Onorati, MC; Reuter, G				Phalke, Sameer; Nickel, Olaf; Walluscheck, Diana; Hortig, Frank; Onorati, Maria Cristina; Reuter, Gunter			Retrotransposon silencing and telomere integrity in somatic cells of Drosophila depends on the cytosine-5 methyltransferase DNMT2	NATURE GENETICS			English	Article							DNA METHYLATION; HETEROCHROMATIN FORMATION; DE-NOVO; MELANOGASTER; HOMOLOG; 5-METHYLCYTOSINE; TRNA(ASP); GERMLINE; REPEATS; PATHWAY	Here we show that the cytosine-5 methyltransferase DNMT2 controls retrotransposon silencing in Drosophila somatic cells. In Drosophila, significant DNMT2-dependent DNA methylation occurs during early embryogenesis. Suppression of white gene silencing by Mt2 (Dnmt2) null mutations in variegated P[w(+)] element insertions identified functional targets of DNMT2. The enzyme controls DNA methylation at retrotransposons in early embryos and initiates histone H4K20 trimethylation catalyzed by the SUV4-20 methyltransferase. In somatic cells, loss of DNMT2 eliminates H4K20 trimethylation at retrotransposons and impairs maintenance of retrotransposon silencing. In Dnmt2 and Suv4-20 null genotypes, retrotransposons are strongly overexpressed in somatic but not germline cells, where retrotransposon silencing depends on an RNAi mechanism. DNMT2 also controls integrity of chromosome 2R and 3R telomeres. In Dnmt2 null strains, we found stable loss of the subtelomeric clusters of defective Invader4 elements. Together, these results demonstrate a previously unappreciated role of DNA methylation in retrotransposon silencing and telomere integrity in Drosophila.	[Phalke, Sameer; Nickel, Olaf; Walluscheck, Diana; Hortig, Frank; Reuter, Gunter] Univ Halle Wittenberg, Inst Biol Dev Genet, Halle, Germany; [Onorati, Maria Cristina] Univ Palermo, Inst Telethon Dulbecco, Dipartimento Sci Biochim Policlin, Palermo, Italy	Martin Luther University Halle Wittenberg; University of Palermo	Reuter, G (corresponding author), Univ Halle Wittenberg, Inst Biol Dev Genet, Halle, Germany.	reuter@genetik.uni-halle.de	Nickel, Olaf/AAB-5506-2022					Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; ELGIN SCR, 2006, EPIGENETICS POSITION; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Meehan RR, 2001, GENE DEV, V15, P3231, DOI 10.1101/gad.954901; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493	31	146	153	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					696	702		10.1038/ng.360	http://dx.doi.org/10.1038/ng.360			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412177				2022-12-17	WOS:000266411700018
J	Dong, PDS; Munson, CA; Norton, W; Crosnier, C; Pan, XF; Gong, ZY; Neumann, CJ; Stainier, DYR				Dong, P. Duc Si; Munson, Chantilly A.; Norton, William; Crosnier, Cecile; Pan, Xiufang; Gong, Zhiyuan; Neumann, Carl J.; Stainier, Didier Y. R.			Fgf10 regulates hepatopancreatic ductal system patterning and differentiation	NATURE GENETICS			English	Article							TRANSGENIC ZEBRAFISH; PANCREAS DEVELOPMENT; DIGESTIVE-SYSTEM; ENDOCRINE-CELLS; MORPHOGENESIS; EPITHELIUM; MAINTAINS; EXOCRINE; REQUIRES; GROWTH	During organogenesis, the foregut endoderm gives rise to the many different cell types that comprise the hepatopancreatic system, including hepatic, pancreatic and gallbladder cells, as well as the epithelial cells of the hepatopancreatic ductal system that connects these organs together and with the intestine. However, the mechanisms responsible for demarcating ducts versus organs are poorly understood. Here, we show that Fgf10 signaling from the adjacent mesenchyme is responsible for refining the boundaries between the hepatopancreatic duct and organs. In zebrafish fgf10 mutants, the hepatopancreatic ductal epithelium is severely dysmorphic, and cells of the hepatopancreatic ductal system and adjacent intestine misdifferentiate toward hepatic and pancreatic fates. Furthermore, Fgf10 also functions to prevent the differentiation of the proximal pancreas and liver into hepatic and pancreatic cells, respectively. These data shed light onto how the multipotent cells of the foregut endoderm, and subsequently those of the hepatopancreatic duct, are directed toward different organ fates.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94158 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94158 USA; European Mol Biol Lab, Dev Biol Program, D-60117 Heidelberg, Germany; Canc Res UK, Vertebrate Dev Lab, London WC2A 3PX, England; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pulm Biol, Cincinnati, OH 45229 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; European Molecular Biology Laboratory (EMBL); Cancer Research UK; National University of Singapore; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	didier_stainier@biochem.ucsf.edu	Gong, Zhiyuan/H-8794-2012; Norton, William/E-9924-2012	Gong, Zhiyuan/0000-0002-9660-5260; Stainier, Didier/0000-0002-0382-0026; Norton, William/0000-0002-3244-0145				Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Jacquemin P, 2006, DEV BIOL, V290, P189, DOI 10.1016/j.ydbio.2005.11.023; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Li JX, 2000, GENE DEV, V14, P464; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Pulkkinen MA, 2003, MECH DEVELOP, V120, P167, DOI 10.1016/S0925-4773(02)00440-9; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021	21	146	152	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					397	402		10.1038/ng1961	http://dx.doi.org/10.1038/ng1961			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259985				2022-12-17	WOS:000244480000024
J	Mak, HY; Nelson, LS; Basson, M; Johnson, CD; Ruvkun, G				Mak, HY; Nelson, LS; Basson, M; Johnson, CD; Ruvkun, G			Polygenic control of Caenorhabditis elegans fat storage	NATURE GENETICS			English	Article							C-ELEGANS; CHEMOSENSORY NEURONS; SENSORY PERCEPTION; LARVAL DEVELOPMENT; GENE FAMILY; TUBBY; PROTEIN; MUTATION; HOMOLOG; INSULIN	Tubby mice(1) and individuals with Bardet-Biedl syndrome(2) have defects in ciliated neuron function and obesity, suggesting an as-yet unknown metabolic signaling axis from ciliated neurons to fat storage tissues. Here we show coordinate regulation of Caenorhabditis elegans fat storage by orthologues of these genes acting in ciliated neurons and by a 3-ketoacyl-coA thiolase (encoded by kat-1) that acts in fat storage tissue. A genetic screen for markedly enhanced fat storage in tub-1 mutants led to the isolation only of kat-1 alleles, which impair fatty acid beta-oxidation. kat-1 acts in the intestine, the major C. elegans fat storage tissue, and is transcriptionally upregulated in animals with high fat storage. A genetic screen for synergistic increase in fat storage of a kat-1 mutant identified bbs-1. bbs-1 acts in 15 ciliated neurons that are poised to sense external and internal nutrient levels, supporting a model in which bbs-1 and tub-1 in ciliated neurons form part of an ancient, conserved neuroendocrine axis. This pathway also includes genes encoding intraflagellar transport proteins and cyclic nucleotide gated channels, demonstrating that C. elegans fat storage is under polygenic control.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Axys Pharmaceut, San Francisco, CA 94080 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Mak, Ho Yi/0000-0002-1500-5328	NIDDK NIH HHS [R01 DK070147] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070147] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Ikeda A, 2002, J CELL SCI, V115, P9; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Sahly I, 1998, HUM MOL GENET, V7, P1437, DOI 10.1093/hmg/7.9.1437; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	30	146	158	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					363	368		10.1038/ng1739	http://dx.doi.org/10.1038/ng1739			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462744				2022-12-17	WOS:000235589600020
J	Wheeler, DB; Carpenter, AE; Sabatini, DM				Wheeler, DB; Carpenter, AE; Sabatini, DM			Cell microarrays and RNA interference chip away at gene function	NATURE GENETICS			English	Article							SCALE CHROMATIN-STRUCTURE; CULTURED-MAMMALIAN-CELLS; DOUBLE-STRANDED-RNA; QUANTITATIVE-ANALYSIS; SUBCELLULAR-LOCALIZATION; TRANSFECTION MICROARRAY; AUTOMATED MICROSCOPY; TISSUE MICROARRAYS; PROTEIN-KINASE; IMAGE-ANALYSIS	The recent development of cell microarrays offers the potential to accelerate high-throughput functional genetic studies. The widespread use of RNA interference (RNAi) has prompted several groups to fabricate RNAi cell microarrays that make possible discrete, in-parallel transfection with thousands of RNAi reagents on a microarray slide. Though still a budding technology, RNAi cell microarrays promise to increase the efficiency, economy and ease of genome-wide RNAi screens in metazoan cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Wheeler, DB (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; /0000-0002-1446-7256				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074; Belien JAM, 2002, CYTOMETRY, V49, P12, DOI 10.1002/cyto.10138; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Carpenter AE, 2004, CYTOM PART A, V58A, P157, DOI 10.1002/cyto.a.10113; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chang FH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh029; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Eils R, 2003, J CELL BIOL, V161, P477, DOI 10.1083/jcb.200302097; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Ghosh RN, 2004, ASSAY DRUG DEV TECHN, V2, P473, DOI 10.1089/adt.2004.2.473; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kato K, 2004, BIOTECHNIQUES, V37, P444, DOI 10.2144/04373RR02; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Liebel U, 2003, FEBS LETT, V554, P394, DOI 10.1016/S0014-5793(03)01197-9; Lindblad J, 2004, CYTOM PART A, V57A, P22, DOI 10.1002/cyto.a.10107; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; MARCUS PI, 1985, VIROLOGY, V142, P411, DOI 10.1016/0042-6822(85)90349-6; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Mehes G, 2000, CYTOMETRY, V42, P357, DOI 10.1002/1097-0320(20001215)42:6<357::AID-CYTO1002>3.0.CO;2-6; Mishina YM, 2004, J BIOMOL SCREEN, V9, P196, DOI 10.1177/1087057103261880; Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Obenauer-Kutner LJ, 2005, MICROSC MICROANAL, V11, P37, DOI 10.1017/S1431927605050038; Oode K, 2000, AM J PATHOL, V157, P723, DOI 10.1016/S0002-9440(10)64585-3; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Palmer E, 2004, COMP FUNCT GENOM, V5, P342, DOI 10.1002/cfg.405; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Perlman ZE, 2005, CHEMBIOCHEM, V6, P145, DOI 10.1002/cbic.200400266; Redmond TM, 2004, MOL CELL PROTEOMICS, V3, P770, DOI 10.1074/mcp.M400018-MCP200; Ruckstuhl T, 2005, BIOSENS BIOELECTRON, V20, P1872, DOI 10.1016/j.bios.2004.06.050; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Searls DB, 2005, NAT REV DRUG DISCOV, V4, P45, DOI 10.1038/nrd1608; Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101; SWAYNE DF, 2003, P 3 ANN WORKSH DISTR; Swedlow JR, 2003, SCIENCE, V300, P100, DOI 10.1126/science.1082602; Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324; Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	66	146	150	0	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37			S			S25	S30		10.1038/ng1560	http://dx.doi.org/10.1038/ng1560			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920526	Bronze			2022-12-17	WOS:000229590000006
J	Ye, JZS; de Lange, T				Ye, JZS; de Lange, T			TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex	NATURE GENETICS			English	Article							POLY(ADP-RIBOSE) POLYMERASE; REGULATOR	Telomere length in humans is partly controlled by a feedback mechanism in which telomere elongation by telomerase is limited by the accumulation of the TRF1 complex at chromosome ends(1-5). TRF1 itself can be inhibited by the poly(ADP-ribose) polymerase (PARP) activity of its interacting partner tankyrase 1, which abolishes its DNA binding activity in vitro and removes the TRF1 complex from telomeres in vivo. Here we report that the inhibition of TRF1 by tankyrase is in turn controlled by a second TRF1-interacting factor, TIN2 (ref. 6). Partial knockdown of TIN2 by small hairpin RNA in a telomerase-positive cell line resulted in telomere elongation, which is typical of reduced TRF1 function. Transient inhibition of TIN2 with small interfering RNA led to diminished telomeric TRF1 signals. This effect could be reversed with the PARP inhibitor 3-aminobenzamide and did not occur in cells overexpressing a PARP-dead mutant of tankyrase 1. TIN2 formed a ternary complex with TRF1 and tankyrase 1 and stabilized their interaction, an effect also observed with the PARP-dead mutant of tankyrase 1. In vitro, TIN2 protected TRF1 from poly(ADP-ribosyl)ation by tankyrase 1 without affecting tankyrase 1 automodification. These data identify TIN2 as a PARP modulator in the TRF1 complex and can explain how TIN2 contributes to the regulation of telomere length.	Rockefeller Univ, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	de Lange, T (corresponding author), NYU, Sch Med, Div Hematol, Dept Med, 550 1St Ave, New York, NY 10016 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; De Rycker M, 2003, BIOCHEM J, V372, P87, DOI 10.1042/BJ20021450; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	20	146	155	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					618	623		10.1038/ng1360	http://dx.doi.org/10.1038/ng1360			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15133513	Bronze			2022-12-17	WOS:000221763700020
J	Herron, BJ; Lu, WN; Rao, C; Liu, SM; Peters, H; Bronson, RT; Justice, MJ; McDonald, JD; Beier, DR				Herron, BJ; Lu, WN; Rao, C; Liu, SM; Peters, H; Bronson, RT; Justice, MJ; McDonald, JD; Beier, DR			Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; MOUSE MUTANT; GENOME-WIDE; GENE; MICE; ETHYLNITROSOUREA; DEFECTS	Treatment with N-ethyl-N-nitrosourea (ENU) efficiently generates single-nucleotide mutations in mice(1-3). Along with the renewed interest in this approach, much attention has been given recently to large screens with broad aims(4,5); however, more finely focused studies have proven very productive as well(6-8). Here we show how mutagenesis together with genetic mapping can facilitate the rapid characterization of recessive loci required for normal embryonic development. We screened third-generation progeny of mutagenized mice at embryonic day (E) 18.5 for abnormalities of organogenesis. We ascertained 15 monogenic mutations in the 54 families that were comprehensively analyzed. We carried out the experiment as an outcross, which facilitated the genetic mapping of the mutations by haplotype analysis. We mapped seven of the mutations and identified the affected locus in two lines. Using a hierarchical approach, it is possible to maximize the effciency of this analysis so that it can be carried out easily with modest infrastructure and resources.	Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Baylor Coll Med, Houston, TX 77030 USA; Wichita State Univ, Wichita, KS USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts University; Baylor College of Medicine; Wichita State University	Beier, DR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA.			Lu, Weining/0000-0002-6570-3044				Beckers J, 2000, MECH DEVELOP, V95, P35, DOI 10.1016/S0925-4773(00)00323-3; BODE VC, 1988, GENETICS, V118, P299; Daniells C, 1998, HUM GENET, V102, P216, DOI 10.1007/s004390050681; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Favor J, 2000, MAMM GENOME, V11, P520, DOI 10.1007/s003350010099; Hentges K, 1999, DEVELOPMENT, V126, P1601; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; LUNA IJ, 1960, MANUAL HISTOLOGIC ST; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Neuhaus IM, 1998, MAMM GENOME, V9, P150, DOI 10.1007/s003359900706; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P3592, DOI 10.1073/pnas.79.11.3592; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Sporle R, 1996, DEVELOPMENT, V122, P79; Sporle R, 1998, DEV GENET, V22, P359, DOI 10.1002/(SICI)1520-6408(1998)22:4<359::AID-DVG6>3.0.CO;2-5; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Turco AE, 1997, HUM MUTAT, V10, P164, DOI 10.1002/(SICI)1098-1004(1997)10:2<164::AID-HUMU9>3.3.CO;2-8; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	23	146	150	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					185	189		10.1038/ng812	http://dx.doi.org/10.1038/ng812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818962				2022-12-17	WOS:000173708700019
J	Sozen, MA; Suzuki, K; Tolarova, MM; Bustos, T; Iglesias, JEF; Spritz, RA				Sozen, MA; Suzuki, K; Tolarova, MM; Bustos, T; Iglesias, JEF; Spritz, RA			Mutation of PVRL1 is associated with sporadic, non-syndromic cleft lip/palate in northern Venezuela	NATURE GENETICS			English	Article							ECTODERMAL DYSPLASIA; PALATE; LIP; GENE	Non-syndromic cleft lip with or without cleft palate (CL/P, MIM 119530) is among the most common of major birth defects. Homozygosity for a nonsense mutation of PVRL1, W185X, results in an autosomal recessive CL/P syndrome on Margarita Island, CLPED1 (ref. 1). Here we demonstrate highly significant association between heterozygosity for this mutation and sporadic, non-syndromic CL/P in northern Venezuela.	Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Pacific, Dept Orthodont, San Francisco, CA USA; Cent Univ Venezuela, Ctr Nacl Genet Humana & Expt, Caracas, Venezuela; Ctr Diagnost Odontol, Porlamar, Isla Margarita, Venezuela	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of the Pacific; University of Central Venezuela	Spritz, RA (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA.	richard.spritz@uchsc.edu			NIDCR NIH HHS [DE13571] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013571] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; BUSTOS T, 1991, AM J MED GENET, V41, P398, DOI 10.1002/ajmg.1320410403; Juriloff DM, 2001, MAMM GENOME, V12, P426, DOI 10.1007/s003350010284; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; Mitchell LE, 1997, EPIDEMIOL REV, V19, P61, DOI 10.1093/oxfordjournals.epirev.a017947; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; SPRITZ RA, 2001, IN PRESS CURRENT OPI, V13; Suzuki K, 1998, AM J HUM GENET, V63, P1102, DOI 10.1086/302072; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; TOLAROVA M, 1987, SCAND J PLAST RECONS, V21, P19, DOI 10.3109/02844318709083574; Tolarova MM, 1998, AM J MED GENET, V75, P126; Young DL, 2000, CRIT REV ORAL BIOL M, V11, P304, DOI 10.1177/10454411000110030201	13	146	150	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2001	29	2					141	142		10.1038/ng740	http://dx.doi.org/10.1038/ng740			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11559849				2022-12-17	WOS:000171374100018
J	Thompson, DA; Li, Y; McHenry, CL; Carlson, TJ; Ding, X; Sieving, PA; Apfelstedt-Sylla, E; Gal, A				Thompson, DA; Li, Y; McHenry, CL; Carlson, TJ; Ding, X; Sieving, PA; Apfelstedt-Sylla, E; Gal, A			Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy	NATURE GENETICS			English	Article							VITAMIN-A; RPE65; PIGMENT; MOUSE	The chromophore of the visual pigments, 11-cis retinal, is derived from vitamin A tall-trans retinol) through a series of reactions that take place in retinal pigment epithelium (RPE); (ref. 1), The first of these reactions is catalyzed by lecithin retinol acyltransferase (LRAT): (ref. 2). We screened 267 retinal dystrophy patients for mutations in LRAT and identified disease-associated mutations (S175R and 396delAA) in three individuals with severe, early-onset disease. We showed that the S175R mutant has no acyltransferase activity in transfected COS-7 cells. Our findings highlight the importance of genetic defects in vitamin A metabolism as causes of retinal dystrophies and extend prospects for retinoid replacement therapy in this group of diseases.	Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI USA; Univ Hamburg, Hosp Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; Dupont Exptl Stn, Wilmington, DE USA; Univ Tubingen, Hosp Eye, Dept 2, Tubingen, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Hamburg; Eberhard Karls University of Tubingen	Thompson, DA (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	dathom@umich.edu		Thompson, Debra/0000-0003-3485-0794	NATIONAL EYE INSTITUTE [R01EY012298] Funding Source: NIH RePORTER; NEI NIH HHS [EY06094, EY07003, EY12298] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BUNGE S, 1996, METH MOL G, V8, P26; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mondal MS, 2000, BIOCHEMISTRY-US, V39, P5215, DOI 10.1021/bi9929554; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ruiz A, 2001, INVEST OPHTH VIS SCI, V42, P31; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Zolfaghari R, 2000, J LIPID RES, V41, P2024	15	146	158	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2001	28	2					123	124		10.1038/88828	http://dx.doi.org/10.1038/88828			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381255				2022-12-17	WOS:000169011800010
J	Laan, M; Paabo, S				Laan, M; Paabo, S			Demographic history and linkage disequilibrium in human populations	NATURE GENETICS			English	Article							FINNISH POPULATION; LINEAGES; FINLAND; GENES	In the human genome, linkage disequilibrium (LD)-the nonrandom association of alleles at chromosomal loci(1)-has been studied mainly in regions surrounding disease genes on affected chromosomes2-6. Consequently, little information is available on the distribution of LD across anonymous genomic regions in the general population. However, demographic history is expected to influence the extent of overall LD across the genome, so a population that has been of constant size will display higher levels of LD than a population that has expanded(7). In support of this, the extent of LD between anonymous loci on chromosome 4 in chimpanzees (as a model of a population of constant size) has been compared to that in Finns (as a model of an expanded population; refs 8,9) and found to exhibit more LD than in the latter population. In Europe, studies of mitochondrial (mt) DNA sequences have suggested that most populations have experienced expansion(10), whereas the Saami in northern Fenno-Scandinavia have been of constant size (Table 1). Thus, in northern Europe, populations with radically different demographic histories live in close geographic proximity to each other. We studied the allelic associations between anonymous microsatellite loci on the X chromosome in the Saami and neighbouring populations and found dramatically higher levels of LD in the Saami than in other populations in the region. This indicates that whereas recently expanded populations, such as the Finns, are well suited to map single disease genes affected by recent mutations, populations that have been of constant size, such as the Saami, may be much better suited to map genes for complex traits that are caused by older mutations.	UNIV MUNICH,INST ZOOL,D-80021 MUNICH,GERMANY	University of Munich			Laan, Maris/A-4100-2011; Peng, Bo/A-6920-2009	Laan, Maris/0000-0002-8519-243X; Peng, Bo/0000-0001-8225-2284				CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; NORIO R, 1973, ANN CLIN RES, V5, P109; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; RAYMOND M, 1994, GENEPOP VERSION 1 0; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SLATKIN M, 1994, GENETICS, V137, P331; Solantie R., 1988, FENNOSCANDIA ARCHAEO, V5, P3; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; TAJIMA F, 1989, GENETICS, V123, P597; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, IN PRESS HUM HERED; Thompson EA, 1997, AM J HUM GENET, V60, P197; Varilo T, 1996, AM J HUM GENET, V58, P506; Watson E, 1996, AM J HUM GENET, V59, P437; Weir B. S., 1996, GENETIC DATA ANAL	25	146	147	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					435	438		10.1038/ng1297-435	http://dx.doi.org/10.1038/ng1297-435			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398845				2022-12-17	WOS:A1997YJ92400024
J	KOOP, BF; HOOD, L				KOOP, BF; HOOD, L			STRIKING SEQUENCE SIMILARITY OVER ALMOST 100 KILOBASES OF HUMAN AND MOUSE T-CELL RECEPTOR DNA	NATURE GENETICS			English	Article							NUCLEOTIDE-SEQUENCE; TRANSCRIPTIONAL ENHANCER; DELTA-GENES; GLOBIN GENE; ALPHA-CHAIN; 95 KB; LOCUS; REGION; RECOGNITION; THYMOCYTES	We report here the comparative DNA sequence analysis of nearly 100 kilobases of contiguous DNA in the C delta to C alpha a region of the alpha/delta T cell receptor loci (TCRAC/TCRDC) of mouse and man. This analysis - The largest genomic sequence comparison so far - provides new insights into the functions of the T cell receptor genes as well as the surrounding chromosome structure through the identification of actively conserved DNA sequences. In this comparison we have identified a very high level of organizational and noncoding sequence similarity (similar to 71%) in contrast to previous findings in the beta-globin gene cluster. This observation begins to question the notion that much of the chromosomal non-coding sequence in junk.	UNIV WASHINGTON,DEPT MOLEC BIOTECHNOL,SEATTLE,WA 98115	University of Washington; University of Washington Seattle	KOOP, BF (corresponding author), UNIV VICTORIA,CTR ENVIRONM HLTH,DEPT BIOL,VICTORIA V8W 2Y2,BC,CANADA.		Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200				ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CHENG SH, 1991, CRIT REV IMMUNOL, V11, P145; CLARK SP, IN PRESS IMMUNOGENET; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEININGER P, 1989, MOBILE DNA; DENDUNNEN JT, 1989, GENE, V78, P201, DOI 10.1016/0378-1119(89)90223-0; DEVILLARTAY JP, 1991, INT IMMUNOL, V3, P1301, DOI 10.1093/intimm/3.12.1301; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FLEIS MD, 1991, BIOCHIM BIOPHYS ACTA, V1072, P177; GILL LL, 1991, EUR J IMMUNOL, V21, P807, DOI 10.1002/eji.1830210339; HARA J, 1991, BLOOD, V78, P2075; HARDISON R, 1993, MOL BIOL EVOL, V10, P73; HESSE JE, 1989, GENE DEV, V3, P1953; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HOOD L, 1992, TRENDS BIOTECHNOL, V10, P19, DOI 10.1016/0167-7799(92)90161-N; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; HUNKAPILLER T, 1989, COLD SPRING HARB SYM, V55, P15; HUNKAPILLER T, 1991, EVOLUTION LIFE FOSSI, P123; IIDA Y, 1990, J THEOR BIOL, V145, P523, DOI 10.1016/S0022-5193(05)80486-2; IRIS FJM, 1993, NAT GENET, V3, P137, DOI 10.1038/ng0293-137; KIMURA N, 1987, EUR J IMMUNOL, V17, P375, DOI 10.1002/eji.1830170312; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; KOOP BF, 1993, BIOTECHNIQUES, V14, P442; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LAI E, 1986, P NATL ACAD SCI USA, V84, P3846; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEIDEN JM, 1992, IMMUNOL TODAY, V13, P22, DOI 10.1016/0167-5699(92)90200-Q; LEWIS S, 1989, CELL, V59, P585, DOI 10.1016/0092-8674(89)90002-0; LI WH, 1991, FUNDAMENTALS MOL EVO, V70, P71; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; LURIA S, 1987, EMBO J, V6, P3307, DOI 10.1002/j.1460-2075.1987.tb02650.x; MARGOT JB, 1989, J MOL BIOL, V205, P15, DOI 10.1016/0022-2836(89)90362-8; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MEIER JT, IN PRESS MOL CELL BI; NADEAU JH, 1992, MAMM GENOME, V3, P480, DOI 10.1007/BF00778825; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OLTZ EM, 1993, MOL CELL BIOL, V13, P6223, DOI 10.1128/MCB.13.10.6223; REDONDO JM, 1990, SCIENCE, V247, P1225, DOI 10.1126/science.2156339; SETO D, IN PRESS GENOMICS; SHEHEE WR, 1989, J MOL BIOL, V205, P41, DOI 10.1016/0022-2836(89)90363-X; SINNETT D, 1992, J MOL BIOL, V226, P689, DOI 10.1016/0022-2836(92)90626-U; SIU G, 1986, J EXP MED, V164, P1600, DOI 10.1084/jem.164.5.1600; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; THOMPSON SD, 1992, IMMUNOGENETICS, V36, P95, DOI 10.1007/BF00215285; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11262; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X	52	146	149	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					48	53		10.1038/ng0594-48	http://dx.doi.org/10.1038/ng0594-48			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075639				2022-12-17	WOS:A1994NJ84200012
J	RUGARLI, EI; LUTZ, B; KURATANI, SC; WAWERSIK, S; BORSANI, G; BALLABIO, A; EICHELE, G				RUGARLI, EI; LUTZ, B; KURATANI, SC; WAWERSIK, S; BORSANI, G; BALLABIO, A; EICHELE, G			EXPRESSION PATTERN OF THE KALLMANN SYNDROME GENE IN THE OLFACTORY SYSTEM SUGGESTS A ROLE IN NEURONAL TARGETING	NATURE GENETICS			English	Article							HYPOGONADOTROPIC HYPOGONADISM; MOLECULES; ANOSMIA; PROTEIN; MOUSE; ADHESION; PLACODE; BRAIN; CELLS; CHICK	Kallmann syndrome is a genetic disorder characterized by a defect in olfactory system development, which appears to be due to an abnormality in the migration of olfactory axons and gonadotropin releasing hormone (Gn-RH) producing neurons. The X-linked Kallmann syndrome gene shares significant similarities with molecules involved in neural development. We have now isolated the evolutionarily conserved chicken homologue of the Kallmann gene. In the developing and adult chicken, high levels of expression were found in the mitral cells of the olfactory bulb (the target of olfactory axons) and in the Purkinje cells of the cerebellar cortex, both areas affected in patients with Kallmann syndrome. We propose a model in which the Kallmann syndrome gene product is a signal molecule required for neuronal targeting throughout life.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			Borsani, Giuseppe/B-1709-2010; Lutz, Beat/AFK-6229-2022; BALLABIO, Andrea/AAL-2672-2020; Kuratani, Shigeru/J-4146-2014	Borsani, Giuseppe/0000-0003-0110-1148; BALLABIO, Andrea/0000-0003-1381-4604; Kuratani, Shigeru/0000-0001-9717-7221; Rugarli, Elena/0000-0002-5782-1067				Ballabio A, 1992, CURR OPIN GENET DEV, V2, P417, DOI 10.1016/S0959-437X(05)80152-2; BESSETTE BB, 1989, VISUAL NEUROSCI, V2, P27, DOI 10.1017/S0952523800004296; BICK D, 1992, NEW ENGL J MED, V326, P1752, DOI 10.1056/NEJM199206253262606; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BRUNJES PC, 1986, BRAIN RES REV, V11, P1, DOI 10.1016/0165-0173(86)90008-1; CALOF A L, 1992, Current Biology, V2, P103, DOI 10.1016/0960-9822(92)90235-3; CAVINESS VS, 1992, NEW ENGL J MED, V326, P1775, DOI 10.1056/NEJM199206253262612; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; De Morster G, 1954, SCHWEIZ ARCH NEUROL, V74, P309; DRENTH J, 1980, J BIOL CHEM, V255, P2652; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FISHER EH, 1991, SCIENCE, V253, P401; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GRAZIADEI GAM, 1979, NEURAL GROWTH DIFFER, P373; GROMPE M, 1992, GENOMICS, V12, P755, DOI 10.1016/0888-7543(92)90306-D; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARDELIN JP, 1992, P NATL ACAD SCI USA, V89, P8190, DOI 10.1073/pnas.89.17.8190; HINDS JW, 1972, J COMP NEUROL, V146, P233, DOI 10.1002/cne.901460207; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; Kawasaki ES, 1990, PCR PROTOCOLS GUIDE; KLINGMULLER D, 1987, J CLIN ENDOCR METAB, V65, P581, DOI 10.1210/jcem-65-3-581; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDER AD, 1989, TRENDS NEUROSCI, V12, P189, DOI 10.1016/0166-2236(89)90070-2; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; MURAKAMI S, 1991, NEUROSCI RES, V12, P421, DOI 10.1016/0168-0102(91)90073-8; NAFTOLIN F, 1971, NATURE, V232, P496, DOI 10.1038/232496a0; PUTT FA, 1972, MANUAL HISTOPATHOLOG; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Sambrook J., 1989, MOL CLONING LAB MANU; SCHWANKHAUS JD, 1989, NEUROLOGY, V39, P223, DOI 10.1212/WNL.39.2.223; SCHWANZELFUKUDA M, 1990, EXPERIENTIA, V46, P956, DOI 10.1007/BF01939389; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Shepherd G. M., 1990, SYNAPTIC ORG BRAIN, P133; SHEPHERD GM, 1992, NATURE, V358, P457, DOI 10.1038/358457a0; SUNDIN OH, 1990, DEVELOPMENT, V108, P47; SUNOHARA N, 1986, ANN NEUROL, V19, P174, DOI 10.1002/ana.410190211; WEGENKE JD, 1975, CLIN GENET, V7, P368; WHITE BJ, 1983, AM J MED GENET, V15, P417, DOI 10.1002/ajmg.1320150307; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; YOUNGREN OM, 1978, J COMP NEUROL, V181, P567, DOI 10.1002/cne.901810307; 1991, GENETICS COMPUTER GR	44	146	147	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					19	26		10.1038/ng0593-19	http://dx.doi.org/10.1038/ng0593-19			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513320				2022-12-17	WOS:A1993LA33700007
J	GINTHER, C; ISSELTARVER, L; KING, MC				GINTHER, C; ISSELTARVER, L; KING, MC			IDENTIFYING INDIVIDUALS BY SEQUENCING MITOCHONDRIAL-DNA FROM TEETH	NATURE GENETICS			English	Article							MATERNAL INHERITANCE; SKELETAL REMAINS; AMPLIFICATION; POPULATION; DIVERSITY; GENOME; REGION; BONE	Mitochondrial DNA (mtDNA) was extracted from teeth stored from 3 months to 20 years, including teeth from the semi-skeletonized remains of a murder victim which had been buried for 10 months. Tooth donors and/or their maternal relatives provided blood or buccal cells, from which mtDNA was also extracted. Enzymatic amplification and direct sequencing of roughly 650 nucleotides from two highly polymorphic regions of mtDNA yielded identical sequences for each comparison of tooth and fresh DNA. Our results suggest that teeth provide an excellent source for high molecular weight mtDNA that can be valuable for extending the time in which decomposed human remains can be genetically identified.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley				King, Mary-Claire/0000-0001-9426-1743				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AQUADRO CF, 1983, GENETICS, V103, P287; CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GYLLENSTEN U, 1985, J HERED, V76, P321, DOI 10.1093/oxfordjournals.jhered.a110103; HAGELBERG E, 1989, NATURE, V342, P485, DOI 10.1038/342485a0; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; HAGELBERG E, 1991, NATURE, V352, P427, DOI 10.1038/352427a0; HANNI C, 1990, CR ACAD SCI III-VIE, V310, P365; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1989, P JPN ACAD B-PHYS, V65, P229, DOI 10.2183/pjab.65.229; INNIS MA, 1990, PCR PROTOCOLS; King M C, 1991, Mol Genet Med, V1, P117; Orrrego C., 1990, PCR PROTOCOLS, P416; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STONEKING M, 1991, AM J HUM GENET, V48, P370; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1990, THESIS U CALIFORNIA; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720	21	146	187	4	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1992	2	2					135	138		10.1038/ng1092-135	http://dx.doi.org/10.1038/ng1092-135			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303263				2022-12-17	WOS:A1992JR08400013
J	PAN, Y; METZENBERG, A; DAS, S; JING, B; GITSCHIER, J				PAN, Y; METZENBERG, A; DAS, S; JING, B; GITSCHIER, J			MUTATIONS IN THE V2 VASOPRESSIN RECEPTOR GENE ARE ASSOCIATED WITH X-LINKED NEPHROGENIC DIABETES-INSIPIDUS	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; RHODOPSIN; HOTSPOTS; DNA	X-linked nephrogenic diabetes insipidus (NDI) is a rare disorder in which the kidney is insensitive to the antidiuretic hormone, vasopressin. It has been proposed that the kidney-specific V2 vasopressin receptor, a G protein-coupled receptor, is defective in this disorder as both the disease and the receptor map to Xq28. We report six unique mutations in the V2 receptor gene of five unrelated NDI patients, with one patient having two mutations. The most severely affected patient has a nonsense mutation which would terminate the protein in transmembrane domain III. Other mutations include three missense mutations, a frameshift and one small in-frame deletion. These results represent one of the first examples of recessive mutations affecting a G protein-coupled receptor.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco								BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BODE HH, 1969, NEW ENGL J MED, V280, P750, DOI 10.1056/NEJM196904032801404; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; JANS DA, 1990, J BIOL CHEM, V265, P15379; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KNOERS N, 1988, HUM GENET, V80, P31, DOI 10.1007/BF00451451; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; LANGLEY JM, 1991, AM J MED GENET, V38, P90, DOI 10.1002/ajmg.1320380120; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; NAIK DV, 1969, AM J PHYSIOL, V217, P1183, DOI 10.1152/ajplegacy.1969.217.4.1183; NAKANO K K, 1969, Hawaii Medical Journal, V28, P205; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAVARESE RM, 1992, BIOCHEM J, V283, P1; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; YAP EPH, 1992, TRENDS GENET, V8, P49, DOI 10.1016/0168-9525(92)90339-6	20	146	152	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					103	106		10.1038/ng1092-103	http://dx.doi.org/10.1038/ng1092-103			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303257				2022-12-17	WOS:A1992JR08400007
J	Barban, N; Jansen, R; de Vlaming, R; Vaez, A; Mandemakers, JJ; Tropf, FC; Shen, X; Wilson, JF; Chasman, DI; Nolte, IM; Tragante, V; van der Laan, SW; Perry, JRB; Kong, A; Ahluwalia, TS; Albrecht, E; Yerges-Armstrong, L; Atzmon, G; Auro, K; Ayers, K; Bakshi, A; Ben-Avraham, D; Berger, K; Bergman, A; Bertram, L; Bielak, LF; Bjornsdottir, G; Bonder, MJ; Broer, L; Bui, M; Barbieri, C; Cavadino, A; Chavarro, JE; Turman, C; Concas, MP; Cordell, HJ; Davies, G; Eibich, P; Eriksson, N; Esko, T; Eriksson, J; Falahi, F; Felix, JF; Fontana, MA; Franke, L; Gandin, I; Gaskins, AJ; Gieger, C; Gunderson, EP; Guo, XQ; Hayward, C; He, CY; Hofer, E; Huang, HY; Joshi, PK; Kanoni, S; Karlsson, R; Kiechl, S; Kifley, A; Kluttig, A; Kraft, P; Lagou, V; Lecoeur, C; Lahti, J; Li-Gao, RF; Lind, PA; Liu, T; Makalic, E; Mamasoula, C; Matteson, L; Mbarek, H; McArdle, PF; McMahon, G; Meddens, SFW; Mihailov, E; Miller, M; Missmer, SA; Monnereau, C; van der Most, PJ; Myhre, R; Nalls, MA; Nutile, T; Kalafati, IP; Porcu, E; Prokopenko, I; Rajan, KB; Rich-Edwards, J; Rietveld, CA; Robino, A; Rose, LM; Rueedi, R; Ryan, KA; Saba, Y; Schmidt, D; Smith, JA; Stolk, L; Streeten, E; Tonjes, A; Thorleifsson, G; Ulivi, S; Wedenoja, J; Wellmann, J; Willeit, P; Yao, J; Yengo, L; Zhao, JH; Zhao, W; Zhernakova, DV; Amin, N; Andrews, H; Balkau, B; Barzilai, N; Bergmann, S; Biino, G; Bisgaard, H; Bonnelykke, K; Boomsma, DI; Buring, JE; Campbell, H; Cappellani, S; Ciullo, M; Cox, SR; Cucca, F; Toniolo, D; Davey-Smith, G; Deary, IJ; Dedoussis, G; Deloukas, P; van Duijn, CM; de Geus, EJC; Eriksson, JG; Evans, DA; Faul, JD; Sala, CF; Froguel, P; Gasparini, P; Girotto, G; Grabe, HJ; Greiser, KH; Groenen, PJF; de Haan, HG; Haerting, J; Harris, TB; Heath, AC; Heikkila, K; Hofman, A; Homuth, G; Holliday, EG; Hopper, J; Hypponen, E; Jacobsson, B; Jaddoe', VWV; Johannesson, M; Kahonen, M; Kajantie, E; Kardia, SLR; Keavney, B; Kolcic, I; Koponen, P; Kovacs, P; Kronenberg, F; Kutalik, Z; La Bianca, M; Lachance, G; Iacono, WG; Lai, S; Lehtimaki, T; Liewald, DC; Lindgren, CM; Liu, YM; Luben, R; Lucht, M; Luoto, R; Magnus, P; Magnusson, PKE; Martin, NG; McGue, M; McQuillan, R; Medland, SE; Meisinger, C; Mellstrom, D; Metspalu, A; Traglia, M; Milani, L; Mitchell, P; Montgomery, GW; Mook-Kanamori, D; de Mutsert, R; Nohr, EA; Ohlsson, C; Olsen, P; Ong, KK; Paternoster, L; Pattie, A; Penninx, BWJH; Perola, M; Peyser, PA; Pirastu, M; Polasek, O; Power, C; Kaprio, J; Raffel, LJ; Raikkonen, K; Raitakari, O; Ridker, PM; Ring, SM; Roll, K; Rudan, I; Ruggiero, D; Rujescu, D; Salomaa, V; Schlessinger, D; Schmidt, H; Schmidt, R; Schupf, N; Smit, J; Sorice, R; Spector, TD; Starr, JM; Stockl, D; Strauch, K; Stumvoll, M; Swertz, MA; Thorsteinsdottir, U; Thurik, AR; Timpson, NJ; Tung, JY; Uitterlinden, AG; Vaccargiu, S; Viikari, J; Vitart, V; Volzke, H; Vollenweider, P; Vuckovic, D; Waage, J; Wagner, GG; Wang, JJ; Wareham, NJ; Weir, DR; Willemsen, G; Willeit, J; Wright, AF; Zondervan, KT; Stefansson, K; Krueger, RF; Lee, JJ; Benjamin, DJ; Cesarini, D; Koellinger, PD; den Hoed, M; Snieder, H; Mills, MC				Barban, Nicola; Jansen, Rick; de Vlaming, Ronald; Vaez, Ahmad; Mandemakers, Jornt J.; Tropf, Felix C.; Shen, Xia; Wilson, James F.; Chasman, Daniel I.; Nolte, Illa M.; Tragante, Vinicius; van der Laan, Sander W.; Perry, John R. B.; Kong, Augustine; Ahluwalia, Tarunveer S.; Albrecht, Eva; Yerges-Armstrong, Laura; Atzmon, Gil; Auro, Kirsi; Ayers, Kristin; Bakshi, Andrew; Ben-Avraham, Danny; Berger, Klaus; Bergman, Aviv; Bertram, Lars; Bielak, Lawrence F.; Bjornsdottir, Gyda; Bonder, Marc Jan; Broer, Linda; Bui, Minh; Barbieri, Caterina; Cavadino, Alana; Chavarro, Jorge E.; Turman, Constance; Concas, Maria Pina; Cordell, Heather J.; Davies, Gail; Eibich, Peter; Eriksson, Nicholas; Esko, Tonu; Eriksson, Joel; Falahi, Fahimeh; Felix, Janine F.; Fontana, Mark Alan; Franke, Lude; Gandin, Ilaria; Gaskins, Audrey J.; Gieger, Christian; Gunderson, Erica P.; Guo, Xiuqing; Hayward, Caroline; He, Chunyan; Hofer, Edith; Huang, Hongyan; Joshi, Peter K.; Kanoni, Stavroula; Karlsson, Robert; Kiechl, Stefan; Kifley, Annette; Kluttig, Alexander; Kraft, Peter; Lagou, Vasiliki; Lecoeur, Cecile; Lahti, Jari; Li-Gao, Ruifang; Lind, Penelope A.; Liu, Tian; Makalic, Enes; Mamasoula, Crysovalanto; Matteson, Lindsay; Mbarek, Hamdi; McArdle, Patrick F.; McMahon, George; Meddens, S. Fleur W.; Mihailov, Evelin; Miller, Mike; Missmer, Stacey A.; Monnereau, Claire; van der Most, Peter J.; Myhre, Ronny; Nalls, Mike A.; Nutile, Teresa; Kalafati, Ioanna Panagiota; Porcu, Eleonora; Prokopenko, Inga; Rajan, Kumar B.; Rich-Edwards, Janet; Rietveld, Cornelius A.; Robino, Antonietta; Rose, Lynda M.; Rueedi, Rico; Ryan, Kathleen-A; Saba, Yasaman; Schmidt, Daniel; Smith, Jennifer A.; Stolk, Lisette; Streeten, Elizabeth; Toenjes, Anke; Thorleifsson, Gudmar; Ulivi, Sheila; Wedenoja, Juho; Wellmann, Juergen; Willeit, Peter; Yao, Jie; Yengo, Loic; Zhao, Jing Hua; Zhao, Wei; Zhernakova, Dania V.; Amin, Najaf; Andrews, Howard; Balkau, Beverley; Barzilai, Nir; Bergmann, Sven; Biino, Ginevra; Bisgaard, Hans; Bonnelykke, Klaus; Boomsma, Dorret I.; Buring, Julie E.; Campbell, Harry; Cappellani, Stefania; Ciullo, Marina; Cox, Simon R.; Cucca, Francesco; Toniolo, Daniela; Davey-Smith, George; Deary, Ian J.; Dedoussis, George; Deloukas, Panos; van Duijn, Cornelia M.; de Geus, Eco J. C.; Eriksson, Johan G.; Evans, Denis A.; Faul, Jessica D.; Sala, Cinzia Felicita; Froguel, Philippe; Gasparini, Paolo; Girotto, Giorgia; Grabe, Hans-Joergen; Greiser, Karin Halina; Groenen, Patrick J. F.; de Haan, Hugoline G.; Haerting, Johannes; Harris, Tamara B.; Heath, Andrew C.; Heikkila, Kauko; Hofman, Albert; Homuth, Georg; Holliday, Elizabeth G.; Hopper, John; Hypponen, Elina; Jacobsson, Bo; Jaddoe', Vincent W. V.; Johannesson, Magnus; Kahonen, Mika; Kajantie, Eero; Kardia, Sharon L. R.; Keavney, Bernard; Kolcic, Ivana; Koponen, Paivikki; Kovacs, Peter; Kronenberg, Florian; Kutalik, Zoltan; La Bianca, Martina; Lachance, Genevieve; Iacono, William G.; Lai, Sandra; Lehtimaki, Terho; Liewald, David C.; Lindgren, Cecilia M.; Liu, Yongmei; Luben, Robert; Lucht, Michael; Luoto, Riitta; Magnus, Per; Magnusson, Patrik K. E.; Martin, Nicholas G.; McGue, Matt; McQuillan, Ruth; Medland, Sarah E.; Meisinger, Christa; Mellstrom, Dan; Metspalu, Andres; Traglia, Michela; Milani, Lili; Mitchell, Paul; Montgomery, Grant W.; Mook-Kanamori, Dennis; de Mutsert, Renee; Nohr, Ellen A.; Ohlsson, Claes; Olsen, Porn; Ong, Ken K.; Paternoster, Lavinia; Pattie, Alison; Penninx, Brenda W. J. H.; Perola, Markus; Peyser, Patricia A.; Pirastu, Mario; Polasek, Ozren; Power, Chris; Kaprio, Jaakko; Raffel, Leslie J.; Raikkonen, Katri; Raitakari, Olli; Ridker, Paul M.; Ring, Susan M.; Roll, Kathryn; Rudan, Igor; Ruggiero, Daniela; Rujescu, Dan; Salomaa, Veikko; Schlessinger, David; Schmidt, Helena; Schmidt, Reinhold; Schupf, Nicole; Smit, Johannes; Sorice, Rossella; Spector, Tim D.; Starr, John M.; Stockl, Doris; Strauch, Konstantin; Stumvoll, Michael; Swertz, Morris A.; Thorsteinsdottir, Unnur; Thurik, A. Roy; Timpson, Nicholas J.; Tung, Joyce Y.; Uitterlinden, Andre G.; Vaccargiu, Simona; Viikari, Jorma; Vitart, Veronique; Voelzke, Henry; Vollenweider, Peter; Vuckovic, Dragana; Waage, Johannes; Wagner, Gert G.; Wang, Jie Jin; Wareham, Nicholas J.; Weir, David R.; Willemsen, Gonneke; Willeit, Johann; Wright, Alan F.; Zondervan, Krina T.; Stefansson, Kari; Krueger, Robert F.; Lee, James J.; Benjamin, Daniel J.; Cesarini, David; Koellinger, Philipp D.; den Hoed, Marcel; Snieder, Harold; Mills, Melinda C.		Bios Consortium; LifeLines Cohort Study	Genome-wide analysis identifies 12 loci influencing human reproductive behavior	NATURE GENETICS			English	Article							POLYCYSTIC-OVARY-SYNDROME; GENE POLYMORPHISMS; QUALITY-CONTROL; HUMAN-DISEASES; ASSOCIATION; FERTILITY; INSIGHTS; PROTEIN; MOUSE; TRANSLOCATION	The genetic architecture of human reproductive behavior age at first birth (AFB) and number of children ever born (NEB) has a strong relationship with fitness, human development, infertility and risk of neuropsychiatric disorders. However, very few genetic loci have been identified, and the underlying mechanisms of AFB and NEB are poorly understood. We report a large genome-wide association study of both sexes including 251,151 individuals for AFB and 343,072 individuals for NEB. We identified 12 independent loci that are significantly associated with AFB and/or NEB in a SNP-based genome-wide association study and 4 additional loci associated in a gene-based effort. These loci harbor genes that are likely to have a role, either directly or by affecting non-local gene expression, in human reproduction and infertility, thereby increasing understanding of these complex traits.	[Barban, Nicola; Tropf, Felix C.; Mills, Melinda C.] Univ Oxford, Dept Sociol, Oxford, England; [Barban, Nicola; Tropf, Felix C.; Mills, Melinda C.] Univ Oxford, Nuffield Coll, Oxford, England; [Jansen, Rick; Penninx, Brenda W. J. H.; Smit, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [de Vlaming, Ronald; Rietveld, Cornelius A.; Thurik, A. Roy; Uitterlinden, Andre G.; Koellinger, Philipp D.] Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [de Vlaming, Ronald; Felix, Janine F.; Monnereau, Claire; Rietveld, Cornelius A.; Amin, Najaf; van Duijn, Cornelia M.; Hofman, Albert; Jaddoe', Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [de Vlaming, Ronald; Meddens, S. Fleur W.; Rietveld, Cornelius A.; Groenen, Patrick J. F.; Hofman, Albert; Thurik, A. Roy; Uitterlinden, Andre G.; Koellinger, Philipp D.] Erasmus Univ, Inst Behav & Biol, Rotterdam, Netherlands; [Vaez, Ahmad; Nolte, Illa M.; Falahi, Fahimeh; van der Most, Peter J.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Vaez, Ahmad] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommunicable Dis, Esfahan, Iran; [Mandemakers, Jornt J.] Wageningen Univ Res, Sociol Consumpt & Households, Wageningen, Netherlands; [Shen, Xia; Karlsson, Robert; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Shen, Xia; Wilson, James F.; Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Shen, Xia; Wilson, James F.; Joshi, Peter K.; Campbell, Harry; McQuillan, Ruth; Rudan, Igor] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Tragante, Vinicius] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [van der Laan, Sander W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Lab Expt Cardiol, Utrecht, Netherlands; [Perry, John R. B.; Zhao, Jing Hua; Ong, Ken K.; Wareham, Nicholas J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Kong, Augustine] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Kong, Augustine; Bjornsdottir, Gyda; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Ahluwalia, Tarunveer S.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr, Gentofte, Denmark; [Ahluwalia, Tarunveer S.; Bisgaard, Hans; Bonnelykke, Klaus; Waage, Johannes] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark; [Albrecht, Eva; Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Yerges-Armstrong, Laura; McArdle, Patrick F.; Ryan, Kathleen-A; Streeten, Elizabeth] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Inst Aging Res, Bronx, NY 10467 USA; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Atzmon, Gil; Ben-Avraham, Danny] Albert Einstein Coll Med, Inst Aging Res, Dept Genet, Bronx, NY 10467 USA; [Atzmon, Gil] Univ Haifa, Dept Nat Sci, Haifa, Israel; [Auro, Kirsi; Perola, Markus; Kaprio, Jaakko; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Auro, Kirsi; Heikkila, Kauko; Perola, Markus; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Ayers, Kristin; Cordell, Heather J.; Mamasoula, Crysovalanto; Keavney, Bernard] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Bakshi, Andrew] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Berger, Klaus; Wellmann, Juergen] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Bertram, Lars] Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt, Inst Neurogenet, Lubeck, Germany; [Bertram, Lars] Univ Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany; [Bertram, Lars] Imperial Coll, Fac Med, Sch Publ Hlth, London, England; [Bielak, Lawrence F.; Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.; Peyser, Patricia A.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bonder, Marc Jan; Franke, Lude; Zhernakova, Dania V.; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Genom Coordinat Ctr, Groningen, Netherlands; [Broer, Linda; Stolk, Lisette; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bui, Minh; Makalic, Enes; Schmidt, Daniel; Hopper, John] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Barbieri, Caterina; Toniolo, Daniela; Sala, Cinzia Felicita; Traglia, Michela] San Raffaele Res Inst, Div Genet & Cell Biol, Milan, Italy; [Cavadino, Alana; Hypponen, Elina; Power, Chris] UCL Inst Child Hlth, Populat Policy & Practice, London, England; [Cavadino, Alana] Queen Mary Univ London, Wolfson Inst Preventat Med, Ctr Environm & Prevent Med, London, England; [Chavarro, Jorge E.; Gaskins, Audrey J.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Chavarro, Jorge E.; Rich-Edwards, Janet] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Chavarro, Jorge E.; Rich-Edwards, Janet] Harvard Med Sch, Boston, MA USA; [Chavarro, Jorge E.; Turman, Constance; Huang, Hongyan; Kraft, Peter; Missmer, Stacey A.; Rich-Edwards, Janet; Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Concas, Maria Pina; Pirastu, Mario; Vaccargiu, Simona] CNR, UOS Sassari, Inst Genet & Biomed Res, Sassari, Italy; [Davies, Gail; Cox, Simon R.; Deary, Ian J.; Liewald, David C.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Cox, Simon R.; Deary, Ian J.; Pattie, Alison] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Eibich, Peter] Univ Oxford, Hlth Econ Res Ctr, Oxford, England; [Eriksson, Nicholas; Tung, Joyce Y.] 23andMe Inc, Mountain View, CA USA; [Mihailov, Evelin; Metspalu, Andres; Milani, Lili; Perola, Markus] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Esko, Tonu] Broad Inst MIT & Harvard, Cambridge, MA USA; [Eriksson, Joel; Mellstrom, Dan; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Felix, Janine F.; Monnereau, Claire; Jaddoe', Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Felix, Janine F.; Monnereau, Claire; Jaddoe', Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Fontana, Mark Alan; Benjamin, Daniel J.] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA USA; [Gandin, Ilaria; Gasparini, Paolo; Girotto, Giorgia; Vuckovic, Dragana] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Gieger, Christian; Meisinger, Christa] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Gunderson, Erica P.] Kaiser Permanente Northern Calif, Div Res, Cardiovasc & Metab Condit Sect, Oakland, CA USA; [Guo, Xiuqing; Yao, Jie; Roll, Kathryn] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [He, Chunyan] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Clin Div Neurogeriatr, Dept Neurol, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Kanoni, Stavroula; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Kiechl, Stefan; Willeit, Peter; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Kifley, Annette; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW, Australia; [Kifley, Annette; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Inst Med Res, Westmead, NSW, Australia; [Kluttig, Alexander; Haerting, Johannes] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Saale, Germany; [Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lagou, Vasiliki] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Lagou, Vasiliki] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lagou, Vasiliki] VIB, Translat Immunol Lab, Leuven, Belgium; [Lecoeur, Cecile; Yengo, Loic; Balkau, Beverley; Froguel, Philippe] Univ Lille, CNRS, Inst Pasteur Lille, Lille, France; [Lahti, Jari; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [Lahti, Jari; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Li-Gao, Ruifang; de Haan, Hugoline G.; Mook-Kanamori, Dennis; de Mutsert, Renee] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Lind, Penelope A.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Psychiat Genet, Herston Brisbane, Qld, Australia; [Liu, Tian] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Liu, Tian] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany; [Matteson, Lindsay] Univ Minnesota, Dept Psychol, Minnesota Ctr Twin & Family Res, Minneapolis, MN USA; [Mbarek, Hamdi; Boomsma, Dorret I.; de Geus, Eco J. C.; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Mbarek, Hamdi; Boomsma, Dorret I.; de Geus, Eco J. C.; Penninx, Brenda W. J. H.; Smit, Johannes; Willemsen, Gonneke] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [McMahon, George] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Meddens, S. Fleur W.; Koellinger, Philipp D.] Vrije Univ Amsterdam, Complex Trait Genet, Amsterdam, Netherlands; [Miller, Mike; Iacono, William G.; McGue, Matt; Krueger, Robert F.; Lee, James J.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Missmer, Stacey A.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA USA; [Missmer, Stacey A.] Harvard Med Sch, Boston, MA USA; [Myhre, Ronny; Jacobsson, Bo; Magnus, Per] Inst Publ Hlth, Area Hlth Data & Digitalizat, Dept Genet & Bioinformat, Oslo, Norway; [Nalls, Mike A.] NIA, Lab Neurogenet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Nutile, Teresa; Ciullo, Marina; Ruggiero, Daniela; Sorice, Rossella] CNR, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Kalafati, Ioanna Panagiota; Dedoussis, George] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Porcu, Eleonora; Cucca, Francesco; Lai, Sandra] Cittadella Univ Monserrato, Ist Ric Genet & Biomed, CMR, Cagliari, Italy; [Porcu, Eleonora; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy; [Prokopenko, Inga] Imperial Coll London, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Prokopenko, Inga; Lindgren, Cecilia M.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Prokopenko, Inga; Lindgren, Cecilia M.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Rajan, Kumar B.; Evans, Denis A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Rich-Edwards, Janet] Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, 75 Francis St, Boston, MA 02115 USA; [Rich-Edwards, Janet] Harvard Med Sch, Boston, MA USA; [Robino, Antonietta; Ulivi, Sheila; Cappellani, Stefania; La Bianca, Martina] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Rueedi, Rico; Bergmann, Sven] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Rueedi, Rico; Bergmann, Sven; Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Wedenoja, Juho; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Willeit, Peter] Kings British Heart Fdn Ctr, Kings Coll London, London, England; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Yengo, Loic] Univ Queensland, Ctr Neurogenet & Stat Genom, Brisbane, Qld, Australia; [Andrews, Howard] New York State Psychiat Inst & Hosp, Data Coordinating Ctr, New York, NY 10032 USA; [Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Ciullo, Marina; Sorice, Rossella] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Davey-Smith, George; Paternoster, Lavinia; Ring, Susan M.; Timpson, Nicholas J.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Eriksson, Johan G.; Lucht, Michael] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Gasparini, Paolo; Girotto, Giorgia; Vuckovic, Dragana] Sidra, Div Expt Genet, Doha, Qatar; [Grabe, Hans-Joergen] Univ Med Greifswald, Dept Psychiat, Greifswald, Germany; [Greiser, Karin Halina] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Groenen, Patrick J. F.] Erasmus Univ, Erasmus Sch Econ, Econometric Inst, Rotterdam, Netherlands; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Heath, Andrew C.; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia; [Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Holliday, Elizabeth G.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Holliday, Elizabeth G.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Hypponen, Elina] Univ South Australia, Sansom Inst Hlth Res, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Hypponen, Elina] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, Stockholm, Sweden; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Kahonen, Mika] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Kajantie, Eero] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, Dept Obstet & Gynecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Keavney, Bernard] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [Kolcic, Ivana; Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split, Croatia; [Koponen, Paivikki] Natl Inst Hlth & Welf, Hlth Monitoring Unit, Helsinki, Finland; [Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Innsbruck, Austria; [Kutalik, Zoltan] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med, Lausanne, Switzerland; [Lachance, Genevieve; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Tampere, Finland; [Lindgren, Cecilia M.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Luben, Robert] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Luoto, Riitta] UKK Inst Hlth Promot, Tampere, Finland; [McGue, Matt] Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, Odense, Denmark; [McGue, Matt] Univ Southern Denmark, Inst Publ Hlth, Danish Twin Registry, Odense, Denmark; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Montgomery, Grant W.] Univ Queensland, Mol Biosci, Brisbane, Qld, Australia; [Mook-Kanamori, Dennis] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Mook-Kanamori, Dennis] King Faisal Specialist Hosp & Res Ctr, Epidemiol Sect, Dept BESC, Riyadh, Saudi Arabia; [Nohr, Ellen A.] Univ Southern Denmark, Dept Clin Res, Res Unit Gynecol & Obstet, Odense, Denmark; [Olsen, Porn] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark; [Raffel, Leslie J.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Saale, Germany; [Schlessinger, David] NIA, Lab Genet, Baltimore, MD 21224 USA; [Schupf, Nicole; Stockl, Doris] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [Schupf, Nicole; Stockl, Doris] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Thurik, A. Roy] Montpellier Business Sch, Montpellier, France; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, Div Med, Turku, Finland; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Vollenweider, Peter] Lausanne Univ Hosp CHUV, Dept Internal Med, Lausanne, Switzerland; [Wagner, Gert G.] Max Planck Inst Human Dev, German Socioecon Panel Study SOEP, Berlin, Germany; [Wagner, Gert G.] Berlin Univ Technol TUB, Berlin, Germany; [Zondervan, Krina T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Zondervan, Krina T.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Endometriosis CaRe Ctr, Oxford, England; [Benjamin, Daniel J.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Cesarini, David] NYU, Dept Econ, New York, NY 10003 USA; [Cesarini, David] Res Inst Ind Econ, Stockholm, Sweden; [den Hoed, Marcel] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden	University of Oxford; University of Oxford; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; University of Groningen; Isfahan University Medical Science; Wageningen University & Research; Karolinska Institutet; University of Edinburgh; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Iceland; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Maryland; University of Maryland Baltimore; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Haifa; Finland National Institute for Health & Welfare; University of Helsinki; Newcastle University - UK; University of Queensland; University of Munster; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Lubeck; University of Lubeck; Imperial College London; University of Michigan System; University of Michigan; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Melbourne; University of London; University College London; University of London; Queen Mary University London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Edinburgh; University of Edinburgh; University of Oxford; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Gothenburg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southern California; University of Trieste; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Medical University of Graz; Medical University of Graz; University of London; Queen Mary University London; Medical University of Innsbruck; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Martin Luther University Halle Wittenberg; Harvard University; Harvard T.H. Chan School of Public Health; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Helsinki; University of Helsinki; Folkhalsan Research Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; QIMR Berghofer Medical Research Institute; Max Planck Society; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Bristol; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Harokopio University Athens; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; University of Sassari; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Rush University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; IRCCS Burlo Garofolo; University of Lausanne; Swiss Institute of Bioinformatics; Medical University of Graz; Leipzig University; University of Helsinki; University of London; King's College London; University of Cambridge; University of Queensland; New York State Psychiatry Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Neuromed; University of Bristol; King Abdulaziz University; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; University of Michigan System; University of Michigan; Sidra Medical & Research Center; Greifswald Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Erasmus University Rotterdam; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); QIMR Berghofer Medical Research Institute; Greifswald Medical School; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Gothenburg; Stockholm School of Economics; Tampere University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Manchester; University of Split; Finland National Institute for Health & Welfare; Leipzig University; Medical University of Innsbruck; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; King's College London; Tampere University; Tampere University; University of Oxford; University of Oxford; Wake Forest University; University of Cambridge; UKK Institute; University of Southern Denmark; University of Southern Denmark; University of Tartu; University of Queensland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; King Faisal Specialist Hospital & Research Center; University of Southern Denmark; Aarhus University; Cedars Sinai Medical Center; University of Turku; University of Turku; Martin Luther University Halle Wittenberg; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University; Columbia University; University of Edinburgh; University of Munich; University of Iceland; Montpellier Business School; University of Turku; University of Turku; Greifswald Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; National Bureau of Economic Research; New York University; Research Institute of Industrial Economics (IFN); Uppsala University	Barban, N; Mills, MC (corresponding author), Univ Oxford, Dept Sociol, Oxford, England.; Snieder, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; den Hoed, M (corresponding author), Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden.	nicola.barban@sociology.ox.ac.uk; marcel.den_hoed@medsci.uu.se; h.snieder@umcg.nl; melinda.mills@nuffield.ox.ac.uk	Sala, Cinzia Felicita/AAN-1900-2020; Cavadino, Alana/CAG-8915-2022; Timpson, Nicholas John/O-7548-2015; Colaus, PsyColaus/K-6607-2013; wang, jie/GRS-0942-2022; Yengo, Loic/D-2692-2017; Traglia, Michela/AAX-5816-2020; Milani, Lili/N-1097-2019; Willeit, Peter/HCI-7091-2022; Lahti, Jari/P-2283-2019; Lind, Penelope A/B-2553-2009; Raitakari, Olli/AAQ-7389-2021; Magnusson, Patrik KE/C-4458-2017; Lai, Sandra/AAY-4176-2020; Rujescu, Dan/GRS-3875-2022; Penninx, Brenda WJH/S-7627-2017; Hypponen, Elina/B-2596-2014; Vaez, Ahmad/B-4336-2018; Attrill, Lauren/V-1688-2018; Kalafati, Ioanna-Panagiota/AAJ-2287-2020; Shen, Xia/AAO-4233-2020; Biino, Ginevra/B-5334-2013; Heikkilä, Kauko/E-5578-2019; Ahluwalia, Tarunveer Singh/C-5549-2009; Stumvoll, Michael/ABE-1121-2021; Schmidt, Reinhold/E-1137-2014; Lind, Penelope A/ABC-5341-2021; Prokopenko, Inga/H-3241-2014; Lehtimäki, Terho/AAD-1094-2022; Prokopenko, Inga/AAU-9895-2020; Gaskins, Audrey/K-6246-2019; Meisinger, Christine/B-5358-2014; Thurik, Roy/A-9386-2012; Lahti, Jari/P-7987-2018; Deary, Ian J/C-6297-2009; ruggiero, daniela/K-5638-2016; Wedenoja, Juho/AAX-7008-2020; Ohlsson, Claes/AGP-3544-2022; Campbell, Harry/E-2959-2010; den Hoed, Marcel/I-7138-2017; Gandin, Ilaria/B-2634-2017; Kolcic, Ivana/E-2713-2017; Dedoussis, George/AAN-7252-2021; de Geus, Eco J.C./M-9318-2015; van der Laan, Sander W./N-1330-2019; FROGUEL, Philippe/O-6799-2017; Wagner, Gert G./AIC-8679-2022; Jacobsson, Bo/O-8007-2014; Gasparini, Paolo/B-6173-2014; Luben, Robert N/H-5519-2015; Medland, Sarah/AAT-7595-2020; Johannesson, Magnus/E-9680-2011; Bisgaard, Hans/N-4761-2016; Kraft, Peter/GQH-8448-2022; Kronenberg, Florian/B-1736-2008; Wilson, James F/A-5704-2009; Kanoni, Stavroula/AAN-7161-2021; Davey Smith, George/A-7407-2013; Bertram, Lars/K-3889-2015; Wang, Jie Jin/P-1499-2014; Concas, Maria Pina/K-2266-2018; Li-Gao, Ruifang/B-7172-2018; Cox, Simon R./HDN-8568-2022; Polasek, Ozren/B-6002-2011; Kaprio, Jaakko/A-1820-2008; Ciullo, Marina/AAE-3041-2020; Chavarro, Jorge E/AAE-5665-2021; Toniolo, Daniela/AAE-2969-2019; Boomsma, Dorret I/AAX-4470-2020; Rudan, Igor/I-1467-2012; Montgomery, Grant W/B-7148-2008; Medland, Sarah E/C-7630-2013; Mitchell, Paul/P-1498-2014; Stefansson, Kari/AAE-7187-2019; Fox, Laura J/C-6249-2016; Zondervan, Krina/M-1143-2013; Robino, Antonietta/K-9398-2016; Franke, Lude/P-7036-2016; Girotto, Giorgia/I-9452-2018	Cavadino, Alana/0000-0002-5709-367X; Timpson, Nicholas John/0000-0002-7141-9189; Yengo, Loic/0000-0002-4272-9305; Milani, Lili/0000-0002-5323-3102; Willeit, Peter/0000-0002-1866-7159; Lahti, Jari/0000-0002-4310-5297; Lind, Penelope A/0000-0002-3887-2598; Magnusson, Patrik KE/0000-0002-7315-7899; Penninx, Brenda WJH/0000-0001-7779-9672; Hypponen, Elina/0000-0003-3670-9399; Vaez, Ahmad/0000-0001-9048-3795; Shen, Xia/0000-0003-4390-1979; Biino, Ginevra/0000-0002-9936-946X; Heikkilä, Kauko/0000-0002-9256-8028; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Stumvoll, Michael/0000-0001-6225-8240; Lind, Penelope A/0000-0002-3887-2598; Prokopenko, Inga/0000-0003-1624-7457; Lehtimäki, Terho/0000-0002-2555-4427; Thurik, Roy/0000-0002-0242-6908; Lahti, Jari/0000-0002-4310-5297; Deary, Ian J/0000-0002-1733-263X; ruggiero, daniela/0000-0003-3898-7827; Wedenoja, Juho/0000-0002-6155-0378; Ohlsson, Claes/0000-0002-9633-2805; Campbell, Harry/0000-0002-6169-6262; den Hoed, Marcel/0000-0001-8081-428X; Gandin, Ilaria/0000-0003-3196-2491; Kolcic, Ivana/0000-0001-7918-6052; Dedoussis, George/0000-0002-7798-6221; de Geus, Eco J.C./0000-0001-6022-2666; van der Laan, Sander W./0000-0001-6888-1404; FROGUEL, Philippe/0000-0003-2972-0784; Jacobsson, Bo/0000-0001-5079-2374; Luben, Robert N/0000-0002-5088-6343; Medland, Sarah/0000-0003-1382-380X; Johannesson, Magnus/0000-0001-8759-6393; Bisgaard, Hans/0000-0003-4131-7592; Kronenberg, Florian/0000-0003-2229-1120; Wilson, James F/0000-0001-5751-9178; Kanoni, Stavroula/0000-0002-1691-9615; Davey Smith, George/0000-0002-1407-8314; Bertram, Lars/0000-0002-0108-124X; Wang, Jie Jin/0000-0001-9491-4898; Concas, Maria Pina/0000-0003-3598-2537; Li-Gao, Ruifang/0000-0003-0650-1351; Cox, Simon R./0000-0003-4036-3642; Polasek, Ozren/0000-0002-5765-1862; Kaprio, Jaakko/0000-0002-3716-2455; Ciullo, Marina/0000-0002-9621-9984; Chavarro, Jorge E/0000-0002-4436-9630; Toniolo, Daniela/0000-0001-9545-6032; Rudan, Igor/0000-0001-6993-6884; Montgomery, Grant W/0000-0002-4140-8139; Medland, Sarah E/0000-0003-1382-380X; Faul, Jessica/0000-0002-6969-6478; Smith, Jennifer Ann/0000-0002-3575-5468; Amin, Najaf/0000-0002-8944-1771; s, hema/0000-0002-3440-9475; NUTILE, TERESA/0000-0001-7062-8352; Bakshi, Andrew/0000-0001-5650-7036; CUCCA, Francesco/0000-0002-7414-1995; Van Duijn, Cornelia/0000-0002-2374-9204; de Vlaming, Ronald/0000-0001-6416-6067; Kovacs, Peter/0000-0002-0290-5423; Barban, Nicola/0000-0002-4362-4652; Bjornsdottir, Gyda/0000-0002-8100-0306; Zondervan, Krina/0000-0002-0275-9905; Kraft, Peter/0000-0002-4472-8103; Joshi, Peter/0000-0002-6361-5059; Ayers, Kristin/0000-0002-4984-5229; Kahonen, Mika/0000-0002-4510-7341; Lagou, Vasiliki/0000-0003-3165-8940; Broer, Linda/0000-0003-0011-123X; Robino, Antonietta/0000-0003-2152-2353; Jansen, Rick/0000-0002-3333-6737; Bonder, Marc Jan/0000-0002-8431-3180; de Haan, Hugoline/0000-0003-1126-4776; Gasparini, Paolo/0000-0002-0859-0856; Saba, Yasaman/0000-0002-3549-2493; cappellani, stefania/0000-0002-1126-5202; Kong, Augustine/0000-0001-8193-5438; Mbarek, Hamdi/0000-0002-1108-0371; Franke, Lude/0000-0002-5159-8802; Willemsen, Gonneke/0000-0003-3755-0236; Cordell, Heather/0000-0002-1879-5572; Bui, Minh/0000-0002-9099-6870; Bergmann, Sven/0000-0002-6785-9034; Girotto, Giorgia/0000-0003-4507-6589; Raikkonen, Katri/0000-0003-3124-3470; Bonnelykke, Klaus/0000-0003-2003-1018; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Koellinger, Philipp/0000-0001-7413-0412; Makalic, Enes/0000-0003-3017-0871; Keavney, Bernard/0000-0001-9573-0812; Lindgren, Cecilia/0000-0002-4903-9374; Vuckovic, Dragana/0000-0001-9343-6142; Groenen, Patrick/0000-0001-6683-8971	ERC Consolidator Grant SOCIOGENOME [615603]; Dutch Science Foundation (NWO) grant (VIDI grant) [452-10-012]; UK ESRC/NCRM SOCGEN grant [ES/N011856/1]; European Union [320116]; Wellcome Trust ISSF; John Fell Fund; Swedish Research Council [2015-03657, 421-2013-1061, 537-2014-371]; Swedish Heart-Lung Foundation [20140543]; US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium'); National Institutes of Health Office of Behavioral and Social Science Research; Ragnar Soderberg Foundation [E9/11]; Jan Wallander and Tom Hedelius Foundation; ERC [647648 EdGe]; Pershing Square Fund of the Foundations of Human Behavior; NIA/NIH [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23, R01-AG042568-02]; British Heart Foundation [RG/15/12/31616] Funding Source: researchfish; Economic and Social Research Council [ES/N011856/1] Funding Source: researchfish; Lundbeck Foundation [R163-2013-16235] Funding Source: researchfish; Medical Research Council [MR/K026992/1, MC_U106179471, MC_PC_U127561128, MC_UU_12015/2, 1201677, G9815508, MC_PC_13048, G1001799, MC_UU_12013/1, MR/J012165/1, MC_UU_12015/1, MC_U106179472, MR/N01104X/1, MC_UU_12013/3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027, NF-SI-0507-10228] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005785, NNF12OC1016374, NNF15OC0016362, NNF14OC0010513] Funding Source: researchfish; ESRC [ES/N011856/1] Funding Source: UKRI; MRC [MC_PC_U127561128, G1001799, MR/J012165/1, MC_UU_12015/1, MC_UU_12013/3, MC_UU_12013/1, MC_U106179472, MC_UU_12015/2, MR/N01104X/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012810, R01AG051635, T32AG000186, ZIAAG006000, ZIAAG000647, ZIAAG000675, R01AG042568, P01AG005842, P30AG038072, U01AG016976] Funding Source: NIH RePORTER	ERC Consolidator Grant SOCIOGENOME; Dutch Science Foundation (NWO) grant (VIDI grant); UK ESRC/NCRM SOCGEN grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Union(European Commission); Wellcome Trust ISSF(Wellcome Trust); John Fell Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium')(National Science Foundation (NSF)); National Institutes of Health Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragnar Soderberg Foundation; Jan Wallander and Tom Hedelius Foundation; ERC(European Research Council (ERC)European Commission); Pershing Square Fund of the Foundations of Human Behavior(Pershing Square Foundation); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	For full acknowledgments, see the Supplementary Note. Funding to lead this consortium was provided by grants awarded to M.C.M.: ERC Consolidator Grant SOCIOGENOME (615603), a Dutch Science Foundation (NWO) grant (VIDI grant 452-10-012), a UK ESRC/NCRM SOCGEN grant (ES/N011856/1), the European Union's FP7 Families And Societies project (320116), and the Wellcome Trust ISSF and John Fell Fund. M.d.H. was supported by grants from the Swedish Research Council (2015-03657) and the Swedish Heart-Lung Foundation (20140543). Research was carried out in collaboration with the Social Science Genetic Association Consortium (SSGAC), with funding from the US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium'), a Supplementary grant from the National Institutes of Health Office of Behavioral and Social Science Research, the Ragnar Soderberg Foundation (E9/11), the Swedish Research Council (421-2013-1061), the Jan Wallander and Tom Hedelius Foundation, an ERC Consolidator Grant (647648 EdGe), the Pershing Square Fund of the Foundations of Human Behavior and the NIA/NIH through grants P01-AG005842, P01-AG005842-20S2, P30-AG012810 and T32-AG000186-23 to NBER and R01-AG042568-02 to the University of Southern California. X.S. was supported by a grant from the Swedish Research Council (537-2014-371). We thank X. Ding for research assistance, N. Pirastu, K. Coward and L. Layman for valuable comments, and the University of Oxford Advanced Research Computing (ARC) facility (http://dx.doi.org/10.5281/zenodo.22558). This research has been conducted using the UK Biobank Resource.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Alves MG, 2015, CELL TISSUE RES, V362, P431, DOI 10.1007/s00441-015-2217-5; Bagley DC, 2012, J BIOL CHEM, V287, P25577, DOI 10.1074/jbc.M112.354043; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Bao S, 2016, J CLIN RES PEDIATR E, V8, P135, DOI 10.4274/jcrpe.2259; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Bonder M.J., 2015, DIS VARIANTS ALTER T; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buensuceso AV, 2016, ENDOCRINOLOGY, V157, P942, DOI 10.1210/en.2015-1216; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cao GT, 2002, J HUM GENET, V47, P373, DOI 10.1007/s100380200053; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chiu YC, 2014, DEV NEUROBIOL, V74, P723, DOI 10.1002/dneu.22166; Day FR, 2016, NAT GENET, V48, P617, DOI 10.1038/ng.3551; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9464; de Mattos CS, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0114-2; El-Alfy M, 2006, J ANDROL, V27, P686, DOI 10.2164/jandrol.106.000596; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Fang WL, 2012, J CELL PHYSIOL, V227, P2430, DOI 10.1002/jcp.22978; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fisher R., 1930, GENETICAL THEORY NAT; Franklin RB, 2003, J INORG BIOCHEM, V96, P435, DOI 10.1016/S0162-0134(03)00249-6; Heath E, 2010, CHROMOSOME RES, V18, P851, DOI 10.1007/s10577-010-9170-7; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Impera L, 2008, ONCOGENE, V27, P6187, DOI 10.1038/onc.2008.214; Jisa E, 2003, J STEROID BIOCHEM, V84, P141, DOI 10.1016/S0960-0760(03)00023-2; Joshi NR, 2015, HUM REPROD, V30, P2881, DOI 10.1093/humrep/dev229; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lamp M, 2011, GYNECOL ENDOCRINOL, V27, P425, DOI 10.3109/09513590.2010.495434; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111; Mehta D, 2016, JAMA PSYCHIAT, V73, P497, DOI 10.1001/jamapsychiatry.2016.0129; MENKEN J, 1985, DEMOGRAPHY, V22, P469, DOI 10.2307/2061583; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Mills MC, 2015, KOLNER Z SOZIOL SOZ, V67, P397, DOI 10.1007/s11577-015-0319-4; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Mojiminiyi OA, 2010, SCAND J CLIN LAB INV, V70, P554, DOI 10.3109/00365513.2010.526242; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Okkelman IA, 2014, CELL TISSUE RES, V358, P481, DOI 10.1007/s00441-014-1972-z; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Perry JRB, 2013, HUM MOL GENET, V22, P1465, DOI 10.1093/hmg/dds551; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pers TH, 2013, NUCLEIC ACIDS RES, V41, pW104, DOI 10.1093/nar/gkt387; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rahmioglu N, 2014, HUM REPROD UPDATE, V20, P702, DOI 10.1093/humupd/dmu015; Reese KL, 2010, MOL REPROD DEV, V77, P759, DOI 10.1002/mrd.21217; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Ruan YB, 2011, J BIOL CHEM, V286, P29417, DOI 10.1074/jbc.M111.274647; Sakamoto O, 1997, J CLIN INVEST, V99, P701, DOI 10.1172/JCI119214; Szucs M, 2015, ANDROLOGIA, V47, P519, DOI 10.1111/and.12296; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tropf FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126821; Tsukamoto S, 2013, J REPROD DEVELOP, V59, P33; Urano A, 2005, MOL CELL BIOL, V25, P6834, DOI 10.1128/MCB.25.15.6834-6845.2005; Vaez A, 2015, CIRC-CARDIOVASC GENE, V8, P487, DOI 10.1161/CIRCGENETICS.114.000714; van der Most PJ, 2014, BIOINFORMATICS, V30, P1185, DOI 10.1093/bioinformatics/btt745; Van Maldergem L, 2006, J MED GENET, V43, P148, DOI 10.1136/jmg.2005.031781; Varshney GK, 2016, NUCLEIC ACIDS RES, V44, pD822, DOI 10.1093/nar/gkv998; Venkatesh T, 2014, APPL CLIN GENET, V7, P235, DOI 10.2147/TACG.S40809; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhang CG, 2013, AM J PHYSIOL-ENDOC M, V305, pE1384, DOI 10.1152/ajpendo.00406.2013; Zhernakova D., 2015, HYPOTHESIS FREE IDEN	79	145	146	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1462	1472		10.1038/ng.3698	http://dx.doi.org/10.1038/ng.3698			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27798627	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000389011100006
J	Shinawi, M; Schaaf, CP; Bhatt, SS; Xia, ZL; Patel, A; Cheung, SW; Lanpher, B; Nagl, S; Herding, HS; Nevinny-Stickel, C; Immken, LL; Patel, GS; German, JR; Beaudet, AL; Stankiewicz, P				Shinawi, Marwan; Schaaf, Christian P.; Bhatt, Samarth S.; Xia, Zhilian; Patel, Ankita; Cheung, Sau Wai; Lanpher, Brendan; Nagl, Sandra; Herding, Heinrich Stephan; Nevinny-Stickel, Claudia; Immken, LaDonna L.; Patel, Gayle Simpson; German, Jennifer Ruth; Beaudet, Arthur L.; Stankiewicz, Pawel			A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; MENTAL-RETARDATION; INCREASE RISK; GENE CHRNA7; SCHIZOPHRENIA; MICRODELETIONS; DUPLICATIONS; DISORDERS; SEIZURES; LOCUS	We report a recurrent 680-kb deletion within chromosome 15q13.3 in ten individuals, from four unrelated families, with neurodevelopmental phenotypes including developmental delay, mental retardation and seizures. This deletion likely resulted from nonallelic homologous recombination between low-copy repeats on the normal and inverted region of chromosome 15q13.3. Although this deletion also affects OTUD7A, accumulated data suggest that haploinsufficiency of CHRNA7 is causative for the majority of neurodevelopmental phenotypes in the 15q13.3 microdeletion syndrome.	[Shinawi, Marwan; Schaaf, Christian P.; Bhatt, Samarth S.; Xia, Zhilian; Patel, Ankita; Cheung, Sau Wai; German, Jennifer Ruth; Beaudet, Arthur L.; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lanpher, Brendan] Vanderbilt Univ, Div Genet & Genom Med, Nashville, TN USA; [Nagl, Sandra; Nevinny-Stickel, Claudia] Med Versorgungszentrum Humane Genet, Munich, Germany; [Stankiewicz, Pawel] Inst Mother & Child Hlth, Dept Med Genet, Warsaw, Poland	Baylor College of Medicine; Vanderbilt University	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.edu	Patel, Ankita/D-3247-2013; Schaaf, Christian P/AAJ-7318-2021; Bhatt, Samarth/H-2892-2019; Stankiewicz, Paweł/AAP-7906-2021	Schaaf, Christian P/0000-0002-2148-7490; Bhatt, Samarth/0000-0001-5706-4572; Stankiewicz, Paweł/0000-0002-6456-7490; shinawi, Marwan/0000-0003-1329-4100	US National Institutes of Health [HD-037283, M01-RR00188]; Mental Retardation and Developmental Disabilities Research Center [HD-024064]; Rare Disease Clinical Research Consortia [RR-019478]; William Stamps Farish Fund; Polish Ministry of Science and Higher Education [R13-0005-04/2008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283, P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019478, M01RR000188] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mental Retardation and Developmental Disabilities Research Center; Rare Disease Clinical Research Consortia; William Stamps Farish Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank all families who participated in this study; C. Carvalho, W. Gu, J. R. Lupski, C. Shaw and M. Strivens for helpful discussion; and P. Eng, Z. Ou and M. Suzuki for technical assistance. A. L. B. was supported by US National Institutes of Health grants HD-037283, M01-RR00188 (General Clinical Research Center), HD-024064 (Mental Retardation and Developmental Disabilities Research Center) and RR-019478 (Rare Disease Clinical Research Consortia) and by generous support from the William Stamps Farish Fund. P. S. was supported in part by grant R13-0005-04/2008 from the Polish Ministry of Science and Higher Education.	Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Broide RS, 2002, MOL PHARMACOL, V61, P695, DOI 10.1124/mol.61.3.695; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Leonard S, 2006, BIOL PSYCHIAT, V60, P115, DOI 10.1016/j.biopsych.2006.03.054; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Makoff AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r114; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Taske NL, 2002, EPILEPSY RES, V49, P157, DOI 10.1016/S0920-1211(02)00027-X; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412	15	145	147	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1269	1271		10.1038/ng.481	http://dx.doi.org/10.1038/ng.481			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19898479	Green Accepted			2022-12-17	WOS:000272144900005
J	Jiang, Z; Tang, H; Ventura, M; Cardone, MF; Marques-Bonet, T; She, X; Pevzner, PA; Eichler, EE				Jiang, Zhaoshi; Tang, Haixu; Ventura, Mario; Cardone, Maria Francesca; Marques-Bonet, Tomas; She, Xinwei; Pevzner, Pavel A.; Eichler, Evan E.			Ancestral reconstruction of segmental duplications reveals punctuated cores of human genome evolution	NATURE GENETICS			English	Article							HOMINOID EVOLUTION; GENE FAMILY; SEQUENCE; EXPANSION; REARRANGEMENTS; TRANSPOSITION; ORGANIZATION; EMERGENCE; INSIGHTS; DELETION	Human segmental duplications are hotspots for nonallelic homologous recombination leading to genomic disorders, copy-number polymorphisms and gene and transcript innovations. The complex structure and history of these regions have precluded a global evolutionary analysis. Combining a modified A-Bruijn graph algorithm with comparative genome sequence data, we identify the origin of 4,692 ancestral duplication loci and use these to cluster 437 complex duplication blocks into 24 distinct groups. The sequence-divergence data between ancestral-derivative pairs and a comparison with the chimpanzee and macaque genome support a `punctuated' model of evolution. Our analysis reveals that human segmental duplications are frequently organized around `core' duplicons, which are enriched for transcripts and, in some cases, encode primate-specific genes undergoing positive selection. We hypothesize that the rapid expansion and fixation of some intrachromosomal segmental duplications during great-ape evolution has been due to the selective advantage conferred by these genes and transcripts embedded within these core duplications.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA 98195 USA; Indiana Univ, Sch Informat, Bloomington, IN 47408 USA; Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47408 USA; Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; Univ Calif Santa Cruz, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universita degli Studi di Bari Aldo Moro; University of California System; University of California Santa Cruz	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Cardone, Maria Francesca/G-8818-2012; Ventura, Mario/E-6420-2011; Marques-Bonet, Tomas/I-4618-2014; Marques-Bonet, Tomas/ABF-3734-2020	Cardone, Maria Francesca/0000-0002-7597-7313; Ventura, Mario/0000-0001-7762-8777; Marques-Bonet, Tomas/0000-0002-5597-3075; Marques-Bonet, Tomas/0000-0002-5597-3075				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Eichler EE, 2001, J HERED, V92, P462, DOI 10.1093/jhered/92.6.462; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Jackson MS, 2005, AM J HUM GENET, V77, P824, DOI 10.1086/497704; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Locke DP, 2005, CYTOGENET GENOME RES, V108, P73, DOI 10.1159/000080804; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Orti R, 1998, CYTOGENET CELL GENET, V83, P262, DOI 10.1159/000015201; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pavlicek A, 2005, GENOME RES, V15, P1487, DOI 10.1101/gr.4281205; Pevzner PA, 2004, GENOME RES, V14, P1786, DOI 10.1101/gr.2395204; Potier MC, 1998, GENOMICS, V51, P417, DOI 10.1006/geno.1998.5389; Regnier V, 1997, HUM MOL GENET, V6, P9, DOI 10.1093/hmg/6.1.9; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	41	145	147	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1361	1368		10.1038/ng.2007.9	http://dx.doi.org/10.1038/ng.2007.9			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17922013				2022-12-17	WOS:000250575900020
J	Batada, NN; Hurst, LD				Batada, Nizar N.; Hurst, Laurence D.			Evolution of chromosome organization driven by selection for reduced gene expression noise	NATURE GENETICS			English	Article							GENOME-WIDE; YEAST; ORDER; HAPLOINSUFFICIENCY; IDENTIFICATION; ARCHITECTURE; LEVEL	The distribution of genes on eukaryotic chromosomes is nonrandom, but the reasons behind this are not well understood. The commonly observed clustering of essential genes is a case in point. Here we model and test a new hypothesis. Essential proteins are unusual in that random fluctuations in abundance (noise) can be highly deleterious. We hypothesize that persistently open chromatin domains are sinks for essential genes, as they enable reduced noise by avoidance of transcriptional bursting associated with chromatin remodeling. Simulation of the model captures clustering and correctly predicts that (i) essential gene clusters are associated with low nucleosome occupancy (ii) noise- sensitive nonessential genes cluster with essential genes (iii) nonessential genes of similar knockout fitness are physically linked (iv) genes in domains rich in essential genes have low noise (v) essential genes are rare subtelomerically and (vi) essential gene clusters are preferentially conserved. We conclude that different noise characteristics of different genomic domains favors nonrandom gene positioning. This has implications for gene therapy and understanding transgenic phenotypes.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Batada, NN (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	nizar.batada@gmail.com; l.d.hurst@bath.ac.uk	Batada, Nizar/D-5605-2009; Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Batada, Nizar/0000-0002-8007-1487	MRC [G0300415] Funding Source: UKRI; Medical Research Council [G0300415] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; BATADA NN, IN PRESS TRENDS GENE; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hentges KE, 2007, PLOS GENET, V3, P661, DOI 10.1371/journal.pgen.0030072; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; NEI M, 1967, GENETICS, V57, P625; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5	25	145	146	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					945	949		10.1038/ng2071	http://dx.doi.org/10.1038/ng2071			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17660811				2022-12-17	WOS:000248446900006
J	Lang, MR; Lapierre, LA; Frotscher, M; Goldenring, JR; Knapik, EW				Lang, Michael R.; Lapierre, Lynne A.; Frotscher, Michael; Goldenring, James R.; Knapik, Ela W.			Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation	NATURE GENETICS			English	Article							TO-GOLGI TRANSPORT; II COLLAGEN GENE; ENDOPLASMIC-RETICULUM; VESICLE FORMATION; LIVING CELLS; ZEBRAFISH; EXPRESSION; MUTATIONS; REVEALS; PATHWAY	An increasing number of human disorders have been linked to mutations in genes of the secretory pathway. The chemically induced zebrafish crusher variant results in malformed craniofacial skeleton, kinked pectoral fins and a short body length. By positional cloning, we identified a nonsense mutation converting leucine to a stop codon (L402X) in the sec23a gene, an integral component of the COPII complex, which is critical for anterograde protein trafficking between endoplasmic reticulum and Golgi apparatus. Zebrafish crusher mutants develop normally until the onset of craniofacial chondrogenesis. crusher chondrocytes accumulate proteins in a distended endoplasmic reticulum, resulting in severe reduction of cartilage extracellular matrix (ECM) deposits, including type II collagen. We demonstrate that the paralogous gene sec23b is also an essential component of the ECM secretory pathway in chondrocytes. In contrast, knockdown of the COPI complex does not hinder craniofacial morphogenesis. As SEC23A lesions cause the cranio-lenticulo-sutural dysplasia syndrome, crusher provides the first vertebrate model system that links the biology of endoplasmic reticulum to Golgi trafficking with a clinically relevant dysmorphology.	Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Univ Freiburg, Inst Biol 1, Dept Biol, D-79104 Freiburg, Germany; Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; Nashville Vet Adm Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; University of Freiburg; Vanderbilt University; University of Freiburg	Knapik, EW (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37232 USA.	ela.knapik@vanderbilt.edu	Knapik, Ela W./J-6172-2014	Knapik, Ela W./0000-0002-2977-3619				Bandoh N, 2005, TISSUE ANTIGENS, V66, P185, DOI 10.1111/j.1399-0039.2005.00462.x; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyadjiev SA, 2003, HUM GENET, V113, P1, DOI 10.1007/s00439-003-0932-6; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Gebe JA, 2002, TISSUE ANTIGENS, V59, P78, DOI 10.1034/j.1399-0039.2002.590202.x; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; Pearson J, 1996, JUVENILE FAM COURT J, V47, P15, DOI 10.1111/j.1755-6988.1996.tb00751.x; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stephens DJ, 2002, J CELL SCI, V115, P1149; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	30	145	147	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1198	1203		10.1038/ng1880	http://dx.doi.org/10.1038/ng1880			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16980978				2022-12-17	WOS:000241251100021
J	Nybakken, K; Vokes, SA; Lin, TY; McMahon, AP; Perrimon, N				Nybakken, K; Vokes, SA; Lin, TY; McMahon, AP; Perrimon, N			A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway	NATURE GENETICS			English	Article							MESSENGER-RNA; CUBITUS INTERRUPTUS; PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; HEDGEHOG; COMPLEX; PHOSPHORYLATION; FAMILY; EXPORT	Members of the Hedgehog (Hh) family of signaling proteins are powerful regulators of developmental processes in many organisms and have been implicated in many human disease states. Here we report the results of a genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway. The screen identified hundreds of potential new regulators of Hh signaling, including many large protein complexes with pleiotropic effects, such as the coat protein complex I ( COPI) complex, the ribosome and the proteasome. We identified the multimeric protein phosphatase 2A (PP2A) and two new kinases, the D. melanogaster orthologs of the vertebrate PITSLRE and cyclin-dependent kinase-9 (CDK9) kinases, as Hh regulators. We also identified a large group of constitutive and alternative splicing factors, two nucleoporins involved in mRNA export and several RNA-regulatory proteins as potent regulators of Hh signal transduction, indicating that splicing regulation and mRNA transport have a previously unrecognized role in Hh signaling. Finally, we showed that several of these genes have conserved roles in mammalian Hh signaling.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Nybakken, K (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	knybakke@receptor.med.harvard.edu; perrimon@receptor.med.harvard.edu	McMahon, Andrew P/ABE-7520-2020	Perrimon, Norbert/0000-0001-7542-472X; Vokes, Steven/0000-0002-1724-0102	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064232] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM064232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOND BJ, 1986, MOL CELL BIOL, V6, P2080, DOI 10.1128/MCB.6.6.2080; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Burnette JM, 1999, GENETICS, V151, P1517; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De Falco G, 1998, J CELL PHYSIOL, V177, P501, DOI 10.1002/(SICI)1097-4652(199812)177:4<501::AID-JCP1>3.0.CO;2-4; De Luca A, 2003, J CELL PHYSIOL, V194, P101, DOI 10.1002/jcp.10196; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Lahti J M, 1995, Prog Cell Cycle Res, V1, P329; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Pyronnet S, 2005, CELL MOL LIFE SCI, V62, P1267, DOI 10.1007/s00018-005-5020-8; Raisin-Tani S, 2002, BIOCHEM BIOPH RES CO, V296, P288, DOI 10.1016/S0006-291X(02)00863-X; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; Wang QT, 1999, DEVELOPMENT, V126, P5097; ZHANG K, 1991, GENE DEV, V5, P1080, DOI 10.1101/gad.5.6.1080	49	145	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1323	1332		10.1038/ng1682	http://dx.doi.org/10.1038/ng1682			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16311596	Green Accepted			2022-12-17	WOS:000233657300011
J	Gu, ZL; Rifkin, SA; White, KP; Li, WH				Gu, ZL; Rifkin, SA; White, KP; Li, WH			Duplicate genes increase gene expression diversity within and between species	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REGULATION; EVOLUTION; EUKARYOTES; MUTATIONS	Using microarray gene expression data from several Drosophila species and strains, we show that duplicated genes, compared with single-copy genes, significantly increase gene expression diversity during development. We show further that duplicate genes tend to cause expression divergences between Drosophila species (or strains) to evolve faster than do single-copy genes. This conclusion is also supported by data from different yeast strains.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University of Chicago; Yale University; Yale University	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	whli@uchicago.edu		Rifkin, Scott/0000-0001-8476-3256; Li, Wen-Hsiung/0000-0003-1086-1456				Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Davidson EH, 2001, GENOMIC REGULATORY S; Force A, 1999, GENETICS, V151, P1531; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Jozefowicz Chris, 2003, Journal of Structural and Functional Genomics, V3, P185, DOI 10.1023/A:1022690723661; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Ohno S., 1970, EVOLUTION GENE DUPLI; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	15	145	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					577	579		10.1038/ng1355	http://dx.doi.org/10.1038/ng1355			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122255	Bronze			2022-12-17	WOS:000221763700012
J	Reich, DE; Gabriel, SB; Altshuler, D				Reich, DE; Gabriel, SB; Altshuler, D			Quality and completeness of SNP databases	NATURE GENETICS			English	Article								To address the quality and completeness of single-nucleotide polymorphism (SNP) databases, we resequenced 173 kb (spanning 17 loci) in 150 chromosomes of west African and European ancestry. Over 88% of SNPs in the public (TSC and BAC overlap) and Celera databases were confirmed in independent resequencing. Approximately 45% of all human heterozygosity is attributable to SNPs already available from the two databases, and of SNPs with minor-allele frequencies >10%, more than half are represented.	MIT, Program Med & Populat Genet, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reich, DE (corresponding author), MIT, Program Med & Populat Genet, Whitehead Inst, Ctr Genome Res, 1 Kendall Sq, Cambridge, MA 02139 USA.		Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107					0	145	150	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					457	458		10.1038/ng1133	http://dx.doi.org/10.1038/ng1133			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652301	Bronze			2022-12-17	WOS:000181928600012
J	Miao, CH; Snyder, RO; Schowalter, DB; Patijn, GA; Donahue, B; Winther, B; Kay, MA				Miao, CH; Snyder, RO; Schowalter, DB; Patijn, GA; Donahue, B; Winther, B; Kay, MA			The kinetics of rAAV integration in the liver	NATURE GENETICS			English	Letter							ADENOASSOCIATED VIRUS VECTOR; TRANSDUCTION; EXPRESSION; CHROMOSOME; MICE		Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Cell Genesys, Foster City, CA USA	University of Washington; University of Washington Seattle; Cell Genesys Inc	Kay, MA (corresponding author), Univ Washington, Div Med Genet, Box 357720,1705 NE Pacific St, Seattle, WA 98195 USA.				NHLBI NIH HHS [HL53682] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053682] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DISTECHE CM, 1985, CYTOGENET CELL GENET, V39, P262, DOI 10.1159/000132155; Du B, 1996, GENE THER, V3, P254; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; REESE JA, 1981, IN VITRO CELL DEV B, V17, P935; Schowalter DB, 1997, GENE THER, V4, P351, DOI 10.1038/sj.gt.3300398; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996	15	145	147	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					13	15		10.1038/ng0598-13	http://dx.doi.org/10.1038/ng0598-13			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590280				2022-12-17	WOS:000073346700008
J	Winter, H; Rogers, MA; Langbein, L; Stevens, HP; Leigh, IM; Labreze, C; Roul, S; Taieb, A; Krieg, T; Schweizer, J				Winter, H; Rogers, MA; Langbein, L; Stevens, HP; Leigh, IM; Labreze, C; Roul, S; Taieb, A; Krieg, T; Schweizer, J			Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix	NATURE GENETICS			English	Article							HUMAN TYPE-I; ICHTHYOSIS BULLOSA; INTERMEDIATE FILAMENTS; ROD DOMAIN; GENE; SEQUENCE; SIEMENS; 2E; EXPRESSION; FOLLICLE	Pathogenic mutations in a large number of human epithelial keratins have been well characterized. However, analogous mutations in the hard alpha-keratins of hair and nail have not yet been described. Monilethrix is a rare autosomal dominant hair defect with variable expression. Hairs from affected individuals show a beaded structure of alternating elliptical nodes and constrictions (internodes). These internodes exhibit a high propensity to weathering and fracture. Strong evidence that trichocyte keratin defects might underlie this hair disorder was provided by genetic linkage analyses that mapped this disease to the type-ii keratin gene cluster on 12q13. All affected individuals from a four-generation British family with monilethrix, previously linked to the type-it keratin gene cluster, as well as three unrelated single monilethrix patients, exhibited a heterozygous point mutation in the gene far type-Il hair cortex keratin hHb6, leading to lysine substitution of a highly conserved glutamic acid residue in the helix termination motif (Glu 410 Lys). In a three-generation French family with monilethrix of a milder and variable phenotype, we detected another heterozygous point mutation in the same glutamic acid codon of hHb6, which resulted in a conservative aspartic acid substitution (Glu 410 Asp). These mutations provide the first direct evidence for involvement of hair keratins in hair disease.	GERMAN CANC RES CTR,DIV CELL BIOL,D-69120 HEIDELBERG,GERMANY; ACAD DEPT DERMATOL,LONDON E1 2AT,ENGLAND; ROYAL LONDON SCH MED & DENT,LONDON E1 2AT,ENGLAND; HOP PELLEGRIN ENFANTS,UNITE DERMATOL PEDIAT,F-33076 BORDEAUX,FRANCE; UNIV COLOGNE,DEPT DERMATOL,D-50924 COLOGNE,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); University of London; Queen Mary University London; CHU Bordeaux; University of Cologne	Winter, H (corresponding author), GERMAN CANC RES CTR,DIV TUMOUR CELL REGULAT,NEUENHEIMER FELD 280,D-69120 HEIDELBERG,GERMANY.		Rogers, Michael A./J-9803-2012; TAIEB, ALAIN/AAB-1085-2021	Rogers, Michael A./0000-0002-3728-2107; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DEBERKER DAR, 1993, BRIT J DERMATOL, V128, P327; FINK P, 1995, BBA-GENE STRUCT EXPR, V1264, P12, DOI 10.1016/0167-4781(95)00122-W; GUMMER CI, 1981, BRIT J DERMATOL, V105, P529, DOI 10.1111/j.1365-2133.1981.tb00796.x; HATZFELD M, 1991, J CELL SCI, V99, P351; HEALY E, 1995, HUM MOL GENET, V4, P2399, DOI 10.1093/hmg/4.12.2399; HEID HW, 1986, DIFFERENTIATION, V32, P101, DOI 10.1111/j.1432-0436.1986.tb00562.x; ITO M, 1990, J INVEST DERMATOL, V95, P186, DOI 10.1111/1523-1747.ep12477967; Korge B. P., 1996, Journal of Investigative Dermatology, V106, P843; KREMER H, 1994, J INVEST DERMATOL, V103, P286, DOI 10.1111/1523-1747.ep12394414; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; MCKEE GM, 1961, J CUTAN DIS SYPH, V34, P444; MCKEE GM, 1961, J CUTAN DIS INCL SYP, V34, P506; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1994, J INVEST DERMATOL, V103, P277, DOI 10.1111/1523-1747.ep12394307; POWELL B, 1992, DEVELOPMENT, V114, P417; Richard G, 1996, J INVEST DERMATOL, V107, P812, DOI 10.1111/1523-1747.ep12330568; ROCK B, 1992, TXB DERMATOLOGY, P1353; ROGERS MA, 1995, EXP CELL RES, V220, P357, DOI 10.1006/excr.1995.1326; Rogers MA, 1997, DIFFERENTIATION, V61, P187, DOI 10.1046/j.1432-0436.1997.6130187.x; Rogers MA, 1996, J INVEST DERMATOL, V107, P633, DOI 10.1111/1523-1747.ep12584243; ROGERS MA, 1995, MOL BIOL REP, V20, P155, DOI 10.1007/BF00990548; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; STEINERT PM, 1993, BIOCHEM BIOPH RES CO, V197, P840, DOI 10.1006/bbrc.1993.2555; STEINERT PM, 1995, INTERMEDIATE FILAMEN, P145; Stevens HP, 1996, J INVEST DERMATOL, V106, P795, DOI 10.1111/1523-1747.ep12346400; WINTER H, 1994, EXP CELL RES, V212, P190, DOI 10.1006/excr.1994.1134	26	145	150	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					372	374		10.1038/ng0897-372	http://dx.doi.org/10.1038/ng0897-372			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241275				2022-12-17	WOS:A1997XM90900020
J	BALLINGER, SW; SHOFFNER, JM; GEBHART, S; KOONTZ, DA; WALLACE, DC				BALLINGER, SW; SHOFFNER, JM; GEBHART, S; KOONTZ, DA; WALLACE, DC			MITOCHONDRIAL DIABETES REVISITED	NATURE GENETICS			English	Letter							GLUCOKINASE; MELLITUS; HEXOKINASE; DEAFNESS; MUTATION		EMORY UNIV,SCH MED,DEPT MED,ATLANTA,GA 30322	Emory University	BALLINGER, SW (corresponding author), EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322, USA.							ADAMS V, 1991, BIOCHEM MED METAB B, V45, P271, DOI 10.1016/0885-4505(91)90032-G; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; MALAISSELAGAE F, 1988, BIOCHEM MED METAB B, V39, P80, DOI 10.1016/0885-4505(88)90061-8; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; STOFFEL M, 1992, NAT GENET, V2, P153, DOI 10.1038/ng1092-153; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368	9	145	148	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					458	459		10.1038/ng0894-458	http://dx.doi.org/10.1038/ng0894-458			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951312				2022-12-17	WOS:A1994PA83200006
J	Chen, JB; Yang, HC; Teo, ASM; Amer, LB; Sherbaf, FG; Tan, CQ; Alvarez, JJS; Lu, BX; Lim, JQ; Takano, A; Nahar, R; Lee, YY; Phual, CZJ; Chua, KP; Suteja, L; Chen, PJ; Chang, MM; Koh, TPT; Ong, BH; Anantham, D; Hsu, AAL; Gogna, A; Too, CW; Aung, ZW; Lee, YF; Wang, LY; Lim, TKH; Wilm, A; Choi, PS; Ng, PY; Toh, CK; Lim, WT; Ma, SM; Lim, B; Liu, J; Tam, WL; Skanderup, AJ; Yeong, JPS; Tan, EH; Creasy, CL; Tan, DSW; Hillmer, AM; Zhai, WW				Chen, Jianbin; Yang, Hechuan; Teo, Audrey Su Min; Amer, Lidyana Bte; Sherbaf, Faranak Ghazi; Tan, Chu Quan; Alvarez, Jacob Josiah Santiago; Lu, Bingxin; Lim, Jia Qi; Takano, Angela; Nahar, Rahul; Lee, Yin Yeng; Phual, Cheryl Zi Jin; Chua, Khi Pin; Suteja, Lisda; Chen, Pauline Jieqi; Chang, Mei Mei; Koh, Tina Puay Theng; Ong, Boon-Hean; Anantham, Devanand; Hsu, Anne Ann Ling; Gogna, Apoorva; Too, Chow Wei; Aung, Zaw Win; Lee, Yi Fei; Wang, Lanying; Lim, Tony Kiat Hon; Wilm, Andreas; Choi, Poh Sum; Ng, Poh Yong; Toh, Chee Keong; Lim, Wan-Teck; Ma, Siming; Lim, Bing; Liu, Jin; Tam, Wai Leong; Skanderup, Anders Jacobsen; Yeong, Joe Poh Sheng; Tan, Eng-Huat; Creasy, Caretha L.; Tan, Daniel Shao Weng; Hillmer, Axel M.; Zhai, Weiwei			Genomic landscape of lung adenocarcinoma in East Asians	NATURE GENETICS			English	Article							CANCER RISK; THERAPEUTIC TARGETS; MUTATIONS; EXPRESSION; DIVERSITY; HETEROGENEITY; MEN; DISCOVERY; FRAMEWORK; PATHWAYS	Lung cancer is the world's leading cause of cancer death and shows strong ancestry disparities. By sequencing and assembling a large genomic and transcriptomic dataset of lung adenocarcinoma (LUAD) in individuals of East Asian ancestry (EAS; n = 305), we found that East Asian LUADs had more stable genomes characterized by fewer mutations and fewer copy number alterations than LUADs from individuals of European ancestry. This difference is much stronger in smokers as compared to nonsmokers. Transcriptomic clustering identified a new EAS-specific LUAD subgroup with a less complex genomic profile and upregulated immune-related genes, allowing the possibility of immunotherapy-based approaches. Integrative analysis across clinical and molecular features showed the importance of molecular phenotypes in patient prognostic stratification. EAS LUADs had better prediction accuracy than those of European ancestry, potentially due to their less complex genomic architecture. This study elucidated a comprehensive genomic landscape of EAS LUADs and highlighted important ancestry differences between the two cohorts. Genomic and transcriptomic analysis of lung adenocarcinoma (LUAD) in Asia indicates that Asian LUADs have fewer mutations, lower driver prevalence and fewer copy number alterations than European LUADs.	[Chen, Jianbin; Yang, Hechuan; Teo, Audrey Su Min; Amer, Lidyana Bte; Sherbaf, Faranak Ghazi; Tan, Chu Quan; Alvarez, Jacob Josiah Santiago; Lu, Bingxin; Lim, Jia Qi; Nahar, Rahul; Lee, Yin Yeng; Phual, Cheryl Zi Jin; Chua, Khi Pin; Chen, Pauline Jieqi; Chang, Mei Mei; Lee, Yi Fei; Wilm, Andreas; Choi, Poh Sum; Ng, Poh Yong; Ma, Siming; Lim, Bing; Tam, Wai Leong; Skanderup, Anders Jacobsen; Tan, Daniel Shao Weng; Hillmer, Axel M.; Zhai, Weiwei] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Yang, Hechuan; Zhai, Weiwei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Takano, Angela; Lim, Tony Kiat Hon; Yeong, Joe Poh Sheng] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore; [Suteja, Lisda; Toh, Chee Keong; Lim, Wan-Teck; Tan, Eng-Huat; Tan, Daniel Shao Weng] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Koh, Tina Puay Theng] Natl Canc Ctr Singapore, Surg Oncol, Singapore, Singapore; [Ong, Boon-Hean] Natl Heart Ctr Singapore, Dept Cardiothorac Surg, Singapore, Singapore; [Anantham, Devanand; Hsu, Anne Ann Ling] Singapore Gen Hosp, Dept Resp & Crit Care Med, Singapore, Singapore; [Gogna, Apoorva; Too, Chow Wei] Singapore Gen Hosp, Dept Vasc & Intervent Radiol, Singapore, Singapore; [Aung, Zaw Win; Wang, Lanying; Tan, Eng-Huat] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Lee, Yi Fei; Tam, Wai Leong; Zhai, Weiwei] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Lim, Wan-Teck; Yeong, Joe Poh Sheng] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Liu, Jin] Duke NUS Med Sch, Ctr Quantitat Med, Program Hlth Serv & Syst Res, Singapore, Singapore; [Tam, Wai Leong] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Tam, Wai Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Creasy, Caretha L.] GlaxoSmithKline, Oncol R&D, Collegeville, PA USA; [Tan, Daniel Shao Weng] Natl Canc Ctr Singapore, Div Med Sci, Canc Therapeut Res Lab, Singapore, Singapore; [Hillmer, Axel M.] Univ Cologne, Fac Med, Inst Pathol, Cologne, Germany; [Hillmer, Axel M.] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Zhai, Weiwei] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Sciences; Institute of Zoology, CAS; Singapore General Hospital; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National Heart Centre Singapore; Singapore General Hospital; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National University of Singapore; GlaxoSmithKline; National Cancer Centre Singapore (NCCS); University of Cologne; University of Cologne; Chinese Academy of Sciences	Tan, DSW; Hillmer, AM; Zhai, WW (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.; Zhai, WW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.; Tan, DSW (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.; Zhai, WW (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Tan, DSW (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Canc Therapeut Res Lab, Singapore, Singapore.; Hillmer, AM (corresponding author), Univ Cologne, Fac Med, Inst Pathol, Cologne, Germany.; Hillmer, AM (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.; Zhai, WW (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.	daniel.tan.s.w@nccs.com.sg; ahillmer@uni-koeln.de; weiweizhai@ioz.ac.cn	Too, Chow Wei/AAU-7478-2020; Lim, Darren Wan Teck/L-2007-2016; Suteja, Lisda/GXG-9227-2022; Lim, Darren Wan-Teck/V-8435-2019; Jacobsen Skanderup, Anders/K-1081-2013	Too, Chow Wei/0000-0002-0073-1554; Lim, Darren Wan Teck/0000-0002-4655-0206; Lim, Darren Wan-Teck/0000-0002-4655-0206; Liu, Jin/0000-0002-5707-2078; LU, BINGXIN/0000-0002-0606-5150; Chua, Khi Pin/0000-0002-0083-0181; Ma, Siming/0000-0002-1810-8357; Wang, Lanying/0000-0002-5414-0055; Toh, Chee-Keong/0000-0002-5691-6144; Zhai, Weiwei/0000-0001-7938-0226; Chen, Jianbin/0000-0002-9430-5838; Tam, Wai Leong/0000-0003-2365-5264; Jacobsen Skanderup, Anders/0000-0001-6847-4980; Lee, Yi Fei/0000-0002-0238-1068	Glaxo Wellcome Manufacturing Pte Ltd; Agency for Science Technology and Research (A*STAR) [GIS/15-IAF100]; National Medical Research Council, Singapore [NMRC/OFLCG/002c/2018, NMRC/OFIRG/0064/2017, NMRC/TCR/007-NCC/2013]; National Research Foundation, Singapore [NRF-NRFF2015-04]; German Cancer Aid [70113510]; Lung Cancer Consortium Singapore (LCCS); Singapore Millennium Foundation; National Key R&D program of China [2018YFC0910400, 2018YFC1406902]; National Science Foundation of China [31970566]	Glaxo Wellcome Manufacturing Pte Ltd; Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation, Singapore(National Research Foundation, Singapore); German Cancer Aid(Deutsche Krebshilfe); Lung Cancer Consortium Singapore (LCCS); Singapore Millennium Foundation(Singapore Millennium Foundation); National Key R&D program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Glaxo Wellcome Manufacturing Pte Ltd, the Agency for Science Technology and Research (A*STAR) (grant no. GIS/15-IAF100), the National Medical Research Council, Singapore (grant nos. NMRC/OFLCG/002c/2018, NMRC/OFIRG/0064/2017 and NMRC/TCR/007-NCC/2013), the National Research Foundation, Singapore (grant no. NRF-NRFF2015-04), German Cancer Aid (grant no. 70113510) and Lung Cancer Consortium Singapore (LCCS). LCCS is jointly supported by philanthropy (including Singapore Millennium Foundation), and institutional and industrial grants. W.Z. is supported in part by the National Key R&D program of China (grant nos. 2018YFC0910400 and 2018YFC1406902) and the National Science Foundation of China (grant no. 31970566). We thank Beijing Genomics Institute for providing the published sequencing data. We thank T. Zhang for contribution to genomic data analysis, C. T. J. Ong, Y. L. Lee, I. M. L. Chua and W. W. J. Soon for the next-generation sequencing work, the GIS Research Pipeline Development team for support with analysis pipelines and Y. Matsuoka for administrative support. We thank Y. Cun for helpful discussions.	Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Cann HM, 2002, SCIENCE, V296, P261; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; D'Angelo SP, 2012, J THORAC ONCOL, V7, P1815, DOI 10.1097/JTO.0b013e31826bb7b2; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Fehrenbacher L, 2018, J THORAC ONCOL, V13, P1156, DOI 10.1016/j.jtho.2018.04.039; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Hu X, 2018, NUCLEIC ACIDS RES, V46, pD1144, DOI 10.1093/nar/gkx1018; Ikeda Y, 2016, ENDOCR-RELAT CANCER, V23, P171, DOI 10.1530/ERC-15-0359; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jain A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123587; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jemal A, 2018, NEW ENGL J MED, V378, P1999, DOI [10.1056/NEJMoa1715907, 10.1056/nejmoa1715907]; Jeon JH, 2015, EUR J CARDIO-THORAC, V47, P556, DOI 10.1093/ejcts/ezu177; Kadara H, 2017, ANN ONCOL, V28, P75, DOI 10.1093/annonc/mdw436; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katsyv I, 2016, ONCOTARGET, V7, P69592, DOI 10.18632/oncotarget.11870; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Korotkevich G., 2021, 060012 BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kuniholm MH, 2014, J INFECT DIS, V209, P1585, DOI 10.1093/infdis/jit672; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee T, 2013, J IMMIGR MINOR HEALT, V15, P646, DOI 10.1007/s10903-012-9651-1; Lee YJ, 2009, J CANCER RES CLIN, V135, P1647, DOI 10.1007/s00432-009-0611-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Liao SD, 2017, GENE DEV, V31, P184, DOI 10.1101/gad.291948.116; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu LP, 2017, CANCER SCI, V108, P2487, DOI 10.1111/cas.13410; Lortet-Tieulent J, 2015, EUR J CANCER, V51, P1144, DOI 10.1016/j.ejca.2013.10.014; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WX, 2018, INT J CANCER, V143, P1696, DOI 10.1002/ijc.31542; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Mroz EA, 2013, ORAL ONCOL, V49, P211, DOI 10.1016/j.oraloncology.2012.09.007; Murumagi A, 2014, BIORXIV, DOI [10.1101/011650, DOI 10.1101/011650V1]; Nahar R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02584-z; Long NP, 2016, CANCER INFORM, V15, P11, DOI 10.4137/CIN.S40301; Nirmal AJ, 2018, CANCER IMMUNOL RES, V6, P1388, DOI 10.1158/2326-6066.CIR-18-0342; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Seow A, 2000, CANCER EPIDEM BIOMAR, V9, P1215; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung H, 2016, ONCOTARGET, V7, P23885, DOI 10.18632/oncotarget.8127; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Tan DSW, 2016, J CLIN ONCOL, V34, P91, DOI 10.1200/JCO.2015.62.0096; Tan VYF, 2013, IEEE T PATTERN ANAL, V35, P1592, DOI 10.1109/TPAMI.2012.240; Tan WL, 2016, LANCET ONCOL, V17, pE347, DOI 10.1016/S1470-2045(16)30123-1; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Teng AM, 2017, GASTRIC CANCER, V20, P752, DOI 10.1007/s10120-016-0671-8; Tokheim CJ, 2016, P NATL ACAD SCI USA, V113, P14330, DOI 10.1073/pnas.1616440113; Wang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04492-2; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05661-x; Wang JW, 2004, ONCOGENE, V23, P4089, DOI 10.1038/sj.onc.1207567; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wu K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10131; Wu YL, 2018, TRANSL LUNG CANCER R, V7, P428, DOI 10.21037/tlcr.2018.04.15; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yuan Y, 2014, NAT BIOTECHNOL, V32, P644, DOI 10.1038/nbt.2940; Zhu YJ, 2014, CLIN LAB, V60, P155, DOI 10.7754/Clin.Lab.2013.121131; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	101	144	150	7	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2020	52	2					177	+		10.1038/s41588-019-0569-6	http://dx.doi.org/10.1038/s41588-019-0569-6		FEB 2020	23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KM6MD	32015526	Green Submitted			2022-12-17	WOS:000510822800001
J	Sundaram, L; Gao, H; Padigepati, SR; McRae, JF; Li, YJ; Kosmicki, JA; Fritzilas, N; Hakenberg, J; Dutta, A; Shon, J; Xu, JB; Batzloglou, S; Li, XL; Farh, KKH				Sundaram, Laksshman; Gao, Hong; Padigepati, Samskruthi Reddy; McRae, Jeremy F.; Li, Yanjun; Kosmicki, Jack A.; Fritzilas, Nondas; Hakenberg, Jorg; Dutta, Anindita; Shon, John; Xu, Jinbo; Batzloglou, Serafim; Li, Xiaolin; Farh, Kyle Kai-How			Predicting the clinical impact of human mutation with deep neural networks	NATURE GENETICS			English	Article							NOVO MUTATIONS; SEQUENCE VARIANTS; GENOME BROWSER; DATABASE; FRAMEWORK; SPECTRUM; DISEASE; PATHOGENICITY; SUBSTITUTIONS; DIVERSITY	Millions of human genomes and exomes have been sequenced, but their clinical applications remain limited due to the difficulty of distinguishing disease-causing mutations from benign genetic variation. Here we demonstrate that common missense variants in other primate species are largely clinically benign in human, enabling pathogenic mutations to be systematically identified by the process of elimination. Using hundreds of thousands of common variants from population sequencing of six non-human primate species, we train a deep neural network that identifies pathogenic mutations in rare disease patients with 88% accuracy and enables the discovery of 14 new candidate genes in intellectual disability at genome-wide significance. Cataloging common variation from additional primate species would improve interpretation for millions of variants of uncertain significance, further advancing the clinical utility of human genome sequencing.	[Sundaram, Laksshman; Gao, Hong; Padigepati, Samskruthi Reddy; McRae, Jeremy F.; Kosmicki, Jack A.; Fritzilas, Nondas; Hakenberg, Jorg; Dutta, Anindita; Shon, John; Batzloglou, Serafim; Farh, Kyle Kai-How] Illumina Inc, Illumina Artificial Intelligence Lab, San Diego, CA 92121 USA; [Sundaram, Laksshman] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Sundaram, Laksshman; Padigepati, Samskruthi Reddy; Li, Yanjun; Li, Xiaolin] Univ Florida, Natl Sci Fdn Ctr Big Learning, Gainesville, FL USA; [Kosmicki, Jack A.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit ATGU, Boston, MA 02114 USA; [Kosmicki, Jack A.] Harvard Med Sch, Boston, MA USA; [Xu, Jinbo] Toyota Technol Inst Chicago, Chicago, IL USA	Illumina; Stanford University; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Toyota Technological Institute - Chicago	Farh, KKH (corresponding author), Illumina Inc, Illumina Artificial Intelligence Lab, San Diego, CA 92121 USA.	kfarh@illumina.com	Li, Yanjun/ADT-1767-2022	Sundaram, Laksshman/0000-0002-8953-3940; Li, Yanjun/0000-0002-6277-4189; Hakenberg, Jorg/0000-0001-8781-7766; Padigepati, Samskruthi Reddy/0000-0003-4049-0107	Health Innovation Challenge Fund [HICF-1009003]; Cambridge South REC [10/H0305/83]; Republic of Ireland REC [GEN/284/12]; National Institute for Health Research, through the Comprehensive Clinical Research Network; National Institute of General Medical Sciences [R01GM110240]; National Science Foundation [CNS-1747783, CNS-1624782, OAC-1229576]; Department of Health; Wellcome Sanger Institute [WT098051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110240, R01GM089753] Funding Source: NIH RePORTER	Health Innovation Challenge Fund; Cambridge South REC; Republic of Ireland REC; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Department of Health; Wellcome Sanger Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank J. K. Pritchard, M. E. Hurles, J. W. Belmont, and R. E. Green for insightful discussions. The authors would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009003), a parallel funding partnership between Wellcome and the Department of Health, and the Wellcome Sanger Institute (grant number WT098051). The views expressed in this publication are those of the authors and not necessarily those of Wellcome or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. L.S., S.R.P., Y.L. and X.L. were partially supported by R01GM110240 from the National Institute of General Medical Sciences and National Science Foundation (grant number CNS-1747783, CNS-1624782, and OAC-1229576).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; [Anonymous], 1984, AM NAT; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Asthana S, 2005, TRENDS GENET, V21, P30, DOI 10.1016/j.tig.2004.11.001; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bazykin GA, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-20; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; BRANDON EP, 1995, CURR BIOL, V5, P758, DOI 10.1016/S0960-9822(95)00152-7; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; Famiglietti ML, 2014, HUM MUTAT, V35, P927, DOI 10.1002/humu.22594; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Harpak A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006489; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Jain S., 2017, P 31 AAAI C ON ARTIF; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10576; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rehm HL, 2017, NAT REV GENET, V18, P259, DOI 10.1038/nrg.2016.162; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sittig LJ, 2016, NEURON, V91, P1253, DOI 10.1016/j.neuron.2016.08.013; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Wang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18962; Whiffin N, 2017, GENET MED, V19, P1151, DOI 10.1038/gim.2017.26; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	92	144	151	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2018	50	8					1161	+		10.1038/s41588-018-0167-z	http://dx.doi.org/10.1038/s41588-018-0167-z			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GO9JP	30038395	Green Accepted			2022-12-17	WOS:000440423400015
J	Martyn, GE; Wienert, B; Yang, L; Shah, M; Norton, LJ; Burdach, J; Kurita, R; Nakamura, Y; Pearson, RCM; Funnell, APW; Quinlan, KGR; Crossley, M				Martyn, Gabriella E.; Wienert, Beeke; Yang, Lu; Shah, Manan; Norton, Laura J.; Burdach, Jon; Kurita, Ryo; Nakamura, Yukio; Pearson, Richard C. M.; Funnell, Alister P. W.; Quinlan, Kate G. R.; Crossley, Merlin			Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding	NATURE GENETICS			English	Article							A-GAMMA-GLOBIN; NONDELETIONAL HEREDITARY PERSISTENCE; DISTAL CCAAT MOTIF; TRANSCRIPTION FACTORS; DNA-BINDING; BETA-HEMOGLOBINOPATHIES; EXPRESSION; GENOME; PROTEINS; PROMOTER	b-hemoglobinopathies such as sickle cell disease (SCD) and beta-thalassemia result from mutations in the adult HBB (beta-globin) gene. Reactivating the developmentally silenced fetal HBG1 and HBG2 (gamma-globin) genes is a therapeutic goal for treating SCD and beta-thalassemia(1). Some forms of hereditary persistence of fetal hemoglobin (HPFH), a rare benign condition in which individuals express the gamma-globin gene throughout adulthood, are caused by point mutations in the gamma-globin gene promoter at regions residing -115 and -200 bp upstream of the transcription start site. We found that the major fetal globin gene repressors BCL11A and ZBTB7A (also known as LRF) directly bound to the sites at -115 and -200 bp, respectively. Furthermore, introduction of naturally occurring HPFH-associated mutations into erythroid cells by CRISPR-Cas9 disrupted repressor binding and raised gamma-globin gene expression. These findings clarify how these HPFH-associated mutations operate and demonstrate that BCL11A and ZBTB7A are major direct repressors of the fetal globin gene.	[Martyn, Gabriella E.; Wienert, Beeke; Yang, Lu; Shah, Manan; Norton, Laura J.; Burdach, Jon; Pearson, Richard C. M.; Funnell, Alister P. W.; Quinlan, Kate G. R.; Crossley, Merlin] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kurita, Ryo] Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Res & Dev Dept, Tokyo, Japan; [Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Ibaraki, Japan	University of New South Wales Sydney; RIKEN	Crossley, M (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	m.crossley@unsw.edu.au	Nakamura, Yukio/A-5263-2016; Crossley, Merlin/D-7888-2011	Nakamura, Yukio/0000-0001-8056-4946; Martyn, Gabriella/0000-0001-5024-428X; Quinlan, Kate/0000-0002-5722-8183; Shah, Manan/0000-0003-1390-5450; Crossley, Merlin/0000-0003-2057-3642; Yang, Lu/0000-0002-8338-1616	Australian National Health and Medical Research Council [APP1098391]; University International Postgraduate Award; Australian Postgraduate Awards; China Scholarship Council - Chinese government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University International Postgraduate Award; Australian Postgraduate Awards(Australian Government); China Scholarship Council - Chinese government(China Scholarship Council)	The px458 plasmid was a gift from F. Zhang (Massachusetts Institute of Technology and Harvard University) (Addgene 48138). We thank M. Porteus (Stanford University) for providing plasmids for genome editing. We acknowledge H. Lebhar and the UNSW Recombinant Products Facility (UNSW Sydney) for HPLC assistance, and C. Brownlee and E. Johansson Beves from BRIL (UNSW Sydney) for assistance with flow cytometry. This work was supported by funding from the Australian National Health and Medical Research Council to M. C. (APP1098391). B.W. was supported by a University International Postgraduate Award. G.E.M., M.S. and L.J.N. were supported by Australian Postgraduate Awards. L.Y. was supported by a China Scholarship Council scholarship granted by the Chinese government.	Amato A, 2014, INT J LAB HEMATOL, V36, P13, DOI 10.1111/ijlh.12094; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Charoensawan V, 2015, BIOESSAYS, V37, P748, DOI 10.1002/bies.201400186; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P4894, DOI 10.1073/pnas.81.15.4894; COSTA FF, 1990, BLOOD, V76, P1896; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; FESSAS P, 1964, BLOOD, V24, P223, DOI 10.1182/blood.V24.3.223.223; FUCHAROEN S, 1990, NUCLEIC ACIDS RES, V18, P5245, DOI 10.1093/nar/18.17.5245; GIGLIONI B, 1984, EMBO J, V3, P2641, DOI 10.1002/j.1460-2075.1984.tb02187.x; GILMAN JG, 1988, BLOOD, V72, P78; GILMAN JG, 1988, NUCLEIC ACIDS RES, V16, P10635, DOI 10.1093/nar/16.22.10635; HATTORI Y, 1986, HEMOGLOBIN, V10, P623, DOI 10.3109/03630268609036566; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee SU, 2013, BLOOD, V121, P918, DOI 10.1182/blood-2012-03-418103; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; MOTUM PI, 1994, BRIT J HAEMATOL, V86, P219, DOI 10.1111/j.1365-2141.1994.tb03284.x; ONER R, 1991, BLOOD, V77, P1124; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tasiopouiou M, 2008, BLOOD CELL MOL DIS, V40, P320, DOI 10.1016/j.bcmd.2007.10.007; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Varala K, 2015, BIOESSAYS, V37, P851, DOI 10.1002/bies.201400205; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wienert B, 2017, BLOOD, V130, P803, DOI 10.1182/blood-2017-02-767400; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Zertal-Zidani S, 1999, HEMOGLOBIN, V23, P159, DOI 10.3109/03630269908996160	53	144	155	3	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					498	+		10.1038/s41588-018-0085-0	http://dx.doi.org/10.1038/s41588-018-0085-0			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	29610478				2022-12-17	WOS:000429529300009
J	Li, YZ; Zhang, KL; Chen, H; Sun, F; Xu, JJ; Wu, ZY; Li, P; Zhang, LY; Du, Y; Luan, HX; Li, X; Wu, LJ; Li, HB; Wu, HX; Li, XP; Li, XM; Zhang, X; Gong, L; Dai, L; Sun, LY; Zuo, XX; Xu, JH; Gong, HP; Li, ZJ; Tong, SQ; Wu, M; Li, XF; Xiao, WG; Wang, GC; Zhu, P; Shen, M; Liu, SY; Zhao, DB; Liu, W; Wang, Y; Huang, CB; Jiang, Q; Liu, GJ; Liu, B; Hu, SX; Zhang, W; Zhang, ZL; You, X; Li, MT; Hao, WX; Zhao, C; Leng, XM; Bi, LQ; Wang, YF; Zhang, FX; Shi, Q; Qi, WC; Zhang, XW; Jia, Y; Su, JM; Li, Q; Hou, Y; Wu, QJ; Xu, D; Zheng, WJ; Zhang, MJ; Wang, Q; Fei, YY; Zhang, X; Li, J; Jiang, Y; Tian, XP; Zhao, LD; Wang, L; Zhou, B; Li, Y; Zhao, Y; Zeng, XF; Ott, J; Wang, J; Zhang, FC				Li, Yongzhe; Zhang, Kunlin; Chen, Hua; Sun, Fei; Xu, Juanjuan; Wu, Ziyan; Li, Ping; Zhang, Liuyan; Du, Yang; Luan, Haixia; Li, Xi; Wu, Lijun; Li, Hongbin; Wu, Huaxiang; Li, Xiangpei; Li, Xiaomei; Zhang, Xiao; Gong, Lu; Dai, Lie; Sun, Lingyun; Zuo, Xiaoxia; Xu, Jianhua; Gong, Huiping; Li, Zhijun; Tong, Shengquan; Wu, Min; Li, Xiaofeng; Xiao, Weiguo; Wang, Guochun; Zhu, Ping; Shen, Min; Liu, Shengyun; Zhao, Dongbao; Liu, Wei; Wang, Yi; Huang, Cibo; Jiang, Quan; Liu, Guijian; Liu, Bin; Hu, Shaoxian; Zhang, Wen; Zhang, Zhuoli; You, Xin; Li, Mengtao; Hao, Weixin; Zhao, Cheng; Leng, Xiaomei; Bi, Liqi; Wang, Yongfu; Zhang, Fengxiao; Shi, Qun; Qi, Wencheng; Zhang, Xuewu; Jia, Yuan; Su, Jinmei; Li, Qin; Hou, Yong; Wu, Qingjun; Xu, Dong; Zheng, Wenjie; Zhang, Miaojia; Wang, Qian; Fei, Yunyun; Zhang, Xuan; Li, Jing; Jiang, Ying; Tian, Xinping; Zhao, Lidan; Wang, Li; Zhou, Bin; Li, Yang; Zhao, Yan; Zeng, Xiaofeng; Ott, Jurg; Wang, Jing; Zhang, Fengchun			A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HLA CLASS-II; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; GENETIC-VARIATION; POPULATION; TNFAIP3; VISUALIZATION; STAT4; RISK	Primary Sjogren's syndrome is one of the most common autoimmune diseases. So far, genetic studies of Sjogren's syndrome have relied mostly on candidate gene approaches. To identify new genetic susceptibility loci for primary Sjogren's syndrome, we performed a three-stage genome-wide association study in Han Chinese. In the discovery stage, we analyzed 556,134 autosomal SNPs in 542 cases and 1,050 controls. We then validated promising associations in 2 replication stages comprising 1,303 cases and 2,727 controls. The combined analysis identified GTF2I at 7q11.23 (rs117026326: P-combined = 1.31 x 10(-53), combined odds ratio (ORcombined) = 2.20) as a new susceptibility locus for primary Sjogren's syndrome. Our analysis also confirmed previously reported associations in Europeans in the regions of STAT4, TNFAIP3 and the major histocompatibility complex (MHC). Fine mapping of the region around GTF2I showed that rs117026326 in GTF2I had the most significant association, with associated SNPs extending from GTF2I to GTF2IRD1-GTF2I.	[Li, Yongzhe; Chen, Hua; Sun, Fei; Xu, Juanjuan; Wu, Ziyan; Li, Ping; Luan, Haixia; Li, Xi; Shen, Min; Zhang, Wen; You, Xin; Li, Mengtao; Leng, Xiaomei; Shi, Qun; Su, Jinmei; Hou, Yong; Wu, Qingjun; Xu, Dong; Zheng, Wenjie; Wang, Qian; Fei, Yunyun; Zhang, Xuan; Li, Jing; Jiang, Ying; Tian, Xinping; Zhao, Lidan; Wang, Li; Zhao, Yan; Zeng, Xiaofeng; Zhang, Fengchun] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100021, Peoples R China; [Li, Yongzhe; Chen, Hua; Sun, Fei; Xu, Juanjuan; Wu, Ziyan; Li, Ping; Luan, Haixia; Li, Xi; Shen, Min; Zhang, Wen; You, Xin; Li, Mengtao; Leng, Xiaomei; Shi, Qun; Su, Jinmei; Hou, Yong; Wu, Qingjun; Xu, Dong; Zheng, Wenjie; Wang, Qian; Fei, Yunyun; Zhang, Xuan; Li, Jing; Jiang, Ying; Tian, Xinping; Zhao, Lidan; Wang, Li; Zhao, Yan; Zeng, Xiaofeng; Zhang, Fengchun] Chinese Acad Med Sci, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Zhang, Kunlin; Zhang, Liuyan; Du, Yang; Ott, Jurg; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Wu, Lijun] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Rheumatol & Immunol, Urumqi, Peoples R China; [Li, Hongbin] Inner Mongolia Med Coll, Affiliated Hosp, Dept Rheumatol, Hohhot, Peoples R China; [Wu, Huaxiang] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Rheumatol, Hangzhou 310027, Zhejiang, Peoples R China; [Li, Xiangpei; Li, Xiaomei] Anhui Med Univ, Affiliated Anhui Prov Hosp, Dept Rheumatol & Immun, Hefei, Peoples R China; [Zhang, Xiao] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China; [Gong, Lu] Tianjin Med Univ, Gen Hosp, Dept Immunol, Tianjin, Peoples R China; [Dai, Lie] Sun Yat Sen Univ, SUN Yat Sen Mem Hosp, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Lingyun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Nanjing 210008, Jiangsu, Peoples R China; [Zuo, Xiaoxia] Cent S Univ, Xiangya Hosp, Dept Rheumatol & Immunol, Changsha 410083, Peoples R China; [Xu, Jianhua] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatol, Hefei, Peoples R China; [Gong, Huiping] Changzhi Med Coll, Affiliated Heping Hosp, Dept Rheumatol & Immunol, Changzhi, Peoples R China; [Li, Zhijun] Bengbu Med Coll, Affiliated Hosp 1, Dept Rheumatol & Immunol, Bengbu, Peoples R China; [Tong, Shengquan] Tangshan Gongren Hosp, Dept Rheumatol & Immunol, Tangshan, Peoples R China; [Wu, Min] First Peoples Hosp Changzhou, Dept Rheumatol & Immunol, Changzhou, Peoples R China; [Li, Xiaofeng] Shanxi Med Univ Second Hosp, Dept Rheumatol & Immunol, Taiyuan, Peoples R China; [Xiao, Weiguo] China Med Univ, Hosp 1, Dept Rheumatol, Shenyang, Peoples R China; [Wang, Guochun] China Japan Friendship Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Zhu, Ping] Fourth Mil Med Univ, Xijing Hosp, Dept Rheumatol & Immunol, Xian 710032, Peoples R China; [Liu, Shengyun] Zhengzhou Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Zhengzhou 450052, Peoples R China; [Zhao, Dongbao] Second Mil Med Univ, Changhai Hosp, Dept Rheumatol & Immunol, Shanghai, Peoples R China; [Liu, Wei] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Dept Rheumatol & Immunol, Tianjin, Peoples R China; [Wang, Yi] Lanzhou Univ, Hosp 2, Dept Rheumatol & Immunol, Lanzhou 730000, Peoples R China; [Huang, Cibo] Beijing Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Jiang, Quan] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Rheumatol, Beijing, Peoples R China; [Liu, Guijian] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Lab, Beijing, Peoples R China; [Liu, Bin] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Rheumatol & Immunol, Qingdao 266071, Peoples R China; [Hu, Shaoxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Immunol & Rheumatol, Wuhan 430074, Peoples R China; [Zhang, Zhuoli] Peking Univ, Hosp 1, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [Hao, Weixin] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100021, Peoples R China; [Hao, Weixin] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhao, Cheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Nanning, Peoples R China; [Bi, Liqi] Jilin Univ, China Japan Union Hosp, Dept Rheumatol & Immunol, Changchun 130023, Peoples R China; [Wang, Yongfu] Baotou Med Coll, Affiliated Hosp 1, Dept Rheumatol & Immunol, Baotou, Peoples R China; [Zhang, Fengxiao] Hebei Peoples Hosp, Dept Rheumatol & Immunol, Shijiazhuang, Peoples R China; [Qi, Wencheng] Tianjin First Cent Hosp, Dept Rheumatol & Immunol, Tianjin, Peoples R China; [Zhang, Xuewu; Jia, Yuan] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [Li, Qin] Yunnan Univ, Peoples Hosp 1, Dept Rheumatol & Immunol, Kunming, Peoples R China; [Zhang, Miaojia] Jiangsu Prov Peoples Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Zhou, Bin] Sichuan Acad Med Sci, Dept Rheumatol & Immunol, Chengdu, Peoples R China; [Zhou, Bin] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Li, Yang] Harbin Med Univ, Affiliated Hosp 2, Dept Rheumatol & Immunol, Harbin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Sciences; Institute of Psychology, CAS; Inner Mongolia Medical University; Zhejiang University; Anhui Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Tianjin Medical University; Sun Yat Sen University; Nanjing University; Central South University; Anhui Medical University; Changzhi Medical College; Bengbu Medical College; Shanxi Medical University; China Medical University; China-Japan Friendship Hospital; Air Force Military Medical University; Zhengzhou University; Naval Medical University; Tianjin University of Traditional Chinese Medicine; Lanzhou University; Beijing Hospital; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Qingdao University; Huazhong University of Science & Technology; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Guangxi Medical University; Jilin University; Baotou Medical College; Tianjin Medical University; Peking University; Yunnan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Harbin Medical University	Zhang, FC (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100021, Peoples R China.	wangjing@psych.ac.cn; zhangfccra@aliyun.com	zhang, xu/GRX-9733-2022; zhang, xuan/AAN-9914-2020; zhang, xuan/GQO-8953-2022; meng, li/GVT-2063-2022; Li, QIn/GXA-1934-2022; zhang, xu/GYE-3558-2022	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; zhang, kun lin/0000-0003-0807-5755; Li, Jing/0000-0003-2504-1629	Research Special Fund for Public Welfare Industry of Health [201202004]; National Science Technology Pillar Program in the 11th Five-Year Plan [2008BAI59B03]; National Program on Key Research Project of New Drug Innovation [2012ZX09303006-002]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; CAS/SAFEA International Partnership Program for Creative Research Teams [Y2CX131003]; National Natural Science Foundation of China [81072486, 81172857, 81101545]	Research Special Fund for Public Welfare Industry of Health; National Science Technology Pillar Program in the 11th Five-Year Plan; National Program on Key Research Project of New Drug Innovation; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all participants recruited in this study. This work was supported by grants from the Research Special Fund for Public Welfare Industry of Health (201202004 to Fengchun Zhang), the National Science Technology Pillar Program in the 11th Five-Year Plan (2008BAI59B03 to Fengchun Zhang), the National Program on Key Research Project of New Drug Innovation (2012ZX09303006-002 to Fengchun Zhang), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-8 to J.W.), the CAS/SAFEA International Partnership Program for Creative Research Teams (Y2CX131003 to J.W.) and the National Natural Science Foundation of China (81072486 and 81172857 to Yongzhe Li and 81101545 to K.Z.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Cobb BL, 2008, RHEUM DIS CLIN N AM, V34, P847, DOI 10.1016/j.rdc.2008.08.003; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gestermann N, 2010, GENES IMMUN, V11, P432, DOI 10.1038/gene.2010.29; Gill HK, 2012, ASIAN PAC J ALLERGY, V30, P313; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Ice JA, 2012, J AUTOIMMUN, V39, P57, DOI 10.1016/j.jaut.2012.01.008; KANG HI, 1993, J IMMUNOL, V150, P3615; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nordmark G, 2009, GENES IMMUN, V10, P68, DOI 10.1038/gene.2008.94; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Palomino-Morales RJ, 2010, J RHEUMATOL, V37, P1016, DOI 10.3899/jrheum.091007; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Perl A, 2009, CURR OPIN RHEUMATOL, V21, P443, DOI 10.1097/BOR.0b013e32832efe6b; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Shimane K, 2010, ARTHRITIS RHEUM-US, V62, P574, DOI 10.1002/art.27190; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Vandeweyer G, 2012, AM J HUM GENET, V90, P1071, DOI 10.1016/j.ajhg.2012.04.020; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Williams PH, 2007, CLIN REV ALLERG IMMU, V32, P201, DOI 10.1007/s12016-007-8002-9; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yang Y, 2009, ANN HUM GENET, V73, P109, DOI 10.1111/j.1469-1809.2008.00480.x; ZHANG NZ, 1995, J RHEUMATOL, V22, P659; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	53	144	149	5	437	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2013	45	11					1361	+		10.1038/ng.2779	http://dx.doi.org/10.1038/ng.2779			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	244JL	24097066				2022-12-17	WOS:000326384100017
J	Koolen, DA; Kramer, JM; Neveling, K; Nillesen, WM; Moore-Barton, HL; Elmslie, FV; Toutain, A; Amiel, J; Malan, V; Tsai, ACH; Cheung, SW; Gilissen, C; Verwiel, ETP; Martens, S; Feuth, T; Bongers, EMHF; de Vries, P; Scheffer, H; Vissers, LELM; de Brouwer, APM; Brunner, HG; Veltman, JA; Schenck, A; Yntema, HG; de Vries, BBA				Koolen, David A.; Kramer, Jamie M.; Neveling, Kornelia; Nillesen, Willy M.; Moore-Barton, Heather L.; Elmslie, Frances V.; Toutain, Annick; Amiel, Jeanne; Malan, Valerie; Tsai, Anne Chun-Hui; Cheung, Sau Wai; Gilissen, Christian; Verwiel, Eugene T. P.; Martens, Sarah; Feuth, Ton; Bongers, Ernie M. H. F.; de Vries, Petra; Scheffer, Hans; Vissers, Lisenka E. L. M.; de Brouwer, Arjan P. M.; Brunner, Han G.; Veltman, Joris A.; Schenck, Annette; Yntema, Helger G.; de Vries, Bert B. A.			Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome	NATURE GENETICS			English	Article							DEVELOPMENTAL DELAY; DROSOPHILA; ASSOCIATION; MOF	We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features. The KANSL1 protein is an evolutionarily conserved regulator of the chromatin modifier KAT8, which influences gene expression through histone H4 lysine 16 (H4K16) acetylation. RNA sequencing studies in cell lines derived from affected individuals and the presence of learning deficits in Drosophila melanogaster mutants suggest a role for KANSL1 in neuronal processes.	[Koolen, David A.; Kramer, Jamie M.; Neveling, Kornelia; Nillesen, Willy M.; Gilissen, Christian; Verwiel, Eugene T. P.; Martens, Sarah; Bongers, Ernie M. H. F.; de Vries, Petra; Scheffer, Hans; Vissers, Lisenka E. L. M.; de Brouwer, Arjan P. M.; Brunner, Han G.; Veltman, Joris A.; Schenck, Annette; Yntema, Helger G.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Koolen, David A.; Kramer, Jamie M.; Neveling, Kornelia; Nillesen, Willy M.; Gilissen, Christian; Verwiel, Eugene T. P.; Martens, Sarah; Bongers, Ernie M. H. F.; de Vries, Petra; Scheffer, Hans; Vissers, Lisenka E. L. M.; de Brouwer, Arjan P. M.; Brunner, Han G.; Veltman, Joris A.; Schenck, Annette; Yntema, Helger G.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Koolen, David A.; Neveling, Kornelia; Nillesen, Willy M.; Gilissen, Christian; Verwiel, Eugene T. P.; Martens, Sarah; Bongers, Ernie M. H. F.; de Vries, Petra; Scheffer, Hans; Vissers, Lisenka E. L. M.; de Brouwer, Arjan P. M.; Brunner, Han G.; Veltman, Joris A.; Yntema, Helger G.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Inst Genet & Metab Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kramer, Jamie M.; de Brouwer, Arjan P. M.; Schenck, Annette; de Vries, Bert B. A.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Moore-Barton, Heather L.; Elmslie, Frances V.] St Georges Univ London, SW Thames Reg Genet Serv, London, England; [Toutain, Annick] Ctr Hosp Reg & Univ CHRU Hop Bretonneau, Serv Genet, Tours, France; [Amiel, Jeanne; Malan, Valerie] Hop Necker Enfants Malad, Dept Genet, Paris, France; [Amiel, Jeanne; Malan, Valerie] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, INSERM, U781, Paris, France; [Tsai, Anne Chun-Hui] Univ Colorado Denver, Childrens Hosp Colorado, Sect Clin Genet & Metab, Aurora, CO USA; [Cheung, Sau Wai] Baylor Coll Med, Med Genet Labs, Dept Mol & Human Genet, Houston, TX 77030 USA; [Feuth, Ton] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; St Georges University London; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Radboud University Nijmegen	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	b.devries@gen.umcn.nl	amiel, jeanne/H-3501-2017; Schenck, Annette/E-4514-2012; de Brouwer, Arjan PM/P-5949-2015; Veltman, Joris A/F-5128-2010; Koolen, D.A./L-4448-2015; Bongers, M.H.F./L-4214-2015; Malan, Valerie/H-7423-2017; Brunner, Han/C-9928-2013; Gilissen, Christian/E-5246-2012; Neveling, K./L-4544-2015; amiel, jeanne/AGX-1124-2022; Vissers, Lisenka ELM/A-2598-2015; Scheffer, Hans/E-4644-2012; Yntema, H.G./L-4771-2015	amiel, jeanne/0000-0001-5973-4728; Schenck, Annette/0000-0002-6918-3314; Veltman, Joris A/0000-0002-3218-8250; Malan, Valerie/0000-0002-3450-4958; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Scheffer, Hans/0000-0002-2986-0915; Toutain, Annick/0000-0002-5999-5300; Verwiel, Eugene/0000-0001-9663-6780	Dutch Brain Foundation [KS 2012(1)-119]; Netherlands Organization for Health Research and Development (ZonMW) [917-66-363, 911-08-025, 916-86-016, 917-96-346, 917-86-319]; European Union- [Health-F5-2009-223143]; AnEUploidy [LSHG-CT-2006-37627]; GENCODYS [HEALTH-F4-2010-241995]	Dutch Brain Foundation; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); European Union-; AnEUploidy; GENCODYS	We thank the subjects and their parents for participation in this study and H. van Bokhoven for his comments on the manuscript. We thank M. Schepens, K. van de Donk and personnel from the Microarray Facility and Sequencing Facility Nijmegen for technical assistance. We thank K. Keleman (Institute of Molecular Pathology) and S. Sweeney (University of York) for Drosophila stocks. This study was financially supported by the Dutch Brain Foundation (KS 2012(1)-119 to D. A. K.), the Netherlands Organization for Health Research and Development (ZonMW; grants 917-66-363 and 911-08-025 to J.A.V., 916-86-016 to L. E. L. M. V., 917-96-346 to A. S. and 917-86-319 to B.B.A.d.V.), the European Union-funded TECHGENE project (Health-F5-2009-223143 to J.A.V. and H. S.), the AnEUploidy project (LSHG-CT-2006-37627 to H. G. B., J.A.V and B.B.A.d.V.) and the GENCODYS project (HEALTH-F4-2010-241995 to A. S. and B.B.A.d.V.). We obtained informed consent for participation in the study and to publish clinical photographs for individuals 1-4. The Medical Review Ethics Committee of the Radboud University Nijmegen Medical Center approved the study.	Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dubourg C, 2011, EUR J MED GENET, V54, P144, DOI 10.1016/j.ejmg.2010.11.003; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lone M, 2010, J CELL SCI, V123, P2369, DOI 10.1242/jcs.060582; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Tan TY, 2009, J MED GENET, V46, P480, DOI 10.1136/jmg.2008.065391	14	144	144	3	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					639	641		10.1038/ng.2262	http://dx.doi.org/10.1038/ng.2262			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22544363				2022-12-17	WOS:000304551100009
J	March, HN; Rust, AG; Wright, NA; ten Hoeve, J; de Ridder, J; Eldridge, M; van der Weyden, L; Berns, A; Gadiot, J; Uren, A; Kemp, R; Arends, MJ; Wessels, LFA; Winton, DJ; Adams, DJ				March, H. Nikki; Rust, Alistair G.; Wright, Nicholas A.; ten Hoeve, Jelle; de Ridder, Jeroen; Eldridge, Matthew; van der Weyden, Louise; Berns, Anton; Gadiot, Jules; Uren, Anthony; Kemp, Richard; Arends, Mark J.; Wessels, Lodewyk F. A.; Winton, Douglas J.; Adams, David J.			Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis	NATURE GENETICS			English	Article							COLORECTAL-CANCER; BETA-CATENIN; APC(MIN/+) MICE; GASTROINTESTINAL-TRACT; ADENOMA FORMATION; COLON-CANCER; APC GENE; MOUSE; WNT; PROGRESSION	The evolution of colorectal cancer suggests the involvement of many genes. To identify new drivers of intestinal cancer, we performed insertional mutagenesis using the Sleeping Beauty transposon system in mice carrying germline or somatic Apc mutations. By analyzing common insertion sites (CISs) isolated from 446 tumors, we identified many hundreds of candidate cancer drivers. Comparison to human data sets suggested that 234 CIS-targeted genes are also dysregulated in human colorectal cancers. In addition, we found 183 CIS-containing genes that are candidate Wnt targets and showed that 20 CISs-containing genes are newly discovered modifiers of canonical Wnt signaling. We also identified mutations associated with a subset of tumors containing an expanded number of Paneth cells, a hallmark of deregulated Wnt signaling, and genes associated with more severe dysplasia included those encoding members of the FGF signaling cascade. Some 70 genes had co-occurrence of CIS pairs, clustering into 38 sub-networks that may regulate tumor development.	[March, H. Nikki; Eldridge, Matthew; Kemp, Richard; Winton, Douglas J.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Rust, Alistair G.; van der Weyden, Louise; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge, England; [Wright, Nicholas A.] Canc Res UK, London Res Inst, Histopathol Unit, London, England; [ten Hoeve, Jelle; de Ridder, Jeroen; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Bioinformat & Stat Grp, Amsterdam, Netherlands; [de Ridder, Jeroen; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Berns, Anton; Gadiot, Jules; Uren, Anthony] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England	Cancer Research UK; CRUK Cambridge Institute; Wellcome Trust Sanger Institute; Cancer Research UK; Netherlands Cancer Institute; Delft University of Technology; Netherlands Cancer Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Winton, DJ (corresponding author), Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England.	doug.winton@cancer.org.uk	Uren, Anthony G/A-5784-2009; van der Weyden, Louise/AAV-5711-2021	Uren, Anthony G/0000-0002-6019-7111; van der Weyden, Louise/0000-0002-0645-1879; Wright, Nicholas/0000-0002-5525-3457; de Ridder, Jeroen/0000-0002-0828-3477; Rust, Alistair/0000-0001-7287-192X; Eldridge, Matthew/0000-0002-5799-8911; Adams, David/0000-0001-9490-0306; Kemp, Richard/0000-0002-0121-7709	Cancer Research-UK; Wellcome Trust; Kay Kendall Leukemia Foundation; Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative; Netherlands Bioinformatics Centre through the Netherlands Genomics Initiative; Cancer Genomics Centre through the Netherlands Genomics Initiative; MRC [MC_UP_A652_1001] Funding Source: UKRI; Medical Research Council [1116184, MC_UP_A652_1001] Funding Source: researchfish	Cancer Research-UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukemia Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; Netherlands Bioinformatics Centre through the Netherlands Genomics Initiative; Cancer Genomics Centre through the Netherlands Genomics Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Cambridge Research Institute core service Biological Resources and Histopathology, and the Sanger Institute sequencing services for their vital contributions to this study. We are grateful to V. Theodorou for critical reading of the manuscript. H.N.M., A.G.R., N.A.W., M.E., R.K., M.J.A., L.v.d.W., D.J.W. and D.J.A. are supported by Cancer Research-UK. D.J.A. is also supported by the Wellcome Trust and L.v.d.W. by the Kay Kendall Leukemia Foundation. A.G.U., L.W., J.t.H. and J.d.R. are supported by the Netherlands Organization for Scientific Research (NWO) Genomics program and the Netherlands Genomics Initiative. J.d.R. was also supported by the BioRange program of the Netherlands Bioinformatics Centre, which is supported by a BSIK grant through the Netherlands Genomics Initiative. A.U. is also supported by the Cancer Genomics Centre through the Netherlands Genomics Initiative.	Alberici P, 2007, AM J PATHOL, V170, P377, DOI 10.2353/ajpath.2007.060853; Albrethsen J, 2010, MOL CELL PROTEOMICS, V9, P988, DOI 10.1074/mcp.M900546-MCP200; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Ciccarelli FD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-74; Ciznadija D, 2009, CELL DEATH DIFFER, V16, P1530, DOI 10.1038/cdd.2009.94; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, CANCER RES, V65, P9607, DOI 10.1158/0008-5472.CAN-05-3085; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Dopeso H, 2009, CANCER RES, V69, P7430, DOI 10.1158/0008-5472.CAN-09-0706; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Hung KE, 2009, CANCER PREV RES, V2, P224, DOI 10.1158/1940-6207.CAPR-08-0153; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Joo M, 2009, HUM PATHOL, V40, P872, DOI 10.1016/j.humpath.2008.12.003; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; Kucherlapati MH, 2008, P NATL ACAD SCI USA, V105, P15493, DOI 10.1073/pnas.0802933105; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Luchtenborg M, 2004, CARCINOGENESIS, V25, P1219, DOI 10.1093/carcin/bgh117; McAlpine CA, 2006, INT J CANCER, V119, P2339, DOI 10.1002/ijc.22115; MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Musteanu M, 2010, GASTROENTEROLOGY, V138, P1003, DOI 10.1053/j.gastro.2009.11.049; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Schinzel AC, 2008, FRONT BIOSCI-LANDMRK, V13, P71, DOI 10.2741/2661; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Segditsas S, 2009, ONCOGENE, V28, P146, DOI 10.1038/onc.2008.361; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940	60	144	145	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1202	U55		10.1038/ng.990	http://dx.doi.org/10.1038/ng.990			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22057237	Green Accepted, Green Submitted			2022-12-17	WOS:000297931400012
J	Louie, CM; Caridi, G; Lopes, VS; Brancati, F; Kispert, A; Lancaster, MA; Schlossman, AM; Otto, EA; Leitges, M; Grone, HJ; Lopez, I; Gudiseva, HV; O'Toole, JF; Vallespin, E; Ayyagari, R; Ayuso, C; Cremers, FPM; den Hollander, AI; Koenekoop, RK; Dallapiccola, B; Ghiggeri, GM; Hildebrandt, F; Valente, EM; Williams, DS; Gleeson, JG				Louie, Carrie M.; Caridi, Gianluca; Lopes, Vanda S.; Brancati, Francesco; Kispert, Andreas; Lancaster, Madeline A.; Schlossman, Andrew M.; Otto, Edgar A.; Leitges, Michael; Groene, Hermann-Josef; Lopez, Irma; Gudiseva, Harini V.; O'Toole, John F.; Vallespin, Elena; Ayyagari, Radha; Ayuso, Carmen; Cremers, Frans P. M.; den Hollander, Anneke I.; Koenekoop, Robert K.; Dallapiccola, Bruno; Ghiggeri, Gian Marco; Hildebrandt, Friedhelm; Valente, Enza Maria; Williams, David S.; Gleeson, Joseph G.			AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis	NATURE GENETICS			English	Article							RHODOPSIN KNOCKOUT MICE; JOUBERT-SYNDROME; IN-VIVO; INTRAFLAGELLAR TRANSPORT; CONNECTING CILIA; MUTATIONS CAUSE; GENE; MOUSE; PROTEIN; DISEASE	Degeneration of photoreceptors is a common feature of ciliopathies, owing to the importance of the specialized ciliary structure of these cells. Mutations in AHI1, which encodes a cilium-localized protein, have been shown to cause a form of Joubert syndrome that is highly penetrant for retinal degeneration(1,2). We show that Ahi1-null mice fail to form retinal outer segments and have abnormal distribution of opsin throughout their photoreceptors. Apoptotic cell death of photoreceptors occurs rapidly between 2 and 4 weeks of age in these mice and is significantly (P = 0.00175 and 0.00613) delayed by a reduced dosage of opsin. This phenotype also shows dosage-sensitive genetic interactions with Nphp1, another ciliopathy-related gene. Although it is not a primary cause of retinal blindness in humans, we show that an allele of AHI1 is associated with a more than sevenfold increase in relative risk of retinal degeneration within a cohort of individuals with the hereditary kidney disease nephronophthisis. Our data support context-specific roles for AHI1 as a contributor to retinopathy and show that AHI1 may explain a proportion of the variability in retinal phenotypes observed in nephronophthisis.	[Louie, Carrie M.; Lancaster, Madeline A.; Schlossman, Andrew M.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat, La Jolla, CA 92093 USA; [Caridi, Gianluca; Ghiggeri, Gian Marco] IRCCS, Ist Giannina Gaslini, Lab Fisiopatol Uremia, Genoa, Italy; [Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90024 USA; [Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Jules Stein Eye Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Lopes, Vanda S.; Williams, David S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Brancati, Francesco; Valente, Enza Maria] Casa Sollievo Sofferenza Hosp, Casa Sollievo Sofferenza Mendel Inst, Rome, Italy; [Brancati, Francesco] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Otto, Edgar A.; O'Toole, John F.; Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Dept Pediat, Ann Arbor, MI 48109 USA; [Otto, Edgar A.; O'Toole, John F.; Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Dept Human Genet, Ann Arbor, MI 48109 USA; [Leitges, Michael] Univ Oslo, Ctr Biotechnol, Oslo, Norway; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-6900 Heidelberg, Germany; [Lopez, Irma; Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ, Canada; [Gudiseva, Harini V.; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Vallespin, Elena; Ayuso, Carmen] CIBERER, Fdn Jimenez Diaz, Dept Med Genet, Madrid, Spain; [Cremers, Frans P. M.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life, NL-6525 ED Nijmegen, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Dept Ophthalmol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy; [Valente, Enza Maria] Univ Messina, Dept Med & Surg Pediat Sci, Messina, Italy	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Genoa; IRCCS Istituto Giannina Gaslini; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; G d'Annunzio University of Chieti-Pescara; Hannover Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Oslo; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; University of California System; University of California San Diego; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Radboud University Nijmegen; Radboud University Nijmegen; IRCCS Bambino Gesu; University of Messina	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Pediat, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Vallespin, Elena/E-5277-2018; Hollander, Anneke den/N-4911-2014; Caridi, Gianluca/F-7052-2010; Cremers, Frans/A-5625-2014; Ghiggeri, Gian Marco/N-4712-2015; Valente, Enza Maria/G-2942-2017; Koenekoop, Robert/AAT-6676-2021; Brancati, Francesco/AAC-3778-2022; Leitges, Michael/AAN-1953-2021; Dallapiccola, Bruno/K-8692-2016	Vallespin, Elena/0000-0002-8080-8629; Caridi, Gianluca/0000-0001-6700-3001; Cremers, Frans/0000-0002-4954-5592; Ghiggeri, Gian Marco/0000-0003-3659-9062; Valente, Enza Maria/0000-0002-0600-6820; Brancati, Francesco/0000-0003-3624-2354; Lancaster, Madeline/0000-0003-2324-8853; Leitges, Michael/0000-0003-4203-6995; Dallapiccola, Bruno/0000-0002-5031-1013; Otto, Edgar/0000-0002-2387-9973; Ayuso, Carmen/0000-0002-9242-7065	University of California at San Diego (UCSD) Neurosciences Microscopy Shared Facility [NINDS P30NS047101]; US National Institutes of Health [R01NS048453, R01DK068306, P30NS047101, F31NS059281, R01EY007042]; National Institute for General Medical Sciences [T32 GM008666]; Telethon-Italy [GP08145]; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY007042, R01EY013408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, F31NS059281] Funding Source: NIH RePORTER	University of California at San Diego (UCSD) Neurosciences Microscopy Shared Facility; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon-Italy(Fondazione Telethon); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Siever and K. Teofilo for assistance with histology; G. Silva, L. Cheng and M. Davidson for assistance with ERG testing; A. Avila for assistance with clinical data and selecting controls; J. Lem, G. Lemke, T. Burstyn-Cohen and A. Wynshaw-Boris for sharing mice and for feedback and suggestions; K. Zhang, L. Goldstein and B. Zheng for feedback and suggestions; T. Li and E. Pierce for sharing antibodies; C.-H. Sung for sharing rhodopsin plasmid; J. Kim and V. Cantagrel for technical advice; and J. Meerloo with the University of California at San Diego (UCSD) Neurosciences Microscopy Shared Facility (NINDS P30NS047101) for microscopy services and support. This work was supported by the US National Institutes of Health R01NS048453 (J.G.G.), R01DK068306 (F.H.), P30NS047101 (J.G.G.), F31NS059281 (C.M.L.), R01EY007042 (D.S.W.), UCSD Genetics Training Program institutional training grant T32 GM008666 from the National Institute for General Medical Sciences (C.M.L. and M.A.L), GP08145 grant from Telethon-Italy (E.M.V.) and the Burroughs Wellcome Fund (J.G.G.). D.S.W. is a Jules and Doris Stein RPB Professor. J.G.G. and F.H. are investigators of the Howard Hughes Medical Institute.	Bhowmick R, 2009, TRAFFIC, V10, P648, DOI 10.1111/j.1600-0854.2009.00896.x; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deretic D, 2006, VISION RES, V46, P4427, DOI 10.1016/j.visres.2006.07.028; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; El Bradey M, 2004, J OCUL PHARMACOL TH, V20, P217, DOI 10.1089/1080768041223657; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fleiss J. L., 2013, STAT METHODS RATES P; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; Kroes HY, 2008, EUR J MED GENET, V51, P24, DOI 10.1016/j.ejmg.2007.10.001; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	46	144	146	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					175	U117		10.1038/ng.519	http://dx.doi.org/10.1038/ng.519			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20081859	Green Submitted, Green Accepted			2022-12-17	WOS:000274084400017
J	Weinberger, LS; Dar, RD; Simpson, ML				Weinberger, Leor S.; Dar, Roy D.; Simpson, Michael L.			Transient-mediated fate determination in a transcriptional circuit of HIV	NATURE GENETICS			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; ESCHERICHIA-COLI; TYPE-1 INFECTION; GENE-EXPRESSION; T-CELLS; RESERVOIR; LATENCY; NOISE; TAT	Steady-state behavior and bistability have been proposed as mechanisms for decision making in gene circuits(1-3). However, transient gene expression has also been proposed to control cell fate(4,5), with the decision arbitrated by the duration of a transient gene expression pulse. Here, using an HIV-1 model system, we directly quantify transcriptional feedback strength and its effects on both the duration of HIV-1 Tat transcriptional pulses and the fate of HIV-infected cells. By measuring shifts in the autocorrelation of noise inherent to gene expression, we found that transcriptional positive feedback extends the single-cell Tat expression lifetime two-to sixfold for both minimal Tat circuits and full length, actively replicating HIV-1. Notably, artificial weakening of Tat positive feedback shortened the duration of Tat expression transients and biased the probability in favor of latency. Thus, transcriptional positive feedback can modulate transient expression lifetime to a greater extent than protein half-life modulation, and it has a critical role in the cell-fate decision in HIV.	[Weinberger, Leor S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dar, Roy D.; Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Dar, Roy D.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Simpson, Michael L.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	University of California System; University of California San Diego; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Weinberger, LS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr 0314, La Jolla, CA 92093 USA.	lsw@ucsd.edu; simpsonml1@ornl.gov	Simpson, Michael/A-8410-2011	Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888				Alon U., 2020, An introduction to systems biology: design principles of biological circuits ed., V2nd edn, P249; Arkin A, 1998, GENETICS, V149, P1633; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Seth N, 2005, J IMMUNOL, V175, P6948, DOI 10.4049/jimmunol.175.10.6948; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; TONGSTARKSEN SE, 1989, J IMMUNOL, V142, P702; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2003, J VIROL, V77, P10028, DOI 10.1128/JVI.77.18.10028-10036.2003; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006	30	144	146	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					466	470		10.1038/ng.116	http://dx.doi.org/10.1038/ng.116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18344999				2022-12-17	WOS:000254388100019
J	Schmahl, J; Raymond, CS; Soriano, P				Schmahl, Jennifer; Raymond, Christopher S.; Soriano, Philippe			PDGF signaling specificity is mediated through multiple immediate early genes	NATURE GENETICS			English	Article							CELL-DEVELOPMENT; RECEPTOR; IDENTIFICATION; EXPRESSION; ALPHA; PATHWAYS; CLONING; ROLES; MOUSE; MICE	Growth factor signaling leads to the induction or repression of immediate early genes, but how these genes act collectively as effectors of downstream processes remains unresolved. We have used gene trap-coupled microarray analysis to identify and mutate multiple platelet-derived growth factor (PDGF) intermediate early genes in mice. Mutations in these genes lead to a high frequency of phenotypes that affect the same cell types and processes as those controlled by the PDGF pathway. We conclude that these genes form a network that controls specific processes downstream of PDGF signaling.	Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Soriano, P (corresponding author), Fred Hutchinson Canc Res Ctr, Program Dev Biol, 1100 Fairview Ave N, Seattle, WA 98109 USA.	psoriano@fhcrc.org	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X; Raymond, Christopher/0000-0003-1128-8524	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024875] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071158] Funding Source: NIH RePORTER; NCI NIH HHS [CA09657] Funding Source: Medline; NICHD NIH HHS [R01 HD024875, R37 HD025326, HD24875] Funding Source: Medline; NIGMS NIH HHS [GM071158] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bertotti A, 2003, TRENDS BIOCHEM SCI, V28, P527, DOI 10.1016/j.tibs.2003.09.001; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; GRUNEBERG H, 1960, GENET RES, V1, P69, DOI 10.1017/S0016672300000094; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	32	144	154	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					52	60		10.1038/ng1922	http://dx.doi.org/10.1038/ng1922			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143286				2022-12-17	WOS:000243136500017
J	Deutscher, D; Meilijson, I; Kupiec, M; Ruppin, E				Deutscher, David; Meilijson, Isaac; Kupiec, Martin; Ruppin, Eytan			Multiple knockout analysis of genetic robustness in the yeast metabolic network	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME; DISPENSABILITY; MUTATIONS; EVOLUTION; SEQUENCE; DELETION; RECONSTRUCTION; PRINCIPLES; DISCOVERY	Genetic robustness characterizes the constancy of the phenotype in face of heritable perturbations. Previous investigations have used comprehensive single and double gene knockouts to study gene essentiality and pairwise gene interactions in the yeast Saccharomyces cerevisiae. Here we conduct an in silico multiple knockout investigation of a flux balance analysis model of the yeast's metabolic network. Cataloging gene sets that provide mutual functional backup, we identify sets of up to eight interacting genes and characterize the 'k robustness' ( the depth of backup interactions) of each gene. We find that 74% ( 360) of the metabolic genes participate in processes that are essential to growth in a standard laboratory environment, compared with only 13% previously found to be essential using single knockouts. The genes' k robustness is shown to be a solid indicator of their biological buffering capacity and is correlated with both the genes' environmental specificity and their evolutionary retention.	Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Math Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University	Ruppin, E (corresponding author), Tel Aviv Univ, Sch Comp Sci, POB 39040, IL-69978 Tel Aviv, Israel.	ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Nelson DL, 2017, LEHNINGER PRINCIPLES, P881; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; SCHAAFFGERSTENSCHLAGER I, 1993, EUR J BIOCHEM, V217, P487, DOI 10.1111/j.1432-1033.1993.tb18268.x; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf YI, 2006, P ROY SOC B-BIOL SCI, V273, P1507, DOI 10.1098/rspb.2006.3472	33	144	149	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					993	998		10.1038/ng1856	http://dx.doi.org/10.1038/ng1856			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16941010				2022-12-17	WOS:000240112100014
J	Mahadevan, MS; Yadava, RS; Yu, Q; Balijepalli, S; D Frenzel-McCardell, C; Bourne, TD; Phillips, LH				Mahadevan, Mani S.; Yadava, Ramesh S.; Yu, Qing; Balijepalli, Sadguna; D Frenzel-McCardell, Carla; Bourne, T. David; Phillips, Lawrence H.			Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy	NATURE GENETICS			English	Article							3 UNTRANSLATED REGION; TRINUCLEOTIDE REPEAT; MIS-REGULATION; NUCLEAR FOCI; PROTEIN; MUSCLEBLIND; SEQUENCE; DMPK; OVEREXPRESSION; TRANSCRIPTS	Myotonic dystrophy (DM1), the most common muscular dystrophy in adults, is caused by an expanded (CTG)(n) tract in the 3' UTR of the gene encoding myotonic dystrophy protein kinase ( DMPK) 1, which results in nuclear entrapment of the 'toxic' mutant RNA and interacting RNA-binding proteins ( such as MBNL1) in ribonuclear inclusions(2). It is unclear if therapy aimed at eliminating the toxin would be beneficial. To address this, we generated transgenic mice expressing the DMPK 3' UTR as part of an inducible RNA transcript encoding green fluorescent protein (GFP). We were surprised to find that mice overexpressing a normal DMPK 3' UTR mRNA reproduced cardinal features of myotonic dystrophy, including myotonia, cardiac conduction abnormalities, histopathology and RNA splicing defects in the absence of detectable nuclear inclusions. However, we observed increased levels of CUG-binding protein (CUG-BP1) in skeletal muscle, as seen in individuals with DM1. Notably, these effects were reversible in both mature skeletal and cardiac muscles by silencing transgene expression. These results represent the first in vivo proof of principle for a therapeutic strategy for treatment of myotonic dystrophy by ablating or silencing expression of the toxic RNA molecules.	Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA	University of Virginia; University of Wisconsin System; University of Wisconsin Madison; University of Virginia	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	mahadevan@virginia.edu	Bourne, Tom/I-6478-2012; Yadava, Ramesh S/AAZ-3099-2021	Bourne, Tom/0000-0003-1421-6059; Yadava, Ramesh S/0000-0002-0092-5033	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045992, R01AR052771] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR052771, R01 AR052771-02, R01 AR045992] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; Berul CI, 2000, J INTERV CARD ELECTR, V4, P351, DOI 10.1023/A:1009842114968; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; MELACINI P, 1995, J AM COLL CARDIOL, V25, P239, DOI 10.1016/0735-1097(94)00351-P; O'Cochlain DF, 2004, HUM MOL GENET, V13, P2505, DOI 10.1093/hmg/ddh266; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Storbeck CJ, 2004, HUM MOL GENET, V13, P589, DOI 10.1093/hmg/ddh064; Storbeck CJ, 1998, J BIOL CHEM, V273, P9139, DOI 10.1074/jbc.273.15.9139; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200	30	144	148	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1066	1070		10.1038/ng1857	http://dx.doi.org/10.1038/ng1857			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16878132	Green Accepted			2022-12-17	WOS:000240112100026
J	Hollanda, LM; Lima, CSP; Cunha, AF; Albuquerque, DM; Vassallo, J; Ozelo, MC; Joazeiro, PP; Saad, STO; Costa, FF				Hollanda, Luciana M.; Lima, Carmen S. P.; Cunha, Anderson F.; Albuquerque, Dulcineia M.; Vassallo, Jose; Ozelo, Margareth C.; Joazeiro, Paulo P.; Saad, Sara T. O.; Costa, Fernando F.			An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis	NATURE GENETICS			English	Article							TRANSIENT MYELOPROLIFERATIVE DISORDER; ACUTE MEGAKARYOBLASTIC LEUKEMIA; X-LINKED THROMBOCYTOPENIA; ACQUIRED MUTATIONS; DOWN-SYNDROME; MACROTHROMBOCYTOPENIA; DIAGNOSIS; CHILDREN; ANEMIA; GENE	Acquired somatic mutations(1-6) in exon 2 of the hematopoietic transcription factor GATA-1 have been found in individuals with Down syndrome with both transient myeloproliferative disorder(2-10) and acute megakaryoblastic leukemia(1-4,6,8-10). These mutations prevent the synthesis of the full-length protein but allow the synthesis of its short isoform, GATA-1s. Experiments in mice(11) suggest that GATA-1s supports normal adult megakaryopoiesis, platelet formation and erythropoiesis. Here we report a mutation, 332G -> C, in exon 2 of GATA1, leading to the synthesis of only the short isoform in seven affected males from two generations of a family. Hematological profiles of affected males demonstrate macrocytic anemia, normal platelet counts and neutropenia in most cases. Altogether, data suggest that GATA-1s alone, produced in low or normal levels, is not sufficient to support normal erythropoiesis. Moreover, this is the first study to indicate that a germline splicing mutation does not lead to leukemia in the absence of other cooperating events, such as Down syndrome.	Univ Estadual Campinas, Sch Med Sci, Hemoctr, Dept Internal Med, BR-13083970 Campinas, SP, Brazil; Univ Estadual Campinas, Sch Med Sci, Dept Anat Pathol, BR-13083970 Campinas, SP, Brazil; Univ Estadual Campinas, Inst Biol, Dept Histol, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Costa, FF (corresponding author), Univ Estadual Campinas, Sch Med Sci, Hemoctr, Dept Internal Med, BR-13083970 Campinas, SP, Brazil.	ferreira@unicamp.br	da Cunha, Anderson Ferreira/B-7931-2012; da Cunha, Anderson Ferreira/M-9038-2019; Costa, Fernando F/D-1566-2012; de Albuquerque, Dulcineia Martins/U-8601-2019; HOLLANDA, LUCIANA MARIA DE/F-7893-2011; Ozelo, Margareth C/K-5819-2012; JOAZEIRO, PAULO/C-6733-2014; VASSALLO, JOSE/AAP-4600-2021; Lima, Carmen Silvia Passos/K-4775-2013	da Cunha, Anderson Ferreira/0000-0003-3485-5659; Costa, Fernando F/0000-0002-4632-572X; HOLLANDA, LUCIANA MARIA DE/0000-0002-6047-4043; Ozelo, Margareth C/0000-0001-5938-0675; VASSALLO, JOSE/0000-0002-2192-4865; 				Ahmed M, 2004, BLOOD, V103, P2480, DOI 10.1182/blood-2003-10-3383; Balduini CL, 2004, THROMB HAEMOSTASIS, V91, P129, DOI 10.1160/TH03-05-0290; Budde U, 2002, SEMIN THROMB HEMOST, V28, P173, DOI 10.1055/s-2002-27820; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; Centurione L, 2004, BLOOD, V104, P3573, DOI 10.1182/blood-2004-01-0193; Conran N, 2004, AM J HEMATOL, V76, P343, DOI 10.1002/ajh.20129; Crispino JD, 2005, PEDIATR BLOOD CANCER, V44, P40, DOI 10.1002/pbc.20066; dos Santos CO, 2004, EXP HEMATOL, V32, P157, DOI 10.1016/j.exphem.2003.11.002; Freson K, 2002, HUM MOL GENET, V11, P147, DOI 10.1093/hmg/11.2.147; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Gao DY, 1999, CRYOBIOLOGY, V38, P225, DOI 10.1006/cryo.1999.2162; GAWAZ MP, 1991, KIDNEY INT, V40, P257, DOI 10.1038/ki.1991.208; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Gurbuxani S, 2004, BLOOD, V103, P399, DOI 10.1182/blood-2003-05-1556; Hitzler JK, 2003, BLOOD, V101, P4301, DOI 10.1182/blood-2003-01-0013; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Mehaffey MG, 2001, BLOOD, V98, P2681, DOI 10.1182/blood.V98.9.2681; Mundschau G, 2003, BLOOD, V101, P4298, DOI 10.1182/blood-2002-12-3904; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pedrazzoli P, 2000, BRIT J HAEMATOL, V108, P653, DOI 10.1046/j.1365-2141.2000.01860.x; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Shimada A, 2004, BLOOD, V103, P366, DOI 10.1182/blood-2003-09-3219; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Stenberg PE, 1998, BLOOD, V91, P1599, DOI 10.1182/blood.V91.5.1599.1599_1599_1608; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Yu CN, 2002, BLOOD, V100, P2040, DOI 10.1182/blood-2002-02-0387	30	144	148	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					807	812		10.1038/ng1825	http://dx.doi.org/10.1038/ng1825			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16783379				2022-12-17	WOS:000238669300017
J	Chudnovsky, Y; Adams, AE; Robbins, PB; Lin, Q; Khavari, PA				Chudnovsky, Y; Adams, AE; Robbins, PB; Lin, Q; Khavari, PA			Use of human tissue to assess the oncogenic activity of melanoma-associated mutations	NATURE GENETICS			English	Article							MALIGNANT-MELANOMA; BRAF MUTATIONS; GENE; TUMORIGENESIS; PROGRESSION; EXPRESSION; CANCER	Multiple genetic alterations occur in melanoma, a lethal skin malignancy of increasing incidence(1,2). These include mutations that activate Ras and two of its effector cascades, Raf and phosphoinositide 3- kinase ( PI3K). Induction of Ras and Raf can be caused by active N- Ras and B- Raf mutants as well as by gene amplification(3-5). Activation of PI3K pathway components occurs by PTEN loss and by AKT3 amplification(6-8). Melanomas also commonly show impairment of the p16(INK4A)- CDK4- Rb and ARF- HDM2- p53 tumor suppressor pathways. CDKN2A mutations can produce p16(INK4A) and ARF protein loss(5,9-11). Rb bypass can also occur through activating CDK4 mutations as well as by CDK4 amplification(5,12). In addition to ARF deletion, p53 pathway disruption can result from dominant negative TP53 mutations(5,13). TERT amplification also occurs in melanoma(5). The extent to which these mutations can induce human melanocytic neoplasia is unknown. Here we characterize pathways sufficient to generate human melanocytic neoplasia and show that genetically altered human tissue facilitates functional analysis of mutations observed in human tumors.	Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Khavari, PA (corresponding author), Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.	khavari@CMGM.stanford.edu			NIAMS NIH HHS [R01 AR043799, R01 AR043799-07] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043799] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Chang S, 2002, P NATL ACAD SCI USA, V99, P12520, DOI 10.1073/pnas.212514699; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng H, 1998, BIOTECHNIQUES, V25, P274, DOI 10.2144/98252gt02; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Hsu MY, 2000, J CELL SCI, V113, P1535; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Kamb A, 1994, Nat Genet, V8, P23; Kannan K, 2003, P NATL ACAD SCI USA, V100, P1221, DOI 10.1073/pnas.0336397100; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Rodolfo M, 2004, CANCER LETT, V214, P133, DOI 10.1016/j.canlet.2004.06.049; Schaffer JV, 2004, J AM ACAD DERMATOL, V51, pS65, DOI 10.1016/j.jaad.2004.01.030; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Weitzman JB, 1999, NATURE, V400, P401, DOI 10.1038/22637; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451	30	144	146	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2005	37	7					745	749		10.1038/ng1586	http://dx.doi.org/10.1038/ng1586			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15951821	Green Accepted			2022-12-17	WOS:000230196400022
J	Firulli, BA; Krawchuk, D; Centonze, VE; Vargesson, N; Virshup, DM; Conway, SJ; Cserjesi, P; Laufer, E; Firulli, AB				Firulli, BA; Krawchuk, D; Centonze, VE; Vargesson, N; Virshup, DM; Conway, SJ; Cserjesi, P; Laufer, E; Firulli, AB			Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities	NATURE GENETICS			English	Article							BHLH TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; BASIC DOMAIN; DNA-BINDING; CHICK LIMB; MUTATIONS; PROTEIN; HEDGEHOG; DHAND; GENE	Autosomal dominant mutations in the gene encoding the basic helix-loop-helix transcription factor Twist1 are associated with limb and craniofacial defects in humans with Saethre-Chotzen syndrome. The molecular mechanism underlying these phenotypes is poorly understood. We show that ectopic expression of the related basic helix-loop-helix factor Hand2 phenocopies Twist1 loss of function in the limb and that the two factors have a gene dosage - dependent antagonistic interaction. Dimerization partner choice by Twist1 and Hand2 can be modulated by protein kinase A - and protein phosphatase 2A - regulated phosphorylation of conserved helix I residues. Notably, multiple Twist1 mutations associated with Saethre-Chotzen syndrome alter protein kinase A - mediated phosphorylation of Twist1, suggesting that misregulation of Twist1 dimerization through either stoichiometric or post-translational mechanisms underlies phenotypes of individuals with Saethre-Chotzen syndrome.	Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Wells Ctr Pediat Res,Dept Pediat, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Wells Ctr Pediat Res,Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular Biol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Biol Struct, San Antonio, TX 78229 USA; Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA; Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Columbia University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Tulane University	Laufer, E (corresponding author), Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Wells Ctr Pediat Res,Dept Pediat, 1044 W Walnut R4 371, Indianapolis, IN 46202 USA.	elaufer@columbia.edu	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; Laufer, Edward/0000-0002-4933-1017; /0000-0001-6687-8949; Vargesson, Neil/0000-0001-8027-114X	NHLBI NIH HHS [R01 HL061677, R01 HL061677-08] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061677] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Charite J, 2000, DEVELOPMENT, V127, P2461; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Corsi AK, 2002, DEVELOPMENT, V129, P2761; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; El Ghouzzi V, 2001, FEBS LETT, V492, P112, DOI 10.1016/S0014-5793(01)02238-4; ElGhouzzi V, 1997, NAT GENET, V15, P42; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Firulli BA, 2000, J BIOL CHEM, V275, P33567, DOI 10.1074/jbc.M005888200; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; Gripp KW, 2000, HUM MUTAT, V15, P150, DOI 10.1002/(SICI)1098-1004(200002)15:2<150::AID-HUMU3>3.0.CO;2-D; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jabs Ethylin Wang, 2004, P401; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; KASPARCOVA VS, 1998, AM J HUM GENET S, V65, pA367; Kaufman M.H., 1992, ATLAS MOUSE DEV; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McFadden DG, 2002, DEVELOPMENT, V129, P3077; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tavares AT, 2001, INT J DEV BIOL, V45, P707; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yang Y, 1997, DEVELOPMENT, V124, P4393; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zuniga A, 2002, MECH DEVELOP, V114, P51, DOI 10.1016/S0925-4773(02)00048-5	44	144	152	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					373	381		10.1038/ng1525	http://dx.doi.org/10.1038/ng1525			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735646	Green Accepted			2022-12-17	WOS:000228040000020
J	Morello, R; Zhou, G; Dreyer, SD; Harvey, SJ; Ninomiya, Y; Thorner, PS; Miner, JH; Cole, W; Winterpacht, A; Zabel, B; Oberg, KC; Lee, B				Morello, R; Zhou, G; Dreyer, SD; Harvey, SJ; Ninomiya, Y; Thorner, PS; Miner, JH; Cole, W; Winterpacht, A; Zabel, B; Oberg, KC; Lee, B			Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome	NATURE GENETICS			English	Article							ALPORT-SYNDROME; IV COLLAGEN; MONOCLONAL-ANTIBODIES; GENE; ALPHA-3(IV); MUTATIONS; IDENTIFICATION; ORGANIZATION; DROSOPHILA; ENHANCER	Basement membrane (BM) morphogenesis is critical for normal kidney function(1). Heterotrimeric type IV collagen, composed of different combinations of six ct-chains lid), is a major matrix component of all BMs (ref. 2). Unlike in other BMs, glomerular BM (CBM) contains primarily the alpha3(IV) and alpha4(IV) chains, together with the alpha5(IV) chain(3,4). A poorly understood, coordinated temporal and spatial switch in gene expression from ubiquitously expressed alpha1(IV) and alpha2(IV) collagen to the alpha3(IV), alpha4(IV) and alpha5(IV) chains occurs during nqrmat embryogenesis of CBM (ref. 4). Structural abnormalities of type IV collagen have been associated with diverse biological processes including defects in molecular filtration in Alport syndrome(5,6), cell differentiation in hereditary leiomyomatosis(7), and autoimmunity in Goodpasture syndrome(7); however, the transcriptional and developmental regulation of type IV collagen expression is unknown. Nail patella syndrome (NPS) is caused by mutations in LMX1B, encoding a LIM homeodomain transcription factor. Some patients have nephrosis-associated renal disease characterized by typical ultrastructural abnormalities of GEM (refs. 8,9). In Lmx1b(-/-) mice, expression of both alpha (3)IV and alpha (4)IV collagen is strongly diminished in GEM, whereas that of alpha1, alpha2 and alpha5(IV) collagen is unchanged. Moreover, LMX1B binds specifically to a putative enhancer sequence in intron 1 of both mouse and human COL4A4 and upregulates reporter constructs containing this enhancer-like sequence. These data indicate that LMX1B directly regulates the coordinated expression of alpha3(IV) and alpha (IV) collagen required for normal CBM morphogenesis and that its dysregulation in CBM contributes to the renal pathology and nephrosis in NPS.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Mainz, Dept Pediat, D-6500 Mainz, Germany; Univ Toronto, Dept Pathobiol, Toronto, ON, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 700, Japan; Washington Univ, Sch Med, Dept Med, Div Renal, St Louis, MO USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA; Hosp Sick Children, Div Orthoped, Toronto, ON M5G 1X8, Canada; Univ Hamburg, Inst Human Genet, D-2000 Hamburg, Germany; Loma Linda Univ, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	Baylor College of Medicine; Johannes Gutenberg University of Mainz; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Okayama University; Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Hamburg; Loma Linda University	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Harvey, Scott/C-8938-2011	Harvey, Scott/0000-0001-6007-785X; Oberg, Kerby/0000-0002-1241-4273	NIAMS NIH HHS [AR44738] Funding Source: Medline; NIDDK NIH HHS [DK53196, DK53763] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044738, R01AR044738, R55AR044738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053196, P01DK053763] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht U., 1998, HUMAN GENOME METHODS, P93; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; DESJARDINS M, 1991, J CELL BIOL, V113, P689, DOI 10.1083/jcb.113.3.689; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Dreyer SD, 2000, HUM MOL GENET, V9, P1067, DOI 10.1093/hmg/9.7.1067; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Haerry TE, 1997, DEV BIOL, V186, P1, DOI 10.1006/dbio.1997.8582; Harvey SJ, 1998, KIDNEY INT, V54, P1857, DOI 10.1046/j.1523-1755.1998.00188.x; HEIKKILA P, 1993, J BIOL CHEM, V268, P24677; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Kalluri R, 2000, J BIOL CHEM, V275, P12719, DOI 10.1074/jbc.275.17.12719; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Lu W, 1999, GENOMICS, V61, P113, DOI 10.1006/geno.1999.5943; McIntosh I, 1998, AM J HUM GENET, V63, P1651, DOI 10.1086/302165; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Momota R, 1998, FEBS LETT, V424, P11, DOI 10.1016/S0014-5793(98)00128-8; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; SUTCLIFFE NP, 1989, NEPHROL DIAL TRANSPL, V4, P262, DOI 10.1093/oxfordjournals.ndt.a091869; TAGUCHI T, 1988, ULTRASTRUCT PATHOL, V12, P175, DOI 10.3109/01913128809058216; VALNIO S, 1997, CELL, V90, P975	30	144	147	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					205	208		10.1038/84853	http://dx.doi.org/10.1038/84853			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175791				2022-12-17	WOS:000166839200024
J	Huang, LP; Kuo, YM; Gitschier, J				Huang, LP; Kuo, YM; Gitschier, J			The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency	NATURE GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; CHEDIAK-HIGASHI-SYNDROME; PALE EAR EP; MUTATION ANALYSIS; MOUSE; COMPLEX; DISTINCT; AP-3; IDENTIFICATION; EXPRESSION		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gitschier, J (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.							Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Gwynn B, 1997, GENOMICS, V42, P532, DOI 10.1006/geno.1997.4764; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; James P, 1996, GENETICS, V144, P1425; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; LYON MF, 1989, GENETIC VARIANTS STR, P274; MARTORANA PA, 1993, LAB INVEST, V68, P233; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; NOVAK EK, 1984, BLOOD, V63, P536; NOVAK EK, 1979, GENETICS, V92, P189; O'Donohue MF, 1998, BIOTECHNIQUES, V24, P910, DOI 10.2144/98246bm01; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Ooi CE, 1997, EMBO J, V16, P4508; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Roberts E, 1931, SCIENCE, V74, P569, DOI 10.1126/science.74.1927.569; ROBINSON PJ, 1981, IMMUNOGENETICS, V14, P449, DOI 10.1007/BF00373326; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; THERIAULT LL, 1970, DEV BIOL, V23, P261, DOI 10.1016/0012-1606(70)90098-9; White R. A., 1997, Mouse Genome, V95, P492; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; Zuberi AR, 1996, GENOMICS, V33, P75, DOI 10.1006/geno.1996.0161	28	144	147	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1999	23	3					329	332		10.1038/15507	http://dx.doi.org/10.1038/15507			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	257QC	10610180				2022-12-17	WOS:000083792200023
J	Dealy, MJ; Nguyen, KVT; Lo, J; Gstaiger, M; Krek, W; Elson, D; Arbeit, J; Kipreos, ET; Johnson, RS				Dealy, MJ; Nguyen, KVT; Lo, J; Gstaiger, M; Krek, W; Elson, D; Arbeit, J; Kipreos, ET; Johnson, RS			Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E	NATURE GENETICS			English	Article							F-BOX PROTEIN; UBIQUITIN LIGASE; COMPLEX; DEGRADATION; TRANSITION; PATHWAY; FAMILY; ASSOCIATION; TARGETS; CDC4P	The sequential timing of cell-cycle transitions is primarily governed by the availability and activity of key cell-cycle proteins(1). Recent studies in yeast have identified a class of ubiquitin ligases (E3 enzymes) called SCF complexes, which regulate the abundance of proteins that promote(2-4) and inhibit(4-6) cell-cycle progression at the G1-S phase transition. SCF complexes consist of three invariable components, Skp1, Cul-1 (Cdc53 in yeast) and Rbx1, and a variable F-box protein that recruits a specific cellular protein to the ubquitin pathway for degradation(2,3,5,7-13). To study the role of Cul-1 in mammalian development and cell-cycle regulation, we generated mice deficient for Cul1 and analysed null embryos and heterozygous cell lines. We show that Cul1 is required for early mouse development and that Cul1 mutants fail to regulate the abundance of the G1 cyclin, cyclin E (encoded by Gene), during embryogenesis.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Calif San Francisco, Dept Surg, Ctr Canc, San Francisco, CA 94143 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University of California System; University of California San Diego; Friedrich Miescher Institute for Biomedical Research; University of California System; University of California San Francisco; University System of Georgia; University of Georgia	Johnson, RS (corresponding author), Univ Calif San Diego, Dept Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Arbeit, Jeffrey/K-6920-2019; Johnson, Randall/AAM-1189-2021	Johnson, Randall/0000-0002-4084-6639				Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; HOGAN B, 1994, MANIPULATING MOUSE E, P61; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Michel JJ, 1998, CELL GROWTH DIFFER, V9, P435; Papaioannou V., 1993, Gene targeting: a practical approach., P107; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Patton EE, 1998, GENE DEV, V12, P3144; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Slingerland J, 1998, Results Probl Cell Differ, V22, P133; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, GENE DEV, V13, P1050; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	30	144	147	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					245	248		10.1038/13886	http://dx.doi.org/10.1038/13886			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508527				2022-12-17	WOS:000082827500030
J	Watanabe, H; Yamada, Y				Watanabe, H; Yamada, Y			Mice lacking link protein develop dwarfism and craniofacial abnormalities	NATURE GENETICS			English	Article							HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; CHONDROCYTE DIFFERENTIATION; SKELETAL DEVELOPMENT; ENDOCHONDRAL BONE; INDIAN HEDGEHOG; CORE PROTEIN; GENE; CARTILAGE; AGGRECAN	Link protein (LP), an extracellular matrix protein in cartilage, stabilizes aggregates of aggrecan and hyaluronan, giving cartilage its tensile strength and elasticity(1-3). Cartilage provides the template for endochondral ossification and is crucial for determining the length and width of the skeleton. During endochondral bone formation, hypertrophic chondrocytes die and the cartilage is replaced with bone matrix. Here, we have generated targeted mutations in mice in the gene encoding LP (Crtl1). Homozygotes showed defects in cartilage development and delayed bone formation with short limbs and craniofacial anomalies. Most Crtl1(tm1Nid/tm1Nid) mice died shortly after birth due to respiratory failure, but some survived and developed progressive dwarfism and lordosis of the cervical spine. They showed small epiphysis, slightly flared metaphysis of long bones and flattened vertebrae, characteristic of spondyloepiphyseal dysplasias. The cartilage contained significantly reduced aggrecan depositions in the hypertrophic zone, and decreased numbers of prehypertrophic and hypertrophic chondrocytes. Reduced Indian hedgehog (Ihh) expression was observed in prehypertrophic chondrocytes, and apoptosis was inhibited in hypertrophic chondrocytes. These results indicate that LP is important for the formation of proteoglycan aggregates and normal organization of hypertrophic chondrocytes, and suggest that cartilage matrix has a role in chondrocyte differentiation and maturation.	Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yamada, Y (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA.	yamada@yoda.nidr.nih.gov						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; DOEGE K, 1987, J BIOL CHEM, V262, P17757; HARDINGHAM TE, 1994, EUR J CLIN CHEM CLIN, V32, P249; Hascall V.C., 1991, CELL BIOL EXTRACELLU, P149; HECHT JT, 1991, NUCLEIC ACIDS RES, V19, P6666, DOI 10.1093/nar/19.23.6666; KONG RYC, 1993, EUR J BIOCHEM, V213, P99, DOI 10.1111/j.1432-1033.1993.tb17739.x; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEE KC, 1995, ENDOCRINOLOGY, V136, P453, DOI 10.1210/en.136.2.453; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Li YF, 1997, MATRIX BIOL, V16, P49, DOI 10.1016/S0945-053X(97)90071-8; McAlister W.H., 1995, DIAGNOSIS BONE JOINT, VThird ed., P4163; MUNDLOS S, 1991, MATRIX, V11, P339, DOI 10.1016/S0934-8832(11)80205-2; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Peters PWJ, 1977, METHODS PRENATAL TOX, P153; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; SEEGMILLER R, 1971, J CELL BIOL, V48, P580, DOI 10.1083/jcb.48.3.580; SPRANGER J, 1992, EUR J PEDIATR, V151, P407; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wallis GA, 1996, CURR BIOL, V6, P1577, DOI 10.1016/S0960-9822(02)70776-8; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154	29	144	147	2	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					225	229		10.1038/6016	http://dx.doi.org/10.1038/6016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988279				2022-12-17	WOS:000078399500029
J	Daw, SCM; Taylor, C; Kraman, M; Call, K; Mao, JI; Schuffenhauer, S; Meitinger, T; Lipson, T; Goodship, J; Scambler, P				Daw, SCM; Taylor, C; Kraman, M; Call, K; Mao, JI; Schuffenhauer, S; Meitinger, T; Lipson, T; Goodship, J; Scambler, P			A common region of 10p deleted in DiGeorge and velocardiofacial syndromes	NATURE GENETICS			English	Letter							PARTIAL MONOSOMY 10P; GENE; HYPOPARATHYROIDISM; HYBRIDIZATION; CLONES; MOUSE		INST CHILD HLTH,MOL MED UNIT,LONDON WC1N 1EH,ENGLAND; GENOME THERAPEUT CORP,WALTHAM,MA 02154; UNIV MUNICH,ABT PADIAT GENET,D-80336 MUNICH,GERMANY; ROYAL ALEXANDRA HOSP CHILDREN,DEPT GENET,PARRAMATTA,NSW 2124,AUSTRALIA; UNIV NEWCASTLE,DIV HUMAN GENET,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND	University of London; University College London; University of Munich; Newcastle University - UK			Scambler, Peter J/C-4998-2008; Clelland, Catherine/AAZ-8551-2021; Scambler, Peter/AAZ-6026-2020; Meitinger, Thomas/O-1318-2015	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Meitinger, Thomas/0000-0002-8838-8403; Kraman, Matthew/0000-0002-5040-0067				GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; GREENBERG F, 1986, J PEDIATR-US, V109, P489, DOI 10.1016/S0022-3476(86)80124-X; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KOSEKI H, 1993, MAMM GENOME, V4, P324, DOI 10.1007/BF00357091; LAI MMR, 1992, J MED GENET, V29, P586, DOI 10.1136/jmg.29.8.586; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; LIPSON A, IN PRESS AM J MED GE; LYNCH S, 1995, J MED GENET, V32, P149; MORROW B, 1995, AM J HUM GENET, V56, P1379; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SCHUFFENHAUER S, 1995, ANN GENET-PARIS, V38, P162; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852	18	144	145	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					458	460		10.1038/ng0896-458	http://dx.doi.org/10.1038/ng0896-458			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696341				2022-12-17	WOS:A1996VB62000027
J	Dryja, TP; Hahn, LB; Reboul, T; Arnaud, B				Dryja, TP; Hahn, LB; Reboul, T; Arnaud, B			Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness	NATURE GENETICS			English	Letter							GS-ALPHA; RHODOPSIN GENE; ONCOGENE; ACTIVATION; ORGANIZATION; PROTEIN; CDNA		HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,TAYLOR SMITH LAB,BOSTON,MA 02114; CHU MONTPELLIER,HOP GUIDE CHAULIAC,SERV OPHTALMOL,F-34295 MONTPELLIER 5,FRANCE	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Universite de Montpellier; CHU de Montpellier	Dryja, TP (corresponding author), HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,OCULAR MOL GENET INST,243 CHARLES ST,BOSTON,MA 02114, USA.				NEI NIH HHS [EY08683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008683] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARMINGTON JC, 1954, AMA ARCH OPHTHALMOL, V52, P725; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; CARR R. E., 1966, INVEST OPHTHALMOL, V5, P497; CHIPPERFIELD RG, 1985, MOL CELL BIOL, V5, P1809, DOI 10.1128/MCB.5.8.1809; CUNIER F, 1838, ANN SOC MED GAND, V4, P383; Cunier F, 1838, ANN OCUL, V1, P32; DEJEAN C, 1949, B SOC OPHTALMOL FR, V1, P96; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FONG SL, 1992, NUCLEIC ACIDS RES, V20, P2865, DOI 10.1093/nar/20.11.2865; FRANCOIS J, 1956, OPHTHALMOLOGICA, V132, P244; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; GOODMAN G, 1957, ARCH OPHTHALMOL-CHIC, V58, P174; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HAHN LB, 1994, INVEST OPHTH VIS SCI, V35, P1077; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; KHANI SC, IN PRESS GENOMICS; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LEE E, 1992, J BIOL CHEM, V267, P1212; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Nettleship Edward, 1907, T OPHTHAL SOC UK, V27, P269; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; SANTOS E, 1983, P NATL ACAD SCI-BIOL, V80, P4679, DOI 10.1073/pnas.80.15.4679; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SLEVING PA, 1995, P NATL ACAD SCI USA, V92, P880; SUBBARAYA I, 1994, J BIOL CHEM, V269, P31080; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TEMELES GL, 1985, NATURE, V313, P700, DOI 10.1038/313700a0; TONG L, 1989, NATURE, V337, P90, DOI 10.1038/337090a0; TRUC H, 1909, B SOC OPHTALMOL FR, V26, P285; YAMAKI K, 1990, J BIOL CHEM, V265, P20757	40	144	148	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					358	360		10.1038/ng0796-358	http://dx.doi.org/10.1038/ng0796-358			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673138				2022-12-17	WOS:A1996UU28300027
J	Azuma, N; Nishina, S				Azuma, N; Nishina, S			PAX6 missense mutation in isolated foveal hypoplasia	NATURE GENETICS			English	Letter							GENE; DOMAIN		NATL CHILDRENS MED RES CTR,SETAGAYA KU,TOKYO 154,JAPAN	National Center for Child Health & Development - Japan	Azuma, N (corresponding author), NATL CHILDRENS HOSP,DEPT OPHTHALMOL,SETAGAYA KU,3-35-31 TAISHIDO,TOKYO 154,JAPAN.							BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; CURRAN RE, 1976, ARCH OPHTHALMOL-CHIC, V94, P48; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FRANCOIS J, 1961, HEREDITY OPHTHALMOLO, V153; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; MARTHA A, 1994, AM J HUM GENET, V54, P801; ODONNELL FE, 1982, ARCH OPHTHALMOL-CHIC, V100, P279, DOI 10.1001/archopht.1982.01030030281009; OLIVER MD, 1987, BRIT J OPHTHALMOL, V71, P926, DOI 10.1136/bjo.71.12.926; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WAARDENBURG PJ, 1963, GENETICS OPHTHALMOLO; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9	17	144	149	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					141	142		10.1038/ng0696-141	http://dx.doi.org/10.1038/ng0696-141			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640214				2022-12-17	WOS:A1996UN39500006
J	TYLERSMITH, C; OAKEY, RJ; LARIN, Z; FISHER, RB; CROCKER, M; AFFARA, NA; FERGUSONSMITH, MA; MUENKE, M; ZUFFARDI, O; JOBLING, MA				TYLERSMITH, C; OAKEY, RJ; LARIN, Z; FISHER, RB; CROCKER, M; AFFARA, NA; FERGUSONSMITH, MA; MUENKE, M; ZUFFARDI, O; JOBLING, MA			LOCALIZATION OF DNA-SEQUENCES REQUIRED FOR HUMAN CENTROMERE FUNCTION THROUGH AN ANALYSIS OF REARRANGED Y-CHROMOSOMES	NATURE GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; INSITU HYBRIDIZATION; YP/18 TRANSLOCATION; FISSION YEAST; SATELLITE DNA; DELETION; CONSTRUCTION; REGION	We have localized the DNA sequences required for mitotic centromere function on the human Y chromosome. Analysis of 33 rearranged Y chromosomes allowed the centromere to be placed in interval 8 of a 24-interval deletion map. Although this interval is polymorphic in size, it can be as small as similar to 500kb. It contains alphoid satellite DNA and similar to 300kb of adjacent Yp sequences. Chromosomes with rearrangements in this region were analysed in detail. Two translocation chromosomes and one monocentric isochromosome had breakpoints within the alphoid array. Of 12 suppressed Y centromeres on translocation chromosomes and dicentric isochromosomes that were also analysed two showed deletions one of which only removed alphoid DNA. These results indicate that alphoid DNA is a functional part of the Y chromosome centromere.	CHURCHILL HOSP,CYTOGENET LAB,OXFORD OX3 7LJ,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,HUMAN MOLEC GENET GRP,CAMBRIDGE CB2 1QP,ENGLAND; UNIV PENN,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PAVIA,I-27100 PAVIA,ITALY; UNIV OXFORD,GENET LAB,OXFORD OX1 3QU,ENGLAND	University of Oxford; University of Cambridge; University of Pennsylvania; University of Pavia; University of Oxford	TYLERSMITH, C (corresponding author), UNIV OXFORD,DEPT BIOCHEM,CRC,CHROMOSOME MOLEC BIOL GRP,S PARKS RD,OXFORD OX1 3QU,OXON,ENGLAND.		Oakey, Rebecca/A-5958-2011; Monaco, Zoia L/C-5762-2011	Oakey, Rebecca/0000-0003-2706-8139; Muenke, Maximilian/0000-0002-7719-6545; zuffardi, orsetta/0000-0002-1466-4559; Jobling, Mark/0000-0002-8061-1308				AFFARA NA, 1987, NUCLEIC ACIDS RES, V15, P7325, DOI 10.1093/nar/15.18.7325; AFFARA NA, 1986, NUCLEIC ACIDS RES, V14, P5353, DOI 10.1093/nar/14.13.5353; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; CHANDLEY AC, 1971, CYTOGENETICS, V10, P295, DOI 10.1159/000130149; CHANDLEY AC, 1989, J MED GENET, V26, P145, DOI 10.1136/jmg.26.3.145; CHANDLEY AC, 1986, HUM GENET, V73, P350, DOI 10.1007/BF00279099; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cooper Katrina F., 1992, Human Molecular Genetics, V1, P753, DOI 10.1093/hmg/1.9.753; COOPER KF, 1993, J MOL BIOL, V230, P787, DOI 10.1006/jmbi.1993.1201; COOPER KF, 1992, J MOL BIOL, V228, P421, DOI 10.1016/0022-2836(92)90831-4; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; EMRIE PA, 1988, SOMAT CELL MOLEC GEN, V14, P105, DOI 10.1007/BF01535054; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; HADLACZKY G, 1991, P NATL ACAD SCI USA, V88, P8106, DOI 10.1073/pnas.88.18.8106; HAHNENBERGER KM, 1989, P NATL ACAD SCI USA, V86, P577, DOI 10.1073/pnas.86.2.577; HEINZEL SS, 1991, MOL CELL BIOL, V11, P2263, DOI 10.1128/MCB.11.4.2263; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; MANN C, 1983, P NATL ACAD SCI-BIOL, V80, P228, DOI 10.1073/pnas.80.1.228; MARASCHIO P, 1990, HUM GENET, V85, P491; MASERATI E, 1986, HUM GENET, V74, P126, DOI 10.1007/BF00282075; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MULLER U, 1992, HUM GENET, V90, P239; MUNKE M, 1988, HUM GENET, V80, P219, DOI 10.1007/BF01790089; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; NIWA O, 1989, EMBO J, V8, P3045, DOI 10.1002/j.1460-2075.1989.tb08455.x; NIWA O, 1986, MOL GEN GENET, V203, P397, DOI 10.1007/BF00422063; O'Reilly Amanda, 1992, Human Molecular Genetics, V1, P379, DOI 10.1093/hmg/1.6.379; OAKEY R, 1990, GENOMICS, V7, P325, DOI 10.1016/0888-7543(90)90165-Q; PETROVIC V, 1992, J MED GENET, V29, P542, DOI 10.1136/jmg.29.8.542; RAUCH A, 1992, CLIN GENET, V42, P84; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153	38	144	151	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					368	375		10.1038/ng1293-368	http://dx.doi.org/10.1038/ng1293-368			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298645				2022-12-17	WOS:A1993ML14500013
J	FRIEDMANN, T				FRIEDMANN, T			A BRIEF-HISTORY OF GENE-THERAPY	NATURE GENETICS			English	Review							HERPES-SIMPLEX VIRUS; HUMAN ADENOSINE-DEAMINASE; THYMIDINE KINASE GENE; HUMAN HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RETROVIRUS-MEDIATED TRANSFER; GENETICALLY MODIFIED CELLS; DEPENDENT DNA POLYMERASE; HEMATOPOIETIC STEM-CELLS; HUMAN FACTOR-IX; ENDOTHELIAL-CELLS	The concepts of gene therapy arose initially during the 1960s and early 1970s whilst the development of genetically marked cells lines and the clarification of mechanisms of cell transformation by the papovaviruses polyoma and SV40 was in progress. With the arrival of recombinant DNA techniques, cloned genes became available and were used to demonstrate that foreign genes could indeed correct genetic defects and disease phenotypes in mammalian cells in vitro. Efficient retroviral vectors and other gene transfer methods have permitted convincing demonstrations of efficient phenotype correction in vitro and in vivo, now making gene therapy a broadly accepted approach to therapy and justifying clinically applied studies with human patients.			FRIEDMANN, T (corresponding author), UNIV CALIF SAN DIEGO, SCH MED, CTR MOLEC GENET, DEPT PEDIAT, LA JOLLA, CA 92093 USA.							ACSADI G, 1991, NATURE, V352, P815, DOI 10.1038/352815a0; ANDERSON WF, 1984, SCIENCE, V226, P401, DOI 10.1126/science.6093246; ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; ANDERSON WF, 1980, NEW ENGL J MED, V303, P1293, DOI 10.1056/NEJM198011273032210; ANDERSON WF, 1989, J MED PHILOS, V14, P681, DOI 10.1093/jmp/14.6.681; APOSHIAN HV, 1970, PERSPECT BIOL MED, V14, P98; APOSHIAN HV, 1972, FED PROC, V31, P1310; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; AXELROD JH, 1990, P NATL ACAD SCI USA, V87, P5173, DOI 10.1073/pnas.87.13.5173; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; BENDICH A, 1971, DNA INDUCED HERITABL, P80; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; BOLOGNESI DP, 1991, ANN INTERN MED, V114, P161, DOI 10.7326/0003-4819-114-2-161; BORENFREUND E, 1961, J BIOPHYS BIOCHEM CY, V9, P81, DOI 10.1083/jcb.9.1.81; BRADLEY TR, 1962, J CELL COMPAR PHYSL, V60, P127; CASEY G, 1991, ONCOGENE, V6, P1791; CHANGEUX JP, 1967, VIROLOGY, V31, P729; CHEN YM, 1991, ONCOGENE, V6, P1799; CHENG J, 1992, CANCER RES, V52, P222; CHIOCCA E A, 1990, New Biologist, V2, P739; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; CLINE MJ, 1980, NATURE, V284, P422, DOI 10.1038/284422a0; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DANIELSON H, 1988, LANCET, V1, P1271; DAVIS BD, 1970, SCIENCE, V170, P1279, DOI 10.1126/science.170.3964.1279; DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; DOEHMER J, 1982, P NATL ACAD SCI-BIOL, V79, P2268, DOI 10.1073/pnas.79.7.2268; ESUMI N, 1991, CANCER RES, V51, P1185; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FERRARI G, 1991, SCIENCE, V251, P1363, DOI 10.1126/science.1848369; FLETCHER JC, 1983, VA LAW REV, V69, P515, DOI 10.2307/1072768; FREESE E, 1972, PROSPECTS GENE THERA; FRIEDMAN.T, 1972, SCIENCE, V178, P649; FRIEDMAN.T, 1971, P NATL ACAD SCI USA, V68, P2574, DOI 10.1073/pnas.68.10.2574; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; FRIEDMANN T, 1976, ANN NY ACAD SCI, V265, P141, DOI 10.1111/j.1749-6632.1976.tb29328.x; FRIEDMANN T, 1985, GENETIC ENG PRINCIPL, V7, P263; FRIEDMANN T, 1983, BIOL NEW APPROACHES; GAGE FH, 1987, NEUROSCIENCE, V23, P795, DOI 10.1016/0306-4522(87)90159-X; GANSBACHER B, 1990, CANCER RES, V50, P7820; GANSBACHER B, 1990, J EXP MED, V172, P1217, DOI 10.1084/jem.172.4.1217; GARVER RI, 1987, SCIENCE, V237, P762, DOI 10.1126/science.3497452; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; GIBLETT ER, 1972, LANCET, V2, P1067; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN MR, 1983, CELL, V35, P137, DOI 10.1016/0092-8674(83)90216-7; GRUBER HE, 1985, SCIENCE, V230, P1057, DOI 10.1126/science.3864246; HARRISON GS, 1991, HUM GENE THER, V2, P53, DOI 10.1089/hum.1991.2.1-53; HILL M, 1972, NATURE-NEW BIOL, V237, P35, DOI 10.1038/newbio237035a0; HILL M, 1970, BIOCHIM BIOPHYS ACTA, V213, P26, DOI 10.1016/0005-2787(70)90004-3; HUBER BE, 1991, P NATL ACAD SCI USA, V88, P8039, DOI 10.1073/pnas.88.18.8039; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; JOHNSON PA, 1992, J VIROL, V66, P2952, DOI 10.1128/JVI.66.5.2952-2965.1992; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; KANTOFF PW, 1986, P NATL ACAD SCI USA, V83, P6563, DOI 10.1073/pnas.83.17.6563; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; KAY ER, 1961, NATURE, V191, P387, DOI 10.1038/191387a0; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KEATING A, 1990, PROG CLIN BIOL RES, V333, P491; LEDLEY FD, 1987, P NATL ACAD SCI USA, V84, P5335, DOI 10.1073/pnas.84.15.5335; LEDLEY FD, 1989, J INHER METAB DIS S1, V9, P85; Levine F, 1991, Curr Opin Biotechnol, V2, P840, DOI 10.1016/S0958-1669(05)80117-X; LEVRERO M, 1991, GENE, V101, P195, DOI 10.1016/0378-1119(91)90411-4; MAJUMDAR A, 1968, INDIAN J MED RES, P603; MANIATIS T, 1976, CELL, V8, P163, DOI 10.1016/0092-8674(76)90001-5; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MATTHEWS TJ, 1991, ADV EXP MED BIOL, V303, P23; MCLAUGHLIN SK, 1988, J VIROL, V62, P1963, DOI 10.1128/JVI.62.6.1963-1973.1988; MERCOLA KE, 1980, SCIENCE, V208, P1033, DOI 10.1126/science.6246577; MILLER AD, 1985, MOL CELL BIOL, V5, P431, DOI 10.1128/MCB.5.3.431; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; MILLER AD, 1983, P NATL ACAD SCI-BIOL, V80, P4709, DOI 10.1073/pnas.80.15.4709; MILLER AD, 1984, SCIENCE, V225, P630, DOI 10.1126/science.6377498; MITSUYA H, 1991, FASEB J, V5, P2369, DOI 10.1096/fasebj.5.10.1712326; MIYANOHARA A, 1992, NEW BIOL, V4, P238; MIYANOHARA A, 1988, P NATL ACAD SCI USA, V85, P6538, DOI 10.1073/pnas.85.17.6538; MORGAN JR, 1987, SCIENCE, V237, P1476; MORROW JF, 1976, ANN NY ACAD SCI, V265, P13, DOI 10.1111/j.1749-6632.1976.tb29316.x; MULLIGAN RC, 1979, NATURE, V277, P108, DOI 10.1038/277108a0; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; MULLIGAN RC, 1981, MOL CELL BIOL, V1, P449, DOI 10.1128/MCB.1.5.449; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; NABEL EG, 1989, SCIENCE, V244, P1342, DOI 10.1126/science.2499928; NEVILLE R, 1976, ANN NY ACAD SCI, V265, P153, DOI 10.1111/j.1749-6632.1976.tb29329.x; NICHOLS EK, 1988, GENE THERAPY; PALMER TD, 1989, BLOOD, V73, P438; PALMER TD, 1987, P NATL ACAD SCI USA, V84, P1055, DOI 10.1073/pnas.84.4.1055; RABOTTI GF, 1963, EXP CELL RES, V31, P562, DOI 10.1016/0014-4827(63)90402-6; ROGERS S, 1973, J EXP MED, V137, P1091, DOI 10.1084/jem.137.4.1091; ROGERS S, 1968, NATURE, V219, P749, DOI 10.1038/219749a0; ROMAN M, IN PRESS SOMAT CELL; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SALMINEN A, 1991, HUM GENE THER, V2, P15, DOI 10.1089/hum.1991.2.1-15; SAMBROOK J, 1968, P NATL ACAD SCI USA, V60, P1288, DOI 10.1073/pnas.60.4.1288; SCZAKIEL G, 1990, BIOCHEM BIOPH RES CO, V169, P643, DOI 10.1016/0006-291X(90)90379-2; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; SELDEN RF, 1987, SCIENCE, V236, P714, DOI 10.1126/science.3472348; SHIMOTOHNO K, 1981, CELL, V26, P67, DOI 10.1016/0092-8674(81)90034-9; SINSHEIMER RL, 1969, AM SCI, V57, P134; SPAETE RR, 1982, CELL, V30, P295, DOI 10.1016/0092-8674(82)90035-6; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; TABIN CJ, 1982, MOL CELL BIOL, V2, P426, DOI 10.1128/MCB.2.4.426; TACKNEY C, 1984, J VIROL, V52, P606, DOI 10.1128/JVI.52.2.606-614.1984; TANAKA K, 1991, NATURE, V349, P340, DOI 10.1038/349340a0; TATUM EL, 1966, PERSPECT BIOL MED, V10, P19; Temin H. M., 1986, Gene transfer., P149; TEMIN HM, 1976, SCIENCE, V192, P1075, DOI 10.1126/science.58444; TEMIN HM, 1971, ANNU REV MICROBIOL, V25, P609, DOI 10.1146/annurev.mi.25.100171.003141; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; TERHEGGEN HG, 1975, Z KINDERHEILKD, V119, P1, DOI 10.1007/BF00464689; TOPP WC, 1981, MOL BIOL DNA TUMOR 2, P205; UZVOLGYI E, 1991, CELL GROWTH DIFFER, V2, P297; VANBEUSECHEM VW, 1990, J EXP MED, V172, P729, DOI 10.1084/jem.172.3.729; VENBATESH LK, 1990, P NATL ACAD SCI USA, V87, P8746; VERMA IM, 1990, SCI AM, V263, P68, DOI 10.1038/scientificamerican1190-68; WADE N, 1981, SCIENCE, V212, P1253, DOI 10.1126/science.6940246; WADE N, 1980, SCIENCE, V210, P509, DOI 10.1126/science.6932738; WADE N, 1981, SCIENCE, V212, P24, DOI 10.1126/science.6259731; WEERASINGHE M, 1991, J VIROL, V65, P5531, DOI 10.1128/JVI.65.10.5531-5534.1991; WEI CM, 1981, J VIROL, V39, P935, DOI 10.1128/JVI.39.3.935-944.1981; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WILLIAMS DA, 1986, P NATL ACAD SCI USA, V83, P2566, DOI 10.1073/pnas.83.8.2566; WILLIS RC, 1984, J BIOL CHEM, V259, P7842; WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614; WOLFF JA, 1987, P NATL ACAD SCI USA, V84, P3344, DOI 10.1073/pnas.84.10.3344; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; WOLFF JA, 1989, P NATL ACAD SCI USA, V86, P9011, DOI 10.1073/pnas.86.22.9011; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; YOUNG JAT, 1990, SCIENCE, V250, P1421, DOI 10.1126/science.2175047	140	144	152	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1992	2	2					93	98		10.1038/ng1092-93	http://dx.doi.org/10.1038/ng1092-93			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303270				2022-12-17	WOS:A1992JR08400005
J	Ghavi-Helm, Y; Jankowski, A; Meiers, S; Viales, RR; Korbel, JO; Furlong, EEM				Ghavi-Helm, Yad; Jankowski, Aleksander; Meiers, Sascha; Viales, Rebecca R.; Korbel, Jan O.; Furlong, Eileen E. M.			Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; CHROMATIN DOMAINS; PAIRED-END; CTCF; COHESIN; MAP; ACTIVATION; PRINCIPLES; LANDSCAPE; ENHANCERS	Chromatin topology is intricately linked to gene expression, yet its functional requirement remains unclear. Here, we comprehensively assessed the interplay between genome topology and gene expression using highly rearranged chromosomes (balancers) spanning similar to 75% of the Drosophila genome. Using transheterozyte (balancer/wild-type) embryos, we measured allele-specific changes in topology and gene expression in cis, while minimizing trans effects. Through genome sequencing, we resolved eight large nested inversions, smaller inversions, duplications and thousands of deletions. These extensive rearrangements caused many changes to chromatin topology, disrupting long-range loops, topologically associating domains (TADs) and promoter interactions, yet these are not predictive of changes in expression. Gene expression is generally not altered around inversion breakpoints, indicating that mis-appropriate enhancer-promoter activation is a rare event. Similarly, shuffling or fusing TADs, changing intra-TAD connections and disrupting long-range inter-TAD loops does not alter expression for the majority of genes. Our results suggest that properties other than chromatin topology ensure productive enhancer-promoter interactions.	[Ghavi-Helm, Yad; Jankowski, Aleksander; Meiers, Sascha; Viales, Rebecca R.; Korbel, Jan O.; Furlong, Eileen E. M.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Ghavi-Helm, Yad] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS UMR 5242, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Ghavi-Helm, Y; Korbel, JO; Furlong, EEM (corresponding author), European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.; Ghavi-Helm, Y (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, CNRS UMR 5242, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France.	yad.ghavi-helm@ens-lyon.fr; korbel@embl.de; furlong@embl.de	Jankowski, Aleksander/D-9044-2014	Jankowski, Aleksander/0000-0002-2212-6224; Furlong, Eileen/0000-0002-9544-8339; Ghavi-Helm, Yad/0000-0003-2397-9576; Rodriguez Viales, Rebecca/0000-0003-3739-7438; Meiers, Sascha/0000-0003-2609-0000	FRM grant [AJE20161236686]; EMBL International PhD Programme; EU Horizon 2020 Marie Sklodowska-Curie grant [708111]; ERC starting grant [336045]; ERC advanced grant DeCRyPT [787611]	FRM grant; EMBL International PhD Programme; EU Horizon 2020 Marie Sklodowska-Curie grant; ERC starting grant(European Research Council (ERC)); ERC advanced grant DeCRyPT	We thank all members of the Furlong Laboratory for discussions and comments on the manuscript. We thank M. Davis, H. Gustafson, D. Garfield, T. Rausch and S. Waszak for useful discussions and suggestions at the various stages of the project. This work was technically supported by the EMBL Genomics Core Facility, with specific thanks to R. Hercog for WGS library preparation. This work was financially supported by an FRM grant (AJE20161236686) to Y.G.-H., the EMBL International PhD Programme to S. M., an EU Horizon 2020 Marie Sklodowska-Curie grant (708111) to A.J., an ERC starting grant (336045) to J.O.K. and ERC advanced grant DeCRyPT (787611) to E.E.M.F.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2014, GENOME BIOL, DOI DOI 10.1186/S13059-014-0550-8; Ashburner M., 2004, DROSOPHILA LAB HDB; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Garrison E., 2012, ARXIV12073907QBIO; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006295; Lettice LA, 2011, HUM MUTAT, V32, P1492, DOI 10.1002/humu.21615; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; Meadows LA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000552; Miller DE, 2018, G3-GENES GENOM GENET, V8, P1161, DOI 10.1534/g3.118.200021; Miller DE, 2016, G3-GENES GENOM GENET, V6, P1959, DOI 10.1534/g3.116.029330; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Ogiyama Y, 2018, MOL CELL, V71, P73, DOI 10.1016/j.molcel.2018.05.032; Oster I. I., 1956, DROS INF SERV, V30, P145; Ramirez F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02525-w; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rodriguez-Carballo E, 2017, GENE DEV, V31, P2264, DOI 10.1101/gad.307769.117; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shao YY, 2018, NATURE, V560, P331, DOI 10.1038/s41586-018-0382-x; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tinderholt V., 1960, DROS INFORM SERV, V34, P53; Tsujimura T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004897; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	61	143	145	3	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2019	51	8					1272	+		10.1038/s41588-019-0462-3	http://dx.doi.org/10.1038/s41588-019-0462-3			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM4EE	31308546	Green Accepted			2022-12-17	WOS:000477946700014
J	Papillon-Cavanagh, S; Lu, C; Gayden, T; Mikael, LG; Bechet, D; Karamboulas, C; Ailles, L; Karamchandani, J; Marchione, DM; Garcia, BA; Weinreb, I; Goldstein, D; Lewis, PW; Dancu, OM; Dhaliwal, S; Stecho, W; Howlett, CJ; Mymryk, JS; Barrett, JW; Nichols, AC; Allis, CD; Majewski, J; Jabado, N				Papillon-Cavanagh, Simon; Lu, Chao; Gayden, Tenzin; Mikael, Leonie G.; Bechet, Denise; Karamboulas, Christina; Ailles, Laurie; Karamchandani, Jason; Marchione, Dylan M.; Garcia, Benjamin A.; Weinreb, Ilan; Goldstein, David; Lewis, Peter W.; Dancu, Octavia Maria; Dhaliwal, Sandeep; Stecho, William; Howlett, Christopher J.; Mymryk, Joe S.; Barrett, John W.; Nichols, Anthony C.; Allis, C. David; Majewski, Jacek; Jabado, Nada			Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas	NATURE GENETICS			English	Article							HUMAN-PAPILLOMAVIRUS; DRIVER MUTATIONS; NSD1 MUTATIONS; REVEALS; CANCER; LANDSCAPE; ACTIVATION; GENES	Human papillomavirus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs) are deadly and common cancers. Recent genomic studies implicate multiple genetic pathways, including cell signaling, cell cycle and immune evasion, in their development. Here we analyze public data sets and uncover a previously unappreciated role of epigenome deregulation in the genesis of 13% of HPV-negative HNSCCs. Specifically, we identify novel recurrent mutations encoding p.Lys36Met (K36M) alterations in multiple H3 histone genes. histones. We further validate the presence of these alterations in multiple independent HNSCC data sets and show that, along with previously described NSD1 mutations, they correspond to a specific DNA methylation cluster. The K36M substitution and NSD1 defects converge on altering methylation of histone H3 at K36 (H3K36), subsequently blocking cellular differentiation and promoting oncogenesis. Our data further indicate limited redundancy for NSD family members in HPV-negative HNSCCs and suggest a potential role for impaired H3K36 methylation in their development. Further investigation of drugs targeting chromatin regulators is warranted in HPV-negative HNSCCs driven by aberrant H3K36 methylation.	[Papillon-Cavanagh, Simon; Gayden, Tenzin; Bechet, Denise; Dancu, Octavia Maria; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Lu, Chao; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA; [Mikael, Leonie G.; Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Mikael, Leonie G.; Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Karamboulas, Christina; Ailles, Laurie] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Karamchandani, Jason] McGill Univ, Montreal Neurol Hosp, Dept Pathol, Montreal, PQ, Canada; [Marchione, Dylan M.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA; [Marchione, Dylan M.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Weinreb, Ilan] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Goldstein, David] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Otolaryngol, Toronto, ON, Canada; [Goldstein, David] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada; [Lewis, Peter W.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA; [Lewis, Peter W.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Dhaliwal, Sandeep] Univ Western Ontario, Dept Otolaryngol Head & Neck Surg, London, ON, Canada; [Dhaliwal, Sandeep; Barrett, John W.; Nichols, Anthony C.] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Stecho, William; Howlett, Christopher J.] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada; [Mymryk, Joe S.] Univ Western Ontario, Dept Microbiol & Immunol, Oncol & Otolaryngol Head & Neck Surg, London, ON, Canada; [Mymryk, Joe S.; Barrett, John W.; Nichols, Anthony C.] London Reg Canc Program, London, ON, Canada; [Mymryk, Joe S.; Barrett, John W.; Nichols, Anthony C.] Lawson Hlth Res Inst, London, ON, Canada	McGill University; Rockefeller University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Majewski, J; Jabado, N (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Dept Pediat, Montreal, PQ, Canada.; Jabado, N (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca	Nichols, Anthony Charles/H-9595-2019; Jabado, Nada/AAN-4026-2020; Papillon-Cavanagh, Simon/AAS-8749-2020; Stecho, William/E-1656-2013; goldstein, David/AAT-6302-2020; barrett, john/ABD-8414-2020	Nichols, Anthony Charles/0000-0002-0760-980X; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Stecho, William/0000-0002-2891-9348; Marchione, Dylan/0000-0001-6941-0604; Lu, Chao/0000-0003-0982-8122; Lewis, Peter/0000-0002-9816-7823	US National Institutes of Health (NIH) [P01CA196539, K99CA212257, T32GM008275]; Rockefeller University; Wisconsin Institute for Discovery; Greater Milwaukee Foundation; Sidney Kimmel Foundation (Kimmel Scholar Award); Canadian Institutes for Health Research (CIHR) [MOP 142491, MOP 340674]; Cedars Cancer Foundation; Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award; Genome Canada; Genome Quebec; Institute for Cancer Research of the CIHR; McGill University; Damon Runyon Cancer Research Foundation [DRG-2195-14]; Fond de la Recherche du Quebec en Sante; Canada Research Chair (tier 2); TD Trust/Montreal Children's Hospital Foundation; CIHR; Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE [K99CA212257, P01CA196539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Wisconsin Institute for Discovery; Greater Milwaukee Foundation; Sidney Kimmel Foundation (Kimmel Scholar Award); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cedars Cancer Foundation; Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award(Leukemia and Lymphoma Society); Genome Canada(Genome Canada); Genome Quebec; Institute for Cancer Research of the CIHR; McGill University; Damon Runyon Cancer Research Foundation; Fond de la Recherche du Quebec en Sante; Canada Research Chair (tier 2)(Canada Research Chairs); TD Trust/Montreal Children's Hospital Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Montreal Children's Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank EMD Millipore for its role in H3.3K36M antibody generation, A. Ponce de Leon for help with figure formatting, and the TCGA group for the wealth of data available and for their rapid and helpful answers to other enquiries we had on this data set. This research was supported by US National Institutes of Health (NIH) grants (P01CA196539 to N.J., J.M., P.W.L., B.A.G. and C.D.A.; K99CA212257 to CL.; T32GM008275 to D.M.M.), the Rockefeller University (to C.D.A.), startup funding provided by the Wisconsin Institute for Discovery (to P.W.L.), the Greater Milwaukee Foundation (to P.W.L.), the Sidney Kimmel Foundation (Kimmel Scholar Award to P.W.L.), Canadian Institutes for Health Research (CIHR) grants (MOP 142491 to J.S.M. and A.C.N.; MOP 340674 to A.C.N.) and the Cedars Cancer Foundation (N.J.). B.A.G. is funded by a Leukemia and Lymphoma Society Dr. Robert Arceci Scholar Award. This work was performed within the context of the I-CHANGE consortium and supported by funding from Genome Canada, Genome Quebec, the Institute for Cancer Research of the CIHR, McGill University and the Montreal Children's Hospital Foundation. C.L. is a Kandarian Family Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2195-14). N.J. is a member of the Penny Cole Laboratory and the recipient of a Chercheur Boursier, Chaire de Recherche Award from the Fond de la Recherche du Quebec en Sante. J.M. holds a Canada Research Chair (tier 2). S.P.-C. is supported by a studentship from the Fond de la Recherche du Quebec en Sante. D.B. and T.G. are supported by a fellowship from the TD Trust/Montreal Children's Hospital Foundation and CIHR, respectively.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Baxi S, 2012, J NATL COMPR CANC NE, V10, P806, DOI 10.6004/jnccn.2012.0084; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Cecco L, 2015, ONCOTARGET, V6, P9627, DOI 10.18632/oncotarget.3301; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gaykalova DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093102; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hammerman PS, 2015, CANCER DISCOV, V5, P239, DOI 10.1158/2159-8290.CD-14-1205; Hayes DN, 2015, J CLIN ONCOL, V33, P3227, DOI 10.1200/JCO.2015.62.1086; Hedberg ML, 2016, J CLIN INVEST, V126, P1606, DOI 10.1172/JCI86862; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Nikbakht H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11185; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Saloura V, 2015, MOL CANCER RES, V13, P293, DOI 10.1158/1541-7786.MCR-14-0292-T; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun WY, 2014, ANN NY ACAD SCI, V1333, P33, DOI 10.1111/nyas.12599; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vokes EE, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv344; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	40	143	146	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					180	185		10.1038/ng.3757	http://dx.doi.org/10.1038/ng.3757			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	28067913	Green Accepted			2022-12-17	WOS:000393148600006
J	Wang, XF; Lee, RS; Alver, BH; Haswel, JR; Wang, S; Mieczkowski, J; Drier, Y; Gillespie, SM; Archer, TC; Wu, JN; Tzvetkov, EP; Troisi, EC; Pomeroy, SL; Biegel, JA; Tolstorukov, MY; Bernstein, BE; Park, PJ; Roberts, CWM				Wang, Xiaofeng; Lee, Ryan S.; Alver, Burak H.; Haswel, Jeffrey R.; Wang, Su; Mieczkowski, Jakub; Drier, Yotam; Gillespie, Shawn M.; Archer, Tenley C.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Pomeroy, Scott L.; Biegel, Jaclyn A.; Tolstorukov, Michael Y.; Bernstein, Bradley E.; Park, Peter J.; Roberts, Charles W. M.			SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation	NATURE GENETICS			English	Article							ATYPICAL TERATOID/RHABDOID TUMORS; SUPER-ENHANCERS; RHABDOID TUMORS; CELL IDENTITY; TRANSCRIPTION FACTORS; CANCER; GENES; SUPPRESSOR; MUTATIONS; TRANSFORMATION	SMARCB1 (also known as SNF5, INI1, and BAF47), a core subunit of the SWI/SNF (BAF) chromatin-remodeling complex(1,2), is inactivated in nearly all pediatric rhabdoid tumors(3-5). These aggressive cancers are among the most genomically stable(6-8), suggesting an epigenetic mechanism by which SMARCB1 loss drives transformation. Here we show that, despite having indistinguishable mutational landscapes, human rhabdoid tumors exhibit distinct enhancer H3K27ac signatures, which identify remnants of differentiation programs. We show that SMARCB1 is required for the integrity of SWI/SNF complexes and that its loss alters enhancer targeting-markedly impairing SWI/SNF binding to typical enhancers, particularly those required for differentiation, while maintaining SWI/SNF binding at super-enhancers. We show that these retained super-enhancers are essential for rhabdoid tumor survival, including some that are shared by all subtypes, such as SPRY1, and other lineage-specific super-enhancers, such as SOX2 in brain-derived rhabdoid tumors. Taken together, our findings identify a new chromatin based epigenetic mechanism underlying the tumor-suppressive activity of SMARCB1.	[Wang, Xiaofeng; Lee, Ryan S.; Haswel, Jeffrey R.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wang, Xiaofeng; Lee, Ryan S.; Haswel, Jeffrey R.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Roberts, Charles W. M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Wang, Xiaofeng; Lee, Ryan S.; Haswel, Jeffrey R.; Wu, Jennifer N.; Tzvetkov, Evgeni P.; Troisi, Emma C.; Roberts, Charles W. M.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Alver, Burak H.; Wang, Su; Park, Peter J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02215 USA; [Mieczkowski, Jakub; Tolstorukov, Michael Y.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02115 USA; [Drier, Yotam; Gillespie, Shawn M.; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Archer, Tenley C.; Pomeroy, Scott L.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Biegel, Jaclyn A.] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Biegel, Jaclyn A.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Ctr Comprehens Canc, 332 N Lauderdale St, Memphis, TN 38105 USA; [Roberts, Charles W. M.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Park, PJ (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02215 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Park, PJ (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Roberts, CWM (corresponding author), St Jude Childrens Res Hosp, Ctr Comprehens Canc, 332 N Lauderdale St, Memphis, TN 38105 USA.; Roberts, CWM (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	bernstein.bradley@mgh.harvard.edu; peter_park@hms.harvard.edu; charles.roberts@stjude.org	Lee, Ryan/AAE-4319-2019; Roberts, Charles/N-2541-2018; Mieczkowski, Jakub/G-7251-2019; Drier, Yotam/K-5208-2012	Roberts, Charles/0000-0003-1135-1896; Mieczkowski, Jakub/0000-0002-2091-012X; Drier, Yotam/0000-0003-1725-2995; Archer, Tenley/0000-0003-2723-4192; Wang, Su/0000-0002-9463-6530; Alver, Burak/0000-0002-5019-7652; Gillespie, Shawn/0000-0003-1913-0860	Pathway to Independence Award from the US National Institutes of Health [K99CA197640]; Rally Foundation for Childhood Cancer Research; Truth 365; St. Baldrick's Foundation; NSF Graduate Research Fellowship; US National Institutes of Health grants [R01CA172152, R0ICA113794, U54HG006991]; Avalanna Fund; Cure AT/RT Now Foundation; Garrett B. Smith Foundation; Miles for Mary; ALSAC/St. Jude; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K99CA197640, R01CA109467, R01CA113794, R01CA172152] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER	Pathway to Independence Award from the US National Institutes of Health; Rally Foundation for Childhood Cancer Research; Truth 365; St. Baldrick's Foundation; NSF Graduate Research Fellowship(National Science Foundation (NSF)); US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avalanna Fund; Cure AT/RT Now Foundation; Garrett B. Smith Foundation; Miles for Mary; ALSAC/St. Jude(American Lebanese Syrian Associated Charities (ALSAC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Roberts and Park laboratories for assistance and discussion. We thank J. Francois (Boston Children's Hospital), J. Roth (Children's Hospital of Philadelphia), M. Lear (St. Jude Children's Research Hospital), and J. Silterra (Broad Institute) for their help in acquiring and performing preliminary clinical analysis of primary tumor samples; R. Rubio (Dana-Farber Cancer Institute) and M. Uziel (Broad Institute) for their assistance in sequencing samples; N. Shoresh (Broad Institute) for assistance in accessing Roadmap Epigenomics data; and R. Tomaino (Harvard Medical School) for assistance in proteomic analysis. X.W. was supported by the Pathway to Independence Award from the US National Institutes of Health (K99CA197640), a postdoctoral fellowship from the Rally Foundation for Childhood Cancer Research and The Truth 365, and a research grant from St. Baldrick's Foundation. R.S.L. was partially supported by an NSF Graduate Research Fellowship. This work was supported by US National Institutes of Health grants R01CA172152 (C.W.M.R.), R0ICA113794 (C.W.M.R.), and U54HG006991 (B.E.B.). The Avalanna Fund, the Cure AT/RT Now Foundation, the Garrett B. Smith Foundation, Miles for Mary, and ALSAC/St. Jude (C.W.M.R.) provided additional support.	Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Biegel JA, 1999, CANCER RES, V59, P74; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Eaton KW, 2011, PEDIATR BLOOD CANCER, V56, P7, DOI 10.1002/pbc.22831; Hasselblatt M, 2013, GENE CHROMOSOME CANC, V52, P185, DOI 10.1002/gcc.22018; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Kaur H, 2015, J NEUROPATH EXP NEUR, V74, P177, DOI 10.1097/NEN.0000000000000161; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wang X, 2011, J CLIN INVEST, V121, P3834, DOI 10.1172/JCI37210; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Yu Y, 2013, CELL, V152, P248, DOI 10.1016/j.cell.2012.12.006; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	30	143	146	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					289	295		10.1038/ng.3746	http://dx.doi.org/10.1038/ng.3746			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27941797	Green Accepted, Green Submitted			2022-12-17	WOS:000393148600019
J	Schmitt, AM; Garcia, JT; Hung, T; Flynn, RA; Shen, Y; Qu, K; Payumo, AY; Peres-da-Silva, A; Broz, DK; Baum, R; Guo, SL; Chen, JK; Attardi, LD; Chang, HY				Schmitt, Adam M.; Garcia, Julia T.; Hung, Tiffany; Flynn, Ryan A.; Shen, Ying; Qu, Kun; Payumo, Alexander Y.; Peres-da-Silva, Ashwin; Broz, Daniela Kenzelmann; Baum, Rachel; Guo, Shuling; Chen, James K.; Attardi, Laura D.; Chang, Howard Y.			An inducible long noncoding RNA amplifies DNA damage signaling	NATURE GENETICS			English	Article							GASTROINTESTINAL-SYNDROME; CELL-TYPES; IN-VIVO; P53; MICE; APOPTOSIS; LNCRNA; EXPRESSION; ENHANCERS; CHROMATIN	Long noncoding RNAs (IncRNAs) are prevalent genes with frequently precise regulation but mostly unknown functions. Here we demonstrate that IncRNAs guide the organismal DNA damage response. DNA damage activated transcription of the DINO (Damage Induced Noncoding) IncRNA via p53. DINO was required for p53-dependent gene expression, cell cycle arrest and apoptosis in response to DNA damage, and DINO expression was sufficient to activate damage signaling and cell cycle arrest in the absence of DNA damage. DINO bound to p53 protein and promoted its stabilization, mediating a p53 auto-amplification loop. Dino knockout or promoter inactivation in mice dampened p53 signaling and ameliorated acute radiation syndrome in vivo. Thus, inducible IncRNA can create a feedback loop with its cognate transcription factor to amplify cellular signaling networks.	[Schmitt, Adam M.; Garcia, Julia T.; Hung, Tiffany; Flynn, Ryan A.; Shen, Ying; Qu, Kun; Peres-da-Silva, Ashwin; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Schmitt, Adam M.; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Payumo, Alexander Y.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Payumo, Alexander Y.; Chen, James K.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Broz, Daniela Kenzelmann; Attardi, Laura D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Schmitt, Adam M.; Baum, Rachel] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Guo, Shuling] Ionis Pharmaceut, Dept Antisense Drug Discovery, Carlsbad, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Memorial Sloan Kettering Cancer Center; Ionis Pharmaceuticals, Inc.	Chang, HY (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.	howchang@stanford.edu	Chen, James/G-9972-2011; Qu, Kun/G-3359-2012	Chen, James/0000-0002-9220-8436; Flynn, Ryan/0000-0001-5013-0442; Baum, Rachel/0000-0002-6419-5279; Schmitt, Adam/0000-0002-7723-0651	NIH [R01-ES023168, R01-CA118750, R01-HG004361, P50-HG007735, DP1-HD075622]; ASCO Conquer Cancer Foundation/Susan G. Komen Young Investigator Award; Stanford Radiation Oncology Kaplan Funds; NIH/NCI Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075622] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009302, P30CA124435, R01CA118750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266, P50GM107615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO Conquer Cancer Foundation/Susan G. Komen Young Investigator Award; Stanford Radiation Oncology Kaplan Funds; NIH/NCI Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Nabel for able assistance. This study was supported by NIH R01-ES023168, R01-CA118750, R01-HG004361, P50-HG007735 to H.Y.C., NIH DP1-HD075622 to J.K.C., and ASCO Conquer Cancer Foundation/Susan G. Komen Young Investigator Award and Stanford Radiation Oncology Kaplan Funds to A.M.S. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002918; Leibowitz BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4494; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Quinn JJ, 2016, GENE DEV, V30, P191, DOI 10.1101/gad.272187.115; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Westphal CH, 1998, CANCER RES, V58, P5637; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	31	143	155	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1370	1376		10.1038/ng.3673	http://dx.doi.org/10.1038/ng.3673			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27668660	Green Accepted			2022-12-17	WOS:000386543400013
J	Bogdanovic, O; Smits, AH; Mustienes, ED; Tena, JJ; Ford, E; Williams, R; Senanayake, U; Schultz, MD; Hontelez, S; van Kruijsbergen, I; Rayon, T; Gnerlich, F; Carell, T; Veenstra, GJC; Manzanares, M; Sauka-Spengler, T; Ecker, JR; Vermeulen, M; Gomez-Skarmeta, JL; Lister, R				Bogdanovic, Ozren; Smits, Arne H.; de la Calle Mustienes, Elisa; Tena, Juan J.; Ford, Ethan; Williams, Ruth; Senanayake, Upeka; Schultz, Matthew D.; Hontelez, Saartje; van Kruijsbergen, Ila; Rayon, Teresa; Gnerlich, Felix; Carell, Thomas; Veenstra, Gert Jan C.; Manzanares, Miguel; Sauka-Spengler, Tatjana; Ecker, Joseph R.; Vermeulen, Michiel; Luis Gomez-Skarmeta, Jose; Lister, Ryan			Active DNA demethylation at enhancers during the vertebrate phylotypic period	NATURE GENETICS			English	Article							ZYGOTIC GENOME ACTIVATION; ZEBRAFISH EARLY EMBRYOS; GENE-EXPRESSION; POSTNATAL-DEVELOPMENT; CHROMATIN SIGNATURES; REGULATORY REGIONS; EPIGENETIC MEMORY; STEM-CELLS; METHYLATION; MOUSE	The vertebrate body plan and organs are shaped during a conserved embryonic phase called the phylotypic stage. However, the mechanisms that guide the epigenome through this transition and their evolutionary conservation remain elusive. Here we report widespread DNA demethylation of enhancers during the phylotypic period in zebrafish, Xenopus tropicalis and mouse. These enhancers are linked to developmental genes that display coordinated transcriptional and epigenomic changes in the diverse vertebrates during embryogenesis. Binding of Tet proteins to (hydroxy) methylated DNA and enrichment of 5-hydroxymethylcytosine in these regions implicated active DNA demethylation in this process. Furthermore, loss of function of Tet1, Tet2 and Tet3 in zebrafish reduced chromatin accessibility and increased methylation levels specifically at these enhancers, indicative of DNA methylation being an upstream regulator of phylotypic enhancer function. Overall, our study highlights a regulatory module associated with the most conserved phase of vertebrate embryogenesis and suggests an ancient developmental role for Tet dioxygenases.	[Bogdanovic, Ozren; Ford, Ethan; Lister, Ryan] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Bogdanovic, Ozren; de la Calle Mustienes, Elisa; Tena, Juan J.; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Bogdanovic, Ozren; Ford, Ethan; Lister, Ryan] Harry Perkins Inst Med Res, Perth, WA, Australia; [Smits, Arne H.; Vermeulen, Michiel] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Williams, Ruth; Senanayake, Upeka; Sauka-Spengler, Tatjana] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Schultz, Matthew D.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Hontelez, Saartje; van Kruijsbergen, Ila; Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Dev Biol, NL-6525 ED Nijmegen, Netherlands; [Rayon, Teresa; Manzanares, Miguel] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Gnerlich, Felix; Carell, Thomas] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Harry Perkins Institute of Medical Research; Radboud University Nijmegen; University of Oxford; Salk Institute; Radboud University Nijmegen; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Munich; Howard Hughes Medical Institute; Salk Institute	Bogdanovic, O (corresponding author), Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia.; Bogdanovic, O; Gomez-Skarmeta, JL (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.; Bogdanovic, O (corresponding author), Harry Perkins Inst Med Res, Perth, WA, Australia.; Vermeulen, M (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	ozren.bogdanovich@uwa.edu.au; michiel.vermeulen@science.ru.nl; jlgomska@upo.es; ryan.lister@uwa.edu.au	Carell, Thomas/G-4799-2012; Rayon, Teresa/AAA-6592-2020; Manzanares, Miguel/E-1702-2015; Tena, Juan J./Q-5995-2019; Vermeulen, Michiel/C-8883-2013; Gomez-Skarmeta, Jose Luis/B-5268-2014; Bogdanovic, Ozren/ABG-9527-2020; Manzanares, Miguel/AAZ-8305-2021; Tena, Juan J/M-2265-2014; Ecker, Joseph R/B-9144-2008; Veenstra, Gert Jan C./D-4963-2012; Lister, Ryan/B-5168-2012	Carell, Thomas/0000-0001-7898-2831; Rayon, Teresa/0000-0001-5173-1442; Manzanares, Miguel/0000-0003-4849-2836; Tena, Juan J./0000-0001-8165-7984; Vermeulen, Michiel/0000-0003-0836-6894; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Bogdanovic, Ozren/0000-0001-5680-0056; Manzanares, Miguel/0000-0003-4849-2836; Tena, Juan J/0000-0001-8165-7984; Ecker, Joseph R/0000-0001-5799-5895; Veenstra, Gert Jan C./0000-0002-7787-4940; Lister, Ryan/0000-0001-6637-7239; Hontelez, Saartje/0000-0002-5286-7859; de la Calle-Mustienes, Elisa/0000-0002-8975-6503; Smits, Arne H/0000-0001-5011-0898; Sauka-Spengler, Tatjana/0000-0001-9289-0263	Spanish government [BFU2013-41322-P, BIO-396]; Andalusian government [BFU2013-41322-P, BIO-396]; Australian Research Council [FT120100862]; Sylvia and Charles Viertel Senior Medical Research Fellowship; National Health and Medical Research Council; Raine Medical Research Foundation; Australian Research Council Discovery Early Career Researcher Award (DECRA) [DE140101962]; Netherlands Organisation for Scientific Research (NWO-VIDI) [864.09.003]; Cancer Genomics Netherlands; European Research Council [309384]; European Union; Gordon and Betty Moore Foundation [GBMF3034]; Ministerio de Economia y Competitividad [BFU2011-23083]; Comunidad Autonoma de Madrid (CELLDD-CM); Pro-CNIC Foundation; US National Institutes of Health (National Institute of Child Health and Human Development) [R01HD069344]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105985] Funding Source: NIH RePORTER; MRC [G0902418, G1000801] Funding Source: UKRI; Medical Research Council [G1000801, G0902418] Funding Source: researchfish	Spanish government(Spanish GovernmentEuropean Commission); Andalusian government; Australian Research Council(Australian Research Council); Sylvia and Charles Viertel Senior Medical Research Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Raine Medical Research Foundation; Australian Research Council Discovery Early Career Researcher Award (DECRA)(Australian Research Council); Netherlands Organisation for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Cancer Genomics Netherlands; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Ministerio de Economia y Competitividad(Spanish Government); Comunidad Autonoma de Madrid (CELLDD-CM)(Comunidad de Madrid); Pro-CNIC Foundation; US National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank D. Secco and A. De Mendoza for critical reading of the manuscript. Spanish and Andalusian government grants BFU2013-41322-P and BIO-396 to J.L.G.-S. supported this work. R.L. was supported by an Australian Research Council Future Fellowship (FT120100862) and a Sylvia and Charles Viertel Senior Medical Research Fellowship, and work in the laboratory of R.L. was funded by the Australian Research Council, National Health and Medical Research Council, and the Raine Medical Research Foundation. O.B. is supported by an Australian Research Council Discovery Early Career Researcher Award (DECRA; DE140101962). The laboratory of M.V. is supported by grants from the Netherlands Organisation for Scientific Research (NWO-VIDI; 864.09.003) and Cancer Genomics Netherlands, a European Research Council starting grant (309384) and the European Union Framework Programme 7 Network of Excellence EpiGeneSys. J.R.E. was supported by the Gordon and Betty Moore Foundation (GBMF3034) and is an Investigator of the Howard Hughes Medical Institute. Work in the laboratory of M.M. is funded by grants from the Ministerio de Economia y Competitividad (BFU2011-23083), Comunidad Autonoma de Madrid (CELLDD-CM), and by the Pro-CNIC Foundation. This work has been supported by a grant from the US National Institutes of Health (National Institute of Child Health and Human Development, grant R01HD069344) to G.J.C.V.	Almeida RD, 2012, EPIGENETICS-US, V7, P383, DOI 10.4161/epi.19375; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen IS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r65; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bray NPH, 2015, NEAR OPTIMAL RNA SEQ; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Ge L, 2014, MOL CELL BIOL, V34, P989, DOI 10.1128/MCB.01061-13; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hontelez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10148; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kamstra JH, 2015, ZEBRAFISH, V12, P230, DOI 10.1089/zeb.2014.1033; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Krebs AR, 2014, ELIFE, V3, DOI 10.7554/eLife.04094; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7315; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li C, 2015, CELL REP, V12, P1133, DOI 10.1016/j.celrep.2015.07.025; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Paranjpe SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-762; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Piasecka B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003476; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wachter E, 2014, ELIFE, V3, DOI 10.7554/eLife.03397; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	79	143	146	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					417	+		10.1038/ng.3522	http://dx.doi.org/10.1038/ng.3522			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26928226	Green Accepted, Green Submitted			2022-12-17	WOS:000372908800013
J	Bailey, JNC; Loomis, SJ; Kang, JH; Allingham, RR; Gharahkhani, P; Khor, CC; Burdon, KP; Aschard, H; Chasman, DI; Igo, RP; Hysi, PG; Glastonbury, CA; Ashley-Koch, A; Brilliant, M; Brown, AA; Budenz, DL; Buil, A; Cheng, CY; Choi, H; Christen, WG; Curhan, G; De Vivo, I; Fingert, JH; Foster, PJ; Fuchs, C; Gaasterland, D; Gaasterland, T; Hewitt, AW; Hu, F; Hunter, DJ; Khawaja, AP; Lee, RK; Li, Z; Lichter, PR; Mackey, DA; McGuffin, P; Mitchell, P; Moroi, SE; Perera, SA; Pepper, KW; Qi, QB; Realini, T; Richards, JE; Ridker, PM; Rimm, E; Ritch, R; Ritchie, M; Schuman, JS; Scott, WK; Singh, K; Sit, AJ; Song, YE; Tamimi, RM; Topouzis, F; Viswanathan, AC; Verma, SS; Vollrath, D; Wang, JJ; Weisschuh, N; Wissinger, B; Wollstein, G; Wong, TY; Yaspan, BL; Zack, DJ; Zhang, K; Weinreb, RN; Pericak-Vance, MA; Small, K; Hammond, CJ; Aung, T; Liu, YT; Vithana, EN; MacGregor, S; Craig, JE; Kraftl, P; Howell, G; Hauser, MA; Pasguale, LR; Haines, JL; Wiggs, JL				Bailey, Jessica N. Cooke; Loomis, Stephanie J.; Kang, Jae H.; Allingham, R. Rand; Gharahkhani, Puya; Khor, Chiea Chuen; Burdon, Kathryn P.; Aschard, Hugues; Chasman, Daniel I.; Igo, Robert P., Jr.; Hysi, Pirro G.; Glastonbury, Craig A.; Ashley-Koch, Allison; Brilliant, Murray; Brown, Andrew A.; Budenz, Donald L.; Buil, Alfonso; Cheng, Ching-Yu; Choi, Hyon; Christen, William G.; Curhan, Gary; De Vivo, Immaculata; Fingert, John H.; Foster, Paul J.; Fuchs, Charles; Gaasterland, Douglas; Gaasterland, Terry; Hewitt, Alex W.; Hu, Frank; Hunter, David J.; Khawaja, Anthony P.; Lee, Richard K.; Li, Zheng; Lichter, Paul R.; Mackey, David A.; McGuffin, Peter; Mitchell, Paul; Moroi, Sayoko E.; Perera, Shamira A.; Pepper, Keating W.; Qi, Qibin; Realini, Tony; Richards, Julia E.; Ridker, Paul M.; Rimm, Eric; Ritch, Robert; Ritchie, Marylyn; Schuman, Joel S.; Scott, William K.; Singh, Kuldev; Sit, Arthur J.; Song, Yeunjoo E.; Tamimi, Rulla M.; Topouzis, Fotis; Viswanathan, Ananth C.; Verma, Shefali Setia; Vollrath, Douglas; Wang, Jie Jin; Weisschuh, Nicole; Wissinger, Bernd; Wollstein, Gadi; Wong, Tien Y.; Yaspan, Brian L.; Zack, Donald J.; Zhang, Kang; Weinreb, Robert N.; Pericak-Vance, Margaret A.; Small, Kerrin; Hammond, Christopher J.; Aung, Tin; Liu, Yutao; Vithana, Eranga N.; MacGregor, Stuart; Craig, Jamie E.; Kraftl, Peter; Howell, Gareth; Hauser, Michael A.; Pasguale, Louis R.; Haines, Jonathan L.; Wiggs, Janey L.		EPIC Norfolk Eye Study; ANZRAG Consortium	Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma	NATURE GENETICS			English	Article							COMMON VARIANTS; METAANALYSIS; STRESS; NUMBER; DYSFUNCTION; PREVALENCE; MUTATIONS; PRESSURE; SPECTRUM; GENES	Primary open-angle glaucoma (POAG) is a leading cause of blindness worldwide. To identify new susceptibility loci, we performed meta-analysis on genome-wide association study (GWAS) results from eight independent studies from the United States (3,853 cases and 33,480 controls) and investigated the most significantly associated SNPs in two Australian studies (1,252 cases and 2,592 controls), three European studies (875 cases and 4,107 controls) and a Singaporean Chinese study (1,037 cases and 2,543 controls). A meta-analysis of the top SNPs identified three new associated loci: rs35934224[T] in TXNRD2 (odds ratio (OR) = 0.78, P = 4.05 x 10(-11)) encoding a mitochondrial protein required for redox homeostasis; rs7137828[T] in ATXN2 (OR = 1.17, P = 8.73 x 10(-10)); and rs2745572[A] upstream of FOXC1 (OR = 1.17, P = 1.76 x 10(-10)). Using RT-PCR and immunohistochemistry, we show TXNRD2 and ATXN2 expression in retinal ganglion cells and the optic nerve head. These results identify new pathways underlying POAG susceptibility and suggest new targets for preventative therapies.	[Bailey, Jessica N. Cooke; Igo, Robert P., Jr.; Song, Yeunjoo E.; Haines, Jonathan L.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Inst Computat Biol, Cleveland, OH 44106 USA; [Loomis, Stephanie J.; Pasguale, Louis R.; Wiggs, Janey L.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Kang, Jae H.; Curhan, Gary; De Vivo, Immaculata; Fuchs, Charles; Rimm, Eric; Tamimi, Rulla M.; Pasguale, Louis R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Gharahkhani, Puya; MacGregor, Stuart] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Khor, Chiea Chuen; Li, Zheng] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Khor, Chiea Chuen; Cheng, Ching-Yu; Wong, Tien Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Burdon, Kathryn P.; Mackey, David A.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Aschard, Hugues; Hu, Frank; Hunter, David J.; Rimm, Eric; Kraftl, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chasman, Daniel I.; Christen, William G.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Hysi, Pirro G.; Glastonbury, Craig A.; Small, Kerrin; Hammond, Christopher J.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Ashley-Koch, Allison; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Brilliant, Murray] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Brown, Andrew A.; Buil, Alfonso] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Budenz, Donald L.] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC USA; [Cheng, Ching-Yu; Perera, Shamira A.; Wong, Tien Y.; Aung, Tin; Vithana, Eranga N.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Cheng, Ching-Yu; Aung, Tin; Vithana, Eranga N.] Duke Nat Univ Singapore Grad Med Sch, Eye Acad Clin Program, Singapore, Singapore; [Choi, Hyon] Boston Univ, Sch Med, Sect Rheumatol & Clin Epidemiol Unit, Boston, MA 02118 USA; [Curhan, Gary] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Fingert, John H.] Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA; [Fingert, John H.] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Foster, Paul J.; Viswanathan, Ananth C.] Moorfields Eye Hosp, Biomed Res Ctr, Nat Inst Hlth Res, London, England; [Foster, Paul J.] UCL, Dept Ophthalmol, London, England; [Fuchs, Charles] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA; [Gaasterland, Douglas] Eye Doctors Washington, Chevy Chase, MD USA; [Gaasterland, Terry] Univ Calif San Diego, Scripps Genome Ctr, San Diego, CA 92103 USA; [Hewitt, Alex W.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Hewitt, Alex W.] Royal Victorian Eye & Ear Hosp, Dept Ophthalmol, Melbourne, Vic 3002, Australia; [Hu, Frank; Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hunter, David J.; Kraftl, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, 665 Huntington Ave, Boston, MA 02115 USA; [Khawaja, Anthony P.] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Lee, Richard K.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Lichter, Paul R.; Moroi, Sayoko E.; Richards, Julia E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [McGuffin, Peter] Kings Coll London, Inst Psychiat, Med Res Council Social Genet & Dev Psychiat Res C, London, England; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Westmead, NSW 2145, Australia; [Perera, Shamira A.] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Pepper, Keating W.; Howell, Gareth] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Qi, Qibin] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Realini, Tony] West Virginia Univ Eye Inst, Dept Ophthalmol, Morgantown, WV USA; [Richards, Julia E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Dept Ophthalmol, Einhorn Clin Res Ctr, New York, NY USA; [Ritchie, Marylyn; Verma, Shefali Setia] Penn State Univ, Ctr Syst Genom, University Pk, PA 16802 USA; [Schuman, Joel S.; Wollstein, Gadi] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Inst Human Genom, Miami, FL 33136 USA; [Singh, Kuldev] Stanford Univ, Sch Med, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Sit, Arthur J.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Topouzis, Fotis] Aristotle Univ Thessaloniki, AHEPA Hosp, Sch Med, Dept Ophthalmol, GR-54006 Thessaloniki, Greece; [Vollrath, Douglas] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA; [Weisschuh, Nicole; Wissinger, Bernd] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalmic Res, Tubingen, Germany; [Yaspan, Brian L.] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Zack, Donald J.] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD USA; [Zhang, Kang; Weinreb, Robert N.] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Liu, Yutao] Georgia Regents Univ, Dept Cell Biol & Anat, Augusta, GA USA; [Liu, Yutao] Georgia Regents Univ, James & Jean Culver Vis Discovery Inst, Augusta, GA USA	Case Western Reserve University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Duke University; QIMR Berghofer Medical Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Tasmania; Menzies Institute for Medical Research; Flinders University South Australia; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; King's College London; Duke University; University of Geneva; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore; Singapore National Eye Center; Boston University; Harvard University; Brigham & Women's Hospital; University of Iowa; University of Iowa; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Diego; Centre for Eye Research Australia; University of Melbourne; Royal Victorian Eye & Ear Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; Bascom Palmer Eye Institute; University of Miami; University of Michigan System; University of Michigan; Lions Eye Institute; University of Western Australia; University of London; King's College London; University of Sydney; Westmead Institute for Medical Research; Jackson Laboratory; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan; New York Eye & Ear Infirmary of Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; Stanford University; Mayo Clinic; Aristotle University of Thessaloniki; Ahepa University Hospital; Stanford University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Roche Holding; Genentech; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Diego; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wiggs, JL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA.	janey_wiggs@meei.harvard.edu	Burdon, Kathryn/AAD-2334-2022; Zhang, Kang/Y-2740-2019; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Foster, Paul/V-7288-2019; Gharahkhani, Puya/AAA-6912-2020; Wang, Jie Jin/P-1499-2014; Fingert, John/F-8787-2012; wang, jie/GRS-0942-2022; Mackey, David A/H-5340-2014; Burdon, Kathryn/A-5026-2009; Mitchell, Paul/P-1498-2014; Igo, Rob/P-3438-2019; Wong, Tien Yin/AAC-9724-2020; Bailey, Jessica Cooke/Q-5062-2019; Schuman, Joel S/K-7304-2012; Macgregor, Stuart/C-6442-2009; Cheng, Ching-Yu/Y-2229-2019; Hewitt, Alex W/D-1936-2013; Fingert, John/AAX-4750-2021; Schuman, Joel S/M-2389-2019; Haines, Jonathan/C-3374-2012	Burdon, Kathryn/0000-0001-8217-1249; Zhang, Kang/0000-0002-4549-1697; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Foster, Paul/0000-0002-4755-177X; Gharahkhani, Puya/0000-0002-4203-5952; Wang, Jie Jin/0000-0001-9491-4898; Fingert, John/0000-0002-0377-0479; Mackey, David A/0000-0001-7914-4709; Burdon, Kathryn/0000-0001-8217-1249; Igo, Rob/0000-0002-0024-1993; Wong, Tien Yin/0000-0002-8448-1264; Bailey, Jessica Cooke/0000-0002-4001-8702; Schuman, Joel S/0000-0002-8885-3766; Macgregor, Stuart/0000-0001-6731-8142; Cheng, Ching-Yu/0000-0003-0655-885X; Hewitt, Alex W/0000-0002-5123-5999; Fingert, John/0000-0002-0377-0479; Schuman, Joel S/0000-0002-8885-3766; Haines, Jonathan/0000-0002-4351-4728; Craig, Jamie/0000-0001-9955-9696; Buil, Alfonso/0000-0002-3097-1014; Khor, Chiea Chuen/0000-0002-1128-4729; Yaspan, Brian/0000-0002-3787-2510; Ashley-Koch, Allison/0000-0001-5409-9155; Topouzis, Fotis/0000-0002-8966-537X; Brown, Andrew/0000-0002-8087-3033; Lichter, Paul/0000-0001-8394-4813; Klebe, Sonja/0000-0002-8976-4714; De Vivo, Immaculata/0000-0002-7185-7402; Mills, Richard/0000-0002-7386-2571; Hammond, Christopher/0000-0002-3227-2620; Kang, Jae/0000-0003-4812-0557; Small, Kerrin/0000-0003-4566-0005; Kraft, Peter/0000-0002-4472-8103; Souzeau, Emmanuelle/0000-0002-2015-6577; Song, Yeunjoo/0000-0002-7452-3731; Scott, William/0000-0001-9336-6404; Glastonbury, Craig/0000-0001-5542-2225; Khawaja, Anthony/0000-0001-6802-8585; Hysi, Pirro/0000-0001-5752-2510; Perera, Shamira/0000-0002-1404-5096; Moroi, Sayoko E/0000-0002-0418-0657; Li, Zheng/0000-0002-7060-2213; Venkatasubramanian, Siddharth/0000-0002-5860-0768	US National Institutes of Health/National Eye Institute (NIH/NEI) [R01EY022305]; UK Medical Research Council [G1000143]; Cancer Research UK [C864/A14136]; NHMRC; Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases; Wellcome Trust, UK; National Institute for Health Research (NIHR); Fight for Sight Early Career Investigator Award; Biomedical Research Council (BMRC) grant in Singapore [BMRC 10/1/35/19/675]; Singapore National Research Foundation [NMRC/TCR/008-SERI/2013]; Royal Australian and New Zealand College of Ophthalmology (RANZCO) Eye Foundation; National Health and Medical Research Council (NHMRC) of Australia [535074, 1031362, 1023911, 1021105]; Medical Research Council [G0401527, MR/K006584/1, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, SRF/01/010] Funding Source: researchfish; Fight for Sight [1329/30, 1895/96] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000428, UL1TR000427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023754, R01EY023512, R01EY015473, R01EY022306, R01EY010886, R01EY022305, R01EY015872, P30EY014104] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006389] Funding Source: NIH RePORTER	US National Institutes of Health/National Eye Institute (NIH/NEI); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases; Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Fight for Sight Early Career Investigator Award; Biomedical Research Council (BMRC) grant in Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation(National Research Foundation, Singapore); Royal Australian and New Zealand College of Ophthalmology (RANZCO) Eye Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NEIGHBORHOOD data collection and analysis are supported by US National Institutes of Health/National Eye Institute (NIH/NEI) grant R01EY022305 (J.L.W.). Support for recruitment in ANZRAG (Australian and New Zealand Registry of Advanced Glaucoma) was provided by the Royal Australian and New Zealand College of Ophthalmology (RANZCO) Eye Foundation and by the National Health and Medical Research Council (NHMRC) of Australia (535074, 1031362, 1023911 and 1021105). EPIC-Norfolk infrastructure and core functions are supported by grants from the UK Medical Research Council (G1000143) and Cancer Research UK (C864/A14136). BMES (Blue Mountains Eye Study) was supported by the NHMRC, the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases, NHMRC Senior Research Fellowships and the Wellcome Trust, UK. Collection and genotyping for the South London Case-Control cohort (UK) were supported by a National Institute for Health Research (NIHR) Senior Research Fellowship (C.J.H.), and analysis was supported by a Fight for Sight Early Career Investigator Award (P.J.H.). The Singapore study (E.N.V., T.A. and C.C.K.) was supported by a Biomedical Research Council (BMRC) grant in Singapore, reference BMRC 10/1/35/19/675. This research was also partly supported by a grant (NMRC/TCR/008-SERI/2013) from the Singapore National Research Foundation under its Translational and Clinical Research Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council. Additional acknowledgment and funding details are in the Supplementary Note.	Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Caprioli Joseph, 2009, Trans Am Ophthalmol Soc, V107, P161; Carnes MU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004372; Chen JH, 2012, INVEST OPHTH VIS SCI, V53, P779, DOI 10.1167/iovs.11-8277; Chen Y, 2006, FEBS LETT, V580, P6596, DOI 10.1016/j.febslet.2006.11.007; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Donovan K, 2014, INVEST OPHTH VIS SCI, V55, P7862, DOI 10.1167/iovs.14-14048; Feuer WJ, 2002, AM J OPHTHALMOL, V133, P19, DOI 10.1016/S0002-9394(01)01338-1; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Ito YA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.8; Lattante S, 2014, NEUROLOGY, V83, P990, DOI 10.1212/WNL.0000000000000778; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Mabuchi F, 2010, AM J OPHTHALMOL, V149, P826, DOI 10.1016/j.ajo.2009.12.030; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schuhmacher LN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-340; Sun ZF, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-32; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Woo D, 2014, AM J HUM GENET, V94, P511, DOI 10.1016/j.ajhg.2014.02.012; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	47	143	147	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					189	194		10.1038/ng.3482	http://dx.doi.org/10.1038/ng.3482			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26752265	Green Submitted, Green Accepted			2022-12-17	WOS:000369043900017
J	Enciso-Mora, V; Broderick, P; Ma, Y; Jarrett, RF; Hjalgrim, H; Hemminki, K; van den Berg, A; Olver, B; Lloyd, A; Dobbins, SE; Lightfoot, T; van Leeuwen, FE; Forsti, A; Diepstra, A; Broeks, A; Vijayakrishnan, J; Shield, L; Lake, A; Montgomery, D; Roman, E; Engert, A; von Strandmann, EP; Reiners, KS; Nolte, IM; Smedby, KE; Adami, HO; Russell, NS; Glimelius, B; Hamilton-Dutoit, S; de Bruin, M; Ryder, LP; Molin, D; Sorensen, KM; Chang, ET; Taylor, M; Cooke, R; Hofstra, R; Westers, H; van Wezel, T; van Eijk, R; Ashworth, A; Rostgaard, K; Melbye, M; Swerdlow, AJ; Houlston, RS				Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Jarrett, Ruth F.; Hjalgrim, Henrik; Hemminki, Kari; van den Berg, Anke; Olver, Bianca; Lloyd, Amy; Dobbins, Sara E.; Lightfoot, Tracy; van Leeuwen, Flora E.; Foersti, Asta; Diepstra, Arjan; Broeks, Annegien; Vijayakrishnan, Jayaram; Shield, Lesley; Lake, Annette; Montgomery, Dorothy; Roman, Eve; Engert, Andreas; von Strandmann, Elke Pogge; Reiners, Katrin S.; Nolte, Ilja M.; Smedby, Karin E.; Adami, Hans-Olov; Russell, Nicola S.; Glimelius, Bengt; Hamilton-Dutoit, Stephen; de Bruin, Marieke; Ryder, Lars P.; Molin, Daniel; Sorensen, Karina Meden; Chang, Ellen T.; Taylor, Malcolm; Cooke, Rosie; Hofstra, Robert; Westers, Helga; van Wezel, Tom; van Eijk, Ronald; Ashworth, Alan; Rostgaard, Klaus; Melbye, Mads; Swerdlow, Anthony J.; Houlston, Richard S.			A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)	NATURE GENETICS			English	Article							KAPPA-B-ALPHA; INFECTIOUS-MONONUCLEOSIS; COLORECTAL-CANCER; NEOPLASTIC-CELLS; PROSTATE-CANCER; INCREASED RISK; C-MYC; DISEASE; GENE; VARIANT	To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide association study of 589 individuals with cHL (cases) and 5,199 controls with validation in four independent samples totaling 2,057 cases and 3,416 controls. We identified three new susceptibility loci at 2p16.1 (rs1432295, REL, odds ratio (OR) = 1.22, combined P = 1.91 x 10(-8)), 8q24.21 (rs2019960, PVT1, OR = 1.33, combined P = 1.26 x 10(-13)) and 10p14 (rs501764, GATA3, OR = 1.25, combined P = 7.05 x 10(-8)). Furthermore, we confirmed the role of the major histocompatibility complex in disease etiology by revealing a strong human leukocyte antigen (HLA) association (rs6903608, OR = 1.70, combined P = 2.84 x 10(-50)). These data provide new insight into the pathogenesis of cHL.	[Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Olver, Bianca; Lloyd, Amy; Dobbins, Sara E.; Vijayakrishnan, Jayaram; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Jarrett, Ruth F.; Shield, Lesley; Lake, Annette; Montgomery, Dorothy] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Hjalgrim, Henrik; Rostgaard, Klaus; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Hemminki, Kari; Diepstra, Arjan] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden; [van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Lightfoot, Tracy; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England; [van Leeuwen, Flora E.; de Bruin, Marieke] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Broeks, Annegien] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Expt Therapy, Amsterdam, Netherlands; [Engert, Andreas; von Strandmann, Elke Pogge; Reiners, Katrin S.] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Smedby, Karin E.] Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; [Russell, Nicola S.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [Glimelius, Bengt] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Glimelius, Bengt; Molin, Daniel] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden; [Hamilton-Dutoit, Stephen] Aarhus Univ Hosp, Inst Pathol, DK-8000 Aarhus, Denmark; [Ryder, Lars P.] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Sorensen, Karina Meden] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark; [Chang, Ellen T.; Swerdlow, Anthony J.] Canc Prevent Inst Calif, Fremont, CA USA; [Chang, Ellen T.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA USA; [Taylor, Malcolm] Univ Manchester, St Marys Hosp, Sch Canc & Enabling Sci, Canc Immunogenet Grp, Manchester M13 0JH, Lancs, England; [Cooke, Rosie] Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; [Hofstra, Robert; Westers, Helga] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van Wezel, Tom; van Eijk, Ronald] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Ashworth, Alan] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London, England	University of London; Institute of Cancer Research - UK; University of Glasgow; Statens Serum Institut; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; University of Groningen; University of York - UK; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Cologne; University of Groningen; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Harvard University; Harvard Medical School; Netherlands Cancer Institute; Karolinska Institutet; Uppsala University; Aarhus University; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Cancer Prevention Institute of California; Stanford University; University of Manchester; University of London; Institute of Cancer Research - UK; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	van Wezel, Tom/A-9599-2008; Molin, Daniel/ABC-2260-2021; van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/Z-3092-2019; Jarrett, Ruth F/A-5570-2012; Hjalgrim, Henrik/AAG-4973-2021; De Bruin, Marie Louise/O-5349-2016; Chang, Ellen/G-5700-2010; van den Berg, Anke/H-1718-2011; Dutoit, Stephen Hamilton/E-1815-2013; ryder, lars p/Q-2060-2015	van Wezel, Tom/0000-0001-5773-7730; van Wezel, Tom/0000-0001-5773-7730; De Bruin, Marie Louise/0000-0001-9197-7068; van den Berg, Anke/0000-0002-8894-2638; ryder, lars p/0000-0002-4744-3496; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Broderick, Peter/0000-0002-8348-5829; Roman, Eve/0000-0001-7603-3704; Hofstra, Robert/0000-0001-7498-3829; Diepstra, Arjan/0000-0001-9239-1050; van Eijk, Ronald/0000-0001-7955-6295; Swerdlow, Anthony/0000-0001-5550-4159; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Houlston, Richard/0000-0002-5268-0242; Rostgaard, Klaus/0000-0001-6220-9414; Jarrett, Ruth/0000-0003-0390-3478; melbye, mads/0000-0001-8264-6785	MRC [G0000934] Funding Source: UKRI; Cancer Research UK [A3351, C1298/A8362] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [076113, 085475, 068545/Z/02] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Breast Cancer Now		Alexander FE, 2003, INT J CANCER, V107, P298, DOI 10.1002/ijc.11156; AMIEL JL, 1967, HISTOCOMPATIBILITY T; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Atayar C, 2005, AM J PATHOL, V166, P127, DOI 10.1016/S0002-9440(10)62238-9; BAKKUS MHC, 1990, ONCOGENE, V5, P1359; Barth TFE, 2003, BLOOD, V101, P3681, DOI 10.1182/blood-2002-08-2577; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Broeks A, 2000, INT J RADIAT BIOL, V76, P693, DOI 10.1080/095530000138367; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; De Bruin ML, 2009, J CLIN ONCOL, V27, P4239, DOI 10.1200/JCO.2008.19.9174; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Faumont N, 2009, J VIROL, V83, P5014, DOI 10.1128/JVI.02264-08; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldin LR, 2005, J MED GENET, V42, P595, DOI 10.1136/jmg.2004.027433; Goldin LR, 2004, CANCER-AM CANCER SOC, V100, P1902, DOI 10.1002/cncr.20189; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hjalgrim H, 2008, J INTERN MED, V264, P537, DOI 10.1111/j.1365-2796.2008.02031.x; Hjalgrim H, 2007, CANCER RES, V67, P2382, DOI 10.1158/0008-5472.CAN-06-3566; Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; HUPPI K, 1990, P NATL ACAD SCI USA, V87, P6964, DOI 10.1073/pnas.87.18.6964; Jarrett RF, 2003, J CLIN PATHOL, V56, P811, DOI 10.1136/jcp.56.11.811; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; KLITZ W, 1994, AM J HUM GENET, V54, P497; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; LA RF, 1994, MOL CELL BIOL, V14, P1039; Lake A, 2009, INT J CANCER, V125, P1334, DOI 10.1002/ijc.24502; Li J, 2009, INT IMMUNOPHARMACOL, V9, P590, DOI 10.1016/j.intimp.2009.01.015; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; OZA AM, 1994, CANCER RES, V54, P5101; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Pettiti D, 1994, METAANALYSIS DECISIO; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; RISCH N, 1987, AM J HUM GENET, V40, P1; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Smith A, 2010, BRIT J HAEMATOL, V148, P739, DOI 10.1111/j.1365-2141.2009.08010.x; Sorensen KM, 2007, GENET TEST, V11, P65, DOI 10.1089/gte.2006.0503; Storlazzi CT, 2004, HUM MOL GENET, V13, P1479, DOI 10.1093/hmg/ddh164; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Swerdlow AJ, 2003, EUR J NUCL MED MOL I, V30, pS3, DOI 10.1007/s00259-003-1154-9; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Leeuwen FE, 2003, JNCI-J NATL CANCER I, V95, P971, DOI 10.1093/jnci/95.13.971; VILLENEUVE L, 1986, MOL CELL BIOL, V6, P1834, DOI 10.1128/MCB.6.5.1834; Willett EV, 2007, EPIDEMIOLOGY, V18, P130, DOI 10.1097/01.ede.0000248899.47399.78; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	67	143	146	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1126	+		10.1038/ng.696	http://dx.doi.org/10.1038/ng.696			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037568	Green Submitted, Green Accepted			2022-12-17	WOS:000284578800017
J	Steidl, U; Rosenbauer, F; Verhaak, RGW; Gu, XS; Ebralidze, A; Otu, HH; Klippel, S; Steidl, C; Bruns, I; Costa, DB; Wagner, K; Aivado, M; Kobbe, G; Valk, PJM; Passegue, E; Libermann, TA; Delwel, R; Tenen, DG				Steidl, Ulrich; Rosenbauer, Frank; Verhaak, Roel G. W.; Gu, Xuesong; Ebralidze, Alexander; Otu, Hasan H.; Klippel, Steffen; Steidl, Christian; Bruns, Ingmar; Costa, Daniel B.; Wagner, Katharina; Aivado, Manuel; Kobbe, Guido; Valk, Peter J. M.; Passegue, Emmanuelle; Libermann, Towia A.; Delwel, Ruud; Tenen, Daniel G.			Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells	NATURE GENETICS			English	Article							CD34(+) HEMATOPOIETIC STEM; GENE-EXPRESSION; SELF-RENEWAL; PROGENITOR CELLS; CANCER; DIFFERENTIATION; PROLIFERATION; INTEGRATION; DISRUPTION; MUTATIONS	Knockdown of the transcription factor PU.1 (encoded by Sfpi1) leads to acute myeloid leukemia (AML) in mice. We examined the transcriptome of preleukemic hematopoietic stem cells (HSCs) in which PU.1 was knocked down (referred to as `PU.1-knockdown HSCs') to identify transcriptional changes preceding malignant transformation. Transcription factors c-Jun and JunB were among the top-downregulated targets. Restoration of c-Jun expression in preleukemic cells rescued the PU.1 knockdown initiated myelomonocytic differentiation block. Lentiviral restoration of JunB at the leukemic stage led to loss of leukemic self-renewal capacity and prevented leukemia in NOD-SCID mice into which leukemic PU.1-knockdown cells were transplanted. Examination of human individuals with AML confirmed the correlation between PU.1 and JunB downregulation. These results delineate a transcriptional pattern that precedes leukemic transformation in PU.1- knockdown HSCs and demonstrate that decreased levels of c-Jun and JunB contribute to the development of PU.1 knockdown-induced AML by blocking differentiation and increasing self-renewal. Therefore, examination of disturbed gene expression in HSCs can identify genes whose dysregulation is essential for leukemic stem cell function and that are targets for therapeutic interventions.	Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA; Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Yeditepe Univ, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey; Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany; Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94314 USA	Harvard University; Harvard Medical School; Harvard University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Yeditepe University; University of Gottingen; Heinrich Heine University Dusseldorf; University of California System; University of California San Francisco	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu	Kobbe, Guido/ABG-9472-2021; Valk, Peter/AAX-2823-2020; Verhaak, Roel/ABE-7058-2020	Bruns, Ingmar/0000-0001-6316-8378; Costa, Daniel/0000-0002-0689-395X; Passegue, Emmanuelle/0000-0002-3516-297X; Libermann, Towia/0000-0002-4006-8179; Tenen, Daniel/0000-0002-6423-3888; Otu, Hasan/0000-0002-9253-8152; Rosenbauer, Frank/0000-0001-7977-9421	NATIONAL CANCER INSTITUTE [R01CA041456] Funding Source: NIH RePORTER; NCI NIH HHS [CA41456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; BORRAS FE, 1995, J BIOL CHEM, V270, P24385, DOI 10.1074/jbc.270.41.24385; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Landgrebe J, 2002, GENOME BIOL, V3; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Phinney DG, 1996, ONCOGENE, V13, P1875; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosenbauer F, 2005, BLOOD, V106, P1519, DOI 10.1182/blood-2005-02-0717; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang Q, 2005, J CELL PHYSIOL, V204, P962, DOI 10.1002/jcp.20355	50	143	146	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1269	1277		10.1038/ng1898	http://dx.doi.org/10.1038/ng1898			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041602				2022-12-17	WOS:000241592700015
J	Parra, EJ; Kittles, RA; Shriver, MD				Parra, EJ; Kittles, RA; Shriver, MD			Implications of correlations between skin color and genetic ancestry for biomedical research	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; ADMIXED POPULATIONS; ADMIXTURE; ASSOCIATION; DISEASE; PIGMENTATION; LINKAGE; DENSITY; PROPORTIONS; DIFFERENCE	Skin pigmentation is a central element of most discussions on 'race' and genetics. Research on the genetic basis of population variation in this phenotype, which is important in mediating both social experiences and environmental exposures, is sparse. We studied the relationship between pigmentation and ancestry in five populations of mixed ancestry with a wide range of pigmentation and ancestral proportions (African Americans from Washington, DC; African Caribbeans living in England; Puerto Ricans from New York; Mexicans from Guerrero; and Hispanics from San Luis Valley). The strength of the relationship between skin color and ancestry was quite variable, with the correlations ranging in intensity from moderately strong (Puerto Rico, rho = 0.633) to weak (Mexico, rho = 0.212). These results demonstrate the utility of ancestry-informative genetic markers and admixture methods and emphasize the need to be cautious when using pigmentation as a proxy of ancestry or when extrapolating the results from one admixed population to another.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University Toronto Mississauga; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, 409 Carpenter Bldg, University Pk, PA 16802 USA.	mds17@psu.edu	Parra, Esteban J/A-4957-2008	Shriver, Mark/0000-0003-0006-0479; parra, esteban J/0000-0002-2057-8577				Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; BONILLA C, IN PRESS AM J PHYS A; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Halder Indrani, 2003, Human Genomics, V1, P52; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; LONG JC, 1991, GENETICS, V127, P417; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Nordlund J.J., 1998, PIGMENTARY SYSTEM PH, V1st; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 1997, AM J PHYS ANTHROPOL, V104, P449, DOI 10.1002/(SICI)1096-8644(199712)104:4<449::AID-AJPA2>3.0.CO;2-N; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Robins A.H., 1991, BIOL PERSPECTIVES HU; Rybicki BA, 2002, HUM HERED, V53, P187, DOI 10.1159/000066193; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Ye J, 2002, J FORENSIC SCI, V47, P593	34	143	149	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S54	S60		10.1038/ng1440	http://dx.doi.org/10.1038/ng1440			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508005	Bronze			2022-12-17	WOS:000224854000012
J	Chen, P; Hao, WS; Rife, L; Wang, XP; Shen, DW; Chen, J; Ogden, T; Van Boemel, GB; Wu, LY; Yang, M; Fong, HKW				Chen, P; Hao, WS; Rife, L; Wang, XP; Shen, DW; Chen, J; Ogden, T; Van Boemel, GB; Wu, LY; Yang, M; Fong, HKW			A photic visual cycle of rhodopsin regeneration is dependent on Rgr	NATURE GENETICS			English	Letter							PIGMENT-EPITHELIUM; VITAMIN-A; OPSIN HOMOLOG; RETINOCHROME; CHROMOPHORE; ISOMERS; RETINA; EYE	During visual excitation, rhodopsin undergoes photoactivation and bleaches to opsin and all-trans-retinal(1,2). To regenerate rhodopsin and maintain normal visual sensitivity, the all-trans isomer must be metabolized and reisomerized to produce the chromophore 11-cis-retinal in biochemical steps that constitute the visual cycle and involve the retinal pigment epithelium (RPE; refs, 3-8). A key step in the visual cycle is isomerization of an all-trans retinoid to 11-cis-retinol in the RPE (refs, 9-11). It could be that the retinochrome-like opsins. peropsin, or the retinal G protein-coupled receptor (RGR) opsin12-16 are isomerases in the RPE. In contrast to visual pigments. RGR is bound predominantly to endogenous all-transretinal, and irradiation of RGR in vitro results in stereospecific conversion of the bound all-trans isomer to 11-cis-retinal(17). Here we show that RGR is involved in the formation of 11-cis-retinal in mice and functions in a light-dependent pathway of the rod visual cycle. Mutations in the human gene encoding RGR are associated with retinitis pigmentosa(18).	Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Microbiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; Doheny Eye Inst, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Doheny Eye Institute	Fong, HKW (corresponding author), Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA.				NATIONAL EYE INSTITUTE [R01EY008364, P30EY003040] Funding Source: NIH RePORTER; NEI NIH HHS [EY03040, EY08364] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1971, J PHYSIOL-LONDON, V217, P447, DOI 10.1113/jphysiol.1971.sp009580; BRIDGES CDB, 1976, EXP EYE RES, V22, P435, DOI 10.1016/0014-4835(76)90182-2; CHEN P, 2001, J BIOL CHEM     0327; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; GROENENDIJK GWT, 1979, ANAL BIOCHEM, V99, P304, DOI 10.1016/S0003-2697(79)80011-1; GROENENDIJK GWT, 1980, BIOCHIM BIOPHYS ACTA, V617, P430, DOI 10.1016/0005-2760(80)90009-0; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HUBBARD R, 1952, J GEN PHYSIOL, V36, P269, DOI 10.1085/jgp.36.2.269; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; LANDERS GM, 1990, METHOD ENZYMOL, V189, P70; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; OZAKI K, 1986, VISION RES, V26, P691, DOI 10.1016/0042-6989(86)90083-0; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; RANDO RR, 1991, J BIOENERG BIOMEMBR, V23, P133; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Stryer L, 1991, Harvey Lect, V87, P129; Tao L, 1998, Mol Vis, V4, P25; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; ZIMMERMAN WF, 1974, VISION RES, V14, P795, DOI 10.1016/0042-6989(74)90143-6; [No title captured]	25	143	145	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					256	260		10.1038/90089	http://dx.doi.org/10.1038/90089			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431696				2022-12-17	WOS:000169656400018
J	Siddiqui, MR; Meisner, S; Tosh, K; Balakrishnan, K; Ghei, S; Fisher, SE; Golding, M; Narayan, NPS; Sitaraman, T; Sengupta, U; Pitchappan, R; Hill, AVS				Siddiqui, MR; Meisner, S; Tosh, K; Balakrishnan, K; Ghei, S; Fisher, SE; Golding, M; Narayan, NPS; Sitaraman, T; Sengupta, U; Pitchappan, R; Hill, AVS			A major susceptibility locus for leprosy in India maps to chromosome 10p13	NATURE GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; AFFECTED RELATIVE PAIRS; GENOME-WIDE SEARCH; SCHISTOSOMA-MANSONI; LINKAGE STRATEGIES; INFECTION; EPIDEMIOLOGY; INTENSITY; 5Q31-Q33; DISEASE	Leprosy, a chronic infectious disease caused by Mycobacterium leprae, is prevalent in India, where about half of the world's estimated 800,000 cases occur(1). A role for the genetics of the host in variable susceptibility to leprosy has been indicated by familial clustering, twin studies, complex segregation analyses and human leukocyte antigen (HLA) association studies. We report here a genetic linkage scan of the genomes of 224 families from South India, containing 245 independent affected sibpairs with leprosy, mainly of the paucibacillary type. In a two-stage genome screen using 396 microsatellite markers, we found significant linkage (maximum lod score (MLS)=4.09, P<2x10(-5)) on chromosome 10p13 for a series of neighboring microsatellite markers, providing evidence for a major locus for this prevalent infectious disease. Thus, despite the polygenic nature of infectious disease susceptibility, some major, non-HLA-linked loci exist that may be mapped through obtainable numbers of affected sibling pairs.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Madurai Kamaraj Univ, Madurai 625021, Tamil Nadu, India; JALMA Inst, Agra, Uttar Pradesh, India; Leprosy Project, Sakthi Nagar, India; Hindu Mission Hosp, Kumbakonam, India	University of Oxford; Wellcome Centre for Human Genetics; Madurai Kamaraj University; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra	Hill, AVS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.		Peng, Bo/A-6920-2009; Fisher, Simon E./E-9130-2012; HILL, Adrian V>S>/C-1306-2008	Peng, Bo/0000-0001-8225-2284; Fisher, Simon E./0000-0002-3132-1996; Karuppiah, Balakrishnan/0000-0002-7494-5010; Siddiqui, Ruby/0000-0002-9638-594X				Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; ABEL L, 1988, AM J HUM GENET, V42, P256; ALI PM, 1966, INT J LEPROSY, V34, P405; Aredath S P, 1984, Lepr Rev, V55, P47; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Chakravartti MR, 1973, TOPICS HUMAN GENETIC, P1; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FEITOSA MF, 1995, AM J HUM GENET, V56, P1179; HAILE RWC, 1985, HUM HERED, V35, P43, DOI 10.1159/000153514; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; TODD JR, 1990, REV INFECT DIS, V12, P63; *WHO, 1998, WKLY EPIDEMIOL REC, V73, P308	24	143	151	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					439	441		10.1038/86958	http://dx.doi.org/10.1038/86958			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279529				2022-12-17	WOS:000167811200022
J	Jeffs, B; Clark, JS; Anderson, NH; Gratton, J; Brosnan, MJ; Gauguier, D; Reid, JL; Macrae, IM; Dominiczak, AF				Jeffs, B; Clark, JS; Anderson, NH; Gratton, J; Brosnan, MJ; Gauguier, D; Reid, JL; Macrae, IM; Dominiczak, AF			Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; HYPERTENSIVE-RATS; ARTERY OCCLUSION; PRONE	Ischaemic stroke is a complex disorder caused by a combination of genetic and environmental factors. clinical and epidemiological studies have provided strong evidence for genetic influences in the development of human stroke(1-3) and several mendelian traits featuring stroke have been described(4,5). The genetic analysis of the non-mendelian, common ischaemic stroke in humans is hindered by the late onset of the disease and the mode of inheritance, which is complex, polygenic and multifactorial. An important approach to the study of such polygenic diseases is the use of appropriate animal models in which individual contributing factors can be recognized and analysed(6,7). The spontaneously hypertensive stroke-prone rat (SHRSP) is an experimental model of stroke characterized by a high frequency of spontaneous strokes(8) as well as an increased sensitivity to experimentally induced focal cerebral ischaemia(9,10). Rubattu et al.(11) performed a genome-wide screen in an F-2 cross obtained by mating SHRSP and SHR, in which latency to stroke on Japanese rat diet was used as a phenotype. This study identified three major quantitative trait loci (QTLs), STR-1-3. Of these, STR-2 and 3 conferred a protective effect against stroke in the presence of SHRSP alleles and STR-2 co-localized with the genes encoding for atrial natriuretic tic and brain natriuretic factors(11). Our investigation was designed to identify the genetic component responsible for large infarct volumes in the SHRSP in response to a focal ischaemic insult by performance of a genome scan in an F-2 cross derived from the SHRSP and the normotensive reference strain, WKY rat. We identified a highly significant QTL on rat chromosome 5 with a lod score trf 16.6 which accounts for 67% of the total variance, co-localizes with the genes encoding atrial and brain natriuretic factor and is blood pressure independent.	UNIV GLASGOW, WESTERN INFIRM,DEPT MED & THERAPEUT, GLASGOW G11 6NT, LANARK, SCOTLAND; UNIV GLASGOW, WELLCOME SURG INST, GLASGOW G61 1QH, LANARK, SCOTLAND; WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7LD, ENGLAND	University of Glasgow; University of Glasgow; University of Oxford; Wellcome Centre for Human Genetics			Dominiczak, Anna F/P-9390-2017; Gauguier, Dominique/G-2190-2016; Dominiczak, Anna F/D-2262-2009	Dominiczak, Anna F/0000-0003-4913-3608; Gauguier, Dominique/0000-0001-6156-9530; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERTS MJ, 1991, STROKE, V22, P276, DOI 10.1161/01.STR.22.2.276; Arribas SM, 1996, STROKE, V27, P1118, DOI 10.1161/01.STR.27.6.1118; BRASS LM, 1992, STROKE, V23, P221, DOI 10.1161/01.STR.23.2.221; Clark JS, 1996, HYPERTENSION, V28, P898, DOI 10.1161/01.HYP.28.5.898; COYLE P, 1983, STROKE, V14, P605, DOI 10.1161/01.STR.14.4.605; COYLE P, 1991, BLOOD VESSELS, V28, P183; COYLE P, 1984, STROKE, V15, P711, DOI 10.1161/01.STR.15.4.711; DAVIDSON AO, 1995, HYPERTENSION, V26, P452, DOI 10.1161/01.HYP.26.3.452; DOMINICZAK AF, 1994, NEWS PHYSIOL SCI, V9, P246; DOMINICZAK AF, 1993, AM J HYPERTENS, V6, P1003, DOI 10.1093/ajh/6.12.1003; ESTRADA V, 1994, AM J HYPERTENS, V7, P1085, DOI 10.1093/ajh/7.12.1085; Gunel M, 1996, NAT GENET, V13, P384, DOI 10.1038/ng0896-384; JACEWICZ M, 1992, HYPERTENSION, V19, P47, DOI 10.1161/01.HYP.19.1.47; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KIELY DK, 1993, STROKE, V24, P1366, DOI 10.1161/01.STR.24.9.1366; Konig JFR, 1963, RAT BRAIN STEREOTAXI; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; OKAMOTO K, 1974, CIRC RES, V34, pI143; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; QUIRION R, 1986, P NATL ACAD SCI USA, V83, P174, DOI 10.1073/pnas.83.1.174; Rawlings O., 1998, APPL REGRESSION ANAL, VSecond, P372, DOI DOI 10.1007/B98890; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Volpe M, 1996, J CLIN INVEST, V98, P256, DOI 10.1172/JCI118787	27	143	146	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					364	367		10.1038/ng0897-364	http://dx.doi.org/10.1038/ng0897-364			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241273				2022-12-17	WOS:A1997XM90900018
J	Armour, JAL; Anttinen, T; May, CA; Vega, EE; Sajantila, A; Kidd, JR; Kidd, KK; Bertranpetit, J; Paabo, S; Jeffreys, AJ				Armour, JAL; Anttinen, T; May, CA; Vega, EE; Sajantila, A; Kidd, JR; Kidd, KK; Bertranpetit, J; Paabo, S; Jeffreys, AJ			Minisatellite diversity supports a recent African origin for modern humans	NATURE GENETICS			English	Article							HYPERVARIABLE LOCUS; MITOCHONDRIAL-DNA; MUTATION; SEQUENCE; D16S309	In a study of human diversity at a highly variable locus, we have mapped the internal structures of tandem-repetitive alleles from different populations at the minisatellite MS205 (D16S309). The results give an unusually detailed view of the different allelic structures represented on modern human chromosomes, and of the ancestral relationships between them. There was a clear difference in allelic diversity between African and non-African populations. A restricted set of allele families was found in non-African populations, and formed a subset of the much greater diversity seen on African chromosomes. The data strongly support a recent African origin for modern human diversity at this locus.	UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,LEICS,ENGLAND; UNIV MUNICH,INST ZOOL,D-80021 MUNICH,GERMANY; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520; UNIV BARCELONA,FAC BIOL,LAB ANTROPOL,E-08028 BARCELONA,SPAIN	University of Leicester; University of Munich; Yale University; University of Barcelona			Sajantila, Antti/AAY-9084-2021; Bertranpetit, Jaume/F-8550-2012	Bertranpetit, Jaume/0000-0003-0100-0590; Armour, John/0000-0002-8558-8506; Sajantila, Antti/0000-0003-4117-5248; May, Celia/0000-0001-8541-2458	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; Armour JAL, 1996, ANN HUM GENET, V60, P11, DOI 10.1111/j.1469-1809.1996.tb01167.x; Armour JAL, 1992, CURR OPIN GENET DEV, V2, P850, DOI 10.1016/S0959-437X(05)80106-6; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FLINT J, 1989, HUM GENET, V83, P257, DOI 10.1007/BF00285167; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIDD KK, CAMBRIDGE S MOL BIOL; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEIL DL, 1993, HUM MOL GENET, V2, P1129; ROYLE NJ, 1992, NUCLEIC ACIDS RES, V20, P1164, DOI 10.1093/nar/20.5.1164; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; TEMPLETON AR, 1995, GENETICS, V140, P767; TEMPLETON AR, 1994, AM ANTHROPOL, V96, P141, DOI 10.1525/aa.1994.96.1.02a00080; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	29	143	144	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					154	160		10.1038/ng0696-154	http://dx.doi.org/10.1038/ng0696-154			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640220				2022-12-17	WOS:A1996UN39500013
J	Kozarsky, KF; Jooss, K; Donahee, M; Strauss, JF; Wilson, JM				Kozarsky, KF; Jooss, K; Donahee, M; Strauss, JF; Wilson, JM			Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; RECOMBINANT; SEQUENCE; PROTEIN	Liver directed gene transfer with adenoviral vectors is being considered for the treatment of several metabolic diseases, including familial hypercholesterolaemia (FH). Gene replacement therapy of human low density lipoprotein (LDL) receptor gene into the murine model of FH transiently corrected the dyslipidaemia; however, humoral and cellular immune responses to LDL receptor developed - possibly contributing to the associated hepatitis and extinguishing of transgene expression. We evaluated an alternative strategy of ectopic expression in the liver of the very low density lipoprotein (VLDL) receptor, which is homologous to the LDL receptor but has a different pattern of expression. Infusion of recombinant adenoviruses containing the VLDL receptor gene corrected the dyslipidaemia in the FH mouse and circumvented immune responses to the transgene leading to a more prolonged metabolic correction.	UNIV PENN,INST HUMAN GENE THERAPY,DEPT MOL & CELLULAR ENGN,PHILADELPHIA,PA 19104; UNIV PENN,INST HUMAN GENE THERAPY,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029946] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-29946] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARR D, 1995, GENE THER, V2, P151; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; DAI Y, 1995, P NATL ACAD SCI USA, V92, P140; ENGELHARDT JF, 1994, HUM GENE THER, V5, P1217, DOI 10.1089/hum.1994.5.10-1217; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GAFVELS ME, 1994, ENDOCRINOLOGY, V135, P387, DOI 10.1210/en.135.1.387; GAFVELS ME, 1993, SOMAT CELL MOLEC GEN, V19, P557, DOI 10.1007/BF01233382; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; GROSSMAN M, 1992, HUM GENE THER, V3, P501, DOI 10.1089/hum.1992.3.5-501; GROSSMAN M, 1995, NAT MED, V1, P1148, DOI 10.1038/nm1195-1148; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; HOFFER MJV, 1993, BIOCHEM BIOPH RES CO, V191, P880, DOI 10.1006/bbrc.1993.1299; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; KASSEISLER A, 1994, GENE THER, V1, P395; KOZARSKY K, 1993, SOMAT CELL MOLEC GEN, V19, P449, DOI 10.1007/BF01233250; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; LI J, 1995, J CLIN INVEST, V95, P768, DOI 10.1172/JCI117725; MOKUNO H, 1994, J BIOL CHEM, V269, P13238; OKA K, 1994, EUR J BIOCHEM, V224, P975, DOI 10.1111/j.1432-1033.1994.00975.x; POLVINO WJ, 1992, SOMAT CELL MOLEC GEN, V18, P443, DOI 10.1007/BF01233084; SHIMANO H, 1994, J CLIN INVEST, V93, P2215, DOI 10.1172/JCI117218; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; VANGINKEL FW, 1995, HUM GENE THER, V6, P895, DOI 10.1089/hum.1995.6.7-895; WIKTOR TJ, 1984, P NATL ACAD SCI-BIOL, V81, P7194, DOI 10.1073/pnas.81.22.7194; WILLNOW TE, 1995, J MOL MED, V73, P213; YAMAMOTO T, 1993, TRENDS CARDIOVAS MED, V3, P144, DOI 10.1016/1050-1738(93)90015-X; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YANG Y, IN PRESS GENE THERAP; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	36	143	146	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					54	62		10.1038/ng0596-54	http://dx.doi.org/10.1038/ng0596-54			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673104	Bronze			2022-12-17	WOS:A1996UH43000016
J	CHENG, S; HIGUCHI, R; STONEKING, M				CHENG, S; HIGUCHI, R; STONEKING, M			COMPLETE MITOCHONDRIAL GENOME AMPLIFICATION	NATURE GENETICS			English	Letter							DNA; EVOLUTION; MUTATIONS		PENN STATE UNIV,DEPT ANTHROPOL,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CHENG, S (corresponding author), ROCHE MOLEC SYST INC,DEPT HUMAN GENET,ALAMEDA,CA 94501, USA.							AVISE JC, 1991, ANNU REV GENET, V25, P45, DOI 10.1146/annurev.ge.25.120191.000401; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Kocher T.D., 1989, PCR TECHNOLOGY PRINC, P137; KONG HM, 1993, J BIOL CHEM, V268, P1965; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; SALKI RK, 1988, SCIENCE, V239, P487; SCHURR TG, 1990, AM J HUM GENET, V46, P613; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1991, AM J HUM GENET, V48, P370; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; TORRONI A, 1992, GENETICS, V130, P153; WALLACE DC, 1993, TRENDS GENET, V9, P128, DOI 10.1016/0168-9525(93)90207-X; WALSH PS, 1991, BIOTECHNIQUES, V10, P501; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	15	143	150	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					350	351		10.1038/ng0794-350	http://dx.doi.org/10.1038/ng0794-350			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920652				2022-12-17	WOS:A1994NU30600006
J	CARON, H; VANSLUIS, P; VANHOEVE, M; DEKRAKER, J; BRAS, J; SLATER, R; MANNENS, M; VOUTE, PA; WESTERVELD, A; VERSTEEG, R				CARON, H; VANSLUIS, P; VANHOEVE, M; DEKRAKER, J; BRAS, J; SLATER, R; MANNENS, M; VOUTE, PA; WESTERVELD, A; VERSTEEG, R			ALLELIC LOSS OF CHROMOSOME-1P36 IN NEUROBLASTOMA IS OF PREFERENTIAL MATERNAL ORIGIN AND CORRELATES WITH N-MYC AMPLIFICATION	NATURE GENETICS			English	Article							NEURO-BLASTOMA; WILMS-TUMORS; RETINOBLASTOMA; MUTATION; CANCER; DNA; GENE	Neuroblastomas frequently have deletions of chromosome 1 p and amplification of the N-myc oncogene. We analysed 53 neuroblastomas for the N-myc copy number, loss of heterozygosity (LOH) of chromosome 1 p36 and the parental origin of the lost alleles. Allelic loss of 1 p36 was found in 15 tumours. All N-myc amplified tumours belonged to this subset. In 13/15 tumours with LOH of 1 p36 the lost allele was of maternal origin. This non-random distribution implies that the two alleles of the putative neuroblastoma suppressor gene on chromosome 1 p36 are functionally different, depending on their parental origin. This is the first evidence as far as we know for genomic imprinting on chromosome 1 p.	UNIV AMSTERDAM,ACAD MED CTR,INST HUMAN GENET,MEIBERGDREEF 15,1105 AZ AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT PATHOL,1105 AZ AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,EMMA KINDER ZIEKENHUIS,DEPT PAEDIAT ONCOL & HAEMATOL,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam			Versteeg, Rogier/AAQ-1765-2020	Versteeg, Rogier/0000-0001-7172-0388				BRODEUR GM, 1992, CANCER-AM CANCER SOC, V70, P1685, DOI 10.1002/1097-0142(19920915)70:4+<1685::AID-CNCR2820701607>3.0.CO;2-H; CLAUSEN N, 1989, ACTA PAEDIATR SCAND, V78, P736, DOI 10.1111/j.1651-2227.1989.tb11135.x; DEROM C, 1985, J MED GENET, V22, P279, DOI 10.1136/jmg.22.4.279; DEVILEE P, 1991, CANCER RES, V51, P1020; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; DRACOPOLI NC, 1989, P NATL ACAD SCI USA, V86, P4614, DOI 10.1073/pnas.86.12.4614; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ELLMEIER W, 1992, EMBO J, V11, P2563, DOI 10.1002/j.1460-2075.1992.tb05321.x; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FONG CT, 1992, CANCER RES, V52, P1780; HALL JG, 1990, AM J HUM GENET, V46, P857; HOOVERS JMN, 1992, LANCET, V339, P1228, DOI 10.1016/0140-6736(92)91164-4; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; KUSHNER BH, 1986, CANCER-AM CANCER SOC, V57, P1887, DOI 10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7; LAUTHIER V, 1992, HUM MOL GENET, V1, P63; LEACH RJ, 1990, CELL GROWTH DIFFER, V1, P401; LEISTER I, 1990, CANCER RES, V50, P7232; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MOLEY JF, 1992, CANCER RES, V52, P770; MULLENBACH R, 1989, TRENDS GENET, V5, P391; PAL N, 1990, ONCOGENE, V5, P1665; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; ROBERTSON CM, 1991, EUR J PEDIATR, V150, P789, DOI 10.1007/BF02026713; SAPIENZA C, 1991, BIOCHIM BIOPHYS ACTA, V1072, P51, DOI 10.1016/0304-419X(91)90006-7; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; STEPHENS K, 1992, HUM GENET, V88, P279; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VERSTEEG R, 1990, MOL CELL BIOL, V10, P5416, DOI 10.1128/MCB.10.10.5416; WEITH A, 1989, GENE CHROMOSOME CANC, V1, P159, DOI 10.1002/gcc.2870010209; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	34	143	145	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					187	190		10.1038/ng0693-187	http://dx.doi.org/10.1038/ng0693-187			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8102298				2022-12-17	WOS:A1993LF81600021
J	Matreyek, KA; Starita, LM; Stephany, JJ; Martin, B; Chiasson, MA; Gray, VE; Kircher, M; Khechaduri, A; Dines, JN; Hause, RJ; Bhatia, S; Evans, WE; Relling, MV; Yang, WJ; Shendure, J; Fowler, DM				Matreyek, Kenneth A.; Starita, Lea M.; Stephany, Jason J.; Martin, Beth; Chiasson, Melissa A.; Gray, Vanessa E.; Kircher, Martin; Khechaduri, Arineh; Dines, Jennifer N.; Hause, Ronald J.; Bhatia, Smita; Evans, William E.; Relling, Mary V.; Yang, Wenjian; Shendure, Jay; Fowler, Douglas M.			Multiplex assessment of protein variant abundance by massively parallel sequencing	NATURE GENETICS			English	Article							THIOPURINE-S-METHYLTRANSFERASE; GREEN-FLUORESCENT PROTEIN; PTEN TUMOR-SUPPRESSOR; FUNCTIONAL-ANALYSIS; STABILITY; MUTATIONS; CANCERS; BINDING; PHOSPHATASE; ASSOCIATION	Determining the pathogenicity of genetic variants is a critical challenge, and functional assessment is often the only option. Experimentally characterizing millions of possible missense variants in thousands of clinically important genes requires generalizable, scalable assays. We describe variant abundance by massively parallel sequencing (VAMP-seq), which measures the effects of thousands of missense variants of a protein on intracellular abundance simultaneously. We apply VAMP-seq to quantify the abundance of 7,801 single-amino-acid variants of PTEN and TPMT, proteins in which functional variants are clinically actionable. We identify 1,138 PTEN and 777 TPMT variants that result in low protein abundance, and may be pathogenic or alter drug metabolism, respectively. We observe selection for low-abundance PTEN variants in cancer, and show that p.Pro38Ser, which accounts for similar to 10% of PTEN missense variants in melanoma, functions via a dominant-negative mechanism. Finally, we demonstrate that VAMP-seq is applicable to other genes, highlighting its generalizability.	[Matreyek, Kenneth A.; Starita, Lea M.; Stephany, Jason J.; Martin, Beth; Chiasson, Melissa A.; Gray, Vanessa E.; Kircher, Martin; Khechaduri, Arineh; Hause, Ronald J.; Shendure, Jay; Fowler, Douglas M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Dines, Jennifer N.] Univ Washington, Dept Med Genet, Seattle, WA 98195 USA; [Bhatia, Smita] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Evans, William E.; Relling, Mary V.; Yang, Wenjian] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fowler, Douglas M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Fowler, Douglas M.] Canadian Inst Adv Res, Genet Networks Program, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Canadian Institute for Advanced Research (CIFAR)	Shendure, J; Fowler, DM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.; Fowler, DM (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Fowler, DM (corresponding author), Canadian Inst Adv Res, Genet Networks Program, Toronto, ON, Canada.	shendure@u.washington.edu; dfowler@uw.edu	Shendure, Jay/AAU-3684-2021; Matreyek, Kenneth/N-8678-2019; Relling, Mary/N-5032-2018; Evans, William E./C-2069-2012; Kircher, Martin/HDL-9392-2022; Kircher, Martin/H-6909-2019	Matreyek, Kenneth/0000-0001-9149-551X; Evans, William E./0000-0002-9333-5322; Kircher, Martin/0000-0001-9278-5471; Martin, Beth/0000-0002-9661-014X; Chiasson, Melissa/0000-0002-1880-3181; Hasle, Vanessa/0000-0001-8007-4891; Hause, Ronald/0000-0002-5229-7366; Loh, Mignon/0000-0003-4099-4700	American Association for Cancer Research; National Institute of General Medical Sciences [1R01GM109110, 5R24GM115277, P50GM115279]; National Cancer Institute [R01CA096670, P30CA21765]; NIH Director's Pioneer Award [DP1HG007811]; National Cancer Institute Interdisciplinary Training Grant in Cancer [2T32CA080416]; National Science Foundation Graduate Research Fellowship; National Institute of General Medical Sciences Training Grant [T32GM007454]; NATIONAL CANCER INSTITUTE [T32CA080416, R01CA036401, R01CA096670, P30CA021765] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115279, R01GM109110, T32GM007454, R24GM115277] Funding Source: NIH RePORTER	American Association for Cancer Research; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Interdisciplinary Training Grant in Cancer; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of General Medical Sciences Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Underwood and K. Munson of the UW PacBio Sequencing Services for assistance with long-read sequencing; A. Leith of the UW Foege Flow Lab and L. Gitari and D. Prunkard of the UW Pathology Flow Cytometry Core Facility for assistance with cell sorting; and B. Shirts and C. Pritchard in the UW Department of Lab Medicine for advice. The authors would like to acknowledge the American Association for Cancer Research and its financial and material support in the development of the AACR Project GENIE registry, as well as members of the consortium for their commitment to data sharing. Interpretations are the responsibility of study authors. This work was supported by the National Institute of General Medical Sciences (1R01GM109110 and 5R24GM115277 to D.M.F., P50GM115279 to M.V.R. and W.E.E., National Cancer Institute R01CA096670 to S.B. and P30CA21765 to M.V.R.) and an NIH Director's Pioneer Award (DP1HG007811 to J.S.). K.A.M. is an American Cancer Society Fellow (PF-15-221-01), and was supported by a National Cancer Institute Interdisciplinary Training Grant in Cancer (2T32CA080416). M.A.C. and V.E.G. are supported by the National Science Foundation Graduate Research Fellowship. J.N.D. is supported by a National Institute of General Medical Sciences Training Grant (T32GM007454). J.S. is an Investigator of the Howard Hughes Medical Institute. D.M.F. is a Canadian Institute for Advanced Research Azrieli Global Scholar.	Aguissa-Toure AH, 2012, CELL MOL LIFE SCI, V69, P1475, DOI 10.1007/s00018-011-0878-0; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Appell ML, 2013, PHARMACOGENET GENOM, V23, P242, DOI 10.1097/FPC.0b013e32835f1cc0; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dillon LM, 2014, CURR DRUG TARGETS, V15, P65, DOI 10.2174/1389450114666140106100909; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hamdan-Khalil R, 2003, BIOCHEM BIOPH RES CO, V309, P1005, DOI 10.1016/j.bbrc.2003.08.103; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; Johnston SB, 2015, BIOCHEMISTRY-US, V54, P1576, DOI 10.1021/acs.biochem.5b00028; Kalia S. S., 2016, GENET MED, V19, P1; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Klesmith JR, 2017, P NATL ACAD SCI USA, V114, P2265, DOI 10.1073/pnas.1614437114; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leslie NR, 2016, SEMIN CELL DEV BIOL, V52, P30, DOI 10.1016/j.semcdb.2016.01.030; Liu C, 2017, CLIN PHARMACOL THER, V101, P373, DOI 10.1002/cpt.463; Majithia AR, 2016, NAT GENET, V48, P1570, DOI 10.1038/ng.3700; Manolio TA, 2017, CELL, V169, P6, DOI 10.1016/j.cell.2017.03.005; Matreyek KA, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx183; Melbarde-Gorkusa I, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-5; Naguib A, 2015, MOL CELL, V58, P255, DOI 10.1016/j.molcel.2015.03.011; Nelen MR, 1999, EUR J HUM GENET, V7, P267, DOI 10.1038/sj.ejhg.5200289; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Redler RL, 2016, J MOL EVOL, V82, P11, DOI 10.1007/s00239-015-9717-5; Relling MV, 2017, CLIN PHARMACOL THER, V102, P897, DOI 10.1002/cpt.755; Relling MV, 2013, CLIN PHARMACOL THER, V93, P324, DOI 10.1038/clpt.2013.4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; Shirts BH, 2016, TRENDS MOL MED, V22, P925, DOI 10.1016/j.molmed.2016.09.007; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Staal FJT, 2002, BRIT J CANCER, V86, P1586, DOI 10.1038/sj/bjc/6600206; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Wei Y, 2015, J BIOL CHEM, V290, P1592, DOI 10.1074/jbc.M114.588590; Whiffin N, 2017, GENET MED, V19, P1151, DOI 10.1038/gim.2017.26; Wu H, 2007, PROTEINS, V67, P198, DOI 10.1002/prot.21272; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhou HY, 2004, PROTEINS, V54, P315, DOI 10.1002/prot.10584	60	142	143	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					874	+		10.1038/s41588-018-0122-z	http://dx.doi.org/10.1038/s41588-018-0122-z			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29785012	Green Accepted, Green Submitted			2022-12-17	WOS:000433621000015
J	Levine, DM; Ek, WE; Zhang, R; Liu, XX; Onstad, L; Sather, C; Lao-Sirieix, P; Gammon, MD; Corley, DA; Shaheen, NJ; Bird, NC; Hardie, LJ; Murray, LJ; Reid, BJ; Chow, WH; Risch, HA; Nyren, O; Ye, WM; Liu, G; Romero, Y; Bernstein, L; Wu, AH; Casson, AG; Chanock, SJ; Harrington, P; Caldas, I; Debiram-Beecham, I; Caldas, C; Hayward, NK; Pharoah, PD; Fitzgerald, RC; MacGregor, S; Whiteman, DC; Vaughan, TL				Levine, David M.; Ek, Weronica E.; Zhang, Rui; Liu, Xinxue; Onstad, Lynn; Sather, Cassandra; Lao-Sirieix, Pierre; Gammon, Marilie D.; Corley, Douglas A.; Shaheen, Nicholas J.; Bird, Nigel C.; Hardie, Laura J.; Murray, Liam J.; Reid, Brian J.; Chow, Wong-Ho; Risch, Harvey A.; Nyren, Olof; Ye, Weimin; Liu, Geoffrey; Romero, Yvonne; Bernstein, Leslie; Wu, Anna H.; Casson, Alan G.; Chanock, Stephen J.; Harrington, Patricia; Caldas, Isabel; Debiram-Beecham, Irene; Caldas, Carlos; Hayward, Nicholas K.; Pharoah, Paul D.; Fitzgerald, Rebecca C.; MacGregor, Stuart; Whiteman, David C.; Vaughan, Thomas L.			A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus	NATURE GENETICS			English	Article							EPIDERMAL-GROWTH-FACTOR; GASTROESOPHAGEAL-REFLUX; QUALITY-CONTROL; CANCER; RISK; POLYMORPHISM; METAANALYSIS; POPULATION; CARCINOMA; VARIANTS	Esophageal adenocarcinoma is a cancer with rising incidence and poor survival. Most such cancers arise in a specialized intestinal metaplastic epithelium, which is diagnostic of Barrett's esophagus. In a genome-wide association study, we compared esophageal adenocarcinoma cases (n = 2,390) and individuals with precancerous Barrett's esophagus (n = 3,175) with 10,120 controls in 2 phases. For the combined case group, we identified three new associations. The first is at 19p13 (rs10419226: P = 3.6 x 10(-10)) in CRTC1 (encoding CREB-regulated transcription coactivator), whose aberrant activation has been associated with oncogenic activity. A second is at 9q22 (rs11789015: P = 1.0 x 10(-9)) in BARX1, which encodes a transcription factor important in esophageal specification. A third is at 3p14 (rs2687201: P = 5.5 x 10(-9)) near the transcription factor FOXP1, which regulates esophageal development. We also refine a previously reported association with Barrett's esophagus near the putative tumor suppressor gene FOXF1 at 16q24 and extend our findings to now include esophageal adenocarcinoma.	[Levine, David M.; Zhang, Rui] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Ek, Weronica E.; MacGregor, Stuart; Whiteman, David C.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Liu, Xinxue; Lao-Sirieix, Pierre; Debiram-Beecham, Irene; Fitzgerald, Rebecca C.] Hutchison MRC Res Ctr, Med Res Council MRC Canc Cell Unit, Cambridge, England; [Liu, Xinxue; Lao-Sirieix, Pierre; Debiram-Beecham, Irene; Fitzgerald, Rebecca C.] Univ Cambridge, Cambridge, England; [Onstad, Lynn; Reid, Brian J.; Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Sather, Cassandra] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gammon, Marilie D.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Corley, Douglas A.] Kaiser Permanente No Calif, San Francisco Med Ctr, San Francisco, CA USA; [Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bird, Nigel C.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Murray, Liam J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Nyren, Olof; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Geoffrey] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Romero, Yvonne] Mayo Clin, Romero Registry, Rochester, MN USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Wu, Anna H.] Univ So Calif, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Harrington, Patricia; Pharoah, Paul D.] Univ Cambridge, Dept Publ Hlth, Cambridge, England; [Harrington, Patricia; Pharoah, Paul D.] Univ Cambridge, Dept Primary Care, Cambridge, England; [Harrington, Patricia; Caldas, Isabel; Caldas, Carlos; Pharoah, Paul D.] Univ Cambridge, Dept Oncol, Cambridge, England; [Caldas, Carlos] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Oncogen Lab, Brisbane, Qld, Australia	University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; University of Cambridge; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sheffield; University of Leeds; Queens University Belfast; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University; Karolinska Institutet; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; Mayo Clinic; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Southern California; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; QIMR Berghofer Medical Research Institute	Vaughan, TL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	tvaughan@u.washington.edu	Caldas, Carlos/U-7250-2019; Pharoah, Paul/V-6658-2019; Hardie, Laura/AAY-6724-2020; Macgregor, Stuart/C-6442-2009; hayward, nick/AAV-8802-2020; Liu, Geoffrey/N-4421-2016; Facility, Biospecimen Processing/AAC-7837-2022; hayward, nicholas k/C-1367-2015; Whiteman, David C/P-2728-2014	Caldas, Carlos/0000-0003-3547-1489; Pharoah, Paul/0000-0001-8494-732X; Hardie, Laura/0000-0001-5039-2100; Macgregor, Stuart/0000-0001-6731-8142; hayward, nicholas k/0000-0003-4760-1033; Whiteman, David C/0000-0003-2563-9559; Liu, Geoffrey/0000-0002-2603-7296; Liu, Xinxue/0000-0003-1107-0365; Fitzgerald, Rebecca/0000-0002-3434-3568	US National Institutes of Health (NIH) [R01CA136725]; Australian Research Council [FT0990987]; Australian National Health and Medical Research Council (NHMRC); NHMRC of Australia; US NIH [NIDDK 02956, R01DK63616, R01CA59636, R01CA100264, P30CA016672, R01CA133996, HHSN268200782096C, U01CA57949, U01CA57983, U01CA57923]; Robert Wood Johnson Foundation; Fraternal Order of the Eagles; National Cancer Institute [R01 CA57947-03]; Swedish Cancer Society [4559-B01-01XAA, 4758-B02-01XAB]; California Tobacco-Related Research Program [3RT-0122, 10RT-0251]; Medical Research Council; Cancer Research UK; Cambridge National Institute for Health Research Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Cancer Research UK [C490/A10119, C490/A10124]; UTMDACC NIH SPORE in Melanoma [2P50CA093459]; Marit Peterson Fund for Melanoma Research; Wellcome Trust [076113]; American Digestive Health Foundation Endoscopic Research Award; American College of Gastroenterology Junior Faculty Development Award; Glaxo Wellcome, Inc.; Institute for Digestive Health Clinical Research Award; Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic (Rochester, Minnesota);  [K05CA124911]; MRC [MC_U105365007] Funding Source: UKRI; Cancer Research UK [16561, 16942] Funding Source: researchfish; Medical Research Council [MC_U105365007] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-011, NF-SI-0611-10154] Funding Source: researchfish; The Francis Crick Institute [10119, 10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA100264, U01CA057923, K05CA124911, R01CA072866, R01CA133996, R01CA136725, P30CA016086, P01CA091955, R01CA057947, U01CA057983, P50CA093459, R01CA059636, U01CA057949, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063616] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Fraternal Order of the Eagles; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); California Tobacco-Related Research Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); UTMDACC NIH SPORE in Melanoma; Marit Peterson Fund for Melanoma Research; Wellcome Trust(Wellcome Trust); American Digestive Health Foundation Endoscopic Research Award; American College of Gastroenterology Junior Faculty Development Award; Glaxo Wellcome, Inc.; Institute for Digestive Health Clinical Research Award; Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic (Rochester, Minnesota); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was primarily funded by a US National Institutes of Health (NIH) grant (R01CA136725) to T. L. V. and D. C. W. T. L. V. is also supported by grant K05CA124911. D. C. W. is supported by a Future Fellowship (FT0990987) from the Australian Research Council. S. M. is supported by an Australian National Health and Medical Research Council (NHMRC) Career Development Award. N.K.H. is supported by Research Fellowships from the NHMRC of Australia. Y.R. is supported in part by a grant from the US NIH (NIDDK 02956), the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program and the Fraternal Order of the Eagles.; The Swedish Esophageal Cancer Study was funded by grants (R01 CA57947-03) from the National Cancer Institute and the Swedish Cancer Society (4559-B01-01XAA and 4758-B02-01XAB). The Kaiser-Permanente Study was supported by grants from the US NIH (R01DK63616 and R01CA59636) and from the California Tobacco-Related Research Program (3RT-0122 and 10RT-0251). The UK Barrett's oesophagus gene study was funded by a Medical Research Council Programme grant, and the UK SOCS study was funded by Cancer Research UK as well as by the Cambridge National Institute for Health Research Biomedical Research Centre and the Cambridge Experimental Cancer Medicine Centre. The SEARCH grant was funded by Cancer Research UK grants C490/A10119 and C490/A10124.; Genotyping of MD Anderson controls (C. Amos, PI) was performed through the University of Texas MD Anderson Cancer Center (UTMDACC) and the Johns Hopkins University Center for Inherited Disease Research (CIDR), supported in part by US NIH grants R01CA100264, P30CA016672 and R01CA133996 and the UTMDACC NIH SPORE in Melanoma 2P50CA093459, as well as by the Marit Peterson Fund for Melanoma Research. CIDR is supported by contract HHSN268200782096C from the US NIH.; This study made use of data generated by the Wellcome Trust Case Control Consortium. Funding for the project was provided by the Wellcome Trust under award 076113. A full list of the investigators who contributed to the generation of the data is available from the website (see URLs).; The Romero Registry is supported in part by the American Digestive Health Foundation Endoscopic Research Award, the American College of Gastroenterology Junior Faculty Development Award, the Glaxo Wellcome, Inc., Institute for Digestive Health Clinical Research Award and the Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic (Rochester, Minnesota). The Romero Registry also receives charitable gifts from five industry partners (Affymetrix, AstraZeneca, Santarus, Takeda and Wyeth). The US Multicenter Study was funded by grants U01CA57949, U01CA57983 and U01CA57923 from the US NIH.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chak A, 2004, AM J GASTROENTEROL, V99, P2107, DOI 10.1111/j.1572-0241.2004.40464.x; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cortes I, 2012, P NATL ACAD SCI USA, V109, P11318, DOI 10.1073/pnas.1118138109; CRABB DW, 1985, ANN INTERN MED, V103, P52, DOI 10.7326/0003-4819-103-1-52; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dura P, 2013, INT J CANCER, V133, P1751, DOI 10.1002/ijc.28160; Ek W.E., J NATL CANC IN PRESS; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fitzgerald RC, 2005, CLIN GASTROENTEROL H, V3, P529, DOI 10.1016/S1542-3565(05)00248-X; Gogarten SM, 2012, BIOINFORMATICS, V28, P3329, DOI 10.1093/bioinformatics/bts610; Groves C, 2005, SCAND J GASTROENTERO, V40, P1127, DOI 10.1080/00365520510023189; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; JANKOWSKI J, 1993, DIGEST DIS, V11, P1, DOI 10.1159/000171396; JOCHEM VJ, 1992, GASTROENTEROLOGY, V102, P1400; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Melzer E, 2006, AM J GASTROENTEROL, V101, P677, DOI 10.1111/j.1572-0241.2006.473_7.x; Menke V, 2012, J HUM GENET, V57, P26, DOI 10.1038/jhg.2011.124; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Poynton AR, 1996, AM J GASTROENTEROL, V91, P1855; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2006, R LANG ENV STAT COMP, P14; Romero Y, 1997, GASTROENTEROLOGY, V113, P1449, DOI 10.1053/gast.1997.v113.pm9352846; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2012, NAT GENET, V44, P1131, DOI 10.1038/ng.2408; Trudgill NJ, 1999, AM J GASTROENTEROL, V94, P1172, DOI 10.1016/S0002-9270(99)00116-1; Venturi Sebastiano, 2009, Nutrition and Health (Bicester), V20, P119; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Woo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022493; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	39	142	144	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1487	U119		10.1038/ng.2796	http://dx.doi.org/10.1038/ng.2796			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24121790	Green Accepted, Green Submitted			2022-12-17	WOS:000327715800017
J	Xie, MC; Hong, CB; Zhang, B; Lowdon, RF; Xing, XY; Li, DF; Zhou, X; Lee, HJ; Maire, CL; Ligon, KL; Gascard, P; Sigaroudinia, M; Tlsty, TD; Kadlecek, T; Weiss, A; O'Geen, H; Farnham, PJ; Madden, PAF; Mungall, AJ; Tam, A; Kamoh, B; Cho, S; Moore, R; Hirst, M; Marra, MA; Costello, JF; Wang, T				Xie, Mingchao; Hong, Chibo; Zhang, Bo; Lowdon, Rebecca F.; Xing, Xiaoyun; Li, Daofeng; Zhou, Xin; Lee, Hyung Joo; Maire, Cecile L.; Ligon, Keith L.; Gascard, Philippe; Sigaroudinia, Mahvash; Tlsty, Thea D.; Kadlecek, Theresa; Weiss, Arthur; O'Geen, Henriette; Farnham, Peggy J.; Madden, Pamela A. F.; Mungall, Andrew J.; Tam, Angela; Kamoh, Baljit; Cho, Stephanie; Moore, Richard; Hirst, Martin; Marra, Marco A.; Costello, Joseph F.; Wang, Ting			DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape	NATURE GENETICS			English	Article							GENE REGULATORY NETWORKS; BINDING; GENOME; METHYLATION; INSERTION; SEQUENCE; CELLS; IDENTIFICATION; EPIGENOMICS; EVOLUTION	Transposable element (TE)-derived sequences comprise half of the human genome and DNA methylome and are presumed to be densely methylated and inactive. Examination of genome-wide DNA methylation status within 928 TE subfamilies in human embryonic and adult tissues identified unexpected tissue-specific and subfamily-specific hypomethylation signatures. Genes proximal to tissue-specific hypomethylated TE sequences were enriched for functions important for the relevant tissue type, and their expression correlated strongly with hypomethylation within the TEs. When hypomethylated, these TE sequences gained tissue-specific enhancer marks, including monomethylation of histone H3 at lysine 4 (H3K4me1) and occupancy by p300, and a majority exhibited enhancer activity in reporter gene assays. Many such TEs also harbored binding sites for transcription factors that are important for tissue-specific functions and showed evidence of evolutionary selection. These data suggest that sequences derived from TEs may be responsible for wiring tissue type-specific regulatory networks and may have acquired tissue-specific epigenetic regulation.	[Xie, Mingchao; Zhang, Bo; Lowdon, Rebecca F.; Xing, Xiaoyun; Li, Daofeng; Zhou, Xin; Lee, Hyung Joo; Wang, Ting] Washington Univ, Sch Med, Dept Genet, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Hong, Chibo; Costello, Joseph F.] Univ Calif San Francisco, Dept Neurosurg, Brain Tumor Res Ctr, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Maire, Cecile L.; Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Dept Med Oncol, Boston, MA 02115 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gascard, Philippe; Sigaroudinia, Mahvash; Tlsty, Thea D.] Univ Calif San Francisco, Dept Pathol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94140 USA; [Kadlecek, Theresa; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Weiss, Arthur] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA USA; [O'Geen, Henriette] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Farnham, Peggy J.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Mungall, Andrew J.; Tam, Angela; Kamoh, Baljit; Cho, Stephanie; Moore, Richard; Hirst, Martin; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	Washington University (WUSTL); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of Southern California; Washington University (WUSTL); British Columbia Cancer Agency; University of British Columbia	Costello, JF (corresponding author), Univ Calif San Francisco, Dept Neurosurg, Brain Tumor Res Ctr, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	jcostello@cc.ucsf.edu; twang@genetics.wustl.edu	Marra, Marco A/B-5987-2008; Li, Daofeng/L-8143-2019; zb, aber/A-6874-2011; Lee, Hyung Joo/D-1398-2009; Mungall, Andrew J./U-7067-2018; Hirst, Martin/B-7684-2016; Li, Daofeng/E-5386-2011	Marra, Marco A/0000-0001-7146-7175; Li, Daofeng/0000-0001-7492-3703; zb, aber/0000-0003-2962-5314; Lee, Hyung Joo/0000-0002-7030-5390; Mungall, Andrew J./0000-0002-0905-2742; Li, Daofeng/0000-0001-7492-3703; Farnham, Peggy/0000-0003-4469-7914; Gascard, Philippe/0000-0001-5912-5228; Kadlecek, Theresa/0000-0002-1020-8169	US National Institutes of Health (NIH) Roadmap Epigenomics Program; National Institute on Drug Abuse (NIDA); National Institute of Environmental Health Sciences (NIEHS); US NIH [5U01ES017154, P01CA095616, P01CA142536, P50CA134254]; NIDA R25 program [DA027995]; March of Dimes Foundation; Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE [P01CA095616, P01CA142536, P50CA134254] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Roadmap Epigenomics Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA R25 program; March of Dimes Foundation(March of Dimes); Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the many collaborators at the Reference Epigenome Mapping Centers (REMCs), the Epigenome Data Analysis and Coordination Center and the NCBI who have generated and processed data that were used in this project. We acknowledge the dedicated system administrators at the Washington University Center for Genome Sciences and Systems Biology who have provided an excellent computing environment. We thank the UCSC Genome Browser bioinformatics team for providing processed ENCODE data. We acknowledge support from the US National Institutes of Health (NIH) Roadmap Epigenomics Program, sponsored by the National Institute on Drug Abuse (NIDA) and the National Institute of Environmental Health Sciences (NIEHS). J.F.C., T. W., P.J.F. and M. H. are supported by US NIH grant 5U01ES017154. B.Z. and X.Z. are supported by the NIDA R25 program DA027995. K. L. L. and C. L. M. are supported by US NIH grants P01CA095616 and P01CA142536. T. W. is supported in part by the March of Dimes Foundation, the Edward Mallinckrodt Jr. Foundation, US NIH grant P50CA134254 and a generous start-up package from the Department of Genetics at the Washington University School of Medicine.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Britten RJ, 1996, MOL PHYLOGENET EVOL, V5, P13, DOI 10.1006/mpev.1996.0003; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Chung DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002111; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Claverie-Martin F, 2003, HUM GENET, V113, P480, DOI 10.1007/s00439-003-0991-8; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunn CA, 2003, P NATL ACAD SCI USA, V100, P12841, DOI 10.1073/pnas.2134464100; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lowe C.B., 2007, P NATL ACAD IN PRESS; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Martinez-Garay I, 2003, CLIN GENET, V64, P491, DOI 10.1046/j.1399-0004.2003.00166.x; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Miller WJ, 1999, GENETICA, V107, P197, DOI 10.1023/A:1004070603792; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Roussa E, 2009, ADV EXP MED BIOL, V651, P81; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Schmid CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011425; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Wang J, 2010, BIOINFORMATICS, V26, P2501, DOI 10.1093/bioinformatics/btq460; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Ward MC, 2013, MOL CELL, V49, P262, DOI 10.1016/j.molcel.2012.11.013; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yan ZH, 2010, BIOCHEMISTRY-US, V49, P1059, DOI 10.1021/bi902022n	58	142	151	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					836	U172		10.1038/ng.2649	http://dx.doi.org/10.1038/ng.2649			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23708189	Green Accepted, Green Submitted			2022-12-17	WOS:000321005200023
J	Stark, MS; Woods, SL; Gartside, MG; Bonazzi, VF; Dutton-Regester, K; Aoude, LG; Chow, D; Sereduk, C; Niemi, NM; Tang, NY; Ellis, JJ; Reid, J; Zismann, V; Tyagi, S; Muzny, D; Newsham, I; Wu, YQ; Palmer, JM; Pollak, T; Youngkin, D; Brooks, BR; Lanagan, C; Schmidt, CW; Kobe, B; MacKeigan, JP; Yin, HW; Brown, KM; Gibbs, R; Trent, J; Hayward, NK				Stark, Mitchell S.; Woods, Susan L.; Gartside, Michael G.; Bonazzi, Vanessa F.; Dutton-Regester, Ken; Aoude, Lauren G.; Chow, Donald; Sereduk, Chris; Niemi, Natalie M.; Tang, Nanyun; Ellis, Jonathan J.; Reid, Jeffrey; Zismann, Victoria; Tyagi, Sonika; Muzny, Donna; Newsham, Irene; Wu, YuanQing; Palmer, Jane M.; Pollak, Thomas; Youngkin, David; Brooks, Bradford R.; Lanagan, Catherine; Schmidt, Christopher W.; Kobe, Bostjan; MacKeigan, Jeffrey P.; Yin, Hongwei; Brown, Kevin M.; Gibbs, Richard; Trent, Jeffrey; Hayward, Nicholas K.			Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing	NATURE GENETICS			English	Article							MALIGNANT-MELANOMA; HUMAN CANCER; APOPTOSIS; KINASE-1; TEMOZOLOMIDE; INHIBITION; ACTIVATION; GENES; BRAF	We sequenced eight melanoma exomes to identify new somatic mutations in metastatic melanoma. Focusing on the mitogen-activated protein (MAP) kinase kinase kinase (MAP3K) family, we found that 24% of melanoma cell lines have mutations in the protein-coding regions of either MAP3K5 or MAP3K9. Structural modeling predicted that mutations in the kinase domain may affect the activity and regulation of these protein kinases. The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating. In in vitro kinase assays, MAP3K5 1780F and MAP3K9 W333* variants had reduced kinase activity. Overexpression of MAP3K5 or MAP3K9 mutants in HEK293T cells reduced the phosphorylation of downstream MAP kinases. Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.	[Stark, Mitchell S.; Woods, Susan L.; Gartside, Michael G.; Bonazzi, Vanessa F.; Dutton-Regester, Ken; Aoude, Lauren G.; Tyagi, Sonika; Palmer, Jane M.; Pollak, Thomas; Lanagan, Catherine; Schmidt, Christopher W.; Hayward, Nicholas K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Dutton-Regester, Ken] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Aoude, Lauren G.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Chow, Donald; Sereduk, Chris; Ellis, Jonathan J.; Zismann, Victoria; Youngkin, David; Yin, Hongwei; Brown, Kevin M.; Trent, Jeffrey] Translat Genom Res Inst, Phoenix, AZ USA; [Niemi, Natalie M.; Brooks, Bradford R.; MacKeigan, Jeffrey P.; Trent, Jeffrey] Van Andel Res Inst, Grand Rapids, MI USA; [Ellis, Jonathan J.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld, Australia; [Ellis, Jonathan J.; Kobe, Bostjan] Univ Queensland, Ctr Infect Dis Res, Brisbane, Qld, Australia; [Reid, Jeffrey; Muzny, Donna; Newsham, Irene; Wu, YuanQing; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Brown, Kevin M.] NCI, Adv Technol Ctr, Gaithersburg, MD USA	QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); University of Queensland; Translational Genomics Research Institute; Van Andel Institute; University of Queensland; University of Queensland; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hayward, NK (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	nick.hayward@qimr.edu.au	Stark, Mitchell S/E-3542-2010; Niemi, Natalie/AAH-6963-2021; hayward, nicholas k/C-1367-2015; Bonazzi, Vanessa F/R-1676-2018; Stark, Mitchell/K-3874-2019; Aoude, Lauren/C-7484-2014; Yin, Hong/AAC-5784-2020; Stark, Mitchell/K-6794-2019; Kobe, Bostjan/D-1292-2009; Tyagi, Sonika/L-2256-2019; Ellis, Jonathan J/F-2920-2010; hayward, nick/AAV-8802-2020; Schmidt, Christopher/A-4353-2009	Stark, Mitchell S/0000-0002-4510-2161; Niemi, Natalie/0000-0002-5174-4005; hayward, nicholas k/0000-0003-4760-1033; Bonazzi, Vanessa F/0000-0002-2574-0334; Aoude, Lauren/0000-0003-1448-3923; Stark, Mitchell/0000-0002-4510-2161; Kobe, Bostjan/0000-0001-9413-9166; Tyagi, Sonika/0000-0003-0181-6258; Ellis, Jonathan J/0000-0003-0410-5064; MacKeigan, Jeffrey/0000-0002-0198-5679; Dutton-Regester, Ken/0000-0002-8884-6355; Woods, Susan/0000-0002-8955-2017; Schmidt, Christopher/0000-0002-3955-5076; Ellis, Jonathan/0000-0003-0218-546X	National Health and Medical Research Council of Australia; Australian Centre for Vaccine Development; US National Cancer Institute [5U01CA129447]; US National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [R01CA129447, U01CA129447, ZIACP010201] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Vaccine Development; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge M. Aziz for data processing, M. Kassner for technical support and J.-C. Deza for graphics support. This work was funded through grants from the National Health and Medical Research Council of Australia, the Australian Centre for Vaccine Development, the US National Cancer Institute (5U01CA129447 to J.T.), the US National Cancer Institute, Division of Cancer Epidemiology and Genetics (to K.M.B.), and a charitable donation by Francis Najafi (to K.M.B. and IT.).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Bisson N, 2008, CELL CYCLE, V7, P909, DOI 10.4161/cc.7.7.5610; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Durkin JT, 2004, BIOCHEMISTRY-US, V43, P16348, DOI 10.1021/bi049866y; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Paige AJW, 2003, CELL MOL LIFE SCI, V60, P2147, DOI 10.1007/s00018-003-3027-6; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; She QB, 2002, CANCER RES, V62, P1343; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wei XM, 2010, MOL CANCER RES, V8, P1513, DOI 10.1158/1541-7786.MCR-10-0262; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001	24	142	146	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2012	44	2					165	169		10.1038/ng.1041	http://dx.doi.org/10.1038/ng.1041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197930	Green Accepted, Green Submitted			2022-12-17	WOS:000299664400013
J	Mi, W; Pawlik, M; Sastre, M; Jung, SS; Radvinsky, DS; Klein, AM; Sommer, J; Schmidt, SD; Nixon, RA; Mathews, PM; Levy, E				Mi, Weiqian; Pawlik, Monika; Sastre, Magdalena; Jung, Sonia S.; Radvinsky, David S.; Klein, Andrew M.; Sommer, John; Schmidt, Stephen D.; Nixon, Ralph A.; Mathews, Paul M.; Levy, Efrat			Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models	NATURE GENETICS			English	Article						`	CEREBRAL-HEMORRHAGE; ANGIOPATHY; PROTEIN; VARIANT; STROKE	Using transgenic mice expressing human cystatin C ( encoded by CST3), we show that cystatin C binds soluble amyloid-beta peptide and inhibits cerebral amyloid deposition in amyloid-beta precursor protein ( APP) transgenic mice. Cystatin C expression twice that of the endogenous mouse cystatin C was sufficient to substantially diminish amyloid-beta deposition. Thus, cystatin C has a protective role in Alzheimer's disease pathogenesis, and modulation of cystatin C concentrations may have therapeutic implications for the disease.	Nathan S Kline Inst, Orangeburg, NY 10962 USA; NYU, Sch Med, New York, NY 10016 USA; Centocor Res & Dev Inc, Radnor, PA 19087 USA	Nathan Kline Institute for Psychiatric Research; New York University; Johnson & Johnson; Johnson & Johnson USA	Levy, E (corresponding author), Nathan S Kline Inst, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Schmidt, Stephen/AAC-6967-2019; Schmidt, Stephen/B-5398-2012	Mathews, Paul/0000-0003-1742-7687	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER; NIA NIH HHS [AG017617] Funding Source: Medline; NINDS NIH HHS [NS42029] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; GUDMUNDSSON G, 1972, BRAIN, V95, P387, DOI 10.1093/brain/95.2.387; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; VINTERS HV, 1990, AM J PATHOL, V137, P233	15	142	148	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1440	1442		10.1038/ng.2007.29	http://dx.doi.org/10.1038/ng.2007.29			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026100				2022-12-17	WOS:000251267400010
J	Bhende, PM; Seaman, WT; Delecluse, HJ; Kenney, SC				Bhende, PM; Seaman, WT; Delecluse, HJ; Kenney, SC			The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; NUCLEAR ANTIGEN-2; DNA METHYLATION; BRLF1 PROMOTER; BZLF1 PROTEIN; TRANSCRIPTION; ZTA; TRANSACTIVATOR; ACETYLATION	DNA methylation promotes gene silencing, yet the Epstein-Barr virus immediate-early protein, BZLF1 (Z), converts the virus from the latent to the lytic form of infection even when the viral genome is highly methylated. Here we show that methylation of CpG motifs in Z-responsive elements of the viral BRLF1 immediate-early promoter enhances Z binding to, and activation of, this promoter. Demethylation of the viral genome impairs Z activation of lytic viral genes. Z is the first transcription factor that preferentially binds to, and activates, a methylated promoter. These results identify an unexpected mechanism by which Epstein-Barr virus circumvents the inhibitory effects of viral genome methylation.	Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; Univ N Carolina, Dept Microbiol, Chapel Hill, NC USA; Univ N Carolina, Dept Immunol, Chapel Hill, NC USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; German Canc Res Ctr, Dept Virus Associated Tumours, D-6900 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; German Cancer Research Center (DKFZ)	Kenney, SC (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	shann@med.unc.edu		Delecluse, Henri-Jacques/0000-0002-1744-6274				Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 1998, VIROLOGY, V251, P187, DOI 10.1006/viro.1998.9396; Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; ERNBERG I, 1989, J GEN VIROL, V70, P2989, DOI 10.1099/0022-1317-70-11-2989; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FLEMINGTON E, 1990, P NATL ACAD SCI USA, V87, P9459, DOI 10.1073/pnas.87.23.9459; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Kieff E., 1996, FIELDS VIROLOGY, P2343; Liu PF, 2003, VIROLOGY, V310, P199, DOI 10.1016/S0042-6822(03)00145-4; MASUCCI MG, 1989, J VIROL, V63, P3135, DOI 10.1128/JVI.63.7.3135-3141.1989; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; Paulson EJ, 1999, J VIROL, V73, P9959, DOI 10.1128/JVI.73.12.9959-9968.1999; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Ragoczy T, 2001, J VIROL, V75, P5240, DOI 10.1128/JVI.75.11.5240-5251.2001; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Robertson KD, 1997, BLOOD, V90, P4480, DOI 10.1182/blood.V90.11.4480.4480_4480_4484; TAKADA K, 1986, J VIROL, V57, P1016, DOI 10.1128/JVI.57.3.1016-1022.1986; THOMPSON JP, 1986, P NATL ACAD SCI USA, V83, P7688, DOI 10.1073/pnas.83.20.7688; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194	30	142	148	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1099	1104		10.1038/ng1424	http://dx.doi.org/10.1038/ng1424			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361873	Bronze			2022-12-17	WOS:000224156500019
J	Suzuki, T; Li, W; Zhang, Q; Karim, A; Novak, EK; Sviderskaya, EV; Hill, SP; Bennett, DC; Levin, AV; Nieuwenhuis, HK; Fong, CT; Castellan, C; Miterski, B; Swank, RT; Spritz, A				Suzuki, T; Li, W; Zhang, Q; Karim, A; Novak, EK; Sviderskaya, EV; Hill, SP; Bennett, DC; Levin, AV; Nieuwenhuis, HK; Fong, CT; Castellan, C; Miterski, B; Swank, RT; Spritz, A			Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene	NATURE GENETICS			English	Article							MULTI-ORGANELLAR DISORDERS; PALE EAR; PIGMENTATION; PROTEIN; EP	Hermansky-Pudlak syndrome (HPS) is a disorder of organelle biogenesis in which oculocutaneous albinism, bleeding and pulmonary fibrosis result from defects of melanosomes, platelet dense granules and lysosomes(1-4). HPS is common in Puerto Rico 5,6, where it is caused by mutations in the genes HPS1(7) and, less often, HPS3 (ref. 8). In contrast, only half of non-Puerto Rican individuals with HPS have mutations in HPS1 (ref. 9), and very few in HPS3 (ref. 10). In the mouse, more than 15 loci manifest mutant phenotypes similar to human HPS 11,12, including pale ear (ep), the mouse homolog of HPS1 (refs 13,14). Mouse ep has a phenotype identical to another mutant, light ear (le)(15-18), which suggests that the human homolog of le is a possible human HPS locus. We have identified and found mutations of the human le homolog, HPS4, in a number of non-Puerto Rican individuals with HPS, establishing HPS4 as an important HPS locus in humans. In addition to their identical phenotypes, le and ep mutant mice have identical abnormalities of melanosomes, and in transfected melanoma cells the HPS4 and HPS1 proteins partially co-localize in vesicles of the cell body. In addition, the HPS1 protein is absent in tissues of le mutant mice. These results suggest that the HPS4 and HPS1 proteins may function in the same pathway of organelle biogenesis.	Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ London St Georges Hosp, Sch Med, Dept Anat & Cell Biol, London SW17 0RE, England; Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Utrecht Hosp, Dept Hematol, Utrecht, Netherlands; Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; Genet Beratungsstelle, Bolzano, Italy; Ruhr Univ Bochum, Abt Mol Humangenet, D-4630 Bochum, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roswell Park Cancer Institute; St Georges University London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utrecht University; Utrecht University Medical Center; University of Rochester; Ruhr University Bochum	Spritz, A (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, 4200 E 9th Ave, Denver, CO 80262 USA.		Sviderskaya, Elena V/D-2419-2009; Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; BENNETT DC, 1993, INT REV CYTOL, V146, P191, DOI 10.1016/S0074-7696(08)60383-6; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHAPMAN VM, 1975, MOUSE NEWS LETT, V53, P61; CUOMO M, 1991, J INVEST DERMATOL, V96, P446, DOI 10.1111/1523-1747.ep12470092; DELLANGELICA EC, 1999, MOL CELL, V3, P1; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; LANE PW, 1967, J HERED, V58, P17, DOI 10.1093/oxfordjournals.jhered.a107529; LANE PW, 1967, J HERED, V58, P21, DOI 10.1093/oxfordjournals.jhered.a107531; Lee ST, 1995, MOL CELLS, V5, P668; MEISLER M, 1980, AM J PATHOL, V101, P581; MEISLER MH, 1984, J HERED, V75, P103, DOI 10.1093/oxfordjournals.jhered.a109881; NOVAK EK, 1984, BLOOD, V63, P536; Oh J, 2000, HUM MOL GENET, V9, P375, DOI 10.1093/hmg/9.3.375; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Spritz RA, 2000, PIGM CELL RES, V13, P15, DOI 10.1034/j.1600-0749.2000.130104.x; Spritz RA, 1999, TRENDS GENET, V15, P337, DOI 10.1016/S0168-9525(99)01785-0; Spritz RA, 1999, CLIN GENET, V55, P309, DOI 10.1034/j.1399-0004.1999.550503.x; Spritz RA, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P389; SUZUKI T, 2001, GENOMICS, V78, P1; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; WITKOP CJ, 1990, OPHTHALMIC PAED GEN, V11, P245, DOI 10.3109/13816819009020986	30	142	146	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					321	324		10.1038/ng835	http://dx.doi.org/10.1038/ng835			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11836498				2022-12-17	WOS:000174157600019
J	Rovio, AT; Marchington, DR; Donat, S; Schuppe, HC; Abe, J; Fritsche, E; Elliott, DJ; Laippala, P; Ahola, AL; McNay, D; Harrison, RF; Hughes, B; Barrett, T; Bailey, DMD; Mehmet, D; Jequier, AM; Hargreave, TB; Kao, SH; Cummins, JM; Barton, DE; Cooke, HJ; Wei, YH; Wichmann, L; Poulton, J; Jacobs, HT				Rovio, AT; Marchington, DR; Donat, S; Schuppe, HC; Abe, J; Fritsche, E; Elliott, DJ; Laippala, P; Ahola, AL; McNay, D; Harrison, RF; Hughes, B; Barrett, T; Bailey, DMD; Mehmet, D; Jequier, AM; Hargreave, TB; Kao, SH; Cummins, JM; Barton, DE; Cooke, HJ; Wei, YH; Wichmann, L; Poulton, J; Jacobs, HT			Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility	NATURE GENETICS			English	Article							MOTILITY; SPERMATOZOA; CELLS	Human mitochondrial DNA polymerase, encoded by POLG, contains a polyglutamine tract encoded by a CAG microsatellite repeat(1,2). Analysis of POLG genotypes in different populations identified an association between absence of the common, ten-repeat allele and male infertility typified by a range of sperm quality defects but excluding azoospermia.	Ancobio Ltd, Glasgow, Lanark, Scotland; Tampere Univ, Inst Med Technol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Tampere Univ, Dept Anat, FIN-33101 Tampere, Finland; Tampere Univ, Sch Publ Hlth, Biometry Unit, FIN-33101 Tampere, Finland; Univ Oxford, Dept Paediat, Oxford OX1 2JD, England; Univ Dusseldorf, Med Inst Environm Hyg, Dept Expt Toxicol, D-4000 Dusseldorf, Germany; Univ Giessen, Ctr Dermatol & Androl, Giessen, Germany; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Rotunda Hosp, Human Assisted Reprod Ireland, Dublin, Ireland; Univ Coll Dublin, Natl Ctr Med Genet, Dublin 2, Ireland; Murdoch Univ, Div Vet & Biomed Sci, Murdoch, WA 6150, Australia; Joondalup Hlth Campus, Perth, WA, Australia; Western Gen Hosp, Dept Urol, Edinburgh EH4 2XU, Midlothian, Scotland; Natl Yang Ming Univ, Dept Biochem, Taipei 112, Taiwan; Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; University of Oxford; Heinrich Heine University Dusseldorf; Justus Liebig University Giessen; University of Edinburgh; University College Dublin; Murdoch University; University of Edinburgh; National Yang Ming Chiao Tung University; University of Glasgow	Jacobs, HT (corresponding author), Ancobio Ltd, Glasgow, Lanark, Scotland.	howy.jacobs@uta.fi	Poulton, Joanna/AAB-4828-2021; Barton, David E/I-1795-2019; Barton, David E/B-9460-2008; Wei, Yau-Huei/ABA-6841-2021; Jacobs, Howard T/G-2434-2011	Barton, David E/0000-0002-2031-9719; Wei, Yau-Huei/0000-0002-6429-2546; Jacobs, Howard/0000-0003-1895-6003; Kao, Shu-Huei/0000-0003-4618-0898; Poulton, Joanna/0000-0002-2460-5587; Elliott, David/0000-0002-6930-0699; McNay, David/0000-0002-4747-0136				CUMMINS JM, 1994, MOL REPROD DEV, V37, P345, DOI 10.1002/mrd.1080370314; Hargreave TB, 2000, BRIT MED BULL, V56, P650, DOI 10.1258/0007142001903454; John JCS, 1997, NAT MED, V3, P124, DOI 10.1038/nm0297-124c; Kao SH, 1998, MOL HUM REPROD, V4, P657, DOI 10.1093/molehr/4.7.657; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; Lestienne P, 1997, MOL HUM REPROD, V3, P811, DOI 10.1093/molehr/3.9.811; Mifsud A, 2001, FERTIL STERIL, V75, P275, DOI 10.1016/S0015-0282(00)01693-9; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244; Ruiz-Pesini E, 2000, CLIN CHIM ACTA, V300, P97, DOI 10.1016/S0009-8981(00)00305-3; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; SOKOL RZ, 1995, CURR OPIN OBSTET GYN, V7, P177, DOI 10.1097/00001703-199506000-00004; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Troiano L, 1998, EXP CELL RES, V241, P384, DOI 10.1006/excr.1998.4064	15	142	147	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					261	262		10.1038/ng759	http://dx.doi.org/10.1038/ng759			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11687794				2022-12-17	WOS:000171911000009
J	Gedeon, AK; Colley, A; Jamieson, R; Thompson, EM; Rogers, J; Sillence, D; Tiller, GE; Mulley, JC; Gecz, J				Gedeon, AK; Colley, A; Jamieson, R; Thompson, EM; Rogers, J; Sillence, D; Tiller, GE; Mulley, JC; Gecz, J			Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda	NATURE GENETICS			English	Article							PROTEIN; LINKAGE; CHROMOSOME; CLONING; ENCODES; DXS16; XP22; MAP	Spondyloepiphyseal dysplasia tarda (SEDL; MIM 313400) is an X-linked recessive osteochondrodysplasia that occurs in approximately two of every one million people(1). This progressive skeletal disorder which manifests in childhood is characterized by disproportionate short stature with short neck and trunk, barrel chest and absence of systemic complications(2-4). Distinctive radiological signs are platyspondyly with hump-shaped central and posterior portions, narrow disc spaces, and mild to moderate epiphyseal dysplasia. The latter usually leads to premature secondary osteoarthritis often requiring hip arthroplasty(3-5), Obligate female carriers are generally clinically and radiographically indistinguishable from the general population(4,5), although some cases have phenotypic changes consistent with expression of the gene defect(2,4,6,7). The SEDL gene has been localized to Xp22 (refs 8,9) in the approximately 2-Mb interval between DXS16 and DXS987 (ref, 10). Here we confirm and refine this localization to an interval of less than 170 kb by critical recombination events at DXS16 and AFMa124wc1 in two families. In one candidate gene we detected three dinucleotide deletions in three Australian families which effect frameshifts causing premature stop codons. The gene designated SEDL is transcribed as a 2.8-kb transcript in many tissues including fetal cartilage. SEDL encodes a 140 amino acid protein with a putative role in endoplasmic reticulum (ER)-to-Golgi vesicular transport.	Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia; Liverpool Hlth Serv, Dept Clin Genet, Liverpool, NSW 2170, Australia; New Childrens Hosp, Dept Clin Genet, Sydney, NSW, Australia; Womens & Childrens Hosp, Ctr Med Genet, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; Victorian Clin Genet Serv, Melbourne, Vic, Australia; Vanderbilt Univ, Sch Med, Dept Pediat, Div Med Genet, Nashville, TN 37232 USA; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia	Womens & Childrens Hospital Australia; University of Sydney; Womens & Childrens Hospital Australia; Vanderbilt University; University of Adelaide	Gecz, J (corresponding author), Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia.	jgecz@mad.adelaide.edu.au	Gedeon, Agi/G-7890-2011; Gecz, Jozef/X-3469-2019; Jamieson, Robyn/M-5161-2019	Gecz, Jozef/0000-0002-7884-6861; Jamieson, Robyn/0000-0002-7285-0253	NIAMS NIH HHS [R55 AR45477] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR045477] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANNERMAN RM, 1971, J MED GENET, V8, P291, DOI 10.1136/jmg.8.3.291; CHANG YPC, 1994, HUM MOL GENET, V3, P1029, DOI 10.1093/hmg/3.6.1029; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Davies JP, 1997, GENOMICS, V41, P131, DOI 10.1006/geno.1997.4644; de Conciliis L, 1998, GENOMICS, V51, P243, DOI 10.1006/geno.1998.5348; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; GOTTESMAN GS, 1996, J BONE MINER RES  S1, V11, pS252; HARPER PS, 1973, BRIT J RADIOL, V46, P676, DOI 10.1259/0007-1285-46-549-676; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HEUERTZ S, 1993, GENOMICS, V18, P100, DOI 10.1006/geno.1993.1431; HEUERTZ S, 1995, HUM GENET, V96, P407, DOI 10.1007/BF00191797; ICETON JA, 1986, J BONE JOINT SURG BR, V68, P616, DOI 10.1302/0301-620X.68B4.3733841; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MacKenzie JJ, 1996, J MED GENET, V33, P823, DOI 10.1136/jmg.33.10.823; Narayanan V, 1998, AM J MED GENET, V78, P165, DOI 10.1002/(SICI)1096-8628(19980630)78:2<165::AID-AJMG13>3.0.CO;2-L; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; SZPIROTAPIA S, 1988, HUM GENET, V81, P61, DOI 10.1007/BF00283731; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Whyte MP, 1999, MEDICINE, V78, P9, DOI 10.1097/00005792-199901000-00002; WYNNEDAVIES R, 1985, J BONE JOINT SURG BR, V67, P133, DOI 10.1302/0301-620X.67B1.3155744	23	142	167	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1999	22	4					400	404		10.1038/11976	http://dx.doi.org/10.1038/11976			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	222FH	10431248				2022-12-17	WOS:000081772500026
J	YAZAWA, I; NUKINA, N; HASHIDA, H; GOTO, J; YAMADA, M; KANAZAWA, I				YAZAWA, I; NUKINA, N; HASHIDA, H; GOTO, J; YAMADA, M; KANAZAWA, I			ABNORMAL GENE-PRODUCT IDENTIFIED IN HEREDITARY DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY (DRPLA) BRAIN	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; HUNTINGTONS-DISEASE GENE; FRAGILE-X SYNDROME; ANDROGEN RECEPTOR; MYOTONIC-DYSTROPHY; TRIPLET REPEAT; RNA-BINDING; FMR-1 GENE; EXPRESSION; PROTEIN	Dentatorubral-pallidoluysian atrophy (DRPLA) is associated with the expansion of an unstable CAG repeat. Using antibodies against a synthetic peptide corresponding to the sequence of the DRPLA gene product C terminus, we have identified the DRPLA gene product in normal human brains as a approximate to 190 kD protein. We also find a larger approximate to 205 kD protein specifically in DRPLA brains. Immunohistochemically, the DRPLA gene product is observed mainly in the neuronal cytoplasm. Our results demonstrate the existence of the expanded CAG repeat gene product and support the possibility that the expanded CAG-encoded polyglutamine stretch may participate in the pathological process of the similar trinucleotide repeat diseases.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN; NATL CHILDRENS MED RES CTR,SETAGAYA KU,TOKYO 154,JAPAN	University of Tokyo; National Center for Child Health & Development - Japan			Nukina, Nobuyuki/GPP-6265-2022					ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; KONDO I, 1990, J MED GENET, V27, P105, DOI 10.1136/jmg.27.2.105; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MATSUURA T, 1992, NEUROLOGY, V42, P1724, DOI 10.1212/WNL.42.9.1724; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NALTO H, 1982, NEUROLOGY, V32, P798; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; SANO A, 1994, HUM GENET, V93, P699; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; VANDERVEN PFM, 1993, HUM MOL GENET, V2, P1889; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJ, 1991, CELL, V65, P5; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213; 1993, CELL, V72, P971	33	142	144	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					99	103		10.1038/ng0595-99	http://dx.doi.org/10.1038/ng0595-99			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647802				2022-12-17	WOS:A1995QX57300023
J	HOSKING, L; TROWSDALE, J; NICOLAI, H; SOLOMON, E; FOULKES, W; STAMP, G; SIGNER, E; JEFFREYS, A				HOSKING, L; TROWSDALE, J; NICOLAI, H; SOLOMON, E; FOULKES, W; STAMP, G; SIGNER, E; JEFFREYS, A			A SOMATIC BRCA1 MUTATION IN AN OVARIAN TUMOR	NATURE GENETICS			English	Letter							HETEROZYGOSITY; CANCER		MONTREAL GEN HOSP, DEPT MED, DIV MED GENET, MONTREAL, PQ H3G 1A4, CANADA; ROYAL POSTGRAD MED SCH, DEPT HISTOPATHOL, LONDON W12 0NN, ENGLAND; UNIV LEICESTER, DEPT GENET, LEICESTER LE1 7RH, LEICS, ENGLAND; IMPERIAL CANC RES FUND, SOMAT CELL GENET LAB, LONDON WC2A 3PX, ENGLAND	McGill University; Imperial College London; University of Leicester; Cancer Research UK	HOSKING, L (corresponding author), IMPERIAL CANC RES FUND, HUMAN IMMUNOGENET LAB, 44 LINCOLNS INN FIELDS, LONDON WC2A 3PX, ENGLAND.		Foulkes, William D./AAR-9586-2021	Foulkes, William D./0000-0001-7427-4651				BROWN MA, 1994, NATURE, V372, P733, DOI 10.1038/372733a0; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; FOULKES WD, 1993, INT J CANCER, V54, P220, DOI 10.1002/ijc.2910540210; FOULKES WD, 1993, BRIT J CANCER, V67, P268, DOI 10.1038/bjc.1993.51; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; JACOBS IJ, 1993, CANCER RES, V53, P1218; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; VOGELSTEIN B, 1994, CELL, V79, P1, DOI 10.1016/0092-8674(94)90393-X	11	142	149	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1995	9	4					343	344		10.1038/ng0495-343	http://dx.doi.org/10.1038/ng0495-343			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795636				2022-12-17	WOS:A1995QQ75300007
J	Wang, YK; Bashashati, A; Anglesio, MS; Cochrane, DR; Grewal, DS; Ha, G; McPherson, A; Horlings, HM; Senz, J; Prentice, LM; Karnezis, AN; Lai, D; Aniba, MR; Zhang, AW; Shumansky, K; Siu, C; Wan, A; McConechy, MK; Li-Chang, H; Tone, A; Provencher, D; de Ladurantaye, M; Fleury, H; Okamoto, A; Yanagida, S; Yanaihara, N; Saito, M; Mungall, AJ; Moore, R; Marra, MA; Gilks, CB; Mes-Masson, AM; McAlpine, JN; Aparicio, S; Huntsman, DG; Shah, SP				Wang, Yi Kan; Bashashati, Ali; Anglesio, Michael S.; Cochrane, Dawn R.; Grewal, Diljot S.; Ha, Gavin; McPherson, Andrew; Horlings, Hugo M.; Senz, Janine; Prentice, Leah M.; Karnezis, Anthony N.; Lai, Daniel; Aniba, Mohamed R.; Zhang, Allen W.; Shumansky, Karey; Siu, Celia; Wan, Adrian; McConechy, Melissa K.; Li-Chang, Hector; Tone, Alicia; Provencher, Diane; de Ladurantaye, Manon; Fleury, Hubert; Okamoto, Aikou; Yanagida, Satoshi; Yanaihara, Nozomu; Saito, Misato; Mungall, Andrew J.; Moore, Richard; Marra, Marco A.; Gilks, C. Blake; Mes-Masson, Anne-Marie; McAlpine, Jessica N.; Aparicio, Samuel; Huntsman, David G.; Shah, Sohrab P.			Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes	NATURE GENETICS			English	Article							OLAPARIB MAINTENANCE THERAPY; MUTATIONAL PROCESSES; DIVERSE MECHANISMS; CARCINOMA; TUMORS; ENDOMETRIOSIS; MICROHOMOLOGY; EVOLUTION; RECURRENT; PATTERNS	We studied the whole-genome point mutation and structural variation patterns of 133 tumors (59 high-grade serous (HGSC), 35 clear cell (CCOC), 29 endometrioid (ENOC), and 10 adult granulosa cell (GCT)) as a substrate for class discovery in ovarian cancer. Ab initio clustering of integrated point mutation and structural variation signatures identified seven subgroups both between and within histotypes. Prevalence of foldback inversions identified a prognostically significant HGSC group associated with inferior survival. This finding was recapitulated in two independent cohorts (n = 576 cases), transcending BRCA1 and BRCA2 mutation and gene expression features of HGSC. CCOC cancers grouped according to APOBEC deamination (26%) and age-related mutational signatures (40%). ENOCs were divided by cases with microsatellite instability (28%), with a distinct mismatch-repair mutation signature. Taken together, our work establishes the potency of the somatic genome, reflective of diverse DNA repair deficiencies, to stratify ovarian cancers into distinct biological strata within the major histotypes.	[Wang, Yi Kan; Bashashati, Ali; Cochrane, Dawn R.; Grewal, Diljot S.; Ha, Gavin; McPherson, Andrew; Horlings, Hugo M.; Senz, Janine; Prentice, Leah M.; Lai, Daniel; Aniba, Mohamed R.; Zhang, Allen W.; Shumansky, Karey; Siu, Celia; Wan, Adrian; Aparicio, Samuel; Huntsman, David G.; Shah, Sohrab P.] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [Anglesio, Michael S.; Grewal, Diljot S.; McPherson, Andrew; Karnezis, Anthony N.; McConechy, Melissa K.; Li-Chang, Hector; Tone, Alicia; Gilks, C. Blake; Aparicio, Samuel; Huntsman, David G.; Shah, Sohrab P.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Anglesio, Michael S.; McAlpine, Jessica N.; Huntsman, David G.] Univ British Columbia, Dept Gynecol & Obstet, Vancouver, BC, Canada; [Zhang, Allen W.] Univ British Columbia, Grad Bioinformat Training Program, Vancouver, BC, Canada; [Zhang, Allen W.] Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Provencher, Diane; de Ladurantaye, Manon; Fleury, Hubert; Mes-Masson, Anne-Marie] CRCHUM, Montreal, PQ, Canada; [Provencher, Diane; de Ladurantaye, Manon; Fleury, Hubert; Mes-Masson, Anne-Marie] Inst Canc Montreal, Montreal, PQ, Canada; [Provencher, Diane] Univ Montreal, Div Gynecol Oncol, Montreal, PQ, Canada; [Okamoto, Aikou; Yanagida, Satoshi; Yanaihara, Nozomu; Saito, Misato] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Mungall, Andrew J.; Moore, Richard; Marra, Marco A.; Shah, Sohrab P.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Gilks, C. Blake] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC, Canada; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Ha, Gavin] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ha, Gavin] Broad Inst, Boston, MA USA; [Tone, Alicia] Princess Margaret Canc Ctr, Div Gynecol Oncol, Toronto, ON, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute; Universite de Montreal; Universite de Montreal; Universite de Montreal; Jikei University; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Huntsman, DG; Shah, SP (corresponding author), BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada.; Huntsman, DG; Shah, SP (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.; Huntsman, DG (corresponding author), Univ British Columbia, Dept Gynecol & Obstet, Vancouver, BC, Canada.; Shah, SP (corresponding author), BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	dhuntsma@bccancer.bc.ca; sshah@bccrc.ca	Mungall, Andrew J./U-7067-2018; Marra, Marco A/B-5987-2008; Ha, Gavin/N-1984-2019; Huntsman, David/ABE-6082-2020; McPherson, Andrew/J-6552-2015	Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Ha, Gavin/0000-0001-7578-7272; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Horlings, Hugo/0000-0003-4782-8828; Aparicio, Samuel/0000-0002-0487-9599; McPherson, Andrew/0000-0002-5654-5101; Anglesio, Michael/0000-0003-1639-5003; Lai, Daniel/0000-0001-9203-6323	BC Cancer Foundation; OvCaRe; Gray Family Ovarian Clear Cell Carcinoma Research Resource; Terry Fox Research Institute New Investigator grant; Canadian Cancer Society Research Institute Impact grant; Reseau de Recherche sur le Cancer; Fonds de Recherche Quebec Sante; Canadian Tumour Repository Network; Canadian Institutes for Health Research (CIHR) Foundation grant; Discovery Frontiers: Advancing Big Data Science in Genomics Research program [RGPGR/448167-2013]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Genome Canada; Canada Foundation for Innovation	BC Cancer Foundation; OvCaRe; Gray Family Ovarian Clear Cell Carcinoma Research Resource; Terry Fox Research Institute New Investigator grant; Canadian Cancer Society Research Institute Impact grant; Reseau de Recherche sur le Cancer; Fonds de Recherche Quebec Sante; Canadian Tumour Repository Network; Canadian Institutes for Health Research (CIHR) Foundation grant(Canadian Institutes of Health Research (CIHR)); Discovery Frontiers: Advancing Big Data Science in Genomics Research program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We wish to acknowledge generous long-term funding support from the BC Cancer Foundation, supporting the research program of S.P.S. and OvCaRe. The authors graciously thank the Gray Family Ovarian Clear Cell Carcinoma Research Resource, which provided funding critical to this project. Additional funding was provided by a Terry Fox Research Institute New Investigator grant to S.P.S. and a Canadian Cancer Society Research Institute Impact grant to D.G.H. and S.P.S. The CRCHUM Ovarian Cancer Tumour Bank was supported by the Reseau de Recherche sur le Cancer, Fonds de Recherche Quebec Sante, affiliated with the Canadian Tumour Repository Network. S.P.S. is a Michael Smith Foundation for Health Research (MSFHR) scholar and holds a Canadian Institutes for Health Research (CIHR) Foundation grant. S.P.S. and D.G.H. hold Canada Research Chairs. Y.K.W. is an MSFHR postdoctoral fellow. Support for the development of software used in this study was provided by the Genome Canada and Genome British Columbia Bioinformatics and Computational Biology program. Finally, the authors wish to acknowledge the funding support to S.P.S. from the Discovery Frontiers: Advancing Big Data Science in Genomics Research program (grant RGPGR/448167-2013, 'The Cancer Genome Collaboratory'), which is jointly funded by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research, Genome Canada, and the Canada Foundation for Innovation and with in-kind support from the Ontario Research Fund of the Ministry of Research, Innovation, and Science.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Anglesio MS, 2013, J PATHOL, V229, P111, DOI 10.1002/path.4088; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Farley John H, 2012, Gynecol Oncol, V126, P319, DOI 10.1016/j.ygyno.2012.06.019; Hermetz KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004139; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le'tourneau I. J., 2012, BMC CANCER, V12, P1; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; McAlpine JN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-433; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Ng CKY, 2012, J PATHOL, V226, P703, DOI 10.1002/path.3980; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Niskakoski A, 2013, INT J CANCER, V133, P2596, DOI 10.1002/ijc.28287; Nissenblatt M, 2011, NEW ENGL J MED, V364, P482, DOI 10.1056/NEJMc1012780; Obata K, 1998, CANCER RES, V58, P2095; Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Rauh-Hain JA, 2008, INT J GYNECOL CANCER, V18, P934, DOI 10.1111/j.1525-1438.2007.01156.x; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Sasaki S, 2003, ONCOGENE, V22, P3792, DOI 10.1038/sj.onc.1206589; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/s1470-2045(16)30559-9, 10.1016/S1470-2045(16)30559-9]; Taghiyar M. J., 2016, KRONOS WORKFLOW ASSE; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu R, 2001, CANCER RES, V61, P8247; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010	51	141	148	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2017	49	6					856	+		10.1038/ng.3849	http://dx.doi.org/10.1038/ng.3849			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV8VM	28436987				2022-12-17	WOS:000402062300010
J	Zhang, XT; Su, JZ; Jeong, M; Ko, M; Huang, Y; Park, HJ; Guzman, A; Lei, Y; Huang, YH; Rao, A; Li, W; Goodall, MA				Zhang, Xiaotian; Su, Jianzhong; Jeong, Mira; Ko, Myunggon; Huang, Yun; Park, Hyun Jung; Guzman, Anna; Lei, Yong; Huang, Yung-Hsin; Rao, Anjana; Li, Wei; Goodall, Margaret A.			DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells	NATURE GENETICS			English	Article							EPIGENETIC REGULATORS; CLONAL HEMATOPOIESIS; B-CELL; MUTATIONS; DNA; 5-HYDROXYMETHYLCYTOSINE; LEADS; MOUSE; 5-METHYLCYTOSINE; HYPERMETHYLATION	Mutations in the epigenetic modifiers DNMT3A and TET2 non-randomly co-occur in lymphoma and leukemia despite their epistasis in the methylation-hydroxymethylation pathway. Using Dnmt3a and Tet2 double-knockout mice in which the development of malignancy is accelerated, we show that the double-knockout methylome reflects regions of independent, competitive and cooperative activity. Expression of lineage-specific transcription factors, including the erythroid regulators Klf1 and Epor, is upregulated in double-knockout hematopoietic stem cells (HSCs). DNMT3A and TET2 both repress Klf1, suggesting a model of cooperative inhibition by epigenetic modifiers. These data demonstrate a dual role for TET2 in promoting and inhibiting HSC differentiation, the loss of which, along with DNMT3A, obstructs differentiation, leading to transformation.	[Zhang, Xiaotian; Jeong, Mira; Guzman, Anna; Lei, Yong; Huang, Yung-Hsin; Goodall, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Zhang, Xiaotian; Jeong, Mira; Guzman, Anna; Lei, Yong; Huang, Yung-Hsin; Goodall, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Zhang, Xiaotian; Goodall, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Su, Jianzhong; Park, Hyun Jung; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Ko, Myunggon; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Ko, Myunggon] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Huang, Yun] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; La Jolla Institute for Immunology; Ulsan National Institute of Science & Technology (UNIST); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Goodall, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.; Goodall, MA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Goodall, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Li, W (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA.	wl1@bcm.edu; goodell@bcm.edu	Lei, Yong/Q-9013-2018	Lei, Yong/0000-0003-4864-7017; Goodell, Margaret A./0000-0003-1111-2932; Su, Jianzhong/0000-0002-1172-7411; Zhang, Xiaotian/0000-0002-9533-4761; Ko, Myunggon/0000-0002-6007-2570; Huang, Yung-Hsin/0000-0002-5180-934X; Huang, Yun/0000-0001-5950-9168; Rao, Anjana/0000-0002-1870-1775	Wellcome Trust Gene-Environment training program; US NIH [DK092883, CA183252, HG007538, CA193466, CA125123, P50CA126752, CA151535]; Samuel Waxman Medical Research Foundation; Edward P. Evans Foundation; Adrienne Helis Malvin Medical Research Foundation; Leukemia and Lymphoma Society; CPRIT [RP140001]; CPRIT Scholar award [RP140053]; NATIONAL CANCER INSTITUTE [P30CA125123, R35CA210043, R01CA193466, R01CA183252, R01CA151535, P50CA126752] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK092883, R01DK092883] Funding Source: NIH RePORTER	Wellcome Trust Gene-Environment training program(Wellcome Trust); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Medical Research Foundation; Edward P. Evans Foundation; Adrienne Helis Malvin Medical Research Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); CPRIT; CPRIT Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kampmann for discussions at AACR, C. Gillespie for editing, and R. Nitsal, S. Hexige and Y. Zheng for assistance with histology, pathology and BMT, respectively. X.Z. is supported by the Wellcome Trust Gene-Environment training program. This work was supported by the US NIH (DK092883, CA183252, HG007538, CA193466, CA125123, P50CA126752 and CA151535), the Samuel Waxman Medical Research Foundation, the Edward P. Evans Foundation, the Adrienne Helis Malvin Medical Research Foundation, the Leukemia and Lymphoma Society (Translational Research Program to A. R. and Special Fellow Award to M.K.), and CPRIT (RP140001) and a CPRIT Scholar award to Y.H. (RP140053).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Celik H, 2015, BLOOD, V125, P619, DOI 10.1182/blood-2014-08-594564; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Cimmino L, 2015, NAT IMMUNOL, V16, P653, DOI 10.1038/ni.3148; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/nchembio.1246, 10.1038/NCHEMBIO.1246]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; Mayle A, 2015, BLOOD, V125, P629, DOI 10.1182/blood-2014-08-594648; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nimmo RA, 2015, TRENDS CELL BIOL, V25, P459, DOI 10.1016/j.tcb.2015.04.004; Orkin SH, 2003, IMMUNITY, V19, P633, DOI 10.1016/S1074-7613(03)00302-9; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pollier Jacob, 2013, Methods Mol Biol, V1011, P305, DOI 10.1007/978-1-62703-414-2_24; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rasmussen KD, 2015, GENE DEV, V29, P910, DOI 10.1101/gad.260174.115; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Scourzic L, 2016, LEUKEMIA, V30, P1388, DOI 10.1038/leu.2016.29; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tsagaratou A, 2014, P NATL ACAD SCI USA, V111, pE3306, DOI 10.1073/pnas.1412327111; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao ZG, 2015, CELL REP, V13, P1692, DOI 10.1016/j.celrep.2015.10.037; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	67	141	143	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1014	+		10.1038/ng.3610	http://dx.doi.org/10.1038/ng.3610			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428748	Green Accepted			2022-12-17	WOS:000382398800011
J	Guemez-Gamboa, A; Nguyen, LN; Yang, HB; Zaki, MS; Kara, M; Ben-Omran, T; Akizu, N; Rosti, RO; Rosti, B; Scott, E; Schroth, J; Copeland, B; Vaux, KK; Cazenave-Gassiot, A; Quek, DQY; Wong, BH; Tan, BC; Wenk, MR; Gunel, M; Gabriel, S; Chi, NC; Silver, DL; Gleeson, JG				Guemez-Gamboa, Alicia; Nguyen, Long N.; Yang, Hongbo; Zaki, Maha S.; Kara, Majdi; Ben-Omran, Tawfeg; Akizu, Naiara; Rosti, Rasim Ozgur; Rosti, Basak; Scott, Eric; Schroth, Jana; Copeland, Brett; Vaux, Keith K.; Cazenave-Gassiot, Amaury; Quek, Debra Q. Y.; Wong, Bernice H.; Tan, Bryan C.; Wenk, Markus R.; Gunel, Murat; Gabriel, Stacey; Chi, Neil C.; Silver, David L.; Gleeson, Joseph G.			Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome	NATURE GENETICS			English	Article							FATTY-ACID COMPOSITION; DOCOSAHEXAENOIC ACID; BARRIER; PERICYTES; NEUROGENESIS; EXPRESSION; DISCOVERY; MOUSE	Docosahexanoic acid (DHA) is the most abundant omega-3 fatty acid in brain, and, although it is considered essential, deficiency has not been linked to disease(1,2). Despite the large mass of DHA in phospholipids, the brain does not synthesize it. DHA is imported across the blood-brain barrier (BBB) through the major facilitator superfamily domain-containing 2a (MFSD2A) protein(3). MFSD2A transports DHA as well as other fatty acids in the form of lysophosphatidylcholine (LPC). We identify two families displaying MFSD2A mutations in conserved residues. Affected individuals exhibited a lethal microcephaly syndrome linked to inadequate uptake of LPC lipids. The MFSD2A mutations impaired transport activity in a cell-based assay. Moreover, when expressed in mfsd2aa-morphant zebrafish, mutants failed to rescue microcephaly, BBB breakdown and lethality. Our results establish a link between transport of DHA and LPCs by MFSD2A and human brain growth and function, presenting the first evidence of monogenic disease related to transport of DHA in humans.	[Guemez-Gamboa, Alicia; Akizu, Naiara; Rosti, Rasim Ozgur; Rosti, Basak; Scott, Eric; Schroth, Jana; Copeland, Brett; Vaux, Keith K.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92103 USA; [Guemez-Gamboa, Alicia; Akizu, Naiara; Rosti, Rasim Ozgur; Rosti, Basak; Scott, Eric; Schroth, Jana; Copeland, Brett; Vaux, Keith K.; Gleeson, Joseph G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Nguyen, Long N.; Quek, Debra Q. Y.; Wong, Bernice H.; Tan, Bryan C.; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Dis, Singapore, Singapore; [Yang, Hongbo; Chi, Neil C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo, Egypt; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha, Qatar; [Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg Neurobiol & Genet, Yale Program Neurogenet, New Haven, CT USA; [Gabriel, Stacey] MIT & Harward, Broad Inst, Cambridge, MA USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; National University of Singapore; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hamad Medical Corporation; National University of Singapore; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92103 USA.	david.silver@duke-nus.edu.sg; jogleeson@rockefeller.edu	Nguyen, Long/AAY-6172-2021; Wang, Guilin/G-8794-2018; Vaux, Keith/R-2716-2019; Cazenave-Gassiot, Amaury/E-4536-2014; Zaki, Maha S/B-9361-2013	Vaux, Keith/0000-0001-8738-5940; Cazenave-Gassiot, Amaury/0000-0002-3050-634X; TAN, BRYAN CASSIDY/0000-0001-6399-8814; Guemez-Gamboa, Alicia/0000-0001-6890-4661; Wong, Bernice/0000-0001-8981-1376; Silver, David/0000-0002-7289-9890; Copeland, Brett/0000-0003-2933-6061; Nguyen, Long N/0000-0002-9857-2239; Zaki, Maha/0000-0001-7840-0002	US National Institutes of Health [P01HD070494, R01NS048453, K99NS089943, U54HG003067, U54HG006504]; Singapore Ministry of Health's National Medical Research Council [CBRG/069/2014]; Singapore National Research Foundation Competitive Research Program [2007-04]; National University of Singapore's Life Sciences Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, K99NS089943] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Singapore National Research Foundation Competitive Research Program(National Research Foundation, Singapore); National University of Singapore's Life Sciences Institute(National University of Singapore); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health, including P01HD070494 (to J.G.G. and N.C.C.), R01NS048453 (to J.G.G.), K99NS089943 (to A.G.-G.), and U54HG003067 to the Broad Institute and U54HG006504 to the Yale Center for Mendelian Disorders (M.G.), grant CBRG/069/2014 from the Singapore Ministry of Health's National Medical Research Council (to D.L.S.), Singapore National Research Foundation Competitive Research Program grant 2007-04 (to M.R.W.) and the National University of Singapore's Life Sciences Institute (to M.R.W.). Sequencing was provided in part by a gift from BGI to Rady Children's Hospital, San Diego for undiagnosed patients. Human brain samples were provided by S. Roy (University of California, San Diego).	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Cordat E, 2000, BIOCHEMISTRY-US, V39, P4493, DOI 10.1021/bi991852i; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Fleming A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077548; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Harata N, 1996, METAB BRAIN DIS, V11, P55, DOI 10.1007/BF02080931; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240	23	141	147	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					809	+		10.1038/ng.3311	http://dx.doi.org/10.1038/ng.3311			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005868	Green Accepted			2022-12-17	WOS:000357090300020
J	Tang, YT; Gao, X; Rosa, BA; Abubucker, S; Hallsworth-Pepin, K; Martin, J; Tyagi, R; Heizer, E; Zhang, X; Bhonagiri-Palsikar, V; Minx, P; Warren, WC; Wang, Q; Zhan, B; Hotez, PJ; Sternberg, PW; Dougall, A; Gaze, ST; Mulvenna, J; Sotillo, J; Ranganathan, S; Rabelo, EM; Wilson, RK; Felgner, PL; Bethony, J; Hawdon, JM; Gasser, RB; Loukas, A; Mitreva, M				Tang, Yat T.; Gao, Xin; Rosa, Bruce A.; Abubucker, Sahar; Hallsworth-Pepin, Kymberlie; Martin, John; Tyagi, Rahul; Heizer, Esley; Zhang, Xu; Bhonagiri-Palsikar, Veena; Minx, Patrick; Warren, Wesley C.; Wang, Qi; Zhan, Bin; Hotez, Peter J.; Sternberg, Paul W.; Dougall, Annette; Gaze, Soraya Torres; Mulvenna, Jason; Sotillo, Javier; Ranganathan, Shoba; Rabelo, Elida M.; Wilson, Richard K.; Felgner, Philip L.; Bethony, Jeffrey; Hawdon, John M.; Gasser, Robin B.; Loukas, Alex; Mitreva, Makedonka			Genome of the human hookworm Necator americanus	NATURE GENETICS			English	Article							TRANSMITTED HELMINTH INFECTIONS; HAMSTERS MESOCRICETUS-AURATUS; MULTIPLE SEQUENCE ALIGNMENT; ANTHELMINTIC EMODEPSIDE; GENE ONTOLOGY; IN-VITRO; PROTEIN; ANNOTATION; IDENTIFICATION; IVERMECTIN	The hookworm Necator americanus is the predominant soil-transmitted human parasite. Adult worms feed on blood in the small intestine, causing iron-deficiency anemia, malnutrition, growth and development stunting in children, and severe morbidity and mortality during pregnancy in women. We report sequencing and assembly of the N. americanus genome (244 Mb, 19,151 genes). Characterization of this first hookworm genome sequence identified genes orchestrating the hookworm's invasion of the human host, genes involved in blood feeding and development, and genes encoding proteins that represent new potential drug targets against hookworms. N. americanus has undergone a considerable and unique expansion of immunomodulator proteins, some of which we highlight as potential treatments against inflammatory diseases. We also used a protein microarray to demonstrate a postgenomic application of the hookworm genome sequence. This genome provides an invaluable resource to boost ongoing efforts toward fundamental and applied postgenomic research, including the development of new methods to control hookworm and human immunological diseases.	[Tang, Yat T.; Gao, Xin; Rosa, Bruce A.; Abubucker, Sahar; Hallsworth-Pepin, Kymberlie; Martin, John; Tyagi, Rahul; Heizer, Esley; Zhang, Xu; Bhonagiri-Palsikar, Veena; Minx, Patrick; Warren, Wesley C.; Wang, Qi; Wilson, Richard K.; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Warren, Wesley C.; Wilson, Richard K.; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA; [Zhan, Bin; Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Houston, TX 77030 USA; [Zhan, Bin; Hotez, Peter J.] Sabin Vaccine Inst, Houston, TX USA; [Zhan, Bin; Hotez, Peter J.] Texas Childrens Hosp Ctr Vaccine Dev, Houston, TX USA; [Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sternberg, Paul W.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Dougall, Annette; Gaze, Soraya Torres; Sotillo, Javier; Loukas, Alex] James Cook Univ, Queensland Trop Hlth Alliance, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia; [Mulvenna, Jason] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Rabelo, Elida M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Bethony, Jeffrey; Hawdon, John M.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; California Institute of Technology; Howard Hughes Medical Institute; James Cook University; QIMR Berghofer Medical Research Institute; Macquarie University; National University of Singapore; Universidade Federal de Minas Gerais; University of California System; University of California Irvine; George Washington University; University of Melbourne; Washington University (WUSTL)	Mitreva, M (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	mmitreva@genome.wustl.edu	Mulvenna, Jason/H-7110-2014; Gaze, Soraya/B-9419-2013; Hawdon, John/I-1201-2019; Pacific-Southwest, RCE/B-6155-2009; Rabelo, Elida ML/C-2401-2015; Wilson, Richard K./AAF-4139-2019; Sotillo, Javier/B-7354-2014; Gao, Cyan/O-9316-2014; Gasser, Robin/ABH-6185-2020; Loukas, Alex/B-7355-2014	Mulvenna, Jason/0000-0003-3521-8061; Gaze, Soraya/0000-0001-8600-2389; Hawdon, John/0000-0002-6164-1413; Rabelo, Elida ML/0000-0002-2566-5012; Wilson, Richard K./0000-0002-1992-1358; Sotillo, Javier/0000-0002-1443-7233; Gasser, Robin/0000-0002-4423-1690; Mitreva, Makedonka/0000-0001-9572-3436; Ranganathan, Shoba/0000-0002-8290-813X; Loukas, Alex/0000-0002-0896-8441; Hotez, Peter/0000-0001-8770-1042; Wolf, Nathaniel/0000-0001-6567-2447; Tyagi, Rahul/0000-0002-6680-8972	US National Institutes of Health (NIH)-National Human Genome Research Institute [U54HG003079]; NIH-National Institute of Allergy and Infectious Diseases [AI081803]; NIH-National Institute of General Medical Sciences [GM097435]; Australian Research Council and Australia's National Health and Medical Research Council; Protein Microarray Laboratory at the University of California-Irvine [U54AI065359]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081803, U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097435] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-National Human Genome Research Institute; NIH-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Research Council and Australia's National Health and Medical Research Council(Australian Research Council); Protein Microarray Laboratory at the University of California-Irvine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the faculty and staff of the Genome Institute at Washington University and the Protein Microarray Laboratory at the University of California-Irvine (U54AI065359) who contributed to this study. The genome sequencing and annotation work was funded by US National Institutes of Health (NIH)-National Human Genome Research Institute grant U54HG003079 to R.K.W. Comparative genome analysis was funded by grants NIH-National Institute of Allergy and Infectious Diseases AI081803 and NIH-National Institute of General Medical Sciences GM097435 to M.M. Funds from the Australian Research Council and Australia's National Health and Medical Research Council to R.B.G. are gratefully acknowledged. P.W.S. is an investigator with the Howard Hughes Medical Institute. We thank the faculty and staff of The Genome Institute at Washington University who contributed to this study.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bull K, 2007, INT J PARASITOL, V37, P627, DOI 10.1016/j.ijpara.2006.10.013; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Cantacessi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031164; Cantacessi C, 2012, MOL CELL PROBE, V26, P54, DOI 10.1016/j.mcp.2011.10.001; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chu D, 2004, INFECT IMMUN, V72, P2214, DOI 10.1128/IAI.72.4.2214-2221.2004; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Culley FJ, 2000, J IMMUNOL, V165, P6447, DOI 10.4049/jimmunol.165.11.6447; Daveson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017366; Diemert DJ, 2008, CLIN INFECT DIS, V46, P282, DOI 10.1086/524070; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; GEARY TG, 1993, EXP PARASITOL, V77, P88, DOI 10.1006/expr.1993.1064; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HANCOCK JM, 1994, COMPUT APPL BIOSCI, V10, P67; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Humphries DL, 1997, T ROY SOC TROP MED H, V91, P518, DOI 10.1016/S0035-9203(97)90007-9; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Jian X, 2003, EXP PARASITOL, V104, P62, DOI 10.1016/S0014-4894(03)00094-8; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kaminsky R, 2008, PARASITOL RES, V103, P931, DOI 10.1007/s00436-008-1080-7; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kotze AC, 2012, VET PARASITOL, V186, P118, DOI 10.1016/j.vetpar.2011.11.052; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; KUMAR S, 1992, J PARASITOL, V78, P917, DOI 10.2307/3283331; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIONEL NDW, 1969, BMJ-BRIT MED J, V4, P340, DOI 10.1136/bmj.4.5679.340; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McSorley HJ, 2010, PARASITE IMMUNOL, V32, P549, DOI 10.1111/j.1365-3024.2010.01224.x; Miller T. A., 1971, Adv Parasitology, V9, P153, DOI 10.1016/S0065-308X(08)60161-X; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Navarro S, 2013, INT J PARASITOL, V43, P225, DOI 10.1016/j.ijpara.2012.11.005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Page AP, 2003, ADV PARASIT, V53, P85, DOI 10.1016/S0065-308X(03)53003-2; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Quinnell RJ, 2010, J INFECT DIS, V202, P954, DOI 10.1086/655813; Ranjit N, 2009, J INFECT DIS, V199, P904, DOI 10.1086/597048; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RICHARDS JC, 1995, INT J PARASITOL, V25, P1185, DOI 10.1016/0020-7519(95)00036-2; Robertson Hugh M, 2006, WormBook, P1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider B, 2011, HUM VACCINES, V7, P1234, DOI 10.4161/hv.7.11.18443; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Sundaresh S, 2006, BIOINFORMATICS, V22, P1760, DOI 10.1093/bioinformatics/btl162; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003505; Taylor CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003149; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Viney ME, 2005, INT J PARASITOL, V35, P1473, DOI 10.1016/j.ijpara.2005.07.006; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Williamson AL, 2003, TRENDS PARASITOL, V19, P417, DOI 10.1016/S1471-4922(03)00189-2; Willson J, 2003, PARASITOLOGY, V126, P79, DOI 10.1017/S0031182002002639; Xiao S, 2008, EXP PARASITOL, V118, P32, DOI 10.1016/j.exppara.2007.05.010; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109	103	141	145	0	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					261	+		10.1038/ng.2875	http://dx.doi.org/10.1038/ng.2875			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24441737	hybrid, Green Accepted			2022-12-17	WOS:000332036700010
J	Safi, H; Lingaraju, S; Amin, A; Kim, S; Jones, M; Holmes, M; McNeil, M; Peterson, SN; Chatterjee, D; Fleischmann, R; Alland, D				Safi, Hassan; Lingaraju, Subramanya; Amin, Anita; Kim, Soyeon; Jones, Marcus; Holmes, Michael; McNeil, Michael; Peterson, Scott N.; Chatterjee, Delphi; Fleischmann, Robert; Alland, David			Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-beta-D-arabinose biosynthetic and utilization pathway genes	NATURE GENETICS			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CODON USAGE; IDENTIFICATION; EXPRESSION; SEQUENCE; DETERMINANTS; ENZYME; DONOR	To study the evolution of drug resistance, we genetically and biochemically characterized Mycobacterium tuberculosis strains selected in vitro for ethambutol resistance. Mutations in decaprenylphosphoryl-beta-D-arabinose (DPA) biosynthetic and utilization pathway genes Rv3806c, Rv3792, embB and embC accumulated to produce a wide range of ethambutol minimal inhibitory concentrations (MICs) that depended on mutation type and number. Rv3806c mutations increased DPA synthesis, causing MICs to double from 2 to 4 mu g/ml in a wild-type background and to increase from 16 to 32 mu g/ml in an embB codon 306 mutant background. Synonymous mutations in Rv3792 increased the expression of downstream embC, an ethambutol target, resulting in MICs of 8 mu g/ml. Multistep selection was required for high-level resistance. Mutations in embC or very high embC expression were observed at the highest resistance level. In clinical isolates, Rv3806c mutations were associated with high-level resistance and had multiplicative effects with embB mutations on MICs. Ethambutol resistance is acquired through the acquisition of mutations that interact in complex ways to produce a range of MICs, from those falling below breakpoint values to ones representing high-level resistance.	[Safi, Hassan; Lingaraju, Subramanya; Alland, David] Rutgers State Univ, New Jersey Med Sch, Div Infect Dis, Newark, NJ 07102 USA; [Safi, Hassan; Lingaraju, Subramanya; Alland, David] Rutgers State Univ, New Jersey Med Sch, Ctr Emerging & Reemerging Pathogens, Newark, NJ 07102 USA; [Safi, Hassan; Lingaraju, Subramanya; Alland, David] Rutgers State Univ, New Jersey Med Sch, Dept Med, Newark, NJ 07102 USA; [Amin, Anita; McNeil, Michael; Chatterjee, Delphi] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Kim, Soyeon] Rutgers State Univ, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07102 USA; [Jones, Marcus; Holmes, Michael; Peterson, Scott N.; Fleischmann, Robert] J Craig Venter Inst, Pathogen Funct Genom Ctr, Rockville, MD USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Colorado State University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; J. Craig Venter Institute	Alland, D (corresponding author), Rutgers State Univ, New Jersey Med Sch, Div Infect Dis, Newark, NJ 07102 USA.	allandda@njms.rutgers.edu	McNeil, Michael/G-3325-2019		National Institute of Allergy and Infectious Diseases, US National Institutes of Health [AI080653, AI065663, AI037139]; Pathogen Functional Genomics Resource Center [N01-AI5447]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI037139, U01AI065663, R01AI037139, R01AI080653] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pathogen Functional Genomics Resource Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Kuppasani for performing the direct Sanger sequencing. This work was supported in part by National Institute of Allergy and Infectious Diseases, US National Institutes of Health grants AI080653, AI065663 and AI037139 and by Pathogen Functional Genomics Resource Center contract N01-AI5447.	Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Escuyer VE, 2001, J BIOL CHEM, V276, P48854, DOI 10.1074/jbc.M102272200; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Goude R, 2009, ANTIMICROB AGENTS CH, V53, P4138, DOI 10.1128/AAC.00162-09; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; Huang H, 2008, MICROBIOL-SGM, V154, P736, DOI 10.1099/mic.0.2007/013532-0; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; Hwang HY, 2003, J MED MICROBIOL, V52, P239, DOI 10.1099/jmm.0.05045-0; Kim SY, 2003, DIAGN MICR INFEC DIS, V47, P497, DOI 10.1016/S0732-8893(03)00132-9; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LEE RE, 1995, J AM CHEM SOC, V117, P11829, DOI 10.1021/ja00153a002; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P3810, DOI 10.1128/JCM.40.10.3810-3813.2002; Ohno H, 1996, ANTIMICROB AGENTS CH, V40, P1053, DOI 10.1128/AAC.40.4.1053; Plinke C, 2010, J ANTIMICROB CHEMOTH, V65, P1359, DOI 10.1093/jac/dkq120; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Safi H, 2004, MOL MICROBIOL, V52, P999, DOI 10.1111/j.1365-2958.2004.04037.x; Safi H, 2008, ANTIMICROB AGENTS CH, V52, P2027, DOI 10.1128/AAC.01486-07; Safi H, 2010, ANTIMICROB AGENTS CH, V54, P103, DOI 10.1128/AAC.01288-09; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Starks AM, 2009, ANTIMICROB AGENTS CH, V53, P1061, DOI 10.1128/AAC.01357-08; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vincent V, 2012, INT J TUBERC LUNG D, V16, P24, DOI 10.5588/ijtld.11.0223; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	38	141	146	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1190	U330		10.1038/ng.2743	http://dx.doi.org/10.1038/ng.2743			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23995136	Green Accepted			2022-12-17	WOS:000324989600015
J	Koenekoop, RK; Wang, H; Majewski, J; Wang, X; Lopez, I; Ren, HN; Chen, YY; Li, YM; Fishman, GA; Genead, M; Schwartzentruber, J; Solanki, N; Traboulsi, EI; Cheng, JL; Logan, CV; McKibbin, M; Hayward, BE; Parry, DA; Johnson, CA; Nageeb, M; Poulter, JA; Mohamed, MD; Jafri, H; Rashid, Y; Taylor, GR; Keser, V; Mardon, G; Xu, HD; Inglehearn, CF; Fu, Q; Toomes, C; Chen, R				Koenekoop, Robert K.; Wang, Hui; Majewski, Jacek; Wang, Xia; Lopez, Irma; Ren, Huanan; Chen, Yiyun; Li, Yumei; Fishman, Gerald A.; Genead, Mohammed; Schwartzentruber, Jeremy; Solanki, Naimesh; Traboulsi, Elias I.; Cheng, Jingliang; Logan, Clare V.; McKibbin, Martin; Hayward, Bruce E.; Parry, David A.; Johnson, Colin A.; Nageeb, Mohammed; Poulter, James A.; Mohamed, Moin D.; Jafri, Hussain; Rashid, Yasmin; Taylor, Graham R.; Keser, Vafa; Mardon, Graeme; Xu, Huidan; Inglehearn, Chris F.; Fu, Qing; Toomes, Carmel; Chen, Rui		Finding Rare Dis Genes FORGE	Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration	NATURE GENETICS			English	Article							WALLERIAN DEGENERATION; MONONUCLEOTIDE ADENYLYLTRANSFERASE; WLD(S); ACTIVATION; IQCB1; MICE	Leber congenital amaurosis (LCA) is a blinding retinal disease that presents within the first year after birth. Using exome sequencing, we identified mutations in the nicotinamide adenine dinucleotide (NAD) synthase gene NMNAT1 encoding nicotinamide mononucleotide adenylyltransferase 1 in eight families with LCA, including the family in which LCA was originally linked to the LCA9 locus. Notably, all individuals with NMNAT1 mutations also have macular colobomas, which are severe degenerative entities of the central retina (fovea) devoid of tissue and photoreceptors. Functional assays of the proteins encoded by the mutant alleles identified in our study showed that the mutations reduce the enzymatic activity of NMNAT1 in NAD biosynthesis and affect protein folding. Of note, recent characterization of the slow Wallerian degeneration (Wld(s)) mouse model, in which prolonged axonal survival after injury is observed, identified NMNAT1 as a neuroprotective protein when ectopically expressed. Our findings identify a new disease mechanism underlying LCA and provide the first link between endogenous NMNAT1 dysfunction and a human nervous system disorder.	[Wang, Hui; Li, Yumei; Solanki, Naimesh; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Koenekoop, Robert K.; Lopez, Irma; Ren, Huanan; Nageeb, Mohammed; Keser, Vafa; Fu, Qing] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ, Canada; [Wang, Hui; Wang, Xia; Chen, Yiyun; Li, Yumei; Cheng, Jingliang; Mardon, Graeme; Xu, Huidan; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Majewski, Jacek; Schwartzentruber, Jeremy] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Majewski, Jacek; Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Fishman, Gerald A.; Genead, Mohammed] Chicago Lighthouse People Who Are Blind Visually, Chicago, IL USA; [Traboulsi, Elias I.] Cole Eye Inst, Ctr Genet Eye Dis, Cleveland, OH USA; [Logan, Clare V.; Hayward, Bruce E.; Parry, David A.; Johnson, Colin A.; Poulter, James A.; Taylor, Graham R.; Inglehearn, Chris F.; Toomes, Carmel] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [McKibbin, Martin] St James Univ Hosp, Dept Ophthalmol, Leeds, W Yorkshire, England; [Mohamed, Moin D.] St Thomas Hosp, Dept Ophthalmol, London, England; [Jafri, Hussain] Gene Tech Labs, Lahore, Pakistan; [Rashid, Yasmin] King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; [Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Fu, Qing] Second Mil Med Univ, Affiliated Hosp 1, Shanghai, Peoples R China; [Chen, Rui] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA	Baylor College of Medicine; McGill University; Baylor College of Medicine; McGill University; University of Leeds; Saint James's University Hospital; Guy's & St Thomas' NHS Foundation Trust; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Naval Medical University; Baylor College of Medicine	Chen, R (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	ruichen@bcm.edu	Traboulsi, Elias/AAY-7443-2020; Poulter, James A/A-8190-2013; Scherer, Stephen W./B-3785-2013; Koenekoop, Robert/AAT-6676-2021; Inglehearn, Chris/GYD-9783-2022; Wang, Xia/O-4036-2014	Poulter, James A/0000-0003-2048-5693; Scherer, Stephen W./0000-0002-8326-1999; Wang, Xia/0000-0002-7750-1167; Logan, Clare/0000-0003-4323-1602; Parry, David/0000-0003-0376-7736; Johnson, Colin/0000-0002-2979-8234; Schwartzentruber, Jeremy/0000-0002-6183-2092; Toomes, Carmel/0000-0001-8373-9545	Foundation Fighting Blindness Canada; Canadian Institutes for Health Research; US National Institutes of Health (NIH); Reseau Vision; Fonds de la Recherche en Sante du Quebec (FRSQ); FORGE Canada; Pangere Corporation; Grousbeck Foundation; Wynn-Gund Foundation; Sir Jules Thorn Charitable Trust [09/JTA]; NIH [1S10RR026550]; Graduate Innovation Foundation of Hunan Province [CX2011B388]; Retinal Research Foundation; National Eye Institute [R01EY018571]; Government of Canada through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia;  [F32EY19430]; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571, F32EY019430] Funding Source: NIH RePORTER	Foundation Fighting Blindness Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reseau Vision; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FORGE Canada; Pangere Corporation; Grousbeck Foundation; Wynn-Gund Foundation; Sir Jules Thorn Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Innovation Foundation of Hunan Province; Retinal Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; ; The Sir Jules Thorn Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank all of the individuals with LCA and their parents who were involved in this study. We thank R. Sifers for scientific discussion and J.E. Zaneveld for critical reading of the manuscript. R.K.K. is supported by the Foundation Fighting Blindness Canada, the Canadian Institutes for Health Research, the US National Institutes of Health (NIH), Reseau Vision, the Fonds de la Recherche en Sante du Quebec (FRSQ) and FORGE Canada. We acknowledge the FORGE Canada Consortium. We thank R. Pigeon for coordinating all the individuals with LCA. G.A.F. acknowledges the Pangere Corporation, Grousbeck Foundation and the Wynn-Gund Foundation for financial support. We sincerely acknowledge The Royal Society (C.T. is a university research fellow), Yorkshire Eye Research and The Sir Jules Thorn Charitable Trust (grant 09/JTA). Exome sequencing was performed at the BCM-Functional Genome Initiative (BCM-FGI) core facility, which is supported by NIH shared instrument grant 1S10RR026550 to R.C.H.W. was supported by postdoctoral fellowship F32EY19430. J.C. was supported by the Graduate Innovation Foundation of Hunan Province (CX2011B388). This work is supported by grants from the Retinal Research Foundation and the National Eye Institute (R01EY018571) to G.M. and R.C.; The FORGE Steering Committee comprises K. Boycott (leader; University of Ottawa, Ottawa, Ontario, Canada), J. Friedman (co-lead; University of British Columbia, Vancouver, British Columbia, Canada), J. Michaud (co-lead; Universite de Montreal, Montreal, Quebec, Canada), F. Bernier (University of Calgary, Calgary, Alberta, Canada), M. Brudno (University of Toronto, Toronto, Ontario, Canada), B. Fernandez (Memorial University, St. John's, Newfoundland, Canada), B. Knoppers (McGill University, Montreal, Quebec, Canada), M. Samuels (Universite de Montreal, Montreal, Quebec, Canada) and S. Scherer (University of Toronto, Toronto, Ontario, Canada). This work was funded in part by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. We thank J. Marcadier (Clinical Coordinator) and C. Beaulieu (Project Manager) for their contribution to the infrastructure of the FORGE Canada Consortium.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LUDWIN SK, 1992, J NEUROL SCI, V109, P140, DOI 10.1016/0022-510X(92)90160-M; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Patel VP, 2011, INT J CLIN EXP PATHO, V4, P215; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Sasaki Y, 2010, J BIOL CHEM, V285, P41211, DOI 10.1074/jbc.C110.193904; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Wishart TM, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-21; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	29	141	148	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1035	+		10.1038/ng.2356	http://dx.doi.org/10.1038/ng.2356			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22842230	Green Accepted			2022-12-17	WOS:000308491200016
J	Gretarsdottir, S; Baas, AF; Thorleifsson, G; Holm, H; den Heijer, M; de Vries, JPPM; Kranendonk, SE; Zeebregts, CJAM; van Sterkenburg, SM; Geelkerken, RH; van Rij, AM; Williams, MJA; Boll, APM; Kostic, JP; Jonasdottir, A; Jonasdottir, A; Walters, GB; Masson, G; Sulem, P; Saemundsdottir, J; Mouy, M; Magnusson, KP; Tromp, G; Elmore, JR; Sakalihasan, N; Limet, R; Defraigne, JO; Ferrell, RE; Ronkainen, A; Ruigrok, YM; Wijmenga, C; Grobbee, DE; Shah, SH; Granger, CB; Quyyumi, AA; Vaccarino, V; Patel, RS; Zafari, AM; Levey, AI; Austin, H; Girelli, D; Pignatti, PF; Olivieri, O; Martinelli, N; Malerba, G; Trabetti, E; Becker, LC; Becker, DM; Reilly, MP; Rader, DJ; Mueller, T; Dieplinger, B; Haltmayer, M; Urbonavicius, S; Lindblad, B; Gottsater, A; Gaetani, E; Pola, R; Wells, P; Rodger, M; Forgie, M; Langlois, N; Corral, J; Vicente, V; Fontcuberta, J; Espana, F; Grarup, N; Jorgensen, T; Witte, DR; Hansen, T; Pedersen, O; Aben, KK; de Graaf, J; Holewijn, S; Folkersen, L; Franco-Cereceda, A; Eriksson, P; Collier, DA; Stefansson, H; Steinthorsdottir, V; Rafnar, T; Valdimarsson, EM; Magnadottir, HB; Sveinbjornsdottir, S; Olafsson, I; Magnusson, MK; Palmason, R; Haraldsdottir, V; Andersen, K; Onundarson, PT; Thorgeirsson, G; Kiemeney, LA; Powell, JT; Carey, DJ; Kuivaniemi, H; Lindholt, JS; Jones, GT; Kong, A; Blankensteijn, JD; Matthiasson, SE; Thorsteinsdottir, U; Stefansson, K				Gretarsdottir, Solveig; Baas, Annette F.; Thorleifsson, Gudmar; Holm, Hilma; den Heijer, Martin; de Vries, Jean-Paul P. M.; Kranendonk, Steef E.; Zeebregts, Clark J. A. M.; van Sterkenburg, Steven M.; Geelkerken, Robert H.; van Rij, Andre M.; Williams, Michael J. A.; Boll, Albert P. M.; Kostic, Jelena P.; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Walters, G. Bragi; Masson, Gisli; Sulem, Patrick; Saemundsdottir, Jona; Mouy, Magali; Magnusson, Kristinn P.; Tromp, Gerard; Elmore, James R.; Sakalihasan, Natzi; Limet, Raymond; Defraigne, Jean-Olivier; Ferrell, Robert E.; Ronkainen, Antti; Ruigrok, Ynte M.; Wijmenga, Cisca; Grobbee, Diederick E.; Shah, Svati H.; Granger, Christopher B.; Quyyumi, Arshed A.; Vaccarino, Viola; Patel, Riyaz S.; Zafari, A. Maziar; Levey, Allan I.; Austin, Harland; Girelli, Domenico; Pignatti, Pier Franco; Olivieri, Oliviero; Martinelli, Nicola; Malerba, Giovanni; Trabetti, Elisabetta; Becker, Lewis C.; Becker, Diane M.; Reilly, Muredach P.; Rader, Daniel J.; Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard; Urbonavicius, Sigitas; Lindblad, Bengt; Gottsater, Anders; Gaetani, Eleonora; Pola, Roberto; Wells, Philip; Rodger, Marc; Forgie, Melissa; Langlois, Nicole; Corral, Javier; Vicente, Vicente; Fontcuberta, Jordi; Espana, Francisco; Grarup, Niels; Jorgensen, Torben; Witte, Daniel R.; Hansen, Torben; Pedersen, Oluf; Aben, Katja K.; de Graaf, Jacqueline; Holewijn, Suzanne; Folkersen, Lasse; Franco-Cereceda, Anders; Eriksson, Per; Collier, David A.; Stefansson, Hreinn; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Valdimarsson, Einar M.; Magnadottir, Hulda B.; Sveinbjornsdottir, Sigurlaug; Olafsson, Isleifur; Magnusson, Magnus Karl; Palmason, Robert; Haraldsdottir, Vilhelmina; Andersen, Karl; Onundarson, Pall T.; Thorgeirsson, Gudmundur; Kiemeney, Lambertus A.; Powell, Janet T.; Carey, David J.; Kuivaniemi, Helena; Lindholt, Jes S.; Jones, Gregory T.; Kong, Augustine; Blankensteijn, Jan D.; Matthiasson, Stefan E.; Thorsteinsdottir, Unnur; Stefansson, Kari			Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm	NATURE GENETICS			English	Article							VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; FAMILY-HISTORY; LOCUS; RISK; HOMEOSTASIS; ARTERIAL; DISEASE; LINKAGE; 9P21	We performed a genome-wide association study on 1,292 individuals with abdominal aortic aneurysms (AAAs) and 30,503 controls from Iceland and The Netherlands, with a follow-up of top markers in up to 3,267 individuals with AAAs and 7,451 controls. The A allele of rs7025486 on 9q33 was found to associate with AAA, with an odds ratio (OR) of 1.21 and P = 4.6 x 10(-10). In tests for association with other vascular diseases, we found that rs7025486[A] is associated with early onset myocardial infarction (OR = 1.18, P = 3.1 x 10(-5)), peripheral arterial disease (OR = 1.14, P = 3.9 x 10(-5)) and pulmonary embolism (OR = 1.20, P = 0.00030), but not with intracranial aneurysm or ischemic stroke. No association was observed between rs7025486[A] and common risk factors for arterial and venous diseases-that is, smoking, lipid levels, obesity, type 2 diabetes and hypertension. Rs7025486 is located within DAB2IP, which encodes an inhibitor of cell growth and survival.	[Gretarsdottir, Solveig; Thorleifsson, Gudmar; Holm, Hilma; Kostic, Jelena P.; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Walters, G. Bragi; Masson, Gisli; Sulem, Patrick; Saemundsdottir, Jona; Mouy, Magali; Stefansson, Hreinn; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Populat Genom, Reykjavik, Iceland; [Baas, Annette F.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Baas, Annette F.; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [den Heijer, Martin; Aben, Katja K.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Kranendonk, Steef E.] TweeSteden Hosp Tilburg, Dept Surg, Tilburg, Netherlands; [Zeebregts, Clark J. A. M.] Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [van Sterkenburg, Steven M.] Locat Rijnstate, Alysis Zorggroep, Div Vasc Surg, Dept Surg, Arnhem, Netherlands; [Geelkerken, Robert H.] Med Spectrum Twente, Dept Surg, Enschede, Netherlands; [van Rij, Andre M.; Jones, Gregory T.] Univ Otago, Dunedin Sch Med, Dept Surg, Dunedin, New Zealand; [Williams, Michael J. A.] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [Boll, Albert P. M.] Canisius Wilhelmina Hosp Nijmegen, Dept Surg, Nijmegen, Netherlands; [Magnusson, Kristinn P.] Univ Akureyri, Borgir Vid Nordurslod, Akureyri, Iceland; [Tromp, Gerard; Carey, David J.; Kuivaniemi, Helena] Weis Ctr Res, Geisinger Clin, Weis Ctr Res, Danville, PA 17822 USA; [Elmore, James R.] Weis Ctr Res, Geisinger Clin, Dept Vasc Surg, Danville, PA 17822 USA; [Sakalihasan, Natzi; Limet, Raymond; Defraigne, Jean-Olivier] Univ Liege, Liege, Belgium; [Ferrell, Robert E.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Ronkainen, Antti] Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland; [Ruigrok, Ynte M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Shah, Svati H.; Granger, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shah, Svati H.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Granger, Christopher B.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA; [Quyyumi, Arshed A.; Vaccarino, Viola; Patel, Riyaz S.; Zafari, A. Maziar; Levey, Allan I.] Emory Univ, Sch Med, Atlanta, GA USA; [Patel, Riyaz S.] Cardiff Univ, Cardiff, S Glam, Wales; [Zafari, A. Maziar] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Austin, Harland] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Girelli, Domenico; Olivieri, Oliviero; Martinelli, Nicola] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy; [Pignatti, Pier Franco; Malerba, Giovanni; Trabetti, Elisabetta] Univ Verona, Dept Life & Reprod Sci, Sect Biol & Genet, I-37100 Verona, Italy; [Becker, Lewis C.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Johns Hopkins GeneSTAR Res Program, Baltimore, MD USA; [Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Mueller, Thomas; Dieplinger, Benjamin; Haltmayer, Meinhard] Konventhosp Barmherzige Brueder, Dept Lab Med, Linz, Austria; [Urbonavicius, Sigitas; Lindholt, Jes S.] Viborg Hosp, Vasc Res Unit, Viborg, Denmark; [Lindblad, Bengt; Gottsater, Anders] Skaane Univ Hosp, Vasc Ctr, Malmo, Sweden; [Gaetani, Eleonora; Pola, Roberto] Catholic Univ, Lab Vasc Biol & Genet, A Gemelli Univ Hosp, Sch Med,Dept Med, Rome, Italy; [Pola, Roberto] Tufts Univ, Sch Med, Dept Med, Div Cardiovasc Res,Caritas St Elizabeths Med Ctr, Boston, MA 02111 USA; [Wells, Philip] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [Rodger, Marc] Ottawa Hosp, Div Hematol, Ottawa, ON, Canada; [Forgie, Melissa] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Langlois, Nicole] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Corral, Javier; Vicente, Vicente] Univ Murcia, Dept Med, Ctr Reg Hemodonac, Murcia, Spain; [Fontcuberta, Jordi] Santa Creu & St Pau Hosp, Hemostasia & Thrombosis Unit, Barcelona, Spain; [Espana, Francisco] Hosp La Fe, Res Ctr, E-46009 Valencia, Spain; [Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Jorgensen, Torben] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Hansen, Torben] Univ So Denmark, Odense, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, DK-1168 Copenhagen, Denmark; [Aben, Katja K.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Aben, Katja K.] Radboud Univ Nijmegen, Dept Gen Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Folkersen, Lasse; Eriksson, Per] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Franco-Cereceda, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Cardiothorac Surg Unit, Stockholm, Sweden; [Collier, David A.] Kings Coll London, Div Psychol Med & Social Genet, London WC2R 2LS, England; [Collier, David A.] Kings Coll London, Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Valdimarsson, Einar M.; Sveinbjornsdottir, Sigurlaug; Olafsson, Isleifur; Magnusson, Magnus Karl; Palmason, Robert; Haraldsdottir, Vilhelmina; Andersen, Karl; Onundarson, Pall T.; Thorgeirsson, Gudmundur] Landspitali Univ Hosp, Reykjavik, Iceland; [Magnadottir, Hulda B.] Upper Valley Neurol Neurosurg, Lebanon, NH USA; [Magnusson, Magnus Karl; Haraldsdottir, Vilhelmina; Andersen, Karl; Onundarson, Pall T.; Thorgeirsson, Gudmundur; Matthiasson, Stefan E.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Powell, Janet T.] Imperial Coll Charing Cross, London, England; [Blankensteijn, Jan D.] VU Med Ctr Amsterdam, Div Surg, Amsterdam, Netherlands; [Blankensteijn, Jan D.] Radboud Univ Nijmegen, Med Ctr, Dept Vasc Surg, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; St. Antonius Hospital Utrecht; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; Rijnstate Hospital; Medical Spectrum Twente; University of Otago; University of Otago; Radboud University Nijmegen; University of Akureyri; University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kuopio University Hospital; University of Eastern Finland; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Duke University; Duke University; Duke University; Emory University; Cardiff University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; University of Verona; University of Verona; Johns Hopkins University; University of Pennsylvania; Konventhospital Der Barmherzigen Bruder; Aarhus University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; St. Elizabeth's Medical Center; Tufts University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Murcia; Hospital Universitari i Politecnic La Fe; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Southern Denmark; University of Copenhagen; Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of London; King's College London; University of London; King's College London; Landspitali National University Hospital; University of Iceland; Radboud University Nijmegen; Imperial College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Stefansson, K (corresponding author), DeCODE Genet, Populat Genom, Reykjavik, Iceland.	solveig.gretarsdottir@decode.is; kstefans@decode.is	Grobbee, Diederick/C-7651-2014; Urbonavicius, Sigitas/U-4209-2019; Vicente, Vicente/L-6185-2019; Pedersen, Oluf/AAG-8015-2020; Powell, Janet/AAW-8669-2021; Kuivaniemi, Helena/Q-8178-2019; Olivieri, Oliviero/A-9126-2008; Kiemeney, Lambertus A./D-3357-2009; Magnusson, Kristinn P Pétur/X-4907-2019; Urbonavicius, Sigitas/D-7997-2015; Walters, G. Bragi/L-4215-2013; Aben, Katja KH/G-9686-2016; , Viola/AAW-5600-2020; Xie, Huangming/B-2260-2012; Witte, Daniel R/C-1722-2008; Michael, Williams J A/C-1759-2008; Stefansson, Kari/AAE-7187-2019; Witte, Daniel/AAF-9535-2019; Onundarson, Pall T./AAJ-1037-2020; Magnusson, Kristinn/A-6479-2011; Collier, David A/D-1649-2011; Wijmenga, Cisca/AAE-7719-2019; Geelkerken, R. H./AAF-7404-2019; Martinelli, Nicola/J-5622-2016; Wijmenga, Cisca/D-2173-2009; Blankensteijn, Jan D/Q-9291-2016; Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018; Malerba, Giovanni/T-3278-2019; de Graaf, J./H-8038-2014; Levey, Allan/F-2104-2011; Granger, Christopher B/D-3458-2014; Zafari, Abarmard/GRF-6849-2022; Girelli, Domenico/B-1183-2008; Grarup, Niels/K-2807-2015; España, Francisco/A-7286-2008; Tromp, Gerard/B-2677-2017; Lindholt, Jes/J-2907-2014; den Heijer, Martin/J-8036-2015	Grobbee, Diederick/0000-0003-4472-4468; Vicente, Vicente/0000-0002-4278-3264; Powell, Janet/0000-0002-3905-1468; Kuivaniemi, Helena/0000-0001-5753-8766; Olivieri, Oliviero/0000-0001-8209-9056; Kiemeney, Lambertus A./0000-0002-2368-1326; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Urbonavicius, Sigitas/0000-0002-1838-2065; Walters, G. Bragi/0000-0002-5415-6487; Aben, Katja KH/0000-0002-0214-2147; Witte, Daniel R/0000-0002-0769-2922; Michael, Williams J A/0000-0003-4822-4962; Witte, Daniel/0000-0002-0769-2922; Magnusson, Kristinn/0000-0003-4528-6826; Collier, David A/0000-0003-4087-1559; Wijmenga, Cisca/0000-0002-5635-1614; Martinelli, Nicola/0000-0001-6465-5119; Blankensteijn, Jan D/0000-0002-2062-8749; Pedersen, Oluf/0000-0002-3321-3972; Levey, Allan/0000-0002-3153-502X; Granger, Christopher B/0000-0002-0045-3291; Girelli, Domenico/0000-0001-9684-1899; Grarup, Niels/0000-0001-5526-1070; Tromp, Gerard/0000-0002-7761-0806; Jorgensen, Torben/0000-0001-9453-2830; Gaetani, Eleonora/0000-0002-7808-1491; Lindholt, Jes/0000-0001-9536-4488; Jones, Gregory T/0000-0002-6950-4210; Kong, Augustine/0000-0001-8193-5438; Rodger, Marc/0000-0001-8166-3487; Corral, Javier/0000-0003-0288-1107; Eriksson, Per/0000-0002-5635-2692; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Reilly, Muredach/0000-0002-3035-9386; Folkersen, Lasse/0000-0003-0708-9530; Langlois, Nicole/0000-0002-4953-6549; Hansen, Torben/0000-0001-8748-3831; Stefansson, Hreinn/0000-0002-9331-6666; Malerba, Giovanni/0000-0001-8705-8560; Pola, Roberto/0000-0001-5224-2931; den Heijer, Martin/0000-0003-3620-5617; Magnusson, Magnus Karl/0000-0001-8593-4934; Espana, Francisco/0000-0001-7829-2021	US National Heart, Lung, and Blood Institute (NHLBI) [HL064310, HL044682, HL087698, HL58625]; National Institutes of Health [R01HL089650-02]; European Community [FP7/2007-2013, HEALTH-F2-2008-200647, HEALTH-F4-2007-201413]; Swedish Research Council [12660]; F. Lundberg; US National Institute of Neurological Disorders and Stroke [NS034395]; American Heart Association; University of Kuopio; Netherlands Heart Foundation [2009T001, 2005T014]; Health Research Council of New Zealand; UK Medical Research Council; British Heart Foundation; Instituto Carlos III, Spain [RECAVA RD06/0014/0004, RD06/0014/0039, 06/0014/0016]; Novartis Foundation for Cardiovascular Excellence; Danish Research Council; Danish Diabetes Association; Danish Centre for Health Technology Assessment; Novo Nordisk; Research Foundation of Copenhagen County; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Velux foundation; MRC [G0501184] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058625] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087698, R18HL058625, R01HL089650, R01HL064310, R01HL058625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034395] Funding Source: NIH RePORTER; Medical Research Council [G0501184, G9817803B] Funding Source: researchfish	US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); F. Lundberg; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); University of Kuopio; Netherlands Heart Foundation(Netherlands Heart Foundation); Health Research Council of New Zealand(Health Research Council of New Zealand); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Instituto Carlos III, Spain(Instituto de Salud Carlos III); Novartis Foundation for Cardiovascular Excellence; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Diabetes Association; Danish Centre for Health Technology Assessment; Novo Nordisk(Novo Nordisk); Research Foundation of Copenhagen County; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Velux foundation(Velux Fonden); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals who participated in the study and whose contribution made this work possible. This study was funded in part through grants from the US National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (R01HL089650-02), and from two projects in the European Community's Seventh Framework Programme (FP7/2007-2013): the Fighting Aneurysmal Disease project grant agreement HEALTH-F2-2008-200647, and ENGAGE project grant agreement HEALTH-F4-2007-201413. The gene expression study in aorta and mammary artery was funded by the Swedish Research Council (12660) and a donation by F. Lundberg. The recruitment of AAA sample sets and controls from Belgium, Canada and Pittsburgh was funded in part by grants from the NHLBI (HL064310 to H. K. and HL044682 to R. E. F.). The Finnish IA sample collection was funded in part by the US National Institute of Neurological Disorders and Stroke (NS034395 to G. Tromp), the American Heart Association, Michigan Affiliate (to G. Tromp) and the University of Kuopio (to A. R.). A. F. B. and Y.M.R. were supported by grants from the Dr. E. Dekker program of the Netherlands Heart Foundation (2009T001 and 2005T014 respectively). New Zealand samples were recruited and genotyped through the Vascular Research Consortium of New Zealand with funding via a program grant from the Health Research Council of New Zealand. Sample collection in Danville, Pennsylvania, was funded by a grant from the American Heart Association (to D.J.C.). UK sample collection was funded partially by grants from the UK Medical Research Council and the British Heart Foundation (to J.T.P.). The recruitment of VTE patients and controls from Spain was funded in part by grants from the Instituto Carlos III (RECAVA RD06/0014/0004, RD06/0014/0039 and 06/0014/0016). DNA isolation of Dutch AAA samples was funded from a grant from the Novartis Foundation for Cardiovascular Excellence. The GeneSTAR Research Program was funded in part by the NHLBI (HL087698 to L. C. B. and HL58625 to D. M. B.). The Danish Study of control subjects was funded by research grants from the Danish Research Council, the Danish Diabetes Association, the Danish Centre for Health Technology Assessment, Novo Nordisk, the Research Foundation of Copenhagen County, the Danish Ministry of Internal Affairs and Health, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, the Becket Foundation and the Velux foundation. The Inter99 was initiated by T.J. (principal investigator), K. Borch-Johnsen (co-principal investigator), H. Ibsen and T. F. Thomsen. The steering committee comprises the former two and C. Pisinger.	Annambhotla S, 2008, WORLD J SURG, V32, P976, DOI 10.1007/s00268-007-9456-x; Assar AN, 2009, POSTGRAD MED J, V85, P268, DOI 10.1136/pgmj.2008.074666; Bown MJ, 2008, CIRC-CARDIOVASC GENE, V1, P39, DOI 10.1161/CIRCGENETICS.108.789727; Braekkan SK, 2008, J THROMB HAEMOST, V6, P1851, DOI 10.1111/j.1538-7836.2008.03102.x; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Crawford CM, 2003, J MANIP PHYSIOL THER, V26, P184, DOI 10.1016/S0161-4754(02)54111-7; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Elmore JR, 2009, J VASC SURG, V49, P1525, DOI 10.1016/j.jvs.2009.01.041; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Grootenboer N, 2009, EUR J VASC ENDOVASC, V38, P278, DOI 10.1016/j.ejvs.2009.05.004; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Iwashita S, 2008, MOL BIOSYST, V4, P213, DOI 10.1039/b716357f; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Ogata T, 2005, J VASC SURG, V42, P891, DOI 10.1016/j.jvs.2005.08.002; Prandoni P, 2007, J INTERN MED, V262, P341, DOI 10.1111/j.1365-2796.2007.01815.x; Qiu GH, 2007, J HEPATOL, V46, P655, DOI 10.1016/j.jhep.2006.11.012; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rice JA., 1995, MATH STAT DATA ANAL, V1, P308; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sandford RM, 2007, EUR J VASC ENDOVASC, V33, P381, DOI 10.1016/j.ejvs.2006.10.025; Shibamura H, 2004, CIRCULATION, V109, P2103, DOI 10.1161/01.CIR.0000127857.77161.A1; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Thompson AR, 2009, EUR J HUM GENET, V17, P391, DOI 10.1038/ejhg.2008.196; van Vlijmen-van Keulen CJ, 2005, EUR J VASC ENDOVASC, V30, P29, DOI 10.1016/j.ejvs.2004.12.029; Wahlgren CM, 2010, J VASC SURG, V51, P3, DOI 10.1016/j.jvs.2009.08.036; Weintraub NL, 2009, NEW ENGL J MED, V361, P1114, DOI 10.1056/NEJMcibr0905244; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168	37	141	148	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					692	U71		10.1038/ng.622	http://dx.doi.org/10.1038/ng.622			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20622881	Green Accepted			2022-12-17	WOS:000280524000014
J	Monti, J; Fischer, J; Paskas, S; Heinig, M; Schulz, H; Gosele, C; Heuser, A; Fischer, R; Schmidt, C; Schirdewan, A; Gross, V; Hummel, O; Maatz, H; Patone, G; Saar, K; Vingron, M; Weldon, SM; Lindpaintner, K; Hammock, BD; Rohde, K; Dietz, R; Cook, SA; Schunck, WH; Luft, FC; Hubner, N				Monti, Jan; Fischer, Judith; Paskas, Svetlana; Heinig, Matthias; Schulz, Herbert; Goesele, Claudia; Heuser, Arnd; Fischer, Robert; Schmidt, Cosima; Schirdewan, Alexander; Gross, Volkmar; Hummel, Oliver; Maatz, Henrike; Patone, Giannino; Saar, Kathrin; Vingron, Martin; Weldon, Steven M.; Lindpaintner, Klaus; Hammock, Bruce D.; Rohde, Klaus; Dietz, Rainer; Cook, Stuart A.; Schunck, Wolf-Hagen; Luft, Friedrich C.; Hubner, Norbert			Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE REGULATION; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; EJECTION FRACTION; NERVOUS-SYSTEM; IDENTIFICATION; MOUSE; MICE; ASSOCIATION	We aimed to identify genetic variants associated with heart failure by using a rat model of the human disease. We performed invasive cardiac hemodynamic measurements in F-2 crosses between spontaneously hypertensive heart failure ( SHHF) rats and reference strains. We combined linkage analyses with genome-wide expression profiling and identified Ephx2 as a heart failure susceptibility gene in SHHF rats. Specifically, we found that cis variation at Ephx2 segregated with heart failure and with increased transcript expression, protein expression and enzyme activity, leading to a more rapid hydrolysis of cardioprotective epoxyeicosatrienoic acids. To confirm our results, we tested the role of Ephx2 in heart failure using knockout mice. Ephx2 gene ablation protected from pressure overload-induced heart failure and cardiac arrhythmias. We further demonstrated differential regulation of EPHX2 in human heart failure, suggesting a cross-species role for Ephx2 in this complex disease.	[Monti, Jan; Fischer, Judith; Paskas, Svetlana; Heinig, Matthias; Schulz, Herbert; Goesele, Claudia; Heuser, Arnd; Fischer, Robert; Schmidt, Cosima; Gross, Volkmar; Hummel, Oliver; Maatz, Henrike; Patone, Giannino; Saar, Kathrin; Rohde, Klaus; Dietz, Rainer; Schunck, Wolf-Hagen; Luft, Friedrich C.; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Monti, Jan; Heuser, Arnd; Fischer, Robert; Schirdewan, Alexander; Dietz, Rainer] Charite Univ Med Berlin, HELIOS, Franz Volhard Clin, Dept Clin & Mol Cardiol, D-13125 Berlin, Germany; [Heinig, Matthias; Vingron, Martin] Max Planck Inst Mol Genet, Dept Bioinformat, D-14195 Berlin, Germany; [Weldon, Steven M.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Lindpaintner, Klaus] F Hoffmann La Roche, CH-4070 Basel, Switzerland; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Canc Res Ctr, Davis, CA 95616 USA; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Luft, Friedrich C.] Charite Univ Med Berlin, HELIOS, Franz Volhard Clin, Dept Nephrol Hypertens, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Boehringer Ingelheim; Roche Holding; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Imperial College London; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	nhuebner@mdc-berlin.de	Cook, Stuart/G-9567-2011	Fischer-Sternjak, Judith/0000-0003-0398-7720; Paskas, Svetlana/0000-0002-1206-5376; Cook, Stuart/0000-0001-6628-194X; Heinig, Matthias/0000-0002-5612-1720; Saar, Kathrin/0000-0002-4483-1557; Luft, Friedrich/0000-0002-8635-1199; Heuser, Arnd/0000-0002-3334-960X	MRC [MC_U120085815] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002710] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Medical Research Council [MC_U120085815] Funding Source: Medline; NIEHS NIH HHS [R37 ES02710, R37 ES002710] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Health		Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Bergman MR, 1999, AM J PHYSIOL-HEART C, V277, pH543, DOI 10.1152/ajpheart.1999.277.2.H543; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Fiala-Beer E, 2007, INT J BIOCHEM CELL B, V39, P1235, DOI 10.1016/j.biocel.2007.03.019; Frantz S, 2003, CARDIOVASC RES, V57, P749, DOI 10.1016/S0008-6363(02)00723-X; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; HAMMOCK BD, 1980, LIFE SCI, V27, P1635, DOI 10.1016/0024-3205(80)90636-0; Heyen JRR, 2002, AM J PHYSIOL-HEART C, V283, pH1775, DOI 10.1152/ajpheart.00305.2002; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2006, CARDIOVASC DRUG REV, V24, P169, DOI 10.1111/j.1527-3466.2006.00169.x; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; McCune SA, 1990, ILAR J, V32, P23; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PFEFFER MA, 1973, CIRC RES, V32, P28; Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Shorofsky SR, 1999, CIRC RES, V84, P424, DOI 10.1161/01.RES.84.4.424; Slama M, 2004, AM J PHYSIOL-HEART C, V286, pH181, DOI 10.1152/ajpheart.00642.2003; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103	49	141	150	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					529	537		10.1038/ng.129	http://dx.doi.org/10.1038/ng.129			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443590	Green Accepted			2022-12-17	WOS:000255366700018
J	Saar, K; Beck, A; Bihoreau, MT; Birney, E; Brocklebank, D; Chen, Y; Cuppen, E; Demonchy, S; Dopazo, J; Flicek, P; Foglio, M; Fujiyama, A; Gut, IG; Gauguier, D; Guigo, R; Guryev, V; Heinig, M; Hummel, O; Jahn, N; Klages, S; Kren, V; Kube, M; Kuhl, H; Kuramoto, T; Kuroki, Y; Lechner, D; Lee, YA; Lopez-Bigas, N; Lathrop, GM; Mashimo, T; Medina, I; Mott, R; Patone, G; Perrier-Cornet, JA; Platzer, M; Pravenec, M; Reinhardt, R; Sakaki, Y; Schilhabel, M; Schulz, H; Serikawa, T; Shikhagaie, M; Tatsumoto, S; Taudien, S; Toyoda, A; Voigt, B; Zelenika, D; Zimdahl, H; Hubner, N				Saar, Kathrin; Beck, Alfred; Bihoreau, Marie-Therese; Birney, Ewan; Brocklebank, Denise; Chen, Yuan; Cuppen, Edwin; Demonchy, Stephanie; Dopazo, Joaquin; Flicek, Paul; Foglio, Mario; Fujiyama, Asao; Gut, Ivo G.; Gauguier, Dominique; Guigo, Roderic; Guryev, Victor; Heinig, Matthias; Hummel, Oliver; Jahn, Niels; Klages, Sven; Kren, Vladimir; Kube, Michael; Kuhl, Heiner; Kuramoto, Takashi; Kuroki, Yoko; Lechner, Doris; Lee, Young-Ae; Lopez-Bigas, Nuria; Lathrop, G. Mark; Mashimo, Tomoji; Medina, Ignacio; Mott, Richard; Patone, Giannino; Perrier-Cornet, Jeanne-Antide; Platzer, Matthias; Pravenec, Michal; Reinhardt, Richard; Sakaki, Yoshiyuki; Schilhabel, Markus; Schulz, Herbert; Serikawa, Tadao; Shikhagaie, Medya; Tatsumoto, Shouji; Taudien, Stefan; Toyoda, Atsushi; Voigt, Birger; Zelenika, Diana; Zimdahl, Heike; Hubner, Norbert		STAR Consortium	SNP and haplotype mapping for genetic analysis in the rat	NATURE GENETICS			English	Article							WISTAR-KYOTO RATS; SEQUENCE; MOUSE; MAP; STRAINS; SET	The laboratory rat is one of the most extensively studied model organisms. Inbred laboratory rat strains originated from limited Rattus norvegicus founder populations, and the inherited genetic variation provides an excellent resource for the correlation of genotype to phenotype. Here, we report a survey of genetic variation based on almost 3 million newly identified SNPs. We obtained accurate and complete genotypes for a subset of 20,238 SNPs across 167 distinct inbred rat strains, two rat recombinant inbred panels and an F-2 intercross. Using 81% of these SNPs, we constructed high-density genetic maps, creating a large dataset of fully characterized SNPs for disease gene mapping. Our data characterize the population structure and illustrate the degree of linkage disequilibrium. We provide a detailed SNP map and demonstrate its utility for mapping of quantitative trait loci. This community resource is openly available and augments the genetic tools for this workhorse of physiological studies.	[Saar, Kathrin; Heinig, Matthias; Hummel, Oliver; Lee, Young-Ae; Patone, Giannino; Schulz, Herbert; Zimdahl, Heike; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-14195 Berlin, Germany; [Beck, Alfred; Klages, Sven; Kube, Michael; Kuhl, Heiner; Mott, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Bihoreau, Marie-Therese; Brocklebank, Denise; Gauguier, Dominique; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Birney, Ewan; Chen, Yuan; Flicek, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Cuppen, Edwin; Guryev, Victor] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Demonchy, Stephanie; Foglio, Mario; Gut, Ivo G.; Lechner, Doris; Lathrop, G. Mark; Perrier-Cornet, Jeanne-Antide; Zelenika, Diana] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atom, F-91057 Evry, France; [Dopazo, Joaquin; Medina, Ignacio] Ctr Invest Principe Felipe, Dept Bioinformat & Funct Genom Node, Valencia 46012, Spain; [Fujiyama, Asao; Kuroki, Yoko; Sakaki, Yoshiyuki; Tatsumoto, Shouji; Toyoda, Atsushi] RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Guigo, Roderic; Lopez-Bigas, Nuria] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Guigo, Roderic; Lopez-Bigas, Nuria; Shikhagaie, Medya] Univ Pompeu Fabra, Expt & Hlth Sci Dept, Barcelona 08003, Catalonia, Spain; [Jahn, Niels; Platzer, Matthias; Schilhabel, Markus; Taudien, Stefan] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800 2, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Kuramoto, Takashi; Mashimo, Tomoji; Serikawa, Tadao; Voigt, Birger] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan; [Lee, Young-Ae] Charite, Pediat Pneumol & Immunol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Prince Felipe Research Center; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Kyoto University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-14195 Berlin, Germany.	nhuebner@mdc-berlin.de	Medina, Ignacio/B-3045-2011; Foglio, mary A./B-9149-2012; Gauguier, Dominique/G-2190-2016; Kuhl, Heiner/L-2737-2019; Dopazo, Joaquin/A-9270-2014; Gut, Ivo/ABF-3188-2020; Guigo, Roderic/D-1303-2010; Gasull, Martina/J-4076-2019; Pravenec, Michal/B-1666-2012; Lopez-Bigas, Nuria/F-6193-2011; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Foglio, mary A./0000-0001-7715-4452; Gauguier, Dominique/0000-0001-6156-9530; Dopazo, Joaquin/0000-0003-3318-120X; Gut, Ivo/0000-0001-7219-632X; Guigo, Roderic/0000-0002-5738-4477; Pravenec, Michal/0000-0001-9197-5871; Lopez-Bigas, Nuria/0000-0003-4925-8988; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Birney, Ewan/0000-0001-8314-8497; Saar, Kathrin/0000-0002-4483-1557; Heinig, Matthias/0000-0002-5612-1720; Shikhagaie, Medya Mara/0000-0003-1978-8048; Guryev, Victor/0000-0002-5810-6022; Reinhardt, Richard/0000-0001-9376-2132; Flicek, Paul/0000-0002-3897-7955; Mott, Richard/0000-0002-1022-9330; Medina, Ignacio/0000-0003-0095-670X				Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Broman KW, 2005, GENETICS, V169, P1133, DOI 10.1534/genetics.104.035212; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, V3, P1154; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Guryev V, 2004, GENOME RES, V14, P1438, DOI 10.1101/gr.2154304; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; HEDRICH HJ, 1990, GENETIC MONITORING I; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; KURTZ TW, 1987, HYPERTENSION, V10, P127, DOI 10.1161/01.HYP.10.1.127; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mashimo T, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-19; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Oliphant A, 2002, BIOTECHNIQUES, P56; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Payseur BA, 2007, GENETICS, V175, P1999, DOI 10.1534/genetics.106.067868; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Shisa H, 1997, MAMM GENOME, V8, P324, DOI 10.1007/s003359900432; Smits BMG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-170; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas MA, 2003, MAMM GENOME, V14, P61, DOI 10.1007/s00335-002-2204-5; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	41	141	142	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					560	566		10.1038/ng.124	http://dx.doi.org/10.1038/ng.124			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443594	Green Accepted			2022-12-17	WOS:000255366700022
J	Conrad, DF; Hurles, ME				Conrad, Donald F.; Hurles, Matthew E.			The population genetics of structural variation	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; POSITIVE SELECTION; DELETION POLYMORPHISMS; RECURRENT DUPLICATION; FINITE POPULATION; NATURAL-SELECTION; HIGH-RESOLUTION	Population genetics is central to our understanding of human variation, and by linking medical and evolutionary themes, it enables us to understand the origins and impacts of our genomic differences. Despite current limitations in our knowledge of the locations, sizes and mutational origins of structural variants, our characterization of their population genetics is developing apace, bringing new insights into recent human adaptation, genome biology and disease. We summarize recent dramatic advances, describe the diverse mutational origins of chromosomal rearrangements and argue that their complexity necessitates a re-evaluation of existing population genetic methods.	[Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Conrad, Donald F.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Wellcome Trust Sanger Institute; University of Chicago	Hurles, ME (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	meh@sanger.ac.uk			Wellcome Trust [077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 1998, GENETICS, V148, P1397; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; HUDSON RR, 1994, GENETICS, V136, P1329; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; KIMURA M, 1964, GENETICS, V49, P725; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Li N, 2003, GENETICS, V165, P2213; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Turner DJ, 2006, NAT METHODS, V3, P439, DOI 10.1038/NMETH881; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VALDES AM, 1993, GENETICS, V133, P737; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	74	141	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S30	S36		10.1038/ng2042	http://dx.doi.org/10.1038/ng2042			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597779	Green Accepted			2022-12-17	WOS:000253974400006
J	den Hollander, AI; Koenekoop, RK; Mohamed, MD; Arts, HH; Boldt, K; Towns, KV; Sedmak, T; Beer, M; Nagel-Wolfrum, K; McKibbin, M; Dharmaraj, S; Lopez, I; Ivings, L; Williams, GA; Springell, K; Woods, CG; Jafri, H; Rashid, Y; Strom, TM; van der Zwaag, B; Gosens, I; Kersten, FFJ; van Wijk, E; Veltman, JA; Zonneveld, MN; van Beersum, SEC; Maumenee, IH; Wolfrum, U; Cheetham, ME; Ueffing, M; Cremers, FPM; Inglehearn, CF; Roepman, R				den Hollander, Anneke I.; Koenekoop, Robert K.; Mohamed, Moin D.; Arts, Heleen H.; Boldt, Karsten; Towns, Katherine V.; Sedmak, Tina; Beer, Monika; Nagel-Wolfrum, Kerstin; McKibbin, Martin; Dharmaraj, Sharola; Lopez, Irma; Ivings, Lenka; Williams, Grange A.; Springell, Kelly; Woods, C. Geoff; Jafri, Hussain; Rashid, Yasmin; Strom, Tim M.; van der Zwaag, Bert; Gosens, Ilse; Kersten, Ferry F. J.; van Wijk, Erwin; Veltman, Joris A.; Zonneveld, Marijke N.; van Beersum, Sylvia E. C.; Maumenee, Irene H.; Wolfrum, Uwe; Cheetham, Michael E.; Ueffing, Marius; Cremers, Frans P. M.; Inglehearn, Chris F.; Roepman, Ronald			Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis	NATURE GENETICS			English	Article							CASEIN KINASE-II; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; ASSOCIATION; NUCLEOLIN; INTERACTS; NUCLEOPHOSMIN/B23; PHOSPHORYLATION; LOCALIZATION; CENTRIOLES	Leber congenital amaurosis ( LCA) causes blindness or severe visual impairment at or within a few months of birth. Here we show, using homozygosity mapping, that the LCA5 gene on chromosome 6q14, which encodes the previously unknown ciliary protein lebercilin, is associated with this disease. We detected homozygous nonsense and frameshift mutations in LCA5 in five families affected with LCA. In a sixth family, the LCA5 transcript was completely absent. LCA5 is expressed widely throughout development, although the phenotype in affected individuals is limited to the eye. Lebercilin localizes to the connecting cilia of photoreceptors and to the microtubules, centrioles and primary cilia of cultured mammalian cells. Using tandem affinity purification, we identified 24 proteins that link lebercilin to centrosomal and ciliary functions. Members of this interactome represent candidate genes for LCA and other ciliopathies. Our findings emphasize the emerging role of disrupted ciliary processes in the molecular pathogenesis of LCA.	Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; McGill Univ, Hlth Sci Ctr, McGill Ocular Genet Ctr, Montreal, PQ H3A 2T5, Canada; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; St Thomas Hosp, Dept Ophthalmol, London, England; GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, Munich, Germany; Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany; Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; St James Univ Hosp, Eye Dept, Leeds, W Yorkshire, England; INRA, FLAVIC, Eye & Nutr Res Grp, Dijon, France; Addenbrookes Hosp, Cambridge Inst Med Tes, Dept Med Genet, Cambridge, England; Gene Tech Lab 146 1, Lahore, Pakistan; King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; Univ Utrecht, Med Ctr, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3508 TC Utrecht, Netherlands; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; UCL, Inst Ophthalmol, Div Mol & Cellular Neurosci, London WC1E 6BT, England	Radboud University Nijmegen; McGill University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Saint James's University Hospital; University of Leeds; Guy's & St Thomas' NHS Foundation Trust; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Saint James's University Hospital; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands.	a.denhollander@antrg.umcn.nl	Nagel-Wolfrum, Kerstin/AAX-6477-2020; arts, heleen/ACL-6040-2022; Roepman, Ronald/B-1339-2014; Hollander, Anneke den/N-4911-2014; Koenekoop, Robert/AAT-6676-2021; Veltman, Joris A/F-5128-2010; Kersten, Ferry F.J./ABC-7666-2020; Boldt, Karsten/B-7538-2014; Inglehearn, Chris/GYD-9783-2022; Cremers, Frans/A-5625-2014; van Beersum, Sylvia E.C./P-8653-2015; woods, christopher g/A-1361-2010; van Wijk, Erwin/J-8913-2014; Cheetham, Michael/B-4672-2011	Roepman, Ronald/0000-0002-5178-8163; Veltman, Joris A/0000-0002-3218-8250; Cremers, Frans/0000-0002-4954-5592; van Beersum, Sylvia E.C./0000-0002-4552-2908; van Wijk, Erwin/0000-0002-5702-3460; Arts, Heleen/0000-0002-9860-3744; Cheetham, Michael/0000-0001-6429-654X	Wellcome Trust [061682, 068579, 073477] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chen CY, 2006, BIOCHEM BIOPH RES CO, V342, P1203, DOI 10.1016/j.bbrc.2006.02.089; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dharmaraj S, 2000, AM J HUM GENET, V66, P319, DOI 10.1086/302719; Faust M, 2002, CELL MOL LIFE SCI, V59, P2155, DOI 10.1007/s000180200022; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Ginisty H, 1999, J CELL SCI, V112, P761; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Lim ACB, 2004, J BIOL CHEM, V279, P4433, DOI 10.1074/jbc.M310563200; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Mohamed MD, 2003, BRIT J OPHTHALMOL, V87, P473, DOI 10.1136/bjo.87.4.473; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	30	141	146	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					889	895		10.1038/ng2066	http://dx.doi.org/10.1038/ng2066			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546029				2022-12-17	WOS:000247619800020
J	Francino, MP				Francino, MP			An adaptive radiation model for the origin of new gene functions	NATURE GENETICS			English	Article							OLFACTORY RECEPTOR GENES; AMPLIFICATION-MUTAGENESIS; TRANSFERRED GENES; NATURAL-SELECTION; GENOME EVOLUTION; FAMILY; DUPLICATION; BACTERIAL; MUTATION; GROWTH	Current models for the evolution of new gene functions after gene duplication presume that the duplication events themselves have no effect on fitness. But those duplications that result in new gene functions are likely to be positively selected from their inception. The evolution of new function may start with the amplification of an existing gene with some level of preadaptation for that function, followed by a period of competitive evolution among the gene copies, resulting in the preservation of the most effective variant and the 'pseudogenization' and eventual loss of the rest.	Lawrence Berkeley Natl Lab, DOE Joint Genome Inst, Evolutionary Genom Dept, Walnut Creek, CA 94598 USA; Lawrence Berkeley Natl Lab, Genom Div, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Francino, MP (corresponding author), Lawrence Berkeley Natl Lab, DOE Joint Genome Inst, Evolutionary Genom Dept, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	mpfrancino@lbl.gov	Francino, M.Pilar/H-9090-2015	Francino, M.Pilar/0000-0002-4510-5653				Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; CAIRNS J, 1991, GENETICS, V128, P695; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Eldredge N., 1972, P82; Force A, 1999, GENETICS, V151, P1531; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Guillemaud T, 1999, HEREDITY, V83, P87, DOI 10.1038/sj.hdy.6885370; Hall BG, 2003, GENETICA, V118, P143, DOI 10.1023/A:1024149508376; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hendrickson H, 2002, P NATL ACAD SCI USA, V99, P2164, DOI 10.1073/pnas.032680899; Holloway AK, 2004, MOL BIOL EVOL, V21, P1625, DOI 10.1093/molbev/msh195; Hooper SD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r48; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Huynen MA, 1998, MOL BIOL EVOL, V15, P583, DOI 10.1093/oxfordjournals.molbev.a025959; Jablonski David, 1996, P256; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Karev GP, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-18; Karev GP, 2003, BIOINFORMATICS, V19, P1889, DOI 10.1093/bioinformatics/btg351; Kim SJ, 1999, BIOTECHNOL BIOENG, V64, P741, DOI 10.1002/(SICI)1097-0290(19990920)64:6<741::AID-BIT14>3.0.CO;2-X; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Newman T, 2003, GENOME RES, V13, P781, DOI 10.1101/gr.769003; Ohno S., 1970, EVOLUTION GENE DUPLI; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Reams AB, 2003, MOL MICROBIOL, V47, P1291, DOI 10.1046/j.1365-2958.2003.03342.x; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Roth JR, 2004, J BACTERIOL, V186, P4855, DOI 10.1128/JB.186.15.4855-4860.2004; Roth JR, 2004, RES MICROBIOL, V155, P342, DOI 10.1016/j.resmic.2004.01.016; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Stanley SM., 1979, MACROEVOLUTION PATTE; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Wagner A, 2002, GENOME BIOL, V3; Wagner PJ, 1996, EVOLUTION, V50, P990, DOI 10.1111/j.1558-5646.1996.tb02341.x; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101	59	141	145	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					573	577		10.1038/ng1579	http://dx.doi.org/10.1038/ng1579			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15920518	Green Submitted			2022-12-17	WOS:000229495300007
J	Rokyta, DR; Joyce, P; Caudle, SB; Wichman, HA				Rokyta, DR; Joyce, P; Caudle, SB; Wichman, HA			An empirical test of the mutational landscape model of adaptation using a single-stranded DNA virus	NATURE GENETICS			English	Article							POPULATION-GENETICS; EVOLUTION	The primary impediment to formulating a general theory for adaptive evolution has been the unknown distribution of fitness effects for new beneficial mutations(1). By applying extreme value theory(2), Gillespie circumvented this issue in his mutational landscape model for the adaptation of DNA sequences(3-5), and Orr recently extended Gillespie's model(1,6), generating testable predictions regarding the course of adaptive evolution. Here we provide the first empirical examination of this model, using a single-stranded DNA bacteriophage related to phi X174, and find that our data are consistent with Orr's predictions, provided that the model is adjusted to incorporate mutation bias. Orr's work suggests that there may be generalities in adaptive molecular evolution that transcend the biological details of a system, but we show that for the model to be useful as a predictive or inferential tool, some adjustments for the biology of the system will be necessary.	Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; Univ Idaho, Program Bioinformat & Computat Biol, Moscow, ID 83844 USA; Univ Idaho, Initiat Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA; Univ Idaho, Dept Math, Moscow, ID 83844 USA; Univ Idaho, Dept Stat, Moscow, ID 83844 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Wichman, HA (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	hwichman@uidaho.edu		Rokyta, Darin/0000-0002-0356-2178				Fisher R., 1930, GENETICAL THEORY NAT; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI [10.2307/2408444, 10.1111/j.1558-5646.1984.tb00380.x]; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Gillespie JH, 1991, CAUSES MOL EVOLUTION; Gumbel E., 1958, STAT EXTREMES; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hartl DL, 1998, GENETICA, V102-3, P525, DOI 10.1023/A:1017071901530; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 2003, J THEOR BIOL, V220, P241, DOI 10.1006/jtbi.2003.3161; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; Rokyta D, 2002, MOL BIOL EVOL, V19, P230, DOI 10.1093/oxfordjournals.molbev.a004076; Swofford DL, 1998, PHYLOGENETIC ANAL US; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahl LM, 2002, GENETICS, V162, P961; Wahl LM, 2001, EVOLUTION, V55, P2606	18	141	143	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					441	444		10.1038/ng1535	http://dx.doi.org/10.1038/ng1535			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15778707				2022-12-17	WOS:000228040000030
J	Kong, A; Barnard, J; Gudbjartsson, DF; Thorleifsson, G; Jonsdottir, G; Sigurdardottir, S; Richardsson, B; Jonsdottir, J; Thorgeirsson, T; Frigge, ML; Lamb, NE; Sherman, S; Gulcher, JR; Stefansson, K				Kong, A; Barnard, J; Gudbjartsson, DF; Thorleifsson, G; Jonsdottir, G; Sigurdardottir, S; Richardsson, B; Jonsdottir, J; Thorgeirsson, T; Frigge, ML; Lamb, NE; Sherman, S; Gulcher, JR; Stefansson, K			Recombination rate and reproductive success in humans	NATURE GENETICS			English	Article							MAXIMUM-LIKELIHOOD; LINKAGE ANALYSIS; MATERNAL AGE; NAIL-PATELLA; SEX; MEIOSIS; NONDISJUNCTION; CHROMOSOME-21; FRACTIONS; MAMMALS	Intergenerational mixing of DNA through meiotic recombinations of homologous chromosomes during gametogenesis is a major event that generates diversity in the eukaryotic genome. We examined genome-wide microsatellite data for 23,066 individuals, providing information on recombination events of 14,140 maternal and paternal meioses each, and found a positive correlation between maternal recombination counts of an offspring and maternal age. We postulated that the recombination rate of eggs does not increase with maternal age, but that the apparent increase is the consequence of selection. Specifically, a high recombination count increased the chance of a gamete becoming a live birth, and this effect became more pronounced with advancing maternal age. Further support for this hypothesis came from our observation that mothers with high oocyte recombination rate tend to have more children. Hence, not only do recombinations have a role in evolution by yielding diverse combinations of gene variants for natural selection, but they are also under selection themselves.	deCODE Genet, IS-101 Reykjavik, Iceland; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA; Emory Univ, Dept Human Genet, Atlanta, GA USA	Cleveland Clinic Foundation; Emory University	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019	Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Thorgeirsson, Thorgeir/0000-0002-5149-7040				Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; ELSTON RC, 1976, AM J HUM GENET, V28, P69; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Haines J L, 1993, Prog Clin Biol Res, V384, P51; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; Hodges CA, 2002, HUM REPROD, V17, P1171, DOI 10.1093/humrep/17.5.1171; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Little RJ, 1987, STAT ANAL MISSING DA; LYNCH M, 1998, GENETICS ANAL QUANTU; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; POLANI PE, 1991, HUM GENET, V88, P64, DOI 10.1007/BF00204931; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; Quintana FA, 1999, COMPUT STAT DATA AN, V29, P429, DOI 10.1016/S0167-9473(98)00075-9; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; Robinson WP, 1998, HUM MOL GENET, V7, P1011, DOI 10.1093/hmg/7.6.1011; SPEED RM, 1983, CHROMOSOMA, V88, P184, DOI 10.1007/BF00285618; TANZI RE, 1992, AM J HUM GENET, V50, P551; WEITKAMP LR, 1973, HUM HERED, V23, P197, DOI 10.1159/000152574	27	141	149	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1203	1206		10.1038/ng1445	http://dx.doi.org/10.1038/ng1445			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15467721	Bronze			2022-12-17	WOS:000224832800024
J	Kim, MJ; Park, BJ; Kang, YS; Kim, HJ; Park, JH; Kang, JW; Lee, SW; Han, JM; Lee, HW; Kim, S				Kim, MJ; Park, BJ; Kang, YS; Kim, HJ; Park, JH; Kang, JW; Lee, SW; Han, JM; Lee, HW; Kim, S			Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation	NATURE GENETICS			English	Article							FAR UPSTREAM ELEMENT; SURFACTANT; MICE; GENE; IDENTIFICATION; TRANSCRIPTION; PROLIFERATION; DEFECTS; COMPLEX; GROWTH	p38 is associated with a macromolecular tRNA synthetase complex(1). It has an essential role as a scaffold for the complex, and genetic disruption of p38 in mice causes neonatal lethality(2). Here we investigated the molecular mechanisms underlying lethality of p38-mutant mice. p38-deficient mice showed defects in lung differentiation and respiratory distress syndrome. p38 was found to interact with FUSE-binding protein (FBP), a transcriptional activator of c-myc(3). Binding of p38 stimulated ubiquitination and degradation of FBP, leading to downregulation of c-myc, which is required for differentiation of functional alveolar type II cells. Transforming growth factor-beta (TGF-beta) induced p38 expression and promoted its translocation to nuclei for the regulation of FBP and c-myc. Thus, this work identified a new activity of p38 as a mediator of TGF-beta signaling and its functional importance in the control of c-myc during lung differentiation.	Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea; Seoul Natl Univ, Biotechnol Incubat Ctr, Seoul 151742, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU)	Kim, S (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Han, Jung Min/0000-0003-3372-7575				Ben-Izhak O, 2002, HISTOPATHOLOGY, V41, P519, DOI 10.1046/j.1365-2559.2002.01444.x; Chinoy MR, 2001, PEDIATR PULM, V32, P129, DOI 10.1002/ppul.1099.abs; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Duncan R, 1996, MOL CELL BIOL, V16, P2274; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Ehrhardt A, 2001, BRIT J CANCER, V84, P813, DOI 10.1054/bjoc.2000.1676; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1183/09031936.99.13614779; Guo QM, 2000, CANCER RES, V60, P5922; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594; Kang J, 2000, J BIOL CHEM, V275, P31682, DOI 10.1074/jbc.M909965199; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; NICOLAIDES NC, 1995, GENOMICS, V29, P329, DOI 10.1006/geno.1995.9997; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; SUGAHARA K, 1994, AM J RESP CELL MOL, V11, P397, DOI 10.1165/ajrcmb.11.4.7917308; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wang XJ, 1998, NEUROSCI LETT, V252, P191, DOI 10.1016/S0304-3940(98)00598-9; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Zhou MY, 1996, J BIOL CHEM, V271, P24769, DOI 10.1074/jbc.271.40.24769	29	141	160	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					330	336		10.1038/ng1182	http://dx.doi.org/10.1038/ng1182			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12819782				2022-12-17	WOS:000183815300023
J	Coghill, EL; Hugill, A; Parkinson, N; Davison, C; Glenister, P; Clements, S; Hunter, J; Cox, RD; Brown, SDM				Coghill, EL; Hugill, A; Parkinson, N; Davison, C; Glenister, P; Clements, S; Hunter, J; Cox, RD; Brown, SDM			A gene-driven approach to the identification of ENU mutants in the mouse	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; SENSORINEURAL DEAFNESS; CONNEXIN-26 MUTATIONS; GENOME-WIDE; MICE; MUTAGENESIS	The construction of parallel archives of DNA and sperm from mice mutagenized with ethylnitrosurea (ENU) represents a potentially powerful and rapid approach for identifying point mutations in any gene in the mouse genome. We provide support for this approach and report the identification of mutations in the gene (Gjb2) encoding connexin 26, using archives established from the UK ENU mutagenesis program.	MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England; UK Mouse Genome Ctr, Harwell OX11 0RD, Berks, England; GlaxoSmithKline, Harlow CM19 5AW, Essex, England	GlaxoSmithKline	Brown, SDM (corresponding author), MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England.			Cox, Roger/0000-0001-7170-5014				Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Gabriel HD, 1998, J CELL BIOL, V140, P1453, DOI 10.1083/jcb.140.6.1453; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Munroe RJ, 2000, NAT GENET, V24, P318, DOI 10.1038/73563; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; STEEL KP, 1996, WHATS WRONG MY MOUSE, P26; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145	15	141	145	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2002	30	3					255	256		10.1038/ng847	http://dx.doi.org/10.1038/ng847			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	526YP	11850622				2022-12-17	WOS:000174157600007
J	Nakano, M; Yamada, K; Fain, J; Sener, EC; Selleck, CJ; Awad, AH; Zwaan, J; Mullaney, PB; Bosley, TM; Engle, EC				Nakano, M; Yamada, K; Fain, J; Sener, EC; Selleck, CJ; Awad, AH; Zwaan, J; Mullaney, PB; Bosley, TM; Engle, EC			Homozygous mutations in ARIX (PHOX2A) result in congenital fibrosis of the extraocular muscles type 2	NATURE GENETICS			English	Article							DUANES RETRACTION SYNDROME; HOMEODOMAIN PROTEIN; GENE; TRANSCRIPTION; MAPS; EXPRESSION; PROMOTER; DEFECTS	Isolated strabismus affects 1-5% of the general population(1). Most forms of strabismus are multifactorial in origin; although there is probably an inherited component, the genetics of these disorders remain unclear. The congenital fibrosis syndromes (CFS) represent a subset of monogenic isolated strabismic disorders that are characterized by restrictive ophthalmoplegia, and include congenital fibrosis of the extraocular muscles (CFEOM) and Duane syndrome (DURS)(2). Neuropathologic studies indicate that these disorders may result from the maldevelopment of the oculomotor (nIII), trochlear (nIV) and abducens (nVI) cranial nerve nuclei(3-5). To date, five CFS loci have been mapped (FEOM1, FEOM2, FEOM3, DURS1 and DURS2)(6-10), but no genes have been identified. Here, we report three mutations in ARIX (also known as PHOX2A) in four CFEOM2 pedigrees. ARIX encodes a homeodomain transcription factor protein previously shown to be required for nIIInIV development in mouse and zebrafish(1,12). Two of the mutations are predicted to disrupt splicing, whereas the third alters an amino acid within the conserved brachyury-like domain(13,14). These findings confirm the hypothesis that CFEOM2 results from the abnormal development of nIII/nIV (ref. 7) and emphasize a critical role for ARIX in the development of these midbrain motor nuclei(13-19).	Hacettepe Univ, Ankara, Turkey; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA; King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Hacettepe University; Harvard University; Boston Children's Hospital; Harvard Medical School; King Khaled Eye Specialist Hospital; University of Texas System; University of Texas Health San Antonio	Engle, EC (corresponding author), Hacettepe Univ, Ankara, Turkey.	engle@enders.tch.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012498] Funding Source: NIH RePORTER; NEI NIH HHS [EY12498] Funding Source: Medline; NICHD NIH HHS [P30HD18655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Appukuttan B, 1999, AM J HUM GENET, V65, P1639, DOI 10.1086/302656; Brown HW., 1950, STRABISMUS OPHTHALMI, P205; Doherty EJ, 1999, INVEST OPHTH VIS SCI, V40, P1687; Engle EC, 1997, AM J HUM GENET, V60, P1150; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; Engle EC, 1998, OX MG MED G, P477; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; ROBERTSON D, 1991, HYPERTENSION, V18, P1, DOI 10.1161/01.HYP.18.1.1; Ross M.T., 1999, CURRENT PROTOCOLS HU; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Swanson DJ, 2000, J BIOL CHEM, V275, P2911, DOI 10.1074/jbc.275.4.2911; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; VALARCHE I, 1993, DEVELOPMENT, V119, P881; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859; Wang SM, 1998, AM J HUM GENET, V63, P517, DOI 10.1086/301980; Yang CY, 1998, J NEUROCHEM, V71, P1813; Zellmer E, 1995, J NEUROSCI, V15, P8109; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	30	141	157	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					315	320		10.1038/ng744	http://dx.doi.org/10.1038/ng744			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11600883				2022-12-17	WOS:000171911000019
J	Vingsbo-Lundberg, C; Nordquist, N; Olofsson, P; Sundvall, M; Saxne, T; Pettersson, U; Holmdahl, R				Vingsbo-Lundberg, C; Nordquist, N; Olofsson, P; Sundvall, M; Saxne, T; Pettersson, U; Holmdahl, R			Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats	NATURE GENETICS			English	Article							BB RAT; SUSCEPTIBILITY	Rheumatoid arthritis (RA) is a chronic and genetically complex inflammatory disorder that leads to erosive destruction of peripheral joints(1-5). The use of animal models mimicking RA, such as pristane-induced arthritis (PIA) in rats, should facilitate its genetic analysis. Pristane is a non-immunogenic synthetic oil that, after a single subcutaneous injection into DA rats, induces arthritis restricted to peripheral joints with a chronic relapsing disease course(6). To identify genes involved in the control of chronic arthritis, we made crosses between susceptible DA rats and resistant E3 rats and analysed the progeny with microsatellite markers covering the entire rat genome. Our results show that different arthritis phenotypes are associated with different chromosomal loci. Loci on chromosomes 4 and 6 (Pia2 and Pia3) influence arthritis onset, whereas a locus on chromosome 12 (Pia4) is associated with severity and joint erosion. We found that chronicity is associated with a different set of loci, one on chromosome 4 and the other on chromosome 14 (Pia5, Pia6). These findings demonstrate for the first time that different phases of a chronic self-perpetuative disease which mimics RA are associated with distinct sets of genes.	Univ Lund, Dept Cell & Mol Biol, Sect Med Inflammat Res, Lund, Sweden; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Univ Lund, Dept Cell & Mol Biol, Sect Connect Tissue Res, Lund, Sweden; Univ Lund, Dept Rheumatol, Lund, Sweden	Lund University; Uppsala University; Lund University; Lund University	Holmdahl, R (corresponding author), Univ Lund, Dept Cell & Mol Biol, Sect Med Inflammat Res, Lund, Sweden.	rikard.holmdahl@inflam.lu.se	Holmdahl, Rikard/AAI-7682-2020; Nordquist, Niklas/B-9334-2011	Nordquist, Niklas/0000-0002-3864-937X; Olofsson, Peter/0000-0003-4849-8541				GOUGH A, 1994, ARTHRITIS RHEUM, V37, P1166, DOI 10.1002/art.1780370809; Holmdahl R, 1998, HUMAN GENOME METHODS, P215; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LINCOLN S, 1992, MAPPING GENES CONTRO; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Lorentzen JC, 1998, P NATL ACAD SCI USA, V95, P6383, DOI 10.1073/pnas.95.11.6383; MANSSON B, 1995, J CLIN INVEST, V95, P1071, DOI 10.1172/JCI117753; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PETTERSSON A, 1995, J AUTOIMMUN, V8, P493, DOI 10.1016/0896-8411(95)90004-7; Remmers EF, 1996, NAT GENET, V14, P82, DOI 10.1038/ng0996-82; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Vingsbo-Lundberg C, 1998, ARTHRITIS RHEUM, V41, P544, DOI 10.1002/1529-0131(199803)41:3<544::AID-ART21>3.0.CO;2-#; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343	17	141	147	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					401	404		10.1038/3887	http://dx.doi.org/10.1038/3887			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843218	Green Published			2022-12-17	WOS:000077199600033
J	Itzhaki, JE; Gilbert, CS; Porter, ACG				Itzhaki, JE; Gilbert, CS; Porter, ACG			Construction by gene targeting in human cells of a 'conditional' CDC2 mutant that rereplicates its DNA	NATURE GENETICS			English	Article							COLI LAC REPRESSOR; INTERFERON-INDUCIBLE GENE; HAMSTER OVARY CELLS; MAMMALIAN-CELLS; PROTEIN-KINASE; FISSION YEAST; S-PHASE; EUKARYOTIC CELLS; CYCLE REGULATION; ANIMAL-CELLS	We describe a novel gene targeting strategy for the genetic analysis of essential genes in mammalian cells and its use to study the role of the cell cycle control gene CDC2 in human cells. A cell line (HT2-19) was generated in which endogenous CDC2 gene expression and cell viability depend on the presence of an inducer in the growth medium. In the absence of inducer, HT2-19 cells undergo extensive DNA rereplication and apoptosis. Rereplication is indicative of a role for human CDC2 in a control mechanism, previously undetected in mammalian cells, that prevents premature entry into S-phase.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, MRC, CTR CLIN SCI, LONDON W12 0NN, ENGLAND; IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND	Imperial College London; Cancer Research UK					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADACHI Y, 1994, EMBO J, V13, P4153, DOI 10.1002/j.1460-2075.1994.tb06733.x; BORDES JC, 1995, CELL, V83, P1001; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; BRUNO S, 1992, CANCER RES, V52, P470; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DURSO G, 1995, CURR OPIN GENET DEV, V5, P12, DOI 10.1016/S0959-437X(95)90047-0; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; FORSBURG SL, 1991, ANNU REV CELL BIOL, V7, P227, DOI 10.1146/annurev.cb.07.110191.001303; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HAMAGUCHI JR, 1992, J CELL BIOL, V117, P1041, DOI 10.1083/jcb.117.5.1041; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Harlow E LD, 1988, ANTIBODIES LAB MANUA; Hayashi S, 1996, DEVELOPMENT, V122, P1051; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; HERZINGER T, 1995, ONCOGENE, V11, P2151; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; ITZHAKI JE, 1992, NAT GENET, V2, P283, DOI 10.1038/ng1292-283; ITZHAKI JE, 1991, NUCLEIC ACIDS RES, V19, P3835, DOI 10.1093/nar/19.14.3835; KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; LOCK RB, 1990, CANCER RES, V50, P3761; LOCK RB, 1992, CANCER RES, V52, P1817; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NORBURY C, 1994, BIOCHEM BIOPH RES CO, V202, P1400, DOI 10.1006/bbrc.1994.2086; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; ONGKEKO W, 1995, J CELL SCI, V108, P2897; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; Porter A. C. G., 1989, Technique, A Journal of Methods in Cell and Molecular Biology, V1, P53; PORTER ACG, 1993, EUR J BIOCHEM, V218, P273, DOI 10.1111/j.1432-1033.1993.tb18375.x; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TANG FJK, 1989, J HISTOCHEM CYTOCHEM, V37, P697, DOI 10.1177/37.5.2703705; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; TRAGANOS F, 1994, J CELL PHYSIOL, V158, P535, DOI 10.1002/jcp.1041580320; TSAI LH, 1993, ONCOGENE, V8, P1593; TSAO YP, 1992, CANCER RES, V52, P1823; USUI T, 1991, J CELL BIOL, V115, P1275, DOI 10.1083/jcb.115.5.1275; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093; WYBORSKI DL, 1991, NUCLEIC ACIDS RES, V19, P4647, DOI 10.1093/nar/19.17.4647; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X; Zhang Y, 1996, J BIOL CHEM, V271, P4266	68	141	148	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					258	265		10.1038/ng0397-258	http://dx.doi.org/10.1038/ng0397-258			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054937				2022-12-17	WOS:A1997WK38600014
J	Mazoyer, S; Dunning, AM; Serova, O; Dearden, J; Puget, N; Healey, CS; Gayther, SA; Mangion, J; Stratton, MR; Lynch, HT; Goldgar, DE; Ponder, BAJ; Lenoir, GM				Mazoyer, S; Dunning, AM; Serova, O; Dearden, J; Puget, N; Healey, CS; Gayther, SA; Mangion, J; Stratton, MR; Lynch, HT; Goldgar, DE; Ponder, BAJ; Lenoir, GM			A polymorphic stop codon in BRCA2	NATURE GENETICS			English	Letter							CANCER; GENE		INT AGCY RES CANC,F-69372 LYON 08,FRANCE; UNIV LYON 1,UMR 5641 CNRS,GENET LAB,F-69008 LYON,FRANCE; ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 2QQ,ENGLAND; INST CANC RES,SECT MOL CARCINOGENESIS,SUTTON SN2 5NG,SURREY,ENGLAND; CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE	World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Institute of Cancer Research - UK; Creighton University			PUGET, Nadine/AAB-9689-2020; Mazoyer, Sylvie/N-7559-2017	Dunning, Alison Margaret/0000-0001-6651-7166; PUGET, Nadine/0000-0003-4046-737X; Mazoyer, Sylvie/0000-0002-2135-0160				Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; DUNNING AM, 1992, AM J HUM GENET, V50, P208; FRIEND S, 1995, NAT GENET, V11, P238, DOI 10.1038/ng1195-238; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; RIBOLI E, 1992, ANN ONCOL, V3, P783, DOI 10.1093/oxfordjournals.annonc.a058097; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	8	141	143	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					253	254		10.1038/ng1196-253	http://dx.doi.org/10.1038/ng1196-253			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896551				2022-12-17	WOS:A1996VQ14600016
J	Donovan, MJ; Hahn, R; Tessarollo, L; Hempstead, BL				Donovan, MJ; Hahn, R; Tessarollo, L; Hempstead, BL			Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development	NATURE GENETICS			English	Letter							NEURAL CREST CELLS; NERVOUS-SYSTEM; TARGETED DISRUPTION; MESSENGER-RNA; TRKC; RECEPTORS; EXPRESSION; HEART; GENE; RAT		NCI,FREDERICK CANC RES & DEV CTR,NEURAL DEV GRP,ABL BASIC RES PROGRAM,FREDERICK,MD 21702; CHILDRENS HOSP,DEPT PATHOL,BOSTON,MA 02115; CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Boston Children's Hospital; Cornell University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auerbach, 1991, DEV VASCULAR SYSTEM, P25; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; BRILL G, 1995, DEVELOPMENT, V121, P2583; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; BROWN NA, 1990, POSTIMPLANTATION MAM, P930; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FRIEDMAN WF, 1988, HEART DIS TXB CARDIO, P895; ICARDO JM, 1992, HEART CARDIOVASCULAR, P1563; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KAHANE N, 1994, J NEUROBIOL, V25, P571, DOI 10.1002/neu.480250509; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KIRBY ML, 1993, DEV DYNAM, V198, P296, DOI 10.1002/aja.1001980407; KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LAMBALLE F, 1994, J NEUROSCI, V14, P14; RAFFIONI S, 1993, ANNU REV BIOCHEM, V62, P823; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TOJO H, 1995, BRAIN RES, V669, P163, DOI 10.1016/0006-8993(94)01219-8; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A	25	141	151	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					210	213		10.1038/ng1096-210	http://dx.doi.org/10.1038/ng1096-210			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841198	Green Published			2022-12-17	WOS:A1996VL44600032
J	SABATE, O; HORELLOU, P; VIGNE, E; COLIN, P; PERRICAUDET, M; BUCCARON, MH; MALLET, J				SABATE, O; HORELLOU, P; VIGNE, E; COLIN, P; PERRICAUDET, M; BUCCARON, MH; MALLET, J			TRANSPLANTATION TO THE RAT-BRAIN OF HUMAN NEURAL PROGENITORS THAT WERE GENETICALLY-MODIFIED USING ADENOVIRUSES	NATURE GENETICS			English	Article							CENTRAL-NERVOUS-SYSTEM; INVIVO GENE-TRANSFER; PARKINSONS-DISEASE; PRECURSOR CELLS; NEURONS; DIFFERENTIATION; PROLIFERATION; DOPAMINE; VECTOR; MODEL	Transplantations for neurological disorders are limited by the supply of human fetal tissue. To generate larger numbers of cells of appropriate phenotype, we investigated whether human neural progenitors expanded in vitro could be modified with recombinant adenoviruses. Strong expression of beta-galactosidase was obtained in vitro. Two or three weeks after transplantation of engineered cells to the rat brain, we observed a small percentage of surviving neuroblasts strongly expressing beta-galactosidase in four out of 13 rats. Thus human precursor cells that have been genetically modified using adenoviruses are a promising tool for ex vivo gene therapy of neurodegenerative diseases.	CNRS,GENET MOLEC NEUROTRANSMISS & PROCESSUS NEURODEGEN,F-91198 GIF SUR YVETTE,FRANCE; INST GUSTAVE ROUSSY,CNRS,URA 1301,F-94805 VILLEJUIF,FRANCE; INST PASTEUR,DEPT BIOL MOLEC,F-75274 PARIS 15,FRANCE; INST PASTEUR,CNRS,ERS 67,F-75274 PARIS 15,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite			Horellou, Philippe/B-4290-2019	Horellou, Philippe/0000-0003-2467-8177				ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BJORKLUND A, 1993, NATURE, V362, P414, DOI 10.1038/362414a0; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; BRUNDIN P, 1992, NEURAL TRANSPLANTATI, V8, P139; BUCCARON MH, IN PRESS NEUROBIOL D; CAILLAUD C, 1993, EUR J NEUROSCI, V5, P1287, DOI 10.1111/j.1460-9568.1993.tb00914.x; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DENOULET P, 1986, GENE, V50, P289, DOI 10.1016/0378-1119(86)90333-1; DURING MJ, 1994, SCIENCE, V266, P1399, DOI 10.1126/science.266.5189.1399; FISHER LJ, 1991, NEURON, V6, P371, DOI 10.1016/0896-6273(91)90246-V; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; HORELLOU P, 1990, NEURON, V5, P393, DOI 10.1016/0896-6273(90)90078-T; HORELLOU P, 1994, NEUROREPORT, V6, P49, DOI 10.1097/00001756-199412300-00014; HORELLOU P, 1993, SEMIN NEUROSCI, V5, P453; JIAO SS, 1993, NATURE, V362, P450, DOI 10.1038/362450a0; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; KATO K, 1984, NEUROCHEM INT, V6, P51, DOI 10.1016/0197-0186(84)90025-1; LAL B, 1994, J HISTOCHEM CYTOCHEM, V42, P953, DOI 10.1177/42.7.8014479; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LEVALLOIS C, 1994, CR ACAD SCI III-VIE, V317, P495; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RIDOUX V, 1994, NEUROREPORT, V5, P801, DOI 10.1097/00001756-199403000-00016; SHIMOHAMA S, 1989, MOL BRAIN RES, V5, P271, DOI 10.1016/0169-328X(89)90061-2; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; STAGAARD M, 1989, ANAT EMBRYOL, V180, P17, DOI 10.1007/BF00321896; STRATFORDPERRIC.LD, 1992, J CLIN INVEST, V90, P626; TOHYAMA T, 1991, J COMP NEUROL, V310, P285, DOI 10.1002/cne.903100302; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362	41	141	150	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					256	260		10.1038/ng0395-256	http://dx.doi.org/10.1038/ng0395-256			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773288				2022-12-17	WOS:A1995QL23200014
J	TEMPLE, IK; JAMES, RS; CROLLA, JA; SITCH, FL; JACOBS, PA; HOWELL, WM; BETTS, P; BAUM, JD; SHIELD, JPH				TEMPLE, IK; JAMES, RS; CROLLA, JA; SITCH, FL; JACOBS, PA; HOWELL, WM; BETTS, P; BAUM, JD; SHIELD, JPH			AN IMPRINTED GENE(S) FOR DIABETES	NATURE GENETICS			English	Letter							TRANSIENT		SALISBURY HLTH CARE NHS TRUST, WESSEX REG GENET LAB, SALISBURY, WILTS, ENGLAND; SOUTHAMPTON UNIV HOSP TRUST, DEPT CHILD HLTH, WESSEX HISTOCOMPATIBIL SERV, SOUTHAMPTON, HANTS, ENGLAND; INST CHILD HLTH, DEPT CHILD HLTH, BRISTOL, AVON, ENGLAND	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Bristol	TEMPLE, IK (corresponding author), SOUTHAMPTON UNIV HOSP TRUST, PRINCESS ANNE HOSP, WESSEX CLIN GENET SERV, COXFORD RD, SOUTHAMPTON SO16 5YA, HANTS, ENGLAND.		Shield, Julian PH/D-6297-2014; temple, isabel K/K-2391-2015	Shield, Julian PH/0000-0003-2601-7575; Temple, Isabel Karen/0000-0002-6045-1781				ABRAMOWICZ MJ, 1994, J CLIN INVEST, V94, P418, DOI 10.1172/JCI117339; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; FERGUSON AW, 1970, ARCH DIS CHILD, V45, P80, DOI 10.1136/adc.45.239.80; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; HAIG D, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10a; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; MILNER RDG, 1971, ARCH DIS CHILD, V46, P724, DOI 10.1136/adc.46.249.724; NIELSEN F, 1989, ACTA PAEDIATR SCAND, V78, P469, DOI 10.1111/j.1651-2227.1989.tb11114.x; PUTHENPURACKAL MM, 1988, CLIN PEDIATR, V27, P247; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SEQUEL A, 1982, AM J DIS CHILD, V136, P626, DOI 10.1001/archpedi.1982.03970430058015; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760	12	141	142	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1995	9	2					110	112		10.1038/ng0295-110	http://dx.doi.org/10.1038/ng0295-110			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719335				2022-12-17	WOS:A1995QE67200009
J	OKUIZUMI, K; ONODERA, O; TANAKA, H; KOBAYASHI, H; TSUJI, S; TAKAHASHI, H; OYANAGI, K; SEKI, K; TANAKA, M; NARUSE, S; MIYATAKE, T; MIZUSAWA, H; KANAZAWA, I				OKUIZUMI, K; ONODERA, O; TANAKA, H; KOBAYASHI, H; TSUJI, S; TAKAHASHI, H; OYANAGI, K; SEKI, K; TANAKA, M; NARUSE, S; MIYATAKE, T; MIZUSAWA, H; KANAZAWA, I			APOE-EPSILON-4 AND EARLY-ONSET ALZHEIMERS	NATURE GENETICS			English	Letter							APOLIPOPROTEIN-E POLYMORPHISM; DISEASE; PROTEIN; HEALTH		NIIGATA UNIV,BRAIN RES INST,DEPT PATHOL,NIIGATA 951,JAPAN; MISHIMA HOSP,NIIGATA 94023,JAPAN; NIIGATA UNIV,BRAIN RES INST,CTR MAT BRAIN DIS,NIIGATA 951,JAPAN; TOKYO MED & DENT UNIV,DEPT NEUROL,TOKYO 113,JAPAN; UNIV TSUKUBA,INST CLIN MED,DEPT NEUROL,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROL,TOKYO 113,JAPAN	Niigata University; Niigata University; Tokyo Medical & Dental University (TMDU); University of Tsukuba; University of Tokyo	OKUIZUMI, K (corresponding author), NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,ASAHI MACHI DORI 1,NIIGATA 951,JAPAN.		Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472				BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; ETO M, 1986, DIABETES, V35, P1374, DOI 10.2337/diabetes.35.12.1374; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; REBECK GW, 1993, NEURON, V11, P575; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; UEKI A, 1993, NEUROSCI LETT, V163, P166, DOI 10.1016/0304-3940(93)90373-S; UTERMANN G, 1987, AM HEART J, V113, P433, DOI 10.1016/0002-8703(87)90610-7; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C	18	141	141	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					10	11		10.1038/ng0594-10b	http://dx.doi.org/10.1038/ng0594-10b			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075630				2022-12-17	WOS:A1994NJ84200006
J	REED, ML; LEFF, SE				REED, ML; LEFF, SE			MATERNAL IMPRINTING OF HUMAN SNRPN, A GENE DELETED IN PRADER-WILLI-SYNDROME	NATURE GENETICS			English	Article							NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE; PARENTAL ORIGIN; TME LOCUS; CHROMOSOME-15; DELETIONS; ANGELMAN; REGION; DNA	Prader-Willi syndrome (PWS), a human neuroendocrine disorder, is associated with deficiencies of paternal chromosome 15q12. Small nuclear ribonucleoprotein polypeptide N (SNRPN) is the first expressed gene identified in the PWS critically deleted region. Following our demonstration that the murine homologue of SNRPN is imprinted, we have characterized a sequence polymorphism within expressed portions of human SNRPN and show that human SNRPN is monoallelically expressed in fetal brain and heart and in adult brain. Analysis of maternal DNA and SNRPN cDNA confirmed that the maternal allele of SNRPN is not expressed in fetal brain and heart. Maternal imprinting of SNRPN supports the hypothesis that paternal absence of SNRPN is responsible for the PWS phenotype.	STANFORD UNIV,SCH MED,DEPT MOLEC PHARMACOL,STANFORD,CA 94305	Stanford University								BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Cassidy S B, 1984, Curr Probl Pediatr, V14, P1; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FEENEY RJ, 1989, J BIOL CHEM, V264, P5576; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GRIMALDI K, 1993, DEV BIOL, V156, P319, DOI 10.1006/dbio.1993.1080; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hayashi K, 1991, PCR Methods Appl, V1, P34; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; NAKATSU Y, 1993, NATURE, V364, P448, DOI 10.1038/364448a0; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; STELTZ JA, 1987, STRUCTURE FUNCTION M, P115; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40; ZIEVE GW, 1990, CRIT REV BIOCHEM MOL, V25, P1, DOI 10.3109/10409239009090604	32	141	144	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					163	167		10.1038/ng0294-163	http://dx.doi.org/10.1038/ng0294-163			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	7512861				2022-12-17	WOS:A1994MU76300011
J	ANDERSEN, LB; FOUNTAIN, JW; GUTMANN, DH; TARLE, SA; GLOVER, TW; DRACOPOLI, NC; HOUSMAN, DE; COLLINS, FS				ANDERSEN, LB; FOUNTAIN, JW; GUTMANN, DH; TARLE, SA; GLOVER, TW; DRACOPOLI, NC; HOUSMAN, DE; COLLINS, FS			MUTATIONS IN THE NEUROFIBROMATOSIS-1 GENE IN SPORADIC MALIGNANT-MELANOMA CELL-LINES	NATURE GENETICS			English	Article							TYPE-1 GENE; TUMOR PROGRESSION; POINT MUTATIONS; PRODUCT; IDENTIFICATION; LOCUS; GAP; HETEROZYGOSITY; RETINOBLASTOMA; HETEROGENEITY	Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder characterized by progressive and variable involvement of tissues predominantly derived from the neural crest and a predisposition toward malignancies. The NF1 gene encodes neurofibromin, a GTPase-activating protein containing a GAP-related domain (NF1-GRD) that is capable of down-regulating ras by stimulating its intrinsic GTPase activity. We report a homozygous deletion of most of NF1 in one of eight malignant melanoma cell lines leading to loss of detectable mRNA and protein, as well as the apparent absence of protein and mRNA in another melanoma. This data suggests that NF1 can function as a tumour suppressor gene in the development or progression of malignant melanoma.	UNIV MICHIGAN,HOWARD HUGHES MED INST,MSRB 2,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,CTR GENOME RES,DEPT BIOL,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)				Dracopoli, Nicholas/0000-0003-3962-4059; Gutmann, David/0000-0002-3127-5045	NCI NIH HHS [1-F32-CA08985-01] Funding Source: Medline; NINDS NIH HHS [NS01590, NS23410] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA008985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001590, R01NS023410] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBINO AP, 1989, ONCOGENE, V4, P1363; ALBINO AP, 1984, NATURE, V308, P69, DOI 10.1038/308069a0; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BEAN MA, 1975, CANCER RES, V35, P2902; BECHER R, 1983, CANCER RES, V43, P5010; Bolande R P, 1981, Adv Neurol, V29, P67; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Crowe FW, 1956, CLIN PATHOLOGICAL GE; DASTON MM, 1992, NEURON, V8, P415, DOI 10.1016/0896-6273(92)90270-N; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; DRACOPOLI NC, 1989, P NATL ACAD SCI USA, V86, P4614, DOI 10.1073/pnas.86.12.4614; DRACOPOLI NC, 1985, P NATL ACAD SCI USA, V82, P1470, DOI 10.1073/pnas.82.5.1470; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; HARLOW E, 1988, ANTIBODIES LABORATOR, P421; HERLYN M, 1987, LAB INVEST, V56, P461; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARTUZA RL, 1985, J INVEST DERMATOL, V85, P347, DOI 10.1111/1523-1747.ep12276952; MILLIKIN D, 1991, CANCER RES, V51, P5449; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; SAMBROOJ J, 1989, MOL CLONING LABORATO; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; UPADHYAYA M, 1990, J MED GENET, V27, P738, DOI 10.1136/jmg.27.12.738; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1989, NUCLEIC ACIDS RES, V17, P1665, DOI 10.1093/nar/17.4.1665; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	39	141	144	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					118	121		10.1038/ng0293-118	http://dx.doi.org/10.1038/ng0293-118			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499944				2022-12-17	WOS:A1993KL01000007
J	THE, I; MURTHY, AE; HANNIGAN, GE; JACOBY, LB; MENON, AG; GUSELLA, JF; BERNARDS, A				THE, I; MURTHY, AE; HANNIGAN, GE; JACOBY, LB; MENON, AG; GUSELLA, JF; BERNARDS, A			NEUROFIBROMATOSIS TYPE-1 GENE-MUTATIONS IN NEUROBLASTOMA	NATURE GENETICS			English	Article							RAS GENE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; NEURO-BLASTOMA; N-MYC; PROTEIN; CHROMOSOME-17; TRANSLOCATION; AMPLIFICATION; ACTIVATION; SEQUENCE	The introduction of human chromosome 17 suppresses the tumourigenicity of a neuroblastoma cell line in the absence of any effects on in vitro growth and the neurofibromatosis type 1 (NF1) gene may be responsible. Here we report that 4 out of 10 human neuroblastoma lines express little or no neurofibromin and that two of these lines show evidence of NF1 mutations, providing further proof that NF1 mutations occur in tumours that are not commonly found in NF1 patients. We also show that NF1 deficient neuroblastomas show only moderately elevated ras-GTP levels, in contrast to NF1 tumour cells, indicating that neurofibromin contributes differently to the negative regulation of ras in different cell types.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,MGH E,BLDG 149,13TH ST,BOSTON,MA 02129; MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital			The, Inge/B-8884-2011; Hannigan, Greg/A-5092-2009		NCI NIH HHS [CA51410] Funding Source: Medline; NINDS NIH HHS [NS22224] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; BERNARDS A, 1987, MOL CELL BIOL, V7, P3231, DOI 10.1128/MCB.7.9.3231; BERNARDS A, IN PRESS DNA CELL BI; BOS JL, 1989, CANCER RES, V49, P4682; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CLAUSEN N, 1989, ACTA PAEDIATR SCAND, V78, P736, DOI 10.1111/j.1651-2227.1989.tb11135.x; DASTON MM, 1992, NEURON, V8, P1; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GILBERT F, 1984, CANCER RES, V44, P5444; HARLOW E, 1988, ANTIBODIES LABORATOR; KUSHNER BH, 1985, J CLIN ONCOL, V3, P117, DOI 10.1200/JCO.1985.3.1.117; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MOLEY JF, 1991, CANCER RES, V51, P1596; NISHI T, 1991, ONCOGENE, V6, P1555; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SOLOMON E, 1976, SOMAT CELL GENET, V2, P125, DOI 10.1007/BF01542626; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	34	141	144	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					62	66		10.1038/ng0193-62	http://dx.doi.org/10.1038/ng0193-62			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490657				2022-12-17	WOS:A1993KF37200014
J	Tedja, MS; Wojciechowski, R; Hysi, PG; Eriksson, N; Furlotte, NA; Verhoeven, VJM; Iglesias, AI; Meester-Smoor, MA; Tompson, SW; Fan, Q; Khawaja, AP; Cheng, CY; Hohn, R; Yamashiro, K; Wenocur, A; Grazal, C; Haller, T; Metspalu, A; Wedenoja, J; Jonas, JB; Wang, YX; Xie, J; Mitchell, P; Foster, PJ; Klein, BEK; Klein, R; Paterson, AD; Hosseini, SM; Shah, RL; Williams, C; Teo, YY; Tham, YC; Gupta, P; Zhao, WT; Shi, Y; Saw, WY; Tai, ES; Sim, XL; Huffman, JE; Polasek, O; Hayward, C; Bencic, G; Rudan, I; Wilson, JF; Joshi, PK; Tsujikawa, A; Matsuda, F; Whisenhunt, KN; Zeller, T; van der Spek, PJ; Haak, R; Meijers-Heijboer, H; van Leeuwen, EM; Iyengar, SK; Lass, JH; Hofman, A; Rivadeneira, F; Uitterlinden, AG; Vingerling, JR; Lehtimaki, T; Raitakari, OT; Biino, G; Concas, MP; Schwantes-An, TH; Igo, RP; Cuellar-Partida, G; Martin, NG; Craig, JE; Gharahkhani, P; Williams, KM; Nag, A; Rahi, JS; Cumberland, PM; Delcourt, C; Bellenguez, C; Ried, JS; Bergen, AA; Meitinger, T; Gieger, C; Wong, TY; Hewitt, AW; Mackey, DA; Simpson, CL; Pfeiffer, N; Parssinen, O; Baird, PN; Vitart, V; Amin, N; van Duijn, CM; Bailey-Wilson, JE; Young, TL; Saw, SM; Stambolian, D; MacGregor, S; Guggenheim, JA; Tung, JY; Hammond, CJ; Klaver, CCW				Tedja, Milly S.; Wojciechowski, Robert; Hysi, Pirro G.; Eriksson, Nicholas; Furlotte, Nicholas A.; Verhoeven, Virginie J. M.; Iglesias, Adriana I.; Meester-Smoor, Magda A.; Tompson, Stuart W.; Fan, Qiao; Khawaja, Anthony P.; Cheng, Ching-Yu; Hoehn, Rene; Yamashiro, Kenji; Wenocur, Adam; Grazal, Clare; Haller, Toomas; Metspalu, Andres; Wedenoja, Juho; Jonas, Jost B.; Wang, Ya Xing; Xie, Jing; Mitchell, Paul; Foster, Paul J.; Klein, Barbara E. K.; Klein, Ronald; Paterson, Andrew D.; Hosseini, S. Mohsen; Shah, Rupal L.; Williams, Cathy; Teo, Yik Ying; Tham, Yih Chung; Gupta, Preeti; Zhao, Wanting; Shi, Yuan; Saw, Woei-Yuh; Tai, E-Shyong; Sim, Xue Ling; Huffman, Jennifer E.; Polasek, Ozren; Hayward, Caroline; Bencic, Goran; Rudan, Igor; Wilson, James F.; Joshi, Peter K.; Tsujikawa, Akitaka; Matsuda, Fumihiko; Whisenhunt, Kristina N.; Zeller, Tanja; van der Spek, Peter J.; Haak, Roxanna; Meijers-Heijboer, Hanne; van Leeuwen, Elisabeth M.; Iyengar, Sudha K.; Lass, Jonathan H.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; Vingerling, Johannes R.; Lehtimaki, Terho; Raitakari, Olli T.; Biino, Ginevra; Concas, Maria Pina; Schwantes-An, Tae-Hwi; Igo, Robert P., Jr.; Cuellar-Partida, Gabriel; Martin, Nicholas G.; Craig, Jamie E.; Gharahkhani, Puya; Williams, Katie M.; Nag, Abhishek; Rahi, Jugnoo S.; Cumberland, Phillippa M.; Delcourt, Cecile; Bellenguez, Celine; Ried, Janina S.; Bergen, Arthur A.; Meitinger, Thomas; Gieger, Christian; Wong, Tien Yin; Hewitt, Alex W.; Mackey, David A.; Simpson, Claire L.; Pfeiffer, Norbert; Parssinen, Olavi; Baird, Paul N.; Vitart, Veronique; Amin, Najaf; van Duijn, Cornelia M.; Bailey-Wilson, Joan E.; Young, Terri L.; Saw, Seang-Mei; Stambolian, Dwight; MacGregor, Stuart; Guggenheim, Jeremy A.; Tung, Joyce Y.; Hammond, Christopher J.; Klaver, Caroline C. W.		CREAM; 23andMe Res Team; UK Biobank Eye Vis Consortium	Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error	NATURE GENETICS			English	Article							HIGH-GRADE MYOPIA; RETINAL-PIGMENT EPITHELIUM; SEROTONIN PATHWAY GENES; FORM-DEPRIVATION MYOPIA; COMMON VARIANTS; OCULAR GROWTH; RETINITIS-PIGMENTOSA; GENOTYPE IMPUTATION; MISSENSE MUTATIONS; DOPAMINE-RECEPTORS	Refractive errors, including myopia, are the most frequent eye disorders worldwide and an increasingly common cause of blindness. This genome-wide association meta-analysis in 160,420 participants and replication in 95,505 participants increased the number of established independent signals from 37 to 161 and showed high genetic correlation between Europeans and Asians (>0.78). Expression experiments and comprehensive in silico analyses identified retinal cell physiology and light processing as prominent mechanisms, and also identified functional contributions to refractive-error development in all cell types of the neurosensory retina, retinal pigment epithelium, vascular endothelium and extracellular matrix. Newly identified genes implicate novel mechanisms such as rod-and-cone bipolar synaptic neurotransmission, anterior-segment morphology and angiogenesis. Thirty-one loci resided in or near regions transcribing small RNAs, thus suggesting a role for post-transcriptional regulation. Our results support the notion that refractive errors are caused by a light-dependent retina-to-sclera signaling cascade and delineate potential pathobiological molecular drivers.	[Tedja, Milly S.; Verhoeven, Virginie J. M.; Iglesias, Adriana I.; Meester-Smoor, Magda A.; van Leeuwen, Elisabeth M.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Tedja, Milly S.; Verhoeven, Virginie J. M.; Iglesias, Adriana I.; Meester-Smoor, Magda A.; van Leeuwen, Elisabeth M.; Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; Amin, Najaf; van Duijn, Cornelia M.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Wojciechowski, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol & Med, Baltimore, MD USA; [Wojciechowski, Robert; Schwantes-An, Tae-Hwi; Simpson, Claire L.; Bailey-Wilson, Joan E.] NHGRI, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Wojciechowski, Robert] Johns Hopkins Med Inst, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Hysi, Pirro G.; Williams, Katie M.; Hammond, Christopher J.] Kings Coll London, Sch Life Course Sci, Sect Acad Ophthalmol, London, England; [Eriksson, Nicholas; Furlotte, Nicholas A.; Tung, Joyce Y.] 23andMe Inc, Mountain View, CA USA; [Verhoeven, Virginie J. M.; Iglesias, Adriana I.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Tompson, Stuart W.; Klein, Barbara E. K.; Klein, Ronald; Whisenhunt, Kristina N.; Young, Terri L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Fan, Qiao; Cheng, Ching-Yu; Zhao, Wanting] DUKE Natl Univ Singapore, Ctr Quantitat Med, Singapore, Singapore; [Khawaja, Anthony P.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Khawaja, Anthony P.; Foster, Paul J.; Rahi, Jugnoo S.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Khawaja, Anthony P.; Foster, Paul J.; Rahi, Jugnoo S.] UCL Inst Ophthalmol, London, England; [Cheng, Ching-Yu; Tham, Yih Chung] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Ocular Epidemiol Res Grp, Singapore, Singapore; [Hoehn, Rene] Univ Bern, Univ Hosp Bern, Dept Ophthalmol, Inselspital, Bern, Switzerland; [Hoehn, Rene; Pfeiffer, Norbert] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Yamashiro, Kenji; Tsujikawa, Akitaka] Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Kyoto, Japan; [Wenocur, Adam; Grazal, Clare; Stambolian, Dwight] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Haller, Toomas; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Wedenoja, Juho] Univ Helsinki, Dept Ophthalmol, Helsinki, Finland; [Wedenoja, Juho] Helsinki Univ Hosp, Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Jonas, Jost B.; Wang, Ya Xing] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Xie, Jing; Hewitt, Alex W.; Mackey, David A.; Baird, Paul N.; 23andMe Res Team] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Surg, Ctr Eye Res Australia,Ophthalmol, Melbourne, Vic, Australia; [Mitchell, Paul] Univ Sydney, Westmead Inst Med Res, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Paterson, Andrew D.; Hosseini, S. Mohsen] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Paterson, Andrew D.; Hosseini, S. Mohsen] Univ Toronto, Toronto, ON, Canada; [Shah, Rupal L.; Guggenheim, Jeremy A.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Williams, Cathy] Univ Bristol Sch Med, Dept Populat Hlth Sci, Bristol, Avon, England; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore, Singapore; [Teo, Yik Ying; Tai, E-Shyong; Sim, Xue Ling; Saw, Seang-Mei] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Gupta, Preeti] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Dept Hlth Serv Res, Singapore, Singapore; [Zhao, Wanting; Shi, Yuan] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Stat Support Platform, Singapore, Singapore; [Saw, Woei-Yuh] Natl Univ Singapore, Inst Life Sci, Singapore, Singapore; [Huffman, Jennifer E.; Hayward, Caroline; Wilson, James F.; Vitart, Veronique] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Polasek, Ozren] Univ Split, Fac Med, Split, Croatia; [Bencic, Goran] Sisters Mercy Univ Hosp, Dept Ophthalmol, Zagreb, Croatia; [Rudan, Igor; Wilson, James F.; Joshi, Peter K.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Matsuda, Fumihiko] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Zeller, Tanja] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [van der Spek, Peter J.; Haak, Roxanna] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Meijers-Heijboer, Hanne; Bergen, Arthur A.] Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Iyengar, Sudha K.; Lass, Jonathan H.; Igo, Robert P., Jr.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Iyengar, Sudha K.; Lass, Jonathan H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Iyengar, Sudha K.; Lass, Jonathan H.] Univ Hosp Eye Inst, Cleveland, OH USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Netherlands Genom Initiat, Netherlands Consortium Hlth Ageing, The Hague, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Lehtimaki, Terho] Univ Tampere, Fac Med & Life Sci, Dept Clin Chem, Finnish Cardiovasc Res Ctr Tampere, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Fimlab Labs, Tampere, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Concas, Maria Pina] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Schwantes-An, Tae-Hwi] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Cuellar-Partida, Gabriel; Gharahkhani, Puya; MacGregor, Stuart] QIMR Berghofer Med Res Inst, Stat Genet, Brisbane, Qld, Australia; [Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia; [Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA, Australia; [Nag, Abhishek] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Rahi, Jugnoo S.; Cumberland, Phillippa M.] UCL, Great Ormond St Inst Child Hlth, London, England; [Rahi, Jugnoo S.] UCL, Ulverscroft Vis Res Grp, London, England; [Delcourt, Cecile] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, Team LEHA,UMR 1219, F-33000 Bordeaux, France; [Bellenguez, Celine] Inst Pasteur, Lille, France; [Bellenguez, Celine] INSERM, RID AGE Risk Factors & Mol Determinants Aging Rel, U1167, Lille, France; [Bellenguez, Celine] Univ Lille, Excellence Lab LabEx DISTALZ U1167, Lille, France; [Ried, Janina S.; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Res Unit Mol Epidemiol, Neuherberg, Germany; [Bergen, Arthur A.] Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Bergen, Arthur A.] Netherlands Inst Neurosci NIN KNAW, Amsterdam, Netherlands; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Klinikum Rechts Isar, Munich, Germany; [Wong, Tien Yin] Acad Med Res Inst, Singapore, Singapore; [Wong, Tien Yin] Singapore Natl Eye Ctr, Retino Ctr, Singapore, Singapore; [Hewitt, Alex W.; Mackey, David A.] Univ Tasmania, Menzies Inst Med Res, Dept Ophthalmol, Hobart, Tas, Australia; [Hewitt, Alex W.; Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia; [Simpson, Claire L.] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Parssinen, Olavi] Cent Hosp Cent Finland, Dept Ophthalmol, Jyvaskyla, Finland; [Parssinen, Olavi] Univ Jyvaskyla, Fac Sport & Hlth Sci, Gerontol Res Ctr, Jyvaskyla, Finland; [Saw, Seang-Mei] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Myopia Res Grp, Singapore, Singapore; [Klaver, Caroline C. W.] Radboud Univ Nijmegen Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Medicine; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; National University of Singapore; Singapore National Eye Center; University of Bern; University Hospital of Bern; Johannes Gutenberg University of Mainz; Kyoto University; University of Pennsylvania; University of Tartu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Ruprecht Karls University Heidelberg; Capital Medical University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Cardiff University; University of Bristol; National University of Singapore; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; University of Edinburgh; University of Split; University of Edinburgh; Kyoto University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Tampere University; Tampere University; University of Turku; University of Turku; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Burlo Garofolo; Indiana University System; Indiana University-Purdue University Indianapolis; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Flinders University South Australia; University of London; King's College London; University of London; University College London; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Singapore National Eye Center; University of Tasmania; Menzies Institute for Medical Research; Lions Eye Institute; University of Western Australia; University of Tennessee System; University of Tennessee Health Science Center; Central Finland Central Hospital; University of Jyvaskyla; National University of Singapore; Singapore National Eye Center; Radboud University Nijmegen	Klaver, CCW (corresponding author), Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands.; Klaver, CCW (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Klaver, CCW (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands.	c.c.w.klaver@erasmusmc.nl	Chen, Li Jia/I-5078-2014; Delcourt, Cecile/I-2627-2013; Rudan, Igor/I-1467-2012; Cheng, Ching-Yu/Y-2229-2019; Kemp, John P./R-3091-2018; KOSUGI, Shinji/GYR-2946-2022; /S-1190-2019; Shah, Rupal L./AAZ-5951-2020; Haller, Toomas/N-3797-2019; Wedenoja, Juho/AAX-7008-2020; Sim, Xueling/AAZ-6652-2020; Paterson, Andrew D/A-4088-2011; Raitakari, Olli/AAQ-7389-2021; Wilson, James F/A-5704-2009; McKay, Gareth/AAZ-2601-2020; Foster, Paul/V-7288-2019; Klaver, Caroline C.W./A-2013-2016; Pfeiffer, Norbert/AAO-7586-2020; Fox, Laura J/C-6249-2016; Bellenguez, Céline/X-4004-2019; Igo, Rob/P-3438-2019; Yazar, Seyhan/U-4032-2018; Polasek, Ozren/B-6002-2011; Chung, Yih/AIF-2414-2022; Timpson, Nicholas John/O-7548-2015; Gharahkhani, Puya/AAA-6912-2020; Lehtimäki, Terho/AAD-1094-2022; Biino, Ginevra/B-5334-2013; Hosseini, S. Mohsen/K-7133-2013; Macgregor, Stuart/C-6442-2009; Mackey, David A/H-5340-2014; Wong, Tien Yin/AAC-9724-2020; wang, YA XING/K-9671-2016; Belllenguez, Céline/Y-3183-2018; Paterson, Andrew/AAQ-7511-2020; Rivadeneira, Fernando/O-5385-2015; Partida, Gabriel Cuellar/C-6686-2017; Attrill, Lauren/V-1688-2018; Aslam, Tariq/A-8532-2016; Yap, Maurice/K-4927-2016; concas, maria pina/K-2266-2018; Steel, David/I-8053-2015; Williams, Cathy/K-4919-2015; Evans, David/H-6325-2013; Rantanen, Taina/O-6579-2016	Chen, Li Jia/0000-0003-3500-5840; Delcourt, Cecile/0000-0002-2099-0481; Rudan, Igor/0000-0001-6993-6884; Cheng, Ching-Yu/0000-0003-0655-885X; Kemp, John P./0000-0002-9105-2249; /0000-0001-7488-250X; Shah, Rupal L./0000-0001-8789-8869; Haller, Toomas/0000-0002-5069-6523; Wedenoja, Juho/0000-0002-6155-0378; Sim, Xueling/0000-0002-1233-7642; Paterson, Andrew D/0000-0002-9169-118X; Wilson, James F/0000-0001-5751-9178; McKay, Gareth/0000-0001-8197-6280; Foster, Paul/0000-0002-4755-177X; Bellenguez, Céline/0000-0002-1240-7874; Igo, Rob/0000-0002-0024-1993; Yazar, Seyhan/0000-0003-0994-6196; Polasek, Ozren/0000-0002-5765-1862; Chung, Yih/0000-0002-6752-797X; Timpson, Nicholas John/0000-0002-7141-9189; Gharahkhani, Puya/0000-0002-4203-5952; Lehtimäki, Terho/0000-0002-2555-4427; Biino, Ginevra/0000-0002-9936-946X; Hosseini, S. Mohsen/0000-0003-3626-9928; Macgregor, Stuart/0000-0001-6731-8142; Mackey, David A/0000-0001-7914-4709; Wong, Tien Yin/0000-0002-8448-1264; wang, YA XING/0000-0003-2749-7793; Belllenguez, Céline/0000-0002-1240-7874; Paterson, Andrew/0000-0002-9169-118X; Rivadeneira, Fernando/0000-0001-9435-9441; Partida, Gabriel Cuellar/0000-0001-7648-4097; stratton, irene/0000-0003-1172-7865; Hammond, Christopher/0000-0002-3227-2620; Sivaprasad, Sobha/0000-0001-8952-0659; Amin, Najaf/0000-0002-8944-1771; Hysi, Pirro/0000-0001-5752-2510; Tompson, Stuart/0000-0001-9788-6730; s, hema/0000-0002-3440-9475; Howe, Laura/0000-0003-3357-2796; Craig, Jamie/0000-0001-9955-9696; Gallacher, John/0000-0002-2394-5299; Liu, Yizhi/0000-0003-4108-9593; Verhoeven, Virginie/0000-0001-7359-7862; Egan, Catherine/0000-0001-5593-1169; Keane, Pearse/0000-0002-9239-745X; Khaw, Sir Peng Tee/0000-0002-8087-2268; Bergen, Arthur/0000-0002-6333-9576; Yates, Max/0000-0003-3977-8920; Iglesias, Adriana I./0000-0001-5532-764X; Joshi, Peter/0000-0002-6361-5059; St Pourcain, Beate/0000-0002-4680-3517; Aslam, Tariq/0000-0002-9739-7280; Tai, E Shyong/0000-0003-2929-8966; Bunce, Catey/0000-0002-0935-3713; Plomin, Robert/0000-0002-0756-3629; McGuinness, Bernadette/0000-0002-7028-5633; Yap, Maurice/0000-0003-4687-4101; Kahonen, Mika/0000-0002-4510-7341; Baird, Paul/0000-0002-1305-3502; Hewitt, Alex/0000-0002-5123-5999; Zeller, Tanja/0000-0003-3379-2641; Bailey-Wilson, Joan/0000-0002-9153-2920; Woodside, Jayne/0000-0002-5691-4659; concas, maria pina/0000-0003-3598-2537; Fruttiger, Marcus/0000-0002-6962-5485; Dick, Andrew/0000-0002-0742-3159; Lotery, Andrew/0000-0001-5541-4305; Guggenheim, Jeremy/0000-0001-5164-340X; Steel, David/0000-0001-8734-3089; Tufail, Adnan/0000-0001-6131-7640; Vitart, Veronique/0000-0002-4991-3797; Williams, Cathy/0000-0002-9133-2021; Evans, David/0000-0003-0663-4621; Rahi, Jugnoo/0000-0002-5718-9209; Khawaja, Anthony/0000-0001-6802-8585; Owen, Christopher/0000-0003-1135-5977; Simpson, Claire/0000-0003-2244-7690; Miyake, Masahiro/0000-0001-7410-3764; /0000-0001-6694-3587; Sudlow, Cathie/0000-0002-7725-7520; Tedja, Milly/0000-0003-0356-9684; Hogg, Ruth/0000-0001-9413-2669; Trucco, Emanuele/0000-0002-5055-0794; Tsujikawa, Akitaka/0000-0003-0779-7799; Rantanen, Taina/0000-0002-1604-1945; Van Duijn, Cornelia/0000-0002-2374-9204; Alipanahi, Babak/0000-0001-8216-7178	European Research Council (ERC) [648268]; Netherlands Organisation for Scientific Research (NWO) [91815655]; National Eye Institute [R01EY020483]; NATIONAL EYE INSTITUTE [R21EY027880, R01EY020483, K08EY022943, R01EY014685, R01EY024233] Funding Source: NIH RePORTER; MRC [MC_UU_00007/10, MR/K023721/1, G19/2, MR/N003284/1, MC_UU_12015/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully thank all study participants, their relatives and the staff at the recruitment centers for their invaluable contributions. We thank all contributors to the CREAM Consortium, 23andMe and UKEV for their generosity in sharing data and help in the production of this publication. Funding for this particular GWAS mega-analysis was provided by the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (grant 648268), the Netherlands Organisation for Scientific Research (NWO, grant 91815655) and the National Eye Institute (grant R01EY020483). Funding agencies that facilitated the execution of the individual studies are acknowledged in the Supplementary Note.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldahmesh MA, 2013, AM J HUM GENET, V93, P313, DOI 10.1016/j.ajhg.2013.06.002; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashby R, 2007, EXP EYE RES, V85, P15, DOI 10.1016/j.exer.2007.02.019; Ashby R, 2016, OPTOMETRY VISION SCI, V93, P1052, DOI 10.1097/OPX.0000000000000978; Bakshi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32894; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Brown BC, 2016, AM J HUM GENET, V99, P76, DOI 10.1016/j.ajhg.2016.05.001; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen PS, 2011, NEUROIMAGE, V56, P1526, DOI 10.1016/j.neuroimage.2010.10.082; Chen S, 2017, INVEST OPHTH VIS SCI, V58, P2306, DOI 10.1167/iovs.16-20402; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Chua SYL, 2016, OPHTHAL PHYSL OPT, V36, P388, DOI 10.1111/opo.12305; Connaughton V, 1995, WEBVISION ORG RETINA; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; D'Souza UM, 2006, HUM MUTAT, V27, P1, DOI 10.1002/humu.20278; Davidson AE, 2013, HUM MUTAT, V34, P506, DOI 10.1002/humu.22264; Dolgin E, 2015, NATURE, V519, P276, DOI 10.1038/519276a; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fan Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11008; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Ferreira MAR, 2017, J ALLERGY CLIN IMMUN, V139, P1148, DOI 10.1016/j.jaci.2016.07.017; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gardner M, 2008, AM J MED GENET B, V147B, P1070, DOI 10.1002/ajmg.b.30717; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Harper AR, 2015, EXP EYE RES, V133, P100, DOI 10.1016/j.exer.2014.07.015; Hawthorne F, 2013, INVEST OPHTH VIS SCI, V54, P2076, DOI 10.1167/iovs.12-11102; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hung GK, 2016, COMPUT BIOL MED, V70, P106, DOI 10.1016/j.compbiomed.2016.01.003; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Keckeis S, 2017, EXP EYE RES, V154, P139, DOI 10.1016/j.exer.2016.12.003; Kelly MP, 2015, CURR PHARM DESIGN, V21, P389; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam CY, 2008, INVEST OPHTH VIS SCI, V49, P3768, DOI 10.1167/iovs.07-1126; LI XX, 1992, VISUAL NEUROSCI, V9, P483, DOI 10.1017/S0952523800011287; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li ZQ, 2011, HUM MOL GENET, V20, P2861, DOI 10.1093/hmg/ddr169; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Liu J, 2014, MOL VIS, V20, P352; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mackay DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132529; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McFadden SA, 2016, OPTOMETRY VISION SCI, V93, P1061, DOI 10.1097/OPX.0000000000000932; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2016, OPTOMETRY VISION SCI, V93, P1058, DOI 10.1097/OPX.0000000000000980; Morgan Ian G, 2003, Clin Exp Optom, V86, P276; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Norton TT, 2016, OPTOMETRY VISION SCI, V93, P1049, DOI 10.1097/OPX.0000000000000917; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Plotnikov D., 2017, UK BIOBANK EYE VISIO; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ritchey ER, 2012, EXP EYE RES, V102, P59, DOI 10.1016/j.exer.2012.07.001; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Shi Y, 2011, AM J HUM GENET, V88, P805, DOI 10.1016/j.ajhg.2011.04.022; Smith EL, 2014, EYE, V28, P180, DOI 10.1038/eye.2013.277; Smith TST, 2009, B WORLD HEALTH ORGAN, V87, P431, DOI 10.2471/BLT.08.055673; Springelkamp H, 2015, HUM MOL GENET, V24, P2689, DOI 10.1093/hmg/ddv027; Stambolian D, 2013, HUM MOL GENET, V22, P2754, DOI 10.1093/hmg/ddt116; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; STONE RA, 1990, CIBA F SYMP, V155, P45; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; Summers JA, 2013, EXP EYE RES, V114, P120, DOI 10.1016/j.exer.2013.03.008; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tideman JWL, 2016, JAMA OPHTHALMOL, V134, P1355, DOI 10.1001/jamaophthalmol.2016.4009; Tran-Viet KN, 2013, AM J HUM GENET, V92, P820, DOI 10.1016/j.ajhg.2013.04.005; Verhoeven VJM, 2015, OPHTHALMOLOGY, V122, P101, DOI 10.1016/j.ophtha.2014.07.030; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Verhoeven VJM, 2012, HUM GENET, V131, P1467, DOI 10.1007/s00439-012-1176-0; Vincent A, 2016, AM J HUM GENET, V98, P1011, DOI 10.1016/j.ajhg.2016.03.021; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; WEISS S, 1993, J COMP PHYSIOL A, V172, P263, DOI 10.1007/BF00216608; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Williams KM, 2015, EUR J EPIDEMIOL, V30, P305, DOI 10.1007/s10654-015-0010-0; Williams KM, 2013, OPHTHAL PHYSL OPT, V33, P339, DOI 10.1111/opo.12042; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wojciechowski R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003442; Yamashita T, 2009, J NEUROSCI, V29, P9748, DOI 10.1523/JNEUROSCI.5854-08.2009; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhang Y, 2015, PROG MOL BIOL TRANSL, V134, P221, DOI 10.1016/bs.pmbts.2015.06.014	115	140	143	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					834	+		10.1038/s41588-018-0127-7	http://dx.doi.org/10.1038/s41588-018-0127-7			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29808027	Green Submitted, Green Accepted			2022-12-17	WOS:000433621000011
J	van der Wijst, MGP; Brugge, H; de Vries, DH; Deelen, P; Swertz, MA; Franke, L				van der Wijst, Monique G. P.; Brugge, Harm; de Vries, Dylan H.; Deelen, Patrick; Swertz, Morris A.; Franke, Lude		LifeLines Cohort Study; BIOS Consortium	Single-cell RNA sequencing identifies celltype-specific cis-eQTLs and co-expression QTLs	NATURE GENETICS			English	Article							GENE-EXPRESSION; GENOTYPE IMPUTATION; IMMUNE CELLS; ASSOCIATIONS; REGULATORS; DRIVERS; PANEL	Genome-wide association studies have identified thousands of genetic variants that are associated with disease(1). Most of these variants have small effect sizes, but their downstream expression effects, so-called expression quantitative trait loci (eQTLs), are often large(2) and celltype-specific(3-5). To identify these celltype-specific eQTLs using an unbiased approach, we used single-cell RNA sequencing to generate expression profiles of similar to 25,000 peripheral blood mononuclear cells from 45 donors. We identified previously reported cis-eQTLs, but also identified new celltype-specific cis-eQTLs. Finally, we generated personalized co-expression networks and identified genetic variants that significantly alter co-expression relationships (which we termed 'co-expression QTLs'). Singlecell eQTL analysis thus allows for the identification of genetic variants that impact regulatory networks.	[van der Wijst, Monique G. P.; Brugge, Harm; de Vries, Dylan H.; Deelen, Patrick; Swertz, Morris A.; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen	Franke, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	lude@ludesign.nl	van der Wijst, Monique/AAF-1521-2020; Deelen, Patrick/B-3566-2013; Franke, Lude/P-7036-2016	Deelen, Patrick/0000-0002-5654-3966; van der Wijst, Monique/0000-0003-1520-3970; Franke, Lude/0000-0002-5159-8802; de Vries, Dylan/0000-0002-0953-0257	Dutch Research Council [ZonMW-VIDI 917.164.455, ZonMW-VIDI 917.14.374]; ERC [637640]; BBMRI-NL - Dutch government [NWO 184.021.007]	Dutch Research Council; ERC(European Research Council (ERC)European Commission); BBMRI-NL - Dutch government	We are very grateful to all the volunteers who participated in this study. Moreover, we thank J. Dekens for arranging informed consent and contact with LifeLines. We thank A. Maatman and M. Platteel for their assistance in the lab. M.A.S. and L.F. are supported by grants from the Dutch Research Council (ZonMW-VIDI 917.164.455 to M.S. and ZonMW-VIDI 917.14.374 to L.F.), and L.F. is supported by an ERC Starting Grant, grant agreement 637640 (ImmRisk). The Biobank-Based Integrative Omics Studies (BIOS) Consortium is funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184.021.007).	[Anonymous], 2017, BIORXIV; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Duong D, 2017, BIOINFORMATICS, V33, pI67, DOI 10.1093/bioinformatics/btx227; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Ishigaki K, 2017, NAT GENET, V49, P1120, DOI 10.1038/ng.3885; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Kasela S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006643; Knowles DA, 2017, NAT METHODS, V14, P699, DOI 10.1038/nmeth.4298; Li WV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03405-7; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Naranbhai V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8545; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dijk D., 2017, BIORXIV, DOI [10.1101/111591, DOI 10.1101/111591]; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Westra HJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005223; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wills QF, 2013, NAT BIOTECHNOL, V31, P748, DOI 10.1038/nbt.2642; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhernakova DV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003594	36	140	141	5	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					493	+		10.1038/s41588-018-0089-9	http://dx.doi.org/10.1038/s41588-018-0089-9			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	29610479	Green Accepted, Green Submitted			2022-12-17	WOS:000429529300008
J	Hoffmann, TJ; Theusch, E; Haldar, T; Ranatunga, DK; Jorgenson, E; Medina, MW; Kvale, MN; Kwok, PY; Schaefer, C; Krauss, RM; Iribarren, C; Risch, N				Hoffmann, Thomas J.; Theusch, Elizabeth; Haldar, Tanushree; Ranatunga, Dilrini K.; Jorgenson, Eric; Medina, Marisa W.; Kvale, Mark N.; Kwok, Pui-Yan; Schaefer, Catherine; Krauss, Ronald M.; Iribarren, Carlos; Risch, Neil			A large electronic-health-record-based genome-wide study of serum lipids	NATURE GENETICS			English	Article							GENETIC EPIDEMIOLOGY RESEARCH; CORONARY-ARTERY-DISEASE; AGING GERA COHORT; GENOTYPE-IMPUTATION; HUMAN LIVER; HUMAN-POPULATIONS; BLOOD-PRESSURE; RARE VARIANTS; PLASMA-LIPIDS; ADULT HEALTH	A genome-wide association study (GWAS) of 94,674 ancestrally diverse Kaiser Permanente members using 478,866 longitudinal electronic health record (EHR)-derived measurements for untreated serum lipid levels empowered multiple new findings: 121 new SNP associations (46 primary, 15 conditional, and 60 in meta-analysis with Global Lipids Genetic Consortium data); an increase of 33-42% in variance explained with multiple measurements; sex differences in genetic impact (greater impact in females for LDL, HDL, and total cholesterol and the opposite for triglycerides); differences in variance explained among non-Hispanic whites, Latinos, African Americans, and East Asians; genetic dominance and epistatic interaction, with strong evidence for both at the ABO and FUT2 genes for LDL; and tissue-specific enrichment of GWAS-associated SNPs among liver, adipose, and pancreas eQTLs. Using EHR pharmacy data, both LDL and triglyceride genetic risk scores (477 SNPs) were strongly predictive of age at initiation of lipid-lowering treatment. These findings highlight the value of longitudinal EHRs for identifying new genetic features of cholesterol and lipoprotein metabolism with implications for lipid treatment and risk of coronary heart disease.	[Hoffmann, Thomas J.; Haldar, Tanushree; Kvale, Mark N.; Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Risch, Neil] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Theusch, Elizabeth; Medina, Marisa W.; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Ranatunga, Dilrini K.; Jorgenson, Eric; Schaefer, Catherine; Iribarren, Carlos; Risch, Neil] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94612 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Kaiser Permanente	Hoffmann, TJ; Risch, N (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Hoffmann, TJ; Risch, N (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Risch, N (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94612 USA.	thomas.hoffmann@ucsf.edu; neil.risch@ucsf.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Theusch, Elizabeth/0000-0002-5678-759X; Medina, Marisa/0000-0002-3631-0129	NIH [P50 GM115318]; US National Institutes of Health [R21 AG046616, K01 DC013300]; National Institute on Aging; National Institute of Mental Health; National Institutes of Health Common Fund [RC2 AG036607]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036607, R21AG046616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K01DC013300] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to the Kaiser Permanente Northern California members who have generously agreed to participate in the Kaiser Permanente Research Program on Genes, Environment, and Health. We would like to thank R. Dobrin for his contribution of the liver and adipose eQTL results table from the RYGB cohort. This work was supported by NIH P50 GM115318 to R.M.K., which partially supported T.H., E.T., M.W.M., C.I., C.S., E.J., R.M.K., and N.R. This work was supported by grants R21 AG046616 and K01 DC013300 to T.J.H. from the US National Institutes of Health for imputation. Support for participant enrollment, survey completion, and biospecimen collection for the RPGEH was provided by the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, and Kaiser Permanente national and regional community benefit programs. Genotyping of the GERA cohort was funded by a grant from the National Institute on Aging, the National Institute of Mental Health, and the National Institutes of Health Common Fund (RC2 AG036607 to C.S. and N.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aung LHH, 2014, INT J MED SCI, V11, P471, DOI 10.7150/ijms.8489; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5; Castro C, 2015, MOL BIOSYST, V11, P1897, DOI 10.1039/c5mb00032g; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen GB, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00107; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; Elbers CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050198; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; GREEN MD, 1994, DRUG METAB DISPOS, V22, P799; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Guan HP, 2015, J LIPID RES, V56, P2183, DOI 10.1194/jlr.M060897; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoenig MR, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-12; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Hoffmann TJ, 2011, GENOMICS, V98, P422, DOI 10.1016/j.ygeno.2011.08.007; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kanoni S, 2016, HUM MOL GENET, V25, P4094, DOI 10.1093/hmg/ddw227; Keller M, 2013, J LIPID RES, V54, P3170, DOI 10.1194/jlr.M039420; Ko A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4983; Kurano M, 2016, J HUM GENET, V61, P427, DOI 10.1038/jhg.2015.170; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Lanktree MB, 2015, J LIPID RES, V56, P1781, DOI 10.1194/jlr.P059477; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu XF, 2017, NAT GENET, V49, P1722, DOI 10.1038/ng.3978; Lu XF, 2016, CIRC-CARDIOVASC GENE, V9, P37, DOI 10.1161/CIRCGENETICS.115.001096; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Musunuru K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036473; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Oshiro C, 2010, PHARMACOGENET GENOM, V20, P211, DOI 10.1097/FPC.0b013e328333b99c; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Sijbrands EJ, 1999, ARTERIOSCL THROM VAS, V19, P2722, DOI 10.1161/01.ATV.19.11.2722; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Tada H, 2014, CIRC-CARDIOVASC GENE, V7, P583, DOI 10.1161/CIRCGENETICS.113.000420; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turgeon D, 2003, DRUG METAB DISPOS, V31, P670, DOI 10.1124/dmd.31.5.670; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; van Leeuwen EM, 2016, J MED GENET, V53, P441, DOI 10.1136/jmedgenet-2015-103439; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323	86	140	142	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					401	+		10.1038/s41588-018-0064-5	http://dx.doi.org/10.1038/s41588-018-0064-5			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29507422	Green Accepted			2022-12-17	WOS:000427933400016
J	Kenna, KP; van Doormaal, PTC; Dekker, AM; Ticozzi, N; Kenna, BJ; Diekstra, FP; van Rheenen, W; van Eijk, KR; Jones, AR; Keaglel, P; Shatunov, A; Sproviero, W; Smiths, BN; van Es, MA; Topps, SD; Kenna, A; Miller, JW; Fallini, C; Tiloca, C; McLaughlin, RL; Vance, C; Troakes, C; Colombrita, C; Mora, G; Calvo, A; Verde, F; Al-Sarraj, S; King, A; Calini, D; de Belleroche, J; Baas, F; van der Kooi, AJ; de Visser, M; ten Asbroek, ALMA; Sapp, PC; McKenna-Yasek, D; Polak, M; Asress, S; Munoz-Blanco, JL; Strom, TM; Meitinger, T; Morrison, KE; Lauria, G; Williams, KL; Leigh, PN; Nicholson, GA; Blair, IP; Leblond, CS; Dion, PA; Rouleau, GA; Pall, H; Shaw, PJ; Turner, MR; Talbot, K; Taroni, F; Boylan, KB; Van Blitterswijk, M; Rademakers, R; Esteban-Perez, J; Garcia-Redondo, A; Van Damme, P; Robberecht, W; Chio, A; Gellera, C; Drepper, C; Sendtner, M; Ratti, A; Glass, JD; Mora, JS; Basak, NA; Hardiman, O; Ludolph, AC; Andersen, PM; Weishaupt, JH; Brown, RH; Al-Chalabi, A; Silani, V; Shaw, CE; van den Berg, LH; Veldink, JH; Landers, JE; D'Alfonso, S; Mazzini, L; Comi, GP; Del Bo, R; Ceroni, M; Gagliardi, S; Querin, G; Bertolin, C; Pensato, V; Castellotti, B; Corti, S; Cereda, C; Corrado, L; Soraru, G				Kenna, Kevin P.; van Doormaal, Perry T. C.; Dekker, Annelot M.; Ticozzi, Nicola; Kenna, Brendan J.; Diekstra, Frank P.; van Rheenen, Wouter; van Eijk, Kristel R.; Jones, Ashley R.; Keaglel, Pamela; Shatunov, Aleksey; Sproviero, William; Smiths, Bradley N.; van Es, Michael A.; Topps, Simon D.; Kenna, Aoife; Miller, Jack W.; Fallini, Claudia; Tiloca, Cinzia; McLaughlin, Russell L.; Vance, Caroline; Troakes, Claire; Colombrita, Claudia; Mora, Gabriele; Calvo, Andrea; Verde, Federico; Al-Sarraj, Safa; King, Andrew; Calini, Daniela; de Belleroche, Jacqueline; Baas, Frank; van der Kooi, Anneke J.; de Visser, Marianne; ten Asbroek, Anneloor L. M. A.; Sapp, Peter C.; McKenna-Yasek, Diane; Polak, Meraida; Asress, Seneshaw; Luis Munoz-Blanco, Jose; Strom, Tim M.; Meitinger, Thomas; Morrison, Karen E.; Lauria, Giuseppe; Williams, Kelly L.; Leigh, P. Nigel; Nicholson, Garth A.; Blair, Ian P.; Leblond, Claire S.; Dion, Patrick A.; Rouleau, Guy A.; Pall, Hardev; Shaw, Pamela J.; Turner, Martin R.; Talbot, Kevin; Taroni, Franco; Boylan, Kevin B.; Van Blitterswijk, Marka; Rademakers, Rosa; Esteban-Perez, Jesus; Garcia-Redondo, Alberto; Van Damme, Phillip; Robberecht, Wim; Chio, Adrian; Gellera, Cinzia; Drepper, Carsten; Sendtner, Michael; Ratti, Antonia; Glass, Jonathan D.; Mora, Jesus S.; Basak, Nazli A.; Hardiman, Orla; Ludolph, Albert C.; Andersen, Peter M.; Weishaupt, Jochen H.; Brown, Robert H., Jr.; Al-Chalabi, Ammar; Silani, Vincenzo; Shaw, Christopher E.; van den Berg, Leonard H.; Veldink, Jan H.; Landers, John E.; D'Alfonso, Sandra; Mazzini, Letizia; Comi, Giacomo P.; Del Bo, Roberto; Ceroni, Mauro; Gagliardi, Stella; Querin, Giorgia; Bertolin, Cinzia; Pensato, Viviana; Castellotti, Barbara; Corti, Stefania; Cereda, Cristina; Corrado, Lucia; Soraru, Gianni		SLAGEN Consortium	NEK1 variants confer susceptibility to amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							NIMA-FAMILY KINASE; WHOLE-GENOME; PRIMARY CILIA; DNA-DAMAGE; MUTATIONS; IDENTIFICATION; ASSOCIATION; FRAMEWORK; DATABASE; GENES	To identify genetic factors contributing to amyotrophic lateral sclerosis (ALS), we conducted whole-exome analyses of 1,022 index familial ALS (FALS) cases and 7,315 controls. In a new screening strategy, we performed gene-burden analyses trained with established ALS genes and identified a significant association between loss-of-function (LOF) NEK1 variants and FALS risk. Independently, autozygosity mapping for an isolated community in the Netherlands identified a NEK1 p.Arg261 His variant as a candidate risk factor. Replication analyses of sporadic ALS (SALS) cases and independent control cohorts confirmed significant disease association for both p.Arg261 His (10,589 samples analyzed) and NEK1 LOF variants (3,362 samples analyzed). In total, we observed NEK1 risk variants in nearly 3% of ALS cases. NEK1 has been linked to several cellular functions, including cilia formation, DNA-damage response, microtubule stability, neuronal morphology and axonal polarity. Our results provide new and important insights into ALS etiopathogenesis and genetic etiology.	[Kenna, Kevin P.; Kenna, Brendan J.; Keaglel, Pamela; Kenna, Aoife; Fallini, Claudia; Sapp, Peter C.; McKenna-Yasek, Diane; Brown, Robert H., Jr.; Landers, John E.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [van Doormaal, Perry T. C.; Dekker, Annelot M.; Diekstra, Frank P.; van Rheenen, Wouter; van Eijk, Kristel R.; van Es, Michael A.; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Brain Ctr, Dept Neurol, Utrecht, Netherlands; [Ticozzi, Nicola; Tiloca, Cinzia; Colombrita, Claudia; Verde, Federico; Calini, Daniela; Ratti, Antonia; Silani, Vincenzo] IRCCS Ist Auxol Italiano, Dept Neurol, Milan, Italy; [Ticozzi, Nicola; Colombrita, Claudia; Verde, Federico; Ratti, Antonia; Silani, Vincenzo; Comi, Giacomo P.; Del Bo, Roberto; Corti, Stefania] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy; [Jones, Ashley R.; Shatunov, Aleksey; Sproviero, William; Smiths, Bradley N.; Topps, Simon D.; Miller, Jack W.; Vance, Caroline; Troakes, Claire; Al-Sarraj, Safa; King, Andrew; Al-Chalabi, Ammar; Shaw, Christopher E.] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England; [Tiloca, Cinzia] Univ Milan, Doctoral Sch Mol Med, Dept Sci & Biomed Technol, Milan, Italy; [McLaughlin, Russell L.; Hardiman, Orla] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Mora, Gabriele] Salvatore Maugeri Fdn, IRCCS, Sci Inst Milano, Milan, Italy; [Calvo, Andrea; Chio, Adrian] Univ Turin, ALS Ctr, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [de Belleroche, Jacqueline] Imperial Coll London, Div Brain Sci, Neurogenet Grp, London, England; [Baas, Frank; ten Asbroek, Anneloor L. M. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [van der Kooi, Anneke J.; de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet & Neurol, Amsterdam, Netherlands; [Polak, Meraida; Asress, Seneshaw; Glass, Jonathan D.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Luis Munoz-Blanco, Jose] Inst Invest Hosp Gregorio Maranon Madrid, Unidad ELA, Madrid, Spain; [Strom, Tim M.] Helmholtz Zentrurn Munchen, German Res Ctr Fnvironm Hlth, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Morrison, Karen E.] Univ Southampton, Fac Med, Southampton, Hants, England; [Lauria, Giuseppe] Fdn IRCCS Ist Neurol Carlo Besta, Motor Neuron Dis Ctr, Neurol Unit 3, Milan, Italy; [Williams, Kelly L.; Nicholson, Garth A.; Blair, Ian P.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Leigh, P. Nigel] Brighton & Sussex Med Sch, Trafford Ctr Med Res, Falmer, England; [Nicholson, Garth A.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW, Australia; [Leblond, Claire S.; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Pall, Hardev] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Studies, Birmingham, W Midlands, England; [Pall, Hardev] Queen Elizabeth Hosp Birmingham, Dept Neurol, Birmingham, W Midlands, England; [Shaw, Pamela J.; Turner, Martin R.; Talbot, Kevin] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Taroni, Franco; Gellera, Cinzia; Pensato, Viviana; Castellotti, Barbara] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Boylan, Kevin B.; Gellera, Cinzia; Pensato, Viviana; Castellotti, Barbara] Mayo Clin Florida, Dept Neurol, Jacksonville, FL 32224 USA; [Van Blitterswijk, Marka; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Esteban-Perez, Jesus; Garcia-Redondo, Alberto] Inst Invest Hosp 12 Octubre Madrid, Unidad ELA, Madrid, Spain; [Esteban-Perez, Jesus; Garcia-Redondo, Alberto] CIBERER, U 723, Madrid, Spain; [Van Damme, Phillip; Robberecht, Wim] Katholieke Univ Leuven, Dept Neurosci, Neurobiol Lab, Leuven, Belgium; [Van Damme, Phillip; Robberecht, Wim] VIB, Vesalius Res Ctr, Leuven, Belgium; [Van Damme, Phillip; Robberecht, Wim] Univ Hosp, Dept Neurol, Leuven, Belgium; [Drepper, Carsten; Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Drepper, Carsten] Univ Hosp Wurzburg, Dept Child & Adolescent Psychiat, Wurzburg, Germany; [Mora, Jesus S.] Hosp San Rafael, ALS Unit Neurol, Madrid, Spain; [Basak, Nazli A.] Bogazici Univ, NDAL, Dept Mol Biol & Genet, Istanbul, Turkey; [Ludolph, Albert C.; Weishaupt, Jochen H.] Univ Ulm, Dept Neurol, Ulm, Germany; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [D'Alfonso, Sandra; Corrado, Lucia] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Mazzini, Letizia] A Avogadro Univ Eastern Piedmont, ALS Ctr, Dept Neurol, Novara, Italy; [Comi, Giacomo P.; Del Bo, Roberto; Corti, Stefania] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy; [Ceroni, Mauro; Gagliardi, Stella; Cereda, Cristina] IRCCS, C Mondino Natl Inst Neurol Fdn, Expt Neurobiol Lab, Pavia, Italy; [Ceroni, Mauro] Univ Pavia, Dept Neurol Sci, Pavia, Italy; [Querin, Giorgia; Bertolin, Cinzia; Soraru, Gianni] Univ Padua, Dept Neurosci, Padua, Italy	University of Massachusetts System; University of Massachusetts Worcester; Utrecht University; Utrecht University Medical Center; IRCCS Istituto Auxologico Italiano; University of Milan; University of London; King's College London; University of Milan; Trinity College Dublin; Istituti Clinici Scientifici Maugeri IRCCS; University of Turin; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emory University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Southampton; IRCCS Istituto Neurologico Besta; Macquarie University; University of Brighton; University of Sussex; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; McGill University; University of Birmingham; University of Birmingham; University of Oxford; IRCCS Istituto Neurologico Besta; Mayo Clinic; Mayo Clinic; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Wurzburg; University of Wurzburg; Bogazici University; Ulm University; Umea University; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Pavia; University of Padua	Veldink, JH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Brain Ctr, Dept Neurol, Utrecht, Netherlands.	j.h.veldink@umcutrecht.nl	Taroni, Franco/N-3879-2013; van Blitterswijk, Marka/H-7274-2012; colombrita, claudia/A-3295-2009; CEREDA, CRISTINA/G-8208-2011; Baas, Frank/F-9574-2010; Meitinger, Thomas/O-1318-2015; Drepper, Carsten/GSN-2009-2022; Fallini, Claudia/AAZ-1244-2020; Pensato, Viviana/J-6533-2016; lauria, giuseppe/AAN-5371-2020; Sendtner, Michael/J-1542-2012; Corti, Stefania/K-6034-2016; Sorarù, Gianni/AAB-8891-2019; van Blitterswijk, Marka/AAL-4126-2021; Comi, Giacomo P/K-5702-2016; REDONDO, ALBERTO GARCÍA/AAD-9453-2020; Research Institute, ANZAC/CAE-9030-2022; ceroni, mauro/G-7080-2011; Van Damme, Philip/A-6464-2009; Williams, Kelly L/A-5545-2010; Sendtner, Michael/M-8137-2014; Lauria, Giuseppe/T-1378-2017; van+Es, Michael/AAC-5772-2021; Gagliardi, Stella/D-6905-2018; Ticozzi, Nicola/K-8094-2016; Leigh, Peter/AAD-5638-2019; Mora, Gabriele/Z-2346-2019; Mazzini, Letizia/AAA-2262-2021; Silani, Vincenzo/P-4421-2017; CALVO, Andrea/K-4141-2016; Hardiman, Orla/Y-3441-2019; Vance, Caroline/Q-2633-2019; Gellera, Cinzia/J-7887-2016; Vance, Caroline/C-3047-2012; CASTELLOTTI, BARBARA/J-4939-2016; D'Alfonso, Sandra/K-7295-2014; Al-Chalabi, Ammar/E-5361-2010	Taroni, Franco/0000-0002-2420-5233; van Blitterswijk, Marka/0000-0002-3054-7053; colombrita, claudia/0000-0001-6567-8910; CEREDA, CRISTINA/0000-0001-9571-0862; Baas, Frank/0000-0003-3912-5428; Fallini, Claudia/0000-0001-8329-3467; Pensato, Viviana/0000-0001-9798-2669; lauria, giuseppe/0000-0001-9773-020X; Sendtner, Michael/0000-0002-4737-2974; Corti, Stefania/0000-0001-5425-969X; van Blitterswijk, Marka/0000-0002-3054-7053; Comi, Giacomo P/0000-0002-1383-5248; ceroni, mauro/0000-0002-8947-5007; Van Damme, Philip/0000-0002-4010-2357; Williams, Kelly L/0000-0001-6319-9473; Sendtner, Michael/0000-0002-4737-2974; Lauria, Giuseppe/0000-0001-9773-020X; Ticozzi, Nicola/0000-0001-5963-7426; Mora, Gabriele/0000-0002-8388-2373; Mazzini, Letizia/0000-0003-2479-9120; Silani, Vincenzo/0000-0002-7698-3854; CALVO, Andrea/0000-0002-5122-7243; Hardiman, Orla/0000-0003-2610-1291; Vance, Caroline/0000-0001-5780-6951; Gellera, Cinzia/0000-0002-3582-665X; Vance, Caroline/0000-0001-5780-6951; Shaw, Christopher/0000-0003-0251-0146; Morrison, Karen Elaine/0000-0003-0216-5717; CASTELLOTTI, BARBARA/0000-0002-9098-3041; Nicholson, Garth/0000-0001-9694-066X; van der Kooi, Anneke/0000-0002-5261-5512; Sproviero, William/0000-0002-9335-9260; Veldink, Jan/0000-0001-5572-9657; D'Alfonso, Sandra/0000-0002-3983-9925; van Es, Michael/0000-0002-7709-5883; Turner, Martin/0000-0003-0267-3180; McLaughlin, Russell/0000-0003-3915-2135; Shatunov, Aleksey/0000-0002-2671-8040; Landers, John/0000-0001-8084-5043; Verde, Federico/0000-0002-3977-6995; Blair, Ian/0000-0003-3083-0075; Shaw, Pamela/0000-0002-8925-2567; Troakes, Claire/0000-0002-1790-7376; Al-Chalabi, Ammar/0000-0002-4924-7712; Talbot, Kevin/0000-0001-5490-1697; Smith, Bradley/0000-0002-6980-2453; Jones, Ashley/0000-0003-0470-0058; Drepper, Carsten/0000-0002-7883-6479; Meitinger, Thomas/0000-0002-8838-8403; Soraru, Gianni/0000-0001-9691-6328; Rapa, Anna/0000-0002-5523-5224; Chio, Adriano/0000-0001-9579-5341; topp, simon/0000-0002-5200-3284	US National Institutes of Health (NU)/National Institutc of Neurological Disorders and Stroke (MINDS) [R01 N5073873]; American ALS Association; Motor Neuron Disease (HIND) Association; Angel Fund; Project ALS/P2AIS; ALS Therapy Alliance; Netherlands ALS Foundation; ALS Lisa Belgium; Suna and Ivan Kirac Foundation; Netherlands Organization for Hcalth Research and Development; National Health and Medical Research Council (NHMRC) of Australia [1095215, 1107644]; Netherlands Organization for Health Research and-Development; EU Joint Programme - Neuro degenerative Disease Research (JPND) project; JPND; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London; European Community's Health Seventh Framework Programme (FP7) [259867]; UK National DNA Bank for MND Research; MND Association; Wellcome Trust; I.R.C.C.S. Istituto Auxologico Italiano; Healthcare Research of the Italian Ministry of Health [RepeatALS 2013]; Italian Ministry of Health [GR-2011-02347820 - IRisALS]; Flemish agency; Interuniversity Attraction Poles (IUAP) program P7/16 of the Belgian Federal Science Policy Office; FWO-Vlaanderen [E-RARE-2]; ERA-Net for Research on Rare Diseases (PYRAMID); EU JPND project (STRENGTH); FWO Vlaanderen; Belgian ALS liga; MND Australia; NHMRC fellowship [1092023]; Canadian Institute of Health Research (CHIR); PALS [208973]; Muscular Dystrophy Association; ALS society of Canada; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders; Laevers Fund for ALS Research; ALS Liga Belgic; fund 'Een Hart voor ALS'; fund 'Opening the Future; European Research Council; European's Seventh Framework Programme (EP7)/ERC [340429]; Geneeskundige Stichting Koningin Elisabeth; Deutsche Forschungsgemeinschaft [SE697/4-1]; BMBF Energl; Deutsche Gesellschaft far Muskelkranke [He 2/2]; German Federal Ministry of Education and Research (JPND STRENGTH consortium; German network for ALS research MND-NET); Charcot Foundation for ALS Research; virtual Helmholtz Institute "RNA-Dysmetabolismus in ALS and FTD"; DFG Swabian ALS Registry; Italian Ministry of Health (Ricerca Sanitaria Finalizzata) [RF-2010-2309849, CR-2010-2320550]; European Community's Health Seventh Framework Programme (FP7); Joint Programme - Neurodegencrative Disease Research (Italian Ministry of Education and University) (Sophia, and Strength Projects); Italian Ministry of Health (Ricerca Sanitaria Finalizzata); FUNDELA - Spanish Foundation; ISCIII Carlos III Institute / Fond de Investigacion Sanitaria of Spain [PT10/00092, PT14/00088]; ADELA ALS Spanish Association; SURF Foundation; Alzheimer's Disease Sequencing Project (ADSP) [phs000572.v7.p4]; National Human Genome Research Institute (NHGRI); Large Scale Sequencing Centers (LSSC); Alzheimer's Disease Genetics Consortium (ADGC); National Institute on Aging (NIA) [U01 AG032984]; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE); NIA [R01 AG033193]; National Heart, Lung, and Blood Institute(NHLBI); other NIH institutes and other foreign governmental and nongovernmental organizations; Adult Changes in Thought (ACT); Alzheimer's Disease Centers (ADC); Chicago Health and Aging Project (CHAP); Memory and Aging Project (MAP); Mayo Clinic; Mayo Parkinson's Disease controls; University of Miami; Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study (MIRAGE); National Cell Repository for Alzheimer's disease (NCRAD); National Institute on Aging Late Onset Alzheimer's Disease Family Study (NIA-LOAD); Religious Orders Study (ROS); Texas Alzheimer's Research and Care Consortium (TARC); Vanderbilt University/Case Western Reserve university VAN/CWRU); Washington Heights-Inwood Columbia Agiisg Project (WHICAP); Washington University Sequencing Project (WUSP); Columbia University Hispanic-Estudio Familiar de Influencia Genetica de Alzheimer (EFIGA); University of Toronto; Genetic Differences (GD); CHARGE cohorts [5RC2HL102419, HL105756]; NHLBI [HH5N268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100090C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; Austrian Stroke Prevention Study (ASPS); Cardiovascular Health Study (CHS); Erasmus Rucphen Family Study (ERE); Framingham Heart Study (FHS); Rutter-dam Study (RS); Human Genome Sequencing Center at the Baylor College of Medicine [U54HG003273]; Broad Institute Ccnome Center [U54HG003067]; Washington University Genome Institute [U54HG003079]; National Cell Repository for Alzheimer's Disease (NCRAD) at Indiana University [U24AG0218861]; NIA; NIA-Alzheimer's Disease Centers (ADCs); National Alzheimer's Coordinating Center (NACC) [U01AG016976]; National Institute on Aging Alzheimer's Disease Data Storage Site (NIAGADS) at the University of Pennsylvania [U24AG041689]; NLA; NIH; private US organizations;  [UF1AG047133];  [U01AG049505];  [U01AG049506];  [U01AG049507];  [U01AG049308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102419, R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049508, U01AG049505, U01AG049506, U24AG021886, U01AG049507, UF1AG047133, U24AG041689, R01AG033193, U01AG016976, U01AG032984] Funding Source: NIH RePORTER; MRC [MR/L016397/1, G0600974, MR/K000039/1, MC_G1000733, G1100695, G0900688, MR/K01014X/1] Funding Source: UKRI; Medical Research Council [MR/K000039/1, MC_G1000733, MR/K01014X/1, G0900688, MR/L016397/1, MR/L501529/1, G1100695, G0600974] Funding Source: researchfish; Medical Research Foundation [MRF-060-0003-RG-SMITH] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish; Motor Neurone Disease Association [Jones/Oct15/958-799, Turner/Jan13/944-795] Funding Source: researchfish	US National Institutes of Health (NU)/National Institutc of Neurological Disorders and Stroke (MINDS); American ALS Association; Motor Neuron Disease (HIND) Association; Angel Fund; Project ALS/P2AIS; ALS Therapy Alliance; Netherlands ALS Foundation; ALS Lisa Belgium; Suna and Ivan Kirac Foundation; Netherlands Organization for Hcalth Research and Development; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Organization for Health Research and-Development(Netherlands Organization for Health Research and Development); EU Joint Programme - Neuro degenerative Disease Research (JPND) project; JPND; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); European Community's Health Seventh Framework Programme (FP7); UK National DNA Bank for MND Research; MND Association; Wellcome Trust(Wellcome TrustEuropean Commission); I.R.C.C.S. Istituto Auxologico Italiano; Healthcare Research of the Italian Ministry of Health; Italian Ministry of Health(Ministry of Health, Italy); Flemish agency; Interuniversity Attraction Poles (IUAP) program P7/16 of the Belgian Federal Science Policy Office; FWO-Vlaanderen(FWO); ERA-Net for Research on Rare Diseases (PYRAMID); EU JPND project (STRENGTH); FWO Vlaanderen(FWO); Belgian ALS liga; MND Australia; NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institute of Health Research (CHIR)(Canadian Institutes of Health Research (CIHR)); PALS; Muscular Dystrophy Association(Muscular Dystrophy Association); ALS society of Canada; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders; Laevers Fund for ALS Research; ALS Liga Belgic; fund 'Een Hart voor ALS'; fund 'Opening the Future; European Research Council(European Research Council (ERC)European Commission); European's Seventh Framework Programme (EP7)/ERC; Geneeskundige Stichting Koningin Elisabeth; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF Energl(Federal Ministry of Education & Research (BMBF)); Deutsche Gesellschaft far Muskelkranke; German Federal Ministry of Education and Research (JPND STRENGTH consortium; German network for ALS research MND-NET); Charcot Foundation for ALS Research; virtual Helmholtz Institute "RNA-Dysmetabolismus in ALS and FTD"; DFG Swabian ALS Registry; Italian Ministry of Health (Ricerca Sanitaria Finalizzata); European Community's Health Seventh Framework Programme (FP7); Joint Programme - Neurodegencrative Disease Research (Italian Ministry of Education and University) (Sophia, and Strength Projects); Italian Ministry of Health (Ricerca Sanitaria Finalizzata); FUNDELA - Spanish Foundation; ISCIII Carlos III Institute / Fond de Investigacion Sanitaria of Spain; ADELA ALS Spanish Association; SURF Foundation; Alzheimer's Disease Sequencing Project (ADSP); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Large Scale Sequencing Centers (LSSC); Alzheimer's Disease Genetics Consortium (ADGC); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); other NIH institutes and other foreign governmental and nongovernmental organizations; Adult Changes in Thought (ACT); Alzheimer's Disease Centers (ADC); Chicago Health and Aging Project (CHAP); Memory and Aging Project (MAP); Mayo Clinic; Mayo Parkinson's Disease controls; University of Miami; Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study (MIRAGE); National Cell Repository for Alzheimer's disease (NCRAD); National Institute on Aging Late Onset Alzheimer's Disease Family Study (NIA-LOAD); Religious Orders Study (ROS); Texas Alzheimer's Research and Care Consortium (TARC); Vanderbilt University/Case Western Reserve university VAN/CWRU); Washington Heights-Inwood Columbia Agiisg Project (WHICAP); Washington University Sequencing Project (WUSP); Columbia University Hispanic-Estudio Familiar de Influencia Genetica de Alzheimer (EFIGA); University of Toronto(University of Toronto); Genetic Differences (GD); CHARGE cohorts; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Stroke Prevention Study (ASPS); Cardiovascular Health Study (CHS); Erasmus Rucphen Family Study (ERE); Framingham Heart Study (FHS); Rutter-dam Study (RS); Human Genome Sequencing Center at the Baylor College of Medicine; Broad Institute Ccnome Center; Washington University Genome Institute; National Cell Repository for Alzheimer's Disease (NCRAD) at Indiana University; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA-Alzheimer's Disease Centers (ADCs); National Alzheimer's Coordinating Center (NACC); National Institute on Aging Alzheimer's Disease Data Storage Site (NIAGADS) at the University of Pennsylvania; NLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); private US organizations; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Motor Neurone Disease Association	We acknowledge all of the study participants and our collaborators for enabling this study by graciously providing samples for this study. Funding was provided by US National Institutes of Health (NU)/National Institutc of Neurological Disorders and Stroke (MINDS) (R01 N5073873, JUL.), the American ALS Association (N.T., VS., C.E.S., J.E.L. and R.H.B.Jr.), the Motor Neuron Disease (HIND) Association (N.T., VS., C.E.S. and J.E.L.), the Angel Fund (R.H.B.Jr.), Project ALS/P2AIS (R.H.B.Jr.), the ALS Therapy Alliance (R.H.B.Jr. and J.E.L.), The Netherlands ALS Foundation (Project Mint; J.H.V. and L.H..v.d.B.), ALS Lisa Belgium (PAT. and WRo.), Suna and Ivan Kirac Foundation Computer resources for this study were provided by the Green High Performance Computing Center at the University of Massachusetts Medical School. L.H.v.d.B. received grants from the Netherlands Organization for Hcalth Research and Development (Vici Scheme; the SOPHLT and STRENGTH projects through the EU Joint Programme - Neurodegenerative Disease Research, JPND). I.P.B. received grant funding from the National Health and Medical Research Council (NHMRC) of Australia (1095215, 1107644). P.C.S. was supported through the auspices of H. Robert Horvitz (Massachusetts Institute of Technology), an Investigator at the Howard Hughes Medical Institute. MA.v.E. received a grant from the Netherlands Organization for Health Research and-Development (Veni scheme) and travel grants from Baxter. This is an EU Joint Programme - Neuro degenerative Disease Research (JPND) project. The project is supported through the following funding organizations under the aegis of JPND (United Kingdom, Medical Research Council; Netherlands, ZonMW; Italy, Minister dell'Istruzione, dell'Universita c della Ricerca; Belgium, Fonds Wetenschappelijk Onderzoek; Germany, Bundesministerium fur Bildung undEorschung). C.E.S. and A.A.-C. receive salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The work leading up to this publication was funded by the European Community's Health Seventh Framework Programme (FP7/2007-2013; grant agreement number 259867). Samples used in this research were in part obtained from the UK National DNA Bank for MND Research, funded by the MND Association and the Wellcome Trust. I.R.C.C.S. Istituto Auxologico Italiano; AriSLA - Fondazione Italiana di Ricerca per la SLA co-financed with support of "5x1000"-Healthcare Research of the Italian Ministry of Health (grants EXOMEFALS 2009 and NOVALS 2012 (N.T., C.T., C.G., V.S. and J.E.L.)), (grant RepeatALS 2013 (S.D.T. and L.C.)), Italian Ministry of Health (grant GR-2011-02347820 - IRisALS (N.T., C.T. and D.C.)). This work was supported by a grant from the Flemish agency for innovation by Science and Technology (IWT, Project MinE), the Interuniversity Attraction Poles (IUAP) program P7/16 of the Belgian Federal Science Policy Office, by the FWO-Vlaanderen under the frame of E-RARE-2, the ERA-Net for Research on Rare Diseases (PYRAMID), by a EU JPND project (STRENGTH). PAW. is supported by FWO Vlaanderen and the Belgian ALS liga. In Australia, this work Was supported by a Leadership Grant to I.P.B. from MND Australia and an NHMRC fellowship (1092023) to K.L.W. G.A.R. is funded by the Canadian Institute of Health Research (CHIR), Genome-wide exon capture for targeted resequencing in patients with PALS (#208973) the Muscular Dystrophy Association, and Whole exome sequencing in patients with FALS (#153959).; We thank JMB Vianney de Jong for collection of clinical data. C.S.L. is recipient of Tim E. Noel fellowship from ALS society of Canada. W.Ro. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the Laevers Fund for ALS Research, the ALS Liga Belgic, the fund 'Een Hart voor ALS' and the fund 'Opening the Future. The research leading to these results has received funding from the European Research Council and the European's Seventh Framework Programme (EP7/20072013)/ERC grant agreement 340429 and from the Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.). M.S. and C.D. were supported by the Deutsche Forschungsgemeinschaft, SE697/4-1, BMBF Energl and the Deutsche Gesellschaft far Muskelkranke, Project He 2/2. This work was supported its whole or in parts by a grant from the German Federal Ministry of Education and Research (JPND STRENGTH consortium; German network for ALS research MND-NET), the Charcot Foundation for ALS Research, the virtual Helmholtz Institute "RNA-Dysmetabolismus in ALS and FTD" and the DFG-funded Swabian ALS Registry. A.Ch. is funded in part by Italian Ministry of Health (Ricerca Sanitaria Finalizzata 2010, grant RF-2010-2309849, project EXPALS), the European Community's Health Seventh Framework Programme (FP7/2007-2013 under grant agreements 259867), the Joint Programme - Neurodegencrative Disease Research (Italian Ministry of Education and University) (Sophia, and Strength Projects), A.C. is funded in part by Italian Ministry of Health (Ricerca Sanitaria Finalizzata 2010, grant CR-2010-2320550, project EXTRAI,S) and Fondazione Vialli e Mauro per la Ricerca sulla SLA onlus (grant #4). FUNDELA - Spanish Foundation to the development of ALS research, ISCIII Carlos III Institute / Fond de Investigacion Sanitaria of Spain (PT10/00092; PT14/00088), ADELA ALS Spanish Association. Part of this work was carried out on the Dutch national e-infrastructure with the support of SURF Foundation. The Alzheimer's Disease Sequencing Project (ADSP), phs000572.v7.p4, is comprised of two Alzheimer's disease (AD) genetics consortia and three National Human Genome Research Institute (NHGRI) funded Large Scale Sequencing Centers (LSSC). The two AD genetics consortia are the Alzheimer's Disease Genetics Consortium (ADGC) funded by the National Institute on Aging (NIA) (U01 AG032984), and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) funded by NIA (R01 AG033193), the National Heart, Lung, and Blood Institute(NHLBI), other NIH institutes and other foreign governmental and nongovernmental organizations. The Discovery Phase analysis of sequence data is supported through UF1AG047133 to G.D. Schellenberg, L.A. Farrer, M.A. Pericak-Vance, R. Mayeux and J.L. Haines; U01AG049505 to S. Seshadri; U01AG049506 to E. Boerwinkle, U01AG049507 to E. Wijsman; and U01AG049308 to A.M.Goate.; The ADGC cohorts include: Adult Changes in Thought (ACT), the Alzheimer's Disease Centers (ADC), the Chicago Health and Aging Project (CHAP), the Memory and Aging Project (MAP), Mayo Clinic, Mayo Parkinson's Disease controls, University of Miami, the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study (MIRAGE), the National Cell Repository for Alzheimer's disease (NCRAD), the National Institute on Aging Late Onset Alzheimer's Disease Family Study (NIA-LOAD), the Religious Orders Study (ROS), the Texas Alzheimer's Research and Care Consortium (TARC), Vanderbilt University/Case Western Reserve university VAN/CWRU), the Washington Heights-Inwood Columbia Agiisg Project (WHICAP) and the Washington University Sequencing Project (WUSP), the Columbia University Hispanic-Estudio Familiar de Influencia Genetica de Alzheimer (EFIGA), the University of Toronto, and Genetic Differences (GD). The CHARGE cohorts, with funding provided by 5RC2HL102419 and HL105756, include the following: Atherosclerosis Risk in Communities (ARIC) Study Which is carried out as a collaborative study supported by NHLBI contracts (HH5N268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100090C, HHSN268201100010C, HHSN2682011000110C and HHSN268201100012C), Austrian Stroke Prevention Study (ASPS), Cardiovascular Health Study (CHS), Erasmus Rucphen Family Study (ERE), Framingham Heart Study (FHS), and Rutter-dam Study (RS). The three LSSC are: the Human Genome Sequencing Center at the Baylor College of Medicine (U54HG003273), tlse Broad Institute Ccnome Center (U54HG003067), and thc Washington University Genome Institute (U54HG003079). Biological samples and associated phenotypic data used in primary data analyses were stored at Study Investigators institutions, and at the National Cell Repository for Alzheimer's Disease (NCRAD, U24AG0218861 at Indiana University funded by NIA. Associated phenotypic data used in primary and secondary data analyses were provided by Study Investigators, the NIA-funded Alzheimer's Disease Centers (ADCs), and the National Alzheimer's Coordinating Center (NACC, U01AG016976) and the National Institute on Aging Alzheimer's Disease Data Storage Site (NIAGADS, U24AG041689) at the University of Pennsylvania, funded by NLA, and at the Database for Genotypes and Phenotypes (dbGaP) funded by NIH. Contributors to the Genetic Analysis Data included Study Investigators on projects that Were individually funded by NIA, and other NIH institutes, and by private US organizations, or foreign governmental or nongovernmental organizations. We thank people with MND, their families and control individuals for their participation in this project.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brenner D, 2016, BRAIN, V139, pCP14, DOI 10.1093/brain/aww033; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551; Chio A, 2012, NEUROLOGY, V79, P1983, DOI 10.1212/WNL.0b013e3182735d36; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Cohen S, 2013, BBA-MOL CELL RES, V1833, P1104, DOI 10.1016/j.bbamcr.2012.12.021; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Coppede F, 2015, MUTAT RES-FUND MOL M, V776, P84, DOI 10.1016/j.mrfmmm.2014.11.010; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206; Kenna KP, 2013, J MED GENET, V50, P776, DOI 10.1136/jmedgenet-2013-101795; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lattante S, 2012, NEUROLOGY, V79, P66, DOI 10.1212/WNL.0b013e31825dceca; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Lee L, 2013, J NEUROSCI RES, V91, P1117, DOI 10.1002/jnr.23238; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Ma XX, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-71; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Pelegrini AL, 2010, MUTAGENESIS, V25, P447, DOI 10.1093/mutage/geq026; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sama R. R., 2014, ASN NEURO, V6; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Tafuri F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00336; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	52	140	144	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1037	+		10.1038/ng.3626	http://dx.doi.org/10.1038/ng.3626			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27455347	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000382398800014
J	Debette, S; Kamatani, Y; Metso, TM; Kloss, M; Chauhan, G; Engelter, ST; Pezzini, A; Thijs, V; Markus, HS; Dichgans, M; Wolf, C; Dittrich, R; Touze, E; Southerland, AM; Samson, Y; Abboud, S; Bejot, Y; Caso, V; Bersano, A; Gschwendtner, A; Sessa, M; Cole, J; Lamy, C; Medeiros, E; Beretta, S; Bonati, LH; Grau, AJ; Michel, P; Majersik, JJ; Sharma, P; Kalashnikova, L; Nazarova, M; Dobrynina, L; Bartels, E; Guillon, B; van den Herik, EG; Fernandez-Cadenas, I; Jood, K; Nalls, MA; De Leeuw, FE; Jern, C; Cheng, YC; Werner, I; Metso, AJ; Lichy, C; Lyrer, PA; Brandt, T; Boncoraglio, GB; Wichmann, HE; Gieger, C; Johnson, AD; Bottcher, T; Castellano, M; Arveiler, D; Ikram, MA; Breteler, MMB; Padovani, A; Meschia, JF; Kuhlenbaumer, G; Rolfs, A; Worrall, BB; Ringelstein, EB; Zelenika, D; Tatlisumak, T; Lathrop, M; Leys, D; Amouyel, P; Dallongeville, J; Lemmens, R; Pandolfo, M; Bodenant, M; Louillet, F; Mas, JL; Deltour, S; Leder, S; Leger, A; Canaple, S; Godefroy, O; Giroud, M; Jacquin, A; Moulin, T; Vullier, F; Tzourio, C; Dos Santos, M; Malik, R; Hausser, I; Thomas-Feles, C; Weber, R; Grond-Ginsbach, C; Hacke, W; Giossi, A; Volonghi, I; Costa, P; del Zotto, E; Morotti, A; Poli, L; Muiesan, ML; Salvetti, M; Rosei, EA; Lanfranconi, S; Baron, P; Ferrarese, C; Susani, E; Bicocca, M; Giacalone, G; Paolucci, S; Palmirotta, R; Guadagni, F; Paciaroni, M; Ballabio, E; Parati, EA; Ciusani, E; Fluri, F; Hatz, F; Gisler, D; Amort, M; Bevan, S; James, T; Olsson, S; Holmegaard, L; Altintas, A; Martin, JJ; Kittner, S; MItchell, B; Stine, C; O'Connell, J; Dueker, N; Koudstaal, PJ; de Lau, LM; Hofman, A; Verhaaren, BF; Uitterlinden, AG; Montaner, J; Mendioroz, M; Yadav, S; Khan, MS; Wilder, M; van Dijk, E; Maaijwee, N; Rutten-Jacobs, L; Kramer, J; Malik, S; Brown, RD; Singleton, A; Hardy, J; Rich, SS; Tanislav, C; Jungehulsing, J				Debette, Stephanie; Kamatani, Yoichiro; Metso, Tiina M.; Kloss, Manja; Chauhan, Ganesh; Engelter, Stefan T.; Pezzini, Alessandro; Thijs, Vincent; Markus, Hugh S.; Dichgans, Martin; Wolf, Christiane; Dittrich, Ralf; Touze, Emmanuel; Southerland, Andrew M.; Samson, Yves; Abboud, Sherine; Bejot, Yannick; Caso, Valeria; Bersano, Anna; Gschwendtner, Andreas; Sessa, Maria; Cole, John; Lamy, Chantal; Medeiros, Elisabeth; Beretta, Simone; Bonati, Leo H.; Grau, Armin J.; Michel, Patrik; Majersik, Jennifer J.; Sharma, Pankaj; Kalashnikova, Ludmila; Nazarova, Maria; Dobrynina, Larisa; Bartels, Eva; Guillon, Benoit; van den Herik, Evita G.; Fernandez-Cadenas, Israel; Jood, Katarina; Nalls, Michael A.; De Leeuw, Frank-Erik; Jern, Christina; Cheng, Yu-Ching; Werner, Inge; Metso, Antti J.; Lichy, Christoph; Lyrer, Philippe A.; Brandt, Tobias; Boncoraglio, Giorgio B.; Wichmann, Heinz-Erich; Gieger, Christian; Johnson, Andrew D.; Bottcher, Thomas; Castellano, Maurizio; Arveiler, Dominique; Ikram, M. Arfan; Breteler, Monique M. B.; Padovani, Alessandro; Meschia, James F.; Kuhlenbaumer, Gregor; Rolfs, Arndt; Worrall, Bradford B.; Ringelstein, Erich-Bernd; Zelenika, Diana; Tatlisumak, Turgut; Lathrop, Mark; Leys, Didier; Amouyel, Philippe; Dallongeville, Jean; Lemmens, R.; Pandolfo, M.; Bodenant, M.; Louillet, F.; Mas, J. L.; Deltour, S.; Leder, S.; Leger, A.; Canaple, S.; Godefroy, O.; Giroud, M.; Jacquin, A.; Moulin, T.; Vullier, F.; Tzourio, C.; Dos Santos, M.; Malik, R.; Hausser, I.; Thomas-Feles, C.; Weber, R.; Grond-Ginsbach, C.; Hacke, W.; Giossi, A.; Volonghi, I.; Costa, P.; del Zotto, E.; Morotti, A.; Poli, L.; Muiesan, M. Lorenza; Salvetti, M.; Rosei, E. Agabiti; Lanfranconi, S.; Baron, P.; Ferrarese, C.; Susani, E.; Bicocca, M.; Giacalone, G.; Paolucci, S.; Palmirotta, R.; Guadagni, Fiorella; Paciaroni, M.; Ballabio, E.; Parati, E. A.; Ciusani, E.; Fluri, F.; Hatz, F.; Gisler, D.; Amort, M.; Bevan, S.; James, T.; Olsson, S.; Holmegaard, L.; Altintas, A.; Martin, J. J.; Kittner, S.; MItchell, B.; Stine, C.; O'Connell, J.; Dueker, N.; Koudstaal, P. J.; de Lau, L. M.; Hofman, A.; Verhaaren, B. F.; Uitterlinden, A. G.; Montaner, J.; Mendioroz, M.; Yadav, S.; Khan, M. S.; Wilder, M.; van Dijk, E.; Maaijwee, N.; Rutten-Jacobs, L.; Kramer, J.; Malik, S.; Brown, R. D., Jr.; Singleton, A.; Hardy, J.; Rich, S. S.; Tanislav, C.; Jungehuelsing, J.		Int Stroke Genetics Consortium; CADISP Grp	Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VASCULAR RISK-FACTORS; ISCHEMIC-STROKE; INTRACRANIAL ANEURYSM; AORTIC-ANEURYSMS; IDENTIFIES 3; LOCI; MIGRAINE; GENE; METAANALYSIS	Cervical artery dissection (CeAD), a mural hematoma in a carotid or vertebral artery, is a major cause of ischemic stroke in young adults although relatively uncommon in the general population (incidence of 2.6/100,000 per year)(1). Minor cervical traumas, infection, migraine and hypertension are putative risk factors(1-3), and inverse associations with obesity and hypercholesterolemia are described(3,4). No confirmed genetic susceptibility factors have been identified using candidate gene approaches(5). We performed genome-wide association studies (GWAS) in 1,393 CeAD cases and 14,416 controls. The rs9349379[G] allele (PHACTR(1)) was associated with lower CeAD risk (odds ratio (OR) = 0.75, 95% confidence interval (CI) = 0.69-0.82; P = 4.46 x 10(-10)), with confirmation in independent follow-up samples (659 CeAD cases and 2,648 controls; P = 3.91 x 10(-3); combined P = 1.00 x 10(-11)). The rs9349379[G] allele was previously shown to be associated with lower risk of migraine and increased risk of myocardial infarction(6-9). Deciphering the mechanisms underlying this pleiotropy might provide important information on the biological underpinnings of these disabling conditions.	[Debette, Stephanie; Amouyel, Philippe; Dallongeville, Jean] INSERM, U744, F-59045 Lille, France; [Debette, Stephanie; Amouyel, Philippe; Dallongeville, Jean] Inst Pasteur, F-59019 Lille, France; [Debette, Stephanie; Amouyel, Philippe] Lille Univ Hosp, Lille, France; [Debette, Stephanie; Leys, Didier] Dept Neurol, Equipe Accueil 1046, Lille, France; [Debette, Stephanie; Chauhan, Ganesh; Leys, Didier; Tzourio, C.] Univ Bordeaux, INSERM, U897, Bordeaux, France; [Kamatani, Yoichiro; Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Kamatani, Yoichiro; Lathrop, Mark] CEPH, Fdn Jean Dausset, Paris, France; [Kamatani, Yoichiro] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Metso, Tiina M.; Metso, Antti J.; Tatlisumak, Turgut] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Kloss, Manja; Werner, Inge; Lichy, Christoph; Grond-Ginsbach, C.; Hacke, W.] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Engelter, Stefan T.; Lyrer, Philippe A.; Fluri, F.; Hatz, F.; Gisler, D.; Amort, M.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Pezzini, Alessandro; Padovani, Alessandro] Brescia Univ Hosp, Neurol Clin, Dept Clin & Expt Sci, Brescia, Italy; [Thijs, Vincent; Lemmens, R.] Leuven Univ Hosp, Dept Neurol, Leuven, Belgium; [Thijs, Vincent; Lemmens, R.] VIB, Vesalius Res Ctr, Leuven, Belgium; [Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Dichgans, Martin; Gschwendtner, Andreas] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin; Gschwendtner, Andreas] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, Dept Stat Genet, D-80804 Munich, Germany; [Dittrich, Ralf; Ringelstein, Erich-Bernd] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Touze, Emmanuel; Louillet, F.; Mas, J. L.] Univ Hosp Sainte Anne, Dept Neurol, Paris, France; [Touze, Emmanuel] Univ Hosp Caen, Dept Neurol, Caen, France; [Southerland, Andrew M.; Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Samson, Yves] Assistance Publ Hop Paris Salpetriere Urgences Ce, Paris, France; [Abboud, Sherine; Pandolfo, M.] Univ Libre Bruxelles, Lab Expt Neurol, Brussels, Belgium; [Bejot, Yannick; Giroud, M.; Jacquin, A.] Dijon Univ Hosp, Dept Neurol, Dijon, France; [Caso, Valeria; Paciaroni, M.] Univ Perugia, Santa Maria Misericordia Hosp, Stroke Unit, SantAndrea Fratte, I-06100 Perugia, Italy; [Caso, Valeria; Paciaroni, M.] Univ Perugia, Santa Maria Misericordia Hosp, Div Cardiovasc Med, SantAndrea Fratte, I-06100 Perugia, Italy; [Bersano, Anna; Boncoraglio, Giorgio B.; Ballabio, E.; Parati, E. A.; Ciusani, E.] Ist Neurol Carlo Besta, Fdn Ist Ricovero Cura Carattere Sci, Dept Cerebrovasc Dis, Milan, Italy; [Sessa, Maria; Giacalone, G.] San Raffaele Univ Hosp, Dept Neurol, Milan, Italy; [Cole, John; Cheng, Yu-Ching; Kittner, S.; MItchell, B.; Stine, C.; O'Connell, J.; Dueker, N.] Univ Maryland, Sch Med, Dept Neurol, Maryland Stroke Ctr, Baltimore, MD 21201 USA; [Lamy, Chantal; Canaple, S.; Godefroy, O.] Amiens Univ Hosp, Dept Neurol, Amiens, France; [Medeiros, Elisabeth; Moulin, T.; Vullier, F.] Besancon Univ Hosp, Dept Neurol, Besancon, France; [Beretta, Simone; Ferrarese, C.; Susani, E.] Univ Milano Bicocca, San Gerardo Hosp, Dept Neurol, Monza, Italy; [Grau, Armin J.; Dos Santos, M.] Klinikum Ludwigshafen, Dept Neurol, Ludwigshafen, Germany; [Michel, Patrik] Univ Lausanne Hosp, Dept Neurol, Lausanne, Switzerland; [Majersik, Jennifer J.] Univ Utah, Dept Neurol, Divis Vasc Neurol, Salt Lake City, UT USA; [Sharma, Pankaj] Royal Holloway Univ London ICR2UL, Inst Cardiovasc Res, London, England; [Sharma, Pankaj] Ashford & St Peters Hosp, London, England; [Kalashnikova, Ludmila; Dobrynina, Larisa] Russian Acad Med Sci, Res Ctr Neurol, Moscow, Russia; [Nazarova, Maria] Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia; [Bartels, Eva] Ctr Neurol Vasc Diagnost, Munich, Germany; [Guillon, Benoit] Nantes Univ Hosp, Dept Neurol, Nantes, France; [Koudstaal, P. J.; de Lau, L. M.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Fernandez-Cadenas, Israel] Fdn Docencia Recerca MutuaTerrassa, Terrassa, Spain; [Fernandez-Cadenas, Israel; Montaner, J.; Mendioroz, M.] Hosp Valle De Hebron, Inst Recerca, Lab Neurovasc, Barcelona, Spain; [Jood, Katarina; Olsson, S.; Holmegaard, L.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Nalls, Michael A.; Singleton, A.] NIA, Neurogenet Lab, Mol Genet Sect, NIH, Bethesda, MD 20892 USA; [De Leeuw, Frank-Erik; Jern, Christina; van Dijk, E.; Maaijwee, N.; Rutten-Jacobs, L.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain,Cognit & Behav,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Brandt, Tobias] Schmieder Klin, Dept Rehabil, Heidelberg, Germany; [Wichmann, Heinz-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Gieger, Christian] Helmholtz Ctr Munich, Inst Genet Epidemiol, Neuherberg, Germany; [Johnson, Andrew D.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Bottcher, Thomas] Rostock Univ Hosp, Dept Neurol, Rostock, Germany; [Castellano, Maurizio; Muiesan, M. Lorenza; Salvetti, M.; Rosei, E. Agabiti] Brescia Univ Hosp, Med Clin, Dept Clin & Expt Sci, Brescia, Italy; [Arveiler, Dominique] Strasbourg Univ, EA 3430, Dept Epidemiol & Publ Hlth, Strasbourg, France; [Ikram, M. Arfan; Breteler, Monique M. B.] Univ Med Ctr, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Univ Med Ctr, Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Netherlands Consortium Healthy Aging, Leiden, Netherlands; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Bottcher, Thomas; Meschia, James F.; Malik, S.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Kuhlenbaumer, Gregor] Univ Kiel, Inst Expt Med, Kiel, Germany; [Worrall, Bradford B.; Rich, S. S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Pandolfo, M.] Free Univ Brussels, Erasme Hosp, Dept Neurol, Brussels, Belgium; [Bodenant, M.] Lille Univ Hosp, Dept Neurol, Lille, France; [Deltour, S.; Leder, S.; Leger, A.] Pitie Salpetriere Univ Hosp, Dept Neurol, Paris, France; [Malik, R.] Univ Hosp Munich, Dept Neurol, Munich, Germany; [Hausser, I.] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany; [Thomas-Feles, C.; Weber, R.] Dept Rehabil Schmieder Klin, Heidelberg, Germany; [Giossi, A.; Volonghi, I.; Costa, P.; del Zotto, E.; Morotti, A.; Poli, L.] Brescia Univ Hosp, Dept Clin Expt Sci, Neurol Clin, Brescia, Italy; [Lanfranconi, S.; Baron, P.] Univ Milan, Dept Neurol, IRCCS Fdn CaGranda Hosp Policlin Hosp, Milan, Italy; [Paolucci, S.] Santa Lucia Hosp, Dept Rehabil, Rome, Italy; [Palmirotta, R.; Guadagni, Fiorella] IRCCS San Raffaele Pisana, Dept Lab Med Adv Biotechnol, Rome, Italy; [Bevan, S.; James, T.] St Georges Univ London, Stroke & Dementia Res Ctr, London, England; [Altintas, A.] Univ Hosp Istanbul, Dept Neurol, Istanbul, Turkey; [Martin, J. J.] Univ Hosp Sanatorio Allende, Dept Neurol, Cordoba, Argentina; [Uitterlinden, A. G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hofman, A.; Verhaaren, B. F.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Yadav, S.; Khan, M. S.] Imperial Coll London, ICCRU, London, England; [Wilder, M.] Univ Utah, Salt Lake City, UT USA; [Kramer, J.] Univ Virginia, Dept Neurol & Publ Hlth Sci, Charlottesville, VA USA; [Malik, S.] Henry Ford Hosp, Detroit, MI USA; [Hardy, J.] UCL, Dept Mol Neuroscience Inst Neurol, London, England; [Rich, S. S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Tanislav, C.] Univ Hosp Giessen, Dept Neurol, Giessen, Germany; [Jungehuelsing, J.] Charite, Dept Neurol, Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; RIKEN; University of Helsinki; Helsinki University Central Hospital; Ruprecht Karls University Heidelberg; University of Basel; University of Brescia; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); University of Cambridge; University of Munich; University of Munich; Max Planck Society; University of Munster; GHU PARIS Psychiatrie Neurosciences; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Virginia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Libre de Bruxelles; CHU Dijon Bourgogne; Hospital Santa Maria della Misericordia; University of Perugia; Hospital Santa Maria della Misericordia; University of Perugia; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University System of Maryland; University of Maryland Baltimore; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Franche-Comte; CHU Besancon; San Gerardo Hospital; University of Milano-Bicocca; Ludwigshafen Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Utah System of Higher Education; University of Utah; Research Center of Neurology; Russian Academy of Medical Sciences; HSE University (National Research University Higher School of Economics); Nantes Universite; CHU de Nantes; Erasmus University Rotterdam; Erasmus MC; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Gothenburg; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Radboud University Nijmegen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Rostock; University of Brescia; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Mayo Clinic; University of Kiel; University of Virginia; McGill University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Munich; Ruprecht Karls University Heidelberg; University of Brescia; University of Milan; IRCCS Santa Lucia; IRCCS San Raffaele Pisana; St Georges University London; Istanbul University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Utah System of Higher Education; University of Utah; University of Virginia; Henry Ford Health System; Henry Ford Hospital; University of London; University College London; University of Virginia; University Hospital of Giessen & Marburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Debette, S (corresponding author), INSERM, U744, F-59045 Lille, France.	stephdebette@wanadoo.fr	Tzourio, christophe/B-4015-2009; LEYS, Didier/G-2955-2016; Beretta, Simone/J-6300-2019; samson, yves/C-5647-2013; Meschia, James/GPP-1636-2022; Béjot, Yannick/D-3942-2019; Dichgans, Martin/HCH-3247-2022; Singleton, Andrew B/C-3010-2009; de Leeuw, H.F./L-4479-2015; bersano, anna/J-8315-2018; Padovani, Alessandro/ABI-7312-2020; Muiesan, M.L./AAC-2060-2022; Johnson, Andrew D/G-6520-2013; Parati, Eugenio Agostino/AAN-5893-2021; Boncoraglio, Giorgio Battista/B-8647-2011; Wichmann, Heinz Erich/AAA-5695-2022; Montaner, Joan/D-3063-2015; Nazarova, Maria A./D-8810-2012; mendioroz, maite/P-9162-2019; JACQUIN, Agnès/AFN-9891-2022; Ferrarese, Carlo/AAC-4903-2022; Kamatani, Yoichiro/N-5513-2015; CASO, VALERIA/AAC-5156-2022; Morotti, Andrea/AAC-5252-2022; de Leeuw, Frank-Erik/E-4795-2012; Breteler, Monique M.B./J-5058-2014; Ciusani, Emilio/J-9822-2016; Bersano, Anna/AAK-2888-2021; Hacke, Werner/ABE-8661-2020; Kalashnikova, Ludmila A/C-5378-2012; CHAUHAN, GANESH/AAI-5110-2021; Debette, Stephanie/T-4946-2019; Palmirotta, Raffaele/E-3286-2017; Dobrynina, Larisa/C-5372-2012; Sessa, Maria/AAC-1943-2022; Ikram, M. Arfan/AAM-5225-2021; Tzourio, christophe/L-6344-2019; Southerland, Andrew M./AAV-6994-2021; Paciaroni, Maurizio/AAC-5067-2022; Michel, Patrik/Q-2275-2016; sharma, pankaj/HGE-4423-2022; Thijs, Vincent/C-3647-2009; Majersik, Jennifer Juhl/J-4236-2019; Bonati, Leo/G-4058-2012; Hardy, John/C-2451-2009; Morotti, Andrea/Q-8873-2019; Castellano, Maurizio/C-1096-2011	Tzourio, christophe/0000-0002-6517-2984; LEYS, Didier/0000-0003-4408-4392; Beretta, Simone/0000-0002-9417-2748; Meschia, James/0000-0002-4475-8142; Béjot, Yannick/0000-0001-7848-7072; Dichgans, Martin/0000-0002-0654-387X; bersano, anna/0000-0002-2493-628X; Padovani, Alessandro/0000-0002-0119-3639; Muiesan, M.L./0000-0002-4007-9441; Johnson, Andrew D/0000-0001-6369-5178; Parati, Eugenio Agostino/0000-0001-5020-6523; Boncoraglio, Giorgio Battista/0000-0002-2551-525X; Montaner, Joan/0000-0003-4845-2279; Nazarova, Maria A./0000-0001-5347-5948; mendioroz, maite/0000-0002-4179-5781; CASO, VALERIA/0000-0002-2020-8891; Morotti, Andrea/0000-0002-6558-1155; Breteler, Monique M.B./0000-0002-0626-9305; Ciusani, Emilio/0000-0002-7285-123X; Bersano, Anna/0000-0002-2493-628X; Debette, Stephanie/0000-0001-8675-7968; Palmirotta, Raffaele/0000-0002-9401-7377; Sessa, Maria/0000-0002-9589-0290; Tzourio, christophe/0000-0002-6517-2984; Southerland, Andrew M./0000-0002-3646-358X; Michel, Patrik/0000-0003-4954-7579; Thijs, Vincent/0000-0002-6614-8417; Bonati, Leo/0000-0003-1163-8133; Hardy, John/0000-0002-3122-0423; Moulin, thierry/0000-0002-6639-8117; Castellano, Maurizio/0000-0002-4569-2659; Lemmens, Robin/0000-0002-4948-5956; Touze, Emmanuel/0000-0002-7254-2162; Engelter, Stefan/0000-0003-3855-6234; Gieger, Christian/0000-0001-6986-9554; Chauhan, Ganesh/0000-0002-8564-5021; Amouyel, Philippe/0000-0001-9088-234X; Verhaaren, Benjamin/0000-0003-3477-9350; Fernandez-Cadenas, Israel/0000-0003-4821-2363; Ikram, Mohammad Arfan/0000-0003-0372-8585	INSERM; Lille 2 University; Institut Pasteur de Lille; Lille University Hospital; European Regional Development Fund; Region Nord-Pas-de-Calais [09120030]; Centre National de Genotypage; Emil Aaltonen Foundation; Paavo Ilmari Ahvenainen Foundation; Helsinki University Central Hospital Research Fund; Helsinki University Medical Foundation; Paivikki and Sakari Sohlberg Foundation; Aarne Koskelo Foundation; Maire Taponen Foundation; Aarne and Aili Turunen Foundation; Lilly Foundation; Alfred Kordelin Foundation; Finnish Medical Foundation; Orion Farmos Research Foundation; Maud Kuistila Foundation; Finnish Brain Foundation; Biomedicum Helsinki Foundation; Projet Hospitalier de Recherche Clinique Regional, Fondation de France; Genopole de Lille; Adrinord; Basel Stroke Funds; Kathe-ZinggSchwichtenberg- Fonds of the Swiss Academy of Medical Sciences; Swiss Heart Foundation; Swiss National Science Foundation [33CM30-124119]; Chair of Excellence from the French National Research Agency (ANR); Leducq Foundation; Vascular Dementia Research Foundation; Spanish Ministry of Health [CP12/03298]; Department of Health (UK); American Heart Association/American Stroke Association National Clinical Research Program (AHA) [3CRP14140001]; Fonds Wetenschappelijk Onderzoek Flanders; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Lille 2 University; Institut Pasteur de Lille; Lille University Hospital; European Regional Development Fund(European Commission); Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Centre National de Genotypage; Emil Aaltonen Foundation; Paavo Ilmari Ahvenainen Foundation; Helsinki University Central Hospital Research Fund; Helsinki University Medical Foundation; Paivikki and Sakari Sohlberg Foundation; Aarne Koskelo Foundation; Maire Taponen Foundation; Aarne and Aili Turunen Foundation; Lilly Foundation; Alfred Kordelin Foundation; Finnish Medical Foundation; Orion Farmos Research Foundation; Maud Kuistila Foundation; Finnish Brain Foundation; Biomedicum Helsinki Foundation; Projet Hospitalier de Recherche Clinique Regional, Fondation de France(Fondation de France); Genopole de Lille; Adrinord; Basel Stroke Funds; Kathe-ZinggSchwichtenberg- Fonds of the Swiss Academy of Medical Sciences; Swiss Heart Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Chair of Excellence from the French National Research Agency (ANR)(French National Research Agency (ANR)); Leducq Foundation(Leducq Foundation); Vascular Dementia Research Foundation; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Department of Health (UK); American Heart Association/American Stroke Association National Clinical Research Program (AHA); Fonds Wetenschappelijk Onderzoek Flanders(FWO); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the staff and participants of all CADISP centers for their important contributions. The CADISP study has been supported by INSERM, Lille 2 University, Institut Pasteur de Lille and Lille University Hospital and received funding from the European Regional Development Fund (FEDER funds) and Region Nord-Pas-de-Calais in the framework of Contrat de Projets Etat-Region 2007-2013 Region Nord-Pas-de-Calais (grant 09120030), Centre National de Genotypage, the Emil Aaltonen Foundation, the Paavo Ilmari Ahvenainen Foundation, the Helsinki University Central Hospital Research Fund, the Helsinki University Medical Foundation, the Paivikki and Sakari Sohlberg Foundation, the Aarne Koskelo Foundation, the Maire Taponen Foundation, the Aarne and Aili Turunen Foundation, the Lilly Foundation, the Alfred Kordelin Foundation, the Finnish Medical Foundation, the Orion Farmos Research Foundation, the Maud Kuistila Foundation, the Finnish Brain Foundation, the Biomedicum Helsinki Foundation, Projet Hospitalier de Recherche Clinique Regional, Fondation de France, Genopole de Lille, Adrinord, the Basel Stroke Funds, the Kathe-ZinggSchwichtenberg- Fonds of the Swiss Academy of Medical Sciences and the Swiss Heart Foundation. L.H.B., S.T.E. and P.A.L. were supported, in part, by a grant from the Swiss National Science Foundation (33CM30-124119). S.D. is supported by a Chair of Excellence from the French National Research Agency (ANR). S.D. and M.D. are supported by a grant from the Leducq Foundation. M.D. is supported by the Vascular Dementia Research Foundation. I.F.-C. is supported by the Miguel Servet programme (CP12/03298) from the Spanish Ministry of Health (Instituto de Salud Carlos III). G.K. is a member of the Deutsche Forschungsgemeinschaft Cluster of Excellence 'Inflammation at Interfaces'. P.S. is supported by a Department of Health (UK) senior fellowship. A.M.S. is supported by the American Heart Association/American Stroke Association National Clinical Research Program (AHA 3CRP14140001). V.T. is supported by Fonds Wetenschappelijk Onderzoek Flanders. More detailed acknowledgments can be found in the Supplementary Note.	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Arnold M, 2009, J NEUROL NEUROSUR PS, V80, P232, DOI 10.1136/jnnp.2008.151324; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Callaghan FM, 2011, AM J PHYSIOL-HEART C, V300, pH1451, DOI 10.1152/ajpheart.00871.2010; Calvet D, 2004, STROKE, V35, P2078, DOI 10.1161/01.STR.0000136721.95301.8d; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Debette S, 2011, NEUROLOGY, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; Debette S, 2009, INT J STROKE, V4, P224, DOI 10.1111/j.1747-4949.2009.00281.x; Debette S, 2011, CIRCULATION, V123, P1537, DOI 10.1161/CIRCULATIONAHA.110.000125; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Debette S, 2009, STROKE, V40, pE459, DOI 10.1161/STROKEAHA.108.534669; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Fils-Aime N, 2013, J BIOL CHEM, V288, P11807, DOI 10.1074/jbc.M112.430934; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hager J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038663; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Lee VH, 2006, NEUROLOGY, V67, P1809, DOI 10.1212/01.wnl.0000244486.30455.71; LeMaire SA, 2011, NAT GENET, V43, P996, DOI 10.1038/ng.934; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Longoni M, 2006, NEUROLOGY, V66, P1273, DOI 10.1212/01.wnl.0000208411.01172.0b; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Mehta Nehal N, 2011, Circ Cardiovasc Genet, V4, P465, DOI 10.1161/CIRCGENETICS.111.960989; Metso TM, 2012, NEUROLOGY, V78, P1221, DOI 10.1212/WNL.0b013e318251595f; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pezzini A, 2002, STROKE, V33, P664, DOI 10.1161/hs0302.103625; Pezzini A, 2007, STROKE, V38, P3145, DOI 10.1161/STROKEAHA.107.491506; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rubinstein SM, 2005, STROKE, V36, P1575, DOI 10.1161/01.STR.0000169919.73219.30; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shantikumar S, 2010, EUR J VASC ENDOVASC, V39, P200, DOI 10.1016/j.ejvs.2009.10.014; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461	51	140	142	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					78	+		10.1038/ng.3154	http://dx.doi.org/10.1038/ng.3154			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25420145	Green Accepted			2022-12-17	WOS:000346990400015
J	Tang, HY; Jin, X; Li, Y; Jiang, H; Tang, XF; Yang, X; Cheng, H; Qiu, Y; Chen, G; Mei, JP; Zhou, FS; Wu, RH; Zuo, XB; Zhang, Y; Zheng, XD; Cai, Q; Yin, XY; Quan, C; Shao, HJ; Cui, Y; Tian, FZ; Zhao, X; Liu, H; Xiao, FL; Xu, FP; Han, JW; Shi, DM; Zhang, AP; Zhou, C; Li, QB; Fan, X; Lin, LY; Tian, HQ; Wang, ZX; Fu, HL; Wang, F; Yang, BQ; Huang, SW; Liang, B; Xie, XF; Ren, YQ; Gu, QQ; Wen, GD; Sun, YL; Wu, XL; Dang, L; Xia, M; Shan, JJ; Li, TH; Yang, L; Zhang, XY; Li, YZ; He, CD; Xu, A; Wei, LP; Zhao, XH; Gao, XH; Xu, JH; Zhang, FR; Zhang, JZ; Li, YR; Sun, LD; Liu, JJ; Chen, RS; Yang, S; Wang, J; Zhang, XJ				Tang, Huayang; Jin, Xin; Li, Yang; Jiang, Hui; Tang, Xianfa; Yang, Xu; Cheng, Hui; Qiu, Ying; Chen, Gang; Mei, Junpu; Zhou, Fusheng; Wu, Renhua; Zuo, Xianbo; Zhang, Yong; Zheng, Xiaodong; Cai, Qi; Yin, Xianyong; Quan, Cheng; Shao, Haojing; Cui, Yong; Tian, Fangzhen; Zhao, Xia; Liu, Hong; Xiao, Fengli; Xu, Fengping; Han, Jianwen; Shi, Dongmei; Zhang, Anping; Zhou, Cheng; Li, Qibin; Fan, Xing; Lin, Liya; Tian, Hongqing; Wang, Zaixing; Fu, Huiling; Wang, Fang; Yang, Baoqi; Huang, Shaowei; Liang, Bo; Xie, Xuefeng; Ren, Yunqing; Gu, Qingquan; Wen, Guangdong; Sun, Yulin; Wu, Xueli; Dang, Lin; Xia, Min; Shan, Junjun; Li, Tianhang; Yang, Lin; Zhang, Xiuyun; Li, Yuzhen; He, Chundi; Xu, Aie; Wei, Liping; Zhao, Xiaohang; Gao, Xinghua; Xu, Jinhua; Zhang, Furen; Zhang, Jianzhong; Li, Yingrui; Sun, Liangdan; Liu, Jianjun; Chen, Runsheng; Yang, Sen; Wang, Jun; Zhang, Xuejun			A large-scale screen for coding variants predisposing to psoriasis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; SUSCEPTIBILITY LOCI; RARE VARIANTS; MISSING HERITABILITY; LOW-FREQUENCY; SEQUENCE; DISEASE; IDENTIFICATION; METAANALYSIS	To explore the contribution of functional coding variants to psoriasis, we analyzed nonsynonymous single-nucleotide variants (SNVs) across the genome by exome sequencing in 781 psoriasis cases and 676 controls and through follow-up validation in 1,326 candidate genes by targeted sequencing in 9,946 psoriasis cases and 9,906 controls from the Chinese population. We discovered two independent missense SNVs in IL23R and GJB2 of low frequency and five common missense SNVs in LCE3D, ERAP1, CARD14 and ZNF816A associated with psoriasis at genome-wide significance. Rare missense SNVs in FUT2 and TARBP1 were also observed with suggestive evidence of association. Single-variant and gene-based association analyses of nonsynonymous SNVs did not identify newly associated genes for psoriasis in the regions subjected to targeted resequencing. This suggests that coding variants in the 1,326 targeted genes contribute only a limited fraction of the overall genetic risk for psoriasis.	[Tang, Huayang; Li, Yang; Tang, Xianfa; Cheng, Hui; Chen, Gang; Zhou, Fusheng; Zuo, Xianbo; Zheng, Xiaodong; Yin, Xianyong; Quan, Cheng; Cui, Yong; Xiao, Fengli; Fan, Xing; Wang, Zaixing; Liang, Bo; Ren, Yunqing; Sun, Liangdan; Liu, Jianjun; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Jin, Xin; Jiang, Hui; Yang, Xu; Mei, Junpu; Wu, Renhua; Zhang, Yong; Shao, Haojing; Zhao, Xia; Xiao, Fengli; Li, Qibin; Lin, Liya; Fu, Huiling; Huang, Shaowei; Xie, Xuefeng; Gu, Qingquan; Wu, Xueli; Xia, Min; Yang, Lin; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Tian, Fangzhen; Shi, Dongmei] Jining 1 Peoples Hosp, Dept Dermatol, Jining, Shandong, Peoples R China; [Cai, Qi] Second Hosp, Dept Dermatol, Chengdu, Peoples R China; [Liu, Hong; Tian, Hongqing; Yang, Baoqi] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Han, Jianwen] Inner Mongolia Med Coll, Affiliated Hosp, Dept Dermatol, Hohhot, Peoples R China; [Zhou, Cheng; Wang, Fang; Wen, Guangdong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100871, Peoples R China; [Sun, Yulin; Zhao, Xiaohang] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Sun, Yulin; Zhao, Xiaohang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yulin; Zhao, Xiaohang] Navy Gen Hosp, Ctr Basic Med Sci, Beijing, Peoples R China; [Dang, Lin; Li, Yuzhen] Harbin Med Univ, Affiliated Hosp 2, Dept Dermatol, Harbin, Peoples R China; [Shan, Junjun; Xu, Aie] Third Peoples Hosp Hangzhou, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [He, Chundi; Gao, Xinghua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Peoples R China; [Wei, Liping] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Xu, Jinhua; Zhang, Xuejun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Anhui Medical University; Beijing Genomics Institute (BGI); South China University of Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Inner Mongolia Medical University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sixth Medical Center of Chinese PLA General Hospital; Harbin Medical University; China Medical University; Peking University; Fudan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Zhang, XJ (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Peoples R China.	wangj@genomics.cn; ayzxj@vip.sina.com	Wang, Jun/A-7261-2013; Shao, Haojing/C-5429-2017; Chen, Gang/G-2722-2010; xu, fengping/AAE-6072-2019; Li, Yingrui/K-1064-2015; Jin, Xin/ABF-1329-2020; wang, fang/GYD-4295-2022; Zhou, Cheng/GMW-6255-2022; Liu, Jianjun/AAK-4989-2020; Cui, Yong/AAF-9300-2020; Fang, Xiaodong/K-6743-2018; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Shao, Haojing/0000-0002-8806-197X; Jin, Xin/0000-0001-7554-4975; Liu, Jianjun/0000-0002-3255-3019; Fang, Xiaodong/0000-0001-7061-3337; Zhou, Cheng/0000-0002-4091-4777; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	National Natural Science Foundation of China [81130031, 81072461, 30971644, 31171224, 31000528, 81000692, 81071285, 81172866, 81172591, 31200939]; National Science Fund for Excellent Young Scholars [81222022]; Outstanding Talents of Organization Department of the CPC (Communist Party of China) Central Committee program; Ministry of Finance of China; New Century Excellent Talents in University [NCET-11-0889]; Science and Technological Fund of Anhui Province for Outstanding Youth [1108085J10]; Pre-National Basic Research Program of China (973 Plan) [2012CB722404]; National Basic Research Program of China (973 Plan) [2009CB825404]; State Key Development Program for Basic Research of China (973 Program) [2011CB809203]; Chinese High-Tech (863) Program [2012AA02A201]; Enterprise Key Laboratory; Guangdong Province; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; National High-Tech Research & Development Program [2012AA020206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Outstanding Talents of Organization Department of the CPC (Communist Party of China) Central Committee program; Ministry of Finance of China; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technological Fund of Anhui Province for Outstanding Youth; Pre-National Basic Research Program of China (973 Plan)(National Basic Research Program of China); National Basic Research Program of China (973 Plan)(National Basic Research Program of China); State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Chinese High-Tech (863) Program(National High Technology Research and Development Program of China); Enterprise Key Laboratory; Guangdong Province; Shenzhen Key Laboratory of Transomics Biotechnologies; National High-Tech Research & Development Program(National High Technology Research and Development Program of China)	We thank the individuals who participated in this project and their families. We also want to thank L. Wu, D. Li, Y. Shi, J. Shen, L. Song, Y. Xue, J. Jv, Y. Sheng and J. Gao who participated in the analysis of exome sequencing data. We thank the State Key Laboratory Incubation Base of Dermatology, Ministry of National Science and Technology (Hefei, China). This study was funded by the Key Program of the National Natural Science Foundation of China (81130031), the National Science Fund for Excellent Young Scholars (81222022), the Outstanding Talents of Organization Department of the CPC (Communist Party of China) Central Committee program, the Local Universities Characteristics and Advantages of Discipline Development Program of the Ministry of Finance of China and the General Program of the National Natural Science Foundation of China (81072461, 30971644, 31171224, 31000528, 81000692, 81071285, 81172866, 81172591 and 31200939), New Century Excellent Talents in University (NCET-11-0889), and the Science and Technological Fund of Anhui Province for Outstanding Youth (1108085J10) as well as the Pre-National Basic Research Program of China (973 Plan; 2012CB722404), the National Basic Research Program of China (973 Plan; 2009CB825404), the State Key Development Program for Basic Research of China (973 Program; 2011CB809203), the Chinese High-Tech (863) Program (2012AA02A201), the Enterprise Key Laboratory, supported by Guangdong Province, and the Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A), and the National High-Tech Research & Development Program (2012AA020206).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Dering C, 2011, GENET EPIDEMIOL, V35, pS12, DOI 10.1002/gepi.20643; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ellinghaus E, 2012, J INVEST DERMATOL, V132, P1133, DOI 10.1038/jid.2011.415; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Madsen B.E., 2009, PLOS GENET, V5; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; WALLENSTEIN S, 1993, BIOMETRICS, V49, P1077, DOI 10.2307/2532249; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zeggini E, 2011, NAT GENET, V43, P287, DOI 10.1038/ng0411-287; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhang XJ, 2012, J DERMATOL SCI, V66, P89, DOI 10.1016/j.jdermsci.2012.02.017	54	140	148	6	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					45	+		10.1038/ng.2827	http://dx.doi.org/10.1038/ng.2827			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24212883				2022-12-17	WOS:000329113500011
J	Hoff, S; Halbritter, J; Epting, D; Frank, V; Nguyen, TMT; van Reeuwijk, J; Boehlke, C; Schell, C; Yasunaga, T; Helmstadter, M; Mergen, M; Filhol, E; Boldt, K; Horn, N; Ueffing, M; Otto, EA; Eisenberger, T; Elting, MW; van Wijk, JAE; Bockenhauer, D; Sebire, NJ; Rittig, S; Vyberg, M; Ring, T; Pohl, M; Pape, L; Neuhaus, TJ; Elshakhs, NAS; Koon, SJ; Harris, PC; Grahammer, F; Huber, TB; Kuehn, EW; Kramer-Zucker, A; Bolz, HJ; Roepman, R; Saunier, S; Walz, G; Hildebrandt, F; Bergmann, C; Lienkamp, SS				Hoff, Sylvia; Halbritter, Jan; Epting, Daniel; Frank, Valeska; Nguyen, Thanh-Minh T.; van Reeuwijk, Jeroen; Boehlke, Christopher; Schell, Christoph; Yasunaga, Takayuki; Helmstaedter, Martin; Mergen, Miriam; Filhol, Emilie; Boldt, Karsten; Horn, Nicola; Ueffing, Marius; Otto, Edgar A.; Eisenberger, Tobias; Elting, Mariet W.; van Wijk, Joanna A. E.; Bockenhauer, Detlef; Sebire, Neil J.; Rittig, Soren; Vyberg, Mogens; Ring, Troels; Pohl, Martin; Pape, Lars; Neuhaus, Thomas J.; Elshakhs, Neveen A. Soliman; Koon, Sarah J.; Harris, Peter C.; Grahammer, Florian; Huber, Tobias B.; Kuehn, E. Wolfgang; Kramer-Zucker, Albrecht; Bolz, Hanno J.; Roepman, Ronald; Saunier, Sophie; Walz, Gerd; Hildebrandt, Friedhelm; Bergmann, Carsten; Lienkamp, Soeren S.			ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; TANDEM AFFINITY PURIFICATION; PROTEIN COMPLEXES; ZEBRAFISH; CILIARY; PRONEPHROS; CILIOPATHIES; MUTATIONS; GENES; NEPHROCYSTIN-3	Nephronophthisis is an autosomal recessive cystic kidney disease that leads to renal failure in childhood or adolescence. Most NPHP gene products form molecular networks. Here we identify ANKS6 as a new NPHP family member that connects NEK8 (NPHP9) to INVS (NPHP2) and NPHP3. We show that ANKS6 localizes to the proximal cilium and confirm its role in renal development through knockdown experiments in zebrafish and Xenopus laevis. We also identify six families with ANKS6 mutations affected by nephronophthisis, including severe cardiovascular abnormalities, liver fibrosis and situs inversus. The oxygen sensor HIF1AN hydroxylates ANKS6 and INVS and alters the composition of the ANKS6-INVS-NPHP3 module. Knockdown of Hif1an in Xenopus results in a phenotype that resembles loss of other NPHP proteins. Network analyses uncovered additional putative NPHP proteins and placed ANKS6 at the center of this NPHP module, explaining the overlapping disease manifestation caused by mutation in ANKS6, NEK8, INVS or NPHP3.	[Hoff, Sylvia; Epting, Daniel; Boehlke, Christopher; Schell, Christoph; Yasunaga, Takayuki; Helmstaedter, Martin; Mergen, Miriam; Grahammer, Florian; Huber, Tobias B.; Kuehn, E. Wolfgang; Kramer-Zucker, Albrecht; Walz, Gerd; Bergmann, Carsten; Lienkamp, Soeren S.] Univ Freiburg, Dept Med, Div Renal, Med Ctr, Freiburg, Germany; [Hoff, Sylvia; Schell, Christoph] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Hoff, Sylvia; Schell, Christoph; Helmstaedter, Martin] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Halbritter, Jan; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA 02114 USA; [Frank, Valeska; Eisenberger, Tobias; Bolz, Hanno J.; Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Nguyen, Thanh-Minh T.; van Reeuwijk, Jeroen; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Nguyen, Thanh-Minh T.; van Reeuwijk, Jeroen; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [Filhol, Emilie; Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U983, Paris, France; [Filhol, Emilie; Saunier, Sophie] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Boldt, Karsten; Horn, Nicola; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Div Expt Ophthalmol, Tubingen, Germany; [Boldt, Karsten; Horn, Nicola; Ueffing, Marius] Univ Tubingen, Med Proteome Ctr, Tubingen, Germany; [Ueffing, Marius] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Prot Sci, Munich, Germany; [Ueffing, Marius] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany; [Otto, Edgar A.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Elting, Mariet W.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [van Wijk, Joanna A. E.] Vrije Univ Amsterdam Med Ctr, Dept Pediat Nephrol, Amsterdam, Netherlands; [Bockenhauer, Detlef] UCL, Inst Child Hlth & Pediat Nephrol, Great Ormond St Hosp, London, England; [Sebire, Neil J.] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England; [Rittig, Soren] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Vyberg, Mogens] Aalborg Univ Hosp, Inst Pathol, Aalborg, Denmark; [Ring, Troels] Aalborg Univ Hosp, Dept Nephrol, Aalborg, Denmark; [Pohl, Martin] Univ Freiburg, Med Ctr, Dept Pediat & Adolescent Med, Freiburg, Germany; [Pape, Lars] Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany; [Neuhaus, Thomas J.] Childrens Hosp Lucerne, Dept Pediat, Luzern, Switzerland; [Elshakhs, Neveen A. Soliman] Cairo Univ, Ctr Pediat Nephrol & Transplantat, Cairo, Egypt; [Elshakhs, Neveen A. Soliman] EGORD, Cairo, Egypt; [Koon, Sarah J.; Harris, Peter C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Huber, Tobias B.; Kuehn, E. Wolfgang; Walz, Gerd] Ctr Biol Signaling Studies BIOSS, Freiburg, Germany; [Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bergmann, Carsten] Univ Freiburg, Clin Res Ctr, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Harvard University; Boston Children's Hospital; Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Michigan System; University of Michigan; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Freiburg; Hannover Medical School; Egyptian Knowledge Bank (EKB); Cairo University; Mayo Clinic; University of Cologne; Howard Hughes Medical Institute; University of Freiburg	Hildebrandt, F (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA 02114 USA.	friedhelm.hildebrandt@childrens.harvard.edu; carsten.bergmann@bioscientia.de; soeren.lienkamp@uniklinik-freiburg.de	Saunier, Sophie/G-6044-2015; Pape, Lars/AAF-1477-2021; Boldt, Karsten/B-7538-2014; Grahammer, Florian/ABB-7775-2021; Boehlke, Christopher/AAZ-6627-2021; van Reeuwijk, Jeroen/P-8665-2015; Lienkamp, Soeren/AAH-6296-2020; Roepman, Ronald/B-1339-2014; Vyberg, Mogens/E-7576-2016; Bockenhauer, Detlef/AAF-6495-2020; Soliman, Neveen/T-2687-2018	Saunier, Sophie/0000-0002-1069-0047; Pape, Lars/0000-0002-3635-6418; Boehlke, Christopher/0000-0002-6985-0201; van Reeuwijk, Jeroen/0000-0002-0658-4399; Lienkamp, Soeren/0000-0003-2963-6865; Roepman, Ronald/0000-0002-5178-8163; Vyberg, Mogens/0000-0002-6392-9517; Bockenhauer, Detlef/0000-0001-5878-941X; Sebire, Neil/0000-0001-5348-9063; Otto, Edgar/0000-0002-2387-9973; Soliman, Neveen/0000-0002-8942-1973; Huber, Tobias B./0000-0001-7175-5062; Halbritter, Jan/0000-0002-1377-9880	Deutsche Forschungsgemeinschaft (DFG) [KFO 201]; DFG [KU 1504, BE 3910/4-1, ZE 205/14-1, SFB/TRR57]; Else-Kroner-Fresenius Stiftung; Excellence Initiative of the German Federal and State Governments [EXC 294-BIOSS, GSC-4]; European Community [241955, 278568]; Netherlands Organisation for Scientific Research (NWO) [Vidi-91786396, Vici-016.130.664]; Agence Nationale de la Recherche [R09087KS, RPV11012KK]; Fondation pour la Recherche Medicale [DEQ20071210558]; US National Institutes of Health [DK068306, DK090917]; Howard Hughes Medical Institute; Deutsche Nierenstiftung; PKD Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, RC4DK090917, R01DK059597] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Else-Kroner-Fresenius Stiftung; Excellence Initiative of the German Federal and State Governments; European Community(European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Nierenstiftung; PKD Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to all patients and family members for their participation. We thank A. Sammarco, C. Engel, B. Muller, L. Schomas, S. Br g and M. Klein for excellent technical assistance, the staff of the Life Imaging Center (LIC) in the Center for Systems Biology, Albert-Ludwigs-University Freiburg for excellent confocal microscopy resources and the support in image recording and analysis, and U. Lanner and E. Haaf of the proteomics core facility. We thank N. Katsanis and J. Willer (Duke University) for providing us with expression constructs for NEK7 and INVS. We thank K. Coene for her help in generating affinity proteomics data for NEK8. We thank E. Jones for making the 3G8 and 4A6 antibodies available through the European Xenopus stock centre. V. F., T. E., H. J. B. and C. Bergmann are employees of Bioscientia, a member of Sonic Healthcare. D. B. is a Higher Education Funding Council for England (HEFCE) Clinical Reader and is supported by Kids Kidney Research. A.K.-Z., G. W., E. W. K., F. G., T. B. H. and S. S. L. are supported by the Deutsche Forschungsgemeinschaft (DFG; KFO 201). E. W. K. is supported by the DFG (KU 1504). C. Boehlke is supported by the Else-Kroner-Fresenius Stiftung. G. W. and T. B. H. are supported by the Excellence Initiative of the German Federal and State Governments (EXC 294-BIOSS). M. U., R. R. and G. W. are supported by the European Community's Seventh Framework Programme (grant agreement 241955, SYSCILIA). R. R. is supported by the Netherlands Organisation for Scientific Research (NWO Vidi-91786396 and Vici-016.130.664). K. B. and M. U. are supported by the European Community's Seventh Framework Programme under grant agreement 278568, PRIMES. This study was supported in part by the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School) and by grants from the Agence Nationale de la Recherche to S. S. (R09087KS and RPV11012KK) and the Fondation pour la Recherche Medicale (DEQ20071210558). This research was supported by grants from the US National Institutes of Health to F. H. (DK068306 and DK090917). F. H. is an Investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist and a Frederick G. L. Huetwell Professor. C. Bergmann received support from the DFG (BE 3910/4-1, ZE 205/14-1 and SFB/TRR57), the Deutsche Nierenstiftung and the PKD Foundation.	Benzing T, 2012, CURR OPIN NEPHROL HY, V21, P272, DOI 10.1097/MNH.0b013e3283520f17; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; Boldt K, 2009, METHOD CELL BIOL, V91, P143, DOI 10.1016/S0091-679X(08)91009-8; Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Fukui H, 2012, FEBS LETT, V586, P2273, DOI 10.1016/j.febslet.2012.05.064; Ganner A, 2009, P NATL ACAD SCI USA, V106, P17799, DOI 10.1073/pnas.0909465106; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Satow R, 2004, BIOCHEM BIOPH RES CO, V321, P487, DOI 10.1016/j.bbrc.2004.06.166; Schodel J, 2010, KIDNEY INT, V78, P857, DOI 10.1038/ki.2010.284; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Tao Y, 2007, KIDNEY INT, V72, P1358, DOI 10.1038/sj.ki.5002550; Tory K, 2009, KIDNEY INT, V75, P839, DOI 10.1038/ki.2008.662; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Wilkins SE, 2012, J BIOL CHEM, V287, P8769, DOI 10.1074/jbc.M111.294678; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	31	140	156	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2013	45	8					951	U160		10.1038/ng.2681	http://dx.doi.org/10.1038/ng.2681			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23793029	Green Accepted, Green Submitted			2022-12-17	WOS:000322374900023
J	Coelho, D; Kim, JC; Miousse, IR; Fung, S; du Moulin, M; Buers, I; Suormala, T; Burda, P; Frapolli, M; Stucki, M; Nurnberg, P; Thiele, H; Robenek, H; Hohne, W; Longo, N; Pasquali, M; Mengel, E; Watkins, D; Shoubridge, EA; Majewski, J; Rosenblatt, DS; Fowler, B; Rutsch, F; Baumgartner, MR				Coelho, David; Kim, Jaeseung C.; Miousse, Isabelle R.; Fung, Stephen; du Moulin, Marcel; Buers, Insa; Suormala, Terttu; Burda, Patricie; Frapolli, Michele; Stucki, Martin; Nuernberg, Peter; Thiele, Holger; Robenek, Horst; Hoehne, Wolfgang; Longo, Nicola; Pasquali, Marzia; Mengel, Eugen; Watkins, David; Shoubridge, Eric A.; Majewski, Jacek; Rosenblatt, David S.; Fowler, Brian; Rutsch, Frank; Baumgartner, Matthias R.			Mutations in ABCD4 cause a new inborn error of vitamin B-12 metabolism	NATURE GENETICS			English	Article							C-OXIDASE DEFICIENCY; CBLD DEFECT; METHYLMALONIC ACIDURIA; PEROXISOMAL MEMBRANE; COBALAMIN METABOLISM; MASS-SPECTROMETRY; LEIGH-SYNDROME; IDENTIFICATION; PROTEIN; TRANSPORTER	Inherited disorders of vitamin B-12 (cobalamin) have provided important clues to how this vitamin, which is essential for hematological and neurological function, is transported and metabolized. We describe a new disease that results in failure to release vitamin B-12 from lysosomes, which mimics the cblF defect caused by LMBRD1 mutations. Using microcell-mediated chromosome transfer and exome sequencing, we identified causal mutations in ABCD4, a gene that codes for an ABC transporter, which was previously thought to have peroxisomal localization and function. Our results show that ABCD4 colocalizes with the lysosomal proteins LAMP1 and LMBD1, the latter of which is deficient in the cblF defect. Furthermore, we show that mutations altering the putative ATPase domain of ABCD4 affect its function, suggesting that the ATPase activity of ABCD4 may be involved in intracellular processing of vitamin B-12.	[Coelho, David; Suormala, Terttu; Burda, Patricie; Frapolli, Michele; Stucki, Martin; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, Zurich, Switzerland; [Coelho, David; Suormala, Terttu; Burda, Patricie; Frapolli, Michele; Stucki, Martin; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, CRC, Zurich, Switzerland; [Coelho, David; Suormala, Terttu; Fowler, Brian] Univ Childrens Hosp, Metab Unit, Basel, Switzerland; [Kim, Jaeseung C.; Miousse, Isabelle R.; Fung, Stephen; Watkins, David; Shoubridge, Eric A.; Majewski, Jacek; Rosenblatt, David S.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [du Moulin, Marcel; Buers, Insa; Rutsch, Frank] Univ Childrens Hosp, Dept Gen Pediat, Munster, Germany; [Stucki, Martin; Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Nuernberg, Peter; Thiele, Holger] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Robenek, Horst] Univ Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Hoehne, Wolfgang] Charite, Dept Biochem, D-13353 Berlin, Germany; [Longo, Nicola] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Longo, Nicola; Pasquali, Marzia] Associated Reg & Univ Pathologists ARUP Labs, Salt Lake City, UT USA; [Pasquali, Marzia] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Mengel, Eugen] Univ Childrens Hosp, Metab Unit, Mainz, Germany; [Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	University Children's Hospital Zurich; University Children's Hospital Zurich; McGill University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Cologne; University of Cologne; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fowler, B (corresponding author), Univ Childrens Hosp, Div Metab, Zurich, Switzerland.	david.rosenblatt@mcgill.ca; brian.fowler@kispi.uzh.ch	Miousse, Isabelle R./K-3512-2013; Coelho, David/AAE-9547-2020; Coelho, David/F-6680-2011; Thiele, Holger/ABE-6792-2020; Baumgartner, Matthias R/Q-2855-2017	Miousse, Isabelle R./0000-0001-6543-3219; Coelho, David/0000-0001-7010-5789; Thiele, Holger/0000-0002-0169-998X; Baumgartner, Matthias R/0000-0002-9270-0826	Swiss National Science Foundation [320000_122568, 31003A_138521]; Deutsche Forschungsgemeinschaft [RU816/5-1]; Canadian Institutes for Health Research [15078]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank S. Lutz for technical assistance in carrying out enzyme assays and K. Locher for fruitful discussions. We thank J. Gartner (University of Gottingen) for providing cell lines with peroxisomal defects and R. Newbold (Brunel University) for providing the mouse-human monochromosomal hybrid cell lines used for microcell-mediated chromosome transfer. This work was supported by the Swiss National Science Foundation (320000_122568 and 31003A_138521) and by the Deutsche Forschungsgemeinschaft (RU816/5-1). D.S.R. is supported by the Canadian Institutes for Health Research (15078).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Alfares A, 2011, J MED GENET, V48, P602, DOI 10.1136/jmedgenet-2011-100230; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Fowler B, 1997, PEDIATR RES, V41, P145, DOI 10.1203/00006450-199701000-00023; Fowler B, 1998, EUR J PEDIATR, V157, pS88, DOI 10.1007/PL00014311; Gloeckner CJ, 2000, BIOCHEM BIOPH RES CO, V271, P144, DOI 10.1006/bbrc.2000.2572; Hunt JD, 1996, ANAL BIOCHEM, V238, P107, DOI 10.1006/abio.1996.0263; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LITZKAS P, 1984, MOL CELL BIOL, V4, P2549, DOI 10.1128/MCB.4.11.2549; Matsukawa T, 2011, NEUROGENETICS, V12, P41, DOI 10.1007/s10048-010-0253-6; Miousse IR, 2009, J PEDIATR-US, V154, P551, DOI 10.1016/j.jpeds.2008.10.043; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; Stucki M, 2012, HUM MOL GENET, V21, P1410, DOI 10.1093/hmg/ddr579; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Watkins D, 1998, CLIN INVEST MED, V21, P151; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541	35	140	149	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2012	44	10					1152	+		10.1038/ng.2386	http://dx.doi.org/10.1038/ng.2386			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922874	Green Accepted			2022-12-17	WOS:000309550200018
J	Baala, L; Briault, S; Etchevers, HC; Laumonnier, F; Natiq, A; Amiel, J; Boddaert, N; Picard, C; Sbiti, A; Asermouh, A; Attie-Bitach, T; Encha-Razavi, F; Munnich, A; Sefiani, A; Lyonnet, S				Baala, Lekbir; Briault, Sylvain; Etchevers, Heather C.; Laumonnier, Frederic; Natiq, Abdelhafid; Amiel, Jeanne; Boddaert, Nathalie; Picard, Capucine; Sbiti, Aziza; Asermouh, Abdellah; Attie-Bitach, Tania; Encha-Razavi, Ferechte; Munnich, Arnold; Sefiani, Abdelaziz; Lyonnet, Stanislas			Homozygous silencing of T-box transcription factor EOMES leads to microcephaly with polymicrogyria and corpus callosum agenesis	NATURE GENETICS			English	Article							RADIAL GLIA; EOMESODERMIN; MOUSE; DIFFERENTIATION; EXPRESSION; NEOCORTEX; TBR2	Neural progenitor proliferation and migration influence brain size during neurogenesis. We report an autosomal recessive microcephaly syndrome cosegregating with a homozygous balanced translocation between chromosomes 3p and 10q, and we show that a position effect at the breakpoint on chromosome 3 silences the eomesodermin transcript (EOMES), also known as T-box-brain2 (TBR2). Together with the expression pattern of EOMES in the developing human brain, our data suggest that EOMES is involved in neuronal division and/or migration. Thus, mutations in genes encoding not only mitotic and apoptotic proteins but also transcription factors may be responsible for malformative microcephaly syndromes.	Hop Necker Enfants Malad, INSERM, U781, Dept Genet, Paris, France; Inst Natl Hyg, Dept Med Genet, Rabat, Morocco; INSERM, Fac Med, U619, Tours, France; Hop Necker Enfants Malad, Serv Radiol Pediat, Paris, France; Ctr Etud Deficits Immunitaires, Paris, France; CHU Avicenne, Hop Enfants, Rabat, Morocco; Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; UDICE-French Research Universities; Universite Paris Cite	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, INSERM, U781, Dept Genet, Paris, France.	lyonnet@necker.fr	Laumonnier, Frederic/N-1165-2016; ATTIE-BITACH, Tania/K-1453-2017; Picard, Capucine/H-3914-2017; amiel, jeanne/AGX-1124-2022; boddaert, nathalie/GWV-2865-2022; Lyonnet, Stanislas/H-5483-2017; Etchevers, Heather C./B-5813-2012; amiel, jeanne/H-3501-2017	Laumonnier, Frederic/0000-0003-2567-0708; ATTIE-BITACH, Tania/0000-0002-1155-3626; Picard, Capucine/0000-0001-8788-5056; Lyonnet, Stanislas/0000-0001-5426-9417; Etchevers, Heather C./0000-0003-0201-3799; amiel, jeanne/0000-0001-5973-4728; boddaert, nathalie/0000-0003-0991-7774				Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fernandez BA, 2005, CLIN GENET, V68, P349, DOI 10.1111/j.1399-0004.2005.00498.x; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Kimura N, 1999, DEV BRAIN RES, V115, P183, DOI 10.1016/S0165-3806(99)00064-4; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515	14	140	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					454	456		10.1038/ng1993	http://dx.doi.org/10.1038/ng1993			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353897				2022-12-17	WOS:000245271200014
J	Kafri, R; Bar-Even, A; Pilpel, Y				Kafri, R; Bar-Even, A; Pilpel, Y			Transcription control reprogramming in genetic backup circuits	NATURE GENETICS			English	Article							DUPLICATE GENES; SACCHAROMYCES-CEREVISIAE; EXPRESSION; EVOLUTION; PRESERVATION; CONSEQUENCES; ROBUSTNESS	A key question in molecular genetics is why severe mutations often do not result in a detectably abnormal phenotype. This robustness was partially ascribed to redundant paralogs(1,2) that may provide backup for one another in case of mutation. Mining mutant viability and mRNA expression data in Saccharomyces cerevisiae, we found that backup was provided predominantly by paralogs that are expressed dissimilarly in most growth conditions. We considered that this apparent inconsistency might be resolved by a transcriptional reprogramming mechanism that allows the intact paralog to rescue the organism upon mutation of its counterpart. We found that in wild-type cells, partial coregulation across growth conditions predicted the ability of paralogs to alter their transcription patterns and to provide backup for one another. Notably, the sets of regulatory motifs that controlled the paralogs with the most efficient backup activity deliberately overlapped only partially; paralogs with highly similar or dissimilar sets of motifs had suboptimal backup activity. Such an arrangement of partially shared regulatory motifs reconciles the differential expression of paralogs with their ability to back each other up.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il		Bar-Even, Arren/0000-0002-1039-4328				Cavalcanti ARO, 2003, J MOL EVOL, V56, P28, DOI 10.1007/s00239-002-2377-2; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Force A, 1999, GENETICS, V151, P1531; Garcia-Rodriguez LJ, 2000, FEBS LETT, V478, P84, DOI 10.1016/S0014-5793(00)01835-4; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kratzer S, 1997, MOL MICROBIOL, V26, P631, DOI 10.1046/j.1365-2958.1997.5611937.x; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; McCammon MT, 2003, ARCH BIOCHEM BIOPHYS, V419, P222, DOI 10.1016/j.abb.2003.08.022; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozcan S, 2002, J BIOL CHEM, V277, P46993, DOI 10.1074/jbc.M208726200; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2003, TRENDS GENET, V19, P417, DOI 10.1016/S0168-9525(03)00174-4; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; Wagner A, 2000, GENETICS, V154, P1389	30	140	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					295	299		10.1038/ng1523	http://dx.doi.org/10.1038/ng1523			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15723064				2022-12-17	WOS:000227297800021
J	Sansom, OJ; Berger, J; Bishop, SM; Hendrich, B; Bird, A; Clarke, AR				Sansom, OJ; Berger, J; Bishop, SM; Hendrich, B; Bird, A; Clarke, AR			Deficiency of Mbd2 suppresses intestinal tumorigenesis	NATURE GENETICS			English	Article							NEOPLASIA; MOUSE; GENE; DNA; HYPERMETHYLATION; PROTEIN; LOCUS; MICE	Gene silencing through de novo methylation of CpG island promoters contributes to cancer. We find that Mbd2, which recruits co-repressor complexes to methylated DNA, is essential for efficient tumorigenesis in the mouse intestine. As Mbd2-deficient mice are viable and fertile, their resistance to intestinal cancer may be of therapeutic relevance.	Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Cardiff University; University of Edinburgh	Bird, A (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.		clarke, alan r/P-2820-2014; Hendrich, Brian/AAG-5898-2020; Clarke, Alan R/A-6256-2008	Hendrich, Brian/0000-0002-0231-3073; Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X				Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Eads CA, 2002, CANCER RES, V62, P1296; Esteller M, 2000, CANCER RES, V60, P4366; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lin XH, 2003, CANCER RES, V63, P498; LUONGO C, 1994, CANCER RES, V54, P5947; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Slack A, 2002, J GENE MED, V4, P381, DOI 10.1002/jgm.288; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108	15	140	151	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					145	147		10.1038/ng1155	http://dx.doi.org/10.1038/ng1155			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730693				2022-12-17	WOS:000183200500017
J	Hess, P; Pihan, G; Sawyers, CL; Flavell, RA; Davis, RJ				Hess, P; Pihan, G; Sawyers, CL; Flavell, RA; Davis, RJ			Survival signaling mediated by c-Jun NH2-terminal kinase in transformed B lymphoblasts	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL ONCOGENE; HEMATOPOIETIC-CELLS; MYELOPROLIFERATIVE DISEASE; PHILADELPHIA-CHROMOSOME; BCL-2 EXPRESSION; BONE-MARROW; PATHWAY; ACTIVATION; APOPTOSIS	The c-Jun NH2-terminal kinase (JNK) is implicated in the apoptotic response of cells exposed to stress(1), but the JNK signal transduction pathway may not act exclusively in apoptosis(1). In some studies of tumor cells, JNK has been implicated in signaling cell survival(1). The possibility that JNK might mediate a survival signal in tumor cells is consistent with the observation that it is activated in response to some oncogenes, such as the leukemogenic oncogene BCR-ABL, which is created by a reciprocal translocation between human chromosomes 9 and 22 (ref. 2). The BCR-ABL protein activates the JNK signaling pathway in hematopoietic cells and increases transcriptional activity mediated by the transcription factor AP1 (ref. 3). Also, inhibition of c-Jun or JNK prevents BCR-ABL-induced cell transformation in vitro(3,4). Although this implicates the JNK signaling pathway in transformation by BCR-ABL, the possible role of JNK in this process is unclear. We find that disruption of the JNK ortholog Mapk8 (also known as Jnk1) in mice causes defective transformation of pre-B cells by BCR-ABL in vitro and in vivo. The Jnk1 protein is required for the survival of the transformed cells in the absence of stromal support. Failure to survive is associated with decreased expression of Bcl2, and the effect of Jnk1 deficiency can be rescued by transgenic expression of Bcl2. Our results show that Jnk1 signals cell survival in transformed B lymphoblasts and suggest that it may contribute to the pathogenesis of some proliferative diseases.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; Yale University; Yale University	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, 373 Plantat St, Worcester, MA 01605 USA.		Sawyers, Charles/G-5327-2016					Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Packham G, 1998, GENE DEV, V12, P2475, DOI 10.1101/gad.12.16.2475; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shuai K, 1996, ONCOGENE, V13, P247; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; WHITLOCK CA, 1984, J IMMUNOL METHODS, V67, P353, DOI 10.1016/0022-1759(84)90475-7; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	29	140	145	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					201	205		10.1038/ng946	http://dx.doi.org/10.1038/ng946			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12161751				2022-12-17	WOS:000177714900023
J	Schafer, K; Braun, T				Schafer, K; Braun, T			Early specification of limb muscle precursor cells by the homeobox gene Lbx1h	NATURE GENETICS			English	Article							CONNECTIVE-TISSUE; PROGENITOR CELLS; CHICK LIMB; EXPRESSION; PAX-3; MOUSE; MIGRATION; MUSCULATURE; EMBRYO	During vertebrate embryogenesis, myogenic precursor cells of limb muscles delaminate from the ventro-lateral edge of the semitic dermomyotome and migrate to the limb buds, where they congregate into dorsal and ventral muscle masses(1,2). It has been proposed that the surrounding connective tissue controls muscle pattern formation in limbs(3-5). Regulatory molecules such as receptor tyrosine kinases like c-Met (ref. 6) and those encoded by homeobox-containing genes, including c-Met (ref. 6), Tbx1 (ref. 7), Mox2 (ref. 8), Six1 and Six2 (ref. 9), Pitx2, Pax3 (refs 10,11) and Lbx1h (refs 12,13), are expressed in migrating limb precursor cells. The role of these genes in the patterning of limb muscles is unknown, although mutation of Pax3 or Met causes disruption of limb muscle development at an initial step, disturbing the epithelial-to-mesenchymal transition of the semitic epithelium(6,10,11). No limb muscle cells form in these mutants, and the early loss of myogenic precursor cells prevented an analysis of later functions of these genes during limb muscle development(14). Based on quail-chick chimaera studies(3,15), it was assumed that a cell-autonomous contribution of myogenic cells to the formation of individual limb muscles is negligible, and that an instructive role of limb mesenchyme is critical in this process. Here we show that Lbx1h determines migratory routes of muscle precursor cells in a cell-autonomous manner, thereby leading to the formation of distinct limb muscle patterns. Inactivation of Lbx1h, which is specifically expressed in migrating muscle precursor cells(12,13) , led to a lack of extensor muscles in forelimbs and an absence of muscles in hindlimbs. The defect was caused by the failure of all muscle precursor cells of hindlimbs and of precursor cells of extensor muscles of forelimbs to migrate to their corresponding muscle anlagen. Our results demonstrate that Lbx1h is a key regulator of muscle precursor cell migration and is required for the acquisition of dorsal identities of forelimb muscles.	Univ Halle Wittenberg, Inst Physiol Chem, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg	Braun, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, Hollystr 1, D-06097 Halle, Germany.	Thomas.Braun@medizin.uni-halle.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804				Bancroft JD, 1990, THEORY PRACTICE HIST; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOBER E, 1994, DEVELOPMENT, V120, P603; BrandSaberi B, 1996, INT J DEV BIOL, V40, P411; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BUTLER J, 1988, DEVELOPMENT, V102, P763; Candia AF, 1996, INT J DEV BIOL, V40, P1179; CHEVALLIER A, 1982, ROUX ARCH DEV BIOL, V191, P277, DOI 10.1007/BF00848416; CHRIST B, 1977, ANAT EMBRYOL, V150, P171, DOI 10.1007/BF00316649; Daston G, 1996, DEVELOPMENT, V122, P1017; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; GOULDING M, 1994, DEVELOPMENT, V120, P957; Isaac A, 1998, DEVELOPMENT, V125, P1867; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; MAUGER A, 1983, J EMBRYOL EXP MORPH, V76, P199; Mennerich D, 1998, MECH DEVELOP, V73, P147, DOI 10.1016/S0925-4773(98)00046-X; OLIVER G, 1995, DEVELOPMENT, V121, P693; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Zweigerdt R, 1997, DEV BIOL, V192, P172, DOI 10.1006/dbio.1997.8759	21	140	144	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1999	23	2					213	216		10.1038/13843	http://dx.doi.org/10.1038/13843			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508520				2022-12-17	WOS:000082827500023
J	KAPLAN, J; GERBER, S; LARGETPIET, D; ROZET, JM; DOLLFUS, H; DUFIER, JL; ODENT, S; POSTELVINAY, A; JANIN, N; BRIARD, ML; FREZAL, J; MUNNICH, A				KAPLAN, J; GERBER, S; LARGETPIET, D; ROZET, JM; DOLLFUS, H; DUFIER, JL; ODENT, S; POSTELVINAY, A; JANIN, N; BRIARD, ML; FREZAL, J; MUNNICH, A			A GENE FOR STARGARDTS-DISEASE (FUNDUS-FLAVIMACULATUS) MAPS TO THE SHORT ARM OF CHROMOSOME-1	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; MACULAR DEGENERATION; LINKAGE; DYSTROPHY	Stargardt's disease (fundus flavimaculatus) is one of the most frequent causes of macular degeneration in childhood and accounts for 7% of all retinal dystrophies. It is an autosomal recessive condition characterized by a bilateral loss of central vision occurring at age 7-12 years. Genetic linkage analysis of eight families has assigned the disease locus to chromosome 1p21-p13. Multipoint linkage analysis and haplotype analysis has allowed us to establish the best estimate for location of the gene over the locus D1S435 (maximum lod score of 12.66). Our results are consistent with the genetic homogeneity of this condition.	INST GUSTAVE ROUSSY,CONSULTAT GENET,F-94805 VILLEJUIF,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,UNITE RECH HANDICAPS GENET ENFANT,U12,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,SERV OPHTHALMOL,F-75743 PARIS 15,FRANCE; UNIV RENNES,F-35056 RENNES,FRANCE; CHR RENNES,F-35056 RENNES,FRANCE; CTR DEPT TROUBLES AUDIT & VIS ENFANTS,F-93200 ST DENIS,FRANCE	UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Rennes 1; CHU Rennes	KAPLAN, J (corresponding author), HOP NECKER ENFANTS MALAD,SERV GENET,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		ROZET, Jean-Michel/E-5737-2016	ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769; Dollfus, Helene/0000-0002-2249-895X				BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P68; Bither P P, 1988, J Am Optom Assoc, V59, P112; BONNIN M P, 1971, Bulletin des Societes d'Ophtalmologie de France, V71, P348; DEUTMAN AF, 1974, GENETIC METABOLIC EY, P367; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; Ewing CC, 1969, T OPHTHAL SOC UK, V89, P29; FERRELL RE, 1983, AM J HUM GENET, V35, P78; FISH G, 1981, BRIT J OPHTHALMOL, V65, P359, DOI 10.1136/bjo.65.5.359; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; FORSIUS H, 1971, BIRTH DEFECTS, V7, P87; Franceschetti A, 1965, Arch Ophtalmol Rev Gen Ophtalmol, V25, P505; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; HADDEN OB, 1976, AM J OPHTHALMOL, V82, P527, DOI 10.1016/0002-9394(76)90539-0; HITTNER HM, 1975, DOC OPHTHALMOL, V39, P29, DOI 10.1007/BF00578758; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; KAPLAN J, 1990, HUM GENET, V85, P635; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Maumenee IH, 1978, 5 C EUR SOC OPHTH AP 5 C EUR SOC OPHTH AP, P80; McKusick V.A., 1992, MENDELIAN INHERITANC; MERIN S, 1970, ARCH OPHTHALMOL-CHIC, V84, P710, DOI 10.1001/archopht.1970.00990040712002; MERIN S, 1991, INHERITED EYE DISEAS, P137; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; OTT J, 1985, VARIABILITY RECOMBIN, P112; RABB MF, 1986, OPHTHALMOLOGY, V93, P1443; RIVAS F, 1986, ANN GENET-PARIS, V29, P42; RUPPS H, 1987, OPHTHALMOLOGY, V94, P1401; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; ZHANG K, 1993, INVEST OPHTH VIS SCI, V34, P3749	32	140	144	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					308	311		10.1038/ng1193-308	http://dx.doi.org/10.1038/ng1193-308			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275096				2022-12-17	WOS:A1993MF12200025
J	CICILA, GT; RAPP, JP; WANG, JM; STLEZIN, E; NG, SC; KURTZ, TW				CICILA, GT; RAPP, JP; WANG, JM; STLEZIN, E; NG, SC; KURTZ, TW			LINKAGE OF 11-BETA-HYDROXYLASE MUTATIONS WITH ALTERED STEROID-BIOSYNTHESIS AND BLOOD-PRESSURE IN THE DAHL RAT	NATURE GENETICS			English	Article							SALT-RESISTANT RATS; MOLECULAR-CLONING; ALDOSTERONE SYNTHASE; ADRENAL-CORTEX; RENIN ALLELES; HYPERTENSION; GENE; CYTOCHROME-P-45011-BETA; SUSCEPTIBILITY; COSEGREGATION	In Dahl salt-hypertension sensitive (S) and resistant (R) strains fed a high NaCl diet, 11beta-hydroxylase polymorphisms cosegregate with the adrenal capacity to synthesize 18-hydroxy-11-deoxycorticosterone (18-OH-DOC) and blood pressure. The R rat carries an 11beta-hydroxylase allele that: (i) differs from those of 12 other rat strains; (ii) is associated with a uniquely reduced capacity to synthesize 18-OH-DOC; and (iii) encodes 5 amino acid substitutions in the 11beta-hydroxylase protein. The robust salt-resistance of the Dahl R rat may be due in part to reduced synthesis of the mineralocorticoid 18-OH-DOC stemming from mutations in the 11beta-hydroxylase gene. 11beta-hydroxylase, located on rat chromosome 7, is the first candidate gene identified in an animal model in which coding sequence mutations have been linked to the regulation of blood pressure.	UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MACROMOLEC BIOCHEM,PRINCETON,NJ 08543; PRINCETON UNIV,DEPT BIOL,PRINCETON,NJ 08544; MED COLL OHIO,DEPT MED,TOLEDO,OH 43699	University of California System; University of California San Francisco; Bristol-Myers Squibb; Princeton University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020176, P01HL035018, R37HL020176] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL35018, HL20176] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CARROLL J, 1981, J STEROID BIOCHEM, V14, P989, DOI 10.1016/0022-4731(81)90206-5; CONNELL JMC, 1991, J HYPERTENS, V9, P97, DOI 10.1097/00004872-199102000-00001; DAHL LK, 1962, J EXP MED, V115, P1173, DOI 10.1084/jem.115.6.1173; DALE SL, 1985, ENDOCRINOLOGY, V117, P2424, DOI 10.1210/endo-117-6-2424; DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; FELDMAN D, 1973, ENDOCRINOLOGY, V92, P1389, DOI 10.1210/endo-92-5-1389; FRASER R, 1985, P158; FRIEDMAN M, 1949, P SOC EXP BIOL MED, V70, P670; HAMET P, 1992, HYPERTENSION, V19, P611, DOI 10.1161/01.HYP.19.6.611.a; IMAI M, 1990, FEBS LETT, V263, P299, DOI 10.1016/0014-5793(90)81398-8; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KIRITA S, 1988, J BIOCHEM-TOKYO, V104, P683, DOI 10.1093/oxfordjournals.jbchem.a122533; LAUBER M, 1989, ARCH BIOCHEM BIOPHYS, V274, P109, DOI 10.1016/0003-9861(89)90421-9; LEVAN G, 1991, GENOMICS, V10, P699, DOI 10.1016/0888-7543(91)90455-N; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MALEE MP, 1991, P NATL ACAD SCI USA, V88, P4731, DOI 10.1073/pnas.88.11.4731; MATSUKAWA N, 1990, BIOCHEM BIOPH RES CO, V169, P245, DOI 10.1016/0006-291X(90)91460-A; MATSUKAWA N, 1992, HYPERTENSION, V20, P443; Melby J C, 1972, Recent Prog Horm Res, V28, P287; MELBY JC, 1990, ENDOCRINE HYPERTENSI, P183; MENEELY GR, 1953, J EXP MED, V98, P71, DOI 10.1084/jem.98.1.71; MORNET E, 1989, J BIOL CHEM, V264, P20961; NICHOLLS MG, 1979, J STEROID BIOCHEM, V10, P67, DOI 10.1016/0022-4731(79)90142-0; NONAKA UY, 1991, EUR J BIOCHEM, V202, P897; NONAKA Y, 1989, FEBS LETT, V255, P21, DOI 10.1016/0014-5793(89)81053-1; ODOWD BF, 1991, HYPERTENSION, V18, P9, DOI 10.1161/01.HYP.18.1.9; OKAMOTO M, 1992, J STEROID BIOCHEM, V41, P415, DOI 10.1016/0960-0760(92)90367-R; PICKERING TG, 1990, NUTRITIONAL FACTORS, P3; PRAVENEC M, 1991, HYPERTENSION, V17, P242, DOI 10.1161/01.HYP.17.2.242; PRAVENEC M, 1992, GENOMICS, V12, P350, DOI 10.1016/0888-7543(92)90384-5; PRAVENEC M, 1991, NATURE, V353, P521; PREUSS MB, 1980, LAB INVEST, V43, P101; RAPP JP, 1985, HYPERTENSION, V7, P340, DOI 10.1161/01.HYP.7.3_Pt_1.340; RAPP JP, 1989, SCIENCE, V243, P542, DOI 10.1126/science.2563177; RAPP JP, 1971, ENDOCRINOLOGY, V88, P52, DOI 10.1210/endo-88-1-52; RAPP JP, 1982, HYPERTENSION, V4, P459, DOI 10.1161/01.HYP.4.4.459; RAPP JP, 1972, ENDOCRINOLOGY, V90, P1435, DOI 10.1210/endo-90-6-1435; RAPP JP, 1972, NATURE, V237, P338, DOI 10.1038/237338a0; RAPP JP, 1990, J HYPERTENS, V8, P457, DOI 10.1097/00004872-199005000-00010; RAPP JP, 1978, ENDOCR RES COMMUN, V5, P35, DOI 10.3109/07435807809073634; RAPP JP, 1990, AM J HYPERTENS, V3, P391, DOI 10.1093/ajh/3.5.391; RAPP JP, 1976, BIOCHEMISTRY-US, V15, P1235, DOI 10.1021/bi00651a010; SMITHBARBARO PA, 1980, P SOC EXP BIOL MED, V165, P283, DOI 10.3181/00379727-165-40972; SOUTHERN EM, 1975, J MOL BIOL, V68, P503; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; SZPIRER J, 1988, CYTOGENET CELL GENET, V47, P42, DOI 10.1159/000132502; WILLIAMS RR, 1988, J CARDIOVASC PHAR S3, V12, P7; YAMORI Y, 1972, JPN CIRCULATION J, V36, P561, DOI 10.1253/jcj.36.561	52	140	140	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					346	353		10.1038/ng0493-346	http://dx.doi.org/10.1038/ng0493-346			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981756				2022-12-17	WOS:A1993KW25700018
J	BROWN, AG; ROSS, FM; DUNNE, EM; STEEL, CM; WEIRTHOMPSON, EM				BROWN, AG; ROSS, FM; DUNNE, EM; STEEL, CM; WEIRTHOMPSON, EM			EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE	NATURE GENETICS			English	Article							PHYSICAL MAP; ABNORMALITIES; CHROMOSOMES; LEUKEMIA; DELETION; LINE	Roughly 25% of human B-cell chronic lymphocytic leukaemias (CLL) are characterized by a chromosomal lesion involving 13q14. This region contains the retinoblastoma gene (RB1). We have used a variety of techniques to determine whether RB1 or some other locus is the critical region in 11 cases of low grade B-cell malignancy (mainly CLL), all with deletions or translocations involving 13q14. In all cases, except the one with minimal disease, there was deletion or a structural lesion in the region of D13S25, with at least 4 cases showing homozyogous disruption. We conclude that D13S25 lies close to a tumour suppressor locus whose inactivation contributes to the initiation or progression of low grade B-cell malignancy. This locus is located at least 530 kilobases telomeric to RB1.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Dunne, Eimear/C-6785-2012	Dunne, Eimear/0000-0001-9862-1398				ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351; ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; BICKMORE WA, 1989, SOMAT CELL MOLEC GEN, V15, P229, DOI 10.1007/BF01534873; BOWCOCK AM, 1991, NUCLEIC ACIDS RES, V18, P7194; CHEN YC, 1990, BLOOD, V76, P2060; CHENG J, 1990, BLOOD, V75, P730; Claflin L, 1978, Curr Top Microbiol Immunol, V81, P107; FORD GM, 1990, GENOMICS, V6, P284, DOI 10.1016/0888-7543(90)90568-F; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FURUKAWA Y, 1990, BLOOD, V76, P272; GINSBERG AM, 1991, BLOOD, V77, P833; HANSEN MF, 1990, CANCER GENET CYTOGEN, V49, P15, DOI 10.1016/0165-4608(90)90159-8; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; HILLION J, 1991, CANCER GENET CYTOGEN, V54, P197, DOI 10.1016/0165-4608(91)90207-B; JULIUSSON G, 1990, NEW ENGL J MED, V323, P720, DOI 10.1056/NEJM199009133231105; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LINK AJ, 1991, GENETICS, V127, P681; LIU Y, 1992, GENE CHROMOSOME CANC, V4, P250, DOI 10.1002/gcc.2870040310; LUND E, 1983, MOL CELL BIOL, V3, P2211, DOI 10.1128/MCB.3.12.2211; Maniatis T, 1989, DECONTAMINATION DILU; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; Melchers F, 1978, Curr Top Microbiol Immunol, V81, pIX; MICKLEM LR, 1987, J IMMUNOL METHODS, V104, P81, DOI 10.1016/0022-1759(87)90490-X; MORRIS CM, 1991, GENE CHROMOSOME CANC, V3, P455, DOI 10.1002/gcc.2870030607; OSCIER D, 1990, BLOOD, V76, P241; ROSS FM, 1987, CANCER GENET CYTOGEN, V25, P109, DOI 10.1016/0165-4608(87)90166-X; SALTMAN DL, 1988, BLOOD, V72, P2026, DOI 10.1182/blood.V72.6.2026.2026; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; WEINBERG RA, 1992, CANCER SURV, V12, P43; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YUNIS JJ, 1975, HUMANGENETIK, V27, P167, DOI 10.1007/BF00278343; 1991, CYTOGENET CELL GENET, V58, P580	33	140	140	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					67	72		10.1038/ng0193-67	http://dx.doi.org/10.1038/ng0193-67			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490658				2022-12-17	WOS:A1993KF37200015
J	Meehan, TF; Conte, N; West, DB; Jacobsen, JO; Mason, J; Warren, J; Chen, CK; Tudose, I; Relac, M; Matthews, P; Karp, N; Santos, L; Fiegel, T; Ring, N; Westerberg, H; Greenaway, S; Sneddon, D; Morgan, H; Codner, GF; Stewart, ME; Brown, J; Horner, N; Haendel, M; Washington, N; Mungall, CJ; Reynolds, CL; Gallegos, J; Gailus-Durner, V; Sorg, T; Pavlovic, G; Bower, LR; Moore, M; Morse, I; Gao, X; Tocchini-Valentini, GP; Obata, Y; Cho, SY; Seong, JK; Seavitt, J; Beaudet, AL; Dickinson, ME; Herault, Y; Wurst, W; de Angelis, MH; Lloyd, KCK; Flenniken, AM; Nutter, LMJ; Newbigging, S; McKerlie, C; Justice, MJ; Murray, SA; Svenson, KL; Braun, RE; White, JK; Bradley, A; Flicek, P; Wells, S; Skarnes, WC; Adams, DJ; Parkinson, H; Mallon, AM; Brown, SDM; Smedley, D				Meehan, Terrence F.; Conte, Nathalie; West, David B.; Jacobsen, Julius O.; Mason, Jeremy; Warren, Jonathan; Chen, Chao-Kung; Tudose, Ilinca; Relac, Mike; Matthews, Peter; Karp, Natasha; Santos, Luis; Fiegel, Tanja; Ring, Natalie; Westerberg, Henrik; Greenaway, Simon; Sneddon, Duncan; Morgan, Hugh; Codner, Gemma F.; Stewart, Michelle E.; Brown, James; Horner, Neil; Haendel, Melissa; Washington, Nicole; Mungall, Christopher J.; Reynolds, Corey L.; Gallegos, Juan; Gailus-Durner, Valerie; Sorg, Tania; Pavlovic, Guillaume; Bower, Lynette R.; Moore, Mark; Morse, Iva; Gao, Xiang; Tocchini-Valentini, Glauco P.; Obata, Yuichi; Cho, Soo Young; Seong, Je Kyung; Seavitt, John; Beaudet, Arthur L.; Dickinson, Mary E.; Herault, Yann; Wurst, Wolfgang; de Angelis, Martin Hrabe; Lloyd, K. C. Kent; Flenniken, Ann M.; Nutter, Lauryl M. J.; Newbigging, Susan; McKerlie, Colin; Justice, Monica J.; Murray, Stephen A.; Svenson, Karen L.; Braun, Robert E.; White, Jacqueline K.; Bradley, Allan; Flicek, Paul; Wells, Sara; Skarnes, William C.; Adams, David J.; Parkinson, Helen; Mallon, Ann-Marie; Brown, Steve D. M.; Smedley, Damian		Int Mouse Phenotyping Consortium	Disease model discovery from 3,328 gene knockouts by The International Mouse Phenotyping Consortium	NATURE GENETICS			English	Article							GENOME-WIDE; EXPRESSION ATLAS; ONTOLOGY; DATABASE; MICE; ASSOCIATION; GENERATION; RESOURCES; MUTATIONS; ORGANISM	Although next-generation sequencing has revolutionized the ability to associate variants with human diseases, diagnostic rates and development of new therapies are still limited by a lack of knowledge of the functions and pathobiological mechanisms of most genes. To address this challenge, the International Mouse Phenotyping Consortium is creating a genome-and phenome-wide catalog of gene function by characterizing new knockout-mouse strains across diverse biological systems through a broad set of standardized phenotyping tests. All mice will be readily available to the biomedical community. Analyzing the first 3,328 genes identified models for 360 diseases, including the first models, to our knowledge, for type C Bernard-Soulier, Bardet-Biedl-5 and Gordon Holmes syndromes. 90% of our phenotype annotations were novel, providing functional evidence for 1,092 genes and candidates in genetically uncharacterized diseases including arrhythmogenic right ventricular dysplasia 3. Finally, we describe our role in variant functional validation with The 100,000 Genomes Project and others.	[Meehan, Terrence F.; Conte, Nathalie; Mason, Jeremy; Warren, Jonathan; Chen, Chao-Kung; Tudose, Ilinca; Relac, Mike; Matthews, Peter; Flicek, Paul; Parkinson, Helen] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [West, David B.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Jacobsen, Julius O.; Smedley, Damian] Queen Mary Univ London, William Harvey Res Inst, London, England; [Karp, Natasha; White, Jacqueline K.; Bradley, Allan; Skarnes, William C.; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton, England; [Santos, Luis; Fiegel, Tanja; Ring, Natalie; Westerberg, Henrik; Greenaway, Simon; Sneddon, Duncan; Morgan, Hugh; Codner, Gemma F.; Stewart, Michelle E.; Brown, James; Horner, Neil; Wells, Sara; Mallon, Ann-Marie; Brown, Steve D. M.] Med Res Council Harwell, Mammalian Genet Unit, Harwell, Berks, England; [Santos, Luis; Fiegel, Tanja; Ring, Natalie; Westerberg, Henrik; Greenaway, Simon; Sneddon, Duncan; Morgan, Hugh; Codner, Gemma F.; Stewart, Michelle E.; Brown, James; Horner, Neil; Wells, Sara; Mallon, Ann-Marie; Brown, Steve D. M.] Mary Lyon Ctr, Harwell, Berks, England; [Haendel, Melissa] Oregon Hlth & Sci Univ, Dept Med Informat, Portland, OR 97201 USA; [Haendel, Melissa] Oregon Hlth & Sci Univ, Clin Epidemiol, Portland, OR 97201 USA; [Haendel, Melissa] Oregon Hlth & Sci Univ, OHSU Lib, Portland, OR 97201 USA; [Washington, Nicole; Mungall, Christopher J.] Lawrence Berkeley Natl Lab, Div Environm Genom & Syst Biol, Berkeley, CA USA; [Reynolds, Corey L.; Gallegos, Juan; Seavitt, John; Beaudet, Arthur L.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gailus-Durner, Valerie; Wurst, Wolfgang; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Expt Genet, Neuherberg, Germany; [Sorg, Tania; Pavlovic, Guillaume; Herault, Yann] ICS, PHENOMIN, CELPHEDIA, Illkirch Graffenstaden, France; [Sorg, Tania; Pavlovic, Guillaume; Herault, Yann] Univ Strasbourg, IGBMC, Illkirch Graffenstaden, France; [Sorg, Tania; Pavlovic, Guillaume; Herault, Yann] Ctr Natl Rech Sci, UMR7104, Illkirch Graffenstaden, France; [Sorg, Tania; Pavlovic, Guillaume; Herault, Yann] Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France; [Bower, Lynette R.; Lloyd, K. C. Kent] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA; [Moore, Mark] IMPC, San Anselmo, CA USA; [Morse, Iva] Charles River Labs, Wilmington, MA USA; [Gao, Xiang] Nanjing Univ, SKL Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Collaborat Innovat Ctr Genet & Dev, Nanjing Biomed Res Inst, Nanjing, Jiangsu, Peoples R China; [Tocchini-Valentini, Glauco P.] Inst Cell Biol & Neurobiol, Italian Natl Res Council, CNR, Monterotondo Mouse Clin, Monterotondo, Italy; [Obata, Yuichi] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Cho, Soo Young; Seong, Je Kyung] Korea Mouse Phenotyping Ctr, Seoul, South Korea; [Cho, Soo Young] Natl Canc Ctr, Goyang, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea; [Flenniken, Ann M.; Nutter, Lauryl M. J.; Newbigging, Susan; McKerlie, Colin] Ctr Phenogen, Toronto, ON, Canada; [Justice, Monica J.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON, Canada; [Murray, Stephen A.; Svenson, Karen L.; Braun, Robert E.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	European Molecular Biology Laboratory (EMBL); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of London; Queen Mary University London; Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Baylor College of Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Davis; Nanjing University; Nanjing University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); RIKEN; National Cancer Center - Korea (NCC); Seoul National University (SNU); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Jackson Laboratory	Smedley, D (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	d.smedley@qmul.ac.uk	Adams, David/GMW-8541-2022; ORSINI, TIZIANA/J-8029-2019; LA SALA, GINA/AAF-5414-2021; Ermakova, Olga/Z-2037-2018; Daniela, Marazziti/AAC-1062-2022; Smedley, Damian/AAL-8172-2021; Mungall, Chris/I-6006-2019; de Angelis, Martin Hrabe/F-5531-2012; Ermakova, Olga/K-5712-2019; Orsini, Tiziana/P-1745-2018; Gailus-Durner, Valerie/M-7337-2014; Mandillo, Silvia/E-6503-2019; Pavlovic, Guillaume/C-9907-2013; Ayabe, Shinya/AAH-6911-2020; Rozman, Jan/A-2540-2010; Herault, Yann/B-5500-2012; Di Pietro, Chiara/AAA-7161-2021; Holter-Koch, Sabine/N-5868-2014	Adams, David/0000-0001-9490-0306; ORSINI, TIZIANA/0000-0003-0023-7916; LA SALA, GINA/0000-0002-1907-5948; Ermakova, Olga/0000-0001-8365-4904; Daniela, Marazziti/0000-0002-1582-9271; Mungall, Chris/0000-0002-6601-2165; de Angelis, Martin Hrabe/0000-0002-7898-2353; Ermakova, Olga/0000-0001-8365-4904; Orsini, Tiziana/0000-0003-0023-7916; Mandillo, Silvia/0000-0002-4869-0974; Pavlovic, Guillaume/0000-0001-9122-4592; Ayabe, Shinya/0000-0003-2737-5315; Rozman, Jan/0000-0002-8035-8904; Herault, Yann/0000-0001-7049-6900; Santos, Luis/0000-0001-6403-4902; Wurst, Wolfgang/0000-0003-4422-7410; Garrett, Lillian/0000-0003-4880-7076; Samaco, Rodney/0000-0001-5636-5314; Matthews, Peter/0000-0001-5482-0328; Karp, Natasha/0000-0002-8404-2907; McKerlie, Colin/0000-0002-2232-0967; Tanaka, Nobuhiko/0000-0002-9568-9917; Rossi, Gianfranco/0000-0002-1428-816X; MATTEONI, RAFAELE/0000-0002-0314-5948; Brown, James/0000-0001-7636-4554; Parkinson, Helen/0000-0003-3035-4195; Meehan, Terrence/0000-0003-1980-3228; Relac, Mike/0000-0002-5597-1942; DI PIETRO, CHIARA/0000-0002-2680-1821; Bradley, Allan/0000-0002-2349-8839; Holter-Koch, Sabine/0000-0003-4878-5241; Flicek, Paul/0000-0002-3897-7955; Ring, Natalie/0000-0002-8971-8507; Codner, Gemma/0000-0002-6967-9803; Jacobsen, Julius/0000-0002-3265-1591; Nutter, Lauryl/0000-0001-9619-146X; Seong, Je Kyung/0000-0003-1177-6958; Lafont, Amy/0000-0001-8396-4216; /0000-0002-2796-5123; Horner, Neil/0000-0002-0550-4537	NIH [U54 HG006370, U42 OD011185, U54 HG006332, U54 HG006348-S1, OD011174, 1R24OD011883, HG006364-03S1, U54H G006364, U42 OD011175]; Wellcome Trust; Medical Research Council [53658]; government of Canada through Genome Canada; government of Canada through Ontario Genomics [OGI-051]; National Centre for Scientific Research (CNRS); French National Institute of Health and Medical Research (INSERM); University of Strasbourg (UDS); Centre Europeen de Recherche en Biologie et en Medecine; Agence Nationale de la Recherche [ANR-10-IDEX-0002-02, ANR-10-INBS-07 PHENOMIN]; German Federal Ministry of Education and Research [01KX1012]; 'EUCOMM: Tools for Functional Annotation of the Mouse Genome' (EUCOMMTOOLS) project [FP7-HEALTH-F4-2010-261492]; Medical Research Council [MC_U142684171, MC_UP_1502/3, MC_U142684172] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006364, UM1HG006370, U54HG006332, U54HG006348, UM1HG006348, U54HG006370] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011883, U42OD012210, U42OD011174, UM1OD023222, UM1OD023221, U42OD011185, U42OD011175] Funding Source: NIH RePORTER; MRC [MC_U142684172, MC_U142684171, MC_UP_1502/3] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); government of Canada through Genome Canada(Genome Canada); government of Canada through Ontario Genomics; National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Strasbourg (UDS)(European Commission); Centre Europeen de Recherche en Biologie et en Medecine; Agence Nationale de la Recherche(French National Research Agency (ANR)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); 'EUCOMM: Tools for Functional Annotation of the Mouse Genome' (EUCOMMTOOLS) project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH grants U54 HG006370 (T.F.M., P.F., A.-M.M., H.P., D.S. and S.D.M.B.), U42 OD011185 (S.A.M.), U54 HG006332 (R.E.B. and K.L.S.), U54 HG006348-S1 and OD011174 (A.L.B.), 1R24OD011883 (C.J.M., M.H., N.W. and D.S.), HG006364-03S1, U54H G006364 (K.C.K.L. and C.M.) and U42 OD011175 (C.M. and K.C.K.L.). Additional support was provided by the Wellcome Trust, Medical Research Council Strategic Award 53658 (S.W. and S.D.M.B.); the government of Canada through Genome Canada and Ontario Genomics (OGI-051) (C.M. and S.D.M.B.); the National Centre for Scientific Research (CNRS); the French National Institute of Health and Medical Research (INSERM); the University of Strasbourg (UDS); the Centre Europeen de Recherche en Biologie et en Medecine; the Agence Nationale de la Recherche under the framework program Investissements d'Avenir labeled ANR-10-IDEX-0002-02, ANR-10-INBS-07 PHENOMIN (Y.H.); the German Federal Ministry of Education and Research through Infrafrontier grant 01KX1012 (S.A.M., V.G.-D. and M.H.d.A.); and the 'EUCOMM: Tools for Functional Annotation of the Mouse Genome' (EUCOMMTOOLS) project, grant agreement FP7-HEALTH-F4-2010-261492 (W.W.).	Adams D, 2013, DIS MODEL MECH, V6, P571, DOI 10.1242/dmm.011833; Adissu HA, 2014, DIS MODEL MECH, V7, P515, DOI 10.1242/dmm.015263; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bello SM, 2015, MAMM GENOME, V26, P285, DOI 10.1007/s00335-015-9582-y; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bone WP, 2016, GENET MED, V18, P608, DOI 10.1038/gim.2015.137; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Cade BE, 2016, AM J RESP CRIT CARE, V194, P886, DOI 10.1164/rccm.201512-2431OC; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Fonio E, 2012, NAT METHODS, V9, P1167, DOI 10.1038/nmeth.2252; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Karp NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052410; Khan SA, 2016, CLIN GENET, V90, P3, DOI 10.1111/cge.12737; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kizil C, 2014, DEVELOPMENT, V141, P3529, DOI 10.1242/dev.108415; Knowles JW, 2016, J CLIN INVEST, V126, P403, DOI 10.1172/JCI85921; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kurbatova N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131274; Lang B, 2014, J CELL SCI, V127, P630, DOI 10.1242/jcs.137604; Levy R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2213-x; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; McIntyre RE, 2016, G3-GENES GENOM GENET, V6, P2343, DOI 10.1534/g3.116.030767; Mungall CJ, 2015, HUM MUTAT, V36, P979, DOI 10.1002/humu.22857; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Rosen B, 2015, MAMM GENOME, V26, P456, DOI 10.1007/s00335-015-9598-3; Santens P, 2015, NEUROLOGY, V84, P1760, DOI 10.1212/WNL.0000000000001521; Savoia A, 2014, HUM MUTAT, V35, P1033, DOI 10.1002/humu.22607; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gky1069, 10.1093/nar/gks1189]; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; Smith CL, 2015, J BIOMED SEMANT, V6, DOI 10.1186/s13326-015-0009-1; West DB, 2015, GENOME RES, V25, P598, DOI 10.1101/gr.184184.114; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022	45	139	143	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2017	49	8					1231	+		10.1038/ng.3901	http://dx.doi.org/10.1038/ng.3901			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FB8OI	28650483	Green Accepted, Green Submitted			2022-12-17	WOS:000406397900013
J	Nava, C; Dalle, C; Rastetter, A; Striano, P; de Kovel, CGF; Nabbout, R; Cances, C; Ville, D; Brilstra, EH; Gobbi, G; Raffo, E; Bouteiller, D; Marie, Y; Trouillard, O; Robbiano, A; Keren, B; Agher, D; Roze, E; Lesage, S; Nicolas, A; Brice, A; Baulac, M; Vogt, C; El Hajj, N; Schneiderr, E; Suls, A; Weckhuysen, S; Gormley, P; Lehesjoki, AE; De Jonghe, P; Helbig, I; Baulac, S; Zara, F; Koeleman, BPC; Haaf, T; LeGuern, E; Depienne, C				Nava, Caroline; Dalle, Carine; Rastetter, Agnes; Striano, Pasquale; de Kovel, Carolien G. F.; Nabbout, Rima; Cances, Claude; Ville, Dorothee; Brilstra, Eva H.; Gobbi, Giuseppe; Raffo, Emmanuel; Bouteiller, Delphine; Marie, Yannick; Trouillard, Oriane; Robbiano, Angela; Keren, Boris; Agher, Dahbia; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Vogt, Cornelia; El Hajj, Nady; Schneiderr, Eberhard; Suls, Arvid; Weckhuysen, Sarah; Gormley, Padhraig; Lehesjoki, Anna-Elina; De Jonghe, Peter; Helbig, Ingo; Baulac, Stephanie; Zara, Federico; Koeleman, Bobby P. C.; Haaf, Thomas; LeGuern, Eric; Depienne, Christel		EuroEPINOMICS RES Consortiumm	De novo mutations in HCN1 cause early infantile epileptic encephalopathy	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; ACTIVATED PACEMAKER CHANNELS; COPY NUMBER VARIANTS; ABSENCE EPILEPSY; CATION CURRENT; MICE LACKING; HIPPOCAMPUS; EXPRESSION; NEURONS; EPILEPTOGENESIS	Hyperpolarization-activated, cyclic nucleotide gated (HCN) channels contribute to cationic current in neurons and regulate the excitability of neuronal networks. Studies in rat models have shown that the Hcn1 gene has a key role in epilepsy, but clinical evidence implicating HCN1 mutations in human epilepsy is lacking. We carried out exome sequencing for parent-offspring trios with fever-sensitive, intractable epileptic encephalopathy, leading to the discovery of two de novo missense HCN1 mutations. Screening of follow-up cohorts comprising 157 cases in total identified 4 additional amino acid substitutions. Patch-clamp recordings of I-h, currents in cells expressing wild-type or mutant human HCN1 channels showed that the mutations had striking but divergent effects on homomeric channels. Individuals with mutations had clinical features resembling those of Dravet syndrome with progression toward atypical absences, intellectual disability and autistic traits. These findings provide clear evidence that de novo HCN1 point mutations cause a recognizable earlyonset epileptic encephalopathy in humans.	[Nava, Caroline; Dalle, Carine; Rastetter, Agnes; Agher, Dahbia; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Baulac, Stephanie; LeGuern, Eric; Depienne, Christel] Hop La Pitie Salpetriere, INSERM, UMR 975, Inst Cerveau & Moelle Epiniere, Paris, France; [Nava, Caroline; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Baulac, Stephanie; LeGuern, Eric] Hop La Pitie Salpetriere, CNRS 7225, Paris, France; [Nava, Caroline; Trouillard, Oriane; Roze, Emmanuel; Lesage, Suzanne; Nicolas, Aude; Brice, Alexis; Baulac, Michel; Baulac, Stephanie; LeGuern, Eric; Depienne, Christel] Univ Paris 06, UMRS 975, Paris, France; [Nava, Caroline; Trouillard, Oriane; Brice, Alexis; LeGuern, Eric] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonctionnelle Neurogenet Mol & Cellulaire, Paris, France; [Dalle, Carine] Inst Cerveau & Moelle Epiniere, Plateforme Electrophysiol, Paris, France; [Striano, Pasquale] G Gaslini Inst Children, Pediat Neurol & Muscular Dis Unit, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [de Kovel, Carolien G. F.; Brilstra, Eva H.; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Nabbout, Rima] Hop Necker Enfants Malad, AP HP, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, Paris, France; [Nabbout, Rima] Univ Paris 05, INSERM, U663, Sorbonne Paris Cite,Hop Necker Enfants Malad, Paris, France; [Cances, Claude] Ctr Hosp Univ Toulouse, Hop Enfants, Serv Neurol Pediat, Toulouse, France; [Ville, Dorothee] Ctr Hosp Univ Lyon, Hop Femme Mere Enfant, Serv Neurol Pediat, Bron, France; [Gobbi, Giuseppe] Inst Neurol Sci Bologna, IRCCS, Child Neurol Unit, Bologna, Italy; [Raffo, Emmanuel] Ctr Hosp Univ Nancy, Hop Enfants Brabois, Serv Neuropediat, Vandoeuvre Les Nancy, France; [Bouteiller, Delphine; Marie, Yannick] Inst Cerveau & Moelle Epiniere, Plateforme Genotypage & Sequencage, Paris, France; [Robbiano, Angela; Zara, Federico] Gaslini Inst, Dept Neurosci, Neurogenet Lab, Genoa, Italy; [Keren, Boris] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonctionnelle Cytogenet, Paris, France; [Vogt, Cornelia; El Hajj, Nady; Schneiderr, Eberhard; Haaf, Thomas; Depienne, Christel] Univ Wurzburg, Inst Humangenet, D-97070 Wurzburg, Germany; [Suls, Arvid; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Suls, Arvid; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Gormley, Padhraig] Wellcome Trust Sanger Inst, Hinxton, England; [Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Mol Neurol & Neurosci Ctr, Helsinki, Finland; [Helbig, Ingo] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU Lyon; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); CHU de Nancy; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Wurzburg; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Wellcome Trust Sanger Institute; University of Helsinki; University of Kiel; Schleswig Holstein University Hospital	Depienne, C (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR 975, Inst Cerveau & Moelle Epiniere, Paris, France.	eric.leguern@psl.aphp.fr; christel.depienne@upmc.fr	May, Patrick/N-1019-2019; Suls, Arvid/M-2694-2013; Stephani, Ulrich/D-1004-2010; Baulac, Stéphanie/O-2099-2016; Brice, Alexis/A-2170-2009; Weckhuysen, Sarah/HGB-9957-2022; Striano, Pasquale/F-9117-2014; Depienne, Christel/AAL-3835-2021; Zara, Federico/U-3477-2017; Muhle, Hiltrud/F-5715-2010; Helbig, Ingo/G-8467-2018; Craiu, Dana/ABE-4886-2020; brice, alexis/AAE-8275-2019; Brilstra, Eva/AAT-3092-2021; Gormley, Padhraig/L-1949-2018; May, Patrick/B-1238-2010; de Kovel, Carolien/AAI-3531-2021	May, Patrick/0000-0001-8698-3770; Suls, Arvid/0000-0003-0328-198X; Baulac, Stéphanie/0000-0001-6430-4693; Weckhuysen, Sarah/0000-0003-2878-1147; Striano, Pasquale/0000-0002-6065-1476; Depienne, Christel/0000-0002-7212-9554; Zara, Federico/0000-0001-9744-5222; Helbig, Ingo/0000-0001-8486-0558; brice, alexis/0000-0002-0941-3990; Gormley, Padhraig/0000-0002-8908-6968; May, Patrick/0000-0001-8698-3770; de Kovel, Carolien/0000-0002-7818-1396; Palotie, Aarno/0000-0002-2527-5874; Moller, Rikke S./0000-0002-9664-1448; Nava, Caroline/0000-0003-1272-0518; Craiu, Dana/0000-0003-4156-6812; Krause, Roland/0000-0001-9938-7126; Balling, Rudi/0000-0003-2902-5650; Serratosa, Jose/0000-0003-2239-8948; Selmer, Kaja Kristine/0000-0003-4871-112X; schneider, eberhard/0000-0003-4320-3652; El Hajj, Nady/0000-0003-3420-8531; Trouillard, Oriane/0000-0003-0228-0942; Klein, Karl Martin/0000-0002-6654-1665; Guerrini, Renzo/0000-0002-7272-7079	University of Wiirzburg, Biocodex, Fondation de France; ERA-NET NEURON EUHFAUTISM; Investissements d'Avenir program [ANR-10-IAIHU-06]; INSERM, AP-HP; Eurocores program EuroEPINOMICS of the European Science Foundation; Fund for Scientific Research Flanders (FWO); University of Antwerp; Genetics Commission of the Italian League Against Epilepsy (LICE); Netherlands National Epilepsy Fund	University of Wiirzburg, Biocodex, Fondation de France; ERA-NET NEURON EUHFAUTISM; Investissements d'Avenir program(French National Research Agency (ANR)); INSERM, AP-HP(Institut National de la Sante et de la Recherche Medicale (Inserm)); Eurocores program EuroEPINOMICS of the European Science Foundation; Fund for Scientific Research Flanders (FWO)(FWO); University of Antwerp; Genetics Commission of the Italian League Against Epilepsy (LICE); Netherlands National Epilepsy Fund	We thank the patients and their families for their participation in this study, J. Stieber (Friedrich Alexander Universitat Erlangen-Nurnberg, Germany) for providing a plasmid containing human HCNI cDNA, the International Parkinson's Disease Genomics Consortium (IPDGC) for granting access to the list of HCN1 variants present in control populations and populations with Parkinson's disease, L. Van de Velde Boermans for genetic tests for SCN1A and PCDH19 and tests on the parents, M. Nizard for case selection, and G. Huguet and T. Bourgeron for helpful discussions. The research generating these results was funded by the University of Wiirzburg, Biocodex, Fondation de France, ERA-NET NEURON EUHFAUTISM, the "Investissements d'Avenir" program ANR-10-IAIHU-06 (IHU-A-ICM), INSERM, AP-HP, the Eurocores program EuroEPINOMICS of the European Science Foundation, the Fund for Scientific Research Flanders (FWO) and the University of Antwerp. P.S. and F.Z. thank the Genetics Commission of the Italian League Against Epilepsy (LICE) for their support. B.P.C.K. and C.G.Ed.K. were supported by the Netherlands National Epilepsy Fund. A.S. is a postdoctoral fellow of the FWO. C.N., A.B. and C. Depienne are members of the Bio-Psy Labex.	Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Cestele S, 2013, P NATL ACAD SCI USA, V110, P17546, DOI 10.1073/pnas.1309827110; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne C., 2012, JASPERS BASIC MECH E, V62, P797; Depienne C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000381; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kase Daisuke, 2012, J Signal Transduct, V2012, P619747, DOI 10.1155/2012/619747; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Munsch T, 1999, J PHYSIOL-LONDON, V519, P505, DOI 10.1111/j.1469-7793.1999.0505m.x; Nava C, 2014, EUR J HUM GENET, V22, P71, DOI 10.1038/ejhg.2013.88; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Poolos N.P., 2012, JASPERS BASIC MECH E, V7, P85; Powell KL, 2008, EPILEPSIA, V49, P1686, DOI 10.1111/j.1528-1167.2008.01593.x; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2010, EPILEPSIA, V51, P1624, DOI 10.1111/j.1528-1167.2010.02554.x; Surges R, 2003, EPILEPSIA, V44, P150, DOI 10.1046/j.1528-1157.2003.36802.x; Tang B, 2008, NEUROBIOL DIS, V29, P59, DOI 10.1016/j.nbd.2007.08.006	40	139	149	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					640	645		10.1038/ng.2952	http://dx.doi.org/10.1038/ng.2952			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24747641	Green Submitted			2022-12-17	WOS:000336870700024
J	Speedy, HE; Di Bernardo, MC; Sava, GP; Dyer, MJS; Holroyd, A; Wang, YF; Sunter, NJ; Mansouri, L; Juliusson, G; Smedby, KE; Roos, G; Jayne, S; Majid, A; Dearden, C; Hall, AG; Mainou-Fowler, T; Jackson, GH; Summerfield, G; Harris, RJ; Pettitt, AR; Allsup, DJ; Bailey, JR; Pratt, G; Pepper, C; Fegan, C; Rosenquist, R; Catovsky, D; Allan, JM; Houlston, RS				Speedy, Helen E.; Di Bernardo, Maria Chiara; Sava, Georgina P.; Dyer, Martin J. S.; Holroyd, Amy; Wang, Yufei; Sunter, Nicola J.; Mansouri, Larry; Juliusson, Gunnar; Smedby, Karin E.; Roos, Groan; Jayne, Sandrine; Majid, Aneela; Dearden, Claire; Hall, Andrew G.; Mainou-Fowler, Tryfonia; Jackson, Graham H.; Summerfield, Geoffrey; Harris, Robert J.; Pettitt, Andrew R.; Allsup, David J.; Bailey, James R.; Pratt, Guy; Pepper, Chris; Fegan, Chris; Rosenquist, Richard; Catovsky, Daniel; Allan, James M.; Houlston, Richard S.			A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia	NATURE GENETICS			English	Article							COLORECTAL-CANCER; TELOMERE LENGTH; CHROMATIN STATES; COMMON VARIATION; CELL-RECEPTOR; LUNG-CANCER; RISK; VARIANTS; PCR; METAANALYSIS	Genome-wide association studies (GWAS) of chronic lymphocytic leukemia (CLL) have shown that common genetic variation contributes to the heritable risk of CLL. To identify additional CLL susceptibility loci, we conducted a GWAS and performed a meta-analysis with a published GWAS totaling 1,739 individuals with CLL (cases) and 5,199 controls with validation in an additional 1,144 cases and 3,151 controls. A combined analysis identified new susceptibility loci mapping to 3q26.2 (rs10936599, P = 1.74 x 10(-9)), 4q26 (rs6858698, P = 3.07 x 10(-9)), 6q25.2 (IPCEF1, rs2236256, P = 1.50 x 10(-10)) and 7q31.33 (POT1, rs17246404, P = 3.40 x 10(-8)). Additionally, we identified a promising association at 5p15.33 (CLPTM1L, rs31490, P = 1.72 x 10(-7)) and validated recently reported putative associations at 5p15.33 (TERT, rs10069690, P = 1.12 x 10(-10)) and 8q22.3 (rs2511714, P = 2.90 x 10(-9)). These findings provide further insights into the genetic and biological basis of inherited genetic susceptibility to CLL.	[Speedy, Helen E.; Di Bernardo, Maria Chiara; Sava, Georgina P.; Holroyd, Amy; Wang, Yufei; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Dyer, Martin J. S.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Sunter, Nicola J.; Hall, Andrew G.; Allan, James M.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mansouri, Larry; Rosenquist, Richard] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Juliusson, Gunnar] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Smedby, Karin E.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Roos, Groan] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden; [Jayne, Sandrine; Majid, Aneela] Univ Leicester, Toxicol Unit, Med Res Council, Leicester, Leics, England; [Dearden, Claire; Catovsky, Daniel] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Mainou-Fowler, Tryfonia] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jackson, Graham H.] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Summerfield, Geoffrey] Queen Elizabeth Hosp, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England; [Harris, Robert J.; Pettitt, Andrew R.] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England; [Allsup, David J.] Hull Royal Infirm, Dept Haematol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bailey, James R.] Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Bailey, James R.] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England; [Pratt, Guy] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England; [Pepper, Chris] Cardiff Univ, Sch Med, Dept Haematol, Cardiff CF10 3AX, S Glam, Wales; [Fegan, Chris] Cardiff & Vale Natl Hlth Serv Trust, Cardiff, S Glam, Wales	University of London; Institute of Cancer Research - UK; University of Leicester; Newcastle University - UK; Uppsala University; Lund University; Karolinska Institutet; Umea University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of London; Institute of Cancer Research - UK; Newcastle University - UK; Newcastle University - UK; University of Liverpool; University of Hull; University of Hull; University of York - UK; University of Hull; Heart of England NHS Foundation Trust; University of Birmingham; Cardiff University	Houlston, RS (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Jackson, Graham/GMW-7638-2022; Allan, James/B-4448-2009; Allsup, David/H-2195-2017; Dyer, Martin/F-2691-2014	Jackson, Graham/0000-0003-0756-969X; Allsup, David/0000-0001-6159-6109; Allan, James/0000-0002-7580-5087; Houlston, Richard/0000-0002-5268-0242; Rosenquist, Richard/0000-0002-0211-8788; Sava, Georgina/0000-0001-5904-3978; Pepper, Chris/0000-0003-3603-8839; Dyer, Martin/0000-0002-5033-2236	Leukaemia and Lymphoma Research [LRF05001, LRF06002]; Cancer Research UK [C1298/A8362]; Arbib Fund; National Health Service; Cancer Research UK [18779, 15116] Funding Source: researchfish	Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Arbib Fund; National Health Service; Cancer Research UK(Cancer Research UK)	Leukaemia and Lymphoma Research provided principal funding for the study (LRF05001 and LRF06002). We acknowledge support from Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund) and the Arbib Fund. We also acknowledge National Health Service funding to the Royal Marsden/Institute of Cancer Research; National Institute for Health Research Biomedical Research Centre. The study made use of genotyping data on the 1958 Birth Cohort; a full list of the investigators who contributed to the generation of these data is available at http://www.wtccc.org.uk/. We thank L. Padyukov (Karolinska Institutet) and the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) group for providing control samples from the Swedish population for the Swedish replication study. We are grateful to all clinicians for their involvement in patient ascertainment. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 1 and 2. A full list of the investigators who contributed to the generation of the data is available at http://www.wtccc.org.uk/. We are grateful to all investigators and all the patients and individuals for their participation. We also thank the clinicians, other hospital staff and study staff that contributed to the blood sample and data collection for this study.	Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chubb D, 2013, NAT GENET, V45, P1221, DOI 10.1038/ng.2733; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Di Bernardo Maria Chiara, 2013, Haematologica, V98, pe23, DOI 10.3324/haematol.2012.072140; Eisen T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-244; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Karlsson R, 2013, HUM MOL GENET, V22, P3373, DOI 10.1093/hmg/ddt188; Mansouri L, 2013, AM J HEMATOL, V88, P647, DOI 10.1002/ajh.23466; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Petitti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Slager SL, 2012, BLOOD, V120, P843, DOI 10.1182/blood-2012-03-413591; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Swerdlow SH., 2017, WHO CLASSIFICATION T; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Verma-Gaur J, 2012, J IMMUNOL, V188, P6175, DOI 10.4049/jimmunol.1103105; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	45	139	140	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					56	+		10.1038/ng.2843	http://dx.doi.org/10.1038/ng.2843			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24292274	Green Accepted			2022-12-17	WOS:000329113500013
J	Smith, RP; Taher, L; Patwardhan, RP; Kim, MJ; Inoue, F; Shendure, J; Ovcharenko, I; Ahituv, N				Smith, Robin P.; Taher, Leila; Patwardhan, Rupali P.; Kim, Mee J.; Inoue, Fumitaka; Shendure, Jay; Ovcharenko, Ivan; Ahituv, Nadav			Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model	NATURE GENETICS			English	Article							GENE-EXPRESSION; ENHANCER; LIVER; ELEMENTS; BINDING; DISSECTION; DISCOVERY; ALIGNMENT; ETS	Despite continual progress in the cataloging of vertebrate regulatory elements, little is known about their organization and regulatory architecture. Here we describe a massively parallel experiment to systematically test the impact of copy number, spacing, combination and order of transcription factor binding sites on gene expression. A complex library of similar to 5,000 synthetic regulatory elements containing patterns from 12 liver-specific transcription factor binding sites was assayed in mice and in HepG2 cells. We find that certain transcription factors act as direct drivers of gene expression in homotypic clusters of binding sites, independent of spacing between sites, whereas others function only synergistically. Heterotypic enhancers are stronger than their homotypic analogs and favor specific transcription factor binding site combinations, mimicking putative native enhancers. Exhaustive testing of binding site permutations suggests that there is flexibility in binding site order. Our findings provide quantitative support for a flexible model of regulatory element activity and suggest a framework for the design of synthetic tissue-specific enhancers.	[Smith, Robin P.; Kim, Mee J.; Inoue, Fumitaka; Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Smith, Robin P.; Kim, Mee J.; Inoue, Fumitaka; Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Taher, Leila; Ovcharenko, Ivan] NIH, Natl Ctr Biotechnol Informat, Computat Biol Branch, Natl Lib Med, Bethesda, MD USA; [Taher, Leila] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Patwardhan, Rupali P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Rostock; University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@u.washington.edu; ovcharen@nih.gov; nadav.ahituv@ucsf.edu	Inoue, Fumitaka/AAD-4423-2022; Shendure, Jay/AAU-3684-2021	Inoue, Fumitaka/0000-0003-0657-434X; Shendure, Jay/0000-0002-1516-1865; Taher, Leila/0000-0002-2013-5426; Ahituv, Nadav/0000-0002-7434-8144	National Human Genome Research Institute (NHGRI) [1R01HG006768]; University of California, San Francisco (UCSF) Liver Center [P30 DK026743]; National Institute of Child and Human Development [R01HD059862]; NHGRI [R01HG005058]; National Institute of General Medical Sciences [GM61390]; National Institute of Neurological Disorders and Stroke [1R01NS079231]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK090382]; Simons Foundation [SFARI 256769]; Canadian Institutes of Health Research (CIHR); US National Institutes of Health [T32 GM007175]; UCSF Quantitative Biosciences Consortium fellowship for Interdisciplinary Research; Amgen Research Excellence in Bioengineering and Therapeutic Sciences fellowship; US National Institutes of Health, National Library of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005058, R01HG006768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090382, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, U19GM061390, T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079231] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of California, San Francisco (UCSF) Liver Center; National Institute of Child and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Simons Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Quantitative Biosciences Consortium fellowship for Interdisciplinary Research; Amgen Research Excellence in Bioengineering and Therapeutic Sciences fellowship; US National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Human Genome Research Institute (NHGRI) grant 1R01HG006768 (N.A. and J.S.) and the Pilot/Feasibility grant from the University of California, San Francisco (UCSF) Liver Center (P30 DK026743). N.A. is also supported by National Institute of Child and Human Development grant R01HD059862, NHGRI grant R01HG005058, National Institute of General Medical Sciences grant GM61390, National Institute of Neurological Disorders and Stroke grant 1R01NS079231, National Institute of Diabetes and Digestive and Kidney Diseases grant 1R01DK090382 and the Simons Foundation (SFARI 256769). R. P. S. was supported in part by a Canadian Institutes of Health Research (CIHR) fellowship in hepatology. M.J.K. was supported in part by US National Institutes of Health training grant T32 GM007175, the UCSF Quantitative Biosciences Consortium fellowship for Interdisciplinary Research and the Amgen Research Excellence in Bioengineering and Therapeutic Sciences fellowship. This work was funded in part by the Intramural Research Program of the US National Institutes of Health, National Library of Medicine (I.O.).	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim MJ, 2011, CLIN PHARMACOL THER, V89, P571, DOI 10.1038/clpt.2010.353; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rastegar S, 2008, DEV BIOL, V318, P366, DOI 10.1016/j.ydbio.2008.03.034; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Schwartz JJ, 2012, NAT METHODS, V9, P913, DOI 10.1038/nmeth.2137; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tomovic A, 2007, BIOINFORMATICS, V23, P933, DOI 10.1093/bioinformatics/btm055; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	47	139	144	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1021	+		10.1038/ng.2713	http://dx.doi.org/10.1038/ng.2713			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23892608	Green Accepted			2022-12-17	WOS:000323748200011
J	Abd El-Aziz, MM; Barragan, I; O'Driscoll, CA; Goodstadt, L; Prigmore, E; Borrego, S; Mena, M; Pieras, JI; El-Ashry, MF; Abu Safieh, L; Shah, A; Cheetham, ME; Carter, NP; Chakarova, C; Ponting, CP; Bhattacharya, SS; Antinolo, G				Abd El-Aziz, Mai M.; Barragan, Isabel; O'Driscoll, Ciara A.; Goodstadt, Leo; Prigmore, Elena; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; El-Ashry, Mohamed F.; Abu Safieh, Leen; Shah, Amna; Cheetham, Michael E.; Carter, Nigel P.; Chakarova, Christina; Ponting, Chris P.; Bhattacharya, Shomi S.; Antinolo, Guillermo			EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa	NATURE GENETICS			English	Article							LOCUS; REFINEMENT; PHYLOGENY; EYES; 6Q	Using a positional cloning approach supported by comparative genomics, we have identified a previously unreported gene, EYS, at the RP25 locus on chromosome 6q12 commonly mutated in autosomal recessive retinitis pigmentosa. Spanning over 2 Mb, this is the largest eye-specific gene identified so far. EYS is independently disrupted in four other mammalian lineages, including that of rodents, but is well conserved from Drosophila to man and is likely to have a role in the modeling of retinal architecture.	[Abd El-Aziz, Mai M.; O'Driscoll, Ciara A.; El-Ashry, Mohamed F.; Abu Safieh, Leen; Shah, Amna; Chakarova, Christina; Bhattacharya, Shomi S.] Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; [Barragan, Isabel; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; Antinolo, Guillermo] Hosp Univ Virgen Rocio, Unidad Gest Clin Genet Reprod & Med Fetal, Seville 41013, Spain; [Barragan, Isabel; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; Antinolo, Guillermo] CIBERER, Seville, Spain; [Goodstadt, Leo; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3QX, England; [Prigmore, Elena; Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cheetham, Michael E.] Inst Ophthalmol, Div Mol & Cellular Neurosci, London EC1V 9EL, England; [Bhattacharya, Shomi S.] Univ Paris 06, INSERM U592, Inst Vis, UMR 592, Paris, France	University of London; University College London; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Oxford; Wellcome Trust Sanger Institute; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bhattacharya, SS (corresponding author), Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England.	smbcssb@ucl.ac.uk; guillermo.antinolo.sspa@juntadeandalucia.es	Shah, Amna/C-4471-2013; IBIS, GENETICA/P-3384-2015; IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; Chakarova, Christina/C-9479-2013; Barragan, Isabel/AAJ-6532-2020; Bhattacharya, Shom/N-2926-2016; Cheetham, Michael/B-4672-2011; Ponting, Chris/AAV-2621-2021	Barragan, Isabel/0000-0002-8586-6502; Bhattacharya, Shom/0000-0002-1601-6344; Cheetham, Michael/0000-0001-6429-654X; Ponting, Chris/0000-0003-0202-7816; Antinolo Gil, Guillermo/0000-0002-2113-074X; Mena, Marcela Daniela/0000-0002-8734-9031	Fondo de Investigacion Sanitaria, Spain [PI050857]; Consejeria de Salud [PI-0334/2007]; Junta de Andalucia, Spain; British Retinitis Pigmentosa Society [GR556]; Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology; Special Trustees of Moorfields Eye Hospital London; UK Medical Research Council; EU-Neurotrain [MEST-CT-2005020235]; EU-GENORET [LSHG-CT-2005-512036]; Wellcome Trust; Medical Research Council [MC_U137761446] Funding Source: researchfish; MRC [MC_U137761446] Funding Source: UKRI	Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); Consejeria de Salud; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); British Retinitis Pigmentosa Society; Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology(National Institute for Health Research (NIHR)); Special Trustees of Moorfields Eye Hospital London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-Neurotrain; EU-GENORET; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the families who participated in the study. This study was funded by Fondo de Investigacion Sanitaria (PI050857), Spain; Consejeria de Salud (PI-0334/2007), Junta de Andalucia, Spain; British Retinitis Pigmentosa Society (grant ref. GR556); Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology, The Special Trustees of Moorfields Eye Hospital London; the UK Medical Research Council and EU-Neurotrain (grant ref. MEST-CT-2005020235); EU-GENORET (grant ref. LSHG-CT-2005-512036). The El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the Instituto de Salud Carlos III. N.P.C. and E. P. were supported by the Wellcome Trust. We would like also to thank R. Molday (University of British Columbia, Vancouver) for the gift of 1D4 antibody and G. Jeffery for his advice with immunohistochemistry.	Barragan I, 2008, ANN HUM GENET, V72, P454, DOI 10.1111/j.1469-1809.2008.00448.x; Barragan I, 2005, OPHTHALMIC RES, V37, P89, DOI 10.1159/000084250; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; El-Aziz MMA, 2008, ANN HUM GENET, V72, P463, DOI 10.1111/j.1469-1809.2008.00455.x; El-Aziz MMA, 2007, ANN HUM GENET, V71, P281, DOI 10.1111/j.1469-1809.2006.00333.x; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Khaliq S, 1999, AM J HUM GENET, V65, P571, DOI 10.1086/302493; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ruiz A, 1998, AM J HUM GENET, V62, P1452, DOI 10.1086/301866; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	13	139	142	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1285	1287		10.1038/ng.241	http://dx.doi.org/10.1038/ng.241			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836446	Green Accepted			2022-12-17	WOS:000260501500018
J	Smits, G; Mungall, AJ; Griffiths-Jones, S; Smith, P; Beury, D; Matthews, L; Rogers, J; Pask, AJ; Shaw, G; VandeBerg, JL; McCarrey, JR; Renfree, MB; Reik, W; Dunham, I				Smits, Guillaume; Mungall, Andrew J.; Griffiths-Jones, Sam; Smith, Paul; Beury, Delphine; Matthews, Lucy; Rogers, Jane; Pask, Andrew J.; Shaw, Geoff; VandeBerg, John L.; McCarrey, John R.; Renfree, Marilyn B.; Reik, Wolf; Dunham, Ian		SAVOIR Consortium	Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians	NATURE GENETICS			English	Article							INSULATOR PROTEIN CTCF; DIFFERENTIAL METHYLATION; CHROMATIN INSULATOR; DNA METHYLATION; GENE; MOUSE; IGF2; EXPRESSION; MAMMALS; SEQUENCES	Comparisons between eutherians and marsupials suggest limited conservation of the molecular mechanisms that control genomic imprinting in mammals. We have studied the evolution of the imprinted IGF2-H19 locus in therians. Although marsupial orthologs of protein-coding exons were easily identified, the use of evolutionarily conserved regions and low-stringency Bl2seq comparisons was required to delineate a candidate H19 noncoding RNA sequence. The therian H19 orthologs show miR-675 and exon structure conservation, suggesting functional selection on both features. Transcription start site sequences and poly(A) signals are also conserved. As in eutherians, marsupial H19 is maternally expressed and paternal methylation upstream of the gene originates in the male germline, encompasses a CTCF insulator, and spreads somatically into the H19 gene. The conservation in all therians of the mechanism controlling imprinting of the IGF2-H19 locus suggests a sequential model of imprinting evolution.	[Smits, Guillaume; Smith, Paul; Beury, Delphine; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Mungall, Andrew J.; Matthews, Lucy; Rogers, Jane; Dunham, Ian] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Griffiths-Jones, Sam] Univ Manchester, Fac Life Sci, Manchester M13 9PL, England; [Pask, Andrew J.; Shaw, Geoff; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Victoria 3010, Australia; [VandeBerg, John L.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; University of Manchester; University of Melbourne; Texas Biomedical Research Institute; University of Texas System; University of Texas at San Antonio (UTSA)	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk; dunham@ebi.ac.uk	Shaw, Geoff/A-6916-2012; Mungall, Andrew J./U-7067-2018; Reik, Wolf/I-6794-2012; Griffiths-Jones, Sam/H-2998-2014	Shaw, Geoff/0000-0002-7421-7136; Mungall, Andrew J./0000-0002-0905-2742; Griffiths-Jones, Sam/0000-0001-6043-807X; Renfree, Marilyn/0000-0002-4589-0436; Dunham, Ian/0000-0003-2525-5598; Reik, Wolf/0000-0003-0216-9881; Steward, Charles/0000-0001-8829-5349; Beury, Delphine/0000-0002-4163-0362; Smits, Guillaume/0000-0003-2845-6758; Pask, Andrew/0000-0002-1900-2263	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S119, BBS/E/B/0000C214] Funding Source: Medline; Medical Research Council [G0400154] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0400154] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ager E, 2007, DEV BIOL, V309, P317, DOI 10.1016/j.ydbio.2007.07.025; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Butler CM, 2008, J ANAT, V212, P55, DOI 10.1111/j.1469-7580.2007.00837.x; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Griffiths-Jones S, 2005, BIOINFORMATICS, V21, P257, DOI 10.1093/bioinformatics/bth489; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; La Salle S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-104; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schmid J, 2003, COMP BIOCHEM PHYS A, V136, P903, DOI 10.1016/S1095-6433(03)00240-X; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Suzuki S, 2005, MECH DEVELOP, V122, P213, DOI 10.1016/j.mod.2004.10.003; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Weidman JR, 2006, EPIGENETICS-US, V1, P49; Weidman JR, 2004, GENOME RES, V14, P1726, DOI 10.1101/gr.2774804; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817	50	139	149	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					971	976		10.1038/ng.168	http://dx.doi.org/10.1038/ng.168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587395				2022-12-17	WOS:000258026900013
J	Hammond, SM				Hammond, Scott M.			MicroRNAs as tumor suppressors	NATURE GENETICS			English	Editorial Material							POSTTRANSCRIPTIONAL REGULATION; LET-7 MICRORNA; C-ELEGANS; CANCER; EXPRESSION; LIN-14		Univ N Carolina, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Hammond, SM (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Hammond@med.unc.edu						Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com	13	139	152	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2007	39	5					582	583		10.1038/ng0507-582	http://dx.doi.org/10.1038/ng0507-582			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17460676				2022-12-17	WOS:000245971300011
J	Rohmann, E; Brunner, HG; Kayserili, H; Uyguner, O; Nurnberg, G; Lew, ED; Dobbie, A; Eswarakumar, VP; Uzumcu, A; Ulubil-Emeroglu, M; Leroy, JG; Li, Y; Becker, C; Lehnerdt, K; Cremers, CWRJ; Yuksel-Apak, M; Nurnberg, P; Kubisch, C; Schlessinger, J; van Bokhoven, H; Wollnik, B				Rohmann, E; Brunner, HG; Kayserili, H; Uyguner, O; Nurnberg, G; Lew, ED; Dobbie, A; Eswarakumar, VP; Uzumcu, A; Ulubil-Emeroglu, M; Leroy, JG; Li, Y; Becker, C; Lehnerdt, K; Cremers, CWRJ; Yuksel-Apak, M; Nurnberg, P; Kubisch, C; Schlessinger, J; van Bokhoven, H; Wollnik, B			Mutations in different components of FGF signaling in LADD syndrome	NATURE GENETICS			English	Article							DENTO-DIGITAL SYNDROME; PATERNAL ORIGIN; RECEPTORS; ANOMALIES	Lacrimo-auriculo-dento-digital (LADD) syndrome is characterized by lacrimal duct aplasia, malformed ears and deafness, small teeth and digital anomalies. We identified heterozygous mutations in the tyrosine kinase domains of the genes encoding fibroblast growth factor receptors 2 and 3 (FGFR2, FGFR3) in LADD families, and in one further LADD family, we detected a mutation in the gene encoding fibroblast growth factor 10 (FGF10), a known FGFR ligand. These findings increase the spectrum of anomalies associated with abnormal FGF signaling.	Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey; Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; RZPD Deutsch Ressourcenzentrum Genomforsch GmbH, D-14059 Berlin, Germany; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; St Jamess Univ Hosp, Genet Serv, Leeds LS9 7TS, W Yorkshire, England; Istanbul Univ, Istanbul Fac Med, Dept Ear Nose & Throat, TR-34390 Istanbul, Turkey; State Univ Ghent Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Klinikum Dortmund, HNO Abt, D-44137 Dortmund, Germany; Univ Cologne, Inst Genet, D-5000 Cologne, Germany	University of Cologne; University of Cologne; Radboud University Nijmegen; Istanbul University; University of Cologne; Yale University; Saint James's University Hospital; University of Leeds; Istanbul University; Ghent University; Ghent University Hospital; Klinikum Dortmund; University of Cologne	Wollnik, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de	van Bokhoven, Hans/D-8764-2012; Kubisch, Christian/F-1893-2011; Cremers, C.W.R.J./L-4254-2015; UYGUNER, OYA Z/Y-3899-2018; Wollnik, Bernd/GRY-6062-2022; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013	Kubisch, Christian/0000-0003-4220-0978; Wollnik, Bernd/0000-0003-2589-0364; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Eswarakumar, Jacob/0000-0003-0784-0507; Eswarakumar, V.P./0000-0001-7941-8714; Uyguner, Zehra Oya/0000-0002-2035-4338	NIAMS NIH HHS [R01-AR051886, R01-AR051448] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051448, R01AR051886] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAMFORTH JS, 1992, AM J MED GENET, V43, P932, DOI 10.1002/ajmg.1320430605; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Gorivodsky M, 2003, DEVELOPMENT, V130, P5471, DOI 10.1242/dev.00795; HOLLISTER DW, 1973, J PEDIATR-US, V83, P438, DOI 10.1016/S0022-3476(73)80268-9; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; LEVY WJ, 1967, AM J OPHTHALMOL, V63, P978, DOI 10.1016/0002-9394(67)90043-8; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775	14	139	148	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					414	417		10.1038/ng1757	http://dx.doi.org/10.1038/ng1757			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16501574				2022-12-17	WOS:000236340500012
J	Camacho, JA; Obie, C; Biery, B; Goodman, BK; Hu, CA; Almashanu, S; Steel, G; Casey, R; Lambert, M; Mitchell, GA; Valle, D				Camacho, JA; Obie, C; Biery, B; Goodman, BK; Hu, CA; Almashanu, S; Steel, G; Casey, R; Lambert, M; Mitchell, GA; Valle, D			Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter	NATURE GENETICS			English	Article							RAT-LIVER MITOCHONDRIA; ARGININE-BIOSYNTHESIS; PHOSPHATE SYNTHETASE; CARRIER PROTEINS; HHH SYNDROME; IDENTIFICATION; CITRULLINE; QUEBEC; PURIFICATION; MEMBRANE	Neurospora crassa ARG13 and Saccharomyces cerevisiae ARG11 I en code mitochondrial carrier family (MCF) proteins that transport ornithine across the mitochondrial inner membrane,. We used their sequences to identify EST candidates that partially encode orthologous mammalian transporters. We thereby identified such a gene (ORNT1) that maps to 13q14 and whose expression, similar to that of other urea cycle (UC) components, was high in liver and varied with changes in dietary protein. ORNT1 expression, restores ornithine metabolism in fibroblasts from patients with hyperammonaemia-hyperornithinaemia-homocitrullinuria (HHH) syndrome. In a survey of 11 HHH probands, we identified 3 ORNT1 mutant alleles that account for 21 of 22 possible mutant ORNT1 genes in our patients: F188 Delta which is common in French-Canadian HHH patients and encodes an unstable protein; E180K, which encodes a stable, properly targeted protein that is inactive; and a 13q14 microdeletion. Our results show that ORNT1 encodes the mitochondrial ornithine transporter involved in UC function and is defective in HHH syndrome.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Obstet & Gynaecol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21218 USA; Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada; Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; University of Saskatchewan; Universite de Montreal	Valle, D (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [C06EY007414] Funding Source: NIH RePORTER; NEI NIH HHS [EY07414] Funding Source: Medline; NICHD NIH HHS [HD24061] Funding Source: Medline; NIGMS NIH HHS [GM07471] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; BRADFORD NM, 1980, FEBS LETT, V113, P294, DOI 10.1016/0014-5793(80)80612-0; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BRODY LC, 1992, J BIOL CHEM, V267, P330; Brusilow SW HA., 1995, METABOLIC MOL BASES, P1187; Carter KC, 1998, EUR J HUM GENET, V6, P61, DOI 10.1038/sj.ejhg.5200153; Cayanis E, 1998, GENOMICS, V47, P26, DOI 10.1006/geno.1997.5087; CHARBONNEAU H, 1987, NAISSANCE POPULATION; CHEUNG CW, 1989, J BIOL CHEM, V264, P4038; Crabeel M, 1996, J BIOL CHEM, V271, P25011, DOI 10.1074/jbc.271.40.25011; DEBRAEKELEER M, 1991, HUM HERED, V41, P168, DOI 10.1159/000153996; FELL V, 1974, AM J DIS CHILD, V127, P752, DOI 10.1001/archpedi.1974.02110240138023; GAMBLE JG, 1973, J BIOL CHEM, V248, P610; GATFIELD PD, 1975, PEDIATR RES, V9, P488, DOI 10.1203/00006450-197505000-00006; Haust MD, 1996, PATHOL RES PRACT, V192, P271, DOI 10.1016/S0344-0338(96)80230-5; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628; INDIVERI C, 1994, BBA-BIOENERGETICS, V1188, P293, DOI 10.1016/0005-2728(94)90048-5; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; INDIVERI C, 1992, EUR J BIOCHEM, V207, P449, DOI 10.1111/j.1432-1033.1992.tb17070.x; Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kramer R, 1996, KIDNEY INT, V49, P947, DOI 10.1038/ki.1996.133; LEMAY JF, 1992, J PEDIATR-US, V121, P725, DOI 10.1016/S0022-3476(05)81900-6; Liu QY, 1996, GENETICS, V143, P1163; MERANTE F, 1993, AM J HUM GENET, V53, P481; METOKI K, 1984, J INHERIT METAB DIS, V7, P9, DOI 10.1007/BF01805611; MITCHELL GA, METABOLIC MOL BASES; MORIN C, 1993, AM J HUM GENET, V53, P488; MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V256, P343, DOI 10.1016/0003-9861(87)90455-3; MOUALIJ B, 1997, YEAST, V13, P573; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; PASSARELLA S, 1990, EUR J BIOCHEM, V193, P221, DOI 10.1111/j.1432-1033.1990.tb19326.x; POWERSLEE SG, 1987, J BIOL CHEM, V262, P15683; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; Schroers A, 1998, J BIOL CHEM, V273, P14269, DOI 10.1074/jbc.273.23.14269; SHIH VE, 1992, PRENATAL DIAG, V12, P717, DOI 10.1002/pd.1970120905; SHIH VE, 1982, CLIN CHIM ACTA, V118, P149, DOI 10.1016/0009-8981(82)90002-X; SHIH VE, 1969, AM J DIS CHILD, V117, P83, DOI 10.1001/archpedi.1969.02100030085009; SIMELL O, 1985, PEDIATR RES, V19, P1283, DOI 10.1203/00006450-198512000-00016; SMITH L, 1992, J PEDIATR GASTR NUTR, V15, P431, DOI 10.1097/00005176-199211000-00011; VALLINA JRP, 1995, PHARM SCI, V1, P185; VICI CD, 1987, PEDIATR RES, V22, P364, DOI 10.1203/00006450-198709000-00025; Vohl MC, 1997, CLIN GENET, V52, P1, DOI 10.1111/j.1399-0004.1997.tb02506.x; Weber FE, 1997, P NATL ACAD SCI USA, V94, P8509, DOI 10.1073/pnas.94.16.8509; Wylin T, 1998, EUR J BIOCHEM, V258, P332, DOI 10.1046/j.1432-1327.1998.2580332.x; YOKOTA S, 1986, HISTOCHEM J, V18, P451, DOI 10.1007/BF01675338; Zammarchi E, 1997, J PEDIATR-US, V131, P440, DOI 10.1016/S0022-3476(97)80072-8	53	139	149	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					151	158		10.1038/9658	http://dx.doi.org/10.1038/9658			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369256				2022-12-17	WOS:000080680900019
J	Ivanova, AV; Bonaduce, MJ; Ivanov, SV; Klar, AJS				Ivanova, AV; Bonaduce, MJ; Ivanov, SV; Klar, AJS			The chromo and SET domains of the Clr4 protein are essential for silencing in fission yeast	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; SCHIZOSACCHAROMYCES-POMBE; DROSOPHILA; GENE; MUTATIONS; DISRUPT; REGION	Heritable inactivation of specific regions of the genome is a widespread, possibly universal phenomenon for gene regulation in eukaryotes. Self-perpetuating, clonally inherited chromatin structure has been proposed as the explanation for such phenomena as position-effect variegation(1,2) (PEV) and control of segment determination and differentiation in flies(3), X-chromosome inactivation and parental imprinting in mammals(4,5), gene silencing by paramutation in maize(6) and silencing of the mating-type loci in yeasts(7,8). We have now found that the clr4 gene, which is essential for silencing of centromeres(9) and the mating-type loci in Schizosaccharomyces pombe(8,10), encodes a protein with high homology to the product of Su(var)3-9, a gene affecting PEV in Drosophila(1). Like Su(var)3-9p, Clr4p contains SET and chrome domains, motifs found in proteins that modulate chromatin structure. Site-directed mutations in the conserved residues of the chrome domain confirm that it is required for proper silencing and directional switching of the mating type, like SET domain. Surprisingly, RNA differential display experiments demonstrated that clr4(+) can mediate transcriptional activation of certain other loci. These results show that clr4 plays a critical role in silencing at mating-type loci and centromeres through the organization of repressive chromatin structure and demonstrate a new, activator function for Clr4p.	NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Klar, AJS (corresponding author), NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA.	klar@ncifcrf.gov		Ivanov, Sergey/0000-0001-9770-7237				Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; ALLSHIRE RC, 1996, EPIGENETIC MECH GENE, P443; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ekwall K, 1996, J CELL SCI, V109, P2637; ENGELKE U, 1987, CURR GENET, V12, P535, DOI 10.1007/BF00419563; Grewal SIS, 1997, GENETICS, V146, P1221; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; HOLLICK JB, 1995, GENETICS, V141, P709; JIANG YW, 1992, MOL CELL BIOL, V12, P4503, DOI 10.1128/MCB.12.10.4503; Klar AJS, 1998, CIBA F SYMP, V214, P87; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LYON MF, 1986, J EMBRYOL EXP MORPH, V97, P75; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Sawin KE, 1996, P NATL ACAD SCI USA, V93, P15146, DOI 10.1073/pnas.93.26.15146; SINGH PB, 1994, J CELL SCI, V107, P2653; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x	30	139	142	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					192	195		10.1038/566	http://dx.doi.org/10.1038/566			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620780				2022-12-17	WOS:000073865100031
J	Craig, JE; Rochette, J; Fisher, CA; Weatherall, DJ; Marc, S; Lathrop, GM; Demenais, F; Thein, SL				Craig, JE; Rochette, J; Fisher, CA; Weatherall, DJ; Marc, S; Lathrop, GM; Demenais, F; Thein, SL			Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; HEREDITARY PERSISTENCE; HEMOGLOBIN EXPRESSION; NORMAL INDIVIDUALS; F-CELLS; CLUSTER; LINKAGE; ADULTS; MODELS; ASSOCIATION	The changes in the type of haemoglobin (Hb) produced during embryonic, fetal and adult life, have served as a paradigm for understanding the developmental regulation of human genes. A genetically determined persistence of fetal Hb synthesis has an ameliorating effect on beta thalassaemia and sickle cell anaemia, globally the commonest single gene disorders. The search for the putative gene(s) controlling the level of fetal Hb production has been extremely difficult because this trait may be influenced by several factors. We have studied a large kindred with hereditary persistence of fetal haemoglobin (HPFH). Using a genetic mapping strategy and statistical methods that account simultaneously for the effects of several genetic factors, we have demonstrated that in addition to the two factors (beta thalassaemia and Xmn I-(G) gamma site) on chromosome 11p, there is a third major genetic determinant for fetal Hb production localized on chromosome 6q.	JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; GENETHON, F-91000 EVRY, FRANCE; WELLCOME TRUST CTR HUMAN GENET, OXFORD, ENGLAND; HOP ST LOUIS, INSERM, U358, F-75010 PARIS, FRANCE	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Demenais, Florence/G-3298-2013	Demenais, Florence/0000-0001-8361-0936; Craig, Jamie/0000-0001-9955-9696	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; CAPPELLINI MD, 1981, BRIT J HAEMATOL, V48, P561, DOI 10.1111/j.1365-2141.1981.tb02753.x; CHANG YC, 1995, BLOOD, V85, P1111, DOI 10.1182/blood.V85.4.1111.bloodjournal8541111; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEMENAIS F, 1994, GENET EPIDEMIOL, V11, P291; DEMENAIS FM, 1990, GENET EPIDEMIOL, V7, P319, DOI 10.1002/gepi.1370070503; DESIMONE J, 1981, BRIT J HAEMATOL, V49, P175, DOI 10.1111/j.1365-2141.1981.tb07213.x; DOVER GJ, 1992, BLOOD, V80, P816; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GIAMPAOLO A, 1984, HUM GENET, V66, P151, DOI 10.1007/BF00286590; GIANNI AM, 1983, EMBO J, V2, P921, DOI 10.1002/j.1460-2075.1983.tb01522.x; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GILMAN JG, 1985, BLOOD, V66, P783; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROSVELD F, 1993, BAILLIERE CLIN HAEM, V6, P31, DOI 10.1016/S0950-3536(05)80065-4; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HIGGS DR, 1993, BAILLIERE CLIN HAEM, V6, P117, DOI 10.1016/S0950-3536(05)80068-X; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MARTINEZ G, 1989, HUM GENET, V82, P335, DOI 10.1007/BF00273993; MARTINEZ M, IN PRESS GENET EPIDE; MELONI R, 1993, NUCLEIC ACIDS RES, V20, P1166; MIYOSHI K, 1988, BLOOD, V72, P1854; MORTON NE, 1956, AM J HUM GENET, V8, P80; Ott J., 1991, ANAL HUMAN GENETIC L; PERRINE RP, 1972, LANCET, V2, P1163; ROCHETTE J, 1990, AM J HEMATOL, V34, P223, DOI 10.1002/ajh.2830340313; RUTLAND PC, 1983, BRIT J HAEMATOL, V53, P673, DOI 10.1111/j.1365-2141.1983.tb07319.x; SAMPIETRO M, 1992, BLOOD, V79, P832; SPARKES RS, 1986, AM J HUM GENET, V39, P186; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; STAMATOYANNOPOULOS G, 1975, BLOOD, V46, P683; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; THEIN SL, 1993, BLOOD, V82, P961; THEIN SL, 1994, AM J HUM GENET, V54, P214; Thein SL, 1989, HEMOGLOBIN SWITCHI B, P97; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZAGO MA, 1979, BLOOD, V53, P977	44	139	141	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1996	12	1					58	64		10.1038/ng0196-58	http://dx.doi.org/10.1038/ng0196-58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528252				2022-12-17	WOS:A1996TM55500015
J	STONE, EM; MATHERS, WD; ROSENWASSER, GOD; HOLLAND, EJ; FOLBERG, R; KRACHMER, JH; NICHOLS, BE; GOREVIC, PD; TAYLOR, CM; STREB, LM; FISHBAUGH, JA; DALEY, TE; SUCHESKI, BM; SHEFFIELD, VC				STONE, EM; MATHERS, WD; ROSENWASSER, GOD; HOLLAND, EJ; FOLBERG, R; KRACHMER, JH; NICHOLS, BE; GOREVIC, PD; TAYLOR, CM; STREB, LM; FISHBAUGH, JA; DALEY, TE; SUCHESKI, BM; SHEFFIELD, VC			3 AUTOSOMAL-DOMINANT CORNEAL DYSTROPHIES MAP TO CHROMOSOME-5Q	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; PRION PROTEIN; MUTATION; DISEASE; GENE; DNA; DEPOSITS; FIBRILS	The two most common autosomal dominant dystrophies of the corneal stroma are lattice corneal dystrophy type I and granular dystrophy. A third autosomal dominant stromal dystrophy (Avellino) has also been recognized. Chromosome linkage analysis of four families with Avellino dystrophy mapped the disease-causing gene to chromosome 5q. Subsequent linkage analysis of two families with typical lattice dystrophy and two with typical granular dystrophy also revealed significant linkage with the same markers. Thus, each of three clinically and histopathologically distinct phenotypes is independently linked to 5q. The maximum combined lod score using all 114 affected patients was 28.6 with marker D5S393. None of the 14 known human amyloid-associated genes map to chromosome 5.	UNIV IOWA, COLL MED, DEPT PATHOL, IOWA CITY, IA 52242 USA; UNIV IOWA, COLL MED, DEPT PEDIAT, IOWA CITY, IA 52242 USA; PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT OPHTHALMOL, HERSHEY, PA 17033 USA; UNIV MINNESOTA, COLL MED, DEPT OPHTHALMOL, MINNEAPOLIS, MN 55455 USA; SUNY STONY BROOK, DIV RHEUMATOL & CLIN IMMUNOL, STONY BROOK, NY 11794 USA	University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	STONE, EM (corresponding author), UNIV IOWA, COLL MED, DEPT OPHTHALMOL, IOWA CITY, IA 52242 USA.			Stone, Edwin M./0000-0003-3343-4414	NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000457] Funding Source: NIH RePORTER; NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [HG00457, P50HG00835] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BENSON MD, 1993, NAT GENET, V3, P252, DOI 10.1038/ng0393-252; DELACHAPELLE A, 1992, NAT GENET, V2, P157, DOI 10.1038/ng1092-157; DWELET FE, 1984, P NATN ACAD SCI USJO, V81, P694; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; GHISO J, 1986, BIOCHEM BIOPH RES CO, V136, P548, DOI 10.1016/0006-291X(86)90475-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOREVIC PD, 1986, P NATL ACAD SCI USA, V83, P7908, DOI 10.1073/pnas.83.20.7908; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HOLLAND EJ, 1992, OPHTHALMOLOGY, V99, P1564; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; Jacobson D R, 1991, Adv Hum Genet, V20, P69; JOHANSSON B, 1987, BIOCHEM BIOPH RES CO, V148, P1087, DOI 10.1016/S0006-291X(87)80243-7; JOHNSON KH, 1989, NEW ENGL J MED, V321, P513; JONES ST, 1961, AM J OPHTHALMOL, V51, P394, DOI 10.1016/0002-9394(61)92085-2; KLUVEBECKERMAN B, 1986, BIOCHEM BIOPH RES CO, V137, P1196, DOI 10.1016/0006-291X(86)90352-9; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; MERETOJA J, 1969, Annals of Clinical Research, V1, P314; MIDURA RJ, 1990, J BIOL CHEM, V265, P15947; Nichols B. E., 1992, American Journal of Human Genetics, V51, pA369; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P688; ROSENWASSER GOD, 1993, ARCH OPHTHALMOL-CHIC, V111, P1546, DOI 10.1001/archopht.1993.01090110112035; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; SLETTEN K, 1990, 6 INT S AM PROG, P113; SZUBRYT SR, 1993, HUM MOL GENET, V2, P90, DOI 10.1093/hmg/2.1.90-a; TAGLIAVINI F, 1991, NEUROSCI LETT, V128, P117, DOI 10.1016/0304-3940(91)90773-M; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOO P, 1987, LANCET, V2, P767	32	139	141	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1994	6	1					47	51		10.1038/ng0194-47	http://dx.doi.org/10.1038/ng0194-47			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136834				2022-12-17	WOS:A1994MQ17700013
J	RICHLER, C; SOREQ, H; WAHRMAN, J				RICHLER, C; SOREQ, H; WAHRMAN, J			X-INACTIVATION IN MAMMALIAN TESTIS IS CORRELATED WITH INACTIVE X-SPECIFIC TRANSCRIPTION	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; CHROMATIN CONFORMATION; ACTIVE CHROMATIN; SEX-CHROMOSOMES; GERM-CELLS; GENE; EXPRESSION; MOUSE; MICE; DNA	X chromosome inactivation occurs twice during the mammalian life cycle. In females one of the two X chromosomes of somatic nuclei is inactive, while in males the solitary X chromosome is inactivated during germ cell development. Despite the different properties of the inactivated chromosomes of females and males, the molecular initiation of inactivation may be the same. X inactive-specific transcripts, XIST, are produced from somatic inactivated X chromosomes. We demonstrate here the existence of XIST transcripts in testes of man and mouse. Inactivation of X chromosomes in males, as in females, may thus be mediated through XIST. Conceivably, the silencing of X-linked genes is the price paid for the evolution of successful mechanisms of chromosomal sex determination.	HEBREW UNIV JERUSALEM,DEPT GENET,IL-91904 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem				Soreq, Hermona/0000-0002-0955-526X				BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROSANI G, 1991, NATURE, V351, P325; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CHANDLEY AC, 1987, CYTOGENET CELL GENET, V44, P22, DOI 10.1159/000132336; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; DAVIES K, 1991, NATURE, V349, P15, DOI 10.1038/349015a0; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; FLETCHER JM, 1979, CHROMOSOMA, V72, P241, DOI 10.1007/BF00293237; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; HANNAH-ALAVA ALOHA, 1965, ADVANCE GENET, V13, P157, DOI 10.1016/S0065-2660(08)60049-8; HENDERSON SA, 1964, CHROMOSOMA, V15, P345, DOI 10.1007/BF00368137; HOTTA Y, 1982, GAMETE RES, V6, P65, DOI 10.1002/mrd.1120060108; HOTTA Y, 1979, CHROMOSOMA, V73, P287, DOI 10.1007/BF00288693; JABLONKA E, 1988, J THEOR BIOL, V133, P23, DOI 10.1016/S0022-5193(88)80022-5; KEREM BS, 1983, NATURE, V304, P88, DOI 10.1038/304088a0; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1989, PROG NUCLEIC ACID RE, V36, P119; MARTIN GR, 1982, CELL, V29, P721, DOI 10.1016/0092-8674(82)90432-9; MESSTHALER H, 1975, CARYOLOGIA, V28, P501, DOI 10.1080/00087114.1975.10796638; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; NUR U, 1981, CHROMOSOMA, V82, P353, DOI 10.1007/BF00285761; RICHLER C, 1989, CHROMOSOMA, V97, P465, DOI 10.1007/BF00295031; RICHLER C, 1987, CHROMOSOMA, V95, P167, DOI 10.1007/BF00330346; ROSENMANN A, 1985, CYTOGENET CELL GENET, V39, P19, DOI 10.1159/000132098; SCARBROUGH K, 1984, MOL CELL BIOL, V4, P599, DOI 10.1128/MCB.4.4.599; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; Tres L. L., 1981, Bioregulators of reproduction., P229; VENOLIA L, 1983, NATURE, V302, P82, DOI 10.1038/302082a0; VENOLIA L, 1984, CHROMOSOMA, V90, P185, DOI 10.1007/BF00292395; WEISBROD S, 1982, NATURE, V297, P289, DOI 10.1038/297289a0; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; 1992, LANCET, V339, P1328	35	139	139	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					192	195		10.1038/ng1192-192	http://dx.doi.org/10.1038/ng1192-192			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345167				2022-12-17	WOS:A1992JW16500007
J	Zapatka, M; Borozan, I; Brewer, DS; Iskar, M; Grundhoff, A; Alawi, M; Desai, N; Sultmann, H; Moch, H; Cooper, CS; Eils, R; Ferretti, V; Lichter, P				Zapatka, Marc; Borozan, Ivan; Brewer, Daniel S.; Iskar, Murat; Grundhoff, Adam; Alawi, Malik; Desai, Nikita; Sueltmann, Holger; Moch, Holger; Cooper, Colin S.; Eils, Roland; Ferretti, Vincent; Lichter, Peter		PCAWG Pathogens; PCAWG Consortium	The landscape of viral associations in human cancers	NATURE GENETICS			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; B-VIRUS INTEGRATION; RNA-SEQ DATA; HEPATOCELLULAR-CARCINOMA; HBV INTEGRATION; HPV; MUTAGENESIS; MUTATIONS; CELL; GENOMES	Viral pathogen load in cancer genomes is estimated through analysis of sequencing data from 2,656 tumors across 35 cancer types using multiple pathogen-detection pipelines, identifying viruses in 382 genomic and 68 transcriptome datasets. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, for which whole-genome and-for a subset-whole-transcriptome sequencing data from 2,658 cancers across 38 tumor types was aggregated, we systematically investigated potential viral pathogens using a consensus approach that integrated three independent pipelines. Viruses were detected in 382 genome and 68 transcriptome datasets. We found a high prevalence of known tumor-associated viruses such as Epstein-Barr virus (EBV), hepatitis B virus (HBV) and human papilloma virus (HPV; for example, HPV16 or HPV18). The study revealed significant exclusivity of HPV and driver mutations in head-and-neck cancer and the association of HPV with APOBEC mutational signatures, which suggests that impaired antiviral defense is a driving force in cervical, bladder and head-and-neck carcinoma. For HBV, HPV16, HPV18 and adeno-associated virus-2 (AAV2), viral integration was associated with local variations in genomic copy numbers. Integrations at the TERT promoter were associated with high telomerase expression evidently activating this tumor-driving process. High levels of endogenous retrovirus (ERV1) expression were linked to a worse survival outcome in patients with kidney cancer.	[Zapatka, Marc; Iskar, Murat; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Borozan, Ivan] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Brewer, Daniel S.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Brewer, Daniel S.; Cooper, Colin S.] Earlham Inst, Norwich, Norfolk, England; [Grundhoff, Adam; Alawi, Malik] Heinrich Pette Inst, Leibniz Inst Expt Virol, Hamburg, Germany; [Alawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Core, Hamburg, Germany; [Desai, Nikita] UCL, Dept Comp Sci, Bioinformat Grp, London, England; [Desai, Nikita] Francis Crick Inst, Biomed Data Sci Lab, London, England; [Sueltmann, Holger] German Canc Res Ctr, Div Canc Genome Res, Heidelberg, Germany; [Sueltmann, Holger] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Sueltmann, Holger; Lichter, Peter] German Canc Consortium DKTK, Heidelberg, Germany; [Moch, Holger] Univ & Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Cooper, Colin S.] Inst Canc Res, London, England; [Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Genom, Heidelberg, Germany; [Eils, Roland] BioQuant Ctr, Heidelberg, Germany; [Eils, Roland] Berlin Inst Hlth, Ctr Digital Hlth, Berlin, Germany; [Eils, Roland] Charite Univ Med Berlin, Berlin, Germany; [Ferretti, Vincent] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON, Canada; [Ferretti, Vincent] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); Ontario Institute for Cancer Research; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Francis Crick Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; University Zurich Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Universite de Montreal	Lichter, P (corresponding author), German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.; Lichter, P (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.	peter.lichter@dkfz-heidelberg.de	Eils, Roland/B-6121-2009; Zapatka, Marc/G-9896-2013; Fink, Lynn/C-2031-2008; Yakneen, Sergei/O-8928-2017; Tsunoda, Tatsuhiko/K-2061-2014; Brewer, Daniel/D-6201-2018	Eils, Roland/0000-0002-0034-4036; Zapatka, Marc/0000-0001-8287-5967; Fink, Lynn/0000-0003-2912-6048; Yakneen, Sergei/0000-0001-7827-9839; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Iskar, Murat/0000-0001-8603-4313; Aparicio, Samuel/0000-0002-0487-9599; Borozan, Ivan/0000-0002-3145-3550; Brewer, Daniel/0000-0003-4753-9794	Ontario Institute for Cancer Research (OICR) - government of Ontario; Leibniz Association [SAW-2015-IPB-2]; German Center for Infection Research [TTU 01.801]; German Federal Ministry of Education and Research (BMBF BioTop grant) [01EK1502C]; German Federal Ministry of Education and Research (ICGC-DE-Mining grant) [01KU1505A-G]; Cancer Research UK [C5047/A14835/A22530/A17528]; Dallaglio Foundation; Bob Champion Cancer Trust; Masonic Charitable Foundation; King Family; Stephen Hargrave Trust; Swiss National Science Foundation [S-87701-03-01]; BBSRC [BBS/E/T/000PR9818] Funding Source: UKRI	Ontario Institute for Cancer Research (OICR) - government of Ontario; Leibniz Association; German Center for Infection Research; German Federal Ministry of Education and Research (BMBF BioTop grant)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (ICGC-DE-Mining grant); Cancer Research UK(Cancer Research UK); Dallaglio Foundation; Bob Champion Cancer Trust; Masonic Charitable Foundation; King Family; Stephen Hargrave Trust; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the IT Core Facility at the DKFZ for technical assistance, M. Hain and R. Kabbe for computational support, S. Gerhardt for technical assistance with the validation experiments. We acknowledge the contributions of the many clinical networks across the ICGC and TCGA who provided samples and data to the PCAWG Consortium, and the contributions of the Technical Working Group and the Germline Working Group of the PCAWG Consortium for collation, realignment and harmonized variant calling of the cancer genomes used in this study. We thank the patients and their families for their participation in the individual ICGC and TCGA projects. V.F. and I.B. received support for their work from the Ontario Institute for Cancer Research (OICR) through funding provided by the government of Ontario. A.G. received support for his work from the Leibniz Association (grant number SAW-2015-IPB-2) and the German Center for Infection Research (grant number TTU 01.801). P.L. and A.G. received support for this work from the German Federal Ministry of Education and Research (BMBF BioTop grant number 01EK1502C, ICGC-DE-Mining grant number 01KU1505A-G). D.S.B. and C.S.C. received support from Cancer Research UK C5047/A14835/A22530/A17528, the Dallaglio Foundation, Bob Champion Cancer Trust, The Masonic Charitable Foundation successor to The Grand Charity, The King Family and the Stephen Hargrave Trust. H.M. was supported by a Swiss National Science Foundation grant (number S-87701-03-01).	Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bialecki ES, 2005, EUR J GASTROEN HEPAT, V17, P485, DOI 10.1097/00042737-200505000-00003; Borozan I, 2018, J VIROL, V92, DOI 10.1128/JVI.01239-17; Borozan I, 2016, BIOINFORMATICS, V32, P453, DOI 10.1093/bioinformatics/btv587; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Borozan I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-206; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Canisius S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1114-x; Cao S, 2016, SCI REP, V6; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eliassen E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00512; Fischer N, 2014, EMERG INFECT DIS, V20, P1072, DOI 10.3201/eid2006.131526; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Furuta Mayuko, 2018, Oncotarget, V9, P25075, DOI 10.18632/oncotarget.25308; Garcia-Martinez A, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0885-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hu Z, 2015, NAT GENET, V47, P158, DOI 10.1038/ng.3178; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kawai-Kitahata F, 2016, J GASTROENTEROL, V51, P473, DOI 10.1007/s00535-015-1126-4; Krug LT, 2014, CURR OPIN VIROL, V9, P170, DOI 10.1016/j.coviro.2014.10.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Li H., 2013, ARXIV13033997 Q BIO, P1303, DOI DOI 10.6084/M9.FIGSHARE.963153.V1; Li N, 2011, J INFECT DIS, V204, P217, DOI 10.1093/infdis/jir248; Li XJ, 2014, J HEPATOL, V60, P975, DOI 10.1016/j.jhep.2013.12.014; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nicoll MP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005539; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; Paces J, 2004, NUCLEIC ACIDS RES, V32, pD50, DOI 10.1093/nar/gkh075; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schlecht NF, 2007, J PATHOL, V213, P283, DOI 10.1002/path.2227; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shen CJ, 2017, J DRUG TARGET, V25, P637, DOI 10.1080/1061186X.2017.1307379; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Smith CC, 2018, J CLIN INVEST, V128, P4804, DOI 10.1172/JCI121476; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tang KW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0265; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Trave G, 2016, CELL CYCLE, V15, P2231, DOI 10.1080/15384101.2016.1191257; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wallace NA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006717; Wang QG, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0126-6; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Zhao LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13591; Zur Hausen H, 2001, ONCOGENE, V20, P7820, DOI 10.1038/sj.onc.1204958	73	138	138	8	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2020	52	3					320	+		10.1038/s41588-019-0558-9	http://dx.doi.org/10.1038/s41588-019-0558-9		FEB 2020	25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KS5DL	32025001	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-17	WOS:000511282900006
J	Angus, L; Smid, M; Wilting, SM; van Riet, J; Van Hoeck, A; Nguyen, L; Nik-Zainal, S; Steenbruggen, TG; Tjan-Heijnen, VCG; Labots, M; van Riel, JMGH; Bloemendal, HJ; Steeghs, N; Lolkema, MP; Voest, EE; van de Werken, HJG; Jager, A; Cuppen, E; Sleijfer, S; Martens, JWM				Angus, Lindsay; Smid, Marcel; Wilting, Saskia M.; van Riet, Job; Van Hoeck, Arne; Luan Nguyen; Nik-Zainal, Serena; Steenbruggen, Tessa G.; Tjan-Heijnen, Vivianne C. G.; Labots, Mariette; van Riel, Johanna M. G. H.; Bloemendal, Haiko J.; Steeghs, Neeltje; Lolkema, Martijn P.; Voest, Emile E.; van de Werken, Harmen J. G.; Jager, Agnes; Cuppen, Edwin; Sleijfer, Stefan; Martens, John W. M.			The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies	NATURE GENETICS			English	Article							EVOLUTION; VARIANTS; GERMLINE; PACKAGE; BRCA1	The whole-genome sequencing of prospectively collected tissue biopsies from 442 patients with metastatic breast cancer reveals that, compared to primary breast cancer, tumor mutational burden doubles, the relative contributions of mutational signatures shift and the mutation frequency of six known driver genes increases in metastatic breast cancer. Significant associations with pretreatment are also observed. The contribution of mutational signature 17 is significantly enriched in patients pretreated with fluorouracil, taxanes, platinum and/or eribulin, whereas the de novo mutational signature I identified in this study is significantly associated with pretreatment containing platinum-based chemotherapy. Clinically relevant subgroups of tumors are identified, exhibiting either homologous recombination deficiency (13%), high tumor mutational burden (11%) or specific alterations (24%) linked to sensitivity to FDA-approved drugs. This study provides insights into the biology of metastatic breast cancer and identifies clinically useful genomic features for the future improvement of patient management.	[Angus, Lindsay; Smid, Marcel; Wilting, Saskia M.; van Riet, Job; Lolkema, Martijn P.; Jager, Agnes; Sleijfer, Stefan; Martens, John W. M.] Erasmus Univ, Erasmus MC Canc Inst, Dept Med Oncol, Med Ctr, Rotterdam, Netherlands; [van Riet, Job; van de Werken, Harmen J. G.] Erasmus Univ, Canc Computat Biol Ctr, Erasmus MC Canc Inst, Med Ctr, Rotterdam, Netherlands; [van Riet, Job; van de Werken, Harmen J. G.] Erasmus MC Canc Inst, Univ Med Ctr, Dept Urol, Rotterdam, Netherlands; [Van Hoeck, Arne; Luan Nguyen; Cuppen, Edwin] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Van Hoeck, Arne; Luan Nguyen; Cuppen, Edwin] Univ Med Ctr Utrecht, Oncode Inst, Utrecht, Netherlands; [Nik-Zainal, Serena] Univ Cambridge, Clin Sch, Dept Med Genet, Cambridge, England; [Steenbruggen, Tessa G.; Steeghs, Neeltje; Voest, Emile E.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Tjan-Heijnen, Vivianne C. G.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Med Oncol, Med Ctr, Maastricht, Netherlands; [Labots, Mariette] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam UMC, Amsterdam, Netherlands; [van Riel, Johanna M. G. H.] Elisabeth TweeSteden Hosp, Dept Internal Med, Tilburg, Netherlands; [Bloemendal, Haiko J.] Meander Med Ctr, Dept Med Oncol, Amersfoort, Netherlands; [Bloemendal, Haiko J.; Steeghs, Neeltje; Lolkema, Martijn P.; Voest, Emile E.; Sleijfer, Stefan; Martens, John W. M.] Ctr Personalized Canc Treatment, Rotterdam, Netherlands; [Cuppen, Edwin] Hartwig Med Fdn, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cambridge; Netherlands Cancer Institute; Maastricht University; University of Amsterdam; Vrije Universiteit Amsterdam; Elisabeth-TweeSteden Ziekenhuis (ETZ); Meander Medisch Centrum	Martens, JWM (corresponding author), Erasmus Univ, Erasmus MC Canc Inst, Dept Med Oncol, Med Ctr, Rotterdam, Netherlands.; Martens, JWM (corresponding author), Ctr Personalized Canc Treatment, Rotterdam, Netherlands.	j.martens@erasmusmc.nl	Lolkema, M.P./AAE-2906-2019; Nguyen, Luan/GYA-2927-2022; Werken, Harmen van de/G-8979-2013; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; jager, agnes/V-6381-2017; Steeghs, Neeltje/GQH-3468-2022; Nik-Zainal, Serena/ABD-4437-2020	Lolkema, M.P./0000-0003-0466-2928; Werken, Harmen van de/0000-0002-9794-1477; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; jager, agnes/0000-0002-7713-1450; Van Hoeck, Arne/0000-0002-6570-1452; van Riet, Job/0000-0001-7767-7923; Angus, Lindsay/0000-0002-7928-1102; Bloemendal, Haiko/0000-0002-8902-4337; Nik-Zainal, Serena/0000-0001-5054-1727; Smid, Marcel/0000-0003-0605-1901	Barcode for Life; Stichting Hetty Odink [R3545]; Pink Ribbon Foundation [204-184]; CZ healthcare insurance [CZ-201300460]; Cancer Genomics Netherlands through the Netherlands Organization of Scientific Research; Daniel den Hoed Foundation	Barcode for Life; Stichting Hetty Odink; Pink Ribbon Foundation; CZ healthcare insurance; Cancer Genomics Netherlands through the Netherlands Organization of Scientific Research; Daniel den Hoed Foundation	We thank Barcode for Life and Stichting Hetty Odink (no. R3545) for the financial support of the clinical studies and WGS analyses. This publication and the underlying study have been made possible partly by the data that the Hartwig Medical Foundation and CPCT have made available to the study. We would like to thank all local principal investigators and medical specialists, and the nurses of all contributing centers for their help with patient recruitment. We are particularly grateful to all participating patients and their families. This work was supported in parts by grants from the Pink Ribbon Foundation (no. 204-184) and CZ healthcare insurance (no. CZ-201300460). M.S. was supported by Cancer Genomics Netherlands through a grant from the Netherlands Organization of Scientific Research. H.V.D.W., J.V.R. and the Erasmus MC Cancer Computational Biology Center were financed through a grant from the Daniel den Hoed Foundation.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Boot A, 2018, GENOME RES, V28, P654, DOI 10.1101/gr.230219.117; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brown D, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14944, 10.1038/ncomms15759]; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Fumagalli D, 2016, ANN ONCOL, V27, P1860, DOI 10.1093/annonc/mdw286; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gel B, 2017, BIOINFORMATICS, V33, P3088, DOI 10.1093/bioinformatics/btx346; Griffith M, 2017, NAT GENET, V49, P170, DOI 10.1038/ng.3774; Hahsler M, 2008, J STAT SOFTW, V25, P1; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Huang MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13321; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; LEHMANN EL, 1963, ANN MATH STAT, V34, P1507, DOI 10.1214/aoms/1177703882; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Martincorena I, 2018, CELL, V173, P1823, DOI 10.1016/j.cell.2018.06.001; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Ng CKY, 2017, CLIN CANCER RES, V23, P4402, DOI 10.1158/1078-0432.CCR-16-3115; Nik-Zainal S, 2017, CLIN CANCER RES, V23, P2617, DOI 10.1158/1078-0432.CCR-16-2810; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pitt JJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06616-0; Priestley P, NATURE; Ramalingam SS, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-CT078; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Savas P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002204; Schrijver WAME, 2018, CANCER RES, V78, P3112, DOI 10.1158/0008-5472.CAN-17-2310; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Smid M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12910; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Tamborero D, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0531-8; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005	49	138	140	1	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2019	51	10					1450	+		10.1038/s41588-019-0507-7	http://dx.doi.org/10.1038/s41588-019-0507-7			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC1CP	31570896	Green Accepted			2022-12-17	WOS:000489016400009
J	Dixon, JR; Xu, J; Dileep, V; Zhan, Y; Songs, F; Le, VT; Yardimci, GA; Chakraborty, A; Bann, DV; Wang, YL; Clark, R; Zhang, LJ; Yang, HB; Liu, TT; Iyyanki, S; An, L; Pool, C; Sasaki, T; Rivera-Mulia, JC; Ozadam, H; Lajoie, BR; Kaul, R; Buckley, M; Lee, K; Diegell, M; Pezic, D; Ernst, C; Hadjur, S; Odom, DT; Stamatoyannopoulos, JA; Broach, JR; Hardison, RC; Ay, F; Noble, WS; Dekker, J; Gilbert, DM; Yue, F				Dixon, Jesse R.; Xu, Jie; Dileep, Vishnu; Zhan, Ye; Songs, Fan; Le, Victoria T.; Yardimci, Galip Airkan; Chakraborty, Abhijit; Bann, Darrin, V; Wang, Yanli; Clark, Royden; Zhang, Lijun; Yang, Hongbo; Liu, Tingting; Iyyanki, Sriranga; An, Lin; Pool, Christopher; Sasaki, Takayo; Rivera-Mulia, Juan Carlos; Ozadam, Hakan; Lajoie, Bryan R.; Kaul, Rajinder; Buckley, Michael; Lee, Kristen; Diegell, Morgan; Pezic, Dubravka; Ernst, Christina; Hadjur, Suzana; Odom, Duncan T.; Stamatoyannopoulos, John A.; Broach, James R.; Hardison, Ross C.; Ay, Ferhat; Noble, William Stafford; Dekker, Job; Gilbert, David M.; Yue, Feng			Integrative detection and analysis of structural variation in cancer genomes	NATURE GENETICS			English	Article							COPY NUMBER; CELL-LINES; CHROMOSOMAL REARRANGEMENTS; ANALYSIS REVEALS; HI-C; WHOLE-GENOME; GENE; IDENTIFICATION; DOMAINS; PATTERNS	Structural variants (SVs) can contribute to oncogenesis through a variety of mechanisms. Despite their importance, the identification of SVs in cancer genomes remains challenging. Here, we present a framework that integrates optical mapping, high-throughput chromosome conformation capture (Hi-C), and whole-genome sequencing to systematically detect SVs in a variety of normal or cancer samples and cell lines. We identify the unique strengths of each method and demonstrate that only integrative approaches can comprehensively identify SVs in the genome. By combining Hi-C and optical mapping, we resolve complex SVs and phase multiple SV events to a single haplotype. Furthermore, we observe widespread structural variation events affecting the functions of noncoding sequences, including the deletion of distal regulatory sequences, alteration of DNA replication timing, and the creation of novel three-dimensional chromatin structural domains. Our results indicate that noncoding SVs may be underappreciated mutational drivers in cancer genomes.	[Dixon, Jesse R.; Le, Victoria T.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Xu, Jie; Zhang, Lijun; Liu, Tingting; Iyyanki, Sriranga; Broach, James R.; Yue, Feng] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Dileep, Vishnu; Sasaki, Takayo; Rivera-Mulia, Juan Carlos; Gilbert, David M.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Zhan, Ye; Ozadam, Hakan; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01655 USA; [Songs, Fan; Wang, Yanli; An, Lin; Yue, Feng] Penn State Univ, Bioinformat & Genom Program, State Coll, PA 16801 USA; [Yardimci, Galip Airkan; Noble, William Stafford] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chakraborty, Abhijit; Ay, Ferhat] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Bann, Darrin, V; Pool, Christopher] Milton S Hershey Med Ctr, Div Otolaryngol Head & Neck Surg, Hershey, PA USA; [Clark, Royden] Penn State Coll Med Informat & Technol, Hershey, PA USA; [Kaul, Rajinder; Buckley, Michael; Lee, Kristen; Diegell, Morgan; Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA USA; [Pezic, Dubravka; Hadjur, Suzana] UCL, Canc Inst, Res Dept Canc Biol, London, England; [Yang, Hongbo; Ernst, Christina; Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Odom, Duncan T.] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Huck Inst Life Sci, State Coll, PA USA; [Ay, Ferhat] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Dekker, Job] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Salk Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University System of Florida; Florida State University; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Washington; University of Washington Seattle; La Jolla Institute for Immunology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of London; University College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of California System; University of California San Diego; Howard Hughes Medical Institute	Dixon, JR (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Yue, F (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Gilbert, DM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01655 USA.; Yue, F (corresponding author), Penn State Univ, Bioinformat & Genom Program, State Coll, PA 16801 USA.; Noble, WS (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Ay, F (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.; Ay, F (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.; Dekker, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	jedixon@salk.edu; ferhatay@lji.org; william-noble@uw.edu; job.dekker@umassmed.edu; gilbert@bio.fsu.edu; fyue@hmc.psu.edu	Dixon, Jesse/AAT-2914-2020; Ernst, Christina/L-3907-2019; Bann, Darrin/ABI-6703-2020; Dileep, Vishnu/S-1328-2018; XU, JIE/GPG-0294-2022; Hardison, Ross C/G-1142-2010; Pool, Christopher/K-1467-2019; Ay, Ferhat/J-7800-2019	Dixon, Jesse/0000-0002-6273-2181; Ernst, Christina/0000-0002-3569-2209; Dileep, Vishnu/0000-0001-9181-2191; Hardison, Ross C/0000-0003-4084-7516; Ay, Ferhat/0000-0002-0708-6914; Pool, Christopher/0000-0002-6566-8883; Yue, Feng/0000-0002-7954-5462; Zhan, Ye/0000-0001-9280-1718; Bann, Darrin/0000-0002-0246-4912; Rivera-Mulia, Juan Carlos/0000-0002-7566-3875; Odom, Duncan/0000-0001-6201-5599; Kaul, Rajinder/0000-0002-7895-9284; An, Lin/0000-0002-8313-0796	NIH [R35GM124820, R01HG009906, U01CA200060, R24DK106766, GM083337, GM085354, DK107965, U54HG004592, HG003143, DK107980, U41HG007000, DP5OD023071]; European Research Council [615584]; Cancer Research UK [20412, 22398]; Wellcome Trust [84459, 106985/ Z/15/Z]; Leona M. and Harry B. Helmsley Charitable Trust grant [2017-PG-MED001]; Institute Leadership Funds from La Jolla Institute for Allergy and Immunology; Leukemia Research Foundation; Penn State Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [U01CA200060] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009906, U41HG007000, R01HG003143, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980, R24DK106766, U54DK107965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124820, R01GM083337, P01GM085354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD023071] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Leona M. and Harry B. Helmsley Charitable Trust grant; Institute Leadership Funds from La Jolla Institute for Allergy and Immunology; Leukemia Research Foundation; Penn State Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R35GM124820, R01HG009906, and U01CA200060 (F.Y.), R24DK106766 (R.C.H. and F.Y.), GM083337 (D.M.G.), GM085354 (D.M.G.), DK107965 (D.M.G.), U54HG004592 (J.D. and J.A.S.), HG003143 and DK107980(J.D.), U41HG007000 (W.S.N.), and DP5OD023071 (J.D.). This work was also supported by European Research Council (No. 615584 to D.T.O. and C.E.), Cancer Research UK (Nos. 20412 and 22398 to D.T.O. and C.E.), Wellcome Trust (No. 84459 to D.T.O. and C.E.), and Wellcome Trust (No. 106985/ Z/15/Z to S.H.). J.D. is an investigator of the Howard Hughes Medical Institute. J.R.D. is also supported by the Leona M. and Harry B. Helmsley Charitable Trust grant No. 2017-PG-MED001. F.A. was supported by Institute Leadership Funds from La Jolla Institute for Allergy and Immunology. F.Y. is also supported by the Leukemia Research Foundation and Penn State Clinical and Translational Science Institute. We thank the ENCODE Data Coordination Center for helping with Hi-C and replication time data deposition. We would also like to thank Jan Karlseder and Nausica Arnault for help with the FISH experiments.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Barutcu AR, 2016, BBA-GENE REGUL MECH, V1859, P1389, DOI 10.1016/j.bbagrm.2016.08.003; Barutcu AR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0768-0; Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Benelli M, 2012, BIOINFORMATICS, V28, P3232, DOI 10.1093/bioinformatics/bts617; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chakraborty A, 2018, BIOINFORMATICS, V34, P338, DOI 10.1093/bioinformatics/btx664; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; DEILEEP V, 2015, COLD SPRING HARB PER, V80, P53; Dileep V, 2015, GENOME RES, V25, P1104, DOI 10.1101/gr.183699.114; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Engreitz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044196; Espino PS, 2009, INT J CANCER, V124, P562, DOI 10.1002/ijc.23959; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Haas B, 2017, STAR FUSION FAST ACC; Hampton OA, 2011, CANCER GENET-NY, V204, P447, DOI 10.1016/j.cancergen.2011.07.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harewood L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1253-8; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu J, 2004, ONCOGENE, V23, P6316, DOI 10.1038/sj.onc.1207795; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marchal C, 2018, NAT PROTOC, V13, P819, DOI 10.1038/nprot.2017.148; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Naumann S, 2001, LEUKEMIA RES, V25, P313, DOI 10.1016/S0145-2126(00)00125-9; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Peng Kun-Jing, 2010, Zoological Research, V31, P113, DOI 10.3724/SP.J.1141.2010.02113; Pope BD, 2012, HUM MOL GENET, V21, P4162, DOI 10.1093/hmg/dds232; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; RHIND N, 2013, COLD SPRING HARB PER, V5; Rivera-Mulia JC, 2015, GENOME RES, V25, P1091, DOI 10.1101/gr.187989.114; Rondon-Lagos M, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-8; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Ryba T, 2012, GENOME RES, V22, P1833, DOI 10.1101/gr.138511.112; Seaman L, 2017, MOL CANCER RES, V15, P821, DOI 10.1158/1541-7786.MCR-16-0374; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Sirivatanauksorn V, 2001, INT J CANCER, V91, P350, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Strefford JC, 2005, CANCER GENET CYTOGEN, V159, P1, DOI 10.1016/j.cancergencyto.2004.09.020; Struski S, 2001, GENE CHROMOSOME CANC, V30, P136, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1071>3.0.CO;2-T; Taberlay PC, 2016, GENOME RES, V26, P719, DOI 10.1101/gr.201517.115; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Wan TSK, 2014, ANN LAB MED, V34, P413, DOI 10.3343/alm.2014.34.6.413; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Wu HJ, 2016, BIOINFORMATICS, V32, P3695, DOI 10.1093/bioinformatics/btw540; Xu H, 2016, MOL CANCER RES, V14, P163, DOI 10.1158/1541-7786.MCR-15-0313; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang J, 2016, GENOME RES, V26, P108, DOI 10.1101/gr.186114.114	74	138	142	4	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2018	50	10					1388	+		10.1038/s41588-018-0195-8	http://dx.doi.org/10.1038/s41588-018-0195-8			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV4DF	30202056	Green Accepted, Green Submitted			2022-12-17	WOS:000446047000011
J	Zhao, W; Rasheed, A; Tikkanen, E; Lee, JJ; Butterworth, AS; Howson, JMM; Assimes, TL; Chowdhury, R; Orho-Melander, M; Damrauer, S; Small, A; Asma, S; Imamura, M; Yamauch, T; Chambers, JC; Chen, P; Sapkota, BR; Shah, N; Jabeen, S; Surendran, P; Lu, YC; Zhang, WH; Imran, A; Abbas, S; Majeed, F; Trindade, K; Qamar, N; Mallick, NH; Yaqoob, Z; Saghir, T; Rizvi, SNH; Memon, A; Rasheed, SZ; Memon, FUR; Mehmood, K; Ahmed, N; Qureshi, IH; Tanveer-us-Salam; Iqbal, W; Malik, U; Mehra, N; Kuo, JZ; Sheu, WHH; Guo, XQ; Hsiung, CA; Juang, JMJ; Taylor, KD; Hung, YJ; Lee, WJ; Quertermous, T; Lee, IT; Hsu, CC; Bottinger, EP; Ralhan, S; Teo, YY; Wang, TD; Alam, DS; Di Angelantonio, E; Epstein, S; Nielsen, SF; Nordestgaard, BG; Tybjaerg-Hansen, A; Young, R; Benn, M; Frikke-Schmidt, R; Kamstrup, PR; Biobank, M; Jukema, JW; Sattar, N; Smit, R; Chung, RH; Liang, KW; Anand, S; Sanghera, DK; Ripatti, S; Loos, RJF; Kooner, JS; Tai, ES; Rotter, JI; Chen, YDI; Frossard, P; Maeda, S; Kadowaki, T; Reilly, M; Pare, G; Melander, O; Salomaa, V; Rader, DJ; Danesh, J; Voight, BF; Saleheen, D				Zhao, Wei; Rasheed, Asif; Tikkanen, Emmi; Lee, Jung-Jin; Butterworth, Adam S.; Howson, Joanna M. M.; Assimes, Themistocles L.; Chowdhury, Rajiv; Orho-Melander, Marju; Damrauer, Scott; Small, Aeron; Asma, Senay; Imamura, Minako; Yamauch, Toshimasa; Chambers, John C.; Chen, Peng; Sapkota, Bishwa R.; Shah, Nabi; Jabeen, Sehrish; Surendran, Praveen; Lu, Yingchang; Zhang, Weihua; Imran, Atif; Abbas, Shahid; Majeed, Faisal; Trindade, Kevin; Qamar, Nadeem; Mallick, Nadeem Hayyat; Yaqoob, Zia; Saghir, Tahir; Rizvi, Syed Nadeem Hasan; Memon, Anis; Rasheed, Syed Zahed; Memon, Fazal-ur-Rehman; Mehmood, Khalid; Ahmed, Naveeduddin; Qureshi, Irshad Hussain; Tanveer-us-Salam; Iqbal, Wasim; Malik, Uzma; Mehra, Narinder; Kuo, Jane Z.; Sheu, Wayne H-H; Guo, Xiuqing; Hsiung, Chao A.; Juang, Jyh-Ming J.; Taylor, Kent D.; Hung, Yi-Jen; Lee, Wen-Jane; Quertermous, Thomas; Lee, I-Te; Hsu, Chih-Cheng; Bottinger, Erwin P.; Ralhan, Sarju; Teo, Yik Ying; Wang, Tzung-Dau; Alam, Dewan S.; Di Angelantonio, Emanuele; Epstein, Steve; Nielsen, Sune F.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne; Young, Robin; Benn, Marianne; Frikke-Schmidt, Ruth; Kamstrup, Pia R.; Biobank, Michigan; Jukema, J. Wouter; Sattar, Naveed; Smit, Roelof; Chung, Ren-Hua; Liang, Kae-Woei; Anand, Sonia; Sanghera, Dharambir K.; Ripatti, Samuli; Loos, Ruth J. F.; Kooner, Jaspal S.; Tai, E. Shyong; Rotter, Jerome I.; Chen, Yii-Der Ida; Frossard, Philippe; Maeda, Shiro; Kadowaki, Takashi; Reilly, Muredach; Pare, Guillaume; Melander, Olle; Salomaa, Veikko; Rader, Daniel J.; Danesh, John; Voight, Benjamin F.; Saleheen, Danish		CHD Exome Consortium; EPIC-CVD Consortium; EPIC-Interact Consortium	Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease	NATURE GENETICS			English	Article							ACID-BINDING PROTEIN; GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; ARTERY-DISEASE; GENETIC ARCHITECTURE; METAANALYSIS; VARIANTS; RISK; AP2; ATHEROSCLEROSIS	To evaluate the shared genetic etiology of type 2 diabetes (T2D) and coronary heart disease (CHD), we conducted a genome-wide, multi-ancestry study of genetic variation for both diseases in up to 265,678 subjects for T2D and 260,365 subjects for CHD. We identify 16 previously unreported loci for T2D and 1 locus for CHD, including a new T2D association at a missense variant in HLA-DRB5 (odds ratio (OR) = 1.29). We show that genetically mediated increase in T2D risk also confers higher CHD risk. Joint T2D-CHD analysis identified eight variants-two of which are coding-where T2D and CHD associations appear to colocalize, including a new joint T2D-CHD association at the CCDC92 locus that also replicated for T2D. The variants associated with both outcomes implicate new pathways as well as targets of existing drugs, including icosapent ethyl and adipocyte fatty-acid-binding protein.	[Zhao, Wei; Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Zhao, Wei; Lee, Jung-Jin; Trindade, Kevin; Rader, Daniel J.; Saleheen, Danish] Univ Penn, Dept Med, Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Rasheed, Asif; Shah, Nabi; Jabeen, Sehrish; Imran, Atif; Majeed, Faisal; Frossard, Philippe; Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Tikkanen, Emmi; Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tikkanen, Emmi; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Butterworth, Adam S.; Howson, Joanna M. M.; Chowdhury, Rajiv; Surendran, Praveen; Di Angelantonio, Emanuele; Young, Robin; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Orho-Melander, Marju; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Damrauer, Scott] Univ Penn, Dept Surg, Div Vasc Surg & Endovasc Therapy, Philadelphia, PA 19104 USA; [Small, Aeron; Rader, Daniel J.; Voight, Benjamin F.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Asma, Senay] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Imamura, Minako; Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Imamura, Minako; Maeda, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom, Nishihara, Okinawa, Japan; [Imamura, Minako; Maeda, Shiro] Univ Ryukyus, Grad Sch Med, Lab Med, Nishihara, Okinawa, Japan; [Imamura, Minako; Maeda, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Nishihara, Okinawa, Japan; [Yamauch, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Chambers, John C.; Zhang, Weihua; Kooner, Jaspal S.] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Chambers, John C.; Zhang, Weihua] Ealing Hosp NHS Trust, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chen, Peng; Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Chen, Peng; Teo, Yik Ying] Natl Univ Hlth Syst, Singapore, Singapore; [Sapkota, Bishwa R.; Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Pediat, Oklahoma City, OK 73190 USA; [Shah, Nabi] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan; [Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Lu, Yingchang; Loos, Ruth J. F.] Vanderbilt Univ, Sch Med, Div Epidemiol, Dep Med,Vanderbilt Ingram Canc Ctr,Vanderbilt Epi, Nashville, TN 37212 USA; [Abbas, Shahid] Faisalabad Inst Cardiol, Faisalabad, Pakistan; [Qamar, Nadeem; Yaqoob, Zia; Saghir, Tahir; Rizvi, Syed Nadeem Hasan; Memon, Anis] Natl Inst Cardiovasc Disorders, Karachi, Pakistan; [Mallick, Nadeem Hayyat] Punjab Inst Cardiol, Lahore, Pakistan; [Rasheed, Syed Zahed] Karachi Inst Heart Dis, Karachi, Pakistan; [Memon, Fazal-ur-Rehman] Red Crescent Inst Cardiol, Hyderabad, Pakistan; [Mehmood, Khalid] Civil Hosp, Dept Med, Karachi, Pakistan; [Ahmed, Naveeduddin] Liaquat Natl Hosp, Dept Neurol, Karachi, Pakistan; [Qureshi, Irshad Hussain; Malik, Uzma] Mayo Hosp, Dept Med, Lahore, Pakistan; [Qureshi, Irshad Hussain; Malik, Uzma] King Edward Med Univ, Lahore, Pakistan; [Tanveer-us-Salam; Iqbal, Wasim] Lahore Gen Hosp, Dept Neurol, Lahore, Pakistan; [Mehra, Narinder] All India Inst Med Sci, New Delhi, India; [Kuo, Jane Z.] CardioDx Inc, Clin & Med Affairs, Redwood City, CA USA; [Kuo, Jane Z.; Guo, Xiuqing; Taylor, Kent D.; Rotter, Jerome I.; Chen, Yii-Der Ida] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Kuo, Jane Z.; Guo, Xiuqing; Taylor, Kent D.; Rotter, Jerome I.; Chen, Yii-Der Ida] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90509 USA; [Sheu, Wayne H-H; Lee, I-Te] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrine & Metab, Taichung, Taiwan; [Sheu, Wayne H-H; Lee, I-Te] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Sheu, Wayne H-H; Lee, I-Te] Chung Shan Med Univ, Taichung, Taiwan; [Hsiung, Chao A.; Hsu, Chih-Cheng; Chung, Ren-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Juang, Jyh-Ming J.; Wang, Tzung-Dau] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Cardiovasc Ctr, Taipei, Taiwan; [Juang, Jyh-Ming J.; Wang, Tzung-Dau] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Div Cardiol,Dept Internal Med, Taipei, Taiwan; [Hung, Yi-Jen] Natl Def Med Ctr, Tri Serv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan; [Lee, Wen-Jane] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Ralhan, Sarju] Hero DMC Heart Inst Ludhiana, Ludhiana 43HERO, Punjab, India; [Teo, Yik Ying] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Teo, Yik Ying] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Life Sci Inst, Singapore, Singapore; [Alam, Dewan S.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Epstein, Steve] MedStar Washington Hosp Ctr, MedStar Heart & Vasc Inst, Washington, DC USA; [Nielsen, Sune F.] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne; Kamstrup, Pia R.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne; Frikke-Schmidt, Ruth] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark; [Benn, Marianne; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst, Utrecht, Netherlands; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Smit, Roelof] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Liang, Kae-Woei] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan; [Anand, Sonia] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Sanghera, Dharambir K.] Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Ripatti, Samuli; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Human Genet, Wellcome Trust Genome Campus, Hinxton, England; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Reilly, Muredach] Columbia Univ, Dept Med, Div Cardiol, New York, NY USA; [Reilly, Muredach] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY USA; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Melander, Olle] Lund Univ, Dept Clin Sci, Hypertens & Cardiovasc Dis, Malmo, Sweden; [Danesh, John] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Danesh, John] Univ Cambridge, NIHR, Blood & Transplant Res Unit Donor Hlth & Genom, Cambridge, England; [Voight, Benjamin F.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Helsinki; University of Helsinki; University of Cambridge; Stanford University; Lund University; University of Pennsylvania; University of Pennsylvania; McMaster University; RIKEN; University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; University of Tokyo; Imperial College London; Imperial College London; National University of Singapore; National University of Singapore; University of Oklahoma System; University of Oklahoma Health Sciences Center; COMSATS University Islamabad (CUI); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Vanderbilt University; Dow University of Health Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Tri-Service General Hospital; Taichung Veterans General Hospital; Dayanand Medical College & Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; International Centre for Diarrhoeal Disease Research (ICDDR); MedStar Washington Hospital Center; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Taichung Veterans General Hospital; McMaster University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; National University of Singapore; Columbia University; Columbia University; McMaster University; Lund University; Wellcome Trust Sanger Institute; University of Cambridge; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Saleheen, D (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.; Saleheen, D (corresponding author), Univ Penn, Dept Med, Translat Med & Human Genet, Philadelphia, PA 19104 USA.; Saleheen, D (corresponding author), Ctr Noncommunicable Dis, Karachi, Pakistan.; Voight, BF (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.; Voight, BF (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Voight, BF (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	bvoight@upenn.edu; saleheen@mail.med.upenn.edu	Loos, Ruth/GON-5877-2022; Shah, Nabi/Q-1008-2016; Rotter, Jerome/AAY-6598-2021; Asma, Senay/Y-5239-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Shah, Nabi/AAG-7378-2021; Loos, Ruth J F/Q-2862-2016; DiAngelantonio, Emanuele/ABE-6852-2020; Chowdhury, Rajiv/AHB-1253-2022; zhang, weihua/GXV-1334-2022; Pare, Guillaume/T-9631-2018; Assimes, Themistocles Leonard/D-9696-2015; Chung, Ren-Hua/AAB-8364-2019; Asma, Senay/AAG-6324-2021; Jukema, J. Wouter/ABD-6503-2021; Jabeen, Sehrish/AAH-4233-2019; Benn, Marianne/O-4164-2019	Shah, Nabi/0000-0003-2764-3615; Shah, Nabi/0000-0003-2764-3615; Loos, Ruth J F/0000-0002-8532-5087; Pare, Guillaume/0000-0002-6795-4760; Assimes, Themistocles Leonard/0000-0003-2349-0009; Asma, Senay/0000-0002-2665-3494; Jukema, J. Wouter/0000-0002-3246-8359; Benn, Marianne/0000-0002-1701-595X; WANG, TZUNG-DAU/0000-0002-7180-3607; Reilly, Muredach/0000-0002-3035-9386; Di Angelantonio, Emanuele/0000-0001-8776-6719; Zhao, Wei/0000-0002-8301-9297; Melander, Olle/0000-0002-2581-484X; Sanghera, Dharambir/0000-0001-7203-8655; Butterworth, Adam/0000-0002-6915-9015; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636; Howson, Joanna/0000-0001-7618-0050; Voight, Benjamin/0000-0002-6205-9994; Lee, I-Te/0000-0003-2665-3635; Quertermous, Thomas/0000-0002-7645-9067; Damrauer, Scott/0000-0001-8009-1632; Nordestgaard, Borge/0000-0002-1954-7220; Tai, E Shyong/0000-0003-2929-8966; Frikke-Schmidt, Ruth/0000-0003-4084-5027	NHLBI; NINDS; Pfizer; Regeneron Pharmaceuticals; Genentech; Eli Lilly; Wellcome Trust, UK; NIH [RC2HL101834, RC1TW008485]; Fogarty International [RC1TW008485, R21NS064908]; NINDS [R21NS064908]; Center for Non-Communicable Diseases (Karachi, Pakistan); American Heart Association [13SDG14330006]; NIH/NIDDK [R01DK101478]; W.W. Smith Charitable Trust [H1201]; Finnish Foundation for Cardiovascular Research; Academy of Finland [251217, 255847]; Center of Excellence in Complex Disease Genetics; European Union's Seventh Framework Programme project ENGAGE [201413]; European Union's Seventh Framework Programme project BioSHaRE [261433]; Sigrid Juselius Foundation; Biocentrum Helsink; Andrea and Charles Bronfman Philanthropies; Canada Research Chair in Ethnic Diversity; Heart and Stroke Michael G. DeGroote Chair in Population Health, McMaster University; Leading Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; UK Medical Research Council [G0800270]; British Heart Foundation [SP/09/002]; UK NIHR Cambridge Biomedical Research Centre; European Research Council [268834]; European Commission's Framework Programme 7 [HEALTH-F2-2012-279233]; Merck; European Union's Seventh Framework Programme (FP7) [HEALTH-F2-2009-223004]; CVD; MRC [MR/P013880/1, MR/P02811X/1, MR/L003120/1, G0800270] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [RC1TW008485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK101478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064908] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067, RG/16/4/32218] Funding Source: researchfish; Medical Research Council [G0800270, MR/P02811X/1, MR/P013880/1, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005339, NNF17OC0026936, NNF14OC0009819] Funding Source: researchfish	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pfizer(Pfizer); Regeneron Pharmaceuticals(Regeneron); Genentech(Roche HoldingGenentech); Eli Lilly(Eli Lilly); Wellcome Trust, UK(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Non-Communicable Diseases (Karachi, Pakistan); American Heart Association(American Heart Association); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); W.W. Smith Charitable Trust; Finnish Foundation for Cardiovascular Research; Academy of Finland(Academy of Finland); Center of Excellence in Complex Disease Genetics(Academy of Finland); European Union's Seventh Framework Programme project ENGAGE; European Union's Seventh Framework Programme project BioSHaRE; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsink; Andrea and Charles Bronfman Philanthropies; Canada Research Chair in Ethnic Diversity; Heart and Stroke Michael G. DeGroote Chair in Population Health, McMaster University; Leading Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); UK NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); European Commission's Framework Programme 7; Merck(Merck & Company); European Union's Seventh Framework Programme (FP7); CVD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	D.S. has received support from NHLBI, NINDS, Pfizer, Regeneron Pharmaceuticals, Genentech, and Eli Lilly. Genotyping in PROMIS was funded by the Wellcome Trust, UK, and Pfizer. Biomarker assays in PROMIS have been funded through grants awarded by the NIH (RC2HL101834 and RC1TW008485) and Fogarty International (RC1TW008485). The RACE study has been funded by NINDS (R21NS064908), Fogarty International (R21NS064908), and the Center for Non-Communicable Diseases (Karachi, Pakistan). B.F.V. was supported by funding from the American Heart Association (13SDG14330006), the W.W. Smith Charitable Trust (H1201), and the NIH/NIDDK (R01DK101478). J.D. is a British Heart Foundation Professor, European Research Council Senior Investigator, and NIHR Senior Investigator. V.S. was supported by the Finnish Foundation for Cardiovascular Research. S. Ripatti was supported by the Academy of Finland (251217 and 255847), the Center of Excellence in Complex Disease Genetics, the European Union's Seventh Framework Programme projects ENGAGE (201413) and BioSHaRE (261433), the Finnish Foundation for Cardiovascular Research, Biocentrum Helsinki, and the Sigrid Juselius Foundation. The Mount Sinai IPM Biobank Program is supported by the Andrea and Charles Bronfman Philanthropies. S. Anand is supported by grants from the Canada Research Chair in Ethnic Diversity and CVD and from the Heart and Stroke Michael G. DeGroote Chair in Population Health, McMaster University. Data contributed by Biobank Japan were partly supported by a grant from the Leading Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank the participants and staff of the Copenhagen Ischemic Heart Disease Study and the Copenhagen General Population Study for their important contributions. The CHD Exome+ Consortium was funded by the UK Medical Research Council (G0800270), the British Heart Foundation (SP/09/002), the UK NIHR Cambridge Biomedical Research Centre, the European Research Council (268834), the European Commission's Framework Programme 7 (HEALTH-F2-2012-279233), Merck, and Pfizer. PROSPER has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement HEALTH-F2-2009-223004.	Ahmad OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8060; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ballantyne CM, 2015, J CLIN LIPIDOL, V9, P377, DOI 10.1016/j.jacl.2014.11.009; Ballantyne CM, 2012, AM J CARDIOL, V110, P984, DOI 10.1016/j.amjcard.2012.05.031; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burak MF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6336; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Evans DM, 2015, ANNU REV GENOM HUM G, V16, P327, DOI 10.1146/annurev-genom-090314-050016; Fall T, 2015, DIABETES, V64, P2676, DOI 10.2337/db14-1710; Feng S, 2014, BIOINFORMATICS, V30, P2828, DOI 10.1093/bioinformatics/btu367; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Grimbert P, 2003, J EXP MED, V198, P797, DOI 10.1084/jem.20030566; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jansen H, 2015, ATHEROSCLEROSIS, V241, P419, DOI 10.1016/j.atherosclerosis.2015.05.033; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ross S, 2015, EUR HEART J, V36, P1454, DOI 10.1093/eurheartj/ehv083; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Saleheen D, 2009, EUR J EPIDEMIOL, V24, P329, DOI 10.1007/s10654-009-9334-y; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schmidt AF, 2017, LANCET DIABETES ENDO, V5, P97, DOI 10.1016/S2213-8587(16)30396-5; Scott RA., 2017, DIABETES, V66, P2888; Scott RA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3744; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Suzuki M, 2015, GEN COMP ENDOCR, V216, P86, DOI 10.1016/j.ygcen.2015.03.009; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	54	138	142	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2017	49	10					1450	+		10.1038/ng.3943	http://dx.doi.org/10.1038/ng.3943			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI3JD	28869590	Green Accepted, Green Submitted			2022-12-17	WOS:000411855800008
J	Solomon, DA; Kim, JS; Bondaruk, J; Shariat, SF; Wang, ZF; Elkahloun, AG; Ozawa, T; Gerard, J; Zhuang, DZ; Zhang, SZ; Navai, N; Siefker-Radtke, A; Phillips, JJ; Robinson, BD; Rubin, MA; Volkmer, B; Hautmann, R; Kufer, R; Hogendoorn, PCW; Netto, G; Theodorescu, D; James, CD; Czerniak, B; Miettinen, M; Waldman, T				Solomon, David A.; Kim, Jung-Sik; Bondaruk, Jolanta; Shariat, Shahrokh F.; Wang, Zeng-Feng; Elkahloun, Abdel G.; Ozawa, Tomoko; Gerard, Julia; Zhuang, DaZhong; Zhang, Shizhen; Navai, Neema; Siefker-Radtke, Arlene; Phillips, Joanna J.; Robinson, Brian D.; Rubin, Mark A.; Volkmer, Bjoern; Hautmann, Richard; Kuefer, Rainer; Hogendoorn, Pancras C. W.; Netto, George; Theodorescu, Dan; James, C. David; Czerniak, Bogdan; Miettinen, Markku; Waldman, Todd			Frequent truncating mutations of STAG2 in bladder cancer	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; INACTIVATION; ANEUPLOIDY	Here we report the discovery of truncating mutations of the gene encoding the cohesin subunit STAG2, which regulates sister chromatid cohesion and segregation, in 36% of papillary non-invasive urothelial carcinomas and 16% of invasive urothelial carcinomas of the bladder. Our studies suggest that STAG2 has a role in controlling chromosome number but not the proliferation of bladder cancer cells. These findings identify STAG2 as one of the most commonly mutated genes in bladder cancer.	[Solomon, David A.; Kim, Jung-Sik; Gerard, Julia; Waldman, Todd] Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Solomon, David A.; Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Bondaruk, Jolanta; Zhang, Shizhen; Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Shariat, Shahrokh F.; Zhuang, DaZhong; Robinson, Brian D.; Rubin, Mark A.] Weill Cornell Coll Med, Dept Urol, New York, NY USA; [Shariat, Shahrokh F.] Weill Cornell Coll Med, Div Med Oncol, New York, NY USA; [Wang, Zeng-Feng; Miettinen, Markku] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA; [Ozawa, Tomoko; James, C. David] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Navai, Neema] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Siefker-Radtke, Arlene] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Robinson, Brian D.; Rubin, Mark A.] Weill Cornell Coll Med, Dept Pathol, New York, NY USA; [Volkmer, Bjoern] Hosp Kassel, Dept Urol, Kassel, Germany; [Hautmann, Richard] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Kuefer, Rainer] Hosp Eichert, Dept Urol, Goppingen, Germany; [Hogendoorn, Pancras C. W.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Netto, George] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Theodorescu, Dan] Univ Colorado, Sch Med, Ctr Canc, Dept Surg, Aurora, CO USA	Georgetown University; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Ulm University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus	Waldman, T (corresponding author), Georgetown Univ, Sch Med, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	waldmant@georgetown.edu	Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015	Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; Siefker-Radtke, Arlene/0000-0002-6328-9599; Rubin, Mark/0000-0002-8321-9950; Netto, George/0000-0003-3915-9134	US National Institutes of Health [R01CA169345, R01CA159467, R21CA143282]; MD Anderson Cancer Center Bladder Cancer SPORE grant [P50CA091846]; National Human Genome Research Institute, US National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169345, P50CA091846, R01CA159467, R21CA143282] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Bladder Cancer SPORE grant; National Human Genome Research Institute, US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank B. Vogelstein for assistance in acquiring samples and preparing genomic DNA. This work was supported by US National Institutes of Health grants R01CA169345, R01CA159467 and R21CA143282 to T. W., by the MD Anderson Cancer Center Bladder Cancer SPORE grant P50CA091846 and by the Intramural Research Program of the National Human Genome Research Institute, US National Institutes of Health.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Howlader N., SEER CANC STAT REV 1; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Miettinen M, 2012, APPL IMMUNOHISTO M M, V20, P410, DOI 10.1097/PAI.0b013e318245c82f; Miettinen M, 2012, AM J SURG PATHOL, V36, P629, DOI 10.1097/PAS.0b013e318243555b; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Rink M., 2012, UROL ONCOL, DOI [10.1016/j.urolonc.2012.06.011, DOI 10.1016/J.UR0L0NC.2012.06.011]; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023	13	138	140	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1428	U171		10.1038/ng.2800	http://dx.doi.org/10.1038/ng.2800			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24121789	Green Accepted, Green Submitted			2022-12-17	WOS:000327715800006
J	van de Ven, JPH; Nilsson, SC; Tan, PL; Buitendijk, GHS; Ristau, T; Mohlin, FC; Nabuurs, SB; Schoenmaker-Koller, FE; Smailhodzic, D; Campochiaro, PA; Zack, DJ; Duvvari, MR; Bakker, B; Paun, CC; Boon, CJF; Uitterlinden, AG; Liakopoulos, S; Klevering, BJ; Fauser, S; Daha, MR; Katsanis, N; Klaver, CCW; Blom, AM; Hoyng, CB; den Hollander, AI				van de Ven, Johannes P. H.; Nilsson, Sara C.; Tan, Perciliz L.; Buitendijk, Gabrille H. S.; Ristau, Tina; Mohlin, Frida C.; Nabuurs, Sander B.; Schoenmaker-Koller, Frederieke E.; Smailhodzic, Dzenita; Campochiaro, Peter A.; Zack, Donald J.; Duvvari, Maheswara R.; Bakker, Bjorn; Paun, Codrut C.; Boon, Camiel J. F.; Uitterlinden, Andre G.; Liakopoulos, Sandra; Klevering, B. Jeroen; Fauser, Sascha; Daha, Mohamed R.; Katsanis, Nicholas; Klaver, Caroline C. W.; Blom, Anna M.; Hoyng, Carel B.; den Hollander, Anneke I.			A functional variant in the CFI gene confers a high risk of age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-I; HEMOLYTIC-UREMIC SYNDROME; C4B-BINDING PROTEIN; MUTATIONS; ANGIOGENESIS; PREVALENCE; ZEBRAFISH; TIMP3; VEGFA; LOCI	Up to half of the heritability of age-related macular degeneration (AMD) is explained by common variants(1-5). Here, we report the identification of a rare, highly penetrant missense mutation in CFI encoding a p.Gly119Arg substitution that confers high risk of AMD (P = 3.79 x 10(-6); odds ratio (OR) = 22.20, 95% confidence interval (CI) = 2.98-164.49). Plasma and sera from cases carrying the p.Gly119Arg substitution mediated the degradation of C3b, both in the fluid phase and on the cell surface, to a lesser extent than those from controls. Recombinant protein studies showed that the Gly119Arg mutant protein is both expressed and secreted at lower levels than wild-type protein. Consistent with these findings, human CFI mRNA encoding Arg119 had reduced activity compared to wild-type mRNA encoding Gly119 in regulating vessel thickness and branching in the zebrafish retina. Taken together, these findings demonstrate that rare, highly penetrant mutations contribute to the genetic burden of AMD.	[van de Ven, Johannes P. H.; Schoenmaker-Koller, Frederieke E.; Smailhodzic, Dzenita; Duvvari, Maheswara R.; Bakker, Bjorn; Paun, Codrut C.; Boon, Camiel J. F.; Klevering, B. Jeroen; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Nilsson, Sara C.; Mohlin, Frida C.; Blom, Anna M.] Lund Univ, Dept Lab Med Malmo, Sect Med Prot Chem, Malmo, Sweden; [Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC USA; [Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Buitendijk, Gabrille H. S.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrille H. S.; Uitterlinden, Andre G.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ristau, Tina; Liakopoulos, Sandra; Fauser, Sascha] Univ Cologne, Ctr Ophthalmol, Dept Vitreoretinal Surg, D-50931 Cologne, Germany; [Nabuurs, Sander B.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Campochiaro, Peter A.; Zack, Donald J.] Johns Hopkins Sch Med, Dept Ophthalmol, Baltimore, MD USA; [Campochiaro, Peter A.; Zack, Donald J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Genet Lab, Rotterdam, Netherlands; [Daha, Mohamed R.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Lund University; Duke University; Duke University; Duke University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Cologne; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.	a.denhollander@ohk.umcn.nl	Bakker, Bjorn/E-2842-2016; Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022; Klevering, B.J./L-4434-2015; Boon, CJF/P-7534-2014	Blom, Anna/0000-0002-1348-1734; Klaver, Caroline/0000-0002-2355-5258; Boon, CJF/0000-0002-6737-7932; Katsanis, Nicholas/0000-0002-2480-0171; Zack, Don/0000-0002-7966-1973	Netherlands Organization for Scientific Research [016.096.309]; Foundation Fighting Blindness [C-GE-0811-0548-RAD04]; Swedish Research Council [K2012-66X-14928-09-5]; Soderberg Foundation	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation	We thank B. Janssen, A. Brucker, T. Janssen-van Kempen and M. Verbiest for excellent technical assistance. This study was supported by the Netherlands Organization for Scientific Research (Vidi Innovational Research Award 016.096.309 to A.I.d.H.), the Foundation Fighting Blindness (grant C-GE-0811-0548-RAD04 to A.I.d.H.), the Swedish Research Council (K2012-66X-14928-09-5 to A. M. B.) and the Soderberg Foundation (to A.M.B.).	Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Bienaime F, 2010, KIDNEY INT, V77, P339, DOI 10.1038/ki.2009.472; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; Despriet DDG, 2007, ARCH OPHTHALMOL-CHIC, V125, P1270, DOI 10.1001/archopht.125.9.1270; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fakhouri F, 2010, J AM SOC NEPHROL, V21, P859, DOI 10.1681/ASN.2009070706; Fauser S, 2011, INVEST OPHTH VIS SCI, V52, P5525, DOI 10.1167/iovs.10-6827; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Ho L, 2011, ARCH OPHTHALMOL-CHIC, V129, P758, DOI 10.1001/archophthalmol.2011.141; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maga TK, 2010, HUM MUTAT, V31, pE1445, DOI 10.1002/humu.21256; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nilsson SC, 2007, MOL IMMUNOL, V44, P1835, DOI 10.1016/j.molimm.2006.10.005; Nilsson SC, 2011, MOL IMMUNOL, V48, P1611, DOI 10.1016/j.molimm.2011.04.004; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Sobrin L, 2010, EUR J HUM GENET, V18, P496, DOI 10.1038/ejhg.2009.185; van de Ven JPH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1038, DOI 10.1001/archophthalmol.2012.265; van Leeuwen R, 2003, OPHTHALMOLOGY, V110, P1540, DOI 10.1016/S0161-6420(03)00501-3; Vingerling JR, 1995, EPIDEMIOL REV, V17, P347, DOI 10.1093/oxfordjournals.epirev.a036198; Wang JY, 2008, J IMMUNOL, V181, P712, DOI 10.4049/jimmunol.181.1.712; Weiner DE, 2011, NEPHROL DIAL TRANSPL, V26, P3159, DOI 10.1093/ndt/gfr022; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zeng XXI, 2009, DEV BIOL, V328, P363, DOI 10.1016/j.ydbio.2009.01.035	42	138	144	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					813	+		10.1038/ng.2640	http://dx.doi.org/10.1038/ng.2640			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23685748				2022-12-17	WOS:000321005200018
J	Vithana, EN; Khor, CC; Qiao, CY; Nongpiur, ME; George, R; Chen, LJ; Do, T; Abu-Amero, KK; Huang, CK; Low, S; Tajudin, LSA; Perera, SA; Cheng, CY; Xu, L; Jia, HY; Ho, CL; Sim, KS; Wu, RY; Tham, CCY; Chew, PTK; Su, DH; Oen, FT; Sarangapani, S; Soumittra, N; Osman, EA; Wong, HT; Tang, GX; Fan, SJ; Meng, HL; Huong, DTL; Wang, H; Feng, B; Baskaran, M; Shantha, B; Ramprasad, VL; Kumaramanickavel, G; Iyengar, SK; How, AC; Lee, KY; Sivakumaran, TA; Yong, VHK; Ting, SML; Li, Y; Wang, YX; Tay, WT; Sim, XL; Lavanya, R; Cornes, BK; Zheng, YF; Wong, TT; Loon, SC; Yong, VKY; Waseem, N; Yaakub, A; Chia, KS; Allingham, RR; Hauser, MA; Lam, DSC; Hibberd, ML; Bhattacharya, SS; Zhang, MZ; Teo, YY; Tan, DT; Jonas, JB; Tai, ES; Saw, SM; Hon, DN; Al-Obeidan, SA; Liu, JJ; Tran, NBC; Simmons, CP; Bei, JX; Zeng, YX; Foster, PJ; Vijaya, L; Wong, TY; Pang, CP; Wang, NL; Aung, T				Vithana, Eranga N.; Khor, Chiea-Chuen; Qiao, Chunyan; Nongpiur, Monisha E.; George, Ronnie; Chen, Li-Jia; Tan Do; Abu-Amero, Khaled K.; Huang, Chor Kai; Low, Sancy; Tajudin, Liza-Sharmini A.; Perera, Shamira A.; Cheng, Ching-Yu; Xu, Liang; Jia, Hongyan; Ho, Ching-Lin; Sim, Kar Seng; Wu, Ren-Yi; Tham, Clement C. Y.; Chew, Paul T. K.; Su, Daniel H.; Oen, Francis T.; Sarangapani, Sripriya; Soumittra, Nagaswamy; Osman, Essam A.; Wong, Hon-Tym; Tang, Guangxian; Fan, Sujie; Meng, Hailin; Huong, Dao T. L.; Wang, Hua; Feng, Bo; Baskaran, Mani; Shantha, Balekudaru; Ramprasad, Vedam L.; Kumaramanickavel, Govindasamy; Iyengar, Sudha K.; How, Alicia C.; Lee, Kelvin Y.; Sivakumaran, Theru A.; Yong, Victor H. K.; Ting, Serena M. L.; Li, Yang; Wang, Ya-Xing; Tay, Wan-Ting; Sim, Xueling; Lavanya, Raghavan; Cornes, Belinda K.; Zheng, Ying-Feng; Wong, Tina T.; Loon, Seng-Chee; Yong, Vernon K. Y.; Waseem, Naushin; Yaakub, Azhany; Chia, Kee-Seng; Allingham, R. Rand; Hauser, Michael A.; Lam, Dennis S. C.; Hibberd, Martin L.; Bhattacharya, Shomi S.; Zhang, Mingzhi; Teo, Yik Ying; Tan, Donald T.; Jonas, Jost B.; Tai, E-Shyong; Saw, Seang-Mei; Do Nhu Hon; Al-Obeidan, Saleh A.; Liu, Jianjun; Tran Nguyen Bich Chau; Simmons, Cameron P.; Bei, Jin-Xin; Zeng, Yi-Xin; Foster, Paul J.; Vijaya, Lingam; Wong, Tien-Yin; Pang, Chi-Pui; Wang, Ningli; Aung, Tin			Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma	NATURE GENETICS			English	Article							COMMON VARIANTS; GENE-EXPRESSION; ADHERENS JUNCTIONS; RISK; POPULATION; EYE; IDENTIFICATION; EPIDEMIOLOGY; POLYMORPHISM; MECHANISMS	Primary angle closure glaucoma (PACG) is a major cause of blindness worldwide. We conducted a genome-wide association study including 1,854 PACG cases and 9,608 controls across 5 sample collections in Asia. Replication experiments were conducted in 1,917 PACG cases and 8,943 controls collected from a further 6 sample collections. We report significant associations at three new loci: rs11024102 in PLEKHA7 (per-allele odds ratio (OR) = 1.22; P = 5.33 x 10(-12)), rs3753841 in COL11A1 (per-allele OR = 1.20; P = 9.22 x 10(-10)) and rs1015213 located between PCMTD1 and ST18 on chromosome 8q (per-allele OR = 1.50; P = 3.29 x 10(-9)). Our findings, accumulated across these independent worldwide collections, suggest possible mechanisms explaining the pathogenesis of PACG.	[Qiao, Chunyan; Jia, Hongyan; Wang, Hua; Feng, Bo; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Vithana, Eranga N.; Khor, Chiea-Chuen; Nongpiur, Monisha E.; Perera, Shamira A.; Cheng, Ching-Yu; Ho, Ching-Lin; Wu, Ren-Yi; Su, Daniel H.; Oen, Francis T.; Baskaran, Mani; How, Alicia C.; Lee, Kelvin Y.; Yong, Victor H. K.; Ting, Serena M. L.; Tay, Wan-Ting; Lavanya, Raghavan; Cornes, Belinda K.; Zheng, Ying-Feng; Wong, Tina T.; Tan, Donald T.; Saw, Seang-Mei; Wong, Tien-Yin; Aung, Tin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Vithana, Eranga N.; Khor, Chiea-Chuen; Nongpiur, Monisha E.; Cheng, Ching-Yu; Chew, Paul T. K.; Zheng, Ying-Feng; Loon, Seng-Chee; Tan, Donald T.; Wong, Tien-Yin; Aung, Tin] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Khor, Chiea-Chuen; Sim, Kar Seng; Hibberd, Martin L.; Teo, Yik Ying; Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Khor, Chiea-Chuen] Natl Univ Hlth Syst, Dept Paediat, Singapore, Singapore; [Khor, Chiea-Chuen; Cheng, Ching-Yu; Chia, Kee-Seng; Hibberd, Martin L.; Teo, Yik Ying; Tai, E-Shyong; Saw, Seang-Mei; Liu, Jianjun; Wong, Tien-Yin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [George, Ronnie; Sarangapani, Sripriya; Soumittra, Nagaswamy; Shantha, Balekudaru; Ramprasad, Vedam L.; Kumaramanickavel, Govindasamy; Vijaya, Lingam] Sankara Nethralaya, Vis Res Fdn, Chennai, Tamil Nadu, India; [Chen, Li-Jia; Tham, Clement C. Y.; Lam, Dennis S. C.; Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Tan Do; Huong, Dao T. L.; Do Nhu Hon] Vietnam Natl Inst Ophthalmol, Hanoi, Vietnam; [Abu-Amero, Khaled K.; Osman, Essam A.; Al-Obeidan, Saleh A.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Abu-Amero, Khaled K.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA; [Huang, Chor Kai; Zhang, Mingzhi] Chinese Univ Hong Kong, Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Low, Sancy; Waseem, Naushin; Bhattacharya, Shomi S.; Foster, Paul J.] Moorfields Eye Hosp, NIHR, Biomed Res Ctr Ophthalmol, London, England; [Low, Sancy; Waseem, Naushin; Bhattacharya, Shomi S.; Foster, Paul J.] UCL, Inst Ophthalmol, London, England; [Tajudin, Liza-Sharmini A.; Li, Yang; Yaakub, Azhany] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kota Baharu, Malaysia; [Xu, Liang; Wang, Ya-Xing] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Wu, Ren-Yi] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Peoples R China; [Wong, Hon-Tym; Yong, Vernon K. Y.] Tan Tock Seng Hosp, Dept Ophthalmol, Singapore, Singapore; [Tang, Guangxian] Xingtai Eye Hosp, Xingtai, Peoples R China; [Fan, Sujie] Handan Eye Hosp, Handan, Peoples R China; [Meng, Hailin] Anyang Eye Hosp, Anyang, Peoples R China; [Iyengar, Sudha K.; Sivakumaran, Theru A.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Sim, Xueling; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Allingham, R. Rand; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany; [Tai, E-Shyong] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Tai, E-Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Tran Nguyen Bich Chau; Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Bei, Jin-Xin; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Bei, Jin-Xin; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Yi-Xin] Chinese Acad Med Sci, Peking Union Med Coll, Beijing 100730, Peoples R China	Capital Medical University; National University of Singapore; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Chinese University of Hong Kong; King Saud University; State University System of Florida; University of Florida; Shantou University; University of London; King's College London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Universiti Sains Malaysia; Capital Medical University; Xiamen University; Tan Tock Seng Hospital; Case Western Reserve University; National University of Singapore; Duke University; Ruprecht Karls University Heidelberg; National University of Singapore; National University of Singapore; University of Oxford; University of Oxford; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wningli@vip.163.com; tin11@pacific.net.sg	Zheng, Yingfeng/AAE-2983-2022; Bhattacharya, Shom/N-2926-2016; Waseem, Naushin/C-9573-2013; Pang, Chi P/I-5388-2014; Yaakub, Azhany/ABC-2143-2020; Sim, Xueling/AAZ-6652-2020; Hibberd, Martin L/D-5050-2009; Bei, Jin-Xin/AAO-1259-2020; Lam, Dennis/AAL-1211-2020; Cheng, Ching-Yu/Y-2229-2019; Tai, E Shyong/J-9831-2013; Tham, Chee Yung Clement/AAD-6528-2020; Al Obeidan, Saleh/AAX-5361-2021; Simmons, Cameron P/ABA-3896-2021; Wong, Tien Yin/AAC-9724-2020; wang, YA XING/K-9671-2016; Tajudin, Liza-Sharmini Ahmad/D-3477-2013; Chen, Li Jia/I-5078-2014; KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021; Liu, Jianjun/AAK-4989-2020; Cheng, Ching-Yu/K-7017-2013; /S-1190-2019; Foster, Paul/V-7288-2019; Zheng, Yingfeng/CAE-9225-2022; Mani, Baskaran/GWZ-8299-2022; Ho, CL/AAB-9149-2020	Bhattacharya, Shom/0000-0002-1601-6344; Yaakub, Azhany/0000-0001-8047-1192; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Tham, Chee Yung Clement/0000-0003-4407-6907; Al Obeidan, Saleh/0000-0002-0573-4017; Simmons, Cameron P/0000-0002-9039-7392; Wong, Tien Yin/0000-0002-8448-1264; wang, YA XING/0000-0003-2749-7793; Tajudin, Liza-Sharmini Ahmad/0000-0001-8144-8816; Chen, Li Jia/0000-0003-3500-5840; KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301; Liu, Jianjun/0000-0002-3255-3019; Cheng, Ching-Yu/0000-0003-0655-885X; /0000-0001-7488-250X; Foster, Paul/0000-0002-4755-177X; Zheng, Yingfeng/0000-0002-0914-7864; Ho, CL/0000-0001-9899-7635; Hibberd, Martin/0000-0001-8587-1849; Perera, Shamira/0000-0002-1404-5096; george, ronnie/0000-0001-7368-0252; Sim, Kar Seng/0000-0002-3822-7759; Khor, Chiea Chuen/0000-0002-1128-4729; Tai, E Shyong/0000-0003-2929-8966	National Medical Research Council, Singapore [NMRC/TCR/002-SERI/2008, R626/47/2008TCR, CSA R613/34/2008, NMRC 0796/2003, STaR/0003/2008]; National Research Foundation of Singapore; Biomedical Research Council, Singapore [BMRC 09/1/35/19/616, 08/1/35/19/550]; Genome Institute of Singapore; Beijing Municipal Natural Science Foundation [7102036]; Key Project of the Beijing Municipal Natural Science Foundation [7081001]; Key Project of the National Natural Science Foundation of China [81030016]	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of Singapore(National Research Foundation, Singapore); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Key Project of the Beijing Municipal Natural Science Foundation; Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank all individuals with PACG and controls who have participated in this genetic study. We thank the following for contribution of cases and controls: J. Chua, D. Goh, R. Husain, N. Amerasinghe and A. Narayanaswamy of the Singapore National Eye Centre/Singapore Eye Research Institute; L.H. Thean, C. Aquino, C. Sng and A. Tan of the National University Hospital, Singapore; B.-A. Lim and L. Yip of Tan Tock Seng Hospital, Singapore; and Y. Liang, S. Li, X. Duan, F. Wang, X. Yang, Q. Zhou and X. Yang of the Handan Eye Study, China. The authors would also like to thank C. Chakarova, P. Ostergaard, S. Jeffery, H.J. Cordell, P.T. Khaw, D.F. Garway-Heath, A.C. Viswanathan, W.-Y. Meah, S. Chen, D. Venkataraman, L.-W. Koh, X.Y. Ng, H.-B. Toh, K.-K. Heng and X.Y. Chen for administrative, technical and genotyping support. This work was supported by grants from the National Medical Research Council, Singapore (NMRC/TCR/002-SERI/2008 (R626/47/2008TCR), CSA R613/34/2008, NMRC 0796/2003 and STaR/0003/2008), the National Research Foundation of Singapore, the Biomedical Research Council, Singapore (BMRC 09/1/35/19/616 and 08/1/35/19/550), Genome Institute of Singapore Intramural funding, the Beijing Municipal Natural Science Foundation (7102036), the Key Project of the Beijing Municipal Natural Science Foundation (7081001) and the Key Project of the National Natural Science Foundation of China (81030016).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amerasinghe N, 2011, OPHTHALMOLOGY, V118, P480, DOI 10.1016/j.ophtha.2010.06.043; Aptel F, 2010, OPHTHALMOLOGY, V117, pc, DOI 10.1016/j.ophtha.2009.10.030; Awadalla MS, 2011, MOL VIS, V17, P2248; Awadalla MS, 2011, MOL VIS, V17, P1420; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Diehn JJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r74; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Hornby SJ, 2000, OPHTHALMOLOGY, V107, P511, DOI 10.1016/S0161-6420(99)00140-2; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jun AS, 2001, ARCH OPHTHALMOL-CHIC, V119, P1629; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li H, 2008, HUM GENET, V122, P589, DOI 10.1007/s00439-007-0435-y; LOWE RF, 1972, BRIT J OPHTHALMOL, V56, P13, DOI 10.1136/bjo.56.1.13; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Michael I, 2008, INVEST OPHTH VIS SCI, V49, P3981, DOI 10.1167/iovs.08-1674; Michael S, 2008, MOL VIS, V14, P661; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Othman MI, 1998, AM J HUM GENET, V63, P1411, DOI 10.1086/302113; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2003, J GLAUCOMA, V12, P167, DOI 10.1097/00061198-200304000-00013; Quigley HA, 2001, BRIT J OPHTHALMOL, V85, P1271, DOI 10.1136/bjo.85.11.1271; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Snead MP, 1999, J MED GENET, V36, P353; Sundin OH, 2005, P NATL ACAD SCI USA, V102, P9553, DOI 10.1073/pnas.0501451102; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Tian BH, 2000, INVEST OPHTH VIS SCI, V41, P619; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013	56	138	151	3	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1142	+		10.1038/ng.2390	http://dx.doi.org/10.1038/ng.2390			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922875	Green Accepted			2022-12-17	WOS:000309550200016
J	Kiemeney, LA; Sulem, P; Besenbacher, S; Vermeulen, SH; Sigurdsson, A; Thorleifsson, G; Gudbjartsson, DF; Stacey, SN; Gudmundsson, J; Zanon, C; Kostic, J; Masson, G; Bjarnason, H; Palsson, ST; Skarphedinsson, OB; Gudjonsson, SA; Witjes, JA; Grotenhuis, AJ; Verhaegh, GW; Bishop, DT; Sak, SC; Choudhury, A; Elliott, F; Barrett, JH; Hurst, CD; de Verdier, PJ; Ryk, C; Rudnai, P; Gurzau, E; Koppova, K; Vineis, P; Polidoro, S; Guarrera, S; Sacerdote, C; Campagna, M; Placidi, D; Arici, C; Zeegers, MP; Kellen, E; Gutierrez, BS; Sanz-Velez, JI; Sanchez-Zalabardo, M; Valdivia, G; Garcia-Prats, MD; Hengstler, JG; Blaszkewicz, M; Dietrich, H; Ophoff, RA; van den Berg, LH; Alexiusdottir, K; Kristjansson, K; Geirsson, G; Nikulasson, S; Petursdottir, V; Kong, A; Thorgeirsson, T; Mungan, NA; Lindblom, A; van Es, MA; Porru, S; Buntinx, F; Golka, K; Mayordomo, JI; Kumar, R; Matullo, G; Steineck, G; Kiltie, AE; Aben, KKH; Jonsson, E; Thorsteinsdottir, U; Knowles, MA; Rafnar, T; Stefansson, K				Kiemeney, Lambertus A.; Sulem, Patrick; Besenbacher, Soren; Vermeulen, Sita H.; Sigurdsson, Asgeir; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Stacey, Simon N.; Gudmundsson, Julius; Zanon, Carlo; Kostic, Jelena; Masson, Gisli; Bjarnason, Hjordis; Palsson, Stefan T.; Skarphedinsson, Oskar B.; Gudjonsson, Sigurjon A.; Witjes, J. Alfred; Grotenhuis, Anne J.; Verhaegh, Gerald W.; Bishop, D. Timothy; Sak, Sei Chung; Choudhury, Ananya; Elliott, Faye; Barrett, Jennifer H.; Hurst, Carolyn D.; de Verdier, Petra J.; Ryk, Charlotta; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Vineis, Paolo; Polidoro, Silvia; Guarrera, Simonetta; Sacerdote, Carlotta; Campagna, Marcello; Placidi, Donatella; Arici, Cecilia; Zeegers, Maurice P.; Kellen, Eliane; Saez Gutierrez, Berta; Sanz-Velez, Jose I.; Sanchez-Zalabardo, Manuel; Valdivia, Gabriel; Garcia-Prats, Maria D.; Hengstler, Jan G.; Blaszkewicz, Meinolf; Dietrich, Holger; Ophoff, Roel A.; van den Berg, Leonard H.; Alexiusdottir, Kristin; Kristjansson, Kristleifur; Geirsson, Gudmundur; Nikulasson, Sigfus; Petursdottir, Vigdis; Kong, Augustine; Thorgeirsson, Thorgeir; Mungan, N. Aydin; Lindblom, Annika; van Es, Michael A.; Porru, Stefano; Buntinx, Frank; Golka, Klaus; Mayordomo, Jose I.; Kumar, Rajiv; Matullo, Giuseppe; Steineck, Gunnar; Kiltie, Anne E.; Aben, Katja K. H.; Jonsson, Eirikur; Thorsteinsdottir, Unnur; Knowles, Margaret A.; Rafnar, Thorunn; Stefansson, Kari			A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer	NATURE GENETICS			English	Article							UROTHELIAL CELL-CARCINOMA; FGFR3 MUTATIONS; DISEASE; RISK; EXPRESSION	Previously, we reported germline DNA variants associated with risk of urinary bladder cancer (UBC) in Dutch and Icelandic subjects. Here we expanded the Icelandic sample set and tested the top 20 markers from the combined analysis in several European case-control sample sets, with a total of 4,739 cases and 45,549 controls. The T allele of rs798766 on 4p16.3 was found to associate with UBC (odds ratio = 1.24, P = 9.9 x 10(-12)). rs798766 is located in an intron of TACC3, 70 kb from FGFR3, which often harbors activating somatic mutations in low-grade, noninvasive UBC. Notably, rs798766[T] shows stronger association with low-grade and low-stage UBC than with more aggressive forms of the disease and is associated with higher risk of recurrence in low-grade stage Ta tumors. The frequency of rs798766[T] is higher in Ta tumors that carry an activating mutation in FGFR3 than in Ta tumors with wildtype FGFR3. Our results show a link between germline variants, somatic mutations of FGFR3 and risk of UBC.	[Kiemeney, Lambertus A.; Vermeulen, Sita H.; Grotenhuis, Anne J.; Aben, Katja K. H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred; Verhaegh, Gerald W.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Sulem, Patrick; Besenbacher, Soren; Sigurdsson, Asgeir; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Stacey, Simon N.; Gudmundsson, Julius; Kostic, Jelena; Masson, Gisli; Bjarnason, Hjordis; Palsson, Stefan T.; Skarphedinsson, Oskar B.; Gudjonsson, Sigurjon A.; Kristjansson, Kristleifur; Kong, Augustine; Thorgeirsson, Thorgeir; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Bishop, D. Timothy; Elliott, Faye; Barrett, Jennifer H.] St James Univ Hosp, Epidemiol & Biostat Sect, Leeds, W Yorkshire, England; [Sak, Sei Chung; Hurst, Carolyn D.; Knowles, Margaret A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Leeds, W Yorkshire, England; [Choudhury, Ananya] Christie Hosp Natl Hlth Serv Fdn Trust, Manchester, Lancs, England; [de Verdier, Petra J.; Ryk, Charlotta] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Vineis, Paolo; Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Inst Sci Interchange ISI Fdn, Turin, Italy; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Sacerdote, Carlotta] Univ Turin, Unit Canc Epidemiol, Turin, Italy; [Sacerdote, Carlotta] CPO Piemonte, Ctr Canc Epidemiol & Prevent, Turin, Italy; [Campagna, Marcello; Placidi, Donatella; Arici, Cecilia; Porru, Stefano] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Med & Ind Hyg, Brescia, Italy; [Zeegers, Maurice P.] Univ Birmingham, Dept Publ Hlth & Epidemiol, Unit Genet Epidemiol, Birmingham, W Midlands, England; [Zeegers, Maurice P.] Maastricht Univ, Nutr & Toxicol Res Inst, Cluster Genet & Cell Biol, Dept Complex Genet, Maastricht, Netherlands; [Kellen, Eliane] Leuven Univ Ctr Canc Prevent LUCK, Leuven, Belgium; [Saez Gutierrez, Berta] Univ Zaragoza, Dept Med, Zaragoza, Spain; [Sanz-Velez, Jose I.] San Jorge Hosp, Div Urol, Huesca, Spain; [Sanchez-Zalabardo, Manuel] Hosp Clin, Div Urol, Zaragoza, Spain; [Valdivia, Gabriel] Univ Zaragoza, Sch Med, Dept Urol, Zaragoza, Spain; [Garcia-Prats, Maria D.] San Jorge Hosp, Div Surg Pathol, Huesca, Spain; [Hengstler, Jan G.; Blaszkewicz, Meinolf; Golka, Klaus] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Dietrich, Holger] Paul Gerhardt Fdn, Dept Urol, Lutherstadt Wittenberg, Germany; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [van den Berg, Leonard H.; van Es, Michael A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Alexiusdottir, Kristin] Landspitali Univ Hosp, Dept Med Oncol, Reykjavik, Iceland; [Geirsson, Gudmundur; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Nikulasson, Sigfus; Petursdottir, Vigdis] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Mungan, N. Aydin] Zonguldak Karaelmas Univ, Dept Urol, Zonguldak, Turkey; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Buntinx, Frank] Katholieke Univ Leuven, Dept Gen Practice, Leuven, Belgium; [Buntinx, Frank] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Zaragoza, Spain; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Steineck, Gunnar] Karolinska Inst, Dept Pathol & Oncol, Sect Clin Canc Epidemiol, Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Acad, Inst Clin Sci, Dept Oncol, Div Clin Canc Epidemiol, Gothenburg, Sweden; [Kiltie, Anne E.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	Radboud University Nijmegen; Radboud University Nijmegen; Saint James's University Hospital; Saint James's University Hospital; University of Leeds; Christie NHS Foundation Trust; Christie Hospital; Karolinska Institutet; Imperial College London; University of Turin; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Brescia; University of Birmingham; Maastricht University; University of Zaragoza; Hospital Universidad San Jorge; University of Zaragoza; Hospital Universidad San Jorge; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; Utrecht University; Utrecht University Medical Center; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Bulent Ecevit University; Karolinska Institutet; KU Leuven; Maastricht University; University of Zaragoza; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; University of Gothenburg; University of Oxford; University of Iceland	Kiemeney, LA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands.	b.kiemeney@ebh.umcn.nl; kstefans@decode.is	Matullo, Giuseppe/K-6383-2016; Buntinx, Frank/E-4950-2011; Witjes, Fred/N-9665-2013; van+Es, Michael/AAC-5772-2021; Campagna, Marcello/L-1011-2016; Grotenhuis, Anne/Q-1596-2015; Steineck, Gunnar/W-1515-2019; Polidoro, Silvia/GYJ-3517-2022; Mayordomo, Jose/K-3453-2013; Stefansson, Kari/AAE-7187-2019; Vermeulen, Sita H./L-4716-2015; Placidi, Donatella/A-6965-2011; Hengstler, Jan G./O-1415-2013; Kiemeney, Lambertus A./D-3357-2009; Kumar, Rajiv/H-6431-2019; Guarrera, Simonetta/AAB-8482-2022; Arici, Cecilia/AAO-7689-2020; Aben, Katja KH/G-9686-2016; Verhaegh, Gerald/L-4708-2015	Matullo, Giuseppe/0000-0003-0674-7757; Campagna, Marcello/0000-0002-5277-8477; Steineck, Gunnar/0000-0002-0787-3969; Vermeulen, Sita H./0000-0003-4913-8601; Placidi, Donatella/0000-0003-1606-5397; Kiemeney, Lambertus A./0000-0002-2368-1326; Kumar, Rajiv/0000-0002-6093-0395; Arici, Cecilia/0000-0003-1493-590X; Aben, Katja KH/0000-0002-0214-2147; Verhaegh, Gerald/0000-0003-0227-2280; Besenbacher, Soren/0000-0003-1455-1738; Knowles, Margaret/0000-0002-9363-8657; Gurzau, Eugen/0000-0002-8688-6118; Kong, Augustine/0000-0001-8193-5438; Bishop, Tim/0000-0002-8752-8785; Hengstler, Jan/0000-0002-1427-5246; Polidoro, Silvia/0000-0003-2968-0575; Saez, Berta/0000-0003-0753-1165; Kiltie, Anne/0000-0001-7208-2912; Gudbjartsson, Daniel/0000-0002-5222-9857; Barrett, Jenny/0000-0002-1720-7724; Choudhury, Ananya/0000-0002-3561-6580; Sacerdote, Carlotta/0000-0002-8008-5096; Gudjonsson, Sigurjon A./0000-0001-9314-7412; van Es, Michael/0000-0002-7709-5883; Ryk, Charlotta/0000-0002-7881-7614; Zanon, Carlo/0000-0003-2539-7238; Thorgeirsson, Thorgeir/0000-0002-5149-7040	FP7-MC-IAPP Grant [218071]; European Commission [POLYGENE: LSHC-CT-2005]; Radboud University Nijmegen Medical Centre; US National Institute of Mental Health; Cancer Research UK and Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility); European Union; Priority 5: 'Food Quality and Safety' [513943]; Compagnia di San Paolo; Italian Association for Cancer Research and of the Piedmont Region Progetti de Ricerca Sanitaria Finalizzata, Italy; Cancer Research UK [10589, 12933] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish	FP7-MC-IAPP Grant; European Commission(European CommissionEuropean Commission Joint Research Centre); Radboud University Nijmegen Medical Centre; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cancer Research UK and Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility); European Union(European Commission); Priority 5: 'Food Quality and Safety'; Compagnia di San Paolo(Compagnia di San Paolo); Italian Association for Cancer Research and of the Piedmont Region Progetti de Ricerca Sanitaria Finalizzata, Italy(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals who participated in the study and whose contribution made this work possible. We also thank the nurses at deCODE's recruitment center and the personnel at the deCODE core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic UBC cases. C.Z. and S.B. are funded by a FP7-MC-IAPP Grant agreement no. 218071 (CancerGene). Collection of samples and data in Iceland and The Netherlands was funded in part by the European Commission (POLYGENE: LSHC-CT-2005) and a research investment grant of the Radboud University Nijmegen Medical Centre. Control samples for the Dutch follow-up group were genotyped with generous support from the 'Prinses Beatrix Fonds', VSB Fonds, H. Kersten and M. Kersten (Kersten Foundation), The Netherlands ALS Foundation, J.R. van Dijk and the Adessium foundation. The controls from the Dutch Schizophrenia GWA study were genotyped with the support of the US National Institute of Mental Health (R.A.O.). The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. The Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union Sixth Framework Program, Priority 5: 'Food Quality and Safety' (Contract No. 513943), and by grants of the Compagnia di San Paolo, of the Italian Association for Cancer Research and of the Piedmont Region Progetti de Ricerca Sanitaria Finalizzata, Italy. The Belgian case-control study on bladder cancer risk	Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Bakkar AA, 2010, MOL CARCINOGEN, V49, P25, DOI 10.1002/mc.20573; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mostofi FK, 1973, HISTOLOGICAL TYPING; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2005, CANCER RES, V65, P10441, DOI 10.1158/0008-5472.CAN-05-1718; *UICC, 1978, TNM CLASS MAL TUM BL, P113; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; Wallerand H, 2005, CARCINOGENESIS, V26, P177, DOI 10.1093/carcin/bgh275; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421	28	138	142	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					415	U67		10.1038/ng.558	http://dx.doi.org/10.1038/ng.558			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20348956	Green Accepted			2022-12-17	WOS:000277179500012
J	Lagresle-Peyrou, C; Six, EM; Picard, C; Rieux-Laucat, F; Michel, V; Ditadi, A; Demerens-de Chappedelaine, C; Morillon, E; Valensi, F; Simon-Stoos, KL; Mullikin, JC; Noroski, LM; Besse, C; Wulffraat, NM; Ferster, A; Abecasis, MM; Calvo, F; Petit, C; Candotti, F; Abel, L; Fischer, A; Cavazzana-Calvo, M				Lagresle-Peyrou, Chantal; Six, Emmanuelle M.; Picard, Capucine; Rieux-Laucat, Frederic; Michel, Vincent; Ditadi, Andrea; Demerens-de Chappedelaine, Corinne; Morillon, Estelle; Valensi, Francoise; Simon-Stoos, Karen L.; Mullikin, James C.; Noroski, Lenora M.; Besse, Celine; Wulffraat, Nicolas M.; Ferster, Alina; Abecasis, Manuel M.; Calvo, Fabien; Petit, Christine; Candotti, Fabio; Abel, Laurent; Fischer, Alain; Cavazzana-Calvo, Marina			Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness	NATURE GENETICS			English	Article							MITOCHONDRIAL-INTERMEMBRANE SPACE; BONE-MARROW-TRANSPLANTATION; RETICULAR DYSGENESIS; CYTOCHROME-C; APOPTOTIC PATHWAY; EXPRESSION; KOSTMANN; SURVIVAL; CELLS; DNA	Reticular dysgenesis is an autosomal recessive form of human severe combined immunodeficiency characterized by an early differentiation arrest in the myeloid lineage and impaired lymphoid maturation. In addition, affected newborns have bilateral sensorineural deafness. Here we identify biallelic mutations in AK2 (adenylate kinase 2) in seven individuals affected with reticular dysgenesis. These mutations result in absent or strongly decreased protein expression. We then demonstrate that restoration of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes the neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted set of hematopoietic lineages. Last, we establish that AK2 is specifically expressed in the stria vascularis region of the inner ear, which provides an explanation of the sensorineural deafness in these individuals. These results identify a previously unknown mechanism involved in regulation of hematopoietic cell differentiation and in one of the most severe human immunodeficiency syndromes.	[Lagresle-Peyrou, Chantal; Six, Emmanuelle M.; Picard, Capucine; Rieux-Laucat, Frederic; Ditadi, Andrea; Demerens-de Chappedelaine, Corinne; Morillon, Estelle; Valensi, Francoise; Fischer, Alain; Cavazzana-Calvo, Marina] INSERM, U768, Res Lab Normal & Pathol Dev Immune Syst, F-75015 Paris, France; [Lagresle-Peyrou, Chantal; Six, Emmanuelle M.; Picard, Capucine; Rieux-Laucat, Frederic; Ditadi, Andrea; Demerens-de Chappedelaine, Corinne; Morillon, Estelle; Abel, Laurent; Fischer, Alain; Cavazzana-Calvo, Marina] Univ Paris 05, Fac Med, IFR94, F-75015 Paris, France; [Lagresle-Peyrou, Chantal] Ecole Prat Hautes Etud, Lab Immunol Cellulaire & Immunopathol, F-75015 Paris, France; [Lagresle-Peyrou, Chantal] Univ Paris 07, CNRS, UMR 7151, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; [Picard, Capucine; Abel, Laurent] INSERM, U550, Lab Human Genet Infect Dis, F-75015 Paris, France; [Michel, Vincent; Petit, Christine] Univ Paris 06, Inst Pasteur, INSERM, Unite Genet & Physiol Audit,UMRS587, F-75015 Paris, France; [Simon-Stoos, Karen L.] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; Candotti, Fabio] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Noroski, Lenora M.] Baylor Coll Med, Dept Pediat, Div Allergy & Immunol, Houston, TX 77030 USA; [Besse, Celine] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91000 Evry, France; [Wulffraat, Nicolas M.] Wilhelmina Childrens Hosp, Utrecht Med Ctr, Dept Immunol BMT, NL-3584 CX Utrecht, Netherlands; [Ferster, Alina] Childrens Univ Hosp Reine Fabiola, Pediat Hematooncol Unit, B-1020 Brussels, Belgium; [Abecasis, Manuel M.] Portuguese Inst Oncol Francisco Gentil, Bone Marrow Transplantat Unit, P-1099023 Lisbon, Portugal; [Calvo, Fabien] Univ Paris 07, Hop St Louis, AP HP, INSERM,U716,Clin Invest Ctr, F-75015 Paris, France; [Petit, Christine] Coll France, F-75015 Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, AP HP, Serv Immunol & Hematol Pediat, F-75015 Paris, France; [Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, AP HP, Dept Biotherapie, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cavazzana-Calvo, M (corresponding author), INSERM, U768, Res Lab Normal & Pathol Dev Immune Syst, F-75015 Paris, France.	m.cavazzana@nck.aphp.fr	Wulffraat, Nico M/AAE-8929-2020; Ditadi, Andrea/K-3461-2016; Peyrou, Chantal Lagresle/H-2911-2017; Abel, Laurent/H-8888-2017; Picard, Capucine/H-3914-2017; Six, Emmanuelle/H-7891-2017; Rieux-Laucat, Frédéric/A-7916-2017; Peyrou, Chantal Lagresle/AAK-9689-2020; Demerens de Chappedelaine, Corinne/H-1648-2017	Wulffraat, Nico M/0000-0001-9548-5562; Ditadi, Andrea/0000-0003-3283-8943; Peyrou, Chantal Lagresle/0000-0002-2216-6453; Abel, Laurent/0000-0001-7016-6493; Picard, Capucine/0000-0001-8788-5056; Six, Emmanuelle/0000-0001-7806-0968; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Peyrou, Chantal Lagresle/0000-0002-2216-6453; Petit, Christine/0000-0002-9069-002X; Cavazzana, Marina/0000-0002-0264-0891; Candotti, Fabio/0000-0001-6399-6042; Vincent, Michel/0000-0002-7025-4343; calvo, fabien/0000-0002-0298-7633; Demerens de Chappedelaine, Corinne/0000-0003-3651-0646	Intramural NIH HHS [Z01 HG000122-10, Z99 HG999999] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330, ZIAHG000122] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; BUJAN W, 1993, BLOOD, V82, P1684, DOI 10.1182/blood.V82.5.1684.bloodjournal8251684a; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; DEVAAL OM, 1959, LANCET, V2, P1123; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Heine P, 1999, EUR J BIOCHEM, V262, P102, DOI 10.1046/j.1432-1327.1999.00347.x; Heltzer ML, 2007, J ALLERGY CLIN IMMUN, V120, P950, DOI 10.1016/j.jaci.2007.07.026; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kohler C, 1999, FEBS LETT, V447, P10, DOI 10.1016/S0014-5793(99)00251-3; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; LEVINSKY RJ, 1983, LANCET, V1, P671; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Peters UR, 1999, CANCER RES, V59, P4233; Reubsaet LL, 2007, BONE MARROW TRANSPL, V39, P307, DOI 10.1038/sj.bmt.1705577; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Solary E, 2008, NAT GENET, V40, P379, DOI 10.1038/ng0408-379; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888	26	138	148	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					106	111		10.1038/ng.278	http://dx.doi.org/10.1038/ng.278			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19043416	Green Accepted			2022-12-17	WOS:000262085300024
J	Aulchenko, YS; Hoppenbrouwers, IA; Ramagopalan, SV; Broer, L; Jafari, N; Hillert, J; Link, J; Lundstrom, W; Greiner, E; Sadovnick, AD; Goossens, D; Van Broeckhoven, C; Del-Favero, J; Ebers, GC; Oostra, BA; van Duijn, CM; Hintzen, RQ				Aulchenko, Yurii S.; Hoppenbrouwers, Ilse A.; Ramagopalan, Sreeram V.; Broer, Linda; Jafari, Naghmeh; Hillert, Jan; Link, Jenny; Lundstrom, Wangko; Greiner, Eva; Sadovnick, A. Dessa; Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen; Ebers, George C.; Oostra, Ben A.; van Duijn, Cornelia M.; Hintzen, Rogier Q.			Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; RISK; DYSFUNCTION; MUTATION	The few loci associated with multiple sclerosis (MS) are all related to immune function. We report a GWA study identifying a new locus replicated in 2,679 cases and 3,125 controls. An rs10492972[C] variant located in the KIF1B gene was associated with MS with an odds ratio of 1.35 (P = 2.5 x 10(-10)). KIF1B is a neuronally expressed gene plausibly implicated in the irreversible axonal loss characterizing MS in the long term.	[Hoppenbrouwers, Ilse A.; Broer, Linda; Jafari, Naghmeh; Hintzen, Rogier Q.] Erasmus MC, MS Ctr ErasMS, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Aulchenko, Yurii S.; Broer, Linda; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 9DU, England; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Dept Clin Neurol, Oxford OX3 9DU, England; [Hillert, Jan; Link, Jenny; Lundstrom, Wangko; Greiner, Eva] Karolinska Inst, Dept Neurol, SE-14186 Stockholm, Sweden; [Sadovnick, A. Dessa] Univ British Columbia, Dept Med Genet, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] VIB, Dept Mol Genet, Appl Mol Genom Grp, B-2610 Antwerp, Belgium; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] Univ Antwerp, B-2610 Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Karolinska Institutet; University of British Columbia; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); University of Antwerp	Hintzen, RQ (corresponding author), Erasmus MC, MS Ctr ErasMS, Dept Neurol, NL-3000 CA Rotterdam, Netherlands.	rhintzen@xs4all.nl	Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019; Aulchenko, Yurii/M-8270-2013; Link, Jenny/J-1629-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Aulchenko, Yurii/0000-0002-7899-1575; Link, Jenny/0000-0002-6134-9404; Van Duijn, Cornelia/0000-0002-2374-9204; Ebers, George/0000-0003-4771-4177; Del Favero, jurgen/0000-0002-7427-7489; Goossens, Dirk/0000-0002-2080-7464; Broer, Linda/0000-0003-0011-123X	MS Research Netherlands; Erasmus University Trust Fund; Netherlands Organisation for Scientific Research; Erasmus MC; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; Centre for Medical Systems Biology (CMSB); Bibbi and Nils Jensen Foundation; Swedish Research Council; EU [LSHM-CT-2005-018637]	MS Research Netherlands(Netherlands Government); Erasmus University Trust Fund; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Erasmus MC; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; Centre for Medical Systems Biology (CMSB); Bibbi and Nils Jensen Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission)	This study was supported by grants from MS Research Netherlands (R. Q. H. and C. M. v. D.), the Erasmus University Trust Fund, The Netherlands Organisation for Scientific Research (ZON-MW, R.Q.H.), the Erasmus MC and the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of the United Kingdom (S.V.R., G.C.E.). The GRIP study is supported by Centre for Medical Systems Biology (CMSB). The Stockholm part of the study was supported by the Bibbi and Nils Jensen Foundation, by the Swedish Research Council and by the EU project no. LSHM-CT-2005-018637, NeuroproMiSe. We are grateful to all participants and their relatives; general practitioners and neurologists for their contributions; P. Veraart for her help in genealogy; D. Lont and the personnel of the VIB Genetic Service Facility for genotyping; and P. Snijders for his help in data collection.	Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2007, MULT SCLER, V13, P17, DOI 10.1177/1352458506071216; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Waxman SG, 2008, ANN NEUROL, V63, P411, DOI 10.1002/ana.21361; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	138	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1402	1403		10.1038/ng.251	http://dx.doi.org/10.1038/ng.251			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997785				2022-12-17	WOS:000261215900013
J	Jeffreys, AJ; Neumann, R; Panayi, M; Myers, S; Donnelly, P				Jeffreys, AJ; Neumann, R; Panayi, M; Myers, S; Donnelly, P			Human recombination hot spots hidden in regions of strong marker association	NATURE GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HAPLOTYPE BLOCKS; HUMAN GENOME; MEIOTIC CROSSOVER; RATES; DIVERSITY; HISTORY	The fine-scale distribution of meiotic recombination events in the human genome can be inferred from patterns of haplotype diversity in human populations(1-5) but directly studied only by high-resolution sperm typing(6-8). Both approaches indicate that crossovers are heavily clustered into narrow recombination hot spots. But our direct understanding of hot-spot properties and distributions is largely limited to sperm typing in the major histocompatibility complex (MHC)(7). We now describe the analysis of an unremarkable 206-kb region on human chromosome 1, which identified localized regions of linkage disequilibrium breakdown that mark the locations of sperm crossover hot spots. The distribution, intensity and morphology of these hot spots are markedly similar to those in the MHC. But we also accidentally detected additional hot spots in regions of strong association. Coalescent analysis of genotype data detected most of the hot spots but showed significant differences between sperm crossover frequencies and historical recombination rates. This raises the possibility that some hot spots, particularly those in regions of strong association, may have evolved very recently and not left their full imprint on haplotype diversity. These results suggest that hot spots could be very abundant and possibly fluid features of the human genome.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Leicester; University of Oxford	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@le.ac.uk	Myers, Simon R/A-6792-2015	Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GRIFFITHS RC, 1996, IMA VOLUME MATH POPU, P257; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li N, 2003, GENETICS, V165, P2213; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morton N. E., 1982, OUTLINE GENETIC EPID; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stumpf MPH, 2004, EUR J HUM GENET, V12, P469, DOI 10.1038/sj.ejhg.5201179; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	30	138	146	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					601	606		10.1038/ng1565	http://dx.doi.org/10.1038/ng1565			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15880103				2022-12-17	WOS:000229495300013
J	Rhodes, DR; Kalyana-Sundaram, S; Mahavisno, V; Barrette, TR; Ghosh, D; Chinnaiyan, AM				Rhodes, DR; Kalyana-Sundaram, S; Mahavisno, V; Barrette, TR; Ghosh, D; Chinnaiyan, AM			Mining for regulatory programs in the cancer transcriptome	NATURE GENETICS			English	Article							NEOPLASTIC TRANSFORMATION; MAMMALIAN EMBRYO; STEM-CELLS; N-MYC; C-MYC; GENE; EXPRESSION; PATTERNS; PROGRESSION; ACTIVATION	DNA microarrays have been widely applied to cancer transcriptome analysis. The Oncomine database contains a large collection of such data, as well as hundreds of derived gene-expression signatures. We studied the regulatory mechanisms responsible for gene deregulation in these cancer signatures by searching for the coordinate regulation of genes with common transcription factor binding sites. We found that genes with binding sites for the archetypal cancer transcription factor, E2F, were disproportionately overexpressed in a wide variety of cancers, whereas genes with binding sites for other transcription factors, such as Myc-Max, c-Rel and ATF, were disproportionately overexpressed in specific cancer types. These results suggest that alterations in pathways activating these transcription factors may be responsible for the observed gene deregulation and cancer pathogenesis.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012	Ghosh, Debashis/0000-0001-6618-1316; Kalyana-Sundaram, Shanker/0000-0002-7309-3848				Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Muller M J, 2001, Obes Rev, V2, P15; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; SETH A, 1990, ONCOGENE, V5, P1761; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SYLLA BS, 1986, MOL CELL BIOL, V6, P4709, DOI 10.1128/MCB.6.12.4709; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	36	138	148	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					579	583		10.1038/ng1578	http://dx.doi.org/10.1038/ng1578			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15920519				2022-12-17	WOS:000229495300008
J	Mira, MT; Alcais, A; Van Thuc, N; Thai, VH; Huong, NT; Ba, NN; Verner, A; Hudson, TJ; Abel, L; Schurr, E				Mira, MT; Alcais, A; Van Thuc, N; Thai, VH; Huong, NT; Ba, NN; Verner, A; Hudson, TJ; Abel, L; Schurr, E			Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population	NATURE GENETICS			English	Article							GENETIC EPIDEMIOLOGY; TUBERCULOID LEPROSY; LINKAGE ANALYSIS; ASSOCIATION; POLYMORPHISM; SEGREGATION; GENOTYPE	Leprosy, a chronic infectious disease caused by Mycobacterium leprae, affects an estimated 700,000 persons each year(1). Clinically, leprosy can be categorized as paucibacillary or multibacillary disease(2). These clinical forms develop in persons that are intrinsically susceptible to leprosy per se, that is, leprosy independent of its specific clinical manifestation(3). We report here on a genome-wide search for loci controlling susceptibility to leprosy per se in a panel of 86 families including 205 siblings affected with leprosy from Southern Vietnam. Using model-free linkage analysis, we found significant evidence for a susceptibility gene on chromosome region 6q25 (maximum likelihood binomial (MLB) lod score 4.31; P=5x10(-6)). We confirmed this by family-based association analysis in an independent panel of 208 Vietnamese leprosy simplex families. Of seven microsatellite markers underlying the linkage peak, alleles of two markers (D6S1035 and D6S305) showed strong evidence for association with leprosy (P=6.7x10(-4) and P=5.9x10(-5), respectively).	McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; Univ Paris 05, Inst Natl Sante & Rech Med, U550, Unite Human Genet Infect Dis,Necker Med Sch, Paris, France; Hosp Dermato Venereol, Ho Chi Minh City, Vietnam; McGill Univ, Montreal Genome Ctr, Ctr Hlth, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University	Schurr, E (corresponding author), McGill Univ, McGill Ctr Study Host Resistance, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	erwin@igloo.epi.mcgill.ca	Mira, Marcelo T/B-5046-2010; Alcais, Alexandre/J-5882-2017; Abel, Laurent/H-8888-2017	Mira, Marcelo T/0000-0002-8087-9400; Alcais, Alexandre/0000-0002-1012-2226; Abel, Laurent/0000-0001-7016-6493				Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Chakravartti MR, 1973, TOPICS HUMAN GENETIC, P1; FEITOSA MF, 1995, AM J HUM GENET, V56, P1179; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jacobson RR, 1999, LANCET, V353, P655, DOI 10.1016/S0140-6736(98)06322-3; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Meisner SJ, 2001, AM J TROP MED HYG, V65, P733, DOI 10.4269/ajtmh.2001.65.733; Rajalingam R, 1997, TISSUE ANTIGENS, V49, P168, DOI 10.1111/j.1399-0039.1997.tb02731.x; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; RISCH N, 1987, AM J HUM GENET, V40, P1; Roy S, 1997, J INFECT DIS, V176, P530, DOI 10.1086/517282; Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536; Shaw MA, 2001, GENES IMMUN, V2, P196, DOI 10.1038/sj.gene.6363754; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; VANEDEN W, 1980, J INFECT DIS, V141, P693, DOI 10.1093/infdis/141.6.693; VANEDEN W, 1985, J INFECT DIS, V151, P9, DOI 10.1093/infdis/151.1.9; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P1	24	138	147	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					412	415		10.1038/ng1096	http://dx.doi.org/10.1038/ng1096			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577057				2022-12-17	WOS:000181312700021
J	Kim, SK; Selleri, L; Lee, JS; Zhang, AY; Gu, XY; Jacobs, Y; Cleary, ML				Kim, SK; Selleri, L; Lee, JS; Zhang, AY; Gu, XY; Jacobs, Y; Cleary, ML			Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus	NATURE GENETICS			English	Article							HOMEODOMAIN PROTEINS; GENE; HOX; MUTATIONS; NOTOCHORD; EXOCRINE; IPF1	Pbx1 is a member of the TALE (three-amino acid loop extension) class of homeodomain transcription factors(1,2), which are components of hetero-oligomeric protein complexes thought to regulate developmental gene expression and to maintain differentiated cell states(3). In vitro studies(4,5) have shown that Pbx1 regulates the activity of Ipf1 (also known as Pdx1), a Para-Hox homeodomain transcription factor(6,7) required for the development and function of the pancreas in mice and humans(8-10). To investigate in vivo roles of Pbx1 in pancreatic development and function, we examined pancreatic Pbx1 expression, and morphogenesis, cell differentiation and function in mice deficient(11,12) for Pbx1. Pbx1(-/-) embryos had pancreatic hypoplasia and marked defects in exocrine and endocrine cell differentiation prior to death at embryonic day (E) 15 or E16. In these embryos, expression of IsI1 and Atoh5, essential regulators of pancreatic morphogenesis and differentiation, was severely reduced. Pbx1(+/-) adults had pancreatic islet malformations, impaired glucose tolerance and hypoinsulinemia. Thus, Pbx1 is essential for normal pancreatic development and function. Analysis of trans-heterozygous Pbx1(+/-) Ipf1(+/-) mice revealed in vivo genetic interactions between Pbx1 and Ipf1 that are essential for postnatal pancreatic function; these mice developed age-dependent overt diabetes mellitus, unlike Pbx1(+/-) or Ipf1(+/-) mice. Mutations affecting the Ipf1 protein may promote diabetes mellitus in mice and humans(13-16). This study suggests that perturbation of Pbx1 activity may also promote susceptibility to diabetes mellitus.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Div Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Dept Med,Div Oncol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Div Oncol, Stanford, CA 94305 USA.			Kim, Seung/0000-0001-6135-7810; Zhang, Andrew/0000-0002-6309-9947				Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; Coulier F, 2000, INT J ONCOL, V17, P439; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Dutta S, 2001, P NATL ACAD SCI USA, V98, P1065, DOI 10.1073/pnas.031561298; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kim SK, 2000, GENE DEV, V14, P1866; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Offield MF, 1996, DEVELOPMENT, V122, P983; PEERS B, 1995, MOL CELL BIOL, V15, P7091; Schnabel CA, 2001, MECH DEVELOP, V100, P131, DOI 10.1016/S0925-4773(00)00516-5; Selleri L, 2001, DEVELOPMENT, V128, P3543; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109	30	138	143	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					430	435		10.1038/ng860	http://dx.doi.org/10.1038/ng860			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11912494				2022-12-17	WOS:000174682000023
J	Healey, CS; Dunning, AM; Teare, MD; Chase, D; Parker, L; Burn, J; Chang-Claude, J; Mannermaa, A; Kataja, V; Huntsman, DG; Pharoah, PDP; Luben, RN; Easton, DF; Ponder, BAJ				Healey, CS; Dunning, AM; Teare, MD; Chase, D; Parker, L; Burn, J; Chang-Claude, J; Mannermaa, A; Kataja, V; Huntsman, DG; Pharoah, PDP; Luben, RN; Easton, DF; Ponder, BAJ			A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability	NATURE GENETICS			English	Article							KLOTHO GENE; DNA-REPAIR; MUTATION; MICE	Inherited mutations in the gene BRCA2 predispose carriers to early onset breast cancer, but such mutations account for fewer than 2% of all cases in East Anglia. It is likely that low penetrance alleles explain the greater part of inherited susceptibility to breast cancer; polymorphic variants in strongly predisposing genes, such as BRCA2, are candidates for this role. BRCA2 is thought to be involved in DNA double strand break-repair(1,2) Few mice in which Brca2 is truncated survive to birth; of those that do, most are male, smaller than their normal littermates and have high cancer incidence(3,4). Here we show that a common human polymorphism (N372H) in exon 10 of BRCA2 confers an increased risk of breast cancer: the HH homozygotes have a 1.31-fold (95% Cl, 1.07-1.61) greater risk than the NN group. Moreover, in normal female controls of all ages there is a significant deficiency of homozygotes compared with that expected from Hardy-Weinberg equilibrium, whereas in males there is an excess of homozygotes: the HH group has an estimated fitness of 0.82 in females and 1.38 in males. Therefore, this variant of BRCA2 appears also to affect fetal survival in a sex-dependent manner.	Univ Cambridge, CRC, Dept Oncol, Strangeways Res Lab, Cambridge, England; Univ Cambridge, CRC, Genet Epidemiol Grp, Strangeways Res Lab, Cambridge, England; Univ Cambridge, EPIC, Strangeways Res Lab, Cambridge, England; Univ Newcastle, Royal Victoria Infirm, Inst Child Hlth, Newcastle Upon Tyne, Tyne & Wear, England; Univ Newcastle, Sch Biochem & Genet, Human Genet Unit, Newcastle Upon Tyne, Tyne & Wear, England; Deutsch Krebsforschungszentrum, Abt Epidemiol, D-6900 Heidelberg, Germany; Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland; Univ Kuopio, Dept Oncol & Radiotherapy, FIN-70211 Kuopio, Finland; Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of Cambridge; University of Cambridge; University of Cambridge; Newcastle University - UK; Newcastle University - UK; Helmholtz Association; German Cancer Research Center (DKFZ); Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; BC Women's Hospital & Health Centre	Healey, CS (corresponding author), Univ Cambridge, CRC, Dept Oncol, Strangeways Res Lab, Cambridge, England.		Pharoah, Paul/V-6658-2019; Luben, Robert N/H-5519-2015; Huntsman, David/ABE-6082-2020	Pharoah, Paul/0000-0001-8494-732X; Luben, Robert N/0000-0002-5088-6343; Dunning, Alison Margaret/0000-0001-6651-7166; Kataja, Vesa/0000-0003-4846-4843; Burn, John/0000-0002-9823-2322; Chase, Diana/0000-0002-3678-0032				Calaf GM, 2000, CARCINOGENESIS, V21, P769, DOI 10.1093/carcin/21.4.769; CHANGCLAUDE J, IN PRESS CANC CAUSES; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Day N, 1999, BRIT J CANCER, V80, P95; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Friedman LS, 1998, CANCER RES, V58, P1338; Fuks F, 1998, ONCOGENE, V17, P2531, DOI 10.1038/sj.onc.1202475; Jernstrom H, 1998, EUR J CANCER, V34, P368, DOI 10.1016/S0959-8049(97)10088-0; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P78; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lomax B, 2000, AM J HUM GENET, V66, P1516, DOI 10.1086/302878; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Spillman MA, 1996, ONCOGENE, V13, P1639	16	138	147	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					362	364		10.1038/81691	http://dx.doi.org/10.1038/81691			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062481				2022-12-17	WOS:000165176500030
J	Svensson, EC; Huggins, GS; Lin, H; Clendenin, C; Jiang, F; Tufts, R; Dardik, FB; Leiden, JM				Svensson, EC; Huggins, GS; Lin, H; Clendenin, C; Jiang, F; Tufts, R; Dardik, FB; Leiden, JM			A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GATA-4; HEART TUBE FORMATION; ATRIOVENTRICULAR JUNCTION; VENTRAL MORPHOGENESIS; NF-ATC; MOUSE; TRISOMY-16; COFACTOR; NKX2-5; VALVE	Tricuspid atresia (TA) is a common form of congenital heart disease, accounting for 1-3% of congenital cardiac disorders(1). TA is characterized by the congenital agenesis of the tricuspid valve connecting the right atrium to the right ventricle and both an atrial septal defect (ASD) and a ventricular septal defect(2) (VSD). Some patients also have pulmonic stenosis. persistence of a left-sided superior vena cava or transposition of the great arteries. Most cases of TA are sporadic, but familiar occurrences with disease in multiple siblings have been reported(3-5). Gata4 is a zinc-finger transcription factor with a role in early cardiac development. Gata4-deficient mice fail to form a ventral heart tube and die of circulatory failure at embryonic day (E) 8.5 (refs 6,7). Zfpm2 (also known as Fog-2) is a multi-zinc-finger protein that is co-expressed with Gata4 in the developing heart beginning at E8.5 (refs 8-10). Zfpm2 interacts specifically with the N-terminal zinc finger of Gata4 and represses Gata4-dependent transcription(8-10). Here we use targeted mutagenesis to explore the role of Zfpm2 in normal cardiac development. Zfpm2-deficient mice died of congestive heart failure at E13 with a syndrome of tricuspid atresia that includes an absent tricuspid valve, a large ASD, a VSD, an elongated left ventricular outflow tract, rightward displacement of the aortic valve and pulmonic stenosis. These mice also display hypoplasia of the compact zone of the left ventricle. Our findings indicate the importance of Zfpm2 in the normal looping and septation of the heart and suggest a genetic basis for the syndrome of tricuspid atresia.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Chicago	Leiden, JM (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003667, R01HL054592] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54592, HL03667, R01 HL054592] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RH, 1998, CARDIOVASC RES, V39, P155, DOI 10.1016/S0008-6363(98)00037-6; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Bonnet D, 1999, J MED GENET, V36, P349; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; GELB BD, 1991, AM J MED GENET, V40, P471, DOI 10.1002/ajmg.1320400420; KUMAR A, 1994, PEDIATR CARDIOL, V15, P201, DOI 10.1007/BF00800676; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LAMERS WH, 1995, CIRCULATION, V91, P111, DOI 10.1161/01.CIR.91.1.111; Lee RY, 1997, CIRC RES, V80, P757; Lin AE, 1998, J MED GENET, V35, P1055, DOI 10.1136/jmg.35.12.1055; Lu JR, 1999, MOL CELL BIOL, V19, P4495; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; RAO PS, 1980, AM HEART J, V99, P799, DOI 10.1016/0002-8703(80)90632-8; SADE RM, 1990, PEDIATR CLIN N AM, V37, P151; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SUJANSKY E, 1993, AM J MED GENET, V47, P512, DOI 10.1002/ajmg.1320470415; SVENSSON E, IN PRESS J BIOL CHEM; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Webb S, 1997, CARDIOVASC RES, V34, P515, DOI 10.1016/S0008-6363(97)00064-3; Webb S, 1999, CIRC RES, V84, P897; Webb S, 1998, CIRC RES, V82, P645, DOI 10.1161/01.RES.82.6.645	28	138	142	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					353	356		10.1038/77146	http://dx.doi.org/10.1038/77146			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888889				2022-12-17	WOS:000087920900029
J	PILLERS, DAM; BULMAN, DE; WELEBER, RG; SIGESMUND, DA; MUSARELLA, MA; POWELL, BR; MURPHEY, WH; WESTALL, C; PANTON, C; BECKER, LE; WORTON, RG; RAY, PN				PILLERS, DAM; BULMAN, DE; WELEBER, RG; SIGESMUND, DA; MUSARELLA, MA; POWELL, BR; MURPHEY, WH; WESTALL, C; PANTON, C; BECKER, LE; WORTON, RG; RAY, PN			DYSTROPHIN EXPRESSION IN THE HUMAN RETINA IS REQUIRED FOR NORMAL FUNCTION AS DEFINED BY ELECTRORETINOGRAPHY	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; STATIONARY NIGHT BLINDNESS; ISLAND EYE DISEASE; B-WAVE; MUDPUPPY RETINA; MESSENGER-RNA; X-CHROMOSOME; GLIAL-CELLS; MUSCLE; GENE	We have studied retinal function by electroretinography in five Becker and six Duchenne muscular dystrophy patients. All had abnormal electroretinograms with a markedly reduced amplitude for the b-wave in the dark-adapted state. Using three antisera raised to different domains of dystrophin, we identified dystrophin in the outer plexiform layer of human retina. The retinal dystrophin is present in multiple isoforms as the result of alternative splicing. The localization of dystrophin to the outer plexiform layer coincident with the abnormal b-wave suggests that dystrophin is required for normal retinal electrophysiology.	UNIV TORONTO, HOSP SICK CHILDREN, DEPT GENET, TORONTO M5G 1X8, ONTARIO, CANADA; OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, PORTLAND, OR 97201 USA; UNIV TORONTO, HOSP SICK CHILDREN, RES INST, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT MED & MOLEC GENET, TORONTO M5G 1X8, ON, CANADA; OREGON HLTH SCI UNIV, DEPT OPHTHALMOL, PORTLAND, OR 97201 USA; HOSP SICK CHILDREN, DEPT OPHTHALMOL, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, DEPT NEUROPATHOL, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, RES INST, TORONTO M5G 1X8, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Oregon Health & Science University; Oregon Health & Science University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Oregon Health & Science University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Westall, Carol A/M-9646-2013					ALITALO T, 1991, AM J HUM GENET, V48, P31; BECHHANSEN NT, 1990, HUM GENET, V84, P406; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BURROW KL, 1991, NEUROLOGY, V41, P661, DOI 10.1212/WNL.41.5.661; CARPENTER S, 1979, BRAIN, V102, P147, DOI 10.1093/brain/102.1.147; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; CHELLY J, 1990, NATURE, V344, P64, DOI 10.1038/344064a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DICK E, 1978, BRAIN RES, V154, P388; EMORY AEH, 1988, DUCHENNE MUSCULAR DY; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FABER DS, 1969, THESIS U NEW YORK BU; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GAL A, 1989, HUM GENET, V81, P315, DOI 10.1007/BF00283682; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HEERY DM, 1990, TRENDS GENET, V6, P173; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEURON, V1, P411, DOI 10.1016/0896-6273(88)90191-2; KLINE RP, 1978, P NATL ACAD SCI USA, V75, P5727, DOI 10.1073/pnas.75.11.5727; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANSMAN JB, 1991, J MUSCLE RES CELL M, V12, P409, DOI 10.1007/BF01738325; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; MEHLER MF, 1992, P NATL ACAD SCI USA, V89, P2461, DOI 10.1073/pnas.89.6.2461; MIIKE T, 1989, BRAIN DEV-JPN, V11, P344, DOI 10.1016/S0387-7604(89)80067-1; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; PILLERS DAM, 1990, AM J MED GENET, V36, P23, DOI 10.1002/ajmg.1320360106; PILLERS DAM, 1990, AM J HUM GENET, V47, P795; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; RONG W, 1990, P NATL ACAD SCI USA, V87, P2117, DOI 10.1073/pnas.87.6.2117; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; WELEBER RG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1170, DOI 10.1001/archopht.1989.01070020236032; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069; ZHAO JE, 1991, BRAIN DEV-JPN, V13, P135, DOI 10.1016/S0387-7604(12)80123-9; ZUBRZYCKAGAARN EE, 1991, EXP CELL RES, V192, P278, DOI 10.1016/0014-4827(91)90187-Y; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	45	138	142	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1993	4	1					82	86		10.1038/ng0593-82	http://dx.doi.org/10.1038/ng0593-82			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513332				2022-12-17	WOS:A1993LA33700019
J	MORAES, CT; RICCI, E; PETRUZZELLA, V; SHANSKE, S; DIMAURO, S; SCHON, EA; BONILLA, E				MORAES, CT; RICCI, E; PETRUZZELLA, V; SHANSKE, S; DIMAURO, S; SCHON, EA; BONILLA, E			MOLECULAR ANALYSIS OF THE MUSCLE PATHOLOGY ASSOCIATED WITH MITOCHONDRIAL-DNA DELETIONS	NATURE GENETICS			English	Article								Large-scale deletions of mitochondrial DNA (mtDNA) are associated with a subgroup of mitochondrial encephalomyopathies. We studied seven patients with Kearns-Sayre syndrome or isolated ocular myopathy who harboured a sub-population of partially-deleted mitochondrial genomes in skeletal muscle. Variable cytochrome c oxidase (COX) deficiencies and reduction of mitochondrially-encoded polypeptides were found in affected muscle fibres, but while many COX-deficient fibres had increased levels of mutant mtDNA, they almost invariably had reduced levels of normal mtDNA. Our results suggest that a specific ratio between mutant and wild-type mitochondrial genomes is the most important determinant of a focal respiratory chain deficiency, even though absolute copy numbers may vary widely.	COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA	Columbia University; Columbia University			Moraes, Carlos/AAT-3818-2021; Ricci, Enzo/AAC-4448-2020	RICCI, Enzo/0000-0003-3092-3597	Telethon [231] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI B, 1971, J MOL BIOL, V55, P231, DOI 10.1016/0022-2836(71)90194-X; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; COLLINS S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P309, DOI 10.1016/0925-4439(91)90086-O; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; GERBITZ KD, 1990, J NEUROL, V237, P5, DOI 10.1007/BF00319660; GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9; KNIGHT E, 1969, BIOCHEMISTRY-US, V8, P5089, DOI 10.1021/bi00840a062; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1992, AM J HUM GENET, V50, P934; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SJOSTROM M, 1982, MUSCLE NERVE, V5, P538, DOI 10.1002/mus.880050708; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822; YONEDA M, 1990, BIOCHEM INT, V21, P789; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	35	138	139	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1992	1	5					359	367		10.1038/ng0892-359	http://dx.doi.org/10.1038/ng0892-359			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1284549				2022-12-17	WOS:A1992JJ12100015
J	Lee, HO; Hong, Y; Etlioglu, HE; Cho, YB; Pomelle, V; Van den Bosch, B; Vanhecke, J; Verbandt, S; Hong, H; Min, JW; Kim, N; Eum, HH; Qian, J; Boeckx, B; Lambrechts, D; Tsantoulis, P; De Hertogh, G; Chung, W; Lee, T; An, M; Shin, HT; Joung, JG; Jung, MH; Ko, G; Wirapati, P; Kim, SH; Kim, HC; Yun, SH; Tan, IBH; Ranjan, B; Lee, WY; Kim, TY; Choi, JK; Kim, YJ; Prabhakar, S; Tejpar, S; Park, WY				Lee, Hae-Ock; Hong, Yourae; Etlioglu, Hakki Emre; Cho, Yong Beom; Pomelle, Valentina; Van den Bosch, Ben; Vanhecke, Jasper; Verbandt, Sara; Hong, Hyekyung; Min, Jae-Woong; Kim, Nayoung; Eum, Hye Hyeon; Qian, Junbin; Boeckx, Bram; Lambrechts, Diether; Tsantoulis, Petros; De Hertogh, Gert; Chung, Woosung; Lee, Taeseob; An, Minae; Shin, Hyun-Tae; Joung, Je-Gun; Jung, Min-Hyeok; Ko, Gunhwan; Wirapati, Pratyaksha; Kim, Seok Hyung; Kim, Hee Cheol; Yun, Seong Hyeon; Tan, Iain Bee Huat; Ranjan, Bobby; Lee, Woo Yong; Kim, Tae-You; Choi, Jung Kyoon; Kim, Young-Joon; Prabhakar, Shyam; Tejpar, Sabine; Park, Woong-Yang			Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer	NATURE GENETICS			English	Article							CONSENSUS MOLECULAR SUBTYPES; COLON-CANCER; T-CELLS; HETEROGENEITY; CLASSIFICATION; ANGIOGENESIS; OSTEOPONTIN; REGULATOR; PHENOTYPE; PERICYTES	Single-cell RNA sequencing of colorectal tumors highlights associations between lineage-related gene expression signatures and specific stromal and immune cell populations. Immunotherapy for metastatic colorectal cancer is effective only for mismatch repair-deficient tumors with high microsatellite instability that demonstrate immune infiltration, suggesting that tumor cells can determine their immune microenvironment. To understand this cross-talk, we analyzed the transcriptome of 91,103 unsorted single cells from 23 Korean and 6 Belgian patients. Cancer cells displayed transcriptional features reminiscent of normal differentiation programs, and genetic alterations that apparently fostered immunosuppressive microenvironments directed by regulatory T cells, myofibroblasts and myeloid cells. Intercellular network reconstruction supported the association between cancer cell signatures and specific stromal or immune cell populations. Our collective view of the cellular landscape and intercellular interactions in colorectal cancer provide mechanistic information for the design of efficient immuno-oncology treatment strategies.	[Lee, Hae-Ock; Hong, Yourae; Min, Jae-Woong; Kim, Nayoung; Eum, Hye Hyeon; Chung, Woosung; Lee, Taeseob; An, Minae; Shin, Hyun-Tae; Joung, Je-Gun; Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Lee, Hae-Ock; Kim, Nayoung; Eum, Hye Hyeon; Park, Woong-Yang] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea; [Hong, Yourae; Cho, Yong Beom; An, Minae; Park, Woong-Yang] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Etlioglu, Hakki Emre; Pomelle, Valentina; Van den Bosch, Ben; Vanhecke, Jasper; Verbandt, Sara; Tejpar, Sabine] Katholieke Univ Leuven, Dept Oncol, Mol Digest Oncol, Leuven, Belgium; [Cho, Yong Beom; Hong, Hyekyung; Kim, Hee Cheol; Yun, Seong Hyeon; Lee, Woo Yong] Sungkyunkwan Univ, Samsung Med Ctr, Dept Surg, Sch Med, Seoul, South Korea; [Qian, Junbin; Boeckx, Bram; Lambrechts, Diether] VIB, Ctr Canc Biol, Leuven, Belgium; [Qian, Junbin; Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium; [Tsantoulis, Petros] Hop Univ Geneve, Ctr Oncol, Geneva, Switzerland; [Tsantoulis, Petros] Hop Univ Geneve, Serv Oncol, Geneva, Switzerland; [Tsantoulis, Petros] Univ Geneva, Geneva, Switzerland; [De Hertogh, Gert] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium; [De Hertogh, Gert] Dept Imaging & Pathol, Leuven, Belgium; [Lee, Taeseob] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Digital Hlth, Seoul, South Korea; [Jung, Min-Hyeok; Kim, Young-Joon] Yonsei Univ, Coll Life Sci & Technol, Dept Biochem, Seoul, South Korea; [Ko, Gunhwan] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon, South Korea; [Wirapati, Pratyaksha] Swiss Inst Bioinformat, Lausanne, Switzerland; [Kim, Seok Hyung] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol, Sch Med, Seoul, South Korea; [Tan, Iain Bee Huat] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Tan, Iain Bee Huat] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Tan, Iain Bee Huat] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore; [Ranjan, Bobby; Prabhakar, Shyam] ASTAR, Genome Inst Singapore, Syst Biol & Data Analyt, Singapore, Singapore; [Kim, Tae-You] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea; [Choi, Jung Kyoon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Kim, Young-Joon] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Grad Sch, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; KU Leuven; Sungkyunkwan University (SKKU); Samsung Medical Center; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Geneva; University of Geneva; University of Geneva; KU Leuven; University Hospital Leuven; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Swiss Institute of Bioinformatics; Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Yonsei University	Park, WY (corresponding author), Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea.; Park, WY (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.; Tejpar, S (corresponding author), Katholieke Univ Leuven, Dept Oncol, Mol Digest Oncol, Leuven, Belgium.	sabine.tejpar@uzleuven.be; woongyang.park@samsung.com	Tsantoulis, Petros/AAM-1653-2020; Lambrechts, Diether/AAJ-3167-2020; Verbandt, Sara/AAJ-1467-2021; Tsantoulis, Petros/AAO-5211-2021; Verbandt, Sara/N-9079-2016	Tsantoulis, Petros/0000-0003-3613-6682; Lambrechts, Diether/0000-0002-3429-302X; Qian, Junbin/0000-0003-1483-1836; Eum, Hye Hyeon/0000-0002-8081-4121; Ranjan, Bobby/0000-0001-5804-7205; Joung, Je-Gun/0000-0003-2859-1036; Lee, Hae-Ock/0000-0001-5123-0322; Hong, Yourae/0000-0001-6683-433X; Verbandt, Sara/0000-0003-1242-3716; Qian, Junbin/0000-0001-6145-045X	Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science ICT [NRF2017M3A9A7050803]; Belgian Federation against Cancer [2018-127, 2016-133]; Fondation Roi-Baudouin; Research Foundation-Flanders	Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science ICT; Belgian Federation against Cancer; Fondation Roi-Baudouin; Research Foundation-Flanders(FWO)	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science & ICT (grant no. NRF2017M3A9A7050803), by the Belgian Federation against Cancer grant nos. 2018-127 and 2016-133 and by a grant from Fondation Roi-Baudouin. S.T. and S.V. are respectively supported by a Senior Clinical Investigator award and a postdoctoral fellowship of the Research Foundation-Flanders.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Benoit ME, 2012, J IMMUNOL, V188, P5682, DOI 10.4049/jimmunol.1103760; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Castello LM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4049098; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Fessler E, 2016, EMBO MOL MED, V8, P745, DOI 10.15252/emmm.201606184; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Green J, 2016, AM J RESP CELL MOL, V54, P532, DOI 10.1165/rcmb.2015-0095OC; Griffioen AW, 1996, BLOOD, V88, P667, DOI 10.1182/blood.V88.2.667.bloodjournal882667; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Guo HT, 2001, J IMMUNOL, V166, P1079, DOI 10.4049/jimmunol.166.2.1079; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kitajima S, 2016, SEMIN CELL DEV BIOL, V58, P127, DOI 10.1016/j.semcdb.2016.06.009; Klement JD, 2018, J CLIN INVEST, V128, P5549, DOI 10.1172/JCI123360; Kumar A, 2017, CELL REP, V19, P1902, DOI 10.1016/j.celrep.2017.05.019; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu ZH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00039-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Perez-Villamil B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-260; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rao M, 2015, GLIA, V63, P2040, DOI 10.1002/glia.22876; Ren XW, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1593-z; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suva ML, 2019, MOL CELL, V75, P7, DOI 10.1016/j.molcel.2019.05.003; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Thanki Ketan, 2017, Int Biol Biomed J, V3, P105; Trinh A, 2018, BRIT J CANCER, V119, P1244, DOI 10.1038/s41416-018-0230-7; Vanuytsel T, 2013, BBA-GEN SUBJECTS, V1830, P2410, DOI 10.1016/j.bbagen.2012.08.006; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zhang W, 2017, J IMMUNOL, V198, P3719, DOI 10.4049/jimmunol.1602039; Zhao Q, 2018, CANCER RES, V78, P2370, DOI 10.1158/0008-5472.CAN-17-2728; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	74	137	137	7	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2020	52	6					594	+		10.1038/s41588-020-0636-z	http://dx.doi.org/10.1038/s41588-020-0636-z		MAY 2020	12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV2FA	32451460				2022-12-17	WOS:000535394900003
J	Tin, A; Marten, J; Kuhns, VLH; Li, Y; Wuttke, M; Kirsten, H; Sieber, KB; Qiu, CX; Gorski, M; Yu, Z; Giri, A; Sveinbjornsson, G; Li, M; Chu, AY; Hoppmann, A; O'Connor, LJ; Prins, B; Nutile, T; Noce, D; Akiyama, M; Cocca, M; Ghasemi, S; van Der Most, PJ; Horn, K; Xu, YZ; Fuchsberger, C; Sedaghat, S; Afaq, S; Amin, N; Arnlo, J; Bakker, SJL; Bansal, N; Baptista, D; Bergmann, S; Biggs, ML; Biino, G; Boerwinkle, E; Bottinger, EP; Boutin, TS; Brumat, M; Burkhardt, R; Campana, E; Campbell, A; Campbell, H; Carroll, RJ; Catamo, E; Chambers, JC; Ciullo, M; Concas, MP; Coresh, J; Corre, T; Cusi, D; Felicita, SC; de Borst, MH; De Grandi, A; de Mutsert, R; de Vries, APJ; Delgado, G; Demirkan, A; Devuyst, O; Dittrich, K; Eckardt, KU; Ehret, G; Endlich, K; Evans, MK; Gansevoort, RT; Gasparini, P; Giedraitis, V; Gieger, C; Girotto, G; Ggele, M; Gordon, SD; Gudbjartsson, DF; Gudnason, V; Haller, T; Hamet, P; Harris, TB; Hayward, C; Hicks, AA; Hofer, E; Holm, H; Huang, W; Hutri-Kahonen, N; Hwang, SJ; Ikram, MA; Lewis, RM; Ingelsson, E; Jakobsdottir, J; Jonsdottir, I; Jonsson, H; Joshi, PK; Josyula, NS; Jung, B; Kahonen, M; Kamatani, Y; Kanai, M; Kerr, SM; Kiess, W; Kleber, ME; Koenig, W; Kooner, JS; Korner, A; Kovacs, P; Kramer, BK; Kronenberg, F; Kubo, M; Kuhnel, B; La Bianca, M; Lange, LA; Lehne, B; Lehtimaki, T; Liu, J; Loeffler, M; Loos, RJF; Lyytikainen, LP; Magi, R; Mahajan, A; Martin, NG; Marz, W; Mascalzoni, D; Matsuda, K; Meisinger, C; Meitinger, T; Metspalu, A; Milaneschi, Y; ODonnell, CJ; Wilson, OD; Gaziano, JM; Mishra, PP; Mohlke, KL; Mononen, N; Montgomery, GW; Mook-Kanamori, DO; Muller-Nurasyid, M; Nadkarni, GN; Nalls, MA; Nauck, M; Nikus, K; Ning, BT; Nolte, IM; Noordam, R; O'Connell, JR; Olafsson, I; Padmanabhan, S; Penninx, BWJH; Perls, T; Peters, A; Pirastu, M; Pirastu, N; Pistis, G; Polasek, O; Ponte, B; Porteous, DJ; Poulain, T; Preuss, MH; Rabelink, TJ; Raffield, LM; Raitakari, OT; Rettig, R; Rheinberger, M; Rice, KM; Rizzi, F; Robino, A; Rudan, I; Krajcoviechova, A; Cifkova, R; Rueedi, R; Ruggiero, D; Ryan, KA; Saba, Y; Salvi, E; Schmidt, H; Schmidt, R; Shaffer, CM; Smith, AV; Smith, BH; Spracklen, CN; Strauch, K; Stumvoll, M; Sulem, P; Tajuddin, SM; Teren, A; Thiery, J; Thio, CHL; Thorsteinsdottir, U; Toniolo, D; Tonjes, A; Tremblay, J; Uitterlinden, AG; Vaccargiu, S; van der Harst, P; van Duijn, CM; Verweij, N; Volker, U; Vollenweider, P; Waeber, G; Waldenberger, M; Whitfield, JB; Wild, SH; Wilson, JF; Yang, Q; Zhang, WH; Zonderman, AB; Bochud, M; Wilson, JG; Pendergrass, SA; Ho, K; Parsa, A; Pramstaller, PP; Psaty, BM; Boger, CA; Snieder, H; Butterworth, AS; Okada, Y; Edwards, TL; Stefansson, K; Susztak, K; Scholz, M; Heid, IM; Hung, AM; Teumer, A; Pattaro, C; Woodward, OM; Vitart, V; Kottgen, A				Tin, Adrienne; Marten, Jonathan; Kuhns, Victoria L. Halperin; Li, Yong; Wuttke, Matthias; Kirsten, Holger; Sieber, Karsten B.; Qiu, Chengxiang; Gorski, Mathias; Yu, Zhi; Giri, Ayush; Sveinbjornsson, Gardar; Li, Man; Chu, Audrey Y.; Hoppmann, Anselm; O'Connor, Luke J.; Prins, Bram; Nutile, Teresa; Noce, Damia; Akiyama, Masato; Cocca, Massimiliano; Ghasemi, Sahar; van Der Most, Peter J.; Horn, Katrin; Xu, Yizhe; Fuchsberger, Christian; Sedaghat, Sanaz; Afaq, Saima; Amin, Najaf; Arnlov, Johan; Bakker, Stephan J. L.; Bansal, Nisha; Baptista, Daniela; Bergmann, Sven; Biggs, Mary L.; Biino, Ginevra; Boerwinkle, Eric; Bottinger, Erwin P.; Boutin, Thibaud S.; Brumat, Marco; Burkhardt, Ralph; Campana, Eric; Campbell, Archie; Campbell, Harry; Carroll, Robert J.; Catamo, Eulalia; Chambers, John C.; Ciullo, Marina; Concas, Maria Pina; Coresh, Josef; Corre, Tanguy; Cusi, Daniele; Felicita, Sala Cinzia; de Borst, Martin H.; De Grandi, Alessandro; de Mutsert, Rene; de Vries, Aiko P. J.; Delgado, Graciela; Demirkan, Ayse; Devuyst, Olivier; Dittrich, Katalin; Eckardt, Kai-Uwe; Ehret, Georg; Endlich, Karlhans; Evans, Michele K.; Gansevoort, Ron T.; Gasparini, Paolo; Giedraitis, Vilmantas; Gieger, Christian; Girotto, Giorgia; Ggele, Martin; Gordon, Scott D.; Gudbjartsson, Daniel F.; Gudnason, Vilmundur; Haller, Toomas; Hamet, Pavel; Harris, Tamara B.; Hayward, Caroline; Hicks, Andrew A.; Hofer, Edith; Holm, Hilma; Huang, Wei; Hutri-Kahonen, Nina; Hwang, Shih-Jen; Ikram, M. Arfan; Lewis, Raychel M.; Ingelsson, Erik; Jakobsdottir, Johanna; Jonsdottir, Ingileif; Jonsson, Helgi; Joshi, Peter K.; Josyula, Navya Shilpa; Jung, Bettina; Kahonen, Mika; Kamatani, Yoichiro; Kanai, Masahiro; Kerr, Shona M.; Kiess, Wieland; Kleber, Marcus E.; Koenig, Wolfgang; Kooner, Jaspal S.; Korner, Antje; Kovacs, Peter; Kramer, Bernhard K.; Kronenberg, Florian; Kubo, Michiaki; Kuhnel, Brigitte; La Bianca, Martina; Lange, Leslie A.; Lehne, Benjamin; Lehtimaki, Terho; Liu, Jun; Loeffler, Markus; Loos, Ruth J. F.; Lyytikainen, Leo-Pekka; Magi, Reedik; Mahajan, Anubha; Martin, Nicholas G.; Marz, Winfried; Mascalzoni, Deborah; Matsuda, Koichi; Meisinger, Christa; Meitinger, Thomas; Metspalu, Andres; Milaneschi, Yuri; ODonnell, Christopher J.; Wilson, Otis D.; Gaziano, J. Michael; Mishra, Pashupati P.; Mohlke, Karen L.; Mononen, Nina; Montgomery, Grant W.; Mook-Kanamori, Dennis O.; Mueller-Nurasyid, Martina; Nadkarni, Girish N.; Nalls, Mike A.; Nauck, Matthias; Nikus, Kjell; Ning, Boting; Nolte, Ilja M.; Noordam, Raymond; O'Connell, Jeffrey R.; Olafsson, Isleifur; Padmanabhan, Sandosh; Penninx, Brenda W. J. H.; Perls, Thomas; Peters, Annette; Pirastu, Mario; Pirastu, Nicola; Pistis, Giorgio; Polasek, Ozren; Ponte, Belen; Porteous, David J.; Poulain, Tanja; Preuss, Michael H.; Rabelink, Ton J.; Raffield, Laura M.; Raitakari, Olli T.; Rettig, Rainer; Rheinberger, Myriam; Rice, Kenneth M.; Rizzi, Federica; Robino, Antonietta; Rudan, Igor; Krajcoviechova, Alena; Cifkova, Renata; Rueedi, Rico; Ruggiero, Daniela; Ryan, Kathleen A.; Saba, Yasaman; Salvi, Erika; Schmidt, Helena; Schmidt, Reinhold; Shaffer, Christian M.; Smith, Albert, V; Smith, Blair H.; Spracklen, Cassandra N.; Strauch, Konstantin; Stumvoll, Michael; Sulem, Patrick; Tajuddin, Salman M.; Teren, Andrej; Thiery, Joachim; Thio, Chris H. L.; Thorsteinsdottir, Unnur; Toniolo, Daniela; Tonjes, Anke; Tremblay, Johanne; Uitterlinden, Andre G.; Vaccargiu, Simona; van der Harst, Pim; van Duijn, Cornelia M.; Verweij, Niek; Voelker, Uwe; Vollenweider, Peter; Waeber, Gerard; Waldenberger, Melanie; Whitfield, John B.; Wild, Sarah H.; Wilson, James F.; Yang, Qiong; Zhang, Weihua; Zonderman, Alan B.; Bochud, Murielle; Wilson, James G.; Pendergrass, Sarah A.; Ho, Kevin; Parsa, Afshin; Pramstaller, Peter P.; Psaty, Bruce M.; Boeger, Carsten A.; Snieder, Harold; Butterworth, Adam S.; Okada, Yukinori; Edwards, Todd L.; Stefansson, Kari; Susztak, Katalin; Scholz, Markus; Heid, Iris M.; Hung, Adriana M.; Teumer, Alexander; Pattaro, Cristian; Woodward, Owen M.; Vitart, Veronique; Koettgen, Anna		German Chronic Kidney Dis Study; Lifelines Cohort Study; VA Million Vet Program	Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; URIC-ACID LEVELS; R PACKAGE; KIDNEY-FUNCTION; FACTOR-BINDING; LOCI; GOUT; RISK; TRAITS	Elevated serum urate levels cause gout and correlate with cardiometabolic diseases via poorly understood mechanisms. We performed a trans-ancestry genome-wide association study of serum urate in 457,690 individuals, identifying 183 loci (147 previously unknown) that improve the prediction of gout in an independent cohort of 334,880 individuals. Serum urate showed significant genetic correlations with many cardiometabolic traits, with genetic causality analyses supporting a substantial role for pleiotropy. Enrichment analysis, fine-mapping of urate-associated loci and colocalization with gene expression in 47 tissues implicated the kidney and liver as the main target organs and prioritized potentially causal genes and variants, including the transcriptional master regulators in the liver and kidney, HNF1A and HNF4A. Experimental validation showed that HNF4A transactivated the promoter of ABCG2, encoding a major urate transporter, in kidney cells, and that HNF4A p.Thr139Ile is a functional variant. Transcriptional coregulation within and across organs may be a general mechanism underlying the observed pleiotropy between urate and cardiometabolic traits.	[Tin, Adrienne; Yu, Zhi; Coresh, Josef; Koettgen, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Tin, Adrienne] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Marten, Jonathan; Boutin, Thibaud S.; Hayward, Caroline; Kerr, Shona M.; Wilson, James F.; Vitart, Veronique] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Kuhns, Victoria L. Halperin; Lewis, Raychel M.; Woodward, Owen M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Li, Yong; Wuttke, Matthias; Hoppmann, Anselm; Koettgen, Anna] Univ Freiburg, Inst Genet Epidemiol, Dept Biometry Epidemiol & Med Bioinformat, Fac Med, Freiburg, Germany; [Li, Yong; Wuttke, Matthias; Hoppmann, Anselm; Koettgen, Anna] Univ Freiburg, Med Ctr, Freiburg, Germany; [Kirsten, Holger; Horn, Katrin; Loeffler, Markus; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Kirsten, Holger; Horn, Katrin; Burkhardt, Ralph; Kiess, Wieland; Korner, Antje; Loeffler, Markus; Poulain, Tanja; Teren, Andrej; Thiery, Joachim; Scholz, Markus] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany; [Sieber, Karsten B.] GlaxoSmithKline, Target Sci Genet, Collegeville, PA USA; [Qiu, Chengxiang; Susztak, Katalin] Univ Penn, Dept Med & Genet, Philadelphia, PA 19104 USA; [Gorski, Mathias; Jung, Bettina; Rheinberger, Myriam; Boeger, Carsten A.] Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Gorski, Mathias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Yu, Zhi] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Giri, Ayush] Vanderbilt Univ, Med Ctr, Inst Med & Publ Hlth,Div Quantitat Sci,Dept Obste, Vanderbilt Genet Inst,Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Giri, Ayush] Vanderbilt Univ, Biomed Lab Res & Dev, Tennessee Valley Healthcare Syst 626, Nashville, TN USA; [Sveinbjornsson, Gardar; Gudbjartsson, Daniel F.; Holm, Hilma; Jonsdottir, Ingileif; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Li, Man; Xu, Yizhe] Univ Utah, Dept Med, Div Nephrol & Hypertens, Salt Lake City, UT 84112 USA; [Chu, Audrey Y.] Merck & Co Inc, Genet, Kenilworth, NJ USA; [O'Connor, Luke J.] Harvard TH Chan Sch Publ Hlth, Epidemiol, Boston, MA USA; [Prins, Bram] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Nutile, Teresa; Ciullo, Marina; Ruggiero, Daniela] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Noce, Damia; Fuchsberger, Christian; De Grandi, Alessandro; Ggele, Martin; Hicks, Andrew A.; Mascalzoni, Deborah; Pramstaller, Peter P.; Pattaro, Cristian] Inst Biomed, Eurac Res, Bolzano, Italy; [Akiyama, Masato; Kamatani, Yoichiro; Kanai, Masahiro] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Akiyama, Masato] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Cocca, Massimiliano; Catamo, Eulalia; Concas, Maria Pina; Gasparini, Paolo; Girotto, Giorgia; La Bianca, Martina; Robino, Antonietta] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Ghasemi, Sahar; Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Ghasemi, Sahar; Endlich, Karlhans; Nauck, Matthias; Voelker, Uwe; Teumer, Alexander] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [van Der Most, Peter J.; Nolte, Ilja M.; Thio, Chris H. L.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Sedaghat, Sanaz; Amin, Najaf; Demirkan, Ayse; Ikram, M. Arfan; Liu, Jun; van Duijn, Cornelia M.] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Afaq, Saima; Chambers, John C.; Lehne, Benjamin; Zhang, Weihua] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Afaq, Saima] Khyber Med Univ, Inst Publ Hlth & Social Sci, Peshawar, Pakistan; [Arnlov, Johan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Stockholm, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Bakker, Stephan J. L.; de Borst, Martin H.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Bansal, Nisha] Univ Washington, Div Nephrol, Seattle, WA 98195 USA; [Bansal, Nisha] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Baptista, Daniela; Ehret, Georg] Geneva Univ Hosp, Cardiol, Geneva, Switzerland; [Bergmann, Sven; Corre, Tanguy; Rueedi, Rico] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Bergmann, Sven; Corre, Tanguy; Rueedi, Rico] Swiss Inst Bioinformat, Lausanne, Switzerland; [Bergmann, Sven] Univ Cape Town, Dept Integrat Biomed Sci, Cape Town, South Africa; [Biggs, Mary L.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Biggs, Mary L.; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Bottinger, Erwin P.] Icahn Sch Med Mt Sinai, Hasso Plattner Inst Digital Hlth Mt Sinai, New York, NY 10029 USA; [Brumat, Marco; Campana, Eric; Gasparini, Paolo; Girotto, Giorgia] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Burkhardt, Ralph; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Burkhardt, Ralph] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany; [Campbell, Archie; Porteous, David J.] Univ Edinburgh, Ctr Genom & Expt Med, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Campbell, Harry; Joshi, Peter K.; Pirastu, Nicola; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Carroll, Robert J.; Shaffer, Christian M.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA; [Chambers, John C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Chambers, John C.; Kooner, Jaspal S.; Zhang, Weihua] Ealing Gen Hosp, Dept Cardiol, London, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, Imperial Coll London, London, England; [Chambers, John C.] Imperial Coll London, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London, England; [Ciullo, Marina; Ruggiero, Daniela] IRCCS Neuromed, Pozzilli, Italy; [Corre, Tanguy; Bochud, Murielle] Univ Lausanne, Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland; [Cusi, Daniele] Italy Natl Res Council, Inst Biomed Technol, Milan, Italy; [Cusi, Daniele] Bio4Dreams, Milan, Italy; [Felicita, Sala Cinzia; Toniolo, Daniela] San Raffaele Res Inst, Milan, Italy; [de Mutsert, Rene; Mook-Kanamori, Dennis O.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [de Vries, Aiko P. J.; Rabelink, Ton J.] Leiden Univ, Dept Internal Med, Sect Nephrol, Med Ctr, Leiden, Netherlands; [Delgado, Graciela; Kleber, Marcus E.; Kramer, Bernhard K.; Marz, Winfried] Heidelberg Univ, Med Fac Mannheim, Dept Med Nephrol Hypertensiol Rheumatol Endocrino, Mannheim, Germany; [Demirkan, Ayse] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Dittrich, Katalin; Kiess, Wieland; Korner, Antje] Univ Leipzig, Hosp Children & Adolescents, Dept Women & Child Hlth, Leipzig, Germany; [Dittrich, Katalin; Kiess, Wieland; Korner, Antje] Univ Leipzig, Ctr Pediat Res, Leipzig, Germany; [Eckardt, Kai-Uwe] Charit Univ Med Berlin, Dept Nephrol & Med Intens Care, Berlin, Germany; [Eckardt, Kai-Uwe] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, Erlangen, Germany; [Endlich, Karlhans] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Evans, Michele K.; Tajuddin, Salman M.; Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Giedraitis, Vilmantas] Uppsala Univ, Dept Publ Hlth & Caring Sci, Mol Geriatr, Uppsala, Sweden; [Gieger, Christian; Kuhnel, Brigitte; Waldenberger, Melanie] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Gieger, Christian; Peters, Annette; Waldenberger, Melanie] Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Gieger, Christian; Peters, Annette] German Ctr Diabet Res, Neuherberg, Germany; [Gordon, Scott D.; Martin, Nicholas G.; Whitfield, John B.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Gudnason, Vilmundur; Jakobsdottir, Johanna] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur; Smith, Albert, V] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland; [Haller, Toomas; Magi, Reedik; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Inst Genom, Tartu, Estonia; [Hamet, Pavel; Tremblay, Johanne] Ctr Hosp Univ Montreal, Montreal Univ Hosp Res Ctr, Montreal, PQ, Canada; [Hamet, Pavel] Medpharmgene, Montreal, PQ, Canada; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Huang, Wei] Chinese Natl Human Genome Ctr, Dept Genet, Shanghai Most Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Huang, Wei] Shanghai Ind Technol Inst, Shanghai, Peoples R China; [Hutri-Kahonen, Nina; Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Mishra, Pashupati P.; Mononen, Nina] Tampere Univ, Dept Clin Chem, Fimlab Labs, Fac Med & Hlth Technol, Tampere, Finland; [Hutri-Kahonen, Nina; Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Mishra, Pashupati P.; Mononen, Nina] Tampere Univ, Fac Med & Hlth Technol, Finnish Cardiovasc Res Ctr, Tampere, Finland; [Hutri-Kahonen, Nina] Tampere Univ, Fac Med & Hlth Technol, Dept Pediat, Tampere, Finland; [Hwang, Shih-Jen] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Hwang, Shih-Jen] NHLBI, Ctr Populat Studies, Framingham, MA USA; [Ingelsson, Erik] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA; [Jakobsdottir, Johanna] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Jonsson, Helgi] Landspitalinn Univ Hosp, Reykjavik, Iceland; [Jonsson, Helgi] Univ Iceland, Reykjavik, Iceland; [Josyula, Navya Shilpa] Geisinger Res Biomed & Translat Informat Inst, Rockville, MD USA; [Kahonen, Mika] Tampere Univ, Tampere Univ Hosp, Dept Clin Physiol, Fac Med & Hlth Technol, Tampere, Finland; [Kahonen, Mika] Tampere Univ, Finnish Cardiovasc Res Ctr Tampere, Fac Med & Hlth Technol, Tampere, Finland; [Kamatani, Yoichiro] Kyoto Univ, Kyoto McGill Int Collaborat Sch Genom Med, Grad Sch Med, Kyoto, Japan; [Kanai, Masahiro] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang; Meitinger, Thomas; Mueller-Nurasyid, Martina; Peters, Annette; Waldenberger, Melanie] German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Inst Epidemiol & Biostat, Ulm, Germany; [Kooner, Jaspal S.] Imperial Coll London, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth 323, London, England; [Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Kovacs, Peter] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Leipzig, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Lange, Leslie A.] Univ Colorado Denver, Div Biomed Informat & Personalized Med, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Liu, Jun; van Duijn, Cornelia M.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Loos, Ruth J. F.; Nadkarni, Girish N.; Preuss, Michael H.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Mahajan, Anubha] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Mahajan, Anubha] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Marz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Mannheim, Germany; [Marz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Lab Clin Genome Sequencing, Tokyo, Japan; [Meisinger, Christa] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Independent Res Grp Clin Epidemiol, Neuherberg, Germany; [Meisinger, Christa] Ludwig Maximilians Univ Munchen UNIKA T Augsburg, Augsburg, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Amsterdam Univ Med Ctr, Dept Psychiat, Amsterdam Neurosci, Amsterdam, Netherlands; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Amsterdam Univ Med Ctr, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [ODonnell, Christopher J.] VA Boston Healthcare Syst, Boston, MA USA; [ODonnell, Christopher J.; Gaziano, J. Michael] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wilson, Otis D.; Hung, Adriana M.] Vanderbilt Univ, Div Nephrol & Hypertens, Med Ctr, Nashville, TN USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, VA Cooperat Studies Program, Boston, MA USA; [Mohlke, Karen L.; Raffield, Laura M.; Spracklen, Cassandra N.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Montgomery, Grant W.] Univ Queensland, St Lucia, Qld, Australia; [Mook-Kanamori, Dennis O.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Mueller-Nurasyid, Martina; Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Fac Med, IBE, Chair Genet Epidemiol, Munich, Germany; [Mueller-Nurasyid, Martina] Hosp Ludwig Maximilians Univ Munich, Dept Internal Med Cardiol 1, Munich, Germany; [Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Nalls, Mike A.] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Nalls, Mike A.] Data Tecn Int, Glen Echo, MD USA; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Nikus, Kjell] Tampere Univ Hosp, Heart Ctr, Dept Cardiol, Tampere, Finland; [Nikus, Kjell] Tampere Univ, Fac Med & Hlth Technol, Finnish Cardiovasc Res Ctr Tampere, Dept Cardiol, Tampere, Finland; [Ning, Boting; Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Noordam, Raymond] Leiden Univ, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland; [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Perls, Thomas] Boston Univ, Boston Med Ctr, Dept Med, Geriatr Sect,Sch Med, Boston, MA USA; [Pirastu, Mario; Vaccargiu, Simona] Natl Res Council Italy, Inst Genet & Biomed Res, UOS Sassari, Sassari, Italy; [Pistis, Giorgio] Univ Hosp Lausanne, Dept Psychiat, Lausanne, Switzerland; [Polasek, Ozren] Univ Split, Fac Med, Split, Croatia; [Polasek, Ozren] Geninfo Ltd, Zagreb, Croatia; [Ponte, Belen] Univ Hosp Geneva, Dept Specialties Internal Med, Nephrol Serv, Geneva, Switzerland; [Porteous, David J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Rabelink, Ton J.] Leiden Univ, Einthoven Lab Expt Vasc Res, Med Ctr, Leiden, Netherlands; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Ctr Populat Hlth Res, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Turku, Finland; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [Rizzi, Federica; Salvi, Erika] Univ Milan, Dept Hlth Sci, Milan, Italy; [Rizzi, Federica] ePhood SRL, ePhood Sci Unit, Milan, Italy; [Krajcoviechova, Alena; Cifkova, Renata] Charles Univ Prague, Fac Med 1, Ctr Cardiovasc Prevent, Prague, Czech Republic; [Krajcoviechova, Alena; Cifkova, Renata] Thomayer Hosp, Prague, Czech Republic; [Cifkova, Renata] Charles Univ Prague, Fac Med 1, Dept Med 2, Prague, Czech Republic; [Ryan, Kathleen A.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Saba, Yasaman] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, Graz, Austria; [Salvi, Erika] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Unit, Milan, Italy; [Schmidt, Helena] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Smith, Blair H.] Univ Dundee, Ninewells Hosp & Med Sch, Div Populat Hlth & Genom, Dundee, Scotland; [Stumvoll, Michael] Univ Leipzig, Div Endocrinol Nephrol & Rheumatol, Leipzig, Germany; [Teren, Andrej] Heart Ctr Leipzig, Leipzig, Germany; [Tonjes, Anke] Univ Leipzig, Dept Endocrinol & Nephrol, Leipzig, Germany; [Tremblay, Johanne] CHUM, Ctr Rech, Montreal, PQ, Canada; [Uitterlinden, Andre G.] Univ Med Ctr Rotterdam, Dept Internal Med, Erasmus MC, Rotterdam, Netherlands; [van der Harst, Pim; Verweij, Niek] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Harst, Pim] Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands; [van Duijn, Cornelia M.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Verweij, Niek] Genomics Plc, Oxford, England; [Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Vollenweider, Peter; Waeber, Gerard] Lausanne Univ Hosp, Dept Med, Internal Med, Lausanne, Switzerland; [Wild, Sarah H.] Univ Edinburgh, Ctr Populat Hlth Sci, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Pendergrass, Sarah A.] Geisinger Res, Biomed & Translat Informat Inst, Danville, PA USA; [Ho, Kevin] Geisinger, Kidney Hlth Res Inst, Danville, PA USA; [Ho, Kevin] Geisinger, Dept Nephrol, Danville, PA USA; [Parsa, Afshin] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA; [Parsa, Afshin] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Dept Epidemiol,Dept Hlth Serv, Seattle, WA USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Boeger, Carsten A.] Kliniken Sudostbayern AG, Dept Nephrol & Rheumatol, Traunstein, Germany; [Butterworth, Adam S.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Okada, Yukinori] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Osaka, Japan; [Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Osaka, Japan; [Edwards, Todd L.] Vanderbilt Univ, Vanderbilt Genet Inst, Dept Med, Div Epidemiol,Med Ctr, Nashville, TN USA; [Edwards, Todd L.; Hung, Adriana M.] Vanderbilt Univ, Dept Vet Affairs, Tennessee Valley Healthcare Syst 626, 221 Kirkland Hall, Nashville, TN 37235 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh; University System of Maryland; University of Maryland Baltimore; University of Freiburg; University of Freiburg; Leipzig University; Leipzig University; GlaxoSmithKline; University of Pennsylvania; University of Regensburg; University of Regensburg; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vanderbilt University; Vanderbilt University; Utah System of Higher Education; University of Utah; Merck & Company; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); European Academy of Bozen-Bolzano; RIKEN; Kyushu University; IRCCS Burlo Garofolo; Greifswald Medical School; German Centre for Cardiovascular Research; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Khyber Medical University; Karolinska Institutet; Dalarna University; University of Groningen; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Geneva; University of Lausanne; Swiss Institute of Bioinformatics; University of Cape Town; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Texas System; University of Texas Health Science Center Houston; Icahn School of Medicine at Mount Sinai; University of Trieste; Leipzig University; University of Regensburg; University of Edinburgh; University of Edinburgh; Vanderbilt University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Imperial College London; Imperial College London; IRCCS Neuromed; University of Lausanne; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ruprecht Karls University Heidelberg; University of Groningen; University of Zurich; Leipzig University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg; Greifswald Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; QIMR Berghofer Medical Research Institute; Icelandic Heart Association; University of Iceland; University of Tartu; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Graz; Medical University of Graz; Tampere University; Tampere University; Tampere University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University; Stanford University; Uppsala University; Stanford University; University of Iceland; Landspitali National University Hospital; University of Iceland; Tampere University; Tampere University Hospital; Tampere University; Kyoto University; Harvard University; Harvard Medical School; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; Imperial College London; Imperial College London; Leipzig University; Medical University of Innsbruck; RIKEN; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oxford; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; SYNLAB Group; Medical University of Graz; University of Tokyo; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; University of Queensland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Greifswald Medical School; Tampere University; Tampere University Hospital; Tampere University; Boston University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University System of Maryland; University of Maryland Baltimore; Landspitali National University Hospital; University of Glasgow; Boston Medical Center; Boston University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Split; University of Geneva; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turku; University of Turku; University of Turku; University of Turku; Greifswald Medical School; University of Milan; Charles University Prague; Thomayer Hospital; Charles University Prague; University System of Maryland; University of Maryland Baltimore; Medical University of Graz; IRCCS Istituto Neurologico Besta; Medical University of Graz; University of Dundee; Leipzig University; Heart Center Leipzig GMBH; Leipzig University; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; Leiden University; Leiden University - Excl LUMC; Greifswald Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Edinburgh; University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; Kaiser Permanente; University of Cambridge; RIKEN; Osaka University; Vanderbilt University; Vanderbilt University	Tin, A; Kottgen, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	atin1@jhu.edu; anna.koettgen@uniklinik-freiburg.de	Ciullo, Marina/AAE-3041-2020; Fuchsberger, Christian/ABD-7127-2021; Rabelink, Ton J./A-5316-2008; Akiyama, Masato/AHC-2589-2022; Raitakari, Olli/AAQ-7389-2021; Campbell, Harry/E-2959-2010; Kanai, Masahiro/AAD-6726-2021; Körner, Antje/B-3988-2015; Teumer, Alexander/S-7438-2019; Stefansson, Kari/AAE-7187-2019; Smith, Albert Vernon/AHC-3838-2022; Ikram, M. Arfan/AAM-5225-2021; Qiu, Chengxiang/X-5040-2019; Loos, Ruth J F/Q-2862-2016; Polasek, Ozren/B-6002-2011; Campbell, Archie/AAZ-1757-2021; Evans, Michele Kim/AAE-4776-2019; Stumvoll, Michael/ABE-1121-2021; EHRET, Georg B/A-9532-2009; Verweij, Niek/ABC-6249-2021; Lehtimäki, Terho/AAD-1094-2022; Gudnason, Vilmundur/AAE-7126-2019; Smith, Blair H/G-2834-2012; Peters, Annette/A-6117-2011; de Vries, Aiko P.J./J-5397-2015; Salvi, Erika/AAA-1415-2019; Susztak, Katalin/ABE-7474-2021; Hicks, Andrew Anthony/E-9518-2017; Loos, Ruth/GON-5877-2022; zhang, weihua/GXV-1334-2022; Müller-Nurasyid, Martina/I-8735-2018; Colaus, PsyColaus/K-6607-2013; Toniolo, Daniela/AAE-2969-2019; Pirastu, Nicola/AHB-6226-2022; Waldenberger, Melanie/B-5355-2014; Hwang, Shih-Jen/HGU-5826-2022; Ärnlöv, Johan/AAF-2746-2019; Wilson, James F/A-5704-2009; ruggiero, daniela/K-5638-2016; Kirsten, Holger/AAP-7250-2020; Mägi, Reedik/AAJ-9679-2021; Porteous, David/AAA-3446-2021; Penninx, Brenda WJH/S-7627-2017; Robino, Antonietta/K-9398-2016; Girotto, Giorgia/I-9452-2018; concas, maria pina/K-2266-2018; Kronenberg, Florian/B-1736-2008; Rudan, Igor/I-1467-2012	Ciullo, Marina/0000-0002-9621-9984; Fuchsberger, Christian/0000-0002-5918-8947; Rabelink, Ton J./0000-0001-6780-5186; Campbell, Harry/0000-0002-6169-6262; Kanai, Masahiro/0000-0001-5165-4408; Körner, Antje/0000-0001-6001-0356; Teumer, Alexander/0000-0002-8309-094X; Smith, Albert Vernon/0000-0003-1942-5845; Qiu, Chengxiang/0000-0002-6346-8669; Loos, Ruth J F/0000-0002-8532-5087; Polasek, Ozren/0000-0002-5765-1862; Stumvoll, Michael/0000-0001-6225-8240; EHRET, Georg B/0000-0002-5730-0675; Verweij, Niek/0000-0002-4303-7685; Lehtimäki, Terho/0000-0002-2555-4427; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Blair H/0000-0002-5362-9430; Peters, Annette/0000-0001-6645-0985; de Vries, Aiko P.J./0000-0002-9284-3595; Salvi, Erika/0000-0002-2724-2291; Susztak, Katalin/0000-0002-1005-3726; Hicks, Andrew Anthony/0000-0001-6320-0411; Müller-Nurasyid, Martina/0000-0003-3793-5910; Toniolo, Daniela/0000-0001-9545-6032; Waldenberger, Melanie/0000-0003-0583-5093; Ärnlöv, Johan/0000-0002-6933-4637; Wilson, James F/0000-0001-5751-9178; ruggiero, daniela/0000-0003-3898-7827; Kirsten, Holger/0000-0002-3126-7950; Porteous, David/0000-0003-1249-6106; Gasparini, Paolo/0000-0002-0859-0856; Sedaghat, Sanaz/0000-0002-8296-1811; Horn, Katrin/0000-0002-5307-6936; Burkhardt, Ralph/0000-0003-1924-1202; Penninx, Brenda WJH/0000-0001-7779-9672; Joshi, Peter/0000-0002-6361-5059; Raffield, Laura/0000-0002-7892-193X; Noordam, Raymond/0000-0001-7801-809X; Kahonen, Mika/0000-0002-4510-7341; Woodward, Owen M./0000-0001-9514-2180; Pramstaller, Peter P/0000-0002-9831-8302; Endlich, Karlhans/0000-0001-6052-6061; Jakobsdottir, Johanna/0000-0002-8019-9683; De Borst, Martin/0000-0002-4127-8733; Robino, Antonietta/0000-0003-2152-2353; Saba, Yasaman/0000-0002-3549-2493; Wuttke, Matthias/0000-0003-3420-5082; Girotto, Giorgia/0000-0003-4507-6589; Kovacs, Peter/0000-0002-0290-5423; Devuyst, Olivier/0000-0003-3744-4767; Van Duijn, Cornelia/0000-0002-2374-9204; concas, maria pina/0000-0003-3598-2537; Boutin, Thibaud/0000-0003-4754-1675; Cusi, Daniele/0000-0002-1006-7597; Tin, Adrienne/0000-0002-4207-5866; Kronenberg, Florian/0000-0003-2229-1120; Ikram, Mohammad Arfan/0000-0003-0372-8585; Sveinbjornsson, Gardar/0000-0003-2429-9468; Liu, Jun/0000-0001-5288-3042; Tajuddin, Salman M./0000-0002-7919-8528; Gordon, Scott/0000-0001-7623-328X; NUTILE, TERESA/0000-0001-7062-8352; Prins, Bram/0000-0001-5774-034X; Gogele, Martin/0000-0003-4785-4348; Preuss, Michael/0000-0001-5266-8465; Pattaro, Cristian/0000-0002-4119-0109; Koenig, Wolfgang/0000-0002-2064-9603; Mascalzoni, Deborah/0000-0003-4156-1464; Rudan, Igor/0000-0001-6993-6884; Mishra, Pashupati/0000-0001-5177-3431; Halperin Kuhns, Victoria/0000-0002-6348-7931; Waeber, Gerard/0000-0003-4193-788X; Thio, Chris/0000-0003-2623-7172	MRC [MC_UU_00007/10] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL129982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR073178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114091, P30DK116074, P30DK090868] Funding Source: NIH RePORTER; British Heart Foundation [RG/18/13/33946, RG/13/13/30194] Funding Source: Medline; Medical Research Council [MC_UU_00007/10, MC_PC_17228, MC_QA137853] Funding Source: Medline; NHGRI NIH HHS [T32 HG002295] Funding Source: Medline; NHLBI NIH HHS [U01 HL130114, T32 HL129982, R01 HL105756, R01 HL120393, U01 HL120393] Funding Source: Medline; NIAMS NIH HHS [R01 AR073178] Funding Source: Medline; NICHD NIH HHS [K12 HD043483] Funding Source: Medline; NIDDK NIH HHS [P30 DK116074, R01 DK114091] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnold M, 2015, BIOINFORMATICS, V31, P1334, DOI 10.1093/bioinformatics/btu779; ASANO T, 1991, J BIOL CHEM, V266, P24632; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Benner C, 2017, AM J HUM GENET, V101, P539, DOI 10.1016/j.ajhg.2017.08.012; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fuchsberger C, 2012, BIOINFORMATICS, V28, P444, DOI 10.1093/bioinformatics/btr679; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; George RL, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0309-8; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gillies CE, 2018, AM J HUM GENET, V103, P232, DOI 10.1016/j.ajhg.2018.07.004; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Haller T, 2015, BRIEF BIOINFORM, V16, P39, DOI 10.1093/bib/bbt066; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Heinz LX, 2012, CELL DEATH DIFFER, V19, P722, DOI 10.1038/cdd.2011.147; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jinno S, 2016, J RHEUMATOL, V43, P1589, DOI 10.3899/jrheum.151432; Jordan DM, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002725; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Ketharnathan S, 2018, HUM MOL GENET, V27, P3964, DOI 10.1093/hmg/ddy295; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ko YA, 2017, AM J HUM GENET, V100, P940, DOI 10.1016/j.ajhg.2017.05.004; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kolz M, 2009, PLOS GENET, V5; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kraus MRC, 2012, HUM MUTAT, V33, P86, DOI 10.1002/humu.21610; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Lee C, 2014, BIOINFORMATICS, V30, P1923, DOI 10.1093/bioinformatics/btu115; Li JC, 2018, NUCLEIC ACIDS RES, V46, P7793, DOI 10.1093/nar/gky678; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Li X, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2376; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindgren D, 2017, CELL REP, V20, P1476, DOI 10.1016/j.celrep.2017.07.043; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lyngdoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039321; MacCluer JW, 2010, AM J KIDNEY DIS, V56, P289, DOI 10.1053/j.ajkd.2010.03.012; Magi R, 2017, HUM MOL GENET, V26, P3639, DOI 10.1093/hmg/ddx280; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Maher JM, 2006, BIOCHEM PHARMACOL, V72, P512, DOI 10.1016/j.bcp.2006.03.016; Major TJ, 2018, NAT REV RHEUMATOL, V14, P341, DOI 10.1038/s41584-018-0004-x; Marable SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97497; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matsuo H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03755; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Merriman TR, 2011, SEMIN NEPHROL, V31, P420, DOI 10.1016/j.semnephrol.2011.08.005; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Noce D, 2017, HUM GENET, V136, P743, DOI 10.1007/s00439-017-1785-8; O'Connor LJ, 2018, NAT GENET, V50, P1728, DOI 10.1038/s41588-018-0255-0; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Pattaro C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0704-9; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Phipps-Green AJ, 2016, ANN RHEUM DIS, V75, P124, DOI 10.1136/annrheumdis-2014-205877; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Prestin K, 2017, AM J PHYSIOL-RENAL, V313, pF973, DOI 10.1152/ajprenal.00650.2016; Prestin K, 2014, AM J PHYSIOL-RENAL, V307, pF1041, DOI 10.1152/ajprenal.00640.2013; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roddy E, 2014, RHEUM DIS CLIN N AM, V40, P155, DOI 10.1016/j.rdc.2014.01.001; Rule AD, 2009, NEPHROL DIAL TRANSPL, V24, P2414, DOI 10.1093/ndt/gfp080; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Schaid DJ, 2018, NAT REV GENET, V19, P491, DOI 10.1038/s41576-018-0016-z; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Sodini SM, 2018, GENETICS, V209, P941, DOI 10.1534/genetics.117.300630; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Tin A, 2011, HUM MOL GENET, V20, P4056, DOI 10.1093/hmg/ddr307; Togawa N, 2012, AM J PHYSIOL-CELL PH, V302, pC1652, DOI 10.1152/ajpcell.00015.2012; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; VANGENNIP AH, 1980, CLIN CHIM ACTA, V104, P227, DOI 10.1016/0009-8981(80)90200-4; Vesuna F, 2005, ANAL BIOCHEM, V342, P345, DOI 10.1016/j.ab.2005.04.047; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wang WJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00075; White J, 2016, LANCET DIABETES ENDO, V4, P327, DOI 10.1016/S2213-8587(15)00386-1; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wuttke M, 2019, NAT GENET, V51, P957, DOI 10.1038/s41588-019-0407-x; Xie Y, 2015, BBA-GENE REGUL MECH, V1849, P317, DOI 10.1016/j.bbagrm.2015.01.003; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zhan XW, 2016, BIOINFORMATICS, V32, P1423, DOI 10.1093/bioinformatics/btw079; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu Q, 2003, DIABETOLOGIA, V46, P567, DOI 10.1007/s00125-003-1067-y	109	137	141	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2019	51	10					1459	+		10.1038/s41588-019-0504-x	http://dx.doi.org/10.1038/s41588-019-0504-x			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC1CP	31578528	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000489016400010
J	Coe, BP; Stessman, HAF; Sulovari, A; Geisheker, MR; Bakken, TE; Lake, AM; Dougherty, JD; Lein, ES; Hormozdiari, F; Bernier, RA; Eichler, EE				Coe, Bradley P.; Stessman, Holly A. F.; Sulovari, Arvis; Geisheker, Madeleine R.; Bakken, Trygve E.; Lake, Allison M.; Dougherty, Joseph D.; Lein, Ed S.; Hormozdiari, Fereydoun; Bernier, Raphael A.; Eichler, Evan E.			Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity	NATURE GENETICS			English	Article							INTELLECTUAL DISABILITY; MISSENSE MUTATION; SEGMENTAL DUPLICATIONS; CLINICAL-SIGNIFICANCE; TRUNCATING MUTATIONS; DEVELOPMENTAL DELAY; MOUSE MODEL; AUTISM; SPECTRUM; HAPLOINSUFFICIENCY	We combined de novo mutation (DNM) data from 10,927 individuals with developmental delay and autism to identify 253 candidate neurodevelopmental disease genes with an excess of missense and/or likely gene-disruptive (LGD) mutations. Of these genes, 124 reach exome-wide significance (P < 5 x 10(-7)) for DNM. Intersecting these results with copy number variation (CNV) morbidity data shows an enrichment for genomic disorder regions (30/253, likelihood ratio (LR) + 1.85, P = 0.0017). We identify genes with an excess of missense DNMs overlapping deletion syndromes (for example, KIF1A and the 2q37 deletion) as well as duplication syndromes, such as recurrent MAPK3 missense mutations within the chromosome 16p11.2 duplication, recurrent CHD4 missense DNMs in the 12p13 duplication region, and recurrent WDFY4 missense DNMs in the 10q11.23 duplication region. Network analyses of genes showing an excess of DNMs highlights functional networks, including cell-specific enrichments in the D1(+) and D2(+) spiny neurons of the striatum.	[Coe, Bradley P.; Sulovari, Arvis; Geisheker, Madeleine R.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Stessman, Holly A. F.] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA; [Bakken, Trygve E.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA USA; [Lake, Allison M.; Dougherty, Joseph D.] Washington Univ, Sch Med, Dept Psychiat, Dept Genet, St Louis, MO 63110 USA; [Hormozdiari, Fereydoun] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Bernier, Raphael A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Creighton University; Allen Institute for Brain Science; Washington University (WUSTL); University of California System; University of California Davis; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	eee@gs.washington.edu	Bakken, Trygve E./R-4622-2017; Sulovari, Arvis/H-3304-2019	Bakken, Trygve E./0000-0003-3373-7386; Sulovari, Arvis/0000-0003-4354-9020; Geisheker, Madeleine/0000-0002-4166-3236; Coe, Bradley/0000-0001-8471-4016; Dougherty, Joseph/0000-0002-6385-3997; Stessman, Holly/0000-0002-0764-3493; Lake, Allison/0000-0003-2562-4226	Simons Foundation Autism Research Initiative [SFARI 303241]; US National Institutes of Health [NIH R01MH101221]; NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation; NIH [5R01MH107515-03]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107515, R01MH101221] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank T. Turner and J. Shendure for helpful discussion and T. Brown for edits. This research was supported, in part, by the following: the Simons Foundation Autism Research Initiative (SFARI 303241) and US National Institutes of Health (NIH R01MH101221) to E.E.E. The J.D.D. laboratory is supported by a NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation and NIH grant 5R01MH107515-03. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E. Wijsman). E. E. E. is supported by the Howard Hughes Medical Institute.	American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asadollahi R, 2014, J MED GENET, V51, P677, DOI 10.1136/jmedgenet-2014-102588; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Balsters JH, 2018, NEUROIMAGE, V170, P412, DOI 10.1016/j.neuroimage.2017.02.019; Berko ER, 2017, J MED GENET, V54, P93, DOI 10.1136/jmedgenet-2016-103943; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Blizinsky KD, 2016, P NATL ACAD SCI USA, V113, P8520, DOI 10.1073/pnas.1607014113; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj.mp.4001011; Carlston CM, 2017, HUM MUTAT, V38, P517, DOI 10.1002/humu.23203; Chen YC, 2016, NAT NEUROSCI, V19, P1513, DOI 10.1038/nn.4380; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; DeMari J, 2016, AM J MED GENET A, V170, P958, DOI 10.1002/ajmg.a.37506; Deshpande A, 2018, DEV NEUROBIOL, V78, P519, DOI 10.1002/dneu.22587; Dheedene A, 2014, MOL SYNDROMOL, V5, P32, DOI 10.1159/000356060; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fergelot P, 2016, AM J MED GENET A, V170, P3069, DOI 10.1002/ajmg.a.37940; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Flanigan M, 2017, J NEUROSCI, V37, P6177, DOI 10.1523/JNEUROSCI.0882-17.2017; Fusco C, 2014, EUR J HUM GENET, V22, P64, DOI 10.1038/ejhg.2013.101; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Guella I, 2017, AM J HUM GENET, V101, P300, DOI 10.1016/j.ajhg.2017.07.004; Halder D, 2017, SCI REP-UK, V7, DOI 10.1038/srep44818; Halvardson J, 2016, J MED GENET, V53, P697, DOI 10.1136/jmedgenet-2016-103814; Han JY, 2017, CLIN CHIM ACTA, V470, P31, DOI 10.1016/j.cca.2017.04.025; Harrington AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20059; Harripaul R, 2018, MOL PSYCHIATR, V23, P973, DOI 10.1038/mp.2017.60; Hashimoto R, 2016, J HUM GENET, V61, P199, DOI 10.1038/jhg.2015.141; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Izumi K, 2010, AM J MED GENET A, V152A, P1028, DOI 10.1002/ajmg.a.33121; Jansen S, 2017, AM J HUM GENET, V100, P650, DOI 10.1016/j.ajhg.2017.02.005; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kaya N, 2016, J MED GENET, V53, P786, DOI 10.1136/jmedgenet-2015-103637; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Kleefstra T, 2009, J MED GENET, V46, P598, DOI 10.1136/jmg.2008.062950; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Koolen DA, 2016, EUR J HUM GENET, V24, P652, DOI 10.1038/ejhg.2015.178; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Labonne JDJ, 2015, AM J MED GENET A, V167, P3011, DOI 10.1002/ajmg.a.37344; Langen M, 2014, BIOL PSYCHIAT, V76, P405, DOI 10.1016/j.biopsych.2013.08.013; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lee H, 2014, HUM MOL GENET, V23, P3481, DOI 10.1093/hmg/ddu056; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2017, AM J HUM GENET, V101, P478, DOI 10.1016/j.ajhg.2017.08.004; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Leroy C, 2013, EUR J HUM GENET, V21, P602, DOI 10.1038/ejhg.2012.230; Levy J, 2017, AM J MED GENET A, V173, P2081, DOI 10.1002/ajmg.a.38302; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; McCool C, 2017, AM J MED GENET A, V173, P716, DOI 10.1002/ajmg.a.37988; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Moreno-Ramos OA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135927; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Paciorkowski AR, 2013, NEUROGENETICS, V14, P99, DOI 10.1007/s10048-013-0356-y; Park SM, 2017, MOL CELLS, V40, P151, DOI 10.14348/molcells.2017.2307; Phelan K., 1993, GENEREVIEWS R; Platt RJ, 2017, CELL REP, V19, P335, DOI 10.1016/j.celrep.2017.03.052; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reim D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00026; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, CURR OPIN GENET DEV, V33, P80, DOI 10.1016/j.gde.2015.10.002; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Schreiweis C, 2014, P NATL ACAD SCI USA, V111, P14253, DOI 10.1073/pnas.1414542111; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shimbo H, 2017, MOL GENET GENOM MED, V5, P429, DOI 10.1002/mgg3.289; Shohat S, 2017, CELL REP, V18, P2217, DOI 10.1016/j.celrep.2017.02.007; Stephenson JR, 2017, J NEUROSCI, V37, P2216, DOI 10.1523/JNEUROSCI.2068-16.2017; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Tavassoli T, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-35; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Turner TN, 2015, HUM MOL GENET, V24, P5995, DOI 10.1093/hmg/ddv309; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang QQ, 2013, GENE DEV, V27, P615, DOI 10.1101/gad.212308.112; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weiss K, 2016, AM J HUM GENET, V99, P934, DOI 10.1016/j.ajhg.2016.08.001; Werling D. M., 2017, BIORXIV, DOI [10.1101/127043, DOI 10.1101/127043]; Witteveen JS, 2016, NAT GENET, V48, P877, DOI 10.1038/ng.3619; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Yuen RKC, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.27; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	102	137	142	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2019	51	1					106	+		10.1038/s41588-018-0288-4	http://dx.doi.org/10.1038/s41588-018-0288-4			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HF3AV	30559488	Green Accepted			2022-12-17	WOS:000454108800018
J	Minster, RL; Hawley, NL; Su, CT; Sun, G; Kershaw, EE; Cheng, H; Buhule, OD; Lin, J; Reupena, MS; Viali, S; Tuitele, J; Naseri, T; Urban, Z; Deka, R; Weeks, DE; McGarvey, ST				Minster, Ryan L.; Hawley, Nicola L.; Su, Chi -Ting; Sun, Guangyun; Kershaw, Erin E.; Cheng, Hong; Buhule, Olive D.; Lin, Jerome; Reupena, Muagututia Sefuiva; Viali, Satupditea; Tuitele, John; Naseri, Take; Urban, Zsolt; Deka, Ranjan; Weeks, Daniel E.; McGarvey, Stephen T.			A thrifty variant in CREBRF strongly influences body mass index in Samoans	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SAMPLE-SIZE REQUIREMENTS; INSULIN-RESISTANCE; AMERICAN-SAMOA; OBESITY; ADIPOSITY; GENE; ADIPOGENESIS; IMPUTATION; SELECTION	Samoans are a unique founder population with a high prevalence of obesity(1-3), making them well suited for identifying new genetic contributors to obesity(4). We conducted a genome-wide association study (GWAS) in 3,072 Samoans, discovered a variant, rs12513649, strongly associated with body mass index (BMI) (P = 5.3 x 10(-14)), and replicated the association in 2,102 additional Samoans (P = 1.2 x 10(-9)). Targeted sequencing identified a strongly associated missense variant, rs373863828 (p.Arg457Gln), in CREBRF (meta P = 1.4 x 10(-20)). Although this variant is extremely rare in other populations, it is common in Samoans (frequency of 0.259), with an effect size much larger than that of any other known common BMI risk variant (1.36-1.45 kg/m(2) per copy of the risk-associated allele). In comparison to wild-type CREBRF, the Arg457Gln variant when overexpressed selectively decreased energy use and increased fat storage in an adipocyte cell model. These data, in combination with evidence of positive selection of the allele encoding p.Arg457Gln, support a 'thrifty' variant hypothesis as a factor in human obesity.	[Minster, Ryan L.; Su, Chi -Ting; Lin, Jerome; Urban, Zsolt; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hawley, Nicola L.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Chron Disease, New Haven, CT USA; [Sun, Guangyun; Cheng, Hong; Deka, Ranjan] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol, Pittsburgh, PA USA; [Buhule, Olive D.; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Reupena, Muagututia Sefuiva] Govt Samoa, Bur Stat, Apia, Samoa, New Zealand; [Viali, Satupditea] Samoa Natl Hlth Serv, Apia, Samoa, New Zealand; [Tuitele, John] Amer Samoa Govt, Dept Hlth, Pago Pago, AS USA; [Naseri, Take] Govt Samoa, Minist Hlth, Apia, Samoa, New Zealand; [McGarvey, Stephen T.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA; [Su, Chi -Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Yunlin, Taiwan; [Buhule, Olive D.] Eunice Kennedy Shrivel Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, Div Intramural Populat Hlth Res, US NIH, Bethesda, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Brown University; National Taiwan University; National Taiwan University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McGarvey, ST (corresponding author), Brown Univ, Sch Publ Hlth, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA.; McGarvey, ST (corresponding author), Brown Univ, Dept Anthropol, Providence, RI 02912 USA.	stephen_mcgarvey@brown.edu	Weeks, Daniel E/B-2995-2012; Kershaw, Erin E/G-9587-2013; Urban, Zsolt/A-2018-2013	Weeks, Daniel E/0000-0001-9410-7228; Kershaw, Erin E/0000-0002-3887-4868; Su, Chi-Ting/0000-0002-2926-3950; Minster, Ryan/0000-0001-7382-6717; Hawley, Nicola/0000-0002-2601-3454; Urban, Zsolt/0000-0003-3890-1843	NIH [R01-HL093093, R01-AG09375, R01-HL52611, R01-DK59642, P30 ES006096, R01-DK55406, R01-HL090648, R01-DK090166]; Brown University student research funds; American Samoan Department of Health; Samoan Ministry of Health; Samoan Bureau of Statistics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093093, R01HL052611, R01HL090648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059642, R01DK090166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University student research funds; American Samoan Department of Health; Samoan Ministry of Health; Samoan Bureau of Statistics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank the Samoan participants of the study, and local village authorities and the many Samoan and other field workers over the years. We acknowledge the Samoan Ministry of Health and the Samoan Bureau of Statistics, and the American Samoan Department of Health for their support of this research. We also acknowledge S.S. Shiva and C.G. Corey at the University of Pittsburgh Center for Metabolism and Mitochondrial Biology for assistance with cellular bioenergetic profiling. This work was funded by NIH grants R01-HL093093 (S.T.M.), R01-AG09375 (S.T.M.), R01-HL52611 (I. Kamboh), R01-DK59642 (S.T.M.), P30 ES006096 (S.M.Ho), R01-DK55406. (R.D.), R01-HL090648 (Z.U.), and R01-DK090166 (E.E.K.) and by Brown University student research funds. Genotyping was performed in the Core Genotyping Laboratory at the University of Cincinnati, funded by NIH grant P30 ES006096 (S.M. Ho). Illumina sequencing was conducted at the Genetic Resources Core Facility, Johns Hopkins Institute of Genetic Medicine (Baltimore).	Aberg K, 2009, OBESITY, V17, P518, DOI 10.1038/oby.2008.558; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc09-S062, 10.2337/dc11-S011, 10.2337/dc12-S064]; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadzow M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00293; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Exome Aggregation Consortium, 2016, AN PROT COD GEN VAR; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Green R. C., 2007, GROWTH COLLAPSE PACI, P203; Hawley NL, 2014, AM J HUM BIOL, V26, P491, DOI 10.1002/ajhb.22553; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kampstra P, 2008, J STAT SOFTWARE, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Keighley ED, 2006, AM J HUM BIOL, V18, P112, DOI 10.1002/ajhb.20469; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kim TH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.490; Kirch P., 2007, GROWTH COLLAPSE PACI, P1; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Ma X, 2011, BIOCHEM J, V439, P27, DOI 10.1042/BJ20101475; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Martyn AC, 2012, MOL CELL BIOL, V32, P5140, DOI 10.1128/MCB.01142-12; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGarvey S. T., 1989, HUMAN POPULATION BIO, P263; MCGARVEY ST, 1994, J POLYNESIAN SOC, V103, P29; MCGARVEY ST, 1993, AM J HUM BIOL, V5, P17, DOI 10.1002/ajhb.1310050106; MCGARVEY ST, 1991, AM J CLIN NUTR, V53, pS1586, DOI 10.1093/ajcn/53.6.1586S; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2004, R LANG ENV STAT COMP; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Stocker H, 2015, DEV CELL, V33, P245, DOI 10.1016/j.devcel.2015.04.013; Swinburn BA, 1999, INT J OBESITY, V23, P1178, DOI 10.1038/sj.ijo.0801053; Szpiech ZA, 2014, MOL BIOL EVOL, V31, P2824, DOI 10.1093/molbev/msu211; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Tishkoff S, 2015, SCIENCE, V349, P1282, DOI 10.1126/science.aad0584; Tsai Hui-ju, 2004, Human Genomics, V1, P327; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang X, 2016, EUR J HUM GENET, V24, P592, DOI 10.1038/ejhg.2015.150; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203	68	137	139	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1049	+		10.1038/ng.3620	http://dx.doi.org/10.1038/ng.3620			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27455349	Green Accepted			2022-12-17	WOS:000382398800016
J	Hunt, VL; Tsai, IJ; Coghlan, A; Reid, AJ; Holroyd, N; Foth, BJ; Tracey', A; Cotton', JA; Stanley, EJ; Beasley, H; Bennett, HM; Brooks, K; Harsha, B; Kajitani, R; Kulkarni, A; Harbecke, D; Nagayasu, E; Nichol, S; Ogura, Y; Quail, MA; Randle, N; Xia, D; Brattig, NW; Soblik, H; Ribeiro, DM; Sanchez-Flores, A; Hayashi, T; Itoh, T; Denver, DR; Grant, W; Stoltzfus, JD; Lok, JB; Murayama, H; Wastling, J; Streit, A; Kikuchi, T; Viney, M; Berriman, M				Hunt, Vicky L.; Tsai, Isheng J.; Coghlan, Avril; Reid, Adam J.; Holroyd, Nancy; Foth, Bernardo J.; Tracey', Alan; Cotton', James A.; Stanley, Eleanor J.; Beasley, Helen; Bennett, Hayley M.; Brooks, Karen; Harsha, Bhavana; Kajitani, Rei; Kulkarni, Arpita; Harbecke, Dorothee; Nagayasu, Eiji; Nichol, Sarah; Ogura, Yoshitoshi; Quail, Michael A.; Randle, Nadine; Xia, Dong; Brattig, Norbert W.; Soblik, Hanns; Ribeiro, Diogo M.; Sanchez-Flores, Alejandro; Hayashi, Tetsuya; Itoh, Takehiko; Denver, Dee R.; Grant, Warwick; Stoltzfus, Jonathan D.; Lok, James B.; Murayama, Haruhiko; Wastling, Jonathan; Streit, Adrian; Kikuchi, Taisei; Viney, Mark; Berriman, Matthew			The genomic basis of parasitism in the Strongyloides clade of nematodes	NATURE GENETICS			English	Article							MITOCHONDRIAL GENOME; PARASTRONGYLOIDES-TRICHOSURI; CHROMATIN DIMINUTION; INTESTINAL NEMATODE; ASPARTIC PROTEASES; MOLECULAR-CLONING; SEX DETERMINATION; ASTACIN FAMILY; C-ELEGANS; HOOKWORM	Soil-transmitted nematodes, including the Strongyloides genus, cause one of the most prevalent neglected tropical diseases. Here we compare the genomes of four Strongyloides species, including the human pathogen Strongyloides stercoralis, and their close relatives that are facultatively parasitic (Parastrongyloides frichosuri) and free-living (Rhabditophanes sp. KR3021). A significant paralogous expansion of key gene families families encoding astacin-like and SCP/TAPS proteins is associated with the evolution of parasitism in this Glade. Exploiting the unique Strongyloides life cycle, we compare the transcriptomes of the parasitic and free-living stages and find that these same gene families are upregulated in the parasitic stages, underscoring their role in nematode parasitism.	[Hunt, Vicky L.; Viney, Mark] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Tsai, Isheng J.; Nagayasu, Eiji; Murayama, Haruhiko; Kikuchi, Taisei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan; [Coghlan, Avril; Reid, Adam J.; Holroyd, Nancy; Foth, Bernardo J.; Tracey', Alan; Cotton', James A.; Stanley, Eleanor J.; Beasley, Helen; Bennett, Hayley M.; Brooks, Karen; Harsha, Bhavana; Nichol, Sarah; Quail, Michael A.; Ribeiro, Diogo M.; Sanchez-Flores, Alejandro; Berriman, Matthew] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Kajitani, Rei; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Kulkarni, Arpita; Harbecke, Dorothee; Streit, Adrian] Max Planck Inst Dev Biol, Tubingen, Germany; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Randle, Nadine; Xia, Dong; Wastling, Jonathan] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Randle, Nadine; Xia, Dong; Wastling, Jonathan] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Brattig, Norbert W.; Soblik, Hanns] Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotecnol, Unidad Secuenciac Masiva & Bioinformat, Cuernavaca 62191, Morelos, Mexico; [Denver, Dee R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Grant, Warwick] La Trobe Univ, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia; [Stoltzfus, Jonathan D.; Lok, James B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Wastling, Jonathan] Keele Univ, Fac Nat Sci, Keele ST5 5BG, Staffs, England	University of Bristol; Academia Sinica - Taiwan; University of Miyazaki; Wellcome Trust Sanger Institute; Tokyo Institute of Technology; Max Planck Society; Kyushu University; University of Liverpool; University of Liverpool; Bernhard Nocht Institut fur Tropenmedizin; Universidad Nacional Autonoma de Mexico; Oregon State University; La Trobe University; University of Pennsylvania; Keele University	Viney, M (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.; Kikuchi, T (corresponding author), Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan.; Berriman, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	taisei_kikuchi@med.miyazaki-u.ac.jp; mark.viney@bristol.ac.uk; mb4@sanger.ac.uk	Tsai, Isheng J/H-6606-2014; Stoltzfus, Jonathan D./AAU-6735-2020; Tsai, Isheng Jason/ABB-8273-2021; Cotton, James A/B-8806-2008; Berriman, Matthew/A-7618-2011; Hayashi, Tetsuya/ABA-1074-2020; Grant, Warwick/AAF-5854-2020; Quail, michael/ABE-6131-2020; Itoh, Takehiko/E-8873-2014; Sanchez-Flores, Alejandro/L-9454-2016	Stoltzfus, Jonathan D./0000-0002-4006-5306; Tsai, Isheng Jason/0000-0002-2123-5058; Cotton, James A/0000-0001-5475-3583; Berriman, Matthew/0000-0002-9581-0377; Grant, Warwick/0000-0002-1187-5270; Itoh, Takehiko/0000-0002-6113-557X; Harsha, Bhavana/0000-0001-8234-9174; Reid, Adam/0000-0002-5926-7768; Kulkarni, Arpita/0000-0003-0775-8044; Ribeiro, Diogo/0000-0002-0482-7342; Xia, Dong/0000-0003-4571-2776; Kajitani, Rei/0000-0002-5013-0052; Sanchez-Flores, Alejandro/0000-0003-0476-3139; Hunt, Vicky/0000-0002-7094-044X; Coghlan, Avril/0000-0002-2775-5951; Kikuchi, Taisei/0000-0003-2759-9167	Wellcome Trust [094462/Z/10/Z, 098051]; Japan Society for the Promotion of Science (JSPS) KAKENHI [24310142, 21590466, 24780044]; KAKENHI [221S0002]; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki; Academia Sinica; US National Institutes of Health (NIH) [AI050668, AI105856]; Resource-Related Research Grant from the US NIH [RR02512]; US NIH training [AI060516]; Max Planck Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060516, R33AI105856, R21AI105856, R01AI050668] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki; Academia Sinica(Academia Sinica - Taiwan); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Resource-Related Research Grant from the US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank, from the Wellcome Trust Sanger Institute, C. Griffiths, D. Willey, R. Rance and DNA Pipelines; J. Keane and D. Gordon for bioinformatics support; M. Dunn for the S. venezuelensis optical map; A. Babbage for laboratory support; and M. Zarowiecki for gene finding and functional annotation advice. We thank for technical help L. Hughes and L. Weldon (University of Bristol); H. Massey, Jr., X. Li and H. Shao (University of Pennsylvania); D.K. Howe and R.I. Wernick (Oregon State University); H. Denise (European Bioinformatics Institute); M. Yabana (Tokyo Institute of Technology); and A. Hino and R. Tanaka (University of Miyazaki) and A. Toyoda (National Institute of Genetics) for sequencing. The S. ratti transcriptome and proteome work was funded by Wellcome Trust grant 094462/Z/10/Z awarded to M.V., J.W. and M.B. The S. ratti, S. stercoralis, S. papillosus, P. trichosuri and Rhabditophanes sp. KR3021 genome sequencing and the S. venezuelensis optical mapping were funded by Wellcome Trust grant 098051. The S. venezuelensis work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (24310142, 21590466 and 24780044), KAKENHI for Innovative Areas 'Genome Science' (221S0002) and the Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki. I.J.T. was supported by Academia Sinica. Work was funded by grants AI050668 and AI105856 from the US National Institutes of Health (NIH) to J.B.L. and by Resource-Related Research Grant RR02512 from the US NIH to M. Haskins, which provided research materials for the study. J.D.S. received support from US NIH training grant AI060516. A.K. was supported by a predoctoral stipend from the Max Planck Society. Work by AK., D.H. and A.S. was funded by the Max Planck Society.	ALBERTSON DG, 1979, CHROMOSOMA, V75, P75, DOI 10.1007/BF00330626; Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Armstrong MR, 2000, GENETICS, V154, P181; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bethony JM, 2008, VACCINE, V26, P2408, DOI 10.1016/j.vaccine.2008.02.049; Blaxter M., NEXT GENERA IN PRESS; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BOLLA RI, 1968, J PARASITOL, V54, P849, DOI 10.2307/3277110; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Chehayeb JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002939; Crompton D.W.T., 1987, BAILLIERE CLIN TROP, P489; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; Dorris M, 2002, INT J PARASITOL, V32, P1507, DOI 10.1016/S0020-7519(02)00156-X; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foth BJ, 2014, NAT GENET, V46, P693, DOI 10.1038/ng.3010; Gallego SG, 2005, PARASITOL INT, V54, P123, DOI 10.1016/j.parint.2005.02.002; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gibson T, 2007, J MOL EVOL, V64, P463, DOI 10.1007/s00239-006-0187-7; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Grant WN, 2006, INT J PARASITOL, V36, P475, DOI 10.1016/j.ijpara.2005.12.002; Grant WN, 2006, INT J PARASITOL, V36, P453, DOI 10.1016/j.ijpara.2005.11.009; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003; HAMMOND MP, 1994, J PARASITOL, V80, P689, DOI 10.2307/3283247; Harvey SC, 2001, GENETICS, V158, P1527; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hino A, 2014, PARASITOLOGY, V141, P1736, DOI 10.1017/S0031182014001036; Hu M, 2003, INT J PARASITOL, V33, P1393, DOI 10.1016/S0020-7519(03)00130-9; Humphreys-Pereira DA, 2015, GENE, V560, P173, DOI 10.1016/j.gene.2015.01.065; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jing YJ, 2010, MOL BIOCHEM PARASIT, V174, P101, DOI 10.1016/j.molbiopara.2010.07.004; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kulkarni A, 2013, PARASITOLOGY, V140, P1822, DOI 10.1017/S0031182013001315; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; Li XS, 2006, INT J PARASITOL, V36, P671, DOI 10.1016/j.ijpara.2005.12.007; Li X, 2011, MOL BIOCHEM PARASIT, V179, P114, DOI 10.1016/j.molbiopara.2011.06.002; Longbottom D, 1997, MOL BIOCHEM PARASIT, V88, P63, DOI 10.1016/S0166-6851(97)00074-1; Lun HM, 2003, PARASITOL RES, V90, P27, DOI 10.1007/s00436-002-0815-0; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; MACKERRAS M. JOSEPHINE, 1959, AUSTRALIAN JOUR ZOOL, V7, P87, DOI 10.1071/ZO9590087; Maruyama H, 2000, J IMMUNOL, V164, P3749, DOI 10.4049/jimmunol.164.7.3749; Maruyama H, 2003, PARASITOLOGY, V126, P165, DOI 10.1017/S0031182002002718; Mello LV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-611; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Nemetschke L, 2010, CURR BIOL, V20, P1687, DOI 10.1016/j.cub.2010.08.014; Nemetschke L, 2010, MOL BIOCHEM PARASIT, V169, P124, DOI 10.1016/j.molbiopara.2009.10.008; Park JO, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-14; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Richardson SJ, 2005, ANN NY ACAD SCI, V1040, P448, DOI 10.1196/annals.1327.086; Saverwyns H, 2008, INT J PARASITOL, V38, P1545, DOI 10.1016/j.ijpara.2008.04.004; Savioli L, 2004, NAT REV MICROBIOL, V2, P618, DOI 10.1038/nrmicro962; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schwarz EM, 2015, NAT GENET, V47, P416, DOI 10.1038/ng.3237; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Selkirk ME, 2005, PARASITOLOGY, V131, pS3; Semenova SA, 2009, BIOCHEM MOSC-SUPPL S, V3, P17, DOI 10.1134/S199075080901003X; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Soblik H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010157-1, 10.1074/mcp.M111.010157]; Stoltzfus JD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001854; Sultana T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-12; Sun LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098558; Tang YT, 2014, NAT GENET, V46, P261, DOI 10.1038/ng.2875; TINDALL NR, 1990, PARASITOLOGY, V100, P281, DOI 10.1017/S003118200006128X; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Viney Mark E, 2015, WormBook, P1, DOI 10.1895/wormbook.1.141.2; VINEY ME, 1993, P ROY SOC B-BIOL SCI, V254, P213, DOI 10.1098/rspb.1993.0148; VINEY ME, 1994, PARASITOLOGY, V109, P511, DOI 10.1017/S0031182000080768; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Williamson AL, 2002, FASEB J, V16, P1458, DOI 10.1096/fj.02-0181fje	74	137	142	1	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					299	307		10.1038/ng.3495	http://dx.doi.org/10.1038/ng.3495			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829753	Green Submitted, Green Accepted, hybrid			2022-12-17	WOS:000370902600014
J	Walsh, KM; Codd, V; Smirnov, IV; Rice, T; Decker, PA; Hansen, HM; Kollmeyer, T; Kosel, ML; Molinaro, AM; McCoy, LS; Bracci, PM; Cabriga, BS; Pekmezci, M; Zheng, SC; Wiemels, JL; Pico, AR; Tihan, T; Berger, MS; Chang, SM; Prados, MD; Lachance, DH; O'Neill, BP; Sicotte, H; Eckel-Passow, JE; van der Harst, P; Wiencke, JK; Samani, NJ; Jenkins, RB; Wrensch, MR				Walsh, Kyle M.; Codd, Veryan; Smirnov, Ivan V.; Rice, Terri; Decker, Paul A.; Hansen, Helen M.; Kollmeyer, Thomas; Kosel, Matthew L.; Molinaro, Annette M.; McCoy, Lucie S.; Bracci, Paige M.; Cabriga, Belinda S.; Pekmezci, Melike; Zheng, Shichun; Wiemels, Joseph L.; Pico, Alexander R.; Tihan, Tarik; Berger, Mitchell S.; Chang, Susan M.; Prados, Michael D.; Lachance, Daniel H.; O'Neill, Brain Patrick; Sicotte, Hugues; Eckel-Passow, Jeanette E.; van der Harst, Pim; Wiencke, John K.; Samani, Nilesh J.; Jenkins, Robert B.; Wrensch, Margaret R.		ENGAGE Consortium Telomere Grp	Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PROMOTER MUTATIONS; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; GLIOBLASTOMA; METAANALYSIS; PATHWAYS; MELANOMA; HUMANS	Glioma, the most common central nervous system cancer in adults, has poor prognosis. Here we identify a new SNP associated with glioma risk, rs1920116 (near TERC), that reached genome-wide significance (P-combined = 8.3 x 10(-9)) in a meta-analysis of genome-wide association studies (GWAS) of high-grade glioma and replication data (1,644 cases and 7,736 controls). This region has previously been associated with mean leukocyte telomere length (LTL). We therefore examined the relationship between LTL and both this new risk locus and other previously established risk loci for glioma using data from a recent GWAS of LTL (n = 37,684 individuals)(1). Alleles associated with glioma risk near TERC and TERT were strongly associated with longer LTL (P = 5.5 x 10(-20) and 4.4 x 10(-19), respectively). In contrast, risk-associated alleles near RTEL1 were inconsistently associated with LTL, suggesting the presence of distinct causal alleles. No other risk loci for glioma were associated with LTL. The identification of risk alleles for glioma near TERC and TERT that also associate with telomere length implicates telomerase in gliomagenesis.	[Walsh, Kyle M.; Rice, Terri; Hansen, Helen M.; McCoy, Lucie S.; Cabriga, Belinda S.; Zheng, Shichun; Wiemels, Joseph L.; Pico, Alexander R.; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Dept Neurol Surg, Div Neuroepidemiol, San Francisco, CA 94132 USA; [Walsh, Kyle M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Program Canc Genet, San Francisco, CA USA; [Codd, Veryan; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Samani, Nilesh J.] Glenfield Hosp, Nat Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Smirnov, Ivan V.; Molinaro, Annette M.; Berger, Mitchell S.; Chang, Susan M.; Prados, Michael D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Decker, Paul A.; Kosel, Matthew L.; Sicotte, Hugues; Eckel-Passow, Jeanette E.] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA; [Kollmeyer, Thomas; Jenkins, Robert B.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Bracci, Paige M.; Wiemels, Joseph L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Pekmezci, Melike; Tihan, Tarik] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Wiemels, Joseph L.; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA USA; [Pico, Alexander R.] Gladstone Inst, Dept Bioinformat, San Francisco, CA USA; [Lachance, Daniel H.; O'Neill, Brain Patrick] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of California System; University of California San Francisco; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Mayo Clinic; University of Groningen; University of Groningen	Walsh, KM (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Div Neuroepidemiol, San Francisco, CA 94132 USA.	kyle.walsh@ucsf.edu	Deelen, Joris/H-3201-2019; Tihan, Tarik/AAU-6371-2021; Suchiman, H. Eka D./F-5024-2017; Hovatta, Iiris/D-6871-2012; Kaprio, Jaakko/A-1820-2008; Viñuela, Ana/L-5015-2019; Slagboom, P. Eline/R-4790-2016; Peters, Annette/A-6117-2011; van Leeuwen, Elisabeth/G-3382-2017; Erdmann, Jeanette/P-7513-2014; Ripatti, Samuli/H-9446-2014; Pico, Alexander/HCH-4305-2022; Medland, Sarah E/C-7630-2013; Rice, Terri/J-6071-2014; Prados, Michael/N-5220-2019; Beekman, Marian/L-3004-2019; Verweij, Niek/ABC-6249-2021; Nyholt, Dale/J-3174-2017	Deelen, Joris/0000-0003-4483-3701; Suchiman, H. Eka D./0000-0002-7168-5516; Hovatta, Iiris/0000-0002-5990-7892; Kaprio, Jaakko/0000-0002-3716-2455; Viñuela, Ana/0000-0003-3771-8537; Slagboom, P. Eline/0000-0002-2875-4723; Peters, Annette/0000-0001-6645-0985; Erdmann, Jeanette/0000-0002-4486-6231; Ripatti, Samuli/0000-0002-0504-1202; Medland, Sarah E/0000-0003-1382-380X; Beekman, Marian/0000-0003-0585-6206; Verweij, Niek/0000-0002-4303-7685; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Ouwehand, Willem/0000-0002-7744-1790; Palotie, Aarno/0000-0002-2527-5874; Eriksson, Johan/0000-0002-2516-2060; Van Duijn, Cornelia/0000-0002-2374-9204; Mannisto, Satu/0000-0002-8668-3046; Tihan, Tarik/0000-0003-4551-2555; Esko, Tonu/0000-0003-1982-6569; Magi, Reedik/0000-0002-2964-6011; Kananen, Laura/0000-0003-3742-8927; Pico, Alexander/0000-0001-5706-2163; Norata, Giuseppe Danilo/0000-0002-6081-1257; Nelson, Christopher/0000-0001-8025-2897; Nyholt, Dale/0000-0001-7159-3040; Karssen, Lennart C./0000-0002-1959-342X; Walsh, Kyle/0000-0002-5879-9981; Codd, Veryan/0000-0002-9430-8254; Broer, Linda/0000-0003-0011-123X; Douroudis, Konstantinos/0000-0002-6383-7145	US National Institutes of Health [R25CA112355, R01CA52689, P50CA097257, R01CAl26831, R01CA139020]; National Brain Tumor Foundation; UCSF Lewis Chair in Brain Tumor Research; UCSF Robert Magnin Newman chair in Neuro-Oncology and donations from the families and friends of John Berard; Helen Glaser; Medical Research Council [MR/K014536/1] Funding Source: researchfish; MRC [MR/K014536/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA052689, R01CA126831, R25CA112355, P50CA108961, P50CA097257, R01CA139020] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP003862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068222] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; UCSF Lewis Chair in Brain Tumor Research; UCSF Robert Magnin Newman chair in Neuro-Oncology and donations from the families and friends of John Berard; Helen Glaser; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work at UCSF was supported by the US National Institutes of Health (grants R25CA112355, R01CA52689, P50CA097257, R01CAl26831 and R01CA139020), as well as by the National Brain Tumor Foundation, the UCSF Lewis Chair in Brain Tumor Research, the UCSF Robert Magnin Newman chair in Neuro-Oncology and donations from the families and friends of John Berardi, Helen Glaser, Elvera Olsen, Raymond E. Cooper and William Martinusen. Work at the Mayo Clinic was supported by the US National Institutes of Health (grants P50CA108961 and P30CA15083), the National Institute of Neurological Disorders and Stroke (grant RC1NS068222Z), the Bernie and Edith Waterman Foundation, and the Ting Tsung and Wei Fong Chao Family Foundation. Work at the University of Leicester was undertaken under the European Union Framework Programme 7 ENGAGE Project (HEALTH-F4-2007-201413). V.C. and N.J.S. are supported by the British Heart Foundation. This project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, US National Institutes of Health, through UCSF Clinical and Translational Science Institute grant UDRR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the US National Institutes of Health. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; by the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California and contract HHSN261201000034C awarded to the Public Health Institute; and by the Centers for Disease Control and Prevention National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the authors, and endorsement by the State of California Department of Public Health, the National Cancer Institute and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred.; The results published here are in part based on data generated by TCGA managed by the National Cancer Institute and the National Human Genome Research Institute. Information about TCGA can be found at http://cancergenome. nih.gov/. This study makes use of data generated by WTCCC. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475.	Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Denham J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069377; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hou LF, 2012, CANCER LETT, V319, P130, DOI 10.1016/j.canlet.2012.01.028; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Melin BS, 2012, GENET EPIDEMIOL, V36, P368, DOI 10.1002/gepi.21630; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Romano GH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003721; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vannier JB, 2013, SCIENCE, V342, P239, DOI 10.1126/science.1241779; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Walsh KM, 2013, NEURO-ONCOLOGY, V15, P1041, DOI 10.1093/neuonc/not051; Walsh KM, 2013, GENET EPIDEMIOL, V37, P222, DOI 10.1002/gepi.21707; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408	33	137	140	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					731	735		10.1038/ng.3004	http://dx.doi.org/10.1038/ng.3004			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	24908248	Green Submitted, Green Accepted			2022-12-17	WOS:000338093800015
J	Berndt, SI; Skibola, CF; Joseph, V; Camp, NJ; Nieters, A; Wang, ZM; Cozen, W; Monnereau, A; Wang, SS; Kelly, RS; Lan, Q; Teras, LR; Chatterjee, N; Chung, CC; Yeager, M; Brooks-Wilson, AR; Hartge, P; Purdue, MP; Birmann, BM; Armstrong, BK; Cocco, P; Zhang, YW; Severi, G; Zeleniuch-Jacquotte, A; Lawrence, C; Burdette, L; Yuenger, J; Hutchinson, A; Jacobs, KB; Call, TG; Shanafelt, TD; Novak, AJ; Kay, NE; Liebow, M; Wang, AH; Smedby, KE; Adami, HO; Melbye, M; Glimelius, B; Chang, ET; Glenn, M; Curtin, K; Cannon-Albright, LA; Jones, B; Diver, WR; Link, BK; Weiner, GJ; Conde, L; Bracci, PM; Riby, J; Holly, EA; Smith, MT; Jackson, RD; Tinker, LF; Benavente, Y; Becker, N; Boffetta, P; Brennan, P; Foretova, L; Maynadie, M; McKay, J; Staines, A; Rabe, KG; Achenbach, SJ; Vachon, CM; Goldin, LR; Strom, SS; Lanasa, MC; Spector, LG; Leis, JF; Cunningham, JM; Weinberg, JB; Morrison, VA; Caporaso, NE; Norman, AD; Linet, MS; De Roos, AJ; Morton, LM; Severson, RK; Riboli, E; Vineis, P; Kaaks, R; Trichopoulos, D; Masala, G; Weiderpass, E; Chirlaque, MD; Vermeulen, RCH; Travis, RC; Giles, GG; Albanes, D; Virtamo, J; Weinstein, S; Clavel, J; Zheng, TZ; Holford, TR; Offit, K; Zelenetz, A; Klein, RJ; Spinelli, JJ; Bertrand, KA; Laden, F; Giovannucci, E; Kraft, P; Kricker, A; Turner, J; Vajdic, CM; Ennas, MG; Ferri, GM; Miligi, L; Liang, LM; Sampson, J; Crouch, S; Park, JH; North, KE; Cox, A; Snowden, JA; Wright, J; Carracedo, A; Lopez-Otin, C; Bea, S; Salaverria, I; Martin-Garcia, D; Campo, E; Fraumeni, JF; de Sanjose, S; Hjalgrim, H; Cerhan, JR; Chanock, SJ; Rothman, N; Slager, SL				Berndt, Sonja I.; Skibola, Christine F.; Joseph, Vijai; Camp, Nicola J.; Nieters, Alexandra; Wang, Zhaoming; Cozen, Wendy; Monnereau, Alain; Wang, Sophia S.; Kelly, Rachel S.; Lan, Qing; Teras, Lauren R.; Chatterjee, Nilanjan; Chung, Charles C.; Yeager, Meredith; Brooks-Wilson, Angela R.; Hartge, Patricia; Purdue, Mark P.; Birmann, Brenda M.; Armstrong, Bruce K.; Cocco, Pierluigi; Zhang, Yawei; Severi, Gianluca; Zeleniuch-Jacquotte, Anne; Lawrence, Charles; Burdette, Laurie; Yuenger, Jeffrey; Hutchinson, Amy; Jacobs, Kevin B.; Call, Timothy G.; Shanafelt, Tait D.; Novak, Anne J.; Kay, Neil E.; Liebow, Mark; Wang, Alice H.; Smedby, Karin E.; Adami, Hans-Olov; Melbye, Mads; Glimelius, Bengt; Chang, Ellen T.; Glenn, Martha; Curtin, Karen; Cannon-Albright, Lisa A.; Jones, Brandt; Diver, W. Ryan; Link, Brian K.; Weiner, George J.; Conde, Lucia; Bracci, Paige M.; Riby, Jacques; Holly, Elizabeth A.; Smith, Martyn T.; Jackson, Rebecca D.; Tinker, Lesley F.; Benavente, Yolanda; Becker, Nikolaus; Boffetta, Paolo; Brennan, Paul; Foretova, Lenka; Maynadie, Marc; McKay, James; Staines, Anthony; Rabe, Kari G.; Achenbach, Sara J.; Vachon, Celine M.; Goldin, Lynn R.; Strom, Sara S.; Lanasa, Mark C.; Spector, Logan G.; Leis, Jose F.; Cunningham, Julie M.; Weinberg, J. Brice; Morrison, Vicki A.; Caporaso, Neil E.; Norman, Aaron D.; Linet, Martha S.; De Roos, Anneclaire J.; Morton, Lindsay M.; Severson, Richard K.; Riboli, Elio; Vineis, Paolo; Kaaks, Rudolph; Trichopoulos, Dimitrios; Masala, Giovanna; Weiderpass, Elisabete; Chirlaque, Mara-Dolores; Vermeulen, Roel C. H.; Travis, Ruth C.; Giles, Graham G.; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Clavel, Jacqueline; Zheng, Tongzhang; Holford, Theodore R.; Offit, Kenneth; Zelenetz, Andrew; Klein, Robert J.; Spinelli, John J.; Bertrand, Kimberly A.; Laden, Francine; Giovannucci, Edward; Kraft, Peter; Kricker, Anne; Turner, Jenny; Vajdic, Claire M.; Ennas, Maria Grazia; Ferri, Giovanni M.; Miligi, Lucia; Liang, Liming; Sampson, Joshua; Crouch, Simon; Park, Ju-Hyun; North, Kari E.; Cox, Angela; Snowden, John A.; Wright, Josh; Carracedo, Angel; Lopez-Otin, Carlos; Bea, Silvia; Salaverria, Itziar; Martin-Garcia, David; Campo, Elias; Fraumeni, Joseph F., Jr.; de Sanjose, Silvia; Hjalgrim, Henrik; Cerhan, James R.; Chanock, Stephen J.; Rothman, Nathaniel; Slager, Susan L.			Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY LOCI; FAS GENE-MUTATIONS; LINKAGE DISEQUILIBRIUM; EPIDEMIOLOGIC RESEARCH; TERT-CLPTM1L LOCUS; LYMPHOID NEOPLASMS; COMMON VARIATION; BREAST-CANCER; VARIANTS; APOPTOSIS	Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL). To identify additional CLL susceptibility loci, we conducted the largest meta-analysis for CLL thus far, including four GWAS with a total of 3,100 individuals with CLL (cases) and 7,667 controls. In the meta-analysis, we identified ten independent associated SNPs in nine new loci at 10q23.31 (ACTA2 or FAS (ACTA2/FAS), P = 1.22 x 10(-14)), 18q21.33 (BCL2, P = 7.76 x 10(-11)), 11p15.5 (C11orf21, P = 2.15 x 10(-10)), 4q25 (LEF1, P = 4.24 x 10(-10)), 2q33.1 (CASP10 or CASP8 (CASP10/CASP8), P = 2.50 x 10(-9)), 9p21.3 (CDKN2B-AS1, P = 1.27 x 10(-8)), 18q21.32 (PMAIP1, P = 2.51 x 10(-8)), 15q15.1 (BMF, P = 2.71 x 10(-10)) and 2p22.2 (QPCT, P = 1.68 x 10(-8)), as well as an independent signal at an established locus (2q13, ACOXL, P = 2.08 x 10(-18)). We also found evidence for two additional promising loci below genome-wide significance at 8q22.3 (ODF1, P = 5.40 x 10(-8)) and 5p15.33 (TERT, P = 1.92 x 10(-7)). Although further studies are required, the proximity of several of these loci to genes involved in apoptosis suggests a plausible underlying biological mechanism.	[Berndt, Sonja I.; Lan, Qing; Chatterjee, Nilanjan; Chung, Charles C.; Hartge, Patricia; Purdue, Mark P.; Goldin, Lynn R.; Caporaso, Neil E.; Linet, Martha S.; Morton, Lindsay M.; Albanes, Demetrius; Weinstein, Stephanie; Sampson, Joshua; Fraumeni, Joseph F., Jr.; Chanock, Stephen J.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Skibola, Christine F.; Conde, Lucia; Riby, Jacques; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Skibola, Christine F.; Conde, Lucia] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Joseph, Vijai; Offit, Kenneth; Zelenetz, Andrew; Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Camp, Nicola J.; Curtin, Karen; Cannon-Albright, Lisa A.; Jones, Brandt] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Nieters, Alexandra] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Hesse, Germany; [Wang, Zhaoming; Chung, Charles C.; Yeager, Meredith; Burdette, Laurie; Yuenger, Jeffrey; Hutchinson, Amy; Jacobs, Kevin B.] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Cozen, Wendy] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Monnereau, Alain; Clavel, Jacqueline] INSERM, U1018 EQ6, Villejuif, France; [Monnereau, Alain] Inst Bergonie, Registre Hemopathies Malignes Gironde, Bordeaux, France; [Wang, Sophia S.] City Hope Beckman Res Inst, Div Canc Etiol, Duarte, CA USA; [Kelly, Rachel S.; Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London, England; [Teras, Lauren R.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Brooks-Wilson, Angela R.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Birmann, Brenda M.; Bertrand, Kimberly A.; Laden, Francine; Giovannucci, Edward] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Birmann, Brenda M.; Bertrand, Kimberly A.; Laden, Francine; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Armstrong, Bruce K.; Kricker, Anne] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Cocco, Pierluigi] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Zhang, Yawei; Zheng, Tongzhang] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA; [Severi, Gianluca; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Zeleniuch-Jacquotte, Anne] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Lawrence, Charles] WESTAT Corp, Hlth Studies Sector, Rockville, MD 20850 USA; [Call, Timothy G.; Kay, Neil E.] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA; [Shanafelt, Tait D.; Novak, Anne J.] Mayo Clin, Coll Med, Dept Med, Rochester, MN USA; [Liebow, Mark] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN USA; [Wang, Alice H.; Rabe, Kari G.; Achenbach, Sara J.; Vachon, Celine M.; Norman, Aaron D.; Cerhan, James R.; Slager, Susan L.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Smedby, Karin E.] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Smedby, Karin E.; Glimelius, Bengt] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Pathol & Oncol, Stockholm, Sweden; [Adami, Hans-Olov; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Adami, Hans-Olov; Trichopoulos, Dimitrios; Bertrand, Kimberly A.; Laden, Francine; Giovannucci, Edward; Kraft, Peter; Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Melbye, Mads; Hjalgrim, Henrik] Statens Serum Inst, Div Hlth Surveillance & Res, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Glimelius, Bengt] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Chang, Ellen T.] Exponent Inc, Hlth Sci, Ctr Epidemiol & Computat Biol, Menlo Pk, CA USA; [Chang, Ellen T.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Glenn, Martha] Huntsman Canc Inst, Dept Internal Med, Salt Lake City, UT USA; [Cannon-Albright, Lisa A.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Link, Brian K.; Weiner, George J.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Tinker, Lesley F.; De Roos, Anneclaire J.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Benavente, Yolanda; de Sanjose, Silvia] Inst Invest Biomed Bellvitge IDIBELL, Canc Epidemiol Res Programme, Unit Infect & Canc UNIC, Barcelona, Spain; [Benavente, Yolanda; Chirlaque, Mara-Dolores; de Sanjose, Silvia] CIBERESP, Barcelona, Spain; [Becker, Nikolaus; Kaaks, Rudolph] German Canc Res Ctr, Div Canc Epidemiol, Baden, Switzerland; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Brennan, Paul] Int Agcy Res Canc, Genet Sect, Grp Genet Epidemiol, F-69372 Lyon, France; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Maynadie, Marc] Univ Burgundy, Registre Hemopathies Malignes Cote dOr, EA 4184, Dijon, France; [McKay, James] Int Agcy Res Canc, Genet Sect, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Staines, Anthony] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Leinster, Ireland; [Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lanasa, Mark C.; Weinberg, J. Brice] Duke Univ, Dept Med, Durham, NC USA; [Lanasa, Mark C.; Weinberg, J. Brice] VA Med Ctr, Durham, NC USA; [Spector, Logan G.] Univ Minnesota, Div Epidemiol & Clin Res, Minneapolis, MN USA; [Leis, Jose F.] Mayo Clin, Coll Med, Div Hematol & Oncol, Phoenix, AZ USA; [Cunningham, Julie M.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Morrison, Vicki A.] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA; [Severson, Richard K.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Vineis, Paolo] Human Genet Fdn, Turin, Italy; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Weiderpass, Elisabete] Univ Tromso, Fac Hlth Sci, Dept Community Med, Breivika, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Folkhalsan Res Ctr, Helsinki, Finland; [Chirlaque, Mara-Dolores] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Vermeulen, Roel C. H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Vermeulen, Roel C. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Travis, Ruth C.] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis & Prevent, Helsinki, Finland; [Holford, Theodore R.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Spinelli, John J.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Laden, Francine] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Kraft, Peter; Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Turner, Jenny] Macquarie Univ, Australian Sch Adv Med, Dept Pathol, Sydney, NSW 2109, Australia; [Turner, Jenny] Douglass Hanly Moir Pathol, Dept Histopathol, Macquarie Pk, NSW, Australia; [Vajdic, Claire M.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Ennas, Maria Grazia] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Ferri, Giovanni M.] Univ Bari, Interdisciplinary Dept Med, Bari, Italy; [Miligi, Lucia] ISPO, Environm & Occupat Epidemiol Unit, Florence, Italy; [Crouch, Simon] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England; [Park, Ju-Hyun] Dongguk Univ Seoul, Seoul, South Korea; [North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Cox, Angela; Snowden, John A.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Snowden, John A.; Wright, Josh] Sheffield Teaching Hosp Natl Hlth Serv NHS Fdn Tr, Dept Haematol, Sheffield, S Yorkshire, England; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Genom Med Grp, Santiago De Compostela, Spain; [Lopez-Otin, Carlos] Univ Oviedo, Inst Oncol, Dept Biochem & Mol Biol, Oviedo, Spain; [Bea, Silvia; Salaverria, Itziar; Martin-Garcia, David; Campo, Elias] Univ Barcelona, Hosp Clin Barcelona, August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley; University of Alabama System; University of Alabama Birmingham; Memorial Sloan Kettering Cancer Center; Utah System of Higher Education; University of Utah; University of Freiburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; City of Hope; Beckman Research Institute of City of Hope; Imperial College London; American Cancer Society; British Columbia Cancer Agency; Simon Fraser University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Sydney; University of Cagliari; Yale University; Cancer Council Victoria; New York University; Westat; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Statens Serum Institut; Uppsala University; Exponent; Stanford University; Huntsman Cancer Institute; US Department of Veterans Affairs; University of Iowa; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; Fred Hutchinson Cancer Center; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Icahn School of Medicine at Mount Sinai; World Health Organization; International Agency for Research on Cancer (IARC); Masaryk Memorial Cancer Institute; Universite de Bourgogne; World Health Organization; International Agency for Research on Cancer (IARC); Dublin City University; University of Texas System; UTMD Anderson Cancer Center; Duke University; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Wayne State University; Imperial College London; Academy of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; UiT The Arctic University of Tromso; University of Oslo; Folkhalsan Research Center; Samfundet Folkhalsan; Murcia Regional Health Council; Utrecht University; Utrecht University; Utrecht University Medical Center; University of Oxford; Finland National Institute for Health & Welfare; Yale University; Memorial Sloan Kettering Cancer Center; British Columbia Cancer Agency; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Macquarie University; University of New South Wales Sydney; University of Cagliari; Universita degli Studi di Bari Aldo Moro; University of York - UK; Dongguk University; University of North Carolina; University of North Carolina Chapel Hill; University of Sheffield; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; University of Oviedo; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Slager, SL (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	slager@mayo.edu	Morton, Lindsay M/B-5234-2015; Cocco, Pierluigi/AAM-7474-2021; Staines, Anthony/AFQ-7565-2022; Weiderpass, Elisabete/AAP-2747-2021; Vermeulen, Roel/F-8037-2011; SALAVERRIA, ITZIAR/L-2246-2015; Clavel, Jacqueline/Q-2750-2016; Weinstein, Stephanie J/P-1627-2017; kelly, rachel/H-4505-2017; Joseph, Vijai/J-9158-2013; Weiderpass, Elisabete/M-4029-2016; Monnereau, Alain/L-1249-2014; Carracedo, Angel/D-4257-2012; SALAVERRIA, ITZIAR/AAW-9019-2021; Benavente, Yolanda/H-9810-2014; Conde, Lucia/D-9295-2011; de Sanjosé Llongueras, Silvia/H-6339-2014; López-Otín, Carlos/AAB-2106-2020; Vajdic, Claire/AAP-5940-2020; Spinelli, John J./B-6210-2013; Campo, Elias/AAC-5593-2019; Wang, Zhaoming/R-5527-2018; Martín, David/AAC-9334-2020; Hjalgrim, Henrik/AAG-4973-2021; Masala, Giovanna/AAC-5474-2022; Diver, Ryan/AAG-3469-2019; Brooks-Wilson, Angela/E-9399-2012; Ferri, Giovanni Maria/S-9518-2019; bea, silvia/K-7699-2014; Boffetta, Paolo/AAI-7767-2021; Yeager, Meredith/AAA-5322-2020; Severi, Gianluca/Q-1824-2019; Purdue, Mark P/C-9228-2016; Klein, Robert/K-1888-2013; Severi, Gianluca/H-3774-2018; FERRI, Giovanni/AAL-2010-2021; Albanes, Demetrius/B-9749-2015; Armstrong, Bruce K/K-9464-2015; Morton, Lindsay/AAE-7495-2022; Berndt, Sonja I/J-8423-2016	Morton, Lindsay M/0000-0001-9767-2310; Staines, Anthony/0000-0001-9161-1357; Weiderpass, Elisabete/0000-0003-2237-0128; Vermeulen, Roel/0000-0003-4082-8163; SALAVERRIA, ITZIAR/0000-0002-2427-9822; Clavel, Jacqueline/0000-0002-3616-7676; Weinstein, Stephanie J/0000-0002-3834-1535; kelly, rachel/0000-0003-3023-1822; Joseph, Vijai/0000-0002-7933-151X; Weiderpass, Elisabete/0000-0003-2237-0128; Monnereau, Alain/0000-0002-5056-1397; Carracedo, Angel/0000-0003-1085-8986; López-Otín, Carlos/0000-0001-6964-1904; Spinelli, John J./0000-0002-9119-3287; Campo, Elias/0000-0001-9850-9793; Wang, Zhaoming/0000-0001-7556-3869; Martín, David/0000-0002-0289-5915; Masala, Giovanna/0000-0002-5758-9069; Diver, Ryan/0000-0002-5418-9000; Brooks-Wilson, Angela/0000-0003-1009-6408; Ferri, Giovanni Maria/0000-0002-6104-9305; bea, silvia/0000-0001-7192-2385; Boffetta, Paolo/0000-0002-3811-2791; Severi, Gianluca/0000-0001-7157-419X; Purdue, Mark P/0000-0003-1177-3108; Klein, Robert/0000-0003-3539-5391; Severi, Gianluca/0000-0001-7157-419X; Armstrong, Bruce K/0000-0001-8940-7525; Morton, Lindsay/0000-0001-9767-2310; Ennas, Maria Grazia/0000-0002-9448-715X; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Conde, Lucia/0000-0001-5180-543X; Birmann, Brenda/0000-0002-7550-5498; melbye, mads/0000-0001-8264-6785; SNOWDEN, JOHN/0000-0001-6819-3476; albright, lisa/0000-0003-2602-3668; Turner, Jennifer/0000-0001-5550-3375; Miligi, Lucia/0000-0002-8223-485X; Cerhan, James/0000-0002-7482-178X; Foretova, Lenka/0000-0003-0494-2620; Cox, Angela/0000-0002-5138-1099; Spector, Logan/0000-0003-2516-0222; Link, Brian/0000-0001-5084-0698; WANG, SOPHIA/0000-0003-2597-9393; Vajdic, Claire/0000-0002-3612-8298; Zelenetz, Andrew/0000-0003-1403-6883; Bertrand, Kimberly/0000-0002-4565-7618; Riboli, Elio/0000-0001-6795-6080; weiner, george/0000-0003-3427-0562; Norman, Aaron/0000-0002-4208-2708; Giles, Graham/0000-0003-4946-9099; Jacobs, Kevin/0000-0002-4657-6473	Division of Cancer Epidemiology and Genetics, NCI, US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010170] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	Division of Cancer Epidemiology and Genetics, NCI, US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Allmer, E. Angelucci, A. Bigelow, I. Brock, K. Butterbach, A. Chabrier, D. Chan-Lam, J.M. Conners, D. Connley, M. Cornelis, K. Corsano, C. Dalley, D. Cox, H. Cramp, R. Cutting, H. Dykes, L. Ershler, A. Gabbas, R.P. Gallagher, R.D. Gascoyne, P. Hui, L. Irish, L. Jacobus, S. Kaul, J. Lunde, M. McAdams, R. Montalvan, M. Rais, T. Rattle, L. Rigacci, K. Snyder, G. Specchia, M. Stagner, P. Taylor, G. Thomas, C. Tornow, G. Wood, M. Yang and M. Zucca for their assistance. The overall GWAS project was supported by the intramural program of the Division of Cancer Epidemiology and Genetics, NCI, US National Institutes of Health. A full list of acknowledgments is provided in the Supplementary Note.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Baseggio L, 2012, BRIT J HAEMATOL, V158, P489, DOI 10.1111/j.1365-2141.2012.09178.x; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Crowther-Swanepoel D, 2011, BRIT J HAEMATOL, V154, P229, DOI 10.1111/j.1365-2141.2011.08706.x; Crowther-Swanepoel D, 2010, BRIT J HAEMATOL, V150, P473, DOI 10.1111/j.1365-2141.2010.08270.x; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Enjuanes A, 2008, CANCER RES, V68, P10178, DOI 10.1158/0008-5472.CAN-08-2221; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; KOUFOS A, 1989, AM J HUM GENET, V44, P711; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lan Q, 2007, CARCINOGENESIS, V28, P823, DOI 10.1093/carcin/bgl196; Lan Q, 2010, EUR J HAEMATOL, V85, P492, DOI 10.1111/j.1600-0609.2010.01518.x; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li N, 2003, GENETICS, V165, P2213; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Morales AA, 2004, LEUKEMIA, V18, P41, DOI 10.1038/sj.leu.2403183; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Reshmi G, 2011, GENOMICS, V98, P189, DOI 10.1016/j.ygeno.2011.06.005; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sheng XJ, 2013, CARCINOGENESIS, V34, P228, DOI 10.1093/carcin/bgs325; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Slager SL, 2012, BLOOD, V120, P843, DOI 10.1182/blood-2012-03-413591; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; STRASSER A, 1993, ONCOGENE, V8, P1; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Turner JJ, 2010, BLOOD, V116, pE90, DOI 10.1182/blood-2010-06-289561; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wang ZM, 2012, NAT GENET, V44, P6, DOI 10.1038/ng.1044; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Wensveen FM, 2012, BLOOD, V119, P1440, DOI 10.1182/blood-2011-09-378877; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	63	137	140	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					868	876		10.1038/ng.2652	http://dx.doi.org/10.1038/ng.2652			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23770605	Green Accepted, Green Submitted			2022-12-17	WOS:000322374900008
J	Xu, JF; Mo, ZN; Ye, DW; Wang, ML; Liu, F; Jin, GF; Xu, CL; Wang, X; Shao, Q; Chen, ZW; Tao, ZH; Qi, J; Zhou, FJ; Wang, Z; Fu, YW; He, DL; Wei, Q; Guo, JM; Wu, DL; Gao, X; Yuan, JL; Wang, GX; Xu, Y; Wang, GZ; Yao, HJ; Dong, P; Jiao, Y; Shen, M; Yang, J; Jun, OY; Jiang, HW; Zhu, Y; Ren, SC; Zhang, ZD; Yin, CJ; Gao, X; Dai, B; Hu, ZB; Yang, YJ; Wu, QJ; Chen, HY; Peng, P; Zheng, Y; Zheng, XD; Xiang, YB; Long, JR; Gong, J; Na, R; Lin, XL; Yu, HJ; Wang, Z; Tao, S; Feng, JJ; Sun, JS; Liu, WN; Hsing, A; Rao, JY; Ding, Q; Wiklund, F; Gronberg, H; Shu, XO; Zheng, W; Shen, HB; Jin, L; Shi, R; Lu, DR; Zhang, XJ; Sun, JL; Zheng, SL; Sun, YH				Xu, Jianfeng; Mo, Zengnan; Ye, Dingwei; Wang, Meilin; Liu, Fang; Jin, Guangfu; Xu, Chuanliang; Wang, Xiang; Shao, Qiang; Chen, Zhiwen; Tao, Zhihua; Qi, Jun; Zhou, Fangjian; Wang, Zhong; Fu, Yaowen; He, Dalin; Wei, Qiang; Guo, Jianming; Wu, Denglong; Gao, Xin; Yuan, Jianlin; Wang, Gongxian; Xu, Yong; Wang, Guozeng; Yao, Haijun; Dong, Pei; Jiao, Yang; Shen, Mo; Yang, Jin; Jun Ou-Yang; Jiang, Haowen; Zhu, Yao; Ren, Shancheng; Zhang, Zhengdong; Yin, Changjun; Gao, Xu; Dai, Bo; Hu, Zhibin; Yang, Yajun; Wu, Qijun; Chen, Hongyan; Peng, Peng; Zheng, Ying; Zheng, Xiaodong; Xiang, Yongbing; Long, Jirong; Gong, Jian; Na, Rong; Lin, Xiaoling; Yu, Hongjie; Wang, Zhong; Tao, Sha; Feng, Junjie; Sun, Jishan; Liu, Wennuan; Hsing, Ann; Rao, Jianyu; Ding, Qiang; Wiklund, Fredirik; Gronberg, Henrik; Shu, Xiao-Ou; Zheng, Wei; Shen, Hongbing; Jin, Li; Shi, Rong; Lu, Daru; Zhang, Xuejun; Sun, Jielin; Zheng, S. Lilly; Sun, Yinghao			Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS; GENE-CLUSTER; CLASS-I; VARIANTS; RECEPTORS	Prostate cancer risk-associated variants have been reported in populations of European descent, African-Americans and Japanese using genome-wide association studies (GWAS). To systematically investigate prostate cancer risk-associated variants in Chinese men, we performed the first GWAS in Han Chinese. In addition to confirming several associations reported in other ancestry groups, this study identified two new risk-associated loci for prostate cancer on chromosomes 9q31.2 (rs817826, P = 5.45 x 10(-14)) and 19q13.4 (rs103294, P = 5.34 x 10(-16)) in 4,484 prostate cancer cases and 8,934 controls. The rs103294 marker at 19q13.4 is in strong linkage equilibrium with a 6.7-kb germline deletion that removes the first six of seven exons in LILRA3, a gene regulating inflammatory response, and was significantly associated with the mRNA expression of LILRA3 in T cells (P < 1 x 10(-4)). These findings may advance the understanding of genetic susceptibility to prostate cancer.	[Xu, Chuanliang; Ren, Shancheng; Gao, Xu; Sun, Yinghao] Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Xu, Jianfeng; Liu, Fang; Wang, Xiang; Jiang, Haowen; Gong, Jian; Na, Rong; Lin, Xiaoling] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Liu, Fang; Chen, Hongyan; Lin, Xiaoling; Yu, Hongjie; Lu, Daru; Sun, Jielin; Zheng, S. Lilly] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Chen, Hongyan; Yu, Hongjie; Lu, Daru] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng; Jin, Guangfu; Wang, Zhong; Tao, Sha; Feng, Junjie; Sun, Jishan; Liu, Wennuan; Ding, Qiang; Sun, Jielin; Zheng, S. Lilly] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China; [Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol, Nanning, Peoples R China; [Ye, Dingwei; Zhu, Yao; Dai, Bo] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China; [Ye, Dingwei; Zhu, Yao; Dai, Bo] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Dept Mol & Genet Toxicol,Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Jin, Guangfu; Zhang, Zhengdong; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Shao, Qiang] Suzhou Municipal Hosp, Dept Urol, Suzhou, Peoples R China; [Chen, Zhiwen] Third Mil Med Univ, Southwest Hosp, Urol Inst Peoples Liberat Army PLA, Chongqing, Peoples R China; [Tao, Zhihua] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China; [Qi, Jun; Jiao, Yang] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Urol, Shanghai 200030, Peoples R China; [Zhou, Fangjian; Dong, Pei] State Key Lab Oncol So China, Guangzhou, Guangdong, Peoples R China; [Zhou, Fangjian; Dong, Pei] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Zhong; Yao, Haijun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol, Shanghai 200030, Peoples R China; [Fu, Yaowen] Jilin Univ, Hosp 1, Dept Urol, Changchun 130023, Peoples R China; [He, Dalin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Urol, Xian 710049, Peoples R China; [Wei, Qiang] Sichuan Univ, W China Hosp, Dept Urol, Chengdu 610064, Peoples R China; [Guo, Jianming] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Wu, Denglong] Tongji Univ, Tongji Hosp, Dept Urol, Shanghai 200092, Peoples R China; [Gao, Xin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Yuan, Jianlin] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Wang, Gongxian] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China; [Xu, Yong] TianJin Med Univ, TianJin Inst Urol, Hosp 2, Dept Urol, Tianjin, Peoples R China; [Wang, Guozeng] Pudong Gongli Hosp, Dept Urol, Shanghai, Peoples R China; [Shen, Mo] Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China; [Yang, Jin] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [Jun Ou-Yang] Suzhou Univ, Peoples Hosp 1, Dept Urol, Suzhou 215006, Peoples R China; [Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Yang, Yajun; Jin, Li; Lu, Daru] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Yang, Yajun; Jin, Li; Lu, Daru] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yang, Yajun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China; [Wu, Qijun] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Renji Hosp, State Key Lab Oncogene & Related Genes,Sch Med, Shanghai 200030, Peoples R China; [Peng, Peng; Zheng, Ying] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Peoples R China; [Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Zheng, Xiaodong; Zhang, Xuejun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Peoples R China; [Xiang, Yongbing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Long, Jirong; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Vanderbilt Epidemiol Ctr,Div Epidemiol, Nashville, TN 37212 USA; [Hsing, Ann] Canc Prevent Inst Calif, Fremont, CA USA; [Rao, Jianyu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Wiklund, Fredirik; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Shi, Rong] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China	Naval Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Army Medical University; Zhejiang University; Shanghai Jiao Tong University; Sun Yat Sen University; Shanghai Jiao Tong University; Jilin University; Xi'an Jiaotong University; Sichuan University; Fudan University; Tongji University; Sun Yat Sen University; Air Force Military Medical University; Nanchang University; Tianjin Medical University; Wenzhou Medical University; Army Medical University; Soochow University - China; Nanjing Medical University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention; Anhui Medical University; Anhui Medical University; Shanghai Jiao Tong University; Vanderbilt University; Cancer Prevention Institute of California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Karolinska Institutet; Shanghai Jiao Tong University	Sun, YH (corresponding author), Second Mil Med Univ, Shanghai Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	sunyh@medmail.com.cn	Chen, Zhiwen/I-1153-2013; zhang, weihua/GXV-1334-2022; Jin, Li/C-1468-2009; Chen, Gang/G-2722-2010; zhang, zheng/HCH-9684-2022; Yu, Hongjie/GZK-5351-2022; Jin, Li/M-5063-2019; Zheng, Wei/O-3351-2013	Jin, Li/0000-0002-4546-2415; Zheng, Wei/0000-0003-1226-070X; mo, zengnan/0000-0002-3047-3138; Long, Jirong/0000-0002-7433-9766; Na, Rong/0000-0001-7470-5108; Shen, Hongbing/0000-0002-2581-5906; Jin, Guangfu/0000-0003-0249-5337; Qi, Jun/0000-0003-0970-8462	National Key Basic Research Program [2012CB518300, 2012CB518301]; National Natural Science Foundation of China [81130047, 30945204, 30973009]; Fudan University; Huashan Hospital; US National Institutes of Health [NCI CA129684]; Ministry of Health [201002007]; National Science & Technology Pillar Program [2011BAI09B00]; NATIONAL CANCER INSTITUTE [R01CA129684] Funding Source: NIH RePORTER	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University; Huashan Hospital; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health; National Science & Technology Pillar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all of the subjects included in this study. This work was partially funded by the National Key Basic Research Program grant 973 (2012CB518300 to Y.S and 2012CB518301 to J.X.), the Key Project of the National Natural Science Foundation of China (81130047 to J.X.), intramural grants from the Fudan University Thousand Talents Program and Huashan Hospital (to J.X.), the US National Institutes of Health (NCI CA129684 to J.X.), the National Natural Science Foundation of China (30945204 to Z.M and 30973009 to D.Y.), the Ministry of Health Special Research Fund for Public Interests (201002007 to L.J.) and the National Science & Technology Pillar Program (2011BAI09B00 to L.J.).	Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Borges L, 1997, J IMMUNOL, V159, P5192; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	26	137	143	1	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1231	1235		10.1038/ng.2424	http://dx.doi.org/10.1038/ng.2424			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23023329	Green Accepted			2022-12-17	WOS:000310495800015
J	Wortmann, SB; Vaz, FM; Gardeitchik, T; Vissers, LELM; Renkema, GH; Schuurs-Hoeijmakers, JHM; Kulik, W; Lammens, M; Christin, C; Kluijtmans, LAJ; Rodenburg, RJ; Nijtmans, LGJ; Grunewald, A; Klein, C; Gerhold, JM; Kozicz, T; van Hasselt, PM; Harakalova, M; Kloosterman, W; Baric, I; Pronicka, E; Ucar, SK; Naess, K; Singhal, KK; Krumina, Z; Gilissen, C; van Bokhoven, H; Veltman, JA; Smeitink, JAM; Lefeber, DJ; Spelbrink, JN; Wevers, RA; Morava, E; Arjan, PMB				Wortmann, Saskia B.; Vaz, Frederic M.; Gardeitchik, Thatjana; Vissers, Lisenka E. L. M.; Renkema, G. Herma; Schuurs-Hoeijmakers, Janneke H. M.; Kulik, Wim; Lammens, Martin; Christin, Christin; Kluijtmans, Leo A. J.; Rodenburg, Richard J.; Nijtmans, Leo G. J.; Gruenewald, Anne; Klein, Christine; Gerhold, Joachim M.; Kozicz, Tamas; van Hasselt, Peter M.; Harakalova, Magdalena; Kloosterman, Wigard; Baric, Ivo; Pronicka, Ewa; Ucar, Sema Kalkan; Naess, Karin; Singhal, Kapil K.; Krumina, Zita; Gilissen, Christian; van Bokhoven, Hans; Veltman, Joris A.; Smeitink, Jan A. M.; Lefeber, Dirk J.; Spelbrink, Johannes N.; Wevers, Ron A.; Morava, Eva; de Brouwer, Arjan P. M.			Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness	NATURE GENETICS			English	Article							3-METHYLGLUTACONIC ACIDURIA; BARTH SYNDROME; BIOSYNTHESIS; CARDIOLIPIN; ASSOCIATION; INTERFACE; FRACTION	Using exome sequencing, we identify SERAC1 mutations as the cause of MEGDEL syndrome, a recessive disorder of dystonia and deafness with Leigh-like syndrome, impaired oxidative phosphorylation and 3-methylglutaconic aciduria. We localized SERAC1 at the interface between the mitochondria and the endoplasmic reticulum in the mitochondria-associated membrane fraction that is essential for phospholipid exchange. A phospholipid analysis in patient fibroblasts showed elevated concentrations of phosphatidylglycerol-34:1 (where the species nomenclature denotes the number of carbon atoms in the two acyl chains: number of double bonds in the two acyl groups) and decreased concentrations of phosphatidylglycerol-36:1 species, resulting in an altered cardiolipin subspecies composition. We also detected low concentrations of bis(monoacyl-glycerol)-phosphate, leading to the accumulation of free cholesterol, as shown by abnormal filipin staining. Complementation of patient fibroblasts with wild-type human SERAC1 by lentiviral infection led to a decrease and partial normalization of the mean ratio of phosphatidylglycerol-34:1 to phosphatidylglycerol-36:1. Our data identify SERAC1 as a key player in the phosphatidylglycerol remodeling that is essential for both mitochondrial function and intracellular cholesterol trafficking.	[Wortmann, Saskia B.; Gardeitchik, Thatjana; Vissers, Lisenka E. L. M.; Renkema, G. Herma; Rodenburg, Richard J.; Nijtmans, Leo G. J.; Gerhold, Joachim M.; Smeitink, Jan A. M.; Lefeber, Dirk J.; Spelbrink, Johannes N.; Wevers, Ron A.; Morava, Eva] RUNMC, IGMD, Nijmegen, Netherlands; [Wortmann, Saskia B.; Gardeitchik, Thatjana; Renkema, G. Herma; Rodenburg, Richard J.; Nijtmans, Leo G. J.; Gerhold, Joachim M.; Smeitink, Jan A. M.; Spelbrink, Johannes N.; Morava, Eva] RUNMC, Dept Pediat, Nijmegen, Netherlands; [Vaz, Frederic M.; Kulik, Wim] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem & Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Gardeitchik, Thatjana; Kluijtmans, Leo A. J.; Rodenburg, Richard J.; Lefeber, Dirk J.; Wevers, Ron A.] RUNMC, Dept Lab Med, Lab Genet Endocrine & Metab Dis LGEM, Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; Schuurs-Hoeijmakers, Janneke H. M.; Gilissen, Christian; van Bokhoven, Hans; Veltman, Joris A.; de Brouwer, Arjan P. M.] RUNMC, Dept Human Genet, Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; van Bokhoven, Hans] RUNMC, Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Renkema, G. Herma] RUNMC, Ctr Syst Biol & Bioenerget, Nijmegen, Netherlands; [Lammens, Martin] RUNMC, Dept Pathol, Nijmegen, Netherlands; [Christin, Christin] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinform, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Gruenewald, Anne; Klein, Christine] Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Kozicz, Tamas; van Bokhoven, Hans] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Kozicz, Tamas] Radboud Univ Nijmegen, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [van Hasselt, Peter M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Harakalova, Magdalena; Kloosterman, Wigard] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Baric, Ivo] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb, Croatia; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Metab Dis, Warsaw, Poland; [Ucar, Sema Kalkan] Ege Univ Fac Med, Dept Pediat, Izmir, Turkey; [Naess, Karin] Karolinska Univ Hosp, Dept Pediat Neurol, Stockholm, Sweden; [Singhal, Kapil K.] All India Inst Med Sci, Dept Neurol, Delhi, India; [Krumina, Zita] Childrens Univ Hosp, Med Genet Clin, Riga, Latvia; [Lefeber, Dirk J.] RUNMC, Dept Neurol, Nijmegen, Netherlands; [Spelbrink, Johannes N.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Spelbrink, Johannes N.] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Lubeck; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Zagreb; University of Zagreb; Children's Memorial Health Institute; Ege University; Karolinska Institutet; Karolinska University Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Radboud University Nijmegen; Tampere University; Tampere University; Tampere University Hospital	Wevers, RA (corresponding author), RUNMC, IGMD, Nijmegen, Netherlands.	s.wortmann@cukz.umcn.nl; r.wevers@labgk.umcn.nl	Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; de Brouwer, Arjan PM/P-5949-2015; Lammens, Martin/H-1503-2011; Uçar, Sema Kalkan/AAO-4465-2020; Smeitink, Jan/C-1351-2013; Wortmann, Saskia/E-6125-2010; Wevers, Ron A./H-8116-2014; Lefeber, Dirk DJ/A-2146-2014; Spelbrink, Johannes N/L-4661-2015; Kozicz, Tamas/G-3161-2012; Gilissen, Christian/E-5246-2012; Kluijtmans, Leo A/L-4437-2015; Gerhold, Joachim/N-3033-2019; lefeber, dirk/G-5063-2012; Lammens, Martin/AAI-9343-2021; Nijtmans, L.G.J./L-4549-2015; van Bokhoven, Hans/D-8764-2012; Morava, E./L-4529-2015; Kozicz, Tamas/N-5154-2014; Veltman, Joris A/F-5128-2010; Renkema, Herma/L-1489-2015; Vissers, Lisenka ELM/A-2598-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; Gerhold, Joachim M/B-7276-2012; Rodenburg, Richard/N-3579-2014	Grünewald, Anne/0000-0002-4179-2994; Lammens, Martin/0000-0002-3881-6692; Uçar, Sema Kalkan/0000-0001-9574-7841; Wevers, Ron A./0000-0003-2278-9746; Spelbrink, Johannes N/0000-0002-9756-2602; Kozicz, Tamas/0000-0001-6915-4364; Gilissen, Christian/0000-0003-1693-9699; Gerhold, Joachim/0000-0002-4972-1947; Kozicz, Tamas/0000-0001-6915-4364; Veltman, Joris A/0000-0002-3218-8250; Renkema, Herma/0000-0002-8174-6538; Vissers, Lisenka ELM/0000-0001-6470-5497; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Gerhold, Joachim M/0000-0002-4972-1947; Rodenburg, Richard/0000-0001-5227-3527; Vaz, Frederic/0000-0002-9048-1041; Pronicka, Ewa/0000-0002-5705-4814; Naess, Karin/0000-0003-4310-7927; Klein, Christine/0000-0003-2102-3431	Dutch Brain Foundation [2010(1)-30, 2011(1)-101]; EU [241995]; Netherlands Organisation for Health Research and Development (ZonMW) [916.86.016, 917.66.363]; Ministry of Science, Education and Sports of the Republic of Croatia [108-1081870-1885]; Stichting Energy4all; IGMD junior scientist grant; EMBO; Marie Curie Actions EMBO [1066_2011, MCA-EMBOCOFUND2010, GA-2010-267146]; Academy of Finland; Tampere University Hospital Medical Research Fund [9J119, 9K126, 9L097]; Netherlands Organization for Scientific Research (NWO: VICI) [865.10.004]	Dutch Brain Foundation; EU(European Commission); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Stichting Energy4all; IGMD junior scientist grant; EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Actions EMBO; Academy of Finland(Academy of Finland); Tampere University Hospital Medical Research Fund; Netherlands Organization for Scientific Research (NWO: VICI)(Netherlands Organization for Scientific Research (NWO))	We thank the patients and their parents for participating in this study. The study was financially supported by the Dutch Brain Foundation (2010(1)-30 to A.P.M.d.B. and 2011(1)-101 to E.M.), the EU 7th framework programme (grant 241995 (GENCODYS) to H.v.B.), the Netherlands Organisation for Health Research and Development (ZonMW 916.86.016 to L.E.L.M.V. and ZonMW 917.66.363 to J.A.V.) and the Ministry of Science, Education and Sports of the Republic of Croatia (108-1081870-1885 to I.B.). S.B.W. is supported by the 'Stichting Energy4all'. T.G. is a recipient of the 'IGMD junior scientist grant 2010'. J.M.G. is a recipient of an EMBO long-term fellowship cofunded by Marie Curie Actions EMBO long-term fellowship 1066_2011 (including MCA-EMBOCOFUND2010 and GA-2010-267146). J.N.S. is supported by the Academy of Finland (Centre of Excellence funding), the Tampere University Hospital Medical Research Fund (9J119, 9K126 and 9L097) and the Netherlands Organization for Scientific Research (NWO: VICI grant 865.10.004). We are grateful to B. van den Ende, M. Seders and S. van de Velde-Vissers (Department of Human Genetics, RUNMC, Nijmegen), as well as to K. Janssen and A. van Heck-Kappen (Department of Laboratory Medicine, RUNMC, Nijmegen), A. Leenders (Department of Pediatrics, RUNMC, Nijmegen), the colleagues of the tissue culture lab of the LGEM (Department of Laboratory Medicine, RUNMC, Nijmegen) and F.S. Stet (University of Amsterdam) for excellent technical assistance. For technical assistance, data analysis, critical discussion and exome sequencing, we are grateful to the Genomic Disorders groups of the Department of Human Genetics, RUNMC, Nijmegen (headed by H. Brunner) and the Department of Medical Genetics, University Medical Center, Utrecht (headed by E. Cuppen). We also thank F.A.J. Muskiet, F. Preijers, A. van Kampen and J. van Dam for useful discussions.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hullin-Matsuda F, 2007, J LIPID RES, V48, P1997, DOI 10.1194/jlr.M700154-JLR200; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Ledvinova J, 1993, Sb Lek, V94, P137; LEWIS JA, 1973, J CELL SCI, V13, P447; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiners JJ, 2011, FREE RADICAL BIO MED, V50, P281, DOI 10.1016/j.freeradbiomed.2010.11.006; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wortmann S, 2006, MOL GENET METAB, V88, P47, DOI 10.1016/j.ymgme.2006.01.013; Wortmann SB, 2012, J INHERIT METAB DIS, V35, P13, DOI 10.1007/s10545-010-9210-7; Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296	24	137	144	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2012	44	7					797	U231		10.1038/ng.2325	http://dx.doi.org/10.1038/ng.2325			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22683713				2022-12-17	WOS:000305886900015
J	Pannicke, U; Honig, M; Hess, I; Friesen, C; Holzmann, K; Rump, EM; Barth, TF; Rojewski, MT; Schulz, A; Boehm, T; Friedrich, W; Schwarz, K				Pannicke, Ulrich; Hoenig, Manfred; Hess, Isabell; Friesen, Claudia; Holzmann, Karlheinz; Rump, Eva-Maria; Barth, Thomas F.; Rojewski, Markus T.; Schulz, Ansgar; Boehm, Thomas; Friedrich, Wilhelm; Schwarz, Klaus			Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2	NATURE GENETICS			English	Article							CONGENITAL ALEUKOCYTOSIS; THYMIC ALYMPHOPLASIA; CELLS; IMMUNODEFICIENCY; ZEBRAFISH; DISEASES	Human severe combined immunodeficiencies (SCID) are phenotypically and genotypically heterogeneous diseases(1). Reticular dysgenesis is the most severe form of inborn SCID. It is characterized by absence of granulocytes and almost complete deficiency of lymphocytes in peripheral blood, hypoplasia of the thymus and secondary lymphoid organs, and lack of innate and adaptive humoral and cellular immune functions, leading to fatal septicemia within days after birth(2-8). In bone marrow of individuals with reticular dysgenesis, myeloid differentiation is blocked at the promyelocytic stage, whereas erythro- and megakaryocytic maturation is generally normal. These features exclude a defect in hematopoietic stem cells but point to a unique aberration of the myelo-lymphoid lineages. The dramatic clinical course of reticular dysgenesis and its unique hematological phenotype have spurred interest in the unknown genetic basis of this syndrome. Here we show that the gene encoding the mitochondrial energy metabolism enzyme adenylate kinase 2 (AK2) is mutated in individuals with reticular dysgenesis. Knockdown of zebrafish ak2 also leads to aberrant leukocyte development, stressing the evolutionarily conserved role of AK2. Our results provide in vivo evidence for AK2 selectivity in leukocyte differentiation. These observations suggest that reticular dysgenesis is the first example of a human immunodeficiency syndrome that is causally linked to energy metabolism and that can therefore be classified as a mitochondriopathy.	[Pannicke, Ulrich; Hoenig, Manfred; Rojewski, Markus T.; Schwarz, Klaus] Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany; [Hoenig, Manfred; Schulz, Ansgar; Friedrich, Wilhelm] Univ Childrens Hosp Ulm, D-89075 Ulm, Germany; [Hess, Isabell; Boehm, Thomas] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Friesen, Claudia] Univ Hosp, Inst Legal Med, D-89075 Ulm, Germany; [Holzmann, Karlheinz] Univ Hosp Ulm, Chip Facil ZKF, D-89069 Ulm, Germany; [Rump, Eva-Maria; Rojewski, Markus T.; Schwarz, Klaus] German Red Cross Blood Serv Baden Wuerttemberg He, Inst Clin Transfus Med & Immunogenet Ulm, D-89081 Ulm, Germany; [Barth, Thomas F.] Univ Hosp Ulm, Inst Pathol, D-89081 Ulm, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Ulm University; Ulm University	Schwarz, K (corresponding author), Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany.	klaus.schwarz@uni-ulm.de	Pannicke, Ulrich/D-7348-2014	Rojewski, Markus/0000-0003-4265-0442	Deutsche Forschungsgemeinschaft [SFB620]; Max-Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society)	We acknowledge the technical assistance of S. Braun, I. Janz, K. Heinrich, T. Kersten and S. Radecke. We are grateful to M. Schorpp for helpful advice. These studies were supported by the German Red Cross Blood Service Baden-Wuerttemberg-Hessen to K. S., the Deutsche Forschungsgemeinschaft (SFB620) and the Max-Planck Society to T. B.	ALONSO K, 1972, ARCH PATHOL, V94, P179; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; DEVAAL OM, 1959, LANCET, V2, P1123; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Emile JF, 1997, J PATHOL, V183, P70; ESPANOL T, 1979, CLIN EXP IMMUNOL, V38, P615; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; GITLIN D, 1964, PEDIATRICS, V33, P184; HAAS RJ, 1977, ACTA PAEDIATR SCAND, V66, P279, DOI 10.1111/j.1651-2227.1977.tb07894.x; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Muller A, 2007, BIOINFORMATICS, V23, P496, DOI 10.1093/bioinformatics/btl608; OWNBY DR, 1976, J PEDIATR-US, V89, P382, DOI 10.1016/S0022-3476(76)80532-X; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Small TN, 1999, J PEDIATR-US, V135, P387, DOI 10.1016/S0022-3476(99)70141-1; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393	20	137	143	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					101	105		10.1038/ng.265	http://dx.doi.org/10.1038/ng.265			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19043417				2022-12-17	WOS:000262085300023
J	Hashibe, M; Mckay, JD; Curado, MP; Oliveira, JC; Koifman, S; Koifman, R; Zaridze, D; Shangina, O; Wunsch, V; Eluf, J; Levi, JE; Matos, E; Lagiou, P; Lagiou, A; Benhamou, S; Bouchardy, C; Szeszenia-Dabrowska, N; Menezes, A; Dall'Agnol, MM; Merletti, F; Richiardi, L; Fernandez, L; Lence, J; Talamini, R; Barzan, L; Mates, D; Mates, IN; Kjaerheim, K; Macfarlane, GJ; Macfarlane, TV; Simonato, L; Canova, C; Holcatova, I; Agudo, A; Castellsague, X; Lowry, R; Janout, V; Kollarova, H; Conway, DI; McKinney, PA; Znaor, A; Fabianova, E; Bencko, V; Lissowska, J; Chabrier, A; Hung, RJ; Gaborieau, V; Boffetta, P; Brennan, P				Hashibe, Mia; Mckay, James D.; Curado, Maria Paula; Oliveira, Jose Carlos; Koifman, Sergio; Koifman, Rosalina; Zaridze, David; Shangina, Oxana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Levi, Jose Eduardo; Matos, Elena; Lagiou, Pagona; Lagiou, Areti; Benhamou, Simone; Bouchardy, Christine; Szeszenia-Dabrowska, Neonilia; Menezes, Ana; Dall'Agnol, Marinel Mor; Merletti, Franco; Richiardi, Lorenzo; Fernandez, Leticia; Lence, Juan; Talamini, Renato; Barzan, Luigi; Mates, Dana; Mates, Ioan Nicolae; Kjaerheim, Kristina; Macfarlane, Gary J.; Macfarlane, Tatiana V.; Simonato, Lorenzo; Canova, Cristina; Holcatova, Ivana; Agudo, Antonio; Castellsague, Xavier; Lowry, Ray; Janout, Vladimir; Kollarova, Helena; Conway, David I.; McKinney, Patricia A.; Znaor, Ariana; Fabianova, Eleonora; Bencko, Vladimir; Lissowska, Jolanta; Chabrier, Amelie; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Brennan, Paul			Multiple ADH genes are associated with upper aerodigestive cancers	NATURE GENETICS			English	Article							ALCOHOL-DEHYDROGENASE	Alcohol is an important risk factor for upper aerodigestive cancers and is principally metabolized by alcohol dehydrogenase (ADH) enzymes. We have investigated six ADH genetic variants in over 3,800 aerodigestive cancer cases and 5,200 controls from three individual studies. Gene variants rs1229984 (ADH1B) and rs1573496 (ADH7) were significantly protective against aerodigestive cancer in each individual study and overall (P = 10(-10) and 10(-9), respectively). These effects became more apparent with increasing alcohol consumption (P for trend = 0.0002 and 0.065, respectively). Both gene effects were independent of each other, implying that multiple ADH genes may be involved in upper aerodigestive cancer etiology.	[Hashibe, Mia; Mckay, James D.; Curado, Maria Paula; Chabrier, Amelie; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Curado, Maria Paula; Oliveira, Jose Carlos] Hosp Araujo Jorge, Goiania, Go, Brazil; [Curado, Maria Paula; Oliveira, Jose Carlos] Populat Canc Register Goiania, Goiania, Go, Brazil; [Koifman, Sergio; Koifman, Rosalina] Escola Nacl Suade Publ, Rio De Janeiro, Brazil; [Zaridze, David; Shangina, Oxana] Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; [Wuensch-Filho, Victor; Eluf-Neto, Jose; Levi, Jose Eduardo] Univ Sao Paulo, Sao Paulo, Brazil; [Matos, Elena] Univ Buenos Aires, Inst Oncol Angel H Roffo, RA-1053 Buenos Aires, DF, Argentina; [Lagiou, Areti; Benhamou, Simone] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Benhamou, Simone] Inst Natl Sante & Rech Med, U794, Evry, France; [Bouchardy, Christine] Geneva Canc Registry, Geneva, Switzerland; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Lodz, Poland; [Menezes, Ana; Dall'Agnol, Marinel Mor] Univ Fed Pelotas, Pelotas, Brazil; [Merletti, Franco; Richiardi, Lorenzo] CeRMS, Canc Epidemiol Unit, Turin, Italy; [Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Turin, Italy; [Fernandez, Leticia; Lence, Juan] Inst Oncol & Radiobiol, Havana, Cuba; [Talamini, Renato] Aviano Canc Ctr, I-33081 Aviano, Italy; [Barzan, Luigi] Gen Hosp, Pordenone, Italy; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania; [Mates, Ioan Nicolae] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Macfarlane, Gary J.; Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland; [Simonato, Lorenzo; Canova, Cristina] Univ Padua, Padua, Italy; [Holcatova, Ivana; Bencko, Vladimir] Inst Hyg & Epidemiol, CR-10042 Prague, Czech Republic; [Agudo, Antonio; Castellsague, Xavier] Inst Catala Oncol, Barcelona, Spain; [Lowry, Ray] Univ Newcastle, Sch Dent, Newcastle Upon Tyne, Tyne & Wear, England; [Janout, Vladimir; Kollarova, Helena] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [McKinney, Patricia A.] Univ Leeds, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [McKinney, Patricia A.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Znaor, Ariana] Croatian Natl Canc Registry, Zagreb, Croatia; [Fabianova, Eleonora] Specialized State Hlth Inst, Banska Bystrica, Slovakia; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Hung, Rayjean J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	World Health Organization; International Agency for Research on Cancer (IARC); Russian Academy of Medical Sciences; Universidade de Sao Paulo; University of Buenos Aires; Athens Medical School; National & Kapodistrian University of Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; Nofer Institute of Occupational Medicine; Universidade Federal de Pelotas; University of Turin; Carol Davila University of Medicine & Pharmacy; University of Oslo; University of Aberdeen; University of Padua; Catalan Institute of Oncology; Newcastle University - UK; Palacky University Olomouc; University of Glasgow; University of Leeds; NHS National Services Scotland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of California System; University of California Berkeley	Brennan, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	Brennan@iarc.fr	Eluf-Neto, Jose/B-2522-2009; Benhamou, Simone/ABD-2590-2020; Agudo, Antonio/J-1805-2016; Benhamou, Simone/K-6554-2015; Znaor, A/H-6718-2019; Filho, Victor Wunsch/C-4475-2012; Pique, Xavier Castellsagué/N-5795-2014; Boffetta, Paolo/AAI-7767-2021; Mates, Ioan Nicolae/E-9255-2017; Zaridze, David/K-5605-2013; Szeszenia-Dabrowska, Neonila/F-7190-2010; Lissowska, Jolanta/AAH-3252-2020; Janout, Vladimir/M-5133-2014; Menezes, Ana MB/G-7266-2012; Macfarlane, Gary J/I-9521-2014; Bencko, Vladimir/H-8598-2017; Hung, Rayjean J/A-7439-2013; Curado, Maria Paula/M-6200-2013; Holcatova, Ivana/C-8327-2017; richiardi, lorenzo/J-3480-2018	Eluf-Neto, Jose/0000-0001-7504-2115; Agudo, Antonio/0000-0001-9900-5677; Pique, Xavier Castellsagué/0000-0002-0802-3595; Boffetta, Paolo/0000-0002-3811-2791; Lissowska, Jolanta/0000-0003-2695-5799; Menezes, Ana MB/0000-0002-2996-9427; Macfarlane, Gary J/0000-0003-2322-3314; Bencko, Vladimir/0000-0003-1935-2228; Curado, Maria Paula/0000-0001-8172-2483; Holcatova, Ivana/0000-0002-1366-0337; BENHAMOU, Simone/0000-0001-5853-8047; SIMONATO, LORENZO/0000-0002-9914-1000; Kollarova, Helena/0000-0001-6951-6716; Macfarlane, Tatiana/0000-0002-9392-0812; CANOVA, CRISTINA/0000-0001-7027-7935; mates, dana/0000-0002-6219-9807; Kjaerheim, Kristina/0000-0003-0691-3735; Ioan Nicoale, Mates/0000-0001-7210-0615; Conway, David/0000-0001-7762-4063; richiardi, lorenzo/0000-0003-0316-9402; Hung, Rayjean/0000-0002-4486-7496	NCI NIH HHS [R01 CA 092039-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birley AJ, 2008, HUM MOL GENET, V17, P179, DOI 10.1093/hmg/ddm295; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; CARR LG, 1989, ALCOHOL CLIN EXP RES, V13, P594, DOI 10.1111/j.1530-0277.1989.tb00383.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPI-05-0710; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; SMITH M, 1986, ADV HUM GENET, V15, P249	8	137	140	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					707	709		10.1038/ng.151	http://dx.doi.org/10.1038/ng.151			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18500343	Green Published			2022-12-17	WOS:000256212000009
J	Chong, SY; Vickaryous, N; Ashe, A; Zamudio, N; Youngson, N; Hemley, S; Stopka, T; Skoultchi, A; Matthews, J; Scott, HS; de Kretser, D; O'Bryan, M; Blewitt, M; Whitelaw, E				Chong, Suyinn; Vickaryous, Nicola; Ashe, Alyson; Zamudio, Natasha; Youngson, Neil; Hemley, Sarah; Stopka, Tomas; Skoultchi, Arthur; Matthews, Jacqui; Scott, Hamish S.; de Kretser, David; O'Bryan, Moira; Blewitt, Marnie; Whitelaw, Emma			Modifiers of epigenetic reprogramming show paternal effects in the mouse	NATURE GENETICS			English	Article							POSITION EFFECT VARIEGATION; SMALL RNAS; EMBRYONIC-DEVELOPMENT; METHYLATION IMPRINTS; AGOUTI LOCUS; GERM-CELLS; INHERITANCE; GENE; MICE; EXPRESSION	There is increasing evidence that epigenetic information can be inherited across generations in mammals, despite extensive reprogramming both in the gametes and in the early developing embryo. One corollary to this is that disrupting the establishment of epigenetic state in the gametes of a parent, as a result of heterozygosity for mutations in genes involved in reprogramming, could affect the phenotype of offspring that do not inherit the mutant allele. Here we show that such effects do occur following paternal inheritance in the mouse. We detected changes to transcription and chromosome ploidy in adult animals. Paternal effects of this type have not been reported previously in mammals and suggest that the untransmitted genotype of male parents can influence the phenotype of their offspring.	Queensland Inst Med Res, Epigenet Lab, Brisbane, Qld 4006, Australia; Monash Inst Med Res, Clayton, Vic 3168, Australia; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Walter & Eliza Hall Inst Med Res, Div Mol Med, Genet & Bioinformat Div, Melbourne, Vic 3050, Australia	QIMR Berghofer Medical Research Institute; Monash University; University of Sydney; Yeshiva University; Albert Einstein College of Medicine; Walter & Eliza Hall Institute	Whitelaw, E (corresponding author), Queensland Inst Med Res, Epigenet Lab, 300 Herston Rd, Brisbane, Qld 4006, Australia.	emma.whitelaw@qimr.edu.au	Chong, Suyinn/B-6715-2012; Scott, Hamish/B-2122-2009; Stopka, Tomáš/D-5864-2017; O'Bryan, Moira K/F-8256-2012; Blewitt, Marnie/B-1796-2012; Youngson, Neil/AAB-7389-2019	Chong, Suyinn/0000-0001-8062-7281; Scott, Hamish/0000-0002-5813-631X; Stopka, Tomáš/0000-0001-7236-6894; O'Bryan, Moira K/0000-0001-7298-4940; Matthews, Jacqueline/0000-0001-8518-3472; Blewitt, Marnie/0000-0002-2984-1474; hemley, sarah/0000-0003-3064-861X; Youngson, Neil/0000-0003-0690-4580; Zamudio, Natasha/0000-0002-2532-5931	NATIONAL CANCER INSTITUTE [R01CA079057] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA079057] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Cattanach B. M., 1974, Birth defects. Proceedings of the Fourth International Conference, Vienna, Austria, 2-8 September, 1973., P129; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Dean J, 2002, J REPROD IMMUNOL, V53, P171, DOI 10.1016/S0165-0378(01)00100-0; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Fitch KR, 1998, CURR TOP DEV BIOL, V38, P1; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Gurtu VE, 2002, GENETICS, V160, P271; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lazzaro MA, 2001, J NEUROCHEM, V77, P1145, DOI 10.1046/j.1471-4159.2001.00324.x; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; LOCKE J, 1988, GENETICS, V120, P181; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; SZABAD J, 1995, GENETICS, V139, P1585; TAKAGI N, 1990, DEVELOPMENT, V109, P189; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; WOLFF GL, 1978, GENETICS, V88, P529; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079	50	137	139	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					614	622		10.1038/ng2031	http://dx.doi.org/10.1038/ng2031			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17450140	Green Accepted			2022-12-17	WOS:000245971300016
J	Park, YG; Zhao, XH; Lesueur, F; Lowy, DR; Lancaster, M; Pharoah, P; Qian, XL; Hunter, KW				Park, YG; Zhao, XH; Lesueur, F; Lowy, DR; Lancaster, M; Pharoah, P; Qian, XL; Hunter, KW			Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1	NATURE GENETICS			English	Article							GTPASE-ACTIVATING PROTEIN; GENE-EXPRESSION; BREAST-CANCER; MAMMARY-TUMOR; IMPORTANT DETERMINANT; RAP1 ACTIVATION; SUPPRESSOR GENE; MULTIPLE CROSS; NEW-GENERATION; CELL-ADHESION	We previously identified loci in the mouse genome that substantially influence the metastatic efficiency of mammary tumors. Here, we present data supporting the idea that the signal transduction molecule, Sipa1, is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Analysis of candidate genes identified a nonsynonymous amino acid polymorphism in Sipa1 that affects the Sipa1 Rap-GAP function. Spontaneous metastasis assays using cells ectopically expressing Sipa1 or cells with knocked-down Sipa1 expression showed that metastatic capacity was correlated with cellular Sipa1 levels. We examined human expression data and found that they were consistent with the idea that Sipa1 concentration has a role in metastasis. Taken together, these data suggest that the Sipa1 polymorphism is one of the genetic polymorphisms underlying the Mtes1 locus. This report is also the first demonstration, to our knowledge, of a constitutional genetic polymorphism affecting tumor metastasis.	NCI, Lab Populat Genet, Bethesda, MD 20892 USA; Univ Cambridge, Hutchinson MRC Res Ctr, Dept Oncol, Cambridge CB2 2XZ, England; NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Populat Genet, Bldg 41,Room 702,41 Lib Dr, Bethesda, MD 20892 USA.	hunterk@mail.nih.gov	Lesueur, Fabienne/R-2178-2017; Pharoah, Paul/V-6658-2019	Lesueur, Fabienne/0000-0001-7404-4549; Pharoah, Paul/0000-0001-8494-732X	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [Z01 CP010146-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC008905, Z01CP010146] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailly S, 1996, MOL IMMUNOL, V33, P999, DOI 10.1016/S0161-5890(96)00042-9; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bois P, 1998, GENOMICS, V50, P317, DOI 10.1006/geno.1998.5329; Day N, 1999, BRIT J CANCER, V80, P95; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Gao QS, 1999, MOL CELL BIOL, V19, P733; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gould KA, 1996, GENETICS, V144, P1777; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heimann R, 2000, CANCER RES, V60, P298; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; Hogue CWV, 1997, TRENDS BIOCHEM SCI, V22, P314, DOI 10.1016/S0968-0004(97)01093-1; Hunter K, 2003, NAT GENET, V34, P23, DOI 10.1038/ng0503-23b; Hunter KW, 2004, BRIT J CANCER, V90, P752, DOI 10.1038/sj.bjc.6601590; Hunter KW, 2003, CANCER LETT, V200, P97, DOI 10.1016/S0304-3835(03)00420-8; Hunter KW, 2001, CANCER RES, V61, P8866; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; LaTulippe E, 2002, CANCER RES, V62, P4499; Le Voyer T, 2000, MAMM GENOME, V11, P883, DOI 10.1007/s003350010163; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; LIOTTA LA, 1993, PRINCIPLES MOL CELL, P134; Miele ME, 1996, MOL CARCINOGEN, V15, P284, DOI 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G; Nakamura Y, 1998, J HUM GENET, V43, P149, DOI 10.1007/s100380050059; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Park YG, 2002, MAMM GENOME, V13, P289, DOI 10.1007/s00335-001-2151-6; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Sekita N, 2001, JPN J CANCER RES, V92, P947, DOI 10.1111/j.1349-7006.2001.tb01185.x; Seraj MJ, 2000, CANCER RES, V60, P2764; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Snove O, 2004, BIOCHEM BIOPH RES CO, V319, P256, DOI 10.1016/j.bbrc.2004.04.175; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7	49	137	145	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1055	1062		10.1038/ng1635	http://dx.doi.org/10.1038/ng1635			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142231	Green Accepted			2022-12-17	WOS:000232185600016
J	Lee, Y; Lee, Y; Lee, J; Bang, S; Hyun, S; Kang, J; Hong, ST; Bae, E; Kaang, BK; Kim, J				Lee, Y; Lee, Y; Lee, J; Bang, S; Hyun, S; Kang, J; Hong, ST; Bae, E; Kaang, BK; Kim, J			Pyrexia is a new thermal transient receptor potential channel endowing tolerance to high temperatures in Drosophila melanogaster	NATURE GENETICS			English	Article							HEAT-EVOKED ACTIVATION; CAPSAICIN-RECEPTOR; EXPRESSION SYSTEM; TRP CHANNEL; ION-CHANNEL; THERMOSENSATION; IDENTIFICATION; NOCICEPTION; PROTEIN; NEURONS	Several transient receptor potential channels were recently found to be activated by temperature stimuli in vitro(1-1)4. Their physiological and behavioral roles are largely unknown. From a temperature-preference behavior screen of 27, 000 Drosophila melanogaster P-insertion mutants, we isolated a gene, named pyrexia (pyx), encoding a new transient receptor potential channel. Pyx was opened by temperatures above 40 degreesC in Xenopus laevis oocytes and HEK293T cells. It was ubiquitously expressed along the dendrites of a subset of peripheral nervous system neurons and was more permeable to K+ than to Na+. Although some pyx alleles resulted in abnormal temperature preferences, pyx null flies did not have significantly different temperature preferences than wild-type flies. But 60% of pyx null flies were paralyzed within 3 min of exposure to 40 degreesC, whereas only 9% of wild-type flies were paralyzed by the same stimulus. From these findings, we propose that the primary in vivo role of Pyx is to protect flies from high-temperature stress.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Seoul Natl Univ, Div Biol Sci, Seoul 151742, South Korea; Korea Adv Inst Sci & Technol, GenExel Inc, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 373-1 Guseong Dong, Taejon 305701, South Korea.	kjaeseob@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021	Kang, Jongkyun/0000-0003-0259-110X; Lee, Youngseok/0000-0003-0459-1138; Hong, Sung-Tae/0000-0001-5981-4859				Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gilchrist GW, 1999, HEREDITY, V83, P15, DOI 10.1038/sj.hdy.6885330; Guler AD, 2002, J NEUROSCI, V22, P6408; HEIINRICH B, 1993, HOT BLOODED INSECTS; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Lee Y, 2003, J NEUROSCI RES, V73, P255, DOI 10.1002/jnr.10652; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	21	137	147	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					305	310		10.1038/ng1513	http://dx.doi.org/10.1038/ng1513			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731759				2022-12-17	WOS:000227297800023
J	Zhang, Q; Zhao, BH; Li, W; Oiso, N; Novak, EK; Rusiniak, ME; Gautam, R; Chintala, S; O'Brien, EP; Zhang, Y; Roe, BA; Elliott, RW; Eicher, EM; Liang, P; Kratz, C; Legius, E; Spritz, RA; O'Sullivan, TN; Copeland, NG; Jenkins, NA; Swank, RT				Zhang, Q; Zhao, BH; Li, W; Oiso, N; Novak, EK; Rusiniak, ME; Gautam, R; Chintala, S; O'Brien, EP; Zhang, Y; Roe, BA; Elliott, RW; Eicher, EM; Liang, P; Kratz, C; Legius, E; Spritz, RA; O'Sullivan, TN; Copeland, NG; Jenkins, NA; Swank, RT			Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6	NATURE GENETICS			English	Article							STORAGE POOL DEFICIENCY; PALE EAR EP; MUTATIONS; TRAFFICKING; MELANOSOMES; BIOGENESIS; DISORDERS; TRANSPORT; PROTEINS; ADAPTER	Hermansky-Pudlak syndrome (HPS) is a genetically heterogeneous disease involving abnormalities of melanosomes, platelet dense granules and lysosomes. Here we have used positional candidate and transgenic rescue approaches to identify the genes mutated in ruby-eye 2 and ruby-eye mice (ru2 and ru, respectively), two 'mimic' mouse models of HPS. We also show that these genes are orthologs of the genes mutated in individuals with HPS types 5 and 6, respectively, and that their protein products directly interact. Both genes are previously unknown and are found only in higher eukaryotes, and together represent a new class of genes that have evolved in higher organisms to govern the synthesis of highly specialized lysosome-related organelles.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Univ Dusseldorf, Klin Padiat Hamatol & Onkol, D-4000 Dusseldorf, Germany; Univ Ziekenhuizen Leuven, Ctr Human Genet, Louvain, Belgium; Natl Canc Inst, Mouse Canc Genet Program, Frederick, MD USA	Roswell Park Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oklahoma System; University of Oklahoma - Norman; Jackson Laboratory; Roswell Park Cancer Institute; Heinrich Heine University Dusseldorf; KU Leuven; University Hospital Leuven; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Swank, RT (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.		Liang, Ping/S-3790-2018; Legius, Eric/H-1735-2011; Liang, Ping/D-2709-2009; Oiso, Naoki/H-6540-2019; Kratz, Christian/AAC-9726-2021	Liang, Ping/0000-0003-4423-0636; Liang, Ping/0000-0003-4423-0636; Oiso, Naoki/0000-0001-5593-6496; 				Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; CHISSOE SL, 1991, METHODS COMPANION ME, V3; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; DUNN LC, 1945, P NATL ACAD SCI USA, V31, P343, DOI 10.1073/pnas.31.11.343; EICHER EM, 1969, GENETICS, V64, P495; EICHER EM, 1977, MOUSE NEWS LETT, V56, P42; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huizing M, 2001, THROMB HAEMOSTASIS, V86, P233, DOI 10.1055/s-0037-1616221; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lee ST, 1995, MOL CELLS, V5, P668; MEISLER MH, 1984, J HERED, V75, P103, DOI 10.1093/oxfordjournals.jhered.a109881; MOORE KJ, 1990, GENETICS, V125, P421; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; NOVAK EK, 1984, BLOOD, V63, P536; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; NOVAK EK, 1980, BIOCHEM GENET, V18, P549, DOI 10.1007/BF00484401; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; OBRIEN EP, 1994, MAMM GENOME, V5, P356, DOI 10.1007/BF00356554; Oh J, 2000, HUM MOL GENET, V9, P375, DOI 10.1093/hmg/9.3.375; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; RUSSELL LB, 1995, GENETICS, V141, P1547; SILVERS WK, 1979, COAT COLORS MICE MOD, P103; Spritz RA, 1999, CLIN GENET, V55, P309, DOI 10.1034/j.1399-0004.1999.550503.x; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SUZUKI T, IN PRESS P NATL ACAD; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Swank RT, 2000, PIGM CELL RES, V13, P59, DOI 10.1034/j.1600-0749.13.s8.12.x; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wixler V, 1999, FEBS LETT, V445, P351, DOI 10.1016/S0014-5793(99)00151-9; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; [No title captured]	42	137	146	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					145	153		10.1038/ng1087	http://dx.doi.org/10.1038/ng1087			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12548288				2022-12-17	WOS:000180773700011
J	Kazantsev, A; Walker, HA; Slepko, N; Bear, JE; Preisinger, E; Steffan, JS; Zhu, YZ; Gertler, FB; Housman, DE; Marsh, JL; Thompson, LM				Kazantsev, A; Walker, HA; Slepko, N; Bear, JE; Preisinger, E; Steffan, JS; Zhu, YZ; Gertler, FB; Housman, DE; Marsh, JL; Thompson, LM			A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila	NATURE GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; TRANSGENIC MOUSE MODEL; NUCLEAR-LOCALIZATION; PROTEIN AGGREGATION; GLUTAMINE REPEATS; MUTANT HUNTINGTIN; CELL-DEATH; DISEASE; RECRUITMENT; CHAPERONES	Huntington disease is caused by the expansion of a polyglutamine repeat in the Huntingtin protein (Htt) that leads to degeneration of neurons in the central nervous system and the appearance of visible aggregates within neurons. We have developed and tested suppressor polypeptides that bind mutant Htt and interfere with the process of aggregation in cell culture. In a Drosophila model, the most potent suppressor inhibits both adult lethality and photoreceptor neuron degeneration. The appearance of aggregates in photoreceptor neurons correlates strongly with the occurrence of pathology, and expression of suppressor polypeptides delays and limits the appearance of aggregates and protects photoreceptor neurons. These results suggest that targeting the protein interactions leading to aggregate formation may be beneficial for the design and development of therapeutic agents for Huntington disease.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine; University of California System; University of California Irvine	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	lmthomps@uci.edu						Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Bates GP, 1998, BRAIN PATHOL, V8, P699, DOI 10.1111/j.1750-3639.1998.tb00196.x; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 1999, J NEUROSCI, V19, P10338; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; GUSELLA JF, 1995, SEMIN CELL BIOL, V6, P21, DOI 10.1016/1043-4682(95)90011-X; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Kafri T, 2001, CURR OPIN MOL THER, V3, P316; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McGowan DP, 2000, NEUROSCIENCE, V100, P677, DOI 10.1016/S0306-4522(00)00391-2; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; NUDFORA FC, 2001, SCIENCE, V291, P2423; Parkansky N, 1995, SURF COAT TECH, V76, P197, DOI 10.1016/0257-8972(95)02588-X; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sigurdsson EM, 2000, J NEUROPATH EXP NEUR, V59, P11, DOI 10.1093/jnen/59.1.11; SKINNER PJ, IN PRESS NEURO MOL M; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TROJANOWSKI JQ, 2000, NY ACAD SCI, V924, P62; TRUMAN JW, 1993, DEV DROSOPHILA MELAN; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	60	137	142	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2002	30	4					367	376		10.1038/ng864	http://dx.doi.org/10.1038/ng864			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11925563	Green Published			2022-12-17	WOS:000174682000013
J	Gamse, JT; Shen, YC; Thisse, C; Thisse, B; Raymond, PA; Halpern, ME; Liang, JO				Gamse, JT; Shen, YC; Thisse, C; Thisse, B; Raymond, PA; Halpern, ME; Liang, JO			Otx5 regulates genes that show circadian expression in the zebrafish pineal complex	NATURE GENETICS			English	Article							HOMEODOMAIN PROTEIN; XENOPUS-LAEVIS; HOMEOBOX GENE; CLOCK; CRX; CLONING; FOREBRAIN; ANTERIOR; ELEMENT; RETINA	The photoneuroendocrine system translates environmental light conditions into the circadian production of endocrine and neuroendocrine signals. Central to this process is the pineal organ, which has a conserved role in the cyclical synthesis and release of melatonin to influence sleep patterns and seasonal reproduction(1). In lower vertebrates, the pineal organ contains photoreceptors; whose activity entrains an endogenous circadian clock and regulates transcription in pinealocytes(1). in mammals, pineal function is influenced by retinal photoreceptors that project to the suprachiasmatic nucleus-the site of the endogenous circadian clock. A multisynaptic pathway then relays information about circadian rhythmicity and photoperiod to the pineal organ(1). The gene cone rod homeobox (crx), a member of the orthodenticle homeobox (otx) family, is thought to regulate pineal circadian activity. In the mouse, targeted inactivation of Crx causes a reduction in pineal gene expression and attenuated entrainment to light/dark cycles(2). Here we show that crx and otx5 orthologs are expressed in both the pineal organ and the asymmetrically positioned parapineal of larval zebrafish. Circadian gene expression is unaffected by a reduction in Crx expression but is inhibited specifically by depletion of Otx5. Our results indicate that Otx5 rather than Crx regulates genes that show circadian expression in the zebrafish pineal complex.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; ULP CU, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Carnegie Institution for Science; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Halpern, ME (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.			Raymond, Pamela/0000-0003-1083-5530; THISSE, Christine/0000-0002-8684-1681				Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; BORG B, 1983, ACTA ZOOL-STOCKHOLM, V64, P211, DOI 10.1111/j.1463-6395.1983.tb00802.x; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Chuang JC, 1999, MECH DEVELOP, V84, P195, DOI 10.1016/S0925-4773(99)00077-5; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Guillaumond F, 2000, J NEUROCHEM, V75, P1398, DOI 10.1046/j.1471-4159.2000.0751398.x; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Korf H.-W., 1998, Advances in Anatomy Embryology and Cell Biology, V146, P1; Kuroda H, 2000, DEV GROWTH DIFFER, V42, P87; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Liang JO, 2000, DEVELOPMENT, V127, P5101; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Sakamoto K, 1999, NEUROSCI LETT, V261, P101, DOI 10.1016/S0304-3940(99)00008-7; Stenkamp D L, 1998, Mol Vis, V4, P26; Vignali R, 2000, MECH DEVELOP, V96, P3, DOI 10.1016/S0925-4773(00)00367-1; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	137	140	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					117	121		10.1038/ng793	http://dx.doi.org/10.1038/ng793			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753388				2022-12-17	WOS:000173105600025
J	Halford, MM; Armes, J; Buchert, M; Meskenaite, V; Grail, D; Hibbs, ML; Wilks, AF; Farlie, PG; Newgreen, DF; Hovens, CM; Stacker, SA				Halford, MM; Armes, J; Buchert, M; Meskenaite, V; Grail, D; Hibbs, ML; Wilks, AF; Farlie, PG; Newgreen, DF; Hovens, CM; Stacker, SA			Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk	NATURE GENETICS			English	Article							INVERSUS SYNDROME BPES; TYROSINE KINASE FAMILY; BLEPHAROPHIMOSIS; EXPRESSION; PTOSIS; DUPLICATION; SELECTION; DELETION; DOMAINS; TARGETS	Secondary palate formation is a complex process that is frequently disturbed in mammals, resulting in the birth defect cleft palate(1,2). Gene targeting has identified components of cytokine/growth factor signalling systems such as Tgf-alpha/Egfr, Eph receptors B2 and B3 (Ephb2 and Ephb3, respectively), Tgf-beta 2, Tgf-beta 3 and activin-beta A (ref. 3) as regulators of secondary palate development, Here we demonstrate that the mouse orphan receptor 'related to tyrosine kinases' (Ryk) is essential for normal development and morphogenesis of craniofacial structures including the secondary palate. Ryk belongs to a subclass of catalytically inactive, but otherwise distantly related, receptor protein tyrosine kinases(4-6) (RTKs). Mice homozygous for a null allele of Ryk have a distinctive craniofacial appearance, shortened limbs and postnatal mortality due to feeding and respiratory complications associated with a complete cleft of the secondary palate. Consistent with cleft palate phenocopy in Ephb2/Ephb3-deficient mice(7) and the role of a Drosophila melanogaster Ryk orthologue, Derailed, in the transduction of repulsive axon pathfinding cues(8,9), our biochemical data implicate Ryk in signalling mediated by Eph receptors and the cell-junction-associated Af-6 (also known as Afadin), Our findings highlight the importance of signal crosstalk between members of different RTK subfamilies.	Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic, Australia; Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Victorian Breast Canc Res Consortium, E Melbourne, Vic, Australia; Peter MacCallum Canc Inst, Dept Pathol, E Melbourne, Vic, Australia; Royal Melbourne Hosp, Dept Surg, Melbourne, Vic, Australia; Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland; Royal Childrens Hosp, Murdoch Inst, Parkville, Vic 3052, Australia	Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Royal Melbourne Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Stacker, SA (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, POB 2008, Melbourne, Vic, Australia.		Armes, Jane/D-6396-2012; Buchert, Michael/Z-1777-2019; Hibbs, Margaret L/D-7013-2011; Wilks, Andrew F/R-5542-2019	Armes, Jane/0000-0002-2215-0347; Buchert, Michael/0000-0003-2672-0148; Hibbs, Margaret L/0000-0002-3751-6751; Stacker, Steven/0000-0003-4096-9273; Wilks, Andrew F/0000-0002-8554-2399; Hovens, Christopher/0000-0002-0610-1289				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; BOHME B, 1993, ONCOGENE, V82, P857; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CIOSSEK T, 1995, ONCOGENE, V10, P97; FEAR C, 1979, ARCH DIS CHILD, V54, P135, DOI 10.1136/adc.54.2.135; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Francis-West P, 1998, MECH DEVELOP, V75, P3, DOI 10.1016/S0925-4773(98)00082-3; FRYNS JP, 1995, CLIN GENET, V48, P111; FUJITA H, 1992, AM J MED GENET, V44, P434, DOI 10.1002/ajmg.1320440409; Gorlin RJ, 1990, PLAST RECONSTR SURG; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Hockley D, 1998, JAVA REP, V3, P6; HOGAN B, 1994, MANIPULATING MOUSE E; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; ISHIKIRIYAMA S, 1994, AM J MED GENET, V52, P245, DOI 10.1002/ajmg.1320520228; JEWETT T, 1993, AM J MED GENET, V47, P1147, DOI 10.1002/ajmg.1320470802; Kamitori K, 1999, DEV BRAIN RES, V114, P149, DOI 10.1016/S0165-3806(99)00033-4; Katso RM, 1999, MOL CELL BIOL, V19, P6427; Koblizek TI, 1997, EUR J BIOCHEM, V244, P774, DOI 10.1111/j.1432-1033.1997.00774.x; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; ROSENFELD W, 1981, AM J MED GENET, V10, P187, DOI 10.1002/ajmg.1320100212; SALAZAR D, 1979, AM J DIS CHILD, V133, P1006, DOI 10.1001/archpedi.1979.02130100030005; Schneider S, 1999, NAT BIOTECHNOL, V17, P170, DOI 10.1038/6172; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; STACKER SA, 1993, ONCOGENE, V8, P1347; WILLIAMSON RA, 1981, AM J MED GENET, V9, P105, DOI 10.1002/ajmg.1320090204	30	137	142	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					414	418		10.1038/78099	http://dx.doi.org/10.1038/78099			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932185				2022-12-17	WOS:000088615000016
J	Niida, H; Matsumoto, T; Satoh, H; Shiwa, M; Tokutake, Y; Furuichi, Y; Shinkai, Y				Niida, H; Matsumoto, T; Satoh, H; Shiwa, M; Tokutake, Y; Furuichi, Y; Shinkai, Y			Severe growth defect in mouse cells lacking the telomerase RNA component	NATURE GENETICS			English	Article							ELONGATION; SENESCENCE; CANCER; YEAST; DNA	The ribonucleoprotein enzyme telomerase synthesizes telomeric DNA onto chromosome ends(1). Telomere length is maintained, by the presence of telomerase activity, in the vast majority of primary tumours and stem cells(2,3), suggesting that telomere maintenance is essential for cellular immortalization. Recently, the telomerase RNA component in human(4) and mouse(5) (TERC and Terc, respectively), a telomerase-associated protein TEP1/TLP1 (refs 6,7) and the human catalytic subunit protein TERT (refs 8,9) have been identified. To examine the role of telomerase in telomere maintenance and cellular viability, we established Terc-deficient embryonic stem (ES) cells. It is known that telomerase activity is absent in cells from Terc-knockout mice(10). Although the study showed that telomere shortening was observed in the Terc-deficient cells from first to six generation animals, whether telomerase-dependent telomere maintenance was essential for cellular viability remained to be elucidated. To address this issue, we examined Terc-deficient ES cells under long-term culture conditions. Accompanying the continual telomere shortening, the growth rate of Terc-deficient ES cells was gradually reduced after more than 300 divisions. An impaired growth rate was maintained to approximately 450 divisions, and then cell growth virtually stopped. These data clearly show that telomerase-dependent telomere maintenance is critical for the growth of mammalian cells.	Nippon Roche Res Ctr, Kamakura, Kanagawa 2478530, Japan; Agene Res Inst, Kamakura, Kanagawa 2478530, Japan	Roche Holding	Shinkai, Y (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto 6068397, Japan.		Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484				BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; RADIC MZ, 1987, CELL, V50, P1101, DOI 10.1016/0092-8674(87)90176-0; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	27	137	144	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					203	206		10.1038/580	http://dx.doi.org/10.1038/580			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620783				2022-12-17	WOS:000073865100034
J	Mortlock, DP; Post, LC; Innis, JW				Mortlock, DP; Post, LC; Innis, JW			The molecular basis of hypodactyly (Hd): A deletion in Hoxa13 leads to arrest of digital arch formation	NATURE GENETICS			English	Article							AUG INITIATOR CODON; LIMB; GENE; MICE; TRANSLATION; CARTILAGE; HOXD-13; MODEL	Hypodactyly (Hd) is a semidominant mutation in mice that maps in a genetic interval overlapping the Hoxa cluster. The profound deficiency of digital arch structures in Hd/Hd mice is consistent with a defect in a gene activated late in limb morphogenesis. We have determined the structure of the Hoxa13 gene and describe a 50-base pair deletion in the first exon of the Hd allele that probably arose from unequal recombination or misalignment between triplet repeats. It is predicted that no Hoxa13 protein is made from Hd mRNA. The hypodactyly limb phenotype is similar to that of Hoxd13-deficient mice in sharing defects along multiple axes and alterations in cartilage maturation; however, the overall effects on digital arch formation are more severe in Hd/Hd mice. Our results confirm the critical role of AbdB-like Hox genes in the development of the autopod, and add to the spectrum of mutations involving triplet repeats.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Morlock, Doug/C-3482-2012; Mortlock, Douglas P/C-9981-2010					Ausubel FM., 2006, ENZYMATIC MANIPULATI; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DOVER G, 1995, NAT GENET, V10, P254, DOI 10.1038/ng0795-254; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; FAVIER B, 1995, P NATL ACAD SCI USA, V92, P310, DOI 10.1073/pnas.92.1.310; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; HALAL F, 1988, AM J MED GENET, V30, P793, DOI 10.1002/ajmg.1320300312; HAN K, 1993, GENE DEV, V7, P492; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; HUMMEL KP, 1970, J HERED, V61, P219, DOI 10.1093/oxfordjournals.jhered.a108088; Innis JW, 1996, MAMM GENOME, V7, P216, DOI 10.1007/s003359900058; Innis JW, 1996, MAMM GENOME, V7, P2, DOI 10.1007/s003359900002; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; Lupski JR, 1996, AM J HUM GENET, V58, P21; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; MORGAN BA, 1994, DEVELOPMENT, P181; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; OSTER GF, 1985, J EMBRYOL EXP MORPH, V89, P93; POZNANSKI AK, 1970, RADIOLOGY, V95, P129, DOI 10.1148/95.1.129; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; REDLINE RW, 1994, LAB INVEST, V71, P663; REDLINE RW, 1992, LAB INVEST, V66, P659; RILI FM, 1995, P NATL ACAD SCI USA, V92, P8185; ROBERTS DJ, 1994, AM J HUM GENET, V55, P1; ROGINA B, 1993, NUCLEIC ACIDS RES, V21, P1316, DOI 10.1093/nar/21.5.1316; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SHUBIN NH, 1986, EVOL BIOL, V20, P319; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; STERN AM, 1970, J PEDIATR-US, V77, P109, DOI 10.1016/S0022-3476(70)80052-X; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; VALDES JM, 1993, HUM MOL GENET, V2, P633, DOI 10.1093/hmg/2.6.633; VANDERHOEVEN F, 1995, X87752 GENB; YOKOUCHI Y, 1995, DEV BIOL, V169, P76, DOI 10.1006/dbio.1995.1128; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0	52	137	141	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					284	289		10.1038/ng0796-284	http://dx.doi.org/10.1038/ng0796-284			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673126				2022-12-17	WOS:A1996UU28300015
J	Heyne, HO; Singh, T; Stamberger, H; Abou Jamra, R; Caglayan, H; Craiu, D; De Jonghe, P; Guerrini, R; Helbig, KL; Koeleman, BPC; Kosmicki, JA; Linnankivi, T; May, P; Muhle, H; Moller, RS; Neubauer, BA; Palotie, A; Pendziwiat, M; Striano, P; Tang, S; Wu, ST; Poduri, A; Weber, YG; Weckhuysen, S; Sisodiya, SM; Daly, MJ; Helbig, I; Lal, D; Lemke, JR				Heyne, Henrike O.; Singh, Tarjinder; Stamberger, Hannah; Abou Jamra, Rami; Caglayan, Hande; Craiu, Dana; De Jonghe, Peter; Guerrini, Renzo; Helbig, Katherine L.; Koeleman, Bobby P. C.; Kosmicki, Jack A.; Linnankivi, Tarja; May, Patrick; Muhle, Hiltrud; Moller, Rikke S.; Neubauer, Bernd A.; Palotie, Aarno; Pendziwiat, Manuela; Striano, Pasquale; Tang, Sha; Wu, Sitao; Poduri, Annapurna; Weber, Yvonne G.; Weckhuysen, Sarah; Sisodiya, Sanjay M.; Daly, Mark J.; Helbig, Ingo; Lal, Dennis; Lemke, Johannes R.		EuroEPINOMICS RES Consortium	De novo variants in neurodevelopmental disorders with epilepsy	NATURE GENETICS			English	Article							AUTISM SPECTRUM DISORDER; KCNQ2 ENCEPHALOPATHY; INTELLECTUAL DISABILITIES; SEQUENCE VARIANTS; ILAE COMMISSION; MUTATIONS; CLASSIFICATION; PREVALENCE; GUIDELINES; PHENOTYPES	Epilepsy is a frequent feature of neurodevelopmental disorders (NDDs), but little is known about genetic differences between NDDs with and without epilepsy. We analyzed de novo variants (DNVs) in 6,753 parent-offspring trios ascertained to have different NDDs. In the subset of 1,942 individuals with NDDs with epilepsy, we identified 33 genes with a significant excess of DNVs, of which SNAP25 and GABRB2 had previously only limited evidence of disease association. Joint analysis of all individuals with NDDs also implicated CACNA1E as a novel disease-associated gene. Comparing NDDs with and without epilepsy, we found missense DNVs, DNVs in specific genes, age of recruitment, and severity of intellectual disability to be associated with epilepsy. We further demonstrate the extent to which our results affect current genetic testing as well as treatment, emphasizing the benefit of accurate genetic diagnosis in NDDs with epilepsy.	[Heyne, Henrike O.; Abou Jamra, Rami; Lemke, Johannes R.] Univ Leipzig Hosp & Clin, Leipzig, Germany; [Heyne, Henrike O.; Singh, Tarjinder; Kosmicki, Jack A.; Palotie, Aarno; Daly, Mark J.; Lal, Dennis] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Heyne, Henrike O.; Singh, Tarjinder; Kosmicki, Jack A.; Palotie, Aarno; Daly, Mark J.; Lal, Dennis] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Heyne, Henrike O.] Univ Leipzig Hosp & Clin, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Heyne, Henrike O.; Singh, Tarjinder; Kosmicki, Jack A.; Daly, Mark J.; Lal, Dennis] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Stamberger, Hannah; De Jonghe, Peter; Weckhuysen, Sarah] VIB, Neurogenet Grp, Ctr Mol Neurol, Antwerp, Belgium; [Stamberger, Hannah; De Jonghe, Peter; Weckhuysen, Sarah] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, Antwerp, Belgium; [Stamberger, Hannah; De Jonghe, Peter; Weckhuysen, Sarah] Univ Hosp Antwerp, Div Neurol, Antwerp, Belgium; [Caglayan, Hande] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Craiu, Dana] Carol Davila Univ Med Bucharest, Alexandru Obregia Hosp, Dept Clin Neurosci 6, Pediat Neurol Clin, Bucharest, Romania; [Guerrini, Renzo] Univ Florence, Pediat Neurol & Neurogenet Unit & Labs, A Meyer Childrens Hosp, Florence, Italy; [Helbig, Katherine L.; Helbig, Ingo] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Linnankivi, Tarja] Univ Helsinki, Childrens Hosp, Dept Pediat Neurol, Helsinki, Finland; [Linnankivi, Tarja] Helsinki Univ Hosp, Helsinki, Finland; [May, Patrick] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Muhle, Hiltrud; Pendziwiat, Manuela; Helbig, Ingo] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Moller, Rikke S.] Danish Epilepsy Ctr, Dianalund, Denmark; [Moller, Rikke S.] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark; [Neubauer, Bernd A.] Univ Hosp Giessen, Dept Pediat Neurol, Giessen, Germany; [Striano, Pasquale] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Mat & Ch, Pediat Neurol & Muscular Dis Unit, G Gaslini Inst, Genoa, Italy; [Tang, Sha; Wu, Sitao] Ambry Genet, Div Clin Genom, Aliso Viejo, CA USA; [Poduri, Annapurna] Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol, Dept Neurol, Epilepsy Genet Program, Boston, MA USA; [Weber, Yvonne G.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Sisodiya, Sanjay M.] Univ Coll London Hosp, UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR,Biomed Res Ctr, London, England; [Sisodiya, Sanjay M.] Epilepsy Soc, Chalfont St Peter Bucks, England; [Lal, Dennis] Cologne Ctr Genom CCG, Cologne, Germany	Leipzig University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leipzig University; Harvard University; Massachusetts General Hospital; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Bogazici University; Carol Davila University of Medicine & Pharmacy; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utrecht University; Utrecht University Medical Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Luxembourg; University of Kiel; Schleswig Holstein University Hospital; University of Southern Denmark; University Hospital of Giessen & Marburg; University of Genoa; IRCCS Istituto Giannina Gaslini; Harvard University; Boston Children's Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London; German Sport University Cologne; University of Cologne	Heyne, HO (corresponding author), Univ Leipzig Hosp & Clin, Leipzig, Germany.; Heyne, HO (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Heyne, HO (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Heyne, HO (corresponding author), Univ Leipzig Hosp & Clin, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany.; Heyne, HO (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	hheyne@broadinstitute.org; johannes.lemke@medizin.uni-leipzig.de	Marini, Carla/AAC-2413-2022; Helbig, Ingo/G-8467-2018; Caglayan, Hande S/A-2368-2016; May, Patrick/B-1238-2010; Craiu, Dana/ABE-4886-2020; Daly, Mark J/B-2453-2017; May, Patrick/N-1019-2019; Craiu, Dana/ABC-2986-2020; Neubauer, Bernd/AAZ-9391-2020; Stamberger, Hannah/ABD-1814-2020; Abou Jamra, Rami/AAC-8192-2019; Striano, Pasquale/F-9117-2014; Muhle, Hiltrud/F-5715-2010; Weckhuysen, Sarah/HGB-9957-2022; Helbig, Katherine/B-7454-2012	Marini, Carla/0000-0002-9212-2691; Helbig, Ingo/0000-0001-8486-0558; Caglayan, Hande S/0000-0001-6402-3306; May, Patrick/0000-0001-8698-3770; Daly, Mark J/0000-0002-0949-8752; May, Patrick/0000-0001-8698-3770; Abou Jamra, Rami/0000-0002-1542-1399; Striano, Pasquale/0000-0002-6065-1476; Weckhuysen, Sarah/0000-0003-2878-1147; Palotie, Aarno/0000-0002-2527-5874; Guerrini, Renzo/0000-0002-7272-7079; Moller, Rikke S./0000-0002-9664-1448; Hoffman-Zacharska, Dorota/0000-0001-7367-512X; Singh, Tarjinder/0000-0003-0601-6815; Selmer, Kaja Kristine/0000-0003-4871-112X; Linnankivi, Tarja/0000-0001-9190-2218; Helbig, Katherine/0000-0001-8249-0549; Stamberger, Hannah/0000-0001-8308-9511; Korff, Christian/0000-0002-3328-7680; Heyne, Henrike/0000-0001-9893-3850; Serratosa, Jose/0000-0003-2239-8948	Eurocores program EuroEPINOMICS; Fund for Scientific Research Flanders (FWO); International Coordination Action (ICA) [G0E8614N]; University of Antwerp; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1501]; German Research Foundation (DFG) [HE7987/1-1]; Fund for Scientific Research Flanders [1125416N]; DFG [WE4896/3-1, HE5415/6-1]; EU Seventh Framework Programme (FP7) under the project DESIRE grant [N602531]; Wellcome Trust [HICF-1009-003]; Department of Health [HICF-1009-003]; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; MRC [MR/J011231/1] Funding Source: UKRI	Eurocores program EuroEPINOMICS; Fund for Scientific Research Flanders (FWO)(FWO); International Coordination Action (ICA); University of Antwerp; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Fund for Scientific Research Flanders(FWO); DFG(German Research Foundation (DFG)); EU Seventh Framework Programme (FP7) under the project DESIRE grant; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all patients and their families who participated in this study, as well as the teams who were involved in recruiting patients and gathering samples and data at the respective study sites. We thank L. Vissers and C. Gilissen for epilepsy and age phenotypes from the cohort of Lelieveld et al.<SUP>23</SUP> and J. McRae for useful discussions on the DDD cohort<SUP>7</SUP>. We are grateful to members of the ATGU and the Institute for Human Genetics in Leipzig for insightful discussions. We thank J. Krause for support in figure design and helpful conversations. This work was supported by the Eurocores program EuroEPINOMICS, the Fund for Scientific Research Flanders (FWO), International Coordination Action (ICA) grant G0E8614N, and the University of Antwerp (research fund). H.O.H. was supported by stipends from the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1501 and the German Research Foundation (DFG): HE7987/1-1. H.S. was supported as a PhD fellow of the Fund for Scientific Research Flanders (1125416N). I.H. and Y.G.W. were supported by DFG grants WE4896/3-1 and HE5415/6-1. R.G. received funding through the EU Seventh Framework Programme (FP7) under the project DESIRE grant N602531. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.	Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Berg Anne T, 2013, Continuum (Minneap Minn), V19, P571, DOI 10.1212/01.CON.0000431377.44312.9e; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blanchard MG, 2015, J MED GENET, V52, P330, DOI 10.1136/jmedgenet-2014-102813; Chambers C, 2016, J GENET COUNS, V25, P213, DOI 10.1007/s10897-015-9906-9; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Haynes WA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19333-x; Helbig I, 2016, MOL SYNDROMOL, V7, P172, DOI 10.1159/000448530; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Howell KB, 2016, EPILEPSIA, V57, P343, DOI 10.1111/epi.13306; Huppke P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00932-7; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Li JC, 2016, MOL PSYCHIATR, V21, P290, DOI 10.1038/mp.2015.40; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; McGrother CW, 2006, SEIZURE-EUR J EPILEP, V15, P376, DOI 10.1016/j.seizure.2006.04.002; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Millichap JJ, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000096; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; OCEBM Levels of Evidence Working Group, 2009, OXF LEV EV; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Singh T, 2017, NAT GENET, V49, P1167, DOI 10.1038/ng.3903; Stamberger H, 2016, NEUROLOGY, V86, P954, DOI 10.1212/WNL.0000000000002457; Thomas S, 2017, J AUTISM DEV DISORD, V47, P224, DOI 10.1007/s10803-016-2938-7; Trujillano D, 2017, EUR J HUM GENET, V25, P176, DOI 10.1038/ejhg.2016.146; Trump N, 2016, J MED GENET, V53, P310, DOI 10.1136/jmedgenet-2015-103263; Wagnon JL, 2016, ANN CLIN TRANSL NEUR, V3, P114, DOI 10.1002/acn3.276; Ware J. S., 2015, CURR PROTOC HUM GENE, V87; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wolff M, 2017, BRAIN, V140, P1316, DOI 10.1093/brain/awx054; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	51	136	138	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					1048	+		10.1038/s41588-018-0143-7	http://dx.doi.org/10.1038/s41588-018-0143-7			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	29942082	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000437224400020
J	Gibson, WJ; Hoivik, EA; Halle, MK; Taylor-Weiner, A; Cherniack, AD; Berg, A; Holst, F; Zack, TI; Werner, HMJ; Staby, KM; Rosenberg, M; Stefansson, IM; Kusonmano, K; Chevalier, A; Mauland, KK; Trovik, J; Krakstad, C; Giannakis, M; Hodis, E; Woie, K; Bjorge, L; Vintermyr, OK; Wala, JA; Lawrence, MS; Getz, G; Carter, SL; Beroukhim, R; Salvesen, HB				Gibson, William J.; Hoivik, Erling A.; Halle, Mari K.; Taylor-Weiner, Amaro; Cherniack, Andrew D.; Berg, Anna; Holst, Frederik; Zack, Travis I.; Werner, Henrica M. J.; Staby, Kjersti M.; Rosenberg, Mara; Stefansson, Ingunn M.; Kusonmano, Kanthida; Chevalier, Aaron; Mauland, Karen K.; Trovik, Jone; Krakstad, Camilla; Giannakis, Marios; Hodis, Eran; Woie, Kathrine; Bjorge, Line; Vintermyr, Olav K.; Wala, Jeremiah A.; Lawrence, Michael S.; Getz, Gad; Carter, Scott L.; Beroukhim, Rameen; Salvesen, Helga B.			The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; PANCREATIC-CANCER; MUTATIONS; HYPERPLASIA; THERAPY; REVEALS; ARID1A; ADENOCARCINOMA; INSTABILITY	Recent studies have detailed the genomic landscape of primary endometrial cancers, but the evolution of these cancers into metastases has not been characterized. We performed whole-exome sequencing of 98 tumor biopsies including complex atypical hyperplasias, primary tumors and paired abdominopelvic metastases to survey the evolutionary landscape of endometrial cancer. We expanded and reanalyzed The Cancer Genome Atlas ( TCGA) data, identifying new recurrent alterations in primary tumors, including mutations in the estrogen receptor cofactor gene NRIP1 in 12% of patients. We found that likely driver events were present in both primary and metastatic tissue samples, with notable exceptions such as ARID1A mutations. Phylogenetic analyses indicated that the sampled metastases typically arose from a common ancestral subclone that was not detected in the primary tumor biopsy. These data demonstrate extensive genetic heterogeneity in endometrial cancers and relative homogeneity across metastatic sites.	[Gibson, William J.; Taylor-Weiner, Amaro; Cherniack, Andrew D.; Holst, Frederik; Zack, Travis I.; Rosenberg, Mara; Chevalier, Aaron; Giannakis, Marios; Hodis, Eran; Wala, Jeremiah A.; Lawrence, Michael S.; Getz, Gad; Carter, Scott L.; Beroukhim, Rameen] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Gibson, William J.; Holst, Frederik; Zack, Travis I.; Wala, Jeremiah A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gibson, William J.; Zack, Travis I.; Giannakis, Marios; Hodis, Eran; Wala, Jeremiah A.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gibson, William J.; Zack, Travis I.; Hodis, Eran; Wala, Jeremiah A.; Beroukhim, Rameen] Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Hoivik, Erling A.; Halle, Mari K.; Berg, Anna; Holst, Frederik; Werner, Henrica M. J.; Mauland, Karen K.; Trovik, Jone; Woie, Kathrine; Bjorge, Line; Salvesen, Helga B.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Hoivik, Erling A.; Halle, Mari K.; Berg, Anna; Holst, Frederik; Werner, Henrica M. J.; Kusonmano, Kanthida; Mauland, Karen K.; Trovik, Jone; Krakstad, Camilla; Bjorge, Line; Salvesen, Helga B.] Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway; [Staby, Kjersti M.; Stefansson, Ingunn M.; Vintermyr, Olav K.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Stefansson, Ingunn M.; Vintermyr, Olav K.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Kusonmano, Kanthida] Univ Bergen, Computat Biol Unit, Bergen, Norway; [Krakstad, Camilla] Univ Bergen, Dept Biomed, Bergen, Norway; [Carter, Scott L.] Brigham & Womens Hosp, Broad Inst, Dana Farber Canc Inst, Joint Ctr Canc Precis Med, 75 Francis St, Boston, MA 02115 USA; [Carter, Scott L.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Carter, Scott L.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kusonmano, Kanthida] King Mongkuts Univ Technol, Bioinformat & Syst Biol Program, Computat Biol Unit, Sch Bioresources & Technol, Bangkok, Thailand	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; King Mongkuts University of Technology North Bangkok; King Mongkuts University of Technology Thonburi	Carter, SL; Beroukhim, R (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA.; Hoivik, EA (corresponding author), Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway.; Hoivik, EA (corresponding author), Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway.; Carter, SL (corresponding author), Brigham & Womens Hosp, Broad Inst, Dana Farber Canc Inst, Joint Ctr Canc Precis Med, 75 Francis St, Boston, MA 02115 USA.; Carter, SL (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Carter, SL (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	erling.hoivik@uib.no; scarter@broadinstitute.org; rameen_beroukhim@dfci.harvard.edu	Holst, Frederik/H-3149-2019; Krakstad, Camilla/AAB-5138-2020; Giannakis, Marios/Z-4908-2019; Cherniack, Andrew D./AAY-8132-2020; Halle, Mari K/AAT-4856-2020; Bjorge, Line/AAD-6179-2021; Lawrence, Michael/AAC-8202-2020; Bjorge, Line/C-1307-2017; Kusonmano, Kanthida/AAQ-2802-2020; salvesen, Helga B/C-1187-2017; Cherniack, Andrew/AAC-5310-2019; Werner, henrica/ABG-1235-2021	Holst, Frederik/0000-0002-5928-2175; Krakstad, Camilla/0000-0002-0174-8139; Cherniack, Andrew D./0000-0003-0470-0111; Bjorge, Line/0000-0002-0240-2770; Bjorge, Line/0000-0002-0240-2770; salvesen, Helga B/0000-0002-4438-8831; Werner, henrica/0000-0001-5186-8369; Rosenberg, Mara/0000-0001-6400-3161; Halle, Mari K/0000-0002-2660-8271	Research Council of Norway; Norwegian Cancer Society, Helse Vest; University of Bergen; Bergen Research Foundation; National Institutes of Health [T32GM007753, 5R01CA188228, 1F30CA192725]; Novartis Institutes for Biomedical Research; NATIONAL CANCER INSTITUTE [R01CA188228, F30CA192725] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society, Helse Vest; University of Bergen; Bergen Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Valen, B. Edvardsen, K. Madissoo, R. Kopperud and B. Nordanger for excellent technical assistance. This study was supported by the Research Council of Norway, the Norwegian Cancer Society, Helse Vest, the University of Bergen, the Bergen Research Foundation, the National Institutes of Health (award numbers T32GM007753, 5R01CA188228 and 1F30CA192725) and the Novartis Institutes for Biomedical Research.	Abedalthagafi MS, 2015, CANCER GENET-NY, V208, P345, DOI 10.1016/j.cancergen.2015.03.005; Berg A, 2015, ONCOTARGET, V6, P1327, DOI 10.18632/oncotarget.2675; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hayes MP, 2006, CLIN CANCER RES, V12, P5932, DOI 10.1158/1078-0432.CCR-06-1375; Hong B, 2015, CURR OPIN GENET DEV, V30, P25, DOI 10.1016/j.gde.2014.12.004; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Novetsky AP, 2013, GYNECOL ONCOL, V128, P470, DOI 10.1016/j.ygyno.2012.10.026; Ren Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03042; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Rosell M, 2014, CANCER RES, V74, P5469, DOI 10.1158/0008-5472.CAN-13-3429; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Torres-Martin M, 2015, CANCER GENET-NY, V208, P327, DOI 10.1016/j.cancergen.2015.03.012; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Veeraraghavan J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5577; Werner HMJ, 2013, MODERN PATHOL, V26, P428, DOI 10.1038/modpathol.2012.174; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wik E, 2014, GYNECOL ONCOL, V134, P599, DOI 10.1016/j.ygyno.2014.06.026; WOODRUFF JD, 1994, AM J OBSTET GYNECOL, V170, P1213; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110; Zhu S, 2011, THEOR POPUL BIOL, V79, P220, DOI 10.1016/j.tpb.2011.03.002	53	136	141	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					848	+		10.1038/ng.3602	http://dx.doi.org/10.1038/ng.3602			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27348297	Green Submitted, Green Accepted			2022-12-17	WOS:000380755100007
J	Petrini, I; Meltzer, PS; Kim, IK; Lucchi, M; Park, KS; Fontanini, G; Gao, J; Zucali, PA; Calabrese, F; Favaretto, A; Rea, F; Rodriguez-Canales, J; Walker, RL; Pineda, M; Zhu, YLJ; Lau, C; Killian, KJ; Bilke, S; Voeller, D; Dakshanamurthy, S; Wang, YS; Giaccone, G				Petrini, Iacopo; Meltzer, Paul S.; Kim, In-Kyu; Lucchi, Marco; Park, Kang-Seo; Fontanini, Gabriella; Gao, James; Zucali, Paolo A.; Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico; Rodriguez-Canales, Jaime; Walker, Robert L.; Pineda, Marbin; Zhu, Yuelin J.; Lau, Christopher; Killian, Keith J.; Bilke, Sven; Voeller, Donna; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe			A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors	NATURE GENETICS			English	Article							FACTOR TFII-I; CELL-CYCLE; GENOME; BIOCHEMISTRY; MANAGEMENT; BIOLOGY; PROTEIN; GENES; KIT	We analyzed 28 thymic epithelial tumors (TETs) using next-generation sequencing and identified a missense mutation (chromosome 7 c.74146970T>A) in GTF2I at high frequency in type A thymomas, a relatively indolent subtype. In a series of 274 TETs, we detected the GTF2I mutation in 82% of type A and 74% of type AB thymomas but rarely in the aggressive subtypes, where recurrent mutations of known cancer genes have been identified. Therefore, GTF2I mutation correlated with better survival. GTF2I beta and delta isoforms were expressed in TETs, and both mutant isoforms were able to stimulate cell proliferation in vitro. Thymic carcinomas carried a higher number of mutations than thymomas (average of 43.5 and 18.4, respectively). Notably, we identified recurrent mutations of known cancer genes, including TP53, CYLD, CDKN2A, BAP1 and PBRM1, in thymic carcinomas. These findings will complement the diagnostic assessment of these tumors and also facilitate development of a molecular classification and assessment of prognosis and treatment strategies.	[Petrini, Iacopo; Gao, James; Voeller, Donna; Wang, Yisong; Giaccone, Giuseppe] NCI, Med Oncol Branch, Bethesda, MD 20892 USA; [Meltzer, Paul S.; Walker, Robert L.; Pineda, Marbin; Zhu, Yuelin J.; Lau, Christopher; Killian, Keith J.; Bilke, Sven] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kim, In-Kyu; Park, Kang-Seo; Dakshanamurthy, Sivanesan; Wang, Yisong; Giaccone, Giuseppe] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Lucchi, Marco; Fontanini, Gabriella] Pisa Univ Hosp, Pisa, Italy; [Zucali, Paolo A.] Humanitas Clin & Res Ctr, Milan, Italy; [Calabrese, Fiorella; Favaretto, Adolfo; Rea, Federico] Padua Univ Hosp, Padua, Italy; [Rodriguez-Canales, Jaime] NCI, Pathol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Padua; Azienda Ospedaliera - Universita di Padova; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giaccone, G (corresponding author), NCI, Med Oncol Branch, Bethesda, MD 20892 USA.	gg496@georgetown.edu	Giaccone, Giuseppe/E-8297-2017; Petrini, Iacopo/P-9318-2019; Zhu, Yuelin/ABD-5743-2021; Zucali, Paolo/AAC-9757-2020; , sivanesan/CAF-4258-2022; Fontanini, Gabriella/O-7636-2015; Petrini, Iacopo/K-7316-2016; Lucchi, Marco/K-2140-2019	Giaccone, Giuseppe/0000-0002-5023-7562; Petrini, Iacopo/0000-0002-7752-6866; Zhu, Yuelin/0000-0003-2762-0755; , sivanesan/0000-0003-3681-4121; Fontanini, Gabriella/0000-0003-1957-2052; Petrini, Iacopo/0000-0002-7752-6866; LUCCHI, MARCO/0000-0001-9909-6820; Kim, In-Kyu/0000-0002-8427-8311; Favaretto, Adolfo/0000-0001-8175-7467; Zucali, Paolo/0000-0002-2274-1702; Walker, Robert/0000-0001-8235-4686	US National Institutes of Health National Cancer Institute; Georgetown University Lombardi Cancer Center; NATIONAL CANCER INSTITUTE [P30CA051008, ZIABC011091, ZIABC010453, ZICBC011040] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgetown University Lombardi Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a US National Institutes of Health National Cancer Institute intramural program and the Georgetown University Lombardi Cancer Center. We thank A. Proietti for her help in reviewing pathology slides.	Arbajian E, 2013, GENE CHROMOSOME CANC, V52, P330, DOI 10.1002/gcc.22033; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Doi-Katayama Y, 2007, PROTEIN SCI, V16, P1788, DOI 10.1110/ps.072792007; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Girard N, 2009, J THORAC ONCOL, V4, P119, DOI 10.1097/JTO.0b013e31818e105c; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Okumura M, 2008, GEN THORAC CARDIOVAS, V56, P143, DOI 10.1007/s11748-007-0185-8; Petrim I, 2010, J THORAC ONCOL, V5, P1447, DOI 10.1097/JTO.0b013e3181e96e30; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Strobel P, 2004, NEW ENGL J MED, V350, P2625, DOI 10.1056/NEJM200406173502523; Travis WD., 2004, TRAVIS WB WHO CLASSI; Verghese ET, 2008, HISTOPATHOLOGY, V53, P218, DOI 10.1111/j.1365-2559.2008.03088.x; Zucali PA, 2013, LUNG CANCER, V79, P236, DOI 10.1016/j.lungcan.2012.11.015	23	136	139	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					844	849		10.1038/ng.3016	http://dx.doi.org/10.1038/ng.3016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	24974848	Green Accepted			2022-12-17	WOS:000339704400012
J	Falk, MJ; Zhang, Q; Nakamaru-Ogiso, E; Kannabiran, C; Fonseca-Kelly, Z; Chakarova, C; Audo, I; Mackay, DS; Zeitz, C; Borman, AD; Staniszewska, M; Shukla, R; Palavalli, L; Mohand-Said, S; Waseem, NH; Jalali, S; Perin, JC; Place, E; Ostrovsky, J; Xiao, R; Bhattacharya, SS; Consugar, M; Webster, AR; Sahel, JA; Moore, AT; Berson, EL; Liu, Q; Gai, XW; Pierce, EA				Falk, Marni J.; Zhang, Qi; Nakamaru-Ogiso, Eiko; Kannabiran, Chitra; Fonseca-Kelly, Zoe; Chakarova, Christina; Audo, Isabelle; Mackay, Donna S.; Zeitz, Christina; Borman, Arundhati Dev; Staniszewska, Magdalena; Shukla, Rachna; Palavalli, Lakshmi; Mohand-Said, Saddek; Waseem, Naushin H.; Jalali, Subhadra; Perin, Juan C.; Place, Emily; Ostrovsky, Julian; Xiao, Rui; Bhattacharya, Shomi S.; Consugar, Mark; Webster, Andrew R.; Sahel, Jose-Alain; Moore, Anthony T.; Berson, Eliot L.; Liu, Qin; Gai, Xiaowu; Pierce, Eric A.			NMNAT1 mutations cause Leber congenital amaurosis	NATURE GENETICS			English	Article							GENE-THERAPY; WALLERIAN DEGENERATION; SUBCELLULAR COMPARTMENTATION; RETINITIS-PIGMENTOSA; PROTEIN; DISEASE; WLD(S); IDENTIFICATION; NICOTINAMIDE; DYSTROPHIES	Leber congenital amaurosis (LCA) is an infantile-onset form of inherited retinal degeneration characterized by severe vision loss(1,2). Two-thirds of LCA cases are caused by mutations in 17 known disease-associated genes(3) (Retinal Information Network (RetNet)). Using exome sequencing we identified a homozygous missense mutation (c.25G> A, p.Val9Met) in NMNAT1 that is likely to be disease causing in two siblings of a consanguineous Pakistani kindred affected by LCA. This mutation segregated with disease in the kindred, including in three other children with LCA. NMNAT1 resides in the previously identified LCA9 locus and encodes the nuclear isoform of nicotinamide mononucleotide adenylyltransferase, a rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD(+)) biosynthesis(4,5). Functional studies showed that the p.Val9Met alteration decreased NMNAT1 enzyme activity. Sequencing NMNAT1 in 284 unrelated families with LCA identified 14 rare mutations in 13 additional affected individuals. These results are the first to link an NMNAT isoform to disease in humans and indicate that NMNAT1 mutations cause LCA.	[Zhang, Qi; Fonseca-Kelly, Zoe; Staniszewska, Magdalena; Place, Emily; Consugar, Mark; Berson, Eliot L.; Liu, Qin; Pierce, Eric A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat,Dept Opht, Boston, MA 02114 USA; [Falk, Marni J.; Place, Emily; Ostrovsky, Julian] Childrens Hosp Philadelphia, Div Human Genet, Dept Pediat, Philadelphia, PA 19104 USA; [Nakamaru-Ogiso, Eiko] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Child Dev & Metab Dis, Philadelphia, PA 19104 USA; [Zhang, Qi; Fonseca-Kelly, Zoe; Staniszewska, Magdalena; Place, Emily; Consugar, Mark; Liu, Qin; Pierce, Eric A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Ocular Genom Inst, Boston, MA USA; [Kannabiran, Chitra; Shukla, Rachna; Palavalli, Lakshmi; Jalali, Subhadra] LVPEI, Kallam Anji Reddy Mol Genet Lab, Hyderabad, Andhra Pradesh, India; [Chakarova, Christina; Mackay, Donna S.; Borman, Arundhati Dev; Waseem, Naushin H.; Bhattacharya, Shomi S.; Webster, Andrew R.; Moore, Anthony T.] UCL, Inst Ophthalmol, London, England; [Audo, Isabelle; Zeitz, Christina; Mohand-Said, Saddek; Sahel, Jose-Alain] INSERM, U968, Paris, France; [Audo, Isabelle; Zeitz, Christina; Mohand-Said, Saddek; Sahel, Jose-Alain] Univ Paris 06, Unite Mixte Rech UMR S 968, Inst Vis, Paris, France; [Audo, Isabelle; Zeitz, Christina; Mohand-Said, Saddek; Sahel, Jose-Alain] CNRS, UMR 7210, Paris, France; [Audo, Isabelle; Mohand-Said, Saddek; Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, DHOS, Ctr Invest Clin 503, Paris, France; [Borman, Arundhati Dev; Webster, Andrew R.; Moore, Anthony T.] Moorfields Eye Hosp, London, England; [Jalali, Subhadra] LVPEI, Srimati Kanuri Santhamma Ctr Vitreoretinal Dis, Hyderabad, Andhra Pradesh, India; [Perin, Juan C.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Bhattacharya, Shomi S.] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci Inst France, Paris, France; [Moore, Anthony T.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Gai, Xiaowu] Loyola Univ, Chicago Hlth Sci Div, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Gai, Xiaowu] Loyola Univ, Chicago Hlth Sci Div, Ctr Biomed Informat, Maywood, IL 60153 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; L. V. Prasad Eye Institute; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; L. V. Prasad Eye Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Fondation Adolphe de Rothschild; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Loyola University Chicago; Loyola University Chicago	Pierce, EA (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat,Dept Opht, Boston, MA 02114 USA.	eric_pierce@meei.harvard.edu	Zeitz, Christina/F-2757-2017; Bhattacharya, Shom/N-2926-2016; Falk, Marni/K-1997-2014; Kannabiran, Chitra/S-9361-2019; Staniszewska, PhD, DSc, Associate Professor, Magdalena/AAE-9903-2019; Sahel, Jose-Alain/F-3172-2017; Chakarova, Christina/C-9479-2013; Waseem, Naushin/C-9573-2013	Zeitz, Christina/0000-0002-3510-1712; Bhattacharya, Shom/0000-0002-1601-6344; Kannabiran, Chitra/0000-0001-8435-0320; Sahel, Jose-Alain/0000-0002-4831-1153; Audo, Isabelle/0000-0003-0698-5309; Mackay, Donna/0000-0002-2499-1203; Pierce, Eric/0000-0002-2354-4102; Falk, Marni/0000-0002-1723-6728; gai, Xiaowu/0000-0001-8679-9703; Fonseca-Kelly, Zoe/0000-0002-3960-7796; Staniszewska, Magdalena/0000-0003-1119-2397	US National Institutes of Health [RO1-EY12910, R03-DK082446, R01-GM097409, P30HD026979, P30EY014104]; Foundation Fighting Blindness USA; Rosanne Silbermann Foundation; Penn Genome Frontiers Institute; Loyola University Stritch School of Medicine; Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia; Clinical and Translational Research Center at the Children's Hospital of Philadelphia [UL1-RR-024134]; Department of Biotechnology, the Government of India; Champalimaud Foundation, Portugal; Hyderabad Eye Research Foundation; Council for Scientific and Industrial Research; Foundation Voir et Entendre, Ville de Paris and Region Ille de France; RP Fighting Blindness (UK); Fight For Sight (UK); Moorfields Eye Hospital National Institute of Health Research (NIHR) British Research Council (BRC) for Ophthalmology; Special Trustees of Moorfields Eye Hospital; Penn Genome Frontiers Institute under Pennsylvania Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979, R01HD065858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014104, R01EY012910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK082521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness USA; Rosanne Silbermann Foundation; Penn Genome Frontiers Institute; Loyola University Stritch School of Medicine; Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia; Clinical and Translational Research Center at the Children's Hospital of Philadelphia; Department of Biotechnology, the Government of India(Department of Biotechnology (DBT) India); Champalimaud Foundation, Portugal; Hyderabad Eye Research Foundation; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Foundation Voir et Entendre, Ville de Paris and Region Ille de France; RP Fighting Blindness (UK); Fight For Sight (UK); Moorfields Eye Hospital National Institute of Health Research (NIHR) British Research Council (BRC) for Ophthalmology; Special Trustees of Moorfields Eye Hospital; Penn Genome Frontiers Institute under Pennsylvania Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health (RO1-EY12910 (E.A.P.), R03-DK082446 (M.J.F.), R01-GM097409 (E.N.-O.), P30HD026979 (M.J.F. and R. X.) and P30EY014104 (Massachusetts Eye and Ear Infirmary core support)); the Foundation Fighting Blindness USA (I.A., A.D.B., E.L.B., S.S.B., Q.L., A.T.M., D.S.M., E.A.P., J.-A.S., S.M.-S. and A.R.W.); the Rosanne Silbermann Foundation (E.A.P.); the Penn Genome Frontiers Institute (E.A.P. and X.G.); the Institutional Fund to the Center for Biomedical Informatics by the Loyola University Stritch School of Medicine (X.G.); the Foerderer Award for Excellence from the Children's Hospital of Philadelphia (M.J.F. and X.G.); the Angelina Foundation Fund from the Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia (M.J.F.); the Clinical and Translational Research Center at the Children's Hospital of Philadelphia (UL1-RR-024134) (M.J.F. and E.A.P.); the Department of Biotechnology, the Government of India and the Champalimaud Foundation, Portugal (C.K.); the Hyderabad Eye Research Foundation (C.K.); a senior research fellowship from the Council for Scientific and Industrial Research (R.S.); the Foundation Voir et Entendre, Ville de Paris and Region Ille de France (C.Z.); RP Fighting Blindness (UK)(A.R.W.); Fight For Sight (UK) (A.D. B., S.S.B., A.T.M., D.S. M. and A.R.W.); Moorfields Eye Hospital National Institute of Health Research (NIHR) British Research Council (BRC) for Ophthalmology (A.D.B., S.S.B., A.T.M., D.S.M. and A.R.W.); and the Special Trustees of Moorfields Eye Hospital (A.D.B., S.S. B., A.T.M., D.S. M. and A.R.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations or the National Institutes of Health. This project is funded, in part, by the Penn Genome Frontiers Institute under a grant with the Pennsylvania Department of Health, which disclaims responsibility for any analyses, interpretations or conclusions.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Weleber Richard G, 2002, Ophthalmic Genet, V23, P71, DOI 10.1076/opge.23.2.71.2214; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416	41	136	144	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2012	44	9					1040	+		10.1038/ng.2361	http://dx.doi.org/10.1038/ng.2361			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22842227	Green Accepted, Green Submitted			2022-12-17	WOS:000308491200017
J	LeMaire, SA; McDonald, MLN; Guo, DC; Russell, L; Miller, CC; Johnson, RJ; Bekheirnia, MR; Franco, LM; Nguyen, M; Pyeritz, RE; Bavaria, JE; Devereux, R; Maslen, C; Holmes, KW; Eagle, K; Body, SC; Seidman, C; Seidman, JG; Isselbacher, EM; Bray, M; Coselli, JS; Estrera, AL; Safi, HJ; Belmont, JW; Leal, SM; Milewicz, DM				LeMaire, Scott A.; McDonald, Merry-Lynn N.; Guo, Dong-chuan; Russell, Ludivine; Miller, Charles C., III; Johnson, Ralph J.; Bekheirnia, Mir Reza; Franco, Luis M.; Nguyen, Mary; Pyeritz, Reed E.; Bavaria, Joseph E.; Devereux, Richard; Maslen, Cheryl; Holmes, Kathryn W.; Eagle, Kim; Body, Simon C.; Seidman, Christine; Seidman, J. G.; Isselbacher, Eric M.; Bray, Molly; Coselli, Joseph S.; Estrera, Anthony L.; Safi, Hazim J.; Belmont, John W.; Leal, Suzanne M.; Milewicz, Dianna M.			Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1	NATURE GENETICS			English	Article							MARFAN-SYNDROME; MOUSE MODEL; MUTATIONS; DISEASE; VALVE; ADULTS	Although thoracic aortic aneurysms and dissections (TAAD) can be inherited as a single-gene disorder, the genetic predisposition in the majority of affected people is poorly understood. In a multistage genome-wide association study (GWAS), we compared 765 individuals who had sporadic TAAD (STAAD) with 874 controls and identified common SNPs at a 15q21.1 locus that were associated with STAAD, with odds ratios of 1.6-1.8 that achieved genome-wide significance. We followed up 107 SNPs associated with STAAD with P < 1 x 10(-5) in the region, in two separate STAAD cohorts. The associated SNPs fall into a large region of linkage disequilibrium encompassing FBN1, which encodes fibrillin-1. FBN1 mutations cause Marfan syndrome, whose major cardiovascular complication is TAAD. This study shows that common genetic variants at 15q21.1 that probably act via FBN1 are associated with STAAD, suggesting a common pathogenesis of aortic disease in Marfan syndrome and STAAD.	[Guo, Dong-chuan; Johnson, Ralph J.; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Internal Med, Houston, TX USA; [LeMaire, Scott A.; Russell, Ludivine; Nguyen, Mary; Coselli, Joseph S.] Baylor Coll Med, Div Cardiothorac Surg, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [McDonald, Merry-Lynn N.; Bekheirnia, Mir Reza; Franco, Luis M.; Belmont, John W.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Miller, Charles C., III; Estrera, Anthony L.; Safi, Hazim J.] Univ Texas Hlth Sci Ctr Houston, Dept Cardiothorac & Vasc Surg, Houston, TX USA; [Pyeritz, Reed E.] Univ Penn, Dept Med, Div Med Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bavaria, Joseph E.] Univ Penn, Dept Surg, Div Cardiovasc Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Devereux, Richard] Weill Cornell Med Coll, Dept Med, Greenberg Div Cardiol, New York, NY USA; [Maslen, Cheryl] Oregon Hlth & Sci Univ, Div Cardiovasc Med, Dept Mol & Med Genet, Portland, OR 97201 USA; [Holmes, Kathryn W.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Eagle, Kim] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Body, Simon C.] Harvard Univ, Sch Med, Dept Anesthesiol, Boston, MA USA; [Seidman, Christine; Seidman, J. G.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Isselbacher, Eric M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bray, Molly] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Milewicz, Dianna M.] St Lukes Episcopal Hosp, Texas Heart Inst, Med Serv, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Oregon Health & Science University; Johns Hopkins University; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Internal Med, Houston, TX USA.	dianna.m.milewicz@uth.tmc.edu	Belmont, John W/AAI-2494-2019; Sander-Effron, Samuel/AAX-2231-2020; Body, Simon/AAQ-7572-2020; Estrera, Anthony/ABG-4175-2021; Body, Simon C/O-2605-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022; Belmont, John/AAH-6084-2021	Belmont, John W/0000-0001-7409-3578; Body, Simon/0000-0001-6721-7050; Body, Simon C/0000-0001-6721-7050; LeMaire, Scott/0000-0002-8736-4266; McDonald, Merry-Lynn/0000-0002-2647-9422	US National Institutes of Health [P50-HL083794, R01-HL62594, UL1RR024148, UL1RR025758 (CTSA), K08-HL080085]; Doris Duke Charitable Trust; Vivian L. Smith Foundation; TexGen Foundation; Thoracic Surgery Foundation for Research and Education; US Federal Government; National Heart, Lung, and Blood Institute [N01-HV-68199]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL080085, P50HL083794, R01HL062594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Trust(Doris Duke Charitable Foundation (DDCF)); Vivian L. Smith Foundation; TexGen Foundation; Thoracic Surgery Foundation for Research and Education; US Federal Government; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the US National Institutes of Health (P50-HL083794 and R01-HL62594 to D. M. M.; UL1RR024148 and UL1RR025758 (CTSA); K08-HL080085 to S. A. L.), as well as the Doris Duke Charitable Trust, the Vivian L. Smith Foundation, the TexGen Foundation and the Thoracic Surgery Foundation for Research and Education.; GenTAC participating centers and their investigators are as follows: Johns Hopkins University School of Medicine, K. W. H., H. C. Dietz, W. Ravekes, K. Lurman; University of Texas Health Science Center at Houston, D. M. M., A. Carlson; Baylor College of Medicine, S. A. L., J. L. Jefferies, I. V. Volguina; Oregon Health & Science University, C. M., H. K. Song, V. Menashe, M. Silberbach, J. D. Kushner; Perelman School of Medicine at the University of Pennsylvania, R. E. P., J. E. B., M. Morales; Weill Cornell Medical College, C. T. Basson, R. D., J. W. Weinsaft, D. McDermott; University of Michigan Medical School, K. E.; US National Heart, Lung, and Blood Institute, H. E. Tolunay, P. Desvigne-Nickens, M. P. Stylianou, M. Mitchell; RTI International, B. L. Kroner, D. Brambilla, T. Hendershot, D. Ringer, M. Cunningham, M. Kindem. The GenTAC registry is supported by US Federal Government Contract N01-HV-68199 from the National Heart, Lung, and Blood Institute and by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brautbar A, 2010, AM J MED GENET A, V152A, P413, DOI 10.1002/ajmg.a.32856; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Eagle KA, 2009, AM HEART J, V157, P319, DOI 10.1016/j.ahj.2008.10.005; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mahan S, 2004, ASSAY DRUG DEV TECHN, V2, P683, DOI 10.1089/adt.2004.2.683; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 2010, CARDIOL CLIN, V28, P191, DOI 10.1016/j.ccl.2010.01.017; Milewicz DM, 1996, CIRCULATION, V94, P2708, DOI 10.1161/01.CIR.94.11.2708; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Svensson LG, 2008, J CARDIOVASC SURG, V49, P297; Svensson LG, 2003, CURR PROB CARDIOLOGY, V28, P417, DOI 10.1016/j.cpcardiol.2003.08.002; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	27	136	141	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					996	U109		10.1038/ng.934	http://dx.doi.org/10.1038/ng.934			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21909107	Green Accepted			2022-12-17	WOS:000295316200015
J	Jenkins, ZA; van Kogelenberg, M; Morgan, T; Jeffs, A; Fukuzawa, R; Pearl, E; Thaller, C; Hing, AV; Porteous, ME; Garcia-Minaur, S; Bohring, A; Lacombe, D; Stewart, F; Fiskerstrand, T; Bindoff, L; Berland, S; Ades, LC; Tchan, M; David, A; Wilson, LC; Hennekam, RCM; Donnai, D; Mansour, S; Cormier-Daire, V; Robertson, SP				Jenkins, Zandra A.; van Kogelenberg, Margriet; Morgan, Tim; Jeffs, Aaron; Fukuzawa, Ryuji; Pearl, Esther; Thaller, Christina; Hing, Anne V.; Porteous, Mary E.; Garcia-Minaur, Sixto; Bohring, Axel; Lacombe, Didier; Stewart, Fiona; Fiskerstrand, Torunn; Bindoff, Laurence; Berland, Siren; Ades, Lesley C.; Tchan, Michel; David, Albert; Wilson, Louise C.; Hennekam, Raoul C. M.; Donnai, Dian; Mansour, Sahar; Cormier-Daire, Valerie; Robertson, Stephen P.			Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis	NATURE GENETICS			English	Article							FOCAL DERMAL HYPOPLASIA; TIME QUANTITATIVE PCR; HIGH-BONE-MASS; GENE-EXPRESSION; BETA-CATENIN; WILMS-TUMOR; WNT; DIFFERENTIATION; OSTEOBLAST; REGULATOR	Abnormalities in WNT signaling are implicated in a broad range of developmental anomalies and also in tumorigenesis(1). Here we demonstrate that germline mutations in WTX (FAM123B), a gene that encodes a repressor of canonical WNT signaling(2), cause an X-linked sclerosing bone dysplasia, osteopathia striata congenita with cranial sclerosis (OSCS; MIM300373)(3). This condition is typically characterized by increased bone density and craniofacial malformations in females and lethality in males. The mouse homolog of WTX is expressed in the fetal skeleton, and alternative splicing implicates plasma membrane localization of WTX as a factor associated with survival in males with OSCS. WTX has also been shown to be somatically inactivated in 11-29% of cases of Wilms tumor(4-6). Despite being germline for such mutations, individuals with OSCS are not predisposed to tumor development. The observed phenotypic discordance dependent upon whether a mutation is germline or occurs somatically suggests the existence of temporal or spatial constraints on the action of WTX during tumorigenesis.	[Jenkins, Zandra A.; van Kogelenberg, Margriet; Morgan, Tim; Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Paediat, Dunedin 9054, New Zealand; [Jeffs, Aaron] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9054, New Zealand; [Fukuzawa, Ryuji] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin 9054, New Zealand; [Pearl, Esther] Univ Otago, Dept Zool, Dunedin 9054, New Zealand; [Thaller, Christina] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hing, Anne V.] Univ Washington, Sch Med, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Porteous, Mary E.; Garcia-Minaur, Sixto] Western Gen Hosp, S E Scotland Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Bohring, Axel] Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Lacombe, Didier] Univ Bordeaux, CHU Bordeaux, F-33800 Bordeaux, France; [Stewart, Fiona] Belfast City Hosp, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland; [Fiskerstrand, Torunn; Berland, Siren] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Bindoff, Laurence] Univ Bergen, Inst Clin Med, N-5021 Bergen, Norway; [Bindoff, Laurence] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Ades, Lesley C.; Tchan, Michel] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2101, Australia; [Ades, Lesley C.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2101, Australia; [David, Albert] Nantes Univ Hosp, Dept Clin Genet, F-44093 Nantes, France; [Wilson, Louise C.; Hennekam, Raoul C. M.] Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 3JH, England; [Donnai, Dian] St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; [Mansour, Sahar] St George Hosp, S W Thames Reg Genet Unit, London SW17 0RE, England; [Cormier-Daire, Valerie] Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France	University of Otago; University of Otago; University of Otago; University of Otago; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Edinburgh; University of Munster; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Belfast City Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Sydney; University of Sydney; Nantes Universite; CHU de Nantes; University of London; University College London; University of Manchester; St Georges University London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Robertson, SP (corresponding author), Univ Otago, Dunedin Sch Med, Dept Paediat, Dunedin 9054, New Zealand.	stephen.robertson@otago.ac.nz	Jeffs, Aaron/B-4324-2008; lacombe, didier/K-7967-2014; cormier-daire, valerie/H-6520-2017	Berland, Siren/0000-0002-8048-6682; Robertson, Stephen/0000-0002-5181-7809; Bindoff, Laurence/0000-0003-0988-276X; Pearl, Esther/0000-0001-6510-0959; cormier-daire, valerie/0000-0002-2839-9856; Lacombe, Didier/0000-0002-8956-2207; garcia, sixto/0000-0003-3406-3424				Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Behninger C, 2000, GENET COUNSEL, V11, P157; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; HURT RL, 1953, J BONE JOINT SURG BR, V35, P89, DOI 10.1302/0301-620X.35B1.89; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; RUTESHOUSER EC, 2008, CANCER, V47, P461; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	30	136	174	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2009	41	1					95	100		10.1038/ng.270	http://dx.doi.org/10.1038/ng.270			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	389IE	19079258				2022-12-17	WOS:000262085300022
J	Van Steen, K; McQueen, MB; Herbert, A; Raby, B; Lyon, H; DeMeo, DL; Murphy, A; Su, J; Datta, S; Rosenow, C; Christman, M; Silverman, EK; Laird, NM; Weiss, ST; Lange, C				Van Steen, K; McQueen, MB; Herbert, A; Raby, B; Lyon, H; DeMeo, DL; Murphy, A; Su, J; Datta, S; Rosenow, C; Christman, M; Silverman, EK; Laird, NM; Weiss, ST; Lange, C			Genomic screening and replication using the same data set in family-based association testing	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; FALSE DISCOVERY RATE; GENERAL-CLASS; POWERFUL; GENETICS; ASTHMA; DISEQUILIBRIUM; PHENOTYPES	The Human Genome Project and its spin- offs are making it increasingly feasible to determine the genetic basis of complex traits using genome- wide association studies. The statistical challenge of analyzing such studies stems from the severe multiple-comparison problem resulting from the analysis of thousands of SNPs. Our methodology for genome- wide family- based association studies, using single SNPs or haplotypes, can identify associations that achieve genome- wide significance. In relation to developing guidelines for our screening tools, we determined lower bounds for the estimated power to detect the gene underlying the disease- susceptibility locus, which hold regardless of the linkage disequilibrium structure present in the data. We also assessed the power of our approach in the presence of multiple disease- susceptibility loci. Our screening tools accommodate genomic control and use the concept of haplotype- tagging SNPs. Our methods use the entire sample and do not require separate screening and validation samples to establish genome- wide significance, as population- based designs do.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Affymetrix Inc, Genom Collaborat Genotyping, Santa Clara, CA 95051 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Affymetrix	Van Steen, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	kvanstee@hsph.harvard.edu	Herbert, Alan/AAY-4286-2020; McQueen, Matthew/X-5845-2019; Raby, Benjamin/AAK-3866-2021	Herbert, Alan/0000-0002-0093-1572; Van Steen, Kristel/0000-0001-9868-5033	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD060726] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni CE., 1937, VOLUME ONORE RICARRD, V2, P1; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; CHURCHILL GA, 1994, GENETICS, V138, P963; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doerge RW, 1996, GENETICS, V142, P285; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; HOLM S, 1979, SCAND J STAT, V6, P65; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lyon H, 2004, GENET EPIDEMIOL, V26, P155, DOI 10.1002/gepi.10298; Marnellos G, 2003, CURR OPIN DRUG DI DE, V6, P317; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Sherry ST, 1999, GENOME RES, V9, P677; SIDAK Z, 1971, ANN MATH STAT, V42, P169, DOI 10.1214/aoms/1177693504; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Van Steen Kristel, 2005, Hum Genomics, V2, P67; Weiss ST, 2004, HUM MOL GENET, V13, pR83, DOI 10.1093/hmg/ddh080; Zhai WW, 2004, GENET EPIDEMIOL, V27, P80, DOI 10.1002/gepi.20014	35	136	142	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					683	691		10.1038/ng1582	http://dx.doi.org/10.1038/ng1582			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15937480				2022-12-17	WOS:000230196400014
J	Charlier, C; Segers, K; Karim, L; Shay, T; Gyapay, G; Cockett, N; Georges, M				Charlier, C; Segers, K; Karim, L; Shay, T; Gyapay, G; Cockett, N; Georges, M			The callipyge mutation enhances the expression of coregulated imprinted genes in cis without affecting their imprinting status	NATURE GENETICS			English	Article							GTL2	The callipyge (CLPG) phenotype (from kappa alpha lambda iota, "beautiful," and pi iota gamma epsilon, "buttocks") described in sheep is an inherited muscular hypertrophy that is subject to unusual parent-of-origin effect referred to as polar overdominance:only heterozygous individuals having inherited the CLPG mutation from their sire exhibit muscular hypertrophy(1). The callipyge (clpg) locus was mapped to a segment of approximately 400 kb (refs, 2-4), which was shown to contain genes (DLK1, GTL2, PEG11 and MEG8) that are preferentially expressed in skeletal muscle and subject to parental imprinting in this tissue(5-9). Here we describe effect of the CLPG mutation on the expression of these four genes, and demonstrate that callipyge individuals have a unique expression profile that may for the observed polar overdominance. for the observed polar overdominance.	Univ Liege B43, Fac Med Vet, Dept Genet, Liege, Belgium; Ctr Natl Sequencage, Genoscope, Evry, France; Utah State Univ, Coll Agr, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	University of Liege; Utah System of Higher Education; Utah State University	Georges, M (corresponding author), Univ Liege B43, Fac Med Vet, Dept Genet, Liege, Belgium.	michel.georges@ulg.ac.be		Charlier, Carole/0000-0002-9694-094X; Georges, Michel/0000-0003-4124-2375				Berghmans S, 2001, MAMM GENOME, V12, P183, DOI 10.1007/s003350010246; CHARLIER C, IN PRESS GENOME RES; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Schmidt JV, 2000, GENE DEV, V14, P1997; Segers K, 2000, ANIM GENET, V31, P352, DOI 10.1046/j.1365-2052.2000.00676.x; Shay TL, 2001, MAMM GENOME, V12, P141, DOI 10.1007/s003350010248; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600	9	136	146	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2001	27	4					367	369		10.1038/86856	http://dx.doi.org/10.1038/86856			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279514				2022-12-17	WOS:000167811200007
J	Costa, RM; Yang, T; Huynh, DP; Pulst, SM; Viskochil, DH; Silva, AJ; Brannan, CI				Costa, RM; Yang, T; Huynh, DP; Pulst, SM; Viskochil, DH; Silva, AJ; Brannan, CI			Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1	NATURE GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 NF1; LONG-TERM-MEMORY; RAS SIGNALING PATHWAY; MORRIS WATER MAZE; TARGETED MUTATION; MUTANT MICE; MOUSE MODEL; GENE; EXPRESSION; GAP	Neurofibromatosis type 1 (NF1) is a commonly inherited autosomal dominant disorder. Previous studies indicated that mice homozygous for a null mutation in Nf1 exhibit mid-gestation lethality, whereas heterozygous mice have an increased predisposition to tumors and learning impairments. Here we show that mice lacking the alternatively spliced exon 23a, which modifies the GTPase-activating protein (CAP) domain of Nf1, are viable and physically normal, and do not have an increased tumor predisposition, but show specific learning impairments. Our findings have implications for the development of a treatment for the learning disabilities associated with NF1 and indicate that the CAP domain of NF1 modulates learning and memory.	Univ Calif Los Angeles, Dept Neurobiol, BRI, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychiat, BRI, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Psychol, BRI, Los Angeles, CA USA; Univ Florida, Coll Med, Inst Brain, Gainesville, FL USA; Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA USA; Univ Utah, Div Med Genet, Salt Lake City, UT USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University System of Florida; University of Florida; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah	Brannan, CI (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, BRI, Los Angeles, CA 90024 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Costa, Rui M./0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS38480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JC., 1992, J BUS-BUS MARK, V1, P3, DOI [DOI 10.1300/J033V01N01_02, 10.1300/J033v01n01_02]; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gutmann DH, 1995, PROG BRAIN RES, V105, P327; Gutmann DH, 1999, ANN NEUROL, V46, P777, DOI 10.1002/1531-8249(199911)46:5<777::AID-ANA15>3.0.CO;2-H; GUTMANN DH, 1994, METABOLIC MOL BASIS, P1; HOGAN B, 1994, MANIPULATING MOUSE E; Huson SHR, 1994, NEUROFIBROMATOSES PA; HUYNH DP, 1994, DEV BIOL, V161, P538, DOI 10.1006/dbio.1994.1052; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Metheny LJ, 1996, EXP CELL RES, V228, P44, DOI 10.1006/excr.1996.0297; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; UPADHYAYA M, 1998, NEUROFIBROMATOSIS TY, V1; Upadhyaya M., 1998, NEUROFIBROMATOSIS TY, P39; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	38	136	144	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					399	405		10.1038/86898	http://dx.doi.org/10.1038/86898			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279521				2022-12-17	WOS:000167811200014
J	Bonyadi, M; Rusholme, SAB; Cousins, FM; Su, HC; Biron, CA; Farrall, M; Akhurst, RJ				Bonyadi, M; Rusholme, SAB; Cousins, FM; Su, HC; Biron, CA; Farrall, M; Akhurst, RJ			Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice	NATURE GENETICS			English	Article							TGF-BETA; TARGETED DISRUPTION; COMPLEX TRAITS; MESSENGER-RNA; NEURAL-TUBE; MOUSE; RECEPTOR; LINKAGE; LOCALIZATION; DISSECTION	The transforming growth factor beta 1 (TGF beta 1) signalling pathway(1,2) is important in embryogenesis(3) and has been implicated in hereditary haemorrhagic telangiectasia (HHT)(4,5) atherosclerosis(6,7), tumorigenesis(8,9) and immunomodulation(10,11) ll. Therefore, identification of factors which modulate TGF beta 1 bioactivity in vivo is important. On a mixed genetic background, similar to 50% Tgfb1(-/-) conceptuses die midgestation from defective yolk sac vasculogenesis(3). The other half are developmentally normal but die three weeks postpartum(3,10,11). Intriguingly, the vascular defects of Tgfb1(-/-) mice share histological similarities to lesions seen in HHT patients(3-5) It has been suggested that dichotomy in Tgfb1(-/-) lethal phenotypes is due to maternal TGF beta 1 rescue of some, but not all, Tgfb1(-/-) embryos(12). Here we show that the Tgfb1(-/-) phenotype depends on the genetic background of the conceptus. In NIH/Ola, C57BL/6J/Ola and F1 conceptuses, Tgfb1(-/-) lethality can be categorized into three developmental classes. A major codominant modifier gene of embryo lethality was mapped to proximal mouse chromosome 5, using a genome scan for non-mendelian distribution of alleles in Tgfb1(-/-) neonatal animals which survive prenatal lethality. This gene accounts for around three quarters of the genetic effect between mouse strains and can, in part, explain the distribution of the three lethal phenotypes. This approach, using neonatal DNA samples, is generally applicable to identification of loci that influence the effect of early embryonic lethal mutations, thus furthering knowledge of genetic interactions that occur during early mammalian development in vivo.	BROWN UNIV,DIV BIOL & MED,PROVIDENCE,RI 02912; UNIV OXFORD,NUFFIELD DEPT MED,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND; UNIV GLASGOW,DUNCAN GUTHRIE INST,DEPT MED GENET,GLASGOW G3 8SJ,LANARK,SCOTLAND	Brown University; University of Oxford; Wellcome Centre for Human Genetics; University of Glasgow			Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110; Bonyadi, Mortaza/0000-0003-3216-2947; AKHURST, ROSEMARY/0000-0002-4474-9668				AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; Bonyadi M, 1996, GENOMICS, V33, P328, DOI 10.1006/geno.1996.0204; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; CUI W, 1996, GROWTH FACTORS CYTOK, P357; DICKINSON ME, 1990, GENOMICS, V6, P505, DOI 10.1016/0888-7543(90)90480-I; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; GAUTAM SC, 1993, ONCOL RES, V5, P423; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LAUREYS G, 1988, GENOMICS, V3, P224, DOI 10.1016/0888-7543(88)90083-3; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MARKOWITZ S, 1995, SCIENCE, V268, P1276; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MOCK BA, 1989, J IMMUNOL, V142, P1372; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; QURESHI ST, 1995, GENOMICS, V26, P165, DOI 10.1016/0888-7543(95)80099-8; RISCH N, 1993, AM J HUM GENET, V53, P702; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; SAUNDERS K B, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P157; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084	32	136	141	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					207	211		10.1038/ng0297-207	http://dx.doi.org/10.1038/ng0297-207			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020852				2022-12-17	WOS:A1997WF08700026
J	WILLEMS, PJ				WILLEMS, PJ			DYNAMIC MUTATIONS HIT DOUBLE FIGURES	NATURE GENETICS			English	Editorial Material							FRAGILE-X-SYNDROME; ANDROGEN RECEPTOR GENE; MENTAL-RETARDATION; HUNTINGTONS-DISEASE; DNA METHYLATION; CPG ISLAND; REPEAT; EXPANSION; FMR-1; SITES				WILLEMS, PJ (corresponding author), UNIV ANTWERP,DEPT MED GENET,B-2610 ANTWERP,BELGIUM.							BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DAVIES K, 1993, NATURE, V364, P88, DOI 10.1038/364088a0; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; HAMEL BCJ, IN PRESS AM J HUM GE; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOLDE R, 1994, NAT GENET, V6, P9; LAIRD C, 1967, TRENDS GENET, V3, P247; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MADDOX J, 1994, NATURE, V368, P685, DOI 10.1038/368685a0; MANDEL JL, 1994, NAT GENET, V7, P453, DOI 10.1038/ng0894-453; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PARRISH JE, 1994, NAT GENET, V8, P236; PERUTZ M, 1985, P NATL ACAD SCI USA, V91, P5355; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; RICHARDS RI, 1993, HUM MOL GENET, V2, P1429, DOI 10.1093/hmg/2.9.1429; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1991, GENET ANAL-BIOMOL E, V8, P161, DOI 10.1016/1050-3862(91)90056-W; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; 1993, CELL, V72, P971	44	136	139	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					213	215		10.1038/ng1194-213	http://dx.doi.org/10.1038/ng1194-213			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874160				2022-12-17	WOS:A1994PP76500005
J	GUAN, XY; MELTZER, PS; DALTON, WS; TRENT, JM				GUAN, XY; MELTZER, PS; DALTON, WS; TRENT, JM			IDENTIFICATION OF CRYPTIC SITES OF DNA-SEQUENCE AMPLIFICATION IN HUMAN BREAST-CANCER BY CHROMOSOME MICRODISSECTION	NATURE GENETICS			English	Article							HOMOGENEOUSLY STAINING REGIONS; CELL-LINES; INSITU HYBRIDIZATION; MALIGNANT-MELANOMA; RAPID GENERATION; CARCINOMAS; ABNORMALITIES; ONCOGENE; DISEASE; PROBES	We have performed microdissection of 16 putative homogeneously staining regions (hsrs) from nine different breast cancer cell lines in order to determine their chromosomal origin and composition. As expected, the most commonly amplified chromosomal band-region was 17q12 (containing ERBB2). However, regions not containing known oncogenes were also identified, including 13q31 (5/9 cases) and 20q12-13.2 (4/9 cases). The chromosomal composition of the integrated amplified DNA within each hsr was determined and in 13/16 cases (81%), hsrs were shown to be composed of two or more chromosomal regions. These studies shed light on the mechanism of formation of hsrs, and identify chromosomal regions likely to harbour genes amplified in breast cancer.	NIH,NATL CTR HUMAN GENOME RES,CANC GENET LAB,BETHESDA,MD 20892; UNIV ARIZONA,ARIZONA COMPREHENS CANC CTR,TUCSON,AZ 85719	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Arizona			/A-3639-2009; Guan, Xin-Yuan/A-3639-2009	/0000-0003-1874-9805; Guan, Xin-Yuan/0000-0002-4485-6017	NATIONAL CANCER INSTITUTE [P01CA041183, P30CA023074] Funding Source: NIH RePORTER; NCI NIH HHS [CA-23074, CA-41183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERNS EMJJ, 1992, CANCER RES, V52, P1036; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; DEVILEE P, 1990, CANCER SURV, V9, P605; DUTRILLAUX B, 1990, CANCER GENET CYTOGEN, V49, P203, DOI 10.1016/0165-4608(90)90143-X; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; GUAN XY, 1992, GENOMICS, V14, P680, DOI 10.1016/S0888-7543(05)80168-5; GUAN XY, 1993, HUM MOL GENET, V2, P1117, DOI 10.1093/hmg/2.8.1117; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; LAFAGE M, 1992, GENE CHROMOSOME CANC, V5, P40, DOI 10.1002/gcc.2870050107; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; LIANG BC, IN PRESS CANCER GENE; MARS WM, 1990, CANCER METAST REV, V9, P35, DOI 10.1007/BF00047587; MATTEI MG, 1991, HUM GENET, V87, P84, DOI 10.1007/BF01213098; MELTZER P, 1991, BRIT J CANCER, V63, P727, DOI 10.1038/bjc.1991.164; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; MITELMAN F, 1991, CATALOG CHROMOSOME A; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RUTA M, 1988, ONCOGENE, V3, P9; SAINTRUF C, 1990, GENE CHROMOSOME CANC, V2, P18, DOI 10.1002/gcc.2870020105; SAINTRUF C, 1991, CANCER GENET CYTOGEN, V52, P27, DOI 10.1016/0165-4608(91)90050-5; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; SU YA, 1994, P NATL ACAD SCI USA, V91, P9121, DOI 10.1073/pnas.91.19.9121; THOMPSON F, 1993, GENE CHROMOSOME CANC, V7, P185, DOI 10.1002/gcc.2870070402; TRENT J, 1993, GENE CHROMOSOME CANC, V7, P194, DOI 10.1002/gcc.2870070403; Trent J M, 1987, Methods Enzymol, V151, P267, DOI 10.1016/S0076-6879(87)51023-0; ZHANG J, 1993, ONCOGENE, V8, P2827; 1992, CANCER FACTS FIGURES	30	136	143	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					155	161		10.1038/ng1094-155	http://dx.doi.org/10.1038/ng1094-155			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842014				2022-12-17	WOS:A1994PL12300017
J	ANGRIST, M; KAUFFMAN, E; SLAUGENHAUPT, SA; MATISE, TC; PUFFENBERGER, EG; WASHINGTON, SS; LIPSON, A; CASS, DT; REYNA, T; WEEKS, DE; SIEBER, W; CHAKRAVARTI, A				ANGRIST, M; KAUFFMAN, E; SLAUGENHAUPT, SA; MATISE, TC; PUFFENBERGER, EG; WASHINGTON, SS; LIPSON, A; CASS, DT; REYNA, T; WEEKS, DE; SIEBER, W; CHAKRAVARTI, A			A GENE FOR HIRSCHSPRUNG DISEASE (MEGACOLON) IN THE PERICENTROMERIC REGION OF HUMAN CHROMOSOME-10	NATURE GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-2A; 3-GENERATION TRANSMISSION; WAARDENBURG SYNDROME; LINKAGE ANALYSIS; IDENTIFICATION; DNA; AGANGLIONOSIS; POLYMORPHISM; CELLS; MAP	Hirschsprung disease (HSCR) is characterized by a congenital absence of enteric ganglia along a variable length of the intestine. Although long considered to be a multifactorial disease, we have identified linkage in a subset of five HSCR families to the pericentromeric region of chromosome 10, thereby proving monogenic inheritance in some families. A maximum two-point lod score of 3.37 (theta = 0.045) was observed between HSCR and D10S176, under an incompletely penetrant dominant model. Multipoint, affecteds-only and non-parametric analyses supported this finding and localize this gene to a region of almost-equal-to 7 centiMorgans, in close proximity to the locus for multiple endocrine neoplasia type 2 (MEN2). The co-occurrence of these two entities in some families might be attributable to shared pathogenetic origins.	UNIV PITTSBURGH,DEPT PSYCHIAT,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; ROYAL ALEXANDRA HOSP CHILDREN,BIRTH DEFECTS UNIT,CAMPERDOWN,NSW 2050,AUSTRALIA; WESTMEAD HOSP,DEPT PEDIAT SURG,WESTMEAD,AUSTRALIA; WILLIAM BEAUMONT ARMY MED CTR,DEPT SURG,PEDIAT SURG SERV,EL PASO,TX 79920; PEDIAT SURG ASSOCIATES,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney; William Beaumont Army Medical Center			Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Puffenberger, Erik/0000-0002-6388-9148	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028088] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-28088] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON DJ, 1993, J NEUROBIOL, V24, P185, DOI 10.1002/neu.480240206; Angrist M., 1992, American Journal of Human Genetics, V51, pA359; BADNER JA, 1990, AM J HUM GENET, V46, P568; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BICKLER SW, 1992, ARCH SURG-CHICAGO, V127, P1047; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; CARNAHAN JF, 1991, DEV BIOL, V148, P552, DOI 10.1016/0012-1606(91)90273-6; CASS D, 1990, J PAEDIATR CHILD H, V26, P351, DOI 10.1111/j.1440-1754.1990.tb02451.x; CHAKRAVARTI A, 1990, BANB REPORT, V33, P307; Chi D., 1992, American Journal of Human Genetics, V51, pA184; Cox Tara K., 1992, American Journal of Human Genetics, V51, pA33; DECKER RA, 1992, GENOMICS, V12, P604, DOI 10.1016/0888-7543(92)90455-2; GARVER KL, 1985, CLIN GENET, V28, P503; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; Hirschsprung H., 1888, JAHRBUCHF RKINDERHEI, V27, P1; HOWE JR, 1992, AM J HUM GENET, V51, P1430; HOWE JR, 1992, SURGERY, V112, P219; IKADAI H, 1979, Congenital Anomalies, V19, P31; KHAN AH, 1987, J PEDIATR SURG, V22, P719, DOI 10.1016/S0022-3468(87)80612-7; LAIRMORE TC, 1991, GENOMICS, V9, P181, DOI 10.1016/0888-7543(91)90237-9; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P181; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMAREC B, 1980, J GENET HUM, V28, P169; LIPSON AH, 1987, CLIN GENET, V32, P175; LIPSON AH, 1990, CLIN GENET, V37, P235; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MAHAFFEY SM, 1990, J PEDIATR SURG, V25, P101, DOI 10.1016/S0022-3468(05)80172-1; MARTUCCIELLO G, 1992, PEDIATR SURG INT, V7, P308; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MCDONALD H, 1992, GENOMICS, V13, P344, DOI 10.1016/0888-7543(92)90251-M; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P848; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ott J., 1991, ANAL HUMAN GENETIC L; Papi L., 1992, Human Molecular Genetics, V1, P450, DOI 10.1093/hmg/1.6.450-a; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PASSARGE E, 1980, GENETICS HETEROGENEI, P441; Patterson Paul H., 1992, Current Opinion in Cell Biology, V4, P962, DOI 10.1016/0955-0674(92)90125-V; Puffenberger E. G., 1992, American Journal of Human Genetics, V51, pA106; PULITI A, 1993, CYTOGENET CELL GENET, V63, P102, DOI 10.1159/000133510; ROUSSEAUMERCK MF, 1992, GENOMICS, V13, P845, DOI 10.1016/0888-7543(92)90166-P; SHERMAN JO, 1989, J PEDIATR SURG, V24, P833, DOI 10.1016/S0022-3468(89)80548-2; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SLAUGENHAUPT SA, 1991, THESIS U PITTSBURGH; Smith B, 1968, J Pediatr Surg, V3, P386, DOI 10.1016/0022-3468(68)90344-8; SORANT AJM, 1989, STATISTICAL ANAL GEN; SWENSON O, 1989, J PEDIATR SURG, V24, P839, DOI 10.1016/S0022-3468(89)80549-4; SWENSON O, 1982, HIRSCHSPRUNGS DISEAS, P3; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TROELSTRA C, 1992, GENOMICS, V12, P745, DOI 10.1016/0888-7543(92)90304-B; VERDY M, 1982, J PEDIATR GASTR NUTR, V1, P603, DOI 10.1097/00005176-198212000-00027; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITEHEAD R, 1990, MUCOSAL BIOPSY GASTR, P391; WU JS, 1989, HUM GENET, V83, P383, DOI 10.1007/BF00291386; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	58	136	136	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					351	356		10.1038/ng0893-351	http://dx.doi.org/10.1038/ng0893-351			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401581				2022-12-17	WOS:A1993LQ17800011
J	SUPER, M; GILLIES, SD; FOLEY, S; SASTRY, K; SCHWEINLE, JE; SILVERMAN, VJ; EZEKOWITZ, RAB				SUPER, M; GILLIES, SD; FOLEY, S; SASTRY, K; SCHWEINLE, JE; SILVERMAN, VJ; EZEKOWITZ, RAB			DISTINCT AND OVERLAPPING FUNCTIONS OF ALLELIC FORMS OF HUMAN MANNOSE BINDING-PROTEIN	NATURE GENETICS			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; CLASSICAL PATHWAY; HUMAN-SERUM; MANNAN; COMPLEMENT; IMMUNODEFICIENCY; SEQUENCE; LECTINS; ZYMOSAN; DEFECT	Human mannose binding protein (MBP) is a C-type serum lectin involved in first-line host defense against a variety of bacterial, fungal and viral pathogens. Recently an association was found between low levels of serum MBP and an increased frequency of recurrent infections in infants. A particular genotype, in which glycine is substituted by aspartic acid at codon 54 of MBP in the fifth collagen repeat, shows apparent concordance with the clinical phenotype. We report, however, that this genotype occurs in 5% of the population and encodes a functional protein. Our results indicate that the Gly54Asp allele does not account for a deficiency state, but instead suggest that MBP may have two predominant allelic forms that have overlapping function and differ only in their ability to activate the classical pathway of complement.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; ABBOTT BIOTECH INC,NEEDHAM,MA; YALE UNIV,SCH MED,DEPT INTERNAL MED,DIV INFECT DIS,NEW HAVEN,CT 06510; BOSTON UNIV,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02118	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yale University; Boston University	SUPER, M (corresponding author), HARVARD UNIV,CHILDRENS HOSP,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115, USA.		Super, Michael/AAW-7952-2021					BENSON B, 1985, P NATL ACAD SCI USA, V82, P6379, DOI 10.1073/pnas.82.19.6379; CHILDS RA, 1990, J BIOL CHEM, V265, P20770; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; EZEKOWITZ R A B, 1992, Current Biology, V2, P147, DOI 10.1016/0960-9822(92)90266-D; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; FLOROS J, 1986, J BIOL CHEM, V261, P9029; GILLIES SD, 1989, BIO-TECHNOL, V7, P799, DOI 10.1038/nbt0889-799; HAMMARSTROM L, 1986, IMMUNOGLOBULIN SUBCL, P50; HIGUCHI R, 1989, AMPLIFICATIONS, V2, P1; IKEDA K, 1987, J BIOL CHEM, V262, P7451; JACENKO O, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P327; JANEWAY CA, 1989, APPROACHING ASYMPTOT, P1; KAWASAKI N, 1983, J BIOCHEM, V94, P937, DOI 10.1093/oxfordjournals.jbchem.a134437; KAWASAKI T, 1978, BIOCHEM BIOPH RES CO, V81, P1018, DOI 10.1016/0006-291X(78)91452-3; KOZUTSUMI Y, 1980, BIOCHEM BIOPH RES CO, V95, P658, DOI 10.1016/0006-291X(80)90836-0; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU J, 1990, J IMMUNOL, V144, P2287; MALHOTRA R, 1990, J EXP MED, V172, P955, DOI 10.1084/jem.172.3.955; MIZUNO Y, 1981, J BIOL CHEM, V256, P4247; OHTA M, 1990, J BIOL CHEM, V265, P1980; REID KBM, 1985, BIOCHEM J, V231, P729, DOI 10.1042/bj2310729; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; SHYUR SD, 1991, PEDIATR INFECT DIS J, V10, P595, DOI 10.1097/00006454-199108000-00009; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUPER M, 1989, LANCET, V2, P1236; SUPER M, 1990, CLIN EXP IMMUNOL, V79, P144; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241	30	136	139	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					50	55		10.1038/ng0992-50	http://dx.doi.org/10.1038/ng0992-50			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303250				2022-12-17	WOS:A1992JM64600016
J	Sakornsakolpat, P; Prokopenko, D; Lamontagne, M; Reeve, NF; Guyatt, AL; Jackson, VE; Shrine, N; Qiao, DD; Bartz, TM; Kim, DK; Lee, MK; Latourelle, JC; Li, XN; Morrow, JD; Obeidat, M; Wyss, AB; Bakke, P; Barr, RG; Beaty, TH; Belinsky, SA; Brusselle, GG; Crapo, JD; de Jong, K; DeMeo, DL; Fingerlin, TE; Gharib, SA; Gulsvik, A; Hall, IP; Hokanson, JE; Kim, WJ; Lomas, DA; London, SJ; Meyers, DA; O'Connor, GT; Rennard, SI; Schwartz, DA; Sliwinski, P; Sparrow, D; Strachan, DP; Tal-Singer, R; Tesfaigzi, Y; Vestbo, J; Vonk, JM; Yim, JJ; Zhou, XB; Bosse, Y; Manichaikul, A; Lahousse, L; Silverman, EK; Boezen, HM; Wain, LV; Tobin, MD; Hobbs, BD; Cho, MH; Batini, C; Zhao, JH; Wielscher, M; Weiss, S; Kentistou, KA; Cook, JP; Hui, JN; Karrasch, S; Imboden, M; Harris, SE; Marten, J; Enroth, S; Kerr, SM; Surakka, I; Vitart, V; Lehtimaki, T; Ewert, R; Gieger, C; Homuth, G; Joshi, PK; Langenberg, C; Lind, L; Luan, JN; Mahajan, A; Murray, A; Porteous, DJ; Rawal, R; Smith, BH; Timmers, PRHJ; Raitakari, OT; Kahonen, M; Polasek, O; Gyllensten, U; Rudan, I; Deary, IJ; Probst-Hensch, NM; Schulz, H; James, AL; Wilson, JF; Stubbe, B; Zeggini, E; Jarvelin, MR; Wareham, N; Hayward, C; Morris, AP; Agusti, A; Anderson, W; Bakerly, N; Bals, R; Barnes, KC; Bleecker, ER; Bowler, R; Brightling, C; de Bruijne, M; Castaldi, P; Celli, B; Coxson, HO; Crystal, R; de Jong, P; Dirksen, A; Dy, J; Foreman, M; Garcia-Aymerich, J; Gevenois, P; Ghosh, S; Gietema, H; Hansel, N; Hersh, CP; Hoffman, E; Kalsheker, N; Kauczor, HU; Laitinen, T; Lambrechts, D; Litonjua, AA; Loth, DW; Lutz, SM; Lynch, D; MacNee, W; McDonald, ML; Newell, JD; Nordestgaard, BG; Oh, YM; Pare, PD; Pistolesi, M; Postma, DS; Puhan, M; Regan, E; Rich, SS; Seo, JB; Short, A; Stoel, B; Sverzellati, N; ter Riet, G; Van Beek, EJR; Van Ginneken, B; Vogelmeier, CF; Wanner, A; Washko, G; Wauters, E; Wouters, EFM; Young, RP; Zeigler-Heitbrock, L				Sakornsakolpat, Phuwanat; Prokopenko, Dmitry; Lamontagne, Maxime; Reeve, Nicola F.; Guyatt, Anna L.; Jackson, Victoria E.; Shrine, Nick; Qiao, Dandi; Bartz, Traci M.; Kim, Deog Kyeom; Lee, Mi Kyeong; Latourelle, Jeanne C.; Li, Xingnan; Morrow, Jarrett D.; Obeidat, Ma'en; Wyss, Annah B.; Bakke, Per; Barr, R. Graham; Beaty, Terri H.; Belinsky, Steven A.; Brusselle, Guy G.; Crapo, James D.; de Jong, Kim; DeMeo, Dawn L.; Fingerlin, Tasha E.; Gharib, Sina A.; Gulsvik, Amund; Hall, Ian P.; Hokanson, John E.; Kim, Woo Jin; Lomas, David A.; London, Stephanie J.; Meyers, Deborah A.; O'Connor, George T.; Rennard, Stephen, I; Schwartz, David A.; Sliwinski, Pawel; Sparrow, David; Strachan, David P.; Tal-Singer, Ruth; Tesfaigzi, Yohannes; Vestbo, Jorgen; Vonk, Judith M.; Yim, Jae-Joon; Zhou, Xiaobo; Bosse, Yohan; Manichaikul, Ani; Lahousse, Lies; Silverman, Edwin K.; Boezen, H. Marike; Wain, Louise, V; Tobin, Martin D.; Hobbs, Brian D.; Cho, Michael H.; Batini, Chiara; Zhao, Jing Hua; Wielscher, Matthias; Weiss, Stefan; Kentistou, Katherine A.; Cook, James P.; Hui, Jennie; Karrasch, Stefan; Imboden, Medea; Harris, Sarah E.; Marten, Jonathan; Enroth, Stefan; Kerr, Shona M.; Surakka, Ida; Vitart, Veronique; Lehtimaki, Terho; Ewert, Ralf; Gieger, Christian; Homuth, Georg; Joshi, Peter K.; Langenberg, Claudia; Lind, Lars; Luan, Jianan; Mahajan, Anubha; Murray, Alison; Porteous, David J.; Rawal, Rajesh; Smith, Blair H.; Timmers, Paul R. H. J.; Raitakari, Olli T.; Kahonen, Mika; Polasek, Ozren; Gyllensten, Ulf; Rudan, Igor; Deary, Ian J.; Probst-Hensch, Nicole M.; Schulz, Holger; James, Alan L.; Wilson, James F.; Stubbe, Beate; Zeggini, Eleftheria; Jarvelin, Marjo-Riitta; Wareham, Nick; Hayward, Caroline; Morris, Andrew P.; Agusti, Alvar; Anderson, Wayne; Bakerly, Nawar; Bals, Robert; Barnes, Kathleen C.; Bleecker, Eugene R.; Bowler, Russell; Brightling, Christopher; de Bruijne, Marleen; Castaldi, Peterj; Celli, Bartolome; Coxson, Harvey O.; Crystal, Ron; de Jong, Pim; Dirksen, Asger; Dy, Jennifer; Foreman, Marilyn; Garcia-Aymerich, Judith; Gevenois, Pierre; Ghosh, Soumitra; Gietema, Hester; Hansel, Nadia; Hersh, Craig P.; Hoffman, Eric; Kalsheker, Noor; Kauczor, Hans-Ulrich; Laitinen, Tarja; Lambrechts, Diether; Litonjua, Augusto A.; Loth, Daan W.; Lutz, Sharon M.; Lynch, David; MacNee, William; McDonald, Merry-Lynn; Newell, John D.; Nordestgaard, Borge G.; Oh, Yeon-Mok; Pare, Peter D.; Pistolesi, Massimo; Postma, Dirkje S.; Puhan, Milo; Regan, Elizabeth; Rich, Stephen S.; Seo, Joon Beom; Short, Andrea; Stoel, Berend; Sverzellati, Nicola; ter Riet, Gerben; Van Beek, Edwin J. R.; Van Ginneken, Bram; Vogelmeier, Claus F.; Wanner, Adam; Washko, George; Wauters, Els; Wouters, Emiel F. M.; Young, Robert P.; Zeigler-Heitbrock, Loems		SpiroMeta Consortium; Int COPD Genetics Consortium; Understanding Soc Sci Grp	Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ACIDIC-MAMMALIAN-CHITINASE; LD SCORE REGRESSION; LUNG-FUNCTION; EXTRACELLULAR-MATRIX; PREDOMINANT EMPHYSEMA; CONNECTIVITY MAP; ATOPIC ASTHMA; RISK LOCI; GWAS	Chronic obstructive pulmonary disease (COPD) is the leading cause of respiratory mortality worldwide. Genetic risk loci provide new insights into disease pathogenesis. We performed a genome-wide association study in 35,735 cases and 222,076 controls from the UK Biobank and additional studies from the International COPD Genetics Consortium. We identified 82 loci associated with P < 5 x 10(-8); 47 of these were previously described in association with either COPD or population-based measures of lung function. Of the remaining 35 new loci, 13 were associated with lung function in 79,055 individuals from the SpiroMeta consortium. Using gene expression and regulation data, we identified functional enrichment of COPD risk loci in lung tissue, smooth muscle, and several lung cell types. We found 14 COPD loci shared with either asthma or pulmonary fibrosis. COPD genetic risk loci clustered into groups based on associations with quantitative imaging features and comorbidities. Our analyses provide further support for the genetic susceptibility and heterogeneity of COPD.	[Sakornsakolpat, Phuwanat; Prokopenko, Dmitry; Qiao, Dandi; Morrow, Jarrett D.; DeMeo, Dawn L.; Zhou, Xiaobo; Silverman, Edwin K.; Hobbs, Brian D.; Cho, Michael H.; Castaldi, Peterj; Hersh, Craig P.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Sakornsakolpat, Phuwanat] Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok, Thailand; [Prokopenko, Dmitry] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02114 USA; [Lamontagne, Maxime; Bosse, Yohan] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Reeve, Nicola F.; Guyatt, Anna L.; Jackson, Victoria E.; Shrine, Nick; Wain, Louise, V; Tobin, Martin D.; Batini, Chiara] Univ Leicester, Genet Epidemiol Grp, Dept Hlth Sci, Leicester, Leics, England; [Bartz, Traci M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Bartz, Traci M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Bartz, Traci M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kim, Deog Kyeom] Seoul Natl Univ, Coll Med, SMG SNU Boramae Med Ctr, Seoul, South Korea; [Lee, Mi Kyeong; Wyss, Annah B.; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, Dept Hlth & Human Serv, Raleigh, NC USA; [Latourelle, Jeanne C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Li, Xingnan; Meyers, Deborah A.; Bleecker, Eugene R.] Univ Arizona, Dept Med, Tucson, AZ USA; [Obeidat, Ma'en; Pare, Peter D.] Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Vancouver, BC, Canada; [Bakke, Per; Gulsvik, Amund] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Beaty, Terri H.] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Belinsky, Steven A.; Tesfaigzi, Yohannes] Lovelace Resp Res Inst, Albuquerque, NM USA; [Brusselle, Guy G.; Lahousse, Lies; Loth, Daan W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands; [Crapo, James D.; Bowler, Russell] Natl Jewish Hlth, Div Pulm & Crit Care Med, Dept Med, Denver, CO USA; [de Jong, Kim; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [de Jong, Kim; Vonk, Judith M.; Boezen, H. Marike; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Groningen, Netherlands; [DeMeo, Dawn L.; Silverman, Edwin K.; Hobbs, Brian D.; Cho, Michael H.; Celli, Bartolome; Hersh, Craig P.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Fingerlin, Tasha E.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Fingerlin, Tasha E.] Univ Colorado Denver, Dept Biostat & Informat, Aurora, CO USA; [Gharib, Sina A.] Univ Washington, Computat Med Core, Ctr Lung Biol, UW Med Sleep Ctr,Dept Med, Seattle, WA 98195 USA; [Hall, Ian P.] Univ Nottingham, Div Resp Med, Queens Med Ctr, Nottingham, England; [Hall, Ian P.] Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England; [Hokanson, John E.] Univ Colorado, Dept Epidemiol, Anschutz Med Campus, Aurora, CO USA; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Environm Hlth Ctr, Chunchon, South Korea; [Lomas, David A.] UCL, UCL Resp, London, England; [O'Connor, George T.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Pulm Ctr, Boston, MA 02118 USA; [Rennard, Stephen, I] Univ Nebraska Med Ctr, Pulm Crit Care Sleep & Allergy Div, Omaha, NE USA; [Rennard, Stephen, I] AstraZeneca, Clin Discovery Unit, Cambridge, England; [Schwartz, David A.; Barnes, Kathleen C.] Univ Colorado Denver, Dept Med, Sch Med, Aurora, CO USA; [Schwartz, David A.] Univ Colorado Denver, Sch Med, Dept Immunol, Aurora, CO USA; [Sliwinski, Pawel] Inst TB & Lung Dis, Dept Resp Med 2, Warsaw, Poland; [Sparrow, David] Boston Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA 02118 USA; [Sparrow, David] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Tal-Singer, Ruth; Ghosh, Soumitra] GlaxoSmithKline R&D, Collegeville, PA USA; [Vestbo, Jorgen] Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea; [Bosse, Yohan] Laval Univ, Dept Mol Med, Quebec City, PQ, Canada; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Manichaikul, Ani] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Lahousse, Lies] Univ Ghent, Dept Bioanal, Ghent, Belgium; [Wain, Louise, V; Tobin, Martin D.; Brightling, Christopher] Glenfield Hosp, Natl Inst Hlth Res, Leicester Resp Biomed Res Ctr, Leicester, Leics, England; [Zhao, Jing Hua] Univ Cambridge, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Wielscher, Matthias; Jarvelin, Marjo-Riitta] Imperial Coll London, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London, England; [Weiss, Stefan; Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Kentistou, Katherine A.; Joshi, Peter K.; Timmers, Paul R. H. J.; Polasek, Ozren; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Kentistou, Katherine A.] Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Cook, James P.; Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Hui, Jennie; James, Alan L.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Inst, Nedlands, WA, Australia; [Hui, Jennie] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Hui, Jennie] Sir Charles Gairdner Hosp, PathWest Lab Med WA, Crawley, WA, Australia; [Hui, Jennie] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Karrasch, Stefan; Schulz, Holger] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Karrasch, Stefan] Ludwig Maximilians Univ Munchen, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Karrasch, Stefan; Schulz, Holger] German Ctr Lung Res DZL, Comprehens Pneumol Ctr Munich, Munich, Germany; [Imboden, Medea; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Imboden, Medea; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Harris, Sarah E.; Porteous, David J.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Ctr Genom & Expt Med, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Marten, Jonathan; Kerr, Shona M.; Vitart, Veronique; Wilson, James F.; Hayward, Caroline] Univ Edinburgh, Med Res Council, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Enroth, Stefan; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Surakka, Ida] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Surakka, Ida] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Fimlab Labs, Fac Med & Life Sci, Tampere, Finland; [Lehtimaki, Terho; Kahonen, Mika] Univ Tampere, Finnish Cardiovasc Res Ctr Tampere, Fac Med & Life Sci, Tampere, Finland; [Ewert, Ralf; Stubbe, Beate] Univ Med Greifswald, Dept Internal Med B Cardiol Intens Care Pulm Med, Greifswald, Germany; [Gieger, Christian; Rawal, Rajesh] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Langenberg, Claudia; Luan, Jianan; Wareham, Nick] Univ Cambridge, Sch Clin Med, Med Res Council, Epidemiol Unit, Cambridge, England; [Lind, Lars] Uppsala Univ, Dept Med Sci, Cardiovasc Epidemiol, Uppsala, Sweden; [Mahajan, Anubha; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Murray, Alison] Univ Aberdeen, Inst Med Sci, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Rawal, Rajesh] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Smith, Blair H.] Univ Dundee, Div Populat Hlth & Genom, Ninewells Hosp & Med Sch, Dundee, Scotland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere Univ Hosp, Tampere, Finland; [Polasek, Ozren] Univ Split, Sch Med, Split, Croatia; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Nedlands, WA, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Zeggini, Eleftheria] Wellcome Sanger Inst, Hinxton, England; [Zeggini, Eleftheria] German Res Ctr Environm Hlth, Inst Translat Genom, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, OYS, Unit Primary Hlth Care, Oulu, Finland; [Jarvelin, Marjo-Riitta] Brunel Univ London, Dept Life Sci, Coll Hlth & Life Sci, Uxbridge, Middx, England; [Agusti, Alvar] Univ Barcelona, IDIBAPS, CIBERES, Resp Inst,Hosp Clin, Barcelona, Spain; [Anderson, Wayne] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Bakerly, Nawar] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Bakerly, Nawar] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Bals, Robert] Saarland Univ, Dept Internal Med Pulmonol Allergol & Crit Care 5, Homburg, Germany; [Brightling, Christopher] Univ Leicester, Dept Resp Med Allergy & Thorac Surg, Glenfield Hosp, Leicester, Leics, England; [de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands; [de Bruijne, Marleen] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [de Bruijne, Marleen] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Coxson, Harvey O.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Crystal, Ron] Weill Cornell Med Coll, Dept Genet Med, New York, NY USA; [Crystal, Ron] Weill Cornell Med Coll, Div Pulm & Crit Care Med, Dept Med, New York, NY USA; [de Jong, Pim] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Dirksen, Asger] Herlev & Gentofte Hosp, Dept Resp Med, Copenhagen, Denmark; [Dy, Jennifer] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Foreman, Marilyn] Morehouse Sch Med, Atlanta, GA 30310 USA; [Garcia-Aymerich, Judith] ISGlobal, Barcelona, Spain; [Garcia-Aymerich, Judith] Univ Pompeu Fabra, Barcelona, Spain; [Garcia-Aymerich, Judith] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Gevenois, Pierre] Univ Libre Bruxelles, Hop Erasme, Dept Radiol, Brussels, Belgium; [Gietema, Hester] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Hansel, Nadia] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Hoffman, Eric; Newell, John D.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Kalsheker, Noor] Univ Nottingham, Sch Life Sci, Nottingham, England; [Kauczor, Hans-Ulrich] Heidelberg Univ, Translat Lung Res Ctr Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Laitinen, Tarja] Turku Univ Hosp, Univ Turku, Dept Pulm Dis & Clin Allergol, Turku, Finland; [Lambrechts, Diether] VIB, Vesalius Res Ctr VRC, Leuven, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Lab Translat Genet, Dept Oncol, Leuven, Belgium; [Oh, Yeon-Mok] Univ Ulsan Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea; [Oh, Yeon-Mok] Univ Ulsan Coll Med, Clin Res Ctr Chron Obstruct Airway Dis, Seoul, South Korea; [Litonjua, Augusto A.] Univ Rochester, Med Ctr, Dept Pediat, Golisano Childrens Hosp Strong,Div Pediat Pulm Me, Rochester, NY 14642 USA; [Lutz, Sharon M.] Harvard Pilgr Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Lutz, Sharon M.] Harvard Med Sch, Boston, MA 02115 USA; [Lynch, David] Natl Jewish Hlth, Dept Radiol, Denver, CO USA; [MacNee, William] Univ Edinburgh, Dept Resp Med, Edinburgh, Midlothian, Scotland; [McDonald, Merry-Lynn] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem & Copenhagen Gen Populat Study, Herlev, Denmark; [Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Pare, Peter D.] Univ British Columbia, St Pauls Hosp, Inst Heart & Lung Hlth, Dept Med, Vancouver, BC, Canada; [Pistolesi, Massimo] Univ Hosp Careggi, Dept Clin & Expt Med, Florence, Italy; [Puhan, Milo] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Regan, Elizabeth] Natl Jewish Hlth, Div Rheumatol, Dept Med, Denver, CO USA; [Seo, Joon Beom] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea; [Seo, Joon Beom] Univ Ulsan, Asan Med Ctr, Res Inst Radiol, Coll Med, Seoul, South Korea; [Short, Andrea] Univ Manchester, Sch Social Sci, Manchester, Lancs, England; [Stoel, Berend] Leiden Univ, Med Ctr, Leiden, Netherlands; [Sverzellati, Nicola] Univ Parma, Dept Med & Surg, Radiol, Parma, Italy; [ter Riet, Gerben] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Van Beek, Edwin J. R.] Univ Edinburgh, Edinburgh Imaging, Edinburgh, Midlothian, Scotland; [Van Ginneken, Bram] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands; [Vogelmeier, Claus F.] Univ Marburg, Pulm Dis, Marburg, Germany; [Wanner, Adam] Univ Miami, Miller Sch Med, Dept Med, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA; [Washko, George] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Wauters, Els] Katholieke Univ Leuven, Lab Pneumol, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [Wouters, Emiel F. M.] Maastricht Univ, Resp Med, Med Ctr, Maastricht, Netherlands; [Young, Robert P.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Young, Robert P.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Zeigler-Heitbrock, Loems] Helmholtz Zentrum Munchen, EvA Study Ctr, Gauting, Germany	Harvard University; Brigham & Women's Hospital; Mahidol University; Harvard University; Massachusetts General Hospital; University of Leicester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seoul National University (SNU); Seoul National University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Boston University; University of Arizona; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Bergen; Columbia University; Columbia University; Johns Hopkins University; Lovelace Respiratory Research Institute; Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; National Jewish Health; University of Groningen; University of Groningen; Harvard University; Brigham & Women's Hospital; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle; University of Nottingham; University of Nottingham; University of Colorado System; University of Colorado Anschutz Medical Campus; Kangwon National University; Kangwon National University; University of London; University College London; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; University of Nebraska System; University of Nebraska Medical Center; AstraZeneca; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; St Georges University London; GlaxoSmithKline; University of Manchester; Seoul National University (SNU); Laval University; University of Virginia; University of Virginia; Ghent University; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Cambridge; Imperial College London; Greifswald Medical School; University of Edinburgh; University of Edinburgh; University of Liverpool; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; Uppsala University; University of Helsinki; Finland National Institute for Health & Welfare; Tampere University; Tampere University; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; University of Aberdeen; University of Munster; University of Dundee; University of Turku; University of Turku; Tampere University; Tampere University Hospital; University of Split; University of Edinburgh; University of Western Australia; University of Western Australia; Wellcome Trust Sanger Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oulu; University of Oulu; University of Oulu; Brunel University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of North Carolina; University of North Carolina Chapel Hill; Salford Royal NHS Foundation Trust; University of Manchester; Universitatsklinikum des Saarlandes; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen; University of British Columbia; Cornell University; Cornell University; Utrecht University; Utrecht University Medical Center; Northeastern University; Morehouse School of Medicine; ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Maastricht University; Johns Hopkins University; University of Iowa; University of Nottingham; Ruprecht Karls University Heidelberg; University of Turku; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Ulsan; University of Ulsan; University of Rochester; Harvard University; Harvard Medical School; National Jewish Health; University of Edinburgh; University of Alabama System; University of Alabama Birmingham; University of Copenhagen; University of Copenhagen; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Zurich; National Jewish Health; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Manchester; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Parma; University of Amsterdam; Academic Medical Center Amsterdam; University of Edinburgh; Radboud University Nijmegen; Philipps University Marburg; University of Miami; Harvard University; Brigham & Women's Hospital; KU Leuven; Maastricht University; University of Auckland; University of Auckland; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Cho, MH (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Cho, MH (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	remhc@channing.harvard.edu	Puhan, Milo/ABE-6298-2020; Polasek, Ozren/B-6002-2011; Vestbo, Jorgen/Y-2912-2019; Sverzellati, Nicola/AIC-5706-2022; Wouters, Emiel/ABD-6200-2021; Timmers, Paul/U-9612-2019; Jackson, Victoria/L-5782-2019; Wielscher, Matthias/GLS-8316-2022; Qiao, Dandi/AAF-2124-2020; J, Garcia-Aymerich/G-6867-2014; Raitakari, Olli/AAQ-7389-2021; Enroth, Stefan/C-7396-2009; Kim, Woo Jin/A-8216-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Hui, Jennie/A-9543-2013; Karrasch, Stefan/GQI-2691-2022; Wilson, James F/A-5704-2009; Lee, Mi Kyeong/C-3046-2017; Porteous, David/AAA-3446-2021; Kauczor, HU/AAX-6033-2021; de Bruijne, Marleen/G-2662-2010; Lahousse, Lies/O-9426-2019; Lehtimäki, Terho/AAD-1094-2022; Lambrechts, Diether/AAJ-3167-2020; Riet, Gerben ter/A-6943-2011; Seo, Joon Beom/AAQ-5445-2021; Smith, Blair H/G-2834-2012; Tal-Singer, Ruth/AAQ-2925-2021; van Ginneken, Bram/A-3728-2012; Rudan, Igor/I-1467-2012; Kauczor, Hans-Ulrich/AAU-5955-2021; London, Stephanie/C-3734-2019	Puhan, Milo/0000-0003-4721-1879; Polasek, Ozren/0000-0002-5765-1862; Timmers, Paul/0000-0002-5197-1267; Jackson, Victoria/0000-0002-9758-9784; Wielscher, Matthias/0000-0003-4138-1383; J, Garcia-Aymerich/0000-0002-7097-4586; Enroth, Stefan/0000-0002-5056-9137; Kim, Woo Jin/0000-0003-2927-370X; Hui, Jennie/0000-0002-1653-2496; Wilson, James F/0000-0001-5751-9178; Lee, Mi Kyeong/0000-0002-3036-3684; Porteous, David/0000-0003-1249-6106; de Bruijne, Marleen/0000-0002-6328-902X; Lahousse, Lies/0000-0002-3494-4363; Lehtimäki, Terho/0000-0002-2555-4427; Lambrechts, Diether/0000-0002-3429-302X; Riet, Gerben ter/0000-0002-2231-7637; Seo, Joon Beom/0000-0003-0271-7884; Smith, Blair H/0000-0002-5362-9430; Tal-Singer, Ruth/0000-0002-5275-8062; van Ginneken, Bram/0000-0003-2028-8972; Rudan, Igor/0000-0001-6993-6884; Brusselle, Guy/0000-0001-7021-8505; Wauters, Els/0000-0002-0115-0030; Yim, Jae-Joon/0000-0002-9605-0074; Morrow, Jarrett/0000-0002-5670-5865; Vestbo, Jorgen/0000-0001-6355-6362; brightling, chris/0000-0002-9345-4903; Rich, Stephen/0000-0003-3872-7793; Tobin, Martin/0000-0002-3596-7874; Sakornsakolpat, Phuwanat/0000-0002-4308-0974; Wain, Louise/0000-0003-4951-1867; Hoffman, Eric/0000-0001-8456-9437; Kentistou, Katherine/0000-0002-5816-664X; Joshi, Peter/0000-0002-6361-5059; GHARIB, SINA A./0000-0002-2480-4367; Nordestgaard, Borge/0000-0002-1954-7220; Guyatt, Anna/0000-0003-1860-6337; Loth, Daan/0000-0003-1260-9326; London, Stephanie/0000-0003-4911-5290; Tesfaigzi, Yohannes/0000-0002-3997-5839; Diar Bakerly, Nawar/0000-0003-2102-1997; Hobbs, Brian/0000-0001-9564-0745; Reeve, Nicola F/0000-0001-9602-6675; Prokopenko, Dmitry/0000-0002-1844-5652; Kahonen, Mika/0000-0002-4510-7341	Prince Mahidol Award Youth Program Scholarship; NHLBI [R01HL084323, R01HL113264, R01HL089856, P01HL105339]; Parker B. Francis Research Opportunity Award [R01HL113264, P01HL105339, R01HL137927, P01HL132825];  [K08HL136928]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135142, R33HL120770, P01HL132825, R01HL137927, R01HL097163, U01HL089856, R01HL113264, K08HL136928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012] Funding Source: NIH RePORTER; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MR/S003762/1, G1000861, MR/N024842/1, MC_PC_12010, MC_UU_00007/10, 1805084, 1805065, MR/N011317/1, G0700704] Funding Source: UKRI	Prince Mahidol Award Youth Program Scholarship; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Research Opportunity Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Prince Mahidol Award Youth Program Scholarship (P. Sakornsakolpat); NHLBI R01HL084323, R01HL113264, R01HL089856, and P01HL105339 (E.K.S.); K08HL136928 (B.D.H.), the Parker B. Francis Research Opportunity Award (B.D.H.); and R01HL113264, R01HL137927, P01HL105339, and P01HL132825 (M.H.C.). This research was conducted by using the UK Biobank resource under application numbers 20915 (M.H.C.) and 648 (M.D.T.). Please refer to the Supplementary Note for full acknowledgements. Funding bodies had no role in the design of the study, the collection, analysis, or interpretation of the data, or the writing of the manuscript.	Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Aminuddin F, 2012, HUM GENET, V131, P1105, DOI 10.1007/s00439-011-1127-1; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Ardini-Poleske ME, 2017, AM J PHYSIOL-LUNG C, V313, pL733, DOI 10.1152/ajplung.00139.2017; Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P52, DOI 10.1016/j.mrfmmm.2011.10.013; Artigas MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9658; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Birben E, 2011, RESP MED, V105, P1160, DOI 10.1016/j.rmed.2011.03.017; Bonas-Guarch S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02380-9; Boschetto P, 2003, EUR RESPIR J, V21, P450, DOI 10.1183/09031936.03.00048703; Boucherat O, 2016, AM J RESP CRIT CARE, V193, P362, DOI 10.1164/rccm.201508-1518PP; Boutten A, 2004, THORAX, V59, P850, DOI 10.1136/thx.2004.025247; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Castaldi PJ, 2014, THORAX, V69, P415, DOI 10.1136/thoraxjnl-2013-203601; Cerveri I, 2013, COPD, V10, P55, DOI 10.3109/15412555.2012.727920; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee R, 2008, J ALLERGY CLIN IMMUN, V122, P202, DOI 10.1016/j.jaci.2008.04.030; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Cho MH, 2015, AM J RESP CRIT CARE, V192, P559, DOI 10.1164/rccm.201501-0148OC; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Claussnitzer M, 2016, NEW ENGL J MED, V374, P192, DOI 10.1056/NEJMc1513316; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Crystal RG, 2014, AM J RESP CRIT CARE, V190, P1355, DOI 10.1164/rccm.201408-1492PP; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fingerlin TE, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0377-2; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Foreman MG, 2017, ANN AM THORAC SOC, V14, P1280, DOI 10.1513/AnnalsATS.201611-838OC; Franks Teri J, 2008, Proc Am Thorac Soc, V5, P763, DOI 10.1513/pats.200803-025HR; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gabriel LAR, 2012, INVEST OPHTH VIS SCI, V53, P461, DOI 10.1167/iovs.10-5955; Ghosh M, 2018, AM J RESP CRIT CARE, V197, P885, DOI 10.1164/rccm.201704-0667OC; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Heinzmann A, 2010, PEDIAT ALLERG IMM-UK, V21, pE679, DOI 10.1111/j.1399-3038.2010.01053.x; Hersh CP, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-164; Higami Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148794; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Hobbs BD, 2016, AM J RESP CRIT CARE, V194, P48, DOI 10.1164/rccm.201510-2053OC; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Jackson V. E., 2018, Wellcome Open Research, V3, P4, DOI 10.12688/wellcomeopenres.12583.3; Jacob A, 2017, CELL STEM CELL, V21, P472, DOI 10.1016/j.stem.2017.08.014; Jiang ZQ, 2016, AM J RESP CRIT CARE, V194, P185, DOI 10.1164/rccm.201505-0999OC; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kulkarni T, 2016, AM J RESP CELL MOL, V54, P751, DOI 10.1165/rcmb.2015-0166PS; Kutz WE, 2011, J BIOL CHEM, V286, P17156, DOI 10.1074/jbc.M111.231571; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lamontagne M, 2018, HUM MOL GENET, V27, P1819, DOI 10.1093/hmg/ddy091; Lao TT, 2016, P NATL ACAD SCI USA, V113, pE4681, DOI 10.1073/pnas.1602342113; Lencz T, 2015, MOL PSYCHIATR, V20, P820, DOI 10.1038/mp.2015.28; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Lu QS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006933; Lutz SM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0299-4; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Markovics JA, 2011, J BIOL CHEM, V286, P36864, DOI 10.1074/jbc.M111.276790; Martin JS, 2017, BIOINFORMATICS, V33, P3793, DOI 10.1093/bioinformatics/btx359; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Mellett M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2127; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Morrow JD, 2018, AM J RESP CRIT CARE, V197, P1275, DOI 10.1164/rccm.201707-1434OC; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ober C, 2009, CURR OPIN ALLERGY CL, V9, P401, DOI 10.1097/ACI.0b013e3283306533; Okawa K, 2016, MOL BIOL EVOL, V33, P3183, DOI 10.1093/molbev/msw198; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qiao DD, 2018, HUM MOL GENET, V27, P3801, DOI 10.1093/hmg/ddy269; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Ross JC, 2018, AM J RESP CRIT CARE, V198, P1033, DOI 10.1164/rccm.201707-1405OC; Saito A, 1999, GENE, V239, P325, DOI 10.1016/S0378-1119(99)00394-7; Sakornsakolpat P, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0744-9; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Shooshtari P, 2017, AM J HUM GENET, V101, P75, DOI 10.1016/j.ajhg.2017.06.001; Shrine N., 2018, NEW GENETIC SIGNALS; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Skronska-Wasek W, 2017, AM J RESP CRIT CARE, V196, P172, DOI 10.1164/rccm.201605-0904OC; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tinkelman DG, 2006, J ASTHMA, V43, P75, DOI 10.1080/02770900500448738; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; World Health Organization, 2020, GLOB HLTH EST 2019 D; Wyss AB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05369-0; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zeltz C, 2016, J CELL SCI, V129, P1284, DOI 10.1242/jcs.188672; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou JJ, 2013, AM J RESP CRIT CARE, V188, P941, DOI 10.1164/rccm.201302-0263OC; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	125	135	141	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2019	51	3					494	+		10.1038/s41588-018-0342-2	http://dx.doi.org/10.1038/s41588-018-0342-2			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN1KZ	30804561	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000459947200017
J	Wallace, DC				Wallace, Douglas C.			Mitochondrial genetic medicine	NATURE GENETICS			English	Article							CYTOCHROME-B GENE; DNA DELETION LEVELS; ALZHEIMER-DISEASE; EXERCISE INTOLERANCE; PRONUCLEAR TRANSFER; PARKINSONS-DISEASE; RAPID SEGREGATION; INCREASED RISK; ATP SYNTHASE; MUTATION	Inherited mitochondrial DNA (mtDNA) diseases were discovered 30 years ago, and their characterization has provided a new perspective on the etiology of the common metabolic and degenerative diseases, cancer, and aging. The maternally inherited mtDNA contains 37 critical bioenergetic genes that are present in hundreds of copies per cell, but the 'mitochondrial genome' encompasses an additional 1,000-2,000 nuclear DNA (nDNA) mitochondrial genes. The interaction between these two mitochondrial genetic systems provides explanations for phenomena such as the non-Mendelian transmission of the common 'complex' diseases, age-related disease risk and progression, variable penetrance and expressivity, and gene-environment interactions. Thus, mtDNA genetics contributes to the quantitative and environmental components of human genetics that cannot be explained by Mendelian genetics. Because mtDNA is maternally inherited and cytoplasmic, it has fostered the first germline gene therapy, nuclear transplantation. However, effective interventions are still lacking for existing patients with mitochondrial dysfunction.	[Wallace, Douglas C.] Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Wallace, Douglas C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Wallace, DC (corresponding author), Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA.; Wallace, DC (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	wallaced1@email.chop.edu			NIH [5R01-NS021328-30, 1R01MH108592-01A1, 1R01MN110185-01A1, R01OD010944-05]; DOD [W81XWH-16-1-0401]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense)	This work was supported by NIH grants 5R01-NS021328-30, 1R01MH108592-01A1, 1R01MN110185-01A1, R01OD010944-05, and DOD W81XWH-16-1-0401 awarded to D.C.W.	Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008; Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chalkia D, 2018, BBA-BIOENERGETICS, V1859, P878, DOI 10.1016/j.bbabio.2018.07.002; Chalkia D, 2017, JAMA PSYCHIAT, V74, P1161, DOI 10.1001/jamapsychiatry.2017.2604; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787; Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L; Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Gomez R, 2009, J TRAUMA, V66, P850, DOI 10.1097/TA.0b013e3181991ac8; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HORTON TM, 1995, NEUROLOGY, V45, P1879, DOI 10.1212/WNL.45.10.1879; Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature183030, 10.1038/nature18303]; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; Jokinen R, 2013, ANN MED, V45, P149, DOI 10.3109/07853890.2012.693190; Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592; Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005; Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Ma H, 2017, CELL STEM CELL, V20, P112, DOI 10.1016/j.stem.2016.10.001; Mancuso M, 2003, J NEUROL SCI, V209, P61, DOI 10.1016/S0022-510X(02)00462-8; Nadeau-Vallee M, 2016, CYTOKINE GROWTH F R, V28, P37, DOI 10.1016/j.cytogfr.2015.11.001; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; Nishigaki Y, 2007, HUM GENET, V120, P827, DOI 10.1007/s00439-006-0269-z; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389; Pham TD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35907; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; Pyle A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005040; Ravi S, 2014, INT J BIOCHEM CELL B, V53, P202, DOI 10.1016/j.biocel.2014.05.019; Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111; Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Slone J., 2017, J MOL GENET MED, V11; SOONG NW, 1992, NAT GENET, V2, P318; Sorrentino V, 2018, ANNU REV PHARMACOL, V58, P353, DOI 10.1146/annurev-pharmtox-010716-104908; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wallace D. C., 2018, PRINCIPLES PRACTICE; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2013, EMERY RIMOINS PRINCI, P1; Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902; Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang YQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006391; Wilson IJ, 2016, HUM MOL GENET, V25, P1031, DOI 10.1093/hmg/ddv626; Wolf DP, 2017, EMBO J, V36, P2177, DOI 10.15252/embj.201797606; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108; Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zheng SZ, 2012, FREE RADICAL BIO MED, V53, P473, DOI 10.1016/j.freeradbiomed.2012.05.019	113	135	140	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1642	1649		10.1038/s41588-018-0264-z	http://dx.doi.org/10.1038/s41588-018-0264-z			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30374071				2022-12-17	WOS:000451434400010
J	Shao, CW; Bao, BL; Xie, ZY; Chen, XY; Li, B; Jia, XD; Yao, QL; Orti, G; Li, WH; Li, XH; Hamre, K; Xu, J; Wang, L; Chen, FY; Tian, YS; Schreiber, AM; Wang, N; Wei, F; Zhang, JL; Dong, ZD; Gao, L; Gai, JW; Sakamoto, T; Mo, SD; Chen, WJ; Shi, Q; Li, H; Xiu, YJ; Li, YZ; Xu, WT; Shi, ZY; Zhang, GJ; Power, DM; Wang, QY; Schartl, M; Chen, SL				Shao, Changwei; Bao, Baolong; Xie, Zhiyuan; Chen, Xinye; Li, Bo; Jia, Xiaodong; Yao, Qiulin; Orti, Guillermo; Li, Wenhui; Li, Xihong; Hamre, Kristin; Xu, Juan; Wang, Lei; Chen, Fangyuan; Tian, Yongsheng; Schreiber, Alex M.; Wang, Na; Wei, Fen; Zhang, Jilin; Dong, Zhongdian; Gao, Lei; Gai, Junwei; Sakamoto, Takashi; Mo, Sudong; Chen, Wenjun; Shi, Qiong; Li, Hui; Xiu, Yunji; Li, Yangzhen; Xu, Wenteng; Shi, Zhiyi; Zhang, Guojie; Power, Deborah M.; Wang, Qingyin; Schartl, Manfred; Chen, Songlin			The genome and transcriptome of Japanese flounder provide insights into flatfish asymmetry	NATURE GENETICS			English	Article							HIPPOGLOSSUS L. LARVAE; THYROID-HORMONE; RETINOIC ACID; METAMORPHOSIS; PIGMENTATION; RECEPTOR; EVOLUTION; PRODUCT; GENES	Flatfish have the most extreme asymmetric body morphology of vertebrates. During metamorphosis, one eye migrates to the contralateral side of the skull, and this migration is accompanied by extensive craniofacial transformations and simultaneous development of lopsided body pigmentation(1-5). The evolution of this developmental and physiological innovation remains enigmatic. Comparative genomics of two flatfish and transcriptomic analyses during metamorphosis point to a role for thyroid hormone and retinoic acid signaling, as well as phototransduction pathways. We demonstrate that retinoic acid is critical in establishing asymmetric pigmentation and, via cross-talk with thyroid hormones, in modulating eye migration. The unexpected expression of the visual opsins from the phototransduction pathway in the skin translates illumination differences and generates retinoic acid gradients that underlie the generation of asymmetry. Identifying the genetic underpinning of this unique developmental process answers long-standing questions about the evolutionary origin of asymmetry, but it also provides insight into the mechanisms that control body shape in vertebrates.	[Shao, Changwei; Jia, Xiaodong; Li, Xihong; Wang, Lei; Tian, Yongsheng; Wang, Na; Dong, Zhongdian; Mo, Sudong; Xiu, Yunji; Li, Yangzhen; Xu, Wenteng; Wang, Qingyin; Chen, Songlin] Yellow Sea Fisheries Res Inst, CAFS, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao, Peoples R China; [Shao, Changwei; Jia, Xiaodong; Li, Xihong; Wang, Lei; Tian, Yongsheng; Wang, Na; Dong, Zhongdian; Mo, Sudong; Xiu, Yunji; Li, Yangzhen; Xu, Wenteng; Wang, Qingyin; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Bao, Baolong; Chen, Xinye; Xu, Juan; Wei, Fen; Gao, Lei; Gai, Junwei; Chen, Wenjun; Li, Hui; Shi, Zhiyi] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Xie, Zhiyuan; Li, Bo; Yao, Qiulin; Li, Wenhui; Chen, Fangyuan; Zhang, Jilin; Shi, Qiong; Zhang, Guojie] BGI Shenzhen, Shenzhen, Peoples R China; [Orti, Guillermo] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Hamre, Kristin] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Hamre, Kristin] Univ Bergen, Dept Biol, Bergen, Norway; [Schreiber, Alex M.] St Lawrence Univ, Dept Biol, Canton, NY 13617 USA; [Sakamoto, Takashi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Power, Deborah M.] Univ Algarve, Ctr Ciencias Mar CCMAR, Comparat Endocrinol & Integrat Biol, Faro, Portugal; [Power, Deborah M.] Shanghai Ocean Univ, Minist Educ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Schartl, Manfred] Univ Wurzburg, Physiol Chem, Biozentrum, Wurzburg, Germany; [Schartl, Manfred] Univ Clin Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Schartl, Manfred] Texas A&M Univ, Inst Adv Studies, College Stn, TX USA	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Beijing Genomics Institute (BGI); George Washington University; University of Bergen; Saint Lawrence University; Tokyo University of Marine Science & Technology; Universidade do Algarve; Shanghai Ocean University; University of Wurzburg; University of Wurzburg; Texas A&M University System; Texas A&M University College Station		dpower@ualg.pt; qywang@public.qd.sd.cn; phch1@biozentrum.uni-wuerzburg.de; chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016; Hamre, Kristin/D-3477-2012; Zhang, Guojie/J-7273-2019; SAKAMOTO, Takashi/O-1949-2014; Power, Deborah M/D-3333-2011; Xu, Wenteng/Q-1552-2018	Shao, Changwei/0000-0002-6953-2203; Hamre, Kristin/0000-0002-8302-3827; Zhang, Guojie/0000-0001-6860-1521; SAKAMOTO, Takashi/0000-0002-8399-851X; Power, Deborah M/0000-0003-1366-0246; Xiu, Yunji/0000-0002-3134-1874; Orti, Guillermo/0000-0002-6886-2323; Zhang, Jilin/0000-0002-9976-1605	National Natural Science Foundation of China [31130057, 31461163005, 31530078, 31472269, 31472262, 31472273]; State 863 High Technology R&D Project of China [2012AA092203, 2012AA10A408, 2012AA10A403-2]; Education and Research of Guangdong Province [2013B090800017]; Taishan Scholar Climb Project Fund of Shandong of China; Taishan Scholar Project Fund of Shandong of China for Young Scientists; Shanghai Universities First-class Disciplines Project of Fisheries; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning; Shanghai Municipal Science, Special Project on the Integration of Industry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Project of China(National High Technology Research and Development Program of China); Education and Research of Guangdong Province; Taishan Scholar Climb Project Fund of Shandong of China; Taishan Scholar Project Fund of Shandong of China for Young Scientists; Shanghai Universities First-class Disciplines Project of Fisheries; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning; Shanghai Municipal Science, Special Project on the Integration of Industry	We sincerely thank Q.S. Tang, F.Z. Zhao, H.R. Lin and J.F. Gui for their support and help with the Japanese flounder genome project. We also thank A.V.M. Canon, J. Rotllant, Y.S. Fu, and J.A. Graves for constructive discussion. We acknowledge financial support from the National Natural Science Foundation of China (grants 31130057, 31461163005, and 31530078 to S.C.; grant 31472269 to C.S.; grant 31472262 to B.B.; and grant 31472273 to NM), the State 863 High Technology R&D Project of China (grants 2012AA092203 and 2012AA10A408 to S.C.; grant 2012AA10A403-2 to C.S.), and the Education and Research of Guangdong Province (grant 2013B090800017 to Q.S.). This research also received funding from the Taishan Scholar Climb Project Fund of Shandong of China (S.C.), the Taishan Scholar Project Fund of Shandong of China for Young Scientists (C.S.), the Shanghai Universities First-class Disciplines Project of Fisheries (B.B.), the Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institutions of Higher Learning (B.B.), and the Shanghai Municipal Science, Special Project on the Integration of Industry (B.B.).	Bao BL, 2011, DEV BIOL, V351, P200, DOI 10.1016/j.ydbio.2010.12.032; Blomhoff R., 1994, Vitamin A in health and disease., P1; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Campinho MA, 2015, MOL CELL ENDOCRINOL, V404, P16, DOI 10.1016/j.mce.2014.12.025; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Davis PJ, 2016, NAT REV ENDOCRINOL, V12, P111, DOI 10.1038/nrendo.2015.205; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Friedman M, 2008, NATURE, V454, P209, DOI 10.1038/nature07108; Hamre K, 2007, AQUACULT NUTR, V13, P65, DOI 10.1111/j.1365-2095.2007.00467.x; Hamre K, 2008, AQUACULTURE, V277, P101, DOI 10.1016/j.aquaculture.2008.02.020; Heimeier RA, 2010, GEN COMP ENDOCR, V168, P181, DOI 10.1016/j.ygcen.2010.02.016; Inoue T, 2010, FEBS LETT, V584, P3233, DOI 10.1016/j.febslet.2010.06.020; INUI Y, 1985, GEN COMP ENDOCR, V60, P450, DOI 10.1016/0016-6480(85)90080-2; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Li LK, 2013, ICHTHYOL RES, V60, P178, DOI 10.1007/s10228-012-0332-9; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Nakamura A, 2007, ACTA TROP, V103, P222, DOI 10.1016/j.actatropica.2007.06.009; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; Power DM, 2008, REV FISH SCI, V16, P95, DOI 10.1080/10641260802325377; Ramirez MD, 2015, J EXP BIOL, V218, P1513, DOI 10.1242/jeb.110908; Schreiber AM, 2013, CURR TOP DEV BIOL, V103, P167, DOI 10.1016/B978-0-12-385979-2.00006-X; Schreiber AM, 2006, J EXP BIOL, V209, P610, DOI 10.1242/jeb.02056; Shao CW, 2015, DNA RES, V22, P161, DOI 10.1093/dnares/dsv001; Silver DL, 2006, ADV EXP MED BIOL, V589, P155; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0	30	135	169	8	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					119	124		10.1038/ng.3732	http://dx.doi.org/10.1038/ng.3732			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27918537	Green Submitted, hybrid, Green Published			2022-12-17	WOS:000390976600017
J	Heap, GA; Weedon, MN; Bewshea, CM; Singh, A; Chen, M; Satchwel, JB; Vivian, JP; So, K; Dubois, PC; Andrews, JM; Annese, V; Bampton, P; Barnardo, M; Bell, S; Cole, A; Connor, SJ; Creed, T; Cummings, FR; D'Amato, M; Daneshmend, TK; Fedorak, RN; Florin, TH; Gaya, DR; Greig, E; Halfvarson, J; Hart, A; Irving, PM; Jones, G; Karban, A; Lawrance, IC; Lee, JC; Lees, C; Lev-Tzion, R; Lindsay, J; Mansfield, J; Mawdsley, J; Mazhar, Z; Parkes, M; Parnell, K; Orchard, TR; Radford-Smith, G; Russell, RK; Reffitt, D; Satsangi, J; Silverberg, MS; Sturniolo, GC; Tremelling, M; Tsianos, EV; van Heel, DA; Walsh, A; Watermeyer, G; Weersma, RK; Zeissig, S; Rossjohn, J; Holden, AL; Ahmad, T				Heap, Graham A.; Weedon, Michael N.; Bewshea, Claire M.; Singh, Abhey; Chen, Mian; Satchwel, Jack B.; Vivian, Julian P.; So, Kenji; Dubois, Patrick C.; Andrews, Jane M.; Annese, Vito; Bampton, Peter; Barnardo, Martin; Bell, Sally; Cole, Andy; Connor, Susan J.; Creed, Tom; Cummings, Fraser R.; D'Amato, Mauro; Daneshmend, Tawfique K.; Fedorak, Richard N.; Florin, Timothy H.; Gaya, Daniel R.; Greig, Emma; Halfvarson, Jonas; Hart, Alisa; Irving, Peter M.; Jones, Gareth; Karban, Amir; Lawrance, Ian C.; Lee, James C.; Lees, Charlie; Lev-Tzion, Raffi; Lindsay, James; Mansfield, John; Mawdsley, Joel; Mazhar, Zia; Parkes, Miles; Parnell, Kirstie; Orchard, Timothy R.; Radford-Smith, Graham; Russell, Richard K.; Reffitt, David; Satsangi, Jack; Silverberg, Mark S.; Sturniolo, Giacomo C.; Tremelling, Mark; Tsianos, Epameinondas V.; van Heel, David A.; Walsh, Alissa; Watermeyer, Gill; Weersma, Rinse K.; Zeissig, Sebastian; Rossjohn, Jamie; Holden, Arthur L.; Ahmad, Tariq		Int Serious Adverse Events Consort; IBD Pharmacogenetics Study Grp	HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants	NATURE GENETICS			English	Article							THERAPY; AZATHIOPRINE; COMPLICATION; GENOTYPE; DISEASE	Pancreatitis occurs in approximately 4% of patients treated with the thiopurines azathioprine or mercaptopurine. Its development is unpredictable and almost always leads to drug withdrawal. We identified patients with inflammatory bowel disease (IBD) who had developed pancreatitis within 3 months of starting these drugs from 168 sites around the world. After detailed case adjudication, we performed a genome-wide association study on 172 cases and 2,035 controls with IBD. We identified strong evidence of association within the class II HLA region, with the most significant association identified at rs2647087 (odds ratio 2.59, 95% confidence interval 2.07-3.26, P = 2 x 10(-16)). We replicated these findings in an independent set of 78 cases and 472 controls with IBD matched for drug exposure. Fine mapping of the H LA region identified association with the HLA-DQA1*02:01-HLA-DRB1*07:01 haplotype. Patients heterozygous at rs2647087 have a 9% risk of developing pancreatitis after administration of a thiopurine, whereas homozygotes have a 17% risk.	[Heap, Graham A.; Bewshea, Claire M.; Singh, Abhey; So, Kenji; Daneshmend, Tawfique K.; Ahmad, Tariq] Royal Devon & Exeter Hosp, IBD Pharmacogenet, Exeter EX2 5DW, Devon, England; [Heap, Graham A.; Weedon, Michael N.; Bewshea, Claire M.; Parnell, Kirstie; Ahmad, Tariq] Univ Exeter, Precis Med Exeter, Exeter, Devon, England; [Chen, Mian; Satchwel, Jack B.; Barnardo, Martin] Oxford Univ Hosp Natl Hlth Serv NHS Trust, Oxford Transplant Ctr, Oxford, England; [Vivian, Julian P.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Dubois, Patrick C.] Kings Coll Hosp London, Dept Gastroenterol, London, England; [Andrews, Jane M.] IBD Serv, Dept Gastroenterol, Adelaide, SA, Australia; [Andrews, Jane M.] Univ Adelaide, Royal Adelaide Hosp, Adelaide, SA, Australia; [Annese, Vito] Univ Careggi, Azienda Osped, Div Gastroenterol, Florence, Italy; [Bampton, Peter] Flinders Univ South Australia, Flinders Med Ctr, Adelaide, SA, Australia; [Bell, Sally] St Vincent Hosp, Dept Gastroenterol, Fitzroy, Vic, Australia; [Cole, Andy] Royal Derby Hosp, Derby, England; [Connor, Susan J.] Liverpool Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia; [Creed, Tom] Univ Hosp Bristol NHS Fdn Trust, Joint Clin Res Unit, Bristol, Avon, England; [Cummings, Fraser R.] Univ Hosp Southampton NHS Fdn Trust, Dept Gastroenterol, Southampton, Hants, England; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Fedorak, Richard N.] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada; [Florin, Timothy H.] Univ Queensland, Sch Med, South Brisbane, Qld, Australia; [Gaya, Daniel R.] Glasgow Royal Infirm, Gastroenterol Unit, Glasgow G4 0SF, Lanark, Scotland; [Greig, Emma] Taunton & Somerset NHS Fdn Trust, Dept Gastroenterol, Taunton, Somerset, England; [Halfvarson, Jonas] Orebro Univ Hosp, Div Gastroenterol, Orebro, Sweden; [Halfvarson, Jonas] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Hart, Alisa] St Marks Hosp, Dept Med, London EC1V 2PS, England; [Hart, Alisa] North West London Hosp NHS Trust, Acad Inst, London, England; [Irving, Peter M.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England; [Jones, Gareth; Lees, Charlie; Satsangi, Jack] Western Gen Hosp, Dept Gastroenterol, Edinburgh EH4 2XU, Midlothian, Scotland; [Karban, Amir] Rambam Med Ctr, Dept Gastroenterol, Haifa, Israel; [Lawrance, Ian C.] Univ Western Australia, Fremantle Hosp, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia; [Lee, James C.; Parkes, Miles] Cambridge Univ Hosp NHS Trust, Dept Gastroenterol, Cambridge, England; [Lev-Tzion, Raffi] Shaare Zedek Med Ctr, Paediatr Gastroenterol & Nutr Unit, Jerusalem, Israel; [Lindsay, James] Barts & London NHS Trust, Dept Gastroenterol, London, England; [Mansfield, John] Newcastle Univ Hosp NHS Trust, Dept Gastroenterol, Newcastle Upon Tyne, Tyne & Wear, England; [Mawdsley, Joel] West Middlesex Univ Hosp NHS Trust, Dept Gastroenterol, Isleworth, England; [Mazhar, Zia] Basildon & Thurrock Hosp NHS Trust, Dept Gastroenterol, Basildon, Essex, England; [Orchard, Timothy R.] Imperial Coll Healthcare NHS, Dept Med, London, England; [Radford-Smith, Graham] Royal Brisbane & Womens Hosp, Dept Gastroenterol, Brisbane, Qld, Australia; [Radford-Smith, Graham] IBD Grp, Queensland Inst Med Res, Brisbane, Qld, Australia; [Radford-Smith, Graham] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Russell, Richard K.] Yorkhill Hosp, Dept Paediat Gastroenterol, Glasgow, Lanark, Scotland; [Reffitt, David] Lewisham & Greenwich NHS Trust, Dept Gastroenterol, London, England; [Silverberg, Mark S.] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Inflammatory Bowel Dis Grp, Toronto, ON M5G 1X5, Canada; [Sturniolo, Giacomo C.] Univ Padua, Padua, Italy; [Tremelling, Mark] Norfolk & Norwich Hosp NHS Trust, Dept Gastroenterol, Norwich, Norfolk, England; [Tsianos, Epameinondas V.] Univ Ioannina, Fac Med, Div Internal Med 1, GR-45110 Ioannina, Greece; [Tsianos, Epameinondas V.] Univ Ioannina, Fac Med, Div Gastroenterol, GR-45110 Ioannina, Greece; [van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Walsh, Alissa] St Vincents Hosp, Dept Gastroenterol, Sydney, NSW 2010, Australia; [Watermeyer, Gill] Groote Schuur Hosp, Gastrointestinal Clin, ZA-7925 Cape Town, South Africa; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Zeissig, Sebastian] Univ Med Ctr Schleswig Holstein, Dept Internal Med, Kiel, Germany; [Holden, Arthur L.] Int Serious Adverse Events Consortium, Chicago, IL USA	University of Exeter; University of Exeter; Oxford University Hospitals NHS Foundation Trust; Monash University; King's College Hospital NHS Foundation Trust; King's College Hospital; Royal Adelaide Hospital; University of Adelaide; University of Florence; Azienda Ospedaliero Universitaria Careggi; Flinders Medical Centre; Flinders University South Australia; St Vincent's Hospital Melbourne; University of Nottingham; Liverpool Hospital; University of Bristol; University of Southampton; University Hospital Southampton NHS Foundation Trust; Karolinska Institutet; University of Alberta; University of Queensland; University of Glasgow; Orebro University; Orebro University; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of Edinburgh; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Western Australia; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Barts Health NHS Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; University of Queensland; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Padua; University of Ioannina; University of Ioannina; University of London; Queen Mary University London; St Vincents Hospital Sydney; University of Cape Town; University of Groningen; University of Kiel; Schleswig Holstein University Hospital	Heap, GA (corresponding author), Royal Devon & Exeter Hosp, IBD Pharmacogenet, Exeter EX2 5DW, Devon, England.	grahamheap@nhs.net; tariq.ahmad1@nhs.net	Annese, Vito/AGW-4200-2022; Lawrance, Ian C/H-5252-2014; D'Amato, Mauro/F-2450-2010; Lee, James/ABD-5920-2020; Silverberg, Mark/B-4183-2008; Halfvarson, Jonas/AAU-4687-2020; Irving, Peter/AAP-4543-2020; Weersma, Rinse/ABE-3807-2021; Zeissig, Sebastian/B-6297-2012; Rossjohn, Jamie/F-9032-2013; Radford-Smith, Graham L/G-5749-2017; D'Amato, Mauro/B-5050-2019; Radford-Smith, Graham/H-2792-2013	Annese, Vito/0000-0002-0082-892X; D'Amato, Mauro/0000-0003-2743-5197; Lee, James/0000-0001-5711-9385; Zeissig, Sebastian/0000-0001-5124-0897; Rossjohn, Jamie/0000-0002-2020-7522; Radford-Smith, Graham L/0000-0002-2047-6239; D'Amato, Mauro/0000-0003-2743-5197; Radford-Smith, Graham/0000-0002-2047-6239; Halfvarson, Jonas/0000-0003-0122-7234; Vivian, Julian/0000-0002-9400-4437; Parkes, Miles/0000-0002-6467-0631; van Heel, David/0000-0002-0637-2265; Chen, Mian/0000-0003-2342-4861; Simmons, Alison/0000-0003-3454-0710; Jones, Gareth-Rhys/0000-0001-7355-2357; Bell, Sally/0000-0002-7002-453X; Fedorak, Richard/0000-0002-7382-0080; Connor, Susan/0000-0001-5606-0270; Cummings, Fraser/0000-0002-9659-3247; Heap, Graham/0000-0003-4131-6792; Bewshea, Claire/0000-0002-0965-9587; Weedon, Michael/0000-0002-6174-6135; Irving, Peter/0000-0003-0972-8148	International Serious Adverse Events Consortium (iSAEC); Crohn's and Colitis UK; Wellcome Trust Institutional Strategic Support Award [WT097835MF]; MRC [G0700545, G0600329, G0800675, MC_UU_12010/7] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL9-Lee] Funding Source: researchfish; Medical Research Council [G0800675, G0700545, G0600329, MC_UU_12010/7] Funding Source: researchfish; National Institute for Health Research [ACF-2014-23-002, NIHR-RP-R3-12-026] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-2, M14-1] Funding Source: researchfish; Chief Scientist Office [ETM/75, ETM/137, CZB/4/540] Funding Source: researchfish	International Serious Adverse Events Consortium (iSAEC); Crohn's and Colitis UK; Wellcome Trust Institutional Strategic Support Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Crohn&quot;s and Colitis UK; Chief Scientist Office	The International Serious Adverse Events Consortium (iSAEC) funded the sample collection and genotyping. The UK National Institute for Health Research (NIHR) provided research nurse support to facilitate recruitment at all UK research sites. We thank Crohn's and Colitis UK for funding support and publicizing this study to its members. A Wellcome Trust Institutional Strategic Support Award (WT097835MF) generously supported the work in this study. Genotyping was undertaken at the Broad Institute, Cambridge, Massachusetts, USA. We thank all the clinicians who assisted with sample collection as part of the IBD Pharmacogenetics Study Group (listed in the Supplementary Note) and the International IBD Genetics Consortium, as well as S. Marriott for her assistance during the trial initiation. We acknowledge The International Serious Adverse Events Scientific Management Committee members (listed in the Supplementary Note), T Frayling, S. Lin and K. Hunt for kindly providing comments on the draft manuscript, as well as C. Heard and M. Parkinson for their ongoing administrative support to the study. We also thank all the patients for their time and participation.	Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaparro M, 2013, INFLAMM BOWEL DIS, V19, P1404, DOI 10.1097/MIB.0b013e318281f28f; Cosnes J, 2013, GASTROENTEROLOGY, V145, P758, DOI 10.1053/j.gastro.2013.04.048; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Gearry RB, 2004, PHARMACOEPIDEM DR S, V13, P563, DOI 10.1002/pds.926; Health and Social Care Information Centre, 2013, Q PRESCR COST AN ENG; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; NOGUEIRA JR, 1972, GASTROENTEROLOGY, V62, P1040; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; TILNEY NL, 1966, NEW ENGL J MED, V274, P1051, DOI 10.1056/NEJM196605122741903; Timmer A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub3	22	135	137	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1131	1134		10.1038/ng.3093	http://dx.doi.org/10.1038/ng.3093			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25217962	Green Accepted			2022-12-17	WOS:000342554100018
J	Tachibana, SI; Sullivan, SA; Kawai, S; Nakamura, S; Kim, HR; Goto, N; Arisue, N; Palacpac, NMQ; Honma, H; Yagi, M; Tougan, T; Katakai, Y; Kaneko, O; Mita, T; Kita, K; Yasutomi, Y; Sutton, PL; Shakhbatyan, R; Horii, T; Yasunaga, T; Barnwell, JW; Escalante, AA; Carlton, JM; Tanabe, K				Tachibana, Shin-Ichiro; Sullivan, Steven A.; Kawai, Satoru; Nakamura, Shota; Kim, Hyunjae R.; Goto, Naohisa; Arisue, Nobuko; Palacpac, Nirianne M. Q.; Honma, Hajime; Yagi, Masanori; Tougan, Takahiro; Katakai, Yuko; Kaneko, Osamu; Mita, Toshihiro; Kita, Kiyoshi; Yasutomi, Yasuhiro; Sutton, Patrick L.; Shakhbatyan, Rimma; Horii, Toshihiro; Yasunaga, Teruo; Barnwell, John W.; Escalante, Ananias A.; Carlton, Jane M.; Tanabe, Kazuyuki			Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade	NATURE GENETICS			English	Article							ALIGNMENT; PARASITE; EVOLUTIONARY; PROTEIN; ORIGIN; TALE	P. cynomolgi, a malaria-causing parasite of Asian Old World monkeys, is the sister taxon of P. vivax, the most prevalent malaria-causing species in humans outside of Africa. Because P. cynomolgi shares many phenotypic, biological and genetic characteristics with P. vivax, we generated draft genome sequences for three P. cynomolgi strains and performed genomic analysis comparing them with the P. vivax genome, as well as with the genome of a third previously sequenced simian parasite, Plasmodium knowlesi. Here, we show that genomes of the monkey malaria clade can be characterized by copy-number variants (CNVs) in multigene families involved in evasion of the human immune system and invasion of host erythrocytes. We identify genome-wide SNPs, microsatellites and CNVs in the P. cynomolgi genome, providing a map of genetic variation that can be used to map parasite traits and study parasite populations. The sequencing of the P. cynomolgi genome is a critical step in developing a model system for P. vivax research and in counteracting the neglect of P. vivax.	[Tachibana, Shin-Ichiro; Honma, Hajime; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Suita, Osaka 565, Japan; [Sullivan, Steven A.; Kim, Hyunjae R.; Sutton, Patrick L.; Shakhbatyan, Rimma; Carlton, Jane M.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Kawai, Satoru] Dokkyo Med Univ, Inst Int Educ & Res, Lab Trop Med & Parasitol, Shimotsuga, Japan; [Nakamura, Shota; Goto, Naohisa; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Suita, Osaka 565, Japan; [Arisue, Nobuko; Palacpac, Nirianne M. Q.; Honma, Hajime; Yagi, Masanori; Tougan, Takahiro; Horii, Toshihiro; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Katakai, Yuko] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki, Japan; [Kaneko, Osamu] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Kaneko, Osamu] Nagasaki Univ, Global COE Ctr Excellence Program, Nagasaki 852, Japan; [Mita, Toshihiro] Juntendo Univ, Grad Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Tokyo, Japan; [Yasutomi, Yasuhiro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan; [Barnwell, John W.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA USA; [Escalante, Ananias A.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA	Osaka University; New York University; Dokkyo Medical University; Osaka University; Osaka University; Nagasaki University; Nagasaki University; Juntendo University; University of Tokyo; National Institute of Health Sciences - Japan; Centers for Disease Control & Prevention - USA; Arizona State University; Arizona State University-Tempe	Tanabe, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Suita, Osaka 565, Japan.	jane.carlton@nyu.edu; kztanabe@biken.osaka-u.ac.jp	, 美田敏宏/D-8494-2015; Kim, Hyunjae/J-5811-2015; Nakamura, Shota/E-3033-2010; Tougan, Takahiro/AAP-5129-2020; Mita, Toshihiro/U-4126-2019	, 美田敏宏/0000-0001-8180-2344; Kim, Hyunjae/0000-0002-1869-0412; Nakamura, Shota/0000-0003-2058-5942; Horii, Toshihiro/0000-0002-3000-2045; Escalante, Ananias/0000-0002-1532-3430; Kita, Kiyoshi/0000-0002-0426-4308; Palacpac, Nirianne Marie/0000-0003-4098-3972	US National Institutes of Health (NIH) [S10 RR026950]; Ministry of Education, Culture, Sports, Science and Technology of Japan [18073013, 18GS03140013, 20390120, 22406012]; NIH [R01 GM080586]; Burroughs Wellcome Fund [1007398]; NIH International Centers of Excellence for Malaria Research grant [U19 AI089676-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080586, R01GM070793] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22700455] Funding Source: KAKEN	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH International Centers of Excellence for Malaria Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sawai for suggestions on genome analysis, D. Fisher for help with genome-wide evolutionary analyses and the NYU Langone Medical Center Genome Technology Core for access to Roche 454 sequencing equipment (funded by grant S10 RR026950 to J.M.C. from the US National Institutes of Health (NIH)). Genome and phylogenetic analyses used the Genome Information Research Center in the Research Institute of Microbial Diseases at Osaka University. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18073013, 18GS03140013, 20390120 and 22406012) to K.T., an NIH grant (R01 GM080586) to A.A.E. and a Burroughs Wellcome Fund grant (1007398) and an NIH International Centers of Excellence for Malaria Research grant (U19 AI089676-01) to J.M.C. The content is soley the responsibility of the authors and does not necessarily represent the official views of the NIH.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; Coatney GR, 1971, PRIMATE MALARIAS; Cornejo OE, 2006, TRENDS PARASITOL, V22, P558, DOI 10.1016/j.pt.2006.09.007; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; Doi M, 2011, VACCINE, V29, P4308, DOI 10.1016/j.vaccine.2011.04.028; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; EYLES DE, 1960, SCIENCE, V131, P1812, DOI 10.1126/science.131.3416.1812; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goudet J., 2001, CLADISTICS; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Okenu DMN, 1997, MOL BIOCHEM PARASIT, V89, P301, DOI 10.1016/S0166-6851(97)00118-7; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Popendorf K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012651; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Saxena AK, 2007, EUKARYOT CELL, V6, P1260, DOI 10.1128/EC.00060-07; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	135	138	0	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2012	44	9					1051	+		10.1038/ng.2375	http://dx.doi.org/10.1038/ng.2375			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	001WP	22863735	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-17	WOS:000308491200019
J	Raveh-Sadka, T; Levo, M; Shabi, U; Shany, B; Keren, L; Lotan-Pompan, M; Zeevi, D; Sharon, E; Weinberger, A; Segal, E				Raveh-Sadka, Tali; Levo, Michal; Shabi, Uri; Shany, Boaz; Keren, Leeat; Lotan-Pompan, Maya; Zeevi, Danny; Sharon, Eilon; Weinberger, Adina; Segal, Eran			Manipulating nucleosome disfavoring sequences allows fine-tune regulation of gene expression in yeast	NATURE GENETICS			English	Article							HISTONE-DNA INTERACTIONS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SATURATION MUTAGENESIS; PROTEIN EXPRESSION; TRANSCRIPTION; BINDING; PROMOTERS; MECHANISM; GENOME	Understanding how precise control of gene expression is specified within regulatory DNA sequences is a key challenge with far-reaching implications. Many studies have focused on the regulatory role of transcription factor-binding sites. Here, we explore the transcriptional effects of different elements, nucleosome-disfavoring sequences and, specifically, poly(dA:dT) tracts that are highly prevalent in eukaryotic promoters. By measuring promoter activity for a large-scale promoter library, designed with systematic manipulations to the properties and spatial arrangement of poly(dA:dT) tracts, we show that these tracts significantly and causally affect transcription. We show that manipulating these elements offers a general genetic mechanism, applicable to promoters regulated by different transcription factors, for tuning expression in a predictable manner, with resolution that can be even finer than that attained by altering transcription factor sites. Overall, our results advance the understanding of the regulatory code and suggest a potential mechanism by which promoters yielding prespecified expression patterns can be designed.	[Raveh-Sadka, Tali; Levo, Michal; Shany, Boaz; Keren, Leeat; Lotan-Pompan, Maya; Zeevi, Danny; Sharon, Eilon; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Raveh-Sadka, Tali; Levo, Michal; Shany, Boaz; Keren, Leeat; Lotan-Pompan, Maya; Zeevi, Danny; Sharon, Eilon; Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Shabi, Uri] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Weinberger, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	adina.weinberger@weizmann.ac.il; eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Keren, Leeat/0000-0002-6799-6303; Sharon, Eilon/0000-0002-1262-350X; Zeevi, Danny/0000-0002-6901-3737; Segal, Eran/0000-0002-6859-1164	European Research Council (ERC); US National Institutes of Health (NIH); Azrieli Foundation	European Research Council (ERC)(European Research Council (ERC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Azrieli Foundation	We wish to dedicate this paper to Jon Widom who inspired and assisted us greatly throughout this project. This work was supported by grants from the European Research Council (ERC) and the US National Institutes of Health (NIH) to E. Segal. E. Segal is the incumbent of the Soretta and Henry Shapiro career development chair. T.R.-S. and M.L. thank the Azrieli Foundation for the award of an Azrieli Fellowship. We thank G. Hornung for his help with the analysis of flow cytometry measurements and E. Mochly for his help with the preparation of Supplementary Figure 9.	Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Bai L, 2010, DEV CELL, V18, P544, DOI 10.1016/j.devcel.2010.02.007; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Ben Yehezkel T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn457; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Dechering KJ, 1998, NUCLEIC ACIDS RES, V26, P4056, DOI 10.1093/nar/26.17.4056; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Linshiz G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.26; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Ptashne M, 2002, GENES SIGNALS; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shabi Uri, 2010, Syst Synth Biol, V4, P227, DOI 10.1007/s11693-010-9059-y; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	43	135	135	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					743	U163		10.1038/ng.2305	http://dx.doi.org/10.1038/ng.2305			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22634752				2022-12-17	WOS:000305886900006
J	Carvalho, CMB; Ramocki, MB; Pehlivan, D; Franco, LM; Gonzaga-Jauregui, C; Fang, P; McCall, A; Pivnick, EK; Hines-Dowell, S; Seaver, LH; Friehling, L; Lee, S; Smith, R; del Gaudio, D; Withers, M; Liu, PF; Cheung, SW; Belmont, JW; Zoghbi, HY; Hastings, PJ; Lupski, JR				Carvalho, Claudia M. B.; Ramocki, Melissa B.; Pehlivan, Davut; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Fang, Ping; McCall, Alanna; Pivnick, Eniko Karman; Hines-Dowell, Stacy; Seaver, Laurie H.; Friehling, Linda; Lee, Sansan; Smith, Rosemarie; del Gaudio, Daniela; Withers, Marjorie; Liu, Pengfei; Cheung, Sau Wai; Belmont, John W.; Zoghbi, Huda Y.; Hastings, P. J.; Lupski, James R.			Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome	NATURE GENETICS			English	Article							BREAK-INDUCED REPLICATION; PELIZAEUS-MERZBACHER-DISEASE; MECP2 DUPLICATION SYNDROME; GENE COPY NUMBER; X-CHROMOSOME; INTRACHROMOSOMAL TRIPLICATIONS; MENTAL-RETARDATION; MECHANISM; MUTATIONS; INVERSION	We identified complex genomic rearrangements consisting of intermixed duplications and triplications of genomic segments at the MECP2 and PLP1 loci. These complex rearrangements were characterized by a triplicated segment embedded within a duplication in 11 unrelated subjects. Notably, only two breakpoint junctions were generated during each rearrangement formation. All the complex rearrangement products share a common genomic organization, duplication-inverted triplication-duplication (DUP-TRP/INV-DUP), in which the triplicated segment is inverted and located between directly oriented duplicated genomic segments. We provide evidence that the DUP-TRP/INV-DUP structures are mediated by inverted repeats that can be separated by >300 kb, a genomic architecture that apparently leads to susceptibility to such complex rearrangements. A similar inverted repeat-mediated mechanism may underlie structural variation in many other regions of the human genome. We propose a mechanism that involves both homology-driven events, via inverted repeats, and microhomologous or nonhomologous events.	[Ramocki, Melissa B.; Hastings, P. J.] Baylor Coll Med, Dept Pediat, Div Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA; [Carvalho, Claudia M. B.; Pehlivan, Davut; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Fang, Ping; del Gaudio, Daniela; Withers, Marjorie; Liu, Pengfei; Cheung, Sau Wai; Belmont, John W.; Zoghbi, Huda Y.; Hastings, P. J.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Pivnick, Eniko Karman] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Div Clin Genet, Memphis, TN USA; [Pivnick, Eniko Karman] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA; [Hines-Dowell, Stacy] LeBonheur Childrens Hosp, Nursing Adm, Div Med Genet, Memphis, TN USA; [Seaver, Laurie H.; Lee, Sansan] Kapiolani Med Specialists, Honolulu, HI USA; [Friehling, Linda] Childrens Med Associates, Alexandria, VA USA; [Smith, Rosemarie] Maine Med Ctr, Dept Pediat, Div Genet, Portland, ME 04102 USA; [Belmont, John W.] Baylor Coll Med, Dept Pediat, Div Cardiol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Franco, Luis M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Seaver, Laurie H.] Univ Hawaii, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96822 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Maine Medical Center; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Hawaii System	Ramocki, MB (corresponding author), Baylor Coll Med, Dept Pediat, Div Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA.	mramocki@bcm.edu; jlupski@bcm.edu	Belmont, John/AAH-6084-2021; Liu, Pengfei/U-9743-2019; Gonzaga-Jauregui, Claudia/H-4752-2019; Belmont, John W/AAI-2494-2019; Pehlivan, Davut/I-3235-2019	Liu, Pengfei/0000-0002-4177-709X; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Belmont, John W/0000-0001-7409-3578; Pehlivan, Davut/0000-0001-5788-0270; Zoghbi, Huda/0000-0002-0700-3349	US National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS058529]; NINDS [R01 HD053862, 5K08NS062711-03]; US National Institute of General Medical Sciences (NIGMS) [R01 GM064022]; Eunice Kennedy Shriver US National Institute of Child Health and Human Development (NICHD) [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS057819, K08NS062711, R01NS058529] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eunice Kennedy Shriver US National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of the families who participated in this study. We acknowledge P. Stankiewicz for helpful discussions. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS058529 to J.R.L., NINDS grant R01 HD053862 to H.Y.Z., US National Institute of General Medical Sciences (NIGMS) grant R01 GM064022 to P.J.H. and NINDS grant 5K08NS062711-03 to M.B.R. Lymphoblast cell lines were developed by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center cell culture core, which is funded by award P30HD024064 from the Eunice Kennedy Shriver US National Institute of Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS, NIGMS, NICHD or the US National Institutes of Health. H.Y.Z. is an investigator of the Howard Hughes Medical Institute.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartsch O, 2010, AM J MED GENET A, V152A, P305, DOI 10.1002/ajmg.a.33198; Beunders G, 2010, J MED GENET, V47, P271, DOI 10.1136/jmg.2009.070490; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; HU XY, 1990, AM J HUM GENET, V46, P682; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Lebofsky R, 2005, MOL CELL BIOL, V25, P6789, DOI 10.1128/MCB.25.15.6789-6797.2005; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee JA, 2005, PRENATAL DIAG, V25, P1188, DOI 10.1002/pd.1308; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Morrow DM, 1997, GENETICS, V147, P371; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Reddy KS, 2000, CLIN GENET, V58, P134, DOI 10.1034/j.1399-0004.2000.580208.x; Sheen CR, 2007, HUM MUTAT, V28, P1198, DOI 10.1002/humu.20591; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Vialard F, 2003, AM J MED GENET A, V118A, P229, DOI 10.1002/ajmg.a.10164; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Wang J, 1999, AM J MED GENET, V82, P312, DOI 10.1002/(SICI)1096-8628(19990212)82:4<312::AID-AJMG7>3.0.CO;2-9; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	41	135	138	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2011	43	11					1074	U59		10.1038/ng.944	http://dx.doi.org/10.1038/ng.944			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842GS	21964572	Green Accepted			2022-12-17	WOS:000296584000010
J	Zody, MC; Jiang, Z; Fung, HC; Antonacci, F; Hillier, LW; Cardone, MF; Graves, TA; Kidd, JM; Cheng, Z; Abouelleil, A; Chen, L; Wallis, J; Glasscock, J; Wilson, RK; Reily, AD; Duckworth, J; Ventura, M; Hardy, J; Warren, WC; Eichler, EE				Zody, Michael C.; Jiang, Zhaoshi; Fung, Hon-Chung; Antonacci, Francesca; Hillier, LaDeana W.; Cardone, Maria Francesca; Graves, Tina A.; Kidd, Jeffrey M.; Cheng, Ze; Abouelleil, Amr; Chen, Lin; Wallis, John; Glasscock, Jarret; Wilson, Richard K.; Reily, Amy Denise; Duckworth, Jaime; Ventura, Mario; Hardy, John; Warren, Wesley C.; Eichler, Evan E.			Evolutionary toggling of the MAPT 17q21.31 inversion region	NATURE GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; COPY-NUMBER; GENOMIC DISORDERS; COMMON INVERSION; DNA-SEQUENCE; TAU-GENE; HAPLOTYPE; REARRANGEMENTS; ARCHITECTURE; POLYMORPHISM	Using comparative sequencing approaches, we investigated the evolutionary history of the European-enriched 17q21.31 MAPT inversion polymorphism. We present a detailed, BAC-based sequence assembly of the inverted human H2 haplotype and compare it to the sequence structure and genetic variation of the corresponding 1.5-Mb region for the noninverted H1 human haplotype and that of chimpanzee and orangutan. We found that inversion of the MAPT region is similarly polymorphic in other great ape species, and we present evidence that the inversions occurred independently in chimpanzees and humans. In humans, the inversion breakpoints correspond to core duplications with the LRRC37 gene family. Our analysis favors the H2 configuration and sequence haplotype as the likely great ape and human ancestral state, with inversion recurrences during primate evolution. We show that the H2 architecture has evolved more extensive sequence homology, perhaps explaining its tendency to undergo microdeletion associated with mental retardation in European populations.	[Hillier, LaDeana W.; Graves, Tina A.; Wallis, John; Glasscock, Jarret; Wilson, Richard K.; Reily, Amy Denise; Warren, Wesley C.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Zody, Michael C.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Zody, Michael C.] Harvard Univ, Cambridge, MA 02142 USA; [Zody, Michael C.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Jiang, Zhaoshi; Antonacci, Francesca; Kidd, Jeffrey M.; Cheng, Ze; Chen, Lin; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Fung, Hon-Chung; Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Fung, Hon-Chung; Hardy, John] UCL, Reta Lila Weston Labs, London WC1N 3BG, England; [Fung, Hon-Chung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Fung, Hon-Chung] Chang Gung Univ, Coll Med, Taipei 10591, Taiwan; [Cardone, Maria Francesca; Ventura, Mario] Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; [Duckworth, Jaime] Natl Inst Aging, Natl Inst Hlth, Neurogenet Lab, Bethesda, MD 20892 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Uppsala University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of London; University College London; University of London; University College London; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Universita degli Studi di Bari Aldo Moro; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Warren, WC (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	wwarren@watson.wustl.edu; eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Antonacci, Francesca/F-5457-2013; Hardy, John/C-2451-2009; Ventura, Mario/E-6420-2011; Cardone, Maria Francesca/G-8818-2012	Wilson, Richard K./0000-0002-1992-1358; Antonacci, Francesca/0000-0002-5833-6186; Hardy, John/0000-0002-3122-0423; Ventura, Mario/0000-0001-7762-8777; Cardone, Maria Francesca/0000-0002-7597-7313; Kidd, Jeffrey/0000-0002-9631-1465	National Human Genome Research Institute; National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01 AG000957-05]; NIH [GM058815, HG002385]; Rosetta Inpharmatics Fellowship (Merck Laboratories); Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000957, Z01AG000932] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosetta Inpharmatics Fellowship (Merck Laboratories); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Marques, D. Reich, A. Navarro, N. Patterson, S. McCarroll, T. Brown and K. Augustyn for critical comments and valuable discussions in the preparation of this manuscript; C. Alkan for providing computational assistance; and members of the Broad Institute Sequence Platform (BISP) and Washington University Genome Sequencing Center (WUGSC) for generating clone-based sequencing data for this project. M. C. Z., A. A., W. C. W., L. W. H., T. A. G., R. K. W., A. D. R., J. W., J. G. and the BISP and WUGSC were supported by grants from the National Human Genome Research Institute. This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services, project number Z01 AG000957-05. This work was supported by NIH grants GM058815 and HG002385 to E. E. E. and a Rosetta Inpharmatics Fellowship (Merck Laboratories) to Z. J. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Cardone MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r28; Casals F, 2007, HEREDITY, V99, P479, DOI 10.1038/sj.hdy.6801046; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; Ebersberger I, 2007, MOL BIOL EVOL, V24, P2266, DOI 10.1093/molbev/msm156; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gagneux P, 2002, TRENDS GENET, V18, P327, DOI 10.1016/S0168-9525(02)02695-1; Gijselinck I, 2006, HUM MUTAT, V27, P1057, DOI 10.1002/humu.20391; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Higgins D G, 1994, Methods Mol Biol, V25, P307; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Kehrer-Sawatzki H, 2005, CYTOGENET GENOME RES, V108, P91, DOI 10.1159/000080806; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Rademakers R, 2005, HUM MOL GENET, V14, P3281, DOI 10.1093/hmg/ddi361; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sundar PD, 2007, HUM MOL GENET, V16, P295, DOI 10.1093/hmg/ddl463; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Yu N, 2003, GENETICS, V164, P1511; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601	45	135	136	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1076	1083		10.1038/ng.193	http://dx.doi.org/10.1038/ng.193			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165922	Green Accepted			2022-12-17	WOS:000258761200020
J	Shinohara, M; Oh, SD; Hunter, N; Shinohara, A				Shinohara, Miki; Oh, Steve D.; Hunter, Neil; Shinohara, Akira			Crossover assurance and crossover interference are distinctly regulated by the ZMM proteins during yeast meiosis	NATURE GENETICS			English	Article							MEIOTIC CHROMOSOME SYNAPSIS; DOUBLE-STRAND-BREAK; SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; HOLLIDAY JUNCTIONS; CHIASMA FORMATION; RECA HOMOLOGS; MUTS HOMOLOG; RECOMBINATION	Meiotic crossing-over is highly regulated such that each homolog pair typically receives at least one crossover (assurance) and adjacent crossovers are widely spaced (interference). Here we provide evidence that interference and assurance are mechanistically distinct processes that are separated by mutations in a new ZMM (Zip, Msh, Mer) protein from Saccharomyces cerevisiae, Spo16. Like other zmm mutants, spo16 cells have defects in both crossing-over and synaptonemal complex formation. Unlike in previously characterized zmm mutants, the residual crossovers in spo16 cells show interference comparable to that in the wild type. Spo16 interacts with a second ZMM protein, Spo22 (also known as Zip4), and spo22 mutants also show normal interference. Notably, assembly of the MutS homologs Msh4 and Msh5 on chromosomes occurs in both spo16 and spo22, but not in other zmm mutants. We suggest that crossover interference requires the normal assembly of recombination complexes containing Msh4 and Msh5 but does not require Spo16- and Spo22-dependent extension of synaptonemal complexes. In contrast, crossover assurance requires all ZMM proteins and full-length synaptonemal complexes.	[Shinohara, Miki; Shinohara, Akira] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Oh, Steve D.; Hunter, Neil] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; [Oh, Steve D.; Hunter, Neil] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; [Shinohara, Akira] Osaka Univ, Grad Sch Sci, Suita, Osaka 5650871, Japan	Osaka University; University of California System; University of California Davis; University of California System; University of California Davis; Osaka University	Shinohara, A (corresponding author), Osaka Univ, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235	NIGMS NIH HHS [GM074223] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; ISUBOUCHI I, 2005, SCIENCE, V308, P870; ISUBOUCHI T, 2006, DEV CELL, V10, P809; JONES G H, 1987, P213; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; MALAVASIC MJ, 1990, MOL CELL BIOL, V10, P2809, DOI 10.1128/MCB.10.6.2809; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Novak JE, 2001, GENETICS, V158, P1013; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; PAPAZIAN HP, 1952, GENETICS, V37, P175; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 2003, GENETICS, V163, P1273; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	49	135	139	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					299	309		10.1038/ng.83	http://dx.doi.org/10.1038/ng.83			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297071				2022-12-17	WOS:000253548400020
J	Kaeser, SA; Herzig, MC; Coomaraswamy, J; Kilger, E; Selenica, ML; Winkler, DT; Staufenbiel, M; Levy, E; Grubb, A; Jucker, M				Kaeser, Stephan A.; Herzig, Martin C.; Coomaraswamy, Janaky; Kilger, Ellen; Selenica, Maj-Linda; Winkler, David T.; Staufenbiel, Matthias; Levy, Efrat; Grubb, Anders; Jucker, Mathias			Cystatin C modulates cerebral beta-amyloidosis	NATURE GENETICS			English	Article							ONSET ALZHEIMER-DISEASE; GENETIC ASSOCIATION; VARIANT; HEMORRHAGE	The CST3 Thr25 allele of CST3, which encodes cystatin C, leads to reduced cystatin C secretion and conveys susceptibility to Alzheimer's disease. Here we show that overexpression of human cystatin C in brains of APP-transgenic mice reduces cerebral amyloid-beta deposition and that cystatin C binds amyloid-beta and inhibits its fibril formation. Our results suggest that cystatin C concentrations modulate cerebral amyloidosis risk and provide an opportunity for genetic risk assessment and therapeutic interventions.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland; NYU, Sch Med, Dept Pharmacol & Psychiat, New York, NY 10016 USA; Nathan S Kline Inst, New York, NY 10962 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University; Skane University Hospital; University of Basel; Novartis; New York University; Nathan Kline Institute for Psychiatric Research	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Otfried Muller Str 27, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	; Herzig, Martin/R-4601-2016	Grubb, Anders/0000-0002-0125-3662; Herzig, Martin/0000-0002-0500-353X				BALBIN M, 1992, BIOL CHEM H-S, V373, P471, DOI 10.1515/bchm3.1992.373.2.471; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Cathcart HM, 2005, NEUROLOGY, V64, P755, DOI 10.1212/01.WNL.0000151980.42337.44; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Eriksson P, 2004, ARTERIOSCL THROM VAS, V24, P551, DOI 10.1161/01.ATV.0000117180.57731.36; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738	15	135	139	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1437	1439		10.1038/ng.2007.23	http://dx.doi.org/10.1038/ng.2007.23			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026102				2022-12-17	WOS:000251267400009
J	Dickins, RA; McJunkin, K; Hernando, E; Premsrirut, PK; Krizhanovsky, V; Burgess, DJ; Kim, SY; Cordon-Cardo, C; Zender, L; Hannon, GJ; Lowe, SW				Dickins, Ross A.; McJunkin, Katherine; Hernando, Eva; Premsrirut, Prem K.; Krizhanovsky, Valery; Burgess, Darren J.; Kim, Sang Yong; Cordon-Cardo, Carlos; Zender, Lars; Hannon, Gregory J.; Lowe, Scott W.			Tissue-specific and reversible RNA interference in transgenic mice	NATURE GENETICS			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; IN-VIVO; P53 RESTORATION; MOUSE; PHENOTYPES; APOPTOSIS; MYC; LYMPHOMAGENESIS; TUMORIGENESIS	Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline ( tet)- responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference ( RNAi) in mice. Transgenic mice harboring a tet- responsive RNA polymerase II promoter driving a microRNA- based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue- specific 'tet- on' or 'tet- off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue- specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Dickins, Ross A/K-2852-2012; Krizhanovsky, Valery/D-1336-2010	Dickins, Ross A/0000-0003-4112-5304; Krizhanovsky, Valery/0000-0002-3977-5482; Kim, Sang Yong/0000-0001-7326-7505; McJunkin, Katherine/0000-0001-9730-442X; Burgess, Darren/0000-0002-8434-7540; Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P01 CA013106, P30 CA008748, P01 CA087497] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA087497, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Ceccarelli AV, 2002, COMPARATIVE MED, V52, P171; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Fritsch L, 2004, EMBO REP, V5, P178, DOI 10.1038/sj.embor.7400064; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; HSU B, 1995, ONCOGENE, V11, P175; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	39	135	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					914	921		10.1038/ng2045	http://dx.doi.org/10.1038/ng2045			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572676	Green Accepted			2022-12-17	WOS:000247619800024
J	Watnick, T; Germino, G				Watnick, T; Germino, G			From cilia to cyst	NATURE GENETICS			English	Editorial Material							NEPHROCYSTIN; PROTEIN; GENE; INTERACTS; INVERSIN; COMPLEX; CELLS	Nephronophthisis is the most common inherited cause of renal failure in children. Two new studies add to the growing body of literature that suggests that cilial dysfunction may underlie all forms of cystic renal disease.	Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University	Watnick, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Ross 958,720 Rutland Ave, Baltimore, MD 21205 USA.			Germino, Gregory/0000-0002-3609-5588				Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; BOLETTA A, IN PRESS TRENDS CELL; Brown NE, 2003, KIDNEY INT, V63, P1220, DOI 10.1046/j.1523-1755.2003.00863.x; Calvet JP, 2003, NAT GENET, V33, P113, DOI 10.1038/ng1078; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4	15	135	142	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					355	356		10.1038/ng0803-355	http://dx.doi.org/10.1038/ng0803-355			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12923538				2022-12-17	WOS:000184470500004
J	Seidel-Rogol, BL; McCulloch, V; Shadel, GS				Seidel-Rogol, BL; McCulloch, V; Shadel, GS			Human mitochondrial transcription factor B1 methylates ribosomal RNA at a conserved stem-loop	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; DIMETHYLATION; YEAST; GENE	Human mitochondrial transcription factor B1 (h-mtTFB1) has an unprecedented relationship to RNA methyltransferases. Here, we show that this protein methylates a conserved stem-loop in bacterial 16S rRNA and that the homologous sequence in the human mitochondrial 12S molecule is similarly modified. Thus, h-mtTFB1 appears to be dual-function protein, acting both as a transcription factor and an rRNA-modification enzyme.	Emory Univ, Sch Med, Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Shadel, GS (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA.							DUBIN DT, 1974, J MOL BIOL, V84, P257, DOI 10.1016/0022-2836(74)90584-1; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; HELSER TL, 1971, NATURE-NEW BIOL, V233, P12, DOI 10.1038/newbio233012a0; Huntington KM, 2000, BIOCHEMISTRY-US, V39, P4543, DOI 10.1021/bi992452y; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; VANBUUL CPJJ, 1985, GENE, V38, P65, DOI 10.1016/0378-1119(85)90204-5; Vila-Sanjurjo A, 1999, J MOL BIOL, V293, P1, DOI 10.1006/jmbi.1999.3160	10	135	142	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					23	24		10.1038/ng1064	http://dx.doi.org/10.1038/ng1064			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12496758				2022-12-17	WOS:000180136100012
J	Betz, RC; Schoser, BGH; Kasper, D; Ricker, K; Ramirez, A; Stein, V; Torbergsen, T; Lee, YA; Nothen, MM; Wienker, TF; Malin, JP; Propping, P; Reis, A; Mortier, W; Jentsch, TJ; Vorgerd, M; Kubisch, C				Betz, RC; Schoser, BGH; Kasper, D; Ricker, K; Ramirez, A; Stein, V; Torbergsen, T; Lee, YA; Nothen, MM; Wienker, TF; Malin, JP; Propping, P; Reis, A; Mortier, W; Jentsch, TJ; Vorgerd, M; Kubisch, C			Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease	NATURE GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CAVEOLIN-3; COMPLEX	Hereditary rippling muscle disease (RMD) is an autosomal dominant human disorder characterized by mechanically triggered contractions of skeletal muscle(1-4). Genome-wide linkage analysis has identified an RMD locus on chromosome 3p25. We found missense mutations in positional candidate CAM (encoding caveolin 3; ref. 5) in all five families analyzed. Mutations in CAM have also been described in limb-girdle muscular dystrophy type 1C (LGMD1C; refs. 6,7), demonstrating the allelism of dystrophic and non-dystrophic muscle diseases.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Hamburg, Neurol Klin, Hamburg, Germany; Univ Hamburg, Znetrum Mol Neurobiol, Hamburg, Germany; Univ Wurzburg, Neurol Klin, D-8700 Wurzburg, Germany; Univ Tromso Hosp, Dept Neurol, N-9012 Tromso, Norway; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Bonn, Inst Med Biometrie Informat & Epidemiol, D-53111 Bonn, Germany; Ruhr Univ Bochum, Padiatr Klin, D-4630 Bochum, Germany	University of Bonn; University of Hamburg; University of Hamburg; University of Wurzburg; UiT The Arctic University of Tromso; University Hospital of North Norway; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn; Ruhr University Bochum	Kubisch, C (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Betz, Regina C/E-8591-2011; Vorgerd, Matthias/GRS-7540-2022; Reis, André/D-2309-2009; Ramirez, Alfredo/S-5126-2019; Kubisch, Christian/F-1893-2011; Schoser, Benedikt/AAH-6286-2020; Nöthen, Markus/B-2027-2009	Betz, Regina C/0000-0001-5024-3623; Vorgerd, Matthias/0000-0002-1782-4642; Reis, André/0000-0002-6301-6363; Ramirez, Alfredo/0000-0003-4991-763X; Kubisch, Christian/0000-0003-4220-0978; Nöthen, Markus/0000-0002-8770-2464; Stein, Valentin/0000-0003-1222-4928; Schoser, Benedikt/0000-0002-2757-8131; Jentsch, Thomas/0000-0002-3509-2553				Carbone I, 2000, NEUROLOGY, V54, P1373, DOI 10.1212/WNL.54.6.1373; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; RICKER K, 1989, ARCH NEUROL-CHICAGO, V46, P405, DOI 10.1001/archneur.1989.00520400065020; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; STEPHAN DA, 1994, NEUROLOGY, V44, P1915, DOI 10.1212/WNL.44.10.1915; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; TORBERGSEN T, 1975, ACTA NEUROL SCAND, V51, P225, DOI 10.1111/j.1600-0404.1975.tb07603.x; Vorgerd M, 1999, NEUROLOGY, V52, P1453, DOI 10.1212/WNL.52.7.1453; Williams G, 1996, AM J PHYSIOL-REG I, V270, pR145, DOI 10.1152/ajpregu.1996.270.1.R145	15	135	141	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					218	219		10.1038/90050	http://dx.doi.org/10.1038/90050			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431690				2022-12-17	WOS:000169656400012
J	Eaves, IA; Merriman, TR; Barber, RA; Nutland, S; Tuomilehto-Wolf, E; Tuomilehto, J; Cucca, F; Todd, JA				Eaves, IA; Merriman, TR; Barber, RA; Nutland, S; Tuomilehto-Wolf, E; Tuomilehto, J; Cucca, F; Todd, JA			The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes	NATURE GENETICS			English	Article							ALLELIC ASSOCIATION; GENOMEWIDE SCAN; LOCI; FAMILIES; IDDM6	The choice of which population to study in the mapping of common disease genes may be critical(1,2). Isolated founder populations, such as that found in Finland, have already proved extremely useful for mapping the genes for specific rare monogenic disorders(3,4) and are being used in attempts to map the genes underlying common, complex diseases(5-8). But simulation results suggest that, under the common disease-common variant hypothesis(9-13), most isolated populations will prove no more useful for linkage disequilibrium (LD) mapping of common disease genes than large outbred populations(12). There is very little empirical data to either support or refute this conclusion at present(14-16) Therefore, we evaluated LD between 21 common microsatellite polymorphisms on chromosome 18q21 in 2 genetic isolates (Finland and Sardinia) and compared the results with those observed in two mixed populations (United Kingdom and United States of America). Mean levels of LD were similar across all four populations. Our results provide empirical support for the expectation that genetic isolates like Finland and Sardinia will not prove significantly more valuable than general populations for LD mapping of common variants underlying complex disease.	Cambridge Inst Med Res, Dept Med Genet, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Cagliari, Ist Clin & Biol Eta Evolut, I-09100 Cagliari, Italy	University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Finland National Institute for Health & Welfare; University of Cagliari	Todd, JA (corresponding author), Cambridge Inst Med Res, Dept Med Genet, Wellcome Trust Ctr Mol Mechanisms Dis, Wellcome Trust MRC Bldg, Cambridge, England.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148	NIDDK NIH HHS [DK73957] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Escamilla MA, 1999, AM J HUM GENET, V64, P1670, DOI 10.1086/302400; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; HEDRICK PW, 1987, GENETICS, V117, P331; Huttley GA, 1999, GENETICS, V152, P1711; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEWONTIN RC, 1964, GENETICS, V49, P49; Lonjou C, 1999, P NATL ACAD SCI USA, V96, P1621, DOI 10.1073/pnas.96.4.1621; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; THOMSON G, 1995, AM J HUM GENET, V57, P487; TODD JA, IN PRESS METABOLIC M; Weir B. S., 1996, GENETIC DATA ANAL; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	25	135	136	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					320	323						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888882				2022-12-17	WOS:000087920900022
J	Lu, WN; Fan, XH; Basora, N; Babakhanlou, H; Law, T; Rifai, N; Harris, PC; Perez-Atayde, AR; Rennke, HG; Zhou, J				Lu, WN; Fan, XH; Basora, N; Babakhanlou, H; Law, T; Rifai, N; Harris, PC; Perez-Atayde, AR; Rennke, HG; Zhou, J			Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes	NATURE GENETICS			English	Letter							POLYCYSTIC KIDNEY-DISEASE; FLUID CONSTITUENTS; PATHOGENESIS; CELLS; LIVER		Harvard Univ, Sch Med, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; John Radcliffe Hosp, MRC, Mol Haematol Unit, Oxford OX3 9DU, England	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Oxford	Zhou, J (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Renal, Boston, MA 02115 USA.			Lu, Weining/0000-0002-6570-3044	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040703, R01DK051050, R37DK051050] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 40703, DK 51050] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; EVERSON GT, 1990, HEPATOLOGY, V11, P557, DOI 10.1002/hep.1840110406; EVERSON GT, 1993, AM J KIDNEY DIS, V22, P520, DOI 10.1016/S0272-6386(12)80923-1; FICK GM, 1994, J AM SOC NEPHROL, V4, P1654; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GABOW PA, 1997, DIS KIDNEY, P521; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; ORELLANA SA, 1995, KIDNEY INT, V47, P490, DOI 10.1038/ki.1995.62; PATTERSON M, 1982, HEPATOLOGY, V2, P475; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; RAMOS A, 1990, ARCH PATHOL LAB MED, V114, P180; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	15	135	137	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					160	161		10.1038/5944	http://dx.doi.org/10.1038/5944			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988265				2022-12-17	WOS:000078399500015
J	Woodage, T; King, SM; Wacholder, S; Hartge, P; Struewing, JP; McAdams, M; Laken, SJ; Tucker, MA; Brody, LC				Woodage, T; King, SM; Wacholder, S; Hartge, P; Struewing, JP; McAdams, M; Laken, SJ; Tucker, MA; Brody, LC			The APC 11307K allele and cancer risk in a community-based study of Ashkenazi Jews	NATURE GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; BREAST-CANCER; BETA-CATENIN; GENE; CARCINOMAS; MUTATIONS	Mutations in APC are classically associated with familial adenomatous polyposis (FAP), a highly penetrant autosomal dominant disorder characterized by multiple intestinal polyps and, without surgical intervention, the development of colorectal cancer(1) (CRC). APC is a tumour-suppressor gene, and somatic Loss occurs in tumours. The germline T-to-A transversion responsible for the APC I1307K allele converts the wild-type sequence to a homopolymer tract (A,) that is genetically unstable and prone to somatic mutation. The I1307K allele was found in 6.1% of unselected Ashkenazi Jews and higher proportions of Ashkenazim with family or personal histories of CRC (ref. 2). To evaluate the role of I1307K in cancer, we genotyped 5,081 Ashkenazi volunteers in a community survey. Risk of developing colorectal, breast and other cancers were compared between genotyped I1307K carriers and non-carriers and their first-degree relatives.	Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; Informat Management Serv Inc, Silver Spring, MD 20904 USA; Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Johns Hopkins University; Johns Hopkins Medicine	Brody, LC (corresponding author), Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.		Struewing, Jeffery P/C-3221-2008; Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/I-7502-2013	Struewing, Jeffery P/0000-0002-4848-3334				CAPORASO N, 1995, PHARMACOGENETICS, V5, pS129, DOI 10.1097/00008571-199512001-00014; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; FEUER EJ, 1997, DEVCAN PROBABILITY D; GIARDIELLO FM, 1991, J PEDIATR-US, V119, P766, DOI 10.1016/S0022-3476(05)80297-5; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; KASHIWABA M, 1994, J CANCER RES CLIN, V120, P727, DOI 10.1007/BF01194271; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; MEDEIROS AC, 1994, CANCER EPIDEM BIOMAR, V3, P331; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Nugent KP, 1996, BRIT J SURG, V83, P1121, DOI 10.1002/bjs.1800830828; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; PETERSEN GM, 1994, ANN MED, V26, P205, DOI 10.3109/07853899409147891; Petrukhin L, 1997, CANCER RES, V57, P5480; Redston M, 1998, NAT GENET, V20, P13, DOI 10.1038/1666; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; THOMPSON AM, 1993, BRIT J CANCER, V68, P64, DOI 10.1038/bjc.1993.287; WACHOLDER S, 1998, IN PRESS AM J EPIDEM	20	135	138	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					62	65		10.1038/1722	http://dx.doi.org/10.1038/1722			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731533				2022-12-17	WOS:000075671400021
J	Paulson, RF; Vesely, S; Siminovitch, KA; Bernstein, A				Paulson, RF; Vesely, S; Siminovitch, KA; Bernstein, A			Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1	NATURE GENETICS			English	Article							STEM-CELL FACTOR; MOTH-EATEN MICE; C-KIT RECEPTOR; HEMATOPOIETIC-CELLS; PROGENITOR CELLS; MOTHEATEN MICE; GROWTH-FACTOR; MUTANT MICE; MAST-CELLS; W-LOCUS	Protein tyrosine phosphorylation plays a key role in regulating eukaryotic cell proliferation and differentiation. Genetic analysis in invertebrates has been invaluable for dissecting the signalling events downstream of receptor tyrosine kinases (RTKs). We have used this approach in mammals to analyse the interactions between the Kit RTK encoded by the murine Dominant white spotting (W) locus and the Shp1 protein tyrosine phosphatase, the product of the murine motheaten (me) gene. Homozygosity for mutations in both W and me ameliorates aspects of both the me and W phenotypes, including the lethal lung disease associated with me and the embryonic lethality and mast cell deficiency associated with W, demonstrating that the Kit receptor plays a role in the pathology of the me phenotype and conversely that Shp1 negatively regulates Kit signalling in vivo.	MT SINAI HOSP, SAMUEL LUNENFELD RES INST, PROGRAM MOL BIOL & CANC, TORONTO, ON M5G 1X5, CANADA; UNIV TORONTO, DEPT MED, TORONTO, ON, CANADA; UNIV TORONTO, DEPT MED & MOLEC GENET, TORONTO, ON, CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto			Siminovitch, Katherine/K-1475-2013					ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953; ADACHI S, 1992, BLOOD, V79, P650; ALAI M, 1992, J BIOL CHEM, V267, P18021; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; BLOUIN R, 1993, CLIN DISORDERS EXPT, P157; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DAVID M, 1995, MOL CELL BIOL, V15, P7050; DENBURG JA, 1992, BLOOD, V79, P846; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FUJITA J, 1988, J CELL PHYSIOL, V134, P78, DOI 10.1002/jcp.1041340109; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; KAYNE PS, 1995, CURR OPIN GENET DEV, V5, P38, DOI 10.1016/S0959-437X(95)90051-9; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOO GC, 1993, J IMMUNOL, V151, P6733; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Little CC, 1937, P NATL ACAD SCI USA, V23, P535, DOI 10.1073/pnas.23.10.535; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; MEININGER CJ, 1992, BLOOD, V79, P958; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; ROSSI GA, 1985, AM REV RESPIR DIS, V131, P150; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHULTZ LD, 1983, EXP HEMATOL, V11, P667; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SHULTZ LD, 1988, CURR TOP MICROBIOL, V137, P216; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; VANZANT G, 1989, EXP HEMATOL, V17, P81; Wang Y., 1993, PROTEIN PHOSPHORYLAT, P121; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; YEUNG YG, 1992, J BIOL CHEM, V267, P23447; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350	57	135	136	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					309	315		10.1038/ng0796-309	http://dx.doi.org/10.1038/ng0796-309			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673130				2022-12-17	WOS:A1996UU28300019
J	Sood, S; Eldadah, ZA; Krause, WL; McIntosh, I; Dietz, HC				Sood, S; Eldadah, ZA; Krause, WL; McIntosh, I; Dietz, HC			Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome	NATURE GENETICS			English	Letter							MISSENSE MUTATION; GENE		JOHNS HOPKINS UNIV,SCH MED,CTR GENET MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; SCOTTISH RITE CHILDRENS MED CTR,DEPT MED GENET,ATLANTA,GA 30342; NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00722] Funding Source: Medline; NHLBI NIH HHS [HL-02815] Funding Source: Medline; NIAMS NIH HHS [AR-41135] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADES LC, 1995, AM J MED GENET, V57, P565, DOI 10.1002/ajmg.1320570410; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELDADAH ZA, 1995, NAT MED, V1, P798, DOI 10.1038/nm0895-798; FURLONG J, 1987, AM J MED GENET, V26, P599, DOI 10.1002/ajmg.1320260314; HEWETT DR, 1994, J MED GENET, V31, P338, DOI 10.1136/jmg.31.4.338; KOSZTOLANYI G, 1995, AM J MED GENET, V58, P213, DOI 10.1002/ajmg.1320580303; Lacombe D, 1993, Clin Dysmorphol, V2, P220; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; SAAL HM, 1995, AM J MED GENET, V57, P573, DOI 10.1002/ajmg.1320570411; SHPRINTZEN RJ, 1982, J CRAN GENET DEV BIO, V2, P65; SUGARMAN G, 1981, SYND IDENT, V7, P16; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813	14	135	139	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					209	211		10.1038/ng0296-209	http://dx.doi.org/10.1038/ng0296-209			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563763				2022-12-17	WOS:A1996TU07900025
J	VITS, L; VANCAMP, G; COUCKE, P; FRANSEN, E; DEBOULLE, K; REYNIERS, E; KORN, B; POUSTKA, A; WILSON, G; SCHRANDERSTUMPEL, C; WINTER, RM; SCHWARTZ, C; WILLEMS, PJ				VITS, L; VANCAMP, G; COUCKE, P; FRANSEN, E; DEBOULLE, K; REYNIERS, E; KORN, B; POUSTKA, A; WILSON, G; SCHRANDERSTUMPEL, C; WINTER, RM; SCHWARTZ, C; WILLEMS, PJ			MASA SYNDROME IS DUE TO MUTATIONS IN THE NEURAL CELL-ADHESION GENE L1CAM	NATURE GENETICS			English	Article							X-LINKED HYDROCEPHALUS; MENTAL-RETARDATION; IMMUNOGLOBULIN SUPERFAMILY; LINKAGE ANALYSIS; MOLECULE L1; SPASTIC PARAPLEGIA; DNA PROBES; XQ28; EXPRESSION; LOCALIZATION	MASA syndrome is a recessive X-linked disorder characterized by mental retardation, adducted thumbs, shuffling gait, aphasia and, in some cases, hydrocephalus. Since it has been shown that X-linked hydrocephalus can be caused by mutations in L1CAM, a neuronal cell adhesion molecule, we performed an L1CAM mutation analysis in eight unrelated patients with MASA syndrome. Three different L1CAM mutations were identified: a deletion removing part of the open reading frame and two point mutations resulting in amino acid substitutions. L1CAM, therefore, harbours mutations leading to either MASA syndrome or HSAS, and might be frequently implicated in X-linked mental retardation with or without hydrocephalus.	UIA,DEPT MED GENET,B-2610 ANTWERP,BELGIUM; DEUTSCH KREBSFORSCHUNGSZENTRUM,W-6900 HEIDELBERG 1,GERMANY; UNIV TEXAS,SW MED CTR,DIV PEDIAT GENET & METAB,DALLAS,TX 75235; UNIV LIMBURG,DEPT GENET & CELL BIOL,6201 BX MAASTRICHT,NETHERLANDS; INST CHILD HLTH,MOTHERCARE UNIT CLIN MED & FETAL MED,LONDON WC1N 1EH,ENGLAND; GREENWOOD GENET CTR,GREENWOOD,SC 29646	Helmholtz Association; German Cancer Research Center (DKFZ); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Hasselt University; University of London; University College London; Greenwood Genetic Center			Fransen, Erik/C-4102-2015; Van Camp, Guy/F-3386-2013	Fransen, Erik/0000-0001-7785-4790; Van Camp, Guy/0000-0001-5105-9000				ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BIANCHINE JW, 1974, CLIN GENET, V5, P298; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Boyd E, 1993, Clin Dysmorphol, V2, P332; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; COUCKE P, 1994, HUM MOL GENET, V3, P671, DOI 10.1093/hmg/3.4.671; DEAN M, 1991, BIOTECHNIQUES, V10, P331; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GAREIS FJ, 1984, AM J MED GENET, V17, P333, DOI 10.1002/ajmg.1320170126; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; JOUET M, 1993, NAT GENET, V4, P331, DOI 10.1038/ng0893-331; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; LEGIUS E, 1991, AM J MED GENET S, V49, pA1959; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MACIAS VR, 1992, AM J MED GENET, V43, P408, DOI 10.1002/ajmg.1320430162; Maestrini Elena, 1992, Human Molecular Genetics, V1, P275, DOI 10.1093/hmg/1.4.275; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; PRINCE JT, 1991, J NEUROSCI RES, V30, P567, DOI 10.1002/jnr.490300315; RIETSCHEL M, 1991, AM J MED GENET, V41, P10, DOI 10.1002/ajmg.1320410104; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SCHUCH U, 1989, NEURON, V3; SERVILLE F, 1992, EUR J PEDIATR, V151, P515, DOI 10.1007/BF01957757; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; STRAUSSBERG R, 1991, CLIN GENET, V40, P337; VANCAMP G, 1993, NAT GENET, V4, P421; Vles J S, 1990, Genet Couns, V1, P97; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1992, AM J HUM GENET, V51, P307; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WINTER RM, 1989, HUM GENET, V82, P367; YEATMAN GW, 1984, AM J MED GENET, V17, P339, DOI 10.1002/ajmg.1320170127	39	135	136	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					408	413		10.1038/ng0794-408	http://dx.doi.org/10.1038/ng0794-408			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920660				2022-12-17	WOS:A1994NU30600016
J	WINTERPACHT, A; HILBERT, M; SCHWARZE, U; MUNDLOS, S; SPRANGER, J; ZABEL, BU				WINTERPACHT, A; HILBERT, M; SCHWARZE, U; MUNDLOS, S; SPRANGER, J; ZABEL, BU			KNIEST AND STICKLER DYSPLASIA PHENOTYPES CAUSED BY COLLAGEN TYPE-II GENE (COL2A1) DEFECT	NATURE GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; SPONDYLOEPIPHYSEAL DYSPLASIA; PROCOLLAGEN; DELETION; FAMILY; INTRON; CHAIN; FORM; EXON; DNA	Kniest and Stickler dysplasia are two chondrodysplasias characterized by specific phenotypes. No basic defect has been found in patients with Kniest dysplasia, whereas Stickler dysplasia is one of four chondrodysplasias for which mutations of type II procollagen gene (COL2A1) have been identified. We studied a 2-year-old girl presenting with manifestations of Kniest dysplasia and her mother showing a Stickler phenotype. Analysing COL2A1 in both patients, we detected the same 28 basepair deletion spanning the 3'-exon/intron boundary of exon 12 in mother and daughter. We were able to prove a somatic mosaic status for this mutation in the mother which accounts for her milder Stickler-like phenotype.			WINTERPACHT, A (corresponding author), UNIV MAINZ,CHILDRENS HOSP,LANGENBECKSTR 1,W-6500 MAINZ,GERMANY.		Mundlos, Stefan/ABH-9585-2020					AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; BARSH GS, 1985, P NATL ACAD SCI USA, V82, P2870, DOI 10.1073/pnas.82.9.2870; Bateman John F., 1992, Human Mutation, V1, P55, DOI 10.1002/humu.1380010109; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; BREATHNACH AS, 1968, J ANAT, V102, P511; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHU ML, 1985, J BIOL CHEM, V260, P691; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; JOHNSON CA, 1992, J BIOL CHEM, V267, P9347; KUIVANIEMI H, 1988, J BIOL CHEM, V263, P11407; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; POOLE AR, 1988, J CLIN INVEST, V81, P579, DOI 10.1172/JCI113356; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P736; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Spranger JV, 1974, BONE DYSPLASIAS; SUPERTIFURGA A, 1988, J BIOL CHEM, V263, P6226; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; VISSING H, 1989, J BIOL CHEM, V264, P18265; WALLIS GA, 1990, AM J HUM GENET, V46, P1034	24	135	135	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					323	326		10.1038/ng0493-323	http://dx.doi.org/10.1038/ng0493-323			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981752				2022-12-17	WOS:A1993KW25700013
J	Jung, I; Schmitt, A; Diao, YR; Lee, AJ; Liu, T; Yang, D; Tang, C; Eom, J; Chan, M; Chee, S; Chiang, Z; Kim, C; Masliah, E; Barr, CL; Li, B; Kuan, S; Kims, D; Ren, B				Jung, Inkyung; Schmitt, Anthony; Diao, Yarui; Lee, Andrew J.; Liu, Tristin; Yang, Dongchan; Tang, Catherine; Eom, Junghyun; Chan, Marilynn; Chee, Sora; Chiang, Zachary; Kim, Changyoun; Masliah, Eliezer; Barr, Cathy L.; Li, Bin; Kuan, Samantha; Kims, Dongsup; Ren, Bing			A compendium of promoter-centered long-range chromatin interactions in the human genome	NATURE GENETICS			English	Article							INTEGRATIVE ANALYSIS; REVEALS; EXPRESSION; ENHANCERS; TRANSCRIPTION; PRINCIPLES; LANDSCAPE; VARIANTS; CONTACTS; LOCI	A large number of putative cis-regulatory sequences have been annotated in the human genome, but the genes they control remain poorly defined. To bridge this gap, we generate maps of long-range chromatin interactions centered on 18,943 well-annotated promoters for protein-coding genes in 27 human cell/tissue types. We use this information to infer the target genes of 70,329 candidate regulatory elements and suggest potential regulatory function for 27,325 noncoding sequence variants associated with 2,117 physiological traits and diseases. Integrative analysis of these promoter-centered interactome maps reveals widespread enhancer-like promoters involved in gene regulation and common molecular pathways underlying distinct groups of human traits and diseases.	[Jung, Inkyung; Lee, Andrew J.; Eom, Junghyun; Li, Bin] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Schmitt, Anthony; Diao, Yarui; Liu, Tristin; Tang, Catherine; Chee, Sora; Kuan, Samantha; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Schmitt, Anthony] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Diao, Yarui] Duke Univ, Sch Med, Dept Cell Biol, Regenerat Next Initiat, Durham, NC USA; [Diao, Yarui] Duke Univ, Sch Med, Dept Orthopaed Surg, Regenerat Next Initiat, Durham, NC USA; [Yang, Dongchan; Kims, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Chan, Marilynn] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chiang, Zachary] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kim, Changyoun; Masliah, Eliezer] NIA, Mol Neuropathol Sect, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Kim, Changyoun; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Barr, Cathy L.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Barr, Cathy L.] Hosp Sick Children, Toronto, ON, Canada; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, Ctr Epigen, Inst Genom Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Korea Advanced Institute of Science & Technology (KAIST); Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Duke University; Duke University; Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California San Francisco; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; University of California System; University of California San Diego; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Diego; University of California System; University of California San Diego	Jung, I (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea.; Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ctr Epigen, Inst Genom Med, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	ijung@kaist.ac.kr; biren@ucsd.edu	Jung, Inkyung/CAJ-5773-2022; Kim, Changyoun/AAZ-5901-2021	Jung, Inkyung/0000-0002-5885-2754; Barr, Cathy/0000-0003-0361-0106; Diao, Yarui/0000-0001-5842-4082; Tan, Catherine/0000-0002-7353-9598; Chee, Sora/0000-0003-2687-7786; Kim, Changyoun/0000-0001-9936-8195	Ludwig Institute for Cancer Research; NIH [1R01ES024984]; Ministry of Science, ICT and Future Planning through the National Research Foundation in Republic of Korea [2017R1C1B2008838]; Korean Ministry of Health and Welfare [HI17C0328]; SUHF Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024984] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, ICT and Future Planning through the National Research Foundation in Republic of Korea; Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); SUHF Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank members of the Ren laboratory for critical suggestions in the course of this work. We thank N. Nariai (UCSD) for sharing LD information. This work was funded in part by the Ludwig Institute for Cancer Research (to B.R.), NIH (grant no.1R01ES024984 to B.R.), the Ministry of Science, ICT and Future Planning through the National Research Foundation in Republic of Korea (grant no. 2017R1C1B2008838 to I.J.), Korean Ministry of Health and Welfare (grant no. HI17C0328 to I.J.) and SUHF Fellowship (to I.J.).	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Dao LTM, 2017, NAT GENET, V49, P1073, DOI 10.1038/ng.3884; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/NMETH.4264, 10.1038/nmeth.4264]; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Freire-Pritchett P, 2017, ELIFE, V6, DOI 10.7554/eLife.21926; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jager R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7178; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Martin P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10069; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Orlando G, 2018, NAT GENET, V50, P1375, DOI 10.1038/s41588-018-0211-z; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Richard M, 1998, GENOMICS, V53, P137, DOI 10.1006/geno.1998.5480; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Sahlen P, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0727-9; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Siersbaek R, 2017, MOL CELL, V66, P420, DOI 10.1016/j.molcel.2017.04.010; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Uslu VV, 2014, NAT GENET, V46, P753, DOI 10.1038/ng.2971; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang DC, 2018, NUCLEIC ACIDS RES, V46, pD52, DOI 10.1093/nar/gkx1017; Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	40	134	135	3	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2019	51	10					1442	+		10.1038/s41588-019-0494-8	http://dx.doi.org/10.1038/s41588-019-0494-8			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC1CP	31501517	Green Accepted			2022-12-17	WOS:000489016400008
J	Zeng, J; de Vlaming, R; Wu, Y; Robinson, MR; Lloyd-Jones, LR; Yengo, L; Yap, CX; Xue, AL; Sidorenko, J; McRae, AF; Powell, JE; Montgomery, GW; Metspalu, A; Esko, T; Gibson, G; Wray, NR; Visscher, PM; Yang, J				Zeng, Jian; de Vlaming, Ronald; Wu, Yang; Robinson, Matthew R.; Lloyd-Jones, Luke R.; Yengo, Loic; Yap, Chloe X.; Xue, Angli; Sidorenko, Julia; McRae, Allan F.; Powell, Joseph E.; Montgomery, Grant W.; Metspalu, Andres; Esko, Tonu; Gibson, Greg; Wray, Naomi R.; Visscher, Peter M.; Yang, Jian			Signatures of negative selection in the genetic architecture of human complex traits	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; MISSING HERITABILITY; HUMAN ADAPTATION; RARE VARIANTS; COMMON; POPULATION; REGRESSION; MUTATION; HEIGHT	We develop a Bayesian mixed linear model that simultaneously estimates single-nucleotide polymorphism (SNP)-based heritability, polygenicity (proportion of SNPs with nonzero effects), and the relationship between SNP effect size and minor allele frequency for complex traits in conventionally unrelated individuals using genome-wide SNP data. We apply the method to 28 complex traits in the UK Biobank data (N = 126,752) and show that on average, 6% of SNPs have nonzero effects, which in total explain 22% of phenotypic variance. We detect significant (P < 0.05/28) signatures of natural selection in the genetic architecture of 23 traits, including reproductive, cardiovascular, and anthropometric traits, as well as educational attainment. The significant estimates of the relationship between effect size and minor allele frequency in complex traits are consistent with a model of negative (or purifying) selection, as confirmed by forward simulation. We conclude that negative selection acts pervasively on the genetic variants associated with human complex traits.	[Zeng, Jian; Wu, Yang; Robinson, Matthew R.; Lloyd-Jones, Luke R.; Yengo, Loic; Yap, Chloe X.; Xue, Angli; Sidorenko, Julia; McRae, Allan F.; Powell, Joseph E.; Montgomery, Grant W.; Wray, Naomi R.; Visscher, Peter M.; Yang, Jian] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [de Vlaming, Ronald] Vrije Univ Amsterdam, Sch Business & Econ, Amsterdam, Netherlands; [de Vlaming, Ronald] Erasmus Univ, Rotterdam Inst Behav & Biol, Rotterdam, Netherlands; [Robinson, Matthew R.] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Sidorenko, Julia; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Gibson, Greg] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Wray, Naomi R.; Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; University of Lausanne; University of Tartu; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Queensland	Yang, J (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.; Yang, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	jian.yang@uq.edu.au	Xue, Angli/L-4843-2016; Wray, Naomi/C-8639-2015; Visscher, Peter/ABB-6151-2020; Yang, Jian/A-5852-2010; Zeng, Jian/D-3884-2017; Lloyd-Jones, Luke R/F-1237-2013; Yap, Chloe/C-4141-2018; McRae, Allan/J-2644-2014; Yengo, Loic/D-2692-2017	Xue, Angli/0000-0002-0285-0426; Wray, Naomi/0000-0001-7421-3357; Visscher, Peter/0000-0002-2143-8760; Yang, Jian/0000-0003-2001-2474; Zeng, Jian/0000-0001-8801-5220; Lloyd-Jones, Luke R/0000-0002-0229-0625; Powell, Joseph/0000-0002-5070-4124; Yap, Chloe/0000-0002-1788-2842; Robinson, Matthew/0000-0001-8982-8813; de Vlaming, Ronald/0000-0001-6416-6067; McRae, Allan/0000-0001-5286-5485; Sidorenko, Julia/0000-0003-1494-6772; Yengo, Loic/0000-0002-4272-9305	University of Queensland's Research Computing Centre (RCC); Australian Research Council [DP160101343, DP160101056, DP160103860, DP160102400]; Australian National Health and Medical Research Council [1107258, 1078901, 1078037, 1083656, 1078399, 1046880, 1113400]; US National Institutes of Health [MH100141, GM099568, ES025052, AG042568]; Sylvia & Charles Viertel Charitable Foundation (Senior Medical Research Fellowship); ERC consolidator grant [647648 EdGe]; UK10K project [EGAS00001000108, EGAS00001000090]	University of Queensland's Research Computing Centre (RCC); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sylvia & Charles Viertel Charitable Foundation (Senior Medical Research Fellowship); ERC consolidator grant(European Research Council (ERC)); UK10K project	We thank The University of Queensland's Research Computing Centre (RCC) for its support in this research. We thank F. Zhang for building the website for the software tool GCTB. This research was supported by the Australian Research Council (DP160101343, DP160101056, DP160103860, and DP160102400), the Australian National Health and Medical Research Council (1107258, 1078901, 1078037, 1083656, 1078399, 1046880, and 1113400), the US National Institutes of Health (MH100141, GM099568, ES025052, and AG042568), and the Sylvia & Charles Viertel Charitable Foundation (Senior Medical Research Fellowship). R.d.V. acknowledges funding from an ERC consolidator grant (647648 EdGe, awarded to Philipp Koellinger). This study makes use of data from dbGaP (accessions: phs000090 and phs000091), UK10K project (EGA accessions: EGAS00001000108 and EGAS00001000090), and UK Biobank Resource (application number: 12514). A full list of acknowledgements for these datasets can be found in part 19 of the Supplementary Note.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2015, UK BIOB GEN QUAL CON; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; de Candia TR, 2013, AM J HUM GENET, V93, P463, DOI 10.1016/j.ajhg.2013.07.007; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Enard D, 2014, GENOME RES, V24, P885, DOI 10.1101/gr.164822.113; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Fernando RL, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-50; Fernando Rohan L, 2013, Methods Mol Biol, V1019, P237, DOI 10.1007/978-1-62703-447-0_10; Field Y, 2016, SCIENCE, V354, P760, DOI 10.1126/science.aag0776; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gelman A., 2014, BAYESIAN DATA ANAL; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lloyd-Jones LR, 2017, GENETICS, V206, P1113, DOI 10.1534/genetics.116.193383; Lloyd-Jones LR, 2017, AM J HUM GENET, V100, P228, DOI 10.1016/j.ajhg.2016.12.008; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mancuso N, 2016, NAT GENET, V48, P30, DOI 10.1038/ng.3446; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Messer PW, 2013, GENETICS, V194, P1037, DOI 10.1534/genetics.113.152181; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Neal RM, 2011, CH CRC HANDB MOD STA, P113; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Palamara PF, 2015, AM J HUM GENET, V97, P775, DOI 10.1016/j.ajhg.2015.10.006; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Storey JD, 2007, J ROY STAT SOC B, V69, P347, DOI 10.1111/j.1467-9868.2007.005592.x; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Turcot V, 2018, NAT GENET, V50, P26, DOI 10.1038/s41588-017-0011-x; Uricchio LH, 2016, GENOME RES, V26, P863, DOI 10.1101/gr.202440.115; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wass P, 1997, HUM REPROD, V12, P2057, DOI 10.1093/humrep/12.9.2057; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zeng J, 2015, THESIS, P2; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	70	134	134	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					746	+		10.1038/s41588-018-0101-4	http://dx.doi.org/10.1038/s41588-018-0101-4			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	29662166	Green Published, Green Submitted			2022-12-17	WOS:000431394900018
J	Nakayama, RT; Pulice, JL; Valencia, AM; McBride, MJ; McKenzie, ZM; Gillespie, MA; Ku, WL; Teng, MX; Cui, KR; Williams, RT; Cassel, SH; Qing, H; Widmer, CJ; Demetri, GD; Irizarry, RA; Zhao, K; Ranish, JA; Kadoch, C				Nakayama, Robert T.; Pulice, John L.; Valencia, Alfredo M.; McBride, Matthew J.; McKenzie, Zachary M.; Gillespie, Mark A.; Ku, Wai Lim; Teng, Mingxiang; Cui, Kairong; Williams, Robert T.; Cassel, Seth H.; Qing, He; Widmer, Christian J.; Demetri, George D.; Irizarry, Rafael A.; Zhao, Keji; Ranish, Jeffrey A.; Kadoch, Cigall			SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters	NATURE GENETICS			English	Article							CHROMATIN REMODELING COMPLEX; MALIGNANT RHABDOID TUMORS; SWI/SNF COMPLEXES; SUPER-ENHANCERS; SUPPRESSOR GENE; CELL IDENTITY; GENOME; MUTATIONS; POLYCOMB; DISRUPTION	Perturbations to mammalian SWI/SNF (mSWI/SNF or BAF) complexes contribute to more than 20% of human cancers, with driving roles first identified in malignant rhabdoid tumor, an aggressive pediatric cancer characterized by biallelic inactivation of the core BAF complex subunit SMARCB1 (BAF47). However, the mechanism by which this alteration contributes to tumorigenesis remains poorly understood. We find that BAF47 loss destabilizes BAF complexes on chromatin, absent significant changes in complex assembly or integrity. Rescue of BAF47 in BAF47-deficient sarcoma cell lines results in increased genome-wide BAF complex occupancy, facilitating widespread enhancer activation and opposition of Polycomb-mediated repression at bivalent promoters. We demonstrate differential regulation by two distinct mSWI/SNF assemblies, BAF and PBAF complexes, enhancers and promoters, respectively, suggesting that each complex has distinct functions that are perturbed upon BAF47 loss. Our results demonstrate collaborative mechanisms of mSWI/SNF-mediated gene activation, identifying functions that are co-opted or abated to drive human cancers and developmental disorders.	[Nakayama, Robert T.; Pulice, John L.; Valencia, Alfredo M.; McBride, Matthew J.; McKenzie, Zachary M.; Williams, Robert T.; Cassel, Seth H.; Qing, He; Widmer, Christian J.; Kadoch, Cigall] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Nakayama, Robert T.; Pulice, John L.; Valencia, Alfredo M.; McBride, Matthew J.; McKenzie, Zachary M.; Williams, Robert T.; Cassel, Seth H.; Qing, He; Widmer, Christian J.; Kadoch, Cigall] Harvard Med Sch, Boston, MA 02115 USA; [Nakayama, Robert T.; Demetri, George D.] Dana Farber Harvard, Ludwig Ctr, Boston, MA USA; [Nakayama, Robert T.; Demetri, George D.] Harvard Med Sch, Dept Med Oncol, Ctr Sarcoma & Bone Oncol, Boston, MA USA; [Pulice, John L.; Kadoch, Cigall] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Valencia, Alfredo M.; McBride, Matthew J.] Harvard Univ, Program Chem Biol, Cambridge, MA USA; [Gillespie, Mark A.; Cui, Kairong; Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA USA; [Ku, Wai Lim; Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Teng, Mingxiang; Irizarry, Rafael A.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Cassel, Seth H.] Harvard Med Sch, Med Scientist Training Program, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kadoch, C (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Kadoch, C (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kadoch, C (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	cigall_kadoch@dfci.harvard.edu		McBride, Matthew/0000-0001-9846-3385; Widmer, Christian J./0000-0002-6575-4845; Ranish, Jeffrey/0000-0001-7181-0287; Pulice, John/0000-0002-2561-9358; Williams, Robert/0000-0002-9509-9327; Valencia, Alfredo/0000-0003-2432-9890; Teng, Mingxiang/0000-0002-8536-8941	NIH [1DP2CA195762-01]; American Cancer Society [RSG-14-051-01-DMC]; Pew-Stewart Scholars in Cancer Research Grant; Alex's Lemonade Stand Foundation; Rare Cancer Research Foundation; WWWW Foundation (QuadW); Uehara Memorial Foundation; US National Institutes of Health (NIH) [5 T32 GM095450-04]; National Institute of General Medical Sciences (NIGMS) [T32GM007753]; NATIONAL CANCER INSTITUTE [DP2CA195762] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084, T32GM095450, T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Pew-Stewart Scholars in Cancer Research Grant; Alex's Lemonade Stand Foundation; Rare Cancer Research Foundation; WWWW Foundation (QuadW); Uehara Memorial Foundation(Uehara Memorial Foundation); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Molecular Biology Core Facility at the Dana-Farber Cancer Institute, especially Z. Herbert, for expertise and technical assistance with ChIP-seq and RNA-seq data sets. We thank G.R. Crabtree, A. Kuo, and W. Wang for anti-BRG1 (J1) and anti-BAF155 rabbit polyclonal antibodies used in ChIP-seq experiments. The authors are grateful to T.J. Triche (Children's Hospital Los Angeles), P. Houghton (The University of Texas Health Science Center), H. Kawashima (Niigata University Graduate School of Medical and Dental Sciences), H. Iwasaki (Fukuoka University), H. Gotoh (Kanagawa Children's Medical Center), and T. Tsukahara (Sapporo Medical University) for providing the MRT and EpS cell lines. This work was supported in part by awards from the NIH DP2 New Innovator Award 1DP2CA195762-01 (C.K.), the American Cancer Society Research Scholar Award RSG-14-051-01-DMC (C.K.), the Pew-Stewart Scholars in Cancer Research Grant (C.K.), the Alex's Lemonade Stand Foundation Young Investigator Award (C.K.), the Rare Cancer Research Foundation (C.K.), the WWWW Foundation (QuadW) (R.T.N.), and the Uehara Memorial Foundation (R.T.N.). Additionally, this work was supported by the US National Institutes of Health (NIH) grant 5 T32 GM095450-04 (A.M.V.) and National Institute of General Medical Sciences (NIGMS) award T32GM007753 (S.H.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the NIH.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biegel JA, 1999, CANCER RES, V59, P74; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Christiaans I, 2011, J MED GENET, V48, P93, DOI 10.1136/jmg.2010.082420; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Filippova D, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-14; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Genovese G, 2017, NATURE, V542, P362, DOI 10.1038/nature21064; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Jadhav U, 2016, CELL, V165, P1389, DOI 10.1016/j.cell.2016.04.031; Jamshidi F, 2016, J PATHOL, V238, P63, DOI 10.1002/path.4636; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kadoch C, 2016, BIOCHEMISTRY-US, V55, P1600, DOI 10.1021/acs.biochem.5b01191; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sen P, 2017, CELL REP, V18, P2135, DOI 10.1016/j.celrep.2017.02.017; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XX, 2016, CELL STEM CELL, V18, P456, DOI 10.1016/j.stem.2016.03.001; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei D, 2014, MOL CANCER RES, V12, P1574, DOI 10.1158/1541-7786.MCR-14-0005; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Yang JL, 2014, EUR J CANCER, V50, P593, DOI 10.1016/j.ejca.2013.11.006; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	69	134	134	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2017	49	11					1613	+		10.1038/ng.3958	http://dx.doi.org/10.1038/ng.3958			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL0OD	28945250	Green Submitted, Green Accepted			2022-12-17	WOS:000413909800010
J	Maurano, MT; Haugen, E; Sandstrom, R; Vierstra, J; Shafer, A; Kaul, R; Stamatoyannopoulos, JA				Maurano, Matthew T.; Haugen, Eric; Sandstrom, Richard; Vierstra, Jeff; Shafer, Anthony; Kaul, Rajinder; Stamatoyannopoulos, John A.			Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo	NATURE GENETICS			English	Article							GLUCOCORTICOID-RECEPTOR BINDING; GENE-EXPRESSION; DNA-BINDING; HUMAN GENOME; CHROMATIN ACCESSIBILITY; HISTONE MODIFICATIONS; DATABASE; CELLS; METHYLATION; SPECIFICITY	The function of human regulatory regions depends exquisitely on their local genomic environment and on cellular context, complicating experimental analysis of common disease- and trait-associated variants that localize within regulatory DNA. We use allelically resolved genomic DNase I footprinting data encompassing 166 individuals and 114 cell types to identify >60,000 common variants that directly influence transcription factor occupancy and regulatory DNA accessibility in vivo. The unprecedented scale of these data enables systematic analysis of the impact of sequence variation on transcription factor occupancy in vivo. We leverage this analysis to develop accurate models of variation affecting the recognition sites for diverse transcription factors and apply these models to discriminate nearly 500,000 common regulatory variants likely to affect transcription factor occupancy across the human genome. The approach and results provide a new foundation for the analysis and interpretation of noncoding variation in complete human genomes and for systems-level investigation of disease-associated variants.	[Maurano, Matthew T.; Haugen, Eric; Sandstrom, Richard; Vierstra, Jeff; Shafer, Anthony; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maurano, MT (corresponding author), NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10012 USA.	matthew.maurano@nyumc.org; jstam@uw.edu		Sandstrom, Richard/0000-0002-3356-1547; Kaul, Rajinder/0000-0002-7895-9284; Vierstra, Jeff/0000-0001-6406-8563; Haugen, Eric/0000-0001-7444-8981	US National Institutes of Health [U54HG004592, U54HG007010, U01ES01156, 1S10RR026770, 1S10OD017999]; National Institute of Mental Health [F31MH094073]; National Science Foundation Graduate Research Fellowship [DGE-071824]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026770] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grants U54HG004592, U54HG007010, U01ES01156, 1S10RR026770 and 1S10OD017999 to J.A.S. and National Institute of Mental Health fellowship F31MH094073 to M.T.M.J.V. was supported by a National Science Foundation Graduate Research Fellowship under grant DGE-071824.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; John Sam, 2013, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2127s103; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Le Novere N, 2001, BIOINFORMATICS, V17, P1226, DOI 10.1093/bioinformatics/17.12.1226; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ni YY, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-46; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893	62	134	135	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1393	+		10.1038/ng.3432	http://dx.doi.org/10.1038/ng.3432			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26502339	Green Accepted			2022-12-17	WOS:000365813200008
J	Gudmundsson, J; Sulem, P; Gudbjartsson, DF; Masson, G; Agnarsson, BA; Benediktsdottir, KR; Sigurdsson, A; Magnusson, OT; Gudjonsson, SA; Magnusdottir, DN; Johannsdottir, H; Helgadottir, HT; Stacey, SN; Jonasdottir, A; Olafsdottir, SB; Thorleifsson, G; Jonasson, JG; Tryggvadottir, L; Navarrete, S; Fuertes, F; Helfand, BT; Hu, QY; Csiki, IE; Mates, IN; Jinga, V; Aben, KKH; van Oort, IM; Vermeulen, SH; Donovan, JL; Hamdy, FC; Ng, CF; Chiu, PKF; Lau, KM; Ng, MCY; Gulcher, JR; Kong, A; Catalona, WJ; Mayordomo, JI; Einarsson, GV; Barkardottir, RB; Jonsson, E; Mates, D; Neal, DE; Kiemeney, LA; Thorsteinsdottir, U; Rafnar, T; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Masson, Gisli; Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Sigurdsson, Asgeir; Magnusson, Olafur Th; Gudjonsson, Sigurjon A.; Magnusdottir, Droplaug N.; Johannsdottir, Hrefna; Helgadottir, Hafdis Th; Stacey, Simon N.; Jonasdottir, Adalbjorg; Olafsdottir, Stefania B.; Thorleifsson, Gudmar; Jonasson, Jon G.; Tryggvadottir, Laufey; Navarrete, Sebastian; Fuertes, Fernando; Helfand, Brian T.; Hu, Qiaoyan; Csiki, Irma E.; Mates, Ioan N.; Jinga, Viorel; Aben, Katja K. H.; van Oort, Inge M.; Vermeulen, Sita H.; Donovan, Jenny L.; Hamdy, Freddy C.; Ng, Chi-Fai; Chiu, Peter K. F.; Lau, Kin-Mang; Ng, Maggie C. Y.; Gulcher, Jeffrey R.; Kong, Augustine; Catalona, William J.; Mayordomo, Jose I.; Einarsson, Gudmundur V.; Barkardottir, Rosa B.; Jonsson, Eirikur; Mates, Dana; Neal, David E.; Kiemeney, Lambertus A.; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari			A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer	NATURE GENETICS			English	Article							WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; COLORECTAL-CANCER; COMMON VARIANTS; RISK; SCAN	In Western countries, prostate cancer is the most prevalent cancer of men and one of the leading causes of cancer-related death in men. Several genome-wide association studies have yielded numerous common variants conferring risk of prostate cancer. Here, we analyzed 32.5 million variants discovered by whole-genome sequencing 1,795 Icelanders. We identified a new low-frequency variant at 8q24 associated with prostate cancer in European populations, rs188140481[A] (odds ratio (OR) 2.90; P-combined = 6.2 x 10(-34)), with an average risk allele frequency in controls of 0.54%. This variant is only very weakly correlated (r(2) <= 0.06) with previously reported risk variants at 8q24, and its association remains significant after adjustment for all known risk-associated variants. Carriers of rs188140481[A] were diagnosed with prostate cancer 1.26 years younger than non-carriers (P = 0.0059). We also report results for a previously described HOXB13 variant (rs138213197[T]), confirming it as a prostate cancer risk variant in populations from across Europe.	[Gudmundsson, Julius; Sulem, Patrick; Gudbjartsson, Daniel F.; Masson, Gisli; Sigurdsson, Asgeir; Magnusson, Olafur Th; Gudjonsson, Sigurjon A.; Magnusdottir, Droplaug N.; Johannsdottir, Hrefna; Helgadottir, Hafdis Th; Stacey, Simon N.; Jonasdottir, Adalbjorg; Olafsdottir, Stefania B.; Thorleifsson, Gudmar; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Jonasson, Jon G.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Jonasson, Jon G.; Tryggvadottir, Laufey; Barkardottir, Rosa B.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [Navarrete, Sebastian; Fuertes, Fernando] Univ Hosp, Div Radiat Oncol, Zaragoza, Spain; [Helfand, Brian T.] N Shore Univ Hlth Syst, Dept Urol, Glenview, IL USA; [Hu, Qiaoyan; Catalona, William J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Csiki, Irma E.; Mates, Dana] Natl Inst Publ Hlth, Bucharest, Romania; [Mates, Ioan N.; Jinga, Viorel] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Aben, Katja K. H.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [van Oort, Inge M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hamdy, Freddy C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England; [Ng, Chi-Fai; Chiu, Peter K. F.] Chinese Univ Hong Kong, Dept Surg, Div Urol, Shatin, Hong Kong, Peoples R China; [Lau, Kin-Mang] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Ng, Maggie C. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Mayordomo, Jose I.] Univ Zaragoza, Div Med Oncol, Zaragoza, Spain; [Einarsson, Gudmundur V.; Jonsson, Eirikur] Landspitali Univ Hosp, Dept Urol, Reykjavik, Iceland; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England	Landspitali National University Hospital; University of Iceland; Miguel Servet University Hospital; Northwestern University; Feinberg School of Medicine; Carol Davila University of Medicine & Pharmacy; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Bristol; University of Oxford; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Zaragoza; Landspitali National University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Stefansson, K (corresponding author), deCODE Genet, Reykjavik, Iceland.	julius@decode.is; kstefans@decodes.is	van Oort, Inge/L-4554-2015; Mayordomo, Jose/K-3453-2013; Aben, Katja KH/G-9686-2016; Vermeulen, Sita H./L-4716-2015; Mates, Ioan Nicolae/E-9255-2017; van Oort, Inge/AAD-1197-2020; Stefansson, Kari/AAE-7187-2019; Kiemeney, Lambertus A./D-3357-2009; Chi-fai, NG/AAV-8270-2021; Ng, Chi-Fai/E-5134-2011	van Oort, Inge/0000-0002-8002-1869; Aben, Katja KH/0000-0002-0214-2147; Vermeulen, Sita H./0000-0003-4913-8601; van Oort, Inge/0000-0002-8002-1869; Kiemeney, Lambertus A./0000-0002-2368-1326; Ng, Chi-Fai/0000-0002-1723-9646; Ioan Nicoale, Mates/0000-0001-7210-0615; mates, dana/0000-0002-6219-9807; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Hamdy, Freddie/0000-0003-2627-2154; Helgadottir, Hafdis/0000-0003-4352-152X; Jonasson, Jon G./0000-0002-2635-5032; Lau, Kin-Mang/0000-0001-5888-1937; Tryggvadottir, Laufey/0000-0001-8067-9030; Neal, David/0000-0002-6033-5086; Gudjonsson, Sigurjon A./0000-0001-9314-7412	European Union [202059]; Urological Research Foundation [U01 CA089600, P50 CA90386, P30 CA60553]; Health Technology Assessment Programme [96/20/06, 96/20/99]; Department of Health, England; Cancer Research UK [C522/A8649]; Medical Research Council of England [G0500966_ID-75466]; National Cancer Research Institute (NCRI), UK; Southwest National Health Service Research and Development; NCRI (ProMPT) study; Cambridge and Oxford British Medical Research Council grants from the National Institute for Health Research; NATIONAL CANCER INSTITUTE [P50CA090386, U01CA089600] Funding Source: NIH RePORTER	European Union(European Commission); Urological Research Foundation; Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Department of Health, England; Cancer Research UK(Cancer Research UK); Medical Research Council of England(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Research Institute (NCRI), UK; Southwest National Health Service Research and Development; NCRI (ProMPT) study; Cambridge and Oxford British Medical Research Council grants from the National Institute for Health Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the individuals who participated in the study and whose contribution made this work possible. This project was funded in part by contract number 202059 (PROMARK) from the Seventh Framework Programme of the European Union and, in part, by the Urological Research Foundation (U01 CA089600, P50 CA90386 and P30 CA60553). The UK ProtecT study is ongoing and is funded by the Health Technology Assessment Programme (projects 96/20/06 and 96/20/99). The ProtecT trial is supported by the Department of Health, England; Cancer Research UK grant C522/A8649; Medical Research Council of England grant G0500966_ID-75466; the National Cancer Research Institute (NCRI), UK; and the Southwest National Health Service Research and Development. The biorepository from ProtecT is supported by the NCRI (ProMPT) study and Cambridge and Oxford British Medical Research Council grants from the National Institute for Health Research.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	21	134	140	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1326	1329		10.1038/ng.2437	http://dx.doi.org/10.1038/ng.2437			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23104005	Green Accepted			2022-12-17	WOS:000311713200010
J	Lee, YC; Kuo, HC; Chang, JS; Chang, LY; Huang, LM; Chen, MR; Liang, CD; Chi, H; Huang, FY; Lee, ML; Huang, YC; Hwang, B; Chiu, NC; Hwang, KP; Lee, PC; Chang, LC; Liu, YM; Chen, YJ; Chen, CH; Chen, YT; Tsai, FJ; Wu, JY				Lee, Yi-Ching; Kuo, Ho-Chang; Chang, Jeng-Sheng; Chang, Luan-Yin; Huang, Li-Min; Chen, Ming-Ren; Liang, Chi-Di; Chi, Hsin; Huang, Fu-Yuan; Lee, Meng-Luen; Huang, Yhu-Chering; Hwang, Betau; Chiu, Nan-Chang; Hwang, Kao-Pin; Lee, Pi-Chang; Chang, Li-Ching; Liu, Yi-Min; Chen, Ying-Ju; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Tsai, Fuu-Jen; Wu, Jer-Yuarn		Taiwan Pediat ID Alliance	Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; SINGLE-NUCLEOTIDE POLYMORPHISM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; EPIDEMIOLOGIC FEATURES; CD40 LIGAND; EXPRESSION; TAIWAN; GENE; CELL; FAMILY	To find new candidate loci predisposing individuals to Kawasaki disease, an acute vasculitis that affects children, we conducted a genome-wide association study in 622 individuals with Kawasaki disease (cases) and 1,107 controls in a Han Chinese population residing in Taiwan, with replication in an independent Han Chinese sample of 261 cases and 550 controls. We report two new loci, one at BLK (encoding B-lymphoid tyrosine kinase) and one at CD40, that are associated with Kawasaki disease at genome-wide significance (P < 5 x 10(-8)). Our findings may lead to a better understanding of the role of immune activation and inflammation in Kawasaki disease pathogenesis.	[Lee, Yi-Ching; Chang, Li-Ching; Liu, Yi-Min; Chen, Ying-Ju; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Yi-Ching] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Kuo, Ho-Chang; Liang, Chi-Di; Hwang, Kao-Pin] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Liang, Chi-Di] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Chang, Luan-Yin; Huang, Li-Min] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Ming-Ren; Chi, Hsin; Huang, Fu-Yuan; Chiu, Nan-Chang] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Lee, Meng-Luen] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Lee, Meng-Luen] Changhua Christian Hosp, Div Pediat Cardiol, Changhua, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hwang, Betau] Taipei City Hosp, Dept Pediat, Zhongxiao Branch, Taipei, Taiwan; [Hwang, Kao-Pin] China Med Univ Hosp, Dept Pediat, Div Pediat Infect Dis, Taichung, Taiwan; [Hwang, Kao-Pin; Chen, Chien-Hsiun; Tsai, Fuu-Jen; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lee, Pi-Chang] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; Mackay Memorial Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei City Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Veterans General Hospital; Duke University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Chen, YT (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	chen0010@ibms.sinica.edu.tw; d0704@mail.cmuh.org.tw; jywu@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Tsai, Fuu-Jen/J-4140-2015; Kuo, Ho-Chang/AAQ-6644-2020; Lee, Yi-Ching/AAE-6900-2022; Chen, Chien Hsiun/Q-3826-2018	Kuo, Ho-Chang/0000-0002-3295-2984; Lee, Yi-Ching/0000-0002-7734-5619; CHANG, LUAN-YIN/0000-0003-2632-1956; Huang, Daniel Tsung-Ning/0000-0001-6940-6701; HUANG, LI-MIN/0000-0002-9291-260X	Translational Resource Center (TRC) [NSC100-2325-B-001-023]; National Center for Genome Medicine (NCGM) at Academia Sinica [NSC100-2319-B-001-001]; Academia Sinica Genomic Medicine Multicenter Study, Taiwan [40-05-GMM]	Translational Resource Center (TRC); National Center for Genome Medicine (NCGM) at Academia Sinica; Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan)	We thank all affected individuals and their families who devoted their time and effort to participate in this study. We gratefully acknowledge the members of the Translational Resource Center (TRC) (NSC100-2325-B-001-023) for Genomic Medicine and the National Center for Genome Medicine (NCGM) (NSC100-2319-B-001-001) at Academia Sinica for their support in subject recruitment, genotyping and statistical analysis. We especially thank H. Lue for his inspirational discussion. This study was supported by the Academia Sinica Genomic Medicine Multicenter Study, Taiwan (40-05-GMM). The funders had no role in study design, data collection or analysis, the decision to publish or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Ban Y, 2006, THYROID, V16, P443, DOI 10.1089/thy.2006.16.443; Blanco-Kelly F, 2010, PLOS ONE, V5; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Chang LY, 2004, PEDIATRICS, V114, pE678, DOI 10.1542/peds.2004-0726; Danese S, 2006, J IMMUNOL, V176, P2617, DOI 10.4049/jimmunol.176.4.2617; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kim S, 2005, CURR OPIN PEDIATR, V17, P695, DOI 10.1097/01.mop.0000187190.97166.83; Kurylowicz A, 2005, THYROID, V15, P1119, DOI 10.1089/thy.2005.15.1119; Law CL, 2009, ADV EXP MED BIOL, V647, P8, DOI 10.1007/978-0-387-89520-8_2; LIN CY, 1992, J PEDIATR-US, V121, P924, DOI 10.1016/S0022-3476(05)80343-9; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Ohta Y, 2004, DERMATOLOGY, V209, P21, DOI 10.1159/000078582; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Onouchi Y, 2009, PEDIATR RES, V65, p46R, DOI 10.1203/PDR.0b013e31819dba60; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Park YW, 2011, PEDIATR INT, V53, P36, DOI 10.1111/j.1442-200X.2010.03178.x; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pyrovolaki K, 2009, ARTHRITIS RHEUM-US, V60, P543, DOI 10.1002/art.24257; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wang CL, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e140; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Yanagawa H, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e33; Yanagawa H, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e65	44	134	151	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					522	+		10.1038/ng.2227	http://dx.doi.org/10.1038/ng.2227			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22446961	Green Submitted			2022-12-17	WOS:000303416300011
J	Wu, C; Miao, XP; Huang, LM; Che, X; Jiang, GL; Yu, DK; Yang, XH; Cao, GW; Hu, ZB; Zhou, YJ; Zuo, CH; Wang, CY; Zhang, XH; Zhou, YF; Yu, XJ; Dai, WJ; Li, ZS; Shen, HB; Liu, LM; Chen, YL; Zhang, S; Wang, XQ; Zhai, K; Chang, J; Liu, Y; Sun, MH; Cao, W; Gao, J; Ma, Y; Zheng, XW; Cheung, ST; Jia, YF; Xu, J; Tan, W; Zhao, P; Wu, TC; Wang, CF; Lin, DX				Wu, Chen; Miao, Xiaoping; Huang, Liming; Che, Xu; Jiang, Guoliang; Yu, Dianke; Yang, Xianghong; Cao, Guangwen; Hu, Zhibin; Zhou, Yongjian; Zuo, Chaohui; Wang, Chunyou; Zhang, Xianghong; Zhou, Yifeng; Yu, Xianjun; Dai, Wanjin; Li, Zhaoshen; Shen, Hongbing; Liu, Luming; Chen, Yanling; Zhang, Sheng; Wang, Xiaoqi; Zhai, Kan; Chang, Jiang; Liu, Yu; Sun, Menghong; Cao, Wei; Gao, Jun; Ma, Ying; Zheng, Xiongwei; Cheung, Siu Tim; Jia, Yongfeng; Xu, Jian; Tan, Wen; Zhao, Ping; Wu, Tangchun; Wang, Chengfeng; Lin, Dongxin			Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations	NATURE GENETICS			English	Article							ABO BLOOD-GROUP; HEME OXYGENASE-1; GENE-EXPRESSION; GROUP ALLELES; GROWTH-FACTOR; RISK; BACH1; DAB2; VARIANTS; RECEPTOR	Pancreatic cancer has the lowest survival rate among human cancers, and there are no effective markers for its screening and early diagnosis. To identify genetic susceptibility markers for this cancer, we carried out a genome-wide association study on 981 individuals with pancreatic cancer (cases) and 1,991 cancer-free controls of Chinese descent using 666,141 autosomal SNPs. Promising associations were replicated in an additional 2,603 pancreatic cancer cases and 2,877 controls recruited from 25 hospitals in 16 provinces or cities in China. We identified five new susceptibility loci at chromosomes 21q21.3, 5p13.1, 21q22.3, 22q13.32 and 10q26.11 (P = 2.24 x 10(-13) to P = 4.18 x 10(-10)) in addition to 13q22.1 previously reported in populations of European ancestry. These results advance our understanding of the development of pancreatic cancer and highlight potential targets for the prevention or treatment of this cancer.	[Wu, Chen; Huang, Liming; Yu, Dianke; Zhai, Kan; Chang, Jiang; Liu, Yu; Xu, Jian; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Wu, Chen; Huang, Liming; Che, Xu; Yu, Dianke; Zhai, Kan; Chang, Jiang; Liu, Yu; Xu, Jian; Tan, Wen; Zhao, Ping; Wang, Chengfeng; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Miao, Xiaoping; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Che, Xu; Zhao, Ping; Wang, Chengfeng] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg, Beijing 100730, Peoples R China; [Jiang, Guoliang] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Yang, Xianghong; Cao, Wei] China Med Univ, Shengjing Hosp, Dept Pathol, Shenyang, Peoples R China; [Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Zhou, Yongjian] Fujian Med Univ, Union Hosp, Dept Gastrointestinal Surg, Fuzhou, Peoples R China; [Zuo, Chaohui] Hunan Prov Tumor Hosp, Dept Gastroduodenal & Pancreat Surg, Changsha, Hunan, Peoples R China; [Wang, Chunyou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China; [Zhang, Xianghong] Hebei Med Univ, Dept Expt Pathol, Shijiazhuang, Peoples R China; [Zhou, Yifeng] Soochow Univ, Coll Med, Lab Canc Mol Genet, Suzhou, Peoples R China; [Yu, Xianjun] Fudan Univ, Canc Hosp, Dept Pancreas & Hepatobiliary Surg, Shanghai 200433, Peoples R China; [Li, Zhaoshen] Second Mil Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shanghai, Peoples R China; [Liu, Luming] Fudan Univ, Dept Integrat Oncol, Canc Hosp, Shanghai 200433, Peoples R China; [Chen, Yanling] Fujian Med Univ, Union Hosp, Dept Hepatobiliary & Pancreat Surg, Fuzhou, Peoples R China; [Zhang, Sheng] Fujian Med Univ, Affiliated Hosp 1, Dept Pathol, Fuzhou, Peoples R China; [Wang, Xiaoqi; Cheung, Siu Tim] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Sun, Menghong] Fudan Univ, Canc Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Zheng, Xiongwei] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou, Peoples R China; [Jia, Yongfeng] Inner Mongolia Sch Med, Affiliated Hosp, Dept Pathol, Hohhot, Inner Mongolia, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Fudan University; China Medical University; Naval Medical University; Nanjing Medical University; Fujian Medical University; Huazhong University of Science & Technology; Hebei Medical University; Soochow University - China; Fudan University; Naval Medical University; Fudan University; Fujian Medical University; Fujian Medical University; University of Hong Kong; Fudan University	Lin, DX (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	wangcf369@medmail.com; lindx72@cicams.ac.cn	miao, xiaoping/C-4336-2011; Chang, Jiang/AAP-6156-2020; Cheung, Siu-Tim/C-4238-2009; Pillay, Nischalan/F-9536-2012; Xu, Jian/H-5349-2019; chen, yanling/GRE-8287-2022	miao, xiaoping/0000-0002-6818-9722; Cheung, Siu-Tim/0000-0003-2147-315X; Xu, Jian/0000-0003-0274-4268; Cao, Guangwen/0000-0002-8094-1278; Shen, Hongbing/0000-0002-2581-5906; Lin, Dongxin/0000-0002-8723-8868; Wu, Chen/0000-0003-4954-1011; yu, xianjun/0000-0002-6697-7143	National High-Tech Research and Development Program of China [2009AA022706]; National Natural Science Foundation of China [81021061]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High-Tech Research and Development Program of China (2009AA022706) and the National Natural Science Foundation of China (81021061) to D. L. We thank L. Liang for help in eQTL analysis. We also thank the subjects and the surgeons who recruited them; M. Yang, L. Wang, X. Wang, C. Yang, L. Du, J. Li, F. Qi, X. Song and L. Zeng.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Argani P, 2001, CANCER RES, V61, P4320; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; Bjursell M, 2007, BIOCHEM BIOPH RES CO, V363, P633, DOI 10.1016/j.bbrc.2007.09.016; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; de Stahl TD, 2005, GENE CHROMOSOME CANC, V44, P161, DOI 10.1002/gcc.20226; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Gu W, 2004, J MOL NEUROSCI, V22, P93, DOI 10.1385/JMN:22:1-2:93; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; Heiser PW, 2008, GASTROENTEROLOGY, V135, P1288, DOI 10.1053/j.gastro.2008.06.089; Huang Y, 2001, LAB INVEST, V81, P863, DOI 10.1038/labinvest.3780295; Iida A, 2009, TOHOKU J EXP MED, V217, P223, DOI 10.1620/tjem.217.223; Iodice S, 2010, EUR J CANCER, V46, P3345, DOI 10.1016/j.ejca.2010.08.009; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; Klein AP, 2001, CANCER J, V7, P266; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Nakao M, 2011, CANCER SCI, V102, P1076, DOI 10.1111/j.1349-7006.2011.01907.x; Ohshio G, 2000, DIGEST DIS SCI, V45, P659, DOI 10.1023/A:1005471005289; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; Yang DH, 2006, AM J PATHOL, V169, P258, DOI 10.2353/ajpath.2006.060036; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yeh TS, 2002, GUT, V51, P712, DOI 10.1136/gut.51.5.712; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071; Zhu X, 2010, WORLD J GASTROENTERO, V16, P2633, DOI 10.3748/wjg.v16.i21.2633	43	134	146	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					62	U90		10.1038/ng.1020	http://dx.doi.org/10.1038/ng.1020			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22158540				2022-12-17	WOS:000298664000015
J	Miki, D; Ochi, H; Hayes, CN; Abe, H; Yoshima, T; Aikata, H; Ikeda, K; Kumada, H; Toyota, J; Morizono, T; Tsunoda, T; Kubo, M; Nakamura, Y; Kamatani, N; Chayama, K				Miki, Daiki; Ochi, Hidenori; Hayes, C. Nelson; Abe, Hiromi; Yoshima, Tadahiko; Aikata, Hiroshi; Ikeda, Kenji; Kumada, Hiromitsu; Toyota, Joji; Morizono, Takashi; Tsunoda, Tatsuhiko; Kubo, Michiaki; Nakamura, Yusuke; Kamatani, Naoyuki; Chayama, Kazuaki			Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ELDERLY-PATIENTS; PLATELET COUNT; PLUS RIBAVIRIN; INFECTION; FIBROSIS; JAPAN; CIRRHOSIS; VARIANTS; DISEASE	Chronic viral hepatitis is the most important risk factor for progression to hepatocellular carcinoma (HCC). To identify genetic risk factors for progression to HCC in individuals with chronic hepatitis C virus (HCV), we analyzed 467,538 SNPs in 212 Japanese individuals with chronic HCV with HCC and 765 individuals with chronic HCV without HCC. We identified one intronic SNP in the DEPDC5 locus on chromosome 22 associated with HCC risk and confirmed the association using an independent case-control population (710 cases and 1,625 controls). The association was highly significant when we analyzed the stages separately as well as together (rs1012068, Pcombined = 1.27 x 10(-13), odds ratio = 1.75). The significance level of the association further increased after adjustment for gender, age and platelet count (P = 1.35 x 10(-14), odds ratio = 1.96). Our findings suggest that common variants within the DEPDC5 locus affect susceptibility to HCC in Japanese individuals with chronic HCV infection.	[Miki, Daiki; Ochi, Hidenori; Hayes, C. Nelson; Abe, Hiromi; Yoshima, Tadahiko; Chayama, Kazuaki] RIKEN, Lab Digest Dis, Ctr Genom Med, Hiroshima, Japan; [Miki, Daiki; Ochi, Hidenori; Hayes, C. Nelson; Abe, Hiromi; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Yoshima, Tadahiko] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Osaka, Japan; [Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Toyota, Joji] Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Morizono, Takashi; Tsunoda, Tatsuhiko] RIKEN Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Kamatani, Naoyuki] RIKEN Ctr Genom Med, Stat Lab, Yokohama, Kanagawa, Japan	RIKEN; Hiroshima University; Dainippon Sumitomo Pharmaceutical Company; Toranomon Hospital; Sapporo Kosei General Hospital; RIKEN; RIKEN; University of Tokyo; RIKEN	Chayama, K (corresponding author), RIKEN, Lab Digest Dis, Ctr Genom Med, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Hayes, C. Nelson N/G-4596-2019; Chayama, Kazuaki/B-2493-2016; Abe-Chayama, Hiromi/M-8256-2019; Kubo, Michiaki/N-7947-2015; Miki, Daiki/L-5069-2018	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Miki, Daiki/0000-0002-6505-9826; Chayama, Kazuaki/0000-0002-5530-5341	Grants-in-Aid for Scientific Research [221S0001, 22659147] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; Kanehira M, 2007, ONCOGENE, V26, P6448, DOI 10.1038/sj.onc.1210466; Kharrat A, 1998, BBA-PROTEIN STRUCT M, V1385, P157, DOI 10.1016/S0167-4838(98)00041-7; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Liver cancer study group of Japan, 2010, LIVER CANC STUDY GRO; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MARGOLIN BH, 1988, ENCY STAT SCI, P334; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Miki D, 2008, J GASTROENTEROL, V43, P550, DOI 10.1007/s00535-008-2194-5; NAM J, 1987, BIOMETRICS, V43, P701, DOI 10.2307/2532006; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ono E, 1999, HEPATOL RES, V15, P192, DOI 10.1016/S1386-6346(98)00075-8; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; Takata A, 2010, INT J MOL MED, V26, P249, DOI 10.3892/ijmm_00000459; Taura N, 2006, ONCOL REP, V16, P837; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	31	134	144	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2011	43	8					797	U108		10.1038/ng.876	http://dx.doi.org/10.1038/ng.876			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	798CD	21725309				2022-12-17	WOS:000293178300017
J	Sun, J; Zheng, SL; Wiklund, F; Isaacs, SD; Purcell, LD; Gao, Z; Hsu, FC; Kim, ST; Liu, W; Zhu, Y; Stattin, P; Adami, HO; Wiley, KE; Dimitrov, L; Sun, J; Li, T; Turner, AR; Adams, TS; Adolfsson, J; Johansson, JE; Lowey, J; Trock, BJ; Partin, AW; Walsh, PC; Trent, JM; Duggan, D; Carpten, J; Chang, BL; Gronberg, H; Isaacs, WB; Xu, JF				Sun, Jielin; Zheng, Siqun Lilly; Wiklund, Fredrik; Isaacs, Sarah D.; Purcell, Lina D.; Gao, Zhengrong; Hsu, Fang-Chi; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Stattin, Paer; Adami, Hans-Olov; Wiley, Kathleen E.; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Adolfsson, Jan; Johansson, Jan-Erik; Lowey, James; Trock, Bruce J.; Partin, Alan W.; Walsh, Patrick C.; Trent, Jeffrey M.; Duggan, David; Carpten, John; Chang, Bao-Li; Gronberg, Henrik; Isaacs, William B.; Xu, Jianfeng			Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; 8Q24; AMERICANS	We carried out a fine-mapping study in the HNF1B gene at 17q12 in two study populations and identified a second locus associated with prostate cancer risk, similar to 26 kb centromeric to the first known locus (rs4430796); these loci are separated by a recombination hot spot. We confirmed the association with a SNP in the second locus (rs11649743) in five additional populations, with P = 1.7 x 10(-9) for an allelic test of the seven studies combined. The association at each SNP remained significant after adjustment for the other SNP.	[Wiklund, Fredrik; Adami, Hans-Olov; Gronberg, Henrik] Karolinska Inst, CLINTEC, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Sun, Jielin; Zheng, Siqun Lilly; Purcell, Lina D.; Gao, Zhengrong; Hsu, Fang-Chi; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC 27157 USA; [Sun, Jielin; Zheng, Siqun Lilly; Purcell, Lina D.; Gao, Zhengrong; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Isaacs, Sarah D.; Wiley, Kathleen E.; Trock, Bruce J.; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; [Hsu, Fang-Chi] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Stattin, Paer] Umea Univ Hosp, Dept Surg & Perioperat Sci, SE-90787 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Adolfsson, Jan] Karolinska Inst, CLINTEC, Ctr Oncol, SE-17177 Stockholm, Sweden; [Johansson, Jan-Erik] Orebro Univ Hosp, Dept Urol, SE-70182 Orebro, Sweden; [Lowey, James; Trent, Jeffrey M.; Duggan, David; Carpten, John] Translat Genom Res Inst, Phoenix, AZ 85004 USA	Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Orebro University; Translational Genomics Research Institute	Gronberg, H (corresponding author), Karolinska Inst, CLINTEC, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	henrik.gronberg@ki.se; wisaacs@jhmi.edu	Kim, Seong-Tae/E-4474-2017; LI, TAO/AAL-5932-2020	Kim, Seong-Tae/0000-0001-7436-1405; LI, TAO/0000-0001-7343-9688; Adolfsson, Jan/0000-0003-2992-1869	National Cancer Institute [CA106523, CA95052, CA112517, CA58236, CA86323]; Department of Defense [PC051264]; Swedish Cancer Society (Cancerfonden); Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA095052, U01CA086323, R01CA106523, R01CA112517, P50CA058236] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the study subjects who participated in this study. We also thank the Regional Cancer Registries and the CAPS-steering committee, including E. Varenhorst. We acknowledge the support of W. T. Gerrard, M. Duhon, Jennifer and John Chalsty and D. Koch. We also thank the National Cancer Institute Cancer Genetic Markers of Susceptibility Initiative (CGEMS) for making the data available publicly. We take full responsibility for the study design, data collection, analysis and interpretation of the data, the decision to submit the manuscript for publication, and the writing of the manuscript. The study is supported by National Cancer Institute (CA106523, CA106523 and CA95052 to J.X., CA112517, CA58236 to W.B.I., CA86323 to A.W.P., Department of Defense grant PC051264 to J. X.), as well as support from Swedish Cancer Society (Cancerfonden) and Swedish Research Council to H. G.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Sun JL, 2008, PROSTATE, V68, P691, DOI 10.1002/pros.20754; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	15	134	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1153	1155		10.1038/ng.214	http://dx.doi.org/10.1038/ng.214			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758462	Green Accepted			2022-12-17	WOS:000259651000011
J	Zhou, WL; Lin, LZ; Majumdar, A; Li, X; Zhang, XX; Liu, W; Etheridge, L; Shi, YQ; Martin, J; Van de Ven, W; Kaartinen, V; Wynshaw-Boris, A; McMahon, AP; Rosenfeld, MG; Evans, SM				Zhou, Wenlai; Lin, Lizhu; Majumdar, Arindam; Li, Xue; Zhang, Xiaoxue; Liu, Wei; Etheridge, Leah; Shi, Yunqing; Martin, James; Van de Ven, Wim; Kaartinen, Vesa; Wynshaw-Boris, Anthony; McMahon, Andrew P.; Rosenfeld, Michael G.; Evans, Sylvia M.			Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGF beta 2	NATURE GENETICS			English	Article							BETA-CATENIN; TRANSFORMING GROWTH-FACTOR-BETA-2; OUTFLOW TRACT; EXPRESSION; HEART; GENE; MOUSE; MICE; ATF-2; PITX2	Transcriptional readout downstream of canonical Wnt signaling is known to be mediated by beta-catenin activation of well-described targets, but potential transcriptional readout in response to noncanonical Wnt signaling remains poorly understood. Here, we define a transcriptional pathway important in noncanonical Wnt signaling. We have found that Wnt11 is a direct target of a canonical beta-catenin pathway in developing heart and that Wnt11 mutants show cardiac outflow tract defects. We provide genetic and biochemical evidence that Wnt11 signaling affects extracellular matrix composition, cytoskeletal rearrangements and polarized cell movement required for morphogenesis of the cardiac outflow tract. Notably, transforming growth factor beta 2 (TGF beta 2), a key effector of organ morphogenesis, is regulated by Wnt11- mediated noncanonical signaling in developing heart and somites via one or more activating transcription factor (ATF)/cyclic AMP response element binding protein ( CREB) family members. Thus, we propose that transcriptional readout mediated at least in part by a Wnt11 -> ATF/CREB -> TGF beta 2 pathway is critical in regulating morphogenesis in response to noncanonical Wnt signaling.	Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm, Dept Med, La Jolla, CA 92093 USA; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; Texas A&M Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Houston, TX 77030 USA; Univ Calif San Diego, Ctr Comprehens Canc, Dept Pediat, La Jolla, CA 92093 USA; Katholieke Univ Leuven, Dept Human Genet, Lab Mol Oncol, B-3000 Louvain, Belgium; Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California San Diego; KU Leuven; University of Southern California; Harvard University	Evans, SM (corresponding author), Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu; syevans@ucsd.edu	Evans, Sylvia/G-1980-2015; McMahon, Andrew P/ABE-7520-2020; Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, R01HL074066, R01HL070867, R01HL066276, DP1HL117649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064744, R01DK054364, R37DK054364, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL066276, HL66276, R01 HL065445, HL74066, DP1 HL117649, HL65445, HL70867, R01 HL070867, R01 HL074066] Funding Source: Medline; NIDDK NIH HHS [DK054364, R01 DK054364, DK18477, DK 064744, R37 DK054364, R01 DK018477, K01 DK064744] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline; NINDS NIH HHS [R01 NS073159] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alward WLM, 2000, AM J OPHTHALMOL, V130, P107, DOI 10.1016/S0002-9394(00)00525-0; Bartram U, 2001, CIRCULATION, V103, P2745; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Campione M, 1999, DEVELOPMENT, V126, P1225; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chien KR, 2000, SEMIN ONCOL, V27, P9, DOI 10.1053/sonc.2000.19892; CHRISTIANSEN JH, 1995, MECH DEVELOP, V51, P341, DOI 10.1016/0925-4773(95)00383-5; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Gruber PJ, 2004, CIRC RES, V94, P273, DOI 10.1161/01.RES.0000116144.43797.3B; Henderson DJ, 2001, CIRC RES, V89, P6, DOI 10.1161/hh1301.092497; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; JAKOWLEW SB, 1994, DIFFERENTIATION, V55, P105, DOI 10.1046/j.1432-0436.1994.5520105.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kelly RG, 2000, MICROSC RES TECHNIQ, V50, P510, DOI 10.1002/1097-0029(20000915)50:6<510::AID-JEMT8>3.0.CO;2-1; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kispert A, 1996, DEVELOPMENT, V122, P3627; Li H, 2001, ARCH BIOCHEM BIOPHYS, V394, P1, DOI 10.1006/abbi.2001.2518; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu CY, 2002, DEVELOPMENT, V129, P5081; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moon RT, 2005, SCI STKE; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; van den Hoff MJB, 2004, BIOESSAYS, V26, P248, DOI 10.1002/bies.20006; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322	50	134	139	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1225	1234		10.1038/ng2112	http://dx.doi.org/10.1038/ng2112			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767158	Green Accepted			2022-12-17	WOS:000249737400018
J	Martin, G; Elena, SF; Lenormand, T				Martin, Guillaume; Elena, Santiago F.; Lenormand, Thomas			Distributions of epistasis in microbes fit predictions from a fitness landscape model	NATURE GENETICS			English	Article							DELETERIOUS MUTATIONS; ESCHERICHIA-COLI; RNA VIRUSES; EVOLUTION; RECOMBINATION; ADAPTATION; STRAINS	How do the fitness effects of several mutations combine? Despite its simplicity, this question is central to the understanding of multilocus evolution. Epistasis (the interaction between alleles at different loci), especially epistasis for fitness traits such as reproduction and survival, influences evolutionary predictions(1,2) "almost whenever multilocus genetics matters''(3). Yet very few models(4,5) have sought to predict epistasis, and none has been empirically tested. Here we show that the distribution of epistasis can be predicted from the distribution of single mutation effects, based on a simple fitness landscape model(6). We show that this prediction closely matches the empirical measures of epistasis that have been obtained for Escherichia coli(7) and the RNA virus vesicular stomatitis virus(8). Our results suggest that a simple fitness landscape model may be sufficient to quantitatively capture the complex nature of gene interactions. This model may offer a simple and widely applicable alternative to complex metabolic network models, in particular for making evolutionary predictions.	CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34293 Montpellier, France; Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; UPV, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Martin, G (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, 1919 Route Mende, F-34293 Montpellier, France.	guillaume.martin@unil.ch	Lenormand, Thomas/A-5328-2012; Martin, Guillaume/P-8964-2016; Elena, Santiago F./A-4191-2011	Lenormand, Thomas/0000-0001-8930-5393; Martin, Guillaume/0000-0002-5203-5091; Elena, Santiago F./0000-0001-8249-5593				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; BURGER R, 2000, MATH THEORY SELECTIO, P158; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1998, GENETICA, V102-3, P349, DOI 10.1023/A:1017031008316; Fisher R., 1930, GENETICAL THEORY NAT; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; LANDE R, 1980, GENETICS, V94, P203; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Malmberg RL, 2005, GENET RES, V86, P89, DOI 10.1017/S0016672305007780; Martin G, 2006, EVOLUTION, V60, P2413, DOI 10.1554/06-162.1; Martin G, 2006, EVOLUTION, V60, P893; Mathai A.M., 1992, QUADRATIC FORMS RAND; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2001, EVOL DEV, V3, P121, DOI 10.1046/j.1525-142x.2001.003003121.x; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SZATHMARY E, 1993, GENETICS, V133, P127; Waxman D, 2005, AM NAT, V166, P447, DOI 10.1086/444404; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Wloch DM, 2001, J EVOLUTION BIOL, V14, P310, DOI 10.1046/j.1420-9101.2001.00267.x	30	134	135	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					555	560		10.1038/ng1998	http://dx.doi.org/10.1038/ng1998			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369829	Green Published			2022-12-17	WOS:000245271200029
J	Huber, C; Dias-Santagata, D; Glaser, A; O'Sullivan, J; Brauner, R; Wu, K; Xu, XS; Pearce, K; Wang, R; Uzielli, MLG; Dagoneau, N; Chemaitilly, W; Superti-Furga, A; Dos Santos, H; Megarbane, A; Morin, G; Gillessen-Kaesbach, G; Hennekam, R; Van der Burgt, I; Black, GCM; Clayton, PE; Read, A; Le Merrer, M; Scambler, PJ; Munnich, A; Pan, ZQ; Winter, R; Cormier-Daire, V				Huber, C; Dias-Santagata, D; Glaser, A; O'Sullivan, J; Brauner, R; Wu, K; Xu, XS; Pearce, K; Wang, R; Uzielli, MLG; Dagoneau, N; Chemaitilly, W; Superti-Furga, A; Dos Santos, H; Megarbane, A; Morin, G; Gillessen-Kaesbach, G; Hennekam, R; Van der Burgt, I; Black, GCM; Clayton, PE; Read, A; Le Merrer, M; Scambler, PJ; Munnich, A; Pan, ZQ; Winter, R; Cormier-Daire, V			Identification of mutations in CUL7 in 3-M syndrome	NATURE GENETICS			English	Article							PROTEIN; COMPLEX; CULLIN	Intrauterine growth retardation is caused by maternal, fetal or placental factors that result in impaired endovascular trophoblast invasion and reduced placental perfusion(1). Although various causes of intrauterine growth retardation have been identified, most cases remain unexplained. Studying 29 families with 3-M syndrome (OMIM 273750), an autosomal recessive condition characterized by severe pre- and postnatal growth retardation, we first mapped the underlying gene to chromosome 6p21.1 and then identified 25 distinct mutations in the gene cullin 7 (CUL7). CUL7 assembles an E3 ubiquitin ligase complex containing Skp1, Fbx29 (also called Fbw8) and ROC1 and promotes ubiquitination. Using deletion analysis, we found that CUL7 uses its central region to interact with the Skp1-Fbx29 heterodimer. Functional studies indicated that the 3-M-associated CUL7 nonsense and missense mutations R1445X and H1464P, respectively, render CUL7 deficient in recruiting ROC1. These results suggest that impaired ubiquitination may have a role in the pathogenesis of intrauterine growth retardation in humans.	Univ Paris Descartes, Fac Med, INSERM,U393, APHP,Hop Necker Enfants Malad, F-75015 Paris, France; Dept Med Genet, F-75015 Paris, France; Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; Inst Child Hlth, London WC1N 1EH, England; St Marys Hosp, Univ Hosp NHS Trust, Dept Clin Genet, Manchester M13 0JH, Lancs, England; CHU Bicetre, Pediat Endocrinol Unit, F-94275 Le Kremlin Bicetre, France; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Florence, Dept Paediat, Genet & Mol Med Unit, Florence, Italy; CHU Vaudois, Div Mol Pediat, CH-1011 Lausanne, Switzerland; Hosp Sta Maria, Med Genet Serv, Lisbon, Portugal; Univ St Joseph, Unite Genet Med, Beirut, Lebanon; Univ Med Ctr Nijmegen, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; Univ Essen Gesamthsch, Inst Humangenet, D-45122 Essen, Germany; Amiens Univ Hosp, Dept Paediat, Clin Genet Unit, Amiens, France; Univ Manchester, Endocrine Sci Res Grp, Manchester M13 9PT, Lancs, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Icahn School of Medicine at Mount Sinai; University of London; University College London; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Icahn School of Medicine at Mount Sinai; University of Florence; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universidade de Lisboa; Hospital Santa Maria; Saint Joseph University Beirut; Radboud University Nijmegen; University of Duisburg Essen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of Manchester	Cormier-Daire, V (corresponding author), Univ Paris Descartes, Fac Med, INSERM,U393, APHP,Hop Necker Enfants Malad, 149 Rue Sevres, F-75015 Paris, France.	cormier@necker.fr	superti-furga, andrea/E-9162-2015; Wang, Rong/A-8721-2009; Megarbane, Andre/ABD-5574-2021; Chemaitilly, Wassim/AAQ-3397-2021; Scambler, Peter/AAZ-6026-2020; Chemaitilly, Wassim/N-8178-2018; Scambler, Peter J/C-4998-2008; Black, Graeme/K-7374-2015; cormier-daire, valerie/H-6520-2017	superti-furga, andrea/0000-0002-3543-7531; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; huber, celine/0000-0002-8601-9655; Black, Graeme/0000-0001-8727-6592; cormier-daire, valerie/0000-0002-2839-9856; Clayton, Peter/0000-0003-1225-4537	MRC [G9901217] Funding Source: UKRI; Medical Research Council [G9901217] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; DAUD AI, 1993, AM J PHYSIOL, V264, pH1693, DOI 10.1152/ajpheart.1993.264.5.H1693; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; GETIN I, 2004, PLACENTA, V25, P753; HENNEKAM RCM, 1987, AM J MED GENET, V28, P195, DOI 10.1002/ajmg.1320280127; KOHRMAN DC, 1992, J VIROL, V66, P1752, DOI 10.1128/JVI.66.3.1752-1760.1992; LEMERRER M, 1991, J MED GENET, V28, P186, DOI 10.1136/jmg.28.3.186; Miller J D, 1975, Birth Defects Orig Artic Ser, V11, P39; MUELLER RF, 1992, J MED GENET, V29, P425, DOI 10.1136/jmg.29.6.425; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; SPRANGER J, 1976, EUR J PEDIATR, V123, P115, DOI 10.1007/BF00442641; van der Wall G, 2001, CLIN DYSMORPHOL, V10, P241, DOI 10.1097/00019605-200110000-00002; WINTER RM, 1984, J MED GENET, V21, P124, DOI 10.1136/jmg.21.2.124; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	16	134	141	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1119	1124		10.1038/ng1628	http://dx.doi.org/10.1038/ng1628			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142236				2022-12-17	WOS:000232185600025
J	Thompson, AA; Nguyen, LT				Thompson, AA; Nguyen, LT			Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation	NATURE GENETICS			English	Article							HOMEOBOX GENES; HEMATOPOIESIS; HOXD13; MOUSE		Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Hematol Oncol,Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thompson, AA (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Hematol Oncol,Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA.		Nguyen, T.T. Loan/D-2495-2019	Nguyen, T.T. Loan/0000-0001-6440-6462				ALTER BP, 1992, J HAND SURG-AM, V17A, P566, DOI 10.1016/0363-5023(92)90372-V; Davis AP, 1996, DEVELOPMENT, V122, P1175; Evans T, 1997, HEMATOL ONCOL CLIN N, V11, P1115, DOI 10.1016/S0889-8588(05)70485-8; Favier B, 1996, DEVELOPMENT, V122, P449; HALL JG, 1987, J MED GENET, V24, P79, DOI 10.1136/jmg.24.2.79; Johnson KR, 1998, HUM MOL GENET, V7, P1033, DOI 10.1093/hmg/7.6.1033; Lawrence HJ, 1996, STEM CELLS, V14, P281, DOI 10.1002/stem.140281; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; SCHROEDERKURTH TM, 1989, FANCONI ANEMIA CLIN, P264; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495	15	134	140	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					397	398		10.1038/82511	http://dx.doi.org/10.1038/82511			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101832				2022-12-17	WOS:000165671700008
J	Wei, J; Hemmings, GP				Wei, J; Hemmings, GP			The NOTCH4 locus is associated with susceptibility to schizophrenia	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENE		Schizophrenia Assoc Great Britain, Inst Biol Psychiat, Bangor, Gwynedd, Wales		Wei, J (corresponding author), Schizophrenia Assoc Great Britain, Inst Biol Psychiat, Bangor, Gwynedd, Wales.			Wei, Jun/0000-0002-2916-4944				FORTINI ME, 1993, CELL, V75, P1245, DOI 10.1016/0092-8674(93)90611-S; Levinson DF, 1996, AM J MED GENET, V67, P580; Li LH, 1998, GENOMICS, V51, P45, DOI 10.1006/geno.1998.5330; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRAUB RE, 1995, NAT GENET, V11, P235; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41	11	134	147	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					376	377		10.1038/78044	http://dx.doi.org/10.1038/78044			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932176				2022-12-17	WOS:000088615000008
J	Steinborn, R; Schinogl, P; Zakhartchenko, V; Achmann, R; Schernthaner, W; Stojkovic, M; Wolf, E; Muller, M; Brem, G				Steinborn, R; Schinogl, P; Zakhartchenko, V; Achmann, R; Schernthaner, W; Stojkovic, M; Wolf, E; Muller, M; Brem, G			Mitochondrial DNA heteroplasmy in cloned cattle produced by fetal and adult cell cloning	NATURE GENETICS			English	Article							NUCLEI; FIBROBLASTS; SHEEP; MICE		Univ Vet Med, Inst Genet & Anim Breeding, Vienna, Austria; Ludwig Boltzmann Inst Immuno Cyto & Mol Genet, Vienna, Austria; Inst Agrobiotechnol, Dept Biotechnol Anim Prod, Tulln, Austria; Univ Munich, Gene Ctr, Dept Mol Anim Breeding & Genet, Munich, Germany	University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; University of Natural Resources & Life Sciences, Vienna; University of Munich	Steinborn, R (corresponding author), Univ Vet Med, Inst Genet & Anim Breeding, Vienna, Austria.	Ralf.Steinborn@vu-wien.ac.at		Muller, Mathias/0000-0002-7879-3552; Zakhartchenko, Valeri/0000-0002-5974-9759; Stojkovic, Miodrag/0000-0001-7526-6573; Wolf, Eckhard/0000-0002-0430-9510				Evans MJ, 1999, NAT GENET, V23, P90, DOI 10.1038/12696; Hiendleder S, 1999, MOL REPROD DEV, V54, P24, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;24::AID-MRD4&gt;3.0.CO;2-S; Irwin MH, 1999, TRANSGENIC RES, V8, P119, DOI 10.1023/A:1008925419758; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; PLANTE Y, 1992, THERIOGENOLOGY, V38, P887; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Steinborn R, 1998, FEBS LETT, V426, P357, DOI 10.1016/S0014-5793(98)00351-2; Steinborn R, 1998, FEBS LETT, V426, P352, DOI 10.1016/S0014-5793(98)00350-0; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zakhartchenko V, 1999, MOL REPROD DEV, V54, P264, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;264::AID-MRD7&gt;3.0.CO;2-Y; Zakhartchenko V, 1999, J REPROD FERTIL, V115, P325, DOI 10.1530/jrf.0.1150325	14	134	141	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2000	25	3					255	257		10.1038/77000	http://dx.doi.org/10.1038/77000			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888867				2022-12-17	WOS:000087920900008
J	Zhong, J; Peters, AHFM; Lee, K; Braun, RE				Zhong, J; Peters, AHFM; Lee, K; Braun, RE			A double-stranded RNA binding protein required for activation of repressed messages in mammalian germ cells	NATURE GENETICS			English	Article							MESSENGER-RNA; MOUSE; MICE; SPERMATOGENESIS; LOCALIZATION; PROTAMINE	Chromatin packaging in mammalian spermatozoa requires an ordered replacement of the somatic histones by two classes of spermatid-specific basic proteins, the transition proteins and the protamines(1). Temporal expression of transition proteins and protamines during spermatid differentiation is under translational control, and premature translation of protamine 1 leads to precocious nuclear condensation and sterility(2). We have previously suggested that the double-stranded (ds) RNA binding protein Prbp (encoded by the gene Tarbp2) functions as a translational regulator during mouse spermatogenesis(3). Here we show that Prbp is required for proper translational activation of the mRNAs encoding the protamines. We generated mice that carry a targeted disruption of Tarbp2 and determined that they were sterile and severely oligospermic. Using immunohistological analysis, we determined that the endogenous Prm2 mRNA and a reporter mRNA carrying protamine 1 translational-control elements were translated in a mosaic pattern. We showed that failure to synthesize the protamines resulted in delayed replacement of the transition proteins and subsequent failure of spermiation. The timing of Prbp expression suggests that it may function as a chaperone in the assembly of specific translationally regulated ribonucleoprotein particles.	Univ Washington, Dept Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Braun, RE (corresponding author), Univ Washington, Dept Genet, Box 357360,1959 NE Pacific, Seattle, WA 98195 USA.			Peters, Antoine/0000-0002-0311-1887	NICHD NIH HHS [U54 HD12629, HD27215] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027215, U54HD012629] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALFONSO PJ, 1993, BIOL REPROD, V48, P522, DOI 10.1095/biolreprod48.3.522; BRAUN RE, 1990, ENZYME, V44, P120, DOI 10.1159/000468752; BRAUN RE, 1989, GENE DEV, V3, P793, DOI 10.1101/gad.3.6.793; CATIGNOL A, 1993, MOL CELL BIOL, V13, P2193; Fajardo MA, 1997, DEV BIOL, V191, P42, DOI 10.1006/dbio.1997.8705; FAJARDO MA, 1994, DEV BIOL, V166, P643, DOI 10.1006/dbio.1994.1344; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; LEBLOND CP, 1952, AM J ANAT, V90, P167, DOI 10.1002/aja.1000900202; Lee K, 1995, P NATL ACAD SCI USA, V92, P12451, DOI 10.1073/pnas.92.26.12451; Lee K, 1996, MOL CELL BIOL, V16, P3023; Meistrich ML, 1993, MOL BIOL MALE REPROD, P67; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Russell L. D., 1990, HISTOLOGICAL HISTOPA; SCHUMACHER JM, 1995, BIOL REPROD, V52, P1274, DOI 10.1095/biolreprod52.6.1274; STANKER LH, 1993, MOL IMMUNOL, V30, P1633, DOI 10.1016/0161-5890(93)90436-F; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979	17	134	148	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					171	174		10.1038/9684	http://dx.doi.org/10.1038/9684			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369260	Green Published			2022-12-17	WOS:000080680900023
J	Ong, KKL; Phillips, DI; Fall, C; Poulton, J; Bennett, ST; Golding, J; Todd, JA; Dunger, DB				Ong, KKL; Phillips, DI; Fall, C; Poulton, J; Bennett, ST; Golding, J; Todd, JA; Dunger, DB			The insulin gene VNTR, type 2 diabetes and birth weight	NATURE GENETICS			English	Letter							FETAL; ASSOCIATION; RESISTANCE; GROWTH; LOCUS		Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2XY, England; John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ Southampton, Southampton Gen Hosp, MRC Unit, Southampton SO16 6YD, Hants, England; Oxagen Ltd, Abingdon OX14 4RY, Oxon, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England; Univ Cambridge, Wellcome Trust, Cambridge Med Res, Dept Med Genet, Cambridge CB2 2XY, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; University of Southampton; Oxagen Limited; University of Bristol; University of Cambridge; Wellcome Trust Sanger Institute	Todd, JA (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Wellcome Trust, MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk; david.dunger@paediatrics.oxford.ac.uk	Todd, John A/A-3542-2010; Poulton, Joanna/AAB-4828-2021	Todd, John A/0000-0003-2740-8148; Golding, Jean/0000-0003-2826-3307; Dunger, Professor David/0000-0002-2566-9304; Poulton, Joanna/0000-0002-2460-5587				AMIEL SA, 1991, J CLIN ENDOCR METAB, V72, P277, DOI 10.1210/jcem-72-2-277; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; JENSEN MD, 1988, AM J PHYSIOL, V254, pF700; JULIER C, 1994, AM J HUM GENET, V55, P1247; McCarthy M, 1998, NAT GENET, V19, P209, DOI 10.1038/876; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; Phillips DIW, 1996, DIABETOLOGIA, V39, P1119; SIMMONS RA, 1993, ENDOCRINOLOGY, V133, P1361, DOI 10.1210/en.133.3.1361; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; Waterworth DM, 1997, LANCET, V349, P986, DOI 10.1016/S0140-6736(96)08368-7	13	134	135	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1999	21	3					262	263		10.1038/6775	http://dx.doi.org/10.1038/6775			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080175				2022-12-17	WOS:000078977900016
J	Paterson, AH; Lan, TH; Reischmann, KP; Chang, C; Lin, YR; Liu, SC; Burow, MD; Kowalski, SP; Katsar, CS; DelMonte, TA; Feldmann, KA; Schertz, KF; Wendel, JF				Paterson, AH; Lan, TH; Reischmann, KP; Chang, C; Lin, YR; Liu, SC; Burow, MD; Kowalski, SP; Katsar, CS; DelMonte, TA; Feldmann, KA; Schertz, KF; Wendel, JF			Toward a unified genetic map of higher plants, transcending the monocot-dicot divergence	NATURE GENETICS			English	Letter							DETAILED RFLP MAP; ARABIDOPSIS-THALIANA; CHROMOSOMAL SEGMENTS; LINKAGE MAPS; GENOME; ORGANIZATION; ANGIOSPERMS; RICE; SEQUENCES; SYNTENY		UNIV DELAWARE,DEPT PLANT & SOIL SCI,NEWARK,DE 19711; UNIV ARIZONA,DEPT PLANT SCI,TUCSON,AZ 85721; IOWA STATE UNIV,DEPT BOT,AMES,IA 50011; TEXAS A&M UNIV,USDA ARS,COLLEGE STN,TX 77843	University of Delaware; University of Arizona; Iowa State University; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Paterson, AH (corresponding author), TEXAS A&M UNIV,DEPT SOIL & CROP SCI,PLANT GENOME MAPPING LAB,COLLEGE STN,TX 77843, USA.			Lin, Yann-rong/0000-0001-6833-8276				AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; CHITTENDEN LM, 1994, THEOR APPL GENET, V87, P925, DOI 10.1007/BF00225786; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Devos KM, 1992, THEOR APPL GENET, V83, P931, DOI 10.1007/BF00232953; KOWALSKI SP, 1994, GENETICS, V138, P499; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; LINDER H P, 1987, Kew Bulletin, V42, P297, DOI 10.2307/4109686; MARCHETTI MA, 1991, PLANT DIS, V75, P773, DOI 10.1094/PD-75-0773; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCGRATH JM, 1993, THEOR APPL GENET, V86, P880, DOI 10.1007/BF00212616; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NADEAU JH, 1992, MAMM GENOME, V3, P480, DOI 10.1007/BF00778825; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; PERIERA MG, 1994, GENOME, V37, P236; PETERSEN G, 1993, PLANT SYST EVOL, V187, P115, DOI 10.1007/BF00994094; PRINCE JP, 1993, GENOME, V36, P404, DOI 10.1139/g93-056; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; REINISCH AJ, 1994, GENETICS, V138, P829; SCHMIDT R, 1995, SCIENCE, V270, P480, DOI 10.1126/science.270.5235.480; SHIELDS R, 1993, NATURE, V365, P297, DOI 10.1038/365297a0; STEBBINS GL, 1966, SCIENCE, V152, P1463, DOI 10.1126/science.152.3728.1463; TANKSLEY SD, 1992, GENETICS, V132, P1141; Thomasson J. R., 1987, GRASS SYSTEMATICS EV, P159; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WHITKUS R, 1992, GENETICS, V132, P1119; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201	31	134	140	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					380	382		10.1038/ng1296-380	http://dx.doi.org/10.1038/ng1296-380			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944014	Green Published			2022-12-17	WOS:A1996VV73000010
J	GOUW, LG; KAPLAN, CD; HAINES, JH; DIGRE, KB; RUTLEDGE, SL; MATILLA, A; LEPPERT, M; ZOGHBI, HY; PTACEK, LJ				GOUW, LG; KAPLAN, CD; HAINES, JH; DIGRE, KB; RUTLEDGE, SL; MATILLA, A; LEPPERT, M; ZOGHBI, HY; PTACEK, LJ			RETINAL DEGENERATION CHARACTERIZES A SPINOCEREBELLAR ATAXIA MAPPING TO CHROMOSOME 3P	NATURE GENETICS			English	Article							LARGE KINDREDS; GENE; LOCUS; MAPS; MUTATIONS; LINKAGE; ATROPHY; REPEAT	A heterogeneous group of neurological disorders known as the spinocerebellar ataxias (SCA) are characterized by degeneration of the cerebellum, spinal cord and brainstem. We describe linkage analysis in four unusual SCA families revealing a distinct disease locus on chromosome 3p14-21.1. The disease in these families is distinguished from other forms of SCA by concomitant retinal degeneration. Initial visual problems leading to blindness, disabling ataxia and anticipation are seen in all kindreds. The anticipation in these families suggests a dynamic mutation at this locus. Eventual molecular characterization of this disease may provide valuable insights into the processes of both neural and retinal degeneration.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT NEUROL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT OPHTHALMOL,SALT LAKE CITY,UT 84112; OREGON EYE ASSOCIATES,EUGENE,OR 97401; UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35233; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Baylor College of Medicine			MATILLA-DUEÑAS, ANTONI/C-7980-2011; Kaplan, Craig/AAO-4500-2021	MATILLA-DUEÑAS, ANTONI/0000-0002-3514-4181; Kaplan, Craig/0000-0002-7518-695X; Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [HD00940] Funding Source: Medline; NINDS NIH HHS [NS27699, NS32711] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032711, R01NS027699] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1993, CLIN FEATURES CLASSI; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOPESCENDES I, 1994, GENOMICS, V21, P270, DOI 10.1006/geno.1994.1257; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ott J., 1991, ANAL HUMAN GENETIC L; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; RANUM LPW, 1992, NEUROLOGY, V42, P344, DOI 10.1212/WNL.42.2.344; RICH SS, 1987, AM J HUM GENET, V41, P524; STEVANIN G, 1994, AM J HUM GENET, V54, P11; STGEORGEHYSLOP P, 1994, AM J HUM GENET, V55, P120; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TO KW, 1993, OPHTHALMOLOGY, V100, P15; TWELLS R, 1994, HUM MOL GENET, V3, P177, DOI 10.1093/hmg/3.1.177; VOIZ A, 1992, CELL GENETICS, V60, P37; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1993, CELL, V72, P971	34	134	141	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					89	93		10.1038/ng0595-89	http://dx.doi.org/10.1038/ng0595-89			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647799				2022-12-17	WOS:A1995QX57300021
J	DIETZ, HC; KENDZIOR, RJ				DIETZ, HC; KENDZIOR, RJ			MAINTENANCE OF AN OPEN READING FRAME AS AN ADDITIONAL LEVEL OF SCRUTINY DURING SPLICE-SITE SELECTION	NATURE GENETICS			English	Article							MESSENGER-RNA PRECURSORS; NONSENSE MUTATIONS; MARFAN-SYNDROME; MISSENSE MUTATION; PREMESSENGER RNA; FIBRILLIN GENE; EXON; INTRON; SEQUENCES; CELLS	Although nonsense mutations have been associated with the skipping of specific constitutively spliced exons in selected genes, notably the fibrillin gene, the basis for this association is unclear. Now, using chimaeric constructs in a model in vivo expression system, premature termination codons are identified as determinants of splice site selection. Nonsense codon recognition prior to RNA splicing necessitates the ability to read the frame of precursor mRNA in the nucleus. We propose that maintenance of an open reading frame can serve as an additional level of scrutiny during exon definition. This process may have pathogenic and evolutionary significance.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	DIETZ, HC (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.							BACH G, 1993, AM J HUM GENET, V53, P330; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; COOPER TA, 1992, J BIOL CHEM, V267, P5330; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DOMENJOUD L, 1991, MOL CELL BIOL, V11, P4581, DOI 10.1128/MCB.11.9.4581; FISHER CW, 1993, AM J HUM GENET, V52, P414; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; KRAWCZAK M, 1992, HUM GENET, V90, P41; LIBRI D, 1990, MOL CELL BIOL, V10, P5036, DOI 10.1128/MCB.10.10.5036; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; NIWA M, 1992, NATURE, V360, P277, DOI 10.1038/360277a0; OSHIMA Y, 1987, J MOL BIOL, V195, P247; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868	39	134	140	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					183	188		10.1038/ng1094-183	http://dx.doi.org/10.1038/ng1094-183			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842017				2022-12-17	WOS:A1994PL12300021
J	MCDONALD, MT; PAPENBERG, KA; GHOSH, S; GLATFELTER, AA; BIESECKER, BB; HELMBOLD, EA; MARKEL, DS; ZOLOTOR, A; MCKINNON, WC; VANDERSTOEP, JL; JACKSON, CE; IANNUZZI, M; COLLINS, FS; BOEHNKE, M; PORTEOUS, ME; GUTTMACHER, AE; MARCHUK, DA				MCDONALD, MT; PAPENBERG, KA; GHOSH, S; GLATFELTER, AA; BIESECKER, BB; HELMBOLD, EA; MARKEL, DS; ZOLOTOR, A; MCKINNON, WC; VANDERSTOEP, JL; JACKSON, CE; IANNUZZI, M; COLLINS, FS; BOEHNKE, M; PORTEOUS, ME; GUTTMACHER, AE; MARCHUK, DA			A DISEASE LOCUS FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA MAPS TO CHROMOSOME 9Q33-34	NATURE GENETICS			English	Article							HEMORRHAGIC TELANGIECTASIA; IDENTIFICATION; POLYMORPHISMS; EXPRESSION; LINKAGE; 9Q32-34; FAMILY; CHAIN; DNA	Hereditary haemorrhagic telangiectasia (HHT), or Osler-Weber-Rendu disease, is an autosomal dominant vascular dysplasia of unknown pathogenesis reading to 'widespread' dermal, mucosal and visceral telangiectases and recurrent haemorrhage. We have mapped the HHT gene, by linkage analysis, to markers on 9q33-34 in two large multi-generation families. Haplotype analysis and mapping of recombination breakpoints gives a 4 cM interval between D9S61 and D9S63 as the most likely location of the gene. The closest marker, D9S65, is estimated to be within 1 cM of the gene and shows a combined lod score of 11.41. Two potential candidate genes, COL5A1 and ZNF79, are also located within 9q33-34. These results provide a starting point for the eventual cloning of the HHT gene.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT & COMMUNICABLE DIS,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT RADIAT ONCOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,CTR HUMAN GENOME,ANN ARBOR,MI 48109; UNIV VERMONT,COLL MED,DEPT PEDIAT,BURLINGTON,VT 05405; HENRY FORD HOSP,DIV CLIN & MOLEC GENET,DETROIT,MI 48202; HENRY FORD HOSP,DIV PULM MED,DETROIT,MI 48202; NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND; WESTERN GEN HOSP,CLIN GENET SERV,EDINBURGH EH4 2XY,MIDLOTHIAN,SCOTLAND; DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Vermont; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Newcastle University - UK; University of Edinburgh; Duke University				Markel, Dorene/0000-0002-3382-6779; Marchuk, Douglas/0000-0002-3110-6671; Biesecker, Barbara/0000-0001-9665-8963	NHLBI NIH HHS [HL49171] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049171] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHR DJ, 1977, AM J MED, V62, P452, DOI 10.1016/0002-9343(77)90846-4; BIRD RM, 1957, NEW ENGL J MED, V257, P105, DOI 10.1056/NEJM195707182570303; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; CARDI G, 1992, HUM GENET, V90, P174; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASHIMOTO K, 1972, ORAL SURG ORAL MED O, V34, P751, DOI 10.1016/0030-4220(72)90293-9; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUEBNER K, 1993, HUM GENET, V91, P217, DOI 10.1007/BF00218259; IANNUZZI MC, 1991, AM J HUM GENET, V48, P757; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEIBOWITZ D, 1985, BLOOD, V65, P526; MAHMIAS J, 1992, HUM MOL GENET, V1, P286; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLER JY, 1978, NOUV PRESSE MED, V7, P1723; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; PORTEOUS MEM, 1992, J MED GENET, V29, P527, DOI 10.1136/jmg.29.8.527; ROMAN G, 1978, ANN NEUROL, V4, P130, DOI 10.1002/ana.410040207; SENSI A, 1986, TISSUE ANTIGENS, V28, P275; Snyder LH, 1944, J LAB CLIN MED, V29, P1211; STEEL D, 1988, AM J CLIN PATHOL, V90, P274, DOI 10.1093/ajcp/90.3.274; VASE P, 1985, ACTA MED SCAND, V218, P105; WEBER JL, 1989, AM J HUM GENET, V44, P388	31	134	143	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					197	204		10.1038/ng0294-197	http://dx.doi.org/10.1038/ng0294-197			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162075				2022-12-17	WOS:A1994MU76300017
J	Kortum, F; Caputo, V; Bauer, CK; Stella, L; Ciolfi, A; Aawi, M; Bocchinfuso, G; Flex, E; Paolacci, S; Dentici, ML; Grammatico, P; Korenke, GC; Leuzzi, V; Mowat, D; Nair, LDV; Nguyen, TTM; Thierry, P; White, SM; Dallapiccola, B; Pizzuti, A; Campeau, PM; Tartaglia, M; Kutsche, K				Kortuem, Fanny; Caputo, Viviana; Bauer, Christiane K.; Stella, Lorenzo; Ciolfi, Andrea; Aawi, Malik; Bocchinfuso, Gianfranco; Flex, Elisabetta; Paolacci, Stefano; Dentici, Maria Lisa; Grammatico, Paola; Korenke, Georg Christoph; Leuzzi, Vincenzo; Mowat, David; Nair, Lal D. V.; Thi Tuyet Mai Nguyen; Thierry, Patrick; White, Susan M.; Dallapiccola, Bruno; Pizzuti, Antonio; Campeau, Philippe M.; Tartaglia, Marco; Kutsche, Kerstin			Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome	NATURE GENETICS			English	Article							VACUOLAR H+-ATPASE; DE-NOVO MUTATION; CANTU SYNDROME; DIFFERENTIAL EXPRESSION; POTASSIUM CHANNEL; V-ATPASE; SUBUNIT; ACIDIFICATION; K(V)10.1; PHYSIOLOGY	Zimmermann-Laband syndrome (ZLS) is a developmental disorder characterized by facial dysmorphism with gingival enlargement, intellectual disability, hypoplasia or aplasia of nails and terminal phalanges, and hypertrichosis(1-4). We report that heterozygous missense mutations in KCNH1 account for a considerable proportion of ZLS. KCNH1 encodes the voltage-gated K+ channel Eag1 (K(v)10.1). Patch-clamp recordings showed strong negative shifts in voltage-dependent activation for all but one KCNH1 channel mutant (Gly469Arg). Coexpression of Gly469Arg with wild-type KCNH1 resulted in heterotetrameric channels with reduced conductance at positive potentials but pronounced conductance at negative potentials. These data support a gain-of-function effect for all ZLS-associated KCNH1 mutants. We also identified a recurrent de novo missense change in ATP6V1B2, encoding the B2 subunit of the multimeric vacuolar H+ ATPase, in two individuals with ZLS. Structural analysis predicts a perturbing effect of the mutation on complex assembly. Our findings demonstrate that KCNH1 mutations cause ZLS and document genetic heterogeneity for this disorder.	[Kortuem, Fanny; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Caputo, Viviana; Paolacci, Stefano; Pizzuti, Antonio] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Bauer, Christiane K.] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Hamburg, Germany; [Stella, Lorenzo; Bocchinfuso, Gianfranco] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Rome, Italy; [Ciolfi, Andrea; Flex, Elisabetta; Paolacci, Stefano; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Aawi, Malik] Univ Med Ctr Hamburg Eppendorf, Bioinformat Serv Facil, Hamburg, Germany; [Aawi, Malik] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Aawi, Malik] Leibniz Inst Expt Virol, Heinrich Pette Inst, Virus Genom, Hamburg, Germany; [Dentici, Maria Lisa; Dallapiccola, Bruno; Tartaglia, Marco] Osped Pediat Bambino Gesu, Ist Ricovero & Cura Carattere Sci, Rome, Italy; [Grammatico, Paola] Univ Roma La Sapienza, Osped San Camillo Forlanini, Dipartimento Med Mol, I-00185 Rome, Italy; [Korenke, Georg Christoph] Klinikum Oldenburg, Zentrum Kinder & Jugendmed, Neuropadiat, Oldenburg, Germany; [Leuzzi, Vincenzo] Univ Roma La Sapienza, Dipartimento Pediat & Neuropsichiatria Infantile, I-00185 Rome, Italy; [Mowat, David] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Mowat, David] Univ New S Wales, Univ New South Wales Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Nair, Lal D. V.] Saveetha Univ, Saveetha Med Coll & Hosp, Dept Pediat, Madras, Tamil Nadu, India; [Thi Tuyet Mai Nguyen] Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Thierry, Patrick] Ctr Hosp Intercommunal Haute Saone, Serv Pediat, Vesoul, France; [White, Susan M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [White, Susan M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Campeau, Philippe M.] Univ Montreal, Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; Sapienza University Rome; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Heinrich Pette Institute; IRCCS Bambino Gesu; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; Klinikum Oldenburg; Sapienza University Rome; University of Sydney; University of New South Wales Sydney; Saveetha Institute of Medical & Technical Science; Saveetha Medical College & Hospital; Universite de Montreal; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Universite de Montreal	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	marco.tartaglia@iss.it; kkutsche@uke.de	Bocchinfuso, Gianfranco/E-9014-2011; Stella, Lorenzo/A-7996-2010; Flex, Elisabetta/A-5958-2017; Tartaglia, Marco/K-2955-2018; Nair, Lal Devayani Vasudevan/J-5275-2019; Ciolfi, Andrea/J-4954-2018; Campeau, Philippe/J-8614-2015; , Malik/AAB-7437-2021; Dentici, Maria Lisa/AAC-7654-2022; Dallapiccola, Bruno/K-8692-2016	Bocchinfuso, Gianfranco/0000-0002-5556-7691; Stella, Lorenzo/0000-0002-5489-7381; Flex, Elisabetta/0000-0002-6802-1356; Tartaglia, Marco/0000-0001-7736-9672; Nair, Lal Devayani Vasudevan/0000-0002-5364-6919; Ciolfi, Andrea/0000-0002-6191-0978; Campeau, Philippe/0000-0001-9713-7107; , Malik/0000-0002-5993-7709; Dentici, Maria Lisa/0000-0002-9505-5906; PIZZUTI, Antonio/0000-0003-3245-1925; Bauer, Christiane K./0000-0002-2078-3503; Dallapiccola, Bruno/0000-0002-5031-1013; Leuzzi, Vincenzo/0000-0002-2314-6139; /0000-0002-5551-7520	Deutsche Forschungsgemeinschaft [KO 4576/1-1, KU 1240/5-1]; Istituto Superiore di Sanita (Ricerca Corrente); Ministero della Salute (Ricerca Finalizzata) [RF-2010-2312766]; Ospedale Pediatrico Bambino Gesu (Gene-Rare)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Istituto Superiore di Sanita (Ricerca Corrente); Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Ospedale Pediatrico Bambino Gesu (Gene-Rare)	We are grateful to the patients and their families who contributed to this study. We thank I. Jantke, S. Cecchetti and S. Venanzi for skillful technical assistance, T. Kock for site-directed mutagenesis, A. Hasse for CHO cell transfection and injection, R. Bahring, J.M. Schroder and E. Neumann for help with the oocyte experiments, P. Meinecke for discussing clinical phenotypes and A. Podolska for help with ATP6V1B2 sequencing. G.B., L.S. and M.T. acknowledge CINECA for computational resources (whole-exome sequencing data and structural analyses). The KCNH1/heag1 clone was kindly provided by S.H. Heinemann (Friedrich Schiller University Jena). This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 4576/1-1 to F.K. and KU 1240/5-1 to K.K.), Istituto Superiore di Sanita (Ricerca Corrente 2013 to M.T.), Ministero della Salute (Ricerca Finalizzata RF-2010-2312766 to B.D.) and Ospedale Pediatrico Bambino Gesu (Gene-Rare to B.D.).	Abo-Dalo B, 2008, CLIN DYSMORPHOL, V17, P181, DOI 10.1097/MCD.0b013e3282f2514c; Abo-Dalo B, 2007, AM J MED GENET A, V143A, P2668, DOI 10.1002/ajmg.a.32034; Alavandar G, 1965, J All India Dent Assoc, V37, P349; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Brownstein CA, 2013, EUR J MED GENET, V56, P678, DOI 10.1016/j.ejmg.2013.09.009; Campeau PM, 2014, AM J MED GENET C, V166, P327, DOI 10.1002/ajmg.c.31412; Castori M, 2013, EUR J MED GENET, V56, P570, DOI 10.1016/j.ejmg.2013.08.004; Chacon-Camacho OF, 2011, AM J MED GENET A, V155A, P1716, DOI 10.1002/ajmg.a.34030; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Correa JD, 2011, ISRN DENT, V2011, DOI DOI 10.5402/2011/497850; Davalos IP, 2005, GENET COUNSEL, V16, P283; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fuster DG, 2008, KIDNEY INT, V73, P1151, DOI 10.1038/ki.2008.96; Garg V, 2012, J GEN PHYSIOL, V140, P307, DOI 10.1085/jgp.201210826; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Jacquinet A, 2010, AM J MED GENET A, V152A, P2322, DOI 10.1002/ajmg.a.33574; Kim HG, 2007, AM J MED GENET A, V143A, P107, DOI 10.1002/ajmg.a.31544; Kohl T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026329; LABAND PETER F., 1964, ORAL SURG ORAL MED AND ORAL PATHOL, V17, P339, DOI 10.1016/0030-4220(64)90506-7; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mortensen LS, 2015, J PHYSIOL-LONDON, V593, P181, DOI 10.1113/jphysiol.2014.281600; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Ninkovic M, 2012, FEBS LETT, V586, P3077, DOI 10.1016/j.febslet.2012.07.055; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Stefanova M, 2003, AM J MED GENET A, V117A, P289, DOI 10.1002/ajmg.a.10174; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Thouta S, 2014, BIOPHYS J, V106, P1057, DOI 10.1016/j.bpj.2014.01.035; Ufartes R, 2013, HUM MOL GENET, V22, P2247, DOI 10.1093/hmg/ddt076; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; VANDYKE RW, 1993, AM J PHYSIOL, V265, pC901, DOI 10.1152/ajpcell.1993.265.4.C901; VANHILLE B, 1994, BIOCHEM J, V303, P191, DOI 10.1042/bj3030191; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; White SM, 2011, AM J MED GENET A, V155A, P2512, DOI 10.1002/ajmg.a.34184; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Wynn Richard L., 2009, General Dentistry, V57, P105; Yang Y, 2013, J NEUROSCI, V33, P16586, DOI 10.1523/JNEUROSCI.2307-13.2013; Yuan YY, 2014, CELL RES, V24, P1370, DOI 10.1038/cr.2014.77; Zhang YY, 2014, J CELL PHYSIOL, V229, P202, DOI 10.1002/jcp.24435	51	133	140	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					661	667		10.1038/ng.3282	http://dx.doi.org/10.1038/ng.3282			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915598	Green Submitted			2022-12-17	WOS:000355386500019
J	Schubert, J; Siekierska, A; Langlois, M; May, P; Huneau, C; Becker, F; Muhle, H; Suls, A; Lemke, JR; de Kovel, CGF; Thiele, H; Konrad, K; Kawalia, A; Toliat, MR; Sander, T; Ruschendorf, F; Caliebe, A; Nagel, I; Kohl, B; Kecskes, A; Jacmin, M; Hardies, K; Weckhuysen, S; Riesch, E; Dorn, T; Brilstra, EH; Baulac, S; Moller, RS; Hjalgrim, H; Koeleman, BPC; Jurkat-Rott, K; Lehman-Horn, F; Roach, JC; Glusman, G; Hood, L; Galas, DJ; Martin, B; de Witte, PAM; Biskup, S; De Jonghe, P; Helbig, I; Balling, R; Nurnberg, P; Crawford, AD; Esguerra, CV; Weber, YG; Lerche, H				Schubert, Julian; Siekierska, Aleksandra; Langlois, Melanie; May, Patrick; Huneau, Clement; Becker, Felicitas; Muhle, Hiltrud; Suls, Arvid; Lemke, Johannes R.; de Kovel, Carolien G. F.; Thiele, Holger; Konrad, Kathryn; Kawalia, Amit; Toliat, Mohammad R.; Sander, Thomas; Rueschendorf, Franz; Caliebe, Almuth; Nagel, Inga; Kohl, Bernard; Kecskes, Angela; Jacmin, Maxime; Hardies, Katia; Weckhuysen, Sarah; Riesch, Erik; Dorn, Thomas; Brilstra, Eva H.; Baulac, Stephanie; Moller, Rikke S.; Hjalgrim, Helle; Koeleman, Bobby P. C.; Jurkat-Rott, Karin; Lehman-Horn, Frank; Roach, Jared C.; Glusman, Gustavo; Hood, Leroy; Galas, David J.; Martin, Benoit; de Witte, Peter A. M.; Biskup, Saskia; De Jonghe, Peter; Helbig, Ingo; Balling, Rudi; Nuernberg, Peter; Crawford, Alexander D.; Esguerra, Camila V.; Weber, Yvonne G.; Lerche, Holger		EuroEPINOMICS RES Consortium	Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes	NATURE GENETICS			English	Article							PAROXYSMAL KINESIGENIC DYSKINESIA; SYNAPTIC VESICLE FUSION; DE-NOVO MUTATIONS; FEBRILE SEIZURES; INFANTILE CONVULSIONS; GENERALIZED EPILEPSY; PRRT2 MUTATIONS; GENERATION; DISORDERS; ZEBRAFISH	Febrile seizures affect 2-4% of all children(1) and have a strong genetic component(2). Recurrent mutations in three main genes (SCN1A, SCN1B and GABRG2)(3-5) have been identified that cause febrile seizures with or without epilepsy. Here we report the identification of mutations in STX1B, encoding syntaxin-1B(6), that are associated with both febrile seizures and epilepsy. Whole-exome sequencing in independent large pedigrees(7,8) identified cosegregating STX1B mutations predicted to cause an early truncation or an in-frame insertion or deletion. Three additional nonsense or missense mutations and a de novo microdeletion encompassing STX1B were then identified in 449 familial or sporadic cases. Video and local field potential analyses of zebrafish larvae with antisense knockdown of stx1b showed seizure-like behavior and epileptiform discharges that were highly sensitive to increased temperature. Wild-type human syntaxin-1B but not a mutated protein rescued the effects of stx1b knockdown in zebrafish. Our results thus implicate STX1B and the presynaptic release machinery in fever-associated epilepsy syndromes.	[Schubert, Julian; Becker, Felicitas; Weber, Yvonne G.; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Siekierska, Aleksandra; Kecskes, Angela; de Witte, Peter A. M.; Crawford, Alexander D.; Esguerra, Camila V.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Leuven, Belgium; [Langlois, Melanie; May, Patrick; Jacmin, Maxime; Galas, David J.; Balling, Rudi; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [May, Patrick; Roach, Jared C.; Glusman, Gustavo; Hood, Leroy; Galas, David J.] Inst Syst Biol, Seattle, WA USA; [Huneau, Clement; Martin, Benoit] INSERM, U1099, Rennes, France; [Huneau, Clement; Martin, Benoit] Univ Rennes 1, LTSI, Rennes, France; [Muhle, Hiltrud; Helbig, Ingo] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Suls, Arvid; Hardies, Katia; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Suls, Arvid; Hardies, Katia; Weckhuysen, Sarah; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2020 Antwerp, Belgium; [Lemke, Johannes R.] Inselspital Bern, Univ Childrens Hosp, Div Human Genet, CH-3010 Bern, Switzerland; [Lemke, Johannes R.] Univ Hosp Leipzig, Inst Human Genet, Leipzig, Germany; [de Kovel, Carolien G. F.; Koeleman, Bobby P. C.] Univ Med Ctr Utrecht, Dept Med Genet, Sect Complex Genet, Utrecht, Netherlands; [Thiele, Holger; Konrad, Kathryn; Kawalia, Amit; Toliat, Mohammad R.; Sander, Thomas] Univ Cologne, CCG, D-50931 Cologne, Germany; [Rueschendorf, Franz] Max Delbruck Ctr Mol Med, Berlin, Germany; [Caliebe, Almuth; Nagel, Inga] Univ Kiel, Inst Human Genet, Kiel, Germany; [Caliebe, Almuth; Nagel, Inga] Univ Hosp Schleswig Holstein, Kiel, Germany; [Kohl, Bernard] Kinderkrankenhaus Wilhelmstift, Rahlstedt, Germany; [Riesch, Erik; Biskup, Saskia] CeGaT, Tubingen, Germany; [Riesch, Erik; Biskup, Saskia] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Dorn, Thomas] Swiss Epilepsy Ctr, Zurich, Switzerland; [Baulac, Stephanie] Univ Paris 06, Sorbonne Univ, CNRS, UMR 7225,UMRS 1127,INSERM U1127, Paris, France; [Baulac, Stephanie] Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Moller, Rikke S.; Hjalgrim, Helle] Danish Epilepsy Ctr, Dianalund, Denmark; [Moller, Rikke S.; Hjalgrim, Helle] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark; [Jurkat-Rott, Karin; Lehman-Horn, Frank] Univ Ulm, Div Neurophysiol, D-89069 Ulm, Germany; [Galas, David J.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; KU Leuven; University of Luxembourg; Institute for Systems Biology (ISB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes 1; University of Kiel; Schleswig Holstein University Hospital; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Bern; University Hospital of Bern; Leipzig University; Utrecht University; Utrecht University Medical Center; University of Cologne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; CeGaT; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Southern Denmark; Ulm University; Pacific Northwest Diabetes Research Institute (PNDRI); University of Cologne; University of Cologne	Lerche, H (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany.	c.v.esguerra@biotek.uio.no; holger.lerche@uni-tuebingen.de	Suls, Arvid/M-2694-2013; de Kovel, Carolien/AAI-3531-2021; Helbig, Ingo/G-8467-2018; Brilstra, Eva/AAT-3092-2021; Thiele, Holger/ABE-6792-2020; Baulac, Stéphanie/O-2099-2016; Weckhuysen, Sarah/HGB-9957-2022; May, Patrick/B-1238-2010; May, Patrick/N-1019-2019; Esguerra, Camila/N-6159-2015; Caliebe, Almuth/G-1248-2018; Muhle, Hiltrud/F-5715-2010	Suls, Arvid/0000-0003-0328-198X; de Kovel, Carolien/0000-0002-7818-1396; Helbig, Ingo/0000-0001-8486-0558; Thiele, Holger/0000-0002-0169-998X; Baulac, Stéphanie/0000-0001-6430-4693; Weckhuysen, Sarah/0000-0003-2878-1147; May, Patrick/0000-0001-8698-3770; May, Patrick/0000-0001-8698-3770; Esguerra, Camila/0000-0002-2271-8094; Caliebe, Almuth/0000-0003-2157-425X; Balling, Rudi/0000-0003-2902-5650; Glusman, Gustavo/0000-0001-8060-5955; Siekierska, Aleksandra/0000-0003-4907-605X; de Witte, Peter/0000-0002-9989-9567; Moller, Rikke S./0000-0002-9664-1448	Federal Ministry for Education and Research (BMBF; NGENplus/EMINet) [01GS08123, 01G508120, 01GM1105]; European Science Foundation from the German Research Foundation (DFG) [Le1030/11-1, He5415/3-1, Sa43415-1, Nu50/8-1]; Swiss National Fund [32EP30_136042/1]; Fund for Scientific Research Flanders [GA13611N]; German Research Foundation (DFG) [WE4896/3-1, HE5415/6-1]; University of Tubingen [AKF 297-0-0]; German Society for Epileptology (DGfE); foundation no-epilep; University of Kiel; Institute of Clinical Molecular Biology in Kiel; BMBF [01EY1103]; Center for Systems Biology P50 grant (US National Institutes of Health) [GM076547]; DEG; University of Luxembourg-Institute for Systems Biology Program; 'Le Plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg' through the Luxembourg Centre for Systems Biomedicine (LCSB); University of Luxembourg; Agency for Innovation by Science and Technology (IWT, Flanders); LCSB KT program; Hertie Foundation; program 'Investissements d'Avenir' [ANR-10-IAIHU-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	Federal Ministry for Education and Research (BMBF; NGENplus/EMINet); European Science Foundation from the German Research Foundation (DFG); Swiss National Fund(Swiss National Science Foundation (SNSF)); Fund for Scientific Research Flanders(FWO); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Tubingen; German Society for Epileptology (DGfE); foundation no-epilep; University of Kiel; Institute of Clinical Molecular Biology in Kiel; BMBF(Federal Ministry of Education & Research (BMBF)); Center for Systems Biology P50 grant (US National Institutes of Health); DEG; University of Luxembourg-Institute for Systems Biology Program; 'Le Plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg' through the Luxembourg Centre for Systems Biomedicine (LCSB); University of Luxembourg; Agency for Innovation by Science and Technology (IWT, Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); LCSB KT program; Hertie Foundation; program 'Investissements d'Avenir'(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the families and their relatives for their cooperation. We thank P. Verstreken (VIB, KU Leuven) for providing access to the electrophysiology equipment. This study was supported by the Federal Ministry for Education and Research (BMBF; NGENplus/EMINet to H.L., RN. and T.S., 01GS08123 and 01G508120; lonNeurONet to H.L., K.J.-R., EL-H. and S. Biskup, 01GM1105), funding to the EuroEPINOMICS Consortium coordinated by the European Science Foundation from the German Research Foundation (DFG; Le1030/11-1 to H.L., He5415/3-1 to I.H., Sa43415-1 to T.S. and Nu50/8-1 to RN.), the Swiss National Fund (32EP30_136042/1 to J.R.L.) and the Fund for Scientific Research Flanders (GA13611N to P.D.J.). Y.G.W. and I.H. were funded by the German Research Foundation (DFG: WE4896/3-1 and HE5415/6-1). Y.G.W. and S. Biskup received intramural funding from the University of Tubingen (AKF 297-0-0). The German Society for Epileptology (DGfE) gave funding to H.L., Y.G.W., I.H. and H.M., and the foundation no-epilep gave funding to H.L. I.H. and H.M. received further support through intramural grants from the University of Kiel and infrastructural support from the Institute of Clinical Molecular Biology in Kiel, supported in part by the popgen 2.0 network (P2N) through a grant from the BMBF (01EY1103) and Cluster of Excellence 'Inflammation at Interfaces' and 'Future Ocean' programs funded by the DEG. The study was further supported by a Center for Systems Biology P50 grant (GM076547, US National Institutes of Health) to L.H. and by the University of Luxembourg-Institute for Systems Biology Program (P.M., J.C.R., G.G., L.H. and D.J.G.). M. Brunkow provided project management for the whole-genome sequencing. P.M. was supported by 'Le Plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg' through the Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg. A. Kecskes and K.H. are recipients of a PhD fellowship from the Agency for Innovation by Science and Technology (IWT, Flanders). A. Suls is a postdoctoral fellow of the Research Foundation-Flanders (FWO Vlaanderen). M.L. and M.J. were supported by the LCSB KT program. EL-H. and K.J.-R. are supported by the Hertie Foundation. S. Baulac received financial support from the program 'Investissements d'Avenir' (ANR-10-IAIHU-06).	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Becker F, 2013, J NEUROL, V260, P1234, DOI 10.1007/s00415-012-6777-y; Berg AT, 2013, HAND CLINIC, V111, P391, DOI 10.1016/B978-0-444-52891-9.00043-9; Bragina L, 2010, NEUROSCIENCE, V165, P934, DOI 10.1016/j.neuroscience.2009.11.009; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Eckhaus J, 2013, EPILEPSY RES, V105, P103, DOI 10.1016/j.eplepsyres.2013.02.011; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Lee HY, 2012, CELL REP, V1, P2, DOI 10.1016/j.celrep.2011.11.001; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lerche H, 2001, NEUROLOGY, V57, P1191, DOI 10.1212/WNL.57.7.1191; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pietri T, 2009, DEV NEUROBIOL, V69, P780, DOI 10.1002/dneu.20741; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Schubert J, 2012, HUM MUTAT, V33, P1439, DOI 10.1002/humu.22126; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289; Weber YG, 2008, EPILEPSIA, V49, P1959, DOI 10.1111/j.1528-1167.2008.01646.x; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307	25	133	140	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1327	1332		10.1038/ng.3130	http://dx.doi.org/10.1038/ng.3130			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25362483				2022-12-17	WOS:000345547300014
J	Buchovecky, CM; Turley, SD; Brown, HM; Kyle, SM; McDonald, JG; Liu, B; Pieper, AA; Huang, WH; Katz, DM; Russell, DW; Shendure, J; Justice, MJ				Buchovecky, Christie M.; Turley, Stephen D.; Brown, Hannah M.; Kyle, Stephanie M.; McDonald, Jeffrey G.; Liu, Benny; Pieper, Andrew A.; Huang, Wenhui; Katz, David M.; Russell, David W.; Shendure, Jay; Justice, Monica J.			A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome	NATURE GENETICS			English	Article							MOUSE MODEL; SQUALENE EPOXIDASE; BRAIN; MUTATIONS; NEURONS; LANOSTEROL; STEROLS; REVEALS; PROTEIN; 24-HYDROXYLASE	Mutations in MECP2, encoding methyl CpG-binding protein 2, cause Rett syndrome, the most severe autism spectrum disorder. Re-expressing Mecp2 in symptomatic Mecp2-null mice markedly improves function and longevity, providing hope that therapeutic intervention is possible in humans. To identify pathways in disease pathology for therapeutic intervention, we carried out a dominant N-ethyl-N-nitrosourea (ENU) mutagenesis suppressor screen in Mecp2-null mice and isolated five suppressors that ameliorate the symptoms of Mecp2 loss. We show that a stop codon mutation in Sqle, encoding squalene epoxidase, a rate-limiting enzyme in cholesterol biosynthesis, underlies suppression in one line. Subsequently, we also show that lipid metabolism is perturbed in the brains and livers of Mecp2-null male mice. Consistently, statin drugs improve systemic perturbations of lipid metabolism, alleviate motor symptoms and confer increased longevity in Mecp2 mutant mice. Our genetic screen therefore points to cholesterol homeostasis as a potential target for the treatment of patients with Rett syndrome.	[Buchovecky, Christie M.; Brown, Hannah M.; Kyle, Stephanie M.; Justice, Monica J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Turley, Stephen D.; Liu, Benny] Univ Texas Southwestern Med Sch, Dept Internal Med, Dallas, TX USA; [McDonald, Jeffrey G.; Russell, David W.] Univ Texas Southwestern Med Sch, Dept Mol Genet, Dallas, TX USA; [Pieper, Andrew A.] Univ Texas Southwestern Med Sch, Dept Psychiat, Dallas, TX USA; [Pieper, Andrew A.] Univ Texas Southwestern Med Sch, Dept Biochem, Dallas, TX USA; [Huang, Wenhui; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Katz, David M.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; Case Western Reserve University	Justice, MJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mjustice@bcm.edu	Shendure, Jay/AAU-3684-2021; Pieper, Andrew A/R-5552-2016	Russell, David/0000-0002-0277-403X; Shendure, Jay/0000-0002-1516-1865; Pieper, Andrew/0000-0001-6299-6577	RSRT; Rett Syndrome Research Foundation; International Rett Syndrome Foundation [2608, 2583]; Autism Science Foundation [11-1015]; US National Institutes of Health (NIH) [NIH T32 GM08307, NIH U54 GM69338, NIH R01 HL09610, NIH R01 CA115503]; National Institute of Neurologic Diseases and Stroke; American Recovery and Reinvestment Act; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [2P30DK079638-05, 5P30HD024064-23]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA115503] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL009610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, T32GM008307] Funding Source: NIH RePORTER	RSRT; Rett Syndrome Research Foundation; International Rett Syndrome Foundation; Autism Science Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Recovery and Reinvestment Act; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by grants from the RSRT, the Rett Syndrome Research Foundation, the International Rett Syndrome Foundation (ANGEL award 2608 to M.J.J. and ANGEL award 2583 to D.M.K.), Autism Science Foundation predoctoral fellowship # 11-1015, US National Institutes of Health (NIH) grants NIH T32 GM08307 to C. M. B., NIH U54 GM69338 to D. W. R., NIH R01 HL09610 to S. D. T. and NIH R01 CA115503 to M.J.J. and the National Institute of Neurologic Diseases and Stroke, including funding from the American Recovery and Reinvestment Act (D.M.K.). Grants to the BCM Diabetes and Endocrinology Research Center (2P30DK079638-05) and the BCM Intellectual and Developmental Disabilities Research Center (5P30HD024064-23) from the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development also supported this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the NIH.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ardern-Holmes SL, 2011, CURR TREAT OPTION NE, V13, P529, DOI 10.1007/s11940-011-0142-9; ASTRUC M, 1977, BIOCHIM BIOPHYS ACTA, V487, P204, DOI 10.1016/0005-2760(77)90056-X; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cibickova L, 2011, J CLIN LIPIDOL, V5, P373, DOI 10.1016/j.jacl.2011.06.007; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; COREY EJ, 1966, J AM CHEM SOC, V88, P4750, DOI 10.1021/ja00972a056; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Dietschy JM, 2009, BIOL CHEM, V390, P287, DOI 10.1515/BC.2009.035; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Garcia-Sabina A, 2012, Farm Hosp, V36, P97, DOI 10.1016/j.farma.2011.02.010; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jolley CD, 1999, AM J PHYSIOL-GASTR L, V276, pG1117, DOI 10.1152/ajpgi.1999.276.5.G1117; Jurevics HA, 1997, J LIPID RES, V38, P723; Justice MJ, 2011, DIS MODEL MECH, V4, P305, DOI 10.1242/dmm.000901; Kavalali ET, 2011, J NEURODEV DISORD, V3, P250, DOI 10.1007/s11689-011-9078-3; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Ko M, 2005, J BIOL CHEM, V280, P42759, DOI 10.1074/jbc.M509164200; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Neuhaus IM, 1998, MAMM GENOME, V9, P150, DOI 10.1007/s003359900706; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Percy AK, 2011, ARCH NEUROL-CHICAGO, V68, P985, DOI 10.1001/archneurol.2011.149; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pose D, 2009, PLANT SIGNAL BEHAV, V4, P873, DOI 10.4161/psb.4.9.9425; Pose D, 2009, PLANT J, V59, P63, DOI 10.1111/j.1365-313X.2009.03849.x; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Shepherd GMG, 2011, CURR OPIN NEUROBIOL, V21, P827, DOI 10.1016/j.conb.2011.06.006; Shibata N, 2001, P NATL ACAD SCI USA, V98, P2244, DOI 10.1073/pnas.041620398; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Stranahan AM, 2011, J NEUROCHEM, V118, P611, DOI 10.1111/j.1471-4159.2011.07351.x; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; YAMAMOTO S, 1970, J BIOL CHEM, V245, P1670; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	63	133	137	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1013	+		10.1038/ng.2714	http://dx.doi.org/10.1038/ng.2714			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23892605	Green Accepted			2022-12-17	WOS:000323748200010
J	Wirschell, M; Olbrich, H; Werner, C; Tritschler, D; Bower, R; Sale, WS; Loges, NT; Pennekamp, P; Lindberg, S; Stenram, U; Carlen, B; Horak, E; Kohler, G; Nurnberg, P; Nurnberg, G; Porter, ME; Omran, H				Wirschell, Maureen; Olbrich, Heike; Werner, Claudius; Tritschler, Douglas; Bower, Raqual; Sale, Winfield S.; Loges, Niki T.; Pennekamp, Petra; Lindberg, Sven; Stenram, Unne; Carlen, Birgitta; Horak, Elisabeth; Koehler, Gabriele; Nuernberg, Peter; Nuernberg, Gudrun; Porter, Mary E.; Omran, Heymut			The nexin-dynein regulatory complex subunit DRC1 is essential for motile cilia function in algae and humans	NATURE GENETICS			English	Article							CHLAMYDOMONAS-FLAGELLA; RADIAL SPOKES; DYSKINESIA; INNER; ARMS; MUTATIONS; IDENTIFICATION; ASYMMETRY; DEFECTS; MUTANTS	Primary ciliary dyskinesia (PCD) is characterized by dysfunction of respiratory cilia and sperm flagella and random determination of visceral asymmetry. Here, we identify the DRC1 subunit of the nexin-dynein regulatory complex (N-DRC), an axonemal structure critical for the regulation of dynein motors, and show that mutations in the gene encoding DRC1, CCDC164, are involved in PCD pathogenesis. Loss-of-function mutations disrupting DRC1 result in severe defects in assembly of the N-DRC structure and defective ciliary movement in Chlamydomonas reinhardtii and humans. Our results highlight a role for N-DRC integrity in regulating ciliary beating and provide the first direct evidence that mutations in DRC genes cause human disease.	[Wirschell, Maureen; Sale, Winfield S.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Olbrich, Heike; Werner, Claudius; Loges, Niki T.; Pennekamp, Petra; Omran, Heymut] Univ Hosp Muenster, Dept Pediat, Munster, Germany; [Tritschler, Douglas; Bower, Raqual; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Lindberg, Sven] Lund Univ, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden; [Lindberg, Sven] Skane Univ Hosp SUS, Lund, Sweden; [Stenram, Unne; Carlen, Birgitta] Lund Univ, Dept Pathol, Lund, Sweden; [Stenram, Unne; Carlen, Birgitta] SUS, Lund, Sweden; [Horak, Elisabeth] Med Univ Innsbruck, Div Cardiol & Pulmonol, Dept Pediat & Adolescents, A-6020 Innsbruck, Austria; [Koehler, Gabriele] Univ Hosp Muenster, Inst Pathol, Munster, Germany; [Nuernberg, Peter; Nuernberg, Gudrun] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter; Nuernberg, Gudrun] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Nuernberg, Peter; Nuernberg, Gudrun] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Emory University; University of Munster; University of Minnesota System; University of Minnesota Twin Cities; Lund University; Lund University; Skane University Hospital; Lund University; Medical University of Innsbruck; University of Munster; University of Cologne; University of Cologne; University of Cologne	Omran, H (corresponding author), Univ Hosp Muenster, Dept Pediat, Munster, Germany.	porte001@umn.edu; heymut.omran@ukmuenster.de		Omran, Heymut/0000-0003-0282-6765	US National Institutes of Health (NIH) [GM-55667, GM-051173]; National Research Service Award (NRSA) postdoctoral fellowship [GM-075446]; Children's Healthcare of Atlanta; Emory University School of Medicine Pediatric Research Center; Deutsche Forschungsgemeinschaft DFG [Om 6/4, Om 6/5, GRK1104, SFB592]; IZKF Muenster; Cell Dynamics and Disease (CEDAD) graduate school; SYSCILIA from the European Community; National Science Foundation (NSF) Major Research Instrumentation grants [9871237, NSF-DBI-0215759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055667, R01GM055667, R37GM051173, F32GM075446, R01GM051173] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA) postdoctoral fellowship; Children's Healthcare of Atlanta; Emory University School of Medicine Pediatric Research Center; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); IZKF Muenster; Cell Dynamics and Disease (CEDAD) graduate school; SYSCILIA from the European Community; National Science Foundation (NSF) Major Research Instrumentation grants(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Piperno for providing the peptide sequences used to identify the Chlamydomonas DRC1 gene. M.E.P. also thanks C. Perrone, T. vy Le, A. Bostrom, J. Mueller and J.A. Knott for assistance with mapping the DRC1 locus, P. Kathir, C. Silflow and S. Dutcher for advice on RFLP mapping and T. Markowski and B. Witthun for assistance with mass spectrometry and spectral counting. We thank the German patient support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V. We also thank A. Heer and C. Westermann for excellent technical assistance. We thank M. Laudon and the Chlamydomonas Genetics Center for strains. For antibodies, we thank R. Linck (University of Minnesota) for antibody to Rib72, M. Sanders (University of Minnesota) for MC1 antibody to centrin, R. Kamiya (University of Tokyo) for antibodies to tektin, p44 and p38, T. Yagi (Kyoto University) for antibodies to DHC5, DHC9 and DHC11, P. Yang (Marquette University) for antibody to RSP16, E. Smith (Dartmouth College) for antibody to CaM-IP3 and G. Piperno (Mount Sinai School of Medicine) for antibody to p28). This work was supported by US National Institutes of Health (NIH) grants to M.E.P. (GM-55667) and W.S.S. (GM-051173), a National Research Service Award (NRSA) postdoctoral fellowship to M.W. (GM-075446), funding to W.S.S. from the Children's Healthcare of Atlanta and Emory University School of Medicine Pediatric Research Center and funding to H. Omran (Deutsche Forschungsgemeinschaft DFG Om 6/4 and Om 6/5, GRK1104, SFB592, IZKF Muenster and the Cell Dynamics and Disease (CEDAD) graduate school as well as SYSCILIA from the European Community). The Center for Mass Spectrometry and Proteomics at the University of Minnesota is supported by multiple grants, including National Science Foundation (NSF) Major Research Instrumentation grants 9871237 and NSF-DBI-0215759. Technical and software support was also provided by the Minnesota Supercomputing Institute.	Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Carlen B, 2003, ULTRASTRUCT PATHOL, V27, P123, DOI 10.1080/01913120309930; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Dymek EE, 2011, MOL BIOL CELL, V22, P2520, DOI 10.1091/mbc.E11-03-0271; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Kabututu ZP, 2010, J CELL SCI, V123, P3587, DOI 10.1242/jcs.073817; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; O'Toole ET, 2012, CYTOSKELETON, V69, P577, DOI 10.1002/cm.21035; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; SILFLOW CD, 1981, COLD SPRING HARB SYM, V46, P157, DOI 10.1101/SQB.1982.046.01.019; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Yagi T, 2009, J CELL SCI, V122, P1306, DOI 10.1242/jcs.045096; Yanagisawa H, 2004, MOL BIOL CELL, V15, P2105, DOI 10.1091/mbc.E03-11-0854; Zadro C, 2010, INT J PEDIATR OTORHI, V74, P494, DOI 10.1016/j.ijporl.2010.02.004; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD	31	133	142	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					262	268		10.1038/ng.2533	http://dx.doi.org/10.1038/ng.2533			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23354437	Green Accepted			2022-12-17	WOS:000315664800009
J	Hatlestad, GJ; Sunnadeniya, RM; Akhavan, NA; Gonzalez, A; Goldman, IL; McGrath, JM; Lloyd, AM				Hatlestad, Gregory J.; Sunnadeniya, Rasika M.; Akhavan, Neda A.; Gonzalez, Antonio; Goldman, Irwin L.; McGrath, J. Mitchell; Lloyd, Alan M.			The beet R locus encodes a new cytochrome P450 required for red betalain production	NATURE GENETICS			English	Article							TABLE BEET; EXPRESSION; BIOSYNTHESIS; CLONING; 5-O-GLUCOSYLTRANSFERASE; IDENTIFICATION; METABOLISM; VECTORS; PLANTS; L.	Anthocyanins are red and violet pigments that color flowers, fruits and epidermal tissues in virtually all flowering plants. A single order, Caryophyllales, contains families in which an unrelated family of pigments, the betalains, color tissues normally pigmented by anthocyanins(1). Here we show that CYP76AD1 encoding a novel cytochrome P450 is required to produce the red betacyanin pigments in beets. Gene silencing of CYP76AD1 results in loss of red pigment and production of only yellow betaxanthin pigment. Yellow betalain mutants are complemented by transgenic expression of CYP76AD1, and an insertion in CYP76AD1 maps to the R locus(2,3) that is responsible for yellow versus red pigmentation. Finally, expression of CYP76AD1 in yeast verifies its position in the betalain biosynthetic pathway. Thus, this cytochrome P450 performs the biosynthetic step that provides the cyclo-DOPA moiety of all red betacyanins. This discovery will contribute to our ability to engineer this simple, nutritionally valuable pathway(4) into heterologous species.	[Hatlestad, Gregory J.; Sunnadeniya, Rasika M.; Akhavan, Neda A.; Gonzalez, Antonio; Lloyd, Alan M.] Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Goldman, Irwin L.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [McGrath, J. Mitchell] ARS, Sugarbeet & Bean Res Unit, USDA, E Lansing, MI USA; [McGrath, J. Mitchell] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA	University of Texas System; University of Texas Austin; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Michigan State University	Lloyd, AM (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	lloyd@uts.cc.utexas.edu	McGrath, Mitch/S-7397-2019		USDA [2008-01111]; US National Science Foundation (NSF) [MCB-1122179]; Div Of Molecular and Cellular Bioscience [1122179] Funding Source: National Science Foundation	USDA(United States Department of Agriculture (USDA)); US National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors dedicate this manuscript to Tom Mabry and thank him for inspiration. The authors thank K. Keller for help with pigment analysis. This work was supported by USDA grant 2008-01111 and US National Science Foundation (NSF) grant MCB-1122179.	BILYK A, 1981, J FOOD SCI, V46, P298, DOI 10.1111/j.1365-2621.1981.tb14588.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Clement JS, 1996, BOT ACTA, V109, P360, DOI 10.1111/j.1438-8677.1996.tb00584.x; Goldman IL, 1996, HORTSCIENCE, V31, P880, DOI 10.21273/HORTSCI.31.5.880; Goldman IL, 2000, THEOR APPL GENET, V100, P337, DOI 10.1007/s001220050044; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller W, 1936, J AGRIC RES, V52, P0027; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kugler F, 2004, J AGR FOOD CHEM, V52, P2975, DOI 10.1021/jf035491w; Lewellen RT, 2004, CROP SCI, V44, P357, DOI 10.2135/cropsci2004.0357; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Sasaki N, 2004, FEBS LETT, V568, P159, DOI 10.1016/j.febslet.2004.04.097; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Stintzing FC, 2004, TRENDS FOOD SCI TECH, V15, P19, DOI 10.1016/j.tifs.2003.07.004; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873	22	133	150	2	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					816	U130		10.1038/ng.2297	http://dx.doi.org/10.1038/ng.2297			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22660548				2022-12-17	WOS:000305886900019
J	Ocbina, PJR; Eggenschwiler, JT; Moskowitz, I; Anderson, KV				Ocbina, Polloneal Jymmiel R.; Eggenschwiler, Jonathan T.; Moskowitz, Ivan; Anderson, Kathryn V.			Complex interactions between genes controlling trafficking in primary cilia	NATURE GENETICS			English	Article							RETROGRADE INTRAFLAGELLAR TRANSPORT; ASPHYXIATING THORACIC DYSTROPHY; REPRESSOR FUNCTIONS; CYTOPLASMIC DYNEIN; HEDGEHOG; PROTEIN; MUTATIONS; CHLAMYDOMONAS; LOCALIZATION; INHERITANCE	Cilia-associated human genetic disorders are striking in the diversity of their abnormalities and their complex inheritance. Inactivation of the retrograde ciliary motor by mutations in DYNC2H1 causes skeletal dysplasias that have strongly variable expressivity. Here we define previously unknown genetic relationships between Dync2h1 and other genes required for ciliary trafficking. Mutations in mouse Dync2h1 disrupt cilia structure, block Sonic hedgehog signaling and cause midgestation lethality. Heterozygosity for Ift172, a gene required for anterograde ciliary trafficking, suppresses cilia phenotypes, Sonic hedgehog signaling defects and early lethality of Dync2h1 homozygotes. Ift122, like Dync2h1, is required for retrograde ciliary trafficking, but reduction of Ift122 gene dosage also suppresses the Dync2h1 phenotype. These genetic interactions illustrate the cell biology underlying ciliopathies and argue that mutations in intraflagellar transport genes cause their phenotypes because of their roles in cilia architecture rather than direct roles in signaling.	[Ocbina, Polloneal Jymmiel R.; Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Ocbina, Polloneal Jymmiel R.] Cornell Univ, Weill Grad Sch Med Sci, Neurosci Program, New York, NY 10021 USA; [Eggenschwiler, Jonathan T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Moskowitz, Ivan] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Moskowitz, Ivan] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Princeton University; University of Chicago; University of Chicago	Anderson, KV (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY USA.	k-anderson@sloankettering.edu		Anderson, Kathryn/0000-0003-1657-2161; Moskowitz, Ivan/0000-0003-0014-4963; eggenschwiler, jonathan/0000-0001-6444-8865	National Institute of Child Health and Human Development; US National Institutes of Health [R01 NS044385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Vallee (Columbia University College of Physicians and Surgeons) for the Dync2h1 antibody, R. Rohatgi and M. Scott (Stanford University) for expression constructs used to generate antibodies against Smo and Ptch1, and S. Weatherbee for help in antibody production. We thank B. Yoder (University of Alabama at Birmingham) for the mouse Ift88 conditional allele and A. Joyner (Memorial Sloan-Kettering Cancer Center (MSKCC)) for Gli2 and Gli3<SUP>XtJ</SUP> mice. We acknowledge N. Lampen (MSKCC Electron Microscopy Facility) for technical support with scanning electron microscopy; Z. Lazar, Y. Romin and S. Fujisawa (MSKCC Molecular Cytology Core) for assistance with confocal microscopy and MetaMorph analysis, and S. Galdeen (Rockefeller University Bio-Imaging Resource Center) for assistance with DeltaVision microscopy. We are grateful to members of the Anderson lab and Timothy Bestor (Columbia University Medical Center) for helpful discussions and critical reading of the manuscript. We obtained monoclonal antibodies from the Developmental Studies Hybridoma Bank, which was developed under the auspices of the National Institute of Child Health and Human Development and is maintained by the Department of Biological Sciences, University of Iowa. This work was supported by the US National Institutes of Health R01 NS044385 to K.V.A.	Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Kamp A, 2010, HUM MOL GENET, V19, P3105, DOI 10.1093/hmg/ddq211; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Mo R, 1997, DEVELOPMENT, V124, P113; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	48	133	137	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					547	U75		10.1038/ng.832	http://dx.doi.org/10.1038/ng.832			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21552265	Green Accepted			2022-12-17	WOS:000291017000011
J	Miki, D; Kubo, M; Takahashi, A; Yoon, KA; Kim, J; Lee, GK; Zo, JI; Lee, JS; Hosono, N; Morizono, T; Tsunoda, T; Kamatani, N; Chayama, K; Takahashi, T; Inazawa, J; Nakamura, Y; Daigo, Y				Miki, Daiki; Kubo, Michiaki; Takahashi, Atsushi; Yoon, Kyong-Ah; Kim, Jeongseon; Lee, Geon Kook; Zo, Jae Ill; Lee, Jin Soo; Hosono, Naoya; Morizono, Takashi; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Chayama, Kazuaki; Takahashi, Takashi; Inazawa, Johji; Nakamura, Yusuke; Daigo, Yataro			Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations	NATURE GENETICS			English	Article							CANCER STATISTICS; HISTOLOGIC TYPE; FAMILY-HISTORY; TRENDS; LOCUS; RISK; P63; MUTATIONS; GEFITINIB; VARIANTS	Lung cancer is the most common cause of death from cancer worldwide, and its incidence is increasing in East Asian and Western countries. To identify genetic factors that modify the risk of lung adenocarcinoma, we conducted a genome-wide association study in a Japanese cohort, with replication in two independent studies in Japanese and Korean individuals, in a total of 2,098 lung adenocarcinoma cases and 11,048 controls. The combined analyses identified two susceptibility loci for lung adenocarcinoma: TERT (rs2736100, combined P = 2.91 x 10(-11), odds ratio (OR) = 1.27) and TP63 (rs10937405, combined P = 7.26 x 10(-12), OR = 1.31). Fine mapping of the region containing TP63 showed that a SNP (rs4488809) in intron 1 of TP63 showed the most significant association. Our results suggest that genetic variation in TP63 may influence susceptibility to lung adenocarcinoma in East Asian populations.	[Miki, Daiki; Nakamura, Yusuke; Daigo, Yataro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Miki, Daiki; Chayama, Kazuaki] Hiroshima Univ, Dept Med Mol Sci, Hiroshima, Japan; [Kubo, Michiaki; Hosono, Naoya] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Yoon, Kyong-Ah; Kim, Jeongseon; Lee, Geon Kook; Zo, Jae Ill; Lee, Jin Soo] Natl Canc Ctr, Res Inst & Hosp, Goyang, Gyeonggi, South Korea; [Morizono, Takashi; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Takahashi, Takashi] Nagoya Univ, Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 466, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 52021, Japan; [Daigo, Yataro] Shiga Univ Med Sci Hosp, Ctr Canc, Otsu, Shiga, Japan	University of Tokyo; Hiroshima University; RIKEN; RIKEN; National Cancer Center - Korea (NCC); RIKEN; Nagoya University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Shiga University of Medical Science; Shiga University of Medical Science	Daigo, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	ydaigo@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Miki, Daiki/L-5069-2018; Tsunoda, Tatsuhiko/K-2061-2014; Takahashi, Takashi/I-7262-2014; KIM, JEONGSEON/AAA-4643-2022	Miki, Daiki/0000-0002-6505-9826; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Takahashi, Takashi/0000-0003-0615-7001; Chayama, Kazuaki/0000-0002-5530-5341; Daigo, Yataro/0000-0002-0915-3025	BioBank Japan Project; Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Research Institute and Hospital, National Cancer Center, Korea; Shiga Prefecture (Japan); Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; National Cancer Center, Korea [0710221, 0940620]	BioBank Japan Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Research Institute and Hospital, National Cancer Center, Korea; Shiga Prefecture (Japan); Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center, Korea	We thank the staff of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN and the Human Genome Center, Institute of Medical Science, The University of Tokyo for their contribution to SNP genotyping. We also thank members of the BioBank Japan project, the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan, and Research Institute and Hospital, National Cancer Center, Korea for supporting our study. Y.D. is a member of the Shiga Cancer Treatment Project supported by Shiga Prefecture (Japan). This work was conducted as a part of the BioBank Japan Project and supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. Management of second replication samples in Korea was supported by grants 0710221 and 0940620 from the National Cancer Center, Korea.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Daigo Y, 2008, GEN THORAC CARDIOVAS, V56, P43, DOI 10.1007/s11748-007-0211-x; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Jee SH, 1998, INT J EPIDEMIOL, V27, P365, DOI 10.1093/ije/27.3.365; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Liam CK, 2006, LUNG CANCER, V53, P23, DOI 10.1016/j.lungcan.2006.03.009; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sobue T, 1999, JPN J CANCER RES, V90, P6, DOI 10.1111/j.1349-7006.1999.tb00659.x; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Yang CH, 2008, LUNG CANCER, V60, pS23, DOI 10.1016/S0169-5002(08)70102-8; Zhang YW, 2007, CANCER EPIDEM BIOMAR, V16, P2432, DOI 10.1158/1055-9965.EPI-07-0398	33	133	138	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					893	+		10.1038/ng.667	http://dx.doi.org/10.1038/ng.667			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20871597				2022-12-17	WOS:000282276600021
J	Jeong, Y; Leskow, FC; El-Jaick, K; Roessler, E; Muenke, M; Yocum, A; Dubourg, C; Li, X; Geng, X; Oliver, G; Epstein, DJ				Jeong, Yongsu; Leskow, Federico Coluccio; El-Jaick, Kenia; Roessler, Erich; Muenke, Maximilian; Yocum, Anastasia; Dubourg, Christele; Li, Xue; Geng, Xin; Oliver, Guillermo; Epstein, Douglas J.			Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein	NATURE GENETICS			English	Article							VENTRAL FOREBRAIN; EYE DEVELOPMENT; GENE; EXPRESSION; MUTATIONS; REPRESSION; MEMBERS; FAMILY; RISK; FACE	In humans, SHH haploinsufficiency results in holoprosencephaly (HPE), a defect in anterior midline formation(1,2). Despite the importance of maintaining SHH transcript levels above a critical threshold, we know little about the upstream regulators of SHH expression in the forebrain. Here we describe a rare nucleotide variant located 460 kb upstream of SHH in an individual with HPE that resulted in the loss of Shh brain enhancer-2 (SBE2) activity in the hypothalamus of transgenic mouse embryos. Using a DNA affinity-capture assay, we screened the SBE2 sequence for DNA-binding proteins and identified members of the Six3 and Six6 homeodomain family as candidate regulators of Shh transcription. Six3 showed reduced binding affinity for the mutant compared to the wild-type SBE2 sequence. Moreover, Six3 with HPE-causing alterations failed to bind and activate SBE2. These data suggest a direct link between Six3 and Shh regulation during normal forebrain development and in the pathogenesis of HPE.	[Jeong, Yongsu; Leskow, Federico Coluccio; Epstein, Douglas J.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [El-Jaick, Kenia; Roessler, Erich; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Yocum, Anastasia] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Dubourg, Christele] Univ Rennes 1, CNRS, UMR 6061, F-35043 Rennes, France; [Li, Xue] Harvard Univ, Sch Med, Childrens Hosp, Dept Urol Surg, Boston, MA 02115 USA; [Geng, Xin; Oliver, Guillermo] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes 1; Harvard University; Boston Children's Hospital; Harvard Medical School; St Jude Children's Research Hospital	Epstein, DJ (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.	epsteind@mail.med.upenn.edu	Jeong, Yongsu/AAK-7397-2020; El-Jaick, Kenia/P-1303-2014	El-Jaick, Kenia/0000-0003-3316-9323; Muenke, Maximilian/0000-0002-7719-6545; Jeong, Yongsu/0000-0002-0008-9928	NINDS [R01 NS39421, R01 NS052386]; March of Dimes [1-FY05-112]; Pew Scholar Award in the Biomedical Sciences; Cancer Center [CA-21765]; American Lebanese Syrian Associated Charities (ALSAC); Division of Intramural Research; National Human Genome Research Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000175, ZIAHG000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039421, R01NS052386] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes(March of Dimes); Pew Scholar Award in the Biomedical Sciences; Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in these studies. We also thank J. Richa and his staff at the University of Pennsylvania Transgenic and Mouse Chimeric Facility for their assistance in transgenic mouse production. We are grateful to V. Cheung, D. Kessler and T. Kadesch for their helpful comments on the manuscript. We are also grateful to K. Ewens and W. Ankener (R. Spielman laboratory) for the control human genotyping data and P. Bovolenta (Instituto Cajal, CSIC, Madrid, Spain) for kindly providing the human Six3 and Six6 expression constructs. This work was supported by NIH grants R01 NS39421 from NINDS (D.J.E.), R01 NS052386 (G.O.), March of Dimes grant # 1-FY05-112 (D.J.E.), a Pew Scholar Award in the Biomedical Sciences (D.J.E.), Cancer Center Support CA-21765 (G.O.), the American Lebanese Syrian Associated Charities (ALSAC) (G.O.) and the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health (M.M.).	Carl M, 2002, DEVELOPMENT, V129, P4057; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li X, 2002, SCIENCE, V297, P1180; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Park SS, 2005, ANAL BIOCHEM, V344, P152, DOI 10.1016/j.ab.2005.05.019; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Treier M, 2001, DEVELOPMENT, V128, P377; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	30	133	137	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1348	1353		10.1038/ng.230	http://dx.doi.org/10.1038/ng.230			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836447	Green Accepted			2022-12-17	WOS:000260501500029
J	Nousiainen, HO; Kestila, M; Pakkasjarvi, N; Honkala, H; Kuure, S; Tallila, J; Vuopala, K; Ignatius, J; Herva, R; Peltonen, L				Nousiainen, Heidi O.; Kestila, Marjo; Pakkasjarvi, Niklas; Honkala, Heli; Kuure, Satu; Tallila, Jonna; Vuopala, Katri; Ignatius, Jaakko; Herva, Riitta; Peltonen, Leena			Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease	NATURE GENETICS			English	Article							BOX PROTEIN DBP5; PATHWAY	The most severe forms of motoneuron disease manifest in utero are characterized by marked atrophy of spinal cord motoneurons and fetal immobility. Here, we report that the defective gene underlying lethal motoneuron syndrome LCCS1 is the mRNA export mediator GLE1. Our finding of mutated GLE1 exposes a common pathway connecting the genes implicated in LCCS1, LCCS2 and LCCS3 and elucidates mRNA processing as a critical molecular mechanism in motoneuron development and maturation.	[Nousiainen, Heidi O.; Kestila, Marjo; Pakkasjarvi, Niklas; Honkala, Heli; Tallila, Jonna; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Kuure, Satu] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Vuopala, Katri] Lapland Cent Hosp, Dept Pathol, Rovaniemi 96100, Finland; [Ignatius, Jaakko] Oulu Univ Hosp, Dept Clin Genet, Oulu 90014, Finland; [Ignatius, Jaakko] Univ Oulu, Oulu 90014, Finland; [Herva, Riitta] Oulu Univ Hosp, Dept Pathol, Oulu 90029, Finland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Broad Inst, Cambridge, MA 02142 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Kestila, M (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland.	marjo.kestila@ktl.fi	, shkuure/AAE-2751-2019	, shkuure/0000-0002-9076-0622	NIEHS NIH HHS [P01 ES011253, P01 ES11253-03] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; HERVA R, 1988, AM J MED GENET, V29, P67, DOI 10.1002/ajmg.1320290109; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Makela-Bengs P, 1998, AM J HUM GENET, V63, P506, DOI 10.1086/301968; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; Pakkasjarvi N, 2005, J NEUROBIOL, V65, P269, DOI 10.1002/neu.20185; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; VUOPALA K, 1995, HUM PATHOL, V26, P12, DOI 10.1016/0046-8177(95)90109-4; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424	15	133	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					155	157		10.1038/ng.2007.65	http://dx.doi.org/10.1038/ng.2007.65			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204449	Green Accepted			2022-12-17	WOS:000252732900012
J	Kozlov, SV; Bogenpohl, JW; Howell, MP; Wevrick, R; Panda, S; Hogenesch, JB; Muglia, LJ; Van Gelder, RN; Herzog, ED; Stewart, CL				Kozlov, Serguei V.; Bogenpohl, James W.; Howell, Maureen P.; Wevrick, Rachel; Panda, Satchin; Hogenesch, John B.; Muglia, Louis J.; Van Gelder, Russell N.; Herzog, Erik D.; Stewart, Colin L.			The imprinted gene Magel2 regulates normal circadian output	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; MOUSE; DISRUPTION; NECDIN; SNRPN; MICE; EXPRESSION; OBESITY; GROWTH; ROLES	Mammalian circadian rhythms of activity are generated within the suprachiasmatic nucleus ( SCN). Transcripts from the imprinted, paternally expressed Magel2 gene, which maps to the chromosomal region associated with Prader-Willi Syndrome (PWS), are highly enriched in the SCN. The Magel2 message is circadianly expressed and peaks during the subjective day. Mice deficient in Magel2 expression entrain to light cycles and express normal running-wheel rhythms, but with markedly reduced amplitude of activity and increased daytime activity. These changes are associated with reductions in food intake and male fertility. Orexin levels and orexin-positive neurons in the lateral hypothalamus are substantially reduced, suggesting that some of the consequences of Magel2 loss are mediated through changes in orexin signaling. The robust rhythmicity of Magel2 expression in the SCN and the altered behavioral rhythmicity of null mice reveal Magel2 to be a clock-controlled circadian output gene whose disruption results in some of the phenotypes characteristic of PWS.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Salk Inst Biol Studies, Regulat Biol Lab, La Jolla, CA 92037 USA; Genom Inst Novartis Res Fdn, San Diego, CA 92121 USA; Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA	Washington University (WUSTL); Washington University (WUSTL); University of Alberta; Salk Institute; Novartis; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stewart, CL (corresponding author), Inst Med Biol, 03-03 Proteos,61 Biopolis Dr, Singapore 113867, Singapore.	stewartc@ncifcrf.gov	Panda, Satchidananda/J-6891-2012; Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Herzog, Erik/0000-0001-7209-5174; Wevrick, Rachel/0000-0002-3343-5794; Bogenpohl, James/0000-0001-7214-3404	Intramural NIH HHS Funding Source: Medline; NEI NIH HHS [EY14988] Funding Source: Medline; NIMH NIH HHS [MH63104] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Card JP, 2000, J BIOL RHYTHM, V15, P453, DOI 10.1177/074873000129001567; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Goldstone AP, 2006, PROG BRAIN RES, V153, P57, DOI 10.1016/S0079-6123(06)53033-1; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Ibata Y, 1999, FRONT NEUROENDOCRIN, V20, P241, DOI 10.1006/frne.1999.0180; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Pagliardini S, 2005, AM J PATHOL, V167, P175, DOI 10.1016/S0002-9440(10)62964-1; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PAXINOS G, 1990, TRENDS NEUROSCI, V13, P169, DOI 10.1016/0166-2236(90)90041-8; Ren J, 2003, J NEUROSCI, V23, P1569; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	29	133	140	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1266	1272		10.1038/ng2114	http://dx.doi.org/10.1038/ng2114			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17893678				2022-12-17	WOS:000249737400024
J	Miller, J; Horner, A; Stacy, T; Lowrey, C; Lian, JB; Stein, G; Nuckolls, GH; Speck, NA				Miller, J; Horner, A; Stacy, T; Lowrey, C; Lian, JB; Stein, G; Nuckolls, GH; Speck, NA			The core-binding factor beta subunit is required for bone formation and hematopoietic maturation	NATURE GENETICS			English	Article							FETAL LIVER HEMATOPOIESIS; RECEPTOR TYROSINE KINASES; CLEIDOCRANIAL DYSPLASIA; CBFA1-DEFICIENT MICE; ENDOTHELIAL-CELLS; DNA RECOGNITION; RUNT DOMAIN; CBF-BETA; GENE; AML1	Core-binding factor beta (Cbfbeta) is the common non-DNA-binding subunit of the Cbf family of heterodimeric transcription factors. Mice deficient in Cbfbeta have a severe block in fetal liver hematopoiesis at the stage of hematopoietic stem cell (HSC) emergence(1,2). Here we show that by providing Cbfbeta function in endothelial cells and hematopoietic progenitors we can rescue fetal liver hematopoiesis in Cbfbeta-deficient embryos. The rescued mice die at birth, however, with severe defects in skeletal development, though intramembranous ossification occurs to some extent. Fetal liver hematopoiesis is restored at embryonic day (E) 12.5, but by E17.5 significant impairments in lymphopoiesis and myelopoiesis are observed. Thus, we conclude that the Cbfbeta subunit is required for HSC emergence, bone formation and normal differentiation of lymphoid and myeloid lineage cells.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; NIAMSD, Cartilage Biol & Orthoped Branch, NIH, Bethesda, MD 20892 USA; Dartmouth Coll Sch Med, Dept Med, Hanover, NH USA; Dartmouth Coll Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA USA	Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Dartmouth College; Dartmouth College; University of Massachusetts System; University of Massachusetts Worcester	Speck, NA (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.			Nuckolls, Glen/0000-0002-7466-6433				Castilla LH, 1999, NAT GENET, V23, P144, DOI 10.1038/13776; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LI QL, 2002, CELL, V109; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagata T, 2001, J MOL BIOL, V308, P191, DOI 10.1006/jmbi.2001.4596; North T, 1999, DEVELOPMENT, V126, P2563; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rucklidge GJ, 1996, BIOCHEM BIOPH RES CO, V224, P297, DOI 10.1006/bbrc.1996.1024; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	29	133	135	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					645	649		10.1038/ng1049	http://dx.doi.org/10.1038/ng1049			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12434155				2022-12-17	WOS:000179593000018
J	Weninger, WJ; Mohun, T				Weninger, WJ; Mohun, T			Phenotyping transgenic embryos: a rapid 3-D screening method based on episcopic fluorescence image capturing	NATURE GENETICS			English	Article							GENE-EXPRESSION; 3-DIMENSIONAL RECONSTRUCTION; ATRIOVENTRICULAR JUNCTION; SERIAL SECTIONS; IN-VIVO; MOUSE; HEART; VISUALIZATION; TRISOMY-16; MORPHOLOGY	We describe a technique suitable for routine three-dimensional (3-D) analysis of mouse embryos that is based on episcopic fluorescence images captured during serial sectioning of wax-embedded specimens. We have used this procedure to describe the cardiac phenotype and associated blood vessels of trisomic 16 (Ts16) and Cited2-null mutant mice, as well as the expression pattern of an Myf5 enhancer/beta-galactosidase transgene. The consistency of the images and their precise alignment are ideally suited for 3-D analysis using video animations, virtual resectioning or commercial 3-D reconstruction software packages. Episcopic fluorescence image capturing (EFIC) provides a simple and powerful tool for analyzing embryo and organ morphology in normal and transgenic embryos.	Univ Vienna, Dept Anat, Integrat Morphol Grp, A-1090 Vienna, Austria; Natl Inst Med Res, Dev Biol Div, London NW7 1AA, England	University of Vienna; MRC National Institute for Medical Research	Weninger, WJ (corresponding author), Univ Vienna, Dept Anat, Integrat Morphol Grp, Waehringerstr 16, A-1090 Vienna, Austria.	Wolfgang.Weninger@univie.ac.at; tmohun@nimr.mrc.ac.uk		Weninger, Wolfgang J/0000-0003-0575-0073				Anderson RH, 1998, CARDIOVASC RES, V39, P155, DOI 10.1016/S0008-6363(98)00037-6; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Hecksher-Sorensen J, 2001, MECH DEVELOP, V100, P59, DOI 10.1016/S0925-4773(00)00508-6; LAAN AC, 1989, ANAT RECORD, V224, P443, DOI 10.1002/ar.1092240313; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; MCLEAN MR, 1987, ANAT REC, V219, P434, DOI 10.1002/ar.1092190415; Mohun TJ, 2000, DEV BIOL, V218, P74, DOI 10.1006/dbio.1999.9559; ODGAARD A, 1990, J MICROSC-OXFORD, V159, P335, DOI 10.1111/j.1365-2818.1990.tb03038.x; Scarborough J, 1997, J ANAT, V191, P117, DOI 10.1046/j.1469-7580.1997.19110117.x; Smith BR, 1999, SCI AM, V280, P76, DOI 10.1038/scientificamerican0399-76; Spoor F, 2000, J ANAT, V197, P61, DOI 10.1046/j.1469-7580.2000.19710061.x; Streicher J, 2000, NAT GENET, V25, P147, DOI 10.1038/75989; Streicher J, 1997, ANAT REC, V248, P583; Summerbell D, 2000, DEVELOPMENT, V127, P3745; TJUVAJEV JG, 1995, CANCER RES, V55, P6126; Tjuvajev JG, 1996, CANCER RES, V56, P4087; VERBEEK FJ, 1995, 3 DIMENSIONAL RECONS; Webb S, 1997, CARDIOVASC RES, V34, P515, DOI 10.1016/S0008-6363(97)00064-3; WENINGER W, 1995, COMPUTER ASSISTED 3; Weninger WJ, 1998, ANAT EMBRYOL, V197, P341, DOI 10.1007/s004290050144	21	133	136	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					59	65		10.1038/ng785	http://dx.doi.org/10.1038/ng785			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743576				2022-12-17	WOS:000173105600014
J	Yoon, BJ; Herman, H; Sikora, A; Smith, LT; Plass, C; Soloway, PD				Yoon, BJ; Herman, H; Sikora, A; Smith, LT; Plass, C; Soloway, PD			Regulation of DNA methylation of Rasgrf1	NATURE GENETICS			English	Article							HMLH1 PROMOTER HYPERMETHYLATION; TUMOR-SUPPRESSOR GENE; IMPRINTED EXPRESSION; CPG METHYLATION; H19 GENE; LOCUS; IGF2; REPEAT; CTCF; INACTIVATION	In mammals, DNA is methylated at cytosines within CpG dinucleoticles. Properly regulated methylation is crucial for normal development(1,2). Inappropriate methylation may contribute to tumorigenesis by silencing tumor-suppressor genes(3-10) or by activating growth-stimulating genes(11-13). Although many genes have been identified that acquire methylation and whose expression is methylation-sensitive(14,15), little is known about how DNA methylation is controlled(16). We have identified a DNA sequence that regulates establishment of DNA methylation in the male germ line at Rasgrf1. In mice, the imprinted Rasgrf1 locus is methylated on the paternal allele within a differentially methylated domain (DMD) 30 kbp 5' of the promoter. Expression is exclusively from the paternal allele in neonatal brain(17). Methylation is regulated by a repeated sequence, consisting of a 41-mer repeated 40 times, found immediately 3' of the DMD. This sequence is present in organisms in which Rasgrf1 is imprinted(18). In addition, DMD methylation is required for imprinted Rasgrf1 expression. Together the DMD and repeat element constitute a binary switch that regulates imprinting at the locus.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA	Roswell Park Cancer Institute; University System of Ohio; Ohio State University	Soloway, PD (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.		Reever, Larson/H-9685-2019; Soloway, Paul/T-8243-2019; Yoon, Bong June/L-7126-2017; Plass, Christoph/H-7192-2014	Reever, Larson/0000-0002-5692-4793; Soloway, Paul/0000-0003-1967-0437	NCI NIH HHS [R01 CA098597, R01 CA098597-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baylin SB, 1998, ADV CANCER RES, V72, P141; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Esteller M, 1999, AM J PATHOL, V155, P1767, DOI 10.1016/S0002-9440(10)65492-2; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Goyon C, 1996, MOL CELL BIOL, V16, P3054; GRAFF JR, 1995, CANCER RES, V55, P5195; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Herman JG, 1996, CANCER RES, V56, P722; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINN F, 1990, MOL GEN GENET, V222, P329, DOI 10.1007/BF00633837; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Shibata H, 1998, GENOMICS, V49, P30, DOI 10.1006/geno.1998.5218; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	30	133	137	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					92	96		10.1038/ng795	http://dx.doi.org/10.1038/ng795			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11753386	Green Accepted			2022-12-17	WOS:000173105600020
J	Radhakrishna, U; Wild, A; Grzeschik, KH; Antonarakis, SE				Radhakrishna, U; Wild, A; Grzeschik, KH; Antonarakis, SE			Mutation in GLI3 in postaxial polydactyly type A	NATURE GENETICS			English	Letter							GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS GENE REGION; FINGER; WORKSHOP; CONTIG		UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,LAB HUMAN MOL GENET,CH-1211 GENEVA,SWITZERLAND; UNIV MARBURG,INST HUMAN GENET,MARBURG,GERMANY; CTR MED UNIV GENEVA,DIV MED GENET,CH-1211 GENEVA,SWITZERLAND	University of Geneva; Philipps University Marburg; University of Geneva			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823				Biesecker LG, 1996, AM J MED GENET, V65, P76, DOI 10.1002/(SICI)1096-8628(19961002)65:1<76::AID-AJMG12>3.0.CO;2-O; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JOHNSON DR, 1969, GENET RES, V13, P275, DOI 10.1017/S0016672300002962; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Radhakrishna U, 1997, AM J HUM GENET, V60, P597; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; SCHIMMANG T, 1993, PROG CLIN BIOL RES, V383, P153; SCHIMMANG T, 1994, MAMM GENOME, V5, P384, DOI 10.1007/BF00356560; Thien H, 1996, BBA-GENE STRUCT EXPR, V1307, P267, DOI 10.1016/0167-4781(96)00079-6; TSUI LC, 1995, CYTOGENET CELL GENET, V71, P1, DOI 10.1159/000134055; VANDERHOEVEN F, 1993, MAMM GENOME, V4, P276, DOI 10.1007/BF00417435; VORTKAMP A, 1995, HUM GENET, V95, P82; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; VORTKAMP A, 1994, GENOMICS, V22, P563, DOI 10.1006/geno.1994.1429; WALTERHOUSE D, 1993, DEV DYNAM, V196, P91, DOI 10.1002/aja.1001960203; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979	19	133	139	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					269	271		10.1038/ng1197-269	http://dx.doi.org/10.1038/ng1197-269			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354785				2022-12-17	WOS:A1997YD66700015
J	Wehner, JM; Radcliffe, RA; Rosmann, ST; Christensen, SC; Rasmussen, DL; Fulker, DW; Wiles, M				Wehner, JM; Radcliffe, RA; Rosmann, ST; Christensen, SC; Rasmussen, DL; Fulker, DW; Wiles, M			Quantitative trait locus analysis of contextual fear conditioning in mice	NATURE GENETICS			English	Article							MUTANT MICE; AMYGDALA; HIPPOCAMPUS; DEFICIENT; EMOTION; HUMANS; MEMORY; BRAIN	Family, twin and adoption studies provide evidence for a Table I Mean scores for measures of learning substantial genetic component underlying individual Altered Auditory differences in general intelligence(1), specific cognitive abilities(2) and susceptibility to psychopathologies related to fear-inducing events(3). Contextual fear conditioning, which is highly conserved across species, can serve as a model for elucidating genes that regulate individual differences in learning and emotion(4-8). In fear conditioning, an initially neutral stimulus, such as shock. Two neural circuits have been implicated in fear conditioning. The fear component is regulated by amyhdaloid pathways, while the contextual component is, at least in part, dependent on the hippocampus(9-14). C57BL/6J (B6) and DBA/2J (D2) mice differ in several types of complex learning(15,16), including contextual fear conditioning(17). A quantitative trait locus (QTL) analysis of contextual fear conditioning was performed in a B6/D2 FZ intercross population. Two QTLs for contextual conditioning (led score>4.3) were identified on chromosomes 10 and 16. QTLs for conditioning to the auditory cue (led score>4.3) were localized to chromosomes 1 and 10. Suggestive QTLs (led score=2.8-4.1) for contextual conditioning were detected on chromosomes 1, 2 and 3.	UNIV COLORADO,SCH PHARM,BOULDER,CO 80309; UNIV COLORADO,DEPT PSYCHOL,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Wehner, JM (corresponding author), UNIV COLORADO,INST BEHAV GENET,BOULDER,CO 80309, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016880, R01MH053668] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-00141] Funding Source: Medline; NIMH NIH HHS [MH-53668, MH-16880] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BUCK KJ, 1997, J NEUROSCI, V17, P3945; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; DEFRIES JC, 1979, BEHAV GENET, V9, P23; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Falconer D. S., 1989, Introduction to quantitative genetics.; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Ferraro TN, 1997, MAMM GENOME, V8, P200, DOI 10.1007/s003359900389; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; FRANKEL WN, 1995, MAMM GENOME, V6, P830, DOI 10.1007/BF00292431; GERSHENFIELD HK, BEHAV GENET, V27, P201; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LABAR KS, 1995, J NEUROSCI, V15, P6846; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; LU Y, IN PRESS BRAIN RES; Markel PD, 1997, GENOME RES, V7, P92, DOI 10.1101/gr.7.2.92; Owen EH, 1997, BEHAV NEUROSCI, V111, P292, DOI 10.1037/0735-7044.111.2.292; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PAYLOR R, 1993, PSYCHOBIOLOGY, V21, P11; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Sambrook J, 1989, MOL CLONING LAB MANU; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075	36	133	135	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					331	334		10.1038/ng1197-331	http://dx.doi.org/10.1038/ng1197-331			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YD667	9354800				2022-12-17	WOS:A1997YD66700030
J	Huang, SW; Weigel, D; Beachy, RN; Li, JY				Huang, Sanwen; Weigel, Detlef; Beachy, Roger N.; Li, Jiayang			A proposed regulatory framework for genome-edited crops	NATURE GENETICS			English	Editorial Material							ZINC-FINGER NUCLEASES; DRAFT SEQUENCE; RICE; DOMESTICATION; CRISPR-CAS9; CUCUMBER; INSIGHTS; SYSTEM; MAP	Crop breeding is being revolutionized by rapid progress in DNA sequencing and targeted alteration of DNA sequences by genome editing. Here we propose a regulatory framework for precision breeding with 'genome-edited crops' (GECs) so that society can fully benefit from the latest advances in plant genetics and genomics.	[Huang, Sanwen] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Huang, Sanwen] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr,Sino Dutch Joint Lab Hort Genom, Beijing 100193, Peoples R China; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Beachy, Roger N.] Univ Calif Davis, World Food Ctr, Davis, CA 95616 USA; [Li, Jiayang] State Key Lab Plant Genom, Beijing, Peoples R China; [Li, Jiayang] Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China; [Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Max Planck Society; University of California System; University of California Davis; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Huang, SW (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China.; Huang, SW (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr,Sino Dutch Joint Lab Hort Genom, Beijing 100193, Peoples R China.; Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.; Beachy, RN (corresponding author), Univ Calif Davis, World Food Ctr, Davis, CA 95616 USA.; Li, JY (corresponding author), State Key Lab Plant Genom, Beijing, Peoples R China.; Li, JY (corresponding author), Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China.; Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	huangsanwen@caas.cn; weigel@tue.mpg.de; rbeachy@ucdavis.edu; jyli@genetics.ac.cn	Li, Jiayang/AAG-4377-2020; Huang, Sanwen/ABE-9053-2020; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021	Huang, Sanwen/0000-0002-8547-5309; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Li, Jiayang/0000-0002-0487-6574				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ledford H, 2013, NATURE, V500, P389, DOI 10.1038/500389a; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Obama B., 2011, FED REGISTER, V76, P3821; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; 2012, EFSA J, V10, P2561	25	132	160	7	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					109	111		10.1038/ng.3484	http://dx.doi.org/10.1038/ng.3484			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26813761				2022-12-17	WOS:000369043900004
J	Hinkley, T; Martins, J; Chappey, C; Haddad, M; Stawiski, E; Whitcomb, JM; Petropoulos, CJ; Bonhoeffer, S				Hinkley, Trevor; Martins, Joao; Chappey, Colombe; Haddad, Mojgan; Stawiski, Eric; Whitcomb, Jeannette M.; Petropoulos, Christos J.; Bonhoeffer, Sebastian			A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase	NATURE GENETICS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; FITNESS; EPISTASIS; EVOLUTION; INHIBITORS; LANDSCAPE	The development of a quantitative understanding of viral evolution and the fitness landscape in HIV-1 drug resistance is a formidable challenge given the large number of available drugs and drug resistance mutations. We analyzed a dataset measuring the in vitro fitness of 70,081 virus samples isolated from HIV-1 subtype B infected individuals undergoing routine drug resistance testing. We assayed virus samples for in vitro replicative capacity in the absence of drugs as well as in the presence of 15 individual drugs. We employed a generalized kernel ridge regression to estimate main fitness effects and epistatic interactions of 1,859 single amino acid variants found within the HIV-1 protease and reverse transcriptase sequences. Models including epistatic interactions predict an average of 54.8% of the variance in replicative capacity across the 16 different environments and substantially outperform models based on main fitness effects only. We find that the fitness landscape of HIV-1 protease and reverse transcriptase is characterized by strong epistasis.	[Hinkley, Trevor; Martins, Joao; Bonhoeffer, Sebastian] ETH, Inst Integrat Biol, Zurich, Switzerland; [Chappey, Colombe; Haddad, Mojgan; Stawiski, Eric; Whitcomb, Jeannette M.; Petropoulos, Christos J.] Monogram Biosci, San Francisco, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bonhoeffer, S (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	cpetropoulos@monogrambio.com; sebastian.bonhoeffer@env.ethz.ch	Martins, Joao/P-4795-2019; Bonhoeffer, Sebastian/A-2735-2008	Martins, Joao/0000-0001-7961-4280; Bonhoeffer, Sebastian/0000-0001-8052-3925	Swiss National Science Foundation [NF 3100A0-116408]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	T.H., J.M. and S.B. thank the Swiss National Science Foundation (NF 3100A0-116408) for financial support. We thank R. Regos, R. Kouyos, J. Engelstadter, S. Alizon and T. Gernhard-Stadler for valuable comments and critical reading of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; Dykes C, 2007, CLIN MICROBIOL REV, V20, P550, DOI 10.1128/CMR.00017-07; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Harrigan PR, 2002, ANTIMICROB AGENTS CH, V46, P909, DOI 10.1128/AAC.46.3.909-912.2002; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Martins JZR, 2010, EPIDEMICS-NETH, V2, P85, DOI 10.1016/j.epidem.2010.03.003; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; PETROPOULOS CJ, 2011, NATURE, DOI DOI 10.1038/NPRE.2011.5668.1>; Provine W.B., 1971, ORIGINS THEORETICAL; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Wolf J.B., 2000, EPISTASIS EVOLUTIONA; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	32	132	134	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2011	43	5					487	+		10.1038/ng.795	http://dx.doi.org/10.1038/ng.795			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21441930				2022-12-17	WOS:000289972600022
J	Aubin, I; Adams, CP; Opsahl, S; Septier, D; Bishop, CE; Auge, N; Salvayre, R; Negre-Salvayre, A; Goldberg, M; Guenet, JL; Poirier, C				Aubin, I; Adams, CP; Opsahl, S; Septier, D; Bishop, CE; Auge, N; Salvayre, R; Negre-Salvayre, A; Goldberg, M; Guenet, JL; Poirier, C			A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse	NATURE GENETICS			English	Article							BRITTLE BONE-DISEASE; FRAGILITAS-OSSIUM; FORM; MINERALIZATION; CERAMIDE; FRO/FRO	The mouse mutation fragilitas ossium (fro) leads to a syndrome of severe osteogenesis and dentinogenesis imperfecta with no detectable collagen defect. Positional cloning of the locus identified a deletion in the gene encoding neutral sphingomyelin phosphodiesterase 3 (Smpd3) that led to complete loss of enzymatic activity. Our knowledge of SMPD3 function is consistent with the pathology observed in mutant mice and provides new insight into human pathologies.	Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Univ Paris 05, Fac Chirurg Dent, EA 2496, F-92120 Montrouge, France; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CHU Rangueil, INSERM, U466, F-31059 Toulouse, France; CHU Rangueil, Dept Biochem, IFR 31, F-31059 Toulouse, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Baylor College of Medicine; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Guenet, JL (corresponding author), Inst Pasteur, Unite Genet Mammiferes, 25 Rue Docteur Roux, F-75724 Paris, France.	guenet@pasteur.fr	Vital, Sibylle/AAK-3479-2021	Vital, Sibylle/0000-0001-6352-2525; Negre-Salvayre, Anne/0000-0003-2136-5706; Auge, Nathalie/0000-0003-2088-7211				Auge N, 1998, J BIOL CHEM, V273, P12893, DOI 10.1074/jbc.273.21.12893; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Goldberg M, 1996, PROG HISTOCHEM CYTOC, V31, P1; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Grey A, 2004, CALCIFIED TISSUE INT, V74, P542, DOI 10.1007/s00223-003-0155-9; GUENET JL, 1981, J HERED, V72, P440, DOI 10.1093/oxfordjournals.jhered.a109554; MURIEL MP, 1991, BONE, V12, P241, DOI 10.1016/8756-3282(91)90070-Y; SILLENCE DO, 1993, AM J MED GENET, V45, P276, DOI 10.1002/ajmg.1320450227; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Takeda H, 1998, FEBS LETT, V422, P255, DOI 10.1016/S0014-5793(98)00005-2; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200	14	132	134	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					803	805		10.1038/ng1603	http://dx.doi.org/10.1038/ng1603			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16025116				2022-12-17	WOS:000230880400008
J	Cornett, J; Cao, FK; Wang, CE; Ross, CA; Bates, GP; Li, SH; Li, XJ				Cornett, J; Cao, FK; Wang, CE; Ross, CA; Bates, GP; Li, SH; Li, XJ			Polyglutamine expansion of huntingtin impairs its nuclear export	NATURE GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN; DISEASE; BRAIN; TPR; GENE; IDENTIFICATION; ABNORMALITIES	Proteins with polyglutamine (polyQ) expansions accumulate in the nucleus and affect gene expression(1,2). The mechanism by which mutant huntingtin (htt) accumulates intranuclearly is not known; wild-type htt, a 350-kDa protein of unknown function, is normally found in the cytoplasm(3-5).N-terminal fragments of mutant htt, which contain a polyQ expansion (>37 glutamines), have no conserved nuclear localization sequences or nuclear export sequences but can accumulate in the nucleus and cause neurological problems in transgenic mice(6,7). Here we report that N-terminal htt shuttles between the cytoplasm and nucleus in a Ran GTPase-independent manner. Small N-terminal htt fragments interact with the nuclear pore protein translocated promoter region(Tpr), which is involved in nuclear export. PolyQ expansion and aggregation decrease this interaction and increase the nuclear accumulation of htt. Reducing the expression of Tpr by RNA interference or deletion of ten amino acids of N-terminal htt, which are essential for the interaction of htt with Tpr, increased the nuclear accumulation of htt. These results suggest that Tpr has a role in the nuclear export of N-terminal htt and that polyQ expansion reduces this nuclear export to cause the nuclear accumulation of htt.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ London Kings Coll, Guys Hosp, GKT Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England	Emory University; Johns Hopkins University; Johns Hopkins University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu	Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305				Boche I, 1997, J CELL BIOL, V139, P313, DOI 10.1083/jcb.139.2.313; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Jackson WS, 2003, HUM MOL GENET, V12, P1621, DOI 10.1093/hmg/ddg163; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Shibata S, 2002, GENES CELLS, V7, P421, DOI 10.1046/j.1365-2443.2002.00525.x; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	29	132	137	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					198	204		10.1038/ng1503	http://dx.doi.org/10.1038/ng1503			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654337				2022-12-17	WOS:000226690100029
J	Winrow, CJ; Hemming, ML; Allen, DM; Quistad, GB; Casida, JE; Barlow, C				Winrow, CJ; Hemming, ML; Allen, DM; Quistad, GB; Casida, JE; Barlow, C			Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity	NATURE GENETICS			English	Article							GULF-WAR; CATALYTIC DOMAIN; INHIBITION; NERVE; BRAIN; NEURODEGENERATION; FAMILY; AGENTS; ATAXIA; HENS	Neuropathy target esterase (NTE) is involved in neural development and is the target for neurodegeneration induced by selected organophosphorus pesticides and chemical warfare agents. We generated mice with disruptions in Nte, the gene encoding NTE. Nte(-/-) mice die after embryonic day 8, and Nte(+/-) mice have lower activity of Nte in the brain and higher mortality when exposed to the Nte-inhibiting compound ethyl octylphosphonofluoridate (EOPF) than do wild-type mice. Nte(+/-) and wild-type mice treated with 1 mg per kg of body weight of EOPF have elevated motor activity, showing that even minor reduction of Nte activity leads to hyperactivity. These studies show that genetic or chemical reduction of Nte activity results in a neurological phenotype of hyperactivity in mammals and indicate that EOPF toxicity occurs directly through inhibition of Nte without the requirement for Nte gain of function or aging.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Environm Chem & Toxicol Lab, Berkeley, CA 94720 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Salk Institute	Barlow, C (corresponding author), Merck Res Labs, 3535 Gen Atom Court, San Diego, CA 92121 USA.	carrolee_barlow@merck.com	Winrow, Christopher/K-1864-2014	Winrow, Christopher/0000-0001-8248-4157; Hemming, Mathew/0000-0003-4674-7778				Akbarsha M. A., 1998, Indian Journal of Experimental Biology, V36, P34; Atkins J, 2000, J BIOL CHEM, V275, P24477, DOI 10.1074/jbc.M002921200; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Burgess JR, 2000, AM J CLIN NUTR, V71, p327S, DOI 10.1093/ajcn/71.1.327S; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Cavanagh J B, 1973, CRC Crit Rev Toxicol, V2, P365, DOI 10.3109/10408447309082021; DEBLEECKER JL, 1992, CLIN NEUROL NEUROSUR, V94, P93, DOI 10.1016/0303-8467(92)90065-B; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; EHRICH M, 1993, CHEM-BIOL INTERACT, V87, P431, DOI 10.1016/0009-2797(93)90071-6; EHRICH M, 2001, HDB PESTICIDE TOXICO, V2, P987; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Enserink M, 2001, SCIENCE, V291, P812, DOI 10.1126/science.291.5505.812; Escudero MA, 1997, J NEUROCHEM, V68, P2170; Forshaw PJ, 2001, J NEUROCHEM, V79, P400, DOI 10.1046/j.1471-4159.2001.00562.x; Glynn P, 1999, BIOCHEM J, V344, P625, DOI 10.1042/0264-6021:3440625; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P231, DOI 10.1001/jama.277.3.231; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P223, DOI 10.1001/jama.277.3.223; Hamm JT, 1998, NEUROTOXICOLOGY, V19, P853; Hardell L, 2002, ENVIRON RES, V88, P141, DOI 10.1006/enrs.2002.4337; Hitt E, 2002, NAT MED, V8, P198, DOI 10.1038/nm0302-198a; HUSAIN K, 1993, J APPL TOXICOL, V13, P143, DOI 10.1002/jat.2550130212; Ishimatsu M, 2002, J NEUROPHYSIOL, V87, P1206, DOI 10.1152/jn.00463.2001; Jamal GA, 1998, ADVERSE DRUG REACT T, V17, P1; Jamal GA, 1997, ADVERSE DRUG REACT T, V16, P133; JOHNSON MK, 1977, ARCH TOXICOL, V37, P113, DOI 10.1007/BF00293860; JOHNSON MK, 1974, J NEUROCHEM, V23, P785, DOI 10.1111/j.1471-4159.1974.tb04404.x; Johnson MK., 2001, HDB PESTICIDE TOXICO, P953, DOI 10.1016/B978-012426260-7.50050-1; KARCZMAR AG, 1984, FUND APPL TOXICOL, V4, pS1, DOI 10.1016/0272-0590(84)90133-7; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lotti M, 2002, MUSCLE NERVE, V25, P492, DOI 10.1002/mus.10086; Lush MJ, 1998, BIOCHEM J, V332, P1; MEREDITH C, 1988, J NEUROCHEM, V51, P1097, DOI 10.1111/j.1471-4159.1988.tb03073.x; MIGNERY GA, 1988, GENE, V62, P27, DOI 10.1016/0378-1119(88)90577-X; Moretto A, 2002, ARCH TOXICOL, V76, P367, DOI 10.1007/s00204-002-0352-8; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Randall JC, 1997, J TOXICOL ENV HEALTH, V51, P571, DOI 10.1080/009841097159845; Ray DE, 2001, TOXICOL LETT, V120, P343, DOI 10.1016/S0378-4274(01)00266-1; Ried Thomas, 1992, Human Molecular Genetics, V1, P307, DOI 10.1093/hmg/1.5.307; Ross CA, 1999, PHILOS T ROY SOC B, V354, P1005, DOI 10.1098/rstb.1999.0452; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Solberg Y, 1997, TRENDS PHARMACOL SCI, V18, P183, DOI 10.1016/S0165-6147(97)89540-5; TORMO N, 1993, J NEUROCHEM, V61, P2164, DOI 10.1111/j.1471-4159.1993.tb07455.x; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Veronesi B, 1997, NEUROTOXICOLOGY, V18, P283; VILANOVA E, 1993, CHEM-BIOL INTERACT, V87, P369, DOI 10.1016/0009-2797(93)90065-7; Wilson BW, 2002, DRUG CHEM TOXICOL, V25, P131, DOI 10.1081/DCT-120003255; WU SY, 1995, CHEM RES TOXICOL, V8, P1070, DOI 10.1021/tx00050a011; Wu SY, 1996, TOXICOL APPL PHARM, V139, P195, DOI 10.1006/taap.1996.0158; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481	50	132	140	2	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					477	485		10.1038/ng1131	http://dx.doi.org/10.1038/ng1131			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12640454	Bronze			2022-12-17	WOS:000181928600018
J	McFarland, R; Clark, KM; Morris, AAM; Taylor, RW; Macphail, S; Lightowlers, RN; Turnbull, DM				McFarland, R; Clark, KM; Morris, AAM; Taylor, RW; Macphail, S; Lightowlers, RN; Turnbull, DM			Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; ABNORMALITIES; DEAFNESS; MUSCLE	Mutations of mitochondrial DNA (mtDNA) are an important cause of genetic disease(1). We describe a family with an unusual homoplasmic mutation that resulted in six neonatal deaths and one surviving child with Leigh syndrome. The mother is clinically normal, but a severe biochemical and molecular genetic defect was present in both a fatally affected child and the mother. This family highlights the role of homoplasmic mt-tRNA mutations in genetic disease.	Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Child Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Obstet & Gynaecol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Turnbull, DM (corresponding author), Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.			McFarland, Robert/0000-0002-8833-2688				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Borner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347; HAYASHI JI, 1994, J BIOL CHEM, V269, P19060; HOWELL N, 1991, AM J HUM GENET, V49, P939; JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	14	132	134	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					145	146		10.1038/ng819	http://dx.doi.org/10.1038/ng819			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799391				2022-12-17	WOS:000173708700011
J	Vrana, PB; Fossella, JA; Matteson, P; del Rio, T; O'Neill, MJ; Tilghman, SM				Vrana, PB; Fossella, JA; Matteson, P; del Rio, T; O'Neill, MJ; Tilghman, SM			Genetic and epigenetic incompatibilities underlie hybrid dysgenesis in Peromyscus	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; PLACENTAL DEVELOPMENT; IMPRINTED GENE; HALDANES RULE; MOUSE; LOCUS; GROWTH; MAP	Crosses between the two North American rodent species Peromyscus polionotus (PO) and Peromyscus maniculatus (BW) yield parent-of-origin effects on both embryonic and placental growth(1,2). The two species are approximately the same size, but a female BW crossed with a male PO produces offspring that are smaller than either parent. In the reciprocal cross, the offspring are oversized and typically die before birth. Rare survivors are exclusively female, consistent with Haldane's rule, which states that in instances of hybrid sterility or inviability, the heterogametic sex tends to be more severely affected(3). To understand these sex- and parent-of-origin-specific patterns of overgrowth, we analysed reciprocal backcrosses. Our studies reveal that hybrid inviability is partially due to a maternally expressed X-linked PO locus and an imprinted paternally expressed autosomal BW locus. In addition, the hybrids display skewing of X-chromosome inactivation in favour of the expression of the BW X chromosome. The most severe overgrowth is accompanied by widespread relaxation of imprinting of mostly paternally expressed genes. Both genetic and epigenetic mechanisms underlie hybrid inviability in Peromyscus and hence have a role in the establishment and maintenance of reproductive isolation barriers in mammals.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Tilghman, SM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051460] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51460] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], GENETICS ORIGIN SPEC; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; CATTANACH BM, 1970, GENET RES, V15, P183, DOI 10.1017/S0016672300001518; CATTANACH BM, 1972, GENET RES, V19, P229, DOI 10.1017/S001667230001449X; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; DARVASI A, 1995, GENETICS, V141, P1199; DAWSON WD, 1965, EVOLUTION, V19, P44, DOI 10.2307/2406294; Dawson WD, 1999, MAMM GENOME, V10, P730, DOI 10.1007/s003359901080; Gray A. P., 1972, MAMMALIAN HYBRIDS; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Muller H.J., 1942, BIOL S, V6, P71; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; ROGERS JF, 1970, J REPROD FERTIL, V21, P255; Shin MK, 1997, P NATL ACAD SCI USA, V94, P13105, DOI 10.1073/pnas.94.24.13105; SIMMLER MC, 1993, MAMM GENOME, V4, P523, DOI 10.1007/BF00364788; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; TURELLI M, 1995, GENETICS, V140, P389; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Zechner U, 1996, NAT GENET, V12, P398, DOI 10.1038/ng0496-398; Zeng LW, 1996, GENETICS, V143, P603	30	132	136	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					120	124		10.1038/75518	http://dx.doi.org/10.1038/75518			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802670				2022-12-17	WOS:000086884000030
J	Herault, Y; Rassoulzadegan, M; Cuzin, F; Duboule, D				Herault, Y; Rassoulzadegan, M; Cuzin, F; Duboule, D			Engineering chromosomes in mice through targeted meiotic recombination (TAMERE)	NATURE GENETICS			English	Article							HOXD COMPLEX; GENES; REGIONS	Functional studies of large transcription units, clustered genes and chromosomal loci require the design of novel experimental toots to engineer genomic macro-rearrangements. Here, we present a strategy to produce deficiencies or duplications by crossing mice carrying loxP sites in homologous loci. This trans-allelic targeted meiotic recombination (TAMERE) protocol allows for the combination of various alleles within a particular locus as well as for generation of interchromosomal unequal exchanges. Novel genetic configurations can thus be produced without multiple targeting and selection steps in embryonic stem (ES) cells. A concomitant deletion/duplication event of the Hoxd12 locus shows the potential of this approach. The high frequency of such targeted exchanges in vivo makes TAMERE a powerful genetic tool applicable to research areas in which complex genomic modifications are required.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Nice, INSERM U470, F-06108 Nice, France	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Sci 3,Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	Denis.Duboule@zoo.unige.ch	Herault, Yann/B-5500-2012; Rassoulzadegan, Minoo/O-7939-2016	Herault, Yann/0000-0001-7049-6900; duboule, denis/0000-0001-9961-2960				Beckers J, 1998, DEV DYNAM, V213, P1; Davis AP, 1996, DEVELOPMENT, V122, P1175; Dupe V, 1997, DEVELOPMENT, V124, P399; Gerard M, 1996, GENE DEV, V10, P2326, DOI 10.1101/gad.10.18.2326; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Herault Y, 1998, DEVELOPMENT, V125, P1669; Kondo T, 1996, DEVELOPMENT, V122, P2651; Kondo T, 1998, MOL CELL, V1, P289, DOI 10.1016/S1097-2765(00)80029-5; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; VIDAL F, IN PRESS MOL REPROD; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	18	132	140	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					381	384		10.1038/3861	http://dx.doi.org/10.1038/3861			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843213				2022-12-17	WOS:000077199600028
J	Liu, XR; Ondek, B; Williams, DS				Liu, XR; Ondek, B; Williams, DS			Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice	NATURE GENETICS			English	Letter							MOUSE		Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Williams, DS (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	dswilliams@ucsd.edu			NEI NIH HHS [EY07042] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.0.CO;2-A; Lord EM, 1929, AM NAT, V63, P435, DOI 10.1086/280276; Mburu Philomena, 1997, Genes and Function, V1, P191; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Usher C. H., 1914, ROY LOND OPHTHAL HOS, V19, P130; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; Wu XF, 1997, J CELL SCI, V110, P847	12	132	134	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					117	118		10.1038/470	http://dx.doi.org/10.1038/470			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620764				2022-12-17	WOS:000073865100015
J	May, WA; Arvand, A; Thompson, AD; Braun, BS; Wright, M; Denny, CT				May, WA; Arvand, A; Thompson, AD; Braun, BS; Wright, M; Denny, CT			EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic	NATURE GENETICS			English	Article							REPRESENTATIONAL DIFFERENCE ANALYSIS; EWS/FLI-1 FUSION GENE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATOR; EWING SARCOMA; NOTCH GENE; TRANSLOCATION; PROTEIN; TUMORS; TRANSFORMATION	EWS/FLI1, a fusion gene found in Ewing's sarcoma, encodes a transcriptional regulator and promotes cellular transformation by modulating the transcription of specific target genes, We have found that EWS/FLI1 and structurally related fusion proteins upregulate manic fringe (MFNG), a recently described member of the Fringe gene family instrumental in somatic development, MFNG is also expressed in human tumour-derived cell lines expressing EWS/FLI1. Overexpression of MFNG in NIH 3T3 cells renders them tumorigenic in mice with severe combined immunodeficiency disease (SCID), These data demonstrate that part of the oncogenic effect of EWS/FLI1 is to transcriptionally deregulate a member of a family of morphogenic genes.	UNIV CALIF LOS ANGELES,MED CTR,INST MOL BIOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,MED CTR,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,MED CTR,GWYNNE HAZEN MEM LABS,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90095; UNIV ALABAMA,SCH MED,DEPT PEDIAT,BIRMINGHAM,AL; UNIV ALABAMA,SCH MED,CTR COMPREHENS CANC,BIRMINGHAM,AL; UNIV CALIF LOS ANGELES,MED CTR,DEPT EXPT PATHOL LAB MED,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center					NATIONAL CANCER INSTITUTE [P01CA032737, P30CA013148] Funding Source: NIH RePORTER; NCI NIH HHS [CA32737, CA13148] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; BONIN G, 1993, CANCER RES, V53, P3655; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DORIT RL, 1993, MOL BIOL, V2; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fu XY, 1997, MOL CELL BIOL, V17, P1503, DOI 10.1128/MCB.17.3.1503; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LESSNICK SL, 1995, ONCOGENE, V10, P423; Look AT, 1995, ADV CANCER RES, V67, P25, DOI 10.1016/S0065-230X(08)60709-5; MAO X, 1994, J BIOL CHEM, V269, P17216; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; OHNO T, 1993, CANCER RES, V53, P5859; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; SORENSEN PHB, 1993, DIAGN MOL PATHOL, V2, P147, DOI 10.1097/00019606-199303000-00022; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Thompson AD, 1996, ONCOGENE, V13, P2649; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8	29	132	141	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					495	497		10.1038/ng1297-495	http://dx.doi.org/10.1038/ng1297-495			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398859				2022-12-17	WOS:A1997YJ92400038
J	ZUCCOTTI, M; MONK, M				ZUCCOTTI, M; MONK, M			METHYLATION OF THE MOUSE XIST GENE IN SPERM AND EGGS CORRELATES WITH IMPRINTED XIST EXPRESSION AND PATERNAL X-INACTIVATION	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; DNA METHYLATION; EMBRYOS; MECHANISMS	Preferential paternal X-inactivation in the extra-embryonic tissues of the female mouse embryo is correlated with imprinted expression of the paternal allele of the Xist gene in pre-implantation development. Here we examine 11 CpG sites in Xist to determine whether differential methylation might be the molecular basis for imprinting. We find that three sites in the promoter region are methylated in eggs but not in sperm and that this differential methylation is maintained to the blastocyst stage when the paternal X-inactivation occurs. This is the first example of a primary gametic methylation imprint governing differential expression of parental alleles in pre-implantation embryos.	UNIV PAVIA,DIPARTIMENTO BIOL ANIM,I-27100 PAVIA,ITALY; UNIV PAVIA,CNR,CTR STUDI ISTOCHIM,I-27100 PAVIA,ITALY	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); University of Pavia	ZUCCOTTI, M (corresponding author), UNIV LONDON,INST CHILD HLTH,MOLEC EMBRYOL UNIT,30 GUILDFORD ST,LONDON WC1N 1EH,ENGLAND.		Conti, Bice/AAC-7792-2022	Conti, Bice/0000-0002-0034-2815				BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GRANT M, 1992, NAT GENET, V2, P161, DOI 10.1038/ng1092-161; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; LYON MF, 1961, NATURE, V190, P373; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1987, DEVELOPMENT, V99, P371; MONK M, 1986, BIOESSAYS, V2, P204; MONK M, 1987, MAMMALIAN DEV PRACTI; NORRIS DP, 1994, CELL, V7, P41; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SALIDO EC, 1992, NAT GENET, V2, P196, DOI 10.1038/ng1192-196; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; SINGERSAM J, 1989, UCLA S MOL CELL BIOL, P128; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; ZUCCOTTI M, 1993, METHOD ENZYMOL, V225, P557	31	132	135	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					316	320		10.1038/ng0395-316	http://dx.doi.org/10.1038/ng0395-316			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773296				2022-12-17	WOS:A1995QL23200024
J	ROSATI, R; HORAN, GSB; PINERO, GJ; GAROFALO, S; KEENE, DR; HORTON, WA; VUORIO, E; DECROMBRUGGHE, B; BEHRINGER, RR				ROSATI, R; HORAN, GSB; PINERO, GJ; GAROFALO, S; KEENE, DR; HORTON, WA; VUORIO, E; DECROMBRUGGHE, B; BEHRINGER, RR			NORMAL LONG-BONE GROWTH AND DEVELOPMENT IN TYPE-X COLLAGEN NULL MICE	NATURE GENETICS			English	Article							CARTILAGE MATRIX; GENE-EXPRESSION; MUTATION; PROTOONCOGENE; ASSOCIATION; DISRUPTION; PROTEIN; ENCODES	To investigate the role of type X collagen in skeletal development, we have generated type X collagen-null mice. Surprisingly, mice without type X collagen were viable and fertile and had no gross abnormalities in long bone growth or development. No differences were detected between the type X collagen-null mice and controls when growth plates of both newborn and 3-week old mice were examined by histology and by immunostaining for extracellular matrix components of bone including osteopontin, osteocalcin and type II collagen. Our results suggest that type X collagen is not required for long bone development. However, mice and humans with dominant acting type X collagen mutations have bone abnormalities, suggesting that only the presence of abnormal type X collagen can modify bone growth and development.	UNIV TEXAS, MD ANDERSON CANC CTR, DEPT MOLEC GENET, HOUSTON, TX 77030 USA; FDN G PASCALE, IST STUDIO CURA TUMORI, NAPLES, ITALY; UNIV TEXAS, HLTH SCI CTR, DEPT BASIC SCI, DENT BRANCH, HOUSTON, TX 77030 USA; SHRINERS HOSP CRIPPLED CHILDRENS, PORTLAND, OR 97201 USA; TURKU UNIV, DEPT MOLEC BIOL & MED BIOCHEM, TURKU, FINLAND	University of Texas System; UTMD Anderson Cancer Center; IRCCS Fondazione Pascale; University of Texas System; University of Texas Health Science Center Houston; University of Turku				Vuorio, Eero/0000-0003-3404-2439; GAROFALO, SILVIO/0000-0001-7460-3179	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040335] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40335] Funding Source: Medline; NICHD NIH HHS [HD 31568] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; CHEN Q, 1990, P NATL ACAD SCI USA, V87, P8046, DOI 10.1073/pnas.87.20.8046; Culling C. F. A., 1985, CELLULAR PATHOLOGY T, P642; DHARMAVARAM RM, 1994, HUM MOL GENET, V3, P507, DOI 10.1093/hmg/3.3.507; ELIMA K, 1993, BIOCHEM J, V289, P247, DOI 10.1042/bj2890247; FITCH JM, 1988, DEV BIOL, V128, P396, DOI 10.1016/0012-1606(88)90301-6; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; GERSTENFELD LC, 1991, J CELL BIOL, V112, P501, DOI 10.1083/jcb.112.3.501; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; KIRSCH T, 1991, EUR J BIOCHEM, V196, P575, DOI 10.1111/j.1432-1033.1991.tb15852.x; KRAMER JM, 1988, CELL, V55, P555, DOI 10.1016/0092-8674(88)90214-0; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARK MP, 1987, J HISTOCHEM CYTOCHEM, V35, P707, DOI 10.1177/35.7.3295029; MCINTOSH I, 1994, HUM MOL GENET, V3, P303, DOI 10.1093/hmg/3.2.303; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; POOLE AR, 1989, J CELL BIOL, V109, P2547, DOI 10.1083/jcb.109.5.2547; POOLE R, 1991, CARTILAGE MOL ASPECT, V6, P179; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SCHMID TM, 1990, DEV BIOL, V138, P53, DOI 10.1016/0012-1606(90)90176-J; SCHMID TM, 1987, STRUCTURE FUNCTION C, P223; SEARLE AG, 1954, J GENET, V52, P68, DOI 10.1007/BF02981491; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; THOMAS JT, 1990, J CELL SCI, V95, P639; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WALLIS GA, 1994, AM J HUM GENET, V54, P169; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; WU LNY, 1989, J BIOL CHEM, V264, P21346; YAMAGUCHI N, 1991, J BIOL CHEM, V266, P4508	38	132	135	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1994	8	2					129	135		10.1038/ng1094-129	http://dx.doi.org/10.1038/ng1094-129			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842010				2022-12-17	WOS:A1994PL12300013
J	ARIEL, M; CEDAR, H; MCCARREY, J				ARIEL, M; CEDAR, H; MCCARREY, J			DEVELOPMENTAL-CHANGES IN METHYLATION OF SPERMATOGENESIS-SPECIFIC GENES INCLUDE REPROGRAMMING IN THE EPIDIDYMIS	NATURE GENETICS			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; TRANSCRIPTION FACTOR; MOUSE EMBRYO; PATTERNS; EMBRYOGENESIS; EXPRESSION	We have determined the status of DNA methylation at specific sites in three spermatogenesis-specific genes, Pgk-2, ApoA1 and Oct-3/4, throughout the development and differentiation of male germ cells in the mouse. We observed a specific demethylation event in the Pgk-2 gene in prospermatogonia at about the time of birth, about 10 days before the onset of transcription which first occurs in primary spermatocytes. All three genes were unmethylated in adult spermatogenic cells in the testis, but were remethylated in mature spermatozoa in the vas deferens. Surprisingly, we found that this remethylation is part of the process of sperm maturation which occurs in the epididymis.	SW FDN BIOMED RES,DEPT GENET,SAN ANTONIO,TX 78228; HEBREW UNIV JERUSALEM,SCH MED,DEPT CELLULAR BIOCHEM,IL-91010 JERUSALEM,ISRAEL	Texas Biomedical Research Institute; Hebrew University of Jerusalem					NICHD NIH HHS [HD 23126] Funding Source: Medline; NIGMS NIH HHS [GM 20468] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023126] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARIEL M, 1991, P NATL ACAD SCI USA, V88, P2317, DOI 10.1073/pnas.88.6.2317; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bedford J. M., 1975, HDB PHYSIOLOGY, P303; BELIVE AR, 1977, J CELL BIOL, V74, P68; BENOIT MJ, 1926, ARCH ANAT HISTOL EMB, V5, P175; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; GEBARA MM, 1992, MOL CELL BIOL, V12, P1422, DOI 10.1128/MCB.12.4.1422; HAHNEL AC, 1986, GAMETE RES, V15, P25, DOI 10.1002/mrd.1120150104; HAMILTON DW, 1977, FRONTIERS REPRODUCTI, P411; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; McCarrey J, 1993, CELL MOL BIOL TESTIS, P58; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; MCCARREY JR, 1987, J EXP ZOOL, V242, P107, DOI 10.1002/jez.1402420116; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MONESI V, 1967, ARCH ANAT MICROSC MO, V56, P61; MONK M, 1987, DEVELOPMENT, V99, P371; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Orgebin-Crist M.-C., 1984, The male in farm animal reproduction., P80; Robaire B., 1988, P999; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; SHEMER R, 1990, J BIOL CHEM, V265, P1010; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P687, DOI 10.1093/nar/18.3.687; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; WALSH A, 1989, J BIOL CHEM, V264, P6488	31	132	136	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					59	63		10.1038/ng0594-59	http://dx.doi.org/10.1038/ng0594-59			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075642				2022-12-17	WOS:A1994NJ84200014
J	MEINDL, A; BERGER, W; MEITINGER, T; VANDEPOL, D; ACHATZ, H; DORNER, C; HAASEMANN, M; HELLEBRAND, H; GAL, A; CREMERS, F; ROPERS, HH				MEINDL, A; BERGER, W; MEITINGER, T; VANDEPOL, D; ACHATZ, H; DORNER, C; HAASEMANN, M; HELLEBRAND, H; GAL, A; CREMERS, F; ROPERS, HH			NORRIE DISEASE IS CAUSED BY MUTATIONS IN AN EXTRACELLULAR PROTEIN RESEMBLING C-TERMINAL GLOBULAR DOMAIN OF MUCINS	NATURE GENETICS			English	Article							VONWILLEBRAND-FACTOR; NUCLEOTIDE-SEQUENCE; MYC-ONCOGENE; GENE; DNA; IDENTIFICATION; EXPRESSION; CONTAINS; FAMILY; ELECTROPHORESIS	A candidate gene for Norrie disease, an X-linked disorder characterized by blindness, deafness and mental disturbances, was recently isolated and found to contain microdeletions in numerous patients. No strong homologies were identified. By studying the number and spacing of cysteine residues, we now detect homologies between the Norrie gene product and a C-terminal domain which is common to a group of proteins including mucins. Three newly-characterized missense mutations, replacing evolutionarily conserved cysteines or creating new cysteine codons, emphasize the functional importance of these sites. These findings and the clinical features of this disorder suggest a possible role for the Norrie gene in neuroectodermal cell-cell interaction.	UNIV MUNICH,KINDERPOLIKLIN,PADIAT GENET ABT,GOETHESTR 29,W-8000 MUNICH 2,GERMANY; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; MARTINSRIED INST PROT SEQUENCES,MARTINSRIED,GERMANY; INST HUMAN GENET & ANTHROPOL,LUBECK,GERMANY	University of Munich; Radboud University Nijmegen			Meitinger, Thomas/O-1318-2015; Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592; Meitinger, Thomas/0000-0002-8838-8403				ARGOS P, 1987, J MOL BIOL, V193, P385, DOI 10.1016/0022-2836(87)90226-9; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BHARGAVA AK, 1990, P NATL ACAD SCI USA, V87, P6798, DOI 10.1073/pnas.87.17.6798; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHEN ZY, 1992, NAT GENET, V1, P204, DOI 10.1038/ng0692-204; COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0; DESILVA DGH, 1988, BRIT J OPHTHALMOL, V72, P62, DOI 10.1136/bjo.72.1.62; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; ECKHARDT AE, 1991, J BIOL CHEM, V266, P9678; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; HALTINER M, 1985, NUCLEIC ACIDS RES, V13, P1015, DOI 10.1093/nar/13.3.1015; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE MG, 1983, CELL, V33, P477; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NORRIE GORDON, 1927, ACTA OPHTHALMOLOGICA, V5, P357; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; PROBST JC, 1990, BIOCHEMISTRY-US, V29, P6240, DOI 10.1021/bi00478a018; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; RUPP RAW, 1987, NUCLEIC ACIDS RES, V15, P9707, DOI 10.1093/nar/15.23.9707; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; Sims K. B., 1992, Human Molecular Genetics, V1, P83, DOI 10.1093/hmg/1.2.83; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; VASICEK TJ, 1983, P NATL ACAD SCI-BIOL, V80, P2127, DOI 10.1073/pnas.80.8.2127; WARBURG M, 1961, ACTA OPHTHALMOL, V39, P757; Warburg M., 1966, ACTA OPHTHALMOL SCAN, V89, P1	40	132	143	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					139	143		10.1038/ng1092-139	http://dx.doi.org/10.1038/ng1092-139			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303264				2022-12-17	WOS:A1992JR08400014
J	MACDONALD, ME; NOVELLETTO, A; LIN, C; TAGLE, D; BARNES, G; BATES, G; TAYLOR, S; ALLITTO, B; ALTHERR, M; MYERS, R; LEHRACH, H; COLLINS, FS; WASMUTH, JJ; FRONTALI, M; GUSELLA, JF				MACDONALD, ME; NOVELLETTO, A; LIN, C; TAGLE, D; BARNES, G; BATES, G; TAYLOR, S; ALLITTO, B; ALTHERR, M; MYERS, R; LEHRACH, H; COLLINS, FS; WASMUTH, JJ; FRONTALI, M; GUSELLA, JF			THE HUNTINGTONS-DISEASE CANDIDATE REGION EXHIBITS MANY DIFFERENT HAPLOTYPES	NATURE GENETICS			English	Article							GENE; LOCALIZATION	Analysis of 78 Huntington's disease (HD) chromosomes with multi-allele markers revealed 26 different haplotypes, suggesting a variety of independent HD mutations. The most frequent haplotype, accounting for about one third of disease chromosomes, suggests that the disease gene is between D4S182 and D4S180. However, the paucity of an expected class of chromosomes that can be related to this major haplotype by assuming single crossovers may reflect the operation of other mechanisms in creating haplotype diverstiy. Some of these mechanisms sustain alternative scenarios that do not require a multiple mutational origin for HD and/or its positioning between D4S182 and DAS180.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED & HUMAN GENET,DEARBORN,MI 48128; UNIV TOR VERGATA ROMA,DIPARTIMENTO BIOL,ROME,ITALY; CNR,IST MED SPERIMENTALE,ROME,ITALY; BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Boston University; Cancer Research UK; University of California System; University of California Irvine	MACDONALD, ME (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,NEUROGENET LAB,BOSTON,MA 02114, USA.		Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305; Novelletto, Andrea/0000-0002-1146-7680; Myers, Richard/0000-0002-8365-2674				ADAM S, 1991, AM J HUM GENET, V48, P595; ALLITTO BA, 1991, NUCLEIC ACIDS RES, V19, P4015, DOI 10.1093/nar/19.14.4015-a; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BATES GP, 1991, AM J HUM GENET, V49, P7; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; Gusella J F, 1991, Adv Hum Genet, V20, P125; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; NOVELLETTO A, 1991, AM J MED GENET, V40, P374, DOI 10.1002/ajmg.1320400326; SEIZINGER BR, 1986, NATURE, V322, P664; SHAW M, 1982, J MED GENET, V19, P161, DOI 10.1136/jmg.19.3.161; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; STEVENS D, 1969, J NEUROL NEUROSUR PS, V32, P140, DOI 10.1136/jnnp.32.2.140; TAYLOR SAM, IN PRESS NUCLEIC ACI; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207	22	132	139	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1992	1	2					99	103		10.1038/ng0592-99	http://dx.doi.org/10.1038/ng0592-99			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302016				2022-12-17	WOS:A1992JC98000007
J	Zhang, YJ; Pitchiaya, S; Cieslik, M; Niknafs, YS; Tien, JCY; Hosono, Y; Iyer, MK; Yazdani, S; Subramaniam, S; Shukla, SK; Jiang, X; Wang, LS; Liu, TY; Uhl, M; Gawronski, AR; Qiao, YY; Xiao, LB; Dhanasekaran, SM; Juckette, KM; Kunju, LP; Cao, XH; Patel, U; Batish, M; Shukla, GC; Paulsen, MT; Ljungman, M; Jiang, H; Mehra, R; Backofen, R; Sahinalp, CS; Freier, SM; Watt, AT; Guo, SL; Wei, JT; Feng, FY; Malik, R; Chinnaiyan, AM				Zhang, Yajia; Pitchiaya, Sethuramasundaram; Cieslik, Marcin; Niknafs, Yashar S.; Tien, Jean C. -Y.; Hosono, Yasuyuki; Iyer, Matthew K.; Yazdani, Sahr; Subramaniam, Shruthi; Shukla, Sudhanshu K.; Jiang, Xia; Wang, Lisha; Liu, Tzu-Ying; Uhl, Michael; Gawronski, Alexander R.; Qiao, Yuanyuan; Xiao, Lanbo; Dhanasekaran, Saravana M.; Juckette, Kristin M.; Kunju, Lakshmi P.; Cao, Xuhong; Patel, Utsav; Batish, Mona; Shukla, Girish C.; Paulsen, Michelle T.; Ljungman, Mats; Jiang, Hui; Mehra, Rohit; Backofen, Rolf; Sahinalp, Cenk S.; Freier, Susan M.; Watt, Andrew T.; Guo, Shuling; Wei, John T.; Feng, Felix Y.; Malik, Rohit; Chinnaiyan, Arul M.			Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression	NATURE GENETICS			English	Article							LONG NONCODING RNA; GENE-EXPRESSION DATA; MESSENGER-RNA; ANTISENSE OLIGONUCLEOTIDES; DEPRIVATION THERAPY; HUMAN TRANSCRIPTOME; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; ABIRATERONE; CASTRATION	The androgen receptor (AR) plays a critical role in the development of the normal prostate as well as prostate cancer. Using an integrative transcriptomic analysis of prostate cancer cell lines and tissues, we identified ARLNC1 (AR-regulated long noncoding RNA 1) as an important long noncoding RNA that is strongly associated with AR signaling in prostate cancer progression. Not only was ARLNC1 induced by the AR protein, but ARLNC1 stabilized the AR transcript via RNA-RNA interaction. ARLNC1 knockdown suppressed AR expression, global AR signaling and prostate cancer growth in vitro and in vivo. Taken together, these data support a role for ARLNC1 in maintaining a positive feedback loop that potentiates AR signaling during prostate cancer progression and identify ARLNC1 as a novel therapeutic target.	[Zhang, Yajia; Pitchiaya, Sethuramasundaram; Cieslik, Marcin; Niknafs, Yashar S.; Tien, Jean C. -Y.; Hosono, Yasuyuki; Iyer, Matthew K.; Yazdani, Sahr; Subramaniam, Shruthi; Shukla, Sudhanshu K.; Jiang, Xia; Wang, Lisha; Qiao, Yuanyuan; Xiao, Lanbo; Dhanasekaran, Saravana M.; Juckette, Kristin M.; Kunju, Lakshmi P.; Cao, Xuhong; Feng, Felix Y.; Malik, Rohit; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Zhang, Yajia; Pitchiaya, Sethuramasundaram; Cieslik, Marcin; Tien, Jean C. -Y.; Qiao, Yuanyuan; Dhanasekaran, Saravana M.; Kunju, Lakshmi P.; Mehra, Rohit; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Zhang, Yajia] Univ Michigan, Mol & Cellular Pathol Program, Ann Arbor, MI 48109 USA; [Zhang, Yajia; Iyer, Matthew K.; Chinnaiyan, Arul M.] Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Chinnaiyan, Arul M.] Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Liu, Tzu-Ying; Jiang, Hui] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Uhl, Michael; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Freiburg, Germany; [Uhl, Michael; Backofen, Rolf] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, Freiburg, Germany; [Gawronski, Alexander R.] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Qiao, Yuanyuan; Kunju, Lakshmi P.; Paulsen, Michelle T.; Ljungman, Mats; Jiang, Hui; Mehra, Rohit; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Patel, Utsav; Batish, Mona] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA; [Batish, Mona] Univ Delaware, Dept Med Lab Sci, Newark, DE USA; [Shukla, Girish C.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Paulsen, Michelle T.; Ljungman, Mats; Feng, Felix Y.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Mehra, Rohit; Wei, John T.; Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Sahinalp, Cenk S.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Sahinalp, Cenk S.] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Freier, Susan M.; Watt, Andrew T.; Guo, Shuling] Ionis Pharmaceut, Carlsbad, CA USA; [Feng, Felix Y.] Univ Michigan, Breast Oncol Program, Ann Arbor, MI 48109 USA; [Shukla, Sudhanshu K.] Indian Inst Technol Dharwad, Dept Biosci & Bioengn, Dharwad, Karnataka, India; [Feng, Felix Y.] Univ Calif San Francisco, Dept Radiat Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Feng, Felix Y.] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Malik, Rohit] Bristol Myers Squibb, Princeton, NJ USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Freiburg; University of Freiburg; Simon Fraser University; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Delaware; University System of Ohio; Cleveland State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington; Ionis Pharmaceuticals, Inc.; University of Michigan System; University of Michigan; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Dharwad; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Bristol-Myers Squibb	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.; Chinnaiyan, AM (corresponding author), Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Backofen, Rolf/AAC-1569-2021; Hosono, Yasuyuki/GOP-1342-2022; Batish, Mona/AAG-8296-2019; Hosono, Yasuyuki/J-4295-2019; Sahinalp, Suleyman Cenk/X-7843-2018; Shukla, Sudhanshu/AAC-8650-2020; Shukla, Sudhanshu/K-7830-2017; Wei, John T/E-8967-2012; Jiang, Hui/Q-8281-2019	Batish, Mona/0000-0001-9039-6149; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Shukla, Sudhanshu/0000-0002-5069-9708; Shukla, Sudhanshu/0000-0002-5069-9708; Jiang, Hui/0000-0003-2718-9811; Uhl, Michael/0000-0002-9563-4991; Qiao, Yuanyuan/0000-0002-1178-3480; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Shukla, Girish/0000-0003-1982-2218	NCI Prostate SPORE grant [P50CA186786]; NCI Prostate EDRN grant [U01 CA214170]; Prostate Cancer Foundation; Howard Hughes Medical Institute; Department of Defense Postdoctoral Award [W81XWH-13-1-0284]; Department of Defense Early Investigator Research Award [W81XWH-17-1-0134]; Prostate Cancer Foundation Young Investigator Award; Department of Defense Idea Development Award [W81XWH-16-1-0314]; University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant; AACR-Bayer Prostate Cancer Research Fellowship [16-40-44-PITC]; US Department of Defense Postdoctoral Fellowship [W81XWH-16-1-0195]; NIH DP5 grant [OD012160]; Department of Defense [W81XWH-14-1-0508, W81XWH-14-1-0509]; German Research Foundation (DFG) [BA2168/11-1 SPP 1738]; NATIONAL CANCER INSTITUTE [P50CA186786, U01CA214170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012160] Funding Source: NIH RePORTER	NCI Prostate SPORE grant; NCI Prostate EDRN grant; Prostate Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Defense Postdoctoral Award; Department of Defense Early Investigator Research Award; Prostate Cancer Foundation Young Investigator Award; Department of Defense Idea Development Award(United States Department of Defense); University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant; AACR-Bayer Prostate Cancer Research Fellowship; US Department of Defense Postdoctoral Fellowship; NIH DP5 grant; Department of Defense(United States Department of Defense); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Poliakov, A. Parolia, V. Kothari and J. Siddiqui for helpful discussions, the University of Michigan Sequencing Core for Sanger sequencing, H. Johansson (LGC-Biosearch) for initial assistance with smFISH probe design, and S. Ellison, S. Gao and K. Giles for critically reading the manuscript and submitting documents. This work was supported in part by NCI Prostate SPORE (P50CA186786 to A.M.C.) and EDRN (U01 CA214170 to A.M.C.) grants. A.M.C. is also supported by the Prostate Cancer Foundation and by the Howard Hughes Medical Institute. A.M.C. is an American Cancer Society Research Professor and a Taubman Scholar of the University of Michigan. R. Malik was supported by a Department of Defense Postdoctoral Award (W81XWH-13-1-0284). Y.Z. is supported by a Department of Defense Early Investigator Research Award (W81XWH-17-1-0134). R. Malik, M.C., Y.S.N., J.C.-Y.T. and Y.Q. were supported by the Prostate Cancer Foundation Young Investigator Award. R. Mehra was supported by a Department of Defense Idea Development Award (W81XWH-16-1-0314). Y.S.N. is supported by a University of Michigan Cellular and Molecular Biology National Research Service Award Institutional Predoctoral Training Grant. S.P. was supported by an AACR-Bayer Prostate Cancer Research Fellowship (16-40-44-PITC). L.X. is supported by a US Department of Defense Postdoctoral Fellowship (W81XWH-16-1-0195). M.B. was supported by NIH DP5 grant OD012160. G.C.S. was supported by the Department of Defense awards W81XWH-14-1-0508 and W81XWH-14-1-0509. M.U. was funded by the German Research Foundation (DFG grant BA2168/11-1 SPP 1738).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Evers MM, 2015, ADV DRUG DELIVER REV, V87, P90, DOI 10.1016/j.addr.2015.03.008; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gawronski AR, 2018, BIOINFORMATICS, V34, P3101, DOI 10.1093/bioinformatics/bty208; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hansen P, 2015, GENOME RES, V25, P1391, DOI 10.1101/gr.189894.115; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hearn JWD, 2016, LANCET ONCOL, V17, P1435, DOI 10.1016/S1470-2045(16)30227-3; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Huggins C, 2002, J UROLOGY, V167, P948, DOI 10.1016/S0022-5347(02)80307-X; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu-Yao GL, 2014, JAMA INTERN MED, V174, P1460, DOI 10.1001/jamainternmed.2014.3028; Malik R, 2014, MOL CANCER RES, V12, P1081, DOI 10.1158/1541-7786.MCR-14-0257; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; Mehra R, 2014, NEOPLASIA, V16, P1121, DOI 10.1016/j.neo.2014.11.006; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mukherji D, 2012, EXPERT OPIN INV DRUG, V21, P227, DOI 10.1517/13543784.2012.651125; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Niknafs YS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12791; Paulsen MT, 2014, METHODS, V67, P45, DOI 10.1016/j.ymeth.2013.08.015; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Rossiello F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13980; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shukla S, 2016, NEOPLASIA, V18, P489, DOI 10.1016/j.neo.2016.07.001; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; The Veterans Administration Co-operative Urological Research Group, 1967, SURG GYNECOL OBSTET, V124, P1011; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wong YNS, 2014, NAT REV CLIN ONCOL, V11, P365, DOI 10.1038/nrclinonc.2014.72; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	71	131	137	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					814	+		10.1038/s41588-018-0120-1	http://dx.doi.org/10.1038/s41588-018-0120-1			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29808028	Green Accepted, Green Submitted			2022-12-17	WOS:000433621000009
J	Jin, Y; Andersen, G; Yorgov, D; Ferrara, TM; Ben, ST; Brownson, KM; Holland, PJ; Birlea, SA; Siebert, J; Hartmann, A; Lienert, A; van Geel, N; Lambert, J; Luiten, RM; Wolkerstorfer, A; van der Veen, JPW; Bennett, DC; Taieb, A; Ezzedine, K; Kemp, EH; Gawkrodger, DJ; Weetman, AP; Koks, S; Prans, E; Kingo, K; Karelson, M; Wallace, MR; McCormack, WT; Overbeck, A; Moretti, S; Colucci, R; Picardo, M; Silverberg, NB; Olsson, M; Valle, Y; Korobko, I; Bohm, M; Lim, HW; Hamzavi, I; Zhou, L; Mi, QS; Fain, PR; Santorico, SA; Spritz, RA				Jin, Ying; Andersen, Genevieve; Yorgov, Daniel; Ferrara, Tracey M.; Ben, Songtao; Brownson, Kelly M.; Holland, Paulene J.; Birlea, Stanca A.; Siebert, Janet; Hartmann, Anke; Lienert, Anne; van Geel, Nanja; Lambert, Jo; Luiten, Rosalie M.; Wolkerstorfer, Albert; van der Veen, J. P. Wietze; Bennett, Dorothy C.; Taieb, Alain; Ezzedine, Khaled; Kemp, E. Helen; Gawkrodger, David J.; Weetman, Anthony P.; Koks, Sulev; Prans, Ele; Kingo, Kulli; Karelson, Maire; Wallace, Margaret R.; McCormack, Wayne T.; Overbeck, Andreas; Moretti, Silvia; Colucci, Roberta; Picardo, Mauro; Silverberg, Nanette B.; Olsson, Mats; Valle, Yan; Korobko, Igor; Boehm, Markus; Lim, Henry W.; Hamzavi, Iltefat; Zhou, Li; Mi, Qing-Sheng; Fain, Pamela R.; Santorico, Stephanie A.; Spritz, Richard A.			Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NONMELANOMA SKIN-CANCER; GENERALIZED VITILIGO; SUSCEPTIBILITY LOCI; COMMON VARIANTS; PARTITIONING HERITABILITY; RHEUMATOID-ARTHRITIS; HAN CHINESE; GRANZYME-B; IN-VIVO	Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of melanocytesl, with epidemiological association with other autoimmune diseases(2). In previous linkage and genome-wide association studies (GWAS1 and GWAS2), we identified 27 vitiligo susceptibility loci in patients of European ancestry. We carried out a third GWAS (GWAS3) in European-ancestry subjects, with augmented GWAS1 and GWAS2 controls, genome-wide imputation, and meta-analysis of all three GWAS, followed by an independent replication. The combined analyses, with 4,680 cases and 39,586 controls, identified 23 new significantly associated loci and 7 suggestive loci. Most encode immune and apoptotic regulators, with some also associated with other autoimmune diseases, as well as several melanocyte regulators. Bioinformatic analyses indicate a predominance of causal regulatory variation, some of which corresponds to expression quantitative trait loci (eQTLs) at these loci. Together, the identified genes provide a framework for the genetic architecture and pathobiology of vitiligo, highlight relationships with other autoimmune diseases and melanoma, and offer potential targets for treatment.	[Jin, Ying; Andersen, Genevieve; Ferrara, Tracey M.; Ben, Songtao; Brownson, Kelly M.; Holland, Paulene J.; Birlea, Stanca A.; Fain, Pamela R.; Santorico, Stephanie A.; Spritz, Richard A.] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO 80045 USA; [Jin, Ying; Fain, Pamela R.; Spritz, Richard A.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Yorgov, Daniel; Santorico, Stephanie A.] Univ Colorado, Dept Math & Stat Sci, Denver, CO 80202 USA; [Birlea, Stanca A.] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO USA; [Siebert, Janet] CytoAnalytics, Denver, CO USA; [Hartmann, Anke; Lienert, Anne] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [van Geel, Nanja; Lambert, Jo] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; [Luiten, Rosalie M.; Wolkerstorfer, Albert; van der Veen, J. P. Wietze] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Netherlands Inst Pigment Disorders, Amsterdam, Netherlands; [van der Veen, J. P. Wietze] Med Ctr Haaglanden, Dept Dermatol, The Hague, Netherlands; [Bennett, Dorothy C.] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Taieb, Alain; Ezzedine, Khaled] Hop St Andre, Dept Dermatol, Ctr Reference Malad Rares Peau, Bordeaux, France; [Kemp, E. Helen; Gawkrodger, David J.; Weetman, Anthony P.] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Koks, Sulev; Prans, Ele] Univ Tartu, Dept Pathophysiol, Tartu, Estonia; [Kingo, Kulli; Karelson, Maire] Univ Tartu, Dept Dermatol, Tartu, Estonia; [Wallace, Margaret R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [McCormack, Wayne T.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Overbeck, Andreas] Lumiderm, Madrid, Spain; [Moretti, Silvia; Colucci, Roberta] Univ Florence, Dept Surg & Translat Med, Sect Dermatol, Florence, Italy; [Picardo, Mauro] Ist Dermatol S Maria & S Gallicano, Lab Fisiopatol Cutanea, Rome, Italy; [Silverberg, Nanette B.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Silverberg, Nanette B.] St Lukes Roosevelt Hosp, Pediat & Adolescent Dermatol, New York, NY USA; [Olsson, Mats] Int Vitiligo Ctr, Uppsala, Sweden; [Valle, Yan; Korobko, Igor] Vitiligo Res Fdn, New York, NY USA; [Korobko, Igor] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Boehm, Markus] Univ Munster, Dept Dermatol, Munster, Germany; [Lim, Henry W.; Hamzavi, Iltefat; Zhou, Li; Mi, Qing-Sheng] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA; [Santorico, Stephanie A.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Erlangen Nuremberg; Ghent University; Ghent University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Haaglanden Medical Center; St Georges University London; CHU Bordeaux; University of Sheffield; University of Tartu; University of Tartu; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Florence; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; University of Munster; Henry Ford Health System; Henry Ford Hospital; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Spritz, RA (corresponding author), Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO 80045 USA.; Spritz, RA (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.	richard.spritz@ucdenver.edu	Lim, HW/GRY-3517-2022; Bennett, Dorothy C/C-2418-2008; Koks, Sulev/H-3655-2015; Kingo, Külli/H-3603-2012; Ezzedine, Khaled/F-2716-2017; TAIEB, ALAIN/AAB-1085-2021; Wolkerstorfer, Albert/F-8866-2013; Jo, Lambert LW/ABD-3264-2021; Hamzavi, Iltefat/AAW-7320-2021; GAWKRODGER, DAVID J./AFO-6373-2022; Jo, Lambert LW/AAG-4880-2021; Ferrara, Tracey/AAL-1991-2021; Santorico, Stephanie/L-7009-2015; Picardo, Mauro/A-6978-2011	Bennett, Dorothy C/0000-0002-3639-7527; Koks, Sulev/0000-0001-6087-6643; Ezzedine, Khaled/0000-0002-5468-4589; Wolkerstorfer, Albert/0000-0003-1421-1493; GAWKRODGER, DAVID J./0000-0002-6863-7011; Ferrara, Tracey/0000-0001-9599-413X; Lambert, Jo/0000-0001-5303-9310; Santorico, Stephanie/0000-0001-7846-0945; Valle, Yan/0000-0002-9340-9045; Picardo, Mauro/0000-0003-4899-6639; Kingo, Kulli/0000-0001-6301-9612	National Science Foundation [CNS-0821794]; University of Colorado Boulder; University of Colorado Denver; National Center for Atmospheric Research; US National Institutes of Health [R01AR045584, R01AR056292, X01HG007484, P30AR057212]; Estonian Ministry of Education and Research [IUT20-46]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056292, R01AR039892, P30AR057212, R01AR045584] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder; University of Colorado Denver; National Center for Atmospheric Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the thousands of patients with vitiligo and normal control individuals around the world who participated in this study. We thank the Center for Inherited Disease Research (CIDR) for genotyping. This work used the Janus supercomputer, which is supported by the National Science Foundation (award CNS-0821794), the University of Colorado Boulder, the University of Colorado Denver, and the National Center for Atmospheric Research. The Janus supercomputer is operated by the University of Colorado Boulder. This work was supported by grants R01AR045584, R01AR056292, X01HG007484, and P30AR057212 from the US National Institutes of Health and by institutional research funding IUT20-46 from the Estonian Ministry of Education and Research.	Akiyama T, 2012, WORLD J ORTHOP, V3, P142, DOI 10.5312/wjo.v3.i9.142; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Cavalli G, 2016, P NATL ACAD SCI USA, V113, P1363, DOI 10.1073/pnas.1523482113; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; Das PK, 2001, TRENDS IMMUNOL, V22, P130, DOI 10.1016/S1471-4906(00)01844-5; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Ferrara TM, 2013, J INVEST DERMATOL, V133, P1677, DOI 10.1038/jid.2013.5; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Gualco G, 2010, APPL IMMUNOHISTO M M, V18, P301, DOI 10.1097/PAI.0b013e3181cf1126; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hayashi M, 2016, P NATL ACAD SCI USA, V113, P1357, DOI 10.1073/pnas.1525001113; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2012, J INVEST DERMATOL, V132, P1730, DOI 10.1038/jid.2012.37; Jin Y, 2010, NAT GENET, V42, P576, DOI 10.1038/ng.602; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Juyal G, 2015, GUT, V64, P571, DOI 10.1136/gutjnl-2013-306625; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Li YZ, 2013, NAT GENET, V45, P1361, DOI 10.1038/ng.2779; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Liu F, 2015, HUM GENET, V134, P823, DOI 10.1007/s00439-015-1559-0; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Paradisi A, 2014, J AM ACAD DERMATOL, V71, P1110, DOI 10.1016/j.jaad.2014.07.050; Paul DS, 2014, BIOESSAYS, V36, P191, DOI 10.1002/bies.201300126; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Praetorius C, 2013, CELL, V155, P1022, DOI 10.1016/j.cell.2013.10.022; Read J, 2016, J MED GENET, V53, P1, DOI 10.1136/jmedgenet-2015-103150; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Renton AE, 2015, JAMA NEUROL, V72, P396, DOI 10.1001/jamaneurol.2014.4103; Ricano-Ponce I, 2013, ANNU REV GENOM HUM G, V14, P325, DOI 10.1146/annurev-genom-091212-153450; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Shoag J, 2013, MOL CELL, V49, P145, DOI 10.1016/j.molcel.2012.10.027; Spritz RA, 2010, GENOME MED, V2, DOI 10.1186/gm199; Stegh AH, 2007, GENE DEV, V21, P98, DOI 10.1101/gad.1480007; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Teulings HE, 2013, BRIT J DERMATOL, V168, P162, DOI 10.1111/bjd.12111; Teulings HE, 2015, J CLIN ONCOL, V33, P773, DOI 10.1200/JCO.2014.57.4756; Visser M, 2015, HUM MOL GENET, V24, P2649, DOI 10.1093/hmg/ddv029; Wang XW, 2009, FEBS LETT, V583, P1873, DOI 10.1016/j.febslet.2009.04.045; Wilbe M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005248; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018	57	131	134	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1418	1424		10.1038/ng.3680	http://dx.doi.org/10.1038/ng.3680			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27723757	Green Accepted			2022-12-17	WOS:000386543400019
J	Zhou, FS; Cao, HZ; Zuo, XB; Zhang, T; Zhang, XG; Liu, XM; Xu, RC; Chen, G; Zhang, YW; Zheng, XD; Jin, X; Gao, JP; Mei, JP; Sheng, YJ; Li, QB; Liang, B; Shen, J; Shen, CB; Jiang, H; Zhu, CH; Fan, X; Xu, FP; Yue, M; Yin, XY; Ye, C; Zhang, CC; Liu, X; Yu, L; Wu, JH; Chen, MY; Zhuang, XH; Tang, LL; Shao, HJ; Wu, LM; Li, J; Xu, Y; Zhang, YJ; Zhao, SL; Wang, Y; Li, G; Xu, HS; Zeng, L; Wang, JN; Bai, MZ; Chen, YL; Chen, W; Kang, T; Wu, YY; Xu, X; Zhu, ZW; Cui, Y; Wang, ZX; Yang, CJ; Wang, PG; Xiang, LH; Chen, X; Zhang, AP; Gao, XH; Zhang, FR; Xu, JH; Zheng, M; Zheng, J; Zhang, JZ; Yu, XQ; Li, YR; Yang, S; Yang, HM; Wang, J; Liu, JJ; Hammarstrom, L; Sun, LD; Wang, J; Zhang, XJ				Zhou, Fusheng; Cao, Hongzhi; Zuo, Xianbo; Zhang, Tao; Zhang, Xiaoguang; Liu, Xiaomin; Xu, Ricong; Chen, Gang; Zhang, Yuanwei; Zheng, Xiaodong; Jin, Xin; Gao, Jinping; Mei, Junpu; Sheng, Yujun; Li, Qibin; Liang, Bo; Shen, Juan; Shen, Changbing; Jiang, Hui; Zhu, Caihong; Fan, Xing; Xu, Fengping; Yue, Min; Yin, Xianyong; Ye, Chen; Zhang, Cuicui; Liu, Xiao; Yu, Liang; Wu, Jinghua; Chen, Mengyun; Zhuang, Xuehan; Tang, Lili; Shao, Haojing; Wu, Longmao; Li, Jian; Xu, Yu; Zhang, Yijie; Zhao, Suli; Wang, Yu; Li, Ge; Xu, Hanshi; Zeng, Lei; Wang, Jianan; Bai, Mingzhou; Chen, Yanling; Chen, Wei; Kang, Tian; Wu, Yanyan; Xu, Xun; Zhu, Zhengwei; Cui, Yong; Wang, Zaixing; Yang, Chunjun; Wang, Peiguang; Xiang, Leihong; Chen, Xiang; Zhang, Anping; Gao, Xinghua; Zhang, Furen; Xu, Jinhua; Zheng, Min; Zheng, Jie; Zhang, Jianzhong; Yu, Xueqing; Li, Yingrui; Yang, Sen; Yang, Huanming; Wang, Jian; Liu, Jianjun; Hammarstrom, Lennart; Sun, Liangdan; Wang, Jun; Zhang, Xuejun			Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HIGH-RESOLUTION HLA; HAN CHINESE; RHEUMATOID-ARTHRITIS; RISK LOCI; VARIANTS; SUSCEPTIBILITY; PSORIASIS; HETEROGENEITY; ANNOTATION	The human major histocompatibility complex (MHC) region has been shown to be associated with numerous diseases. However, it remains a challenge to pinpoint the causal variants for these associations because of the extreme complexity of the region. We thus sequenced the entire 5-Mb MHC region in 20,635 individuals of Han Chinese ancestry (10,689 controls and 9,946 patients with psoriasis) and constructed a Han-MHC database that includes both variants and HLA gene typing results of high accuracy. We further identified multiple independent new susceptibility loci in HLA-C, HLA-B, HLA-DPB1 and BTNL2 and an intergenic variant, rs118179173, associated with psoriasis and confirmed the well-established risk allele HLA-C*06:02. We anticipate that our Han-MHC reference panel built by deep sequencing of a large number of samples will serve as a useful tool for investigating the role of the MHC region in a variety of diseases and thus advance understanding of the pathogenesis of these disorders.	[Zhou, Fusheng; Zuo, Xianbo; Zhang, Xiaoguang; Chen, Gang; Zheng, Xiaodong; Gao, Jinping; Sheng, Yujun; Liang, Bo; Shen, Changbing; Zhu, Caihong; Fan, Xing; Yue, Min; Yin, Xianyong; Zhang, Cuicui; Yu, Liang; Chen, Mengyun; Tang, Lili; Wu, Longmao; Xu, Yu; Zhao, Suli; Li, Ge; Zeng, Lei; Wu, Yanyan; Zhu, Zhengwei; Wang, Zaixing; Wang, Peiguang; Xiang, Leihong; Zhang, Anping; Yang, Sen; Liu, Jianjun; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Hosp 1, Dept Dermatol, Hefei, Peoples R China; [Zhou, Fusheng; Zuo, Xianbo; Zhang, Xiaoguang; Chen, Gang; Zheng, Xiaodong; Gao, Jinping; Sheng, Yujun; Liang, Bo; Shen, Changbing; Zhu, Caihong; Fan, Xing; Yue, Min; Yin, Xianyong; Zhang, Cuicui; Yu, Liang; Chen, Mengyun; Tang, Lili; Wu, Longmao; Xu, Yu; Zhao, Suli; Li, Ge; Zeng, Lei; Wu, Yanyan; Zhu, Zhengwei; Wang, Zaixing; Wang, Peiguang; Xiang, Leihong; Zhang, Anping; Yang, Sen; Liu, Jianjun; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Peoples R China; [Cao, Hongzhi; Zhang, Tao; Liu, Xiaomin; Zhang, Yuanwei; Jin, Xin; Mei, Junpu; Li, Qibin; Shen, Juan; Jiang, Hui; Xu, Fengping; Ye, Chen; Liu, Xiao; Wu, Jinghua; Zhuang, Xuehan; Shao, Haojing; Li, Jian; Zhang, Yijie; Wang, Yu; Xu, Hanshi; Wang, Jianan; Chen, Yanling; Chen, Wei; Kang, Tian; Xu, Xun; Li, Yingrui; Yang, Huanming; Wang, Jian; Hammarstrom, Lennart; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Cao, Hongzhi; Bai, Mingzhou; Li, Yingrui; Wang, Jun] iCarbonX, Shenzhen, Peoples R China; [Cao, Hongzhi; Jiang, Hui; Xu, Fengping; Liu, Xiao; Li, Jian; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Xu, Ricong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Minist Hlth,Key Lab Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yuanwei] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Cui, Yong; Zhang, Xuejun] China Japan Friendship Hosp, Dept Dermatol, Beijing, Peoples R China; [Yang, Chunjun; Zhang, Xuejun] Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Peoples R China; [Chen, Xiang] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Gao, Xinghua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang 110001, Peoples R China; [Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Xu, Jinhua; Zhang, Xuejun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Xu, Jinhua; Zhang, Xuejun] Fudan Univ, Collaborat Innovat Ctr Complex & Severe Skin Dis, Shanghai 200433, Peoples R China; [Zheng, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai, Peoples R China; [Zhang, Jianzhong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100871, Peoples R China; [Li, Yingrui] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wang, Jian] James D Watson Inst Genome Sci, Hangzhou, Zhejiang, Peoples R China; [Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Jun] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China	Anhui Medical University; Anhui Medical University; Beijing Genomics Institute (BGI); University of Copenhagen; Sun Yat Sen University; Southeast University - China; China-Japan Friendship Hospital; Anhui Medical University; Central South University; China Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Fudan University; Fudan University; Zhejiang University; Shanghai Jiao Tong University; Peking University; University of Queensland; Karolinska Institutet; Karolinska University Hospital; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Hong Kong	Sun, LD; Zhang, XJ (corresponding author), Anhui Med Univ, Minist Educ, Hosp 1, Dept Dermatol, Hefei, Peoples R China.; Sun, LD; Zhang, XJ (corresponding author), Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Peoples R China.; Hammarstrom, L; Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.; Wang, J (corresponding author), iCarbonX, Shenzhen, Peoples R China.; Wang, J (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.; Zhang, XJ (corresponding author), China Japan Friendship Hosp, Dept Dermatol, Beijing, Peoples R China.; Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Peoples R China.; Zhang, XJ (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China.; Zhang, XJ (corresponding author), Fudan Univ, Collaborat Innovat Ctr Complex & Severe Skin Dis, Shanghai 200433, Peoples R China.; Hammarstrom, L (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Stockholm, Sweden.; Wang, J (corresponding author), King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia.; Wang, J (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China.; Wang, J (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.; Wang, J (corresponding author), Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China.	lennart.hammarstrom@ki.se; ahmusld@163.com; wangj@genomics.cn; ayzxj@vip.sina.com	xu, fengping/AAE-6072-2019; Kang, Tian/AAU-1423-2021; zhou, hua/A-6862-2017; SHENG, Yu/GXZ-8269-2022; Liu, Jianjun/AAK-4989-2020; Xu, Xun/AAI-6763-2020; Jin, Xin/ABF-1329-2020; Cui, Yong/AAF-9300-2020; Liu, Xiao/P-2732-2015; chen, yanling/GRE-8287-2022; 周, 伏圣/ABA-4499-2022	Liu, Jianjun/0000-0002-3255-3019; Xu, Xun/0000-0002-5338-5173; Jin, Xin/0000-0001-7554-4975; Liu, Xiao/0000-0002-8073-0534; Liu, Xiaomin/0000-0003-2155-3627; Zhang, Tao/0000-0003-2765-2802; Zhang, Yuanwei/0000-0002-5988-2787	National Natural Science Foundation of China [81130031, 81573035, 81273301, 81271747, 81370044, 8157120504, 81502713]; National Science Fund for Excellent Young Scholars [81222022]; Top-Notch Young Talents Program of China; Pre-National Basic Research Program of China [2012CB722404]; Natural Science Foundation of Anhui Province [1508085JGD05]; Program of Outstanding Talents of Anhui Medical University; Shenzhen municipal government of China [CXZZ20140904154910774]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Top-Notch Young Talents Program of China; Pre-National Basic Research Program of China; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Program of Outstanding Talents of Anhui Medical University; Shenzhen municipal government of China	We thank the faculty and staff at Anhui Medical University and BGI-Shenzhen who contributed to the Han-MHC project. We acknowledge grant support from the Key Program of the National Natural Science Foundation of China (81130031), the National Science Fund for Excellent Young Scholars (81222022), the Top-Notch Young Talents Program of China, the Pre-National Basic Research Program of China (973 plan; 2012CB722404), the National Natural Science Foundation of China (81573035, 81273301, 81271747, 81370044, 8157120504 and 81502713), the Natural Science Foundation of Anhui Province (1508085JGD05), the Program of Outstanding Talents of Anhui Medical University and the Shenzhen municipal government of China (CXZZ20140904154910774).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnett HA, 2014, NAT REV IMMUNOL, V14, P559, DOI 10.1038/nri3715; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052853, 10.1371/journal.pone.0076946]; Cao HZ, 2015, NAT BIOTECHNOL, V33, P617, DOI 10.1038/nbt.3200; Chan CJ, 2014, CELL DEATH DIFFER, V21, P5, DOI 10.1038/cdd.2013.26; Chang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099724; Chen PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016635; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Corvin A, 2014, BIOL PSYCHIAT, V75, P276, DOI 10.1016/j.biopsych.2013.09.018; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Detrait M, 2015, BONE MARROW TRANSPL, V50, P1316, DOI 10.1038/bmt.2015.157; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Erlich HA, 2013, DIABETES, V62, P2618, DOI 10.2337/db12-1387; Fan X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000038; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Gourraud PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097282; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Jiang L, 2014, ARTHRITIS RHEUMATOL, V66, P1121, DOI 10.1002/art.38353; Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6902; Kim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112546; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YZ, 2013, NAT GENET, V45, P1361, DOI 10.1038/ng.2779; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yin XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7916; Zhang XJ, 2002, J INVEST DERMATOL, V119, P1361, DOI 10.1046/j.1523-1747.2002.19612.x; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhou F., 2015, GIGASCIENCE DATABASE; Zuo XB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7793	54	131	139	8	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					740	+		10.1038/ng.3576	http://dx.doi.org/10.1038/ng.3576			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27213287				2022-12-17	WOS:000378840100011
J	Li, CL; Gu, LF; Gao, L; Chen, C; Wei, CQ; Qiu, Q; Chien, CW; Wang, SK; Jiang, LH; Ai, LF; Chen, CY; Yang, SG; Nguyen, V; Qi, YH; Snyder, MP; Burlingame, AL; Kohalmi, SE; Huang, SZ; Cao, XF; Wang, ZY; Wu, KQ; Chen, XM; Cui, YH				Li, Chenlong; Gu, Lianfeng; Gao, Lei; Chen, Chen; Wei, Chuang-Qi; Qiu, Qi; Chien, Chih-Wei; Wang, Suikang; Jiang, Lihua; Ai, Lian-Feng; Chen, Chia-Yang; Yang, Songguang; Nguyen, Vi; Qi, Yanhua; Snyder, Michael P.; Burlingame, Alma L.; Kohalmi, Susanne E.; Huang, Shangzhi; Cao, Xiaofeng; Wang, Zhi-Yong; Wu, Keqiang; Chen, Xuemei; Cui, Yuhai			Concerted genomic targeting of H3K27 demethylase REF6 and chromatin-remodeling ATPase BRM in Arabidopsis	NATURE GENETICS			English	Article							HISTONE MODIFICATIONS; SWI/SNF COMPLEX; GENE; TRANSCRIPTION; PROTEINS; EXPRESSION; RESPONSES; RNA; MODULATION; MECHANISMS	SWI/SNF-type chromatin remodelers, such as BRAHMA (BRM), and H3K27 demethylases both have active roles in regulating gene expression at the chromatin level(1-5), but how they are recruited to specific genomic sites remains largely unknown. Here we show that RELATIVE OF EARLY FLOWERING 6 (REF6), a plant-unique H3K27 demethylase(6), targets genomic loci containing a CTCTGYTY motif via its zinc-finger (ZnF) domains and facilitates the recruitment of BRM. Genome-wide analyses showed that REF6 colocalizes with BRM at many genomic sites with the CTCTGYTY motif. Loss of REF6 results in decreased BRM occupancy at BRM-REF6 co-targets. Furthermore, REF6 directly binds to the CTCTGYTY motif in vitro, and deletion of the motif from a target gene renders it inaccessible to REF6 in vivo. Finally, we show that, when its ZnF domains are deleted, REF6 loses its genomic targeting ability. Thus, our work identifies a new genomic targeting mechanism for an H3K27 demethylase and demonstrates its key role in recruiting the BRM chromatin remodeler.	[Li, Chenlong; Chen, Chen; Nguyen, Vi; Cui, Yuhai] Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada; [Li, Chenlong; Chen, Chen; Kohalmi, Susanne E.; Cui, Yuhai] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gu, Lianfeng] Fujian Agr & Forestry Univ, Haixia Inst Sci & Technol, Fuzhou, Peoples R China; [Gu, Lianfeng; Gao, Lei; Wang, Suikang; Chen, Xuemei] Univ Calif Riverside, Inst Integrat Genome Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Gu, Lianfeng; Qiu, Qi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Gu, Lianfeng; Qiu, Qi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Wei, Chuang-Qi; Chien, Chih-Wei; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Wei, Chuang-Qi] Hebei Normal Univ, Life Sci Coll, Shijiazhuang, Peoples R China; [Wang, Suikang; Qi, Yanhua] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Lihua; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ai, Lian-Feng] Hebei Entry Exit Inspect & Quarantine Bur, Shijiazhuang, Peoples R China; [Chen, Chia-Yang; Wu, Keqiang] Natl Taiwan Univ, Coll Life Sci, Inst Plant Biol, Taipei 10764, Taiwan; [Yang, Songguang] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Gene Imp, Guangzhou, Guangdong, Peoples R China; [Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Huang, Shangzhi] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Shangzhi] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resource, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Xiaofeng] Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Mol Plant Sci, Beijing, Peoples R China; [Chen, Xuemei] Univ Calif Riverside, Howard Hughes Med Inst, Riverside, CA 92521 USA	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Fujian Agriculture & Forestry University; University of California System; University of California Riverside; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Carnegie Institution for Science; Hebei Normal University; Zhejiang University; Stanford University; National Taiwan University; Chinese Academy of Sciences; South China Botanical Garden, CAS; University of California System; University of California San Francisco; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Howard Hughes Medical Institute; University of California System; University of California Riverside	Cui, YH (corresponding author), Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada.; Cui, YH (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	yuhai.cui@agr.gc.ca	Alex, Chen/AAH-7096-2021; Gao, Lei/I-4159-2013; Wang, Zhi-Yong/E-3810-2012; chen, chen/AAK-1684-2021; Wu, Keqiang/C-9743-2013	Gao, Lei/0000-0002-6488-0292; Wang, Zhi-Yong/0000-0003-4602-3390; Wu, Keqiang/0000-0002-5791-3594; Chen, Xuemei/0000-0002-5209-1157; Wei, Chuangqi/0000-0001-7781-7674; Snyder, Michael/0000-0003-0784-7987; Li, Chenlong/0000-0003-3405-6056; Chen, Chen/0000-0001-6196-3255	Agriculture and Agri-Food Canada A-base; National Science and Engineering Research Council of Canada [R4019A01]; Natural Science Foundation of China [31128001, 31210103901]; State Key Laboratory of Plant Genomics [2015B0129-01]; US National Institutes of Health [GM061146, R01GM066258]; Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258, R01GM061146] Funding Source: NIH RePORTER	Agriculture and Agri-Food Canada A-base(Agriculture & Agri Food Canada); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Plant Genomics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Arabidopsis Biological Resource Center (ABRC) for seeds for T-DNA insertion lines; A. Molnar for help with figure preparation; X. Shi of the Clinical Genomics Centre at Mount Sinai Hospital for overseeing the next-generation sequencing; and S. Rothstein for critical reading of the manuscript. C.C. is supported by a graduate fellowship from the Chinese Scholarship Council. This work was supported by funding from the Agriculture and Agri-Food Canada A-base and the National Science and Engineering Research Council of Canada (R4019A01) to Y.C., the Natural Science Foundation of China (31128001 to K.W. and Y.C. and 31210103901 to X. Cao and X. Chen), the State Key Laboratory of Plant Genomics (2015B0129-01 to X. Cao), and the US National Institutes of Health to X. Chen (GM061146) and Z.-Y.W. (R01GM066258).	Archacki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058588; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Efroni I, 2013, DEV CELL, V24, P438, DOI 10.1016/j.devcel.2013.01.019; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hurtado L, 2006, PLANT MOL BIOL, V62, P291, DOI 10.1007/s11103-006-9021-2; Jerzmanowski A, 2007, BBA-GENE STRUCT EXPR, V1769, P330, DOI 10.1016/j.bbaexp.2006.12.003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li CL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004944; Li CL, 2009, J EXP BOT, V60, P4371, DOI 10.1093/jxb/erp275; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Luo CY, 2013, PLANT J, V73, P77, DOI 10.1111/tpj.12017; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Reyes JC, 2014, MOL PLANT, V7, P454, DOI 10.1093/mp/sst147; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Tang XR, 2008, PLANT PHYSIOL, V147, P1143, DOI 10.1104/pp.108.121996; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Wu MF, 2012, P NATL ACAD SCI USA, V109, P3576, DOI 10.1073/pnas.1113409109; Yang SG, 2015, PLANT CELL, V27, P1670, DOI 10.1105/tpc.15.00091; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005125	47	131	136	3	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					687	+		10.1038/ng.3555	http://dx.doi.org/10.1038/ng.3555			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27111034	Green Accepted			2022-12-17	WOS:000376744200018
J	Fischer, U; Forster, M; Rinaldi, A; Risch, T; Sungalee, S; Warnatz, HJ; Bornhauser, B; Gombert, M; Kratsch, C; Stutz, AM; Sultan, M; Tchinda, J; Worth, CL; Amstislavskiy, V; Badarinarayan, N; Baruchel, A; Bartram, T; Basso, G; Canpolat, C; Cario, G; Cave, H; Dakaj, D; Delorenzi, M; Dobay, MP; Eckert, C; Ellinghaus, E; Eugster, S; Frismantas, V; Ginzel, S; Haas, OA; Heidenreich, O; Hemmrich-Stanisak, G; Hezaveh, K; Holl, JI; Hornhardt, S; Husemann, P; Kachroo, P; Kratz, CP; te Kronnie, G; Marovca, B; Niggli, F; McHardy, AC; Moorman, AV; Panzer-Grumayer, R; Petersen, BS; Raeder, B; Ralser, M; Rosenstiel, P; Schafer, D; Schrappe, M; Schreiber, S; Schutte, M; Stade, B; Thiele, R; von der Weid, N; Vora, A; Zaliova, M; Zhang, LH; Zichner, T; Zimmermann, M; Lehrach, H; Borkhardt, A; Bourquin, JP; Franke, A; Korbel, JO; Stanulla, M; Yaspo, ML				Fischer, Ute; Forster, Michael; Rinaldi, Anna; Risch, Thomas; Sungalee, Stephanie; Warnatz, Hans-Joerg; Bornhauser, Beat; Gombert, Michael; Kratsch, Christina; Stuetz, Adrian M.; Sultan, Marc; Tchinda, Joelle; Worth, Catherine L.; Amstislavskiy, Vyacheslav; Badarinarayan, Nandini; Baruchel, Andre; Bartram, Thies; Basso, Giuseppe; Canpolat, Cengiz; Cario, Gunnar; Cave, Helene; Dakaj, Dardane; Delorenzi, Mauro; Dobay, Maria Pamela; Eckert, Cornelia; Ellinghaus, Eva; Eugster, Sabrina; Frismantas, Viktoras; Ginzel, Sebastian; Haas, Oskar A.; Heidenreich, Olaf; Hemmrich-Stanisak, Georg; Hezaveh, Kebria; Hoell, Jessica I.; Hornhardt, Sabine; Husemann, Peter; Kachroo, Priyadarshini; Kratz, Christian P.; te Kronnie, Geertruy; Marovca, Blerim; Niggli, Felix; McHardy, Alice C.; Moorman, Anthony V.; Panzer-Gruemayer, Renate; Petersen, Britt S.; Raeder, Benjamin; Ralser, Meryem; Rosenstiel, Philip; Schaefer, Daniel; Schrappe, Martin; Schreiber, Stefan; Schuette, Moritz; Stade, Bjoern; Thiele, Ralf; von der Weid, Nicolas; Vora, Ajay; Zaliova, Marketa; Zhang, Langhui; Zichner, Thomas; Zimmermann, Martin; Lehrach, Hans; Borkhardt, Arndt; Bourquin, Jean-Pierre; Franke, Andre; Korbel, Jan O.; Stanulla, Martin; Yaspo, Marie-Laure			Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options	NATURE GENETICS			English	Article							B-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR; CHROMOSOMAL TRANSLOCATIONS; HEMATOPOIETIC STEM; PROGENITOR CELLS; GENE-EXPRESSION; RAS PATHWAY; E2A-HLF; PRECURSOR; LINEAGE	TCF3-HLF-positive acute lymphoblastic leukemia (ALL) is currently incurable. Using an integrated approach, we uncovered distinct mutation, gene expression and drug response profiles in TCF3-HLF-positive and treatment-responsive TCF3-PBX1-positive ALL. We identified recurrent intragenic deletions of PAX5 or VPREB1 in constellation with the fusion of TCF3 and HLF. Moreover somatic mutations in the non-translocated allele of TCF3 and a reduction of PAX5 gene dosage in TCF3-HLF ALL suggest cooperation within a restricted genetic context. The enrichment for stem cell and myeloid features in the TCF3-HLF signature may reflect reprogramming by TCF3-HLF of a lymphoid-committed cell of origin toward a hybrid, drug-resistant hematopoietic state. Drug response profiling of matched patient-derived xenografts revealed a distinct profile for TCF3-HLF ALL with resistance to conventional chemotherapeutics but sensitivity to glucocorticoids, anthracyclines and agents in clinical development. Striking on-target sensitivity was achieved with the BCL2-specific inhibitor venetoclax (ABT-199). This integrated approach thus provides alternative treatment options for this deadly disease.	[Fischer, Ute; Gombert, Michael; Ginzel, Sebastian; Hezaveh, Kebria; Hoell, Jessica I.; Husemann, Peter; Schaefer, Daniel; Zhang, Langhui; Borkhardt, Arndt] Univ Dusseldorf, Fac Med, Clin Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Forster, Michael; Badarinarayan, Nandini; Ellinghaus, Eva; Hemmrich-Stanisak, Georg; Kachroo, Priyadarshini; Petersen, Britt S.; Rosenstiel, Philip; Schreiber, Stefan; Stade, Bjoern; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rinaldi, Anna; Bornhauser, Beat; Tchinda, Joelle; Dakaj, Dardane; Eugster, Sabrina; Frismantas, Viktoras; Marovca, Blerim; Niggli, Felix; Bourquin, Jean-Pierre] Univ Childrens Hosp Zurich, Childrens Res Ctr, Pediat Oncol, Zurich, Switzerland; [Risch, Thomas; Warnatz, Hans-Joerg; Sultan, Marc; Worth, Catherine L.; Amstislavskiy, Vyacheslav; Ralser, Meryem; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Sungalee, Stephanie; Stuetz, Adrian M.; Raeder, Benjamin; Zichner, Thomas; Korbel, Jan O.] European Mol Biol Lab EMBL, Genome Biol Unit, Heidelberg, Germany; [Kratsch, Christina; McHardy, Alice C.] Univ Dusseldorf, Dept Algorithm Bioinformat, Dusseldorf, Germany; [Baruchel, Andre] Hop Robert Debre, Dept Pediat Hematoimmunol, F-75019 Paris, France; [Baruchel, Andre; Cave, Helene] Paris Diderot Univ, Paris, France; [Bartram, Thies; Cario, Gunnar; Schrappe, Martin] Univ Kiel, Dept Pediat, Kiel, Germany; [Bartram, Thies; Cario, Gunnar; Schrappe, Martin] Univ Med Ctr Schleswig Holstein, Kiel, Germany; [Basso, Giuseppe; te Kronnie, Geertruy] Univ Padua, Dept Pediat, Lab Pediat Hematol Oncol, Padua, Italy; [Canpolat, Cengiz] Acibadem Univ, Sch Med, Dept Pediat, Istanbul, Turkey; [Cave, Helene] Hop Robert Debre, Dept Genet, F-75019 Paris, France; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Delorenzi, Mauro; Dobay, Maria Pamela] Swiss Inst Bioinformat SIB, Lausanne, Switzerland; [Eckert, Cornelia] Charite, Pediat Hematol & Oncol, Berlin, Germany; [Ginzel, Sebastian; Thiele, Ralf] Bonn Rhine Sieg Univ Appl Sci, Dept Comp Sci, St Augustin, Germany; [Haas, Oskar A.; Panzer-Gruemayer, Renate] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Heidenreich, Olaf; Moorman, Anthony V.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hornhardt, Sabine] Fed Off Radiat Protect, Oberschleissheim, Germany; [Kratz, Christian P.; Zaliova, Marketa; Zimmermann, Martin; Stanulla, Martin] Hannover Med Sch, Pediatr Hematol & Oncol, Hannover, Germany; [Schuette, Moritz; Lehrach, Hans] Alacris Theranost GmbH, Berlin, Germany; [von der Weid, Nicolas] Univ Kinderspital Beider Basel UKBB, Basel, Switzerland; [Vora, Ajay] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; [Zaliova, Marketa] Charles Univ Prague, Childhood Leukaemia Invest Prague CLIP, Dept Pediat Hematol Oncol, Fac Med 2, Prague, Czech Republic; [Zhang, Langhui] Fujian Med Univ, Union Hosp, Dept Hematol, Fuzhou, Peoples R China; [Lehrach, Hans] Dahlem Ctr Genome Res & Med Syst Biol, Berlin, Germany	Heinrich Heine University Dusseldorf; University of Kiel; University Children's Hospital Zurich; Max Planck Society; European Molecular Biology Laboratory (EMBL); Heinrich Heine University Dusseldorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Padua; Acibadem University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Swiss Institute of Bioinformatics; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hochschule Bonn Rhein Sieg; Saint Anna Children's Hospital; Newcastle University - UK; Hannover Medical School; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Charles University Prague; Fujian Medical University	Stanulla, M (corresponding author), Hannover Med Sch, Pediatr Hematol & Oncol, Hannover, Germany.	jean-pierre.bourquin@kispi.uzh.ch; stanulla.martin@mh-hannover.de	Rosenstiel, Philip/A-5137-2009; Kronnie, Geertruy te/L-1014-2016; Haas, Oskar/AAM-5794-2020; Bornhauser, Beat/M-4437-2014; McHardy, Alice/ABF-2322-2020; Franke, Andre/B-2151-2010; Heidenreich, Olaf/AAP-5045-2021; Eckert, Cornelia/R-8623-2019; Schrappe, Martin/ABA-6144-2020; Bourquin, Jean-Pierre/C-2802-2011; Moorman, Anthony/F-5518-2010; Hoell, Jessica/J-8136-2016; Cario, Gunnar/D-2535-2010; Ellinghaus, Eva/E-6490-2012; Kronnie, Geertruij te/O-5251-2019; Stanulla, Martin/N-4674-2017; Niggli, Felix/L-6547-2017; McHardy, Alice C/K-9377-2018; Löscher, Britt-Sabina/I-1671-2012; Kachroo, Priyadarshini/M-1923-2019; Kratz, Christian/AAC-9726-2021	Rosenstiel, Philip/0000-0002-9692-8828; McHardy, Alice/0000-0003-2370-3430; Franke, Andre/0000-0003-1530-5811; Heidenreich, Olaf/0000-0001-5404-6483; Bourquin, Jean-Pierre/0000-0001-6571-6227; Hoell, Jessica/0000-0002-5532-9845; Ellinghaus, Eva/0000-0003-2914-3382; Stanulla, Martin/0000-0002-3834-0727; Niggli, Felix/0000-0002-7553-3712; McHardy, Alice C/0000-0003-2370-3430; Löscher, Britt-Sabina/0000-0001-9022-9017; Kachroo, Priyadarshini/0000-0002-5807-1333; Sungalee, Stephanie/0000-0001-5633-8826; Bornhauser, Beat/0000-0003-2890-3191; Cave, Helene/0000-0003-2840-1511; Worth, Catherine/0000-0002-1796-9606; BASSO, GIUSEPPE/0000-0002-2634-9302; Kratsch, Christina/0000-0003-0565-1112; te Kronnie, Geertruy/0000-0001-7143-4795; Forster, Michael/0000-0001-9927-5124; Rinaldi, Anna/0000-0003-4106-8127; Raeder, Benjamin/0000-0002-9494-8884; Badarinarayan, Nandini/0000-0002-6944-748X; /0000-0001-5636-1006; Zichner, Thomas/0000-0001-9848-7598	German Federal Office for Radiation Protection [St.Sch. 3611S70014]; Swiss National Research Foundation [SNF 310030-133108]; foundation 'Kinderkrebsforschung Schweiz'; Krebsliga Zurich; Sassella Foundation; Fondation Panacee; clinical research focus program 'Human Hemato-Lymphatic Diseases' of the University of Zurich; Deutsche Forschungsgemeinschaft (DFG), Clusters of Excellence 'Inflammation at Interfaces'; EU [262055, 261474, 260791]; Katharina Hardt Stiftung; Deutsche Jose Carreras Leukamie-Stiftung; Madeleine Schickedanz-Kinderkrebs-Stiftung; Deutsche Krebshilfe - Dr. Mildred Scheel Stiftung [108613, 102588, 108588]; Foundation of Experimental Biomedicine in Zurich; Max Planck Society; Verein fur krebskranke Kinder Hannover e.V.; Cancer Research UK [12788] Funding Source: researchfish	German Federal Office for Radiation Protection; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); foundation 'Kinderkrebsforschung Schweiz'; Krebsliga Zurich; Sassella Foundation; Fondation Panacee; clinical research focus program 'Human Hemato-Lymphatic Diseases' of the University of Zurich; Deutsche Forschungsgemeinschaft (DFG), Clusters of Excellence 'Inflammation at Interfaces'(German Research Foundation (DFG)); EU(European Commission); Katharina Hardt Stiftung; Deutsche Jose Carreras Leukamie-Stiftung; Madeleine Schickedanz-Kinderkrebs-Stiftung; Deutsche Krebshilfe - Dr. Mildred Scheel Stiftung(Deutsche Krebshilfe); Foundation of Experimental Biomedicine in Zurich; Max Planck Society(Max Planck SocietyFoundation CELLEX); Verein fur krebskranke Kinder Hannover e.V.; Cancer Research UK(Cancer Research UK)	We thank all participants and personnel involved in the clinical trials in Austria, France, Germany, United Kingdom and Switzerland. We thank T. Radimerski and Novartis for providing essential compounds. We thank the Leukaemia & Lymphoma Research (LLR) Childhood Leukaemia Cell Bank in the UK for providing primary patient samples. This work was supported by the German Federal Office for Radiation Protection (grant St.Sch. 3611S70014), by the Swiss National Research Foundation SNF 310030-133108, the foundation 'Kinderkrebsforschung Schweiz', the 'Krebsliga Zurich', the Sassella Foundation, the Fondation Panacee, the clinical research focus program 'Human Hemato-Lymphatic Diseases' of the University of Zurich, the Deutsche Forschungsgemeinschaft (DFG), Clusters of Excellence 'Inflammation at Interfaces', the EU Seventh Framework Program (FP7/2007-2013, grant 262055, ESGI; FP7-HEALTH-F2-2011 grant 261474, ENCCA; ERA-Net Transcan, Validation of biomarkers for personalized cancer medicine, TRANSCALL; Health-F2-2010 grant 260791, EUROCANPLATFORM), the 'Katharina Hardt Stiftung', the 'Deutsche Jose Carreras Leukamie-Stiftung', the 'Madeleine Schickedanz-Kinderkrebs-Stiftung', the 'Deutsche Krebshilfe - Dr. Mildred Scheel Stiftung' (grants 108613, 102588 and 108588), the Foundation of Experimental Biomedicine in Zurich, the Max Planck Society, and the 'Verein fur krebskranke Kinder Hannover e.V.'. We thank A. Dehos, B. Grosche, T. Jung, W. Weiss and G. Ziegelberger, German Federal Office for Radiation Protection, as well as B. Heinzow, State Office for Social Services of Schleswig-Holstein, and A. Bottger, German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety for their support and critical discussions. We are grateful for the excellent technical assistance offered by the sequencing team of the Department of Vertebrate Genomics of the Max Planck Institute for Molecular Genetics (Berlin) and by the team of the Genomics Core facility of the European Molecular Biology Laboratory. We thank K. Alemazkour for excellent technical assistance regarding whole exome sequencing at the Department of Pediatric Oncology, Hematology and Clinical Immunology (Dusseldorf, Germany). We thank N. Forgo, Institute for Legal Informatics, Leibniz University Hannover, and H.-D. Troger, Hannover Medical School, for legal and ethical counselling.	Akahane K, 2010, LEUKEMIA, V24, P865, DOI 10.1038/leu.2010.8; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Balbin OA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3617; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bauer M. J., 2010, ISMB ISBC; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Boutter J, 2014, ONCOTARGET, V5, P11501, DOI 10.18632/oncotarget.2572; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clappier E, 2014, LEUKEMIA, V28, P70, DOI 10.1038/leu.2013.277; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dorge P, 2013, HAEMATOLOGICA, V98, P428, DOI 10.3324/haematol.2011.056135; El Omari K, 2013, CELL REP, V4, P135, DOI 10.1016/j.celrep.2013.06.008; Felice MS, 2011, LEUKEMIA LYMPHOMA, V52, P1215, DOI 10.3109/10428194.2011.565436; Festing Michael F W, 2002, ILAR J, V43, P244; Forster M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks836; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Harrison CJ, 2010, BRIT J HAEMATOL, V151, P132, DOI 10.1111/j.1365-2141.2010.08314.x; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Honda H, 1999, BLOOD, V93, P2780; Hunger SP, 1996, BLOOD, V87, P1211, DOI 10.1182/blood.V87.4.1211.bloodjournal8741211; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Inukai T, 2007, LEUKEMIA, V21, P288, DOI 10.1038/sj.leu.2404496; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Irving J, 2014, BLOOD, V124, P3420, DOI 10.1182/blood-2014-04-531871; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu DH, 2014, J BIOL CHEM, V289, P23809, DOI 10.1074/jbc.M114.568170; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Mangum DS, 2014, LEUKEMIA, V28, P216, DOI 10.1038/leu.2013.223; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Moorman AV, 2014, BLOOD, V124, P1434, DOI 10.1182/blood-2014-03-562918; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Nissim S, 2014, DEV CELL, V28, P423, DOI 10.1016/j.devcel.2014.01.006; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Peirs S, 2014, BLOOD, V124, P3738, DOI 10.1182/blood-2014-05-574566; Ratei R, 2013, KLIN PADIATR, V225, pS34, DOI 10.1055/s-0033-1337961; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schmitz M, 2011, BLOOD, V118, P1854, DOI 10.1182/blood-2010-11-320309; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Simmons S, 2012, BLOOD, V120, P3688, DOI 10.1182/blood-2012-03-414821; Smith KS, 1999, MOL CELL BIOL, V19, P4443; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stade B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S8; Stark Z, 2012, CLIN GENET, V81, P590, DOI 10.1111/j.1399-0004.2011.01754.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiemels JL, 2002, P NATL ACAD SCI USA, V99, P15101, DOI 10.1073/pnas.222481199; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	84	131	133	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2015	47	9					1020	+		10.1038/ng.3362	http://dx.doi.org/10.1038/ng.3362			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CQ1XQ	26214592	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000360394100012
J	Weinreb, I; Piscuoglio, S; Martelotto, LG; Waggott, D; Ng, CKY; Perez-Ordonez, B; Harding, NJ; Alfaro, J; Chu, KC; Viale, A; Fusco, N; Paula, AD; Marchio, C; Sakr, RA; Lim, R; Thompson, LDR; Chiosea, SI; Seethala, RR; Skalova, A; Stelow, EB; Fonseca, I; Assaad, A; How, C; Wang, JX; de Borja, R; Chan-Seng-Yue, M; Howlett, CJ; Nichols, AC; Wen, YH; Katabi, N; Buchner, N; Mullen, L; Kislinger, T; Wouters, BG; Liu, FF; Norton, L; McPherson, JD; Rubin, BP; Clarke, BA; Weigelt, B; Boutros, PC; Reis, JS				Weinreb, Ilan; Piscuoglio, Salvatore; Martelotto, Luciano G.; Waggott, Daryl; Ng, Charlotte K. Y.; Perez-Ordonez, Bayardo; Harding, Nicholas J.; Alfaro, Javier; Chu, Kenneth C.; Viale, Agnes; Fusco, Nicola; Paula, Arnaud da Cruz; Marchio, Caterina; Sakr, Rita A.; Lim, Raymond; Thompson, Lester D. R.; Chiosea, Simion I.; Seethala, Raja R.; Skalova, Alena; Stelow, Edward B.; Fonseca, Isabel; Assaad, Adel; How, Christine; Wang, Jianxin; de Borja, Richard; Chan-Seng-Yue, Michelle; Howlett, Christopher J.; Nichols, Anthony C.; Wen, Y. Hannah; Katabi, Nora; Buchner, Nicholas; Mullen, Laura; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei; Norton, Larry; McPherson, John D.; Rubin, Brian P.; Clarke, Blaise A.; Weigelt, Britta; Boutros, Paul C.; Reis-Filho, Jorge S.			Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adeno carcinomas of the salivary glands	NATURE GENETICS			English	Article							CANCER; ADENOCARCINOMA; CULTURES; PROTEIN; BREAST	Polymorphous low-grade adenocarcinoma (PLGA) is the second most frequent type of malignant tumor of the minor salivary glands. We identified PRKD1 hotspot mutations encoding p.Glu710Asp in 72.9% of PLGAs but not in other salivary gland tumors. Functional studies demonstrated that this kinase-activating alteration likely constitutes a driver of PLGA.	[Weinreb, Ilan; Perez-Ordonez, Bayardo; Clarke, Blaise A.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Piscuoglio, Salvatore; Martelotto, Luciano G.; Ng, Charlotte K. Y.; Fusco, Nicola; Paula, Arnaud da Cruz; Marchio, Caterina; Lim, Raymond; Wen, Y. Hannah; Katabi, Nora; Weigelt, Britta; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Waggott, Daryl; Harding, Nicholas J.; Alfaro, Javier; Chu, Kenneth C.; Wang, Jianxin; de Borja, Richard; Chan-Seng-Yue, Michelle; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Waggott, Daryl; Alfaro, Javier; How, Christine; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Waggott, Daryl; How, Christine; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei] Univ Hlth Network, Campbell Family Inst Canc Res, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Alfaro, Javier; Kislinger, Thomas; Wouters, Bradly G.; Liu, Fei-Fei; McPherson, John D.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10021 USA; [Fusco, Nicola] Univ Milan, Sch Pathol, Milan, Italy; [Paula, Arnaud da Cruz] Inst Portugues Oncol Francisco Gentil, Oporto, Portugal; [Sakr, Rita A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Thompson, Lester D. R.] Kaiser Permanente, Woodland Hills Med Ctr, Dept Pathol, Woodland Hills, CA USA; [Chiosea, Simion I.; Seethala, Raja R.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; [Skalova, Alena] Charles Univ Prague, Dept Pathol & Lab Med, Plzen, Czech Republic; [Stelow, Edward B.] Univ Virginia, Med Ctr, Dept Pathol, Charlottesville, VA USA; [Fonseca, Isabel] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; [Fonseca, Isabel] Fac Med Lisbon, Lisbon, Portugal; [Assaad, Adel; McPherson, John D.] Virginia Mason Hosp, Dept Pathol, Seattle, WA USA; [Assaad, Adel; McPherson, John D.] Seattle Med Ctr, Seattle, WA USA; [Howlett, Christopher J.; Nichols, Anthony C.] Univ Western Ontario, London, ON, Canada; [Buchner, Nicholas; Mullen, Laura] Ontario Inst Canc Res, Canc Genom Platform, Toronto, ON, Canada; [Liu, Fei-Fei] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada; [Liu, Fei-Fei] Univ Toronto, Toronto, ON, Canada; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rubin, Brian P.] Lerner Res Inst, Dept Mol Genet, Cleveland, OH USA; [Rubin, Brian P.] Cleveland Clin, Taussig Canc Ctr, Robert J Tomsich Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Memorial Sloan Kettering Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Memorial Sloan Kettering Cancer Center; University of Milan; Portuguese Institute of Oncology; Memorial Sloan Kettering Cancer Center; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Charles University Prague; University of Virginia; Portuguese Institute of Oncology; Universidade de Lisboa; Virginia Mason Medical Center; Western University (University of Western Ontario); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Memorial Sloan Kettering Cancer Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Toronto	Reis, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	reisfilj@mskcc.org	Martelotto, Luciano/D-1946-2015; Piscuoglio, Salvatore/AAB-4959-2022; McPherson, John D/D-2633-2017; Alfaro, Javier/ABA-5639-2020; Thompson, Lester D. R./J-8404-2016; Nichols, Anthony Charles/H-9595-2019; Ng, Charlotte K Y/AAA-1670-2020; Wouters, Bradly/T-1525-2017; Ng, Charlotte K Y/AAY-3178-2021; Fusco, Nicola/D-6264-2016; Kislinger, Thomas/A-5934-2008; Fonseca, Isabel/A-7396-2008; Marchio, Caterina/J-9152-2016	Martelotto, Luciano/0000-0002-9625-1183; Piscuoglio, Salvatore/0000-0003-2686-2939; McPherson, John D/0000-0001-8049-9347; Thompson, Lester D. R./0000-0003-3714-1432; Nichols, Anthony Charles/0000-0002-0760-980X; Wouters, Bradly/0000-0002-8187-592X; Ng, Charlotte K Y/0000-0002-6100-0026; Fusco, Nicola/0000-0002-9101-9131; Fonseca, Isabel/0000-0002-1359-6494; Marchio, Caterina/0000-0003-2024-6131; Harding, Nicholas/0000-0001-5907-0773; Da Cruz Paula, Arnaud/0000-0001-7694-8760; Kislinger, Thomas/0000-0003-3525-5540; Lim, Raymond/0000-0001-8772-3882; Spence, Tara/0000-0001-7098-4103; Alfaro, Javier/0000-0002-5553-6991; Norton, Larry/0000-0003-3701-9250; Perez-Ordonez, Bayardo/0000-0003-1222-8208; Boutros, Paul/0000-0003-0553-7520; Clarke, Blaise/0000-0002-2585-8391; Liu, Fei-Fei/0000-0003-4344-6486; Chiosea, Simion/0000-0002-5766-8779	IDEAS grant from Princess Margaret Hospital; Head and Neck Translational Research Program; Ontario Institute for Cancer Research; government of Ontario; Terry Fox Research Institute; Wharton family, Joe's Team, Gordon Tozer; Campbell Family Institute for Cancer Research; Ministry of Health and Long-Term Planning, Canada	IDEAS grant from Princess Margaret Hospital; Head and Neck Translational Research Program; Ontario Institute for Cancer Research; government of Ontario; Terry Fox Research Institute; Wharton family, Joe's Team, Gordon Tozer; Campbell Family Institute for Cancer Research; Ministry of Health and Long-Term Planning, Canada	This work was supported in part by an IDEAS grant from Princess Margaret Hospital, the Head and Neck Translational Research Program (I.W, B.A.C., P.C.B. and J.D.M.), the Ontario Institute for Cancer Research and the government of Ontario (P.C.B. and J.D.M.) and by a Terry Fox Research Institute New Investigator Award (P.C.B.). C.H. and F.-F.L. acknowledge support from the Wharton family, Joe's Team, Gordon Tozer, the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-Term Planning, Canada.	Barnes L, 2005, WORLD HEALTH ORGANIZ; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Evans HL, 2000, AM J SURG PATHOL, V24, P1319, DOI 10.1097/00000478-200010000-00001; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foschini MP, 2009, PATHOLOGY, V41, P48, DOI 10.1080/00313020802563528; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Perez-Ordonez B, 1998, HISTOPATHOLOGY, V32, P521, DOI 10.1046/j.1365-2559.1998.t01-2-00410.x; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Weinreb I, 2013, ADV ANAT PATHOL, V20, P367, DOI 10.1097/PAP.0b013e3182a92cc3	12	131	133	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1166	1169		10.1038/ng.3096	http://dx.doi.org/10.1038/ng.3096			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25240283	Green Submitted			2022-12-17	WOS:000344131900006
J	Shiraishi, K; Kunitoh, H; Daigo, Y; Takahashi, A; Goto, K; Sakamoto, H; Ohnami, S; Shimada, Y; Ashikawa, K; Saito, A; Watanabe, S; Tsuta, K; Kamatani, N; Yoshida, T; Nakamura, Y; Yokota, J; Kubo, M; Kohno, T				Shiraishi, Kouya; Kunitoh, Hideo; Daigo, Yataro; Takahashi, Atsushi; Goto, Koichi; Sakamoto, Hiromi; Ohnami, Sumiko; Shimada, Yoko; Ashikawa, Kyota; Saito, Akira; Watanabe, Shun-ichi; Tsuta, Koji; Kamatani, Naoyuki; Yoshida, Teruhiko; Nakamura, Yusuke; Yokota, Jun; Kubo, Michiaki; Kohno, Takashi			A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population	NATURE GENETICS			English	Article							ULCERATIVE-COLITIS; NEVER SMOKERS; CANCER RISK; GENOTYPES; STRATIFICATION; VARIANTS; 5P15.33; IMPACT; SCAN; TP63	Lung adenocarcinoma is the most common histological type of lung cancer, and its incidence is increasing worldwide. To identify genetic factors influencing risk of lung adenocarcinoma, we conducted a genome-wide association study and two validation studies in the Japanese population comprising a total of 6,029 individuals with lung adenocarcinoma (cases) and 13,535 controls. We confirmed two previously reported risk loci, 5p15.33 (rs2853677, P-combined = 2.8 x 10(-40), odds ratio (OR) = 1.41) and 3q28 (rs10937405, P-combined = 6.9 x 10(-17), OR = 1.25), and identified two new susceptibility loci, 17q24.3 (rs7216064, P-combined = 7.4 x 10(-11), OR = 1.20) and 6p21.3 (rs3817963, P-combined = 2.7 x 10(-10), OR = 1.18). These data provide further evidence supporting a role for genetic susceptibility in the development of lung adenocarcinoma.	[Shiraishi, Kouya; Shimada, Yoko; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Kunitoh, Hideo] Natl Canc Ctr, Div Thorac Oncol, Tokyo, Japan; [Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Shiga, Japan; [Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Kanagawa, Japan; [Goto, Koichi] Natl Canc Ctr Hosp E, Thorac Oncol Div, Chiba, Japan; [Sakamoto, Hiromi; Ohnami, Sumiko; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Ashikawa, Kyota; Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Kanagawa, Japan; [Saito, Akira] StaGen Co Ltd, Stat Genet Anal Div, Tokyo, Japan; [Watanabe, Shun-ichi] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan; [Yokota, Jun] Natl Canc Ctr, Res Inst, Div Multistep Carcinogenesis, Tokyo 104, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Shiga University of Medical Science; University of Tokyo; RIKEN; National Cancer Center - Japan; National Cancer Center - Japan; RIKEN; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Kohno, T (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan.	tkkohno@ncc.go.jp	Kubo, Michiaki/N-7947-2015	Daigo, Yataro/0000-0002-0915-3025	Ministry of Health, Labor and Welfare for Research on Applying Health Technology and for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Innovative Areas [22131006]; Japan Society for the Promotion of Science for Research Activity Start-up [23800073]; Young Scientists (B) [24790340]; National Cancer Center Research and Development Fund; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Cancer Center Research and Development Fund, Japan; Grants-in-Aid for Scientific Research [24790340] Funding Source: KAKEN	Ministry of Health, Labor and Welfare for Research on Applying Health Technology and for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Innovative Areas; Japan Society for the Promotion of Science for Research Activity Start-up; Young Scientists (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all of the subjects for participating in the study, and we also thank the collaborating physicians for assisting with sample collection. We are grateful to the members of BioBank Japan, the National Cancer Center Biobank and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We thank Y. Aoi, T. Odaka, M. Okuyama, H. Totsuka, S. Chiku, A. Kuchiba and the technical staff of the Center for Genome Medicine, National Cancer Center Research Institute, for providing technical and methodological assistance. We also thank H. Hirose of Health Center, Keio University and D. Saito of National Cancer Center Hospital (present affiliation: Nihonbashi Daizo Clinic) for DNA samples of control subjects. This work was supported in part by Grants-in-Aid from the Ministry of Health, Labor and Welfare for Research on Applying Health Technology and for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Innovative Areas (22131006); from the Japan Society for the Promotion of Science for Research Activity Start-up (23800073) and for Young Scientists (B) (24790340); and by the National Cancer Center Research and Development Fund. This work was also conducted as a part of the BioBank Japan Project supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Breslow N.E., 1987, STAT METHODS CANC RE, VII, P2; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Colvy T.V, 2004, WHO CLASSIFICATION T, P35; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kohno T, 2010, CARCINOGENESIS, V31, P834, DOI 10.1093/carcin/bgq003; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Travis WD, 1999, INT HISTOLOGICAL CLA; Wang YF, 2011, CANCER EPIDEM BIOMAR, V20, P1453, DOI 10.1158/1055-9965.EPI-11-0042; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421	30	131	133	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2012	44	8					900	+		10.1038/ng.2353	http://dx.doi.org/10.1038/ng.2353			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	979WV	22797724				2022-12-17	WOS:000306854700015
J	Rugg-Gunn, PJ; Ferguson-Smith, AC; Pedersen, RA				Rugg-Gunn, PJ; Ferguson-Smith, AC; Pedersen, RA			Epigenetic status of human embryonic stem cells	NATURE GENETICS			English	Article							IMPRINTED GENES; MOUSE EMBRYOS; EXPRESSION; CULTURE; H19; METHYLATION	We examined the allele-specific expression of six imprinted genes and the methylation profiles of three imprinting control regions to assess the epigenetic status of human embryonic stem cells. We identified generally monoallelic gene expression and normal methylation patterns. During prolonged passage, one cell line became biallelic with respect to H19, but without loss of the gametic methylation imprint. These data argue for a substantial degree of epigenetic stability in human embryonic stem cells.	Univ Cambridge, Dept Surg, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge; University of Cambridge	Rugg-Gunn, PJ (corresponding author), Univ Cambridge, Dept Surg, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	pjr36@cam.ac.uk	Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894; Rugg-Gunn, Peter/0000-0002-9601-5949	Medical Research Council [G0800784, G0100501] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dean W, 1998, DEVELOPMENT, V125, P2273; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Lee MP, 1999, HUM MOL GENET, V8, P683, DOI 10.1093/hmg/8.4.683; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Onyango P, 2002, P NATL ACAD SCI USA, V99, P10599, DOI 10.1073/pnas.152327599; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	15	131	136	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37	6					585	587		10.1038/ng1556	http://dx.doi.org/10.1038/ng1556			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15864307				2022-12-17	WOS:000229495300009
J	Conant, GC; Wagner, A				Conant, GC; Wagner, A			Convergent evolution of gene circuits	NATURE GENETICS			English	Article							EXPRESSION PATTERNS; ADAPTIVE EVOLUTION; DUPLICATE GENES; NETWORK MOTIFS; YEAST	Convergent evolution is a potent indicator of optimal design. We show here that convergent evolution occurs in genetic networks. Specifically, we show that multiple types of transcriptional regulation circuitry in Escherichia coli and the yeast Saccharomyces cerevisiae have evolved independently and not by duplication of one or a few ancestral circuits.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Wagner, A (corresponding author), Univ New Mexico, Dept Biol, 167 Castetter Hall, Albuquerque, NM 87131 USA.		Yang, Chen/G-1379-2010; Conant, Gavin/R-7022-2019	Conant, Gavin/0000-0002-8677-4933				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Futuyma D.J., 1998, EVOL BIOL; Gould SJ, 1989, WONDERFUL LIFE BURGE; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; Wagner A, 2000, P NATL ACAD SCI USA, V97, P6579, DOI 10.1073/pnas.110147097; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913	15	131	137	3	20	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					264	266		10.1038/ng1181	http://dx.doi.org/10.1038/ng1181			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12819781				2022-12-17	WOS:000183815300012
J	Meeks, JJ; Weiss, J; Jameson, JL				Meeks, JJ; Weiss, J; Jameson, JL			Dax1 is required for testis determination	NATURE GENETICS			English	Article							ADRENAL HYPOPLASIA CONGENITA; SEX REVERSAL; CHROMOSOME; GENE	The orphan nuclear receptor, Dax1, was originally proposed to act as an 'anti-testis' factor. We find, however, that Nr0b1 (also called Dax1 and Ahch, which encodes Dax1) is in fact required for testis differentiation.	Northwestern Univ, Dept Med, Div Endocrinol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Jameson, JL (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol, Feinberg Sch Med, Chicago, IL 60611 USA.			Jameson, James/0000-0001-9538-4059				BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Meeks JJ, 2003, DEVELOPMENT, V130, P1029, DOI 10.1242/dev.00316; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; VALERIE VPI, 2001, NAT GENET, V28, P216; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822	11	131	140	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					32	33		10.1038/ng1141	http://dx.doi.org/10.1038/ng1141			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12679814				2022-12-17	WOS:000182667900013
J	Chen, M; Kasahara, N; Keene, DR; Chan, L; Hoeffler, WK; Finlay, D; Barcova, M; Cannon, PM; Mazurek, C; Woodley, DT				Chen, M; Kasahara, N; Keene, DR; Chan, L; Hoeffler, WK; Finlay, D; Barcova, M; Cannon, PM; Mazurek, C; Woodley, DT			Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa	NATURE GENETICS			English	Article							MODIFIED RETROVIRAL VECTORS; HEMATOPOIETIC STEM-CELLS; ANCHORING FIBRILS; LENTIVIRUS VECTOR; GENE-TRANSFER; IN-VIVO; KERATINOCYTES; TRANSDUCTION; DELIVERY; THERAPY	Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders caused by mutations in the human type VII collagen gene (COL7A1). Individuals with DEB lack type VII collagen and anchoring fibrils, structures that attach epidermis and dermis. The current lack of treatment for DEB is an impetus to develop gene therapy strategies that efficiently transfer and stably express genes delivered to skin cells in vivo. In this study, we delivered and expressed full-length type VII collagen using a self-inactivating minimal lentivirus-based vector. Transduction of lentiviral vectors containing the COL7A1 transgene into recessive DEB (RDEB) keratinocytes and fibroblasts (in which type VII collagen was absent) resulted in persistent synthesis and secretion of type VII collagen. Unlike RDEB parent cells, the gene-corrected cells had normal morphology, proliferative potential, matrix attachment and motility. We used these gene-corrected cells to regenerate human skin on immune-deficient mice. Human skin regenerated by gene-corrected RDEB cells had restored expression of type VII collagen and formation of anchoring fibrils at the dermal-epidermal junction in vivo. These studies demonstrate that it is possible to restore type VII collagen gene expression in RDEB skin in vivo.	Univ So Calif, Dept Med, Div Dermatol, Los Angeles, CA 90033 USA; Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Dept Biochem, Los Angeles, CA 90033 USA; Shriners Hosp Children, Portland, OR 97201 USA; Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA; Xgene Corp, San Carlos, CA USA	University of Southern California; University of Southern California; University of Southern California; Northwestern University	Chen, M (corresponding author), Univ So Calif, Dept Med, Div Dermatol, CRL 204,1303 Mission Rd, Los Angeles, CA 90033 USA.			Kasahara, Noriyuki/0000-0002-6069-9082				ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Anderson WF, 1998, NATURE, V392, P25; BOYCE ST, 1983, J INVEST DERMATOL S1, V81, P335; BRIGGAMAN RA, 1975, J INVEST DERMATOL, V65, P71, DOI 10.1111/1523-1747.ep12598050; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; Chen M, 1999, EXP CELL RES, V249, P231, DOI 10.1006/excr.1999.4473; Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200; Chen M, 2000, J BIOL CHEM, V275, P24429, DOI 10.1074/jbc.M003440200; Choate KA, 1997, HUM GENE THER, V8, P895, DOI 10.1089/hum.1997.8.8-895; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CHRISTIANO AM, 1996, CURR OPIN DERMATOL, V3, P225; Cui Y, 1999, J VIROL, V73, P6171, DOI 10.1128/JVI.73.7.6171-6176.1999; Fenjves ES, 1996, J INVEST DERMATOL, V106, P576, DOI 10.1111/1523-1747.ep12344976; GAMMON WR, 1984, J INVEST DERMATOL, V82, P139, DOI 10.1111/1523-1747.ep12259692; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; Kuhn U, 2002, J VIROL, V76, P1496, DOI 10.1128/JVI.76.3.1496-1504.2002; MORGAN RA, 1993, ANNU REV BIOCHEM, V62, P191; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; OKEEFE EJ, 1988, J INVEST DERMATOL, V90, P2, DOI 10.1111/1523-1747.ep12462409; Robbins PB, 1997, J VIROL, V71, P9466, DOI 10.1128/JVI.71.12.9466-9474.1997; Robbins PB, 1998, P NATL ACAD SCI USA, V95, P10182, DOI 10.1073/pnas.95.17.10182; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sirven A, 2000, BLOOD, V96, P4103; UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713; Wang CK, 2000, J INVEST DERMATOL, V114, P674, DOI 10.1046/j.1523-1747.2000.00938.x; WOODLEY DT, 1988, J CELL PHYSIOL, V136, P140, DOI 10.1002/jcp.1041360118; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	30	131	145	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					670	675		10.1038/ng1041	http://dx.doi.org/10.1038/ng1041			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426566				2022-12-17	WOS:000179593000023
J	Vetter, DE; Li, CE; Zhao, LY; Contarino, A; Liberman, MC; Smith, GW; Marchuk, Y; Koob, GF; Heinemann, SF; Vale, W; Lee, KF				Vetter, DE; Li, CE; Zhao, LY; Contarino, A; Liberman, MC; Smith, GW; Marchuk, Y; Koob, GF; Heinemann, SF; Vale, W; Lee, KF			Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior	NATURE GENETICS			English	Article							CORTICOTROPIN-RELEASING FACTOR; RAT OLIVOCOCHLEAR NEURONS; TYPE-2 CRF RECEPTORS; GENE-RELATED PEPTIDE; LATERAL-LINE ORGAN; GUINEA-PIG; HORMONE RECEPTOR-2; UROTENSIN-I; MAMMALIAN COCHLEA; BASILAR-MEMBRANE	Urocortin is a member of the corticotropin-releasing hormone peptide family and is found in many discrete brain regions. The distinct expression pattern of urocortin suggests that it influences such behaviors as feeding, anxiety and auditory processing. To better define the physiological roles of urocortin, we have generated mice carrying a null mutation of the urocortin gene. Urocortin-deficient mice have normal basal feeding behavior and stress responses, but show heightened anxiety-like behaviors in the elevated plus maze and open-field tests. In addition, hearing is impaired in the mutant mice at the level of the inner ear, suggesting that urocortin is involved in the normal development of cochlear sensory-cell function. These results provide the first example of a function for any peptidergic system in hearing.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA	Salk Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Vetter, Douglas E./O-8150-2019; Contarino, Angelo/C-9429-2014	Contarino, Angelo/0000-0002-7286-6941	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005209] Funding Source: NIH RePORTER; NIDCD NIH HHS [P30 DC005209] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABOUMADI L, 1987, HEARING RES, V30, P135, DOI 10.1016/0378-5955(87)90131-6; ADAMS JC, 1987, BRAIN RES, V419, P347, DOI 10.1016/0006-8993(87)90606-8; ALTSCHULER RA, 1984, J HISTOCHEM CYTOCHEM, V32, P839, DOI 10.1177/32.8.6379037; ALTSCHULER RA, 1985, HEARING RES, V17, P249, DOI 10.1016/0378-5955(85)90069-3; Bailey GP, 2000, J NEUROSCI, V20, P5163; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bittencourt JC, 1999, J COMP NEUROL, V415, P285; CHADWICK D, 1993, CORTICOTROPIN RELEAS; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; HASHIMOTO S, 1990, ACTA OTO-LARYNGOL, V109, P228, DOI 10.3109/00016489009107438; HOFFMAN DW, 1985, HEARING RES, V17, P47, DOI 10.1016/0378-5955(85)90129-7; HOFFMAN DW, 1983, HEARING RES, V9, P71, DOI 10.1016/0378-5955(83)90135-1; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Kihara N, 2001, AM J PHYSIOL-GASTR L, V280, pG406, DOI 10.1152/ajpgi.2001.280.3.G406; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6; LEDERIS K, 1982, SCIENCE, V218, P162, DOI 10.1126/science.6981844; LEDERIS K, 1982, P W PHARMACOL SOC, V25, P223; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V18, P113; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; RUGGERO MA, 1992, PHILOS T ROY SOC B, V336, P307, DOI 10.1098/rstb.1992.0063; SEWELL WF, 1991, J NEUROPHYSIOL, V65, P1158, DOI 10.1152/jn.1991.65.5.1158; Skelton KH, 2000, J NEUROSCI, V20, P1240, DOI 10.1523/JNEUROSCI.20-03-01240.2000; Slawecki CJ, 1999, PEPTIDES, V20, P211, DOI 10.1016/S0196-9781(98)00160-0; Smagin GN, 1998, NEUROREPORT, V9, P1601, DOI 10.1097/00001756-199805110-00063; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Spina MG, 2002, PSYCHOPHARMACOLOGY, V160, P113, DOI 10.1007/s00213-001-0940-y; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Turnbull AV, 1999, ENDOCRINOLOGY, V140, P71, DOI 10.1210/en.140.1.71; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; VETTER DE, 1992, ANAT EMBRYOL, V185, P1, DOI 10.1007/BF00213596; VETTER DE, 1991, SYNAPSE, V7, P21, DOI 10.1002/syn.890070104; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Warr W.B., 1992, Springer Handbook of Auditory Research, V1, P410	44	131	134	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					363	369		10.1038/ng914	http://dx.doi.org/10.1038/ng914			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12091910				2022-12-17	WOS:000177147100010
J	Nikaido, M; Kawakami, A; Sawada, A; Furutani-Seiki, M; Takeda, H; Araki, K				Nikaido, M; Kawakami, A; Sawada, A; Furutani-Seiki, M; Takeda, H; Araki, K			Tbx24, encoding a T-box protein, is mutated in the zebrafish somite-segmentation mutant fused somites	NATURE GENETICS			English	Article							GENE; EXPRESSION; MUTATIONS; EMBRYOS; SOMITOGENESIS; SPADETAIL; MESODERM; FAMILY; GENOME; MOTIF	Somites are fundamental structures within the paraxial mesoderm of the vertebrate embryo that give rise to the vertebrae and muscle of the trunk and tail. Studies of knockout mice and gene expression analyses have shown that the Notch pathway is crucial in establishing the reiterative pattern of somites(1). A large-scale screen in zebrafish previously identified five mutants that show abnormalities in somite boundary formation(2). Four have essentially the same phenotype, with posterior somite defects(2-4) and neuronal hyperplasia(5,6); recent work has suggested that genes affected in these mutants encode components of the Notch signaling cascade(5). The fifth mutant, fused somites (fss), shows a different phenotype characterized by complete lack of somite formation along the entire antero-posterior axis(2,3). Gene expression and phenotypic analyses in mutant embryos have implicated Fss in somite formation independent of Notch signaling(4,5), suggesting the presence of a new pathway regulating somite boundary formation. We show here that the fss gene encodes a T-box transcription factor that is expressed in intermediate to anterior presomitic mesoderm (PSM) and is involved in PSM maturation.	Natl Inst Genet, Div Early Embryogenesis, Mishima, Shizuoka, Japan; Natl Res Inst Aquaculture, Div Genet, Cell Engn Sect, Mie, Wataria 5190423, Japan; Japan Sci & Technol Corp, ERATO Kondoh Differentiat Signaling Project, Sakyo Ku, Kyoto 6068305, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Fisheries Research & Education Agency (FRA); Japan Science & Technology Agency (JST)	Takeda, H (corresponding author), Natl Inst Genet, Div Early Embryogenesis, Mishima, Shizuoka, Japan.		TAKEDA, HIROYUKI/G-4950-2014; Kawakami, Atsushi/D-3785-2019	Kawakami, Atsushi/0000-0001-9461-6372				Alexandre D, 1996, DEVELOPMENT, V122, P735; Amemiya CT, 1999, METHOD CELL BIOL, V60, P235; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Durbin L, 2000, DEVELOPMENT, V127, P1703; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Gray M, 2001, DEV BIOL, V237, P306, DOI 10.1006/dbio.2001.0381; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Holley SA, 2000, GENE DEV, V14, P1678; Hug B, 1997, DEV BIOL, V183, P61, DOI 10.1006/dbio.1996.8490; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; Kwok C, 1998, NUCLEIC ACIDS RES, V26, P3562, DOI 10.1093/nar/26.15.3562; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Reifers F, 1998, DEVELOPMENT, V125, P2381; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5	30	131	135	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					195	199		10.1038/ng899	http://dx.doi.org/10.1038/ng899			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021786				2022-12-17	WOS:000175903500018
J	Shirasawa, S; Arata, A; Onimaru, H; Roth, KA; Brown, GA; Horning, S; Arata, S; Okumura, K; Sasazuki, T; Korsmeyer, SJ				Shirasawa, S; Arata, A; Onimaru, H; Roth, KA; Brown, GA; Horning, S; Arata, S; Okumura, K; Sasazuki, T; Korsmeyer, SJ			Rnx deficiency results in congenital central hypoventilation	NATURE GENETICS			English	Article							HOMEOBOX GENE-EXPRESSION; SPINAL CORD PREPARATIONS; ONDINES-CURSE; DEVELOPMENTAL EXPRESSION; NEWBORN RATS; CHICK-EMBRYO; HOX11 GENE; BRAIN; MEDULLA; HINDBRAIN	The genes Tlx1 (Hox11), Enx (Hox11L1, Tlx-2) and Rnx (Hox11L2, Tlx-3) constitute a family of orphan homeobox genes(1-10). In situ hybridization has revealed considerable overlap in their expression within the nervous system, but Rnx is singularly expressed in the developing dorsal and ventral region of the medulla oblongata. Tlx1-deficient and Enx-deficient mice display phenotypes in tissues where the mutated gene is singularly expressed, resulting in asplenogenesis(3,4) and hyperganglionic megacolon(8), respectively. To determine the developmental role of Rnx. we disrupted the locus in mouse embryonic stem (ES) cells. Rnx-deficient mice developed to term, but all died within 24 hours after birth from a central respiratory failure. The electromyographic activity of intercostal muscles coupled with the C4 ventral root activity assessed in a medulla-spinal cord preparation revealed a high respiratory rate with short inspiratory duration and frequent apnea. Furthermore, a coordinate pattern existed between the abnormal activity of inspiratory neurons in the ventrolateral medulla and C4 motorneuron output, indicating a central respiratory defect in Rnx(-/-) mice. Thus, Rnx is critical for the development of the ventral medullary respiratory centre and its deficiency results in a syndrome resembling congenital central hypoventilation.	Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA; Kyushu Univ, Med Inst Bioregulat, Dept Genet, Fukuoka 812, Japan; Tokyo Metropolitan Inst Neurosci, Dept Neurobiol, Tokyo 138, Japan; Showa Univ, Sch Med, Dept Physiol, Tokyo 142, Japan; Showa Univ, Ctr Biotechnol, Tokyo 142, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Kyushu University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Showa University; Showa University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Korsmeyer, SJ (corresponding author), Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.			Arata, Akiko/0000-0001-7418-8294; Roth, Kevin/0000-0002-0643-995X				Amiel J, 1998, AM J HUM GENET, V62, P715, DOI 10.1086/301759; ARATA A, 1990, BRAIN RES BULL, V24, P599, DOI 10.1016/0361-9230(90)90165-V; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Bolk S, 1996, NAT GENET, V13, P395, DOI 10.1038/ng0896-395; DEAR TN, 1993, P NATL ACAD SCI USA, V90, P4431, DOI 10.1073/pnas.90.10.4431; DEAR TN, 1995, DEVELOPMENT, V121, P2909; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; Masson N, 1998, MOL CELL BIOL, V18, P3502, DOI 10.1128/MCB.18.6.3502; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MELLINS RB, 1970, MEDICINE, V49, P487, DOI 10.1097/00005792-197011000-00003; NAKAHARA S, 1995, J PEDIATR SURG, V30, P1481, DOI 10.1016/0022-3468(95)90413-1; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; ONIMARU H, 1995, NEUROSCI RES, V21, P183, DOI 10.1016/0168-0102(94)00863-B; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; RAJU K, 1993, MECH DEVELOP, V44, P51, DOI 10.1016/0925-4773(93)90016-Q; RICKLING JC, 1996, J NEUROPHYSIOL, V75, P795; ROBEL P, 1994, TRENDS ENDOCRIN MET, V5, P1, DOI 10.1016/1043-2760(94)90114-7; ROBERTS CWM, 1995, AM J PATHOL, V146, P1089; RUBENSTEIN JLR, 1994, CURR TOP DEV BIOL, V29, P1, DOI 10.1016/S0070-2153(08)60546-3; Shirasawa S, 1997, NAT MED, V3, P646, DOI 10.1038/nm0697-646; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; VERLOES A, 1993, EUR J PEDIATR, V152, P75, DOI 10.1007/BF02072522; WEESEMAYER DE, 1993, AM J MED GENET, V47, P360, DOI 10.1002/ajmg.1320470313	27	131	138	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					287	290		10.1038/73516	http://dx.doi.org/10.1038/73516			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700185				2022-12-17	WOS:000085590600022
J	Elchebly, M; Wagner, J; Kennedy, TE; Lanctot, C; Michaliszyn, E; Itie, A; Drouin, J; Tremblay, ML				Elchebly, M; Wagner, J; Kennedy, TE; Lanctot, C; Michaliszyn, E; Itie, A; Drouin, J; Tremblay, ML			Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma	NATURE GENETICS			English	Article							MOTOR AXON GUIDANCE; GENE; LAR; DROSOPHILA; EXPRESSION; SYSTEM; RAT	Protein tyrosine phosphatase sigma (PTP-sigma, encoded by the Ptprs gene) is a member of the LAR subfamily of receptor-like protein tyrosine phosphatases that is highly expressed during mammalian embryonic development in the germinal cell layer lining the lateral ventricles of the developing brain, dorsal root ganglia, Rathke's pouch, olfactory epithelium, retina and developing lung and heart(1-4). On the basis of its expression and homology with the Drosophila melanogaster orthologues DPTP99 and DPTP100A (refs 5,6), which have roles in the targeting of axonal growth cones, we hypothesized that PTP-sigma may also have a modulating function in cell-cell interactions, as well as in axon guidance during mammalian embryogenesis, To investigate its function in vivo, we generated Ptprs-deficient mice. The resulting Ptprs(-/-) animals display retarded growth, increased neonatal mortality, hyposmia and hypofecundity. Anatomical and histological analyses showed a decrease in overall brain size with a severe depletion of luteinizing hormone-releasing hormone (LHRH)immunoreactive cells in Ptprs(-/-) hypothalamus. Ptprs(-/-) mice have an enlarged intermediate pituitary lobe, but smaller anterior and posterior lobes, These results suggest that tyrosine phosphorylation-dependent signalling pathways regulated by PTP-sigma influence the proliferation and/or adhesiveness of various cell types in the developing hypothalamo-pituitary axis.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Inst Rech Clin Montreal, Montreal, PQ M2W 1R7, Canada	McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Tremblay, ML (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.			Drouin, Jacques/0000-0001-8226-5691				Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Deiss V, 1997, PHYSIOL BEHAV, V61, P209, DOI 10.1016/S0031-9384(96)00402-7; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Kim H, 1996, AM J PHYSIOL-LUNG C, V270, pL566, DOI 10.1152/ajplung.1996.270.4.L566; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; OGRADY P, 1994, J BIOL CHEM, V269, P25193; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; SAHIN M, 1993, J NEUROSCI, V13, P4968; Schaapveld RQJ, 1997, DEV BIOL, V188, P134, DOI 10.1006/dbio.1997.8630; UETANI N, 1997, KINASES PHOSPHATASES, P313; WALTON KM, 1993, NEURON, V11, P387, DOI 10.1016/0896-6273(93)90193-U; WANG H, 1995, J NEUROSCI RES, V41, P297, DOI 10.1002/jnr.490410303; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	16	131	135	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1999	21	3					330	333		10.1038/6859	http://dx.doi.org/10.1038/6859			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080191				2022-12-17	WOS:000078977900032
J	Aitman, TJ; Gotoda, T; Evans, AL; Imrie, H; Heath, KE; Trembling, PM; Truman, H; Wallace, CA; Rahman, A; Dore, C; Flint, J; Kren, V; Zidek, V; Kurtz, TW; Pravenec, M; Scott, J				Aitman, TJ; Gotoda, T; Evans, AL; Imrie, H; Heath, KE; Trembling, PM; Truman, H; Wallace, CA; Rahman, A; Dore, C; Flint, J; Kren, V; Zidek, V; Kurtz, TW; Pravenec, M; Scott, J			Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats	NATURE GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; RECOMBINANT INBRED STRAINS; NITRIC-OXIDE SYNTHASE; UPPER-BODY OBESITY; INSULIN-RESISTANCE; BLOOD-PRESSURE; GENETIC-MAP; LINKAGE MAP; APOLIPOPROTEIN; CHROMOSOME-4	Coronary heart disease, hypertension, non-insulin-dependent diabetes and obesity are major causes of ill health in industrial societies, Disturbances of carbohydrate and lipid metabolism are a common feature of these disorders(1-9). The bases for these disturbances and their roles in disease pathogenesis are poorly understood, The spontaneously hypertensive rat (SHR), a widely used animal model of essential hypertension(10), has a global defect in insulin action on glucose metabolism and shows reduced catecholamine action on lipolysis in fat cells(11-14). In our study we used cellular defects in carbohydrate and lipid metabolism to dissect the genetics of defective insulin and catecholamine action in the SHR strain. In a genome screen for loci linked to insulin and catecholamine action, we identified two quantitative trait loci (QTLs) for defective insulin action, on chromosomes 4 and 12. We found that the major (and perhaps only) genetic determinant of defective control of lipolysis in SHR maps to the same region of chromosome 4. These linkage results were ascertained in at least two independent crosses. As the SHR strain manifests many of the defining features of human metabolic Syndrome X, in which hypertension associates with insulin resistance, dyslipidaemia and abdominal obesity, the identification of genes for defective insulin and catecholamine action in SHR may facilitate gene identification in this syndrome and in related human conditions, such as type-2 diabetes and familial combined hyperlipidaemia.	HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0NN,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED STAT & EVALUAT,LONDON W12 0NN,ENGLAND; INST MOL MED,OXFORD OX3 9DU,ENGLAND; CHARLES UNIV,FAC MED 1,DEPT BIOL,PRAGUE 12800 2,CZECH REPUBLIC; ACAD SCI CZECH REPUBL,INST PHYSIOL,CR-14220 PRAGUE 4,CZECH REPUBLIC; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143	Imperial College London; Imperial College London; University of Oxford; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of California System; University of California San Francisco	Aitman, TJ (corresponding author), HAMMERSMITH HOSP,MRC,CTR CLIN SCI,MOL MED GRP,LONDON W12 0NN,ENGLAND.		Zidek, Vaclav/C-6685-2012; Dore, Caroline J/J-4716-2012; Heath, Karen Elise/K-7760-2014; Pravenec, Michal/B-1666-2012; Heath, K. E./ABG-4658-2020	Dore, Caroline J/0000-0001-9796-4970; Heath, Karen Elise/0000-0002-5816-7044; Pravenec, Michal/0000-0001-9197-5871; Heath, K. E./0000-0002-5816-7044; Aitman, Timothy/0000-0002-7875-4502; Trembling, Paul/0000-0002-5016-4607				Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; BECKERS MC, 1994, GENOMICS, V23, P685, DOI 10.1006/geno.1994.1557; Belknap JK, 1996, BEHAV GENET, V26, P149, DOI 10.1007/BF02359892; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; DECINGOLANI GEC, 1988, METABOLISM, V37, P318, DOI 10.1016/0026-0495(88)90130-8; Dohi Y, 1996, HYPERTENSION, V28, P732, DOI 10.1161/01.HYP.28.5.732; EVANS DJ, 1984, J CLIN INVEST, V74, P1515, DOI 10.1172/JCI111565; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GOLDMUNTZ EA, 1995, MAMM GENOME, V6, P459, DOI 10.1007/BF00360654; GORDON RD, 1995, NAT GENET, V11, P6, DOI 10.1038/ng0995-6; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; HUBNER N, 1995, MAMM GENOME, V6, P758, DOI 10.1007/BF00354306; HUNT SC, 1989, ARTERIOSCLEROSIS, V9, P335, DOI 10.1161/01.ATV.9.3.335; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; Kirkwood TBL, 1979, BIOMETRICS, V35, P908; KLOCKE R, 1993, GENOMICS, V18, P568, DOI 10.1016/S0888-7543(05)80358-1; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MARTIN ML, 1991, J CLIN INVEST, V88, P609, DOI 10.1172/JCI115345; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MCLAUGHLIN MG, 1995, CIRCULATION, V92, P1; PATERNOSTRO G, 1995, CARDIOVASC RES, V30, P205, DOI 10.1016/0008-6363(95)00019-4; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Pravenec M, 1996, MAMM GENOME, V7, P117, DOI 10.1007/s003359900031; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; Reaven Gerald M., 1996, New England Journal of Medicine, V334, P374; REAVEN GM, 1989, DIABETES, V38, P1155, DOI 10.2337/diabetes.38.9.1155; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/BF00408482; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; RIESS O, 1994, GENOMICS, V19, P298, DOI 10.1006/geno.1994.1061; RODBELL M, 1964, J BIOL CHEM, V239, P375; SCHERRER U, 1994, J CLIN INVEST, V94, P2511, DOI 10.1172/JCI117621; Scott J, 1996, NATURE, V379, P113, DOI 10.1038/379113a0; Simon JS, 1996, MAMM GENOME, V7, P380, DOI 10.1007/s003359900109; Todd JA, 1996, NATURE, V384, P407, DOI 10.1038/384407a0; YAMORI Y, 1984, HDB HYPERTENSION, V4, P224	47	131	135	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					197	201		10.1038/ng0697-197	http://dx.doi.org/10.1038/ng0697-197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171835				2022-12-17	WOS:A1997XB54300024
J	BUDARF, ML; COLLINS, J; GONG, WL; ROE, B; WANG, ZL; BAILEY, LC; SELLINGER, B; MICHAUD, D; DRISCOLL, DA; EMANUEL, BS				BUDARF, ML; COLLINS, J; GONG, WL; ROE, B; WANG, ZL; BAILEY, LC; SELLINGER, B; MICHAUD, D; DRISCOLL, DA; EMANUEL, BS			CLONING A BALANCED TRANSLOCATION ASSOCIATED WITH DIGEORGE-SYNDROME AND IDENTIFICATION OF A DISRUPTED CANDIDATE GENE	NATURE GENETICS			English	Article							CARDIO-FACIAL SYNDROME; TOPOISOMERASE-II; DNA-SEQUENCE; MUSCULAR-DYSTROPHY; MOLECULAR ANALYSIS; CLUSTER REGION; BCR GENE; 22Q11; MICRODELETIONS; RECOMBINATION	DiGeorge syndrome (DGS), a developmental defect, is characterized by cardiac defects and aplasia or hypoplasia of the thymus and parathyroid glands. DGS has been associated with visible chromosomal abnormalities and microdeletions of 22q11, but only one balanced translocation - ADU/VDU t(2;22)(q14;q11.21). We now report the cloning of this translocation, the identification of a gene disrupted by the rearrangement and the analysis of other transcripts in its vicinity. Transcripts were identified by direct screening of cDNA libraries, exon amplification, cDNA selection and genomic sequence analysis using GRAIL. Disruption of a gene in 22q11.2 by the breakpoint and haploinsufficiency of this locus in deleted DGS patients make it a strong candidate for the major features associated with this disorder.	UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104; UNIV OKLAHOMA,DEPT CHEM,NORMAN,OK 73019	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Oklahoma System; University of Oklahoma - Norman	BUDARF, ML (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104, USA.		Michaud, Dominique S/I-5231-2014		NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL051533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000425] Funding Source: NIH RePORTER; NCI NIH HHS [CA39926] Funding Source: Medline; NHGRI NIH HHS [HG00425] Funding Source: Medline; NHLBI NIH HHS [HL51533] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUBRY M, 1993, HUM MOL GENET, V2, P1583, DOI 10.1093/hmg/2.10.1583; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BALROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013; Bodenteich A, 1993, AUTOMATED DNA SEQUEN, P42; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BODRUG SE, 1991, EMBO J, V10, P3931, DOI 10.1002/j.1460-2075.1991.tb04963.x; BUDARF ML, 1995, HUM MOL GENET, V4, P763, DOI 10.1093/hmg/4.4.763; BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; CAREY AH, 1992, AM J HUM GENET, V51, P964; CHEN SJ, 1989, ONCOGENE, V4, P195; CHISSOE S L, 1991, Methods (Orlando), V3, P55, DOI 10.1016/S1046-2023(05)80164-1; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; DELACHAPELLE A, 1981, HUM GENET, V57, P523; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; Emanuel Beverly S., 1993, V384, P207; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/jmg.30.10.807; Gong W., 1994, American Journal of Human Genetics, V55, pA259; GREENBERG F, 1993, J MED GENET, V30, P803, DOI 10.1136/jmg.30.10.803; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HALFORD S, 1993, HUM MOL GENET, V2, P1577, DOI 10.1093/hmg/2.10.1577; HALFORD S, 1993, HUM MOL GENET, V12, P2099; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KELLY D, 1993, AM J MED GENET, V45, P308, DOI 10.1002/ajmg.1320450306; KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102; KROWCZYNSKA AM, 1990, NUCLEIC ACIDS RES, V18, P1121, DOI 10.1093/nar/18.5.1121; KURAHASHI K, 1995, HUM MOL GENET, V4, P541; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Li M., 1994, American Journal of Human Genetics, V55, pA10; MCDERMID HE, 1989, GENOMICS, V5, P1, DOI 10.1016/0888-7543(89)90079-7; MCLEAN SD, 1993, AM J DIS CHILD, V147, P1212; NISSON PE, 1994, CURRENT PROTOCOLS HU, V1; NOVAK RW, 1993, AM J MED GENET, V50, P311; PAPADOPOULOS PC, 1990, GENE CHROMOSOME CANC, V1, P233, DOI 10.1002/gcc.2870010308; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SOWERBY SJ, 1993, ONCOGENE, V8, P1679; SPERRY AO, 1989, P NATL ACAD SCI USA, V86, P5497, DOI 10.1073/pnas.86.14.5497; SPINNER NB, 1994, AM J HUM GENET, V55, P238; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VERGA V, 1991, AM J HUM GENET, V48, P1133; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILSON TA, 1993, AM J MED GENET, V47, P1078, DOI 10.1002/ajmg.1320470729; WORLEY KC, 1995, HUMAN GENOME CTR; YEN PH, 1991, P NATL ACAD SCI USA, V88, P8944, DOI 10.1073/pnas.88.20.8944; 1991, PROGRAM MANUAL GCG P	57	131	135	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					269	278		10.1038/ng0795-269	http://dx.doi.org/10.1038/ng0795-269			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670464				2022-12-17	WOS:A1995RG38600009
J	BLUMENFELD, A; SLAUGENHAUPT, SA; AXELROD, FB; LUCENTE, DE; MAAYAN, C; LIEBERT, CB; OZELIUS, LJ; TROFATTER, JA; HAINES, JL; BREAKEFIELD, XO; GUSELLA, JF				BLUMENFELD, A; SLAUGENHAUPT, SA; AXELROD, FB; LUCENTE, DE; MAAYAN, C; LIEBERT, CB; OZELIUS, LJ; TROFATTER, JA; HAINES, JL; BREAKEFIELD, XO; GUSELLA, JF			LOCALIZATION OF THE GENE FOR FAMILIAL DYSAUTONOMIA ON CHROMOSOME-9 AND DEFINITION OF DNA MARKERS FOR GENETIC DIAGNOSIS	NATURE GENETICS			English	Article							NERVE GROWTH-FACTOR	Familial dysautonomia (DYS), the Riley-Day syndrome, is an autosomal recessive disorder characterized by developmental loss of neurons from the sensory and autonomic nervous system. It is limited to the Ashkenazi Jewish population, where the carrier frequency is 1 in 30. We have mapped the DYS gene to chromosome 9q31-q33 by linkage with ten DNA markers in 26 families. The maximum lod score of 21.1 with no recombinants was achieved with D9S58. This marker also showed strong linkage disequilibrium with DYS, with one allele present on 73% of affected chromosomes compared to 5.4% of controls (chi2=3142, 15 d.f. p<0.0001). D9S53 and D9S105 represent the closest flanking markers for the disease gene. This localization will permit prenatal diagnosis of DYS in affected families and aid the isolation of the disease gene.	MASSACHUSETTS GEN HOSP,NEUROL SERV,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; HADASSAH UNIV HOSP,DEPT PEDIAT,JERUSALEM,ISRAEL; NYU,SCH MED,DEPT PEDIAT,NEW YORK,NY 10017	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; New York University			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728				AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; Axelrod FB, 1984, CELL MOL BIOL NEURON, P331; BERKEMEIER LR, 1992, SOMAT CELL MOLEC GEN, V18, P233, DOI 10.1007/BF01233860; BLUMENFELD A, 1993, J MED GENET, V30, P47, DOI 10.1136/jmg.30.1.47; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; BREAKEFIELD XO, 1986, MOL BIOL MED, V3, P483; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; FURLONG RA, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925; GUSELLA JF, 1989, FASEB J, V3, P2036, DOI 10.1096/fasebj.3.9.2568302; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; MAAYAN C, 1987, CLIN GENET, V32, P106; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MIOZZO M, 1990, ONCOGENE, V5, P1411; Ozelius L., 1992, Human Molecular Genetics, V1, P141, DOI 10.1093/hmg/1.2.141-a; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; POVEY S, 1992, ANN HUM GENET, V56, P167, DOI 10.1111/j.1469-1809.1992.tb01145.x; RILEY CM, 1949, PEDIATRICS, V3, P468; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; VERGE VMK, 1992, J NEUROSCI, V12, P4011; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	31	131	133	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					160	164		10.1038/ng0693-160	http://dx.doi.org/10.1038/ng0693-160			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8102296				2022-12-17	WOS:A1993LF81600016
J	Werling, DM; Brand, H; An, JY; Stone, MR; Zhu, LX; Glessner, JT; Collins, RL; Dong, S; Layer, RM; Markenscoff-Papadimitriou, E; Farrell, A; Schwartz, GB; Wang, HZ; Currall, BB; Zhao, XF; Dea, J; Duhn, C; Erdman, CA; Gilson, MC; Yadav, R; Handsaker, RE; Kashin, S; Klei, L; Mandell, JD; Nowakowski, TJ; Liu, YW; Pochareddy, S; Smith, L; Walker, MF; Waterman, MJ; He, X; Kriegstein, AR; Rubenstein, JL; Sestan, N; McCarroll, SA; Neale, BM; Coon, H; Willsey, AJ; Buxbaum, JD; Daly, MJ; State, MW; Quinlan, AR; Marth, GT; Roeder, K; Devlin, B; Talkowski, ME; Sanders, SJ				Werling, Donna M.; Brand, Harrison; An, Joon-Yong; Stone, Matthew R.; Zhu, Lingxue; Glessner, Joseph T.; Collins, Ryan L.; Dong, Shan; Layer, Ryan M.; Markenscoff-Papadimitriou, Eirene; Farrell, Andrew; Schwartz, Grace B.; Wang, Harold Z.; Currall, Benjamin B.; Zhao, Xuefang; Dea, Jeanselle; Duhn, Clif; Erdman, Carolyn A.; Gilson, Michael C.; Yadav, Rachita; Handsaker, Robert E.; Kashin, Seva; Klei, Lambertus; Mandell, Jeffrey D.; Nowakowski, Tomasz J.; Liu, Yuwen; Pochareddy, Sirisha; Smith, Louw; Walker, Michael F.; Waterman, Matthew J.; He, Xin; Kriegstein, Arnold R.; Rubenstein, John L.; Sestan, Nenad; McCarroll, Steven A.; Neale, Benjamin M.; Coon, Hilary; Willsey, A. Jeremy; Buxbaum, Joseph D.; Daly, Mark J.; State, Matthew W.; Quinlan, Aaron R.; Marth, Gabor T.; Roeder, Kathryn; Devlin, Bernie; Talkowski, Michael E.; Sanders, Stephan J.			An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; SIMONS SIMPLEX COLLECTION; WIDE ASSOCIATION; CANDIDATE GENES; DISCOVERY; SCHIZOPHRENIA; VARIANTS; INDEL; ARCHITECTURE; ANNOTATION	Genomic association studies of common or rare protein-coding variation have established robust statistical approaches to account for multiple testing. Here we present a comparable framework to evaluate rare and de novo noncoding single-nucleotide variants, insertion/deletions, and all classes of structural variation from whole-genome sequencing (WGS). Integrating genomic annotations at the level of nucleotides, genes, and regulatory regions, we define 51,801 annotation categories. Analyses of 519 autism spectrum disorder families did not identify association with any categories after correction for 4,123 effective tests. Without appropriate correction, biologically plausible associations are observed in both cases and controls. Despite excluding previously identified gene-disrupting mutations, coding regions still exhibited the strongest associations. Thus, in autism, the contribution of de novo noncoding variation is probably modest in comparison to that of de novo coding variants. Robust results from future WGS studies will require large cohorts and comprehensive analytical strategies that consider the substantial multiple-testing burden.	[Werling, Donna M.; An, Joon-Yong; Dong, Shan; Markenscoff-Papadimitriou, Eirene; Schwartz, Grace B.; Dea, Jeanselle; Duhn, Clif; Erdman, Carolyn A.; Gilson, Michael C.; Mandell, Jeffrey D.; Nowakowski, Tomasz J.; Smith, Louw; Walker, Michael F.; Rubenstein, John L.; Willsey, A. Jeremy; State, Matthew W.; Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA; [Werling, Donna M.; Brand, Harrison; Stone, Matthew R.; Glessner, Joseph T.; Collins, Ryan L.; Wang, Harold Z.; Currall, Benjamin B.; Zhao, Xuefang; Yadav, Rachita; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Brand, Harrison; Stone, Matthew R.; Glessner, Joseph T.; Collins, Ryan L.; Wang, Harold Z.; Currall, Benjamin B.; Zhao, Xuefang; Yadav, Rachita; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Glessner, Joseph T.; Collins, Ryan L.; Currall, Benjamin B.; Zhao, Xuefang; Yadav, Rachita; Talkowski, Michael E.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Brand, Harrison; Glessner, Joseph T.; Currall, Benjamin B.; Zhao, Xuefang; Yadav, Rachita; Kashin, Seva; McCarroll, Steven A.; Neale, Benjamin M.; Daly, Mark J.; Talkowski, Michael E.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Brand, Harrison; Glessner, Joseph T.; Currall, Benjamin B.; Zhao, Xuefang; Yadav, Rachita; Kashin, Seva; McCarroll, Steven A.; Neale, Benjamin M.; Daly, Mark J.; Talkowski, Michael E.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Zhu, Lingxue; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Collins, Ryan L.] Harvard Med Sch, Div Med Sci, Program Bioinformat & Integrat Genom, Boston, MA USA; [Layer, Ryan M.; Farrell, Andrew; Quinlan, Aaron R.; Marth, Gabor T.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Layer, Ryan M.; Farrell, Andrew; Quinlan, Aaron R.; Marth, Gabor T.] Univ Utah, Sch Med, USTAR Ctr Genet Discovery, Salt Lake City, UT USA; [Handsaker, Robert E.; Kashin, Seva; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cel, San Francisco, CA 94143 USA; [Liu, Yuwen; He, Xin] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pochareddy, Sirisha; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT USA; [Pochareddy, Sirisha; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Waterman, Matthew J.] Eastern Nazarene Coll, Dept Biol, Quincy, MA USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Neale, Benjamin M.] Harvard Med Sch, Dept Med, Boston, MA USA; [Coon, Hilary] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Coon, Hilary; Quinlan, Aaron R.] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Willsey, A. Jeremy] Univ Calif San Francisco, Inst Neurodegenerat Dis, UCSF Weill Inst Neurosci, San Francisco, CA USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Roeder, Kathryn] Carnegie Mellon Univ, Dept Computat Biol, Pittsburgh, PA 15213 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Werling, Donna M.; Brand, Harrison; An, Joon-Yong; Stone, Matthew R.; Zhu, Lingxue] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Carnegie Mellon University; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Chicago; Yale University; Yale University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Sanders, SJ (corresponding author), Univ Calif San Francisco, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Talkowski, ME (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Talkowski, ME (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Talkowski, ME (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Devlin, B (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.; Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	devlinbj@upmc.edu; talkowski@chgr.mgh.harvard.edu; stephan.sanders@ucsf.edu	Buxbaum, Joseph D/G-6001-2010; Daly, Mark J/B-2453-2017; Yadav, Rachita/AAU-6389-2021; Sanders, Stephan/S-8645-2019; Zhu, Lingxue/J-7692-2019; DONG, Shan/GVS-5706-2022; State, Matthew/W-2256-2019	Daly, Mark J/0000-0002-0949-8752; Yadav, Rachita/0000-0003-2123-5223; Zhu, Lingxue/0000-0002-1438-1655; Sanders, Stephan/0000-0001-9112-5148; Glessner, Joseph/0000-0001-5131-2811; Mandell, Jeffrey/0000-0002-3839-2543; Buxbaum, Joseph/0000-0001-8898-8313; Quinlan, Aaron/0000-0003-1756-0859; State, Matthew/0000-0003-1624-8302; An, Joon-Yong/0000-0001-8839-6297; Dong, Shan/0000-0001-9130-0225; Collins, Ryan/0000-0003-1268-9995; Werling, Donna/0000-0001-7731-0873	Simons Foundation for Autism Research Initiative [SFARI 385110, 385027, 388196, 346042]; US National Institutes of Health [R37MH057881, U01MH111658, HD081256, GM061354, U01MH105575, U01MH111662, R01MH110928, U01MH100239-03S1, U01MH111661, K99DE026824, U01MH100229]; Autism Science Foundation; March of Dimes; Desmond and Ann Heathwood MGH Research Scholars award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE026824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, U01MH100239, R01MH109901, R01MH110928, U01MH111662, R01MH109900, U01MH111660, U01MH105575, U01MH100229, U01MH111661, U01MH111658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097305] Funding Source: NIH RePORTER	Simons Foundation for Autism Research Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Science Foundation; March of Dimes(March of Dimes); Desmond and Ann Heathwood MGH Research Scholars award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the families participating in the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC). This work was supported by grants from the Simons Foundation for Autism Research Initiative (SFARI 385110 to N.S., A.J.W., M.W.S., S.J.S.; 385027 to M.E.T., J.D.B., B.D., M.J.D., X.H., K.R.; 388196 to G.M., H.C., A.R.Q.; and 346042 to M.E.T.), the US National Institutes of Health (R37MH057881 and U01MH111658 to B.D. and K.R.; HD081256 and GM061354 to M.E.T.; U01MH105575 to M.W.S.; U01MH111662 to M.W.S. and S.J.S.; R01MH110928 and U01MH100239-03S1 to M.W.S., S.J.S., A.J.W.; U01MH111661 to J.D.B.; K99DE026824 to H.B.; U01MH100229 to M.J.D.), the Autism Science Foundation to D.M.W., and the March of Dimes to M.E.T. M.E.T. was also supported by the Desmond and Ann Heathwood MGH Research Scholars award. We thank the SSC principal investigators (A.L. Beaudet, R. Bernier, J. Constantino, E.H. Cook Jr, E. Fombonne, D. Geschwind, D.E. Grice, A. Klin, D.H. Ledbetter, C. Lord, C. L. Martin, D.M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M.W. State, W. Stone, J.S. Sutcliffe, C. A. Walsh, and E. Wijsman) and the coordinators and staff at the SSC clinical sites; the SFARI staff, in particular N. Volfovsky; D. B. Goldstein for contributing to the experimental design; the Rutgers University Cell and DNA repository for accessing biomaterials; and the New York Genome Center for generating the WGS data.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Brand H, 2015, AM J HUM GENET, V97, P170, DOI 10.1016/j.ajhg.2015.05.012; Brandler W. M., 2017, PATERNALLY INHERITED, DOI [10.1101/102327, DOI 10.1101/102327]; CASKEY CT, 1968, SCIENCE, V162, P135, DOI 10.1126/science.162.3849.135; Chaste P, 2015, BIOL PSYCHIAT, V77, P775, DOI 10.1016/j.biopsych.2014.09.017; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Collins RL, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1158-6; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Farrell MS, 2015, MOL PSYCHIATR, V20, P555, DOI 10.1038/mp.2015.16; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gardner EJ, 2017, GENOME RES, V27, P1916, DOI 10.1101/gr.218032.116; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Johnson EC, 2017, BIOL PSYCHIAT, V82, P702, DOI 10.1016/j.biopsych.2017.06.033; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kronenberg ZN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004572; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Munoz A., 2017, NOVO INDELS INTRONS, DOI [10.1101/137471, DOI 10.1101/137471]; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pedersen BS, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix090; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Redin C, 2017, NAT GENET, V49, P36, DOI 10.1038/ng.3720; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sanders SJ, 2017, NAT NEUROSCI, V20, P1661, DOI 10.1038/s41593-017-0017-9; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shibata M, 2015, TRENDS GENET, V31, P77, DOI 10.1016/j.tig.2014.12.004; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wei Q, 2015, BIOINFORMATICS, V31, P1375, DOI 10.1093/bioinformatics/btu839; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	78	130	131	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					727	+		10.1038/s41588-018-0107-y	http://dx.doi.org/10.1038/s41588-018-0107-y			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	29700473	Green Accepted			2022-12-17	WOS:000431394900016
J	Jabara, HH; Boyden, SE; Chou, J; Ramesh, N; Massaad, MJ; Benson, H; Bainter, W; Fraulino, D; Rahimov, F; Sieff, C; Liu, ZJ; Alshemmari, SH; Al-Ramadi, BK; Al-Dhekri, H; Arnaout, R; Abu-Shukair, M; Vatsayan, A; Silver, E; Ahuja, S; Davies, EG; Sola-Visner, M; Ohsumi, TK; Andrews, NC; Notarangelo, LD; Fleming, MD; Al-Herz, W; Kunkel, LM; Geha, RS				Jabara, Haifa H.; Boyden, Steven E.; Chou, Janet; Ramesh, Narayanaswamy; Massaad, Michel J.; Benson, Halli; Bainter, Wayne; Fraulino, David; Rahimov, Fedik; Sieff, Colin; Liu, Zhi-Jian; Alshemmari, Salem H.; Al-Ramadi, Basel K.; Al-Dhekri, Hasan; Arnaout, Rand; Abu-Shukair, Mohammad; Vatsayan, Anant; Silver, Eli; Ahuja, Sanjay; Davies, E. Graham; Sola-Visner, Martha; Ohsumi, Toshiro K.; Andrews, Nancy C.; Notarangelo, Luigi D.; Fleming, Mark D.; Al-Herz, Waleed; Kunkel, Louis M.; Geha, Raif S.			A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency	NATURE GENETICS			English	Article							IRON HOMEOSTASIS; INDUCTION; INTERNALIZATION; IDENTIFICATION; LYMPHOCYTE; PROTEINS; SIGNAL; CD40	Patients with a combined immunodeficiency characterized by normal numbers but impaired function of T and B cells had a homozygous p. Tyr20His substitution in transferrin receptor 1 (TfR1), encoded by TFRC. The substitution disrupts the TfR1 internalization motif, resulting in defective receptor endocytosis and markedly increased TfR1 expression on the cell surface. Iron citrate rescued the lymphocyte defects, and expression of wild-type but not mutant TfR1 rescued impaired transferrin uptake in patient-derived fibroblasts. Tfrc(Y20H/Y20H) mice recapitulated the immunological defects of patients. Despite the critical role of TfR1 in erythrocyte development and function, patients had only mild anemia and only slightly increased TfR1 expression in erythroid precursors. We show that STEAP3, a metalloreductase expressed in erythroblasts, associates with TfR1 and partially rescues transferrin uptake in patient-derived fibroblasts, suggesting that STEAP3 may provide an accessory TfR1 endocytosis signal that spares patients from severe anemia. These findings demonstrate the importance of TfR1 in adaptive immunity.	[Jabara, Haifa H.; Chou, Janet; Ramesh, Narayanaswamy; Massaad, Michel J.; Benson, Halli; Bainter, Wayne; Fraulino, David; Notarangelo, Luigi D.; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Jabara, Haifa H.; Chou, Janet; Ramesh, Narayanaswamy; Massaad, Michel J.; Sieff, Colin; Liu, Zhi-Jian; Sola-Visner, Martha; Notarangelo, Luigi D.; Kunkel, Louis M.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Boyden, Steven E.; Rahimov, Fedik; Kunkel, Louis M.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Boyden, Steven E.; Rahimov, Fedik; Kunkel, Louis M.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Boyden, Steven E.; Ohsumi, Toshiro K.; Kunkel, Louis M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Sieff, Colin] Boston Childrens Hosp, Div Hematol, Boston, MA USA; [Liu, Zhi-Jian; Sola-Visner, Martha] Boston Childrens Hosp, Div Neonatol, Boston, MA USA; [Alshemmari, Salem H.] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait; [Al-Ramadi, Basel K.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Al Ain, U Arab Emirates; [Al-Dhekri, Hasan; Arnaout, Rand] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Abu-Shukair, Mohammad] Queen Rania Hosp Children, Immunol Allergy & Rheumatol Div, Amman, Jordan; [Vatsayan, Anant; Ahuja, Sanjay] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp, Dept Pediat Hematol Oncol, Cleveland, OH 44106 USA; [Silver, Eli] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp, Div Pulmonol & Sleep Med, Cleveland, OH 44106 USA; [Davies, E. Graham] Great Ormond St Hosp Sick Children, Ctr Immunodeficiency, London, England; [Davies, E. Graham] Inst Child Hlth, London, England; [Ohsumi, Toshiro K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Andrews, Nancy C.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Fleming, Mark D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Fleming, Mark D.] Harvard Univ, Sch Med, Boston, MA USA; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Kuwait University; United Arab Emirates University; King Faisal Specialist Hospital & Research Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Harvard University; Massachusetts General Hospital; Duke University; Duke University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Kuwait University	Geha, RS (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu	Ahuja, Sanjay/AFT-3324-2022; Alshemmari, Salem/AHA-2072-2022; Notarangelo, Luigi D/F-9718-2016	Ahuja, Sanjay/0000-0002-0178-7947; Alshemmari, Salem/0000-0002-5597-5839; Notarangelo, Luigi D/0000-0002-8335-0262; Fleming, Mark/0000-0003-0948-4024; Andrews, Nancy/0000-0003-0243-4462; Rahimov, Fedik/0000-0001-6519-7404	US National Institutes of Health (NIH) [AI-076210, AI-007512, 1K08AI116979- 01, DK-089705]; Dubai Harvard Foundation for Medical Research; Perkins Fund; Howard Hughes Medical Institute; Manton Center for Orphan Disease Research; Kuwait Foundation for Advancement of Sciences [2010-1302-05]; Jeffrey Modell Foundation Translational Research Program Grant; Manton Center Pilot Award; US NIH grant through the Intellectual and Developmental Disabilities Research Center [P30-HD18655]; US NIH grant through the Neuromuscular Disease Project [P50-NS40828]; US NIH Tetramer Core Facility [HHSN272201300006C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007512, P01AI076210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087992, R01DK089705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dubai Harvard Foundation for Medical Research; Perkins Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Manton Center for Orphan Disease Research; Kuwait Foundation for Advancement of Sciences; Jeffrey Modell Foundation Translational Research Program Grant; Manton Center Pilot Award; US NIH grant through the Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant through the Neuromuscular Disease Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH Tetramer Core Facility; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	thank F. Alkuraya, H. Oettgen and T. Chatila for valuable discussions and the immunology laboratory staff at the Faculty of Medicine of Kuwait University for technical assistance. This work was supported by US National Institutes of Health (NIH) grants AI-076210, AI-007512 (R.S.G.), 1K08AI116979- 01 (J.C.) and DK-089705 (N.C.A.), a grant from the Dubai Harvard Foundation for Medical Research (R.S.G.), the Perkins Fund (R.S.G.), the Howard Hughes Medical Institute (L.M.K.), the Manton Center for Orphan Disease Research (L.M.K.), the Kuwait Foundation for Advancement of Sciences 2010-1302-05 (W.A.-H.), a Jeffrey Modell Foundation Translational Research Program Grant award (J.C.) and a Manton Center Pilot Award (J.C.). Microarray genotyping and Sanger DNA sequencing were performed in the Molecular Genetics Core Facility at Boston Children's Hospital, supported by US NIH grant P30-HD18655 through the Intellectual and Developmental Disabilities Research Center and US NIH grant P50-NS40828 through the Neuromuscular Disease Project. We acknowledge the US NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of the mouse CD1d tetramers.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Arezes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079870; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; Crotzer VL, 2004, J EXP MED, V199, P981, DOI 10.1084/jem.20031105; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Jabara HH, 2001, J CLIN INVEST, V107, P371, DOI 10.1172/JCI10168; JABARA HH, 1990, J IMMUNOL, V145, P3468; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; NECKERS LM, 1983, P NATL ACAD SCI-BIOL, V80, P3494, DOI 10.1073/pnas.80.11.3494; Ned RM, 2003, BLOOD, V102, P3711, DOI 10.1182/blood-2003-04-1086; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pinto JP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00024; Roebroek AJM, 2011, METHODS MOL BIOL, V693, P257, DOI 10.1007/978-1-60761-974-1_15; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366	24	130	133	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					74	+		10.1038/ng.3465	http://dx.doi.org/10.1038/ng.3465			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26642240	Green Submitted, Green Accepted			2022-12-17	WOS:000367255300016
J	Cybulski, C; Carrot-Zhang, F; Kluzniak, W; Rivera, B; Kashyap, A; Wokolorczyk, D; Giroux, S; Nadaf, J; Hamel, N; Zhang, SY; Huzarski, T; Gronwald, J; Byrski, T; Szwiec, M; Jakubowska, A; Rudnicka, H; Lener, M; Masojc, B; Tonin, PN; Rousseau, F; Gorski, B; Debniak, T; Majewski, J; Lubinski, J; Foulkes, WD; Narod, SA; Akbari, MR				Cybulski, Cezary; Carrot-Zhang, Flan; Kluzniak, Wojciech; Rivera, Barbara; Kashyap, Aniruddh; Wokolorczyk, Dominika; Giroux, Sylvie; Nadaf, Javad; Hamel, Nancy; Zhang, Shiyu; Huzarski, Tomasz; Gronwald, Jacek; Byrski, Tomasz; Szwiec, Marek; Jakubowska, Anna; Rudnicka, Helena; Lener, Marcin; Masojc, Bartiomiej; Tonin, Patrica N.; Rousseau, Francois; Gorski, Bohdan; Debniak, Tadeusz; Majewski, Jacek; Lubinski, Jan; Foulkes, William D.; Narod, Steven A.; Akbari, Mohammad R.			Germline RECQL mutations are associated with breast cancer susceptibility	NATURE GENETICS			English	Article							GENE; HELICASE; PROTEIN; CLONING; BRCA1; IDENTIFICATION; PALB2	Several moderate- and high-risk breast cancer susceptibility genes have been discovered, but more are likely to exist. To discover new breast cancer susceptibility genes, we used 2 populations (from Poland and Quebec, Canada) and applied whole-exome sequencing in a discovery phase (n = 195), followed by validation. We identified rare recurrent RECQL mutations in each population. In Quebec, 7 of 1,013 higher-risk breast cancer cases and 1 of 7,136 newborns carried the c.634C>T (p.Arg215*) variant (P = 0.00004). In Poland, 30 of 13,136 unselected breast cancer cases and 2 of 4,702 controls carried the c.1667_1667+3delAGTA (p.K555delinsMYKLIHYSFR) variant (P = 0.008). RECQL is implicated in resolving stalled DNA replication forks to prevent double-stranded DNA (dsDNA) breaks. This function is related to that of other known breast cancer susceptibility genes, many of which are involved in repairing dsDNA breaks. We conclude that RECQL is a breast cancer susceptibility gene.	[Cybulski, Cezary; Kluzniak, Wojciech; Kashyap, Aniruddh; Wokolorczyk, Dominika; Huzarski, Tomasz; Gronwald, Jacek; Byrski, Tomasz; Jakubowska, Anna; Rudnicka, Helena; Lener, Marcin; Masojc, Bartiomiej; Gorski, Bohdan; Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Carrot-Zhang, Flan; Rivera, Barbara; Nadaf, Javad; Hamel, Nancy; Tonin, Patrica N.; Majewski, Jacek; Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Carrot-Zhang, Flan; Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Carrot-Zhang, Flan; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Rivera, Barbara; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Dept Med Genet, Montreal, PQ H3T 1E2, Canada; [Giroux, Sylvie; Rousseau, Francois] Ctr Hosp Univ Quebec, Ctr Rech, Unite Rech Genet Humaine & Mol, Axe Sante Populat & Prat Optim Sante, Quebec City, PQ, Canada; [Hamel, Nancy; Tonin, Patrica N.; Foulkes, William D.] McGill Univ, Dept Med Genet, Montreal, PQ, Canada; [Hamel, Nancy; Tonin, Patrica N.; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Zhang, Shiyu; Narod, Steven A.; Akbari, Mohammad R.] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Szwiec, Marek] Adeusz Koszarowski Reg Oncol Ctr, Opole, Poland; [Rousseau, Francois] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada; [Foulkes, William D.] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Narod, Steven A.; Akbari, Mohammad R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Pomeranian Medical University; McGill University; McGill University; Lady Davis Institute; McGill University; Laval University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Laval University; McGill University; University of Toronto	Akbari, MR (corresponding author), Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	mohammad.akban@utoronto.ca	Szwiec, Marek/ABD-8838-2021; BYRSKI, Tomasz/I-2844-2014; Narod, Steven A/AAA-6112-2022; Hamel, Nancy/L-5122-2016; Huzarski, Tomasz/AAQ-2161-2021; Gronwald, Jacek/A-4576-2017; Rivera, Barbara/AAI-8047-2020; Rivera, Barbara/AFM-6892-2022; Kashyap, Aniruddh/AAE-5053-2022; Foulkes, William D./AAR-9586-2021; Pinheiro, Maísa/E-7424-2012; Jakubowska, Anna/O-8050-2014; Carrot-Zhang, Jian/K-8618-2019	BYRSKI, Tomasz/0000-0001-9181-5026; Hamel, Nancy/0000-0001-8971-0428; Huzarski, Tomasz/0000-0003-3857-4854; Gronwald, Jacek/0000-0002-3643-2871; Rivera, Barbara/0000-0001-9434-6288; Rivera, Barbara/0000-0001-9434-6288; Foulkes, William D./0000-0001-7427-4651; Jakubowska, Anna/0000-0002-5650-0501; Kashyap, Aniruddh/0000-0001-7374-7912; Lubinski, Jan/0000-0003-2931-3003	Polish National Science Centre [DEC-2011/03/N/NZ2/01510]; Women's College Research Institute's internal fund; Susan G. Komen; Cancer Research Society/Quebec Breast Cancer Foundation; Fundacion Alfonso Martin Escudero; Cedars Cancer Institute; Canadian Institutes of Health Research (CIHR); Cancer Research Society; Quebec Breast Cancer Foundation; Fonds de Recherche du Quebec-Sante; Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation	Polish National Science Centre; Women's College Research Institute's internal fund; Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Cancer Research Society/Quebec Breast Cancer Foundation; Fundacion Alfonso Martin Escudero; Cedars Cancer Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Quebec Breast Cancer Foundation; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This paper is dedicated to the memory of Parviz Ghadirian. The whole-exome sequencing and part of the Sanger sequencing for these projects were carried out by the McGill University and Genome Quebec Innovation Centre. The study was funded in part by the Polish National Science Centre on the basis of decision number DEC-2011/03/N/NZ2/01510 and by the Women's College Research Institute's internal fund. W.D.F. was funded by Susan G. Komen and the Cancer Research Society/Quebec Breast Cancer Foundation. B.R. was funded by Fundacion Alfonso Martin Escudero and a fellowship from the Cedars Cancer Institute. J.C.-Z. was funded by the Canadian Institutes of Health Research (CIHR). P.N.T. was funded by the Cancer Research Society, the Quebec Breast Cancer Foundation and the Fonds de Recherche du Quebec-Sante. M.R.A. is funded by the Canadian Cancer Society Research Institute and the Canadian Breast Cancer Foundation.	Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Cybulski C, 2015, CLIN GENET, V88, P366, DOI 10.1111/cge.12524; Cybulski C, 2007, BREAST CANCER RES TR, V102, P119, DOI 10.1007/s10549-006-9320-y; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Futami K, 2008, CANCER SCI, V99, P71, DOI 10.1111/j.1349-7006.2007.00647.x; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Grepmeier U, 2005, INT J ONCOL, V27, P481; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Parvathaneni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062481; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Popuri V, 2014, NUCLEIC ACIDS RES, V42, P5671, DOI 10.1093/nar/gku200; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Steffen J, 2006, INT J CANCER, V119, P472, DOI 10.1002/ijc.21853; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	29	130	136	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					643	646		10.1038/ng.3284	http://dx.doi.org/10.1038/ng.3284			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25915596				2022-12-17	WOS:000355386500016
J	Isidor, B; Lindenbaum, P; Pichon, O; Bezieau, S; Dina, C; Jacquemont, S; Martin-Coignard, D; Thauvin-Robinet, C; Le Merrer, M; Mandel, JL; David, A; Faivre, L; Cormier-Daire, V; Redon, R; Le Caignec, C				Isidor, Bertrand; Lindenbaum, Pierre; Pichon, Olivier; Bezieau, Stephane; Dina, Christian; Jacquemont, Sebastien; Martin-Coignard, Dominique; Thauvin-Robinet, Christel; Le Merrer, Martine; Mandel, Jean-Louis; David, Albert; Faivre, Laurence; Cormier-Daire, Valerie; Redon, Richard; Le Caignec, Cedric			Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis	NATURE GENETICS			English	Article							ALAGILLE-SYNDROME; OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAY	Hajdu-Cheney syndrome is a rare autosomal dominant skeletal disorder with facial anomalies, osteoporosis and acro-osteolysis. We sequenced the exomes of six unrelated individuals with this syndrome and identified heterozygous nonsense and frameshift mutations in NOTCH2 in five of them. All mutations cluster to the last coding exon of the gene, suggesting that the mutant mRNA products escape nonsense-mediated decay and that the resulting truncated NOTCH2 proteins act in a gain-of-function manner.	[Isidor, Bertrand; Lindenbaum, Pierre; Pichon, Olivier; Bezieau, Stephane; David, Albert; Redon, Richard; Le Caignec, Cedric] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Lindenbaum, Pierre; Dina, Christian; Redon, Richard; Le Caignec, Cedric] INSERM, Inst Thorax, UMR915, Nantes, France; [Lindenbaum, Pierre; Bezieau, Stephane; Dina, Christian; Redon, Richard; Le Caignec, Cedric] Univ Nantes, Nantes, France; [Dina, Christian; Le Caignec, Cedric] CNRS, ERL3147, Nantes, France; [Jacquemont, Sebastien] CHUV, Serv Genet Med, Lausanne, Switzerland; [Martin-Coignard, Dominique] Ctr Hosp Mans, Unit Genet Clin, Le Mans, France; [Thauvin-Robinet, Christel; Faivre, Laurence] CHU, Ctr Genet, Ctr Reference Malad Rares Anomalies Dev & Syndrom, Est Hop Enfants, Dijon, France; [Thauvin-Robinet, Christel; Faivre, Laurence] Univ Bourgogne, Dijon, France; [Le Merrer, Martine; Cormier-Daire, Valerie] INSERM, U781, Paris, France; [Le Merrer, Martine; Cormier-Daire, Valerie] Hop Necker Enfants Malad, Dept Genet, Paris, France; [Le Merrer, Martine; Cormier-Daire, Valerie] Univ Paris 05, Paris, France; [Mandel, Jean-Louis] Coll France, IGBMC, Translat Med & Neurogenet Program, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] INSERM, U964, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] CNRS, UMR 7104, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] Univ Strasbourg, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] CHU Strasbourg, F-67000 Strasbourg, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre Hospitalier Le Mans; CHU Dijon Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Le Caignec, C (corresponding author), CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France.	cedric.lecaignec@chu-nantes.fr	Lindenbaum, Pierre/A-7154-2008; Jacquemont, Sebastien/AAS-5060-2021; Isidor, Bertrand/L-2435-2015; Le Caignec, Cedric/K-8467-2015; Isidor, Bertrand/AAJ-3456-2021; Redon, Richard/F-3303-2014; Dina, Christian R/D-3535-2015; Bézieau, stéphane/G-5621-2015; Mandel, Jean Louis/Q-2668-2016; cormier-daire, valerie/H-6520-2017	Lindenbaum, Pierre/0000-0003-0148-9787; Jacquemont, Sebastien/0000-0001-6838-8767; Isidor, Bertrand/0000-0001-6480-126X; Le Caignec, Cedric/0000-0002-0598-653X; Isidor, Bertrand/0000-0001-6480-126X; Redon, Richard/0000-0001-7751-2280; Dina, Christian R/0000-0002-7722-7348; Bézieau, stéphane/0000-0003-0095-1319; Faivre, Laurence/0000-0001-9770-444X; Mandel, Jean Louis/0000-0002-0535-6589; cormier-daire, valerie/0000-0002-2839-9856	Inserm; Fondation pour la Recherche Medicale; Federation Francaise de Cardiologie; Region Pays-de-la-Loire; Direction Hospitaliere de l'Organisation des Soins (DHOS); bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation Francaise de Cardiologie; Region Pays-de-la-Loire(Region Pays de la Loire); Direction Hospitaliere de l'Organisation des Soins (DHOS); bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne	We are grateful to the affected subjects and their families who participated in this study. We thank F. Gros, H. Eldjouzi, A. Briand, C. Beneteau and S. Lecointe for technical assistance, and R. Houlgatte and C. Chevalier from Biogenouest de Nantes. This research was funded by grants from Inserm, Fondation pour la Recherche Medicale, Federation Francaise de Cardiologie and Region Pays-de-la-Loire. P.L. is supported by the Direction Hospitaliere de l'Organisation des Soins (DHOS). S.J. is funded by the "bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne."	Bales CB, 2010, J PEDIATR GASTR NUTR, V51, P66, DOI 10.1097/MPG.0b013e3181cb9629; Brennan AM, 2001, AM J MED GENET, V100, P292, DOI 10.1002/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McCright B, 2001, DEVELOPMENT, V128, P491; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140	15	130	139	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					306	308		10.1038/ng.778	http://dx.doi.org/10.1038/ng.778			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21378989				2022-12-17	WOS:000288903700008
J	Sanna, S; Pitzalis, M; Zoledziewska, M; Zara, I; Sidore, C; Murru, R; Whalen, MB; Busonero, F; Maschio, A; Costa, G; Melis, MC; Deidda, F; Poddie, F; Morelli, L; Farina, G; Li, Y; Dei, M; Lai, S; Mulas, A; Cuccuru, G; Porcu, E; Liang, LM; Zavattari, P; Moi, L; Deriu, E; Urru, MF; Bajorek, M; Satta, MA; Cocco, E; Ferrigno, P; Sotgiu, S; Pugliatti, M; Traccis, S; Angius, A; Melis, M; Rosati, G; Abecasis, GR; Uda, M; Marrosu, MG; Schlessinger, D; Cucca, F				Sanna, Serena; Pitzalis, Maristella; Zoledziewska, Magdalena; Zara, Ilenia; Sidore, Carlo; Murru, Raffaele; Whalen, Michael B.; Busonero, Fabio; Maschio, Andrea; Costa, Gianna; Melis, Maria Cristina; Deidda, Francesca; Poddie, Fausto; Morelli, Laura; Farina, Gabriele; Li, Yun; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Cuccuru, Gianmauro; Porcu, Eleonora; Liang, Liming; Zavattari, Patrizia; Moi, Loredana; Deriu, Elisa; Urru, M. Francesca; Bajorek, Michele; Satta, Maria Anna; Cocco, Eleonora; Ferrigno, Paola; Sotgiu, Stefano; Pugliatti, Maura; Traccis, Sebastiano; Angius, Andrea; Melis, Maurizio; Rosati, Giulio; Abecasis, Goncalo R.; Uda, Manuela; Marrosu, Maria Giovanna; Schlessinger, David; Cucca, Francesco			Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis	NATURE GENETICS			English	Article							CELL ANERGY INDUCTION; SUSCEPTIBILITY LOCI; NEGATIVE REGULATION; ACTIVATION	A genome-wide association scan of similar to 6.6 million genotyped or imputed variants in 882 Sardinian individuals with multiple sclerosis (cases) and 872 controls suggested association of CBLB gene variants with disease, which was confirmed in 1,775 cases and 2,005 controls (rs9657904, overall P = 1.60 x 10(-10), OR = 1.40). CBLB encodes a negative regulator of adaptive immune responses, and mice lacking the ortholog are prone to experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis.	[Sanna, Serena; Sidore, Carlo; Busonero, Fabio; Maschio, Andrea; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Cuccuru, Gianmauro; Porcu, Eleonora; Uda, Manuela; Cucca, Francesco] CNR, Ist Neurogenet & Neurofarmacol, Monserrato, Italy; [Pitzalis, Maristella; Zoledziewska, Magdalena; Deidda, Francesca; Poddie, Fausto; Morelli, Laura; Deriu, Elisa; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Zara, Ilenia] Ctr Adv Studies Res & Dev Sardinia CRS4, Lab Bioinformat, Pula, Italy; [Sidore, Carlo; Whalen, Michael B.; Urru, M. Francesca; Angius, Andrea] CRS4, Lab Genom, Pula, Italy; [Murru, Raffaele; Costa, Gianna; Melis, Maria Cristina; Moi, Loredana; Cocco, Eleonora; Marrosu, Maria Giovanna] Univ Cagliari, Dipartimento Sci Neurol & Cardiovasc, Ctr Sclerosi Multipla, Cagliari, Italy; [Farina, Gabriele; Sotgiu, Stefano; Pugliatti, Maura; Rosati, Giulio] Univ Sassari, Ist Clin Neurol, I-07100 Sassari, Italy; [Li, Yun; Liang, Liming; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Zavattari, Patrizia] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, Cagliari, Italy; [Bajorek, Michele] Azienda Osped Brotzu, Ctr Trasfusionale, Cagliari, Italy; [Satta, Maria Anna] Azienda Sanit Locale 1, Sassari, Italy; [Ferrigno, Paola; Melis, Maurizio] Azienda Osped Brotzu, Div Neurol, Cagliari, Italy; [Traccis, Sebastiano] Presidio Osped, Div Neurol, Ozieri, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); University of Sassari; University of Cagliari; University of Sassari; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cucca, F (corresponding author), CNR, Ist Neurogenet & Neurofarmacol, Monserrato, Italy.	francesco.cucca@inn.cnr.it	Angius, Andrea/B-8966-2015; Mulas, Antonella/B-4231-2015; Sidore, Carlo/AAV-7967-2020; Lai, Sandra/AAY-4176-2020; Uda, Manuela/AAC-2645-2019; Angius, Andrea/P-9549-2015; Cocco, Eleonora/G-5064-2012; Abecasis, Goncalo R/B-7840-2010; sotgiu, stefano/M-1011-2017; Maschio, Andrea/AAX-8185-2020; Deidda, Francesca/P-1541-2018; Dei, Mariano/AAY-3870-2020; Pugliatti, Maura/K-4071-2016; sanna, serena/H-3009-2019	Sidore, Carlo/0000-0001-7504-7477; Uda, Manuela/0000-0002-4890-6456; Angius, Andrea/0000-0003-2596-6461; Cocco, Eleonora/0000-0002-3878-8820; Deidda, Francesca/0000-0003-3447-7440; Pugliatti, Maura/0000-0001-9396-8683; sanna, serena/0000-0002-3768-1749; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; LAI, SANDRA/0000-0003-4198-9989; Pitzalis, Maristella/0000-0003-4975-6987; Marrosu, Maria Giovanna/0000-0003-2334-2081; maschio, andrea/0000-0002-4238-9144; Abecasis, Goncalo/0000-0003-1509-1825; Zoledziewska, Magdalena/0000-0002-3033-6133; Angius, Andrea/0000-0001-9372-1162; Poddie, Fausto PierAngelo/0000-0003-2893-9549; Mulas, Antonella/0000-0002-6856-1483; cuccuru, gianmauro/0000-0002-5335-545X; Dei, Mariano/0000-0002-7404-508X; MURRU, RAFFAELE/0000-0001-8830-5084; CUCCA, Francesco/0000-0002-7414-1995	Fondazione Italiana Sclerosi Multipla (FISM) [Cod. 2008/R/7]; Italian Ministry of Scientific Research (MIUR) [2007KXNKNP]; US National Institutes of Health [NO1-AG-1-2109]; National Institute of Aging (NIA); NIH [HG002651, HG005214, MH084698]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005214, R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Fondazione Italiana Sclerosi Multipla (FISM) Cod. 2008/R/7 to F.C., by the Italian Ministry of Scientific Research (MIUR grant 2007KXNKNP) and by US National Institutes of Health contract NO1-AG-1-2109 from National Institute of Aging (NIA) to the SardiNIA ('ProgeNIA') team. The contributions of G.R.A., Y.L. and L.L. were supported in part by NIH grants HG002651, HG005214 and MH084698.	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Loeser S, 2007, SEMIN IMMUNOL, V19, P206, DOI 10.1016/j.smim.2007.02.004; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Qiao GL, 2007, J IMMUNOL, V179, P4473, DOI 10.4049/jimmunol.179.7.4473; Schmitz ML, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.276pe38; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	14	130	133	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					495	497		10.1038/ng.584	http://dx.doi.org/10.1038/ng.584			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20453840	Green Submitted, Green Accepted			2022-12-17	WOS:000278081500013
J	Morison, IM; Cramer Borde, EM; Cheesman, EJ; Cheong, PL; Holyoake, AJ; Fichelson, S; Weeks, RJ; Lo, A; Davies, SMK; Wilbanks, SM; Fagerlund, RD; Ludgate, MW; Tatley, FMDS; Coker, MSA; Bockett, NA; Hughes, G; Pippig, DA; Smith, MP; Capron, C; Ledgerwood, EC				Morison, Ian M.; Cramer Borde, Elisabeth M.; Cheesman, Emma J.; Cheong, Pak Leng; Holyoake, Andrew J.; Fichelson, Serge; Weeks, Robert J.; Lo, Alexandra; Davies, Stefan M. K.; Wilbanks, Sigurd M.; Fagerlund, Robert D.; Ludgate, Mathew W.; Tatley, Fernanda M. da Silva; Coker, Melanie S. A.; Bockett, Nicholas A.; Hughes, Gillian; Pippig, Diana A.; Smith, Mark P.; Capron, Claude; Ledgerwood, Elizabeth C.			A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia	NATURE GENETICS			English	Article							PLATELET FORMATION; BONE-MARROW; MEGAKARYOCYTES; ACTIVATION	We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.	[Morison, Ian M.; Cheesman, Emma J.; Cheong, Pak Leng; Weeks, Robert J.; Lo, Alexandra; Davies, Stefan M. K.; Wilbanks, Sigurd M.; Fagerlund, Robert D.; Ludgate, Mathew W.; Tatley, Fernanda M. da Silva; Coker, Melanie S. A.; Bockett, Nicholas A.; Hughes, Gillian; Pippig, Diana A.; Ledgerwood, Elizabeth C.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Cramer Borde, Elisabeth M.; Capron, Claude] Univ Versailles, Fac Med Paris Ilede France Ouest, St Quentin en Yvelines, France; [Cramer Borde, Elisabeth M.; Fichelson, Serge; Capron, Claude] INSERM, Inst Cochin, U567, F-75014 Paris, France; [Holyoake, Andrew J.] Pacific Edge Biotechnol Ltd, Dunedin 9054, New Zealand; [Fichelson, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104,INSERM U567, Paris, France; [Smith, Mark P.] Caanterbury District Hlth Board, Christchurch 8140, New Zealand	University of Otago; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Morison, IM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.	ian.morison@otago.ac.nz	Ledgerwood, Elizabeth/M-3939-2018; Weeks, Robert J/A-6876-2012; Capron, Claude/AAJ-2710-2021; Morison, Ian M/A-1236-2008; Cheong, Pak Leng/D-3603-2013; Holyoake, Andrew/H-9570-2013	Ledgerwood, Elizabeth/0000-0002-4956-6043; Weeks, Robert J/0000-0003-0474-9089; Morison, Ian M/0000-0003-3616-0025; Cheong, Pak Leng/0000-0002-0095-4459; Bockett, Nicholas/0000-0002-7630-7637; Cramer Borde, Elisabeth/0000-0001-7595-0885; Wilbanks, Sigurd/0000-0001-7565-8913; Fagerlund, Robert/0000-0002-3939-1489				Banci L, 1999, J BIOL INORG CHEM, V4, P824, DOI 10.1007/s007750050356; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Cooper C. E., 1995, BIOENERGETICS PRACTI, P85; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sharonov GV, 2005, APOPTOSIS, V10, P797, DOI 10.1007/s10495-005-0366-9; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200	15	130	133	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					387	389		10.1038/ng.103	http://dx.doi.org/10.1038/ng.103			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18345000				2022-12-17	WOS:000254388100006
J	Tarpey, P; Thomas, S; Sarvananthan, N; Mallya, U; Lisgo, S; Talbot, CJ; Roberts, EO; Awan, M; Surendran, M; McLean, RJ; Reinecke, RD; Langmann, A; Lindner, S; Koch, M; Jain, S; Woodruff, G; Gale, RP; Degg, C; Droutsas, K; Asproudis, I; Zubcov, AA; Pieh, C; Veal, CD; Machado, RD; Backhouse, OC; Baumber, L; Constantinescu, CS; Brodsky, MC; Hunter, DG; Hertle, RW; Read, RJ; Edkins, S; O'Meara, S; Parker, A; Stevens, C; Teague, J; Wooster, R; Futreal, PA; Trembath, RC; Stratton, MR; Raymond, FL; Gottlob, I				Tarpey, Patrick; Thomas, Shery; Sarvananthan, Nagini; Mallya, Uma; Lisgo, Steven; Talbot, Chris J.; Roberts, Eryl O.; Awan, Musarat; Surendran, Mylvaganam; McLean, Rebecca J.; Reinecke, Robert D.; Langmann, Andrea; Lindner, Susanne; Koch, Martina; Jain, Sunila; Woodruff, Geoffrey; Gale, Richard P.; Degg, Chris; Droutsas, Konstantinos; Asproudis, Ioannis; Zubcov, Alina A.; Pieh, Christina; Veal, Colin D.; Machado, Rajiv D.; Backhouse, Oliver C.; Baumber, Laura; Constantinescu, Cris S.; Brodsky, Michael C.; Hunter, David G.; Hertle, Richard W.; Read, Randy J.; Edkins, Sarah; O'Meara, Sarah; Parker, Adrian; Stevens, Claire; Teague, Jon; Wooster, Richard; Futreal, P. Andrew; Trembath, Richard C.; Stratton, Michael R.; Raymond, F. Lucy; Gottlob, Irene			Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus	NATURE GENETICS			English	Article							MOTOR NYSTAGMUS; MODEL; GENE	Idiopathic congenital nystagmus is characterized by involuntary, periodic, predominantly horizontal oscillations of both eyes. We identified 22 mutations in FRMD7 in 26 families with X-linked idiopathic congenital nystagmus. Screening of 42 singleton cases of idiopathic congenital nystagmus (28 male, 14 females) yielded three mutations (7%). We found restricted expression of FRMD7 in human embryonic brain and developing neural retina, suggesting a specific role in the control of eye movement and gaze stability.	Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Leicester, Sch Med, Ophthalmol Grp, Leicester LE2 7LX, Leics, England; Univ Newcastle Upon Tyne, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Wills Eye Hosp & Res Inst, Foerderer Eye Movement Ctr Children, Philadelphia, PA 19107 USA; Med Univ Graz, Dept Ophthalmol, A-8036 Graz, Austria; Royal Preston Hosp, Preston PR2 9HT, Lancs, England; Leeds Gen Infirm, Dept Ophthalmol, Leeds LS2 9NS, W Yorkshire, England; Univ Hosp Leicester, Dept Med Phys, Leicester LE1 5WW, Leics, England; Univ Giessen, Dept Ophthalmol, D-35392 Giessen, Germany; Univ Hosp Ioannina, Fac Med, Dept Ophthalmol, GR-45110 Ioannina, Greece; Univ Frankfurt, Hosp Eye, D-60590 Frankfurt, Germany; Univ Freiburg, Dept Ophthalmol, Freiburg, Germany; Kings Coll London, Div Med & Mol Genet, London SE1 9RT, England; Univ Nottingham, Sch Med & Surg Sci, Div Clin Neurol, Nottingham NG7 2UH, England; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72202 USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Paediat Ophthalmol, Pittsburgh, PA 15213 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Leicester; Newcastle University - UK; University of Leicester; Jefferson University; Medical University of Graz; Royal Preston Hospital; Leeds General Infirmary; University of Leeds; University Hospitals of Leicester NHS Trust; University of Leicester; Justus Liebig University Giessen; University Hospital Ioannina; Goethe University Frankfurt; University of Freiburg; University of London; King's College London; University of Nottingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Harvard University; Boston Children's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Read, RJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	flr24@cam.ac.uk; ig15@leicester.ac.uk	Southgate, Laura/H-7924-2019; Machado, Rajiv D./AAD-7813-2019; Read, Randy J/L-1418-2013	Southgate, Laura/0000-0002-2090-1450; Machado, Rajiv D./0000-0001-9247-0744; Read, Randy J/0000-0001-8273-0047; Lisgo, Steven/0000-0001-5186-3971; Talbot, Christopher/0000-0001-7406-8962; Veal, Colin/0000-0002-9840-2512; Constantinescu, Cris/0000-0003-2066-7585; Thomas, Shery/0000-0002-4722-9182; Trembath, Richard/0000-0003-0550-3400; Hunter, David/0000-0002-4587-4794	Medical Research Council [G9900837, G9826762] Funding Source: Medline; Wellcome Trust [050211] Funding Source: Medline; MRC [G9900837, G9826762] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Cabot A, 1999, AM J HUM GENET, V64, P1141, DOI 10.1086/302324; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlob I, 2001, CURR OPIN OPHTHALMOL, V12, P378, DOI 10.1097/00055735-200110000-00010; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Jacobs JB, 2004, J VISION, V4, P604, DOI 10.1167/4.7.7; Kerrison J B, 2001, Ophthalmic Genet, V22, P241, DOI 10.1076/opge.22.4.241.2216; Kerrison JB, 1999, AM J HUM GENET, V64, P600, DOI 10.1086/302244; Kubo T, 2002, J NEUROSCI, V22, P8504; Pilling RF, 2005, BRIT J OPHTHALMOL, V89, P1278, DOI 10.1136/bjo.2005.070045; STAYTE M, 1993, BRIT J OPHTHALMOL, V77, P228, DOI 10.1136/bjo.77.4.228; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Zhang BR, 2005, HUM GENET, V116, P128, DOI 10.1007/s00439-004-1188-5	14	130	145	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1242	1244		10.1038/ng1893	http://dx.doi.org/10.1038/ng1893			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013395	Green Accepted, Green Published			2022-12-17	WOS:000241592700010
J	Fraser, HB				Fraser, HB			Modularity and evolutionary constraint on proteins	NATURE GENETICS			English	Article							COEVOLUTION; EXPRESSION	Modularity, which has been found in the functional and physical protein interaction networks of many organisms, has been postulated to affect both the mode and tempo of evolution. Here I show that in the yeast Saccharomyces cerevisiae, protein interaction hubs situated in single modules are highly constrained, whereas those connecting different modules are more plastic. This pattern of change could reflect a tendency for evolutionary innovations to occur by altering the proteins and interactions between rather than within modules, in a manner somewhat similar to the evolution of new proteins through the shuffling of conserved protein domains.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fraser, HB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	hunter@ocf.berkeley.edu						DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Fisher R., 1930, GENETICAL THEORY NAT; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Needham J, 1933, BIOL REV BIOL P CAMB, V8, P180, DOI 10.1111/j.1469-185X.1933.tb01153.x; Schlosser G, 2002, THEOR BIOSCI, V121, P1, DOI 10.1078/1431-7613-00049; Schlosser G., 2004, MODULARITY DEV EVOLU; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waxman D, 1998, SCIENCE, V279, P1210, DOI 10.1126/science.279.5354.1210	15	130	136	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					351	352		10.1038/ng1530	http://dx.doi.org/10.1038/ng1530			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15750592				2022-12-17	WOS:000228040000016
J	Tate, SK; Goldstein, DB				Tate, SK; Goldstein, DB			Will tomorrow's medicines work for everyone?	NATURE GENETICS			English	Review							BLOOD-PRESSURE RESPONSE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONVERTING-ENZYME-INHIBITOR; CELL LUNG-CANCER; HLA-B REGION; RACIAL-DIFFERENCES; ETHNIC-DIFFERENCES; ANTIHYPERTENSIVE RESPONSE; MULTIDRUG-RESISTANCE; ENDOTHELIAL FUNCTION	Throughout much of the world, 'race' and 'ethnicity' are key determinants of health. For example, African Americans have, by some estimates, a twofold higher incidence of fatal heart attacks and a 10% higher incidence of cancer(1,2) than European Americans, and South Asian- or Caribbean-born British are similar to3.5 times as likely to die as a direct result of diabetes than are British of European ancestry(3). The health care that people receive also depends on 'race' and 'ethnicity'. African Americans are less likely to receive cancer-screening services and more likely to have late-stage cancer when diagnosed(2) than European Americans. Health disparities such as these are one of the greatest social injustices in the developed world and one of the most important scientific and political challenges.	UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Goldstein, DB (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020					*AG HEALTHC RES QU, NAT HEALTHC DISP REP; Aviv A, 1996, Ethn Health, V1, P275; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065; Blann A, 1999, BRIT J HAEMATOL, V107, P207, DOI 10.1046/j.1365-2141.1999.01672.x; Blann A, 2004, J THROMB HAEMOST, V2, P525, DOI 10.1111/j.1538-7933.2003.00620.x; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cardillo C, 1999, CIRCULATION, V99, P90, DOI 10.1161/01.CIR.99.1.90; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Cepeda MS, 2001, CLIN PHARMACOL THER, V70, P351, DOI 10.1016/S0009-9236(01)45600-1; Chapman AB, 2002, KIDNEY INT, V61, P1047, DOI 10.1046/j.1523-1755.2002.00200.x; CHUNG H, 1995, PSYCHIATR SERV, V46, P586; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Collazo Y, 1996, MT SINAI J MED, V63, P310; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cooper RS, 2001, INT J EPIDEMIOL, V30, pS48, DOI 10.1093/ije/30.suppl_1.S48; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CUBEDDU LX, 1986, JAMA-J AM MED ASSOC, V256, P2214, DOI 10.1001/jama.256.16.2214; Cushman WC, 2000, ARCH INTERN MED, V160, P825, DOI 10.1001/archinte.160.6.825; Danoff TM, 2004, PHARMACOGENOMICS J, V4, P49, DOI 10.1038/sj.tpj.6500221; De Maria N, 2002, HEPATO-GASTROENTEROL, V49, P788; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Evelyn B, 2001, J NATL MED ASSOC, V93, p18S; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Ferdinand KC, 2003, AM J HYPERTENS, V16, p50S, DOI 10.1016/S0895-7061(03)01069-0; *FOOD DRUG ADM, 2004, GUID IND PHARM DAT S; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; FREIS ED, 1983, AM J CARDIOL, V52, P1230; FRIEDMAN B, 1983, AM J CARDIOL, V52, pD43, DOI 10.1016/0002-9149(83)90641-0; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; Hassaballa H, 2001, NEUROLOGY, V57, P691, DOI 10.1212/WNL.57.4.691; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Holtzman NA, 2003, PHARMACOGENOMICS: SOCIAL, ETHICAL, AND CLINICAL DIMENSIONS, P163, DOI 10.1002/047142613X.ch9; Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; JANN MW, 1989, PSYCHIAT RES, V30, P45, DOI 10.1016/0165-1781(89)90170-4; Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7; JOHNSON JA, 1995, J CARDIOVASC PHARM, V25, P90, DOI 10.1097/00005344-199501000-00015; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; Kimball P, 2001, J MED VIROL, V65, P510, DOI 10.1002/jmv.2065; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LANG CC, 1995, NEW ENGL J MED, V333, P155, DOI 10.1056/NEJM199507203330304; Lang CC, 1997, HYPERTENSION, V30, P157, DOI 10.1161/01.HYP.30.2.157; Li RL, 2004, AM J HYPERTENS, V17, P560, DOI 10.1016/j.amjhyper.2004.02.013; LIN KM, 1989, AM J PSYCHIAT, V146, P1307; Lindpaintner K, 2003, J MOL MED-JMM, V81, P141, DOI 10.1007/s00109-002-0416-5; Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1016/S0009-9236(03)00224-8; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; *LOND HLTH OSB, 2004, ETHN DISP HLTH HLTH; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Matsuda KT, 1996, PSYCHOPHARMACOL BULL, V32, P253; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; McLeod HL, 2002, PHARMACOGENOMICS, V3, P89, DOI 10.1517/14622416.3.1.89; Millward MJ, 2003, ANN ONCOL, V14, P449, DOI 10.1093/annonc/mdg118; Mokwe E, 2004, HYPERTENSION, V43, P1202, DOI 10.1161/01.HYP.0000127924.67353.86; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Netland PA, 2003, ADV THER, V20, P149, DOI 10.1007/BF02850202; Oselin K, 2003, FUND CLIN PHARMACOL, V17, P463, DOI 10.1046/j.1472-8206.2003.00163.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Robertson JA, 2003, PHARMACOGENOMICS: SOCIAL, ETHICAL, AND CLINICAL DIMENSIONS, P291, DOI 10.1002/047142613X.ch15; Rosenbaum DA, 2002, ARTERIOSCL THROM VAS, V22, P1023, DOI 10.1161/01.ATV.0000017704.45007.1D; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 2002, NAT REV DRUG DISCOV, V1, P541, DOI 10.1038/nrd840; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; SAUNDERS E, 1991, PRIMARY CARE, V18, P607; Schmith VD, 2003, CELL MOL LIFE SCI, V60, P1636, DOI 10.1007/s00018-003-2369-4; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Segal SP, 1996, PSYCHIAT SERV, V47, P282; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sofowora GG, 2003, CLIN PHARMACOL THER, V73, P366, DOI 10.1016/S0009-9236(02)17734-4; Stein CM, 1997, CLIN PHARMACOL THER, V62, P436, DOI 10.1016/S0009-9236(97)90122-3; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; STRAKOWSKI SM, 1993, J CLIN PSYCHIAT, V54, P96; Takahashi H, 2003, CLIN PHARMACOL THER, V73, P253, DOI 10.1067/mcp.2003.26a; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; TORNATORE KM, 1995, TRANSPLANTATION, V59, P729, DOI 10.1097/00007890-199503150-00016; Walkup JT, 2000, J CLIN PSYCHIAT, V61, P344, DOI 10.4088/JCP.v61n0504; WATKINS LL, 1995, LIFE SCI, V57, P1411, DOI 10.1016/0024-3205(95)02103-P; WEIR MR, 1995, HYPERTENSION, V26, P124, DOI 10.1161/01.HYP.26.1.124; Weir MR, 1998, AM J HYPERTENS, V11, P914, DOI 10.1016/S0895-7061(98)00087-9; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xie HG, 2001, PHARMACOGENETICS, V11, P191, DOI 10.1097/00008571-200104000-00002; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Zanchi A, 2003, CURR HYPERTENS REP, V5, P346, DOI 10.1007/s11906-003-0045-6; ZHOU HH, 1993, CLIN PHARMACOL THER, V54, P507, DOI 10.1038/clpt.1993.182	105	130	137	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S34	S42		10.1038/ng1437	http://dx.doi.org/10.1038/ng1437			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508001	Bronze			2022-12-17	WOS:000224854000009
J	Van Raamsdonk, CD; Fitch, KR; Fuchs, H; de Angelis, MH; Barsh, GS				Van Raamsdonk, CD; Fitch, KR; Fuchs, H; de Angelis, MH; Barsh, GS			Effects of G-protein mutations on skin color	NATURE GENETICS			English	Article							ENDOTHELIN RECEPTOR-B; CREST-DERIVED MELANOCYTES; NERVOUS-SYSTEM; GENOME-WIDE; COAT COLOR; MOUSE; MICE; EXPRESSION; KIT; MIGRATION	A new class of dominant dark skin (Dsk) mutations discovered in a screen of similar to30,000 mice is caused by increased dermal melanin. We identified three of four such mutations as hypermorphic alleles of Gnaq and Gna11, which encode widely expressed Galphaq subunits, act in an additive and quantitative manner, and require Ednrb. Interactions between Gq and Kit receptor tyrosine kinase signaling can mediate coordinate or independent control of skin and hair color. Our results provide a mechanism that can explain several aspects of human pigmentary variation and show how polymorphism of essential proteins and signaling pathways can affect a single physiologic system.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; GSF Natl res Ctr Environm & Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany	Stanford University; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Barsh, GS (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	gbarsh@cmgm.stanford.edu	Van Raamsdonk, Catherine D./B-6207-2017; Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012	Van Raamsdonk, Catherine D./0000-0002-4309-3513; Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353	NIGMS NIH HHS [R01 GM068882] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bastiani CA, 2003, GENETICS, V165, P1805; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Dong QH, 1996, J CLIN ENDOCR METAB, V81, P1134, DOI 10.1210/jc.81.3.1134; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hou L, 2004, DEVELOPMENT, V131, P3239, DOI 10.1242/dev.01193; Hou L, 2000, DEVELOPMENT, V127, P5379; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ivey K, 2003, DEV BIOL, V255, P230, DOI 10.1016/S0012-1606(02)00097-0; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; Kunisada T, 2000, MECH DEVELOP, V94, P67, DOI 10.1016/S0925-4773(00)00308-7; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Opdecamp K, 1998, BIOCHEM CELL BIOL, V76, P1093, DOI 10.1139/bcb-76-6-1093; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Shiroishi T, 2001, Tanpakushitsu Kakusan Koso, V46, P2613; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Wilkie AL, 2002, DEVELOPMENT, V129, P3349; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WILKIE TM, 1994, SOC GEN PHY, V49, P249; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x; Yoshida H, 1996, DEVELOPMENT, V122, P1207; Yoshida R, 2002, ZOOL SCI, V19, P1079, DOI 10.2108/zsj.19.1079; [No title captured]	43	130	134	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					961	968		10.1038/ng1412	http://dx.doi.org/10.1038/ng1412			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322542	Green Accepted, Bronze			2022-12-17	WOS:000223658100022
J	Chae, TH; Kim, S; Marz, KE; Hanson, PI; Walsh, CA				Chae, TH; Kim, S; Marz, KE; Hanson, PI; Walsh, CA			The hyh mutation uncovers roles for alpha Snap in apical protein localization and control of neural cell fate	NATURE GENETICS			English	Article							DROSOPHILA NEUROBLAST; ASYMMETRIC DIVISIONS; COMPLEX; MOUSE; TRAFFICKING; FUSION; GENE; PROLIFERATION; HYDROCEPHALUS; CHROMOSOME-7	The hyh (hydrocephalus with hop gait) mouse shows a markedly small cerebral cortex at birth and dies postnatally from progressive enlargement of the ventricular system(1,2). Here we show that the small hyh cortex reflects altered cell fate. Neural progenitor cells withdraw prematurely from the cell cycle, producing more early-born, deep-layer cerebral cortical neurons but depleting the cortical progenitor pool, such that late-born, upper-layer cortical neurons are underproduced, creating a small cortex. hyh mice carry a hypomorphic missense mutation in the gene Napa encoding solubleN- ethylmaleimide-sensitive factor (NSF) attachment protein alpha (alphaSnap), involved in SNAP receptor (SNARE)- mediated vesicle fusion in many cellular contexts. A targeted null Napa mutation is embryonically lethal. Altered neural cell fate is accompanied by abnormal localization of many apical proteins implicated in regulation of neural cell fate, including E-cadherin, beta-catenin, atypical protein kinase C (aPKC) and INADL(inactivation-no-afterpotential D-like, also known as protein associated with Lin7, or Pals1). Apical localization of the SNARE Vamp7 is also disrupted. Thus, Snap is essential for apical protein localization and cell fate determination in neuroepithelial cells.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL)	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, HIM 816,4 Blackfan Circle, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	Hanson, Phyllis/E-9420-2012	Walsh, Christopher/0000-0002-0156-2238				Bogdanovic A, 2002, BIOCHEM J, V368, P29, DOI 10.1042/BJ20020845; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CAVINESS VS, 1995, BRAIN DEV-JPN, V17, P159, DOI 10.1016/0387-7604(95)00029-B; Chae TH, 2002, MAMM GENOME, V13, P239, DOI 10.1007/s00335-001-2144-5; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Coco S, 1999, J NEUROSCI, V19, P9803; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jimenez AJ, 2001, J NEUROPATH EXP NEUR, V60, P1105, DOI 10.1093/jnen/60.11.1105; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pearlman A L, 1996, Prog Brain Res, V108, P117; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PUSCHEL AW, 1994, FEBS LETT, V347, P55, DOI 10.1016/0014-5793(94)00505-2; REH TA, 1989, J NEUROSCI, V9, P4179; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P375, DOI 10.1073/pnas.91.1.375; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	30	130	132	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					264	270		10.1038/ng1302	http://dx.doi.org/10.1038/ng1302			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14758363	Bronze			2022-12-17	WOS:000189250400015
J	Martin, N; Jaubert, J; Gounon, P; Salido, E; Haase, G; Szatanik, M; Guenet, JL				Martin, N; Jaubert, J; Gounon, P; Salido, E; Haase, G; Szatanik, M; Guenet, JL			A missense mutation in Tbce causes progressive motor neuronopathy in mice	NATURE GENETICS			English	Article							FISSION YEAST; TUBULIN; PROTEINS; DYNAMICS	Mice that are homozygous with respect to the progressive motor neuronopathy (pmn) mutation (chromosome 13) develop a progressive caudio-cranial degeneration of their motor axons from the age of two weeks and die four to six weeks after birth(1). The mutation is fully penetrant, and expressivity does not depend on the genetic background. Based on its pathological features, the pmn mutation has been considered an excellent model for the autosomal recessive proximal childhood form of spinal muscular atrophy (SMA). Previously, we demonstrated that the genes responsible for these disorders were not orthologous(2,3). Here, we identify the pmn mutation as resulting in a Trp524Gly substitution at the last residue of the tubulin-specific chaperone e (Tbce) protein that leads to decreased protein stability. Electron microscopy of the sciatic and phrenic nerves of affected mice showed a reduced number of microtubules, probably due to defective stabilization. Transgenic complementation with a wildtype Tbce cDNA restored a normal phenotype in mutant mice. Our observations indicate that Tbce is critical for the maintenance of microtubules in mouse motor axons, and suggest that altered function of tubulin cofactors might be implicated in human motor neuron diseases.	Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; Inst Pasteur, Stn Cent Microscopie Elect, Paris, France; Hosp Univ Canarias, Unidad Invest, Tenerife, Spain; Univ Mediterranee, INSERM, CNRS, Inst Biol Dev Marseille, Marseille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidad de la Laguna; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Guenet, JL (corresponding author), Inst Pasteur, Unite Genet Mammiferes, 25 Rue Dr Roux, F-75724 Paris, France.		Salido, Eduardo C/I-2232-2015	Salido, Eduardo C/0000-0001-9599-9854				BRUNIALTI ALB, 1995, GENOMICS, V29, P131, DOI 10.1006/geno.1995.1223; Fleming JA, 2000, GENETICS, V156, P69; Grishchuk EL, 1999, J CELL SCI, V112, P1979; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hoyt MA, 1997, GENETICS, V146, P849; Hunter AW, 2000, J CELL SCI, V113, P4379; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Martin N, 2001, GENOMICS, V75, P9, DOI 10.1006/geno.2001.6595; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Viollet L, 1997, GENOMICS, V40, P185, DOI 10.1006/geno.1996.4551	15	130	133	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					443	447		10.1038/ng1016	http://dx.doi.org/10.1038/ng1016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12389029				2022-12-17	WOS:000179034800024
J	Yamauchi, T; Oike, Y; Kamon, J; Waki, H; Komeda, K; Tsuchida, A; Date, Y; Li, MX; Miki, H; Akanuma, Y; Nagai, R; Kimura, S; Saheki, T; Nakazato, M; Naitoh, T; Yamamura, K; Kadowaki, T				Yamauchi, T; Oike, Y; Kamon, J; Waki, H; Komeda, K; Tsuchida, A; Date, Y; Li, MX; Miki, H; Akanuma, Y; Nagai, R; Kimura, S; Saheki, T; Nakazato, M; Naitoh, T; Yamamura, K; Kadowaki, T			Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice	NATURE GENETICS			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; PROTEIN; ACTIVATION; MECHANISMS; RECEPTORS; OBESITY; LACKING; ALPHA	The CBP protein (cAMP response element binding protein (CREB) binding protein)(1) is a co-activator(2) for several transcription factors with a wide range of important biological functions, such as sterol regulatory element binding proteins (SREBPs)(3), CCAAT/enhancer-binding proteins (C/EBPs)(4), nuclear receptors(5,6) (including peroxisome proliferator-activated receptors, PPARS)(7), and signal transducers and activators of transcription (STATs)(8). In contrast to these individual transcription factors, the biological roles of CBP are poorly understood. CBP enhances transcriptional activities via histone acetylation and the recruitment of additional co-activators such as SRC (steroid coactivator)-1 (ref. 9). To identify its physiological functions using a loss-of-function mutant, we analyzed CBP-deficient mice(10-12). As Crebbp null mice (Crebbp(-/-)) died during embryogenesis(10-12), we used Crebbp(+/-) mice(12). Unexpectedly, Crebbp(+/-) mice showed markedly reduced weight of white adipose tissue (WAT) but not of other tissues. Despite this lipodystrophy, Crebbp(+/-) mice showed increased insulin sensitivity and glucose tolerance and were completely protected from body weight gain induced by a high-fat (HF) diet. We observed increased leptin sensitivity and increased serum adiponectin levels in Crebbp(+/-) mice. These increased effects of insulin-sensitizing hormones secreted from WAT may explain, at least in part, the phenotypes of Crebbp(+/-) mice. This study demonstrates that CBP may function as a 'master-switch' between energy storage and expenditure.	Univ Tokyo, Dept Internal Med, Grad Sch Med, Tokyo 1138655, Japan; Kumamoto Univ, Dept Cell Differentiat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Nissan Chem Ind Co Ltd, Biol Res Labs, Saito 3490294, Japan; Tokyo Med & Dent Univ, Div Lab Anim Sci, Anim Res Ctr, Tokyo 1608402, Japan; Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan; Kagoshima Univ, Fac Med, Dept Biochem, Kagoshima 8908520, Japan; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 1000005, Japan; Kumamoto Univ, Dept Dev Genet, Inst Mol Embryol & Genet, Kumamoto 8620976, Japan	University of Tokyo; Kumamoto University; Nissan Chemical Corporation; Tokyo Medical & Dental University (TMDU); University of Miyazaki; Kagoshima University; Asahi Life Foundation; Kumamoto University	Kadowaki, T (corresponding author), Univ Tokyo, Dept Internal Med, Grad Sch Med, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp	Waki, Hironori/AAE-3942-2020	Waki, Hironori/0000-0002-5302-9793				AILAUD G, 1998, HDB OBESITY, P359; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Goodman RH, 2000, GENE DEV, V14, P1553; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; HOUSTEK J, 1988, BIOCHIM BIOPHYS ACTA, V935, P19, DOI 10.1016/0005-2728(88)90103-X; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KIM JB, 1995, MOL CELL BIOL, V15, P2582; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mark M, 1999, P NUTR SOC, V58, P609, DOI 10.1017/S0029665199000798; MCKENNA NJ, 2000, J STEROID BIOCHEM, V74, P255; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Rosen ED, 2000, GENE DEV, V14, P1293; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Westin S, 2000, ADV PHARMACOL, V47, P89; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; YAMAUCHI T, 2001, NAT MED, V7, P641; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	30	130	138	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					221	226		10.1038/ng829	http://dx.doi.org/10.1038/ng829			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818964				2022-12-17	WOS:000173708700026
J	Tsai, SC; Valkov, N; Yang, WM; Gump, J; Sullivan, D; Seto, E				Tsai, SC; Valkov, N; Yang, WM; Gump, J; Sullivan, D; Seto, E			Histone deacetylase interacts directly with DNA topoisomerase II	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REPRESSION; ALPHA; BETA; GENE; PHOSPHORYLATION; PROLIFERATION; ACETYLATION; COMPLEX; INVIVO	Histone deacetylases (HDACs) modify nucleosomal histones, have a key role in the regulation of gene transcription(1,2), and may be involved in cell-cycle regulation, differentiation and human cancer(3,4). Purified recombinant human HDAC1 protein was used to screen a cDNA expression library, and one of the clones identified encoded DNA topoisomerase II (Topo II), an enzyme known to have a role in transcriptional regulation and chromatin organization(5,6). Coimmunoprecipitation experiments indicate that HDAC1 and HDAC2 are associated with Topo II in vivo under normal physiological conditions. Complexes containing Topo II possess HDAC activities, and complexes containing HDAC1 or HDAC2 possess Topo II activities. HDAC and Topo II modify each other's activity in vitro and in vivo. Our results indicate the existence of a functionally coupled complex between these two enzymes and offer insights into the potential mechanisms of action of both enzymes.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Seto, E (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33620 USA.			Yang, Wen-Ming/0000-0002-5871-5979	NIGMS NIH HHS [GM58486] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058486] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; BOEGE F, 1995, AM J PATHOL, V146, P1302; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hochhauser D, 1999, J CELL BIOCHEM, V75, P245; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Kimura K, 1996, J BIOL CHEM, V271, P21439, DOI 10.1074/jbc.271.35.21439; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; SULLIVAN DM, 1989, BIOCHEMISTRY-US, V28, P5680, DOI 10.1021/bi00439a051; SWEDLOW JR, 1993, CELL, V73, P97, DOI 10.1016/0092-8674(93)90163-K; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Valkov NI, 2000, BRIT J HAEMATOL, V108, P331; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhang BG, 1997, DYN CONTIN DISCRET I, V3, P89; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	28	130	132	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					349	353		10.1038/81671	http://dx.doi.org/10.1038/81671			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062478				2022-12-17	WOS:000165176500027
J	Sarkar, PS; Appukuttan, B; Han, J; Ito, Y; Ai, CW; Tsai, WL; Chai, Y; Stout, JT; Reddy, S				Sarkar, PS; Appukuttan, B; Han, J; Ito, Y; Ai, CW; Tsai, WL; Chai, Y; Stout, JT; Reddy, S			Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts	NATURE GENETICS			English	Article							DYSTROPHY PROTEIN-KINASE; UNSTABLE CTG REPEAT; MYOTONIC-DYSTROPHY; REDUCES EXPRESSION; TRIPLET REPEAT; MESSENGER-RNAS; GENE; EXPANSION; MUTATION; DISRUPTION	Myotonic dystrophy (DM) is an autosomal dominant disorder characterized by skeletal muscle wasting, myotonia, cardiac arrhythmia, hyperinsulinaemia, mental retardation and ocular cataracts(1). The genetic defect in DM is a CTG repeat expansion located in the 3' untranslated region of DMPK and 5' of a homeodomain-encoding gene, SIX5 (formerly DMAHP; refs 2-5). There are three mechanisms by which CTG expansion can result in DM. First, repeat expansion may alter the processing or transport of the mutant DMPK mRNA and consequently reduce DMPK levels(6). Second, CTG expansion may establish a region of heterochromatin 3' of the repeat sequence and decrease SIX5 transcription(7-9). Third, toxic effects of the repeat expansion may be intrinsic to the repeated elements at the level of DNA or RNA (refs 10,11). Previous studies have demonstrated that a dose-dependent loss of Dm15 (the mouse DMPK homologue) in mice produces a partial DM phenotype characterized by decreased development of skeletal muscle force and cardiac conduction disorders(12-15). To test the role of Six5 loss in DM, we have analysed a strain of mice in which Six5 was deleted. Our results demonstrate that the rate and severity of cataract formation is inversely related to Six5 dosage and is temporally progressive. Six5(+/-) and Six(5-/-) mice show increased steady-state levels of the Na+/K+-ATPase alpha-1 subunit and decreased Dm15 mRNA levels. Thus, altered ion homeostasis within the lens may contribute to cataract formation. As ocular cataracts are a characteristic feature of DM, these results demonstrate that decreased SIX5 transcription is important in the aetiology of DM. Our data support the hypothesis that DM is a contiguous gene syndrome associated with the partial loss of both DMPK and SIX5.	Univ So Calif, Keck Sch med, Inst Med Genet, Los Angeles, CA 90089 USA; Univ So Calif, Childrens Hosp Los Angeles, Div Ophthalmol, Los Angeles, CA USA; Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Reddy, S (corresponding author), Univ So Calif, Keck Sch med, Inst Med Genet, Los Angeles, CA 90089 USA.	sitaredd@hsc.usc.edu			NEI NIH HHS [EYO3040] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY003040] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Benders AAGM, 1997, J CLIN INVEST, V100, P1440, DOI 10.1172/JCI119664; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GRAW J, 1989, EXP EYE RES, V49, P469, DOI 10.1016/0014-4835(89)90055-9; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; JOHNS KJ, 1995, BASIC CLIN SCI COURS; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Murakami Y, 1998, HUM MOL GENET, V7, P2103, DOI 10.1093/hmg/7.13.2103; Ohto H, 1999, MOL CELL BIOL, V19, P6815; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WILKINSON DG, 1998, PRACTICAL APPROACH S; Winchester CL, 1999, HUM MOL GENET, V8, P481, DOI 10.1093/hmg/8.3.481; Zhao JS, 1996, DEV BIOL, V180, P242, DOI 10.1006/dbio.1996.0298	30	130	134	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2000	25	1					110	114		10.1038/75500	http://dx.doi.org/10.1038/75500			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802668				2022-12-17	WOS:000086884000028
J	Sullivan, LS; Heckenlively, JR; Bowne, SJ; Zuo, J; Hide, WA; Gal, A; Denton, M; Inglehearn, CF; Blanton, SH; Daiger, SP				Sullivan, LS; Heckenlively, JR; Bowne, SJ; Zuo, J; Hide, WA; Gal, A; Denton, M; Inglehearn, CF; Blanton, SH; Daiger, SP			Mutations in a novel retina-specific gene cause autosomal dominant retinitis pigmentosa	NATURE GENETICS			English	Article							RECESSIVE MUTATIONS; ALPHA-SUBUNIT; PROTEIN; PHOSPHODIESTERASE; DOUBLECORTIN; LINKAGE; REGION; TULP1; MOUSE; ABCR	Inherited retinal diseases are a common cause of visual impairment in children and young adults, often resulting in severe loss of vision in later life. The most frequent form of inherited retinopathy is retinitis pigmentosa (RP), with an approximate incidence of 1 in 3,500 individuals worldwide(1,2). RP is characterized by night blindness and progressive degeneration of the midperipheral retina, accompanied by bone spicule-like pigmentary deposits and a reduced or absent electroretinogram (ERG). The disease process culminates in severe reduction of visual fields or blindness. RP is genetically heterogeneous, with autosomal dominant, autosomal recessive and X-linked forms. Here we have identified two mutations in a novel retina-specific gene from chromosome 8q that cause the RP1 form of autosomal dominant RP in three unrelated families. The protein encoded by this gene is 2,156 amino acids and its function is currently unknown, although the amino terminus has similarity to that of the doublecortin protein, whose gene (DCX) has been implicated in lissencephaly in humans(17). Two families have a nonsense mutation in codon 677 of this gene (Arg677stop), whereas the third family has a nonsense mutation in codon 679 (Gln679stop). In one family, two individuals homozygous for the mutant gene have more severe retinal disease compared with heterozygotes.	Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; Univ Hosp Eppendorf, Inst Human Genet, Hamburg, Germany; Univ Otago, Dept Biochem, Dunedin, New Zealand; Univ Leeds, Mol Med Unit, Leeds LS2 9JT, W Yorkshire, England; Univ Virginia, Dept Pediat, Charlottesville, VA 22903 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; St Jude Children's Research Hospital; South African National Biodiversity Institute; University of the Western Cape; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Otago; University of Leeds; University of Virginia	Sullivan, LS (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, 6901 Bertner St, Houston, TX 77030 USA.		Inglehearn, Chris/GYD-9783-2022; Blanton, Susan Halloran/ABF-1323-2021; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017	Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271	NATIONAL EYE INSTITUTE [R01EY007142] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY007142-12A2, EY07142, R01 EY007142] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Daiger SP, 1997, DEGENERATIVE RETINAL DISEASES, P277; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hannan AJ, 1999, J NEUROSCI RES, V55, P650, DOI 10.1002/(SICI)1097-4547(19990301)55:5<650::AID-JNR12>3.3.CO;2-J; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; HECKENLIVELY JR, 1997, PRINCIPALS PRACTICES, P2555; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; INGLEHEARN CF, IN PRESS J MED GENET; JIMENEZ JB, 1991, HUM GENET, V86, P265; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Matsumoto N, 1999, GENOMICS, V56, P179, DOI 10.1006/geno.1998.5673; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Omori Y, 1998, J HUM GENET, V43, P169, DOI 10.1007/s100380050063; Roderick TH, 1997, GENOMICS, V42, P393, DOI 10.1006/geno.1997.4717; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Sossey-Alaoui K, 1998, HUM MOL GENET, V7, P1327, DOI 10.1093/hmg/7.8.1327; Xu SY, 1996, HUM GENET, V98, P741, DOI 10.1007/s004390050296	28	130	137	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1999	22	3					255	259		10.1038/10314	http://dx.doi.org/10.1038/10314			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	210VT	10391212	Green Accepted			2022-12-17	WOS:000081125900017
J	Sheffield, VC; Kraiem, Z; Beck, JC; Nishimura, D; Stone, EM; Salameh, M; Sadeh, O; Glaser, B				Sheffield, VC; Kraiem, Z; Beck, JC; Nishimura, D; Stone, EM; Salameh, M; Sadeh, O; Glaser, B			Pendred syndrome maps to chromosome 7q2134 and is caused by an intrinsic defect in thyroid iodine organification	NATURE GENETICS			English	Letter							CONGENITAL GOITER; GENE; MUTATION		UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; CARMEL HOSP,ENDOCRINE RES UNIT,HAIFA,ISRAEL; TECHNION ISRAEL INST TECHNOL,FAC MED,HAIFA,ISRAEL; UNIV IOWA,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; HADASSAH UNIV HOSP,DEPT ENDOCRINOL & METAB,IL-91120 JERUSALEM,ISRAEL	University of Iowa; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Iowa; Hebrew University of Jerusalem			Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000; Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835	NHGRI NIH HHS [R01HG00457] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABDELMOUMENE N, 1978, J MOL MED-NETH, V3, P305; ABRAMOWICZ MJ, 1992, J CLIN INVEST, V90, P1200, DOI 10.1172/JCI115981; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BATSAKIS JG, 1962, ARCHIV OTOLARYNGOL, V76, P401; BILLERBECK AEC, 1994, THYROID, V4, P279, DOI 10.1089/thy.1994.4.279; BURROW GN, 1973, J CLIN ENDOCR METAB, V36, P522, DOI 10.1210/jcem-36-3-522; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; CAVE WT, 1975, J CLIN ENDOCR METAB, V41, P590, DOI 10.1210/jcem-41-3-590; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; ILLUM P, 1972, ARCHIV OTOLARYNGOL, V96, P297; KRAIEM Z, 1989, BRIT J PHARMACOL, V96, P465, DOI 10.1111/j.1476-5381.1989.tb11839.x; KRAIEM Z, 1995, ENDOCRINOLOGY, V136, P585, DOI 10.1210/en.136.2.585; KRAIEM Z, 1991, J ENDOCRINOL, V131, P499, DOI 10.1677/joe.0.1310499; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LJUNGGREN JG, 1973, ACTA ENDOCRINOL-COP, V72, P171; MANGKLABRUKS A, 1991, J CLIN ENDOCR METAB, V72, P471, DOI 10.1210/jcem-72-2-471; MASON ME, 1995, J CLIN ENDOCR METAB, V80, P497, DOI 10.1210/jc.80.2.497; MORGANS ME, 1958, LANCET, V1, P607; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NIEPOMNISZCZE H, 1978, ACTA ENDOCRINOL-COP, V89, P70, DOI 10.1530/acta.0.0890070; PENDRED V, 1896, LANCET, V2, P523; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; VANWOUWE JP, 1986, AM J MED GENET, V24, P211, DOI 10.1002/ajmg.1320240202; VASSART G, 1995, METABOLIC MOL BASES, P2883	28	130	141	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					424	426		10.1038/ng0496-424	http://dx.doi.org/10.1038/ng0496-424			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630498				2022-12-17	WOS:A1996UC55300023
J	WHITTINGTON, MA; SIDLE, KCL; GOWLAND, I; MEADS, J; HILL, AF; PALMER, MS; JEFFERYS, JGR; COLLINGE, J				WHITTINGTON, MA; SIDLE, KCL; GOWLAND, I; MEADS, J; HILL, AF; PALMER, MS; JEFFERYS, JGR; COLLINGE, J			RESCUE OF NEUROPHYSIOLOGICAL PHENOTYPE SEEN IN PRP NULL MICE BY TRANSGENE ENCODING HUMAN PRION PROTEIN	NATURE GENETICS			English	Article							CREUTZFELDT-JAKOB DISEASE; SCRAPIE; GENE; LACKING	The prion protein (PrP) is central to the aetiology of the prion diseases, transmissible neurodegenerative conditions of humans and animals. PrP null mice show abnormalities of synaptic neurophysiology, in particular weakened GABA(A) receptor-mediated fast inhibition and impaired long-term potentiation in the hippocampus. Here we demonstrate that this PrP null phenotype is rescued in mice with a high copy number of a transgene encoding human PrP but not in low copy number mice, confirming the specificity of the phenotype for loss of function of PrP. The ability of human PrP to compensate for loss of murine PrP will allow direct study of the functional consequences of the 18 human PrP mutations, which cause the inherited prion diseases; this phenotype can now form the basis of the first functional assay for PrP.	UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT PHYSIOL & BIOPHYS,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,DEPT NEUROL,LONDON W2 1NY,ENGLAND	Imperial College London; Imperial College London; Imperial College London			Jefferys, John G R/AAF-1164-2021; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009; Hill, Andrew/GZL-4124-2022; Jefferys, John/E-6132-2012	Jefferys, John G R/0000-0003-0106-4412; Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew/0000-0001-5581-2354; Jefferys, John/0000-0003-0106-4412; Whittington, Miles Adrian/0000-0002-0247-1362	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRENNER HR, 1992, P ROY SOC B-BIOL SCI, V250, P151, DOI 10.1098/rspb.1992.0143; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CATHALA F, 1987, P467; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Collinge J, 1992, CURR OPIN GENET DEV, V2, P448, DOI 10.1016/S0959-437X(05)80156-X; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; GABRIEL J, 1992, PRION DISEASES HUMAN; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; HARRIS DA, 1993, P NATL ACAD SCI USA, V90, P4309, DOI 10.1073/pnas.90.9.4309; HARRIS DA, 1991, P NATL ACAD SCI USA, V88, P7664, DOI 10.1073/pnas.88.17.7664; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; JEFFERYS JGR, 1994, J PHYSIOL-LONDON, V476P, pP9; JEFFERYS JGR, 1994, NEUROBIOL DIS, V1, P3; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANSON J, 1992, DEVELOPMENT, V115, P117; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; WEISSMANN C, 1991, NATURE, V349, P569, DOI 10.1038/349569a0; WELLER RO, 1989, PSYCHOL MED, V19, P1, DOI 10.1017/S0033291700010965; WESTAWAY D, 1986, NUCLEIC ACIDS RES, V14, P2035, DOI 10.1093/nar/14.5.2035	33	130	131	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					197	201		10.1038/ng0295-197	http://dx.doi.org/10.1038/ng0295-197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719349				2022-12-17	WOS:A1995QE67200023
J	OHISHI, M; FUJII, K; MINAMINO, T; HIGAKI, J; KAMITANI, A; RAKUGI, H; ZHAO, Y; MIKAMI, H; MIKI, T; OGIHARA, T				OHISHI, M; FUJII, K; MINAMINO, T; HIGAKI, J; KAMITANI, A; RAKUGI, H; ZHAO, Y; MIKAMI, H; MIKI, T; OGIHARA, T			A POTENT GENETIC RISK FACTOR FOR RESTENOSIS	NATURE GENETICS			English	Letter							ANGIOTENSIN-CONVERTING ENZYME; DELETION POLYMORPHISM		OSAKA UNIV,SCH MED,DEPT GERIATR MED,SUITA,OSAKA 565,JAPAN	Osaka University	OHISHI, M (corresponding author), SAKURABASHI WATANABE HOSP,DIV CARDIOL,OSAKA,OSAKA 530,JAPAN.			Rakugi, Hiromi/0000-0001-6508-4338				CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ZHAO Y, IN PRESS HYPERTENS R; 1992, CIRCULATION, V86, P100	5	130	130	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					324	325		10.1038/ng1293-324	http://dx.doi.org/10.1038/ng1293-324			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298638				2022-12-17	WOS:A1993ML14500006
J	GARIBOLDI, M; MANENTI, G; CANZIAN, F; FALVELLA, FS; RADICE, MT; PIEROTTI, MA; DELLAPORTA, G; BINELLI, G; DRAGANI, TA				GARIBOLDI, M; MANENTI, G; CANZIAN, F; FALVELLA, FS; RADICE, MT; PIEROTTI, MA; DELLAPORTA, G; BINELLI, G; DRAGANI, TA			A MAJOR SUSCEPTIBILITY LOCUS TO MURINE LUNG CARCINOGENESIS MAPS ON CHROMOSOME-6	NATURE GENETICS			English	Article							ALVEOLAR CELL-CARCINOMA; RAS PROTOONCOGENE; TUMOR SUSCEPTIBILITY; QUANTITATIVE TRAITS; MOUSE GENOME; CANCER; MICE; LINKAGE; ACTIVATION; GENE	Lung tumours represent a major cause of death in humans, and although smoking represents the main pathogenetic factor, inheritance also plays a part. However, the identification of possible predisposing genetic factors is difficult, because of their low penetrance. We took advantage of murine strains that are genetically susceptible or resistant to lung tumour development, to map murine genes associated with susceptibility to lung carcinogenesis. An F2 population of urethan-treated A/J x C3H/He mice was scored with 83 genetic markers. A chromosome 6 distal region, spanning 35 centiMorgans, contained a major lung tumour susceptibility locus. No other chromosomal region was significantly associated with lung tumour development.	IST NAZL TUMORI,DIV EXPTL ONCOL A,I-20133 MILAN,ITALY; UNIV MILAN,DEPT GENET & MICROBIOL,I-20122 MILAN,ITALY	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan			Manenti, Giacomo/J-3339-2017; Canzian, Federico/I-2804-2014; Pierotti, Marco Alessandro/AAC-4728-2022; Gariboldi, Manuela/K-4744-2016; Dragani, Tommaso A./K-4493-2016	Manenti, Giacomo/0000-0002-4887-4482; Pierotti, Marco Alessandro/0000-0002-7431-8332; Gariboldi, Manuela/0000-0001-8406-165X; Canzian, Federico/0000-0002-4261-4583; Dragani, Tommaso A./0000-0001-5915-4598				AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BIRAN H, 1991, LUNG CANCER, V7, P345; BIRRER MJ, 1989, ANNU REV MED, V40, P305; CAPORASO NE, 1990, J NATL CANCER I, V82, P1264, DOI 10.1093/jnci/82.15.1264; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DEVEREUX TR, 1991, CARCINOGENESIS, V12, P299, DOI 10.1093/carcin/12.2.299; DIETRICH W, 1992, GENETICS, V131, P423; DRAGANI TA, 1991, CANCER RES, V51, P6299; Hillyard A. L., 1992, LOCUS MAP MOUSE COMP; JOISHY SK, 1977, ANN INTERN MED, V87, P447, DOI 10.7326/0003-4819-87-4-447; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LAW MR, 1990, BRIT J CANCER, V61, P195, DOI 10.1038/bjc.1990.37; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; MALKINSON AM, 1992, CANCER RES, V52, pS2670; MALKINSON AM, 1985, J NATL CANCER I, V75, P971, DOI 10.1093/jnci/75.5.971; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; OOI WL, 1986, J NATL CANCER I, V76, P217; OOMEN LCJM, 1991, EXP LUNG RES, V17, P283, DOI 10.3109/01902149109064419; PATERSON AH, 1991, GENETICS, V127, P181; PAUL SM, 1987, J SURG ONCOL, V36, P249, DOI 10.1002/jso.2930360407; PIEROTTI M A, 1992, Current Opinion in Oncology, V4, P127, DOI 10.1097/00001622-199202000-00017; PONDER BAJ, 1990, TRENDS GENET, V6, P213, DOI 10.1016/0168-9525(90)90181-5; RE FC, 1992, MOL CARCINOGEN, V5, P155, DOI 10.1002/mc.2940050211; RYAN J, 1987, J NATL CANCER I, V79, P1351; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Shimkin M B, 1975, Adv Cancer Res, V21, P1, DOI 10.1016/S0065-230X(08)60970-7; STOWERS SJ, 1987, CANCER RES, V47, P3212; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; UEMATSU F, 1991, JPN J CANCER RES, V82, P254, DOI 10.1111/j.1349-7006.1991.tb01838.x; WELLER JI, 1988, GENETICS, V118, P329; Wright S., 1952, Quantitative inheritance. Papers read at a colloquium held at the Institute of Animal Genetics Edinburgh University under the auspices of the Agricultural Research Council April 4th to 6th, 1950., P5; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; YOU M, 1992, P NATL ACAD SCI USA, V89, P5804, DOI 10.1073/pnas.89.13.5804; 1988, SAS USERS GUIDE STAT	39	130	130	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					132	136		10.1038/ng0293-132	http://dx.doi.org/10.1038/ng0293-132			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499946				2022-12-17	WOS:A1993KL01000010
J	RICHARDS, RI; SUTHERLAND, GR				RICHARDS, RI; SUTHERLAND, GR			HERITABLE UNSTABLE DNA-SEQUENCES	NATURE GENETICS			English	Editorial Material											RICHARDS, RI (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012; Richards, Robert/ABE-6423-2020	Richards, Robert Ian/0000-0002-5978-6453				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DURCKHEIM KG, 1988, WAY TRANSFORMATION; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARPER PS, IN PRESS AM J HUM GE; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KREMER EJ, 1991, AM J HUM GENET, V49, P656; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pirsig Robert M., 1991, LILA INQUIRY MORALS; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; YU S, IN PRESS AM J HUM GE; ZHU QS, 1990, NUCLEIC ACIDS RES, V18, P7119, DOI 10.1093/nar/18.23.7119	28	130	132	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					7	9		10.1038/ng0492-7	http://dx.doi.org/10.1038/ng0492-7			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1302002				2022-12-17	WOS:A1992JC97800003
J	Granja, JM; Corces, MR; Pierce, SE; Bagdatli, ST; Choudhry, H; Chang, HY; Greenleaf, WJ				Granja, Jeffrey M.; Corces, M. Ryan; Pierce, Sarah E.; Bagdatli, S. Tansu; Choudhry, Hani; Chang, Howard Y.; Greenleaf, William J.			ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis	NATURE GENETICS			English	Article							REGULATORS; DYNAMICS; ELEMENTS	The advent of single-cell chromatin accessibility profiling has accelerated the ability to map gene regulatory landscapes but has outpaced the development of scalable software to rapidly extract biological meaning from these data. Here we present a software suite for single-cell analysis of regulatory chromatin in R (ArchR; https://www.archrproject.com/) that enables fast and comprehensive analysis of single-cell chromatin accessibility data. ArchR provides an intuitive, user-focused interface for complex single-cell analyses, including doublet removal, single-cell clustering and cell type identification, unified peak set generation, cellular trajectory identification, DNA element-to-gene linkage, transcription factor footprinting, mRNA expression level prediction from chromatin accessibility and multi-omic integration with single-cell RNA sequencing (scRNA-seq). Enabling the analysis of over 1.2 million single cells within 8 h on a standard Unix laptop, ArchR is a comprehensive software suite for end-to-end analysis of single-cell chromatin accessibility that will accelerate the understanding of gene regulation at the resolution of individual cells.	[Granja, Jeffrey M.; Pierce, Sarah E.; Bagdatli, S. Tansu; Chang, Howard Y.; Greenleaf, William J.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Program Biophys, Stanford, CA 94305 USA; [Granja, Jeffrey M.; Corces, M. Ryan; Chang, Howard Y.; Greenleaf, William J.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Corces, M. Ryan] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Corces, M. Ryan] Gladstone Inst Data Sci & Biotechnol, Gladstone Inst Neurol Dis, San Francisco, CA USA; [Corces, M. Ryan] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Pierce, Sarah E.] Stanford Univ, Program Canc Biol, Sch Med, Stanford, CA 94305 USA; [Choudhry, Hani] King Abdulaziz Univ, Dept Biochem, King Fahd Ctr Med Res, Fac Sci,Canc & Mutagenesis Unit, Jeddah, Saudi Arabia; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Greenleaf, William J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Stanford University; King Abdulaziz University; Howard Hughes Medical Institute; Stanford University; Stanford University	Granja, JM; Chang, HY; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Granja, JM (corresponding author), Stanford Univ, Program Biophys, Stanford, CA 94305 USA.; Granja, JM; Chang, HY; Greenleaf, WJ (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	jgranja.stanford@gmail.com; howchang@stanford.edu; wjg@stanford.edu		Pierce, Sarah/0000-0002-9145-9559	NIH [RM1-HG007735, UM1-HG009442, R35-CA209919, UM1-HG009436, 1UM1-HG009442, U2CCA233311, U54-GH010426, U19-AI057266, K99-AG059918]; American Society of Hematology Scholar Award; International Collaborative Award; Defense Advanced Research Project Agency [W911NF1920185]; Stanford Cancer Institute-Goldman Sachs Foundation Cancer Research Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Scholar Award; International Collaborative Award; Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Stanford Cancer Institute-Goldman Sachs Foundation Cancer Research Award	We thank members of the Greenleaf and Chang laboratories for helpful comments. This work was supported by the NIH RM1-HG007735 and UM1-HG009442 (to H.Y.C. and W.J.G.), R35-CA209919 (to H.Y.C.), UM1-HG009436, 1UM1-HG009442, U2CCA233311, U54-GH010426, and U19-AI057266 (to W.J.G.), K99-AG059918 and the American Society of Hematology Scholar Award (to M.R.C.), an International Collaborative Award (to H.Y.C. and H.C.), the Defense Advanced Research Project Agency (W911NF1920185 to W.J.G.), a gift from the Ray and Dagmar Dolby Family Fund (to the Gladstone Institutes) and a Stanford Cancer Institute-Goldman Sachs Foundation Cancer Research Award (to W.J.G). W.J.G. is a Chan Zuckerberg investigator. H.Y.C. is an Investigator of the Howard Hughes Medical Institute.	Andersson R, 2020, NAT REV GENET, V21, P71, DOI 10.1038/s41576-019-0173-8; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Arnosti DN, 2003, ANNU REV ENTOMOL, V48, P579, DOI 10.1146/annurev.ento.48.091801.112749; Baglama, 2019, FAST TRUNCATED SINGU; Baglama J, 2005, SIAM J SCI COMPUT, V27, P19, DOI 10.1137/04060593X; Baker SM, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky950; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Calderon D, 2019, NAT GENET, V51, P1494, DOI 10.1038/s41588-019-0505-9; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Corces M.R., 2020, SINGLE CELL EPIGENOM, DOI 10.1101/2020.01.06.896159; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cusanovich DA, 2018, CELL, V174, P1309, DOI 10.1016/j.cell.2018.06.052; Cusanovich DA, 2018, NATURE, V555, P538, DOI 10.1038/nature25981; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; de Boer CG, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2255-6; Fang R, 2019, FAST ACCURATE CLUSTE; Gonzalez-Blas CB, 2019, NAT METHODS, V16, P397, DOI 10.1038/s41592-019-0367-1; Granja JM, 2019, NAT BIOTECHNOL, V37, P1458, DOI 10.1038/s41587-019-0332-7; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Ji ZC, 2017, BIOINFORMATICS, V33, P2930, DOI 10.1093/bioinformatics/btx315; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Lareau CA, 2019, NAT BIOTECHNOL, V37, P916, DOI 10.1038/s41587-019-0147-6; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Pierce S.E, 2020, HIGHTHROUGHPUT SINGL, DOI 10.1101/2020.11.02.364265; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Regev Aviv, 2017, Elife, V6, DOI 10.7554/eLife.27041; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Satpathy AT, 2018, NAT MED, V24, P580, DOI 10.1038/s41591-018-0008-8; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van Galen P, 2019, CELL, V176, P1265, DOI 10.1016/j.cell.2019.01.031; Wei S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1619-6; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Zamanighomi M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04629-3	45	129	130	11	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2021	53	3					403	+		10.1038/s41588-021-00790-6	http://dx.doi.org/10.1038/s41588-021-00790-6		FEB 2021	28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QT6UK	33633365	Green Published, hybrid, Green Submitted			2022-12-17	WOS:000621739700001
J	Dao, LTM; Galindo-Albarran, AO; Castro-Mondragon, JA; Andrieu-Soler, C; Medina-Rivera, A; Souaid, C; Charbonnier, G; Griffon, A; Vanhille, L; Stephen, T; Alomairi, J; Martin, D; Torres, M; Fernandez, N; Soler, E; van Helden, J; Puthier, D; Spicuglia, S				Dao, Lan T. M.; Galindo-Albarran, Ariel O.; Castro-Mondragon, Jaime A.; Andrieu-Soler, Charlotte; Medina-Rivera, Alejandra; Souaid, Charbel; Charbonnier, Guillaume; Griffon, Aurelien; Vanhille, Laurent; Stephen, Tharshana; Alomairi, Jaafar; Martin, David; Torres, Magali; Fernandez, Nicolas; Soler, Eric; van Helden, Jacques; Puthier, Denis; Spicuglia, Salvatore			Genome-wide characterization of mammalian promoters with distal enhancer functions	NATURE GENETICS			English	Article							CHROMOSOME CONFORMATION CAPTURE; HIGH-THROUGHPUT; R/BIOCONDUCTOR PACKAGE; CHROMATIN INTERACTIONS; GENE-EXPRESSION; SEQUENCING DATA; TRANSCRIPTION; ARCHITECTURE; DISCOVERY; RNA	Gene expression in mammals is precisely regulated by the combination of promoters and gene-distal regulatory regions, known as enhancers. Several studies have suggested that some promoters might have enhancer functions. However, the extent of this type of promoters and whether they actually function to regulate the expression of distal genes have remained elusive. Here, by exploiting a high-throughput enhancer reporter assay, we unravel a set of mammalian promoters displaying enhancer activity. These promoters have distinct genomic and epigenomic features and frequently interact with other gene promoters. Extensive CRISPR-Cas9 genomic manipulation demonstrated the involvement of these promoters in the cis regulation of expression of distal genes in their natural loci. Our results have important implications for the understanding of complex gene regulation in normal development and disease.	[Dao, Lan T. M.; Galindo-Albarran, Ariel O.; Castro-Mondragon, Jaime A.; Souaid, Charbel; Charbonnier, Guillaume; Griffon, Aurelien; Vanhille, Laurent; Alomairi, Jaafar; Torres, Magali; Fernandez, Nicolas; van Helden, Jacques; Puthier, Denis; Spicuglia, Salvatore] Aix Marseille Univ, INSERM, TAGC, UMR 1090, Marseille, France; [Souaid, Charbel; Stephen, Tharshana; Soler, Eric] Univ Paris Saclay, Univ Paris Diderot, Lab Mol Hematopoiesis, INSERM,UMR 967,CEA,DRF,iRCM, Fontenay Aux Roses, France; [Andrieu-Soler, Charlotte; Soler, Eric] Univ Sorbonne Paris Cite, Labex GR Ex, Paris, France; [Andrieu-Soler, Charlotte; Stephen, Tharshana; Martin, David; Soler, Eric] Univ Montpellier, IGMM, CNRS, Montpellier, France; [Medina-Rivera, Alejandra] Univ Nacl Autonoma Mexico, Lab Int Invest Genoma Humano, Juriquilla, Mexico; [Dao, Lan T. M.] Vinmec Res Inst Stem Cell & Gene Technol, Hanoi, Vietnam	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universidad Nacional Autonoma de Mexico	Spicuglia, S (corresponding author), Aix Marseille Univ, INSERM, TAGC, UMR 1090, Marseille, France.	salvatore.spicuglia@inserm.fr	Puthier, Denis/N-5018-2016; Inserm U1090, TAGC/ABE-9980-2021; Medina-Rivera, Alejandra/P-7827-2019; van Helden, Jacques/D-8590-2013; Castro-Mondragon, Jaime/P-6297-2019; Alomairi, Jaafar/P-8009-2019; puthier, denis/AFV-1973-2022; Soler, Eric/ABE-9723-2021; Spicuglia, Salvatore/L-2268-2016	Medina-Rivera, Alejandra/0000-0002-7912-2718; van Helden, Jacques/0000-0002-8799-8584; Castro-Mondragon, Jaime/0000-0003-4069-357X; puthier, denis/0000-0002-7240-5280; Soler, Eric/0000-0003-0521-7463; Souaid, Charbel/0000-0002-2495-1308; Charbonnier, Guillaume/0000-0001-5615-1287; Andrieu-Soler, Charlotte/0000-0002-3287-6117; Spicuglia, Salvatore/0000-0002-8101-7108; Galindo Albarran, Ariel Oswaldo/0000-0002-5492-7368	INSERM; Aix-Marseille University; European Union [282510-BLUEPRINT]; ARC [PJA 20151203149]; A*MIDEX [ANR-11-IDEX-0001-02]; Vietnam International Education Development [911]; CONACYT; FRM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; European Union(European Commission); ARC(Australian Research Council); A*MIDEX(French National Research Agency (ANR)); Vietnam International Education Development; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FRM(Fondation pour la Recherche Medicale)	We thank J.-C. Andrau and J. Imbert for critical reading of the manuscript. We thank the IBiSA 'Transcriptomics and Genomics Marseille-Luminy' (TGML) platform for sequencing of CapStarr-seq samples and the cell biology platform for management of cell culture. Work in the laboratory of S.S. was supported by recurrent funding from INSERM and Aix-Marseille University and by specific grants from the European Union's FP7 Programme (282510-BLUEPRINT), ARC (PJA 20151203149) and A*MIDEX (ANR-11-IDEX-0001-02). L.T.M.D., A.G. and G.C. were supported, respectively, by Vietnam International Education Development (911), CONACYT and FRM.	Andersson R, 2015, BIOESSAYS, V37, P314, DOI 10.1002/bies.201400162; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Benaglia T, 2009, J STAT SOFTW, V32, P1; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dailey L, 2015, GENOMICS, V106, P151, DOI 10.1016/j.ygeno.2015.06.004; Dao L. T. M., 2015, PROTOCOL EXCHANGE; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Glusman G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077885; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kuznetsova T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0832-9; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; MOMBAERTS P, 1995, P NATL ACAD SCI USA, V92, P7420, DOI 10.1073/pnas.92.16.7420; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nejepinska J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043283; Nguyen TA, 2016, GENOME RES, V26, P1023, DOI 10.1101/gr.204834.116; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaffner W, 2015, BIOL CHEM, V396, P311, DOI 10.1515/hsz-2014-0303; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Stadhouders R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9893; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vanhille L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7905; Vieux-Rochas M, 2015, P NATL ACAD SCI USA, V112, P4672, DOI 10.1073/pnas.1504783112; Walter C, 2014, BIOINFORMATICS, V30, P3268, DOI 10.1093/bioinformatics/btu497; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	51	129	134	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1073	+		10.1038/ng.3884	http://dx.doi.org/10.1038/ng.3884			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28581502				2022-12-17	WOS:000404253300016
J	Meyer, E; Carss, KJ; Rankin, J; Nichols, JME; Grozeva, D; Joseph, AP; Mencacci, NE; Papandreou, A; Ng, J; Barra, S; Ngoh, A; Ben-Pazi, H; Willemsen, MA; Arkadir, D; Barnicoat, A; Bergman, H; Bhate, S; Boys, A; Darin, N; Foulds, N; Gutowski, N; Hills, A; Houlden, H; Hurst, JA; Israe, Z; Kaminska, M; Limousin, P; Lumsden, D; Mckee, S; Misra, S; Mohammed, SS; Nakou, V; Nicolai, J; Nilsson, M; Pall, H; Peall, KJ; Peters, GB; Prabhakar, P; Reuter, MS; Rump, P; Sege, R; Sinnema, M; Smith, M; Turnpenny, P; White, SM; Wieczorek, D; Wiethoff, S; Wilson, BT; Winter, G; Wragg, C; Pope, S; Heales, SJH; Morrogh, D; Pittman, A; Carr, LJ; Perez-Duenas, B; Lin, JP; Reis, A; Gahl, WA; Toro, C; Bhatia, KP; Wood, NW; Kamsteeg, EJ; Chong, WK; Gissen, P; Topf, M; Dale, RC; Chubby, JR; Raymond, FL; Kurian, MA				Meyer, Esther; Carss, Keren J.; Rankin, Julia; Nichols, John M. E.; Grozeva, Detelina; Joseph, Agnel P.; Mencacci, Niccolo E.; Papandreou, Apostolos; Ng, Joanne; Barra, Serena; Ngoh, Adeline; Ben-Pazi, Hilla; Willemsen, Michel A.; Arkadir, David; Barnicoat, Angela; Bergman, Hagai; Bhate, Sanjay; Boys, Amber; Darin, Niklas; Foulds, Nicola; Gutowski, Nicholas; Hills, Alison; Houlden, Henry; Hurst, Jane A.; Israe, Zvi; Kaminska, Margaret; Limousin, Patricia; Lumsden, Daniel; Mckee, Shane; Misra, Shibalik; Mohammed, Shekeeb S.; Nakou, Vasiliki; Nicolai, Joost; Nilsson, Magnus; Pall, Hardev; Peall, Kathryn J.; Peters, Gregory B.; Prabhakar, Prab; Reuter, Miriam S.; Rump, Patrick; Sege, Reeval; Sinnema, Margje; Smith, Martin; Turnpenny, Peter; White, Susan M.; Wieczorek, Dagmar; Wiethoff, Sarah; Wilson, Brian T.; Winter, Gidon; Wragg, Christopher; Pope, Simon; Heales, Simon J. H.; Morrogh, Deborah; Pittman, Alan; Carr, Lucinda J.; Perez-Duenas, Belen; Lin, Jean-Pierre; Reis, Andre; Gahl, William A.; Toro, Camilo; Bhatia, Kailash P.; Wood, Nicholas W.; Kamsteeg, Erik-Jan; Chong, Wui K.; Gissen, Paul; Topf, Maya; Dale, Russell C.; Chubby, Jonathan R.; Raymond, F. Lucy; Kurian, Manju A.		UK10K Consortium; Deciphering Dev Disorders Study; NIHR BioResource Rare	Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia	NATURE GENETICS			English	Article							PROTEIN STABILITY; NEURODEGENERATION; METHYLATION; DISORDERS	Histone lysine methylation, mediated by mixed-lineage leukemia (MLL) proteins, is now known to be critical in the regulation of gene expression, genomic stability, cell cycle and nuclear architecture. Despite MLL proteins being postulated as essential for normal development, little is known about the specific functions of the different MLL lysine methyltransferases. Here we report heterozygous variants in the gene KMT2B (also known as MLL4) in 27 unrelated individuals with a complex progressive childhood-onset dystonia, often associated with a typical facial appearance and characteristic brain magnetic resonance imaging findings. Over time, the majority of affected individuals developed prominent cervical, cranial and laryngeal dystonia. Marked clinical benefit, including the restoration of independent ambulation in some cases, was observed following deep brain stimulation (DBS). These findings highlight a clinically recognizable and potentially treatable form of genetic dystonia, demonstrating the crucial role of KMT2B in the physiological control of voluntary movement.	[Meyer, Esther; Ng, Joanne; Barra, Serena; Ngoh, Adeline; Kurian, Manju A.] UCL Inst Child Hlth, London, England; [Carss, Keren J.] Univ Cambridge, NHS Blood & Transplant Ctr, Dept Hematol, Cambridge, England; [Carss, Keren J.; Raymond, F. Lucy] Cambridge Univ Hosp, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge, England; [Rankin, Julia; Turnpenny, Peter] Royal Devon & Exeter NHS Fdn Trust, Clin Genet, Exeter, Devon, England; [Nichols, John M. E.; Gissen, Paul; Chubby, Jonathan R.] UCL, MRC Lab Mol Cell Biol, London, England; [Nichols, John M. E.; Gissen, Paul; Chubby, Jonathan R.] UCL, Dept Cell & Dev Biol, London, England; [Grozeva, Detelina; Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Joseph, Agnel P.; Topf, Maya] Univ London, Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol,Crystallog, London, England; [Mencacci, Niccolo E.; Houlden, Henry; Wiethoff, Sarah; Pittman, Alan; Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Papandreou, Apostolos; Ng, Joanne; Ngoh, Adeline; Bhate, Sanjay; Prabhakar, Prab; Carr, Lucinda J.; Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Neurol, London, England; [Ben-Pazi, Hilla; Winter, Gidon] Shaare Zedek Mem Hosp, Pediatr Neurol & Dev, Jerusalem, Israel; [Willemsen, Michel A.] Radboud Univ Nijmegen Med Ctr, Donders Ctr Brain Cognit & Behav, Dept Paediat Neurol, Nijmegen, Netherlands; [Arkadir, David] Hadassah Med Ctr, Dept Neurol, Jerusalem, Israel; [Arkadir, David] Hebrew Univ Jerusalem, Jerusalem, Israel; [Barnicoat, Angela; Hurst, Jane A.; Wilson, Brian T.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London, England; [Bergman, Hagai] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurobiol & Neurosurg, Jerusalem, Israel; [Boys, Amber; White, Susan M.] Murdoch Childrens Res Inst, Victoria Clin Genet Serv, Parkville, Vic, Australia; [Darin, Niklas] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Foulds, Nicola] Southampton Gen Hosp, Dept Clin Genet, Southampton, Hants, England; [Gutowski, Nicholas] Royal Devon & Exeter NHS Fdn Trust, Dept Neurol, Exeter, Devon, England; [Hills, Alison; Wragg, Christopher] Southmead Hosp, Bristol Genet Lab, Pathol Sci, Bristol, Avon, England; [Israe, Zvi] Hadassah Univ Hosp, Funct & Restorat Neurosurg, Jerusalem, Israel; [Kaminska, Margaret; Lumsden, Daniel; Nakou, Vasiliki; Lin, Jean-Pierre] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Complex Motor Disorders Serv, London, England; [Limousin, Patricia; Bhatia, Kailash P.] Natl Hosp Neurol & Neurosurg, Sobell Dept, London, England; [Mckee, Shane] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast, Antrim, North Ireland; [Misra, Shibalik; Mohammed, Shekeeb S.; Dale, Russell C.] Univ Sydney, Child & Adolescent Hlth, Sydney, NSW, Australia; [Misra, Shibalik; Mohammed, Shekeeb S.; Dale, Russell C.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Nicolai, Joost] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Papandreou, Apostolos; Nilsson, Magnus] Pitea Hosp, Dept Pediat, Umea, Sweden; [Nilsson, Magnus] Umea Univ Hosp, Umea, Sweden; [Pall, Hardev] Univ Birmingham, Coll Med & Dent Studies, Birmingham, W Midlands, England; [Peall, Kathryn J.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales; [Peters, Gregory B.] Childrens Hosp Westmead, Dept Cytogenet, Westmead, NSW, Australia; [Reuter, Miriam S.; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Sege, Reeval] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Sege, Reeval] Shaare Zedek Med Ctr, Pediat, Jerusalem, Israel; [Sege, Reeval] Hebrew Univ Jerusalem, Sch Med, Jerusalem, Israel; [Sinnema, Margje] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Sinnema, Margje] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Smith, Martin] John Radcliffe Hosp, Dept Pediat Neurol, Oxford, England; [White, Susan M.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Wieczorek, Dagmar] Univ Duisburg Essen, Inst Human Genet, Essen, Germany; [Wieczorek, Dagmar] Heinrich Heine Univ, Fac Med, Inst Human Genet, Dusseldorf, Germany; [Heales, Simon J. H.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, England; [Heales, Simon J. H.] NHS Fdn Trust, Great Ormond St Hosp, Clin Chem, London, England; [Morrogh, Deborah] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London, England; [Perez-Duenas, Belen] Univ Barcelona, Hosp St Joan de Deu, Dept Child Neurol, Barcelona, Spain; [Perez-Duenas, Belen] Hosp St Joan de Deu, Ctr Biomed Res Rare Dis CIBERER ISCIII, Barcelona, Spain; [Gahl, William A.; Toro, Camilo] US Natl Inst Hlth, Off Director, Common Fund, NIH Undiagnosed Dis Program, Bethesda, MD USA; [Kamsteeg, Erik-Jan] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Chong, Wui K.] Great Ormond St Hosp Sick Children, Dept Radiol, London, England	University of London; University College London; University of Cambridge; University of Cambridge; University of Exeter; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Cambridge; University of London; Birkbeck University London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Radboud University Nijmegen; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hebrew University of Jerusalem; Hadassah University Medical Center; Murdoch Children's Research Institute; Sahlgrenska University Hospital; University of Gothenburg; University of Southampton; University of Exeter; Southmead Hospital; Hebrew University of Jerusalem; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Belfast City Hospital; University of Sydney; University of Sydney; Maastricht University; Umea University; University of Birmingham; Cardiff University; University of Sydney; University of Erlangen Nuremberg; University of Groningen; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Maastricht University; Maastricht University; University of Oxford; University of Melbourne; University of Duisburg Essen; Heinrich Heine University Dusseldorf; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; National Institutes of Health (NIH) - USA; Radboud University Nijmegen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Kurian, MA (corresponding author), UCL Inst Child Hlth, London, England.; Kurian, MA (corresponding author), Great Ormond St Hosp Sick Children, Dept Neurol, London, England.	manju.kurian@ucl.ac.uk	Lin, Jean-Pierre/R-3779-2019; Bergman, Hagai/AAI-4683-2021; Perez-Duenas, Belen/AAG-9054-2019; Wood, Nicholas W/C-2505-2009; Mohammad, Shekeeb/AAD-1282-2022; Pittman, Alan M/D-6231-2012; Houlden, Henry J/C-1532-2008; Wieczorek, Dagmar/AAU-6008-2021; Willemsen, Michel A.A.P./H-8119-2014; Reis, André/D-2309-2009; Pittman, Alan/AAP-2534-2020; Kamsteeg, Erik-Jan/L-4421-2015; Darin, Niklas/AAL-6345-2020	Lin, Jean-Pierre/0000-0001-9314-2259; Bergman, Hagai/0000-0002-2402-6673; Wood, Nicholas W/0000-0002-9500-3348; Mohammad, Shekeeb/0000-0003-1219-4781; Pittman, Alan M/0000-0002-8112-2987; Houlden, Henry J/0000-0002-2866-7777; Wieczorek, Dagmar/0000-0003-2812-6492; Reis, André/0000-0002-6301-6363; Pittman, Alan/0000-0002-8112-2987; Lumsden, Daniel/0000-0002-5524-6177; Kingston, Nathalie/0000-0002-9190-2231; Carss, Keren/0000-0003-4939-156X; Chong, Kling/0000-0002-4335-3864; barral, serena/0000-0002-1430-3614; Kelly, Kirsten/0000-0003-4234-543X; Pope, Simon Alexander Samuel/0000-0002-2991-3722; Prabhakar, Prab/0000-0002-1641-8714; Mencacci, Niccolo Emanuele/0000-0003-3383-9665; Grozeva, Detelina/0000-0003-3239-8415; Papandreou, Apostolos/0000-0001-5093-6075; Gissen, Paul/0000-0002-9712-6122; McKee, Shane/0000-0002-1772-0106; Topf, Maya/0000-0002-8185-1215; Ng, Joanne/0000-0002-7946-9965; Nichols, John/0000-0003-2061-1485; benpazi, hilla/0000-0002-8039-4761; Reis, AlessanRSS/0000-0001-8486-7469	Rosetrees Trust; Great Ormond Street Hospital Children's Charity; Gracious Heart Foundation; UK Department of Health's NIHR Biomedical Research Centers; Daniel Turnberg Trust Fund; MRC; Wellcome Trust (Synaptopathies award); Prusiner-Abramsky Award; Dystonia Society (UK); La Marato de TV3 [20143130]; Ministerio Espanol de Economia y Competitividad [PI15/00287]; Guy's and St Thomas' Charity New Services and Innovation Grant [G060708]; Dystonia Society (UK) [01/2011, 07/2013]; Action Medical Research [AMR-GN2097]; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; University of Cambridge; NIHR for the BioResource for Rare Diseases [RG65966]; Wellcome Trust [UK10K (WT091310)]; DDD study; Health Innovation Challenge Fund [HICF-1009-003]; Intramural Research Program of the National Human Genome Research Institute; Common Fund, NIH Office of the Director; German Ministry of Research and Education as part of National Genome Research Network [0IGS08160, 01GS08167]; German Ministry of Research and Education (German Mental Retardation Network) as part of National Genome Research Network; Deutsche Forschungsgemeinschaft [AB393/2-2]; UK Human Brain Expression Consortium (UKBEC); MRC [G108/638, MR/K02342X/1, G1001253, MR/P008593/1, G0802760, MR/J004758/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL11-Peall] Funding Source: researchfish; Medical Research Council [G1001253, MR/P008593/1, G108/638, G0802760, MR/J004758/1, MR/K02342X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082, NF-SI-0507-10376, NF-SI-0513-10064] Funding Source: researchfish; Parkinson&quot;s UK [G-1107] Funding Source: researchfish; Rosetrees Trust [M576] Funding Source: researchfish; Action Medical Research [2465, 2358] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1284] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215, ZIDHG200352] Funding Source: NIH RePORTER	Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Children's Charity; Gracious Heart Foundation; UK Department of Health's NIHR Biomedical Research Centers; Daniel Turnberg Trust Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Synaptopathies award)(Wellcome Trust); Prusiner-Abramsky Award; Dystonia Society (UK); La Marato de TV3; Ministerio Espanol de Economia y Competitividad(Spanish Government); Guy's and St Thomas' Charity New Services and Innovation Grant; Dystonia Society (UK); Action Medical Research; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); University of Cambridge(University of Cambridge); NIHR for the BioResource for Rare Diseases; Wellcome Trust(Wellcome Trust); DDD study; Health Innovation Challenge Fund; Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Common Fund, NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Research and Education as part of National Genome Research Network; German Ministry of Research and Education (German Mental Retardation Network) as part of National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Human Brain Expression Consortium (UKBEC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Rosetrees Trust(Rosetrees Trust); Action Medical Research; Great Ormond Street Hospital Childrens Charity; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all our patients and their families for taking part in this study and encouraging international collaboration to seek out similar cases. Thanks are given to M. Ishida (GOS-ICH) for kindly providing the fetal cDNA, K. Tuschl (GOS-ICH) for kindly providing the human cDNA panel, L. Bassioni (Great Ormond Street Hospital, GOSH) for kindly selecting DaTSCAN images for the supplementary manuscript, M. Adams (National Hospital for Neurology and Neurosurgery, NHNN) for reviewing the imaging of the patients at NHNN and R. Meijer for helping with the sequencing analysis at the Department of Human Genetics (Nijmegen). We thank G. Moore (GOS-ICH) and P. Stanier (GOS-ICH) for proofreading the manuscript. Many thanks are given to A. Panahian-Jand (GOSH) for excellent administrative support. M.A.K. has a Wellcome Intermediate Clinical Fellowship (WT098524MA). E.M. and M.A.K. received funding from the Rosetrees Trust, the Great Ormond Street Hospital Children's Charity and the Gracious Heart Foundation. N.E.M. receives support from the UK Department of Health's NIHR Biomedical Research Centers funding streams. A. Papandreou has a joint Action Medical Research/British Paediatric Neurology Association Research Training Fellowship. J. Ng has an MRC Research Training Fellowship. A.N. has an Action Medical Research Training Fellowship. H.B.-P. has a DBS training travel grant from the Daniel Turnberg Trust Fund. H.H. is funded by the MRC and Wellcome Trust (Synaptopathies award). D.A. is supported by the Prusiner-Abramsky Award. H.P. has received grant support from the Dystonia Society (UK). K.J.P. has an Academy of Medical Sciences Clinical Starter Grant. B.P.-D. received funding from grants 20143130-La Marato de TV3 and PI15/00287-Ministerio Espanol de Economia y Competitividad. J.-P.L. has been supported by Guy's and St Thomas' Charity New Services and Innovation Grant G060708, the Dystonia Society (UK), grants 01/2011 and 07/2013 and an Action Medical Research, AMR-GN2097. This research was supported by the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust, University College London and University of Cambridge and by funding from the NIHR for the BioResource for Rare Diseases (grant RG65966). This study makes use of data generated by the DECIPHER community. A full list of centers contributing to the generation of the data is available from http://decipher.sanger.ac.uk/ and via e-mail from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust for UK10K (WT091310) and the DDD study. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003); see http://www.ddduk.org/access.html for full acknowledgment. This work was supported in part by the Intramural Research Program of the National Human Genome Research Institute and the Common Fund, NIH Office of the Director. This work was supported in part by the German Ministry of Research and Education (grants 0IGS08160 and 01GS08167; German Mental Retardation Network) as part of the National Genome Research Network to A.R. and D.W., and by the Deutsche Forschungsgemeinschaft (AB393/2-2) to A.R. Brain expression data were provided by the UK Human Brain Expression Consortium (UKBEC), which comprises John A. Hardy, Mina Ryten, Michael Weale, Daniah Trabzuni, Adaikalavan Ramasamy, Colin Smith and Robert Walker, affiliated with the UCL Institute of Neurology (J.A.H., M.R. and D.T.), King's College London (M.R., M.W. and A.R.) and the University of Edinburgh (C.S. and R.W.).	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Balint B, 2015, EUR J NEUROL, V22, P610, DOI 10.1111/ene.12650; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Charlesworth G, 2013, BRAIN, V136, P2017, DOI 10.1093/brain/awt138; Chubb JR, 2006, DEV BIOL, V292, P519, DOI 10.1016/j.ydbio.2005.12.054; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dale RC, 2012, DEV MED CHILD NEUROL, V54, P618, DOI 10.1111/j.1469-8749.2012.04287.x; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jakovcevski M, 2015, J NEUROSCI, V35, P5097, DOI 10.1523/JNEUROSCI.3004-14.2015; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin JP, 2014, J NEUROL NEUROSUR PS, V85, P1239, DOI 10.1136/jnnp-2013-307041; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Malan V, 2009, J MED GENET, V46, P635, DOI 10.1136/jmg.2008.062034; Marras K. C., 2003, GENEREVIEWS; Meyer E, 2015, ANNU REV GENOM HUM G, V16, P257, DOI 10.1146/annurev-genom-090314-025011; Micale L, 2014, HUM MUTAT, V35, P841, DOI 10.1002/humu.22547; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ozelius L., 1999, GENEREVIEWS; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Shanker Vicki, 2016, Continuum (Minneap Minn), V22, P1227, DOI 10.1212/CON.0000000000000352; Shao GB, 2014, IN VITRO CELL DEV-AN, V50, P603, DOI 10.1007/s11626-014-9741-6; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Wang Y, 2014, GENOMICS, V103, P222, DOI 10.1016/j.ygeno.2014.02.002; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	40	129	135	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					223	237		10.1038/ng.3740	http://dx.doi.org/10.1038/ng.3740			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992417	Green Submitted, Green Accepted			2022-12-17	WOS:000393148600011
J	Chung, CC; Kanetsky, PA; Wang, ZM; Hildebrandt, MAT; Koster, R; Skotheim, RI; Kratz, CP; Turnbull, C; Cortessis, VK; Bakken, AC; Bishop, DT; Cook, MB; Erickson, RL; Fossa, SD; Jacobs, KB; Korde, LA; Kraggerud, SM; Lothe, RA; Loud, JT; Rahman, N; Skinner, EC; Thomas, DC; Wu, XF; Yeager, M; Schumacher, FR; Greene, MH; Schwartz, SM; McGlynn, KA; Chanock, SJ; Nathanson, KL				Chung, Charles C.; Kanetsky, Peter A.; Wang, Zhaoming; Hildebrandt, Michelle A. T.; Koster, Roelof; Skotheim, Rolf I.; Kratz, Christian P.; Turnbull, Clare; Cortessis, Victoria K.; Bakken, Anne C.; Bishop, D. Timothy; Cook, Michael B.; Erickson, R. Loren; Fossa, Sophie D.; Jacobs, Kevin B.; Korde, Larissa A.; Kraggerud, Sigrid M.; Lothe, Ragnhild A.; Loud, Jennifer T.; Rahman, Nazneen; Skinner, Eila C.; Thomas, Duncan C.; Wu, Xifeng; Yeager, Meredith; Schumacher, Fredrick R.; Greene, Mark H.; Schwartz, Stephen M.; McGlynn, Katherine A.; Chanock, Stephen J.; Nathanson, Katherine L.			Meta-analysis identifies four new loci associated with testicular germ cell tumor	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MIXED LINEAGE KINASE; MARIJUANA USE; LINKAGE DISEQUILIBRIUM; DOMAIN-LIKE; CANCER; PROTEIN; BREAST; RISK; SUSCEPTIBILITY	We conducted a meta-analysis to identify new susceptibility loci for testicular germ cell tumor (TGCT). In the discovery phase, we analyzed 931 affected individuals and 1,975 controls from 3 genome-wide association studies (GWAS). We conducted replication in 6 independent sample sets comprising 3,211 affected individuals and 7,591 controls. In the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 x 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 x 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 x 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 x 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 x 10(-9)), a locus that includes TEX14, RAD51C and PPM1E. These new TGCT susceptibility loci contain biologically plausible genes encoding proteins important for male germ cell development, chromosomal segregation and the DNA damage response.	[Chung, Charles C.; Wang, Zhaoming; Kratz, Christian P.; Cook, Michael B.; Jacobs, Kevin B.; Korde, Larissa A.; Loud, Jennifer T.; Yeager, Meredith; Greene, Mark H.; McGlynn, Katherine A.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, US Natl Inst Hlth, US Dept HHS, Bethesda, MD 20892 USA; [Chung, Charles C.; Wang, Zhaoming; Jacobs, Kevin B.; Yeager, Meredith] NCI Frederick, Canc Genome Res Lab, Div Canc Epidemiol & Genet, SAIC Frederick, Frederick, MD USA; [Kanetsky, Peter A.; Nathanson, Katherine L.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kanetsky, Peter A.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Koster, Roelof; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Dept Med Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Skotheim, Rolf I.; Bakken, Anne C.; Kraggerud, Sigrid M.; Lothe, Ragnhild A.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Norwegian Radium Hosp, Oslo, Norway; [Skotheim, Rolf I.; Bakken, Anne C.; Kraggerud, Sigrid M.; Lothe, Ragnhild A.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Cortessis, Victoria K.; Thomas, Duncan C.; Schumacher, Fredrick R.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Bishop, D. Timothy] St James Univ Hosp, Leeds Inst Mol Med, Sect Epidemiol & Biostat, Canc Res UK Clin Ctr Leeds, Leeds, W Yorkshire, England; [Erickson, R. Loren] Walter Reed Army Inst Res, Silver Spring, MD USA; [Fossa, Sophie D.] Univ Oslo, Dept Oncol, Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway; [Korde, Larissa A.] Univ Washington, Div Med Oncol, Seattle Canc Care Alliance, Seattle, WA 98195 USA; [Skinner, Eila C.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Schwartz, Stephen M.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Schwartz, Stephen M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Oslo; University of Oslo; University of London; Institute of Cancer Research - UK; University of Southern California; Cancer Research UK; Saint James's University Hospital; University of Leeds; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Oslo; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Stanford University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Nathanson, KL (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	knathans@exchange.upenn.edu	Skotheim, Rolf I./H-6192-2017; Yeager, Meredith/AAA-5322-2020; Kratz, Christian/AAC-9726-2021; Koster, Roelof/E-2158-2016; Turnbull, Clare/AAA-6596-2019; Schumacher, Fredrick/R-6043-2019; Cook, Michael B/A-5641-2009; Wang, Zhaoming/R-5527-2018; Rahman, Nazneen/D-2802-2013	Skotheim, Rolf I./0000-0002-5609-4048; Koster, Roelof/0000-0003-1424-8579; Schumacher, Fredrick/0000-0002-3073-7463; Cook, Michael B/0000-0002-0533-7302; Wang, Zhaoming/0000-0001-7556-3869; Nathanson, Katherine/0000-0002-6740-0901; Schwartz, Stephen/0000-0001-7499-8502; Rahman, Nazneen/0000-0003-4376-0440; Turnbull, Clare/0000-0002-1734-5772; Cortessis, Victoria/0000-0002-2339-1089; Jacobs, Kevin/0000-0002-4657-6473; Lothe, Ragnhild A./0000-0002-1693-1032; Bishop, Tim/0000-0002-8752-8785	Intramural Research Program of the NCI; Westat, Inc. [HHSN261200655004C]; Abramson Cancer Center at the University of Pennsylvania; US National Institutes of Health grant [R01CA114478, R01CA085914]; Multiethnic Cohort Study [NCI U01-CA98758]; California Cancer Research Program [99-00505V-10260, 03-00174VRS-30021]; NCI grant [R01CA102042]; Whittier Foundation; Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment; MD Anderson Senior Research Trust Fellowship; Institute of Cancer Research; Wellcome Trust; Norwegian Cancer Society; Health Region South-Eastern Norway; Norwegian ExtraFoundation for Health and Rehabilitation; Cancer Research UK; NATIONAL CANCER INSTITUTE [P30CA016672, ZIACP010144, P30CA016520, U01CA098758, R01CA114478, R01CA102042, R01CA085914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; Cancer Research UK [10589] Funding Source: researchfish	Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Westat, Inc.; Abramson Cancer Center at the University of Pennsylvania; US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiethnic Cohort Study; California Cancer Research Program; NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Whittier Foundation; Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment; MD Anderson Senior Research Trust Fellowship; Institute of Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Health Region South-Eastern Norway; Norwegian ExtraFoundation for Health and Rehabilitation; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK)	A portion of this work was supported by the Intramural Research Program of the NCI and by support services contract HHSN261200655004C with Westat, Inc. The Penn GWAS (UPENN) and replication effort for the TestPAC study were supported by the Abramson Cancer Center at the University of Pennsylvania and US National Institutes of Health grant R01CA114478 to P.A.K. and K.L.N. The replication effort for the ATLAS study was supported by US National Institutes of Health grant R01CA085914 to S.M.S. The analysis of the USC GWAS controls was supported by the Multiethnic Cohort Study (NCI U01-CA98758). The analyses of the USC GWAS testicular cases and the Familial Study were supported by the California Cancer Research Program (99-00505V-10260 and 03-00174VRS-30021) and by an NCI grant (R01CA102042) to V.K.C. and a Whittier Foundation award to the Norris Comprehensive Cancer Center. The study at MD Anderson was supported by the Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment and by an MD Anderson Senior Research Trust Fellowship to X.W. The UK testicular cancer study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust and made use of control data generated by the Wellcome Trust Case Control Consortium 2 (WTCCC2). Support was provided by the Norwegian Cancer Society to R.A.L. and R.I.S., by Health Region South-Eastern Norway to R.A.L. and S.D.F., and by the Norwegian ExtraFoundation for Health and Rehabilitation to S.D.F.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; ATKIN NB, 1982, LANCET, V2, P1349; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P519, DOI 10.1007/BF00054160; Bromen K, 2004, CANCER EPIDEM BIOMAR, V13, P1316; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chia VM, 2009, INT J CANCER, V124, P952, DOI 10.1002/ijc.23971; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; Daling JR, 2009, CANCER, V115, P1215, DOI 10.1002/cncr.24159; Fearnhead P, 2002, J ROY STAT SOC B, V64, P657, DOI 10.1111/1467-9868.00355; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Ferlin A, 2012, ENDOCR-RELAT CANCER, V19, P101, DOI 10.1530/ERC-11-0340; Fu XY, 2010, P NATL ACAD SCI USA, V107, P4579, DOI 10.1073/pnas.0912094107; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guo YL, 2010, J MED GENET, V47, P616, DOI 10.1136/jmg.2009.074252; Heimdal K, 1996, BRIT J CANCER, V73, P970, DOI 10.1038/bjc.1996.174; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Howlader N, 2012, SEER CANC STAT REV 1; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ishida A, 2008, BRIT J PHARMACOL, V154, P729, DOI 10.1038/bjp.2008.127; Iwanaga Y, 2002, J BIOL CHEM, V277, P31005, DOI 10.1074/jbc.M110666200; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Karlberg S, 2004, NEW ENGL J MED, V351, P2559, DOI 10.1056/NEJM200412093512423; Karlberg S, 2011, J CLIN ENDOCR METAB, V96, P3399, DOI 10.1210/jc.2011-1493; Kim SJ, 2012, P NATL ACAD SCI USA, V109, P6549, DOI 10.1073/pnas.1118210109; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lacson JCA, 2012, CANCER-AM CANCER SOC, V118, P5374, DOI 10.1002/cncr.27554; Li N, 2003, GENETICS, V165, P2213; Liu SF, 2011, J BIOL CHEM, V286, P22314, DOI 10.1074/jbc.M111.222802; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; McGlynn KA, 2012, NAT REV UROL, V9, P339, DOI 10.1038/nrurol.2012.61; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Monda G, 2012, MOL CELL, V45, P680, DOI 10.1016/j.molcel.2012.01.013; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; Neale RE, 2008, BRIT J CANCER, V98, P171, DOI 10.1038/sj.bjc.6604136; Park JM, 2007, CANCER RES, V67, P881, DOI 10.1158/0008-5472.CAN-05-3767; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; RODRIGUEZ E, 1992, CANCER RES, V52, P2285; Rosen A, 2011, EUR UROL, V60, P374, DOI 10.1016/j.eururo.2011.05.004; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Schoor M, 1999, MECH DEVELOP, V85, P73, DOI 10.1016/S0925-4773(99)00090-8; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Skotheim RI, 2006, CELL ONCOL, V28, P315; Sonneveld DJA, 1999, EUR J CANCER, V35, P1368, DOI 10.1016/S0959-8049(99)00140-9; Stang A, 2012, INT J ANDROL, V35, P616, DOI 10.1111/j.1365-2605.2011.01245.x; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Trabert B, 2011, CANCER-AM CANCER SOC, V117, P848, DOI 10.1002/cncr.25499; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	70	129	134	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					680	+		10.1038/ng.2634	http://dx.doi.org/10.1038/ng.2634			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23666239	Green Accepted			2022-12-17	WOS:000319563900017
J	Holliday, EG; Maguire, JM; Evans, TJ; Koblar, SA; Jannes, J; Sturm, JW; Hankey, GJ; Baker, R; Golledge, J; Parsons, MW; Malik, R; McEvoy, M; Biros, E; Lewis, MD; Lincz, LF; Peel, R; Oldmeadow, C; Smith, W; Moscato, P; Barlera, S; Bevan, S; Bis, JC; Boerwinkle, E; Boncoraglio, GB; Brott, TG; Brown, RD; Cheng, YC; Cole, JW; Cotlarciuc, I; Devan, WJ; Fornage, M; Furie, KL; Gretarsdottir, S; Gschwendtner, A; Ikram, MA; Longstreth, WT; Meschia, JF; Mitchell, BD; Mosley, TH; Nalls, MA; Parati, EA; Psaty, BM; Sharma, P; Stefansson, K; Thorleifsson, G; Thorsteinsdottir, U; Traylor, M; Verhaaren, BFJ; Wiggins, KL; Worrall, BB; Sudlow, C; Rothwell, PM; Farrall, M; Dichgans, M; Rosand, J; Markus, HS; Scott, RJ; Levi, C; Attia, J				Holliday, Elizabeth G.; Maguire, Jane M.; Evans, Tiffany-Jane; Koblar, Simon A.; Jannes, Jim; Sturm, Jonathan W.; Hankey, Graeme J.; Baker, Ross; Golledge, Jonathan; Parsons, Mark W.; Malik, Rainer; McEvoy, Mark; Biros, Erik; Lewis, Martin D.; Lincz, Lisa F.; Peel, Roseanne; Oldmeadow, Christopher; Smith, Wayne; Moscato, Pablo; Barlera, Simona; Bevan, Steve; Bis, Joshua C.; Boerwinkle, Eric; Boncoraglio, Giorgio B.; Brott, Thomas G.; Brown, Robert D., Jr.; Cheng, Yu-Ching; Cole, John W.; Cotlarciuc, Ioana; Devan, William J.; Fornage, Myriam; Furie, Karen L.; Gretarsdottir, Solveig; Gschwendtner, Andreas; Ikram, M. Arfan; Longstreth, W. T., Jr.; Meschia, James F.; Mitchell, Braxton D.; Mosley, Thomas H.; Nalls, Michael A.; Parati, Eugenio A.; Psaty, Bruce M.; Sharma, Pankaj; Stefansson, Kari; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Traylor, Matthew; Verhaaren, Benjamin F. J.; Wiggins, Kerri L.; Worrall, Bradford B.; Sudlow, Cathie; Rothwell, Peter M.; Farrall, Martin; Dichgans, Martin; Rosand, Jonathan; Markus, Hugh S.; Scott, Rodney J.; Levi, Christopher; Attia, John		Australian Stroke Genetics Collabo; International Stroke Genetics Cons; Wellcome Trust Case Control Consor	Common variants at 6p21.1 are associated with large artery atherosclerotic stroke	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; L GENE-CLUSTER; ISCHEMIC-STROKE; HERITABILITY; RISK; CLASSIFICATION; VISUALIZATION; METAANALYSIS; PHENOTYPES; LESIONS	Genome-wide association studies (GWAS) have not consistently detected replicable genetic risk factors for ischemic stroke, potentially due to etiological heterogeneity of this trait. We performed GWAS of ischemic stroke and a major ischemic stroke subtype (large artery atherosclerosis, LAA) using 1,162 ischemic stroke cases (including 421 LAA cases) and 1,244 population controls from Australia. Evidence for a genetic influence on ischemic stroke risk was detected, but this influence was higher and more significant for the LAA subtype. We identified a new LAA susceptibility locus on chromosome 6p21.1 (rs556621: odds ratio (OR) = 1.62, P = 3.9 x 10(-8)) and replicated this association in 1,715 LAA cases and 52,695 population controls from 10 independent population cohorts (meta-analysis replication OR = 1.15, P = 3.9 x 10(-4); discovery and replication combined OR = 1.21, P = 4.7 x 10(-8)). This study identifies a genetic risk locus for LAA and shows how analyzing etiological subtypes may better identify genetic risk alleles for ischemic stroke.	[Holliday, Elizabeth G.; McEvoy, Mark; Peel, Roseanne; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Holliday, Elizabeth G.; Evans, Tiffany-Jane; Moscato, Pablo; Scott, Rodney J.; Attia, John] Hunter Med Res Inst, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW, Australia; [Maguire, Jane M.] Univ Newcastle, Sch Nursing & Midwifery, Newcastle, NSW 2300, Australia; [Maguire, Jane M.; Parsons, Mark W.; Lincz, Lisa F.; Levi, Christopher] Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW 2300, Australia; [Maguire, Jane M.; Sturm, Jonathan W.] Gosford Hosp, Cent Coast Area Hlth, Dept Neurosci, Gosford, NSW, Australia; [Evans, Tiffany-Jane; Lincz, Lisa F.; Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Koblar, Simon A.; Jannes, Jim; Lewis, Martin D.] Univ Adelaide, Sch Med, Stroke Res Program, Adelaide, SA, Australia; [Koblar, Simon A.; Jannes, Jim] Queen Elizabeth Hosp, Dept Neurol, Stroke Unit, Adelaide, SA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Baker, Ross] Royal Perth Hosp, Dept Haematol, Perth, WA, Australia; [Baker, Ross] Murdoch Univ, Ctr Thrombosis & Haemophilia, Perth, WA, Australia; [Golledge, Jonathan; Biros, Erik] James Cook Univ, Sch Med & Dent, Vasc Biol Unit, Townsville, Qld, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc Surg, Townsville, Qld, Australia; [Malik, Rainer; Gschwendtner, Andreas; Dichgans, Martin] Univ Munich, Inst Stroke & Dementia Res ISD, Med Ctr, Klinikum Univ Munchen, Munich, Germany; [McEvoy, Mark; Peel, Roseanne; Smith, Wayne] Hunter Med Res Inst, Publ Hlth Res Program, Newcastle, NSW, Australia; [Lewis, Martin D.] Univ Adelaide, Discipline Genet, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Lincz, Lisa F.] Calvary Mater Newcastle Hosp, Hunter Haematol Res Grp, Newcastle, NSW, Australia; [Oldmeadow, Christopher] Hunter Med Res Inst, Clin Res Design IT & Stat Support Unit, Newcastle, NSW, Australia; [Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Newcastle, NSW 2300, Australia; [Barlera, Simona] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Bevan, Steve; Traylor, Matthew; Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Ctr, London, England; [Bis, Joshua C.; Psaty, Bruce M.; Wiggins, Kerri L.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Boerwinkle, Eric; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Boerwinkle, Eric; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX USA; [Boncoraglio, Giorgio B.; Parati, Eugenio A.] Ist Neurol Carlo Besta, Dept Cerebrovasc Dis, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Brott, Thomas G.; Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Brown, Robert D., Jr.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Cheng, Yu-Ching; Mitchell, Braxton D.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Cole, John W.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; [Cole, John W.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Cotlarciuc, Ioana; Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, ICCRU, London, England; [Devan, William J.; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Devan, William J.; Furie, Karen L.; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Devan, William J.; Furie, Karen L.; Rosand, Jonathan] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gretarsdottir, Solveig; Stefansson, Kari; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur] deCODE Genet, Reykjavik, Iceland; [Ikram, M. Arfan; Verhaaren, Benjamin F. J.] Univ Med Ctr, Erasmus Med Ctr MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan; Verhaaren, Benjamin F. J.] Erasmus MC Univ Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Longstreth, W. T., Jr.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Med, Seattle, WA USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Nalls, Michael A.] NIA, Lab Neurogenet, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth, Seattle, WA USA; [Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Sudlow, Cathie] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Rothwell, Peter M.] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Scott, Rodney J.] Hunter Area Pathol Serv, Div Genet, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; Florey Institute of Neuroscience & Mental Health; University of Newcastle; University of Adelaide; Royal Perth Hospital; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Murdoch University; James Cook University; University of Munich; Hunter Medical Research Institute; University of Newcastle; University of Adelaide; Calvary Mater Newcastle Hospital; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; St Georges University London; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; IRCCS Istituto Neurologico Besta; Mayo Clinic; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; Imperial College London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Iceland; University of Virginia; University of Edinburgh; University of Edinburgh; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Holliday, EG (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia.	liz.holliday@newcastle.edu.au	Verhaaren, Benjamin F.J./R-1450-2016; MOSCATO, PABLO ALBERTO/G-7668-2013; Stefansson, Kari/AAE-7187-2019; Jannes, Jim/O-7906-2018; Ikram, M. Arfan/AAM-5225-2021; Hankey, Graeme J/H-4968-2014; Dichgans, Martin/HCH-3247-2022; sharma, pankaj/HGE-4423-2022; Sander-Effron, Samuel/AAX-2231-2020; Scott, Rodney J/B-2827-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022; Mitchell, Braxton/CAF-0876-2022; Boncoraglio, Giorgio Battista/B-8647-2011; Parati, Eugenio Agostino/AAN-5893-2021; Lewis, Martin/A-3881-2010; Baker, Ross/AAG-5798-2021; EVANS, TIFFANY-JANE/G-8001-2013; Brown, Matthew A/E-5749-2010; Rothwell, Peter/ABE-5913-2020; Maguire, Jane M.M./D-8427-2017; Parsons, Mark W./G-3750-2014; Peel, Roseanne/G-7726-2013; Meschia, James/GPP-1636-2022; Attia, John R/F-5376-2013; golledge, jonathan/I-2371-2013	Jannes, Jim/0000-0003-1440-2572; Hankey, Graeme J/0000-0002-6044-7328; Dichgans, Martin/0000-0002-0654-387X; Scott, Rodney J/0000-0001-7724-3404; Boncoraglio, Giorgio Battista/0000-0002-2551-525X; Parati, Eugenio Agostino/0000-0001-5020-6523; Baker, Ross/0000-0002-2728-6788; EVANS, TIFFANY-JANE/0000-0001-7525-461X; Brown, Matthew A/0000-0003-0538-8211; Rothwell, Peter/0000-0001-9739-9211; Maguire, Jane M.M./0000-0001-5722-8311; Peel, Roseanne/0000-0001-9912-3198; Meschia, James/0000-0002-4475-8142; Attia, John R/0000-0001-9800-1308; Levi, Christopher/0000-0002-9474-796X; Sudlow, Cathie/0000-0002-7725-7520; Malik, Rainer/0000-0001-9212-2520; Oldmeadow, Christopher/0000-0001-6104-1322; Verhaaren, Benjamin/0000-0003-3477-9350; Koblar, Simon/0000-0002-8667-203X; Moscato, Pablo/0000-0003-2570-5966; Wiggins, Kerri L/0000-0003-2749-1279; McEvoy, Mark/0000-0002-5505-5557; Lewis, Martin/0000-0002-3332-3776; Ikram, Mohammad Arfan/0000-0003-0372-8585; Mitchell, Braxton/0000-0003-4920-4744; Lincz, Lisa/0000-0002-1612-2382; Bevan, Steve/0000-0003-0490-6830; Traylor, Matthew/0000-0001-6624-8621	University of Newcastle; Australian National Health and Medical Research Council (NHMRC) [569257]; Australian National Heart Foundation (NHF) [G 04S 1623]; Gladys M Brawn Fellowship scheme; Vincent Fairfax Family Foundation in Australia; Australian Office of Health and Medical Research; Wellcome Trust [085475/B/08/Z, 085475/Z/08/Z, WT084724MA, 090532/Z/09/Z]; European Community [LSHM-CT-2007037273]; AstraZeneca; US National Institute of Neurological Disorders and Stroke [U01NS069208]; Netherlands Heart Foundation [2009B102]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL105756, R01HL087641, R41HL055019, R42HL055018, R01HL086694, R01HL073410, R01HL093029, R41HL055018, U01HL096917, R01HL087676, R01HL085251] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004446, U01HG004436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069208, P50NS051343, R01NS045012, K23NS042720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015, Z01AG000015, Z01AG000954] Funding Source: NIH RePORTER; Medical Research Council [G0500987] Funding Source: researchfish; MRC [G0500987] Funding Source: UKRI	University of Newcastle; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian National Heart Foundation (NHF)(National Heart Foundation of Australia); Gladys M Brawn Fellowship scheme; Vincent Fairfax Family Foundation in Australia; Australian Office of Health and Medical Research; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); AstraZeneca(AstraZeneca); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Netherlands Heart Foundation(Netherlands Heart Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A complete list of funding acknowledgments is included in the Supplementary Note. We are grateful to the participants with ischemic stroke and also to their families for participating in this study. Australian population control data were derived from the Hunter Community Study. We also thank the University of Newcastle for funding and the men and women of the Hunter region who participated in this study. This research was funded by grants from the Australian National Health and Medical Research Council (NHMRC; project grant 569257), the Australian National Heart Foundation (NHF; project grant G 04S 1623), the University of Newcastle, the Gladys M Brawn Fellowship scheme and the Vincent Fairfax Family Foundation in Australia. E.G.H. is supported by the Australian NHMRC Fellowship scheme. J.G. is supported by a Practitioner Fellowship from the NHMRC and a Senior Clinical Research Fellowship from the Australian Office of Health and Medical Research. The principal funding for the Wellcome Trust Case Control Consortium 2 (WTCCC2) ischemic stroke study was provided by the Wellcome Trust, as part of the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z and WT084724MA). This work was also supported by the European Community's Sixth Framework Programme (LSHM-CT-2007037273), the Wellcome Trust core award (090532/Z/09/Z) and AstraZeneca. M. Farrall is a member of the Oxford British Heart Foundation (BHF) Centre of Research Excellence. The Siblings with Ischemic Stroke Study (SWISS) and the Ischemic Stroke Genetics Study (ISGS) were funded by grants from the US National Institute of Neurological Disorders and Stroke. Additional funding was provided by the US National Institute of Neurological Disorders and Stroke (U01NS069208). The Rotterdam Study received principal funding for this report from the Netherlands Heart Foundation (grant 2009B102).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Duchateau PN, 2000, J LIPID RES, V41, P1231; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Flossmann E, 2005, CEREBROVASC DIS, V19, P1, DOI 10.1159/000081905; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horrevoets AJG, 1999, BLOOD, V93, P3418, DOI 10.1182/blood.V93.10.3418.410k23_3418_3431; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Moskau S, 2005, STROKE, V36, P5, DOI 10.1161/01.STR.0000149936.33498.83; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Smith JG, 2009, CIRC-CARDIOVASC GENE, V2, P159, DOI 10.1161/CIRCGENETICS.108.835173; StataCorp, 2009, STAT REL 11 STAT SOF; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Turner ST, 2004, HYPERTENSION, V43, P483, DOI 10.1161/01.HYP.0000112303.26158.92; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; World Health Organization, 2004, ATLAS HEART DIS STRO; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	37	129	135	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1147	+		10.1038/ng.2397	http://dx.doi.org/10.1038/ng.2397			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22941190	Green Accepted			2022-12-17	WOS:000309550200017
J	Ucar, A; Vafaizadeh, V; Jarry, H; Fiedler, J; Klemmt, PAB; Thum, T; Groner, B; Chowdhury, K				Ucar, Ahmet; Vafaizadeh, Vida; Jarry, Hubertus; Fiedler, Jan; Klemmt, Petra A. B.; Thum, Thomas; Groner, Bernd; Chowdhury, Kamal			miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development	NATURE GENETICS			English	Article							TGF-BETA; BRANCHING MORPHOGENESIS; IN-VIVO; MICRORNA; GROWTH; EXPRESSION; RECEPTOR; CELLS; AMPHIREGULIN; MAINTENANCE	MicroRNAs are small noncoding RNAs that carry out post-transcriptional regulation of the expression of their target genes. However, their roles in mammalian organogenesis are only beginning to be understood. Here we show that the microRNA-212/132 family ( which comprises miR-212 and miR-132) is indispensable during the development of the mammary glands in mice, particulary for the regulation of the outgrowth of the epithelial ducts. Mammary transplantation experiments revealed that the function of the miR-212/132 family is required in the stroma but not in the epithelia. Both miR-212 and miR-132 are expressed exclusively in mammary stroma and directly target the matrix metalloproteinase MMP-9. In glands that lack miR-212 and miR-132, MMP-9 expression increases and accumulates around the ducts. This may interfere with collagen deposition and lead to hyperactivation of the tumor growth factor-beta signaling pathway, thereby impairing ductal outgrowth. Our results identify the miR-212/132 family as one of the main regulators of the epithelial-stromal interactions that are required for proper pubertal development of the mammary gland.	[Ucar, Ahmet; Chowdhury, Kamal] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Vafaizadeh, Vida; Klemmt, Petra A. B.; Groner, Bernd] Inst Biomed Res, Frankfurt, Germany; [Jarry, Hubertus] Univ Gottingen, Dept Endocrinol, Gottingen, Germany; [Fiedler, Jan] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany	Max Planck Society; University of Gottingen; Hannover Medical School	Chowdhury, K (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany.	kchowdh@gwdg.de	Ucar, Ahmet/E-8981-2012	Ucar, Ahmet/0000-0002-6551-3486; Thum, Thomas/0000-0003-4360-1511; Vafaizadeh, Vida/0000-0002-0875-6246	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [GR 536/9-2, GR 536/11-1, TH 903/7-2]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank S. Geisendorf for technical assistance, S. Hille for DNA sequencing, S. Mahsur and U. Franke for technical help in generation of knockout mouse line, A. Kurth, A. Driehorst, K. Kiel and U. Teichman for animal care work, M. Smalley for discussion about mammary epithelial transplantation method, N. Ba Tiep for technical help with collecting blood samples, A. Yalcin for creative contribution to the initial phase of the work, and P. Gruss and G. Eichele for encouragement and support. Funded by the Max Planck Society. Additional funding was provided by the Deutsche Forschungsgemeinschaft (DFG, GR 536/9-2 and GR 536/11-1 to B.G. and TH 903/7-2 to T.T.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Daniel CW, 1996, J MAMMARY GLAND BIOL, V1, P331, DOI 10.1007/BF02017389; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Howlin J, 2006, ONCOGENE, V25, P1532, DOI 10.1038/sj.onc.1209183; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Konrad L, 2009, REGUL PEPTIDES, V155, P28, DOI 10.1016/j.regpep.2009.04.012; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; Okamoto T, 2009, BIOCHEM BIOPH RES CO, V383, P475, DOI 10.1016/j.bbrc.2009.04.038; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Rasmussen S. B., 2000, METHODS MAMMARY GLAN, P75; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; Sangai T, 2006, BIOCHEM BIOPH RES CO, V346, P1173, DOI 10.1016/j.bbrc.2006.06.025; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; SILBERSTEIN GB, 1990, J CELL BIOL, V110, P2209, DOI 10.1083/jcb.110.6.2209; Sinpitaksakul SN, 2008, BIOCHEM BIOPH RES CO, V371, P713, DOI 10.1016/j.bbrc.2008.04.128; Smibert P, 2008, CELL CYCLE, V7, P2500, DOI 10.4161/cc.7.16.6454; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Wilson TJ, 2009, MOL CANCER RES, V7, P1224, DOI 10.1158/1541-7786.MCR-09-0028; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Young LJT, 2000, METHODS MAMMARY GLAN, P67; Yu Q, 2000, GENE DEV, V14, P163; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	48	129	137	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2010	42	12					1101	U100		10.1038/ng.709	http://dx.doi.org/10.1038/ng.709			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057503	Green Published			2022-12-17	WOS:000284578800013
J	Petretto, E; Sarwar, R; Grieve, I; Lu, H; Kumaran, MK; Muckett, PJ; Mangion, J; Schroen, B; Benson, M; Punjabi, PP; Prasad, SK; Pennell, DJ; Kiesewetter, C; Tasheva, ES; Corpuz, LM; Webb, MD; Conrad, GW; Kurtz, TW; Kren, V; Fischer, J; Hubner, N; Pinto, YM; Pravenec, M; Aitman, TJ; Cook, SA				Petretto, Enrico; Sarwar, Rizwan; Grieve, Ian; Lu, Han; Kumaran, Mande K.; Muckett, Phillip J.; Mangion, Jonathan; Schroen, Blanche; Benson, Matthew; Punjabi, Prakash P.; Prasad, Sanjay K.; Pennell, Dudley J.; Kiesewetter, Chris; Tasheva, Elena S.; Corpuz, Lolita M.; Webb, Megan D.; Conrad, Gary W.; Kurtz, Theodore W.; Kren, Vladimir; Fischer, Judith; Hubner, Norbert; Pinto, Yigal M.; Pravenec, Michal; Aitman, Timothy J.; Cook, Stuart A.			Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; CARDIAC-HYPERTROPHY; HEART-FAILURE; PRESSURE; DISEASE; ECHOCARDIOGRAPHY; IDENTIFICATION; HERITABILITY; TRANSCRIPTS; STRESS	Left ventricular mass ( LVM) and cardiac gene expression are complex traits regulated by factors both intrinsic and extrinsic to the heart. To dissect the major determinants of LVM, we combined expression quantitative trait locus(1) and quantitative trait transcript(2) ( QTT) analyses of the cardiac transcriptome in the rat. Using these methods and in vitro functional assays, we identified osteoglycin ( Ogn) as a major candidate regulator of rat LVM, with increased Ogn protein expression associated with elevated LVM. We also applied genome-wide QTT analysis to the human heart and observed that, out of similar to 22,000 transcripts, OGN transcript abundance had the highest correlation with LVM. We further confirmed a role for Ogn in the in vivo regulation of LVM in Ogn knockout mice. Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis.	[Petretto, Enrico; Sarwar, Rizwan; Grieve, Ian; Lu, Han; Kumaran, Mande K.; Muckett, Phillip J.; Mangion, Jonathan; Schroen, Blanche; Benson, Matthew; Aitman, Timothy J.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, MRC,Clin Sci Ctr, London W12 0NN, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Epidemiol Publ Hlth & Primary Care, London W2 1PG, England; [Punjabi, Prakash P.; Prasad, Sanjay K.; Pennell, Dudley J.; Kiesewetter, Chris; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Tasheva, Elena S.; Corpuz, Lolita M.; Webb, Megan D.; Conrad, Gary W.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kren, Vladimir; Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Ctr Appl Genom, Prague 14220 4, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague 12800 2, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Gen Teaching Hosp, Prague 12800 2, Czech Republic; [Fischer, Judith; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Pinto, Yigal M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Mol Genet & Rheumatol, London W12 0NN, England; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London; Kansas State University; University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; General University Hospital Prague; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, MRC,Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk; stuart.cook@imperial.ac.uk	Punjabi, Prakash P/AAG-8724-2019; Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011	Punjabi, Prakash P/0000-0002-6587-1603; Pravenec, Michal/0000-0001-9197-5871; Pennell, Dudley/0000-0001-5523-1314; Fischer-Sternjak, Judith/0000-0003-0398-7720; Benson, Matthew/0000-0003-4459-0439; Cook, Stuart/0000-0001-6628-194X; Aitman, Timothy/0000-0002-7875-4502	MRC [MC_U120085815, MC_U120061454] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY013395, R01EY000952] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120097112, MC_U120061454, MC_U120085815] Funding Source: Medline; NEI NIH HHS [EY000952, EY13395, R01 EY013395, R01 EY000952] Funding Source: Medline; Wellcome Trust [066780] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); British Heart Foundation(British Heart Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome Trust); Department of Health		Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Caruthers SD, 2003, CIRCULATION, V108, P2236, DOI 10.1161/01.CIR.0000095268.47282.A1; Cerutti C, 2006, PHYSIOL GENOMICS, V27, P295, DOI 10.1152/physiolgenomics.00318.2005; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Cook SA, 1999, CIRC RES, V85, P940; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Devereux RB, 1997, CIRCULATION, V96, P1416, DOI 10.1161/01.CIR.96.5.1416; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hashimoto J, 2007, AM J HYPERTENS, V20, P378, DOI 10.1016/j.amjhyper.2006.09.019; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Lorell BH, 2000, CIRCULATION, V102, P470; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Tasheva ES, 2002, MOL VIS, V8, P407; Tasheva ES, 1997, J BIOL CHEM, V272, P32551, DOI 10.1074/jbc.272.51.32551; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	30	129	136	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					546	552		10.1038/ng.134	http://dx.doi.org/10.1038/ng.134			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443592	Green Accepted			2022-12-17	WOS:000255366700020
J	Khaja, R; Zhang, JJ; MacDonald, JR; He, YS; Joseph-George, AM; Wei, J; Rafiq, MA; Qian, C; Shago, M; Pantano, L; Aburatani, H; Jones, K; Redon, R; Hurles, M; Armengol, L; Estivill, X; Mural, RJ; Lee, C; Scherer, SW; Feuk, L				Khaja, Razi; Zhang, Junjun; MacDonald, Jeffrey R.; He, Yongshu; Joseph-George, Ann M.; Wei, John; Rafiq, Muhammad A.; Qian, Cheng; Shago, Mary; Pantano, Lorena; Aburatani, Hiroyuki; Jones, Keith; Redon, Richard; Hurles, Matthew; Armengol, Lluis; Estivill, Xavier; Mural, Richard J.; Lee, Charles; Scherer, Stephen W.; Feuk, Lars			Genome assembly comparison identifies structural variants in the human genome	NATURE GENETICS			English	Article							DNA-SEQUENCE; POLYMORPHISMS; DATABASE	Numerous types of DNA variation exist, ranging from SNPs to larger structural alterations such as copy number variants (CNVs) and inversions. Alignment of DNA sequence from different sources has been used to identify SNPs(1,2) and intermediate-sized variants (ISVs)(3). However, only a small proportion of total heterogeneity is characterized, and little is known of the characteristics of most smaller-sized (< 50 kb) variants. Here we show that genome assembly comparison is a robust approach for identification of all classes of genetic variation. Through comparison of two human assemblies (Celera's R27c compilation and the Build 35 reference sequence), we identified megabases of sequence (in the form of 13,534 putative non-SNP events) that were absent, inverted or polymorphic in one assembly. Database comparison and laboratory experimentation further demonstrated overlap or validation for 240 variable regions and confirmed < 1.5 million SNPs. Some differences were simple insertions and deletions, but in regions containing CNVs, segmental duplication and repetitive DNA, they were more complex. Our results uncover substantial undescribed variation in humans, highlighting the need for comprehensive annotation strategies to fully interpret genome scanning and personalized sequencing projects.	Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; MaRS Ctr, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; S Inst Informat Technol, Dept Biosci, Commiss Sci & Technol Sustainable Dev, Islamabad 44000, Pakistan; Charles Darwin SN, Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Catalonia, Spain; Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Lab, Tokyo 1538904, Japan; Affymetrix Inc, Santa Clara, CA 95051 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Pompeu Fabra Univ, Barcelona, Spain; Natl Genotyping Ctr, Barcelona, Spain; Windber Res Inst, Windber, PA 15963 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; COMSATS University Islamabad (CUI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Tokyo; Affymetrix; Wellcome Trust Sanger Institute; Pompeu Fabra University; Windber Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Scherer, SW (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Redon, Richard/F-3303-2014; MacDonald, Jeffrey Robert/GLU-2255-2022; Scherer, Stephen W./B-3785-2013; Estivill, Xavier/E-2957-2012; Estivill, Xavier/A-3125-2013	Redon, Richard/0000-0001-7751-2280; Scherer, Stephen W./0000-0002-8326-1999; Estivill, Xavier/0000-0002-0723-2256; MacDonald, Jeffrey/0000-0001-5058-2393	Wellcome Trust [077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams MD, 2003, P NATL ACAD SCI USA, V100, P3025, DOI 10.1073/pnas.0637478100; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; MOBARRY C, 2003, P 3 ANN RECOMB SAT M; Myers EW, 2002, P NATL ACAD SCI USA, V99, P4145, DOI 10.1073/pnas.092136699; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; REDON R, IN PRESS NATURE; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Tsui C, 2003, NUCLEIC ACIDS RES, V31, P4910, DOI 10.1093/nar/gkg664; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Waterston RH, 2003, P NATL ACAD SCI USA, V100, P3022, DOI 10.1073/pnas.0634129100; Waterston RH, 2002, P NATL ACAD SCI USA, V99, P3712, DOI 10.1073/pnas.042692499; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	129	135	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1413	1418		10.1038/ng1921	http://dx.doi.org/10.1038/ng1921			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115057	Green Accepted			2022-12-17	WOS:000242404200018
J	Williamson, CM; Ball, ST; Nottingham, WT; Skinner, JA; Plagge, A; Turner, MD; Powles, N; Hough, T; Papworth, D; Fraser, WD; Maconochie, M; Peters, J				Williamson, CM; Ball, ST; Nottingham, WT; Skinner, JA; Plagge, A; Turner, MD; Powles, N; Hough, T; Papworth, D; Fraser, WD; Maconochie, M; Peters, J			A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas	NATURE GENETICS			English	Article							GENE; ANTISENSE; CLUSTER; IDENTIFICATION; TRANSCRIPTS; METHYLATION; MUTATIONS; DELETION; MICE; NESP	Genomic imprinting brings about allele-specific silencing according to parental origin(1). Silencing is controlled by cis-acting regulatory regions that are differentially marked during gametogenesis and can act over hundreds of kilobases to silence many genes(2-6). Two candidate imprinting control regions (ICRs) have been identified at the compact imprinted Gnas cluster on distal mouse chromosome 2, one at exon 1A upstream of Gnas itself(7) and one covering the promoters for Gnasxl and the antisense Nespas (ref. 8). This imprinted cluster is complex, containing biallelic, maternally and paternally expressed transcripts that share exons(9). Gnas itself is mainly biallelically expressed but is weakly paternally repressed in specific tissues(10). Here we show that a paternally derived targeted deletion of the germline differentially methylated region at exon 1A abolishes tissue-specific imprinting of Gnas. This rescues the abnormal phenotype of mice with a maternally derived Gnas mutation(11,12). Imprinting of alternative transcripts, Nesp, Gnasxl and Nespas (ref. 13), in the cluster is unaffected. The results establish that the differentially methylated region at exon 1A contains an imprinting control element that specifically regulates Gnas and comprises a characterized ICR for a gene that is only weakly imprinted in a minority of tissues. There must be a second ICR regulating the alternative transcripts.	MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Babraham Inst, Dev Genet Programme, Cambridge CB2 4AT, England; Univ Liverpool, Dept Clin Chem, Liverpool L69 3GA, Merseyside, England	MRC Harwell; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Liverpool	Peters, J (corresponding author), MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England.	j.peters@har.mrc.ac.uk	Williamson, Christine/GSE-3696-2022; Plagge, Antonius/AAH-3877-2019; Turner, Martin/N-9976-2014	Plagge, Antonius/0000-0001-6592-1343; Turner, Martin/0000-0002-3801-9896				Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHANDRASEKARAN B, 1994, IEEE EXPERT, V9, P2, DOI 10.1109/64.363254; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Ischia R, 1997, J BIOL CHEM, V272, P11657; KEHLENBACH RH, 1994, NATURE, V372, P804; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li T, 2000, GENOMICS, V69, P295, DOI 10.1006/geno.2000.6337; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	29	129	131	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					894	899		10.1038/ng1398	http://dx.doi.org/10.1038/ng1398			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273687				2022-12-17	WOS:000222974000025
J	Benson, KF; Li, FQ; Person, RE; Albani, D; Duan, ZJ; Wechsler, J; Meade-White, K; Williams, K; Acland, GM; Niemeyer, G; Lothrop, CD; Horwitz, M				Benson, KF; Li, FQ; Person, RE; Albani, D; Duan, ZJ; Wechsler, J; Meade-White, K; Williams, K; Acland, GM; Niemeyer, G; Lothrop, CD; Horwitz, M			Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase	NATURE GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; CATHEPSIN-G; BETA-3A SUBUNIT; SORTING SIGNALS; PROTEIN COMPLEX; AP-3 ADAPTER; DISTINCT; IDENTIFICATION; TRAFFICKING; MEMBRANES	Cyclic hematopoiesis is a stem cell disease in which the number of neutrophils and other blood cells oscillates in weekly phases. Autosomal dominant mutations of ELA2, encoding the protease neutrophil elastase(1), found in lysosome-like granules, cause cyclic hematopoiesis(2) and most cases of the pre-leukemic disorder severe congenital neutropenia (SCN; ref. 3) in humans. Over 20 different mutations of neutrophil elastase have been identified, but their consequences are elusive, because they confer no consistent effects on enzymatic activity(4). The similar autosomal recessive disease of dogs, canine cyclic hematopoiesis(5), is not caused by mutations in ELA2 ( data not shown). Here we show that homozygous mutation of the gene encoding the dog adaptor protein complex 3 (AP3) beta-subunit, directing trans-Golgi export of transmembrane cargo proteins to lysosomes, causes canine cyclic hematopoiesis. C-terminal processing of neutrophil elastase exposes an AP3 interaction signal responsible for redirecting neutrophil elastase trafficking from membranes to granules. Disruption of either neutrophil elastase or AP3 perturbs the intracellular trafficking of neutrophil elastase. Most mutations in ELA2 that cause human cyclic hematopoiesis prevent membrane localization of neutrophil elastase, whereas most mutations in ELA2 that cause SCN lead to exclusive membrane localization.	Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cornell University; Auburn University System; Auburn University	Horwitz, M (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Box 357720,1705 NE Pacific St,HSB-K236B, Seattle, WA 98195 USA.	horwitz@u.washington.edu		Horwitz, Marshall/0000-0002-1683-1680				Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; ALLEN DH, 1995, J BIOL CHEM, V270, P1408, DOI 10.1074/jbc.270.3.1408; Bainton DF, 1999, J IMMUNOL METHODS, V232, P153, DOI 10.1016/S0022-1759(99)00173-8; BIETH JG, 1998, HDB PROTEOLYTIC ENZY, P54; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; CLARK JM, 1980, J CELL BIOL, V84, P102, DOI 10.1083/jcb.84.1.102; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; FUKS A, 1983, BIOCHIM BIOPHYS ACTA, V755, P195, DOI 10.1016/0304-4165(83)90203-9; GULLBERG U, 1995, J BIOL CHEM, V270, P12912, DOI 10.1074/jbc.270.21.12912; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Kaup M, 2002, BIOL CHEM, V383, P1011, DOI 10.1515/BC.2002.108; KJELDSEN L, 1993, BLOOD, V82, P3183; Kolkenbrock H, 2000, BIOL CHEM, V381, P49, DOI 10.1515/BC.2000.007; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; LOTHROP CD, 1987, ENDOCRINOLOGY, V120, P1027, DOI 10.1210/endo-120-3-1027; Mardones G, 2003, J IMMUNOL METHODS, V275, P169, DOI 10.1016/S0022-1759(03)00015-2; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PAIGEN K, 1989, PROG NUCLEIC ACID RE, V37, P155; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Vita F, 1996, EXP CELL RES, V227, P367, DOI 10.1006/excr.1996.0286; Yang W, 2000, J CELL SCI, V113, P4077	29	129	133	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					90	96		10.1038/ng1224	http://dx.doi.org/10.1038/ng1224			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12897784				2022-12-17	WOS:000185018500016
J	Reboul, J; Vaglio, P; Tzellas, N; Thierry-Mieg, N; Moore, T; Jackson, C; Shin-i, T; Kohara, Y; Thierry-Mieg, D; Thierry-Mieg, J; Lee, H; Hitti, J; Doucette-Stamm, L; Hartley, JL; Temple, GF; Brasch, MA; Vandenhaute, J; Lamesch, PE; Hill, DE; Vidal, M				Reboul, J; Vaglio, P; Tzellas, N; Thierry-Mieg, N; Moore, T; Jackson, C; Shin-i, T; Kohara, Y; Thierry-Mieg, D; Thierry-Mieg, J; Lee, H; Hitti, J; Doucette-Stamm, L; Hartley, JL; Temple, GF; Brasch, MA; Vandenhaute, J; Lamesch, PE; Hill, DE; Vidal, M			Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C-elegans	NATURE GENETICS			English	Letter							CLONING	The genome sequences of Caenorhabditis elegans. Drosophila melanogaster and Arabidopsis thaliana have been predicted to contain 19,000, 13,600 and 25,500 genes, respectively(1-3). Before this information can be fully used for evolutionary and functional studies, several issues need to be addressed. First, the gene number estimates obtained in silico and not yet supported by any experimental data need to be verified. For example, it seems biologically paradoxical that C.elegans would have 50% more genes than Drosophilia. Second, intron/exon predictions need to be tested experimentally. Third, complete sets of open reading frames (ORFs). or "ORFeomes."(4) need to be cloned into various expression vectors. To address these issues simultaneously, we have designed and applied to C. elegans the following strategy. Predicted ORFs are amplified by PCR from a highly representative cDNA library(4) using ORF-specific primers, cloned by Gateway recombination cloning(4-6) and then sequenced to generate ORF sequence tags (OSTs) as a way to verify identity and splicing. In a sample (n=1,222) of the nearly 10,000 genes predicted ab initio (that is, for which no expressed sequence tag (EST) is available so far), at least 70% were verified by OSTs. We also observed that 27% of these experimentally confirmed genes have a structure different from that predicted by GeneFinder. We now have experimental evidence that supports the existence of at least 17,300 genes in C. elegans. Hence we suggest that gene counts based primarily on ESTs may underestimate the number of genes in human and in other organisms.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; IMAG, Lab LSR, St Martin Dheres, France; Res Genet Huntsville, Huntsville, AL USA; Natl Inst Genet, Genome Biol Lab, Mishima, Shizuoka 411, Japan; NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Genome Therapeut Corp, Waltham, MA USA; Life Technol Inc, Rockville, MD USA; Fac Univ Notre Dame Paix, Dept Biol, B-5000 Namur, Belgium	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Thermo Fisher Scientific; University of Namur	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Thierry-Mieg, Nicolas/M-6007-2014; Reboul, Jerome/P-9103-2016; Hill, David E/B-6617-2011; THIERRY-MIEG, Jean/F-1975-2017	Thierry-Mieg, Nicolas/0000-0002-7667-2853; Reboul, Jerome/0000-0002-5513-4546; THIERRY-MIEG, Jean/0000-0002-0396-6789; Vaglio, Philippe/0000-0003-2900-5596; Thierry-Mieg, Danielle/0000-0001-9568-4211	NATIONAL CANCER INSTITUTE [R21CA081658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA81658 A 01] Funding Source: Medline; NHGRI NIH HHS [R01 HG01715-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Gopal S, 2001, NAT GENET, V27, P337, DOI 10.1038/85922; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Liang F, 2000, NAT GENET, V26, P501; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X	13	129	129	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					332	336		10.1038/85913	http://dx.doi.org/10.1038/85913			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242119				2022-12-17	WOS:000167304200029
J	Clarke, G; Goldberg, AFX; Vidgen, D; Collins, L; Ploder, L; Schwarz, L; Molday, LL; Rossant, J; Szel, A; Molday, RS; Birch, DG; McInnes, RR				Clarke, G; Goldberg, AFX; Vidgen, D; Collins, L; Ploder, L; Schwarz, L; Molday, LL; Rossant, J; Szel, A; Molday, RS; Birch, DG; McInnes, RR			Rom-1 is required for rod photoreceptor viability and the regulation of disk morphogenesis	NATURE GENETICS			English	Article							RDS MUTANT MICE; MEMBRANE MORPHOGENESIS; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; RIM PROTEIN; PERIPHERIN/RDS; CLONING; CELLS; CONE; LOCALIZATION	The homologous membrane proteins Rom-1 and peripherin-2 are localized to the disk rims of photoreceptor outer segments (OSs), where they associate as tetramers and larger oligomers(1-3). Disk rims are thought to be critical for disk morphogenesis, OS renewal(4) and the maintenance of OS structure(5), but the molecules which regulate these processes are unknown. Although peripherin-2 is known to be required for OS formation (because Prph2(-/-) mice do not form OSs; ref. 6), and mutations in RDS (the human homologue of Prph2) cause retinal degeneration(7), the relationship of Rom-1 to these processes is uncertain. Here we show that Rom1(-/-) mice form OSs in which peripherin-2 homotetramers are localized to the disk rims, indicating that peripherin-2 alone is sufficient for both disk and OS morphogenesis, The disks produced in Rom1(-/-) mice were large, rod OSs were highly disorganized (a phenotype which largely normalized with age) and rod photoreceptors died slowly by apoptosis. Furthermore, the maximal photoresponse of Rom1(-/-) rod photoreceptors was lower than that of controls. We conclude that Rom-1 is required for the regulation of disk morphogenesis and the viability of mammalian rod photoreceptors, and that mutations in human ROM1 may cause recessive photoreceptor degeneration.	Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Genet Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Semmelweis Univ, Sch Med, Electron Microscopy Lab, Dept Anat Histol & Embryol 2, Budapest, Hungary	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of British Columbia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Semmelweis University	McInnes, RR (corresponding author), Hosp Sick Children, Res Inst, Program Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.			Birch, David/0000-0002-6594-2897	NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER; NEI NIH HHS [EY02422] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; GOLDBERG AFX, 1995, BIOCHEMISTRY-US, V34, P14213, DOI 10.1021/bi00043a028; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; Kedzierski W, 1999, J BIOL CHEM, V274, P29181, DOI 10.1074/jbc.274.41.29181; Kohl S, 1998, ACTA ANAT, V162, P75; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MICHON JJ, 1991, INVEST OPHTH VIS SCI, V32, P280; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; ROHLICH P, 1993, CURR EYE RES, V12, P935, DOI 10.3109/02713689309020400; Sambrook J, 1989, MOL CLONING LAB MANU; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WILLIAMS DS, 1991, BIOESSAYS, V13, P171, DOI 10.1002/bies.950130405; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	30	129	130	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					67	73		10.1038/75621	http://dx.doi.org/10.1038/75621			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802659				2022-12-17	WOS:000086884000019
J	Kazazian, HH				Kazazian, HH			An estimated frequency of endogenous insertional mutations in humans	NATURE GENETICS			English	Letter							L1; GENE		Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazazian, HH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Meischl Christof, 1998, European Journal of Haematology, V60, P349; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; Rohrer J, 1999, CLIN IMMUNOL, V90, P28, DOI 10.1006/clim.1998.4629; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Yoshida K, 1998, HUM MOL GENET, V7, P1129, DOI 10.1093/hmg/7.7.1129	15	129	129	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					130	130		10.1038/9638	http://dx.doi.org/10.1038/9638			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369250	Bronze			2022-12-17	WOS:000080680900013
J	Lewandoski, M; Martin, GR				Lewandoski, M; Martin, GR			Cre-mediated chromosome loss in mice	NATURE GENETICS			English	Article							DNA; EXPRESSION; MOUSE; YEAST; CELLS; GENE	Chromosome loss in early human embryos is thought to cause a large proportion of spontaneous abortions(1); when it occurs in specific cell lineages in older embryos or adults, it can result in neoplasia(2). Although early embryonic chromosome loss can be modelled by breeding mice carrying robertsonian translocation chromosomes(3), there is currently no method for producing mice with tissue-specific monosomies. Here we demonstrate that DNA recombination mediated by the site-specific recombinase Cre(4) causes loss of a chromosome carrying loxP sites (Cre recognition sites) in an inverted orientation. Thus, when male mice carrying a Y-linked transgene containing inverted loxP sites are mated with females carrying a cre gene that is ubiquitously expressed in the early embryo, almost all their XY progeny lose the Y chromosome early in embryogenesis and develop as XO females. Because inverted loxP sites can be targetted to any mouse chromosome and mice can be produced that express cre in specific cell lineages, these data suggest a method for engineering tissue-specific loss of particular chromosomes to provide mouse models for human diseases caused by or associated with specific monosomies.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT ANAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco				Lewandoski, Mark/0000-0002-1066-3735	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025331] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD25331] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREASON GL, 1988, BIOTECHNIQUES, V6, P650; Bouffler SD, 1996, MUTAT RES-REV GENET, V366, P129, DOI 10.1016/S0165-1110(96)90033-0; CATTANACH BM, 1962, GENET RES, V3, P487, DOI 10.1017/S0016672300003335; Epstein C.J, 1986, CONSEQUENCES CHROMOS; EPSTEIN CJ, 1985, TRENDS GENET, V1, P129, DOI 10.1016/0168-9525(85)90054-X; FALCO SC, 1982, CELL, V29, P573, DOI 10.1016/0092-8674(82)90173-8; GOLIC KG, 1994, GENETICS, V137, P551; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Heim S, 1995, CANC CYTOGENETICS; HOGAN B, 1994, MANIPULATING MOUSE E, P226; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWANDOSKI M, IN PRESS COLD SPRING; LUNAFINEMAN S, 1995, BLOOD, V85, P1985, DOI 10.1182/blood.V85.8.1985.bloodjournal8581985; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; NAGAMINE CM, 1987, NUCLEIC ACIDS RES, V15, P9227, DOI 10.1093/nar/15.22.9227; Nagy A., 1993, Gene targeting: a practical approach., P147; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M	22	129	136	2	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					223	225		10.1038/ng1097-223	http://dx.doi.org/10.1038/ng1097-223			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326948				2022-12-17	WOS:A1997XZ55500034
J	Flint, J; Thomas, K; Micklem, G; Raynham, H; Clark, K; Doggett, NA; King, A; Higgs, DR				Flint, J; Thomas, K; Micklem, G; Raynham, H; Clark, K; Doggett, NA; King, A; Higgs, DR			The relationship between chromosome structure and function at a human telomeric region	NATURE GENETICS			English	Article							GLOBIN GENE-CLUSTER; HUMAN ZETA-GLOBIN; ALPHA-THALASSEMIA; LENGTH POLYMORPHISM; REGULATORY ELEMENT; HUMAN GENOME; DNA; SEQUENCE; EXPRESSION; CHROMATIN	We have sequenced a contiguous 284,495-bp segment of DNA extending from the terminal (TTAGGC)(n) repeats of the short arm of chromosome 16, providing a full description of the transition from telomeric through subtelomeric DNA to sequences that are unique to the chromosome. To complement and extend analysis of the primary sequence, we have characterized mRNA transcripts, patterns of DNA methylation and DNase I sensitivity. Together with previous data these studies describe in detail the structural and functional organization of a human telomeric region.	JOHN RADCLIFFE HOSP, INST MOL MED, MRC, MOL HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; SANGER CTR, CAMBRIDGE CB10 1RQ, ENGLAND; LOS ALAMOS NATL LAB, DIV LIFE SCI, LOS ALAMOS, NM 87545 USA	University of Oxford; Wellcome Trust Sanger Institute; United States Department of Energy (DOE); Los Alamos National Laboratory				Micklem, Gos/0000-0002-6883-6168; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS MD, 1995, NATURE, V377, P3; BICKMORE WA, 1989, TRENDS GENET, V5, P144, DOI 10.1016/0168-9525(89)90055-3; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHENSOLAL MM, 1982, DNA-J MOLEC CELL BIO, V1, P355, DOI 10.1089/dna.1982.1.355; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; FLINT J, 1994, AM J HUM GENET, V55, P505; FOUGEROUSSE F, 1992, NUCLEIC ACIDS RES, V20, P1165, DOI 10.1093/nar/20.5.1165-a; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; GOURDON G, 1994, NUCLEIC ACIDS RES, V22, P4139, DOI 10.1093/nar/22.20.4139; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HARDISON RC, 1986, NUCLEIC ACIDS RES, V14, P1903, DOI 10.1093/nar/14.4.1903; Harris Peter C., 1993, V5, P107; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Higgs DR, 1993, CHROMOSOMES TODAY, V11, P35; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; HSU SL, 1988, NATURE, V331, P94, DOI 10.1038/331094a0; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JARMAN AP, 1988, AM J HUM GENET, V42, P8; JURKA J, 1988, NUCLEIC ACIDS RES, V16, P766, DOI 10.1093/nar/16.2.766; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; JURKA J, 1992, J MOL EVOL, V35, P286, DOI 10.1007/BF00161166; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; Kitsberg D, 1991, CURR OPIN GENET DEV, V1, P534, DOI 10.1016/S0959-437X(05)80204-7; LAMB J, 1993, AM J HUM GENET, V52, P668; LARSEN F, 1993, HUM MOL GENET, V2, P1589, DOI 10.1093/hmg/2.10.1589; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; LEUNG S, 1987, NATURE, V329, P551, DOI 10.1038/329551a0; NELLIST M, 1993, CELL, V75, P1305; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; PROUDFOOT NJ, 1980, CELL, V21, P537, DOI 10.1016/0092-8674(80)90491-2; Raynham H, 1996, QJM-MON J ASSOC PHYS, V89, P169; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHEDL P, CHROMATIN STRUCTURE; Solovyev V V, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P367; SONNHAMMER E, 1994, P INT SOC MOL BIOL, V94, P363; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VICKERS MA, 1993, P NATL ACAD SCI USA, V90, P3437, DOI 10.1073/pnas.90.8.3437; VYAS P, 1995, GENOMICS, V29, P679, DOI 10.1006/geno.1995.9951; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; WARD CJ, 1994, CELL, V77, P881; WILKIE AOM, 1992, GENOMICS, V13, P81, DOI 10.1016/0888-7543(92)90205-7; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601	56	129	133	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					252	257		10.1038/ng0397-252	http://dx.doi.org/10.1038/ng0397-252			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054936				2022-12-17	WOS:A1997WK38600013
J	WHITNEY, MA; SAITO, H; JAKOBS, PM; GIBSON, RA; MOSES, RE; GROMPE, M				WHITNEY, MA; SAITO, H; JAKOBS, PM; GIBSON, RA; MOSES, RE; GROMPE, M			A COMMON MUTATION IN THE FACC GENE CAUSES FANCONI-ANEMIA IN ASHKENAZI JEWS	NATURE GENETICS			English	Article							SEQUENCE STATISTICS; PRENATAL-DIAGNOSIS; SPLICE JUNCTIONS; CELL LINES; DNA; ANEMIA; HETEROGENEITY	Fanconi anaemia is an autosomal recessive disease for which four known complementation groups exist. Recently, the gene defective in complementation group C (FACC) has been cloned. In order to determine the fraction of Fanconi anaemia caused by FACC mutations, we used reverse transcription PCR and chemical mismatch cleavage (CMC) to examine the FACC cDNA in 17 FA cell lines. 4/17 patients (23.5%) had mutations in this gene. Two Ashkenazi-Jewish individuals were homozygous for an identical splice mutation. Three additional Jewish patients bearing this allele were found upon screening 21 other families. We conclude that a common mutation in FACC accounts for the majority of Fanconi anaemia in Ashkenazi-Jewish families.	OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, 3181 SAM JACKSON PK RD, L 103, PORTLAND, OR 97201 USA; UMDS, GUYS HOSP, DIV MED & MOLEC GENET, LONDON SE1 9RT, ENGLAND; OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA	Oregon Health & Science University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Oregon Health & Science University				Grompe, Markus/0000-0002-6616-4345; Gibson, Rachel/0000-0002-1338-1290				AUERBACH AD, 1986, HUM GENET, V73, P86, DOI 10.1007/BF00292671; AUERBACH AD, 1992, LINKAGE FANCONI ANEM, P18; BEUTLER E, 1992, BLOOD, V79, P1662; BILLARDON B, 1986, MUTAT RES, V174, P241, DOI 10.1016/0165-7992(86)90158-2; BOYD JB, 1992, GENETIC MOL ANAL DRO, P15; BUCHWALD M, 1992, CLONING FANCONI ANEM, P1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHEN MM, 1979, CYTOGENET CELL GENET, V23, P44, DOI 10.1159/000131301; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COTTON RGH, 1991, ADV GENOME BIOL UNFO, V1, P253; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GIBSON RA, IN PRESS HUM MOL GEN; GRAVEL RA, 1991, CAN J NEUROL SCI; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; MONONEN I, 1992, J BIOL CHEM, V267, P3196; MOSES RE, 1978, NUCLEIC ACIDS RES, V5, P463, DOI 10.1093/nar/5.2.463; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIENHUIS AW, 1992, GENE THERAPY APPROAC, P34; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; SUN Y, 1991, SOMAT CELL MOLEC GEN, V17, P229, DOI 10.1007/BF01232819; WU DY, 1989, DNA-J MOLEC CELL BIO, V8, P135, DOI 10.1089/dna.1.1989.8.135	30	129	131	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1993	4	2					202	205		10.1038/ng0693-202	http://dx.doi.org/10.1038/ng0693-202			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348157				2022-12-17	WOS:A1993LF81600024
J	MCCARREY, JR; DILWORTH, DD				MCCARREY, JR; DILWORTH, DD			EXPRESSION OF XIST IN MOUSE GERM-CELLS CORRELATES WITH X-CHROMOSOME INACTIVATION	NATURE GENETICS			English	Article							SPERMATOGENIC CELLS; MORPHOLOGICAL CHARACTERIZATION; GENE; HPRT; RNA	Mammals compensate for different doses of X-chromosome-linked genes in male (XY) and female (XX) somatic cells by terminally inactivating all but one X chromosome in each cell. A transiently inactive X chromosome is also found in germ cells, specifically in premeiotic oogenic cells and in meiotic and postmeiotic spermatogenic cells. Here we show that the Xist gene, which is a expressed predominantly from the inactive X-chromosome in female somatic cells, is also expressed in germ cells of both sexes, but only at those stages when an inactive X chromosome is present. This suggests support for the putative role of Xist as a regulator of X-chromosome inactivation and suggest a common mechanism for the initiation and/or maintenance of X-chromosome inactivation in all cell types.			MCCARREY, JR (corresponding author), SW FDN BIOMED RES, DEPT GENET, POB 28147, SAN ANTONIO, TX 78228 USA.							Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN SDM, 1991, BIOESSAYS, V13, P607, DOI 10.1002/bies.950131112; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dilworth D D, 1992, PCR Methods Appl, V1, P279; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HAHNEL AC, 1990, DEVELOPMENT, V110, P555; HAHNEL AC, 1986, GAMETE RES, V15, P25, DOI 10.1002/mrd.1120150104; HANDEL MA, 1991, ANN NY ACAD SCI, V637, P64, DOI 10.1111/j.1749-6632.1991.tb27301.x; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KRATZER PG, 1981, P NATL ACAD SCI-BIOL, V78, P3093, DOI 10.1073/pnas.78.5.3093; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCCARREY JR, 1987, J EXP ZOOL, V242, P107, DOI 10.1002/jez.1402420116; MCCARREY JR, IN PRESS GEN ANAL TE; MCCARREY JR, IN PRESS DEV BIOL, V153; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MONESI V, 1967, ARCH ANAT MICROSC MO, V56, P61; MURAKAWA GJ, 1988, DNA-J MOLEC CELL BIO, V7, P287, DOI 10.1089/dna.1988.7.287; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P1413, DOI 10.1073/pnas.89.4.1413; TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829; VENOLIA L, 1984, CHROMOSOMA, V90, P185, DOI 10.1007/BF00292395	29	129	129	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					200	203		10.1038/ng1192-200	http://dx.doi.org/10.1038/ng1192-200			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345169				2022-12-17	WOS:A1992JW16500009
J	O'Connor, LJ; Price, AL				O'Connor, Luke J.; Price, Alkes L.			Distinguishing genetic correlation from causation across 52 diseases and complex traits	NATURE GENETICS			English	Article							BODY-MASS INDEX; MENDELIAN RANDOMIZATION; SUBCLINICAL HYPOTHYROIDISM; DOUBLE-BLIND; THYROID-FUNCTION; UK BIOBANK; VARIANTS; RISK; ASSOCIATION; COMMON	Mendelian randomization, a method to infer causal relationships, is confounded by genetic correlations reflecting shared etiology. We developed a model in which a latent causal variable mediates the genetic correlation; trait 1 is partially genetically causal for trait 2 if it is strongly genetically correlated with the latent causal variable, quantified using the genetic causality proportion. We fit this model using mixed fourth moments E(alpha(2)(1)alpha(1)alpha(2) and E(alpha(2)(2)alpha(1)alpha(2)) of marginal effect sizes for each trait; if trait 1 is causal for trait 2, then SNPs affecting trait 1 (large alpha(2)(1)) will have correlated effects on trait 2 (large alpha(1)alpha(2)), but not vice versa. In simulations, our method avoided false positives due to genetic correlations, unlike Mendelian randomization. Across 52 traits (average n = 331,000), we identified 30 causal relationships with high genetic causality proportion estimates. Novel findings included a causal effect of low-density lipoprotein on bone mineral density, consistent with clinical trials of statins in osteoporosis.	[O'Connor, Luke J.; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [O'Connor, Luke J.] Harvard Grad Sch Arts & Sci, Program Bioinformat & Integrat Genom, Cambridge, MA 02138 USA; [Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Price, Alkes L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	O'Connor, LJ; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; O'Connor, LJ (corresponding author), Harvard Grad Sch Arts & Sci, Program Bioinformat & Integrat Genom, Cambridge, MA 02138 USA.; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Price, AL (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	loconnor@g.harvard.edu; aprice@hsph.harvard.edu			National Institutes of Health [16549];  [R01 MH107649];  [U01 CA194393];  [R01 MH101244]; NATIONAL CANCER INSTITUTE [U01CA194393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107649, R01MH101244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to B. Neale, S. Raychaudhuri, C. Patel, S. Kathiresan, B. Pasaniuc, and H. Finucane for helpful discussions and to P.-R. Loh and S. Gazal for producing BOLTLMM summary statistics for UK Biobank traits. This research was conducted using the UK Biobank Resource under Application #16549 and was funded by National Institutes of Health grants R01 MH107649, U01 CA194393, and R01 MH101244.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brenta G, 2009, THYROID, V19, P665, DOI 10.1089/thy.2009.0108; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Burgess S, 2015, INT J EPIDEMIOL, V44, P484, DOI 10.1093/ije/dyu176; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Chaker L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0693-4; Child D, 1990, ESSENTIALS FACTOR AN; Clarke TK, 2016, MOL PSYCHIATR, V21, P419, DOI 10.1038/mp.2015.12; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hagg S, 2015, INT J EPIDEMIOL, V44, P578, DOI 10.1093/ije/dyv094; Hartwig FP, 2017, INT J EPIDEMIOL, V46, P1985, DOI 10.1093/ije/dyx102; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Holmes MV, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.78; Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014; Kang H, 2016, J AM STAT ASSOC, V111, P132, DOI 10.1080/01621459.2014.994705; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Kolesar M, 2015, J BUS ECON STAT, V33, P474, DOI 10.1080/07350015.2014.978175; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Lyall DM, 2017, JAMA CARDIOL, V2, P882, DOI 10.1001/jamacardio.2016.5804; Meier C., 2001, J CLIN ENDOCR METAB, V86, P4430; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Monzani F, 2001, J CLIN ENDOCR METAB, V86, P1110, DOI 10.1210/jc.86.3.1110; Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669; Mullins N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15833; Nagasaki T, 2009, EUR J ENDOCRINOL, V160, P409, DOI 10.1530/EJE-08-0742; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Paaby AB, 2013, TRENDS GENET, V29, P66, DOI 10.1016/j.tig.2012.10.010; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Sanjak JS, 2018, P NATL ACAD SCI USA, V115, P151, DOI 10.1073/pnas.1707227114; Schoech A, 2017, BIORXIV, DOI [10.1101/188086, DOI 10.1101/188086]; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang ZZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003042; Ware JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20092; Welsh P, 2010, J CLIN ENDOCR METAB, V95, P93, DOI 10.1210/jc.2009-1064; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yerges-Armstrong LM, 2013, J CLIN ENDOCR METAB, V98, pE1999, DOI 10.1210/jc.2013-2471; Zhao JV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07592-z; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	60	128	128	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2018	50	12					1728	+		10.1038/s41588-018-0255-0	http://dx.doi.org/10.1038/s41588-018-0255-0			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HB9TA	30374074	Green Accepted, Green Submitted			2022-12-17	WOS:000451434400020
J	Zhou, WD; Dinh, HQ; Ramjan, Z; Weisenberger, DJ; Nicolet, CM; Shen, H; Laird, PW; Berman, BP				Zhou, Wanding; Dinh, Huy Q.; Ramjan, Zachary; Weisenberger, Daniel J.; Nicolet, Charles M.; Shen, Hui; Laird, Peter W.; Berman, Benjamin P.			DNA methylation loss in late-replicating domains is linked to mitotic cell division	NATURE GENETICS			English	Article							SOMATIC RETROTRANSPOSITION; HYPOMETHYLATED BLOCKS; WHOLE-GENOME; DYNAMICS; WIDE; 5-METHYLCYTOSINE; MAINTENANCE; TUMORS; TRANSCRIPTION; ORGANIZATION	DNA methylation loss occurs frequently in cancer genomes, primarily within lamina-associated, late-replicating regions termed partially methylated domains (PMDs). We profiled 39 diverse primary tumors and 8 matched adjacent tissues using wholegenome bisulfite sequencing (WGBS) and analyzed them alongside 343 additional human and 206 mouse WGBS datasets. We identified a local CpG sequence context associated with preferential hypomethylation in PMDs. Analysis of CpGs in this context ('solo-WCGWs') identified previously undetected PMD hypomethylation in almost all healthy tissue types. PMD hypomethylation increased with age, beginning during fetal development, and appeared to track the accumulation of cell divisions. In cancer, PMD hypomethylation depth correlated with somatic mutation density and cell cycle gene expression, consistent with its reflection of mitotic history and suggesting its application as a mitotic clock. We propose that late replication leads to lifelong progressive methylation loss, which acts as a biomarker for cellular aging and which may contribute to oncogenesis.	[Zhou, Wanding; Shen, Hui; Laird, Peter W.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Dinh, Huy Q.; Berman, Benjamin P.] Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Ramjan, Zachary] Van Andel Inst, Grand Rapids, MI USA; [Weisenberger, Daniel J.; Nicolet, Charles M.] Univ Southern Calif, USC Norris Comprehens Canc Ctr, Los Angeles, CA USA	Van Andel Institute; Cedars Sinai Medical Center; Van Andel Institute; University of Southern California	Shen, H; Laird, PW (corresponding author), Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA.; Berman, BP (corresponding author), Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA.	hui.shen@vai.org; peter.laird@vai.org; benjamin.berman@csmc.edu	BERMAN, BENJAMIN/AAT-3720-2021; Weisenberger, Daniel/AAA-8314-2020; Laird, Peter W/G-8683-2012; Shen, Hui/AAO-4387-2020; Dinh, Huy/M-8646-2016	BERMAN, BENJAMIN/0000-0002-2099-9005; Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Shen, Hui/0000-0001-9767-4084; Dinh, Huy/0000-0002-3307-1126	Van Andel Research Institute; Cedars-Sinai Center for Bioinformatics and Functional Genomics; Samuel Oschin Comprehensive Cancer Institute; University of Southern California USC Epigenome Center; National Institutes of Health/National Cancer Institute grants [U24 CA143882, R01 CA170550, U01 CA184826, U24 CA210969]; Ovarian Cancer Research Fund Grant [373933]; National Institutes of Health/National Human Genome Research Institute grant [R01 HG006705]; NATIONAL CANCER INSTITUTE [R01CA170550, U01CA184826, U24CA210969, U24CA143882] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006705] Funding Source: NIH RePORTER	Van Andel Research Institute; Cedars-Sinai Center for Bioinformatics and Functional Genomics; Samuel Oschin Comprehensive Cancer Institute; University of Southern California USC Epigenome Center; National Institutes of Health/National Cancer Institute grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund Grant; National Institutes of Health/National Human Genome Research Institute grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Hinoue and H. Noushmehr for help selecting TCGA WGBS samples based on analysis of other TCGA data types and H. Goodridge and D.-C. Lin for useful discussions and comments. We thank The Cancer Genome Atlas Research program office, especially K. Shaw, for helping to get the WGBS project up and running. We also thank the members of the TCGA Research Network along with the dozens of other research groups that generated the published datasets that were used here to gain new insights. This project was supported by the Van Andel Research Institute, the Cedars-Sinai Center for Bioinformatics and Functional Genomics and the Samuel Oschin Comprehensive Cancer Institute, and the University of Southern California USC Epigenome Center. The work was funded by the following grants: National Institutes of Health/National Cancer Institute grants U24 CA143882 (P.W.L., B.P.B., H.Q.D., and H.S.); R01 CA170550 (P.W.L.); U01 CA184826 (B.P.B.); U24 CA210969 (P.W.L., B.P.B., and H.S.), Ovarian Cancer Research Fund Grant 373933 (H.S.), and National Institutes of Health/National Human Genome Research Institute grant R01 HG006705 (B.P.B.).	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Amendola M, 2015, EMBO REP, V16, P610, DOI 10.15252/embr.201439789; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Bashtrykov P, 2012, FEBS LETT, V586, P1821, DOI 10.1016/j.febslet.2012.05.026; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brennan K, 2012, CANCER PREV RES, V5, P1345, DOI 10.1158/1940-6207.CAPR-12-0316; Burnet F M, 1976, CA Cancer J Clin, V26, P119, DOI 10.3322/canjclin.26.2.119; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Flynn J, 1998, J MOL BIOL, V279, P101, DOI 10.1006/jmbi.1998.1761; Fortin JP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0741-y; Gaidatzis D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004143; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2014, GENOME RES, V24, P177, DOI 10.1101/gr.157743.113; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Knight AK, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1068-z; Knijnenburg TA, 2014, NAT METHODS, V11, P689, DOI [10.1038/NMETH.2924, 10.1038/nmeth.2924]; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li ZG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0685-2; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Papillon-Cavanagh S, 2017, NAT GENET, V49, P180, DOI 10.1038/ng.3757; Quante T, 2016, NAT REV MOL CELL BIO, V17, P257, DOI 10.1038/nrm.2015.31; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rodriguez-Martin B., 2017, PAN CANC ANAL WHOLE, DOI [10.1101/179705, DOI 10.1101/17970]; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Slieker RC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1053-6; Solyom S, 2012, HUM MUTAT, V33, P369, DOI 10.1002/humu.21663; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Timp W, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0061-y; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Vandiver AR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0644-y; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967	76	128	129	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					591	+		10.1038/s41588-018-0073-4	http://dx.doi.org/10.1038/s41588-018-0073-4			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	29610480	Bronze, Green Accepted			2022-12-17	WOS:000429529300019
J	Lagarde, J; Uszczynska-Ratajczak, B; Carbonell, S; Perez-Lluch, S; Abad, A; Davis, C; Gingeras, TR; Frankish, A; Harrow, J; Guigo, R; Johnson, R				Lagarde, Julien; Uszczynska-Ratajczak, Barbara; Carbonell, Silvia; Perez-Lluch, Silvia; Abad, Amaya; Davis, Carrie; Gingeras, Thomas R.; Frankish, Adam; Harrow, Jennifer; Guigo, Roderic; Johnson, Rory			High-throughput annotation of full-length long noncoding RNAs with capture long-read sequencing	NATURE GENETICS			English	Article							SMALL ORFS; GENE; REVEALS; IDENTIFICATION; LANDSCAPE; DATABASE; QUANTIFICATION; RECONSTRUCTION; TRANSCRIPTOME; DISCOVERY	Accurate annotation of genes and their transcripts is a foundation of genomics, but currently no annotation technique combines throughput and accuracy. As a result, reference gene collections remain incomplete-many gene models are fragmentary, and thousands more remain uncataloged, particularly for long noncoding RNAs (lncRNAs). To accelerate lncRNA annotation, the GENCODE consortium has developed RNA Capture Long Seq (CLS), which combines targeted RNA capture with third-generation long-read sequencing. Here we present an experimental reannotation of the GENCODE intergenic lncRNA populations in matched human and mouse tissues that resulted in novel transcript models for 3,574 and 561 gene loci, respectively. CLS approximately doubled the annotated complexity of targeted loci, outperforming existing short-read techniques. Full-length transcript models produced by CLS enabled us to definitively characterize the genomic features of lncRNAs, including promoter and gene structure, and protein-coding potential. Thus, CLS removes a long-standing bottleneck in transcriptome annotation and generates manual-quality full-length transcript models at high-throughput scales.	[Lagarde, Julien; Uszczynska-Ratajczak, Barbara; Perez-Lluch, Silvia; Abad, Amaya; Guigo, Roderic; Johnson, Rory] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain; [Lagarde, Julien; Uszczynska-Ratajczak, Barbara; Perez-Lluch, Silvia; Abad, Amaya; Guigo, Roderic; Johnson, Rory] Univ Pompeu Fabra, Barcelona, Spain; [Carbonell, Silvia] Quantitat Genom Med Labs qGenomics, R&D Dept, Barcelona, Spain; [Davis, Carrie; Gingeras, Thomas R.] Cold Spring Harbor Lab, Funct Genom Grp, POB 100, Cold Spring Harbor, NY 11724 USA; [Frankish, Adam; Harrow, Jennifer] Wellcome Trust Sanger Inst, Hinxton, England; [Uszczynska-Ratajczak, Barbara] Ctr New Technol, Warsaw, Poland; [Harrow, Jennifer] Illumina, Cambridge, England; [Johnson, Rory] Univ Bern, Dept Clin Res, Bern, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Cold Spring Harbor Laboratory; Wellcome Trust Sanger Institute; University of Warsaw; Illumina; University of Bern	Guigo, R; Johnson, R (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain.; Guigo, R; Johnson, R (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.	roderic.guigo@crg.cat; rory.johnson@dbmr.unibe.ch	Johnson, Rory/ABE-2503-2021; Pérez-Lluch, Sílvia/AAC-5618-2021; Pérez-Lluch, Sílvia/H-5403-2015; Uszczynska-Ratajczak, Barbara/G-9814-2015; Lagarde, Julien/AAI-1686-2020; Guigo, Roderic/D-1303-2010	Johnson, Rory/0000-0003-4607-2782; Pérez-Lluch, Sílvia/0000-0002-6863-7193; Pérez-Lluch, Sílvia/0000-0002-6863-7193; Uszczynska-Ratajczak, Barbara/0000-0003-0150-3841; Lagarde, Julien/0000-0002-0290-7445; Guigo, Roderic/0000-0002-5738-4477; Abad, Amaya/0000-0002-6865-9149; Gingeras, Thomas/0000-0001-9106-3573; Frankish, Adam/0000-0002-4333-628X; Harrow, Jennifer/0000-0003-0338-3070	National Human Genome Research Institute of the US National Institutes of Health [U41HG007234, U41HG007000, U54HG007004]; Wellcome Trust [WT098051]; Ramon y Cajal Subprogram of the Spanish Ministry of Economy and Competitiveness [RYC-2011-08851]; National Human Genome Research Institute [U41HG007234, U54HG0070, R01MH101814]; NCCR RNA & Disease - Swiss National Science Foundation; Spanish Ministry of Economy and Competitiveness; Centro de Excelencia Severo Ochoa [SEV-2012-0208]; CERCA Programme, Generalitat de Catalunya; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007004, U41HG007234, U41HG007000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101814] Funding Source: NIH RePORTER	National Human Genome Research Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); Ramon y Cajal Subprogram of the Spanish Ministry of Economy and Competitiveness; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCCR RNA & Disease - Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Centro de Excelencia Severo Ochoa; CERCA Programme, Generalitat de Catalunya; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Guigo laboratory for their valuable input and help with sample handling, data analysis and writing of the manuscript, including E. Palumbo, F. Reverter, A. Breschi, D. Pervouchine, C. Arnan and F. Camara. We thank L. Armengol (qGenomics) for advice on RNA capture, D. Garrido (CRG) for help with eQTL analysis, S. Bonnin (CRG) for help with data manipulation in R, and I. Jungreis (MIT) for advice on PhyloCSF. J. Wright and J. Choudhary (Sanger Institute) helped with the search for peptide hits to putative coding regions. S. Djebali (INRA, France) kindly made available the Compmerge utility. This work and its publication were supported by the National Human Genome Research Institute of the US National Institutes of Health (grants U41HG007234, U41HG007000 and U54HG007004) and the Wellcome Trust (grant WT098051 to R.G.). R. J. was supported by the Ramon y Cajal Subprogram of the Spanish Ministry of Economy and Competitiveness (grant RYC-2011-08851). Work in the laboratory of R.G. was supported by the National Human Genome Research Institute (awards U54HG0070, R01MH101814 and U41HG007234). This research was partly supported by NCCR RNA & Disease, funded by the Swiss National Science Foundation (to R. J.). We thank R. Garrido (CRG) for administrative support. We acknowledge support from the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208), and from the CERCA Programme, Generalitat de Catalunya.	Alam T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109443; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Blanco Enrique, 2007, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0403s18; Bussotti G, 2016, GENOME RES, V26, P705, DOI 10.1101/gr.199760.115; Bussotti G, 2011, NUCLEIC ACIDS RES, V39, P6886, DOI 10.1093/nar/gkr335; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Clark MB, 2015, NAT METHODS, V12, P339, DOI [10.1038/nmeth.3321, 10.1038/NMETH.3321]; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ferdin J, 2013, CELL DEATH DIFFER, V20, P1675, DOI 10.1038/cdd.2013.119; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948; Georgakilas G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6700; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kralj JG, 2013, ANAL BIOANAL CHEM, V405, P315, DOI 10.1007/s00216-012-6445-1; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lagarde J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12339; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Mackowiak SD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0742-x; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Marques AC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r131; Mele M, 2017, GENOME RES, V27, P27, DOI 10.1101/gr.214205.116; Mercer TR, 2014, NAT PROTOC, V9, P989, DOI 10.1038/nprot.2014.058; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Nissan A, 2012, INT J CANCER, V130, P1598, DOI 10.1002/ijc.26170; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wan XC, 2016, ONCOTARGET, V7, P60503, DOI 10.18632/oncotarget.11391; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	57	128	129	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1731	+		10.1038/ng.3988	http://dx.doi.org/10.1038/ng.3988			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	29106417	Green Accepted, Green Published			2022-12-17	WOS:000416480600012
J	Ji, SG; Juran, BD; Mucha, S; Folseraas, T; Jostins, L; Melum, E; Kumasaka, N; Atkinson, EJ; Schlicht, EM; Liu, JZ; Shah, T; Gutierrez-Achury, J; Boberg, KM; Bergquist, A; Vermeire, S; Eksteen, B; Durie, PR; Farkkila, M; Muller, T; Schramm, C; Sterneck, M; Weismuller, TJ; Gotthardt, DN; Ellinghaus, D; Braun, F; Teufel, A; Laudes, M; Lieb, W; Jacobs, G; Beuers, U; Weersma, RK; Wijmenga, C; Marschall, HU; Milkiewicz, P; Pares, A; Kontula, K; Chazouilleres, O; Invernizzi, P; Goode, E; Spiess, K; Moore, C; Sambrook, J; Ouwehand, WH; Roberts, DJ; Danesh, J; Floreani, A; Gulamhusein, AF; Eaton, JE; Schreiber, S; Coltescu, C; Bowlus, CL; Luketic, VA; Odin, JA; Chopra, KB; Kowdley, KV; Chalasani, N; Manns, MP; Srivastava, B; Mells, G; Sandford, RN; Alexander, G; Gaffney, DJ; Chapman, RW; Hirschfield, GM; de Andrade, M; Rushbrook, SM; Franke, A; Karlsen, TH; Lazaridis, KN; Anderson, CA				Ji, Sun-Gou; Juran, Brian D.; Mucha, Soeren; Folseraas, Trine; Jostins, Luke; Melum, Espen; Kumasaka, Natsuhiko; Atkinson, Elizabeth J.; Schlicht, Erik M.; Liu, Jimmy Z.; Shah, Tejas; Gutierrez-Achury, Javier; Boberg, Kirsten M.; Bergquist, Annika; Vermeire, Severine; Eksteen, Bertus; Durie, Peter R.; Farkkila, Martti; Mueller, Tobias; Schramm, Christoph; Sterneck, Martina; Weismueller, Tobias J.; Gotthardt, Daniel N.; Ellinghaus, David; Braun, Felix; Teufel, Andreas; Laudes, Mattias; Lieb, Wolfgang; Jacobs, Gunnar; Beuers, Ulrich; Weersma, Rinse K.; Wijmenga, Cisca; Marschall, Hanns-Ulrich; Milkiewicz, Piotr; Pares, Albert; Kontula, Kimmo; Chazouilleres, Olivier; Invernizzi, Pietro; Goode, Elizabeth; Spiess, Kelly; Moore, Carmel; Sambrook, Jennifer; Ouwehand, Willem H.; Roberts, David J.; Danesh, John; Floreani, Annarosa; Gulamhusein, Aliya F.; Eaton, John E.; Schreiber, Stefan; Coltescu, Catalina; Bowlus, Christopher L.; Luketic, Velimir A.; Odin, Joseph A.; Chopra, Kapil B.; Kowdley, Kris V.; Chalasani, Naga; Manns, Michael P.; Srivastava, Brijesh; Mells, George; Sandford, Richard N.; Alexander, Graeme; Gaffney, Daniel J.; Chapman, Roger W.; Hirschfield, Gideon M.; de Andrade, Mariza; Rushbrook, Simon M.; Franke, Andre; Karlsen, Tom H.; Lazaridis, Konstantinos N.; Anderson, Carl A.		UK-PSC Consortium; Int IBD Genetics Consortium; Int PSC Study Grp	Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; PSORIATIC-ARTHRITIS; ULCERATIVE-COLITIS; TRANSCRIPTOME; METAANALYSIS; VARIANTS; REVEALS; REGIONS	Primary sclerosing cholangitis (PSC) is a rare progressive disorder leading to bile duct destruction; similar to 75% of patients have comorbid inflammatory bowel disease (IBD). We undertook the largest genome-wide association study of PSC (4,796 cases and 19,955 population controls) and identified four new genome-wide significant loci. The most associated SNP at one locus affects splicing and expression of UBASH3A, with the protective allele (C) predicted to cause nonstop-mediated mRNA decay and lower expression of UBASH3A. Further analyses based on common variants suggested that the genome-wide genetic correlation (r(G)) between PSC and ulcerative colitis (UC) (r(G) = 0.29) was significantly greater than that between PSC and Crohn's disease (CD) (r(G) = 0.04) (P = 2.55 x 10(-15)). UC and CD were genetically more similar to each other (r(G) = 0.56) than either was to PSC (P < 1.0 x 10(-15)). Our study represents a substantial advance in understanding of the genetics of PSC.	[Ji, Sun-Gou; Kumasaka, Natsuhiko; Liu, Jimmy Z.; Shah, Tejas; Gutierrez-Achury, Javier; Ouwehand, Willem H.; Danesh, John; Gaffney, Daniel J.; Anderson, Carl A.] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England; [Juran, Brian D.; Schlicht, Erik M.; Gulamhusein, Aliya F.; Eaton, John E.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Mucha, Soeren; Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Folseraas, Trine; Melum, Espen; Boberg, Kirsten M.; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Norwegian PSC Res Ctr, N-0450 Oslo, Norway; [Folseraas, Trine; Melum, Espen; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Folseraas, Trine; Boberg, Kirsten M.; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Jostins, Luke] Univ Oxford Christ Church, Oxford OX1 1DP, England; [Atkinson, Elizabeth J.; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Boberg, Kirsten M.; Karlsen, Tom H.] Oslo Univ Hosp, Rikshosp, Div Canc Surg & Transplantat, Dept Transplantat Med,Sect Gastroenterol, Oslo, Norway; [Bergquist, Annika] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Vermeire, Severine] Katholieke Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium; [Vermeire, Severine] Univ Hosp Leuven, Dept Gastroenterol, Leuven, Belgium; [Eksteen, Bertus] Univ Calgary, Dept Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Durie, Peter R.] Hosp Sick Children, Res Inst, Physiol & Expt Med, Toronto, ON, Canada; [Farkkila, Martti] Univ Helsinki, Helsinki, Finland; [Farkkila, Martti] Helsinki Univ Hosp, Gastroenterol Clin, Helsinki, Finland; [Mueller, Tobias] Charite, Dept Internal Med Hepatol & Gastroenterol, Berlin, Germany; [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Sterneck, Martina] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary Surg & Transplantat, Hamburg, Germany; [Weismueller, Tobias J.; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Weismueller, Tobias J.; Manns, Michael P.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Weismueller, Tobias J.] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany; [Gotthardt, Daniel N.] Univ Heidelberg Hosp, Dept Med, Heidelberg, Germany; [Braun, Felix] Univ Med Ctr Schleswig Holstein, Dept Gen Visceral Thorac Transplantat & Pediat Su, Campus Kiel, Kiel, Germany; [Teufel, Andreas] Univ Med Ctr, Dept Med 1, Regensburg, Germany; [Laudes, Mattias] Univ Hosp Schleswig Holstein, Clin Internal Med 1, Kiel, Germany; [Lieb, Wolfgang; Jacobs, Gunnar] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang; Jacobs, Gunnar] Univ Hosp Schleswig Holstein, Biobank PopGen, Kiel, Germany; [Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Milkiewicz, Piotr] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Liver & Internal Med Unit, Warsaw, Poland; [Pares, Albert] Univ Barcelona, CIBERehd, IDIBAPS, Liver Unit,Hosp Clin, Barcelona, Spain; [Kontula, Kimmo] Univ Helsinki, Dept Med, Helsinki, Finland; [Chazouilleres, Olivier] Univ Paris 06, Hop St Antoine, AP HP, Dept Hepatol, Paris, France; [Invernizzi, Pietro] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Milan, Italy; [Goode, Elizabeth; Spiess, Kelly; Srivastava, Brijesh; Mells, George; Sandford, Richard N.; Rushbrook, Simon M.] Univ Cambridge, Acad Dept Med Genet, Cambridge, England; [Ouwehand, Willem H.; Roberts, David J.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Moore, Carmel; Sambrook, Jennifer; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, INTERVAL Coordinating Ctr, Cambridge, England; [Sambrook, Jennifer; Ouwehand, Willem H.] Univ Cambridge, Dept Hematol, Cambridge, England; [Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge, England; [Roberts, David J.] John Radcliffe Hosp, NHS Blood & Transplant Oxford Ctr, Oxford, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford, England; [Floreani, Annarosa] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Schreiber, Stefan] Univ Hosp Schleswig, Dept Gen Internal Med, Holstein Campus Kiel, Kiel, Germany; [Coltescu, Catalina] Toronto Western Hosp, Ctr Liver, Toronto, ON, Canada; [Bowlus, Christopher L.] Univ Calif Davis, Div Gastroenterol & Hepatol, Davis, CA 95616 USA; [Luketic, Velimir A.] Virginia Commonwealth Univ, Gastroenterol & Hepatol Sect, Richmond, VA USA; [Odin, Joseph A.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Chopra, Kapil B.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Kowdley, Kris V.] Swedish Med Ctr, Liver Care Network & Organ Care Res, Seattle, WA USA; [Chalasani, Naga] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Mells, George] Addenbrookes Hosp, Div Gastroenterol & Hepatol, Cambridge, England; [Alexander, Graeme] Univ Cambridge, Div Hepatol, Dept Med, Cambridge, England; [Chapman, Roger W.] Oxford Univ Hosp NHS Trust, Dept Translat Gastroenterol, Oxford, England; [Hirschfield, Gideon M.] Univ Birmingham, NIHR Biomed Res Unit, Liver Res Ctr, Birmingham, W Midlands, England; [Hirschfield, Gideon M.] Univ Toronto, Toronto, ON, Canada; [Hirschfield, Gideon M.] Toronto Western Hosp, Ctr Liver, Toronto, ON, Canada	Wellcome Trust Sanger Institute; Mayo Clinic; University of Kiel; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Mayo Clinic; University of Oslo; National Hospital Norway; Karolinska Institutet; Karolinska University Hospital; KU Leuven; KU Leuven; University Hospital Leuven; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School; University of Bonn; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen; University of Gothenburg; Medical University of Warsaw; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Helsinki; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; University of Padua; University of Kiel; Schleswig Holstein University Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California Davis; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Swedish Medical Center; Indiana University System; Indiana University Bloomington; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; University of Birmingham; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Anderson, CA (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England.; Lazaridis, KN (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA.	lazaridis.konstantinos@mayo.edu; carl.anderson@sanger.ac.uk	Invernizzi, Pietro/AAB-8367-2022; D'Amato, Mauro/B-5050-2019; D'Amato, Mauro/F-2450-2010; Braun, Felix/AAK-8329-2021; Färkkilä, Martti/AAG-6970-2021; Franke, Andre/B-2151-2010; Ellinghaus, David/ABC-3610-2020; Pares, Albert/M-6268-2019; Ellinghaus, David/G-4467-2012; Lieb, Wolfgang/AAC-7650-2022; Weismüller, Tobias J./I-1879-2019; Marschall, Hanns-Ulrich/K-8842-2017; Wijmenga, Cisca/AAE-7719-2019; Pares, Albert/G-1328-2011; Laudes, Matthias/C-8885-2011; Kowdley, Kris/AAF-5202-2019; Teufel, Andreas/ABD-8000-2021; Weersma, Rinse/ABE-3807-2021; Hirschfield, Gideon/M-2143-2015; Bowlus, Christopher/N-9276-2016	Invernizzi, Pietro/0000-0003-3262-1998; D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; Braun, Felix/0000-0002-5296-2020; Färkkilä, Martti/0000-0002-0250-8559; Franke, Andre/0000-0003-1530-5811; Ellinghaus, David/0000-0002-4332-6110; Pares, Albert/0000-0002-5413-9687; Weismüller, Tobias J./0000-0001-9736-1483; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Wijmenga, Cisca/0000-0002-5635-1614; Pares, Albert/0000-0002-5413-9687; Mueller, Tobias/0000-0003-3426-5421; Roberts, David/0000-0003-0648-6585; Bergquist, Annika/0000-0002-3858-6241; Milkiewicz, Piotr/0000-0002-1817-0724; Mucha, Soren/0000-0002-1647-2526; Hirschfield, Gideon/0000-0002-6736-2255; Vermeire, Severine/0000-0001-9942-3019; Gutierrez-Achury, Javier/0000-0002-4971-1474; Anderson, Carl/0000-0003-1719-7009; Bowlus, Christopher/0000-0002-3906-6811; Ji, Sun-Gou/0000-0001-8652-6318	National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; German Ministry for Education and Research [01EY1103]; Mayo Clinic Biobank; Mayo Clinic Center for Individualized Medicine; INTERVAL study; National Health Service Blood and Transplant (NHSBT); FOCUS biobank; NoPSC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1DK084960]; Wellcome Trust [098759/Z/12/Z, 098051]; Kwanjeong Educational Foundation; German Federal Ministry of Education and Research (B.M.B.F.); SysInflame grant [01ZX1306A]; YAEL-Foundation; DFG [SFB841]; National Institute of Health Research (NIHR); NIHR BioResource; NIHR Cambridge Biomedical Research Centre; NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council [G0800270]; British Heart Foundation [SP/09/002]; NIHR Research Cambridge Biomedical Research Centre; the Netherlands Organization for Scientific Research [90.700.281]; Medical Research Council, United Kingdom; Deutsche Forschungsgemeinschaft; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestives (CIBERehd); Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion [PI071318]; Ministerio de Economia y Competitvidad, Spain [PI12/01448]; Canadian Institutes of Health research (CIHR); Genome Canada; Celiac Disease Consortium [BSIK03009]; Netherlands Organization for Scientific Research (NWO, VICI grant) [918.66.620]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036495, U01AG009740, RC4AG039029] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, RP-PG-0310-1002, NF-SI-0510-10214, NF-SI-0513-10151, RP-PG-0310-1004] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Mayo Clinic Biobank; Mayo Clinic Center for Individualized Medicine; INTERVAL study; National Health Service Blood and Transplant (NHSBT); FOCUS biobank; NoPSC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Kwanjeong Educational Foundation; German Federal Ministry of Education and Research (B.M.B.F.)(Federal Ministry of Education & Research (BMBF)); SysInflame grant; YAEL-Foundation; DFG(German Research Foundation (DFG)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR BioResource; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Blood and Transplant Research Unit in Donor Health and Genomics; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); NIHR Research Cambridge Biomedical Research Centre; the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestives (CIBERehd); Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitvidad, Spain; Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Celiac Disease Consortium; Netherlands Organization for Scientific Research (NWO, VICI grant)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and healthy controls for their participation, and are grateful to the physicians, scientists and nursing staff who recruited individuals whose data is used in our study. We acknowledge the use of DNA or genotype data from a number of sources, including: the Health and Retirement Study (HSR) conducted by the University of Michigan, funded by the National Institute on Aging (grant numbers U01AG009740, RC2AG036495 and RC4AG039029) and accessed via dbGaP; Popgen 2.0, supported by a grant from the German Ministry for Education and Research (01EY1103); The Mayo Clinic Biobank, supported by the Mayo Clinic Center for Individualized Medicine; the INTERVAL study, undertaken by the University of Cambridge with funding from the National Health Service Blood and Transplant (NHSBT) (the views expressed in this publication are those of the authors and not necessarily those of the NHSBT); the FOCUS biobank. We thank the investigators of the 1000 Genomes and UK10K projects for generating and sharing the population haplotypes and Jie Huang for advice regarding imputation. We thank all members of the International IBD Genetics Consortium for sharing genetic data vital to the success of our study. This study was supported by NoPSC, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK RO1DK084960, KNL), the Wellcome Trust (098759/Z/12/Z: L.J.; 098051: S.-G.J., J.Z.L., T.S., J.G.-A., N.K., D.J.G. and C.A.A.), the Kwanjeong Educational Foundation (S.-G.J.), the German Federal Ministry of Education and Research (B.M.B.F.) within the framework of the e:Med research and funding concept (SysInflame grant 01ZX1306A) and the Chris M. Carlos and Catharine Nicole Jockisch Carlos Endowment in PSC. This project received infrastructure support from the DFG Excellence Cluster 306 "Inflammation at Interfaces" and the PopGen Biobank (Kiel, Germany), an endowment professorship (A.F.) by the Foundation for Experimental Medicine (Zurich, Switzerland). The recruitment of patients in Hamburg was supported by the YAEL-Foundation and the DFG (SFB841). B.A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet in Oslo are acknowledged for sharing the healthy Norwegian controls. Participants in the INTERVAL randomized controlled trial were recruited with the active collaboration of NHS Blood and Transplant England (http://www.nhsbt.nhs.uk), which has supported field work and other elements of the trial. DNA extraction and genotyping was funded by the National Institute of Health Research (NIHR), the NIHR BioResource (http://bioresource.nihr.ac.uk/) and the NIHR Cambridge Biomedical Research Centre (http://www.cambridge-brc.org.uk). The academic coordinating centre for INTERVAL was supported by core funding from: NIHR Blood and Transplant Research Unit in Donor Health and Genomics, UK Medical Research Council (G0800270), British Heart Foundation (SP/09/002), and NIHR Research Cambridge Biomedical Research Centre. We thank K. Cloppenborg-Schmidt, I. Urbach, I. Pauselis, T. Wesse, T. Henke, R. Vogler, V. Pelkonen, K. Holm, H. Dahlen Sollid, B. Woldseth, J. Andreas and L. Wenche Torbjornsen for expert help. R.K.W. is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research. B.E. receives support from Medical Research Council, United Kingdom. T.M. and D.G. are supported by Deutsche Forschungsgemeinschaft, Grant. A.P.; is supported by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestives (CIBERehd), grant PI071318 Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, and grant PI12/01448, from Ministerio de Economia y Competitvidad, Spain. P.R.D. is supported by Canadian Institutes of Health research (CIHR) and Genome Canada. C.W. is supported by grants from the Celiac Disease Consortium (BSIK03009) and Netherlands Organization for Scientific Research (NWO, VICI grant918.66.620). We acknowledge members of the International PSC Study Group, the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC), and the UK-PSC Consortium for their participation. We thank J. Rud for secretarial support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; Boonstra K, 2012, INFLAMM BOWEL DIS, V18, P2270, DOI 10.1002/ibd.22938; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; de Vries AB, 2015, WORLD J GASTROENTERO, V21, P1956, DOI 10.3748/wjg.v21.i6.1956; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Ellinghaus D, 2013, HEPATOLOGY, V58, P1074, DOI 10.1002/hep.25977; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Karlsen TH, 2011, SEMIN LIVER DIS, V31, P188, DOI 10.1055/s-0031-1276647; Karlsen TH, 2010, DIGEST LIVER DIS, V42, P390, DOI 10.1016/j.dld.2010.01.011; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Srivastava B, 2012, SCAND J GASTROENTERO, V47, P820, DOI 10.3109/00365521.2012.682090; Stuart PE, 2015, AM J HUM GENET, V97, P816, DOI 10.1016/j.ajhg.2015.10.019; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	34	128	130	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2017	49	2					269	273		10.1038/ng.3745	http://dx.doi.org/10.1038/ng.3745			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ3YM	27992413	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000393148600016
J	Lessel, D; Vaz, B; Halder, S; Lockhart, PJ; Marinovic-Terzic, I; Lopez-Mosqueda, J; Philipp, M; Sim, JCH; Smith, KR; Oehler, J; Cabrera, E; Freire, R; Pope, K; Nahid, A; Norris, F; Leventer, RJ; Delatycki, MB; Barbi, G; von Ameln, S; Hogel, J; Degoricija, M; Fertig, R; Burkhalter, MD; Hofmann, K; Thiele, H; Altmuller, J; Nurnberg, G; Nurnberg, P; Bahlo, M; Martin, GM; Aalfs, CM; Oshima, J; Terzic, J; Amor, DJ; Dikic, I; Ramadan, K; Kubisch, C				Lessel, Davor; Vaz, Bruno; Halder, Swagata; Lockhart, Paul J.; Marinovic-Terzic, Ivana; Lopez-Mosqueda, Jaime; Philipp, Melanie; Sim, Joe C. H.; Smith, Katherine R.; Oehler, Judith; Cabrera, Elisa; Freire, Raimundo; Pope, Kate; Nahid, Amsha; Norris, Fiona; Leventer, Richard J.; Delatycki, Martin B.; Barbi, Gotthold; von Ameln, Simon; Hoegel, Josef; Degoricija, Marina; Fertig, Regina; Burkhalter, Martin D.; Hofmann, Kay; Thiele, Holger; Altmueller, Janine; Nuernberg, Gudrun; Nuernberg, Peter; Bahlo, Melanie; Martin, George M.; Aalfs, Cora M.; Oshima, Junko; Terzic, Janos; Amor, David J.; Dikic, Ivan; Ramadan, Kristijan; Kubisch, Christian			Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features	NATURE GENETICS			English	Article							DNA-DAMAGE; REPLICATION-FORK; TRANSLESION SYNTHESIS; DVC1 C1ORF124; SPARTAN/C1ORF124; CANCER; REGULATOR; CHECKPOINT; STRESS; GENE	Age-related degenerative and malignant diseases represent major challenges for health care systems. Elucidation of the molecular mechanisms underlying carcinogenesis and age-associated pathologies is thus of growing biomedical relevance. We identified biallelic germline mutations in SPRTN (also called C1orf124 or DVC1)(1-7) in three patients from two unrelated families. All three patients are affected by a new segmental progeroid syndrome characterized by genomic instability and susceptibility toward early onset hepatocellular carcinoma. SPRTN was recently proposed to have a function in translesional DNA synthesis and the prevention of mutagenesis(1-7). Our in vivo and in vitro characterization of identified mutations has uncovered an essential role for SPRTN in the prevention of DNA replication stress during general DNA replication and in replication-related G2/M-checkpoint regulation. In addition to demonstrating the pathogenicity of identified SPRTN mutations, our findings provide a molecular explanation of how SPRTN dysfunction causes accelerated aging and susceptibility toward carcinoma.	[Lessel, Davor; Barbi, Gotthold; von Ameln, Simon; Hoegel, Josef; Kubisch, Christian] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Lessel, Davor; Kubisch, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Vaz, Bruno; Halder, Swagata; Oehler, Judith; Ramadan, Kristijan] Univ Oxford, Canc Res UK, Oxford, England; [Vaz, Bruno; Halder, Swagata; Oehler, Judith; Ramadan, Kristijan] Univ Oxford, MRC, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Halder, Swagata; Oehler, Judith; Fertig, Regina; Ramadan, Kristijan] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Lockhart, Paul J.; Sim, Joe C. H.; Pope, Kate; Delatycki, Martin B.; Amor, David J.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; [Lockhart, Paul J.; Leventer, Richard J.; Delatycki, Martin B.; Amor, David J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Marinovic-Terzic, Ivana; Degoricija, Marina; Terzic, Janos] Univ Split, Sch Med, Dept Immunol & Med Genet, Split, Croatia; [Lopez-Mosqueda, Jaime; Dikic, Ivan] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany; [Lopez-Mosqueda, Jaime; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60054 Frankfurt, Germany; [Philipp, Melanie] Univ Ulm, Dept Biochem & Mol Biol, D-89069 Ulm, Germany; [Smith, Katherine R.; Nahid, Amsha; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Smith, Katherine R.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Cabrera, Elisa; Freire, Raimundo; Bahlo, Melanie] Hosp Univ Canarias, Unidad Invest, Inst Tecnol Biomed, Tenerife, Spain; [Norris, Fiona] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; [Delatycki, Martin B.] Austin Hlth, Austin, Australia; [Burkhalter, Martin D.] Fritz Lippmann Inst, Leibniz Inst Age Res, Jena, Germany; [Hofmann, Kay; Thiele, Holger; Altmueller, Janine; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Inst Genet, Cologne, Germany; [Thiele, Holger; Altmueller, Janine; Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3052, Australia; [Martin, George M.; Oshima, Junko] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Aalfs, Cora M.] Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cancer Research UK; University of Oxford; University of Oxford; University of Zurich; Murdoch Children's Research Institute; University of Melbourne; University of Split; Goethe University Frankfurt; Goethe University Frankfurt; Ulm University; Walter & Eliza Hall Institute; University of Melbourne; Universidad de la Laguna; Murdoch Children's Research Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Melbourne; University of Washington; University of Washington Seattle; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Kubisch, C (corresponding author), Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany.	janos.terzic@mefst.hr; david.amor@vcgs.org.au; dikic@biochem2.um-frankfurt.de; kristijan.ramadan@oncology.ox.ac.uk; c.kubisch@uke.de	Degoricija, Marina/D-5578-2017; Philipp, Melanie/B-5198-2016; Cabrera, Elisa/GPX-3455-2022; Lessel, Davor/ABD-6088-2021; Amor, David J/A-6478-2018; Marinovic Terzic, Ivana/D-5020-2017; Thiele, Holger/ABE-6792-2020; Kubisch, Christian/F-1893-2011; Freire, Raimundo/Q-7660-2019; Lockhart, Paul J/E-7753-2011; Dikic, Ivan/O-4650-2015	Degoricija, Marina/0000-0001-7023-9381; Philipp, Melanie/0000-0003-2714-965X; Amor, David J/0000-0001-7191-8511; Marinovic Terzic, Ivana/0000-0003-1109-4682; Thiele, Holger/0000-0002-0169-998X; Kubisch, Christian/0000-0003-4220-0978; Freire, Raimundo/0000-0003-4473-8894; Lockhart, Paul J/0000-0003-2531-8413; Dikic, Ivan/0000-0001-8156-9511; Lessel, Davor/0000-0003-4496-244X; Altmuller, Janine/0000-0003-4372-1521; Bahlo, Melanie/0000-0001-5132-0774; von Ameln, Simon/0000-0002-2242-3165; Oehler, Judith/0000-0002-8397-6492; Terzic, Janos/0000-0003-3228-2076; Burkhalter, Martin/0000-0002-8646-3131; Vaz, Bruno/0000-0002-7751-171X; Smith, Katherine Rose/0000-0002-0329-5938	Deutsche Forschungsgemeinschaft; Cluster of Excellence 'Macromolecular Complexes' of Goethe University Frankfurt [EXC115]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz program Ubiquitin Networks of the State of Hesse, Germany; European Research Council under the European Union's Seventh Framework Programme/European Research Council [250241-LineUb]; European Commission (Marie Curie Reintegration) [268333]; Deutsche Stiftung far Herzforschung; Medical Research Council [MC_PC_ 12001/1]; Swiss National Science Foundation [31003A_141197]; US National Institutes of Health (NIH) National Cancer Institute [R24CA78088, R24AG042328]; NIH National Institute on Aging [R21AG033313]; Ellison Medical Foundation; German Research Foundation (DFG); EMBO long-term fellowship; Croatian Ministry of Science, Education and Sport [216-0000000-3348]; City of Split grant; Pratt Foundation; Australian Research Council [FT100100764]; National Health and Medical Research Council (NHMRC) [APP1032364]; NATIONAL CANCER INSTITUTE [R24CA078088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033313, R24AG042328] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence 'Macromolecular Complexes' of Goethe University Frankfurt; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz program Ubiquitin Networks of the State of Hesse, Germany; European Research Council under the European Union's Seventh Framework Programme/European Research Council(European Research Council (ERC)); European Commission (Marie Curie Reintegration); Deutsche Stiftung far Herzforschung; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); City of Split grant; Pratt Foundation; Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are thankful to the family members for participation, G. Gilles for assistance with patient samples, J. Schafer for zebrafish care and Z. Garajova for technical assistance. We thank A. Ray Chaudhuri for initial help with the DNA fiber assay. We thank F. Bohm, Y. Boge and A. Weber from the University of Zurich and L. Campo and K. Myers from the University of Oxford for providing healthy and HCC human liver biopsies and performing histological and immunohistochemical staining. The zebrafish gamma-H2AX antibody was a kind gift of J. Amatruda (University of Texas Southwestern). This work was supported by grants from Deutsche Forschungsgemeinschaft, the Cluster of Excellence 'Macromolecular Complexes' of Goethe University Frankfurt (EXC115), the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz program Ubiquitin Networks of the State of Hesse, Germany and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/European Research Council grant agreement number 250241-LineUb to ID., the European Commission (Marie Curie Reintegration Grant 268333 to M.P.), the Deutsche Stiftung far Herzforschung (M.P.), the Medical Research Council (MC_PC_ 12001/1) and the Swiss National Science Foundation (31003A_141197) to K.R., grants from the US National Institutes of Health (NIH) National Cancer Institute (R24CA78088 and R24AG042328) to G.M.M., the NIH National Institute on Aging (R21AG033313) to J. Oshima, the Ellison Medical Foundation to J. Oshima, the German Research Foundation (DFG) in the framework of the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases to C.K., an EMBO long-term fellowship to J.L.-M., a grant from the Croatian Ministry of Science, Education and Sport (216-0000000-3348) and a City of Split grant to J.T. and I.D. K.R.S. is supported by a PhD scholarship funded by the Pratt Foundation. M.B. is supported by an Australian Research Council Future Fellowship (FT100100764). P.J.L. is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (APP1032364). This work was made possible through Victorian State Government Operational Infrastructure Support and the Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; HOEHN H, 1975, CYTOGENET CELL GENET, V15, P282, DOI 10.1159/000130526; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kim MS, 2013, NUCLEIC ACIDS RES, V41, P1661, DOI 10.1093/nar/gks1267; King KL, 1998, J GASTROEN HEPATOL, V13, P273, DOI 10.1111/j.1440-1746.1998.01555.x; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Machida Y, 2012, CELL CYCLE, V11, P3395, DOI 10.4161/cc.21694; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214; Nowsheen S, 2012, CANCER LETT, V327, P142, DOI 10.1016/j.canlet.2011.11.022; Oshima J, 2014, GERONTOLOGY, V60, P239, DOI 10.1159/000356030; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Ruijs MWG, 2003, AM J MED GENET A, V116A, P295, DOI 10.1002/ajmg.a.10730; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Vaz Bruno, 2013, Frontiers in Genetics, V4, P60, DOI 10.3389/fgene.2013.00060; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	32	128	133	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1239	1244		10.1038/ng.3103	http://dx.doi.org/10.1038/ng.3103			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25261934	Green Accepted			2022-12-17	WOS:000344131900016
J	Zhan, XW; Larson, DE; Wang, CL; Koboldt, DC; Sergeev, YV; Fulton, RS; Fulton, LL; Fronick, CC; Branham, KE; Bragg-Gresham, J; Jun, G; Hu, YN; Kang, HM; Liu, DJ; Othman, M; Brooks, M; Ratnapriya, R; Boleda, A; Grassmann, F; von Strachwitz, C; Olson, LM; Buitendijk, GHS; Hofman, A; van Duijn, CM; Cipriani, V; Moore, AT; Shahid, H; Jiang, YD; Conley, YP; Morgan, DJ; Kim, IK; Johnson, MP; Cantsilieris, S; Richardson, AJ; Guymer, RH; Luo, HR; Ouyang, H; Licht, C; Pluthero, FG; Zhang, MM; Zhang, K; Baird, PN; Blangero, J; Klein, ML; Farrer, LA; DeAngelis, MM; Weeks, DE; Gorin, MB; Yates, JRW; Klaver, CCW; Pericak-Vance, MA; Haines, JL; Weber, BHF; Wilson, RK; Heckenlively, JR; Chew, EY; Stambolian, D; Mardis, ER; Swaroop, A; Abecasis, GR				Zhan, Xiaowei; Larson, David E.; Wang, Chaolong; Koboldt, Daniel C.; Sergeev, Yuri V.; Fulton, Robert S.; Fulton, Lucinda L.; Fronick, Catrina C.; Branham, Kari E.; Bragg-Gresham, Jennifer; Jun, Goo; Hu, Youna; Kang, Hyun Min; Liu, Dajiang; Othman, Mohammad; Brooks, Matthew; Ratnapriya, Rinki; Boleda, Alexis; Grassmann, Felix; von Strachwitz, Claudia; Olson, Lana M.; Buitendijk, Gabrielle H. S.; Hofman, Albert; van Duijn, Cornelia M.; Cipriani, Valentina; Moore, Anthony T.; Shahid, Humma; Jiang, Yingda; Conley, Yvette P.; Morgan, Denise J.; Kim, Ivana K.; Johnson, Matthew P.; Cantsilieris, Stuart; Richardson, Andrea J.; Guymer, Robyn H.; Luo, Hongrong; Ouyang, Hong; Licht, Christoph; Pluthero, Fred G.; Zhang, Mindy M.; Zhang, Kang; Baird, Paul N.; Blangero, John; Klein, Michael L.; Farrer, Lindsay A.; DeAngelis, Margaret M.; Weeks, Daniel E.; Gorin, Michael B.; Yates, John R. W.; Klaver, Caroline C. W.; Pericak-Vance, Margaret A.; Haines, Jonathan L.; Weber, Bernhard H. F.; Wilson, Richard K.; Heckenlively, John R.; Chew, Emily Y.; Stambolian, Dwight; Mardis, Elaine R.; Swaroop, Anand; Abecasis, Goncalo R.			Identification of a rare coding variant in complement 3 associated with age-related macular degeneration	NATURE GENETICS			English	Article							HEMOLYTIC-UREMIC SYNDROME; GENOME-WIDE ASSOCIATION; FACTOR-H POLYMORPHISM; COMMON DISEASES; SEQUENCING DATA; EYE DISEASE; FACTOR-B; RISK; SUSCEPTIBILITY; MUTATIONS	Macular degeneration is a common cause of blindness in the elderly. To identify rare coding variants associated with a large increase in risk of age-related macular degeneration (AMD), we sequenced 2,335 cases and 789 controls in 10 candidate loci (57 genes). To increase power, we augmented our control set with ancestry-matched exome-sequenced controls. An analysis of coding variation in 2,268 AMD cases and 2,268 ancestry-matched controls identified 2 large-effect rare variants: previously described p. Arg1210Cys encoded in the CFH gene (case frequency (f(case)) = 0.51%; control frequency (f(control)) = 0.02%; odds ratio (OR) = 23.11) and newly identified p. Lys155Gln encoded in the C3 gene (f(case) = 1.06%; f(control) = 0.39%; OR = 2.68). The variants suggest decreased inhibition of C3 by complement factor H, resulting in increased activation of the alternative complement pathway, as a key component of disease biology.	[Zhan, Xiaowei; Wang, Chaolong; Bragg-Gresham, Jennifer; Jun, Goo; Hu, Youna; Kang, Hyun Min; Liu, Dajiang; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Larson, David E.; Koboldt, Daniel C.; Fulton, Robert S.; Fulton, Lucinda L.; Fronick, Catrina C.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Wang, Chaolong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, Bethesda, MD 20892 USA; [Branham, Kari E.; Othman, Mohammad; Heckenlively, John R.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Brooks, Matthew; Ratnapriya, Rinki; Boleda, Alexis; Swaroop, Anand] NEI, US Natl Inst Hlth, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA; [Grassmann, Felix; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [von Strachwitz, Claudia] Southwest Eye Ctr, Stuttgart, Germany; [Olson, Lana M.; Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Olson, Lana M.; Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Buitendijk, Gabrielle H. S.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrielle H. S.; Hofman, Albert; van Duijn, Cornelia M.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hofman, Albert] Netherlands Genom Initiat, Netherlands Consortium Hlth Aging, The Hague, Netherlands; [Cipriani, Valentina; Moore, Anthony T.; Yates, John R. W.] UCL, UCL Inst Ophthalmol, London, England; [Cipriani, Valentina; Moore, Anthony T.; Yates, John R. W.] Moorfields Eye Hosp, London, England; [Shahid, Humma; Yates, John R. W.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Shahid, Humma] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Cambridge, England; [Jiang, Yingda; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Promot & Dev, Pittsburgh, PA USA; [Morgan, Denise J.; DeAngelis, Margaret M.] Univ Utah, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Kim, Ivana K.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv, Boston, MA USA; [Kim, Ivana K.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA; [Johnson, Matthew P.; Blangero, John] Texas Biomed Res Inst, San Antonio, TX USA; [Cantsilieris, Stuart; Richardson, Andrea J.; Guymer, Robyn H.; Baird, Paul N.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Luo, Hongrong; Ouyang, Hong; Zhang, Mindy M.; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Luo, Hongrong; Ouyang, Hong; Zhang, Mindy M.; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Licht, Christoph] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Pluthero, Fred G.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Klein, Michael L.] Oregon Hlth & Sci Univ, Casey Eye Inst, Macular Degenerat Ctr, Portland, OR 97201 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med, Sect Biomed Genet, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Gorin, Michael B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Chew, Emily Y.] NEI, US Natl Inst Hlth, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Stambolian, Dwight] Univ Penn, Sch Med, Dept Ophthalmol & Human Genet, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Regensburg; Vanderbilt University; Vanderbilt University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Texas Biomedical Research Institute; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Oregon Health & Science University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Miami; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Pennsylvania	Abecasis, GR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	goncalo@umich.edu	DeAngelis, e/J-7863-2015; Farrer, Lindsay/AAS-1035-2020; Wilson, Richard K./AAF-4139-2019; Klaver, Caroline C.W./A-2013-2016; Haines, Jonathan/C-3374-2012; Branham, Kari/AAA-8336-2022; luo, hongrong/B-2714-2015; Jun, Goo/M-5235-2016; Zhang, Kang/Y-2740-2019; Cipriani, Valentina/A-8549-2012; Jun, Goo/F-1941-2017; Pluthero, Fred/T-8593-2019; Mardis, Elaine/W-2202-2019; Blangero, John/ABA-7175-2021; Weeks, Daniel E/B-2995-2012	Wilson, Richard K./0000-0002-1992-1358; Haines, Jonathan/0000-0002-4351-4728; luo, hongrong/0000-0001-7994-1193; Jun, Goo/0000-0003-0891-0204; Zhang, Kang/0000-0002-4549-1697; Cipriani, Valentina/0000-0002-0839-9955; Jun, Goo/0000-0003-0891-0204; Weeks, Daniel E/0000-0001-9410-7228; Ouyang, Hong/0000-0002-7622-7733; Larson, David/0000-0001-7934-5906; Klaver, Caroline/0000-0002-2355-5258; Grassmann, Felix/0000-0003-1390-7528; Baird, Paul/0000-0002-1305-3502; Kim, Ivana/0000-0003-0310-6129; Van Duijn, Cornelia/0000-0002-2374-9204; Swaroop, Anand/0000-0002-1975-1141; Farrer, Lindsay/0000-0001-5533-4225; Conley, Yvette/0000-0002-1784-6067; Wang, Chaolong/0000-0003-3945-1012; Pluthero, Fred/0000-0002-0451-5840; Branham, Kari/0000-0002-2492-254X; Guymer, Robyn/0000-0002-9441-4356; Liu, Dajiang/0000-0001-6553-858X; Ratnapriya, Rinki/0000-0002-0469-4631	US National Institutes of Health (National Eye Institute, National Human Genome Research Institute) [EY022005, HG007022, HG005552, EY016862, U54HG003079, EY09859]; Medical Research Council, UK [G0000067]; Deutsche Forschungsgemeinschaft [WE1259/19-2]; Thome Memorial Foundation; Harold and Pauline Price Foundation; MRC [G0000067] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY021532, R01EY022005, R01EY009859, ZIAEY000475, R01EY016862, R01EY012118, ZIAEY000476] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513, RC2HG005552, U54HG003079, R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084698] Funding Source: NIH RePORTER; Medical Research Council [MR/K006584/1, G0000067] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish	US National Institutes of Health (National Eye Institute, National Human Genome Research Institute); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thome Memorial Foundation; Harold and Pauline Price Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all study participants for their generous volunteering. We thank B. Li, W. Chen, C. Sidore, T. Teslovich, L. Fritsche and M. Boehnke for useful discussion and suggestions. This project was supported by grants from the US National Institutes of Health (National Eye Institute, National Human Genome Research Institute; grants EY022005, HG007022, HG005552, EY016862, U54HG003079 and EY09859); the Medical Research Council, UK (grant G0000067); the Deutsche Forschungsgemeinschaft (grant WE1259/19-2); the Alcon Research Institute; The UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and the UCL Institute of Ophthalmology; Research to Prevent Blindness (New York); the Thome Memorial Foundation; the Harold and Pauline Price Foundation; and the National Health and Medical Research Council of Australia (NHMRC) Clinical Research Excellence (grant 529923, NHMRC practitioner fellowship 529905 and NHMRC Senior Research Fellowship 1028444). The study was also supported by the Intramural Research Program (Computational Medicine Initiative) of the National Eye Institute. The Centre for Eye Research Australia (CERA) receives operational infrastructure support from the Victorian Government. The views expressed in the publication are those of the authors and not necessarily those of their employers or the funders.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chew EY, 2012, OPHTHALMOLOGY, V119, P2282, DOI 10.1016/j.ophtha.2012.05.027; Cox DH, 1989, ANAL BINARY DATA; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Heurich M, 2011, P NATL ACAD SCI USA, V108, P8761, DOI 10.1073/pnas.1019338108; HIRJI KF, 1987, J AM STAT ASSOC, V82, P1110, DOI 10.2307/2289388; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Priya RR, 2012, OPHTHALMOLOGY, V119, P2526, DOI 10.1016/j.ophtha.2012.06.042; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	43	128	129	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2013	45	11					1375	+		10.1038/ng.2758	http://dx.doi.org/10.1038/ng.2758			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	244JL	24036949	Green Submitted, Green Accepted			2022-12-17	WOS:000326384100020
J	Quan, C; Ren, YQ; Xiang, LH; Sun, LD; Xu, AE; Gao, XH; Chen, HD; Pu, XM; Wu, RN; Liang, CZ; Li, JB; Gao, TW; Zhang, JZ; Wang, XL; Wang, J; Yang, RY; Liang, L; Yu, JB; Zuo, XB; Zhang, SQ; Zhang, SM; Chen, G; Zheng, XD; Li, P; Zhu, J; Li, YW; Wei, XD; Hong, WS; Ye, Y; Zhang, Y; Wu, WS; Cheng, H; Dong, PL; Hu, DY; Li, Y; Li, M; Zhang, X; Tang, HY; Tang, XF; Xu, SX; He, SM; Lv, YM; Shen, M; Jiang, HQ; Wang, Y; Li, K; Kang, XJ; Liu, YQ; Sun, L; Liu, ZF; Xie, SQ; Zhu, CY; Xu, QA; Gao, JP; Hu, WL; Ni, C; Pan, TM; Li, Y; Yao, S; He, CF; Liu, YS; Yu, ZY; Yin, XY; Zhang, FY; Yang, S; Zhou, YW; Zhang, XJ				Quan, Cheng; Ren, Yun-Qing; Xiang, Lei-Hong; Sun, Liang-Dan; Xu, Ai-E; Gao, Xing-Hua; Chen, Hong-Duo; Pu, Xiong-Ming; Wu, Ri-Na; Liang, Chao-Zhao; Li, Jia-Bin; Gao, Tian-Wen; Zhang, Jian-Zhong; Wang, Xiu-Li; Wang, Jun; Yang, Rong-Ya; Liang, Ling; Yu, Jian-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Li, Yong-Wei; Wei, Xiao-Dong; Hong, Wei-Song; Ye, Ying; Zhang, Yong; Wu, Wei-Su; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Shen, Min; Jiang, Hong-Quan; Wang, Ying; Li, Kai; Kang, Xiao-Jing; Liu, Yu-Qin; Sun, Li; Liu, Zhi-Fang; Xie, Shao-Qiong; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun			Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC	NATURE GENETICS			English	Article							GENERALIZED VITILIGO; AUTOIMMUNE-DISEASES; ROMANIAN POPULATION; IN-VIVO; GENE; HLA; LINKAGE; FAMILIES; FOP; EPIDEMIOLOGY	We conducted a genome-wide association study of generalized vitiligo in the Chinese Han population by genotyping 1,117 cases and 1,429 controls. The 34 most promising SNPs were carried forward for replication in samples from individuals of the Chinese Han (5,910 cases and 9,916 controls) and Chinese Uygur (713 cases and 824 controls) populations. We identified two independent association signals within the major histocompatibility complex (MHC) region (rs11966200, P-combined = 1.48 x 10(-48), OR = 1.90; rs9468925, P-combined = 2.21 x 10(-33), OR = 0.74). Further analyses suggested that the strong association at rs11966200 might reflect the reported association of the HLA-A*3001, HLA-B*1302, HLA-C*0602 and HLA-DRB1*0701 alleles and that the association at rs9468925 might represent a previously unknown HLA susceptibility allele. We also identified one previously undescribed risk locus at 6q27 (rs2236313, P-combined = 9.72 x 10(-17), OR = 1.20), which contains three genes: RNASET2, FGFR1OP and CCR6. Our study provides new insights into the genetic basis of vitiligo.	[Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Liang, Chao-Zhao; Li, Jia-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Liang, Chao-Zhao; Li, Jia-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Xu, Ai-E; Pu, Xiong-Ming; Liang, Chao-Zhao; Li, Jia-Bin; Wang, Xiu-Li; Yang, Rong-Ya; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Li, Yong-Wei; Wei, Xiao-Dong; Hong, Wei-Song; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Kang, Xiao-Jing; Liu, Yu-Qin; Xie, Shao-Qiong; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Dept Dermatol & Venerol, Hefei, Anhui, Peoples R China; [Quan, Cheng; Ren, Yun-Qing; Sun, Liang-Dan; Liang, Chao-Zhao; Li, Jia-Bin; Zuo, Xian-Bo; Zhang, Sheng-Quan; Zhang, Shu-Mei; Chen, Gang; Zheng, Xiao-Dong; Li, Pan; Zhu, Jun; Cheng, Hui; Dong, Pu-Ling; Hu, Da-Yan; Li, Yang; Li, Min; Zhang, Xin; Tang, Hua-Yang; Tang, Xian-Fa; Xu, Sheng-Xin; He, Su-Min; Lv, Yong-Mei; Zhu, Cheng-Yao; Xu, Qiang; Gao, Jin-Ping; Hu, Wen-Long; Ni, Cheng; Pan, Ting-Meng; Li, Yun; Yao, Sha; He, Cai-Feng; Liu, Yang-Sheng; Yu, Ze-Ying; Yin, Xian-Yong; Zhang, Feng-Yu; Yang, Sen; Zhou, Youwen; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Xiang, Lei-Hong; Ye, Ying; Zhang, Yong; Zhang, Xue-Jun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Xu, Ai-E; Li, Yong-Wei; Wei, Xiao-Dong; Hong, Wei-Song] Third Peoples Hosp Hangzhou, Hangzhou, Zhejiang, Peoples R China; [Gao, Xing-Hua; Chen, Hong-Duo; Wu, Wei-Su] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Liaoning, Peoples R China; [Pu, Xiong-Ming; Kang, Xiao-Jing; Liu, Yu-Qin] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Dermatol, Urumqi, Xinjiang, Peoples R China; [Wu, Ri-Na; Sun, Li; Liu, Zhi-Fang] Inner Mongolia Med Coll, Affiliated Hosp, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Gao, Tian-Wen; Li, Kai] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Zhang, Jian-Zhong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100871, Peoples R China; [Wang, Xiu-Li; Xie, Shao-Qiong] Shanghai Skin Dis & STD Hosp, Shanghai, Peoples R China; [Wang, Jun] Yijishan Hosp, Wannan Med Coll, Dept Dermatol, Wuhu, Anhui, Peoples R China; [Yang, Rong-Ya] Beijing Mil Command PLA, Gen Hosp, Dept Dermatol, Beijing, Peoples R China; [Liang, Ling] Guangxi Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanning, Guangxi, Peoples R China; [Yu, Jian-Bin] Zhengzhou Univ, Affiliated Hosp 1, Dept Dermatol, Zhengzhou, Henan, Peoples R China; [Shen, Min; Jiang, Hong-Quan; Wang, Ying] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Fudan University; China Medical University; Inner Mongolia Medical University; Air Force Military Medical University; Peking University; Wannan Medical College; Academy of Military Medical Sciences - China; Guangxi Medical University; Zhengzhou University	Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 2, Dept Dermatol, Hefei, Anhui, Peoples R China.	Youwen.Zhou@vch.ca; ayzxj@vip.sina.com	Zhang, Fengyu/M-1396-2019; Chen, Gang/G-2722-2010; Hu, Wenlong/GQY-6243-2022	Zhang, Fengyu/0000-0001-8504-0770; Hu, Wenlong/0000-0001-9706-3769	Chinese National Natural Science Foundation [30530670]; Chinese Key National Natural Science Foundation for Overseas Youth [30628021]; Anhui Provincial Special Scientific Program	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Key National Natural Science Foundation for Overseas Youth(National Natural Science Foundation of China (NSFC)); Anhui Provincial Special Scientific Program	We thank all study participants. We also thank J.-J. Liu, J.-M. Chen and K. Seng Sim at the Genome Institute of Singapore for performing the imputation, association and LD analyses of HLA alleles. This study was supported in part by the Key Project of the Chinese National Natural Science Foundation (No. 30530670), the Cooperation Project of the Chinese Key National Natural Science Foundation for Overseas Youth (No. 30628021) and the Anhui Provincial Special Scientific Program (2007-7).	Acquati F, 2001, ONCOGENE, V20, P980, DOI 10.1038/sj.onc.1204178; Acquaviva C, 2009, CELL CYCLE, V8, P1217, DOI 10.4161/cc.8.8.8248; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Alkhateeb A, 2002, HUM MOL GENET, V11, P661, DOI 10.1093/hmg/11.6.661; Arcos-Burgos M, 2002, HUM GENET, V110, P334, DOI 10.1007/s00439-002-0687-5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Birlea SA, 2008, ARCH DERMATOL, V144, P310, DOI 10.1001/archderm.144.3.310; Birlea SA, 2010, J INVEST DERMATOL, V130, P798, DOI 10.1038/jid.2009.347; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Chen JJ, 2005, AM J HUM GENET, V76, P1057, DOI 10.1086/430279; DAS S K, 1985, Genetic Epidemiology, V2, P71; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hann S, 2000, VITILIGO; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jin Y, 2007, J INVEST DERMATOL, V127, P2558, DOI 10.1038/sj.jid.5700953; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Levy C, 2006, BLOOD, V107, P2839, DOI 10.1182/blood-2005-08-3325; Liu JB, 2007, J EUR ACAD DERMATOL, V21, P205, DOI 10.1111/j.1468-3083.2006.01899.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Monti L, 2008, ONCOL RES, V17, P69, DOI 10.3727/096504008784523658; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; PORTER J, 1979, GEN HOSP PSYCHIAT, V1, P73, DOI 10.1016/0163-8343(79)90081-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ren YQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000523; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Tastan HB, 2004, PIGM CELL RES, V17, P181, DOI 10.1111/j.1600-0749.2004.00141.x; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Zamani M, 2001, BRIT J DERMATOL, V145, P90, DOI 10.1046/j.1365-2133.2001.04288.x; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang XJ, 2004, J AM ACAD DERMATOL, V51, P383, DOI 10.1016/j.jaad.2003.12.044; Zhang XJ, 2004, J DERMATOL SCI, V35, P165, DOI 10.1016/j.jdermsci.2004.05.003; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhang Z, 2009, ARCH DERMATOL RES, V301, P167, DOI 10.1007/s00403-008-0900-z	47	128	143	4	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2010	42	7					614	U192		10.1038/ng.603	http://dx.doi.org/10.1038/ng.603			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	616WO	20526339				2022-12-17	WOS:000279242400015
J	McMahon, FJ; Akula, N; Schulze, TG; Muglia, P; Tozzi, F; Detera-Wadleigh, SD; Steele, CJM; Breuer, R; Strohmaier, J; Wendland, JR; Mattheisen, M; Muhleisen, TW; Maier, W; Nothen, MM; Cichon, S; Farmer, A; Vincent, JB; Holsboer, F; Preisig, M; Rietschel, M				McMahon, Francis J.; Akula, Nirmala; Schulze, Thomas G.; Muglia, Pierandrea; Tozzi, Federica; Detera-Wadleigh, Sevilla D.; Steele, C. J. M.; Breuer, Rene; Strohmaier, Jana; Wendland, Jens R.; Mattheisen, Manuel; Muehleisen, Thomas W.; Maier, Wolfgang; Noethen, Markus M.; Cichon, Sven; Farmer, Anne; Vincent, John B.; Holsboer, Florian; Preisig, Martin; Rietschel, Marcella		Bipolar Disorder Genome Study BiGS	Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1	NATURE GENETICS			English	Article							BIPOLAR DISORDER; LINKAGE	The major mood disorders, which include bipolar disorder and major depressive disorder (MDD), are considered heritable traits, although previous genetic association studies have had limited success in robustly identifying risk loci. We performed a meta-analysis of five case-control cohorts for major mood disorder, including over 13,600 individuals genotyped on high-density SNP arrays. We identified SNPs at 3p21.1 associated with major mood disorders (rs2251219, P = 3.63 x 10(-8); odds ratio = 0.87; 95% confidence interval, 0.83-0.92), with supportive evidence for association observed in two out of three independent replication cohorts. These results provide an example of a shared genetic susceptibility locus for bipolar disorder and MDD.	[McMahon, Francis J.; Akula, Nirmala; Schulze, Thomas G.; Detera-Wadleigh, Sevilla D.; Steele, C. J. M.; Wendland, Jens R.] NIMH, Unit Genet Basis Mood & Anxiety Disorders, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Schulze, Thomas G.; Breuer, Rene; Strohmaier, Jana; Rietschel, Marcella] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Muglia, Pierandrea; Tozzi, Federica] GlaxoSmithKline, Res & Dev, Neurosci Ctr Excellence Drug Discovery, Verona, Italy; [Muglia, Pierandrea; Vincent, John B.] Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mattheisen, Manuel; Muehleisen, Thomas W.; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, D-5300 Bonn, Germany; [Mattheisen, Manuel; Muehleisen, Thomas W.; Noethen, Markus M.; Cichon, Sven; Rietschel, Marcella] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Farmer, Anne] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Holsboer, Florian] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Preisig, Martin] Univ Hosp Ctr, Lausanne, Switzerland; [Preisig, Martin] Univ Lausanne, Dept Psychiat, Lausanne, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central Institute of Mental Health; GlaxoSmithKline; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of London; King's College London; Max Planck Society; University of Lausanne	McMahon, FJ (corresponding author), NIMH, Unit Genet Basis Mood & Anxiety Disorders, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	mcmahonf@mail.nih.gov	Greenwood, Tiffany/F-6356-2012; Tozzi, Federica/AAP-5462-2021; Wendland, Jens R/A-1809-2012; Mattheisen, Manuel/S-3725-2019; Cichon, Sven/B-9618-2014; Mattheisen, Manuel/B-4949-2012; Muglia, Pierandrea/ABD-9235-2020; Mahon, Pamela Belmonte/O-9806-2018; Nöthen, Markus/B-2027-2009; McMahon, Francis J/A-7290-2009; Smith, Erin/E-5933-2011; Colaus, PsyColaus/K-6607-2013; Cichon, Sven/H-8803-2013; Schulze, Thomas G/H-2157-2013	Greenwood, Tiffany/0000-0002-6080-6503; Tozzi, Federica/0000-0002-3536-2920; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; Muglia, Pierandrea/0000-0002-3973-8606; Mahon, Pamela Belmonte/0000-0002-3947-441X; Nöthen, Markus/0000-0002-8770-2464; McMahon, Francis J/0000-0002-9469-305X; Cichon, Sven/0000-0002-9475-086X; Preisig, Martin/0000-0001-5689-4259	US NIMH Intramural Research Program; Deutsche Forschungsgemeinschaft (DFG); National Genome Research Network (NGFN) of the Federal German Ministry of Education and Research; NARSAD; National German Genome Research Network Plus (NGFNplus); Federal German Ministry of Education and Research [01GS08144, 01GS08147]; Heinz Nixdorf Foundation; Alfried Krupp von Bohlen und Halbach-Stiftung; NIMH; US National Human Genome Research Institute [MH078151, MH081804, MH059567]; National Library of Medicine; NIH; Swiss National Science Foundation [3200B0-105993, 32003B-118308, 33CSCO-122661]; GlaxoSmithKline; Medical Research Council [G9817803B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002843, R01MH078151, R01MH059567, ZIAMH002810, R01MH081804, ZIAMH002842] Funding Source: NIH RePORTER	US NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Genome Research Network (NGFN) of the Federal German Ministry of Education and Research; NARSAD(NARSAD); National German Genome Research Network Plus (NGFNplus); Federal German Ministry of Education and Research; Heinz Nixdorf Foundation; Alfried Krupp von Bohlen und Halbach-Stiftung; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Genotyping of the GAIN major depression and NIMH bipolar disorder samples was provided through the Genetic Association Information Network (GAIN), Foundation for NIH (the US National Institutes of Health). The data sets used for the analyses described in this manuscript were obtained from the Database of Genotypes and Phenotypes (dbGaP). Samples and associated phenotype data were provided by the contributing studies. We thank the Wellcome Trust Case Control Consortium, the STEP-BD group, the Netherlands Study of Depression and Anxiety and the Netherlands Twin Registry for making data or results available for analysis. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. Postmortem brain tissue was supplied by the Stanley Medical Research Institute. Additional acknowledgments are included in the Supplementary Note. Funded by the US NIMH Intramural Research Program, Deutsche Forschungsgemeinschaft (DFG), the National Genome Research Network (NGFN) of the Federal German Ministry of Education and Research, NARSAD (Independent Investigator Award to F.J.M. and Young Investigator Award to T.G.S.), the National German Genome Research Network Plus (NGFNplus) and the MooDS-Net (grant 01GS08144 to S. C. and M.M.N., grant 01GS08147 to M.R.) of the Federal German Ministry of Education and Research, the Heinz Nixdorf Foundation (G. Schmidt, chairman), the Alfried Krupp von Bohlen und Halbach-Stiftung, the DFG Graduate College 793, University of Heidelberg and grants from the NIMH and US National Human Genome Research Institute to J.R.K. (MH078151, MH081804, MH059567 supplement). This research was also supported in part by the Intramural Research Program of the National Library of Medicine, NIH. The replication samples were supported by the Swiss National Science Foundation (3200B0-105993, 32003B-118308 and 33CSCO-122661) and GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Verona).	Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; GOODWIN FK, 2007, MANIC DEPRESSIVE ILL, P8; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Li Y, 2006, AM J HUM GENET S, VS79, P2290; LITTELL JH, 2008, SYSTEMATIC REV METAA, V62; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sagoo GS, 2008, AM J EPIDEMIOL, V168, P1233, DOI 10.1093/aje/kwn235; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386	28	128	133	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2010	42	2					128	U52		10.1038/ng.523	http://dx.doi.org/10.1038/ng.523			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20081856	Green Accepted			2022-12-17	WOS:000274084400008
J	Blaydon, DC; Ishii, Y; O'Toole, EA; Unsworth, HC; Teh, MT; Ruschendorf, F; Sinclair, C; Hopsu-Havu, VK; Tidman, N; Moss, C; Watson, R; de Berker, D; Wajid, M; Christiano, AM; Kelsell, DP				Blaydon, Diana C.; Ishii, Yoshiyuki; O'Toole, Edel A.; Unsworth, Harriet C.; Teh, Muy-Teck; Rueschendorf, Franz; Sinclair, Claire; Hopsu-Havu, Vaino K.; Tidman, Nicholas; Moss, Celia; Watson, Rosemarie; de Berker, David; Wajid, Muhammad; Christiano, Angela M.; Kelsell, David P.			The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia	NATURE GENETICS			English	Article							NAIL-PATELLA SYNDROME; R-SPONDIN; FAMILY; LMX1B; LIMB	Anonychia and hyponychia congenita (OMIM 206800) are rare autosomal recessive conditions in which the only presenting phenotype is the absence or severe hypoplasia of all fingernails and toenails. After determining linkage to chromosome 20p13, we identified homozygous or compound heterozygous mutations in the gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, in eight affected families. Rspo4 expression was specifically localized to developing mouse nail mesenchyme at embryonic day 15.5, suggesting a crucial role in nail morphogenesis.	Univ London Queen Mary Coll, Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Cutaneous Res, London E1 4AT, England; Columbia Univ Coll Phys & Surg, Dept Dermatol & Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Dev, New York, NY 10032 USA; Max Delbruck Ctr Mol Med, Dept Funct Genet & Genom, D-13092 Berlin, Germany; Univ Turku, Cent Hosp, Dept Dermatol, FIN-20520 Turku, Finland; Canc Res UK, London WC2A 3PX, England; Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; Bristol Royal Infirm & Gen Hosp, Bristol Dermatol Ctr, Bristol BS2 8HW, Avon, England	University of London; Queen Mary University London; Columbia University; Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Turku; Cancer Research UK; University of Birmingham; Our Ladys Children Hospital Crumlin; Bristol Royal Infirmary	Kelsell, DP (corresponding author), Univ London Queen Mary Coll, Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Cutaneous Res, Whitechapel, London E1 4AT, England.	d.p.kelsell@qmul.ac.uk	Wajid, Muhammad/F-5087-2015; Kelsell, David P/F-8767-2011; Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355; Blaydon, Diana/0000-0002-9998-2563; O'Toole, Edel/0000-0002-4084-4836; Kelsell, David/0000-0002-9910-7144	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044924] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01AR44924] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chuong CM, 1996, J INVEST DERMATOL, V107, P639, DOI 10.1111/1523-1747.ep12584254; DAWBER R, 2001, DIS NAILS THEIR MANA; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HOPSUHAVU VK, 1973, ARCH DERMATOL, V107, P752; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137	14	128	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1245	1247		10.1038/ng1883	http://dx.doi.org/10.1038/ng1883			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041604				2022-12-17	WOS:000241592700011
J	Le Stunff, C; Fallin, D; Schork, NJ; Bougneres, P				Le Stunff, C; Fallin, D; Schork, NJ; Bougneres, P			The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity	NATURE GENETICS			English	Article							DIABETES SUSCEPTIBILITY; LOCUS; MINISATELLITE; SECRETION; MELLITUS; WEIGHT; REGION; IDDM2	In millions of people, obesity leads to type 2 diabetes (T2D; also known as non-insulin-dependent diabetes mellitus(1)). During the early stages of juvenile obesity, the increase of insulin secretion in proportion to accumulated fat balances insulin resistance and protects patients from hyperglycaemia(2). After several decades, however, beta -cell function deteriorates and T2D develops in approximately 20% of obese patients(3,4). In modern societies, obesity has thus become the leading risk factor for T2D (ref. 5). The factors that predispose obese patients to alteration of insulin secretion upon gaining weight remain unknown. To determine which genetic factors predispose obese patients to beta -cell dysfunction, and possibly T2D, we studied single-nucleotide polymorphisms (SNPs) in the region of the insulin gene (INS) among 615 obese children. We found that, in the early phase of obesity, alleles of the INS variable number of tandem repeat (VNTR) locus are associated with different effects of body fatness on insulin secretion. Young obese patients homozygous for class I VNTR alleles secrete more insulin than those with other genotypes.	Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Genset Corp, La Jolla, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health	Bougneres, P (corresponding author), Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75674 Paris, France.		LE STUNFF, CATHERINE/Y-3270-2018	LE STUNFF, CATHERINE/0000-0001-8419-0451; Schork, Nicholas/0000-0003-0920-5013				Ahmed S, 1999, DIABETIC MED, V16, P910, DOI 10.1046/j.1464-5491.1999.00169.x; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Brancati FL, 1999, ARCH INTERN MED, V159, P957, DOI 10.1001/archinte.159.9.957; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARAM JH, 1963, DIABETES, V12, P197, DOI 10.2337/diab.12.3.197; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LESTUNFF C, 1994, DIABETES, V43, P696, DOI 10.2337/diabetes.43.5.696; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; Ong KKL, 1999, NAT GENET, V21, P262, DOI 10.1038/6775; OWERBACH D, 1982, LANCET, V1, P880; PEDERSEN P, 1989, DIABETES METAB REV, V5, P505; PERMUTT MA, 1985, DIABETES, V34, P311, DOI 10.2337/diabetes.34.4.311; Snieder H, 1999, GENET EPIDEMIOL, V16, P426, DOI 10.1002/(SICI)1098-2272(1999)16:4<426::AID-GEPI8>3.3.CO;2-2; WEAVER H, 1992, PHYS WORLD, V5, P22, DOI 10.1088/2058-7058/5/11/23	23	128	133	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					444	446		10.1038/82579	http://dx.doi.org/10.1038/82579			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101842				2022-12-17	WOS:000165671700017
J	Abdel-Majid, RM; Leong, WL; Schalkwyk, LC; Smallman, DS; Wong, ST; Storm, DR; Fine, A; Dobson, MJ; Guernsey, DL; Neumann, PE				Abdel-Majid, RM; Leong, WL; Schalkwyk, LC; Smallman, DS; Wong, ST; Storm, DR; Fine, A; Dobson, MJ; Guernsey, DL; Neumann, PE			Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex	NATURE GENETICS			English	Article							ARTIFICIAL CHROMOSOME LIBRARY; DEVELOPING RAT; MUTANT MICE; SEROTONIN; GENOME; RECEPTORS; CONSTRUCTION; ACTIVATION; INSERTION; BEHAVIOR	The somatosensory (SI) cortex of mice displays a patterned, nonuniform distribution of neurons in layer IV called the "barrelfield' (ref. 1). Thalamocortical afferents (TCAs) that terminate in layer IV are segregated such that each barrel, a readily visible cylindrical array of neurons surrounding a cell-sparse center, represents a distinct receptive field. TCA arbors are confined to the barrel hollow and synapse on barrel-wail neurons whose dendrites are oriented toward the center of the barrel(2). Mice homozygous for the barrelless (brl) mutation, which occurred spontaneously in ICR stock at Universitd de Lausanne (Switzerland), fail to develop this patterned distribution of neurons, but still display normal topological organization of the SI cortex(3). Despite the absence of barrels and the overlapping zones of TCA arborization, the size of individual whisker representations, as judged by 2-deoxyglucose uptake, is similar to that of wild-type mice. We identified adenylyl cyclase type I(Adcy1) as the gene disrupted in brl mutant mice by fine mapping of proximal chromosome 11, enzyme assay, mutation analysis and examination of mice homozygous for a targeted disruption of Adcy1. These results provide the first evidence for involvement of cAMP signalling pathways in pattern formation of the brain.	Dalhousie Univ, Fac Med, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Surg, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Phys & Biophys, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Biochem, Halifax, NS B3H 4H7, Canada; Max Planck Inst Mol Genet, Abt Lehrach, Berlin, Germany; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Max Planck Society; University of Washington; University of Washington Seattle	Neumann, PE (corresponding author), Dalhousie Univ, Fac Med, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada.	neumannp@tupdean1.med.dal.ca	Schalkwyk, Leonard C/A-2150-2010	Schalkwyk, Leonard C/0000-0001-7030-5756; Neumann, Paul/0000-0002-8480-4799; Dobson, Melanie/0000-0001-9291-7200				BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; BOUHELAL R, 1988, EUR J PHARMACOL, V151, P189, DOI 10.1016/0014-2999(88)90799-6; BYRNE JH, 1991, ANN NY ACAD SCI, V627, P124, DOI DOI 10.1111/J.1749-6632.1991.TB25918.X; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CLAUDIO JO, 1994, GENOMICS, V21, P437, DOI 10.1006/geno.1994.1291; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; EDELHOFF S, 1995, MAMM GENOME, V6, P111, DOI 10.1007/BF00303253; Haldi ML, 1996, MAMM GENOME, V7, P767, DOI 10.1007/s003359900228; JOHNSON RA, 1973, J BIOL CHEM, V248, P5114; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LARIN Z, 1993, METHOD ENZYMOL, V225, P623; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; MITREITER K, 1994, VIROLOGY, V200, P837, DOI 10.1006/viro.1994.1253; Mitrovic N, 1996, EUR J NEUROSCI, V8, P1793, DOI 10.1111/j.1460-9568.1996.tb01323.x; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; WU ZL, 1993, J BIOL CHEM, V268, P23766; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526	30	128	132	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					289	291		10.1038/980	http://dx.doi.org/10.1038/980			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662407				2022-12-17	WOS:000074565900030
J	Lu, SL; Kawabata, M; Imamura, T; Akiyama, Y; Nomizu, T; Miyazono, K; Yuasa, Y				Lu, SL; Kawabata, M; Imamura, T; Akiyama, Y; Nomizu, T; Miyazono, K; Yuasa, Y			HNPCC associated with germline mutation in the TGF-beta type II receptor gene	NATURE GENETICS			English	Letter							NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CELLS		Tokyo Med & Dent Univ, Dept Hyg & Oncol, Sch Med, Bunkyo Ku, Tokyo 113, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 170, Japan; Hoshi Gen Hosp, Dept Surg, Koriyama, Fukushima 963, Japan	Tokyo Medical & Dental University (TMDU); Japanese Foundation for Cancer Research	Yuasa, Y (corresponding author), Tokyo Med & Dent Univ, Dept Hyg & Oncol, Sch Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 113, Japan.	yyuasa.hgen@med.tmd.ac.jp						AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Akiyama Y, 1997, CANCER RES, V57, P3920; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LU SL, 1995, BIOCHEM BIOPH RES CO, V216, P452, DOI 10.1006/bbrc.1995.2644; Lu SL, 1996, CANCER RES, V56, P4595; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Muta H, 1996, CANCER, V77, P265, DOI 10.1002/(SICI)1097-0142(19960115)77:2<265::AID-CNCR7>3.3.CO;2-L; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; WU C, 1994, ONCOGENE, V9, P991	14	128	136	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					17	18		10.1038/ng0598-17	http://dx.doi.org/10.1038/ng0598-17			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590282				2022-12-17	WOS:000073346700010
J	Relaix, F; Wei, XJ; Wu, XW; Sassoon, DA				Relaix, F; Wei, XJ; Wu, XW; Sassoon, DA			Peg3/Pw1 is an imprinted gene involved in the TNF-NF kappa B signal transduction pathway	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; DOMAIN-CONTAINING RECEPTOR; RING FINGER PROTEIN; CYTOPLASMIC DOMAIN; DEATH-DOMAIN; CELL-DEATH; ACTIVATION; APOPTOSIS; CD40; CHROMOSOME-7	Tumor necrosis factor (TNF) mediates a variety of biological activities including cell proliferation, differentiation and programmed cell death. The specific response to TNF depends upon cell type and reflects the presence of specific regulatory proteins that participate in the TNF response pathway. TNF signal transduction is mediated by TRAF2 which binds the TNF Receptor2 (TNFR2) and activates NF kappa B. We previously identified a gene Pw1, which encodes a large zinc-finger containing protein(1). We have determined that Pw1 is identical to Peg3, a paternally expressed gene of unknown function(2) (and will therefore be referred to as Peg3 throughout this text). We report here that Peg3 associates specifically with TRAF2 but not with other TRAF family members. Peg3 expression activates NF kappa B via I kappa B-NF kappa B dissociation and acts synergistically with TRAF2. Transfection of a truncated Peg3 containing the TRAF2 interaction site, abolishes NF kappa B activation by TRAF2 and/or TNF. We conclude that Peg3 is a regulator of the TNF response. These data reveal the involvement of an imprinted gene in this pathway.	Mt Sinai Med Ctr, Brookdale Ctr Mol & Dev Biol, New York, NY 10029 USA; Mt Sinai Med Ctr, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sassoon, DA (corresponding author), Mt Sinai Med Ctr, Brookdale Ctr Mol & Dev Biol, 1 Gustave Levy Pl, New York, NY 10029 USA.	dsassoo@smtplink.mssm.edu	SASSOON, David A/G-2502-2013	SASSOON, David A/0000-0001-6074-048X; Relaix, Frederic/0000-0003-1270-1472	PHS HHS [C873678/01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BROWN SDM, 1993, GENOMICS, V18, P459, DOI 10.1006/geno.1993.1502; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; HERMEKING H, 1994, SCIENCE, V165, P1091; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; JANSEN G, 1993, HUM MOL GENET, V2, P1221, DOI 10.1093/hmg/2.8.1221; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; RUBIO MP, 1994, CANCER RES, V54, P4760; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SONG HY, 1995, BIOCHEM J, V309, P825, DOI 10.1042/bj3090825; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; YONG WH, 1995, J NEUROPATH EXP NEUR, V54, P622, DOI 10.1097/00005072-199509000-00002	36	128	134	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					287	291		10.1038/ng0398-287	http://dx.doi.org/10.1038/ng0398-287			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500555				2022-12-17	WOS:000072325000031
J	Cohen, B; Bashirullah, A; Dagnino, L; Campbell, C; Fisher, WW; Leow, CC; Whiting, E; Ryan, D; Zinyk, D; Boulianne, G; Hui, CC; Gallie, B; Phillips, RA; Lipshitz, HD; Egan, SE				Cohen, B; Bashirullah, A; Dagnino, L; Campbell, C; Fisher, WW; Leow, CC; Whiting, E; Ryan, D; Zinyk, D; Boulianne, G; Hui, CC; Gallie, B; Phillips, RA; Lipshitz, HD; Egan, SE			Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila	NATURE GENETICS			English	Article							GENE SERRATE ENCODES; TRANSMEMBRANE PROTEIN; VERTEBRATE DEVELOPMENT; NEUROGENIC GENE; CELL FATE; DELTA; EXPRESSION; MELANOGASTER; MORPHOGENESIS; COMPLEX		HOSP SICK CHILDREN,DIV IMMUNOL & CANC RES,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,DIV ENDOCRINOL,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,PROGRAM DEV BIOL,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,DIV NEUROL,TORONTO,ON M5G 1X8,CANADA; CALTECH,DIV BIOL,PASADENA,CA 91125; UNIV TORONTO,DEPT MOL & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); California Institute of Technology; University of Toronto; University of Toronto				Lipshitz, Howard/0000-0002-7372-4419; Gallie, Brenda/0000-0002-9697-9211; Dagnino, Lina/0000-0003-1483-5159				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; BRAND AH, 1993, DEVELOPMENT, V118, P401; CONLON RA, 1995, DEVELOPMENT, V121, P1533; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Lardelli M, 1995, INT J DEV BIOL, V39, P769; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Lawrence P.A., 1986, P229; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; PARODY TR, 1993, GENETICS, V135, P527; PARR BA, 1994, CURR OPIN GENET DEV, V4, P523, DOI 10.1016/0959-437X(94)90067-D; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; THOMAS U, 1991, DEVELOPMENT, V111, P749; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; Wu JY, 1996, SCIENCE, V273, P355, DOI 10.1126/science.273.5273.355; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8	36	128	135	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					283	288		10.1038/ng0797-283	http://dx.doi.org/10.1038/ng0797-283			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207795				2022-12-17	WOS:A1997XG60900025
J	DUBAY, C; VINCENT, M; SAMANI, NJ; HILBERT, P; KAISER, MA; BERESSI, JP; KOTELEVTSEV, Y; BECKMANN, JS; SOUBRIER, F; SASSARD, J; LATHROP, GM				DUBAY, C; VINCENT, M; SAMANI, NJ; HILBERT, P; KAISER, MA; BERESSI, JP; KOTELEVTSEV, Y; BECKMANN, JS; SOUBRIER, F; SASSARD, J; LATHROP, GM			GENETIC-DETERMINANTS OF DIASTOLIC AND PULSE PRESSURE MAP TO DIFFERENT LOCI IN LYON HYPERTENSIVE RATS	NATURE GENETICS			English	Article							BLOOD-PRESSURE; RENIN GENE; ANGIOTENSIN; STRAIN	Several genetic loci involved in blood pressure regulation have recently been localized in experimental models of hypertension, but the manner in which they influence blood pressure remains unknown. Here, we report a study of the Lyon hypertensive rat strain showing that different loci are involved in the regulation of steady-state (diastolic pressure) and pulsatile (systolic - diastolic, or pulse pressure) components of blood pressure. Significant linkage was established between diastolic blood pressure and a microsatellite marker of the renin gene (REN) on rat chromosome 13, and between pulse pressure and the carboxypeptidase B gene (CPB) on chromosome 2. These findings show that two independent loci influence different haemodynamic components of blood pressure, and that pulse pressure has a specific genetic determination.	CTR ETUD POLYMORPHISME HUMAIN,INSERM,U358,F-75010 PARIS,FRANCE; FAC PHARM LYON,DEPT PHYSIOL & PHARMACOL CLIN,CNRS,URA 1483,F-69373 LYON,FRANCE; UNIV LEICESTER,ROYAL INFIRM,DEPT MED,LEICESTER LE2 7LX,ENGLAND; IRIBNH,B-1070 BRUSSELS,BELGIUM; COLL FRANCE,INSERM,U36,F-75005 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Leicester; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France			Beckmann, Jacques S/A-9772-2008; Kotelevtsev, Yuri V/R-1772-2016	Beckmann, Jacques S/0000-0002-9741-1900; Kotelevtsev, Yuri/0000-0002-7255-7794	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS M, 1984, BIOCHEM GENET, V22, P611, DOI 10.1007/BF00485848; CANESSA M, 1980, NEW ENGL J MED, V302, P772, DOI 10.1056/NEJM198004033021403; DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267; DIXON WJ, 1988, BMDP STATISTICAL SOF; GUSTIN MP, 1990, COMPUT BIOL MED, V20, P205, DOI 10.1016/0010-4825(90)90006-B; HALL JE, 1980, AM J PHYSIOL, V239, pF271, DOI 10.1152/ajprenal.1980.239.3.F271; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HOLLENBERG NK, 1986, AM J MED, V81, P412, DOI 10.1016/0002-9343(86)90291-3; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KURTZ TW, 1990, J CLIN INVEST, V85, P1328, DOI 10.1172/JCI114572; LARAGH JH, 1982, FED PROC, V41, P2415; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LINDPAINTENER K, 1991, HYPERTENSION, V8, P763; NICOLS WW, 1990, MCDONALD BLOOD FLOW, P216; PRAVENEC M, 1991, GENOMICS, V9, P466, DOI 10.1016/0888-7543(91)90412-8; RAPP JP, 1989, SCIENCE, V243, P542, DOI 10.1126/science.2563177; SAFAR ME, 1989, J HYPERTENS, V7, P769, DOI 10.1097/00004872-198910000-00001; SERIKAWA, 1992, GENETICS, V131, P703; SOUBRIER F, 1991, GENETIC APPROACHES C, P27; SU DF, 1986, AM J PHYSIOL, V251, pH1111, DOI 10.1152/ajpheart.1986.251.6.H1111; VINCENT M, 1979, JAP HEART J, V20, P135; WARD R, 1990, HYPERTENSION PATHOPH, P81; ZINNER SH, 1976, AM J EPIDEMIOL, V104, P124, DOI 10.1093/oxfordjournals.aje.a112282	23	128	130	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					354	357		10.1038/ng0493-354	http://dx.doi.org/10.1038/ng0493-354			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981757				2022-12-17	WOS:A1993KW25700019
J	Martin, AR; Williams, E; Foulger, RE; Leigh, S; Daugherty, LC; Niblock, O; Leong, IUS; Smith, KR; Gerasimenko, O; Haraldsdottir, E; Thomas, E; Scott, RH; Baple, E; Tucci, A; Brittain, H; de Burca, A; Ibanez, K; Kasperaviciute, D; Smedley, D; Caulfield, M; Rendon, A; McDonagh, EM				Martin, Antonio Rueda; Williams, Eleanor; Foulger, Rebecca E.; Leigh, Sarah; Daugherty, Louise C.; Niblock, Olivia; Leong, Ivone U. S.; Smith, Katherine R.; Gerasimenko, Oleg; Haraldsdottir, Eik; Thomas, Ellen; Scott, Richard H.; Baple, Emma; Tucci, Arianna; Brittain, Helen; de Burca, Anna; Ibanez, Kristina; Kasperaviciute, Dalia; Smedley, Damian; Caulfield, Mark; Rendon, Augusto; McDonagh, Ellen M.			PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels	NATURE GENETICS			English	Editorial Material							DISEASE; STANDARDS; GENOMICS		[Martin, Antonio Rueda; Williams, Eleanor; Foulger, Rebecca E.; Leigh, Sarah; Daugherty, Louise C.; Niblock, Olivia; Leong, Ivone U. S.; Smith, Katherine R.; Gerasimenko, Oleg; Haraldsdottir, Eik; Thomas, Ellen; Scott, Richard H.; Baple, Emma; Tucci, Arianna; Brittain, Helen; de Burca, Anna; Ibanez, Kristina; Kasperaviciute, Dalia; Smedley, Damian; Caulfield, Mark; Rendon, Augusto; McDonagh, Ellen M.] Genom England, London, England; [Smith, Katherine R.; Kasperaviciute, Dalia; Smedley, Damian; Caulfield, Mark; McDonagh, Ellen M.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Thomas, Ellen] Imperial Coll Healthcare NHS Trust, London, England; [Baple, Emma] Univ Exeter, Royal Devon & Exeter NHS Fdn Trust, RILD Wellcome Wolfson Ctr, Inst Biomed & Clin Sci,Med Sch, Exeter, Devon, England; [Baple, Emma] Royal Devon & Exeter Hosp, Peninsula Clin Genet Serv, Exeter, Devon, England; [de Burca, Anna] Oxford Univ Hosp, Oxford Ctr Genom Med, Oxford, England; [Rendon, Augusto] Univ Cambridge, Dept Haematol, Cambridge, England	University of London; Queen Mary University London; Imperial College London; University of Exeter; University of Exeter; University of Cambridge	McDonagh, EM (corresponding author), Genom England, London, England.; McDonagh, EM (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	ellen.mcdonagh@genomicsengland.co.uk	Smedley, Damian/AAL-8172-2021; de Burca, Anna/GYV-1552-2022	Smith, Katherine Rose/0000-0002-0329-5938; McDonagh, Ellen M/0000-0001-5806-6174; Leong, Ivone/0000-0002-0831-3461; Daugherty, Louise/0000-0003-4546-6667; Foulger, Rebecca/0000-0001-8682-8754; Williams, Eleanor/0000-0002-0851-7990; Tucci, Arianna/0000-0001-5644-0070; Baple, Emma/0000-0002-6637-3411	National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Center at Barts and The London School of Medicine and Dentistry; MRC eMedLab award; NIHR; NHSE; Wellcome Trust; Cancer Research UK; Medical Research Council; MRC [G9521010, MR/M009203/1, MC_EX_MR/M009203/1, MC_PC_14089] Funding Source: UKRI	National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Center at Barts and The London School of Medicine and Dentistry; MRC eMedLab award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); NHSE; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all PanelApp reviewers and those who have contributed feedback or gene lists to help in the development of PanelApp; individual panels show the names and affiliations of contributors. We thank all participants in the 100,000 Genomes Project. We extend special thanks to the following contributors to PanelApp development, curation, documentation and outreach: R. Jones, A. Gardham, C. Wright, C. Boustred, K. McCaffrey, C. Campbell, J. Whittaker, C. Turnbull, M. Ryten, A. Devereau, T. Fowler, Members of the E&I GeCIP Domain (S. Ellard, S. Abbs, D. McCullun, H. Firth and W. Newman), V. Fryer, C. Johnson, J. Carroll, E. Ivanov, P. Hayes, M. Athanasopoulou, L. Carr, L. Dinh, A. Sosinsky, M. Parker, L. Hawkes, and J. Deller; and to M. Child for critical reading of the manuscript. M. Caulfield was funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Center at Barts and The London School of Medicine and Dentistry. He is supported as an NIHR senior investigator, and this work was funded by the MRC eMedLab award. This research was made possible through access to the data and findings generated by the 100,000 Genomes Project. The 100,000 Genomes Project is managed by Genomics England Limited (a wholly owned company of the Department of Health). The 100,000 Genomes Project is funded by the NIHR and NHSE. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the NHSE as part of their care and support.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Chambers C, 2016, J GENET COUNS, V25, P213, DOI 10.1007/s10897-015-9906-9; Cui Y, 2016, BIOINFORMATICS, V32, P1740, DOI 10.1093/bioinformatics/btw041; Davies S.C., 2016, ANN REPORT CHIEF MED; Hoyle J., 2015, JOINT UKGTN ACGS WOR; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Platt J, 2014, J GENET COUNS, V23, P594, DOI 10.1007/s10897-013-9683-2; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015; Turnbull C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1687; Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	17	127	126	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2019	51	11					1560	+		10.1038/s41588-019-0528-2	http://dx.doi.org/10.1038/s41588-019-0528-2			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JK2ZE	31676867				2022-12-17	WOS:000494714300002
J	Salojarvi, J; Smolander, OP; Nieminen, K; Rajaraman, S; Safronov, O; Safdari, P; Lamminmaki, A; Immanen, J; Lan, TY; Tanskanen, J; Rastas, P; Amiryousefi, A; Jayaprakash, B; Kammonen, JI; Hagqvist, R; Eswaran, G; Ahonen, VH; Serra, JA; Asiegbu, FO; Barajas-Lopez, JD; Blande, D; Blokhina, O; Blomster, T; Broholm, S; Brosche, M; Cui, FQ; Dardick, C; Ehonen, SE; Elomaa, P; Escamez, S; Fagerstedt, KV; Fujii, H; Gauthier, A; Gollan, PJ; Halimaa, P; Heino, PI; Himanen, K; Hollender, C; Kangasjarvi, S; Kauppinen, L; Kelleher, CT; Kontunen-Soppela, S; Koskinen, JP; Kovalchuk, A; Karenlampi, SO; Karkonen, AK; Lim, KJ; Leppala, J; Macpherson, L; Mikola, J; Mouhu, K; Mahonen, AP; Niinemets, U; Oksanen, E; Overmyer, K; Palva, ET; Pazouki, L; Pennanen, V; Puhakainen, T; Poczai, P; Possen, BJHM; Punkkinen, M; Rahikainen, MM; Rousi, M; Ruonala, R; van der Schoot, C; Shapiguzov, A; Sierla, M; Sipila, TP; Sutela, S; Teeri, TH; Tervahauta, AI; Vaattovaara, A; Vahala, J; Vetchinnikova, L; Welling, A; Wrzaczek, M; Xu, EJ; Paulin, LG; Schulman, AH; Lascoux, M; Albert, VA; Auvinen, P; Helariutta, Y; Kangasjarvi, J				Salojarvi, Jarkko; Smolander, Olli-Pekka; Nieminen, Kaisa; Rajaraman, Sitaram; Safronov, Omid; Safdari, Pezhman; Lamminmaki, Airi; Immanen, Juha; Lan, Tianying; Tanskanen, Jaakko; Rastas, Pasi; Amiryousefi, Ali; Jayaprakash, Balamuralikrishna; Kammonen, Juhana I.; Hagqvist, Risto; Eswaran, Gugan; Ahonen, Viivi Helena; Serra, Juan Alonso; Asiegbu, Fred O.; Barajas-Lopez, Juan de Dios; Blande, Daniel; Blokhina, Olga; Blomster, Tiina; Broholm, Suvi; Brosche, Mikael; Cui, Fuqiang; Dardick, Chris; Ehonen, Sanna E.; Elomaa, Paula; Escamez, Sacha; Fagerstedt, Kurt V.; Fujii, Hiroaki; Gauthier, Adrien; Gollan, Peter J.; Halimaa, Pauliina; Heino, Pekka I.; Himanen, Kristiina; Hollender, Courtney; Kangasjarvi, Saijaliisa; Kauppinen, Leila; Kelleher, Colin T.; Kontunen-Soppela, Sari; Koskinen, J. Patrik; Kovalchuk, Andriy; Karenlampi, Sirpa O.; Karkonen, Anna K.; Lim, Kean-Jin; Leppala, Johanna; Macpherson, Lee; Mikola, Juha; Mouhu, Katriina; Mahonen, Ari Pekka; Niinemets, Ulo; Oksanen, Elina; Overmyer, Kirk; Palva, E. Tapio; Pazouki, Leila; Pennanen, Ville; Puhakainen, Tuula; Poczai, Peter; Possen, Boy J. H. M.; Punkkinen, Matleena; Rahikainen, Moona M.; Rousi, Matti; Ruonala, Raili; van der Schoot, Christiaan; Shapiguzov, Alexey; Sierla, Maija; Sipila, Timo P.; Sutela, Suvi; Teeri, Teemu H.; Tervahauta, Arja I.; Vaattovaara, Aleksia; Vahala, Jorma; Vetchinnikova, Lidia; Welling, Annikki; Wrzaczek, Michael; Xu, Enjun; Paulin, Lars G.; Schulman, Alan H.; Lascoux, Martin; Albert, Victor A.; Auvinen, Petri; Helariutta, Yka; Kangasjarvi, Jaakko			Genome sequencing and population genomic analyses provide insights into the adaptive landscape of silver birch	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; FLOWERING TIME; PHYTOCHROME-C; ARABIDOPSIS; CYTOKININ; SIZE; GROWTH; AUXIN; EVOLUTION; HYBRIDIZATION	Silver birch (Betula pendula) is a pioneer boreal tree that can be induced to flower within 1 year. Its rapid life cycle, small (440-Mb) genome, and advanced germplasm resources make birch an attractive model for forest biotechnology. We assembled and chromosomally anchored the nuclear genome of an inbred B. pendula individual. Gene duplicates from the paleohexaploid event were enriched for transcriptional regulation, whereas tandem duplicates were overrepresented by environmental responses. Population resequencing of 80 individuals showed effective population size crashes at major points of climatic upheaval. Selective sweeps were enriched among polyploid duplicates encoding key developmental and physiological triggering functions, suggesting that local adaptation has tuned the timing of and cross-talk between fundamental plant processes. Variation around the tightly-linked light response genes PHYC and FRS10 correlated with latitude and longitude and temperature, and with precipitation for PHYC. Similar associations characterized the growth-promoting cytokinin response regulator ARR1, and the wood development genes KAK and MED5A.	[Salojarvi, Jarkko; Rajaraman, Sitaram; Safronov, Omid; Safdari, Pezhman; Lamminmaki, Airi; Immanen, Juha; Amiryousefi, Ali; Eswaran, Gugan; Serra, Juan Alonso; Blokhina, Olga; Blomster, Tiina; Broholm, Suvi; Brosche, Mikael; Cui, Fuqiang; Ehonen, Sanna E.; Fagerstedt, Kurt V.; Gauthier, Adrien; Leppala, Johanna; Mahonen, Ari Pekka; Overmyer, Kirk; Shapiguzov, Alexey; Sierla, Maija; Sipila, Timo P.; Vaattovaara, Aleksia; Vahala, Jorma; Welling, Annikki; Wrzaczek, Michael; Xu, Enjun; Helariutta, Yka; Kangasjarvi, Jaakko] Univ Helsinki, Dept Biosci, Div Plant Biol, Helsinki, Finland; [Salojarvi, Jarkko; Rajaraman, Sitaram; Safronov, Omid; Safdari, Pezhman; Lamminmaki, Airi; Immanen, Juha; Tanskanen, Jaakko; Amiryousefi, Ali; Eswaran, Gugan; Serra, Juan Alonso; Asiegbu, Fred O.; Blomster, Tiina; Broholm, Suvi; Brosche, Mikael; Cui, Fuqiang; Ehonen, Sanna E.; Elomaa, Paula; Fagerstedt, Kurt V.; Gauthier, Adrien; Heino, Pekka I.; Himanen, Kristiina; Kovalchuk, Andriy; Karkonen, Anna K.; Lim, Kean-Jin; Leppala, Johanna; Mouhu, Katriina; Mahonen, Ari Pekka; Overmyer, Kirk; Palva, E. Tapio; Pennanen, Ville; Shapiguzov, Alexey; Sierla, Maija; Sipila, Timo P.; Teeri, Teemu H.; Vaattovaara, Aleksia; Vahala, Jorma; Xu, Enjun; Schulman, Alan H.; Helariutta, Yka; Kangasjarvi, Jaakko] Univ Helsinki, Viikki Plant Sci Ctr, Helsinki, Finland; [Smolander, Olli-Pekka; Immanen, Juha; Tanskanen, Jaakko; Jayaprakash, Balamuralikrishna; Kammonen, Juhana I.; Eswaran, Gugan; Serra, Juan Alonso; Blomster, Tiina; Broholm, Suvi; Koskinen, J. Patrik; Mahonen, Ari Pekka; Ruonala, Raili; Paulin, Lars G.; Schulman, Alan H.; Auvinen, Petri; Helariutta, Yka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Nieminen, Kaisa; Tanskanen, Jaakko; Karkonen, Anna K.; Schulman, Alan H.] Nat Resources Inst Finland Luke, Green Technol, Helsinki, Finland; [Lan, Tianying; Albert, Victor A.] Univ Buffalo, Dept Biol Sci, Buffalo, NY USA; [Rastas, Pasi] Univ Cambridge, Dept Zool, Cambridge, England; [Hagqvist, Risto] Nat Resources Inst Finland Luke, Green Technol, Haapastensyrja, Layliainen, Finland; [Ahonen, Viivi Helena; Blande, Daniel; Karenlampi, Sirpa O.; Tervahauta, Arja I.] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Asiegbu, Fred O.; Kovalchuk, Andriy] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Fujii, Hiroaki; Gollan, Peter J.; Kangasjarvi, Saijaliisa; Punkkinen, Matleena; Rahikainen, Moona M.] Univ Turku, Dept Biochem, Mol Plant Biol, Turku, Finland; [Broholm, Suvi; Elomaa, Paula; Himanen, Kristiina; Karkonen, Anna K.; Lim, Kean-Jin; Mouhu, Katriina; Teeri, Teemu H.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Brosche, Mikael] Univ Tartu, Inst Technol, Tartu, Estonia; [Dardick, Chris; Hollender, Courtney] USDA, Appalachian Fruit Res Stn, Agr Res Serv, Kearnysville, WV USA; [Escamez, Sacha] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Heino, Pekka I.; Palva, E. Tapio; Pennanen, Ville; Puhakainen, Tuula] Univ Helsinki, Dept Biosci, Div Genet, Helsinki, Finland; [Kauppinen, Leila] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Kelleher, Colin T.] Natl Bot Gardens Ireland, DBN Plant Mol Lab, Dublin, Ireland; [Kontunen-Soppela, Sari; Oksanen, Elina] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Macpherson, Lee] Kings Coll London, Dept Haemato Oncol, London, England; [Mikola, Juha] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Niinemets, Ulo; Pazouki, Leila] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia; [Poczai, Peter] Univ Helsinki, Finnish Museum Nat Hist Botany, Helsinki, Finland; [Possen, Boy J. H. M.; Rousi, Matti] Nat Resources Inst Finland Luke, Management & Prod Renewable Resources, Helsinki, Finland; [van der Schoot, Christiaan] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Shapiguzov, Alexey] Russian Acad Sci, Inst Plant Physiol, Moscow, Russia; [Sutela, Suvi] Univ Oulu, Genet & Physiol Unit, Oulu, Finland; [Vetchinnikova, Lidia] Russian Acad Sci, Karelian Res Ctr, Forest Res Inst, Petrozavodsk, Russia; [Lascoux, Martin] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden; [Lascoux, Martin] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Ruonala, Raili; Helariutta, Yka] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Rastas, Pasi; Jayaprakash, Balamuralikrishna; Ahonen, Viivi Helena; Broholm, Suvi; Cui, Fuqiang; Gauthier, Adrien; Koskinen, J. Patrik; Karkonen, Anna K.; Puhakainen, Tuula; Possen, Boy J. H. M.; Ruonala, Raili; Welling, Annikki; Xu, Enjun] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Jayaprakash, Balamuralikrishna] Natl Inst Hlth & Welf THL, Kuopio, Finland; [Ahonen, Viivi Helena] Work Environm Labs, Finnish Inst Occupat Hlth, Kuopio, Finland; [Cui, Fuqiang] Zhejiang Agr & Forestry Univ, Sch Forest Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Gauthier, Adrien] UniLaSalle, Unite AGRI TERR, Campus Rouen, Mont St Aignan, France; [Koskinen, J. Patrik] Blueprint Genet, Helsinki, Finland; [Xu, Enjun] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Puhakainen, Tuula] Sci Agr Soc Finland, Agr & Food Sci, Lemu, Finland; [Possen, Boy J. H. M.] Royal Haskoning DHV, Maastricht Airport, Beek, Netherlands; [Welling, Annikki] Finnish Food Safety Author Evira, Chem & Toxicol Res Unit, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Cambridge; Natural Resources Institute Finland (Luke); University of Eastern Finland; University of Helsinki; Finland National Institute for Health & Welfare; University of Turku; University of Helsinki; University of Tartu; United States Department of Agriculture (USDA); Umea University; University of Helsinki; University of Helsinki; University of Eastern Finland; University of London; King's College London; University of Helsinki; Estonian University of Life Sciences; University of Helsinki; Natural Resources Institute Finland (Luke); Norwegian University of Life Sciences; Russian Academy of Sciences; Timiryazev Institute of Plant Physiology; University of Oulu; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Forest Research Institute of Karelian Research Centre Russian Academy of Sciences; Uppsala University; Uppsala University; University of Cambridge; University of Helsinki; Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; Zhejiang A&F University; Chinese Academy of Sciences; Institute of Botany, CAS; Finnish Food Authority	Helariutta, Y; Kangasjarvi, J (corresponding author), Univ Helsinki, Dept Biosci, Div Plant Biol, Helsinki, Finland.; Helariutta, Y; Kangasjarvi, J (corresponding author), Univ Helsinki, Viikki Plant Sci Ctr, Helsinki, Finland.; Auvinen, P; Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.; Albert, VA (corresponding author), Univ Buffalo, Dept Biol Sci, Buffalo, NY USA.; Helariutta, Y (corresponding author), Univ Cambridge, Sainsbury Lab, Cambridge, England.	vaalbert@buffalo.edu; petri.auvinen@helsinki.fi; yrjo.helariutta@helsinki.fi; jaakko.kangasjarvi@helsinki.fi	Auvinen, Petri/AAP-8117-2021; Kangasjärvi, Saijaliisa/H-9013-2013; Wrzaczek, Michael/AAU-5105-2020; Auvinen, Petri/D-5044-2009; Lim, Kean-Jin/AAC-3851-2021; Brosché, Mikael/H-2260-2015; Gollan, Peter J/S-1105-2017; Kärkönen, Anna/AAF-2542-2020; Fagerstedt, Kurt.V/AAC-2896-2019; Albert, Victor A/A-1690-2010; Mähönen, Ari Pekka/B-9764-2015; Shapiguzov, Alexey/W-6830-2019; Tervahauta, Arja/AAI-2343-2019; Niinemets, Ülo/A-3816-2008; Overmyer, Kirk/GLV-3507-2022; Gauthier, Adrien/J-7862-2019; Helariutta, Yrjo/AAE-8149-2020; Salojärvi, Jarkko/E-9103-2016; Schulman, Alan/A-9322-2011; Elomaa, Paula/AAX-1200-2020; Smolander, Olli-Pekka/AAP-4468-2020; Kangasjärvi, Jaakko/AAP-8639-2021; Escamez, Sacha/U-4877-2018; Vetchinnikova, Lidia/J-5665-2018; Kangasjärvi, Jaakko/A-3024-2015; Kelleher, Colin/L-1986-2019; Gollan, Peter/O-2320-2019; Himanen, Kristiina/W-2434-2019; Mikola, Juha/A-1630-2015; GAUTHIER, Adrien/H-5745-2013; Nieminen, Kaisa/N-9051-2015	Kangasjärvi, Saijaliisa/0000-0002-7605-8546; Wrzaczek, Michael/0000-0002-5946-9060; Auvinen, Petri/0000-0002-3947-4778; Lim, Kean-Jin/0000-0003-2147-0215; Brosché, Mikael/0000-0002-1135-2496; Gollan, Peter J/0000-0002-9023-3611; Fagerstedt, Kurt.V/0000-0002-6839-2958; Mähönen, Ari Pekka/0000-0001-6051-866X; Shapiguzov, Alexey/0000-0001-7199-1882; Tervahauta, Arja/0000-0002-3043-7786; Niinemets, Ülo/0000-0002-3078-2192; Overmyer, Kirk/0000-0002-7398-3453; Gauthier, Adrien/0000-0002-1351-353X; Helariutta, Yrjo/0000-0002-7287-8459; Salojärvi, Jarkko/0000-0002-4096-6278; Schulman, Alan/0000-0002-4126-6177; Elomaa, Paula/0000-0001-6512-0810; Smolander, Olli-Pekka/0000-0002-6795-7734; Kangasjärvi, Jaakko/0000-0002-8959-1809; Escamez, Sacha/0000-0001-7049-6978; Vetchinnikova, Lidia/0000-0003-2091-905X; Kangasjärvi, Jaakko/0000-0002-8959-1809; Gollan, Peter/0000-0002-9023-3611; Himanen, Kristiina/0000-0003-4975-9467; Mikola, Juha/0000-0002-4336-2648; GAUTHIER, Adrien/0000-0002-1351-353X; Xu, Enjun/0000-0002-8799-6490; Pennanen, Ville/0000-0003-1577-0588; Sierla, Maija/0000-0002-8493-3582; Leppala, Johanna/0000-0001-7603-3907; Kovalchuk, Andriy/0000-0001-8704-4644; Vaattovaara, Aleksia/0000-0003-3452-0947; Asiegbu, Fred O/0000-0003-0223-7194; Barajas Lopez, Juan de Dios/0000-0003-1515-5059; Kelleher, Colin/0000-0002-1551-8297; Oksanen, Elina/0000-0002-1866-736X; Nieminen, Kaisa/0000-0001-7004-9422; Sutela, Suvi/0000-0003-0426-0718; Teeri, Teemu/0000-0002-3812-7213; van der Schoot, Chris/0000-0002-6219-1610; Alonso Serra, Juan/0000-0002-2810-4691; Welling, Annikki/0000-0002-5273-3922; Rajaraman, Sitaram/0000-0001-5171-3578; Karkonen, Anna/0000-0001-8870-3250; Eswaran, Gugan/0000-0002-3439-3696; Sipila, Timo/0000-0001-6739-1606; Rahikainen, Moona/0000-0001-5365-8963; Kammonen, Juhana/0000-0002-6914-0111; Mouhu, Katriina/0000-0003-3023-4978; Rastas, Pasi/0000-0003-2768-1339; Lamminmaki, Airi/0000-0002-6133-8553; Safronov, Omid/0000-0003-2044-3258; Kontunen-Soppela, Sari/0000-0003-3952-594X; Fujii, Hiroaki/0000-0002-0013-5891	Finnish Technology Development Agency (TEKES) grant; Finnish Centre of Excellence in Molecular Biology of Primary Producers (Academy of Finland CoE program) [271832]; Gatsby Foundation; European Research Council Advanced Investigator Grant SYMDEV; US National Science foundation [0922742, 1442190]; University of Helsinki; TEKES; Direct For Biological Sciences [1442190] Funding Source: National Science Foundation	Finnish Technology Development Agency (TEKES) grant; Finnish Centre of Excellence in Molecular Biology of Primary Producers (Academy of Finland CoE program); Gatsby Foundation; European Research Council Advanced Investigator Grant SYMDEV; US National Science foundation(National Science Foundation (NSF)); University of Helsinki; TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Korpijaakko, A. Korpilahti, S. Koskela, K. Lipponen, P. Laamanen, H. Kangas, M. Rantanen, and E.-M. Turkki for excellent assistance, and L. Schulman and L. Junikka (University of Helsinki Botanical Gardens) for providing birch species samples. Birch sequencing was supported by a Finnish Technology Development Agency (TEKES) grant to J.K., Y.H., and P. A. J.K. and Y.H. were supported by the Finnish Centre of Excellence in Molecular Biology of Primary Producers (Academy of Finland CoE program 2014-2019, decision 271832). Y.H. was funded by the Gatsby Foundation and the European Research Council Advanced Investigator Grant SYMDEV. V.A.A. acknowledges support from the US National Science foundation (0922742 and 1442190). J.S. acknowledges a University of Helsinki 3-year grant. A. H. S. and J.T. acknowledge Academy of Finland decision (266430). EST libraries were created with TEKES funding to E.T.P.	Anamthawat-Jonsson K, 2003, PLANT CELL TISS ORG, V75, P99, DOI 10.1023/A:1025063123552; Ashburner K., 2013, GENUS BETULA TAXONOM; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Bartrina I, 2017, PLANT PHYSIOL, V173, P1783, DOI 10.1104/pp.16.01903; Bensussan M, 2015, PLANT PHYSIOL, V168, P452, DOI 10.1104/pp.15.00122; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Crowther TW, 2015, NATURE, V525, P201, DOI 10.1038/nature14967; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Dong ZB, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.27452; Doyle SM, 2015, P NATL ACAD SCI USA, V112, pE806, DOI 10.1073/pnas.1424856112; Edwards K.D., 2015, LOW TEMPERATURE SPEC; Eidesen PB, 2015, MOL ECOL, V24, P3993, DOI 10.1111/mec.13289; El Refy A, 2004, MOL GENET GENOMICS, V270, P403, DOI 10.1007/s00438-003-0932-1; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Fogelqvist J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0461-7; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Gao DY, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0867-y; Gaudet P, 2017, METHODS MOL BIOL, V1446, P189, DOI 10.1007/978-1-4939-3743-1_14; Gauthier S, 2015, SCIENCE, V349, P819, DOI 10.1126/science.aaa9092; Gegas VC, 2014, J EXP BOT, V65, P2757, DOI 10.1093/jxb/ert473; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Guan YF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004384; Gursanscky NR, 2016, PLANT J, V86, P210, DOI 10.1111/tpj.13169; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Head MJ, 2015, QUATERN INT, V383, P4, DOI 10.1016/j.quaint.2015.06.039; Hollender CA, 2015, NEW PHYTOL, V206, P541, DOI 10.1111/nph.13204; Immanen J, 2016, CURR BIOL, V26, P1990, DOI 10.1016/j.cub.2016.05.053; Imura Y, 2012, PLANT CELL PHYSIOL, V53, P287, DOI 10.1093/pcp/pcs002; Iskow RC, 2012, TRENDS GENET, V28, P245, DOI 10.1016/j.tig.2012.03.002; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Jiao YNA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0355; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Nguyen KH, 2016, P NATL ACAD SCI USA, V113, P3090, DOI 10.1073/pnas.1600399113; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Lascoux M, 2004, PHILOS T ROY SOC B, V359, P197, DOI 10.1098/rstb.2003.1390; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Lin RC, 2004, PLANT PHYSIOL, V136, P4010, DOI 10.1104/pp.104.052191; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; LONGMAN KA, 1959, NATURE, V184, P2037, DOI 10.1038/1842037b0; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Mendez-Vigo B, 2011, PLANT PHYSIOL, V157, P1942, DOI 10.1104/pp.111.183426; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; MYKING T, 1995, TREE PHYSIOL, V15, P697, DOI 10.1093/treephys/15.11.697; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Rodgers-Melnick E, 2012, GENOME RES, V22, P95, DOI 10.1101/gr.125146.111; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Samis KE, 2008, EVOLUTION, V62, P2971, DOI 10.1111/j.1558-5646.2008.00484.x; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Sofiev M, 2006, INT J BIOMETEOROL, V50, P392, DOI 10.1007/s00484-006-0027-x; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; Veyres N, 2008, PLANT J, V55, P665, DOI 10.1111/j.1365-313X.2008.03541.x; Wang H, 2015, MOL PLANT, V8, P540, DOI 10.1016/j.molp.2014.11.021; Wang JH, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-94; Wang J, 2016, GENETICS, V202, P1185, DOI 10.1534/genetics.115.183152; Wang N, 2016, ANN BOT-LONDON, V117, P1023, DOI 10.1093/aob/mcw048; Wang T, 2016, NATURE, V531, P241, DOI 10.1038/nature16975; Welling A, 2008, PLANT PHYSIOL, V147, P1199, DOI 10.1104/pp.108.117812; WOLFE JA, 1978, AM SCI, V66, P694; Yoshihara T, 2013, PLANT J, V74, P267, DOI 10.1111/tpj.12118; Zhu J, 2015, PLANT CELL PHYSIOL, V56, P727, DOI 10.1093/pcp/pcu217	78	127	134	7	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2017	49	6					904	+		10.1038/ng.3862	http://dx.doi.org/10.1038/ng.3862			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV8VM	28481341	Green Published, hybrid			2022-12-17	WOS:000402062300015
J	Crowley, JJ; Zhabotynsky, V; Sun, W; Huang, SP; Pakatci, IK; Kim, Y; Wang, JR; Morgan, AP; Calaway, JD; Aylor, DL; Yun, ZN; Bell, TA; Buus, RJ; Calaway, ME; Didion, JP; Gooch, TJ; Hansen, SD; Robinson, NN; Shaw, GD; Spence, JS; Quackenbush, CR; Barrick, CJ; Nonneman, RJ; Kim, K; Xenakis, J; Xie, YY; Valdar, W; Lenarcic, AB; Wang, W; Welsh, CE; Fu, CP; Zhang, ZJ; Holt, J; Guo, ZS; Threadgill, DW; Tarantino, LM; Miller, DR; Zou, F; McMillan, L; Sullivan, PF; de Villena, FPM				Crowley, James J.; Zhabotynsky, Vasyl; Sun, Wei; Huang, Shunping; Pakatci, Isa Kemal; Kim, Yunjung; Wang, Jeremy R.; Morgan, Andrew P.; Calaway, John D.; Aylor, David L.; Yun, Zaining; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Spence, Jason S.; Quackenbush, Corey R.; Barrick, Cordelia J.; Nonneman, Randal J.; Kim, Kyungsu; Xenakis, James; Xie, Yuying; Valdar, William; Lenarcic, Alan B.; Wang, Wei; Welsh, Catherine E.; Fu, Chen-Ping; Zhang, Zhaojun; Holt, James; Guo, Zhishan; Threadgill, David W.; Tarantino, Lisa M.; Miller, Darla R.; Zou, Fei; McMillan, Leonard; Sullivan, Patrick F.; de Villena, Fernando Pardo-Manuel			Analyses of allele-specific gene expression in highly divergent mouse crosses identifies pervasive allelic imbalance	NATURE GENETICS			English	Article							MAMMALIAN X-CHROMOSOME; DOSAGE COMPENSATION; RNA-SEQ; IMPRINTED GENES; UP-REGULATION; LINKED GENES; HUMAN GENOME; INACTIVATION; EVOLUTION; ORIGIN	Complex human traits are influenced by variation in regulatory DNA through mechanisms that are not fully understood. Because regulatory elements are conserved between humans and mice, a thorough annotation of cis regulatory variants in mice could aid in further characterizing these mechanisms. Here we provide a detailed portrait of mouse gene expression across multiple tissues in a three-way diallel. Greater than 80% of mouse genes have cis regulatory variation. Effects from these variants influence complex traits and usually extend to the human ortholog. Further, we estimate that at least one in every thousand SNPs creates a cis regulatory effect. We also observe two types of parent-of-origin effects, including classical imprinting and a new global allelic imbalance in expression favoring the paternal allele. We conclude that, as with humans, pervasive regulatory variation influences complex genetic traits in mice and provide a new resource toward understanding the genetic control of transcription in mammals.	[Crowley, James J.; Zhabotynsky, Vasyl; Sun, Wei; Kim, Yunjung; Morgan, Andrew P.; Calaway, John D.; Aylor, David L.; Yun, Zaining; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Spence, Jason S.; Quackenbush, Corey R.; Barrick, Cordelia J.; Nonneman, Randal J.; Xie, Yuying; Valdar, William; Lenarcic, Alan B.; Miller, Darla R.; Sullivan, Patrick F.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sun, Wei; Kim, Kyungsu; Xenakis, James] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Huang, Shunping; Pakatci, Isa Kemal; Wang, Jeremy R.; Wang, Wei; Welsh, Catherine E.; Fu, Chen-Ping; Zhang, Zhaojun; Holt, James; Guo, Zhishan; McMillan, Leonard] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Morgan, Andrew P.; Calaway, John D.; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Valdar, William; Miller, Darla R.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Morgan, Andrew P.; Calaway, John D.; Bell, Timothy A.; Buus, Ryan J.; Calaway, Mark E.; Didion, John P.; Gooch, Terry J.; Hansen, Stephanie D.; Robinson, Nashiya N.; Shaw, Ginger D.; Miller, Darla R.; Sullivan, Patrick F.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Threadgill, David W.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Tarantino, Lisa M.; Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	de Villena, FPM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	fernando@med.unc.edu	Valdar, William/AAE-4354-2019; Threadgill, David W/N-4425-2013; Guo, Zhishan/AAG-4292-2020; Wang, Jeremy/L-7971-2019	Threadgill, David W/0000-0003-3538-1635; Guo, Zhishan/0000-0002-5967-1058; Wang, Jeremy/0000-0002-0673-9418; Zhabotynsky, Vasyl/0000-0003-1575-5732; Holt, James/0000-0001-6411-9236; Kim, Yunjung/0000-0001-9080-4739; Didion, John/0000-0002-8111-6261; Wang, Wei/0000-0002-8180-2886; Crowley, James/0000-0001-9051-1557	National Institute of Mental Health/National Human Genome Research Institute Center of Excellence for Genome Sciences grant [P50MH090338, P50HG006582]; National Institute of General Medical Sciences [R01GM074175]; National Institute of Mental Health [K01MH094406]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079124] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES021535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105785, R01GM074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH103925, P50MH090338, K01MH094406] Funding Source: NIH RePORTER	National Institute of Mental Health/National Human Genome Research Institute Center of Excellence for Genome Sciences grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Mieczkowski, A. Brandt, E. Malc, M. Vernon, J. Brennan and M. Calabrese for helpful discussions. Major funding was provided by National Institute of Mental Health/National Human Genome Research Institute Center of Excellence for Genome Sciences grants (P50MH090338 and P50HG006582, co-principal investigators F.P.-M.d.V. and P.F.S.). This work was also supported by grants R01GM074175 (principal investigator F.Z.) from the National Institute of General Medical Sciences and K01MH094406 (principal investigator J.J.C.) from the National Institute of Mental Health.	Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Calaway JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003853; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CATTANACH BM, 1970, GENET RES, V16, P293, DOI 10.1017/S001667230000255X; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Cui XQ, 2006, GENETICS, V174, P627, DOI 10.1534/genetics.106.060251; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hayden EC, 2012, NATURE, V484, P428, DOI 10.1038/484428a; He XL, 2011, NAT GENET, V43, P1171, DOI 10.1038/ng.1010; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang SP, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau057; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Jue NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-150; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kharchenko PV, 2011, NAT GENET, V43, P1167, DOI 10.1038/ng.991; Kim Y, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.96; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Lin FQ, 2012, P NATL ACAD SCI USA, V109, P11752, DOI 10.1073/pnas.1201816109; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Lin H, 2011, NAT GENET, V43, P1169, DOI 10.1038/ng.992; Lopes AM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-82; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; OHNO S, 1959, EXP CELL RES, V18, P415, DOI 10.1016/0014-4827(59)90031-X; Ohno S., 1967, SEX CHROMOSOMES SEX; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Wang X, 2011, GENETICS, V189, P109, DOI 10.1534/genetics.111.130088; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhang ZJ, 2013, BIOINFORMATICS, V29, P291, DOI 10.1093/bioinformatics/btt216; Zou F, 2014, GENETICS, V197, P389, DOI 10.1534/genetics.113.160119	58	127	130	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					353	U102		10.1038/ng.3222	http://dx.doi.org/10.1038/ng.3222			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25730764	Green Accepted, Green Submitted			2022-12-17	WOS:000351922900010
J	von Mentzer, A; Connor, TR; Wieler, LH; Semmler, T; Iguchi, A; Thomson, NR; Rasko, DA; Joffre, E; Corander, J; Pickard, D; Wiklund, G; Svennerholm, AM; Sjoling, A; Dougan, G				von Mentzer, Astrid; Connor, Thomas R.; Wieler, Lothar H.; Semmler, Torsten; Iguchi, Atsushi; Thomson, Nicholas R.; Rasko, David A.; Joffre, Enrique; Corander, Jukka; Pickard, Derek; Wiklund, Gudrun; Svennerholm, Ann-Mari; Sjoling, Asa; Dougan, Gordon			Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution	NATURE GENETICS			English	Article							COLONIZATION FACTOR; VIRULENCE FACTORS; STRAINS; DIARRHEA; TRANSMISSION; EPIDEMIOLOGY; EXPRESSION; EVOLUTION; COUNTRIES; PLASMIDS	Enterotoxigenic Escherichia coli (ETEC), a major cause of infectious diarrhea, produce heat-stable and/or heat-labile enterotoxins and at least 25 different colonization factors that target the intestinal mucosa. The genes encoding the enterotoxins and most of the colonization factors are located on plasmids found across diverse E. coli serogroups. Whole-genome sequencing of a representative collection of ETEC isolated between 1980 and 2011 identified globally distributed lineages characterized by distinct colonization factor and enterotoxin profiles. Contrary to current notions, these relatively recently emerged lineages might harbor chromosome and plasmid combinations that optimize fitness and transmissibility. These data have implications for understanding, tracking and possibly preventing ETEC disease.	[von Mentzer, Astrid; Joffre, Enrique; Wiklund, Gudrun; Svennerholm, Ann-Mari; Sjoling, Asa] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [von Mentzer, Astrid; Connor, Thomas R.; Thomson, Nicholas R.; Pickard, Derek; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Connor, Thomas R.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Wieler, Lothar H.; Semmler, Torsten] Free Univ Berlin, Ctr Infect Med, Inst Microbiol & Epizoot, Berlin, Germany; [Iguchi, Atsushi] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Gothenburg; Wellcome Trust Sanger Institute; Cardiff University; Free University of Berlin; University of Miyazaki; University System of Maryland; University of Maryland Baltimore; University of Helsinki; Karolinska Institutet	von Mentzer, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden.	astrid.von.mentzer@gu.se; ann-mari.svennerholm@microbio.gu.se; asa.sjoling@ki.se; gdl@sanger.ac.uk	Joffre, Enrique/AHA-2603-2022; Semmler, Torsten/O-9540-2019; Connor, Thomas/ABD-6533-2021; Joffré, Enrique/AAW-7546-2021; Connor, Thomas/ABE-5989-2020; Thomson, Nicholas R/P-5988-2014; Semmler, Torsten/Q-7716-2018; von Mentzer, Astrid/I-5449-2018	Joffre, Enrique/0000-0003-0328-518X; Semmler, Torsten/0000-0002-2225-7267; Joffré, Enrique/0000-0003-0328-518X; Connor, Thomas/0000-0003-2394-6504; Thomson, Nicholas R/0000-0002-4432-8505; Semmler, Torsten/0000-0002-2225-7267; von Mentzer, Astrid/0000-0002-2167-1394; , Atsushi/0000-0003-3826-7520; Wieler, Lothar H./0000-0003-4365-3717; David, Rasko/0000-0002-7337-7154; Sjoling, Asa/0000-0003-1529-1720	Wellcome Trust [098051]; Swedish Research Council [2012-3464, 2011-3435]; Swedish Strategic Foundation [SB12-0072]; European Research Council [239784]; Medical Research Council [MR/L015080/1] Funding Source: researchfish; MRC [MR/L015080/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Foundation; European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant 098051), the Swedish Research Council (grants 2012-3464 and 2011-3435), the Swedish Strategic Foundation (grant SB12-0072) and the European Research Council (grant 239784).	Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Grossman L.C, 2010, J BACTERIOL, V192, P5822; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Pupo GM, 1997, INFECT IMMUN, V65, P2685, DOI 10.1128/IAI.65.7.2685-2692.1997; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Regua-Mangia AH, 2004, FEMS IMMUNOL MED MIC, V40, P155, DOI 10.1016/S0928-8244(03)00308-0; Rodrigues J, 1996, INFECT IMMUN, V64, P2680, DOI 10.1128/IAI.64.7.2680-2686.1996; Sabui S, 2010, J MED MICROBIOL, V59, P770, DOI 10.1099/jmm.0.017582-0; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; SMITH HW, 1973, P ROY SOC MED, V66, P272, DOI 10.1177/003591577306600335; Steinsland H, 2004, J CLIN MICROBIOL, V42, P3100, DOI 10.1128/JCM.42.7.3100-3107.2004; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Svennerholm AM, 2012, EXPERT REV VACCINES, V11, P495, DOI [10.1586/erv.12.12, 10.1586/ERV.12.12]; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Valvatne H, 2002, APMIS, V110, P665, DOI 10.1034/j.1600-0463.2002.1100911.x; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; WHO, 2009, DIARRH DIS; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569	32	127	128	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1321	1326		10.1038/ng.3145	http://dx.doi.org/10.1038/ng.3145			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25383970				2022-12-17	WOS:000345547300013
J	Desjardins, CA; Cerqueira, GC; Goldberg, JM; Hotopp, JCD; Haas, BJ; Zucker, J; Ribeiro, JMC; Saif, S; Levin, JZ; Fan, L; Zeng, QD; Russ, C; Wortman, JR; Fink, DL; Birren, BW; Nutman, TB				Desjardins, Christopher A.; Cerqueira, Gustavo C.; Goldberg, Jonathan M.; Hotopp, Julie C. Dunning; Haas, Brian J.; Zucker, Jeremy; Ribeiro, Jose M. C.; Saif, Sakina; Levin, Joshua Z.; Fan, Lin; Zeng, Qiandong; Russ, Carsten; Wortman, Jennifer R.; Fink, Doran L.; Birren, Bruce W.; Nutman, Thomas B.			Genomics of Loa loa, a Wolbachia-free filarial parasite of humans	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; PATHWAY/GENOME DATABASES; BIOCYC COLLECTION; PROTEIN-KINASES; BRUGIA-MALAYI; MATRIX; MODEL; TOOL; IDENTIFICATION; ANNOTATION	Loa loa, the African eyeworm, is a major filarial pathogen of humans. Unlike most filariae, L. loa does not contain the obligate intracellular Wolbachia endosymbiont. We describe the 91.4-Mb genome of L. loa and that of the related filarial parasite Wuchereria bancrofti and predict 14,907 L. loa genes on the basis of microfilarial RNA sequencing. By comparing these genomes to that of another filarial parasite, Brugia malayi, and to those of several other nematodes, we demonstrate synteny among filariae but not with nonparasitic nematodes. The L. loa genome encodes many immunologically relevant genes, as well as protein kinases targeted by drugs currently approved for use in humans. Despite lacking Wolbachia, L. loa shows no new metabolic synthesis or transport capabilities compared to other filariae. These results suggest that the role of Wolbachia in filarial biology is more subtle than previously thought and reveal marked differences between parasitic and nonparasitic nematodes.	[Desjardins, Christopher A.; Cerqueira, Gustavo C.; Goldberg, Jonathan M.; Haas, Brian J.; Zucker, Jeremy; Saif, Sakina; Levin, Joshua Z.; Fan, Lin; Zeng, Qiandong; Russ, Carsten; Wortman, Jennifer R.; Birren, Bruce W.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hotopp, Julie C. Dunning] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA; [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; [Fink, Doran L.; Nutman, Thomas B.] NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nutman, TB (corresponding author), NIAID, Parasit Dis Lab, Bethesda, MD 20892 USA.	tnutman@niaid.nih.gov	Cerqueira, Gustavo/AAV-7398-2020; Dunning Hotopp, Julie/E-7762-2010; Zucker, Jeremy/M-3643-2016; Zeng, Qiandong/AAF-3305-2019	Cerqueira, Gustavo/0000-0002-7692-3886; Dunning Hotopp, Julie/0000-0003-3862-986X; Zucker, Jeremy/0000-0002-7276-9009; Wortman, Jennifer/0000-0002-8713-1227; Levin, Joshua/0000-0002-0170-3598; Desjardins, Christopher/0000-0002-3160-4734; Ribeiro, Jose/0000-0002-9107-0818	National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200900018C]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NIH [1-DP2-OD007372]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000512, ZIAAI000810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007372] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH), Department of Health and Human Services; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Broad Institute Genomics Platform for sequencing and D. Neafsey for comments on the manuscript. This project has been funded in part by the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH), Department of Health and Human Services under contract number HHSN272200900018C and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. J.C.D.H. is funded by the NIH Director's New Innovator Award Program (1-DP2-OD007372).	Anuradha R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001681; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Beckmann S, 2010, INT J PARASITOL, V40, P521, DOI 10.1016/j.ijpara.2010.01.007; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coulibaly YI, 2009, NEW ENGL J MED, V361, P1448, DOI 10.1056/NEJMoa0900863; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dissous C, 2011, TRENDS PARASITOL, V27, P59, DOI 10.1016/j.pt.2010.09.001; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gilliland WD, 2007, PLOS GENET, V3, P1178, DOI 10.1371/journal.pgen.0030113; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haas Brian J, 2011, Mycology, V2, P118; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klion A. D., 2011, TROPICAL INFECT DIS, P735; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meier B, 2001, CURR BIOL, V11, pR865, DOI 10.1016/S0960-9822(01)00518-8; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajan TV, 2004, J PARASITOL, V90, P1184, DOI 10.1645/GE-308R; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swofford D.L., 2003, PAUP PHYLOGENETIC AN; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; van der Linden AM, 2008, GENETICS, V180, P1475, DOI 10.1534/genetics.108.094771; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	56	127	133	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2013	45	5					495	U55		10.1038/ng.2585	http://dx.doi.org/10.1038/ng.2585			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	23525074	Green Accepted, hybrid, Green Submitted			2022-12-17	WOS:000318158200010
J	Hor, H; Kutalik, Z; Dauvilliers, Y; Valsesia, A; Lammers, GJ; Donjacour, CEHM; Iranzo, A; Santamaria, J; Adrados, RP; Vicario, JL; Overeem, S; Arnulf, I; Theodorou, I; Jennum, P; Knudsen, S; Bassetti, C; Mathis, J; Lecendreux, M; Mayer, G; Geisler, P; Beneto, A; Petit, B; Pfister, C; Burki, JV; Didelot, G; Billiard, M; Ercilla, G; Verduijn, W; Claas, FHJ; Vollenwider, P; Waeber, G; Waterworth, DM; Mooser, V; Heinzer, R; Beckmann, JS; Bergmann, S; Tafti, M				Hor, Hyun; Kutalik, Zoltan; Dauvilliers, Yves; Valsesia, Armand; Lammers, Gert J.; Donjacour, Claire E. H. M.; Iranzo, Alex; Santamaria, Joan; Adrados, Rosa Peraita; Vicario, Jose L.; Overeem, Sebastiaan; Arnulf, Isabelle; Theodorou, Ioannis; Jennum, Poul; Knudsen, Stine; Bassetti, Claudio; Mathis, Johannes; Lecendreux, Michel; Mayer, Geert; Geisler, Peter; Beneto, Antonio; Petit, Brice; Pfister, Corinne; Buerki, Julie Vienne; Didelot, Gerard; Billiard, Michel; Ercilla, Guadalupe; Verduijn, Willem; Claas, Frans H. J.; Vollenwider, Peter; Waeber, Gerard; Waterworth, Dawn M.; Mooser, Vincent; Heinzer, Raphael; Beckmann, Jacques S.; Bergmann, Sven; Tafti, Mehdi			Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; SLEEP-DISORDERS; CATAPLEXY; GENETICS; DISEASES; RISK; 2ND	Narcolepsy is a rare sleep disorder with the strongest human leukocyte antigen (HLA) association ever reported. Since the associated HLA-DRB1*1501-DQB1*0602 haplotype is common in the general population (15-25%), it has been suggested that it is almost necessary but not sufficient for developing narcolepsy. To further define the genetic basis of narcolepsy risk, we performed a genome-wide association study (GWAS) in 562 European individuals with narcolepsy (cases) and 702 ethnically matched controls, with independent replication in 370 cases and 495 controls, all heterozygous for DRB1*1501-DQB1*0602. We found association with a protective variant near HLA-DQA2 (rs2858884; P < 3 x 10(-8)). Further analysis revealed that rs2858884 is strongly linked to DRB1*03DQB1*02 (P < 4 x 10(-43)) and DRB1*1301-DQB1*0603 (P < 3 x 10(-7)). Cases almost never carried a trans DRB1*1301-DQB1*0603 haplotype (odds ratio = 0.02; P < 6 x 10(-14)). This unexpected protective HLA haplotype suggests a virtually causal involvement of the HLA region in narcolepsy susceptibility.	[Hor, Hyun; Petit, Brice; Pfister, Corinne; Buerki, Julie Vienne; Didelot, Gerard; Tafti, Mehdi] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Hor, Hyun; Dauvilliers, Yves] INSERM, U888, Montpellier, France; [Kutalik, Zoltan; Valsesia, Armand; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Valsesia, Armand; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Dauvilliers, Yves; Billiard, Michel] Gui de Chauliac Hosp, Dept Neurol, Natl Reference Network Orphan Dis Narcolepsy & Id, Montpellier, France; [Valsesia, Armand] Ludwig Inst Canc Res, Lausanne, Switzerland; [Lammers, Gert J.; Donjacour, Claire E. H. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Iranzo, Alex; Santamaria, Joan] Hosp Clin Barcelona, Neurol Serv, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Iranzo, Alex; Santamaria, Joan] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Adrados, Rosa Peraita] Gregorio Maranon Univ Hosp, Sleep & Epilepsy Unit, Dept Clin Neurophysiol, Madrid, Spain; [Vicario, Jose L.] Blood Ctr Community Madrid, Madrid, Spain; [Overeem, Sebastiaan] Sleep Med Ctr Kempenhaeghe, Heeze, Netherlands; [Overeem, Sebastiaan] Radboud Univ Nijmegen, Dept Neurol, Donders Inst Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Arnulf, Isabelle] Hop La Pitie Salpetriere, Sleep Disorders Unit, Natl Reference Network Orphan Dis Narcolepsy & Id, Paris, France; [Theodorou, Ioannis] Hop La Pitie Salpetriere, INSERM, U543, Paris, France; [Jennum, Poul; Knudsen, Stine] Univ Copenhagen, Dept Clin Neurophysiol, Glostrup, Denmark; [Bassetti, Claudio] Osped Civico, Neuroctr Ente Osped Cantonale Svizzera Italiana, Lugano, Switzerland; [Mathis, Johannes] Univ Bern, Inselspital, Abt Klin Neurophysiol, CH-3010 Bern, Switzerland; [Lecendreux, Michel] Univ Paris 07, Pediat Sleep Ctr, Natl Reference Network Orphan Dis Narcolepsy & Id, Dept Child & Adolescent Psychopathol,Robert Debre, Paris, France; [Mayer, Geert] Hephata Clin Neurol, Schwalmstadt, Germany; [Geisler, Peter] Univ Hosp Regensburg, Sleep Disorders & Res Ctr, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Beneto, Antonio] Hosp Univ La Fe, Unidad Sueno, Serv Neurofisiol Clin, Valencia, Spain; [Ercilla, Guadalupe] Hosp Clin Barcelona, Serv Immunol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Verduijn, Willem; Claas, Frans H. J.] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Vollenwider, Peter; Waeber, Gerard] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet Res & Dev, King Of Prussia, PA USA; [Heinzer, Raphael; Tafti, Mehdi] CHU Vaudois, Ctr Invest & Res Sleep, Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland	University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Lausanne; Swiss Institute of Bioinformatics; Universite de Montpellier; CHU de Montpellier; Ludwig Institute for Cancer Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; General University Gregorio Maranon Hospital; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; University of Bern; University Hospital of Bern; UDICE-French Research Universities; Universite Paris Cite; University of Regensburg; Hospital Universitari i Politecnic La Fe; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tafti, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	mehdi.tafti@unil.ch	Knudsen, Stine/O-2358-2017; Colaus, PsyColaus/K-6607-2013; Overeem, Sebastiaan/D-2139-2010; Valsesia, Armand/F-1724-2010; Beckmann, Jacques S/A-9772-2008; Tafti, Mehdi/A-8887-2017	Knudsen, Stine/0000-0003-1946-1125; Beckmann, Jacques S/0000-0002-9741-1900; Tafti, Mehdi/0000-0002-6997-3914; Bassetti, Claudio/0000-0002-4535-0245; Arnulf, Isabelle/0000-0002-2240-2516; Dauvilliers, yves/0000-0003-0683-6506; Heinzer, Raphael/0000-0002-3215-7788; Peraita-Adrados, Rosa/0000-0002-4172-4000; Overeem, Sebastiaan/0000-0002-6445-9836; Lammers, Gert Jan/0000-0003-4755-7060; Valsesia, Armand/0000-0003-0746-9664; Waeber, Gerard/0000-0003-4193-788X; Bergmann, Sven/0000-0002-6785-9034; Geisler, Peter/0000-0002-1790-4909	French Ministry of Research and Higher Education; Agence Nationale de la Recherche-07-MRAR (France) [PHRC 2007-P070138]; European Narcolepsy Network; UCB Pharma S.A. (Belgium); University and the State of Vaud (Switzerland); Swiss National Science Foundation [3100AO-108478/2, 3100AO-116323/1, 310000-112552/1]; European Framework Project 6; GlaxoSmithKline; Giorgi-Cavaglieri Foundation; Leenaards Foundation	French Ministry of Research and Higher Education; Agence Nationale de la Recherche-07-MRAR (France)(French National Research Agency (ANR)); European Narcolepsy Network; UCB Pharma S.A. (Belgium)(UCB Pharma SA); University and the State of Vaud (Switzerland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Framework Project 6; GlaxoSmithKline(GlaxoSmithKline); Giorgi-Cavaglieri Foundation; Leenaards Foundation	We thank all the subjects for their generous participation in this study; our colleagues K. Harshman and O. Hagenbuchle and the staff of the Lausanne DNA array facility for their expert technical assistance; and F. Canellas from the University Hospital Son Dureta, Palma-Spain and P. Young from the Department of Neurology, University Hospital Muenster-Germany for providing additional data on narcolepsy patients. Support for this research was provided by the French Ministry of Research and Higher Education, Project Agence Nationale de la Recherche-07-MRAR (France), PHRC 2007-P070138 (France), European Narcolepsy Network, an unrestricted grant from UCB Pharma S. A. (Belgium), the University and the State of Vaud (Switzerland), the Swiss National Science Foundation (grants 3100AO-108478/2, 3100AO-116323/1 and 310000-112552/1), the European Framework Project 6 (EuroDia and the AnEuploidy projects) and GlaxoSmithKline (which sponsored in part the CoLaus study). S. B. is funded by the Giorgi-Cavaglieri Foundation and the Leenaards Foundation. Special thanks to T. Johnson for his valuable advice on data analysis. The computations were performed in part at the Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics. This study was conducted on behalf of the European Narcolepsy Network.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Billiard M, 2007, SLEEP MED REV, V11, P377, DOI 10.1016/j.smrv.2007.04.001; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Mignot E, 1997, TISSUE ANTIGENS, V49, P329, DOI 10.1111/j.1399-0039.1997.tb02761.x; MIGNOT E, 1994, SLEEP, V17, P60; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Tafti M, 2007, CURR OPIN GENET DEV, V17, P222, DOI 10.1016/j.gde.2007.04.007; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	25	127	128	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					786	U80		10.1038/ng.647	http://dx.doi.org/10.1038/ng.647			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20711174				2022-12-17	WOS:000281388400016
J	Kleppe, M; Lahortiga, I; El Chaar, T; De Keersmaecker, K; Mentens, N; Graux, C; Van Roosbroeck, K; Ferrando, AA; Langerak, AW; Meijerink, JPP; Sigaux, F; Haferlach, T; Wlodarska, I; Vandenberghe, P; Soulier, J; Cools, J				Kleppe, Maria; Lahortiga, Idoya; El Chaar, Tiama; De Keersmaecker, Kim; Mentens, Nicole; Graux, Carlos; Van Roosbroeck, Katrien; Ferrando, Adolfo A.; Langerak, Anton W.; Meijerink, Jules P. P.; Sigaux, Francois; Haferlach, Torsten; Wlodarska, Iwona; Vandenberghe, Peter; Soulier, Jean; Cools, Jan			Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							MOLECULAR PATHOGENESIS; ACTIVATION; IDENTIFICATION; TRANSLOCATION; REGULATOR; FUSION; ABL1	PTPN2 (protein tyrosine phosphatase non-receptor type 2, also known as TC-PTP) is a cytosolic tyrosine phosphatase that functions as a negative regulator of a variety of tyrosine kinases and other signaling proteins(1-3). In agreement with its role in the regulation of the immune system, PTPN2 was identified as a susceptibility locus for autoimmune diseases(4,5). In this work, we describe the identification of focal deletions of PTPN2 in human T-cell acute lymphoblastic leukemia (T-ALL). Deletion of PTPN2 was specifically found in T-ALLs with aberrant expression of the TLX1 transcription factor oncogene(6), including four cases also expressing the NUP214-ABL1 tyrosine kinase(7). Knockdown of PTPN2 increased the proliferation and cytokine sensitivity of T-ALL cells. In addition, PTPN2 was identified as a negative regulator of NUP214-ABL1 kinase activity. Our study provides genetic and functional evidence for a tumor suppressor role of PTPN2 and suggests that expression of PTPN2 may modulate response to treatment.	[El Chaar, Tiama; Sigaux, Francois; Soulier, Jean] INSERM, U944, Paris, France; [El Chaar, Tiama; Sigaux, Francois; Soulier, Jean] Hop St Louis, Hematol Lab, Inst Univ Hematol, Paris, France; [Kleppe, Maria; Lahortiga, Idoya; De Keersmaecker, Kim; Mentens, Nicole; Van Roosbroeck, Katrien; Cools, Jan] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Kleppe, Maria; Lahortiga, Idoya; De Keersmaecker, Kim; Mentens, Nicole; Van Roosbroeck, Katrien; Wlodarska, Iwona; Vandenberghe, Peter; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [De Keersmaecker, Kim; Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY USA; [Graux, Carlos] Clin Univ Mt Godinne, Yvoir, Belgium; [Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Langerak, Anton W.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Meijerink, Jules P. P.] Erasmus Med Ctr Sophia, Dept Pediat, Rotterdam, Netherlands; [Haferlach, Torsten] Munich Leukemia Lab, Munich, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Flanders Institute for Biotechnology (VIB); KU Leuven; Columbia University; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Columbia University; Columbia University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; MLL Munich Leukemia Laboratory	Soulier, J (corresponding author), INSERM, U944, Paris, France.	jean.soulier@sls.aphp.fr; jan.cools@cme.vib-kuleuven.be	Kleppe, Maria/C-6341-2014; De Keersmaecker, Kim/W-9702-2018; Meijerink, Jules/D-4393-2017	Kleppe, Maria/0000-0002-4372-6704; De Keersmaecker, Kim/0000-0002-7420-9531; Vandenberghe, Peter/0000-0003-4719-1935; Meijerink, Jules/0000-0002-6860-798X; Cools, Jan/0000-0001-6626-5843	K.U. Leuven; FWO-Vlaanderen [G.0287.07]; Foundation against Cancer [SCIE2006-34]; European Research Council; European Hematology Association; Federal Office for Scientific, Technical and Cultural Affairs, Belgium; French program Carte d'Identite des Tumeurs; Canceropole d'Ile de France; New York Community Trust; National Institutes of Health [CA120196, CA129382]; NATIONAL CANCER INSTITUTE [R01CA120196, R01CA129382] Funding Source: NIH RePORTER	K.U. Leuven(KU Leuven); FWO-Vlaanderen(FWO); Foundation against Cancer; European Research Council(European Research Council (ERC)European Commission); European Hematology Association; Federal Office for Scientific, Technical and Cultural Affairs, Belgium; French program Carte d'Identite des Tumeurs; Canceropole d'Ile de France(Region Ile-de-France); New York Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Aerts for assistance with data analysis. This work was supported by grants from the K.U. Leuven (concerted action grant to J.C., I. W. and P. V.), the FWO-Vlaanderen (G.0287.07, J.C.), the Foundation against Cancer (SCIE2006-34, J.C.), a European Research Council starting grant (J.C.), a Jose-Carreras Fellowship grant from the European Hematology Association (J.C.), the Interuniversity Attraction Poles granted by the Federal Office for Scientific, Technical and Cultural Affairs, Belgium (J.C. and P. V.), a grant from the French program Carte d'Identite des Tumeurs (CIT, Ligue Contre le Cancer) and from Canceropole d'Ile de France (F. S. and J.S.); a Blood Disease Research Project research grant from The New York Community Trust (A. A. F.) and the National Institutes of Health (grants CA120196 and CA129382 to A. A. F.). A. A. F. is a Leukemia and Lymphoma Society Scholar. K. D. K. is a postdoctoral researcher, and P. V. is a senior clinical investigator of FWO-Vlaanderen.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; BENE MC, 1995, LEUKEMIA, V9, P1783; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; De Keersmaecker K, 2005, BLOOD, V105, P4849, DOI 10.1182/blood-2004-12-4897; De Keersmaecker K, 2008, MOL CELL, V31, P134, DOI 10.1016/j.molcel.2008.05.005; De Keersmaecker K, 2008, HAEMATOLOGICA, V93, P533, DOI 10.3324/haematol.11894; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; JAFFE ES, 2001, WHO CLASSIFICATION T, P84; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; WRIGHT DD, 1994, MOL CELL BIOL, V14, P2429, DOI 10.1128/MCB.14.4.2429	31	127	131	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					530	U84		10.1038/ng.587	http://dx.doi.org/10.1038/ng.587			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20473312	Green Accepted			2022-12-17	WOS:000278081500020
J	Barnes, C; Plagnol, V; Fitzgerald, T; Redon, R; Marchini, J; Clayton, D; Hurles, ME				Barnes, Chris; Plagnol, Vincent; Fitzgerald, Tomas; Redon, Richard; Marchini, Jonathan; Clayton, David; Hurles, Matthew E.			A robust statistical method for case-control association testing with copy number variation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; STRUCTURAL VARIATION; ALPHA-THALASSEMIA; DISEASE; SUSCEPTIBILITY; DUPLICATIONS; POLYMORPHISM; PREDISPOSES; SCALE	Copy number variation (CNV) is pervasive in the human genome and can play a causal role in genetic diseases. The functional impact of CNV cannot be fully captured through linkage disequilibrium with SNPs. These observations motivate the development of statistical methods for performing direct CNV association studies. We show through simulation that current tests for CNV association are prone to false-positive associations in the presence of differential errors between cases and controls, especially if quantitative CNV measurements are noisy. We present a statistical framework for performing case-control CNV association studies that applies likelihood ratio testing of quantitative CNV measurements in cases and controls. We show that our methods are robust to differential errors and noisy data and can achieve maximal theoretical power. We illustrate the power of these methods for testing for association with binary and quantitative traits, and have made this software available as the R package CNVtools.	[Barnes, Chris; Fitzgerald, Tomas; Redon, Richard; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Plagnol, Vincent; Clayton, David] Univ Cambridge, Cambridge Inst Med Res,Dept Med Genet, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Oxford	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	Plagnol, Vincent/A-5667-2011; Marchini, Jonathan/ABE-9024-2020; Redon, Richard/F-3303-2014	Marchini, Jonathan/0000-0003-0610-8322; Redon, Richard/0000-0001-7751-2280; Plagnol, Vincent/0000-0002-5597-9215; Barnes, Chris/0000-0002-9459-1395; Fitzgerald, Tomas/0000-0002-2370-8496	Wellcome Trust; WT; National Institute of General Medical Sciences; Juvenile Diabetes Research Foundation (JDRF) fellowship; JDRF/WT fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); WT; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Juvenile Diabetes Research Foundation (JDRF) fellowship(Juvenile Diabetes Research Foundation); JDRF/WT fellowship(Juvenile Diabetes Research Foundation)	C.B., T.F., R.R. and M. E. H. are funded by the Wellcome Trust (WT), J.M. is funded by the WT and the National Institute of General Medical Sciences, V. P. is supported by a Juvenile Diabetes Research Foundation (JDRF) fellowship, and D. C. is supported by a JDRF/WT fellowship. The authors would like to thank the Wellcome Trust Case Control Consortium, D. Conrad, A. Moses, N. Carter, M. Dermitzakis, B. Stranger, J. Armour and E. Hollox for data access and helpful discussions.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Armour JAL, 2002, HUM MUTAT, V20, P325, DOI 10.1002/humu.10133; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chong SS, 2000, BLOOD, V95, P360; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Lupski J.R., 2006, GENOMIC DISORDERS TH; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.1093/biomet/80.2.267; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; R Development Core Team, 2007, R LANG ENV STAT COMP; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257	23	127	137	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1245	1252		10.1038/ng.206	http://dx.doi.org/10.1038/ng.206			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776912	Green Accepted			2022-12-17	WOS:000259651000027
J	Brown, SDM; Chambon, P; de Angelis, MH				Brown, SDM; Chambon, P; de Angelis, MH		Eumorphia Consortium	EMPReSS: standardized phenotype screens for functional annotation of the mouse genome	NATURE GENETICS			English	Letter							MUTANT MICE; STEM-CELLS; MUTAGENESIS; WIDE					s.brown@har.mrc.ac.uk	Fuchs, Helmut/M-7347-2014; Wahli, Walter/B-1398-2009; Daniela, Marazziti/AAC-1062-2022; Gkoutos, Georgios/AAS-9936-2020; de Angelis, Martin Hrabe/F-5531-2012; Muller, Werner/B-9044-2008; Golini, Elisabetta/AAX-2849-2020; Mandillo, Silvia/E-6503-2019; Ermakova, Olga/Z-2037-2018; Beckers, Johannes/K-7237-2012; Hölter, Sabine M./N-5868-2014; Hancock, John/A-2442-2009	Fuchs, Helmut/0000-0002-5143-2677; Wahli, Walter/0000-0002-5966-9089; Daniela, Marazziti/0000-0002-1582-9271; Gkoutos, Georgios/0000-0002-2061-091X; de Angelis, Martin Hrabe/0000-0002-7898-2353; Muller, Werner/0000-0002-1297-9725; Mandillo, Silvia/0000-0002-4869-0974; Ermakova, Olga/0000-0001-8365-4904; Beckers, Johannes/0000-0001-7874-3822; Hölter, Sabine M./0000-0003-4878-5241; Hancock, John/0000-0003-2991-2217; Michalik, Liliane/0000-0003-2963-2100; Aubert, Denise/0000-0002-1442-3384; Tucci, Valter/0000-0002-3796-3826; MATTEONI, RAFAELE/0000-0002-0314-5948; DEIDDA, GIANCARLO/0000-0002-0828-5800; Cartwright, Elizabeth/0000-0002-6836-7795				Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Green ECJ, 2005, BIOINFORMATICS, V21, P2930, DOI 10.1093/bioinformatics/bti441; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622	10	127	132	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1155	1155		10.1038/ng1105-1155	http://dx.doi.org/10.1038/ng1105-1155			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254554				2022-12-17	WOS:000233045200002
J	Ching, TT; Maunakea, AK; Jun, P; Hong, CB; Zardo, G; Pinkel, D; Albertson, DG; Fridlyand, J; Mao, JH; Shchors, K; Weiss, WA; Costello, JF				Ching, TT; Maunakea, AK; Jun, P; Hong, CB; Zardo, G; Pinkel, D; Albertson, DG; Fridlyand, J; Mao, JH; Shchors, K; Weiss, WA; Costello, JF			Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; 22Q13 DELETION SYNDROME; CPG-ISLANDS; HUMAN GENOME; ARRAY CGH; IMMUNODEFICIENCY SYNDROME; COPY NUMBER; GERM-LINE; MOUSE; EXPRESSION	CpG islands are present in one-half of all human and mouse genes and typically overlap with promoters or exons. We developed a method for high-resolution analysis of the methylation status of CpG islands genome-wide, using arrays of BAC clones and the methylation-sensitive restriction enzyme NotI. Here we demonstrate the accuracy and specificity of the method. By computationally mapping all NotI sites, methylation events can be defined with single-nucleotide precision throughout the genome. We also demonstrate the unique expandability of the array method using a different methylation-sensitive restriction enzyme, BssHII. We identified and validated new CpG island loci that are methylated in a tissue-specific manner in normal human tissues. The methylation status of the CpG islands is associated with gene expression for several genes, including SHANK3, which encodes a structural protein in neuronal postsynaptic densities. Defects in SHANK3 seem to underlie human 22q13 deletion syndrome. Furthermore, these patterns for SHANK3 are conserved in mice and rats.	Univ Calif San Francisco, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Costello, JF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94143 USA.	jcostello@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Ching, Tsui-Ting/0000-0001-7650-1766; Weiss, William/0000-0003-2230-9132				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gartler S M, 1992, Mol Genet Med, V2, P121; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huang THM, 1997, CANCER RES, V57, P1030; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; MCCLELLAND M, 1982, NUCLEIC ACIDS RES, V10, P7865, DOI 10.1093/nar/10.23.7865; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Trasler JM, 1996, DEV DYNAM, V206, P239, DOI 10.1002/(SICI)1097-0177(199607)206:3<239::AID-AJA2>3.3.CO;2-M; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATT JL, 1985, J MED GENET, V22, P283, DOI 10.1136/jmg.22.4.283; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	43	127	138	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					645	651		10.1038/ng1563	http://dx.doi.org/10.1038/ng1563			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895082				2022-12-17	WOS:000229495300021
J	Shirane, D; Sugao, K; Namiki, S; Tanabe, M; Iino, M; Hirose, K				Shirane, D; Sugao, K; Namiki, S; Tanabe, M; Iino, M; Hirose, K			Enzymatic production of RNAi libraries from cDNAs	NATURE GENETICS			English	Article							SHORT-INTERFERING RNAS; MAMMALIAN-CELLS; GENE-EXPRESSION; INOSITOL 1,4,5-TRISPHOSPHATE; CAENORHABDITIS-ELEGANS; STEM-CELLS; GENOME; MESSENGER; SEQUENCE; RECEPTOR	RNA interference (RNAi) induced by small interfering (siRNA) or short hairpin RNA (shRNA) is an important research approach in mammalian genetics. Here we describe a technology called enzymatic production of RNAi library (EPRIL) by which cDNAs are converted by a sequence of enzymatic treatments into an RNAi library consisting of a vast array of different shRNA expression constructs. We applied EPRIL to a single cDNA source and prepared an RNAi library consisting of shRNA constructs with various RNAi efficiencies. High-throughput screening allowed us to rapidly identify the best shRNA constructs from the library. We also describe a new selection scheme using the thymidine kinase gene for obtaining efficient shRNA constructs. Furthermore, we show that EPRIL can be applied to constructing an RNAi library from a cDNA library, providing a basis for future whole-genome phenotypic screening of genes.	Univ Tokyo, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirose, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kenzo@m.u-tokyo.ac.jp	Namiki, Shigeyuki/AAF-6157-2019	Namiki, Shigeyuki/0000-0003-1520-8261; Hirose, Kenzo/0000-0002-8944-6513				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; BOYD AC, 1986, NUCLEIC ACIDS RES, V14, P5255, DOI 10.1093/nar/14.13.5255; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; DESMEDT H, 1994, J BIOL CHEM, V269, P21691; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	28	127	153	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					190	196		10.1038/ng1290	http://dx.doi.org/10.1038/ng1290			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14704669	Bronze			2022-12-17	WOS:000188542700023
J	Zardo, G; Tiirikainen, MI; Hong, CB; Misra, A; Feuerstein, BG; Volik, S; Collins, CC; Lamborn, KR; Bollen, A; Pinkel, D; Albertson, DG; Costello, JF				Zardo, G; Tiirikainen, MI; Hong, CB; Misra, A; Feuerstein, BG; Volik, S; Collins, CC; Lamborn, KR; Bollen, A; Pinkel, D; Albertson, DG; Costello, JF			Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors	NATURE GENETICS			English	Article							DNA COPY NUMBER; GLIOBLASTOMA-MULTIFORME; METHYLATION; CANCER; LOCI; HYPERMETHYLATION; CHROMOSOME-10; CARCINOMA; PATTERNS; LUNG	Aberrant methylation of CpG islands and genomic deletion are two predominant mechanisms of gene inactivation in tumorigenesis, but the extent to which they interact is largely unknown. The lack of an integrated approach to study these mechanisms has limited the understanding of tumor genomes and cancer genes. Restriction landmark genomic scanning (RLGS; ref. 1) is useful for global analysis of aberrant methylation of CpG islands, but has not been amenable to alignment with deletion maps because the identity of most RLGS fragments is unknown. Here, we determined the nucleotide sequence and exact chromosomal position of RLGS fragments throughout the genome using the whole chromosome of origin of the fragments 2 and in silico restriction digestion of the human genome sequence. To study the interaction of these gene-inactivation mechanisms in primary brain tumors, we integrated RLGS-based methylation analysis with high-resolution deletion maps from microarray-based comparative genomic hybridization (array CGH; ref. 3). Certain subsets of gene-associated CpG islands were preferentially affected by convergent methylation and deletion, including genes that exhibit tumor-suppressor activity, such as CISH1 (encoding SOCS1; ref. 4), as well as genes such as COE3 that have been missed by traditional non-integrated approaches. Our results show that most aberrant methylation events are focal and independent of deletions, and the rare convergence of these mechanisms can pinpoint biallelic gene inactivation without the use of positional cloning.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94115 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Costello, JF (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA.		Tirikainen, M/B-6954-2012; Feuerstein, Burt G/A-5186-2015	Tirikainen, M/0000-0002-8124-3818; Feuerstein, Burt G/0000-0001-7276-8842				Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fruhwald MC, 2001, ONCOGENE, V20, P5033, DOI 10.1038/sj.onc.1204613; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; Ginzinger DG, 2000, CANCER RES, V60, P5405; HATADA I, 1991, P NATL ACAD SCI USA, V88, P9523, DOI 10.1073/pnas.88.21.9523; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; KARLBOM AE, 1993, HUM GENET, V92, P169; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Mohapatra G, 1998, GENE CHROMOSOME CANC, V21, P195, DOI 10.1002/(SICI)1098-2264(199803)21:3<195::AID-GCC3>3.3.CO;2-A; Rouillard JM, 2001, GENOME RES, V11, P1453, DOI 10.1101/gr.181601; Rush LJ, 2001, BLOOD, V97, P3226, DOI 10.1182/blood.V97.10.3226; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; von Deimling A, 2000, J NEUROPATH EXP NEUR, V59, P544, DOI 10.1093/jnen/59.6.544; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Yoshikawa H, 1996, GENOMICS, V31, P28, DOI 10.1006/geno.1996.0005	21	127	140	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					453	458		10.1038/ng1007	http://dx.doi.org/10.1038/ng1007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12355068				2022-12-17	WOS:000179034800026
J	Hogema, BM; Gupta, M; Senephansiri, H; Burlingame, TG; Taylor, M; Jakobs, C; Schutgens, RBH; Froestl, W; Snead, OC; Diaz-Arrastia, R; Bottiglieri, T; Grompe, M; Gibson, KM				Hogema, BM; Gupta, M; Senephansiri, H; Burlingame, TG; Taylor, M; Jakobs, C; Schutgens, RBH; Froestl, W; Snead, OC; Diaz-Arrastia, R; Bottiglieri, T; Grompe, M; Gibson, KM			Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase	NATURE GENETICS			English	Article							GAMMA-HYDROXYBUTYRIC ACID; GABA(B) RECEPTORS; RAT HIPPOCAMPUS; TAURINE RELEASE; BINDING-SITES; FIRING RATE; BRAIN; ACTIVATION; CELLS; NEURONS	Succinate semialdehyde dehydrogenase (ALDH5A1, encoding SSADH deficiency is a defect of 4-aminobutyric acid (GABA) degradation that manifests in humans as 4-hydroxybutyric (gamma-hydroxybutyric, GHB) aciduria. It is characterized by a non-specific neurological disorder including psychomotor retardation, language delay, seizures, hypotonia and ataxia. The current therapy, vigabatrin (VGB), is not uniformly successful(1). Here we report the development of Aldh5a1-deficient mice. At postnatal day 16-22 Aldh5a1(-/-) mice display ataxia and develop generalized seizures leading to rapid death. We observed increased amounts of GHB and total GABA in urine, brain and liver homogenates and detected significant gliosis in the hippocampus of Aldh5a1(-/-) mice. We found therapeutic intervention with phenobarbital or pherytoin ineffective, whereas intervention with vigabatrin or the GABA(B) receptor antagonist CGP 35348 (ref. 2) prevented tonic-clonic convulsions and significantly enhanced survival of the mutant mice. Because neurologic deterioration coincided with weaning, we hypothesized the presence of a protective compound in breast milk. Indeed, treatment of mutant mice with the amino acid taurine rescued Aldh5a1(-/-) mice. These findings provide insight into pathomechanisms and may have therapeutic relevance for the human SSADH deficiency disease and GHB overdose and toxicity.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands; Erasmus Univ, Fac Med, Cardiovasc Res Inst COEUR, Dept Biochem, NL-3000 DR Rotterdam, Netherlands; Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97201 USA; Novartis Pharma Inc, CH-4002 Basel, Switzerland; Hosp Sick Children, Fac Med, Dept Pediat, Div Neurol, Toronto, ON, Canada; Hosp Sick Children, Fac Med, Program Brain & Behav, Toronto, ON, Canada; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA; Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA	Oregon Health & Science University; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Oregon Health & Science University; Novartis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center	Gibson, KM (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, 2525 SW 3rd Ave, Portland, OR 97201 USA.		Gupta, Maneesh/GSE-3631-2022	Grompe, Markus/0000-0002-6616-4345; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIA NIH HHS [R03 AG16450, P30 AG12300] Funding Source: Medline; NINDS NIH HHS [NS 40270] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG016450, P30AG012300] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENAVIDES J, 1982, LIFE SCI, V30, P953, DOI 10.1016/0024-3205(82)90624-5; CLEMENTS JR, 1989, SYNAPSE, V4, P70, DOI 10.1002/syn.890040108; del Olmo N, 2000, BRAIN RES, V864, P298, DOI 10.1016/S0006-8993(00)02211-3; DIANA M, 1991, BRAIN RES, V566, P208, DOI 10.1016/0006-8993(91)91700-B; ENG LF, 1992, PROG BRAIN RES, V94, P353; Erhardt S, 1998, N-S ARCH PHARMACOL, V357, P611, DOI 10.1007/PL00005215; Fernandes MJD, 1999, J CEREBR BLOOD F MET, V19, P195; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; GIBSON KM, 1990, BIOMED ENVIRON MASS, V19, P89, DOI 10.1002/bms.1200190207; GIBSON KM, 1995, J INHERIT METAB DIS, V18, P143, DOI 10.1007/BF00711750; GIBSON KM, 2001, METABOLIC MOL BASES, P2079; Hardus P, 2001, EPILEPSIA, V42, P262, DOI 10.1046/j.1528-1157.2001.4220262.x; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; Mathivet P, 1997, EUR J PHARMACOL, V321, P67, DOI 10.1016/S0014-2999(96)00916-8; MILLER DB, 1995, EXP GERONTOL, V30, P383, DOI 10.1016/0531-5565(94)00064-A; Minn A, 1998, GLIA, V22, P338, DOI 10.1002/(SICI)1098-1136(199804)22:4<338::AID-GLIA3>3.0.CO;2-#; Motalli R, 1999, J NEUROPHYSIOL, V82, P638, DOI 10.1152/jn.1999.82.2.638; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Oja SS, 2000, PROG NEUROBIOL, V62, P407, DOI 10.1016/S0301-0082(00)00005-8; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; Rizvi TA, 1999, BRAIN RES, V816, P111, DOI 10.1016/S0006-8993(98)01133-0; Saransaari P, 2000, AMINO ACIDS, V18, P17, DOI 10.1007/s007260050002; Sarwar G, 1998, BRIT J NUTR, V79, P129, DOI 10.1079/BJN19980023; SMITH SS, 1991, NEUROSCI LETT, V132, P59, DOI 10.1016/0304-3940(91)90433-T; SNEAD OC, 1994, BRAIN RES, V659, P147, DOI 10.1016/0006-8993(94)90874-5; SNEAD OC, 1984, BIOCHEM PHARMACOL, V33, P2587; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Timby N, 2000, AM J MED, V108, P518, DOI 10.1016/S0002-9343(99)00468-4	31	127	137	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					212	216		10.1038/ng727	http://dx.doi.org/10.1038/ng727			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544478				2022-12-17	WOS:000171374100030
J	Wu, Y; Berends, MJW; Sijmons, RH; Mensink, RGJ; Verlind, E; Kooi, KA; van der Sluis, T; Kempinga, C; van der Zee, AGJ; Hollema, H; Buys, CHCM; Kleibeuker, JH; Hofstra, RMW				Wu, Y; Berends, MJW; Sijmons, RH; Mensink, RGJ; Verlind, E; Kooi, KA; van der Sluis, T; Kempinga, C; van der Zee, AGJ; Hollema, H; Buys, CHCM; Kleibeuker, JH; Hofstra, RMW			A role for MLH3 in hereditary nonpolyposis colorectal cancer	NATURE GENETICS			English	Article							INTERNATIONAL-COLLABORATIVE-GROUP; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; ICG-HNPCC; MUTATIONS; MUTL	We investigated a possible role of the mismatch-repair gene MLH3 in hereditary nonpolyposis colorectal cancer by scanning for mutations in 39 HNPCC families and in 288 patients suspected of having HNPCC. We identified ten different germline MLH3 variants, one frameshift and nine missense mutations, in 12 patients suspected of HNPCC. Three of the 12 also carried a mutation in MSH6.	Univ Groningen, Dept Med Genet, Groningen, Netherlands; Univ Groningen, Dept Gastroenterol, Groningen, Netherlands; Univ Groningen, Dept Pathol, Groningen, Netherlands; Univ Groningen, Dept Gynecol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Hofstra, RMW (corresponding author), Univ Groningen, Dept Med Genet, Groningen, Netherlands.		Sijmons, Rolf/E-5829-2012	Sijmons, Rolf/0000-0001-8446-2779; Hofstra, Robert/0000-0001-7498-3829				Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Boland CR, 1998, CANCER RES, V58, P5248; Dietmaier W, 1997, CANCER RES, V57, P4749; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Jiricny J, 2000, NAT GENET, V24, P6, DOI 10.1038/71698; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Park JG, 1999, DIS COLON RECTUM, V42, P710, DOI 10.1007/BF02236922; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	13	127	133	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					137	138		10.1038/ng1001-137	http://dx.doi.org/10.1038/ng1001-137			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586295				2022-12-17	WOS:000171374100016
J	Johnson, KR; Zheng, QY; Bykhovskaya, Y; Spirina, O; Fischel-Ghodsian, N				Johnson, KR; Zheng, QY; Bykhovskaya, Y; Spirina, O; Fischel-Ghodsian, N			A nuclear-mitochondrial DNA interaction affecting hearing impairment in mice	NATURE GENETICS			English	Article							RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; MOUSE; GENE; STRAINS; PHENOTYPE	The pathophysiologic pathways and clinical expression of mitochondrial DNA (mtDNA) mutations are not well understood. This is mainly the result of the heteroplasmic nature of most pathogenic mtDNA mutations and of the absence of clinically relevant animal models with mtDNA mutations, mtDNA mutations predisposing to hearing impairment in humans are generally homoplasmic, yet some individuals with these mutations have severe hearing loss, whereas their maternal relatives with the identical mtDNA mutation have normal hearing(1,2). Epidemiologic, biochemical and genetic data indicate that nuclear genes are often the main determinants of these differences in phenotype(3-5). To identify a mouse model for maternally inherited hearing loss, we screened reciprocal backcrosses of three inbred mouse strains, A/J. NOD/LtJ and SKH2/J, with age-related hearing loss (AHL). In the (A/JxCAST/Ei)xA/J backcross. mtDNA derived from the A/J strain exerted a significant detrimental effect on hearing when compared with mtDNA from the CAST/Ei strain. This effect was not seen in the (NOD/LtJ xCAST/Ei)xNOD/LtJ and (SKH2/JxCAST/Ei)xSKH2/J backcrosses. Genotyping revealed that this effect was seen only in mice homozygous for the A/J allele at the Ahl locus on mouse chromosome 10. Sequencing of the mitochondrial genome in the three inbred strains revealed a single nucleotide insertion in the fRNA-Arg gene (mt-Tr) as the probable mediator of the mitochondrial effect. This is the first mouse model with a naturally occurring mtDNA mutation affecting a clinical phenotype, and it provides an experimental model to dissect the pathophysiologic processes connecting mtDNA mutations to hearing loss.	Jackson Lab, Bar Harbor, ME 04609 USA; Cedars Sinai Med Ctr, Ahmanson Dept Pediat,Burns & Allen Res Inst, Steven Spielberg Pediat Res Ctr, Ctr Med Genet Birth Defects, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Jackson Laboratory; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fischel-Ghodsian, N (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Zheng, Qing/C-1731-2012		NIDCD NIH HHS [R01 DC004301-01, R01 DC005827, R01 DC001402, R01 DC005827-01, R03 DC004376-01A1, R01 DC004092-01, R01 DC001402-07, R01 DC004301] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402, R01DC004092, R03DC004376, R01DC005827, R01DC004301] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAL U, 1997, AM J OTOL, V18, P449; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Bykhovskaya Y, 2000, AM J HUM GENET, V66, P1905, DOI 10.1086/302914; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Fischel-Ghodsian N, 1998, MOL GENET METAB, V65, P97, DOI 10.1006/mgme.1998.2751; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955; LI HS, 1994, ORL J OTO-RHINO-LARY, V56, P61, DOI 10.1159/000276611; Liu W, 1999, BBA-GEN SUBJECTS, V1473, P356, DOI 10.1016/S0304-4165(99)00143-9; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; SLIGH JE, 2000, AM J HUM GENET S2, V67, pA53; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; WAYNE S, 1996, HUM MOL GENET, V10, P1689; Willott JF, 1998, HEARING RES, V119, P27, DOI 10.1016/S0378-5955(98)00029-X; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	30	127	135	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2001	27	2					191	194		10.1038/84831	http://dx.doi.org/10.1038/84831			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	399XH	11175788	Green Accepted			2022-12-17	WOS:000166839200021
J	Guarente, L				Guarente, L			Diverse and dynamic functions of the Sir silencing complex	NATURE GENETICS			English	Article							CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; ATAXIA-TELANGIECTASIA; RIBOSOMAL DNA; YEAST KU; PROTEIN; TELOMERES; GENE; REGULATOR; END	The yeast Sir protein complex has been implicated in transcriptional silencing and suppression of recombination. The Sir complex creates structured chromosomal domains at telomeres, silent mating-type loci and ribosomal DNA to invoke these functional states. Mechanistic insights into the function of Sir proteins implicate a range of activities in yeast, including repair of DNA double-strand breaks, regulation of the mitotic cell cycle, meiosis and ageing. I speculate that the Sir proteins may be capable of enzymatic modification of chromatin and other substrates, which enables them to carry out a broad range of cellular functions.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CRAIG IW, 1994, J INHERIT METAB DIS, V17, P391, DOI 10.1007/BF00711355; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Jeggo PA, 1998, TRENDS GENET, V14, P312, DOI 10.1016/S0168-9525(98)01511-X; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; Park PU, 1999, MOL CELL BIOL, V19, P3848; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; RINE J, 1987, GENETICS, V116, P9; Rothstein R, 1999, NAT GENET, V22, P4, DOI 10.1038/8705; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sinclair DA, 1998, TRENDS BIOCHEM SCI, V23, P131, DOI 10.1016/S0968-0004(98)01188-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tsang AW, 1996, J BACTERIOL, V178, P7016, DOI 10.1128/jb.178.23.7016-7019.1996; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	52	127	137	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1999	23	3					281	285		10.1038/15458	http://dx.doi.org/10.1038/15458			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	257QC	10545947				2022-12-17	WOS:000083792200015
J	Nilsson, M; Krejci, K; Koch, J; Kwiatkowski, M; Gustavsson, P; Landegren, U				Nilsson, M; Krejci, K; Koch, J; Kwiatkowski, M; Gustavsson, P; Landegren, U			Padlock probes reveal single-nucleotide differences, parent of origin and in situ distribution of centromeric sequences in human chromosomes 13 and 21	NATURE GENETICS			English	Article							ALPHA-SATELLITE DNA; IN-SITU; LABELING PRINS; ORGANIZATION; LIGASE; OLIGONUCLEOTIDES; IDENTIFICATION; HYBRIDIZATION; CONSTRUCTION; POLYMORPHISM		DANISH CANC SOC,DEPT CYTOGENET,DK-8000 AARHUS C,DENMARK; UPPSALA CHILDRENS HOSP,DEPT CLIN GENET,UPPSALA,SWEDEN	Danish Cancer Society	Nilsson, M (corresponding author), UNIV UPPSALA,CTR BIOMED,DEPT MED GENET,BEIJER LAB,BOX 589,S-75123 UPPSALA,SWEDEN.		Landegren, Ulf D/A-8197-2019	Nilsson, Mats/0000-0001-9985-0387				BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; CHARLIEU JP, 1992, GENOMICS, V14, P515, DOI 10.1016/S0888-7543(05)80256-3; CONNOLLY BA, 1987, TETRAHEDRON LETT, V28, P463, DOI 10.1016/S0040-4039(00)95757-5; Finelli P, 1996, GENOMICS, V38, P325, DOI 10.1006/geno.1996.0635; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; GREIG GM, 1993, J MOL EVOL, V37, P464, DOI 10.1007/BF00160427; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; KOCH J, 1995, CYTOGENET CELL GENET, V71, P142, DOI 10.1159/000134094; KOCH JE, 1989, CHROMOSOMA, V98, P259, DOI 10.1007/BF00327311; Kwiatkowski M, 1996, NUCLEIC ACIDS RES, V24, P4632, DOI 10.1093/nar/24.23.4632; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; LOU J, 1996, NUCLEIC ACIDS RES, V24, P3071; MARCAIS B, 1991, J MOL EVOL, V33, P42, DOI 10.1007/BF02100194; MARCAIS B, 1991, HUM GENET, V86, P311; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; OKeefe CL, 1996, HUM MOL GENET, V5, P1793, DOI 10.1093/hmg/5.11.1793; PELLESTOR F, 1994, HUM GENET, V94, P346; PELLESTOR F, 1995, HUM GENET, V95, P12; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SUND C, 1988, NUCLEOS NUCLEOT, V7, P655, DOI 10.1080/07328318808056303; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0	25	127	143	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					252	255		10.1038/ng0797-252	http://dx.doi.org/10.1038/ng0797-252			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207789				2022-12-17	WOS:A1997XG60900019
J	Lindberg, RLP; Porcher, C; Grandchamp, B; Ledermann, B; Burki, K; Brandner, S; Aguzzi, A; Meyer, UA				Lindberg, RLP; Porcher, C; Grandchamp, B; Ledermann, B; Burki, K; Brandner, S; Aguzzi, A; Meyer, UA			Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria	NATURE GENETICS			English	Letter							DELTA-AMINOLEVULINIC-ACID; INTERMITTENT ACUTE PORPHYRIA; MOLECULAR-GENETICS		UNIV BASEL, BIOCTR, DEPT PHARMACOL, CH-4056 BASEL, SWITZERLAND; FAC XAVIER BICHAT, INSERM, U409, F-75018 PARIS, FRANCE; SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND; UNIV ZURICH HOSP, INST NEUROPATHOL, CH-8091 ZURICH, SWITZERLAND	University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Novartis; Sandoz; University of Zurich; University Zurich Hospital			Brandner, Sebastian/J-4562-2014; Aguzzi, Adriano/A-3351-2008; Porcher, Catherine/D-7026-2016	Brandner, Sebastian/0000-0002-9821-0342; Aguzzi, Adriano/0000-0002-0344-6708				ALBERS JW, 1978, MUSCLE NERVE, V1, P292, DOI 10.1002/mus.880010405; ANDERSSON C, 1994, J INTERN MED, V236, P169, DOI 10.1111/j.1365-2796.1994.tb01279.x; BEAUMONT C, 1989, J BIOL CHEM, V264, P14829; Bielschowsky M, 1904, J PSYCHOL NEUROL, V3, P169; BONKOVSKY HL, 1993, GASTROENTEROLOGY, V105, P590, DOI 10.1016/0016-5085(93)90739-Y; Bonkowsky H L, 1982, Semin Liver Dis, V2, P108, DOI 10.1055/s-2008-1040701; BRENNAN MJW, 1979, NATURE, V280, P514, DOI 10.1038/280514a0; BROWNLIE PD, 1994, PROTEIN SCI, V3, P1644, DOI 10.1002/pro.5560031004; CAVANAGH JB, 1965, J NEUROL NEUROSUR PS, V28, P320, DOI 10.1136/jnnp.28.4.320; CHEN CH, 1994, J CLIN INVEST, V94, P1927, DOI 10.1172/JCI117543; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; EALES L, 1971, South African Journal of Laboratory and Clinical Medicine, V17, P89; ELDER GH, 1993, J CLIN PATHOL, V46, P977, DOI 10.1136/jcp.46.11.977; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; HRUSKA RE, 1979, LIFE SCI, V25, P171, DOI 10.1016/0024-3205(79)90389-8; JOHNSON P, 1990, GENE, V88, P207, DOI 10.1016/0378-1119(90)90033-N; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LITMAN DA, 1983, SCIENCE, V222, P1031, DOI 10.1126/science.6648517; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; MEYER UA, 1972, NEW ENGL J MED, V286, P1277, DOI 10.1056/NEJM197206152862401; MULLER WE, 1977, ANN NEUROL, V2, P340, DOI 10.1002/ana.410020415; NORDMANN Y, 1990, ANN MED, V22, P387, DOI 10.3109/07853899009147275; POLAND A, 1973, SCIENCE, V179, P476, DOI 10.1126/science.179.4072.476; TISHLER PV, 1985, AM J PSYCHIAT, V142, P1430; TOMOKUNI K, 1987, CLIN CHEM, V33, P1665	26	127	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					195	199		10.1038/ng0296-195	http://dx.doi.org/10.1038/ng0296-195			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563760				2022-12-17	WOS:A1996TU07900022
J	DACOSTA, LT; LIU, B; ELDEIRY, WS; HAMILTON, SR; KINZLER, KW; VOGELSTEIN, B; MARKOWITZ, S; WILLSON, JKV; DELACHAPELLE, A; DOWNEY, KM; SO, AG				DACOSTA, LT; LIU, B; ELDEIRY, WS; HAMILTON, SR; KINZLER, KW; VOGELSTEIN, B; MARKOWITZ, S; WILLSON, JKV; DELACHAPELLE, A; DOWNEY, KM; SO, AG			POLYMERASE-DELTA VARIANTS IN RER COLORECTAL TUMORS	NATURE GENETICS			English	Letter							CATALYTIC SUBUNIT; MISMATCH REPAIR; DNA; REPLICATION; MUTATIONS; CANCER; YEAST		JOHNS HOPKINS UNIV,DEPT PATHOL,BALTIMORE,MD 21231; CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,DEPT MED,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,IRELAND CANC CTR,CLEVELAND,OH 44106; UNIV HELSINKI,DEPT MED GENET,SF-00290 HELSINKI,FINLAND; UNIV MIAMI,DEPT MED,MIAMI,FL 33101; UNIV MIAMI,DEPT BIOCHEM MOLEC BIOL,MIAMI,FL 33101	Johns Hopkins University; Case Western Reserve University; University of Helsinki; University of Miami; University of Miami	DACOSTA, LT (corresponding author), JOHNS HOPKINS UNIV,PROGRAM HUMAN GENET,BALTIMORE,MD 21231, USA.			El-Deiry, Wafik/0000-0002-9577-8266				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; CHUNG DW, 1991, P NATL ACAD SCI USA, V88, P11197, DOI 10.1073/pnas.88.24.11197; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; LIU B, 1994, CANCER RES, V54, P4590; SCHAAPER RM, 1989, EMBO J, V8, P3511, DOI 10.1002/j.1460-2075.1989.tb08516.x; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; UMAR A, 1994, J BIOL CHEM, V269, P14367; YANG CL, 1992, NUCLEIC ACIDS RES, V20, P735, DOI 10.1093/nar/20.4.735	14	127	129	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					10	11		10.1038/ng0195-10	http://dx.doi.org/10.1038/ng0195-10			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704014				2022-12-17	WOS:A1995PZ91300006
J	SALIDO, EC; YEN, PH; MOHANDAS, TK; SHAPIRO, LJ				SALIDO, EC; YEN, PH; MOHANDAS, TK; SHAPIRO, LJ			EXPRESSION OF THE X-INACTIVATION-ASSOCIATED GENE XIST DURING SPERMATOGENESIS	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; MEIOTIC PROPHASE; MOUSE	Mammalian X-chromosome inactivation is thought to be controlled by the X inactivation centre (XIC, X-controlling element -Xce- in mice). A human gene, XIST and its mouse counterpart, Xist, which map to the XIC/Xce, are expressed exclusively from inactive X chromosomes, suggesting their involvement in the process of X-inactivation. We now report the presence of Xist/XIST transcripts in newborn and adult mouse testes, and in human testicular tissue with normal spermatogenesis, but not in the testes of patients who lack germ cells. Our results indicate that while the X chromosome in males is active in somatic cells, it undergoes inactivation during spermatogenesis.	UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT PEDIAT,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT BIOL CHEM,TORRANCE,CA 90509; UNIV LA LAGUNA,SCH MED,DEPT PATHOL,E-38071 TENERIFE,SPAIN	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad de la Laguna	SALIDO, EC (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,HOWARD HUGHES MED INST,TORRANCE,CA 90509, USA.		Salido, Eduardo C/I-2232-2015	Salido, Eduardo C/0000-0001-9599-9854				BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH B, 1961, GENET RES, V2, P156, DOI 10.1017/S001667230000063X; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HANDEL MA, 1987, SPERMATOGENESIS GENE, P1; HENDERSON SA, 1964, CHROMOSOMA, V15, P345, DOI 10.1007/BF00368137; KIERSZEN.AL, 1974, J CELL BIOL, V63, P923, DOI 10.1083/jcb.63.3.923; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Klinefelter HF, 1942, J CLIN ENDOCRINOL, V2, P615, DOI 10.1210/jcem-2-11-615; KOFMANALFARO S, 1970, CHROMOSOMA, V31, P404, DOI 10.1007/BF00285832; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1974, NATURE, V250, P651, DOI 10.1038/250651a0; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; ODARTCHE.N, 1970, SCIENCE, V167, P1133, DOI 10.1126/science.167.3921.1133; OHNO S., 1963, CYTOGENETICS [BASEL], V2, P232, DOI 10.1159/000129781; PATHAK S, 1980, HU MGENET, P171; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; SAMBOOK J, 1989, MOL CLONING LABORATO; SEARLE AG, 1962, HEREDITY, V17, P297; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; VANDYKE DL, 1986, AM J HUM GENET, V39, P88; [No title captured]	29	127	127	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					196	199		10.1038/ng1192-196	http://dx.doi.org/10.1038/ng1192-196			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345168				2022-12-17	WOS:A1992JW16500008
J	Yuan, Y; Ju, YS; Kim, Y; Li, J; Wang, YM; Yoon, CJ; Yang, Y; Martincorena, I; Creighton, CJ; Weinstein, JN; Xu, YX; Han, L; Kim, HL; Nakagawa, H; Park, K; Campbell, PJ; Liang, H				Yuan, Yuan; Ju, Young Seok; Kim, Youngwook; Li, Jun; Wang, Yumeng; Yoon, Christopher J.; Yang, Yang; Martincorena, Inigo; Creighton, Chad J.; Weinstein, John N.; Xu, Yanxun; Han, Leng; Kim, Hyung-Lae; Nakagawa, Hidewaki; Park, Keunchil; Campbell, Peter J.; Liang, Han		PCAWG Consortium	Comprehensive molecular characterization of mitochondrial genomes in human cancers	NATURE GENETICS			English	Article							DNA COPY NUMBER; MUTATIONAL PROCESSES; POINT MUTATIONS; LANDSCAPE; TUMORS; DAMAGE	Mitochondria are essential cellular organelles that play critical roles in cancer. Here, as part of the International Cancer Genome Consortium/The Cancer Genome Atlas Pan-Cancer Analysis of Whole Genomes Consortium, which aggregated whole-genome sequencing data from 2,658 cancers across 38 tumor types, we performed a multidimensional, integrated characterization of mitochondrial genomes and related RNA sequencing data. Our analysis presents the most definitive mutational landscape of mitochondrial genomes and identifies several hypermutated cases. Truncating mutations are markedly enriched in kidney, colorectal and thyroid cancers, suggesting oncogenic effects with the activation of signaling pathways. We find frequent somatic nuclear transfers of mitochondrial DNA, some of which disrupt therapeutic target genes. Mitochondrial copy number varies greatly within and across cancers and correlates with clinical variables. Co-expression analysis highlights the function of mitochondrial genes in oxidative phosphorylation, DNA repair and the cell cycle, and shows their connections with clinically actionable genes. Our study lays a foundation for translating mitochondrial biology into clinical applications. Analysis of mitochondrial genomes (mtDNA) by using whole-genome sequencing data from 2,658 cancer samples across 38 cancer types identifies hypermutated mtDNA cases, frequent somatic nuclear transfer of mtDNA and high variability of mtDNA copy number in many cancers.	[Yuan, Yuan; Li, Jun; Wang, Yumeng; Weinstein, John N.; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Ju, Young Seok; Martincorena, Inigo; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Ju, Young Seok; Yoon, Christopher J.] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Kim, Youngwook] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Sch Med, Seoul, South Korea; [Wang, Yumeng; Liang, Han] Baylor Coll Med, Quantitat & Computat Biosci Grad Program, Houston, TX 77030 USA; [Yang, Yang] Univ Texas Hlth Sci Ctr Houston, Div Biostat, Sch Publ Hlth, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Duncan L Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Weinstein, John N.; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Xu, Yanxun] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA; [Han, Leng] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA; [Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Nakagawa, Hidewaki] RIKEN, Lab Canc Genom, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Park, Keunchil] Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Sch Med, Seoul, South Korea; [Campbell, Peter J.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Texas System; UTMD Anderson Cancer Center; Wellcome Trust Sanger Institute; Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Samsung Medical Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; Ewha Womans University; RIKEN; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Cambridge	Liang, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.; Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.; Liang, H (corresponding author), Baylor Coll Med, Quantitat & Computat Biosci Grad Program, Houston, TX 77030 USA.; Liang, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.; Park, K (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Sch Med, Seoul, South Korea.; Campbell, PJ (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.	kpark@skku.edu; pc8@sanger.ac.uk; hliang1@mdanderson.org	Park, Keunchil/ABD-7072-2021; Fink, Lynn/C-2031-2008; Li, Jun/AAE-4393-2022; Yakneen, Sergei/O-8928-2017; Park, Keunchil/ABD-5852-2021; Tsunoda, Tatsuhiko/K-2061-2014; Han, Leng/HCH-3491-2022; Yuan, Yuan/H-4007-2013; Ju, Young Seok/E-1324-2012	Fink, Lynn/0000-0003-2912-6048; Li, Jun/0000-0002-1171-7141; Yakneen, Sergei/0000-0001-7827-9839; Park, Keunchil/0000-0002-4846-7449; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Han, Leng/0000-0002-7380-2640; Weinstein, John/0000-0001-9401-6908; Aparicio, Samuel/0000-0002-0487-9599; Yuan, Yuan/0000-0003-4706-7897; Martincorena, Inigo/0000-0003-1122-4416; Ju, Young Seok/0000-0002-5514-4189; Yoon, Christopher/0000-0001-5714-7087	MD Anderson Cancer Center Faculty Scholar Award; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; Institute for Information and Communications Technology Promotion grant - Korean government (Ministry of Science, ICT and Future Planning) [B0101-15-0104]; Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI14C0072, HI17C1836]; Korean National Research Foundation [NRF-2016R1D1A1B03934110, NRF-2017R1A2B2012796]	MD Anderson Cancer Center Faculty Scholar Award; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; Institute for Information and Communications Technology Promotion grant - Korean government (Ministry of Science, ICT and Future Planning); Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea; Korean National Research Foundation(National Research Foundation of Korea)	This study was partially supported by an MD Anderson Cancer Center Faculty Scholar Award (to H.L.), the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine (to J.N.W.), an Institute for Information and Communications Technology Promotion grant funded by the Korean government (Ministry of Science, ICT and Future Planning) (B0101-15-0104; the development of a supercomputing system for genome analysis), the Korea Health Technology Research and Development Project (through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea) (HI14C0072 to H.-L.K. and HI17C1836 to Y.S.J.) and the Korean National Research Foundation (NRF-2016R1D1A1B03934110 and NRF-2017R1A2B2012796). We also thank the Electronics and Telecommunications Research Institute in Korea for its commitment to the ICGC PCAWG projects, the MD Anderson Cancer Center High-Performance Computing Core Facility for computing, and L. Chastain for editorial assistance. We acknowledge the contributions of the members of the many clinical networks across ICGC and TCGA who provided samples and data to the PCAWG Consortium, and the contributions of the Technical Working Group and the Germline Working Group of the PCAWG Consortium for collation, realignment and harmonized variant calling of the cancer genomes used in this study. We thank the patients and their families for participation in the individual ICGC and TCGA projects.	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Caro P, 2010, MITOCHONDRION, V10, P479, DOI 10.1016/j.mito.2010.05.004; Chen DZ, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-36; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cui HH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-110; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Dayama G, 2014, NUCLEIC ACIDS RES, V42, P12640, DOI 10.1093/nar/gku1038; Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hopkins JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00377-y; Joshi S, 2015, CELL REP, V13, P1895, DOI 10.1016/j.celrep.2015.10.059; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Ju YS, 2015, GENOME RES, V25, P814, DOI 10.1101/gr.190470.115; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koczor CA, 2009, J BIOL CHEM, V284, P36191, DOI 10.1074/jbc.M109.036020; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li YL, 2020, NATURE, V578, P112, DOI 10.1038/s41586-019-1913-9; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Simone D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-517; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Srinivasainagendra V, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0420-6; Stewart JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005333; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; van Osch FHM, 2015, CARCINOGENESIS, V36, P1502, DOI 10.1093/carcin/bgv151; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	54	126	132	18	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2020	52	3					342	+		10.1038/s41588-019-0557-x	http://dx.doi.org/10.1038/s41588-019-0557-x		FEB 2020	13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KS5DL	32024997	Green Published, hybrid, Green Submitted			2022-12-17	WOS:000511282900005
J	Liu, QZ; Liu, K; Cui, GZ; Huang, XZ; Yao, S; Guo, WK; Qin, Z; Li, Y; Yang, R; Pu, WJ; Zhang, LB; He, LJ; Zhao, H; Yu, W; Tang, MX; Tian, XY; Cai, DQ; Nie, Y; Hu, SS; Ren, T; Qiao, ZY; Huang, HF; Zeng, YA; Jing, NH; Peng, GD; Ji, HB; Zhou, B				Liu, Qiaozhen; Liu, Kuo; Cui, Guizhong; Huang, Xiuzhen; Yao, Shun; Guo, Wenke; Qin, Zhen; Li, Yan; Yang, Rui; Pu, Wenjuan; Zhang, Libo; He, Lingjuan; Zhao, Huan; Yu, Wei; Tang, Muxue; Tian, Xueying; Cai, Dongqing; Nie, Yu; Hu, Shengshou; Ren, Tao; Qiao, Zengyong; Huang, Hefeng; Zeng, Yi Arial; Jing, Naihe; Peng, Guangdun; Ji, Hongbin; Zhou, Bin			Lung regeneration by multipotent stem cells residing at the bronchioalveolar-duct junction	NATURE GENETICS			English	Article							ENDOTHELIAL-CELLS; BASAL-CELLS; PROGENITOR; AIRWAY; ALVEOLAR; REPAIR; DIFFERENTIATION; MECHANISMS; RENEWAL; IDENTIFICATION	Characterizing the stem cells responsible for lung repair and regeneration is important for the treatment of pulmonary diseases. Recently, a unique cell population located at the bronchioalveolar-duct junctions has been proposed to comprise endogenous stem cells for lung regeneration. However, the role of bronchioalveolar stem cells (BASCs) in vivo remains debated, and the contribution of such cells to lung regeneration is not known. Here we generated a genetic lineage-tracing system that uses dual recombinases (Cre and Dre) to specifically track BASCs in vivo. Fate-mapping and clonal analysis showed that BASCs became activated and responded distinctly to different lung injuries, and differentiated into multiple cell lineages including club cells, ciliated cells, and alveolar type 1 and type 2 cells for lung regeneration. This study provides in vivo genetic evidence that BASCs are bona fide lung epithelial stem cells with deployment of multipotency and self-renewal during lung repair and regeneration.	[Liu, Qiaozhen; Liu, Kuo; Cui, Guizhong; Huang, Xiuzhen; Yao, Shun; Guo, Wenke; Qin, Zhen; Li, Yan; Yang, Rui; Pu, Wenjuan; Zhang, Libo; He, Lingjuan; Zhao, Huan; Yu, Wei; Tang, Muxue; Zeng, Yi Arial; Jing, Naihe; Peng, Guangdun; Ji, Hongbin; Zhou, Bin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai, Peoples R China; [Liu, Qiaozhen; Huang, Xiuzhen; Li, Yan; Yang, Rui; Pu, Wenjuan; He, Lingjuan; Zhao, Huan; Yu, Wei; Zhou, Bin] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Guo, Wenke; Jing, Naihe; Ji, Hongbin; Zhou, Bin] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Tang, Muxue] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Tian, Xueying; Cai, Dongqing; Zhou, Bin] Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Nie, Yu; Hu, Shengshou] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Nie, Yu; Hu, Shengshou] Peking Union Med Coll, Beijing, Peoples R China; [Ren, Tao] Shanghai Jiao Tong Univ, Dept Resp Med, Affiliated Peoples Hosp 6, Shanghai, Peoples R China; [Qiao, Zengyong] Southern Med Univ, Dept Cardiovasc Med, Affiliated Fengxian Hosp, Shanghai, Peoples R China; [Huang, Hefeng] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai, Peoples R China; [Peng, Guangdun] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Peng, Guangdun] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Peng, Guangdun] Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou, Guangdong, Peoples R China; [Peng, Guangdun; Zhou, Bin] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Zhou, Bin] Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; East China Normal University; Jinan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; Southern Medical University - China; Shanghai Jiao Tong University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences; Nanjing Medical University	Peng, GD; Ji, HB; Zhou, B (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai, Peoples R China.; Zhou, B (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.; Ji, HB; Zhou, B (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Zhou, B (corresponding author), Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Peng, GD (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.; Peng, GD (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China.; Peng, GD (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab GRMH, Guangzhou, Guangdong, Peoples R China.; Peng, GD; Zhou, B (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.; Zhou, B (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing, Jiangsu, Peoples R China.	peng_guangdun@gibh.ac.cn; hbji@sibcb.ac.cn; zhoubin@sibs.ac.cn	Huang, Hefeng/ABF-1117-2020; Peng, Guangdun/AAH-9044-2019; Huang, He-Feng/AAN-7985-2020; Huang, Hefeng/AAR-7184-2021	Huang, He-Feng/0000-0003-4344-8019; Cui, Guizhong/0000-0001-6394-2773; NIE, Yu/0000-0002-8744-0046; Peng, Guangdun/0000-0002-8586-0637; Zhou, Bin/0000-0001-5278-5522	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB19000000, XDA16020204, XDA16020404, XDA16020501]; National Science Foundation of China [31730112, 91639302, 31625019, 91849202, 81761138040, 31601168, 31701292, 81872241, 31571503, 91749122, 81872132, 81430066, 31621003]; National Key Research and Development Program of China [2018YFA0107900, 2016YFC1300600, 2018YFA0108100, 2017YFC1001303, 2017YFA0505500]; Key Project of Frontier Sciences of CAS [QYZDB-SSW-SMC003]; Shanghai Science and Technology Commission [17ZR1449600, 17ZR1449800, 15XD1504000]; Shanghai Yangfan Project [16YF1413400]; China Postdoctoral Innovative Talent Support Program [BX20180338]; China Young Talents Lift Engineering [YESS20160050, 2017QNRC001]; Research Beyond Borders at Boehringer Ingelheim Pharma GmbH; Astrazeneca; Royal Society-Newton Advanced Fellowship [NA170109]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S347]; Genome Tagging Project (GTP) Center	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Key Project of Frontier Sciences of CAS; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Yangfan Project; China Postdoctoral Innovative Talent Support Program; China Young Talents Lift Engineering; Research Beyond Borders at Boehringer Ingelheim Pharma GmbH; Astrazeneca(AstraZeneca); Royal Society-Newton Advanced Fellowship; Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Genome Tagging Project (GTP) Center	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS, XDB19000000 to H.J. and B.Z.; XDA16020204 to B.Z.; XDA16020404 to G.P.; and XDA16020501 to N.J.), the National Science Foundation of China (31730112, 91639302, 31625019, 91849202 and 81761138040 to B.Z.; 31601168 to Q.L.; 31701292 and 81872241 to L.H.; and 31571503, 91749122 and 81872132 to X.T.; 81430066 and 31621003 to H.J.), the National Key Research and Development Program of China (2018YFA0107900 and 2016YFC1300600 to X.T.; 2018YFA0108100 and 2017YFC1001303 to L.H.; 2017YFA0505500 to H.J.), the Key Project of Frontier Sciences of CAS (QYZDB-SSW-SMC003), the Shanghai Science and Technology Commission (17ZR1449600 to B.Z., 17ZR1449800 to X.T., 15XD1504000 to H.J. and 15XD1504000 to B.Z.), the Shanghai Yangfan Project (16YF1413400 to L.H.), the China Postdoctoral Innovative Talent Support Program (BX20180338 to Y.L.), China Young Talents Lift Engineering (YESS20160050 to Q.L. and 2017QNRC001 to L.H.), the collaboration fund of Research Beyond Borders at Boehringer Ingelheim Pharma GmbH (B.Z.), Astrazeneca (B.Z.) and a Royal Society-Newton Advanced Fellowship (B.Z., NA170109) and the Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2017ZT07S347 to B.Z.). We thank the Shanghai Model Organisms Center, Inc. (SMOC) and Nanjing Biomedical Research Institute of Nanjing University for mouse generation. We also acknowledge technical help from L. Qiu, W. Bian, T. Zhang and members of National Center for Protein Science Shanghai for assistance in flow cytometry and microscopy and Y. Xing for antibody sharing. We thank P. Nicklin, M. Franti and W. Zhang for valuable suggestions and comments on this study. We also thank the Genome Tagging Project (GTP) Center for support.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Chen F, 2014, SCIENCE, V343, P186, DOI 10.1126/science.1241442; Chen J, 2017, NAT PROTOC, V12, P566, DOI 10.1038/nprot.2017.003; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; He LJ, 2017, J CLIN INVEST, V127, P2968, DOI 10.1172/JCI93868; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Honda H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13556; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Jain R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7727; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Liu QZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7020; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Noh MS, 2009, BIOMATERIALS, V30, P3915, DOI 10.1016/j.biomaterials.2009.03.059; Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Peng T, 2015, NATURE, V526, P578, DOI 10.1038/nature14984; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schultz CJ, 2002, AM J PHYSIOL-LUNG C, V283, pL288, DOI 10.1152/ajplung.00204.2001; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zhang H, 2016, NAT GENET, V48, P537, DOI 10.1038/ng.3536; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202; Zhang XD, 2014, INT J CLIN EXP MED, V7, P1190; Zhang XD, 2014, AM J TRANSL RES, V6, P267; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	58	126	127	5	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					728	+		10.1038/s41588-019-0346-6	http://dx.doi.org/10.1038/s41588-019-0346-6			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30778223				2022-12-17	WOS:000462767500019
J	Baud, A; Hermsen, R; Guryev, V; Stridh, P; Graham, D; McBride, MW; Foroud, T; Calderari, S; Diez, M; Ockinger, J; Beyeen, AD; Gillett, A; Abdelmagid, N; Guerreiro-Cacais, AO; Jagodic, M; Tuncel, J; Norin, U; Beattie, E; Huynh, N; Miller, WH; Koller, DL; Alam, I; Falak, S; Osborne-Pellegrin, M; Martinez-Membrives, E; Canete, T; Blazquez, G; Vicens-Costa, E; Mont-Cardona, C; Diaz-Moran, S; Tobena, A; Hummel, O; Zelenika, D; Saar, K; Patone, G; Bauerfeind, A; Bihoreau, MT; Heinig, M; Lee, YA; Rintisch, C; Schulz, H; Wheeler, DA; Worley, KC; Muzny, DM; Gibbs, RA; Lathrop, M; Lansu, N; Toonen, P; Ruzius, FP; de Bruijn, E; Hauser, H; Adams, DJ; Keane, T; Atanur, SS; Aitman, TJ; Flicek, P; Malinauskas, T; Jones, EY; Ekman, D; Lopez-Aumatell, R; Dominiczak, AF; Johannesson, M; Holmdahl, R; Olsson, T; Gauguier, D; Hubner, N; Fernandez-Teruel, A; Cuppen, E; Mott, R; Flint, J				Baud, Amelie; Hermsen, Roel; Guryev, Victor; Stridh, Pernilla; Graham, Delyth; McBride, Martin W.; Foroud, Tatiana; Calderari, Sophie; Diez, Margarita; Ockinger, Johan; Beyeen, Amennai D.; Gillett, Alan; Abdelmagid, Nada; Guerreiro-Cacais, Andre Ortlieb; Jagodic, Maja; Tuncel, Jonatan; Norin, Ulrika; Beattie, Elisabeth; Ngan Huynh; Miller, William H.; Koller, Daniel L.; Alam, Imranul; Falak, Samreen; Osborne-Pellegrin, Mary; Martinez-Membrives, Esther; Canete, Toni; Blazquez, Gloria; Vicens-Costa, Elia; Mont-Cardona, Carme; Diaz-Moran, Sira; Tobena, Adolf; Hummel, Oliver; Zelenika, Diana; Saar, Kathrin; Patone, Giannino; Bauerfeind, Anja; Bihoreau, Marie-Therese; Heinig, Matthias; Lee, Young-Ae; Rintisch, Carola; Schulz, Herbert; Wheeler, David A.; Worley, Kim C.; Muzny, Donna M.; Gibbs, Richard A.; Lathrop, Mark; Lansu, Nico; Toonen, Pim; Ruzius, Frans Paul; de Bruijn, Ewart; Hauser, Heidi; Adams, David J.; Keane, Thomas; Atanur, Santosh S.; Aitman, Tim J.; Flicek, Paul; Malinauskas, Tomas; Jones, E. Yvonne; Ekman, Diana; Lopez-Aumatell, Regina; Dominiczak, Anna F.; Johannesson, Martina; Holmdahl, Rikard; Olsson, Tomas; Gauguier, Dominique; Hubner, Norbert; Fernandez-Teruel, Alberto; Cuppen, Edwin; Mott, Richard; Flint, Jonathan		Rat Genome Sequencing Mapping Cons	Combined sequence-based and genetic mapping analysis of complex traits in outbred rats	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ABC-ME; LOCI; EXPRESSION; PHENOTYPES; ARTHRITIS; ALIGNMENT; GATA-1; RISK; QTLS	Genetic mapping on fully sequenced individuals is transforming understanding of the relationship between molecular variation and variation in complex traits. Here we report a combined sequence and genetic mapping analysis in outbred rats that maps 355 quantitative trait loci for 122 phenotypes. We identify 35 causal genes involved in 31 phenotypes, implicating new genes in models of anxiety, heart disease and multiple sclerosis. The relationship between sequence and genetic variation is unexpectedly complex: at approximately 40% of quantitative trait loci, a single sequence variant cannot account for the phenotypic effect. Using comparable sequence and mapping data from mice, we show that the extent and spatial pattern of variation in inbred rats differ substantially from those of inbred mice and that the genetic variants in orthologous genes rarely contribute to the same phenotype in both species.	[Baud, Amelie; Lopez-Aumatell, Regina; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [Hermsen, Roel; Guryev, Victor; Lansu, Nico; Toonen, Pim; Ruzius, Frans Paul; de Bruijn, Ewart; Cuppen, Edwin] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands; [Hermsen, Roel; Guryev, Victor; Lansu, Nico; Toonen, Pim; Ruzius, Frans Paul; de Bruijn, Ewart; Cuppen, Edwin] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Guryev, Victor] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands; [Stridh, Pernilla; Diez, Margarita; Ockinger, Johan; Beyeen, Amennai D.; Gillett, Alan; Abdelmagid, Nada; Guerreiro-Cacais, Andre Ortlieb; Jagodic, Maja; Olsson, Tomas] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Graham, Delyth; McBride, Martin W.; Beattie, Elisabeth; Ngan Huynh; Miller, William H.; Dominiczak, Anna F.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow Cardiovasc Res Ctr, BHF, Glasgow, Lanark, Scotland; [Foroud, Tatiana; Koller, Daniel L.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Calderari, Sophie; Gauguier, Dominique] Cordeliers Res Ctr, INSERM, Unite Mixte Rech Sci UMRS 872, Paris, France; [Tuncel, Jonatan; Norin, Ulrika; Ekman, Diana; Johannesson, Martina; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden; [Alam, Imranul] Indiana Univ Sch Med, Dept Orthoped Surg, Indianapolis, IN 46202 USA; [Falak, Samreen; Hummel, Oliver; Saar, Kathrin; Patone, Giannino; Bauerfeind, Anja; Heinig, Matthias; Lee, Young-Ae; Rintisch, Carola; Schulz, Herbert; Hubner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Osborne-Pellegrin, Mary] Hop Bichat Claude Bernard, INSERM, U698, F-75877 Paris, France; [Martinez-Membrives, Esther; Canete, Toni; Blazquez, Gloria; Vicens-Costa, Elia; Mont-Cardona, Carme; Diaz-Moran, Sira; Tobena, Adolf; Lopez-Aumatell, Regina; Fernandez-Teruel, Alberto] Univ Autonoma Barcelona, Inst Neurosci, Dept Psychiat & Forens Med, Med Psychol Unit, E-08193 Barcelona, Spain; [Zelenika, Diana; Bihoreau, Marie-Therese; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Heinig, Matthias] Max Planck Inst Mol Genet, Dept Computat Biol, D-14195 Berlin, Germany; [Lee, Young-Ae] Charite, Pediat Allergol Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Wheeler, David A.; Worley, Kim C.; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Hauser, Heidi; Adams, David J.; Keane, Thomas] Wellcome Trust Sanger Inst, Cambridge, England; [Atanur, Santosh S.; Aitman, Tim J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Physiol Genom & Med Grp,Med Res Council,Clin Sci, London, England; [Flicek, Paul] European Bioinformat Inst, Cambridge, England; [Malinauskas, Tomas; Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England; [Hubner, Norbert] DZHK German Ctr Cardiovasc Res, Berlin, Germany	University of Oxford; Wellcome Centre for Human Genetics; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; Karolinska Institutet; University of Glasgow; Indiana University System; Indiana University Bloomington; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Karolinska Institutet; Indiana University System; Indiana University Bloomington; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Autonomous University of Barcelona; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Baylor College of Medicine; Wellcome Trust Sanger Institute; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); European Molecular Biology Laboratory (EMBL); University of Oxford; Wellcome Centre for Human Genetics; German Centre for Cardiovascular Research	Fernandez-Teruel, A (corresponding author), Univ Autonoma Barcelona, Inst Neurosci, Dept Psychiat & Forens Med, Med Psychol Unit, E-08193 Barcelona, Spain.	albert.fernandez.teruel@uab.es; e.cuppen@hubrecht.eu; rmott@well.ox.ac.uk; jf@well.ox.ac.uk	Fernandez-Teruel, Alberto/F-9374-2011; Wheeler, David A/M-9740-2018; Stridh, Pernilla/J-2918-2012; Jones, Yvonne/J-2293-2016; Martinez-Membrives, Esther/L-9786-2015; johannesson, martina/F-4131-2011; Baud, Amelie/AAB-1606-2021; Cuppen, Edwin/H-2389-2016; Guerreiro-Cacais, Andre Ortlieb/AAE-8417-2019; Malinauskas, Tomas/H-3133-2012; Jones, Yvonne/N-8111-2019; Dominiczak, Anna F/P-9390-2017; Gauguier, Dominique/G-2190-2016; Cuppen, Edwin/F-5696-2011; Holmdahl, Rikard/AAI-7682-2020; tobena, adolf/G-1032-2010; Malinauskas, Tomas/AAA-9511-2020; Ockinger, Johan/F-4543-2010	Fernandez-Teruel, Alberto/0000-0001-5993-7058; Wheeler, David A/0000-0002-9056-6299; Stridh, Pernilla/0000-0003-4855-0039; Jones, Yvonne/0000-0002-3834-1893; Martinez-Membrives, Esther/0000-0001-5659-1549; johannesson, martina/0000-0002-4353-7583; Baud, Amelie/0000-0003-2448-0283; Cuppen, Edwin/0000-0002-0400-9542; Malinauskas, Tomas/0000-0002-4847-5529; Jones, Yvonne/0000-0002-3834-1893; Dominiczak, Anna F/0000-0003-4913-3608; Gauguier, Dominique/0000-0001-6156-9530; Cuppen, Edwin/0000-0002-0400-9542; Malinauskas, Tomas/0000-0002-4847-5529; Heinig, Matthias/0000-0002-5612-1720; Flint, Jonathan/0000-0002-9427-4429; Canete Ramirez, Toni/0000-0002-8950-8120; Ockinger, Johan/0000-0003-4300-3415; Adams, David/0000-0001-9490-0306; Guryev, Victor/0000-0002-5810-6022; Worley, Kim/0000-0002-0282-1000; Aitman, Timothy/0000-0002-7875-4502; Saar, Kathrin/0000-0002-4483-1557; Olsson, Tomas/0000-0002-2938-1877; Norin, Ulrika/0000-0003-1063-6339; Tobena, Adolf/0000-0001-6137-0660; Flicek, Paul/0000-0002-3897-7955; Calderari, Sophie/0000-0002-9669-681X; Mott, Richard/0000-0002-1022-9330; Abdelmagid, Nada/0000-0002-8200-347X; Guerreiro-Cacais, Andre Ortlieb/0000-0002-4561-2823; Tuncel, Jonatan/0000-0001-6749-2327	European Union [HEALTH-F4-2010-241504]; Wellcome Trust [090532/Z/09/Z, 083573/Z/07/Z, 089269/Z/09/Z]; Swedish Research Council [K2008-66X-20776-01-4]; Harald and Greta Jeanssons Foundation; Swedish Association for Persons with Neurological Disabilities; Ake Wibergs Foundation; Ake Lownertz Foundation; Karolinska Institutet funds; European Union's Sixth Framework Programme EURATools [LSHG-CT-2005-019015]; Bibbi and Nils Jensens Foundation; Soderbergs Foundation; Knut and Alice Wallenbergs Foundation; Imperial BHF Centre of Research Excellence; Prof. Nanna Svartz Foundation; Swedish Rheumatism Association; King Gustaf V 80th Anniversary Foundation; Institute of Cardiometabolism and Nutrition (ICAN) [ANR-10-IAHU-05]; Cancer Research UK [A10976]; UK Medical Research Council [G9900061]; U.S. National Institutes of Health [R01 AR047822]; MRC [MC_U120061454, G9900061, G0900084] Funding Source: UKRI; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [MC_U120061454, G9900061, G0900084] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047822] Funding Source: NIH RePORTER	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald and Greta Jeanssons Foundation; Swedish Association for Persons with Neurological Disabilities; Ake Wibergs Foundation; Ake Lownertz Foundation; Karolinska Institutet funds; European Union's Sixth Framework Programme EURATools; Bibbi and Nils Jensens Foundation; Soderbergs Foundation; Knut and Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Imperial BHF Centre of Research Excellence; Prof. Nanna Svartz Foundation; Swedish Rheumatism Association; King Gustaf V 80th Anniversary Foundation; Institute of Cardiometabolism and Nutrition (ICAN); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to T. Serikawa (Kyoto University) for the LE/Stm BAC clones. The Human Genome Sequencing Center sequence production teams at the Baylor College of Medicine produced the Sanger sequencing data for the eight sequenced strains used to define the RATDIV SNP genotyping array (see ref. 8 for a list of Baylor College of Medicine HGSC sequencing contributors). We thank E. Redei for providing the NIH-HS rat colony. The funders we would like to acknowledge are as follows: the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement HEALTH-F4-2010-241504 (EURATRANS); The Wellcome Trust (090532/Z/09/Z, 083573/Z/07/Z, 089269/Z/09/Z); The Swedish Research Council (grant K2008-66X-20776-01-4); the Harald and Greta Jeanssons Foundation; The Swedish Association for Persons with Neurological Disabilities; the Ake Wibergs Foundation; the Ake Lownertz Foundation; Karolinska Institutet funds; the European Union's Sixth Framework Programme EURATools (grant LSHG-CT-2005-019015); the Bibbi and Nils Jensens Foundation; the Soderbergs Foundation; and the Knut and Alice Wallenbergs Foundation. We also thank the Ministerio de Ciencia e Innovacion (reference PSI2009-10532 and the Formacion de Personal Investigador fellowship to C. M.-C.); the Fundacio La Marato TV3 (reference 092630); the Direccio General de la Recerca (reference 2009SGR-0051); and the British Heart Foundation (BHFRG/07/005/23633). T.J.A. and S. S. A. acknowledge funding from the Imperial BHF Centre of Research Excellence. M. Johannesson acknowledges support from Prof. Nanna Svartz Foundation, The Swedish Rheumatism Association and The King Gustaf V 80th Anniversary Foundation. D. Gauguier acknowledges support from the Institute of Cardiometabolism and Nutrition (ICAN; ANR-10-IAHU-05). T. M. and E.Y.J. acknowledge support from Cancer Research UK (A10976) and the UK Medical Research Council (G9900061). T. F., D. L. K. and I. A. acknowledge support from the U.S. National Institutes of Health (R01 AR047822).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brenner M, 2007, MOL MED, V13, P277, DOI 10.2119/2007-00003.Brenner; Chang SJ, 2008, J IMMUNOL, V181, P8372, DOI 10.4049/jimmunol.181.12.8372; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Fiddy S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-210; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Hyde BB, 2012, CELL DEATH DIFFER, V19, P1117, DOI 10.1038/cdd.2011.195; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jagodic M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000278; Johannesson M, 2009, GENOME RES, V19, P150, DOI 10.1101/gr.081497.108; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mayosi BM, 2003, EUR J HUM GENET, V11, P395, DOI 10.1038/sj.ejhg.5200967; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; *R COR DEV TEAM, 2004, LANG ENV STAT COMP; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Serikawa T, 2009, EXP ANIM TOKYO, V58, P333, DOI 10.1538/expanim.58.333; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; WALLSTROM EOT, 2007, SOURCEBOOK MODELS BI, P547; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085	46	126	126	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2013	45	7					767	+		10.1038/ng.2644	http://dx.doi.org/10.1038/ng.2644			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23708188	Green Accepted, Green Published			2022-12-17	WOS:000321005200011
J	Su, Z; Gay, LJ; Strange, A; Palles, C; Band, G; Whiteman, DC; Lescai, F; Langford, C; Nanji, M; Edkins, S; van der Winkel, A; Levine, D; Sasieni, P; Bellenguez, C; Howarth, K; Freeman, C; Trudgill, N; Tucker, AT; Pirinen, M; Peppelenbosch, MP; van der Laan, LJW; Kuipers, EJ; Drenth, JPH; Peters, WH; Reynolds, JV; Kelleher, DP; McManus, R; Grabsch, H; Prenen, H; Bisschops, R; Krishnadath, K; Siersema, PD; van Baal, JWPM; Middleton, M; Petty, R; Gillies, R; Burch, N; Bhandari, P; Paterson, S; Edwards, C; Penman, I; Vaidya, K; Ang, Y; Murray, I; Patel, P; Ye, WM; Mullins, P; Wu, AH; Bird, NC; Dallal, H; Shaheen, NJ; Murray, LJ; Koss, K; Bernstein, L; Romero, Y; Hardie, LJ; Zhang, R; Winter, H; Corley, DA; Panter, S; Risch, HA; Reid, BJ; Sargeant, I; Gammon, MD; Smart, H; Dhar, A; McMurtry, H; Ali, H; Liu, G; Casson, AG; Chow, WH; Rutter, M; Tawil, A; Morris, D; Nwokolo, C; Isaacs, P; Rodgers, C; Ragunath, K; MacDonald, C; Haigh, C; Monk, D; Davies, G; Wajed, S; Johnston, D; Gibbons, M; Cullen, S; Church, N; Langley, R; Griffin, M; Alderson, D; Deloukas, P; Hunt, SE; Gray, E; Dronov, S; Potter, SC; Tashakkori-Ghanbaria, A; Anderson, M; Brooks, C; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Markus, HS; Mathew, CG; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, N; Trynka, G; Wijmenga, C; Cazier, JB; Atherfold, P; Nicholson, AM; Gellatly, NL; Glancy, D; Cooper, SC; Cunningham, D; Lind, T; Hapeshi, J; Ferry, D; Rathbone, B; Brown, J; Love, S; Attwood, S; MacGregor, S; Watson, P; Sanders, S; Ek, W; Harrison, RF; Moayyedi, P; de Caestecker, J; Barr, H; Stupka, E; Vaughan, TL; Peltonen, L; Spencer, CCA; Tomlinson, I; Donnelly, P; Jankowski, JAZ				Su, Zhan; Gay, Laura J.; Strange, Amy; Palles, Claire; Band, Gavin; Whiteman, David C.; Lescai, Francesco; Langford, Cordelia; Nanji, Manoj; Edkins, Sarah; van der Winkel, Anouk; Levine, David; Sasieni, Peter; Bellenguez, Celine; Howarth, Kimberley; Freeman, Colin; Trudgill, Nigel; Tucker, Art T.; Pirinen, Matti; Peppelenbosch, Maikel P.; van der Laan, Luc J. W.; Kuipers, Ernst J.; Drenth, Joost P. H.; Peters, Wilbert H.; Reynolds, John V.; Kelleher, Dermot P.; McManus, Ross; Grabsch, Heike; Prenen, Hans; Bisschops, Raf; Krishnadath, Kausila; Siersema, Peter D.; van Baal, Jantine W. P. M.; Middleton, Mark; Petty, Russell; Gillies, Richard; Burch, Nicola; Bhandari, Pradeep; Paterson, Stuart; Edwards, Cathryn; Penman, Ian; Vaidya, Kishor; Ang, Yeng; Murray, Iain; Patel, Praful; Ye, Weimin; Mullins, Paul; Wu, Anna H.; Bird, Nigel C.; Dallal, Helen; Shaheen, Nicholas J.; Murray, Liam J.; Koss, Konrad; Bernstein, Leslie; Romero, Yvonne; Hardie, Laura J.; Zhang, Rui; Winter, Helen; Corley, Douglas A.; Panter, Simon; Risch, Harvey A.; Reid, Brian J.; Sargeant, Ian; Gammon, Marilie D.; Smart, Howard; Dhar, Anjan; McMurtry, Hugh; Ali, Haythem; Liu, Geoffrey; Casson, Alan G.; Chow, Wong-Ho; Rutter, Matt; Tawil, Ashref; Morris, Danielle; Nwokolo, Chuka; Isaacs, Peter; Rodgers, Colin; Ragunath, Krish; MacDonald, Chris; Haigh, Chris; Monk, David; Davies, Gareth; Wajed, Saj; Johnston, David; Gibbons, Michael; Cullen, Sue; Church, Nicholas; Langley, Ruth; Griffin, Michael; Alderson, Derek; Deloukas, Panos; Hunt, Sarah E.; Gray, Emma; Dronov, Serge; Potter, Simon C.; Tashakkori-Ghanbaria, Avazeh; Anderson, Mark; Brooks, Claire; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Markus, Hugh S.; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas; Trynka, Gosia; Wijmenga, Cisca; Cazier, Jean-Baptiste; Atherfold, Paul; Nicholson, Anna M.; Gellatly, Nichola L.; Glancy, Deborah; Cooper, Sheldon C.; Cunningham, David; Lind, Tore; Hapeshi, Julie; Ferry, David; Rathbone, Barrie; Brown, Julia; Love, Sharon; Attwood, Stephen; MacGregor, Stuart; Watson, Peter; Sanders, Scott; Ek, Weronica; Harrison, Rebecca F.; Moayyedi, Paul; de Caestecker, John; Barr, Hugh; Stupka, Elia; Vaughan, Thomas L.; Peltonen, Leena; Spencer, Chris C. A.; Tomlinson, Ian; Donnelly, Peter; Jankowski, Janusz A. Z.		Esophageal Adenocarcinoma Genetics; Wellcome Trust Case Control Consor	Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus	NATURE GENETICS			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK-FACTORS; ADENOCARCINOMA; CANCER; MANAGEMENT; MORTALITY; DIAGNOSIS; GENETICS	Barrett's esophagus is an increasingly common disease that is strongly associated with reflux of stomach acid and usually a hiatus hernia, and it strongly predisposes to esophageal adenocarcinoma (EAC), a tumor with a very poor prognosis. We report the first genome-wide association study on Barrett's esophagus, comprising 1,852 UK cases and 5,172 UK controls in the discovery stage and 5,986 cases and 12,825 controls in the replication stage. Variants at two loci were associated with disease risk: chromosome 6p21, rs9257809 (P-combined = 4.09 x 10(-9); odds ratio (OR) = 1.21, 95% confidence interval (CI) = 1.13-1.28), within the major histocompatibility complex locus, and chromosome 16q24, rs9936833 (P-combined = 2.74 x 10(-10); OR = 1.14, 95% CI = 1.10-1.19), for which the closest protein-coding gene is FOXF1, which is implicated in esophageal development and structure. We found evidence that many common variants of small effect contribute to genetic susceptibility to Barrett's esophagus and that SNP alleles predisposing to obesity also increase risk for Barrett's esophagus.	[Gay, Laura J.; Nanji, Manoj; Nicholson, Anna M.; Gellatly, Nichola L.; Stupka, Elia; Jankowski, Janusz A. Z.] Queen Mary Univ London, Ctr Digest Dis, Blizard Inst, London, England; [Su, Zhan; Strange, Amy; Palles, Claire; Band, Gavin; Bellenguez, Celine; Howarth, Kimberley; Freeman, Colin; Pirinen, Matti; Rautanen, Anna; Cazier, Jean-Baptiste; Spencer, Chris C. A.; Tomlinson, Ian; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford, England; [Palles, Claire; Tomlinson, Ian] Oxford Natl Inst Hlth Res, Comprehens Biomed Res Ctr, Oxford, England; [Whiteman, David C.; MacGregor, Stuart; Ek, Weronica] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Lescai, Francesco; Stupka, Elia] UCL, Inst Canc, London, England; [Langford, Cordelia; Edkins, Sarah; Deloukas, Panos; Hunt, Sarah E.; Gray, Emma; Dronov, Serge; Potter, Simon C.; Tashakkori-Ghanbaria, Avazeh] Wellcome Trust Sanger Inst, Cambridge, England; [van der Winkel, Anouk; Peppelenbosch, Maikel P.; Kuipers, Ernst J.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Levine, David; Zhang, Rui] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Sasieni, Peter] Barts & London Queen Marys Sch Med & Dent, Ctr Canc Prevent, Wolfson Inst Prevent Med, London, England; [Trudgill, Nigel; Cooper, Sheldon C.] Sandwell Gen Hosp, Dept Gastroenterol, Lyndon, England; [Tucker, Art T.] Queen Mary Univ London, Ctr Clin Pharmacol, William Harvey Res Inst, London, England; [van der Laan, Luc J. W.] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Drenth, Joost P. H.; Peters, Wilbert H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Reynolds, John V.] St James Hosp, Dept Surg, Inst Mol Med, Dublin 8, Ireland; [Reynolds, John V.; Kelleher, Dermot P.; McManus, Ross] Trinity Coll Dublin, Dublin, Ireland; [Kelleher, Dermot P.; McManus, Ross] St James Hosp, Inst Mol Med, Dept Clin Med, Dublin 8, Ireland; [Grabsch, Heike] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Pathol & Tumour Biol, Leeds, W Yorkshire, England; [Prenen, Hans; Bisschops, Raf] Univ Hosp Gasthuisberg, Dept Digest Oncol, B-3000 Louvain, Belgium; [Krishnadath, Kausila] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Siersema, Peter D.; van Baal, Jantine W. P. M.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Middleton, Mark; Gillies, Richard; Jankowski, Janusz A. Z.] Univ Oxford, Dept Med Oncol, Churchill Hosp, Oxford, England; [Petty, Russell] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen, Scotland; [Burch, Nicola; Glancy, Deborah; Rathbone, Barrie; Jankowski, Janusz A. Z.] Leicester Royal Infirm, Ctr Digest Dis, Leicester, Leics, England; [Bhandari, Pradeep] Queen Alexandra Hosp, Gastroenterol & Hepatol Serv, Portsmouth, Hants, England; [Paterson, Stuart] Forth Valley Royal Hosp, Dept Gastroenterol, Larbert, England; [Edwards, Cathryn] Torbay Hosp, Dept Gastroenterol, Torquay, England; [Penman, Ian] Western Gen Hosp, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Penman, Ian] Royal Infirm Edinburgh NHS Trust, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Vaidya, Kishor] Victoria Hosp, Gastrointestinal Unit, Kirkcaldy, England; [Ang, Yeng] Natl Hlth Serv NHS Trust, Dept Gastroenterol, Royal Albert Edward Infirm, Wigan, England; [Murray, Iain] Royal Cornwall Hosp, Dept Gastroenterol, Truro, England; [Patel, Praful] Southampton Univ Hosp, NHS Trust, Dept Gastroenterol, Southampton, Hants, England; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mullins, Paul] NHS Trust Royal Blackburn Hosp, E Lancashire Hosp, Dept Gastroenterol, Blackburn, Lancs, England; [Wu, Anna H.] Univ So Calif, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Bird, Nigel C.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Dallal, Helen] S Tees NHS Fdn Trust, Middlesbrough, Cleveland, England; [Shaheen, Nicholas J.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Murray, Liam J.] Queens Univ, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Koss, Konrad] Macclesfield Gen Hosp, Dept Gastroenterol, Macclesfield, Cheshire, England; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Winter, Helen] Great Western Hosp, Dept Oncol, Swindon, Wilts, England; [Corley, Douglas A.] Kaiser Permanente, Oakland Med Ctr, Div Res, Oakland, CA USA; [Panter, Simon] S Tyneside Dist Hosp, Dept Gastroenterol, S Shields, England; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Sargeant, Ian] Lister Hosp, Gastroenterol & Hepatol Serv, London, England; [Gammon, Marilie D.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Smart, Howard] Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool, Merseyside, England; [Smart, Howard] Royal Liverpool Univ Hosp, Dept Hepatol, Liverpool, Merseyside, England; [Dhar, Anjan] Cty Durham & Darlington NHS Fdn Trust, Darlington, Durham, England; [McMurtry, Hugh] Lancashire Teaching Hosp NHS Fdn Trust, Chorley, England; [Ali, Haythem] Maidstone Hlth Author, Dept Surg, Maidstone, Kent, England; [Liu, Geoffrey] Univ Toronto, Dept Med, Princess Margaret Hosp, Univ Hlth Network,Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Liu, Geoffrey] Univ Toronto, Dept Med Biophys, Princess Margaret Hosp, Univ Hlth Network,Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Liu, Geoffrey] Univ Toronto, Div Epidemiol, Princess Margaret Hosp, Univ Hlth Network,Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Chow, Wong-Ho] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Rutter, Matt] Univ Hosp N Tees, Dept Gastroenterol, Stockton On Tees, England; [Tawil, Ashref] N Devon Dist Hosp, Gastroenterol & Hepatol Serv, Barnstaple, England; [Morris, Danielle] E&N Herts NHS Trust, Queen Elizabeth Hosp, Dept Gastroenterol, Welwyn Garden City, Herts, England; [Nwokolo, Chuka] Univ Hosp Coventry, Dept Gastroenterol, Coventry, W Midlands, England; [Isaacs, Peter] Blackpool Victoria Hosp, Gastroenterol & Hepatol Serv, Blackpool, England; [Rodgers, Colin] Antrim & Whiteabbey United Hosp, Dept Gastroenterol, Whiteabbey, Antrim, North Ireland; [Ragunath, Krish] Queens Med Ctr, Wolfson Digest Dis Ctr, Nottingham NG7 2UH, England; [MacDonald, Chris] Cumberland Infirm, Gastroenterol Clin, Carlisle, England; [Haigh, Chris] Wansbeck Gen Hosp, Dept Gastroenterol, Ashington, England; [Monk, David] Countess Chester Hosp, Dept Gen Surg, Chester, Cheshire, England; [Davies, Gareth] Harrogate Dist Hosp, Gastroenterol & Hepatol Serv, Harrogate, England; [Wajed, Saj] Royal Devon & Exeter NHS Fdn Trust, Dept Thorac & Upper Gastrointestinal Surg, Exeter, Devon, England; [Johnston, David] Ninewells Hosp, Dept Gastroenterol, Dundee DD1 9SY, Scotland; [Gibbons, Michael] Craigavon Area Hosp, Dept Gastroenterol, Craigavon, England; [Cullen, Sue] Wycombe Hosp, Dept Gastroenterol, High Wycombe, Bucks, England; [Church, Nicholas] Royal Edinburgh Infirm, Ctr Liver & Digest Dis, Edinburgh, Midlothian, Scotland; [Langley, Ruth] MRC, Clin Trials Unit, London, England; [Griffin, Michael] Royal Victoria Infirm, No Osophago Gastirc Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Alderson, Derek] Univ Birmingham, Queen Elizabeth Hosp, Acad Dept Surg, Sch Canc Sci,Coll Med & Dent Sci, Birmingham B15 2TH, W Midlands, England; [Anderson, Mark] City Hosp Birmingham, Gastrointestinal Unit, Birmingham, W Midlands, England; [Brooks, Claire] Univ Oxford, Dept Oncol, Oncol Clin Trials Off, Oxford, England; [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Bramon, Elvira] Kings Coll London, Dept Psychoisis Studies, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth,Inst Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Corvin, Aiden] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Markus, Hugh S.] St Georges Univ London, Ctr Clin Neurosci, London, England; [Mathew, Christopher G.; Trembath, Richard C.] Guys Hosp, Dept Med & Mol Genet, Kings Coll London, London SE1 9RT, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas] UCL, Dept Mol Neurosci, Inst Neurol, London, England; [Trynka, Gosia; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Trynka, Gosia; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Atherfold, Paul] UCB Pharma, Slough, Berks, England; [Atherfold, Paul] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Cunningham, David] Royal Marsden Hosp, Gastrointestinal Unit, London SW3 6JJ, England; [Lind, Tore] AstraZeneca, Res & Dev, Lund, Sweden; [Hapeshi, Julie] Gloucestershire Royal Hosp, Gloucestershire Res & Dev Support Unit, Gloucester GL1 3NN, England; [Ferry, David] Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Dept Oncol, Wolverhampton, W Midlands, England; [Brown, Julia] Leeds Inst Mol Med, Clin Trial Res Unit, Leeds, W Yorkshire, England; [Love, Sharon] Ctr Stat Med, Oxford Clin Trials Res Unit, Oxford, England; [Sanders, Scott] Warwick Hosp, Dept Cellular Pathol, Warwick, England; [Harrison, Rebecca F.] Leicester Royal Infirm, Dept Pathol, Leicester LE2 7LX, Leics, England; [Moayyedi, Paul] McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada; [de Caestecker, John] Leicester Gen Hosp, Dept Gastroenterol, Leicester LE5 4PW, Leics, England; [Barr, Hugh] Gloucestershire Royal Hosp, Dept Upper Gastrointestinal Surg, Gloucester GL1 3NN, England; [Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Jankowski, Janusz A. Z.] Univ Oxford, Gastrointestinal Canc Grp, Oxford, England	University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; QIMR Berghofer Medical Research Institute; University of London; University College London; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of London; Queen Mary University London; University of London; Queen Mary University London; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Saint James's University Hospital; University of Leeds; KU Leuven; University Hospital Leuven; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Aberdeen; University of Leicester; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Cornwall Hospital; University of Southampton; Karolinska Institutet; University of Southern California; University of Sheffield; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Queens University Belfast; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Mayo Clinic; University of Leeds; Kaiser Permanente; Yale University; Fred Hutchinson Cancer Center; Lister Hospital; University of North Carolina; University of North Carolina Chapel Hill; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University Hospital of North Tees; University of Warwick; University of Nottingham; University of Exeter; University of Dundee; Royal Infirmary of Edinburgh; Medical Research Council Clinical Trials Unit; Newcastle University - UK; University of Birmingham; University of Oxford; Telethon Kids Institute; University of Western Australia; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; University of Queensland; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Trinity College Dublin; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Groningen; University of Groningen; UCB Pharma SA; University of Oxford; Royal Marsden NHS Foundation Trust; AstraZeneca; Gloucestershire Royal Hospital; New Cross Hospital; University of Leeds; University of Oxford; University of Leicester; McMaster University; University Hospitals of Leicester NHS Trust; Leicester General Hospital; Gloucestershire Royal Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fred Hutchinson Cancer Center; University of Oxford; University of Oxford	Jankowski, JAZ (corresponding author), Queen Mary Univ London, Ctr Digest Dis, Blizard Inst, London, England.	iant@well.ox.ac.uk; donnelly@well.ox.ac.uk; j.a.jankowski@qmul.ac.uk	van der Laan, Luc/M-5495-2019; Siersema, Peter/V-1636-2019; Moayyedi, Paul/M-6178-2014; Bramon, Elvira/HHC-3809-2022; McManus, Ross/AAE-9236-2020; Drenth, J.P.H./H-8025-2014; Cazier, Jean-Baptiste/GLR-2949-2022; Deloukas, Panos/B-2922-2013; Whiteman, David C/P-2728-2014; Bellenguez, Céline/X-4004-2019; Kuipers, Ernst J/H-3293-2019; Peters, W.H.M./L-4572-2015; Peppelenbosch, Maikel P./U-5304-2019; Drenth, Joost/V-7436-2019; Macgregor, Stuart/C-6442-2009; Wijmenga, Cisca/D-2173-2009; Palmer, Colin NA/C-7053-2008; Shaheen, Nicholas J/A-1898-2013; Brown, Matthew A/E-5749-2010; Mathew, Christopher G/G-3434-2015; Rutter, Michael/C-8570-2013; Bramon, Elvira/A-9463-2011; Belllenguez, Céline/Y-3183-2018; Jankowski, Janusz/H-2706-2012; Blackwell, Jenefer M/H-3015-2015; Hardie, Laura/AAY-6724-2020; Liu, Geoffrey/N-4421-2016; Reid, Brian John/AFT-8587-2022; Wijmenga, Cisca/AAE-7719-2019; Barr, Hugh/G-4673-2014; Cazier, Jean-Baptiste/F-2369-2010; Wood, Nicholas/C-2505-2009	van der Laan, Luc/0000-0002-0651-5334; Moayyedi, Paul/0000-0002-3616-9292; Bramon, Elvira/0000-0003-1369-5983; Cazier, Jean-Baptiste/0000-0001-7581-9051; Deloukas, Panos/0000-0001-9251-070X; Whiteman, David C/0000-0003-2563-9559; Bellenguez, Céline/0000-0002-1240-7874; Kuipers, Ernst J/0000-0002-0633-3098; Macgregor, Stuart/0000-0001-6731-8142; Palmer, Colin NA/0000-0002-6415-6560; Brown, Matthew A/0000-0003-0538-8211; Mathew, Christopher G/0000-0003-4178-1838; Belllenguez, Céline/0000-0002-1240-7874; Jankowski, Janusz/0000-0003-2130-9181; Hardie, Laura/0000-0001-5039-2100; Reid, Brian John/0000-0002-9613-979X; Wijmenga, Cisca/0000-0002-5635-1614; Barr, Hugh/0000-0002-2919-5660; Cazier, Jean-Baptiste/0000-0001-7581-9051; McManus, Ross/0000-0002-0529-9617; Trynka, Gosia/0000-0002-6955-9529; Donnelly, Peter/0000-0001-9495-3408; Trembath, Richard/0000-0003-0550-3400; Cunningham, David/0000-0001-5158-1069; Corvin, Aiden/0000-0001-6717-4089; Hunt, Sarah/0000-0002-8350-1235; Palles, Claire/0000-0002-9670-2263; Wajed, Shahjehan/0000-0002-8767-0490; Lescai, Francesco/0000-0002-6399-9101; Murray, Iain/0000-0002-1795-3647; Cooper, Sheldon/0000-0003-3621-4345; Pirinen, Matti/0000-0002-1664-1350; Ghanbarian, Avazeh/0000-0003-3920-5807; Plomin, Robert/0000-0002-0756-3629; Reynolds, John V/0000-0002-5501-9521; Prenen, Hans/0000-0001-8802-7352; Liu, Geoffrey/0000-0002-2603-7296; Bisschops, Raf/0000-0002-9994-8226; Wood, Nicholas/0000-0002-9500-3348; Stupka, Elia/0000-0003-3154-4011; Sasieni, Peter/0000-0003-1509-8744; Peppelenbosch, Maikel/0000-0001-9112-6028; Love, Sharon/0000-0002-6695-5390; Ang, Yeng/0000-0003-0496-6710; bhandari, pradeep/0000-0002-1241-2083; de Caestecker, John/0000-0001-5526-8176; Ragunath, Krish/0000-0001-6571-5435; Walters, James/0000-0002-6980-4053	WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Wellcome Trust [072894/Z/03/Z, 090532/Z/09/Z, 075491/Z/04/B, 068545/Z/02]; Wolfson-Royal Society Merit Award; Australian Research Council; Australian National Health & Medical Research Council (NHMRC) Career Development Award; Wellcome Trust Fellowship [097364/Z/11/Z]; UK Medical Research Council [G0000934]; UK National Blood Service controls; Esophageal Adenocarcinoma GenE Consortia incorporating the ChOPIN project [C548/A5675]; AspECT [HDRMJQ0]; BOSS clinical trials project [MGAG1G7R]; Cancer Research UK (AspECT) [C548/A4584, D9612L00090]; Histological AssessmeNt Determining EpitheliaL Response (HANDEL) [C548/A9085]; AstraZeneca UK educational grant; University Hospitals of Leicester R and D grant; US National Institutes of Health [R01CA13672501]; Health Research Board and the Wellcome Trust; Science Foundation Ireland [09/IN.1/B2640]; NATIONAL CANCER INSTITUTE [R01CA072866, R01CA136725, K05CA124911, P01CA091955, P30CA015704] Funding Source: NIH RePORTER; MRC [G0901310, G0000934] Funding Source: UKRI; Medical Research Council [G0901310, G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, NF-SI-0611-10065, PDA/02/06/016, 05/12/01] Funding Source: researchfish; Chief Scientist Office [ETM/116, CZB/4/747] Funding Source: researchfish	WTCCC2 project; Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson-Royal Society Merit Award(Royal Society of London); Australian Research Council(Australian Research Council); Australian National Health & Medical Research Council (NHMRC) Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Fellowship(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Blood Service controls; Esophageal Adenocarcinoma GenE Consortia incorporating the ChOPIN project; AspECT; BOSS clinical trials project; Cancer Research UK (AspECT); Histological AssessmeNt Determining EpitheliaL Response (HANDEL); AstraZeneca UK educational grant(AstraZeneca); University Hospitals of Leicester R and D grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Board and the Wellcome Trust; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	We acknowledge the individuals with Barrett's esophagus who participated in the study and the physicians who helped in recruitment. We thank the many research nurses who also helped recruit, including S. Prew. We thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, A. Wilk, C. R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We also thank J. Barrett for design of the Immunochip array. Funding for this study was provided by the WTCCC2 project (085475/B/08/Z and 085475/Z/08/Z) and the Wellcome Trust (072894/Z/03/Z, 090532/Z/09/Z and 075491/Z/04/B). P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. D.C.W. is supported by a Future Fellowship from the Australian Research Council. S.M. is supported by an Australian National Health & Medical Research Council (NHMRC) Career Development Award. C.C.A.S. was supported by a Wellcome Trust Fellowship (097364/Z/11/Z). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the UK Medical Research Council (grant G0000934) and the Wellcome Trust (grant 068545/Z/02), the UK National Blood Service controls, funded by the Wellcome Trust, and the People of the British Isles collection, funded by the Wellcome Trust. This work was also supported by the Esophageal Adenocarcinoma GenE Consortia incorporating the ChOPIN project (grant C548/A5675) and Inherited Predisposition of neoplasia analysis of genomic DNA (IPOD) from AspECT and BOSS clinical trials project (grant MGAG1G7R); Cancer Research UK (AspECT, grants C548/A4584 and D9612L00090, and Histological AssessmeNt Determining EpitheliaL Response (HANDEL), grant C548/A9085); AstraZeneca UK educational grant; University Hospitals of Leicester R and D grant; and AspECT (T91 5211 University of Oxford grant HDRMJQ0). The Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS) within the BEACON Consortium was supported by US National Institutes of Health grant R01CA13672501. We acknowledge the Dublin Centre for Clinical Research (funded by the Health Research Board and the Wellcome Trust) for support in sample collection and the Irish Blood Transfusion Service and TCD DNA Biobank for provision of control samples. R.M. is supported by the Science Foundation Ireland grant 09/IN.1/B2640.	Akiyama T, 2011, DIGESTION, V83, P142, DOI 10.1159/000321810; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Bennett C, 2012, GASTROENTEROLOGY, V143, P336, DOI 10.1053/j.gastro.2012.04.032; Chak A, 2002, GUT, V51, P323, DOI 10.1136/gut.51.3.323; Chak A, 2006, CANCER EPIDEM BIOMAR, V15, P1668, DOI 10.1158/1055-9965.EPI-06-0293; Corley DA, 2001, INT J EPIDEMIOL, V30, P1415, DOI 10.1093/ije/30.6.1415; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Drovdlic CM, 2003, J MED GENET, V40, P651, DOI 10.1136/jmg.40.9.651; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000694; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jankowski J, 2006, BRIT MED J, V332, P1512, DOI 10.1136/bmj.332.7556.1512; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5; Jankowski JA, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31599; Jankowski J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4551; Koek GH, 2008, GUT, V57, P1056, DOI 10.1136/gut.2006.119206; Kulig M, 2004, J CLIN EPIDEMIOL, V57, P580, DOI 10.1016/j.jclinepi.2003.10.010; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Martin V, 2010, PEDIATR SURG INT, V26, P769, DOI 10.1007/s00383-010-2622-5; Moayyedi P, 2008, ALIMENT PHARM THERAP, V27, P316, DOI 10.1111/j.1365-2036.2007.03582.x; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Robertson EV, 2008, AM J GASTROENTEROL, V103, P443, DOI 10.1111/j.1572-0241.2007.01574.x; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shalauta MD, 2004, AM FAM PHYSICIAN, V69, P2113; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Shepherd N.A., 2005, REPORT WORKING PARTY, P1; Sikkema M, 2010, CLIN GASTROENTEROL H, V8, P235, DOI 10.1016/j.cgh.2009.10.010; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Sun XQ, 2010, CANCER EPIDEM BIOMAR, V19, P666, DOI 10.1158/1055-9965.EPI-09-1136; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Thomas T, 2007, ALIMENT PHARM THER, V26, P1465, DOI 10.1111/j.1365-2036.2007.03528.x; Trudgill NJ, 1999, AM J GASTROENTEROL, V94, P1172, DOI 10.1016/S0002-9270(99)00116-1; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Winberg H, 2012, SCAND J GASTROENTERO, V47, P397, DOI 10.3109/00365521.2012.667145; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127	47	126	127	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1131	+		10.1038/ng.2408	http://dx.doi.org/10.1038/ng.2408			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22961001	Green Submitted, Green Accepted			2022-12-17	WOS:000309550200014
J	Zhang, FR; Liu, H; Chen, SM; Low, H; Sun, LD; Cui, Y; Chu, TS; Li, Y; Fu, X; Yu, YX; Yu, GQ; Shi, BQ; Tian, HQ; Liu, DC; Yu, XL; Li, JH; Lu, N; Bao, FF; Yuan, CY; Liu, J; Liu, HX; Zhang, L; Sun, YH; Chen, MF; Yang, Q; Yang, HT; Yang, RD; Zhang, LH; Wang, Q; Liu, H; Zuo, FG; Zhang, HZ; Khor, CC; Hibberd, ML; Yang, S; Liu, JJ; Zhang, XJ				Zhang, Furen; Liu, Hong; Chen, Shumin; Low, Huiqi; Sun, Liangdan; Cui, Yong; Chu, Tongsheng; Li, Yi; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Shi, Benqing; Tian, Hongqing; Liu, Dianchang; Yu, Xiulu; Li, Jinghui; Lu, Nan; Bao, Fangfang; Yuan, Chunying; Liu, Jian; Liu, Huaxu; Zhang, Lin; Sun, Yonghu; Chen, Mingfei; Yang, Qing; Yang, Haitao; Yang, Rongde; Zhang, Lianhua; Wang, Qiang; Liu, Hong; Zuo, Fuguang; Zhang, Haizhen; Khor, Chiea Chuen; Hibberd, Martin L.; Yang, Sen; Liu, Jianjun; Zhang, Xuejun			Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; METAANALYSIS; VARIANTS	We performed a genome-wide association study with 706 individuals with leprosy and 5,581 control individuals and replicated the top 24 SNPs in three independent replication samples, including a total of 3,301 individuals with leprosy and 5,299 control individuals from China. Two loci not previously associated with the disease were identified with genome-wide significance: rs2275606 (combined P = 3.94 x 10(-14), OR = 1.30) on 6q24.3 and rs3762318 (combined P = 3.27 x 10(-11), OR = 0.69) on 1p31.3. These associations implicate IL23R and RAB32 as new susceptibility genes for leprosy. Furthermore, we identified evidence of interaction between the NOD2 and RIPK2 loci, which is consistent with the biological association of the proteins encoded by these genes (NOD2-RIPK2 complex) in activating the NF-kappa B pathway as a part of the host defense response to infection. Our findings have expanded the biological functions of IL23R by uncovering its involvement in infectious disease susceptibility and suggest a potential involvement of autophagocytosis in leprosy pathogenesis. The IL23R association supports previous observations of the marked overlap of susceptibility genes for leprosy and Crohn's disease, implying common pathogenesis mechanisms.	[Zhang, Furen; Liu, Hong; Chen, Shumin; Chu, Tongsheng; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Liu, Dianchang; Yu, Xiulu; Li, Jinghui; Lu, Nan; Bao, Fangfang; Yuan, Chunying; Liu, Jian; Liu, Huaxu; Zhang, Lin; Sun, Yonghu; Chen, Mingfei; Yang, Qing; Liu, Hong; Zuo, Fuguang; Zhang, Haizhen; Liu, Jianjun] Prov Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Zhang, Furen; Shi, Benqing; Tian, Hongqing] Shandong Univ, Shandong Prov Hosp Skin Dis, Jinan 250100, Peoples R China; [Zhang, Furen; Liu, Hong; Chen, Shumin; Chu, Tongsheng; Fu, Xi'an; Yu, Yongxiang; Yu, Gongqi; Liu, Dianchang; Yu, Xiulu; Li, Jinghui; Lu, Nan; Bao, Fangfang; Yuan, Chunying; Liu, Jian; Liu, Huaxu; Zhang, Lin; Sun, Yonghu; Chen, Mingfei; Yang, Qing; Liu, Hong; Zuo, Fuguang; Zhang, Haizhen] Shandong Prov Key Lab Dermatovenereol, Jinan, Peoples R China; [Zhang, Furen; Shi, Benqing; Tian, Hongqing] Shandong Prov Med Ctr Dermatovenereol, Jinan, Peoples R China; [Low, Huiqi; Li, Yi; Khor, Chiea Chuen; Hibberd, Martin L.; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Sun, Liangdan; Cui, Yong; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liangdan; Cui, Yong; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Peoples R China; [Sun, Liangdan; Cui, Yong; Yang, Sen; Zhang, Xuejun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Peoples R China; [Yang, Haitao; Zhang, Lianhua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Yang, Rongde] Wenshan Inst Dermatol, Wenshan, Peoples R China; [Wang, Qiang] Anhui Prov Inst Dermatol, Hefei, Peoples R China; [Khor, Chiea Chuen; Liu, Jianjun] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Hibberd, Martin L.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Anhui Medical University; Anhui Medical University; Jiangsu Provincial Center for Disease Control & Prevention; National University of Singapore; National University of Singapore; Anhui Medical University	Zhang, FR (corresponding author), Prov Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China.	zhangfuren@hotmail.com	Hibberd, Martin L/D-5050-2009; Liu, Jianjun/AAK-4989-2020; Cui, Yong/AAF-9300-2020; Chen, Gang/G-2722-2010	Liu, Jianjun/0000-0002-3255-3019; Khor, Chiea Chuen/0000-0002-1128-4729; Sun, Yonghu/0000-0003-4553-2871; Hibberd, Martin/0000-0001-8587-1849	National Natural Science Foundation of China [81071288, 81072391]; Research Foundation of the Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support; Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore; Project of Taishan scholar; Project of Medical leading scholar of Shandong Province; Taishan scholar award; Medical Leading Scholar of Shandong Province award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of the Shandong Provincial Institute of Dermatology and Venereology; Shandong Provincial Leprosy Control Special Financial Support; Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Project of Taishan scholar; Project of Medical leading scholar of Shandong Province; Taishan scholar award; Medical Leading Scholar of Shandong Province award	We thank the individuals who participated in this project. This work was funded by grants from the National Natural Science Foundation of China (81071288, 81072391), the Project of Research Foundation of the Shandong Provincial Institute of Dermatology and Venereology (2008.07-2011.07), the Shandong Provincial Leprosy Control Special Financial Support (2009-2011), the Anhui Provincial Special Scientific Program (2007.07-2011.07) and the Agency for Science, Technology, and Research of Singapore. Grant support was also provided by the Project of Taishan scholar (2008-) and the Project of Medical leading scholar of Shandong Province (2010-). F. Zhang was supported by funding from the Project of Taishan scholar award (2008-) and the Project of Medical Leading Scholar of Shandong Province award (2010-).	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P337; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; MANTEL N, 1959, J NATL CANCER I, V22, P719; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Sheng YJ, 2011, RHEUMATOLOGY, V50, P682, DOI 10.1093/rheumatology/keq313; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	31	126	132	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1247	U111		10.1038/ng.973	http://dx.doi.org/10.1038/ng.973			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22019778				2022-12-17	WOS:000297931400021
J	Gitler, AD; Zhu, Y; Ismat, FA; Lu, MM; Yamauchi, Y; Parada, LF; Epstein, JA				Gitler, AD; Zhu, Y; Ismat, FA; Lu, MM; Yamauchi, Y; Parada, LF; Epstein, JA			Nf1 has an essential role in endothelial cells	NATURE GENETICS			English	Article							NEURAL CREST; NEUROFIBROMATOSIS TYPE-1; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; CARDIAC DEVELOPMENT; TRANSGENIC MICE; MODEL; TRANSFORMATION; ABNORMALITIES; MORPHOGENESIS	Neurofibromatosis type 1 (NF1) or von Recklinghausen neurofibromatosis is a genetic disorder that occurs in 1 of 4000 births and is characterized by benign and malignant tumors. Cardiovascular defects also contribute to NF1, though the pathogenesis is still unclear. Deficiency in neurofibromin (encoded by Nf1) in mice results in mid-embryonic lethality owing to cardiac abnormalities previously thought to be secondary to cardiac neural-crest defects. Using tissue-specific gene inactivation, we show that endothelial-specific inactivation of Nf1 recapitulates key aspects of the complete null phenotype, including multiple cardiovascular abnormalities involving the endocardial cushions and myocardium. This phenotype is associated with an elevated level of ras signaling in Nf1(-/-) endothelial cells and greater nuclear localization of the transcription factor Nfatc1. Inactivation of Nf1 in the neural crest does not cause cardiac defects but results in tumors of neural-crest origin resembling those seen in humans with NF1. These results establish a new and essential role for Nf1 in endothelial cells and confirm the requirement for neurofibromin in the neural crest.	Univ Penn Hlth Syst, Dept Med, Div Cardiol, Philadelphia, PA 19104 USA; Univ Penn Hlth Syst, Dept Dev & Cell Biol, Philadelphia, PA 19104 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA; Kumamoto Univ, Sch Med, Dept Dev Genet, Kumamoto 860, Japan	University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Kumamoto University	Epstein, JA (corresponding author), Univ Penn Hlth Syst, Dept Med, Div Cardiol, 954 BRB II-III,421 Curie Blvd, Philadelphia, PA 19104 USA.		Ismat, Fraz Ahmed/AAG-7470-2019; Zhu, Yuan/ABF-8405-2020; Parada, luis F/B-9400-2014	Ismat, Fraz/0000-0002-2172-146X; Epstein, Jonathan/0000-0001-8637-4465; Gitler, Aaron/0000-0001-8603-1526	NINDS NIH HHS [R01 NS034296-06, R01 NS034296] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034296] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Epstein JA, 1996, TRENDS CARDIOVAS MED, V6, P255, DOI 10.1016/S1050-1738(96)00110-7; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Feiner L, 2001, DEVELOPMENT, V128, P3061; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jiang XB, 2000, DEVELOPMENT, V127, P1607; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; Li J, 2000, GENESIS, V26, P162, DOI 10.1002/(SICI)1526-968X(200002)26:2<162::AID-GENE21>3.0.CO;2-R; Lin AE, 2000, AM J MED GENET, V95, P108, DOI 10.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; RICCI A, 1984, AM J SURG PATHOL, V8, P19, DOI 10.1097/00000478-198401000-00002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; WOODROW MA, 1993, J IMMUNOL, V150, P3853; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; YANG JT, 1995, DEVELOPMENT, V121, P549; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	30	126	128	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					75	79		10.1038/ng1059	http://dx.doi.org/10.1038/ng1059			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12469121	Green Accepted			2022-12-17	WOS:000180136100021
J	Hoogenraad, CC; Koekkoek, B; Akhmanova, A; Krugers, H; Dortland, B; Miedema, M; van Alphen, A; Kistler, WM; Jaegle, M; Koutsourakis, M; Van Camp, N; Verhoye, M; van der Linden, A; Kaverina, I; Grosveld, F; De Zeeuw, CI; Galjart, N				Hoogenraad, CC; Koekkoek, B; Akhmanova, A; Krugers, H; Dortland, B; Miedema, M; van Alphen, A; Kistler, WM; Jaegle, M; Koutsourakis, M; Van Camp, N; Verhoye, M; van der Linden, A; Kaverina, I; Grosveld, F; De Zeeuw, CI; Galjart, N			Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice	NATURE GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; BEUREN-SYNDROME; IN-VIVO; MUTANT MICE; PROTEIN; 7Q11.23; GENE; DELETION; BRAIN; FEAR	Williams syndrome is a neurodevelopmental disorder caused by the hemizygous deletion of 1.6 Mb on human chromosome 7q11.23. This region comprises the gene CYLN2, encoding CLIP-115, a microtubule-binding protein of 115 kD. Using a gene-targeting approach, we provide evidence that mice with haploinsufficiency for Cyln2 have features reminiscent of Williams syndrome, including mild growth deficiency, brain abnormalities, hippocampal dysfunction and particular deficits in motor coordination. Absence of CLIP-115 also leads to increased levels of CLIP-170 (a closely related cytoplasmic linker protein) and dynactin at the tips of growing microtubules. This protein redistribution may affect dynein motor regulation and, together with the loss of CLIP-115-specific functions, underlie neurological alterations in Williams syndrome.	Erasmus Univ, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, MGC Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands; Univ Antwerp, RUCA, Bioimaging Lab, B-2020 Antwerp, Belgium; Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria	Erasmus University Rotterdam; Erasmus University Rotterdam; University of Amsterdam; University of Antwerp; Austrian Academy of Sciences	Galjart, N (corresponding author), Erasmus Univ, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	dezeeuw@anat.fgg.eur.nl; galjart@ch1.fgg.eur.nl	Galjart, Niels/D-1146-2010; Van Camp, Nadja/AAC-4357-2019; Akhmanova, Anna S/B-8896-2011; Hoogenraad, Casper/B-8866-2011; Van der Linden, Annemie/L-7855-2017; Van Camp, Nadja/H-5141-2017	Galjart, Niels/0000-0003-1964-3607; Van Camp, Nadja/0000-0002-2261-7314; Akhmanova, Anna S/0000-0002-9048-8614; Hoogenraad, Casper/0000-0002-2666-0758; Van der Linden, Annemie/0000-0003-2941-6520; Van Camp, Nadja/0000-0002-2261-7314; Verhoye, Marleen/0000-0002-6267-0611				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Bloedel JR, 1981, HDB PHYSL, VII, P735; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Franceschi S., 1996, Journal of Epidemiology and Biostatistics, V1, P59; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Hoogenraad CC, 1998, GENOMICS, V53, P348, DOI 10.1006/geno.1998.5529; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kooy RF, 1999, EUR J HUM GENET, V7, P526, DOI 10.1038/sj.ejhg.5200348; Krugers HJ, 1997, NEUROREPORT, V8, P2505, DOI 10.1097/00001756-199707280-00018; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; Osborne LR, 1999, MOL GENET METAB, V67, P1, DOI 10.1006/mgme.1999.2844; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; PANKAU R, 1992, EUR J PEDIATR, V151, P751, DOI 10.1007/BF01959084; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Schmitt JE, 2001, DEV MED CHILD NEUROL, V43, P155, DOI 10.1017/S0012162201000305; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sijbers J, 1997, MAGN RESON IMAGING, V15, P679, DOI 10.1016/S0730-725X(97)00033-7; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Tarantino LM, 2000, MAMM GENOME, V11, P555, DOI 10.1007/s003350010107; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vaughan KT, 1999, J CELL SCI, V112, P1437; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; YUAN C, 1993, JMRI-J MAGN RESON IM, V3, P894, DOI 10.1002/jmri.1880030617	49	126	129	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					116	127		10.1038/ng954	http://dx.doi.org/10.1038/ng954			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12195424				2022-12-17	WOS:000177714900010
J	Berger, J; Suzuki, T; Senti, KA; Stubbs, J; Schaffner, G; Dickson, BJ				Berger, J; Suzuki, T; Senti, KA; Stubbs, J; Schaffner, G; Dickson, BJ			Genetic mapping with SNP markers in Drosophila	NATURE GENETICS			English	Article							GENOME; MELANOGASTER; MOSAICS; DISCOVERY; SEQUENCE; KINASE	Map-based positional cloning of Drosophila melanogaster genes is hampered by both the time-consuming, error-prone nature of traditional methods for genetic mapping and the difficulties in aligning the genetic and cytological maps with the genome sequence. The identification of sequence polymorphisms in the Drosophila genome will make it possible to map mutations directly to the genome sequence with high accuracy and resolution. Here we report the identification of 7,223 single-nucleotide polymorphisms (SNPs) and 1,392 insertions/deletions (InDels) in common laboratory strains of Drosophila. These sequence polymorphisms define a map of 787 autosomal marker loci with a resolution of 114 kb. We have established PCR product-length polymorphism (PLP) or restriction fragment-length polymorphism (RFLP) assays for 215 of these markers. We demonstrate the use of this map by delimiting two mutations to intervals of 169 kb and 307 kb, respectively. Using a local high-density SNP map, we also mapped a third mutation to a resolution of approximately 2 kb, sufficient to localize the mutation within a single gene. These methods should accelerate the rate of positional cloning in Drosophila.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019; Suzuki, Takashi/D-3651-2019; Senti, Kirsten-Andre/AAB-3036-2020	Dickson, Barry/0000-0003-0715-892X; Suzuki, Takashi/0000-0001-9093-2562; Senti, Kirsten-Andre/0000-0002-7208-7593				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hoskins RA, 2001, GENOME RES, V11, P1100, DOI 10.1101/gr.GR-1780R; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Liu YR, 1999, DEVELOPMENT, V126, P1869; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Newsome TP, 2000, DEVELOPMENT, V127, P851; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Pichaud F, 2001, DEVELOPMENT, V128, P815; Rorth P, 1998, DEVELOPMENT, V125, P1049; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Teeter K, 2000, J EXP ZOOL, V288, P63, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;63::AID-JEZ7&gt;3.0.CO;2-1; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	23	126	132	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2001	29	4					475	481		10.1038/ng773	http://dx.doi.org/10.1038/ng773			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726933				2022-12-17	WOS:000172507500026
J	Sprecher, E; Bergman, R; Richard, G; Lurie, R; Shalev, S; Petronius, D; Shalata, A; Anbinder, Y; Leibu, R; Perlman, I; Cohen, N; Szargel, R				Sprecher, E; Bergman, R; Richard, G; Lurie, R; Shalev, S; Petronius, D; Shalata, A; Anbinder, Y; Leibu, R; Perlman, I; Cohen, N; Szargel, R			Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin	NATURE GENETICS			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; IN-VITRO; EXPRESSION; MICE	Congenital hypotrichosis associated with juvenile macular dystrophy (HJMD; MIM601553) is an autosomal recessive disorder of unknown etiology, characterized by hair loss heralding progressive macular degeneration and early blindness(1,2). We used homozygosity mapping in four consanguineous families to localize the gene defective in HJMD to 16q22.1. This region contains CDH3, encoding P-cadherin, which is expressed in the retinal pigment epithelium and hair follicles. Mutation analysis shows in all families a common homozygous deletion in exon 8 of CDH3. These results establish the molecular etiology of HJMD and implicate for the first time a cadherin molecule in the pathogenesis of a human hair and retinal disorder.	Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel; Rambam Med Ctr, Dept Pediat Surg, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Human Genet, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Physiol & Biophys, IL-31096 Haifa, Israel; Thomas Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA USA; Thomas Jefferson Med Coll, Thomas Jefferson Inst Mol Med, Philadelphia, PA USA; Schneider Childrens Hosp, Pediat Dermatol Unit, Petah Tiqwa, Israel; Haemek Med Ctr, Inst Human Genet, Afula, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Jefferson University; Jefferson University; Emek Medical Center	Sprecher, E (corresponding author), Rambam Med Ctr, Dept Dermatol, IL-31096 Haifa, Israel.							Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; Chen GTC, 1998, ENDOCRINE, V9, P263, DOI 10.1385/ENDO:9:3:263; Da Cruz L, 2001, BRIT J OPHTHALMOL, V85, P239; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LEWIS JE, 1994, J INVEST DERMATOL, V102, P870, DOI 10.1111/1523-1747.ep12382690; Muller-Rover S, 1999, EXP DERMATOL, V8, P237; QUMSIYEH MB, 1997, GENETIC DISORDERS AR, P232; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SOUIED E, 1995, OPHTHALMIC GENET, V16, P11, DOI 10.3109/13816819509057848; Yagi T, 2000, GENE DEV, V14, P1169	15	126	132	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					134	136		10.1038/ng716	http://dx.doi.org/10.1038/ng716			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544476				2022-12-17	WOS:000171374100015
J	Douglas, JA; Boehnke, M; Gillanders, E; Trent, JA; Gruber, SB				Douglas, JA; Boehnke, M; Gillanders, E; Trent, JA; Gruber, SB			Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies	NATURE GENETICS			English	Article							FREQUENCIES; INDIVIDUALS; PHENOTYPES	The study of complex genetic traits in humans is limited by the expense and difficulty of ascertaining populations of sufficient sample size to detect subtle genetic contributions to disease. Here we introduce an application of a somatic cell hybrid construction strategy called conversion(1-4) that maximizes the genotypic information from each sampled individual. The approach permits direct observation of individual haplotypes, thereby eliminating the need for collecting and genotyping DNA from family members for haplotype-based analyses. We describe experimental data that validate the use of conversion as a whole-genome haplotyping too[ and evaluate the theoretical efficiency of using conversion-derived haplotypes instead of conventional genotypes in the context of haplotype-frequency estimation. We show that, particularly when phenotyping is expensive, conversion-based haplotyping can be more efficient and cost-effective than standard genotyping.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; NHGRI, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	boehnke@umich.edu			NATIONAL CANCER INSTITUTE [R01CA081488] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA81488] Funding Source: Medline; NHGRI NIH HHS [R01-HG00376] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Laken SJ, 1999, P NATL ACAD SCI USA, V96, P2322, DOI 10.1073/pnas.96.5.2322; LONG JC, 1995, AM J HUM GENET, V56, P799; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; McKeigue PM, 2000, AM J HUM GENET, V67, P1626, DOI 10.1086/316912; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Veldman T, 1997, NAT GENET, V15, P406, DOI 10.1038/ng0497-406; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yen H, 2000, SCIENCE, V289, P1890	17	126	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					361	364		10.1038/ng582	http://dx.doi.org/10.1038/ng582			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11443299				2022-12-17	WOS:000170174800017
J	Tsujikawa, M; Kurahashi, H; Tanaka, T; Nishida, K; Shimomura, Y; Tano, Y; Nakamura, Y				Tsujikawa, M; Kurahashi, H; Tanaka, T; Nishida, K; Shimomura, Y; Tano, Y; Nakamura, Y			Identification of the gene responsible for gelatinous drop-like corneal dystrophy	NATURE GENETICS			English	Article							FAMILIAL AMYLOIDOSIS; MONOCLONAL-ANTIBODY; GELSOLIN GENE; SEQUENCE; SPECIFICITY; RS7-3G11; MUTATION; FINNISH; PIP2; DNA	Gelatinous drop-like corneal dystrophy (GDLD; OMIM 204870) is an autosomal recessive disorder characterized by severe corneal amyloidosis leading to blindness(1-4), with an incidence of 1 in 300,000 in Japan(5). Our previous genetic linkage study localized the gene responsible to a 2.6-cM interval on chromosome 1p (ref. 6). Clinical manifestations, which appear in the first decade of life, include blurred vision, photophobia and foreign-body sensation. By the third decade, raised, yellowish-grey, gelatinous masses severely impair visual acuity, and lamellar keratoplasty is required for most patients'. Here we report DNA sequencing, cDNA cloning and mutational analyses of four deleterious mutations (Q118X, 632delA, Q207X and S170X) in M1S1 (formerly TROP2 and GA733-1), encoding a gastrointestinal tumour-associated antigen. The Q118X mutation was the most common alteration in the GDLD patients examined, accounting for 33 of 40 (82.5%) disease alleles in our panel of families. Protein expression anaysis revealed aggregation of the mutated, truncated protein in the perinuclear region, whereas the normal protein was distributed diffusely in the cytoplasm with a homogenous or fine granular pattern. Our successful identification of the gene that is defective in GDLD should facilitate genetic diagnosis and potentially treatment of the disease, and enhance general understanding of the mechanisms of amyloidosis.	Osaka Univ, Sch Med, Ctr Biomed Res, Dept Med Genet,Div Clin Genet, Suita, Osaka 565, Japan; Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 565, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 602, Japan	Osaka University; Osaka University; University of Tokyo; Kyoto Prefectural University of Medicine	Nakamura, Y (corresponding author), Osaka Univ, Sch Med, Ctr Biomed Res, Dept Med Genet,Div Clin Genet, Suita, Osaka 565, Japan.		Tanaka, Toshihiro/J-9310-2014	Tanaka, Toshihiro/0000-0001-6201-9784; Nishida, Kohji/0000-0001-9069-3610				BASU A, 1995, INT J CANCER, V62, P472, DOI 10.1002/ijc.2910620419; DELACHAPELLE A, 1992, GENOMICS, V13, P898, DOI 10.1016/0888-7543(92)90182-R; El Sewedy T, 1998, INT J CANCER, V75, P324, DOI 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.3.CO;2-5; HALTIA M, 1992, AM J MED GENET, V42, P357, DOI 10.1002/ajmg.1320420321; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; KIEFER MC, 1991, J BIOL CHEM, V266, P9043; Lambrechts A, 1997, EMBO J, V16, P484, DOI 10.1093/emboj/16.3.484; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MIOTTI S, 1987, INT J CANCER, V39, P297, DOI 10.1002/ijc.2910390306; MONDINO BJ, 1981, AM J OPHTHALMOL, V92, P732, DOI 10.1016/S0002-9394(14)74671-9; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; NAKAIZUMI Y, 1914, ACTA SOC OPHTHALMOL, V18, P949; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; SANTO RM, 1995, OPHTHALMOLOGY, V102, P557, DOI 10.1016/S0161-6420(95)30982-7; SMOLIN G, 1994, CORNEA, P499; STEIN R, 1993, INT J CANCER, V55, P938, DOI 10.1002/ijc.2910550611; Tsujikawa M, 1998, AM J HUM GENET, V63, P1073, DOI 10.1086/302071; WEBER FL, 1980, ARCH OPHTHALMOL-CHIC, V98, P144, DOI 10.1001/archopht.1980.01020030146017; YU FX, 1992, J BIOL CHEM, V267, P14616	20	126	137	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					420	423		10.1038/7759	http://dx.doi.org/10.1038/7759			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192395				2022-12-17	WOS:000079439700026
J	Scoles, DR; Huynh, DP; Morcos, PA; Coulsell, ER; Robinson, NGG; Tamanoi, F; Pulst, SM				Scoles, DR; Huynh, DP; Morcos, PA; Coulsell, ER; Robinson, NGG; Tamanoi, F; Pulst, SM			Neurofibromatosis 2 tumour suppressor schwannomin interacts with beta II-spectrin	NATURE GENETICS			English	Article							RETINAL-PIGMENT EPITHELIUM; NF2 GENE; ACTIN-BINDING; VESTIBULAR SCHWANNOMAS; CELL-ADHESION; TYPE-2; MEMBRANE; PRODUCT; MUTATIONS; PROTEIN	NF2 is the most commonly mutated gene in benign tumours of the human nervous system. The NF2 protein, called schwannomin or merlin, is absent in virtually all schwannomas, and many meningiomas and ependymomas(1-3). Using the yeast two-hybrid system, we identified beta II-spectrin (also known as fodrin) as a schwannomin-binding protein. Interaction occurred between the carboxy-terminal domain of schwannomin isoform 2 and the ankyrin-binding region of beta II-spectrin. Isoform 1 of schwannomin, in contrast, interacted weakly with beta II-spectrin, presumably because of its strong self-interaction. Thus, alternative splicing of NF2 may regulate beta II-spectrin binding. Schwannomin co-immunoprecipitated with beta II-spectrin at physiological concentrations. The two proteins interacted in vitro and co-localized in several target tissues and in STS26T cells. Three naturally occurring NF2 missense mutations showed reduced, but not absent, beta II-spectrin binding, suggesting an explanation for the milder phenotypes seen in patients with missense mutations. STS26T cells treated with NF2 antisense oligonucleotides showed alterations of the actin cytoskeleton. Schwannomin itself lacks the actin binding sites found in ezrin, radixin and moesin, suggesting that signalling to the actin cytoskeleton occurs via actin-binding sites on beta II-spectrin. Thus, schwannomin is a tumour suppressor directly involved in actin-cytoskeleton organization, which suggests that alterations in the cytoskeleton are an early event in the pathogenesis of some tumour types.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, CSMC Burns & Allen Res Inst,Neurogenet Lab, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, CSMC Burns & Allen Res Inst,Div Neurol, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Pulst, SM (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, CSMC Burns & Allen Res Inst,Neurogenet Lab, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.				NINDS NIH HHS [NS10524-01, NS01428-01A1] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENNETT V, 1991, J CLIN INVEST, V87, P1483, DOI 10.1172/JCI115157; Bretscher A, 1995, BIOCHEMISTRY-US, V34, P16830, DOI 10.1021/bi00051a034; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Claudio JO, 1997, NEUROREPORT, V8, P2025, DOI 10.1097/00001756-199705260-00044; Deguen B, 1998, HUM MOL GENET, V7, P217, DOI 10.1093/hmg/7.2.217; DENBAKKER MA, 1995, ONCOGENE, V10, P757; DEPREZ RHL, 1994, AM J HUM GENET, V54, P1022; DISCHER D, 1993, J BIOL CHEM, V268, P7186; EVANS DGR, 1995, J MED GENET, V32, P470, DOI 10.1136/jmg.32.6.470; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; GUNDERSEN D, 1991, J CELL BIOL, V112, P863, DOI 10.1083/jcb.112.5.863; HU RJ, 1992, J BIOL CHEM, V267, P18715; Huynh DP, 1996, ONCOGENE, V13, P73; Huynh DP, 1997, J NEUROPATH EXP NEUR, V56, P382, DOI 10.1097/00005072-199704000-00007; HUYNH DP, 1994, HUM MOL GENET, V3, P1075, DOI 10.1093/hmg/3.7.1075; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; Kluwe L, 1996, HUM GENET, V97, P224, DOI 10.1007/BF02265270; MARRS JA, 1995, J CELL BIOL, V129, P507, DOI 10.1083/jcb.129.2.507; Mautner VF, 1996, NEUROSURGERY, V38, P880, DOI 10.1097/00006123-199605000-00004; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; Morcos P, 1996, MOL CELL BIOL, V16, P2496; POULLET P, 1995, METHOD ENZYMOL, V255, P488; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SAINZ J, 1994, HUM MOL GENET, V3, P885, DOI 10.1093/hmg/3.6.885; Sanderson J, 1996, BIOCHEM BIOPH RES CO, V218, P893, DOI 10.1006/bbrc.1996.0159; SANTOS A, 1994, RETINA-J RET VIT DIS, V14, P6, DOI 10.1097/00006982-199401000-00002; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; SIANO M, 1997, J CELL SCI, V110, P2249; TAKESHIMA H, 1994, ONCOGENE, V9, P2135; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; VYBIRAL T, 1992, CELL MOTIL CYTOSKEL, V21, P293, DOI 10.1002/cm.970210405; WINKELMANN JC, 1993, BLOOD, V81, P3173	34	126	128	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					354	359		10.1038/ng0498-354	http://dx.doi.org/10.1038/ng0498-354			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537418				2022-12-17	WOS:000072755500018
J	Bergstrom, TF; Josefsson, A; Erlich, HA; Gyllensten, U				Bergstrom, TF; Josefsson, A; Erlich, HA; Gyllensten, U			Recent origin of HLA-DRB1 alleles and implications for human evolution	NATURE GENETICS			English	Article							HUMAN IA ANTIGENS; CLASS-II REGION; DR-BETA LOCI; NUCLEOTIDE SUBSTITUTION; MITOCHONDRIAL-DNA; OVERDOMINANT SELECTION; LINKAGE DISEQUILIBRIUM; COALESCENT PROCESS; GENE CONVERSION; POLYMORPHISM	The HLA class I and class II loci are the most highly polymorphic coding regions in the human genome. Based on the similarity of the coding sequences of alleles between species, it has been claimed that the HLA polymorphism is ancient and predates the separation of human (Homo) and chimpanzee (Pan), 4-7.4 Myr ago. Analysis of intron sequences, however, provides support for a more recent origin and for rapid generation of alleles at the HLA class II DRB1 locus. The human DRB1 alleles can be divided into groups (allelic lineages); most of these lineages have diverged from each other before the separation of Homo and Pan. Alleles within such a lineage, however, appear to be, on average, 250,000 years old, implying that the vast majority (greater than 90%) of the more than 135 contemporary human DRB1 alleles have been generated after the separation of Homo and Pan. The coalescence time of alleles within allelic lineages indicates that the effective population size (N-e) for early hominids (over the last 1 Myr) was approximately 10(4) individuals, similar to estimates based on other nuclear loci and mitochondrial DNA. With a single exception, the genetic mechanisms (gene conversion and point mutation) that have diversified the exon-2 sequences do not appear to extend into the adjacent intron sequences. The part of exon 2 encoding the beta-sheet evolves in concert with the surrounding introns, while the alpha-helix appears to have been subjected to gene conversion-like events, suggesting that such exchange events are highly localised and occur over extremely short sequence tracts.	Uppsala Univ, Ctr Biomed, Unit Med Genet, Dept Genet & Pathol, S-75123 Uppsala, Sweden; Roche Mol Syst Inc, Dept Human Genet, Alameda, CA 94501 USA	Uppsala University; Roche Holding	Gyllensten, U (corresponding author), Uppsala Univ, Ctr Biomed, Unit Med Genet, Dept Genet & Pathol, Box 589, S-75123 Uppsala, Sweden.	ulf.gyllensten@medgen.uu.se	Bergström, Tomas/B-4681-2017	Bergström, Tomas/0000-0002-7480-2669				ARDEN B, 1982, P NATL ACAD SCI-BIOL, V79, P2342, DOI 10.1073/pnas.79.7.2342; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; AYALA FJ, 1994, P NATL ACAD SCI USA, V91, P6787, DOI 10.1073/pnas.91.15.6787; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P188, DOI 10.1006/mpev.1996.0013; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHARLESWORTH B, 1993, GENETICS, V134, P1289; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; GORSKI J, 1986, NATURE, V322, P67, DOI 10.1038/322067a0; Gyllensten U, 1996, TISSUE ANTIGENS, V47, P212, DOI 10.1111/j.1399-0039.1996.tb02543.x; GYLLENSTEN UB, 1991, P NATL ACAD SCI USA, V88, P3686, DOI 10.1073/pnas.88.9.3686; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Hickson RE, 1997, J MOL EVOL, V45, P589, DOI 10.1007/PL00006263; HOLMES EC, 1989, J HUM EVOL, V18, P775, DOI 10.1016/0047-2484(89)90089-4; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HUDSON RR, 1988, GENETICS, V120, P831; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; JUKES T H, 1969, P21; KAPLAN NL, 1988, GENETICS, V120, P819; KAPLAN NL, 1989, GENETICS, V123, P887; KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LI WH, 1991, GENETICS, V129, P513; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Mack SJ, 1998, TISSUE ANTIGENS, V51, P41, DOI 10.1111/j.1399-0039.1998.tb02945.x; MARSH SGE, 1995, TISSUE ANTIGENS, V46, P258, DOI 10.1111/j.1399-0039.1995.tb03125.x; MAYER WE, 1988, EMBO J, V7, P2765, DOI 10.1002/j.1460-2075.1988.tb03131.x; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCCONNELL TJ, 1988, NATURE, V332, P651, DOI 10.1038/332651a0; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; NEI M, 1986, MOL BIOL EVOL, V3, P418; OHTA T, 1995, J MOL EVOL, V41, P115, DOI 10.1007/BF00170662; RIPLEY LS, 1991, MOL EVOLUTION MAJOR, P63; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satta Y, 1996, J MOL EVOL, V42, P648, DOI 10.1007/BF02338798; SATTA Y, 1991, MOL EVOLUTION MAJOR, P51; Sneath PHA., 1973, NUMERICAL TAXONOMY; STROBECK C, 1983, GENETICS, V103, P545; Svensson AC, 1996, IMMUNOGENETICS, V43, P304, DOI 10.1007/BF02440998; SVENSSON AC, 1995, IMMUNOGENETICS, V41, P74; TAJIMA F, 1989, GENETICS, V123, P585; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TAKAHATA N, IN PRESS IMMUNOGENET; TITUSTRACHTENBERG EA, 1994, AM J HUM GENET, V55, P160; TROWSDALE J, 1995, IMMUNOGENETICS, V41, P1, DOI 10.1007/BF00188427; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WU SK, 1986, NATURE, V324, P676, DOI 10.1038/324676a0	53	126	128	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					237	242		10.1038/ng0398-237	http://dx.doi.org/10.1038/ng0398-237			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500545				2022-12-17	WOS:000072325000021
J	Olschwang, S; Serova-Sinilnikova, OM; Lenoir, GM; Thomas, G				Olschwang, S; Serova-Sinilnikova, OM; Lenoir, GM; Thomas, G			PTEN germ-line mutations in juvenile polyposis coli	NATURE GENETICS			English	Letter							DISEASE; GENE		CNRS, UMR5641, F-69372 Lyon, France; Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, INSERM, U434, F-75010 Paris, France; Ctr Int Rech Canc, F-69372 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); World Health Organization; International Agency for Research on Cancer (IARC)	Lenoir, GM (corresponding author), CNRS, UMR5641, 150 Cours Albert Thomas, F-69372 Lyon, France.		Olschwang, Sylviane/G-2716-2013	Olschwang, Sylviane/0000-0001-7078-3029				CARLSON GJ, 1984, AM J SURG PATHOL, V8, P763, DOI 10.1097/00000478-198410000-00005; DESAI DC, 1995, BRIT J SURG, V82, P14, DOI 10.1002/bjs.1800820106; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; HEISS KF, 1993, J PEDIATR SURG, V28, P1188, DOI 10.1016/0022-3468(93)90162-E; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; JASS JR, 1988, HISTOPATHOLOGY, V13, P619; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; OLSCHWANG S, 1993, AM J HUM GENET, V52, P273; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; STECK PA, 1997, NAT GENET, V15, P35; Thomas HJW, 1996, AM J HUM GENET, V58, P770; WALPOLE IR, 1989, AM J MED GENET, V32, P1, DOI 10.1002/ajmg.1320320102	16	126	128	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					12	14		10.1038/ng0198-12	http://dx.doi.org/10.1038/ng0198-12			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425889				2022-12-17	WOS:000071259600010
J	Lee, SB; Kolquist, KA; Nichols, K; Englert, C; Maheswaran, S; Ladanyi, M; Gerald, WL; Haber, DA				Lee, SB; Kolquist, KA; Nichols, K; Englert, C; Maheswaran, S; Ladanyi, M; Gerald, WL; Haber, DA			The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour	NATURE GENETICS			English	Article							FACTOR-A-CHAIN; GROWTH-FACTOR; WILMS-TUMOR; GENE-PRODUCT; TRANSCRIPTION FACTOR; SUBNUCLEAR LOCALIZATION; SUPPRESSOR WT1; FUSION; BINDING; RECEPTOR	Chromosomal translocations resulting in chimaeric transcription factors underlie specific malignancies, but few authentic target genes regulated by these fusion proteins have been identified. Desmoplastic small round-cell tumour (DSRT) is a multiphenotypic primitive tumour characterized by massive reactive fibrosis surrounding nests of tumour cells(1). The t(11;22)(p13;q12) chromosomal translocation that defines DSRT produces a chimaeric protein containing the potential transactivation domain of the Ewing-sarcoma protein (EWS) fused to zinc fingers 2-4 of the Wilms tumour suppressor and transcriptional repressor WT1 (refs 2,3). By analogy with other EWS fusion products, the EWS-WT1 chimaera may encode a transcriptional activator whose target genes overlap with those repressed by WT1 (ref. 4). To characterize its functional properties, we generated osteosarcoma cell lines with tightly regulated inducible expression of EWS-WT1. Expression of EWS-WT1 induced the expression of endogenous platelet-derived growth factor-A (PDGFA), a potent secreted mitogen and chemoattractant whose promoter contains the many potential WT1-binding sites(5,6). Native PDGFA was not regulated by wild-type WT1, indicating a difference in target gene specificity between this tumour suppressor and its oncogenic derivative. PDGFA was expressed within tumour cells in primary DSRT specimens, but it was absent in Wilms tumours expressing WT1 and Ewing sarcomas with an EWS-Fli translocation. We conclude that the oncogenic fusion of EWS to WT1 in DSRT results in the induction of PDGFA, a potent fibroblast growth factor that contributes to the characteristic reactive fibrosis associated with this unique tumour.	MASSACHUSETTS GEN HOSP,CTR CANC,CHARLESTOWN,MA 02129; HARVARD UNIV,SCH MED,CHARLESTOWN,MA 02129; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021	Harvard University; Massachusetts General Hospital; Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center			Ladanyi, Marc/AAG-8585-2019; Nichols, Kim/AAP-8592-2020	Nichols, Kim/0000-0002-5581-6555; Englert, Christoph/0000-0002-5931-3189; Lee, Sean/0000-0001-6211-3498	NATIONAL CANCER INSTITUTE [T32CA060376, F32CA071167, R01CA068273] Funding Source: NIH RePORTER; NCI NIH HHS [CA 68273, CA60376, CA71167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anan K, 1996, SURGERY, V119, P333, DOI 10.1016/S0039-6060(96)80120-6; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; EMING SA, 1995, J INVEST DERMATOL, V105, P756, DOI 10.1111/1523-1747.ep12325550; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GERALD WL, 1991, AM J SURG PATHOL, V15, P499, DOI 10.1097/00000478-199106000-00001; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; LADANYI M, 1994, CANCER RES, V54, P2837; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; RABBOTTS TJ, 1994, MATIRE, V372, P143; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; REDDY JC, 1995, J BIOL CHEM, V270, P29976; Rorsman F, 1992, GROWTH FACTORS, V7, DOI 10.3109/08977199209046928; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; TAKIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P1686, DOI 10.1073/pnas.88.5.1686; VIGNAUD JM, 1994, CANCER RES, V54, P5455; WANG ZY, 1993, P NATL ACAD SCI USA, V90, P8896, DOI 10.1073/pnas.90.19.8896; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	31	126	135	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					309	313		10.1038/ng1197-309	http://dx.doi.org/10.1038/ng1197-309			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354795				2022-12-17	WOS:A1997YD66700025
J	Haber, D; Harlow, E				Haber, D; Harlow, E			Tumour-suppressor genes: evolving definitions in the genomic age	NATURE GENETICS			English	Editorial Material							RETINOBLASTOMA				Haber, D (corresponding author), MASSACHUSETTS GEN HOSP,CTR CANC,CHARLESTOWN,MA 02129, USA.							Boveri T, 1929, ORIGIN MALIGNANT TUM; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Steiner P, 1997, NAT GENET, V16, P332, DOI 10.1038/ng0897-332	8	126	129	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					320	322		10.1038/ng0897-320	http://dx.doi.org/10.1038/ng0897-320			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241260				2022-12-17	WOS:A1997XM90900003
J	ROSENBERG, HF; DYER, KD; TIFFANY, HL; GONZALEZ, M				ROSENBERG, HF; DYER, KD; TIFFANY, HL; GONZALEZ, M			RAPID EVOLUTION OF A UNIQUE FAMILY OF PRIMATE RIBONUCLEASE GENES	NATURE GENETICS			English	Article							EOSINOPHIL CATIONIC PROTEIN; AMINO-ACID-SEQUENCE; MOLECULAR-CLONING; NEUROTOXIN; CDNA; NUCLEOTIDE; HOMOLOGY	We have traced the rapid molecular evolution of eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP), two host defense proteins that are members of the mammalian ribonuclease gene family. The EDN/ECP gene pair arose from a recent duplication event that occurred after the divergence of New World and Old World monkeys. Since duplication, the genes encoding EDN and ECP have accumulated nonsilent mutations at rates exceeding those of all other functional coding sequences studied in primates, while retaining both the structural and catalytic components required for ribonuclease activity. These results suggest that both EDN and ECP may be responding to unusual evolutionary constraints, which has prompted a reexamination of their physiologic function.	GEORGE WASHINGTON UNIV,GRAD PROGRAM GENET,WASHINGTON,DC 20052	George Washington University	ROSENBERG, HF (corresponding author), NIAID,HOST DEF LAB,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							ARDELT W, 1991, J BIOL CHEM, V266, P245; BARKER RL, 1989, J IMMUNOL, V143, P952; BLACKBURN P, 1982, ENZYMES, P317; DIDONATO A, 1994, J BIOL CHEM, V269, P17394; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; GULLBERG U, 1986, BIOCHEM BIOPH RES CO, V139, P1239, DOI 10.1016/S0006-291X(86)80310-2; HAMANN KJ, 1989, GENE, V83, P161, DOI 10.1016/0378-1119(89)90414-9; HAMANN KJ, 1990, GENOMICS, V7, P535, DOI 10.1016/0888-7543(90)90197-3; HAUGG M, 1992, NUCLEIC ACIDS RES, V20, P612, DOI 10.1093/nar/20.3.612; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; KURACHI K, 1985, BIOCHEMISTRY-US, V24, P5494, DOI 10.1021/bi00341a032; LACCETTI P, 1994, CANCER RES, V54, P4253; LI HW, 1991, FUNDAMENTALS MOL EVO; LI WH, 1985, MOL BIOL EVOL, V2, P150; MACDONALD RJ, 1982, J BIOL CHEM, V251, P14582; MAKINO S, 1993, EOSINOPHILS BIOL CLI; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWTON DL, 1994, J NEUROSCI, V14, P538; NITTA K, 1994, CANCER RES, V54, P920; RETIEF JD, 1993, EUR J BIOCHEM, V214, P609, DOI 10.1111/j.1432-1033.1993.tb17960.x; RETIEF JD, 1993, J MOL EVOL; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; ROSENBERG HF, 1989, J EXP MED, V170, P163, DOI 10.1084/jem.170.1.163; SAMUELSON LC, 1991, NUCLEIC ACIDS RES, V19, P6935, DOI 10.1093/nar/19.24.6935; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; SORRENTINO S, 1992, J BIOL CHEM, V267, P14589; Spry CJ, 1988, EOSINOPHILS COMPREHE; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WU YN, 1993, J BIOL CHEM, V268, P10686	34	126	138	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					219	223		10.1038/ng0695-219	http://dx.doi.org/10.1038/ng0695-219			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663519				2022-12-17	WOS:A1995RA85700021
J	MORAES, CT; CIACCI, F; BONILLA, E; IONASESCU, V; SCHON, EA; DIMAURO, S				MORAES, CT; CIACCI, F; BONILLA, E; IONASESCU, V; SCHON, EA; DIMAURO, S			A MITOCHONDRIAL TRANSFER-RNA ANTICODON SWAP ASSOCIATED WITH A MUSCLE DISEASE	NATURE GENETICS			English	Article							TRANSFER RNALEU(UUR) GENE; KEARNS-SAYRE SYNDROME; DNA; MUTATION; TRANSCRIPTION; GENOMES; METHIONINE; MYOPATHY; EPILEPSY; SEQUENCE	We have identified an unusual mitochondrial (mt) tRNA mutation in a seven year-old girl with a pure myopathy. This G to A transition at mtDNA position 15990 changed the anticodon normally found in proline tRNAs (UGG) to the one found in serine tRNAs (UGA), and is the first pathogenic anticodon alteration described in a higher eukaryote. The mutant mtDNA was heteroplasmic (85% mutant) in muscle but was undetectable in white blood cells from the patient and her mother. Analysis of single muscle fibres indicated that mutant mtDNAs severely impaired mitochondrial protein synthesis and respiratory chain activity, but only when present at greater than 90%. The recessive behaviour of this mtDNA alteration may explain the patient's relatively mild clinical phenotype.	COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; UNIV IOWA, DEPT PEDIAT, IOWA CITY, IA 52242 USA	Columbia University; Columbia University; University of Iowa			Moraes, Carlos/AAT-3818-2021					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445; BOULET L, 1992, AM J HUM GENET, V51, P1187; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; KUMAZAWA Y, 1991, J BIOCHEM, V109, P421, DOI 10.1093/oxfordjournals.jbchem.a123397; LENINGHER AL, 1982, BIOCHEMISTRY; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1992, AM J HUM GENET, V50, P934; MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359; NAKASE H, 1990, AM J HUM GENET, V46, P418; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; RUANO G, 1992, BIOTECHNIQUES, V13, P266; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SCHULMAN LH, 1990, NUCLEIC ACIDS RES, V18, P285, DOI 10.1093/nar/18.2.285; SCHULMAN LH, 1991, PROG NUCLEIC ACID RE, V41, P23; SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; YONEDA M, 1990, BIOCHEM INT, V21, P789; Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80	36	126	127	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					284	288		10.1038/ng0793-284	http://dx.doi.org/10.1038/ng0793-284			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	7689388				2022-12-17	WOS:A1993LJ84200017
J	CHOU, YHW; BROWN, EM; LEVI, T; CROWE, G; ATKINSON, AB; ARNQVIST, HJ; TOSS, G; EL-HAJJ FULEIHAN, G; SEIDMAN, JG; SEIDMAN, CE				CHOU, YHW; BROWN, EM; LEVI, T; CROWE, G; ATKINSON, AB; ARNQVIST, HJ; TOSS, G; EL-HAJJ FULEIHAN, G; SEIDMAN, JG; SEIDMAN, CE			THE GENE RESPONSIBLE FOR FAMILIAL HYPOCALCIURIC HYPERCALCEMIA MAPS TO CHROMOSOME-3Q IN 4 UNRELATED FAMILIES	NATURE GENETICS			English	Article							BENIGN HYPERCALCEMIA; DNA POLYMORPHISMS; LINKAGE; RHODOPSIN; KINDREDS; LOCUS; CHAIN	Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant syndrome of unknown aetiology characterized by lifelong elevation in serum calcium concentration and low urinary calcium excretion. These features suggest that the causal gene is important for maintenance of extracellular calcium homeostasis by the parathyroid gland and kidney. To identify the chromosomal location of FHH gene(s), we clinically evaluated 114 individuals in four unrelated affected families and performed linkage analyses. The disease gene mapped to the long arm of chromosome 3 in each family (combined maximum multipoint lod score = 20.67). We suggest that this is the predominant FHH locus and anticipate that identification of the FHH gene will improve our understanding of the molecular basis for physiologic and pathologic regulation of calcium.	BRIGHAM & WOMENS HOSP, DIV CARDIOL, BOSTON, MA 02115 USA; HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV ENDOCRINOL HYPERTENS, BOSTON, MA 02115 USA; ROYAL VICTORIA HOSP, SIR GEORGE E CLARK METAB UNIT, BELFAST BT12 6BA, NORTH IRELAND; LINKOPING UNIV, DEPT INTERNAL MED, S-58185 LINKOPING, SWEDEN	Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Linkoping University								ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ATTIE MF, 1983, J CLIN INVEST, V72, P667, DOI 10.1172/JCI111016; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CHIN H, 1991, GENOMICS, V11, P914, DOI 10.1016/0888-7543(91)90014-6; DOAK S, 1991, NUC ACID RES, V19, P4017; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FARRAR GJ, 1990, GENOMICS, V8, P35; FOLEY TP, 1972, J PEDIATR-US, V81, P1060, DOI 10.1016/S0022-3476(72)80232-4; GARCIA D, 1991, 8TH P INT C HUM GEN, P352; GRANGVIST M, 1991, NUCLEIC ACIDS RES, V19, P4017; HEATH H, 1991, J BONE MINER RES, pS176; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; LEVY ER, GENOME DATA BASE VER; LYONS TJ, 1986, BRIT J SURG, V73, P188, DOI 10.1002/bjs.1800730310; MARX SJ, 1978, AM J MED, V65, P235, DOI 10.1016/0002-9343(78)90814-8; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MCALPINE PJ, 1987, CYTOGENET CELL GENET, V46, P659; MENKO FH, 1984, HUM GENET, V67, P452, DOI 10.1007/BF00291409; NEMETH EF, 1986, FEBS LETT, V203, P15, DOI 10.1016/0014-5793(86)81427-2; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; OTT J, 1983, ANAL HUMAN LINKAGE; RICHARDS E, 1987, CURRENT PROTOCOLS MO; SPARKES RS, 1986, CURR EYE RES, V5, P797, DOI 10.3109/02713688609000021; TONOKI H, 1991, CYTOGENET CELL GENET, V56, P103, DOI 10.1159/000133059; TOSS G, 1989, J INTERN MED, V225, P201, DOI 10.1111/j.1365-2796.1989.tb00064.x; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4635, DOI 10.1093/nar/18.15.4635-a; WEBER JL, 1989, AM J HUM GENET, V44, P388	30	126	131	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1992	1	4					295	300		10.1038/ng0792-295	http://dx.doi.org/10.1038/ng0792-295			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302026				2022-12-17	WOS:A1992JC98400015
J	Onabajo, OO; Banday, AR; Stanifer, ML; Yan, WS; Obajemu, A; Santer, DM; Florez-Vargas, O; Piontkivska, H; Vargas, JM; Ring, TMJ; Kee, C; Doldan, P; Tyrrell, DL; Mendoza, JL; Boulant, S; Prokunina-Olsson, L				Onabajo, Olusegun O.; Banday, A. Rouf; Stanifer, Megan L.; Yan, Wusheng; Obajemu, Adeola; Santer, Deanna M.; Florez-Vargas, Oscar; Piontkivska, Helen; Vargas, Joselin M.; Ring, Timothy J.; Kee, Carmon; Doldan, Patricio; Tyrrell, D. Lorne; Mendoza, Juan L.; Boulant, Steeve; Prokunina-Olsson, Ludmila			Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor	NATURE GENETICS			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; COVID-19	dACE2 is a newly identified isoform of ACE2 that is unable to bind the SARS-CoV-2 spike protein. Truncated dACE2, but not full-length ACE2, is induced by interferons and viruses, thus suggesting that such conditions are unlikely to increase cellular entry of SARS-CoV-2. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, utilizes angiotensin-converting enzyme 2 (ACE2) for entry into target cells.ACE2has been proposed as an interferon-stimulated gene (ISG). Thus, interferon-induced variability inACE2expression levels could be important for susceptibility to COVID-19 or its outcomes. Here, we report the discovery of a novel, transcriptionally independent truncated isoform ofACE2, which we designate asdeltaACE2(dACE2). We demonstrate thatdACE2, but notACE2, is an ISG. In The Cancer Genome Atlas, the expression ofdACE2was enriched in squamous tumors of the respiratory, gastrointestinal and urogenital tracts. In vitro, dACE2, which lacks 356 amino-terminal amino acids, was non-functional in binding the SARS-CoV-2 spike protein and as a carboxypeptidase. Our results suggest that the ISG-type induction ofdACE2in IFN-high conditions created by treatments, an inflammatory tumor microenvironment or viral co-infections is unlikely to increase the cellular entry of SARS-CoV-2 and promote infection.	[Onabajo, Olusegun O.; Banday, A. Rouf; Yan, Wusheng; Obajemu, Adeola; Florez-Vargas, Oscar; Vargas, Joselin M.; Ring, Timothy J.; Prokunina-Olsson, Ludmila] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Stanifer, Megan L.] Univ Hosp Heidelberg, Mol Virol, Dept Infect Dis, Heidelberg, Germany; [Santer, Deanna M.; Tyrrell, D. Lorne] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Santer, Deanna M.; Tyrrell, D. Lorne] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Piontkivska, Helen] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Piontkivska, Helen] Kent State Univ, Brain Hlth Res Inst, Kent, OH 44242 USA; [Kee, Carmon; Doldan, Patricio; Boulant, Steeve] German Canc Res Ctr, Div Cellular Polar & Viral Infect, Heidelberg, Germany; [Kee, Carmon; Doldan, Patricio; Boulant, Steeve] Univ Hosp Heidelberg, Virol, Dept Infect Dis, Heidelberg, Germany; [Mendoza, Juan L.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Mendoza, Juan L.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ruprecht Karls University Heidelberg; University of Alberta; University of Alberta; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Chicago; University of Chicago	Prokunina-Olsson, L (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	prokuninal@mail.nih.gov	Piontkivska, Helen/AAK-3915-2020; Banday, A. Rouf/AAB-9082-2022; Prokunina-Olsson, Ludmila/A-8240-2019	Piontkivska, Helen/0000-0003-1844-864X; Santer, Deanna/0000-0001-6169-7735; vargas, Joselin/0000-0003-4550-0925; Stanifer, Megan/0000-0002-5606-1297; Florez-Vargas, Oscar/0000-0002-4393-2612; Ring, Timothy/0000-0002-0062-5145; BANDAY, ABDUL ROUF/0000-0002-1521-340X; Prokunina-Olsson, Ludmila/0000-0002-9622-2091	Intramural Research Program of the DCEG/NCI; NIH [R21AG064479-01]; Brain Health Research Institute Pilot Award from Kent State University; Deutsche Forschungsgemeinschaft [240245660 (SFB1129), 415089553, 272983813 (TRR179), 416072091]; Li Ka Shing Institute of Virology	Intramural Research Program of the DCEG/NCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Health Research Institute Pilot Award from Kent State University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Li Ka Shing Institute of Virology	We thank N. Cole (DCEG/NCI) for help with the acquisition of TCGA sliced BAM files and D. Proud (University of Calgary) for providing NHBE cells. We thank the CGR/DCEG/NCI for help with RNA-seq and authentication of cell lines by Identifiler profiling. The results are partially based on data generated by the TCGA Research Network. The project was supported by the Intramural Research Program of the DCEG/NCI; the NIH grant R21AG064479-01 and a Brain Health Research Institute Pilot Award from Kent State University (H.P.); S.B. and M.L.S. received financial support from the Deutsche Forschungsgemeinschaft: project numbers 240245660 (SFB1129) 415089553 (Heisenberg) and 272983813 (TRR179) to S.B. and project number 416072091 to M.L.S. D.M.S. and D.L.T. received financial support from the Li Ka Shing Institute of Virology.	Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Chu H, 2020, CLIN INFECT DIS, V71, P1400, DOI 10.1093/cid/ciaa410; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; de Maat S, 2020, SEMIN THROMB HEMOST, V46, P835, DOI 10.1055/s-0040-1712960; Diamond B, 2020, J EXP MED, V217, DOI 10.1084/jem.20201000; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1789, DOI 10.1002/jmv.25900; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu Q, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.21; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; Mehta V, 2020, CANCER DISCOV, V10, P935, DOI 10.1158/2159-8290.CD-20-0516; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Minas TZ, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0193-5; Nikkila J, 2002, NEURAL NETWORKS, V15, P953, DOI 10.1016/S0893-6080(02)00070-9; O'Brien TR, 2020, CLIN INFECT DIS, V71, P1410, DOI 10.1093/cid/ciaa453; Obajemu AA, 2017, J IMMUNOL, V199, P3808, DOI 10.4049/jimmunol.1700807; Prokunina-Olsson L, 2020, J EXP MED, V217, DOI 10.1084/jem.20200653; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Re RN, 2004, NAT CLIN PRACT CARD, V1, P42, DOI 10.1038/ncpcardio0012; Santer DM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008515; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shahmuradov IA, 2015, BIOINFORMATICS, V31, P3544, DOI 10.1093/bioinformatics/btv404; Stanifer ML, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107863; Thijsen S, 2020, J INFECTION, V81, P480, DOI 10.1016/j.jinf.2020.06.015; van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wen B, 2019, GENOME RES, V29, P485, DOI 10.1101/gr.235028.118; Zhou Q, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00295; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zores F, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00071; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594	43	125	128	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2020	52	12					1283	1293		10.1038/s41588-020-00731-9	http://dx.doi.org/10.1038/s41588-020-00731-9		OCT 2020	11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA2UH	33077916	Bronze, Green Published, Green Accepted			2022-12-17	WOS:000579693500002
J	Rodriguez-Martin, B; Alvarez, EG; Baez-Ortega, A; Zamora, J; Supek, F; Demeulemeester, J; Santamarina, M; Ju, YS; Temes, J; Garcia-Souto, D; Detering, H; Li, YL; Rodriguez-Castro, J; Dueso-Barroso, A; Bruzos, AL; Dentro, SC; Blanco, MG; Contino, G; Ardeljan, D; Tojo, M; Roberts, ND; Zumalave, S; Edwards, PAW; Weischenfeldt, J; Puiggros, M; Chong, ZC; Chen, K; Lee, EA; Wala, JA; Raine, K; Butler, A; Waszak, SM; Navarro, FCP; Schumacher, SE; Monlong, J; Maura, F; Bolli, N; Bourque, G; Gerstein, M; Park, PJ; Wedge, DC; Beroukhim, R; Torrents, D; Korbel, JO; Martincorena, I; Fitzgerald, RC; Van Loo, P; Kazazian, HH; Burns, KH; Campbell, PJ; Tubio, JMC; Akdemir, KC; Boutros, PC; Bowtell, DDL; Brors, B; Chan, K; Cortes-Ciriano, I; Dunford, AJ; Edwards, PA; Estivill, X; Etemadmoghadam, D; Feuerbach, L; Fink, JL; Frenkel-Morgenstern, M; Garsed, DW; Gordenin, DA; Haan, D; Haber, JE; Hess, JM; Hutter, B; Imielinski, M; Jones, DTW; Kazanov, MD; Klimczak, LJ; Koh, Y; Kumar, K; Lee, JJK; Lynch, AG; Macintyre, G; Markowetz, F; Martinez-Fundichely, A; Meyerson, M; Miyano, S; Nakagawa, H; Ossowski, S; Pearson, JV; Rippe, K; Roberts, SA; Scully, R; Shackleton, M; Sidiropoulos, N; Sieverling, L; Stewart, C; Villasante, I; Waddell, N; Yang, LX; Yao, XT; Yoon, SS; Zhang, CZ				Rodriguez-Martin, Bernardo; Alvarez, Eva G.; Baez-Ortega, Adrian; Zamora, Jorge; Supek, Fran; Demeulemeester, Jonas; Santamarina, Martin; Ju, Young Seok; Temes, Javier; Garcia-Souto, Daniel; Detering, Harald; Li, Yilong; Rodriguez-Castro, Jorge; Dueso-Barroso, Ana; Bruzos, Alicia L.; Dentro, Stefan C.; Blanco, Miguel G.; Contino, Gianmarco; Ardeljan, Daniel; Tojo, Marta; Roberts, Nicola D.; Zumalave, Sonia; Edwards, Paul A. W.; Weischenfeldt, Joachim; Puiggros, Montserrat; Chong, Zechen; Chen, Ken; Lee, Eunjung Alice; Wala, Jeremiah A.; Raine, Keiran; Butler, Adam; Waszak, Sebastian M.; Navarro, Fabio C. P.; Schumacher, Steven E.; Monlong, Jean; Maura, Francesco; Bolli, Niccolo; Bourque, Guillaume; Gerstein, Mark; Park, Peter J.; Wedge, David C.; Beroukhim, Rameen; Torrents, David; Korbel, Jan O.; Martincorena, Inigo; Fitzgerald, Rebecca C.; Van Loo, Peter; Kazazian, Haig H.; Burns, Kathleen H.; Campbell, Peter J.; Tubio, Jose M. C.; Akdemir, Kadir C.; Boutros, Paul C.; Bowtell, David D. L.; Brors, Benedikt; Chan, Kin; Cortes-Ciriano, Isidro; Dunford, Andrew J.; Edwards, Paul A.; Estivill, Xavier; Etemadmoghadam, Dariush; Feuerbach, Lars; Fink, J. Lynn; Frenkel-Morgenstern, Milana; Garsed, Dale W.; Gordenin, Dmitry A.; Haan, David; Haber, James E.; Hess, Julian M.; Hutter, Barbara; Imielinski, Marcin; Jones, David T. W.; Kazanov, Marat D.; Klimczak, Leszek J.; Koh, Youngil; Kumar, Kiran; Lee, Jake June-Koo; Lynch, Andy G.; Macintyre, Geoff; Markowetz, Florian; Martinez-Fundichely, Alexander; Meyerson, Matthew; Miyano, Satoru; Nakagawa, Hidewaki; Ossowski, Stephan; Pearson, John, V; Rippe, Karsten; Roberts, Steven A.; Scully, Ralph; Shackleton, Mark; Sidiropoulos, Nikos; Sieverling, Lina; Stewart, Chip; Villasante, Izar; Waddell, Nicola; Yang, Lixing; Yao, Xiaotong; Yoon, Sung-Soo; Zhang, Cheng-Zhong		PCAWG Struct Variation Working Grp; PCAWG Consortium	Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition	NATURE GENETICS			English	Article							L1 RETROTRANSPOSITION; SOMATIC RETROTRANSPOSITION; READ ALIGNMENT; ELEMENTS; DNA; INSTABILITY; LANDSCAPE; DELETION	About half of all cancers have somatic integrations of retrotransposons. Here, to characterize their role in oncogenesis, we analyzed the patterns and mechanisms of somatic retrotransposition in 2,954 cancer genomes from 38 histological cancer subtypes within the framework of the Pan-Cancer Analysis of Whole Genomes (PCAWG) project. We identified 19,166 somatically acquired retrotransposition events, which affected 35% of samples and spanned a range of event types. Long interspersed nuclear element (LINE-1; L1 hereafter) insertions emerged as the first most frequent type of somatic structural variation in esophageal adenocarcinoma, and the second most frequent in head-and-neck and colorectal cancers. Aberrant L1 integrations can delete megabase-scale regions of a chromosome, which sometimes leads to the removal of tumor-suppressor genes, and can induce complex translocations and large-scale duplications. Somatic retrotranspositions can also initiate breakage-fusion-bridge cycles, leading to high-level amplification of oncogenes. These observations illuminate a relevant role of L1 retrotransposition in remodeling the cancer genome, with potential implications for the development of human tumors. An analysis of 2,954 genomes from 38 cancer subtypes identified 19,166 retrotransposition events in 35% of samples. Aberrant LINE-1 retrotranspositions can lead to the deletion of tumor-suppressor genes as well as the amplification of oncogenes.	[Rodriguez-Martin, Bernardo; Alvarez, Eva G.; Zamora, Jorge; Santamarina, Martin; Temes, Javier; Garcia-Souto, Daniel; Rodriguez-Castro, Jorge; Bruzos, Alicia L.; Zumalave, Sonia; Tubio, Jose M. C.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Genomes & Dis, Santiago De Compostela, Spain; [Rodriguez-Martin, Bernardo; Alvarez, Eva G.; Zamora, Jorge; Santamarina, Martin; Bruzos, Alicia L.; Zumalave, Sonia; Tubio, Jose M. C.] Univ Santiago de Compostela, Dept Zool Genet & Phys Anthropol, Santiago De Compostela, Spain; [Rodriguez-Martin, Bernardo; Alvarez, Eva G.; Zamora, Jorge; Santamarina, Martin; Detering, Harald; Bruzos, Alicia L.; Tubio, Jose M. C.] Univ Vigo, Biomed Res Ctr CINBIO, Vigo, Spain; [Baez-Ortega, Adrian] Univ Cambridge, Dept Vet Med, Transmissible Canc Grp, Cambridge, England; [Supek, Fran] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Genome Data Sci, Barcelona, Spain; [Supek, Fran; Torrents, David] ICREA, Barcelona, Spain; [Demeulemeester, Jonas; Dentro, Stefan C.; Van Loo, Peter] Francis Crick Inst, London, England; [Demeulemeester, Jonas; Van Loo, Peter] Univ Leuven, Dept Human Genet, Leuven, Belgium; [Ju, Young Seok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Ju, Young Seok; Li, Yilong; Roberts, Nicola D.; Raine, Keiran; Butler, Adam; Maura, Francesco; Wedge, David C.; Martincorena, Inigo; Burns, Kathleen H.; Campbell, Peter J.; Tubio, Jose M. C.] Wellcome Sanger Inst, Canc Ageing & Somat Mutat Programme, Cambridge, England; [Detering, Harald; Tojo, Marta] Univ Vigo, Dept Biochem Genet & Immunol, Vigo, Spain; [Detering, Harald] Galicia Hlth Res Inst, Vigo, Spain; [Dueso-Barroso, Ana; Puiggros, Montserrat; Torrents, David] CNS, BSC, Barcelona, Spain; [Dueso-Barroso, Ana] Univ Vic, Fac Sci & Technol, Cent Univ Catalonia UVic UCC, Vic, Spain; [Dentro, Stefan C.] Wellcome Sanger Inst, Expt Canc Genet, Cambridge, England; [Dentro, Stefan C.; Wedge, David C.] Univ Oxford, Oxford Big Data Inst, Oxford, England; [Blanco, Miguel G.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, DNA Repair & Genome Integr, Santiago De Compostela, Spain; [Blanco, Miguel G.] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Santiago De Compostela, Spain; [Contino, Gianmarco; Fitzgerald, Rebecca C.] Univ Cambridge, MRC, Canc Unit, Cambridge, England; [Ardeljan, Daniel; Kazazian, Haig H.; Burns, Kathleen H.] Johns Hopkins Univ, Dept Genet Med, Sch Med, Baltimore, MD USA; [Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge, England; [Edwards, Paul A. W.; Edwards, Paul A.; Lynch, Andy G.; Macintyre, Geoff; Markowetz, Florian] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Weischenfeldt, Joachim] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Weischenfeldt, Joachim] Rigshosp, Finsen Lab, Copenhagen, Denmark; [Weischenfeldt, Joachim; Waszak, Sebastian M.; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Chong, Zechen; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Chong, Zechen] Univ Alabama Birmingham, Sch Med, Dept Genet, Birmingham, AL USA; [Chong, Zechen] Univ Alabama Birmingham, Sch Med, Informat Inst, Birmingham, AL USA; [Lee, Eunjung Alice] Harvard Med Sch, Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Lee, Eunjung Alice; Wala, Jeremiah A.; Schumacher, Steven E.; Beroukhim, Rameen] Broad Inst Harvard & MIT, Cambridge, MA USA; [Wala, Jeremiah A.; Schumacher, Steven E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wala, Jeremiah A.; Schumacher, Steven E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Navarro, Fabio C. P.; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Navarro, Fabio C. P.; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Navarro, Fabio C. P.; Gerstein, Mark] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA; [Monlong, Jean; Bourque, Guillaume] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Maura, Francesco; Bolli, Niccolo] Univ Milan, Dept Oncol & Onco Hematol, Milan, Italy; [Maura, Francesco; Bolli, Niccolo] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, Milan, Italy; [Park, Peter J.; Cortes-Ciriano, Isidro; Lee, Jake June-Koo] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Wedge, David C.] Oxford NIHR Biomed Res Ctr, Oxford, England; [Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Burns, Kathleen H.; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Chen, Ken; Akdemir, Kadir C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rodriguez-Martin, Bernardo; Alvarez, Eva G.; Zamora, Jorge] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Wala, Jeremiah A.; Dunford, Andrew J.; Hess, Julian M.; Kumar, Kiran; Meyerson, Matthew; Stewart, Chip; Zhang, Cheng-Zhong] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wala, Jeremiah A.; Meyerson, Matthew; Zhang, Cheng-Zhong] Harvard Med Sch, Boston, MA 02115 USA; [Boutros, Paul C.] Ontario Inst Canc Res, Computat Biol Program, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Bowtell, David D. L.; Etemadmoghadam, Dariush; Garsed, Dale W.; Shackleton, Mark] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bowtell, David D. L.; Etemadmoghadam, Dariush; Garsed, Dale W.; Shackleton, Mark] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Brors, Benedikt; Feuerbach, Lars; Sieverling, Lina] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Brors, Benedikt; Hutter, Barbara] Natl Ctr Tumor Dis NCT Heidelberg, Heidelberg, Germany; [Burns, Kathleen H.] Johns Hopkins Sch Med, Baltimore, MD USA; [Zamora, Jorge; Ju, Young Seok; Li, Yilong; Roberts, Nicola D.; Burns, Kathleen H.; Campbell, Peter J.] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Chan, Kin] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Cortes-Ciriano, Isidro] Univ Cambridge, Ctr Mol Sci Informat, Dept Chem, Cambridge, England; [Cortes-Ciriano, Isidro] Harvard Med Sch, Ludwig Ctr, Boston, MA 02115 USA; [Dueso-Barroso, Ana; Puiggros, Montserrat; Torrents, David; Fink, J. Lynn; Villasante, Izar] Barcelona Supercomp Ctr, Barcelona, Spain; [Edwards, Paul A.; Lynch, Andy G.; Markowetz, Florian] Univ Cambridge, Cambridge, England; [Estivill, Xavier] Sidra Med, Doha, Qatar; [Fink, J. Lynn] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, St Lucia, Qld, Australia; [Frenkel-Morgenstern, Milana] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Gerstein, Mark] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Gordenin, Dmitry A.] NIEHS, Genome Integr & Struct Biol Lab, Durham, NC USA; [Haan, David] Univ Calif Santa Cruz, Biomol Engn Dept, Santa Cruz, CA 95064 USA; [Haber, James E.] Brandeis Univ, Waltham, MA USA; [Hess, Julian M.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Hutter, Barbara] German Canc Consortium DKTK, Heidelberg, Germany; [Hutter, Barbara] German Canc Res Ctr, Heidelberg Ctr Personalized Oncol DKFZ HIPO, Heidelberg, Germany; [Imielinski, Marcin; Yao, Xiaotong] New York Genome Ctr, New York, NY USA; [Imielinski, Marcin] Weill Cornell Med, New York, NY USA; [Jones, David T. W.] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany; [Jones, David T. W.] German Canc Res Ctr, Pediat Glioma Res Grp, Heidelberg, Germany; [Ju, Young Seok] Korea Adv Inst Sci & Technol, Daejeon, South Korea; [Kazanov, Marat D.] Skolkovo Inst Sci & Technol, Moscow, Russia; [Kazanov, Marat D.] AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Kazanov, Marat D.] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia; [Klimczak, Leszek J.] NIEHS, Integrat Bioinformat Support Grp, Durham, NC USA; [Koh, Youngil] Seoul Natl Univ Hosp, Ctr Med Innovat, Seoul, South Korea; [Koh, Youngil; Yoon, Sung-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Korbel, Jan O.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Lee, Jake June-Koo] Ludwig Ctr Harvard, Boston, MA USA; [Lynch, Andy G.] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Lynch, Andy G.] Univ St Andrews, Sch Math & Stat, St Andrews, Fife, Scotland; [Martinez-Fundichely, Alexander] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Martinez-Fundichely, Alexander] Weill Cornell Med, Englander Inst Precis Med, New York, NY USA; [Martinez-Fundichely, Alexander] Weill Cornell Med, Inst Computat Biomed, New York, NY USA; [Wala, Jeremiah A.; Meyerson, Matthew; Zhang, Cheng-Zhong] Dana Farber Canc Inst, Boston, MA 02115 USA; [Meyerson, Matthew] Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland; [Meyerson, Matthew] Univ Bern, Bern, Switzerland; [Meyerson, Matthew] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Miyano, Satoru] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Nakagawa, Hidewaki] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Ossowski, Stephan] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain; [Ossowski, Stephan] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona, Spain; [Pearson, John, V; Waddell, Nicola] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Pearson, John, V; Waddell, Nicola] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Rippe, Karsten] German Canc Res Ctr, Heidelberg, Germany; [Roberts, Steven A.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Roberts, Steven A.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Scully, Ralph] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Shackleton, Mark] Univ Melbourne, Melbourne, Vic, Australia; [Weischenfeldt, Joachim; Sidiropoulos, Nikos] Univ Copenhagen, Finsen Lab, Copenhagen, Denmark; [Weischenfeldt, Joachim; Sidiropoulos, Nikos] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Sieverling, Lina] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Weischenfeldt, Joachim] Charite Univ Med Berlin, Dept Urol, Berlin, Germany; [Yang, Lixing] Univ Chicago, Ben May Dept Canc Res, Dept Human Genet, Chicago, IL 60637 USA; [Yao, Xiaotong] Weill Cornell Med, Triinst PhD Program Computat Biol & Med, New York, NY USA	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Vigo; CINBIO; University of Cambridge; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Francis Crick Institute; KU Leuven; Korea Advanced Institute of Science & Technology (KAIST); Wellcome Trust Sanger Institute; Universidade de Vigo; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Wellcome Trust Sanger Institute; University of Oxford; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Cambridge; Johns Hopkins University; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Copenhagen; Rigshospitalet; University of Copenhagen; European Molecular Biology Laboratory (EMBL); University of Texas System; UTMD Anderson Cancer Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Yale University; Yale University; Yale University; McGill University; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Harvard University; Harvard Medical School; University of Oxford; Johns Hopkins University; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; Universidade de Santiago de Compostela; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johns Hopkins University; Johns Hopkins Medicine; Wellcome Trust Sanger Institute; University of Ottawa; University of Cambridge; Harvard University; Harvard Medical School; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Cambridge; Sidra Medical & Research Center; University of Queensland; Bar Ilan University; Princeton University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Santa Cruz; Brandeis University; Harvard University; Massachusetts General Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Cornell University; Helmholtz Association; German Cancer Research Center (DKFZ); Korea Advanced Institute of Science & Technology (KAIST); Skolkovo Institute of Science & Technology; Kharkevich Institute for Information Transmission Problems of the RAS; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; European Molecular Biology Laboratory (EMBL); University of St Andrews; University of St Andrews; Cornell University; Cornell University; Cornell University; Harvard University; Dana-Farber Cancer Institute; University of Bern; University Hospital of Bern; University of Bern; University of Melbourne; University of Tokyo; RIKEN; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Eberhard Karls University of Tubingen; Pompeu Fabra University; QIMR Berghofer Medical Research Institute; University of Queensland; Helmholtz Association; German Cancer Research Center (DKFZ); Washington State University; Washington State University; Harvard University; Beth Israel Deaconess Medical Center; University of Melbourne; University of Copenhagen; University of Copenhagen; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Chicago; Cornell University	Tubio, JMC (corresponding author), Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Genomes & Dis, Santiago De Compostela, Spain.; Tubio, JMC (corresponding author), Univ Santiago de Compostela, Dept Zool Genet & Phys Anthropol, Santiago De Compostela, Spain.; Tubio, JMC (corresponding author), Univ Vigo, Biomed Res Ctr CINBIO, Vigo, Spain.; Campbell, PJ; Tubio, JMC (corresponding author), Wellcome Sanger Inst, Canc Ageing & Somat Mutat Programme, Cambridge, England.; Campbell, PJ (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.	pc8@sanger.ac.uk; jose.mc.tubio@usc.es	Supek, Fran/B-2359-2012; Martinez-Fundichely, Alexander/AAR-7309-2020; Scully, Ralph/F-5008-2013; Souto, Daniel García/H-2213-2015; Waszak, Sebastian M./D-7828-2015; Monlong, Jean/AAZ-8589-2020; Wedge, David/AAC-4977-2021; Fink, Lynn/C-2031-2008; Bowtell, David/H-1007-2016; Bourque, Guillaume/AFR-2927-2022; Waddell, Nicola/H-4929-2015; Weischenfeldt, Joachim/O-3681-2015; Pearson, John/AAT-4211-2020; Bruzos, Alicia L./D-7235-2018; Castro, Jorge Rodríguez/E-5345-2018; Rippe, Karsten/A-3562-2012; Chen, Ken/AAU-1432-2021; Yakneen, Sergei/O-8928-2017; Kazanov, Marat D/D-6381-2013; Ciriano, Isidro Cortes/ABE-1794-2021; Brors, Benedikt/E-5620-2013; Blanco, Miguel González/J-6424-2012; Tsunoda, Tatsuhiko/K-2061-2014; Blanco, Miguel González/R-5754-2017; Demeulemeester, Jonas/J-6130-2014; Bolli, Niccolo/D-4057-2011; MAURA, FRANCESCO/AAG-7416-2021; Sidiropoulos, Nikos/O-3687-2015; Ju, Young Seok/E-1324-2012; Tubio, Jose/H-5076-2015	Supek, Fran/0000-0002-7811-6711; Martinez-Fundichely, Alexander/0000-0002-7660-5511; Souto, Daniel García/0000-0002-0997-8799; Waszak, Sebastian M./0000-0003-3042-9521; Monlong, Jean/0000-0002-9737-5516; Fink, Lynn/0000-0003-2912-6048; Bowtell, David/0000-0001-9089-7525; Bourque, Guillaume/0000-0002-3933-9656; Waddell, Nicola/0000-0002-3950-2476; Weischenfeldt, Joachim/0000-0002-3917-5524; Bruzos, Alicia L./0000-0003-4362-545X; Castro, Jorge Rodríguez/0000-0003-2912-9601; Rippe, Karsten/0000-0001-9951-9395; Chen, Ken/0000-0003-4013-5279; Yakneen, Sergei/0000-0001-7827-9839; Kazanov, Marat D/0000-0002-2314-5507; Ciriano, Isidro Cortes/0000-0002-2036-494X; Brors, Benedikt/0000-0001-5940-3101; Blanco, Miguel González/0000-0002-2883-7326; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Blanco, Miguel González/0000-0002-2883-7326; Demeulemeester, Jonas/0000-0002-2660-2478; Bolli, Niccolo/0000-0002-1018-5139; MAURA, FRANCESCO/0000-0002-5017-1620; Dueso-Barroso, Ana/0000-0003-2000-9718; Martincorena, Inigo/0000-0003-1122-4416; Roberts, Nicola/0000-0002-0469-1043; Raine, Keiran/0000-0002-5634-1539; Sidiropoulos, Nikos/0000-0002-1854-1193; Aparicio, Samuel/0000-0002-0487-9599; Baez-Ortega, Adrian/0000-0002-9201-4420; Zumalave, Sonia/0000-0002-2108-1861; Temes, Javier/0000-0003-3370-4728; Ju, Young Seok/0000-0002-5514-4189; , IIS Galicia Sur/0000-0003-3812-7413; Lynch, Andy/0000-0002-7876-7338; Tubio, Jose/0000-0003-3540-2459; SANTAMARINA GARCIA, MARTIN/0000-0001-5914-0540; Contino, Gianmarco/0000-0001-5874-0405; G Alvarez, Eva/0000-0002-3522-5088; Fitzgerald, Rebecca/0000-0002-3434-3568; Frenkel-Morgenstern, Milana/0000-0002-0329-4599; Wedge, David/0000-0002-7572-3196; Dentro, Stefan/0000-0002-0478-9729; Rodriguez-Martin, Bernardo/0000-0003-4693-3140	European Research Council (ERC) [716290]; Ramon y Cajal grant [RYC-2014-14999]; Spanish Ministry of Economy, Industry and Competitiveness (MINECO) grant [SAF2015-66368-P]; Xunta de Galicia (Spain) [ED481A-2016/151, ED481A-2017/299, ED481A-2017/306, ED481A-2018/199]; ERC [757700]; MINECO [BFU2017-89833-P, BES-2016-078166, SAF2015-73916-JIN]; MINECO Severo Ochoa award; CERCA Programme of the Catalan Government; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C2387]; National Institutes of Health [U24CA210978, R01CA188228]; AEI; Xunta de Galicia; FEDER [BFU2013-41554-P, BFU2016-78121-P, ED431F 2016/019]; My First AIRC grant from the Associazione Italiana Ricerca sul Cancro [17658]; European Union [703594-DECODE]; NIH [R01 CA172652, U41 HG007497]; American Heart Association Institutional Data Fellowship Award [17IF33890015]; Cancer Research UK [C57387/A21777]; A.I.L. (Associazione Italiana Contro le Leucemie-Linfomi e Mieloma ONLUS); S.I.E.S. (Societa Italiana di Ematologia Sperimentale); SNSF Early Postdoc Mobility fellowship [P2ELP3_155365]; EMBO Long-Term Fellowship [ALTF 755-2014]; Danish Medical Research Council [DFF-4183-00233]; Li Ka Shing foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; ERC; Francis Crick Institute from Cancer Research UK [FC001202]; UK Medical Research Council [FC001202]; Wellcome Trust [FC001202]; National Institute of General Medical Sciences [P50GM107632, 1R01GM099875]; TransTumVar project [PN013600]; Wellcome Trust grant [09805];  [K01AG051791];  [R01CA163705];  [R01GM124531]	European Research Council (ERC)(European Research Council (ERC)European Commission); Ramon y Cajal grant(Spanish Government); Spanish Ministry of Economy, Industry and Competitiveness (MINECO) grant; Xunta de Galicia (Spain)(Xunta de Galicia); ERC(European Research Council (ERC)European Commission); MINECO(Spanish Government); MINECO Severo Ochoa award; CERCA Programme of the Catalan Government; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AEI; Xunta de Galicia(Xunta de GaliciaEuropean Commission); FEDER(European Commission); My First AIRC grant from the Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Institutional Data Fellowship Award(American Heart Association); Cancer Research UK(Cancer Research UK); A.I.L. (Associazione Italiana Contro le Leucemie-Linfomi e Mieloma ONLUS); S.I.E.S. (Societa Italiana di Ematologia Sperimentale); SNSF Early Postdoc Mobility fellowship; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Li Ka Shing foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); ERC(European Research Council (ERC)European Commission); Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); TransTumVar project; Wellcome Trust grant(Wellcome Trust); ; ; 	J.M.C.T. is supported by European Research Council (ERC) Starting Grant 716290 `SCUBA CANCERS', Ramon y Cajal grant RYC-2014-14999 and Spanish Ministry of Economy, Industry and Competitiveness (MINECO) grant SAF2015-66368-P. B.R.-M., E.G.A., M.S.G. and S.Z. are supported by PhD fellowships from Xunta de Galicia (Spain) ED481A-2016/151, ED481A-2017/299, ED481A-2017/306 and ED481A-2018/199, respectively. F.S. was supported by ERC Starting Grant 757700 `HYPER-INSIGHT', MINECO grant BFU2017-89833-P `RegioMut', and further acknowledges institutional funding from the MINECO Severo Ochoa award and from the CERCA Programme of the Catalan Government. Y.S.J. was supported by Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI16C2387).; A.L.B. is supported by MINECO PhD fellowship BES-2016-078166. M.T. was supported by MINECO grant SAF2015-73916-JIN. R.B. received funding through the National Institutes of Health (U24CA210978 and R01CA188228). M.G.B. received funding through MINECO, AEI, Xunta de Galicia and FEDER (BFU2013-41554-P, BFU2016-78121-P, ED431F 2016/019). N.B. is supported by a My First AIRC grant from the Associazione Italiana Ricerca sul Cancro (number 17658). J.D. is a postdoctoral fellow of the Research Foundation Flanders (FWO) and the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant agreement number 703594-DECODE). K.C. and Z.C. are supported by NIH R01 CA172652 and U41 HG007497. Z.C. is supported by an American Heart Association Institutional Data Fellowship Award (17IF33890015). P.A.W.E. is supported by Cancer Research UK. E.A.L. is supported by K01AG051791. I.M. is supported by Cancer Research UK (C57387/A21777). F.M. is supported by A.I.L. (Associazione Italiana Contro le Leucemie-Linfomi e Mieloma ONLUS) and by S.I.E.S. (Societa Italiana di Ematologia Sperimentale). S.M.W. received funding through a SNSF Early Postdoc Mobility fellowship (P2ELP3_155365) and an EMBO Long-Term Fellowship (ALTF 755-2014). J.W. received funding from the Danish Medical Research Council (DFF-4183-00233). D.C.W. is funded by the Li Ka Shing foundation and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. J.O.K. is supported by an ERC Starting Grant. P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation's support towards the establishment of The Francis Crick Institute. This work is supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202) and the Wellcome Trust (FC001202). H.H.K. is supported by grants from the National Institute of General Medical Sciences (P50GM107632 and 1R01GM099875). K.H.B. is supported by P50GM107632, R01CA163705 and R01GM124531. This work was supported by the TransTumVar project PN013600. R.C.F. thanks Cancer Research UK Programme Grant for esophageal ICGC, Cambridge BRC and ECMC infrastructure support. This work was supported by the Wellcome Trust grant 09805. We acknowledge the contributions of the many clinical networks across the ICGC and TCGA who provided samples and data to the PCAWG Consortium, and the contributions of the Technical Working Group and the Germline Working Group of the PCAWG Consortium for collation, realignment and harmonized variant calling of the cancer genomes used in this study. We thank the patients and their families for their participation in the individual ICGC and TCGA projects.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Burns KH, 2017, NAT REV CANCER, V17, P415, DOI 10.1038/nrc.2017.35; Calabrese C, 2020, NATURE, V578, P129, DOI 10.1038/s41586-020-1970-0; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388; Ewing AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r22; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Jung H, 2018, GENOME RES, V28, P1136, DOI 10.1101/gr.231837.117; Kazazian HH, 2017, NEW ENGL J MED, V377, P361, DOI 10.1056/NEJMra1510092; Kazazian HH, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-20; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Maciejowski J, 2017, NAT REV MOL CELL BIO, V18, P175, DOI 10.1038/nrm.2016.171; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mita P, 2018, ELIFE, V7, DOI 10.7554/eLife.30058; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Sen SK, 2007, NUCLEIC ACIDS RES, V35, P3741, DOI 10.1093/nar/gkm317; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Wylie A, 2016, GENE DEV, V30, P64, DOI 10.1101/gad.266098.115; Xu W, 2011, J GENET GENOMICS, V38, P439, DOI 10.1016/j.jgg.2011.09.002; Zhou CC, 2017, ONCOTARGET, V8, P50071, DOI 10.18632/oncotarget.18412	57	125	128	6	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2020	52	3					306	+		10.1038/s41588-019-0562-0	http://dx.doi.org/10.1038/s41588-019-0562-0		FEB 2020	17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KS5DL	32024998	Green Published, hybrid			2022-12-17	WOS:000511282900007
J	Williams, MJ; Werner, B; Heide, T; Curtis, C; Barnes, CP; Sottoriva, A; Graham, TA				Williams, Marc J.; Werner, Benjamin; Heide, Timon; Curtis, Christina; Barnes, Chris P.; Sottoriva, Andrea; Graham, Trevor A.			Quantification of subclonal selection in cancer from bulk sequencing data	NATURE GENETICS			English	Article							TUMOR EVOLUTION; INTRATUMOR HETEROGENEITY; MUTATIONAL PROCESSES; MODEL SELECTION; POINT MUTATIONS; BREAST-CANCER; POPULATION; GROWTH; DRIVER; CELLS	Subclonal architectures are prevalent across cancer types. However, the temporal evolutionary dynamics that produce tumor subclones remain unknown. Here we measure clone dynamics in human cancers by using computational modeling of subclonal selection and theoretical population genetics applied to high-throughput sequencing data. Our method determined the detectable subclonal architecture of tumor samples and simultaneously measured the selective advantage and time of appearance of each subclone. We demonstrate the accuracy of our approach and the extent to which evolutionary dynamics are recorded in the genome. Application of our method to high-depth sequencing data from breast, gastric, blood, colon and lung cancer samples, as well as metastatic deposits, showed that detectable subclones under selection, when present, consistently emerged early during tumor growth and had a large fitness advantage (>20%). Our quantitative framework provides new insight into the evolutionary trajectories of human cancers and facilitates predictive measurements in individual tumors from widely available sequencing data.	[Williams, Marc J.; Graham, Trevor A.] Queen Mary Univ London, Barts Canc Inst, Evolut & Canc Lab, London, England; [Williams, Marc J.; Barnes, Chris P.] UCL, Dept Cell & Dev Biol, London, England; [Williams, Marc J.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Werner, Benjamin; Heide, Timon; Sottoriva, Andrea] Inst Canc Res, Evolutionary Genom & Modelling Lab, Ctr Evolut & Canc, London, England; [Curtis, Christina] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Barnes, Chris P.] UCL, UCL Genet Inst, London, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; University of London; University College London	Graham, TA (corresponding author), Queen Mary Univ London, Barts Canc Inst, Evolut & Canc Lab, London, England.; Barnes, CP (corresponding author), UCL, Dept Cell & Dev Biol, London, England.; Sottoriva, A (corresponding author), Inst Canc Res, Evolutionary Genom & Modelling Lab, Ctr Evolut & Canc, London, England.; Barnes, CP (corresponding author), UCL, UCL Genet Inst, London, England.	christopher.barnes@ucl.ac.uk; andrea.sottoriva@icr.ac.uk; t.graham@qmul.ac.uk		Werner, Benjamin/0000-0002-6857-8699; Barnes, Chris/0000-0002-9459-1395; Williams, Marc/0000-0001-5524-4174; Curtis, Christina/0000-0003-0166-3802; Graham, Trevor/0000-0001-9582-1597; Sottoriva, Andrea/0000-0001-6709-9533; Heide, Timon/0000-0002-1386-7469	Chris Rokos Fellowship in Evolution and Cancer; Cancer Research UK [A22909, A19771]; Wellcome Trust [097319/Z/11/Z, 202778/B/16/Z, 202778/Z/16/Z, 105104/Z/14/Z]; Geoffrey W. Lewis Postdoctoral Training fellowship; NIH [R01CA182514]; Susan G. Komen Foundation [IIR13260750]; Breast Cancer Research Foundation [BCRF16-032]; Medical Research Council student scholarship; NATIONAL CANCER INSTITUTE [R01CA182514] Funding Source: NIH RePORTER	Chris Rokos Fellowship in Evolution and Cancer; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Geoffrey W. Lewis Postdoctoral Training fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Medical Research Council student scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Huang and K. Chkhaidze for fruitful discussions. We are grateful to A. Chinnaiyan and M. Cieslik for providing us with data from the MET500 cohort and to S. Leung for providing access to the gastric cancer cohort. A. S. is supported by the Chris Rokos Fellowship in Evolution and Cancer and by Cancer Research UK (grant no. A22909). T.A.G. is supported by Cancer Research UK (grant no. A19771). C.P.B. is supported by the Wellcome Trust (grant no. 097319/Z/11/Z). B.W. is supported by the Geoffrey W. Lewis Postdoctoral Training fellowship. A. S. and T.A.G. are jointly supported by the Wellcome Trust (grant no. 202778/B/16/Z and 202778/Z/16/Z, respectively). C.C. is supported by awards from the NIH (R01CA182514), Susan G. Komen Foundation (IIR13260750) and the Breast Cancer Research Foundation (BCRF16-032). M.J.W. is supported by a Medical Research Council student scholarship. This work was also supported by Wellcome Trust funding to the Center for Evolution and Cancer (grant no. 105104/Z/14/Z).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Barnes CP, 2012, STAT COMPUT, V22, P1181, DOI 10.1007/s11222-012-9335-7; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Burrell RA, 2016, TRENDS CANCER, V2, P263, DOI 10.1016/j.trecan.2016.04.002; Castro-Giner F, 2015, NAT REV CANCER, V15, P680, DOI 10.1038/nrc3999; Cheek D., 2017, PREPRINT; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Del Moral P, 2006, J R STAT SOC B, V68, P411, DOI 10.1111/j.1467-9868.2006.00553.x; Durrett R, 2015, MATH BIOSCI INST LEC, V1-1, P1, DOI 10.1007/978-3-319-16065-8; Durrett R, 2013, ANN APPL PROBAB, V23, P230, DOI 10.1214/11-AAP824; Enriquez-Navas PM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7842; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Fu YX, 1997, MOL BIOL EVOL, V14, P195, DOI 10.1093/oxfordjournals.molbev.a025753; Fusco D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12760; Gay Laura, 2016, F1000Res, V5, DOI 10.12688/f1000research.7210.1; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Gillespie JH, 2000, GENETICS, V155, P909; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffith M, 2015, CELL SYST, V1, P210, DOI 10.1016/j.cels.2015.08.015; Hartl DL, 1997, PRINCIPLES POPULATIO; Honda O, 2009, LUNG CANCER, V66, P211, DOI 10.1016/j.lungcan.2009.01.018; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kessler DA, 2015, J STAT PHYS, V158, P783, DOI 10.1007/s10955-014-1143-3; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; Lassig M, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0077; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Lugli N, 2017, CELL REP, V19, P2185, DOI 10.1016/j.celrep.2017.05.051; Marjoram P, 2006, NAT REV GENET, V7, P759, DOI 10.1038/nrg1961; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Rutledge SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22828; SESHADRI R, 1987, CANCER RES, V47, P407; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stead LF, 2013, HUM MUTAT, V34, P1432, DOI 10.1002/humu.22365; Sun RP, 2017, NAT GENET, V49, P1015, DOI 10.1038/ng.3891; Tavare S, 1997, GENETICS, V145, P505; Tilanus-Linthorst MMA, 2007, CLIN CANCER RES, V13, P7357, DOI 10.1158/1078-0432.CCR-07-0689; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Tsao JL, 1999, AM J PATHOL, V154, P1815, DOI 10.1016/S0002-9440(10)65437-5; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Wu CI, 2016, ANNU REV GENET, V50, P347, DOI 10.1146/annurev-genet-112414-054842; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01968-5	58	125	125	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2018	50	6					895	+		10.1038/s41588-018-0128-6	http://dx.doi.org/10.1038/s41588-018-0128-6			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GH7KD	29808029	Green Submitted, Green Accepted			2022-12-17	WOS:000433621000017
J	Zengini, E; Hatzikotoulas, K; Tachmazidou, I; Steinberg, J; Hartwig, FP; Southam, L; Hackinger, S; Boer, CG; Styrkarsdottir, U; Gilly, A; Suveges, D; Killian, B; Ingvarsson, T; Jonsson, H; Babis, GC; McCaskie, A; Uitterlinden, AG; van Meurs, JBJ; Thorsteinsdottir, U; Stefansson, K; Smith, GD; Wilkinson, JM; Zeggini, E				Zengini, Eleni; Hatzikotoulas, Konstantinos; Tachmazidou, Ioanna; Steinberg, Julia; Hartwig, Fernando P.; Southam, Lorraine; Hackinger, Sophie; Boer, Cindy G.; Styrkarsdottir, Unnur; Gilly, Arthur; Suveges, Daniel; Killian, Britt; Ingvarsson, Thorvaldur; Jonsson, Helgi; Babis, George C.; McCaskie, Andrew; Uitterlinden, Andre G.; van Meurs, Joyce B. J.; Thorsteinsdottir, Unnur; Stefansson, Kari; Smith, George Davey; Wilkinson, Jeremy M.; Zeggini, Eleftheria			Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis	NATURE GENETICS			English	Article							TRANSFORMING-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; ARTICULAR-CARTILAGE; MICE; RISK; BONE; EXPRESSION; VARIANTS; GDF5; P38	Osteoarthritis is a common complex disease imposing a large public-health burden. Here, we performed a genome-wide association study for osteoarthritis, using data across 16.5 million variants from the UK Biobank resource. After performing replication and meta-analysis in up to 30,727 cases and 297,191 controls, we identified nine new osteoarthritis loci, in all of which the most likely causal variant was noncoding. For three loci, we detected association with biologically relevant radiographic endophenotypes, and in five signals we identified genes that were differentially expressed in degraded compared with intact articular cartilage from patients with osteoarthritis. We established causal effects on osteoarthritis for higher body mass index but not for triglyceride levels or genetic predisposition to type 2 diabetes.	[Zengini, Eleni; Wilkinson, Jeremy M.] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Zengini, Eleni] Dromokaiteio Psychiat Hosp, Psychiat Dept 5, Athens, Greece; [Hatzikotoulas, Konstantinos; Tachmazidou, Ioanna; Steinberg, Julia; Southam, Lorraine; Hackinger, Sophie; Gilly, Arthur; Suveges, Daniel; Killian, Britt; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Human Genet, Hinxton, England; [Tachmazidou, Ioanna] Med Res Ctr, GSK, R&D Target Sci, Stevenage, Herts, England; [Steinberg, Julia] Canc Council NSW, Canc Res Div, Sydney, NSW, Australia; [Hartwig, Fernando P.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Hartwig, Fernando P.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Southam, Lorraine] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Boer, Cindy G.; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Boer, Cindy G.; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Styrkarsdottir, Unnur; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet Amgen, Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Akureyri Hosp, Dept Orthopaed Surg, Akureyri, Iceland; [Ingvarsson, Thorvaldur; Jonsson, Helgi; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, Akureyri, Iceland; [Jonsson, Helgi] Natl Univ Hosp Iceland, Landspitali, Dept Med, Reykjavik, Iceland; [Babis, George C.] Univ Athens, Konstantopouleio Gen Hosp, Dept Orthopaed Surg 2, Athens, Greece; [McCaskie, Andrew] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Div Trauma & Orthopaed Surg, Cambridge, England; [Smith, George Davey] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Smith, George Davey] Univ Hosp Bristol, NHS Fdn Trust, Bristol Biomed Res Ctr, Natl Inst Hlth Res, Bristol, Avon, England; [Smith, George Davey] Univ Bristol, Bristol, Avon, England	University of Sheffield; Wellcome Trust Sanger Institute; GlaxoSmithKline; Cancer Council New South Wales; Universidade Federal de Pelotas; University of Bristol; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Iceland; University of Akureyri; Landspitali National University Hospital; National & Kapodistrian University of Athens; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; Bristol Eye Hospital; University of Bristol; University of Bristol	Zeggini, E (corresponding author), Wellcome Trust Sanger Inst, Human Genet, Hinxton, England.	eleftheria@sanger.ac.uk	Davey Smith, George/A-7407-2013; Babis, George C/I-3397-2019; Boer, Cindy Germaine/I-7314-2019; Steinberg, Julia/S-2007-2019; Baillie, John Kenneth/F-3124-2011; Hartwig, Fernando/AAG-5578-2020; Stefansson, Kari/AAE-7187-2019	Davey Smith, George/0000-0002-1407-8314; Babis, George C/0000-0002-5710-7314; Boer, Cindy Germaine/0000-0003-4809-0044; Steinberg, Julia/0000-0002-0585-2312; Baillie, John Kenneth/0000-0001-5258-793X; Hatzikotoulas, Konstantinos/0000-0002-4699-3672; Suveges, Daniel/0000-0003-4133-0447; Southam, Loz/0000-0002-7546-9650; s, hema/0000-0002-3440-9475; van Meurs, Joyce/0000-0001-6245-2123; McCaskie, Andrew/0000-0001-6476-0832; Jonsson, Helgi/0000-0003-0187-8985; Styrkarsdottir, Unnur/0000-0001-8146-8278	Wellcome Trust [WT098051]; NIHR Cambridge Biomedical Research Centre; Erasmus Medical Center; Erasmus University; Organization for Health Research and Development (ZonMw); Netherlands Genomics Initiative (NGI)/Netherlands Organisation of Scientific Research (NWO); Netherlands Consortium for Healthy Aging (NCHA); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; MRC [MC_UU_00011/1, MR/P020941/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Erasmus Medical Center; Erasmus University; Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Genomics Initiative (NGI)/Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Consortium for Healthy Aging (NCHA); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was conducted by using the UK Biobank Resource under application no. 9979. This work was funded by the Wellcome Trust (WT098051). We are grateful to R. Brooks, J. Choudhary and T. Roumeliotis for their contribution to the functional genomics data collection. The Human Research Tissue Bank is supported by the NIHR Cambridge Biomedical Research Centre. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Organization for Health Research and Development (ZonMw); the Netherlands Genomics Initiative (NGI)/Netherlands Organisation of Scientific Research (NWO); the Netherlands Consortium for Healthy Aging (NCHA), Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P3693, DOI 10.1002/art.22968; Appleton CTG, 2010, LAB INVEST, V90, P20, DOI 10.1038/labinvest.2009.111; Baldwin JN, 2017, OSTEOARTHR CARTILAGE, V25, P1282, DOI 10.1016/j.joca.2017.03.007; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Broome DT, 2016, CONNECT TISSUE RES, V57, P175, DOI 10.3109/03008207.2015.1125480; Callahan LF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3492; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Castano-Betancourt MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006260; Castanon MJ, 2013, HISTOCHEM CELL BIOL, V140, P33, DOI 10.1007/s00418-013-1102-0; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Daans M, 2011, ANN RHEUM DIS, V70, P208, DOI 10.1136/ard.2010.134619; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Franklin J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3033; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hemani G, 2016, MR BASE PLATFORM SYS; Hussain SM, 2017, J RHEUMATOL, V44, P1071, DOI 10.3899/jrheum.151384; Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477; Iotchkova V, 2016, NAT GENET, V48, P1303, DOI 10.1038/ng.3668; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Ochiai S, 2008, J ORTHOP RES, V26, P894, DOI 10.1002/jor.20579; Palmieri A, 2008, CELL BIOL INT, V32, P733, DOI 10.1016/j.cellbi.2008.02.003; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Prasadam I, 2012, RHEUMATOLOGY, V51, P813, DOI 10.1093/rheumatology/ker360; Prasadam I, 2010, ARTHRITIS RHEUM-US, V62, P1349, DOI 10.1002/art.27397; Prasadam I, 2010, BONE, V46, P226, DOI 10.1016/j.bone.2009.10.014; Prieto-Alhambra D, 2013, ANN RHEUM DIS, V72, P911, DOI 10.1136/annrheumdis-2012-201451; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Steinberg J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09335-6; Styrkarsdottir U, 2017, NAT GENET, V49, P801, DOI 10.1038/ng.3816; Takada T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0792-1; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Tseng KY, 2017, ONCOTARGET, V8, P20588, DOI 10.18632/oncotarget.15246; Uhalte EC, 2017, HUM MOL GENET, V26, pR193, DOI 10.1093/hmg/ddx302; Usmani SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30434; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wang Q, 2015, ACTA HISTOCHEM, V117, P40, DOI 10.1016/j.acthis.2014.10.010; Wei L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1891; Wesseling J, 2009, ANN RHEUM DIS, V68, P1413, DOI 10.1136/ard.2008.096164; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zhang Y, 2014, CELL TISSUE RES, V358, P633, DOI 10.1007/s00441-014-2010-x; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	58	125	126	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					549	+		10.1038/s41588-018-0079-y	http://dx.doi.org/10.1038/s41588-018-0079-y			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	29559693	Green Accepted, Green Submitted			2022-12-17	WOS:000429529300015
J	Saintenac, C; Lee, WS; Cambon, F; Rudd, JJ; King, RC; Marande, W; Powers, SJ; Berges, H; Phillips, AL; Uauy, C; Hammond-Kosack, KE; Langin, T; Kanyuka, K				Saintenac, Cyrille; Lee, Wing-Sham; Cambon, Florence; Rudd, Jason J.; King, Robert C.; Marande, William; Powers, Stephen J.; Berges, Helene; Phillips, Andy L.; Uauy, Cristobal; Hammond-Kosack, Kim E.; Langin, Thierry; Kanyuka, Kostya			Wheat receptor-kinase-like protein Stb6 controls gene-for-gene resistance to fungal pathogen Zymoseptoria tritici	NATURE GENETICS			English	Article							BLOTCH MYCOSPHAERELLA-GRAMINICOLA; DISEASE-RESISTANCE; PLANT IMMUNITY; CELL-DEATH; CULTIVARS; RECOGNITION; EFFECTORS; TRANSFORMATION; EVOLUTION; VECTORS	Deployment of fast-evolving disease-resistance genes is one of the most successful strategies used by plants to fend off pathogens(1,2). In gene-for-gene relationships, most cloned disease-resistance genes encode intracellular nucleotide-binding leucine-rich-repeat proteins (NLRs) recognizing pathogen-secreted isolate-specific avirulence (Avr) effectors delivered to the host cytoplasm(3,4). This process often triggers a localized hypersensitive response, which halts further disease development(5). Here we report the map-based cloning of the wheat Stb6 gene and demonstrate that it encodes a conserved wall-associated receptor kinase (WAK)-like protein, which detects the presence of a matching apoplastic effector(6-8) and confers pathogen resistance without a hypersensitive response(9). This report demonstrates gene-for-gene disease resistance controlled by this class of proteins in plants. Moreover, Stb6 is, to our knowledge, the first cloned gene specifying resistance to Zymoseptoria tritici, an important foliar fungal pathogen affecting wheat and causing economically damaging septoria tritici blotch (STB) disease(10-12).	[Saintenac, Cyrille; Cambon, Florence; Langin, Thierry] INRA, UBP UMR GDEC 1095, Clermont Ferrand, France; [Lee, Wing-Sham; Rudd, Jason J.; Hammond-Kosack, Kim E.; Kanyuka, Kostya] Rothamsted Res, Biointeract & Crop Protect, Harpenden, Herts, England; [King, Robert C.; Powers, Stephen J.] Rothamsted Res, Computat & Analyt Sci, Harpenden, Herts, England; [Marande, William; Berges, Helene] INRA UPR 1258, CNRGV, Castanet Tolosan, France; [Phillips, Andy L.] Rothamsted Res, Plant Sci, Harpenden, Herts, England; [Uauy, Cristobal] John Innes Ctr, Crop Genet, Norwich Res Pk, Norwich, Norfolk, England	INRAE; Universite Clermont Auvergne (UCA); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; INRAE; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Saintenac, C (corresponding author), INRA, UBP UMR GDEC 1095, Clermont Ferrand, France.; Kanyuka, K (corresponding author), Rothamsted Res, Biointeract & Crop Protect, Harpenden, Herts, England.	cyrille.saintenac@inra.fr; kostya.kanyuka@rothamsted.ac.uk	Uauy, Cristobal/T-4382-2019; king, rob/AAT-3739-2020; Kanyuka, Kostya/F-9156-2016	Uauy, Cristobal/0000-0002-9814-1770; Hammond-Kosack, kim/0000-0002-9699-485X; Rudd, Jason/0000-0002-4743-1401; Kanyuka, Kostya/0000-0001-6324-4123; Saintenac, Cyrille/0000-0002-3791-301X	Institute Strategic Program from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC) [BB/J/00426x/1, BB/P016855/1]; French National Institute for Agricultural Research (INRA); BBSRC [BBS/E/C/00005202, BB/I000712/1, BBS/E/C/000I0220, BBS/E/J/000PR9780, BBS/E/C/000I0250, BBS/E/C/00005203, BBS/E/J/000PR8000, BB/I025077/1, BB/J012017/1, BB/J003743/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J003743/1, BBS/E/J/000PR9780, BBS/E/C/000I0250, BBS/E/C/000I0220, BB/J012017/1, BBS/E/C/00005202, BBS/E/C/00005203, BB/I000712/1] Funding Source: researchfish	Institute Strategic Program from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French National Institute for Agricultural Research (INRA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Biological Resource Centre on Small Grain Cereals (INRA, Clermont-Ferrand, France), the National Plant Germplasm System (USDA, US), the Germplasm Resources Unit (John Innes Centre, Norwich, UK), and the breeding companies KWS, Limagrain, RAGT Seeds, Saaten Union, Senova, Syngenta, Agri Obtentions, and Saatzucht Josef Breun GmbH & Co. KG for providing seed samples of different wheat species and varieties; E. Paux and H. Rimbert (INRA GDEC) for providing Stb6 expression data at different developmental stages; A. Doherty, A. Huttly, and C. Sparks (Rothamsted Research, Harpenden, UK) for vectors and wheat transformation; P. Isaac (iDNA Genetics Ltd., Norwich, UK) for transgene copy number analyses; INRA GDEC facilities for genotyping (GENTYANE) and wheat transformation; and S. Thomas (Rothamsted Research, Harpenden, UK) for providing vectors and protocols, and advice on the Y2H assay. We are also grateful to the International Wheat Genome Sequencing Consortium and K. Eversole for prepublication access to the IWGSC v1.0 wheat genome assembly. Research was funded by the Institute Strategic Program Grants' 20:20 Wheat' (BB/J/00426x/1) and Designing Future Wheat (BB/P016855/1) from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC) and the French National Institute for Agricultural Research (INRA).	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Antolin-Llovera M, 2012, ANNU REV PHYTOPATHOL, V50, P451, DOI 10.1146/annurev-phyto-081211-173002; Arraiano LS, 2006, PLANT PATHOL, V55, P726, DOI 10.1111/j.1365-3059.2006.01444.x; Arraiano LS, 2009, PLANT PATHOL, V58, P910, DOI 10.1111/j.1365-3059.2009.02118.x; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Brading PA, 2002, PHYTOPATHOLOGY, V92, P439, DOI 10.1094/PHYTO.2002.92.4.439; Brown JKM, 2015, FUNGAL GENET BIOL, V79, P33, DOI 10.1016/j.fgb.2015.04.017; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chartrain L, 2004, PHYTOPATHOLOGY, V94, P497, DOI 10.1094/PHYTO.2004.94.5.497; Chartrain L, 2005, PLANT PATHOL, V54, P134, DOI 10.1111/j.1365-3059.2005.01164.x; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Cools HJ, 2013, PEST MANAG SCI, V69, P150, DOI 10.1002/ps.3348; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; De Wit PJGM, 2016, NEW PHYTOL, V212, P805, DOI 10.1111/nph.14144; Dickman MB, 2013, ANNU REV PHYTOPATHOL, V51, P543, DOI 10.1146/annurev-phyto-081211-173027; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Eriksen L, 2003, THEOR APPL GENET, V107, P515, DOI 10.1007/s00122-003-1276-2; Estep LK, 2015, PLANT PATHOL, V64, P961, DOI 10.1111/ppa.12314; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Fones H, 2015, FUNGAL GENET BIOL, V79, P3, DOI 10.1016/j.fgb.2015.04.004; Ghaffary SMT, 2012, THEOR APPL GENET, V124, P125, DOI 10.1007/s00122-011-1692-7; Ghaffary SMT, 2011, THEOR APPL GENET, V123, P741, DOI 10.1007/s00122-011-1623-7; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kema G. H. J., 2018, NAT GENET; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P777, DOI 10.1094/Phyto-86-777; Keon J, 2007, MOL PLANT MICROBE IN, V20, P178, DOI 10.1094/MPMI-20-2-0178; Kettles GJ, 2017, NEW PHYTOL, V213, P338, DOI 10.1111/nph.14215; Kettles GJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00508; King R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137549; Kohorn BD, 2016, J EXP BOT, V67, P489, DOI 10.1093/jxb/erv467; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Krattinger SG, 2016, NEW PHYTOL, V212, P320, DOI 10.1111/nph.14097; Lee WS, 2015, FUNGAL GENET BIOL, V79, P84, DOI 10.1016/j.fgb.2015.04.006; Lee WS, 2014, MOL PLANT MICROBE IN, V27, P236, DOI 10.1094/MPMI-07-13-0201-R; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Marin-de la Rosa N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005337; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; McDonald BA, 2016, PHYTOPATHOLOGY, V106, P948, DOI 10.1094/PHYTO-03-16-0131-RVW; Michelmore RW, 2013, ANNU REV PHYTOPATHOL, V51, P291, DOI 10.1146/annurev-phyto-082712-102334; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rudd JJ, 2008, PLANT PHYSIOL, V147, P802, DOI 10.1104/pp.108.119511; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Sanchez-Vallet A, 2015, FUNGAL GENET BIOL, V79, P29, DOI 10.1016/j.fgb.2015.04.001; Shi GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600822; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Sparks CA, 2014, METHODS MOL BIOL, V1099, P201, DOI 10.1007/978-1-62703-715-0_17; Stotz HU, 2014, TRENDS PLANT SCI, V19, P491, DOI 10.1016/j.tplants.2014.04.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tassy C, 2014, PLANT CELL TISS ORG, V119, P171, DOI 10.1007/s11240-014-0524-2; Taylor I, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-22; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Torriani SFF, 2015, FUNGAL GENET BIOL, V79, P8, DOI 10.1016/j.fgb.2015.04.010; Torriani SFF, 2009, PEST MANAG SCI, V65, P155, DOI 10.1002/ps.1662; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; Zhong ZM, 2017, NEW PHYTOL, V214, P619, DOI 10.1111/nph.14434; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	68	125	125	4	104	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					368	+		10.1038/s41588-018-0051-x	http://dx.doi.org/10.1038/s41588-018-0051-x			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29434355	Green Published, Green Submitted			2022-12-17	WOS:000427933400012
J	Gharahkhani, P; Burdon, KP; Fogarty, R; Sharma, S; Hewitt, AW; Martin, S; Law, MH; Cremin, K; Bailey, JNC; Loomis, SJ; Pasquale, LR; Haines, JL; Hauser, MA; Viswanathan, AC; McGuffin, P; Topouzis, F; Foster, PJ; Graham, SL; Casson, RJ; Chehade, M; White, AJ; Zhou, T; Souzeau, E; Landers, J; Fitzgerald, JT; Klebe, S; Ruddle, JB; Goldberg, I; Healey, PR; Mills, RA; Wang, JJ; Montgomery, GW; Martin, NG; Radford-Smith, G; Whiteman, DC; Brown, MA; Wiggs, JL; Mackey, DA; Mitchell, P; MacGregor, S; Craig, JE				Gharahkhani, Puya; Burdon, Kathryn P.; Fogarty, Rhys; Sharma, Shiwani; Hewitt, Alex W.; Martin, Sarah; Law, Matthew H.; Cremin, Katie; Bailey, Jessica N. Cooke; Loomis, Stephanie J.; Pasquale, Louis R.; Haines, Jonathan L.; Hauser, Michael A.; Viswanathan, Ananth C.; McGuffin, Peter; Topouzis, Fotis; Foster, Paul J.; Graham, Stuart L.; Casson, Robert J.; Chehade, Mark; White, Andrew J.; Zhou, Tiger; Souzeau, Emmanuelle; Landers, John; Fitzgerald, Jude T.; Klebe, Sonja; Ruddle, Jonathan B.; Goldberg, Ivan; Healey, Paul R.; Mills, Richard A.; Wang, Jie Jin; Montgomery, Grant W.; Martin, Nicholas G.; Radford-Smith, Graham; Whiteman, David C.; Brown, Matthew A.; Wiggs, Janey L.; Mackey, David A.; Mitchell, Paul; MacGregor, Stuart; Craig, Jamie E.		Wellcome Trust Case Control Consor; NEIGHBORHOOD Consortium	Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BIOLOGICAL FUNCTION; AQUEOUS-HUMOR; GENE; IDENTIFICATION; AFAP-110; ABILITY	Primary open-angle glaucoma (POAG) is a major cause of irreversible blindness worldwide. We performed a genome-wide association study in an Australian discovery cohort comprising 1,155 cases with advanced POAG and 1,992 controls. We investigated the association of the top SNPs from the discovery stage in two Australian replication cohorts (932 cases and 6,862 controls total) and two US replication cohorts (2,616 cases and 2,634 controls total). Meta-analysis of all cohorts identified three loci newly associated with development of POAG. These loci are located upstream of ABCA1 (rs2472493[G], odds ratio (OR) = 1.31, P = 2.1 x 10(-19)), within AFAP1 (rs4619890[G], OR = 1.20, P = 7.0 x 10(-10)) and within GMDS (rs11969985[G], OR = 1.31, P = 7.7 x 10(-10)). Using RT-PCR and immunolabeling, we show that these genes are expressed within human retina, optic nerve and trabecular meshwork and that ABCA1 and AFAP1 are also expressed in retinal ganglion cells.	[Gharahkhani, Puya; Law, Matthew H.; Montgomery, Grant W.; Martin, Nicholas G.; Whiteman, David C.; MacGregor, Stuart] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Burdon, Kathryn P.; Fogarty, Rhys; Sharma, Shiwani; Martin, Sarah; Zhou, Tiger; Souzeau, Emmanuelle; Landers, John; Fitzgerald, Jude T.; Mills, Richard A.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Burdon, Kathryn P.; Mackey, David A.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Burdon, Kathryn P.; Hewitt, Alex W.; Ruddle, Jonathan B.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, CERA, Melbourne, Vic, Australia; [Cremin, Katie; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Bailey, Jessica N. Cooke; Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Bailey, Jessica N. Cooke; Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Loomis, Stephanie J.; Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Loomis, Stephanie J.; Pasquale, Louis R.; Wiggs, Janey L.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Pasquale, Louis R.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Hauser, Michael A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Viswanathan, Ananth C.; Foster, Paul J.] Moorfields Eye Hosp Natl Hlth Serv NHS Fdn Trus, Biomed Res Ctr, NIHR, London, England; [Viswanathan, Ananth C.; Foster, Paul J.] UCL, Inst Ophthalmol, London, England; [McGuffin, Peter] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, MRC, London, England; [Topouzis, Fotis] Aristotle Univ Thessaloniki, Sch Med, AHEPA Hosp, Dept Ophthalmol, Thessaloniki, Greece; [Graham, Stuart L.] Macquarie Univ, Sydney, NSW 2109, Australia; [Casson, Robert J.; Chehade, Mark] Univ Adelaide, South Australian Inst Ophthalmol, Adelaide, SA, Australia; [White, Andrew J.; Healey, Paul R.; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Westmead, NSW 2145, Australia; [Klebe, Sonja] Flinders Univ S Australia, Flinders Med Ctr, Dept Anat Pathol, Adelaide, SA 5001, Australia; [Goldberg, Ivan] Univ Sydney, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Radford-Smith, Graham] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Craig, Jamie E.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	QIMR Berghofer Medical Research Institute; Flinders University South Australia; University of Tasmania; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Queensland; Vanderbilt University; Case Western Reserve University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Duke University; Duke University; University of London; King's College London; University of London; University College London; University of London; King's College London; Aristotle University of Thessaloniki; Ahepa University Hospital; Macquarie University; University of Adelaide; University of Sydney; Westmead Institute for Medical Research; Flinders Medical Centre; Flinders University South Australia; University of Sydney; University of Queensland; Lions Eye Institute; University of Western Australia; South Australian Health & Medical Research Institute (SAHMRI)	Craig, JE (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia.	puya.gharahkhani@qimrberghofer.edu.au; jamie.craig@flinders.edu.au	Gharahkhani, Puya/AAA-6912-2020; Martin, Nicholas/R-9235-2019; White, Andrew JR/E-8462-2013; Burdon, Kathryn/A-5026-2009; Radford-Smith, Graham L/G-5749-2017; Haines, Jonathan/C-3374-2012; Fingert, John/AAX-4750-2021; Mackey, David A/H-5340-2014; wang, jie/GRS-0942-2022; Wang, Jie Jin/P-1499-2014; Macgregor, Stuart/C-6442-2009; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Brown, Matthew A/E-5749-2010; Montgomery, Grant W/B-7148-2008; Burdon, Kathryn/AAD-2334-2022; Hewitt, Alex W/D-1936-2013; Mitchell, Paul/P-1498-2014; Whiteman, David C/P-2728-2014; Bailey, Jessica Cooke/Q-5062-2019; Radford-Smith, Graham/H-2792-2013; Law, Matthew H./AAJ-4066-2021; Foster, Paul/V-7288-2019; Souzeau, Emmanuelle/AAB-5608-2022; Fingert, John/F-8787-2012	Gharahkhani, Puya/0000-0002-4203-5952; Martin, Nicholas/0000-0003-4069-8020; Burdon, Kathryn/0000-0001-8217-1249; Radford-Smith, Graham L/0000-0002-2047-6239; Haines, Jonathan/0000-0002-4351-4728; Fingert, John/0000-0002-0377-0479; Mackey, David A/0000-0001-7914-4709; Wang, Jie Jin/0000-0001-9491-4898; Macgregor, Stuart/0000-0001-6731-8142; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Brown, Matthew A/0000-0003-0538-8211; Montgomery, Grant W/0000-0002-4140-8139; Burdon, Kathryn/0000-0001-8217-1249; Hewitt, Alex W/0000-0002-5123-5999; Whiteman, David C/0000-0003-2563-9559; Bailey, Jessica Cooke/0000-0002-4001-8702; Radford-Smith, Graham/0000-0002-2047-6239; Law, Matthew H./0000-0002-4303-8821; Foster, Paul/0000-0002-4755-177X; Souzeau, Emmanuelle/0000-0002-2015-6577; Fingert, John/0000-0002-0377-0479; Klebe, Sonja/0000-0002-8976-4714; Graham, Stuart/0000-0001-7519-969X; Craig, Jamie/0000-0001-9955-9696; Mills, Richard/0000-0002-7386-2571; Sharma, Shiwani/0000-0002-0828-025X; Topouzis, Fotis/0000-0002-8966-537X	Royal Australian; New Zealand College of Ophthalmology (RANZCO) Eye Foundation; National Health and Medical Research Council (NHMRC) of Australia [535074, 1023911]; NHMRC [1031362, 1037838, 1048037, 1009844, 1031920]; Alcon Research Institute grant; Allergan Unrestricted grant; BrightFocus Foundation; Ramaciotti Establishment Grant; Queensland Cancer Fund; NHMRC of Australia [199600, 552429, 241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485, 552498]; US National Cancer Institute [5 R01 CA 001833, R01 CA 136725]; NHMRC Medical Genomics Grant; US National Institutes of Health (NIH) Center for Inherited Research (CIDR), NIH/National Eye Institute (NEI) [1RO1EY018246]; Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC), Cerylid Biosciences (Melbourne); NHMRC, Canberra Australia [974159, 211069, 457349, 512423, 475604, 529912]; Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases; NHMRC Senior Research Fellowships [358702, 632909]; Wellcome Trust, UK, Wellcome Trust Case Control Consortium 2 [085475B08Z, 08547508Z, 076113]; Medical Research Council (MRC) [G0401527]; Research Into Ageing [262]; NIHR (UK) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology funds [BRC2_009]; NEI [HG005259-01]; NIH [HHSN268200782096C, EY015543, EY006827, HL73042, HL073389, EY13315, EY023646, CA87969]; NEI through American Recovery and Reinvestment Act (ARRA) [3R01EY015872-05S1, 3R01EY019126-02S1]; Harvard Glaucoma Center for Excellence; Margolis Fund; Glaucoma Research Foundation; American Health Assistance Foundation; Glaucoma Foundation; Research to Prevent Blindness; NIH GEI (Gene Environment Initiative) [U01HG04424, U01HG004728]; GENEVA Coordinating Center [U01HG004446]; Australian Research Council (ARC); NHMRC Fellowships; Australian NHMRC Fellowships; ARC; NHMRC;  [EY022305];  [CA49449];  [CA55075];  [EY009149];  [HG004608];  [EY008208];  [EY015473];  [EY012118];  [EY015682];  [EY011671];  [EY09580];  [EY013178];  [RR015574];  [EY015872];  [EY010886];  [EY009847];  [EY014104];  [EY011008];  [EY144428];  [EY144448];  [EY18660];  [T32 EY007157];  [T32 EY21453-2]; NATIONAL CANCER INSTITUTE [R01CA136725, R01CA001833] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022305, R01EY015473, P30EY014104, R01EY023512] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004728] Funding Source: NIH RePORTER; Medical Research Council [G1000143, MR/K006584/1, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	Royal Australian; New Zealand College of Ophthalmology (RANZCO) Eye Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alcon Research Institute grant(Novartis); Allergan Unrestricted grant(AbbVieAllergan); BrightFocus Foundation(BrightFocus Foundation); Ramaciotti Establishment Grant; Queensland Cancer Fund; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHMRC Medical Genomics Grant(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health (NIH) Center for Inherited Research (CIDR), NIH/National Eye Institute (NEI); Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC), Cerylid Biosciences (Melbourne)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC, Canberra Australia(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases; NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK, Wellcome Trust Case Control Consortium 2; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Into Ageing; NIHR (UK) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology funds; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI through American Recovery and Reinvestment Act (ARRA); Harvard Glaucoma Center for Excellence; Margolis Fund; Glaucoma Research Foundation; American Health Assistance Foundation; Glaucoma Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH GEI (Gene Environment Initiative); GENEVA Coordinating Center; Australian Research Council (ARC)(Australian Research Council); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG): support for recruitment of ANZRAG was provided by the Royal Australian and New Zealand College of Ophthalmology (RANZCO) Eye Foundation. Genotyping was funded by the National Health and Medical Research Council (NHMRC) of Australia (#535074 and #1023911). This work was also supported by funding from NHMRC #1031362 awarded to J.E.C., NHMRC #1037838 awarded to A.W.H., NHMRC #1048037 awarded to S.L.G., NHMRC #1009844 awarded to R.J.C. and I.G., NHMRC #1031920 and an Alcon Research Institute grant awarded to D.A.M., an Allergan Unrestricted grant awarded to A.J.W., the BrightFocus Foundation and a Ramaciotti Establishment Grant. The authors acknowledge the support of B. Usher-Ridge in patient recruitment and data collection and P. Danoy and J. Hadler for genotyping.; Controls for the ANZRAG discovery cohort were drawn from the Australian Cancer Study, the Study of Digestive Health and a study of inflammatory bowel diseases. The Australian Cancer Study was supported by the Queensland Cancer Fund and the NHMRC of Australia (program number 199600, awarded to D.C.W., A.C. Green, N.K. Hayward, P.G. Parsons, D.M. Purdie and P.M. Webb, and program number 552429, awarded to D.C.W.). The Study of Digestive Health was supported by grant number 5 R01 CA 001833 from the US National Cancer Institute (awarded to D.C.W.).; The Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS) sponsored the genotyping of cases with esophageal cancer and Barrett's esophagus, which were used as unscreened controls in the ANZRAG discovery cohort. BEAGESS was funded by grant R01 CA 136725 from the US National Cancer Institute.; Genotyping for part of the Australian twin control sample included in the ANZRAG replication cohort was funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder of twin controls was performed by the US National Institutes of Health (NIH) Center for Inherited Research (CIDR) as part of NIH/National Eye Institute (NEI) grant 1RO1EY018246, and we are grateful to C. Day and staff We acknowledge with appreciation all women who participated in the QIMR endometriosis study. We thank Endometriosis Associations for supporting study recruitment. We thank S. Nicolaides and the Queensland Medical Laboratory for pro bono collection and delivery of blood samples and other pathology services for assistance with blood collection. The QIMR twin and endometriosis studies were supported by grants from the NHMRC of Australia (241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485 and 552498), the Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC), Cerylid Biosciences (Melbourne) and donations from N. and S. Hawkins. We thank M.J. Wright, M.J. Campbell, A. Caracella, S. Gordon, D.R. Nyholt, A.K. Henders, B. Haddon, D. Smyth, H. Beeby, O. Zheng and B. Chapman for their input into project management, databases, sample processing and genotyping. We are grateful to the many research assistants and interviewers for assistance with the studies contributing to the QIMR twin collection.; Blue Mountains Eye Study (BMES): BMES was supported by the NHMRC, Canberra Australia (974159, 211069, 457349, 512423, 475604 and 529912), the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases, NHMRC Senior Research Fellowships (358702 and 632909 to J.J.W.) and the Wellcome Trust, UK, as part of Wellcome Trust Case Control Consortium 2 (A.C.V., P. McGuffin, P. Mitchell, F.T. and P.J.F.) for genotyping costs of the entire BMES population (085475B08Z, 08547508Z, 076113). P.J.F. is also supported by Medical Research Council (MRC) G0401527, Research Into Ageing (Ref 262) and NIHR (UK) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology (BRC2_009) funds.; The BMES acknowledges E. Rochtchina from the Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute University of Sydney, J. Attia, R. Scott and E.G. Holliday from the University of Newcastle, J. Xie and P.N. Baird from the Centre for Eye Research Australia, University of Melbourne, M.T. Inouye, Medical Systems Biology, Department of Pathology and Department of Microbiology and Immunology, University of Melbourne and X. Sim, National University of Singapore.; NEI Glaucoma Human Genetics Collaboration (NEIGHBOR): genotyping services for the NEIGHBOR study were provided by the CIDR and were supported by the NEI through grant HG005259-01 (J.L.W.). Additionally, CIDR is funded through a federal contract from the NIH to The Johns Hopkins University, contract number HHSN268200782096C. Collecting and processing samples for the NEIGHBOR data set was supported by the NEI through American Recovery and Reinvestment Act (ARRA) grants 3R01EY015872-05S1 (J.L.W.) and 3R01EY019126-02S1 (M.A.H.). Genotype imputation and meta-analysis were supported by EY022305 (J.L.W.). Funding for the collection of cases and controls was provided by the following NIH grants: EY015543 (R.R. Allingham); EY006827 (D. Gaasterland); HL73042, HL073389, EY13315, EY023646 (M.A.H.); CA87969, CA49449, CA55075 (J.H. Kang); EY009149 (P.R. Lichter); HG004608 (C. McCarty); EY008208 (EA. Medeiros); EY015473 (L.R.P.); EY012118 (M. Pericak-Vance); EY015682 (A. Realini); EY011671, EY09580 (J.E. Richards); EY013178 (J.S. Schuman); RR015574, EY015872, EY010886, EY009847, EY014104 (J.L.W.); EY011008, EY144428, EY144448 and EY18660 (K. Zhang). J.L.W. and L.R.P. are also supported by the Harvard Glaucoma Center for Excellence and the Margolis Fund. Y. Liu is supported by the Glaucoma Research Foundation, the American Health Assistance Foundation and the Glaucoma Foundation. J.L.W., L.R.P., D.C. Musch and J.E. Richards are supported by Research to Prevent Blindness. J.N.C.B. is supported by NIH T32 EY007157 (CWRU) and T32 EY21453-2 (VUMC).; MEEI case-control sample: genotyping for the Massachusetts Eye and Ear Infirmary (MEEI) case-control sample was performed at the Broad Institute of MIT and Harvard with funding support from the NIH GEI (Gene Environment Initiative) (U01HG04424 and U01HG004728). The GENEVA Coordinating Center (U01HG004446) assisted with genotype cleaning. Imputation was supported by NIH EY022305. Collection of cases and controls was supported by NIH EY015872.; Support for molecular analysis of the associated genes was provided by the Ophthalmic Research Institute of Australia. The authors acknowledge the support of M. Philpott in collection of cadaveric human eye tissues and N. Mabarrack for initial optimization of the antibody to AFAP.; S. MacGregor is supported by Australian Research Council (ARC) and NHMRC Fellowships. G.W.M., M.A.B., K.P.B., D.C.W. and J.E.C. are supported by Australian NHMRC Fellowships. D.C.W. was funded by the ARC and G.R.-S. was funded by NHMRC during the period of this study. The authors acknowledge C. Abbot (Alcon Research Ltd.) for providing normal and glaucomatous trabecular meshwork cell lines, NTM-5 and GTM-3, respectively, as a kind gift.	Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bellincampi L, 2001, BIOCHEM BIOPH RES CO, V283, P590, DOI 10.1006/bbrc.2001.4823; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; HANSON IM, 1993, HUM MOL GENET, V2, P915; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Inoue T, 2013, PROG RETIN EYE RES, V37, P1, DOI 10.1016/j.preteyeres.2013.05.002; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Karasinska JM, 2013, NEUROBIOL DIS, V54, P445, DOI 10.1016/j.nbd.2013.01.018; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Qian Y, 2000, EXP CELL RES, V255, P102, DOI 10.1006/excr.1999.4795; Qian Y, 2002, MOL BIOL CELL, V13, P2311, DOI 10.1091/mbc.E01-12-0148; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Singaraja RR, 2005, J LIPID RES, V46, P2061, DOI 10.1194/jlr.M500133-JLR200; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Tserentsoodol N, 2006, MOL VIS, V12, P1319; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	33	125	132	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1120	1125		10.1038/ng.3079	http://dx.doi.org/10.1038/ng.3079			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25173105	Green Accepted, Green Submitted			2022-12-17	WOS:000342554100016
J	Gunawardana, J; Chan, FC; Telenius, A; Woolcock, B; Kridel, R; Tan, KL; Ben-Neriah, S; Mottok, A; Lim, RS; Boyle, M; Rogic, S; Rimsza, LM; Guiter, C; Leroy, K; Gaulard, P; Haioun, C; Marra, MA; Savage, KJ; Connors, JM; Shah, SP; Gascoyne, RD; Steidl, C				Gunawardana, Jay; Chan, Fong Chun; Telenius, Adele; Woolcock, Bruce; Kridel, Robert; Tan, King L.; Ben-Neriah, Susana; Mottok, Anja; Lim, Raymond S.; Boyle, Merrill; Rogic, Sanja; Rimsza, Lisa M.; Guiter, Chrystelle; Leroy, Karen; Gaulard, Philippe; Haioun, Corinne; Marra, Marco A.; Savage, Kerry J.; Connors, Joseph M.; Shah, Sohrab P.; Gascoyne, Randy D.; Steidl, Christian			Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma	NATURE GENETICS			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MOLECULAR PATHOGENESIS; MULTIDRUG-RESISTANCE; BREAST-CANCER; EXPRESSION; GENOME; ACTIVATION; LEUKEMIA; FREQUENT; SOCS-1	Classical Hodgkin lymphoma and primary mediastinal B cell lymphoma (PMBCL) are related lymphomas sharing pathological, molecular and clinical characteristics. Here we discovered by whole-genome and whole-transcriptome sequencing recurrent somatic coding-sequence mutations in the PTPN1 gene. Mutations were found in 6 of 30 (20%) Hodgkin lymphoma cases, in 6 of 9 (67%) Hodgkin lymphoma-derived cell lines, in 17 of 77 (22%) PMBCL cases and in 1 of 3 (33%) PMBCL-derived cell lines, consisting of nonsense, missense and frameshift mutations. We demonstrate that PTPN1 mutations lead to reduced phosphatase activity and increased phosphorylation of JAK-STAT pathway members. Moreover, silencing of PTPN1 by RNA interference in Hodgkin lymphoma cell line KM-H2 resulted in hyperphosphorylation and overexpression of downstream oncogenic targets. Our data establish PTPN1 mutations as new drivers in lymphomagenesis.	[Gunawardana, Jay; Chan, Fong Chun; Telenius, Adele; Woolcock, Bruce; Kridel, Robert; Tan, King L.; Ben-Neriah, Susana; Mottok, Anja; Boyle, Merrill; Savage, Kerry J.; Connors, Joseph M.; Gascoyne, Randy D.; Steidl, Christian] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gunawardana, Jay; Kridel, Robert; Shah, Sohrab P.; Gascoyne, Randy D.; Steidl, Christian] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Chan, Fong Chun] Univ British Columbia, Bioinformat Training Program, Vancouver, BC V5Z 1M9, Canada; [Rogic, Sanja] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Guiter, Chrystelle; Leroy, Karen; Gaulard, Philippe] INSERM U955, Creteil, France; [Leroy, Karen; Gaulard, Philippe; Haioun, Corinne] Univ Paris Est, Creteil, France; [Leroy, Karen; Gaulard, Philippe; Haioun, Corinne] Grp Hosp Henri MONDOR, AP HP, Dept Pathol, Serv Hematol Plateforme Ressources, Creteil, France; [Marra, Marco A.] BC Canc Agcy, Genom Sci Ctr, Vancouver, BC, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of Arizona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; British Columbia Cancer Agency; University of British Columbia	Steidl, C (corresponding author), BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada.	csteidl@bccancer.bc.ca	Leroy, Karen/E-9235-2011; Connors, Joseph/AAF-5284-2019; Kridel, Robert/V-8739-2019; Mottok, Anja/AAO-1801-2021; Savage, Kerry/HCH-5539-2022; Gunawardana, Jay/P-1446-2018; Marra, Marco A/B-5987-2008	Leroy, Karen/0000-0002-4379-0140; Connors, Joseph/0000-0002-1361-7531; Gunawardana, Jay/0000-0003-2695-3849; Marra, Marco A/0000-0001-7146-7175; Mottok, Anja/0000-0003-3125-0494; Rogic, Sanja/0000-0002-9988-3661; Kridel, Robert/0000-0003-0287-7124; Lim, Raymond/0000-0001-8772-3882; Haioun, Corinne/0000-0003-0095-5379	BC Cancer Foundation; Canada Foundation for Innovation; Leukemia & Lymphoma Society of Canada (LLSC); Terry Fox Research Institute [1023]; Michael Smith Foundation for Health Research (MSFHR); Canadian Institutes of Health Research (CIHR) [178536]; Terry Fox Foundation [019001]; Mildred Scheel Cancer Foundation; CIHR; MSFHR; University of British Columbia	BC Cancer Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Leukemia & Lymphoma Society of Canada (LLSC); Terry Fox Research Institute; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Mildred Scheel Cancer Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); University of British Columbia	We thank the BC Cancer Foundation and the Canada Foundation for Innovation for their support. We also thank T. Van Tol, M. Drake, R. Tong, the Genome Sciences Centre (GSC) production group and the Center for Translational and Applied Genomics (CTAG) for excellent technical support. This work is supported by a research grant from the Leukemia & Lymphoma Society of Canada (LLSC) and by a Terry Fox Research Institute team grant (1023) to C. S. and a Scholarship award from the Michael Smith Foundation for Health Research (MSFHR) to C. S. R. D. G. is supported by a Canadian Institutes of Health Research (CIHR) grant (178536) and a Terry Fox Foundation program project grant (019001). A. M. is supported by a fellowship award from the Mildred Scheel Cancer Foundation. R. K. is supported by fellowship awards from CIHR, MSFHR and the University of British Columbia.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, CELL CYCLE, V3, P550; Dunleavy K, 2013, NEW ENGL J MED, V368, P1408, DOI 10.1056/NEJMoa1214561; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Johnson Peter W M, 2008, Hematology Am Soc Hematol Educ Program, P349, DOI 10.1182/asheducation-2008.1.349; Kimm LR, 2007, GENE CHROMOSOME CANC, V46, P1090, DOI 10.1002/gcc.20495; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; Kleppe M, 2011, HAEMATOL-HEMATOL J, V96, P1723, DOI 10.3324/haematol.2011.041921; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Koyama N, 2006, CLIN CANCER RES, V12, P2025, DOI 10.1158/1078-0432.CCR-04-2392; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Melzner I, 2005, BLOOD, V105, P2535, DOI 10.1182/blood-2004-09-3701; Moller P, 2001, INT J CANCER, V92, P348, DOI 10.1002/ijc.1211; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Nanney LB, 1997, J CUTAN PATHOL, V24, P521, DOI 10.1111/j.1600-0560.1997.tb01456.x; Oschlies I, 2011, HAEMATOL-HEMATOL J, V96, P262, DOI 10.3324/haematol.2010.030809; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Popov SW, 2007, CANCER RES, V67, P6555, DOI 10.1158/0008-5472.CAN-06-2166; Rieger M, 2011, ANN ONCOL, V22, P664, DOI 10.1093/annonc/mdq418; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Ritz O, 2009, BLOOD, V114, P1236, DOI 10.1182/blood-2009-03-209759; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Savage KJ, 2006, ONCOLOGIST, V11, P488, DOI 10.1634/theoncologist.11-5-488; Scheeren FA, 2008, BLOOD, V111, P4706, DOI 10.1182/blood-2007-08-105643; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Steidl C, 2011, BLOOD, V118, P2659, DOI 10.1182/blood-2011-05-326538; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Warabi M, 2000, EXP MOL PATHOL, V68, P187, DOI 10.1006/exmp.2000.2303; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; ZHAI YF, 1993, CANCER RES, V53, P2272; Zhang HY, 2012, J CANCER RES THER, V8, P226, DOI 10.4103/0973-1482.98975	62	125	128	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					329	+		10.1038/ng.2900	http://dx.doi.org/10.1038/ng.2900			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24531327				2022-12-17	WOS:000334510100007
J	Alcais, A; Alter, A; Antoni, G; Orlova, M; Van Thuc, N; Singh, M; Vanderborght, PR; Katoch, K; Mira, MT; Thai, VH; Huong, NT; Ba, NN; Moraes, M; Mehra, N; Schurr, E; Abel, L				Alcais, Alexandre; Alter, Andrea; Antoni, Guillemette; Orlova, Marianna; Van Thuc, Nguyen; Singh, Meenakshi; Vanderborght, Patricia R.; Katoch, Kiran; Mira, Marcelo T.; Thai, Vu Hong; Huong, Ngyuen Thu; Ba, Nguyen Ngoc; Moraes, Milton; Mehra, Narinder; Schurr, Erwin; Abel, Laurent			Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy	NATURE GENETICS			English	Article							TUBERCULOID LEPROSY; GENETIC DISSECTION; BOVIS BCG; LT-ALPHA; SUSCEPTIBILITY; TNF; ASSOCIATIONS; INFECTION; IMMUNITY; MARKERS	Host genetics has an important role in leprosy, and variants in the shared promoter region of PARK2 and PACRG were the first major susceptibility factors identified by positional cloning(1,2). Here we report the linkage disequilibrium mapping of the second linkage peak of our previous genome- wide scan1, located close to the HLA complex. In both a Vietnamese familial sample and an Indian case- control sample, the lowproducing lymphotoxin-alpha (LTA)+80 A allele was significantly associated with an increase in leprosy risk (P = 0.007 and P 0.01, respectively). Analysis of an additional case- control sample from Brazil and an additional familial sample from Vietnam showed that the LTA+80 effect was much stronger in young individuals. In the combined sample of 298 Vietnamese familial trios, the odds ratio of leprosy for LTA+80 AA/AC versus CC subjects was 2.11 (P = 0.000024), which increased to 5.63 (P = 0.0000004) in the subsample of 121 trios of affected individuals diagnosed before 16 years of age. In addition to identifying LTA as a major gene associated with early- onset leprosy, our study highlights the critical role of case- and population- specific factors in the dissection of susceptibility variants in complex diseases.	INSERM, U550, Lab Genet Humaine Malad Infectieuses, F-75015 Paris, France; Univ Paris Rene Descartes, Fac Med Necker, F-75015 Paris, France; McGill Univ, Mcgill Ctr Study Host Resistence, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; Hosp Dermatovenereol, Chi Minh City, Vietnam; All India Inst Med Sci, Dept Transplant Immunol & Immunogenet, New Delhi 110029, India; Fiocruz MS, Leprosy Lab, Trop Med Dept, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, Brazil; Cent JALMA Inst Leprosy & Other Infect Dis, Agra 282001, Uttar Pradesh, India; Pontificia Univ Catolica Parana, Ctr Ciencias Biol & Saude, BR-80215901 Curitiba, Parana, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; McGill University; McGill University; All India Institute of Medical Sciences (AIIMS) New Delhi; Fundacao Oswaldo Cruz; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Pontificia Universidade Catolica do Parana	Alcais, A (corresponding author), INSERM, U550, Lab Genet Humaine Malad Infectieuses, F-75015 Paris, France.	abel@necker.fr; erwin.schurr@mcgill.ca	Moraes, Milton Ozório/G-9753-2011; Mira, Marcelo T/B-5046-2010; Moraes, Milton/AFF-1842-2022; Alcais, Alexandre/J-5882-2017; Abel, Laurent/H-8888-2017	Moraes, Milton Ozório/0000-0003-2653-0037; Mira, Marcelo T/0000-0002-8087-9400; Alcais, Alexandre/0000-0002-1012-2226; Orlova, Marianna/0000-0002-8108-938X; Abel, Laurent/0000-0001-7016-6493				ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell PA, 2002, BIOTECHNIQUES, P70; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; DEVRIES RRP, 1980, TISSUE ANTIGENS, V16, P294, DOI 10.1111/j.1399-0039.1980.tb00309.x; Dupuis J, 1999, GENETICS, V151, P373; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Griffin TJ, 2000, TRENDS BIOTECHNOL, V18, P77, DOI 10.1016/S0167-7799(99)01401-8; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Knight JC, 2004, NAT GENET, V36, P394, DOI 10.1038/ng1331; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Mira MT, 2006, MICROBES INFECT, V8, P1124, DOI 10.1016/j.micinf.2005.10.024; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P309; Zerva L, 1996, J EXP MED, V183, P829, DOI 10.1084/jem.183.3.829	27	125	130	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					517	522		10.1038/ng2000	http://dx.doi.org/10.1038/ng2000			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353895				2022-12-17	WOS:000245271200022
J	Clee, SM; Yandell, BS; Schueler, KM; Rabaglia, ME; Richards, OC; Raines, SM; Kabara, EA; Klass, DM; Mui, ETK; Stapleton, DS; Gray-Keller, MP; Young, MB; Stoehr, JP; Lan, H; Boronenkov, I; Raess, PW; Flowers, MT; Attie, AD				Clee, Susanne M.; Yandell, Brian S.; Schueler, Kathryn M.; Rabaglia, Mary E.; Richards, Oliver C.; Raines, Summer M.; Kabara, Edward A.; Klass, Daniel M.; Mui, Eric T-K; Stapleton, Donald S.; Gray-Keller, Mark P.; Young, Matthew B.; Stoehr, Jonathan P.; Lan, Hong; Boronenkov, Igor; Raess, Philipp W.; Flowers, Matthew T.; Attie, Alan D.			Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus	NATURE GENETICS			English	Article							GENETIC-ANALYSIS; PROPEPTIDE CLEAVAGE; PANCREATIC-ISLETS; MELLITUS; INSULIN; RECEPTOR; CELLS; CROSSES; OBESITY; DOMAIN	We previously mapped the type 2 diabetes mellitus-2 locus (T2dm2), which affects fasting insulin levels, to distal chromosome 19 in a leptin-deficient obese F-2 intercross derived from C57BL/6 (B6) and BTBR T+ tf/J (BTBR) mice(1). Introgression of a 7-Mb segment of the B6 chromosome 19 into the BTBR background (strain 1339A) replicated the reduced insulin linked to T2dm2. The 1339A mice have markedly impaired insulin secretion in vivo and disrupted islet morphology. We used subcongenic strains derived from 1339A to localize the T2dm2 quantitative trait locus (QTL) to a 242-kb segment comprising the promoter, first exon and most of the first intron of the Sorcs1 gene. This was the only gene in the 1339A strain for which we detected amino acid substitutions and expression level differences between mice carrying B6 and BTBR alleles of this insert, thereby identifying variation within the Sorcs1 gene as underlying the phenotype associated with the T2dm2 locus. SorCS1 binds platelet-derived growth factor, a growth factor crucial for pericyte recruitment to the microvasculature, and may thus have a role in expanding or maintaining the islet vasculature. Our identification of the Sorcs1 gene provides insight into the pathway underlying the pathophysiology of obesity-induced type 2 diabetes mellitus.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Univ Wisconsin, Dept Stat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Attie, AD (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	attie@biochem.wisc.edu	Clee, Susanne/F-7312-2010; Clee, Susanne/AAC-4278-2020	Clee, Susanne/0000-0001-7946-688X; Raess, Philipp/0000-0002-6841-4993	PHS HHS [66369, 58037] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Clee Susanne M, 2005, Am J Ther, V12, P491, DOI 10.1097/01.mjt.0000178781.89789.25; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Hampe W, 2001, HUM GENET, V108, P529, DOI 10.1007/s004390100504; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hermey G, 2003, J BIOL CHEM, V278, P7390, DOI 10.1074/jbc.M210851200; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kim JH, 2001, GENOMICS, V74, P273, DOI 10.1006/geno.2001.6569; Kluge R, 2000, DIABETOLOGIA, V43, P1565, DOI 10.1007/s001250051570; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Parikh H, 2004, REV ENDOCR METAB DIS, V5, P151, DOI 10.1023/B:REMD.0000021437.46773.26; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stoehr JP, 2000, DIABETES, V49, P1946, DOI 10.2337/diabetes.49.11.1946; Wei SW, 1999, MAMM GENOME, V10, P249, DOI 10.1007/s003359900982; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Westergaard UB, 2005, FEBS LETT, V579, P1172, DOI 10.1016/j.febslet.2004.12.088; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Zou F, 2001, GENETICS, V158, P1339	30	125	145	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					688	693		10.1038/ng1796	http://dx.doi.org/10.1038/ng1796			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682971				2022-12-17	WOS:000237954800024
J	Desrosiers, MP; Kielczewska, A; Loredo-Osti, JC; Adam, SG; Makrigiannis, AP; Lemieux, S; Pham, T; Lodoen, MB; Morgan, K; Lanier, LL; Vidal, SM				Desrosiers, MP; Kielczewska, A; Loredo-Osti, JC; Adam, SG; Makrigiannis, AP; Lemieux, S; Pham, T; Lodoen, MB; Morgan, K; Lanier, LL; Vidal, SM			Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection	NATURE GENETICS			English	Article							GENE-COMPLEX; VIRAL-INFECTIONS; BAC CONTIG; RECEPTOR; LY49; MAP; RECOGNITION; MICE; HLA; LIGAND	Experimental infection with mouse cytomegalovirus ( MCMV) has been used to elucidate the intricate host-pathogen mechanisms that determine innate resistance to infection. Linkage analyses in F-2 progeny from MCMV-resistant MA/My (H2(k)) and MCMV-susceptible BALB/c (H2(d)) and BALB. K ( H2k) mouse strains indicated that only the combination of alleles encoded by a gene in the Klra ( also called Ly49) cluster on chromosome 6, and one in the major histocompatibility complex (H2) on chromosome 17, is associated with virus resistance. We found that natural killer cell - activating receptor Ly49P specifically recognized MCMV-infected cells, dependent on the presence of the H2k haplotype. This binding was blocked using antibodies to H-2D(k) but not antibodies to H-2K(k). These results are suggestive of a new natural killer cell mechanism implicated in MCMV resistance, which depends on the functional interaction of the Ly49P receptor and the major histocompatibility complex class I molecule H-2D(k) on MCMV-infected cells.	McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Univ Quebec, INRS, Laval, PQ H7V 1B7, Canada; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McGill University; McGill University	Vidal, SM (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.	silvia.vidal@mcgill.ca	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Pham, Trung/0000-0003-2724-2547; Makrigiannis, Andrew/0000-0002-7258-9411	NATIONAL CANCER INSTITUTE [R01CA089294] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA089294] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Belkin D, 2003, J IMMUNOL, V171, P3056, DOI 10.4049/jimmunol.171.6.3056; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Britt W. J., 1996, FIELDS VIROLOGY, P2493; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; CHALMER JE, 1977, J GEN VIROL, V37, P107, DOI 10.1099/0022-1317-37-1-107; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Franksson L, 1999, EUR J IMMUNOL, V29, P2748, DOI 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C; GRUNDY JE, 1981, INFECT IMMUN, V32, P277, DOI 10.1128/IAI.32.1.277-286.1981; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lee SH, 2001, IMMUNOGENETICS, V53, P501, DOI 10.1007/s002510100359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Makrigiannis AP, 1999, J IMMUNOL, V163, P4931; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; Makrigiannis AP, 2001, J IMMUNOL, V166, P5034, DOI 10.4049/jimmunol.166.8.5034; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Nakamura MC, 2000, J EXP MED, V192, P447, DOI 10.1084/jem.192.3.447; Nakamura MC, 2001, IMMUNOL REV, V181, P138, DOI 10.1034/j.1600-065X.2001.1810111.x; Peng SL, 1996, BIOTECHNIQUES, V21, P362; Peruzzi M, 1996, J EXP MED, V184, P1585, DOI 10.1084/jem.184.4.1585; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Reusser PE, 2002, SWISS MED WKLY, V132, P374; Scalzo AA, 2000, METH MOL B, V121, P163; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Silver ET, 2000, J IMMUNOL, V165, P1771, DOI 10.4049/jimmunol.165.4.1771; Silver ET, 2001, J IMMUNOL, V166, P2333, DOI 10.4049/jimmunol.166.4.2333; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Trincado DE, 2001, J PAEDIATR CHILD H, V37, P187, DOI 10.1046/j.1440-1754.2001.00645.x; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	42	125	127	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					593	599		10.1038/ng1564	http://dx.doi.org/10.1038/ng1564			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895081	Green Accepted			2022-12-17	WOS:000229495300012
J	Li, BJ; Boast, S; de los Santos, K; Schieren, I; Quiroz, M; Teitelbaum, SL; Tondravi, MM; Goff, SP				Li, BJ; Boast, S; de los Santos, K; Schieren, I; Quiroz, M; Teitelbaum, SL; Tondravi, MM; Goff, SP			Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation	NATURE GENETICS			English	Article							C-ABL; CLEIDOCRANIAL DYSPLASIA; BONE; DIFFERENTIATION; MOUSE; CELLS; GENE; EXPRESSION; MUTATION; CBFA1	The c-Abl protein is a non-receptor tyrosine kinase involved in many aspects of mammalian development. c-Abl kinase is widely expressed, but high levels are found in hyaline cartilage in the adult, bone tissue in newborn mice, and osteoblasts and associated neovasculature at sites of endochondrial ossification in the fetus(1,2). Mice homozygous for mutations in the gene encoding c-Abl (Abl) display increased perinatal mortality, reduced fertility, foreshortened crania and defects in the maturation of B cells in bone marrow(3,4). Here we demonstrate that Abl(-/-) mice are also osteoporotic. The long bones of mutant mice contain thinner cortical bone and reduced trabecular bone volume. The osteoporotic phenotype is not due to accelerated bone turnover-both the number and activity of osteoclasts are similar to those of control littermates-but rather to dysfunctional osteoblasts. In addition, the rate of mineral apposition in the mutant animals is reduced. Osteoblasts from both stromal and calvarial explants showed delayed maturation in vitro as measured by expression of alkaline phosphatase (ALP), induction of mRNA encoding osteocalcin and mineral deposition.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63130 USA; Amer Red Cross, Dept Tissue Biol, Rockville, MD USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Washington University (WUSTL); American Red Cross	Goff, SP (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.	goff@cuccfa.ccc.columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Teitelbaum, Steven/0000-0002-4054-6679	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044089, R01AR032788] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR32788, AR44089] Funding Source: Medline; NIDCR NIH HHS [DE05413] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; BLAIR HC, 1986, J CELL BIOL, V102, P1164, DOI 10.1083/jcb.102.4.1164; Cook HC, 1974, MANUAL HISTOLOGICAL; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Engelman VW, 1997, J CLIN INVEST, V99, P2284, DOI 10.1172/JCI119404; HARDIN JD, 1995, CELL IMMUNOL, V165, P44, DOI 10.1006/cimm.1995.1185; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Moursi AM, 1996, J CELL SCI, V109, P1369; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; ONeill AJ, 1997, J PATHOL, V183, P325, DOI 10.1002/(SICI)1096-9896(199711)183:3<325::AID-PATH941>3.0.CO;2-A; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN M, 1988, CIBA F SYMP, V136, P42; QUARLES LD, 1992, J BONE MINER RES, V7, P683; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; STEIN CA, 1990, PRINCIPLES PRACT ONC, V4, P1; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P1504, DOI 10.1210/endo-123-3-1504; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x	22	125	131	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2000	24	3					304	308		10.1038/73542	http://dx.doi.org/10.1038/73542			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700189				2022-12-17	WOS:000085590600026
J	Peters, JM; Barnes, R; Bennett, L; Gitomer, WM; Bowcock, AM; Garg, A				Peters, JM; Barnes, R; Bennett, L; Gitomer, WM; Bowcock, AM; Garg, A			Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; EXTREMITIES; RECEPTOR; HUMANS; ARNT	Obesity is strongly implicated in the pathophysiology of insulin resistance, diabetes mellitus and dyslipidemia(1-3). The mechanisms, however, by which obesity causes these complications are not known, The study of single-gene disorders affecting adipose tissue may elucidate some of the mechanisms involved in these processes. Familial partial lipodystrophy, Dunnigan variety, (FPLD, OMIM 308980) is an autosomal-dominant condition characterized by marked loss of subcutaneous adipose tissue affecting the trunk and extremities but with excess fat deposition in the head and neck areas(4-14). Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus, dyslipidemia and acanthosis nigricans(4-14). The genetic basis of FPLD is unknown. We carried out a genome-wide scan with a set of highly polymorphic short tandem-repeats (STR) in individuals from five well-characterized pedigrees and mapped the FPLD locus to chromosome 1q21-22. The maximum two-point lod score obtained with a highly polymorphic microsatellite at D1S2624 at theta(max) = 0 was 5.84. Multipoint-linkage analysis yielded a peak lod score of 8.25 between D1S305 and D1S1600. There was no evidence for genetic heterogeneity (alpha=1) in the pedigrees.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Mineral Metab, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garg, A (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA.			Bowcock, Anne/0000-0001-8691-9090; Bennett, Lynda/0000-0001-7491-5797	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00633] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BURN J, 1986, J MED GENET, V23, P128, DOI 10.1136/jmg.23.2.128; DAVIDSON MB, 1975, DIABETOLOGIA, V11, P561, DOI 10.1007/BF01222107; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; DUNNIGAN MG, 1974, Q J MED, V49, P33; FEDER J, 1985, AM J HUM GENET, V37, P635; Flagiello D, 1997, CYTOGENET CELL GENET, V76, P17, DOI 10.1159/000134502; HOOK B, 1984, HAUTARZT, V35, P530; Jackson SNJ, 1997, QJM-INT J MED, V90, P27; JOHNSON B, 1993, GENOMICS, V17, P592, DOI 10.1006/geno.1993.1377; KOBBERLING J, 1975, HUMANGENETIK, V29, P111, DOI 10.1007/BF00430347; KOBBERLING J, 1986, J MED GENET, V23, P120, DOI 10.1136/jmg.23.2.120; Kobberling J, 1981, VERH DTSCH GES INN M, V87, P958; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Landsberg L, 1996, Hypertens Res, V19 Suppl 1, pS51, DOI 10.1291/hypres.19.SupplementI_S51; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LILLYSTONE D, 1975, ARCH DIS CHILD, V50, P737, DOI 10.1136/adc.50.9.737; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; OZER FL, 1973, CLIN RES, V21, P533; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROBBINS DC, 1982, METABOLISM, V31, P445, DOI 10.1016/0026-0495(82)90232-3; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Wanner R, 1996, BBA-MOL BASIS DIS, V1317, P105, DOI 10.1016/S0925-4439(96)00038-5	23	125	128	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					292	295		10.1038/ng0398-292	http://dx.doi.org/10.1038/ng0398-292			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500556				2022-12-17	WOS:000072325000032
J	Allikmets, R				Allikmets, R			A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy (vol 15, pg 236, 1997)	NATURE GENETICS			English	Correction, Addition													Allikmets, Rando/ABD-4533-2021					Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236	1	125	126	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					122	122		10.1038/ng0997-122b	http://dx.doi.org/10.1038/ng0997-122b			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288113	Bronze			2022-12-17	WOS:A1997XU72400033
J	MCCLATCHEY, AI; MCKENNAYASEK, D; CROS, D; WORTHEN, HG; KUNCL, RW; DESILVA, SM; CORNBLATH, DR; GUSELLA, JF; BROWN, RH				MCCLATCHEY, AI; MCKENNAYASEK, D; CROS, D; WORTHEN, HG; KUNCL, RW; DESILVA, SM; CORNBLATH, DR; GUSELLA, JF; BROWN, RH			NOVEL MUTATIONS IN FAMILIES WITH UNUSUAL AND VARIABLE DISORDERS OF THE SKELETAL-MUSCLE SODIUM-CHANNEL	NATURE GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; PARAMYOTONIA-CONGENITA; MALIGNANT HYPERTHERMIA; ALPHA-SUBUNIT; GENE; LINKAGE; CHROMOSOME-17; HETEROGENEITY; SUBTYPES; LOCUS	Mutations in the skeletal muscle sodium channel gene (SCN4A) have been described in paramyotonia congenita (PMC) and hyperkalaemic periodic paralysis (HPP). We have found two mutations in SCN4A which affect regions of the sodium channel not previously associated with a disease phenotype. Furthermore, affected family members display an unusual mixture of clinical features reminiscent of PMC, HPP and of a third disorder, myotonia congenita (MC). The highly variable individual expression of these symptoms, including in some cases apparent non-penetrance, implies the existence of modifying factors. Mutations in SCN4A can produce a broad range of phenotypes in muscle diseases characterized by episodic abnormalities of membrane excitability.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT CLIN NEUROPHYSIOL,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DAY NEUROMUSCULAR RES LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115; CAMBRIDGE CITY HOSP,CAMBRIDGE,MA 02142; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; TEMPLE UNIV,DEPT NEUROL,PHILADELPHIA,PA 19140	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University								DESILVA SM, 1990, MUSCLE NERVE, V13, P21, DOI 10.1002/mus.880130106; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; EBERS GC, 1991, ANN NEUROL, V30, P810, DOI 10.1002/ana.410300610; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; HAIMOVICH B, 1987, J NEUROSCI, V7, P2957; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; KOCH MC, 1991, J MED GENET, V28, P583, DOI 10.1136/jmg.28.9.583; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; PTACEK LJ, 1992, NEUROLOGY, V42, P431, DOI 10.1212/WNL.42.2.431; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; SCHOTLAND DL, 1991, MUSCLE NERVE, V14, P142, DOI 10.1002/mus.880140209; SEIZINGER BR, 1986, NATURE, V322, P664	20	125	134	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					148	152		10.1038/ng1092-148	http://dx.doi.org/10.1038/ng1092-148			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1338909				2022-12-17	WOS:A1992JR08400016
J	Sinnott-Armstrong, N; Tanigawa, Y; Amar, D; Mars, N; Benner, C; Aguirre, M; Venkataraman, GR; Wainberg, M; Ollila, HM; Kiiskinen, T; Havulinna, AS; Pirruccello, JP; Qian, JY; Shcherbina, A; Rodriguez, F; Assimes, TL; Agarwala, V; Tibshirani, R; Hastie, T; Ripatti, S; Pritchard, JK; Daly, MJ; Rivas, MA				Sinnott-Armstrong, Nasa; Tanigawa, Yosuke; Amar, David; Mars, Nina; Benner, Christian; Aguirre, Matthew; Venkataraman, Guhan Ram; Wainberg, Michael; Ollila, Hanna M.; Kiiskinen, Tuomo; Havulinna, Aki S.; Pirruccello, James P.; Qian, Junyang; Shcherbina, Anna; Rodriguez, Fatima; Assimes, Themistocles L.; Agarwala, Vineeta; Tibshirani, Robert; Hastie, Trevor; Ripatti, Samuli; Pritchard, Jonathan K.; Daly, Mark J.; Rivas, Manuel A.		FinnGen	Genetics of 35 blood and urine biomarkers in the UK Biobank	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; KIDNEY-FUNCTION; CYSTATIN C; MACULAR DEGENERATION; RISK PREDICTION; CROHNS-DISEASE; LOCI; METAANALYSIS; ARCHITECTURE	Clinical laboratory tests are a critical component of the continuum of care. We evaluate the genetic basis of 35 blood and urine laboratory measurements in the UK Biobank (n = 363,228 individuals). We identify 1,857 loci associated with at least one trait, containing 3,374 fine-mapped associations and additional sets of large-effect (>0.1 s.d.) protein-altering, human leukocyte antigen (HLA) and copy number variant (CNV) associations. Through Mendelian randomization (MR) analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke. Finally, we develop polygenic risk scores (PRSs) for each biomarker and build 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout and alcoholic cirrhosis genetic risk stratification in an independent dataset (FinnGen; n =135,500) relative to single-disease PRSs. Together, our results delineate the genetic basis of biomarkers and their causal influences on diseases and improve genetic risk stratification for common diseases.	[Sinnott-Armstrong, Nasa; Pritchard, Jonathan K.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Sinnott-Armstrong, Nasa; Mars, Nina; Benner, Christian; Ollila, Hanna M.; Kiiskinen, Tuomo; Havulinna, Aki S.; Shcherbina, Anna; Ripatti, Samuli; Daly, Mark J.] Univ Helsinki, Inst Mol Med Finland, FIMM, HiLIFE, Helsinki, Finland; [Sinnott-Armstrong, Nasa; Assimes, Themistocles L.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Tanigawa, Yosuke; Amar, David; Aguirre, Matthew; Venkataraman, Guhan Ram; Tibshirani, Robert; Hastie, Trevor; Rivas, Manuel A.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Amar, David; Shcherbina, Anna; Rodriguez, Fatima; Assimes, Themistocles L.; Agarwala, Vineeta] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Amar, David; Shcherbina, Anna; Rodriguez, Fatima; Assimes, Themistocles L.; Agarwala, Vineeta] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Wainberg, Michael] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Ollila, Hanna M.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA; [Ollila, Hanna M.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Ollila, Hanna M.] Harvard Med Sch, Boston, MA 02115 USA; [Kiiskinen, Tuomo; Havulinna, Aki S.] Finnish Inst Hlth & Welf, Helsinki, Finland; [Pirruccello, James P.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Pirruccello, James P.; Ripatti, Samuli; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Pirruccello, James P.; Ripatti, Samuli; Daly, Mark J.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Qian, Junyang; Tibshirani, Robert; Hastie, Trevor] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Clinicum, Helsinki, Finland; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA	Stanford University; University of Helsinki; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; University of Helsinki; Stanford University; Harvard University; Massachusetts General Hospital	Sinnott-Armstrong, N (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Sinnott-Armstrong, N (corresponding author), Univ Helsinki, Inst Mol Med Finland, FIMM, HiLIFE, Helsinki, Finland.; Sinnott-Armstrong, N (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.; Tanigawa, Y; Rivas, MA (corresponding author), Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA.	nasa@stanford.edu; ytanigaw@tanford.edu; mrivas@stanford.edu	Havulinna, Aki/AAM-4769-2021; Ollila, Hanna M/GQA-6308-2022; Tanigawa, Yosuke/AAI-7931-2020; Assimes, Themistocles Leonard/D-9696-2015	Ollila, Hanna M/0000-0002-5302-6429; Tanigawa, Yosuke/0000-0001-9759-157X; Assimes, Themistocles Leonard/0000-0003-2349-0009; Amar, David/0000-0002-9719-0837; Mars, Nina/0000-0002-7259-5993; Kiiskinen, Tuomo/0000-0002-6306-8227; Hastie, Trevor/0000-0002-0164-3142	Common Fund of the Office of the Director of the National Institutes of Health (NIH); NCI; National Human Genome Research Institute (NHGRI); NHLBI; NIDA; NIMH; NINDS; NHGRI of the NIH [R01HG010140, R01EB001988-21, R01HG008140]; Department of Defense through a National Defense Science and Engineering grant; Stanford Graduate Fellowship; Funai Overseas Scholarship from the Funai Foundation for Information Technology; Stanford University School of Medicine; Academy of Finland [331671, 309643]; National Heart, Lung, and Blood Institute [1K01HL144607]; Business Finland [HUS 4685/31/2016, UH 4386/31/2016]; AbbVie Inc; AstraZeneca UK Ltd.; Biogen MA Inc.; Celgene Corporation; Celgene International II Sarl; Genentech Inc; Merck Sharp Dohme Corp; Pfizer Inc.; GlaxoSmithKline Intellectual Property Development Ltd.; Sanofi US Services Inc.; Maze Therapeutics Inc.; Janssen Biotech Inc.; Novartis AG; NIH Center for Multi-and Trans-ethnic Mapping of Mendelian and Complex Diseases grant [5U01 HG009080]; Stanford University; Stanford Research Computing Center	Common Fund of the Office of the Director of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Defense through a National Defense Science and Engineering grant; Stanford Graduate Fellowship(Stanford University); Funai Overseas Scholarship from the Funai Foundation for Information Technology; Stanford University School of Medicine; Academy of Finland(Academy of Finland); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Business Finland; AbbVie Inc(AbbVie); AstraZeneca UK Ltd.(AstraZeneca); Biogen MA Inc.; Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); Celgene International II Sarl(Bristol-Myers SquibbCelgene Corporation); Genentech Inc(Roche HoldingGenentech); Merck Sharp Dohme Corp(Merck & Company); Pfizer Inc.(Pfizer); GlaxoSmithKline Intellectual Property Development Ltd.; Sanofi US Services Inc.; Maze Therapeutics Inc.; Janssen Biotech Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis AG; NIH Center for Multi-and Trans-ethnic Mapping of Mendelian and Complex Diseases grant; Stanford University(Stanford University); Stanford Research Computing Center	This research was conducted using the UK Biobank Resource under application number 24983, `Generating effective therapeutic hypotheses from genomic and hospital linkage data' (http://www.ukbiobank.ac.uk/wp-content/uploads/2017/06/2 4983-Dr-Manuel-Rivas.pdf). Based on the information provided in protocol 44532, the Stanford IRB has determined that the research does not involve human subjects as defined in 45 CFR 46.102(f) or 21 CFR 50.3(g). All participants in the UK Biobank study provided written informed consent (more information is available at https://www.ukbiobank.ac.uk/2018/02/gdpr/).The FinnGen project is approved by the Finnish Institute for Health and Welfare (THL), approval number THL/2031/6.02.00/2017, amendments THL/1101/5.05.00/2017, THL/341/6.02.00/2018,THL/2222/6.02.00/2018, THL/283/6.02.00/2019), Digital and population data service agency VRK43431/2017-3, VRK/6909/2018-3, the Social Insurance Institution (KELA) KELA 58/522/2017, KELA 131/522/2018, KELA 70/522/2019 and Statistics Finland TK-53-1041-17. The Biobank Access Decisions for FinnGen samples and data include: THL Biobank BB2017_55, BB2017_111, BB2018_19, BB_2018_34, BB_2018_67, BB2018_71, BB2019_7 Finnish Red Cross Blood Service Biobank 7.12.2017, Helsinki Biobank HUS/359/2017, Auria Biobank AB17-5154, Biobank Borealisof Northern Finland_2017_1013, Biobank of Eastern Finland 1186/2018, Finnish Clinical Biobank Tampere MH0004, Central Finland Biobank 1-2017, and Terveystalo Biobank STB 2018001. The following biobanks are acknowledged for collecting the FinnGen project samples: Auria Biobank (https://www.auria.fi/biopankki), THL Biobank (https://thl.fi/fi/web/thl-biopankki), Helsinki Biobank (https://www.terveyskyla.fi/helsinginbiopankki), Biobank Borealis of Northern Finland (https://www.oulu.fi/university/node/38474), Finnish Clinical Biobank Tampere (https://www.tays.fi/en-US/Research_and_development/Finnish_Clinical_Biobank_Tampere), Biobank of Eastern Finland (https://ita-suomenbiopankki.fi), Central Finland Biobank (https://www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (https://www.veripalvelu.fi/verenluovutus/biopankkitoiminta) and Terveystalo Biobank (https://www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/).All Finnish Biobanks are members of the BBMRI.fi infrastructure (www.bbmri.fi).Statin adjustment analyses were further conducted via UK Biobank application 7089 using a protocol approved by the Partners HealthCare Institutional Review Board. We thank all the participants in the UK Biobank and FinnGen studies. We thank A. Paterson and members of the Rivas, Pritchard and Bejerano labs for their feedback. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health (NIH) and by the NCI, the National Human Genome Research Institute (NHGRI), NHLBI, NIDA, NIMH and NINDS. The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 19 October 2020. This work was supported by the NHGRI of the NIH under awards R01HG010140 (M.A.R.), R01EB001988-21 (T.H.) and R01HG008140 (J.K.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Some of the computing for this project was performed on the Sherlock cluster at Stanford University. We would like to thank Stanford University and the Stanford Research Computing Center for providing computational resources and support that contributed to these research results. N.S.-A.; is supported by the Department of Defense through a National Defense Science and Engineering grant and by a Stanford Graduate Fellowship. Y.T. is supported by a Funai Overseas Scholarship from the Funai Foundation for Information Technology and the Stanford University School of Medicine. N.M. is supported by the Academy of Finland (no. 331671). H.M.O. is supported by the Academy of Finland (no. 309643). F.R. is supported by a National Heart, Lung, and Blood Institute grant (1K01HL144607). The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and by 12 industry partners (AbbVie Inc, AstraZeneca UK Ltd., Biogen MA Inc., Celgene Corporation, Celgene International II Sarl, Genentech Inc, Merck Sharp & Dohme Corp, Pfizer Inc., GlaxoSmithKline Intellectual Property Development Ltd., Sanofi US Services Inc., Maze Therapeutics Inc., Janssen Biotech Inc. and Novartis AG). M.A.R. is in part supported by the NHGRI of the NIH under award R01HG010140 (M.A.R.) and an NIH Center for Multi-and Trans-ethnic Mapping of Mendelian and Complex Diseases grant (5U01 HG009080). The land upon which some of this work was performed is the ancestral and unceded land of the Muwekma Ohlone, and we pay our respects to their elders past and present.	Abhary S, 2009, INVEST OPHTH VIS SCI, V50, P5552, DOI 10.1167/iovs.09-3694; Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Aguirre M, 2019, AM J HUM GENET, V105, P373, DOI 10.1016/j.ajhg.2019.07.001; Alkhatatbeh MJ, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.1; Amar D., 2019, CONSTRAINT BASED ANA, DOI [10.1101/566133, DOI 10.1101/566133]; Barton JC, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/9826930; Benjamini Y, 2001, ANN STAT, V29, P1165; Benner C, 2017, AM J HUM GENET, V101, P539, DOI 10.1016/j.ajhg.2017.08.012; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bowden J., 2018, INT J EPIDEMIOL, V47, P1264, DOI DOI 10.1093/ije/dyy265; Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Colijn JM, 2019, OPHTHALMOLOGY, V126, P393, DOI 10.1016/j.ophtha.2018.09.045; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; De Silva NMG, 2019, DIABETES, V68, P1681, DOI 10.2337/db18-1048; DeBoever C, 2020, AM J HUM GENET, V106, P611, DOI 10.1016/j.ajhg.2020.03.007; DeBoever C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03910-9; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eastwood SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162388; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fry D, 2019, UK BIOBANK BIOMARKER; Gonzalez Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-19; Gorski M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45040; Graham SE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09861-z; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Huang GX, 2016, NEUROL RES, V38, P518, DOI 10.1080/01616412.2016.1187825; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Jiang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02662-2; Joshi AD, 2016, GASTROENTEROLOGY, V151, P351, DOI 10.1053/j.gastro.2016.04.007; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kay P, 2014, INVEST OPHTH VIS SCI, V55, P926, DOI 10.1167/iovs.13-13239; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Khalili H, 2015, INFLAMM BOWEL DIS, V21, P361, DOI 10.1097/MIB.0000000000000283; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Klein R, 2009, ARCH OPHTHALMOL-CHIC, V127, P193, DOI 10.1001/archophthalmol.2008.551; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kuhn T, 2017, BRIT J CANCER, V117, P1572, DOI 10.1038/bjc.2017.313; Lall K, 2017, GENET MED, V19, P322, DOI 10.1038/gim.2016.103; Larson NB, 2015, ANN HUM GENET, V79, P264, DOI 10.1111/ahg.12119; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Lu XF, 2017, NAT GENET, V49, P1722, DOI 10.1038/ng.3978; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Marks J D, 1989, ASAIO Trans, V35, P436, DOI 10.1097/00002480-198907000-00085; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McComb R.B., 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; Nasser M, 2015, HORM MOL BIOL CLIN I, V22, P111, DOI 10.1515/hmbci-2015-0014; Nishigori H, 1998, DIABETES, V47, P1354, DOI 10.2337/diabetes.47.8.1354; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Pietzsch J, 1998, DIABETES, V47, P1928, DOI 10.2337/diabetes.47.12.1928; Qian JY, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009141; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raju Kalyani, 2018, Int J Appl Basic Med Res, V8, P57, DOI 10.4103/ijabmr.IJABMR_402_16; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Ruth KS, 2020, NAT MED, V26, P252, DOI 10.1038/s41591-020-0751-5; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi HWB, 2017, AM J HUM GENET, V101, P737, DOI 10.1016/j.ajhg.2017.09.022; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Slob EAW, 2017, INT J EPIDEMIOL, V46, P2094, DOI 10.1093/ije/dyx191; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Spracklen CN, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007275; Stitziel NO., 2016, NEW ENGL J MED, V374, P1134; Tanigawa Y., 2020, DATASETS DESCRIBED G, DOI [10.35092/yhjc.c.5043872.v1, DOI 10.35092/YHJC.C.5043872.V1]; Tanigawa Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11953-9; Teumer A, 2016, DIABETES, V65, P803, DOI 10.2337/db15-1313; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; van der Laan SW, 2016, J AM COLL CARDIOL, V68, P934, DOI 10.1016/j.jacc.2016.05.092; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wainberg M, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002982, 10.1371/journal.pmed.1002982.r001, 10.1371/journal.pmed.1002982.r002, 10.1371/journal.pmed.1002982.r003, 10.1371/journal.pmed.1002982.r004, 10.1371/journal.pmed.1002982.r005]; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wheeler E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002383; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wray NR, 2019, GENETICS, V211, P1131, DOI 10.1534/genetics.119.301859; Wuttke M, 2019, NAT GENET, V51, P957, DOI 10.1038/s41588-019-0407-x; Zhang PH, 2017, MOL MED REP, V16, P9279, DOI 10.3892/mmr.2017.7831; Zurdel J, 2002, BRIT J OPHTHALMOL, V86, P214, DOI 10.1136/bjo.86.2.214	94	124	125	10	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2021	53	2					185	+		10.1038/s41588-020-00757-z	http://dx.doi.org/10.1038/s41588-020-00757-z		JAN 2021	16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QD3KE	33462484	Green Submitted, Green Accepted			2022-12-17	WOS:000608658900001
J	Wedge, DC; Gundem, G; Mitchell, T; Woodcock, DJ; Martincorena, I; Ghori, M; Zamora, J; Butler, A; Whitaker, H; Kote-Jarai, Z; Alexandrov, LB; Van Loo, P; Massie, CE; Dentro, S; Warren, AY; Verrill, C; Berney, DM; Dennis, N; Merson, S; Hawkins, S; Howat, W; Lu, YJ; Lambert, A; Kay, J; Kremeyer, B; Karaszi, K; Luxton, H; Camacho, N; Marsden, L; Edwards, S; Matthews, L; Bo, V; Leongamornlert, D; McLaren, S; Ng, A; Yu, YW; Zhang, HW; Dadaev, T; Thomas, S; Easton, DF; Ahmed, M; Bancroft, E; Fisher, C; Livni, N; Nicol, D; Tavare, S; Gill, P; Greenman, C; Khoo, V; Van As, N; Kumar, P; Ogden, C; Cahill, D; Thompson, A; Mayer, E; Rowe, E; Dudderidge, T; Gnanapragasam, V; Shah, NC; Raine, K; Jones, D; Menzies, A; Stebbings, L; Teague, J; Hazell, S; Corbishley, C; de Bono, J; Attard, G; Isaacs, W; Visakorpi, T; Fraser, M; Boutros, PC; Bristow, RG; Workman, P; Sander, C; Hamdy, FC; Futreal, A; McDermott, U; Al-Lazikani, B; Lynch, AG; Bova, GS; Foster, CS; Brewer, DS; Neal, DE; Cooper, CS; Eeles, RA				Wedge, David C.; Gundem, Gunes; Mitchell, Thomas; Woodcock, Dan J.; Martincorena, Inigo; Ghori, Mohammed; Zamora, Jorge; Butler, Adam; Whitaker, Hayley; Kote-Jarai, Zsofia; Alexandrov, Ludmil B.; Van Loo, Peter; Massie, Charlie E.; Dentro, Stefan; Warren, Anne Y.; Verrill, Clare; Berney, Dan M.; Dennis, Nening; Merson, Sue; Hawkins, Steve; Howat, William; Lu, Yong-Jie; Lambert, Adam; Kay, Jonathan; Kremeyer, Barbara; Karaszi, Katalin; Luxton, Hayley; Camacho, Niedzica; Marsden, Luke; Edwards, Sandra; Matthews, Lucy; Bo, Valeria; Leongamornlert, Daniel; McLaren, Stuart; Ng, Anthony; Yu, Yongwei; Zhang, Hongwei; Dadaev, Tokhir; Thomas, Sarah; Easton, Douglas F.; Ahmed, Mahbubl; Bancroft, Elizabeth; Fisher, Cyril; Livni, Naomi; Nicol, David; Tavare, Simon; Gill, Pelvender; Greenman, Christopher; Khoo, Vincent; Van As, Nicholas; Kumar, Pardeep; Ogden, Christopher; Cahill, Declan; Thompson, Alan; Mayer, Erik; Rowe, Edward; Dudderidge, Tim; Gnanapragasam, Vincent; Shah, Nimish C.; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Teague, Jon; Hazell, Steven; Corbishley, Cathy; de Bono, Johann; Attard, Gerhardt; Isaacs, William; Visakorpi, Tapio; Fraser, Michael; Boutros, Paul C.; Bristow, Robert G.; Workman, Paul; Sander, Chris; Hamdy, Freddie C.; Futreal, Andrew; McDermott, Ultan; Al-Lazikani, Bissan; Lynch, Andrew G.; Bova, G. Steven; Foster, Christopher S.; Brewer, Daniel S.; Neal, David E.; Cooper, Colin S.; Eeles, Rosalind A.		CAMCAP Study Grp; TCGA Consortium	Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets	NATURE GENETICS			English	Article							COPY NUMBER ANALYSIS; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; DNA-REPAIR; DISCOVERY KNOWLEDGEBASE; MUTATIONAL PROCESSES; SOMATIC MUTATIONS; GROWTH; METASTASIS; EXPRESSION	Prostate cancer represents a substantial clinical challenge because it is difficult to predict outcome and advanced disease is often fatal. We sequenced the whole genomes of 112 primary and metastatic prostate cancer samples. From joint analysis of these cancers with those from previous studies (930 cancers in total), we found evidence for 22 previously unidentified putative driver genes harboring coding mutations, as well as evidence for NEAT1 and FOXA1 acting as drivers through noncoding mutations. Through the temporal dissection of aberrations, we identified driver mutations specifically associated with steps in the progression of prostate cancer, establishing, for example, loss of CHD1 and BRCA2 as early events in cancer development of ETS fusion-negative cancers. Computational chemogenomic (canSAR) analysis of prostate cancer mutations identified 11 targets of approved drugs, 7 targets of investigational drugs, and 62 targets of compounds that may be active and should be considered candidates for future clinical trials.	[Wedge, David C.; Woodcock, Dan J.; Dentro, Stefan] Univ Oxford, Oxford Big Data Inst, Oxford, England; [Wedge, David C.; Gundem, Gunes; Mitchell, Thomas; Martincorena, Inigo; Ghori, Mohammed; Zamora, Jorge; Butler, Adam; Alexandrov, Ludmil B.; Van Loo, Peter; Dentro, Stefan; Kremeyer, Barbara; Leongamornlert, Daniel; McLaren, Stuart; Raine, Keiran; Jones, David; Menzies, Andrew; Stebbings, Lucy; Teague, Jon; Futreal, Andrew; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Wedge, David C.; Verrill, Clare] Oxford NIHR Biomed Res Ctr, Oxford, England; [Gundem, Gunes; Camacho, Niedzica] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Mitchell, Thomas; Shah, Nimish C.] Addenbrookes Hosp, Dept Urol, Cambridge, England; [Mitchell, Thomas; Massie, Charlie E.; Hawkins, Steve] Cambridge Inst, Urooncol Res Grp, Canc Res UK, Cambridge, England; [Whitaker, Hayley; Kay, Jonathan; Luxton, Hayley] UCL, Mol Diagnost & Therapeut Grp, London, England; [Kote-Jarai, Zsofia; Merson, Sue; Camacho, Niedzica; Edwards, Sandra; Leongamornlert, Daniel; Dadaev, Tokhir; Ahmed, Mahbubl; Bancroft, Elizabeth; de Bono, Johann; Attard, Gerhardt; Workman, Paul; Al-Lazikani, Bissan; Brewer, Daniel S.; Cooper, Colin S.; Eeles, Rosalind A.] Inst Canc Res, London, England; [Van Loo, Peter; Dentro, Stefan] Francis Crick Inst, Canc Gen, London, England; [Massie, Charlie E.] Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Ctr, Early Detect Programme, Cambridge, England; [Warren, Anne Y.; Howat, William] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, England; [Verrill, Clare; Lambert, Adam; Karaszi, Katalin; Marsden, Luke; Matthews, Lucy; Gill, Pelvender; Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Berney, Dan M.; Lu, Yong-Jie] Queen Mary Univ London, Barts Canc Inst, Barts & London Sch Med & Dent, Ctr Mol Oncol, London, England; [Dennis, Nening; Thomas, Sarah; Bancroft, Elizabeth; Fisher, Cyril; Livni, Naomi; Nicol, David; Khoo, Vincent; Van As, Nicholas; Kumar, Pardeep; Ogden, Christopher; Cahill, Declan; Thompson, Alan; Mayer, Erik; Rowe, Edward; Dudderidge, Tim; Hazell, Steven; Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London, England; [Dennis, Nening; Thomas, Sarah; Bancroft, Elizabeth; Fisher, Cyril; Livni, Naomi; Nicol, David; Khoo, Vincent; Van As, Nicholas; Kumar, Pardeep; Ogden, Christopher; Cahill, Declan; Thompson, Alan; Mayer, Erik; Rowe, Edward; Dudderidge, Tim; Hazell, Steven; Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Bo, Valeria; Tavare, Simon; Lynch, Andrew G.] Canc Res UK Cambridge Inst, Stat & Computat Biol Lab, Cambridge, England; [Ng, Anthony] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Yu, Yongwei; Zhang, Hongwei] Second Mil Med Univ, Shanghai, Peoples R China; [Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Greenman, Christopher; Brewer, Daniel S.; Cooper, Colin S.; Eeles, Rosalind A.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Gnanapragasam, Vincent; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge, England; [Corbishley, Cathy] St Georges Healthcare NHS Trust, London, England; [Isaacs, William; Bova, G. Steven] Johns Hopkins Sch Med, Baltimore, MD USA; [Visakorpi, Tapio] Univ Tampere, Inst Biosci & Med Technol, BioMediTech, Tampere, Finland; [Visakorpi, Tapio] Tampere Univ Hosp, Fimlab Labs, Tampere, Finland; [Fraser, Michael] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Boutros, Paul C.; Bristow, Robert G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Bristow, Robert G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Sander, Chris] Dana Farber Canc Inst, cBio Ctr, Boston, MA 02115 USA; [Sander, Chris] Harvard Med Sch, Boston, MA USA; [Foster, Christopher S.] Univ St Andrews, Sch Med, Sch Math & Stat, St Andrews, Fife, Scotland; [Foster, Christopher S.] Univ Liverpool, Liverpool, Merseyside, England; [Brewer, Daniel S.] HCA Labs, London, England; [Wedge, David C.; Gundem, Gunes; Mitchell, Thomas] Earlham Inst, Norwich, Norfolk, England	University of Oxford; Wellcome Trust Sanger Institute; University of Oxford; Memorial Sloan Kettering Cancer Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Francis Crick Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Oxford; University of London; Queen Mary University London; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research UK; CRUK Cambridge Institute; Chinese University of Hong Kong; Naval Medical University; University of Cambridge; University of East Anglia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; St Georges University London; Johns Hopkins University; Johns Hopkins Medicine; Tampere University; Tampere University; Tampere University Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of St Andrews; University of Liverpool; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute	Wedge, DC (corresponding author), Univ Oxford, Oxford Big Data Inst, Oxford, England.; Wedge, DC (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.; Wedge, DC (corresponding author), Oxford NIHR Biomed Res Ctr, Oxford, England.; Eeles, RA (corresponding author), Inst Canc Res, London, England.; Eeles, RA (corresponding author), Royal Marsden NHS Fdn Trust, London, England.; Eeles, RA (corresponding author), Royal Marsden NHS Fdn Trust, Sutton, Surrey, England.; Wedge, DC (corresponding author), Earlham Inst, Norwich, Norfolk, England.	david.wedge@bdi.ox.ac.uk; rosalind.eeles@icr.ac.uk	Wedge, David/AAC-4977-2021; Luxton, Hayley/AAT-2450-2020; Brewer, Daniel S/D-6201-2018; Alexandrov, Ludmil/AAS-1454-2021; Kay, Jonathan/HGE-1248-2022; Nicol, David L/M-6809-2016; Al-Lazikani, Bissan/AFK-6457-2022; Dudderidge, Tim/AAO-1430-2020; Ng, Chi-Fai/E-5134-2011; Al-Lazikani, Bissan/AAG-4723-2022; Mayer, Erik/A-6207-2013	Luxton, Hayley/0000-0003-1431-3844; Brewer, Daniel S/0000-0003-4753-9794; Alexandrov, Ludmil/0000-0003-3596-4515; Nicol, David L/0000-0002-5623-7467; Ng, Chi-Fai/0000-0002-1723-9646; Boutros, Paul/0000-0003-0553-7520; Bova, George/0000-0003-1639-3104; Martincorena, Inigo/0000-0003-1122-4416; Bristow, Robert/0000-0002-8553-9544; Al-Lazikani, Bissan/0000-0003-3367-2519; Mayer, Erik/0000-0002-5509-4580; Hamdy, Freddie/0000-0003-2627-2154; Leongamornlert, Daniel/0000-0002-3486-3168; McDermott, Ultan/0000-0001-9032-4700; Dudderidge, Tim/0000-0001-6373-3613; Van Loo, Peter/0000-0003-0292-1949; Woodcock, Dan/0000-0003-0576-044X; Bancroft, Elizabeth/0000-0002-5482-5660; Dentro, Stefan/0000-0002-0478-9729; Eeles, Rosalind/0000-0002-3698-6241; Raine, Keiran/0000-0002-5634-1539; Mitchell, Thomas/0000-0003-0761-9503; Nicol, David/0000-0003-0107-6990; Wedge, David/0000-0002-7572-3196; Lynch, Andy/0000-0002-7876-7338; de Bono, Johann S/0000-0002-2034-595X	Cancer Research UK [C5047/A14835/A22530/A17528, C309/A11566, C368/A6743, A368/A7990, C14303/A17197]; Dallaglio Foundation (CR-UK Prostate Cancer ICGC Project and Pan Prostate Cancer Group); PC-UK/Movember; NIHR; Royal Marsden NHS Foundation Trust; Cancer Research UK; National Cancer Research Institute (National Institute of Health Research (NIHR)) [G0500966/75466]; Li Ka Shing Foundation; Academy of Finland; Cancer Society of Finland; NIHR Cambridge Biomedical Research Centre; Core Facilities at the Cancer Research UK Cambridge Institute; Orchid and Cancer Research UK; Orchid; NIHR Oxford Biomedical Research Centre (Molecular Diagnostics Theme/Multimodal Pathology sub-theme); Bob Champion Cancer Trust; Masonic Charitable Foundation; King Family; Stephen Hargrave Trust; CRUK [C35696/A23187]; Cancer Research UK [15007, 21777, 19556, 11566, 22897, 14835, 22530, 17528, 22744, 26718] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096, CL-2014-14-004, NF-SI-0513-10121, CL-2008-22-001, NF-SI-0509-10242] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish; Cancer Foundation Finland sr [130073, 170104, 150069] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Dallaglio Foundation (CR-UK Prostate Cancer ICGC Project and Pan Prostate Cancer Group); PC-UK/Movember; NIHR(National Institute for Health Research (NIHR)); Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Cancer Research UK(Cancer Research UK); National Cancer Research Institute (National Institute of Health Research (NIHR)); Li Ka Shing Foundation; Academy of Finland(Academy of Finland); Cancer Society of Finland; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Core Facilities at the Cancer Research UK Cambridge Institute; Orchid and Cancer Research UK; Orchid; NIHR Oxford Biomedical Research Centre (Molecular Diagnostics Theme/Multimodal Pathology sub-theme); Bob Champion Cancer Trust; Masonic Charitable Foundation; King Family; Stephen Hargrave Trust; CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; Cancer Foundation Finland sr	The authors thank those men with prostate cancer and the subjects who have donated their time and their samples to the Cambridge, Oxford, The Institute of Cancer Research, John Hopkins and University of Tampere BioMediTech Biorepositories for this study. We also acknowledge support of the research staff in S4 who so carefully curated the samples and the follow-up data (J. Burge, M. Corcoran, A. George and S. Stearn). We thank M. Stratton for discussions when setting up the CR-UK Prostate Cancer ICGC Project. We acknowledge support from Cancer Research UK C5047/A14835/A22530/A17528, C309/A11566, C368/A6743, A368/A7990, C14303/A17197 (Z.K.-J., S. Merson, N.C., S.E., D.L., T. Dadaev, M. A., E.B., J.B., G.A., P.W., B.A.-L., D.S.B., C.S.C., R.A.E.), the Dallaglio Foundation (CR-UK Prostate Cancer ICGC Project and Pan Prostate Cancer Group), PC-UK/Movember (Z.K.-J.), the NIHR support to The Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust (Z.K.-J., N.D., S. Merson, N.C., S.E., D.L., T. Dadaev, S. Thomas, M. A., E.B., C.F., N.L., D.N., V.K., N.A., P.K., C.O., D.C., A.T., E.M., E.R., T. Dudderidge, S. Hazell, J.B., G.A., P.W., B.A.-L., D.S.B., C.S.C., R.A.E.), Cancer Research UK funding to The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust CRUK Centre, the National Cancer Research Institute (National Institute of Health Research (NIHR) Collaborative Study: "Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT)" (grant G0500966/75466) (D.E.N., V.G.), the Li Ka Shing Foundation (D.C.W., D.J.W.) and the Academy of Finland and Cancer Society of Finland (G.S.B.). We thank the National Institute for Health Research, Hutchison Whampoa Limited, University of Cambridge and the Human Research Tissue Bank (Addenbrooke's Hospital), which is supported by the NIHR Cambridge Biomedical Research Centre; The Core Facilities at the Cancer Research UK Cambridge Institute, Orchid and Cancer Research UK, D. Holland from the Infrastructure Management Team, and P. Clapham from the Informatics Systems Group at the Wellcome Trust Sanger Institute. D.M.B. is supported by Orchid. C.V.'s academic time was supported by the NIHR Oxford Biomedical Research Centre (Molecular Diagnostics Theme/Multimodal Pathology sub-theme). We also acknowledge support from the Bob Champion Cancer Trust, The Masonic Charitable Foundation successor to The Grand Charity, The King Family and the Stephen Hargrave Trust (C.S.C., D.S.B.). P.W. is a Cancer Research Life Fellow. We acknowledge core facilities provided by CRUK funding to the CRUK ICR Centre, the CRUK Cancer Therapeutics Unit and support for canSAR C35696/A23187 (P.W., G.A.).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Bostrom PJ, 2015, EUR UROL, V68, P1033, DOI 10.1016/j.eururo.2015.04.008; Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; Burkhardt L, 2013, CANCER RES, V73, P2795, DOI 10.1158/0008-5472.CAN-12-1342; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Castro E, 2015, EUR UROL, V68, P186, DOI 10.1016/j.eururo.2014.10.022; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collart MA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00061; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Daniels G, 2014, ENDOCR-RELAT CANCER, V21, P127, DOI 10.1530/ERC-13-0293; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Fischer K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00244; FitzGerald LM, 2009, EUR J HUM GENET, V17, P368, DOI 10.1038/ejhg.2008.171; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Goodwin JF, 2015, CANCER CELL, V28, P97, DOI 10.1016/j.ccell.2015.06.004; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klein EA, 2016, UROLOGY, V90, P148, DOI 10.1016/j.urology.2016.01.012; Kluth M, 2015, INT J CANCER, V137, P2354, DOI 10.1002/ijc.29613; Kluth M, 2014, INT J CANCER, V135, P1369, DOI 10.1002/ijc.28784; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Leongamornlert D, 2014, BRIT J CANCER, V110, P1663, DOI 10.1038/bjc.2014.30; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu W, 2012, ONCOGENE, V31, P3939, DOI 10.1038/onc.2011.554; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Loriot Y, 2015, LANCET ONCOL, V16, P509, DOI 10.1016/S1470-2045(15)70113-0; Luca B.-A, 2017, EUR UROL FOCUS, DOI [10.1016/j.euf.2017.01.016, DOI 10.1016/J.EUF.2017.01.016(2017)]; Malik R, 2015, NAT MED, V21, P344, DOI 10.1038/nm.3830; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mitsopoulos C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004597; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Nickerson ML, 2013, HUM MUTAT, V34, P1231, DOI 10.1002/humu.22346; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Parray A, 2014, INT J CANCER, V135, P2493, DOI 10.1002/ijc.28919; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodrigues LU, 2015, CANCER RES, V75, P1021, DOI 10.1158/0008-5472.CAN-14-1596; Rudnicka C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005085; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Seigne C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-395; Shin SY, 2016, STAT SINICA, V26, P235, DOI 10.5705/ss.2014.233; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Svensson C, 2014, NUCLEIC ACIDS RES, V42, P999, DOI 10.1093/nar/gkt921; Takayama K, 2014, MOL ENDOCRINOL, V28, P2012, DOI 10.1210/me.2014-1171; Tarish FL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5671; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turner H, 2012, J STAT SOFTW, V48, P1; Tym JE, 2016, NUCLEIC ACIDS RES, V44, pD938, DOI 10.1093/nar/gkv1030; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Williams JL, 2014, CANCER GENET-NY, V207, P474, DOI 10.1016/j.cancergen.2014.09.003; Workman P, 2013, NAT REV DRUG DISCOV, V12, P889, DOI 10.1038/nrd4184; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yang YA, 2015, GENES DIS, V2, P144, DOI 10.1016/j.gendis.2015.01.003; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhao W, 2015, BIOMED PHARMACOTHER, V75, P142, DOI 10.1016/j.biopha.2015.07.015	83	124	126	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					682	+		10.1038/s41588-018-0086-z	http://dx.doi.org/10.1038/s41588-018-0086-z			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	29662167	Green Accepted, Green Submitted			2022-12-17	WOS:000431394900011
J	Majithia, AR; Tsuda, B; Agostini, M; Gnanapradeepan, K; Rice, R; Peloso, G; Patel, KA; Zhang, XL; Broekema, MF; Patterson, N; Duby, M; Sharpe, T; Kalkhoven, E; Rosen, ED; Barroso, I; Ellard, S; Kathiresan, S; O'Rahilly, S; Chatterjee, K; Florez, JC; Mikkelsen, T; Savage, DB; Altshuler, D				Majithia, Amit R.; Tsuda, Ben; Agostini, Maura; Gnanapradeepan, Keerthana; Rice, Robert; Peloso, Gina; Patel, Kashyap A.; Zhang, Xiaolan; Broekema, Marjoleine F.; Patterson, Nick; Duby, Marc; Sharpe, Ted; Kalkhoven, Eric; Rosen, Evan D.; Barroso, Ines; Ellard, Sian; Kathiresan, Sekar; O'Rahilly, Stephen; Chatterjee, Krishna; Florez, Jose C.; Mikkelsen, Tarjei; Savage, David B.; Altshuler, David		UK Monogenic Diabetes Consortium; Myocardial Infarction Genetics Con; Uk Congenital Lipodystrophy Consor	Prospective functional classification of all possible missense variants in PPARG	NATURE GENETICS			English	Article							INSULIN-RESISTANCE; RARE VARIANTS; GAMMA; MUTATIONS; RISK; DIFFERENTIATION; BINDING; DNA	Clinical exome sequencing routinely identifies missense variants in disease-related genes, but functional characterization is rarely undertaken, leading to diagnostic uncertainty(1,2). For example, mutations in PPARG cause Mendelian lipodystrophy(3,4) and increase risk of type 2 diabetes (T2D)(5). Although approximately 1 in 500 people harbor missense variants in PPARG, most are of unknown consequence. To prospectively characterize PPAR gamma variants, we used highly parallel oligonucleotide synthesis to construct a library encoding all 9,595 possible single-amino acid substitutions. We developed a pooled functional assay in human macrophages, experimentally evaluated all protein variants, and used the experimental data to train a variant classifier by supervised machine learning. When applied to 55 new missense variants identified in population-based and clinical sequencing, the classifier annotated 6 variants as pathogenic; these were subsequently validated by single variant assays. Saturation mutagenesis and prospective experimental characterization can support immediate diagnostic interpretation of newly discovered missense variants in disease-related genes.	[Majithia, Amit R.; Tsuda, Ben; Gnanapradeepan, Keerthana; Rice, Robert; Peloso, Gina; Zhang, Xiaolan; Patterson, Nick; Duby, Marc; Sharpe, Ted; Kathiresan, Sekar; Florez, Jose C.; Mikkelsen, Tarjei; Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Majithia, Amit R.; Florez, Jose C.; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [Majithia, Amit R.; Kathiresan, Sekar; Florez, Jose C.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet, Boston, MA 02114 USA; [Majithia, Amit R.; Rosen, Evan D.; Kathiresan, Sekar; Florez, Jose C.; Altshuler, David] Harvard Med Sch, Dept Med, Boston, MA USA; [Agostini, Maura; Barroso, Ines; O'Rahilly, Stephen; Chatterjee, Krishna; Savage, David B.] Univ Cambridge, Metab Res Labs, Wellcome Trust Med Res Council Inst Metab Sci, Cambridge, England; [Peloso, Gina] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Patel, Kashyap A.; Ellard, Sian] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Broekema, Marjoleine F.; Kalkhoven, Eric] Univ Med Ctr Utrecht, Mol Canc Res, Utrecht, Netherlands; [Broekema, Marjoleine F.; Kalkhoven, Eric] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, Boston, MA 02215 USA; [Ellard, Sian] Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Dept Mol Genet, Exeter, Devon, England; [Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Mikkelsen, Tarjei] 10X Genom Inc, Pleasanton, CA USA; [Altshuler, David] Vertex Pharmaceut, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge; Boston University; University of Exeter; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Vertex Pharmaceuticals	Majithia, AR (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA.; Majithia, AR (corresponding author), Massachusetts Gen Hosp, Dept Med, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA.; Majithia, AR (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet, Boston, MA 02114 USA.; Majithia, AR (corresponding author), Harvard Med Sch, Dept Med, Boston, MA USA.	amajithia@mgh.harvard.edu	Altshuler, David M/A-4476-2009; O'Rahilly, Stephen/ABF-6509-2020; Mikkelsen, Tarjei S/A-1306-2007; Patel, Kashyap/AAR-1475-2021	Altshuler, David M/0000-0002-7250-4107; O'Rahilly, Stephen/0000-0003-2199-4449; Mikkelsen, Tarjei S/0000-0002-8133-3135; Patel, Kashyap/0000-0002-9240-8104; Ellard, Sian/0000-0002-7620-5526; Savage, David Bousfield/0000-0002-7857-7032; Barroso, Ines/0000-0001-5800-4520; Chatterjee, Vengalil Krishna/0000-0002-2654-8854	National Institute of Diabetes and Digestive and Kidney Diseases [1K08DK102877-01, 1R01DK097768-01]; NIH/Harvard Catalyst [1KL2TR001100-01]; Broad Institute; Wellcome Trust [095564, 107064]; MRC [MC_UU_12012/5] Funding Source: UKRI; Medical Research Council [MC_UU_12012/5, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [CL-2013-23-001, NF-SI-0514-10176, NF-SI-0507-10380, NF-SI-0513-10109] Funding Source: researchfish; Wellcome Trust [110082/Z/15/Z] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768, K24DK110550, K08DK102877] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/Harvard Catalyst(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (1K08DK102877-01, to ARM.; 1R01DK097768-01, to D.A.), NIH/Harvard Catalyst (1KL2TR001100-01, to ARM.), the Broad Institute (SPARC award, to A.R.M. and T.M.), and the Wellcome Trust (095564, to K.C.; 107064, to D.B.S.).	Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Barnes M, 2003, BIOINFORMATICS GENET; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Demir T, 2016, DIABETIC MED, V33, P1445, DOI 10.1111/dme.13061; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; McLaughlin HM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0134-1; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	26	124	125	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2016	48	12					1570	1575		10.1038/ng.3700	http://dx.doi.org/10.1038/ng.3700			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED7BQ	27749844	Green Accepted, Green Submitted			2022-12-17	WOS:000389011100019
J	Il Je, B; Gruel, J; Lee, YK; Bommert, P; Arevalo, ED; Eveland, AL; Wu, QY; Goldshmidt, A; Meeley, R; Bartlett, M; Komatsu, M; Sakai, H; Jonsson, H; Jackson, D				Il Je, Byoung; Gruel, Jeremy; Lee, Young Koung; Bommert, Peter; Arevalo, Edgar Demesa; Eveland, Andrea L.; Wu, Qingyu; Goldshmidt, Alexander; Meeley, Robert; Bartlett, Madelaine; Komatsu, Mai; Sakai, Hajime; Jonsson, Henrik; Jackson, David			Signaling from maize organ primordia via FASCIATED EAR3 regulates stem cell proliferation and yield traits	NATURE GENETICS			English	Article							RECEPTOR-LIKE KINASE; ARABIDOPSIS SHOOT MERISTEM; GENE ENCODES; PROTEIN; MAINTENANCE; PLANT; EXPRESSION; CLAVATA1; RICE; DIVERSIFICATION	Shoot apical meristems are stem cell niches that balance proliferation with the incorporation of daughter cells into organ primordia. This balance is maintained by CLAVATA-WUSCHEL feedback signaling between the stem cells at the tip of the meristem and the underlying organizing center. Signals that provide feedback from organ primordia to control the stem cell niche in plants have also been hypothesized, but their identities are unknown. Here we report FASCIATED EAR3 (FEA3), a leucinerich- repeat receptor that functions in stem cell control and responds to a CLAVATA3/ESR-related (CLE) peptide expressed in organ primordia. We modeled our results to propose a regulatory system that transmits signals from differentiating cells in organ primordia back to the stem cell niche and that appears to function broadly in the plant kingdom. Furthermore, we demonstrate an application of this new signaling feedback, by showing that weak alleles of fea3 enhance hybrid maize yield traits.	[Il Je, Byoung; Lee, Young Koung; Bommert, Peter; Arevalo, Edgar Demesa; Eveland, Andrea L.; Wu, Qingyu; Goldshmidt, Alexander; Jackson, David] Cold Spring Harbor Lab, New York, NY USA; [Gruel, Jeremy; Jonsson, Henrik] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Meeley, Robert] DuPont Pioneer, Agr Biotechnol, Johnston, IA USA; [Bartlett, Madelaine] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Komatsu, Mai; Sakai, Hajime] DuPont Pioneer, Agr Biotechnol, Wilmington, DC USA; [Jonsson, Henrik] Lund Univ, Computat Biol & Biol Phys Grp, Lund, Sweden; [Eveland, Andrea L.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Cold Spring Harbor Laboratory; University of Cambridge; DuPont; Pioneer Hi-Bred International, Inc.; University of Massachusetts System; University of Massachusetts Amherst; Lund University; Donald Danforth Plant Science Center	Jackson, D (corresponding author), Cold Spring Harbor Lab, New York, NY USA.	jacksond@cshl.edu	Demesa-Arevalo, Edgar/AAX-8477-2020; Wu, Qingyu/E-4636-2017; Wu, Qingyu/AAF-3675-2020; Eveland, Andrea/M-9886-2014	Demesa-Arevalo, Edgar/0000-0002-2793-5928; Wu, Qingyu/0000-0003-3064-2445; Wu, Qingyu/0000-0003-3064-2445; Eveland, Andrea/0000-0003-4825-1282; Goldshmidt, Alexander/0000-0001-7468-6779	DuPont Pioneer; NSF Plant Genome Research program [IOS-1238202, MCB-1027445]; Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2016-67013-24572]; Gatsby Charitable Foundation [GAT3395/PR4]; Swedish Research Council [VR2013-4632]; Next-Generation BioGreen 21 Program (SSAC) from Rural Development Administration, Republic of Korea [PJ01184302]; Direct For Biological Sciences [1238202] Funding Source: National Science Foundation	DuPont Pioneer; NSF Plant Genome Research program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture; Gatsby Charitable Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Next-Generation BioGreen 21 Program (SSAC) from Rural Development Administration, Republic of Korea; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The fea3-0 allele was kindly provided by V. Shcherbak (Krasnodar Research Institute of Agriculture). We also thank U. Hernandez for assistance with cloning, A. Masson for assistance with peptide assays, and members of the Jackson laboratory for comments on the manuscript. We acknowledge funding from a collaborative agreement with DuPont Pioneer and from NSF Plant Genome Research program grant IOS-1238202 and grant MCB-1027445 and from Agriculture and Food Research Initiative competitive grant 2016-67013-24572 of the USDA National Institute of Food and Agriculture. The study also received support from the Gatsby Charitable Foundation (GAT3395/PR4) and the Swedish Research Council (VR2013-4632) to H.J. and through the Next-Generation BioGreen 21 Program (SSAC; project PJ01184302) from the Rural Development Administration, Republic of Korea.	Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Crawford KM, 2000, CURR BIOL, V10, P1032, DOI 10.1016/S0960-9822(00)00657-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Gruel J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500989; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Iliev I, 2011, PLANT GROWTH REGUL, V63, P115, DOI 10.1007/s10725-010-9540-3; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; JONSSON H, 2003, GROWTH FORM COMPUTER, P156; Juarez MT, 2004, DEVELOPMENT, V131, P4533, DOI 10.1242/dev.01328; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Krishnakumar V, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu178; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; McCarty Donald R., 2009, P561, DOI 10.1007/978-0-387-77863-1_28; Mohanty A, 2009, PLANT PHYSIOL, V149, P601, DOI 10.1104/pp.108.130146; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; OpsahlFerstad HG, 1997, PLANT J, V12, P235, DOI 10.1046/j.1365-313X.1997.12010235.x; Osterrieder A, 2009, TRAFFIC, V10, P1034, DOI 10.1111/j.1600-0854.2009.00930.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scanlon MJ, 2003, PLANT PHYSIOL, V133, P597, DOI 10.1104/pp.103.026880; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Suzaki T, 2008, PLANT CELL, V20, P2049, DOI 10.1105/tpc.107.057257; Suzaki T, 2006, PLANT CELL PHYSIOL, V47, P1591, DOI 10.1093/pcp/pcl025; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Tanaka W, 2012, PLANT CELL, V24, P80, DOI 10.1105/tpc.111.094797; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Whipple CJ, 2011, P NATL ACAD SCI USA, V108, pE506, DOI 10.1073/pnas.1102819108; Wu QY, 2013, INT J DEV BIOL, V57, P535, DOI 10.1387/ijdb.130240qw; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176	56	124	135	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					785	+		10.1038/ng.3567	http://dx.doi.org/10.1038/ng.3567			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27182966	Green Accepted			2022-12-17	WOS:000378840100016
J	Durruthy-Durruthy, J; Sebastiano, V; Wossidlo, M; Cepeda, D; Cui, J; Grow, EJ; Davila, J; Mall, M; Wong, WH; Wysocka, J; Au, KF; Pera, RAR				Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Grow, Edward J.; Davila, Jonathan; Mall, Moritz; Wong, Wing H.; Wysocka, Joanna; Au, Kin Fai; Pera, Renee A. Reijo			The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; SELF-RENEWAL; LINE-1 RETROTRANSPOSONS; TRANSPOSABLE ELEMENTS; MICRORNA; TRANSCRIPTION; EVOLUTION; PROTEINS; NANOG	Long intergenic noncoding RNAs (lincRNAs) are derived from thousands of loci in mammalian genomes and are frequently enriched in transposable elements (TEs). Although families of TE-derived lincRNAs have recently been implicated in the regulation of pluripotency, little is known of the specific functions of individual family members. Here we characterize three new individual TE-derived human lincRNAs, human pluripotency-associated transcripts 2, 3 and 5 (HPAT2, HPAT3 and HPAT5). Loss-of-function experiments indicate that HPAT2, HPAT3 and HPAT5 function in preimplantation embryo development to modulate the acquisition of pluripotency and the formation of the inner cell mass. CRISPR-mediated disruption of the genes for these lincRNAs in pluripotent stem cells, followed by whole-transcriptome analysis, identifies HPAT5 as a key component of the pluripotency network. Protein binding and reporter-based assays further demonstrate that HPAT5 interacts with the let-7 microRNA family. Our results indicate that unique individual members of large primate-specific lincRNA families modulate gene expression during development and differentiation to reinforce cell fate.	[Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Grow, Edward J.; Pera, Renee A. Reijo] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Davila, Jonathan; Mall, Moritz] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wong, Wing H.; Au, Kin Fai] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Pera, RAR (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	vsebast@stanford.edu; renee.reijopera@montana.edu	Cui, Jun/G-6230-2015; Wossidlo, Mark/M-9690-2019; Mall, Moritz/AAA-3558-2019	Cui, Jun/0000-0002-1926-1759; Wossidlo, Mark/0000-0002-3184-0753; Mall, Moritz/0000-0002-1278-2594; Reijo Pera, Renee/0000-0002-6487-1329	Stanford University Center for Reproductive and Stem Cell Biology [U54-1U54HD068158-01]; Basic and Translational Research of iPSC-based Hematologic and Vascular Therapies [U01-1U01HL100397-01]; US National Institutes of Health [R01HG006018]; California Institute of Regenerative Medicine [RB3-2209]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD068158, P50HD068158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006018, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112720, T32GM007790] Funding Source: NIH RePORTER	Stanford University Center for Reproductive and Stem Cell Biology; Basic and Translational Research of iPSC-based Hematologic and Vascular Therapies; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Reijo Pera laboratory for thoughtful feedback and comments regarding manuscript preparation. We thank Z. Siprashvili for assistance in the protein microarray experiments. We thank S. Marro for the neural transdifferentiation experiments and L.B. Torrez for the siRNA experiments. We thank G. Glinsky for thoughtful feedback regarding data assessment. This work was funded by grants U54-1U54HD068158-01 (Stanford University Center for Reproductive and Stem Cell Biology), U01-1U01HL100397-01 (Basic and Translational Research of iPSC-based Hematologic and Vascular Therapies), R01HG006018 (US National Institutes of Health) and RB3-2209 (California Institute of Regenerative Medicine). No federal funding was used for human embryo studies.	Alcid EA, 2014, GENE DEV, V28, P2348, DOI 10.1101/gad.250902.114; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; HARADA F, 1987, NUCLEIC ACIDS RES, V15, P9153, DOI 10.1093/nar/15.22.9153; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lazzeroni L, 2002, STAT SINICA, V12, P61; Li JJ, 2014, GENOME RES, V24, P775, DOI 10.1101/gr.162230.113; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Ohms S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00338; Ohms S, 2014, ONCOTARGET, V5, P4103, DOI 10.18632/oncotarget.1822; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Siprashvili Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-633; Spengler RM, 2014, HUM MOL GENET, V23, P1783, DOI 10.1093/hmg/ddt569; Tanaka Y, 2012, MOL CELLS, V34, P509, DOI 10.1007/s10059-012-0242-8; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Worringer KA, 2014, CELL STEM CELL, V14, P40, DOI 10.1016/j.stem.2013.11.001; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011	56	124	137	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					44	+		10.1038/ng.3449	http://dx.doi.org/10.1038/ng.3449			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26595768	Green Accepted			2022-12-17	WOS:000367255300012
J	Abrams, AJ; Hufnagel, RB; Rebelo, A; Zanna, C; Patel, N; Gonzalez, MA; Campeanu, IJ; Griffin, LB; Groenewald, S; Strickland, AV; Tao, FF; Speziani, F; Abreu, L; Schule, R; Caporali, L; La Morgia, C; Maresca, A; Liguori, R; Lodi, R; Ahmed, ZM; Sund, KL; Wang, XJ; Krueger, LA; Peng, YY; Prada, CE; Prows, CA; Schorry, EK; Antonellis, A; Zimmerman, HH; Abdul-Rahman, OA; Yang, YP; Downes, SM; Prince, J; Fontanesi, F; Barrientos, A; Nemeth, AH; Carelli, V; Huang, TS; Zuchner, S; Dallman, JE				Abrams, Alexander J.; Hufnagel, Robert B.; Rebelo, Adriana; Zanna, Claudia; Patel, Neville; Gonzalez, Michael A.; Campeanu, Ion J.; Griffin, Laurie B.; Groenewald, Saskia; Strickland, Alleene V.; Tao, Feifei; Speziani, Fiorella; Abreu, Lisa; Schuele, Rebecca; Caporali, Leonardo; La Morgia, Chiara; Maresca, Alessandra; Liguori, Rocco; Lodi, Raffaele; Ahmed, Zubair M.; Sund, Kristen L.; Wang, Xinjian; Krueger, Laura A.; Peng, Yanyan; Prada, Carlos E.; Prows, Cynthia A.; Schorry, Elizabeth K.; Antonellis, Anthony; Zimmerman, Holly H.; Abdul-Rahman, Omar A.; Yang, Yaping; Downes, Susan M.; Prince, Jeffery; Fontanesi, Flavia; Barrientos, Antonio; Nemeth, Andrea H.; Carelli, Valerio; Huang, Taosheng; Zuchner, Stephan; Dallman, Julia E.			Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder	NATURE GENETICS			English	Article							MITOCHONDRIAL DYNAMICS; OPA1; FUSION; OUTER; RECRUITMENT; NEUROPATHY; ZEBRAFISH; GTPASE; UGO1P; CELLS	Dominant optic atrophy (DOA)(1,2) and axonal peripheral neuropathy (Charcot-Marie-Tooth type 2, or CMT2)(3) are hereditary neurodegenerative disorders most commonly caused by mutations in the canonical mitochondrial fusion genes OPA1 and MFN2, respectively(4). In yeast, homologs of OPA1 (Mgm1) and MFN2 (Fzo1)(5,6) work in concert with Ugo1, for which no human equivalent has been identified thus far(7). By whole-exome sequencing of patients with optic atrophy and CMT2, we identified four families with recessive mutations in SLC25A46. We demonstrate that SLC25A46, like Ugo1, is a modified carrier protein that has been recruited to the outer mitochondrial membrane and interacts with the inner membrane remodeling protein mitofilin (Fcj1). Loss of function in cultured cells and in zebrafish unexpectedly leads to increased mitochondrial connectivity, while severely affecting the development and maintenance of neurons in the fish. The discovery of SLC25A46 strengthens the genetic overlap between optic atrophy and CMT2 while exemplifying a new class of modified solute transporters linked to mitochondrial dynamics.	[Abrams, Alexander J.; Rebelo, Adriana; Gonzalez, Michael A.; Strickland, Alleene V.; Tao, Feifei; Speziani, Fiorella; Abreu, Lisa; Schuele, Rebecca; Zuchner, Stephan] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, John P Hussman Inst Human Gen, Miami, FL 33124 USA; [Abrams, Alexander J.; Rebelo, Adriana; Gonzalez, Michael A.; Strickland, Alleene V.; Tao, Feifei; Speziani, Fiorella; Abreu, Lisa; Schuele, Rebecca; Zuchner, Stephan] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL USA; [Abrams, Alexander J.; Patel, Neville; Campeanu, Ion J.; Groenewald, Saskia; Prince, Jeffery; Dallman, Julia E.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Hufnagel, Robert B.; Sund, Kristen L.; Wang, Xinjian; Krueger, Laura A.; Peng, Yanyan; Prada, Carlos E.; Prows, Cynthia A.; Schorry, Elizabeth K.; Huang, Taosheng] Cincinnati Childrens Hosp, Div Human Genet, Cincinnati, OH USA; [Zanna, Claudia; Caporali, Leonardo; La Morgia, Chiara; Maresca, Alessandra; Liguori, Rocco; Carelli, Valerio] Osped Bellaria, Ist Sci Neurol Bologna, IRCCS, Bologna, Italy; [Zanna, Claudia; La Morgia, Chiara; Maresca, Alessandra; Liguori, Rocco; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy; [Griffin, Laurie B.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Griffin, Laurie B.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Schuele, Rebecca] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Schuele, Rebecca] German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Lodi, Raffaele] Univ Bologna, Policlin S Orsola Malpighi Dept Biomed & Neuromot, Bologna, Italy; [Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Antonellis, Anthony] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Antonellis, Anthony] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Zimmerman, Holly H.; Abdul-Rahman, Omar A.] Univ Mississippi, Med Ctr, Dept Pediat, Div Med Genet, Jackson, MS 39216 USA; [Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Downes, Susan M.; Nemeth, Andrea H.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Downes, Susan M.] Oxford Eye Hosp Natl Hlth Serv NHS Trust, Oxford, England; [Fontanesi, Flavia; Barrientos, Antonio] Univ Miami, Dept Biochem & Mol Biol, Miami, FL USA; [Barrientos, Antonio] Univ Miami, Dept Neurol, Miami, FL USA; [Nemeth, Andrea H.] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford, England	University of Miami; University of Miami; University of Miami; Cincinnati Children's Hospital Medical Center; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bologna; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Mississippi; University of Mississippi Medical Center; Baylor College of Medicine; University of Oxford; University of Miami; University of Miami; Oxford University Hospitals NHS Foundation Trust	Zuchner, S (corresponding author), Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, John P Hussman Inst Human Gen, Miami, FL 33124 USA.	taosheng.huang@cchmc.org; szuchner@med.miami.edu	Schüle, Rebecca/B-5763-2019; Griffin, Laurie/ABE-4525-2021; Maresca, Alessandra/J-7393-2016; Zanna, Claudia/GVT-1932-2022; Caporali, Leonardo/J-7398-2016; La Morgia, Chiara/H-6765-2012; Lodi, Raffaele/K-4984-2016; Dallman, Julia/AGG-3507-2022; Peng, Yanyan/I-1515-2019; Dallman, Julia/I-1414-2019; Tao, Feifei/AAI-6256-2021; Liguori, Rocco/AAB-7860-2020	Schüle, Rebecca/0000-0002-7781-2766; Maresca, Alessandra/0000-0002-8959-8832; Caporali, Leonardo/0000-0002-0666-4380; Dallman, Julia/0000-0002-5839-807X; Peng, Yanyan/0000-0002-1176-4837; Tao, Feifei/0000-0003-4477-2304; Lodi, Raffaele/0000-0003-3878-304X; Hufnagel, Robert/0000-0003-3015-3545; Fontanesi, Flavia/0000-0003-0509-3835; Liguori, Rocco/0000-0002-1815-1013; Prada, Carlos/0000-0003-3348-3531; CARELLI, VALERIO/0000-0003-4923-6404; Huang, Taosheng/0000-0001-6601-6687; Nemeth, Andrea/0000-0002-2941-7657; LA MORGIA, Chiara/0000-0002-4639-8929	US National Institutes of Health (NIH) [R01NS075764, 5R01NS072248, U54NS065712]; CMT Association; Muscular Dystrophy Association; Lois Pope Life Foundation; Cincinnati Children's Hospital Medical Center (CCHMC) Research Foundation; Division of Human Genetics; US NIH [R01DC012564, T32GM007315, T32GM07863, F30 NRSA NS092238, RO1GM071775, GM105781, GM112179]; ERMION, the E-RARE European consortium; UK Oxford Partnership Comprehensive Biomedical Research Centre; UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; European Union [01GM1408B, PIOF-GA-2012-326681]; Interdisciplinary Center for Clinical Research (IZKF) Tubingen [1970-0-0]; National Institute of Neurological Disorders and Stroke; American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775, T32GM007315, R01GM105781, R01GM112179, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712, R01NS073748, R01NS072248, R01NS075764, F30NS092238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012564] Funding Source: NIH RePORTER; Action Medical Research [2063] Funding Source: researchfish	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CMT Association; Muscular Dystrophy Association(Muscular Dystrophy Association); Lois Pope Life Foundation; Cincinnati Children's Hospital Medical Center (CCHMC) Research Foundation; Division of Human Genetics; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERMION, the E-RARE European consortium; UK Oxford Partnership Comprehensive Biomedical Research Centre; UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; European Union(European Commission); Interdisciplinary Center for Clinical Research (IZKF) Tubingen; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Action Medical Research	We would like to thank all families for participating in this study. We thank A. Torroni and A. Olivieri for their kind help with the control population samples from Sardinia. From the University of Miami, we are thankful to R. Cepeda for his excellent care and maintenance of the zebrafish facility, the transmission electron microscopy class of J. Prince, and to R. Duncan, W. Browne and P. Tsouflas for advice concerning phylogenic analysis. We are thankful to F. Poulain from the University of Utah for providing the Islet2-b fish and B. Schmid from the German Center for Neurodegenerative Diseases (DZNE) for donating the mitofish construct. This study was supported by US National Institutes of Health (NIH) grants R01NS075764, 5R01NS072248 and U54NS065712 (to S.Z.) and by the CMT Association and the Muscular Dystrophy Association. A.J.A. received additional support from the Lois Pope Life Foundation development award. This study was partially supported by the Cincinnati Children's Hospital Medical Center (CCHMC) Research Foundation and the Division of Human Genetics (to T.H.), US NIH grant R01DC012564 (to Z.M.A.) and ERMION, the E-RARE European consortium on optic atrophies (to V.C.). A.H.N. and S.M.D. were funded by the UK Oxford Partnership Comprehensive Biomedical Research Centre with funding from the UK Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. R.S. was funded by the European Union (E-RARE JTC grants 'NEUROLIPID' 01GM1408B and 'HSP/CMT genetics' PIOF-GA-2012-326681) and the Interdisciplinary Center for Clinical Research (IZKF) Tubingen (grant 1970-0-0). A.A. is supported by the National Institute of Neurological Disorders and Stroke, and L.B.G. is supported by US NIH Cellular and Molecular Biology Training Grant T32GM007315, US NIH Medical Scientist Training Grant T32GM07863 and US NIH grant F30 NRSA NS092238. A.B. is supported by US NIH grants RO1GM071775, GM105781 and GM112179. F.F. is supported by a Development grant from the American Heart Association.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Braathen GJ, 2012, ACTA NEUROL SCAND, V126, DOI 10.1111/ane.12013; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Coonrod EM, 2007, TRAFFIC, V8, P500, DOI 10.1111/j.1600-0854.2007.00550.x; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hoppins S, 2009, J CELL BIOL, V184, P569, DOI 10.1083/jcb.200809099; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kucenas S, 2008, NEURON GLIA BIOL, V4, P71, DOI 10.1017/S1740925X09990123; Lamarca V, 2007, AM J PHYSIOL-CELL PH, V293, pC1347, DOI 10.1152/ajpcell.00431.2006; Li YC, 2004, BRAIN RES, V1026, P235, DOI 10.1016/j.brainres.2004.08.016; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Narendra DP, 2012, NATURE, V483, P418, DOI 10.1038/nature10952; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Plucinska G, 2012, J NEUROSCI, V32, P16203, DOI 10.1523/JNEUROSCI.1327-12.2012; Polyakov VY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P838, DOI 10.1023/A:1025738712958; Poulain FE, 2013, NEURON, V78, P49, DOI 10.1016/j.neuron.2013.02.005; Prince J, 1998, J EXP BIOL, V201, P1595; Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shamas-Din A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.234; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797; Zuchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9	40	124	128	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					926	+		10.1038/ng.3354	http://dx.doi.org/10.1038/ng.3354			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26168012	Green Accepted, Green Submitted			2022-12-17	WOS:000358674100019
J	Kohl, S; Zobor, D; Chiang, WC; Weisschuh, N; Staller, J; Menendez, IG; Chang, S; Beck, SC; Garrido, MG; Sothilingam, V; Seeliger, MW; Stanzial, F; Benedicenti, F; Inzana, F; Heon, E; Vincent, A; Beis, J; Strom, TM; Rudolph, G; Roosing, S; den Hollander, AI; Cremers, FPM; Lopez, I; Ren, H; Moore, AT; Webster, AR; Michaelides, M; Koenekoop, RK; Zrenner, E; Kaufman, RJ; Tsang, SH; Wissinger, B; Lin, JH				Kohl, Susanne; Zobor, Ditta; Chiang, Wei-Chieh; Weisschuh, Nicole; Staller, Jennifer; Menendez, Irene Gonzalez; Chang, Stanley; Beck, Susanne C.; Garrido, Marina Garcia; Sothilingam, Vithiyanjali; Seeliger, Mathias W.; Stanzial, Franco; Benedicenti, Francesco; Inzana, Francesca; Heon, Elise; Vincent, Ajoy; Beis, Jill; Strom, Tim M.; Rudolph, Guenther; Roosing, Susanne; den Hollander, Anneke I.; Cremers, Frans P. M.; Lopez, Irma; Ren, Huanan; Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel; Koenekoop, Robert K.; Zrenner, Eberhart; Kaufman, Randal J.; Tsang, Stephen H.; Wissinger, Bernd; Lin, Jonathan H.			Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; OPTICAL COHERENCE TOMOGRAPHY; TRANSCRIPTION FACTOR; RETINAL STRUCTURE; ALPHA-SUBUNIT; GENE-THERAPY; MOUSE MODEL; CONGENITAL ACHROMATOPSIA; TOTAL COLOURBLINDNESS; LONG-TERM	Achromatopsia (ACHM) is an autosomal recessive disorder characterized by color blindness, photophobia, nystagmus and severely reduced visual acuity. Using homozygosity mapping and whole-exome and candidate gene sequencing, we identified ten families carrying six homozygous and two compound-heterozygous mutations in the ATF6 gene (encoding activating transcription factor 6A), a key regulator of the unfolded protein response (UPR) and cellular endoplasmic reticulum (ER) homeostasis. Patients had evidence of foveal hypoplasia and disruption of the cone photoreceptor layer. The ACHM-associated ATF6 mutations attenuate ATF6 transcriptional activity in response to ER stress. Atf6(-/-) mice have normal retinal morphology and function at a young age but develop rod and cone dysfunction with increasing age. This new ACHM-related gene suggests a crucial and unexpected role for ATF6A in human foveal development and cone function and adds to the list of genes that, despite ubiquitous expression, when mutated can result in an isolated retinal photoreceptor phenotype.	[Kohl, Susanne; Zobor, Ditta; Weisschuh, Nicole; Staller, Jennifer; Menendez, Irene Gonzalez; Beck, Susanne C.; Garrido, Marina Garcia; Sothilingam, Vithiyanjali; Seeliger, Mathias W.; Zrenner, Eberhart; Wissinger, Bernd] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Chiang, Wei-Chieh; Lin, Jonathan H.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Chang, Stanley; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Chang, Stanley] New York Presbyterian Hosp, Edward Harkness Eye Inst, New York, NY USA; [Stanzial, Franco; Benedicenti, Francesco; Inzana, Francesca] Reg Hosp Bozen, Clin Genet Serv, Bolzano, Italy; [Heon, Elise; Vincent, Ajoy] Univ Toronto, Hosp Sick Children, Dept Ophthalmol & Vis Sci, Programme Genet & Genom, Toronto, ON M5G 1X8, Canada; [Beis, Jill] IWK Hlth Ctr, Med Genet, Halifax, NS, Canada; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Rudolph, Guenther] Univ Munich, Univ Eye Hosp, Munich, Germany; [Roosing, Susanne; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Lopez, Irma; Ren, Huanan; Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Ctr, Montreal, PQ, Canada; [Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel] UCL, Inst Ophthalmol, London, England; [Moore, Anthony T.; Webster, Andrew R.; Michaelides, Michel] Moorfields Eye Hosp, London, England; [Moore, Anthony T.] Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; [Zrenner, Eberhart] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, Degenerat Dis Program, La Jolla, CA USA; [Tsang, Stephen H.] Columbia Univ, Jonas Lab Stem Cell & Regenerat Med, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Brown Glaucoma Lab, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Lin, Jonathan H.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California San Diego; Columbia University; NewYork-Presbyterian Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Dalhousie University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Radboud University Nijmegen; Radboud University Nijmegen; McGill University; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California San Diego	Kohl, S (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	susanne.kohl@uni-tuebingen.de; jlin@ucsd.edu	Roosing, Susanne/F-1616-2018; Chang, Stanley/AAL-2741-2021; Vincent, Ajoy/D-1149-2018; Koenekoop, Robert/AAT-6676-2021; Hollander, Anneke den/N-4911-2014; Roosing, Susanne/ABF-9604-2021; Cremers, Frans/A-5625-2014; Roosing, Susanne/AAK-3454-2020	Roosing, Susanne/0000-0001-9038-0067; Vincent, Ajoy/0000-0001-6446-3846; Roosing, Susanne/0000-0001-9038-0067; Cremers, Frans/0000-0002-4954-5592; Roosing, Susanne/0000-0001-9038-0067; Chiang, Wei-Chieh/0000-0002-1268-3019; Lin, Jonathan/0000-0002-7438-6941; Benedicenti, Francesco/0000-0002-9458-0688; Kohl, Susanne/0000-0002-6438-6331	Bundesministerium fur Bildung und Forschung (BMBF) grant [01GM1108A]; US National Institutes of Health [EY001919, EY020846, DK042394, DK088227, HL052173, 5P30EY019007]; post-doctoral Foundation Fighting Blindness fellowship; National Institute for Health Research, Biomedical Research Centre at Moorfields Eye Hospital, National Health Service (NHS) Foundation Trust; University College London Institute of Ophthalmology, Fight For Sight, Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness; Foundation Fighting Blindness (US); Wellcome Trust [099173/Z/12/Z]; Foundation Fighting Blindness Career Development Award; Mira Godard Research fund; Cannon; National Cancer Institute [5P30CA013696]; Research to Prevent Blindness (RPB); Columbia University; New York RPB Physician-Scientist Award; Schneeweiss Stem Cell Fund, New York State [N09G-302, N13G-275]; Gebroe Family Foundation [R01EY018213]; Foundation Fighting Blindness (US) [BR-GE-0510-0489-RAD, C-GE-0811-0545-RAD01]; Prof. Dr. H.J. Flieringa Foundation Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO); Rotterdam Eye Hospital; Center for Integrative Neuroscience-DFG Center of Excellence, University of Tubingen, Germany [EXC 307]; Foundation Fighting Blindness (Canada); CIHR (Canadian Institutes for Health Research); NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R37EY001919, R01EY020846, R01EY001919, P30EY019007, R01EY018213] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394, R01DK088227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088485] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002284] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish; Fight for Sight [24RP131, 1317/18] Funding Source: researchfish	Bundesministerium fur Bildung und Forschung (BMBF) grant(Federal Ministry of Education & Research (BMBF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); post-doctoral Foundation Fighting Blindness fellowship; National Institute for Health Research, Biomedical Research Centre at Moorfields Eye Hospital, National Health Service (NHS) Foundation Trust; University College London Institute of Ophthalmology, Fight For Sight, Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness; Foundation Fighting Blindness (US); Wellcome Trust(Wellcome Trust); Foundation Fighting Blindness Career Development Award; Mira Godard Research fund; Cannon; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Columbia University; New York RPB Physician-Scientist Award; Schneeweiss Stem Cell Fund, New York State; Gebroe Family Foundation; Foundation Fighting Blindness (US); Prof. Dr. H.J. Flieringa Foundation Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO); Rotterdam Eye Hospital; Center for Integrative Neuroscience-DFG Center of Excellence, University of Tubingen, Germany; Foundation Fighting Blindness (Canada); CIHR (Canadian Institutes for Health Research)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	We want to thank C.W. Seok for data analysis. These studies were supported by various grants to the different authors and institutions: Bundesministerium fur Bildung und Forschung (BMBF) grant 01GM1108A to B.W. and S.K.; US National Institutes of Health grants EY001919 and EY020846 to J.H.L. and DK042394, DK088227 and HL052173 to R.J.K. and a post-doctoral Foundation Fighting Blindness fellowship to W.-C.C.; National Institute for Health Research, Biomedical Research Centre at Moorfields Eye Hospital, National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology, Fight For Sight, Moorfields Eye Hospital Special Trustees, Retinitis Pigmentosa Fighting Blindness and the Foundation Fighting Blindness (US) all to A.T.M., M.M. and A.R.W.; and the Wellcome Trust (099173/Z/12/Z) to M.M. and A.R.W.M.M. is supported by a Foundation Fighting Blindness Career Development Award; Mira Godard Research fund to E.H.; the imaging facilities at the Barbara and Donald Jonas Laboratory of Stem Cells and Regenerative Medicine and the Bernard and Shirlee Brown Glaucoma Laboratory are supported by Cannon, US National Institutes of Health Core grant 5P30EY019007, National Cancer Institute Core grant 5P30CA013696 and unrestricted funds from Research to Prevent Blindness (RPB), a Columbia University, New York RPB Physician-Scientist Award, the Schneeweiss Stem Cell Fund, New York State (N09G-302 and N13G-275) and the Gebroe Family Foundation, grant R01EY018213 to S.H.T.; Foundation Fighting Blindness (US) grants BR-GE-0510-0489-RAD to A.I.d.H. and C-GE-0811-0545-RAD01 to F.P.M.C., the Prof. Dr. H.J. Flieringa Foundation Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO) and the Rotterdam Eye Hospital to F.P.M.C. and A.I.d.H.E.Z. is supported by Center for Integrative Neuroscience-DFG Center of Excellence EXC 307, University of Tubingen, Germany. R.K.K. is supported by the Foundation Fighting Blindness (Canada) and the CIHR (Canadian Institutes for Health Research).	Aboshiha J, 2014, INVEST OPHTH VIS SCI, V55, P5733, DOI 10.1167/iovs.14-14937; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Aligianis IA, 2002, J MED GENET, V39, P656, DOI 10.1136/jmg.39.9.656; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P188, DOI 10.3389/fgene.2013.00188; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Hong IH, 2014, OSLI RETINA, V45, P74, DOI 10.3928/23258160-20131220-12; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Park SP, 2014, OSLI RETINA, V45, P469, DOI 10.3928/23258160-20140908-01; Park SP, 2013, EUR J HUM GENET, V21, P1240, DOI 10.1038/ejhg.2013.21; Park SP, 2013, GRAEF ARCH CLIN EXP, V251, P2299, DOI 10.1007/s00417-013-2296-5; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sundaram V, 2014, OPHTHALMOLOGY, V121, P234, DOI 10.1016/j.ophtha.2013.08.017; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Thomas MG, 2011, OPHTHALMOLOGY, V118, P1653, DOI 10.1016/j.ophtha.2011.01.028; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Thuerauf DJ, 2002, J BIOL CHEM, V277, P20734, DOI 10.1074/jbc.M201749200; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	48	124	130	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					757	+		10.1038/ng.3319	http://dx.doi.org/10.1038/ng.3319			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26029869	Green Accepted			2022-12-17	WOS:000357090300012
J	Weisenfeld, NI; Yin, SY; Sharpe, T; Lau, B; Hegarty, R; Holmes, L; Sogoloff, B; Tabbaa, D; Williams, L; Russ, C; Nusbaum, C; Lander, ES; MacCallum, L; Jaffe, DB				Weisenfeld, Neil I.; Yin, Shuangye; Sharpe, Ted; Lau, Bayo; Hegarty, Ryan; Holmes, Laurie; Sogoloff, Brian; Tabbaa, Diana; Williams, Louise; Russ, Carsten; Nusbaum, Chad; Lander, Eric S.; MacCallum, Lain; Jaffe, David B.			Comprehensive variation discovery in single human genomes	NATURE GENETICS			English	Article							DNA-SEQUENCING DATA; IDENTIFICATION; FRAMEWORK; COMMON	Complete knowledge of the genetic variation in individual human genomes is a crucial foundation for understanding the etiology of disease. Genetic variation is typically characterized by sequencing individual genomes and comparing reads to a reference. Existing methods do an excellent job of detecting variants in approximately 90% of the human genome; however, calling variants in the remaining 10% of the genome (largely low-complexity sequence and segmental duplications) is challenging. To improve variant calling, we developed a new algorithm, DISCOVAR, and examined its performance on improved, low-cost sequence data. Using a newly created reference set of variants from the finished sequence of 103 randomly chosen fosmids, we find that some standard variant call sets miss up to 25% of variants. We show that the combination of new methods and improved data increases sensitivity by several fold, with the greatest impact in challenging regions of the human genome.	[Weisenfeld, Neil I.; Yin, Shuangye; Sharpe, Ted; Lau, Bayo; Hegarty, Ryan; Holmes, Laurie; Sogoloff, Brian; Tabbaa, Diana; Williams, Louise; Russ, Carsten; Nusbaum, Chad; Lander, Eric S.; MacCallum, Lain; Jaffe, David B.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jaffe, DB (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	jaffe@broadinstitute.org	Yin, Shuangye/C-3707-2009	Yin, Shuangye/0000-0002-2779-2584; Lau, Bayo/0000-0001-7243-9221	National Human Genome Research Institute; US National Institutes of Health; US Department of Health and Human Services [R01HG003474, U54HG003067]; National Institute of Allergy and Infectious Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG003474] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Broad Institute Genomics Platform for generating data for this project and J. Bochicchio for project management. We thank the 1000 Genomes Project for early access to 250-base reads from the Centre d'Etude du Polymorphisme Humain (CEPH) trio. We thank Illumina for the use of sequence data from the 17-member CEPH pedigree and M. Eberle for detailed information on these data. We thank Z. lqbal for detailed advice regarding running Cortex on 250-base reads and M. Carneiro and E. Banks for detailed advice regarding running GATK on the same data. We thank H. Li for early access to bwa-mem and for his extensive examination of our manuscript. We thank S. Fisher for help preparing the data cost estimate. We thank M. Daly, M. DePristo, S. Gabriel, Z. Iqbal, D. MacArthur, D. Neafsey and M. Zody for helpful comments. This project has been funded in part with federal funds from the National Human Genome Research Institute, US National Institutes of Health, US Department of Health and Human Services, under grants R01HG003474 and U54HG003067, and in part with federal funds from the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services, under contract HHSN272200900018C.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; Labeit S, 2011, FASEB J, V25, P822, DOI 10.1096/fj.10-157412; Li BS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002944; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; O'Fallon BD, 2013, BIOINFORMATICS, V29, P1361, DOI 10.1093/bioinformatics/btt172; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112	21	124	130	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1350	1355		10.1038/ng.3121	http://dx.doi.org/10.1038/ng.3121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25326702	Green Submitted, Green Accepted			2022-12-17	WOS:000345547300018
J	Tarpey, PS; Behjati, S; Cooke, SL; Van Loo, P; Wedge, DC; Pillay, N; Marshall, J; O'Meara, S; Davies, H; Nik-Zainal, S; Beare, D; Butler, A; Gamble, J; Hardy, C; Hinton, J; Jia, MM; Jayakumar, A; Jones, D; Latimer, C; Maddison, M; Martin, S; McLaren, S; Menzies, A; Mudie, L; Raine, K; Teague, JW; Tubio, JMC; Halai, D; Tirabosco, R; Amary, F; Campbell, PJ; Stratton, MR; Flanagan, AM; Futreal, PA				Tarpey, Patrick S.; Behjati, Sam; Cooke, Susanna L.; Van Loo, Peter; Wedge, David C.; Pillay, Nischalan; Marshall, John; O'Meara, Sarah; Davies, Helen; Nik-Zainal, Serena; Beare, David; Butler, Adam; Gamble, John; Hardy, Claire; Hinton, Jonathon; Jia, Ming Ming; Jayakumar, Alagu; Jones, David; Latimer, Calli; Maddison, Mark; Martin, Sancha; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Raine, Keiran; Teague, Jon W.; Tubio, Jose M. C.; Halai, Dina; Tirabosco, Roberto; Amary, Fernanda; Campbell, Peter J.; Stratton, Michael R.; Flanagan, Adrienne M.; Futreal, P. Andrew			Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma	NATURE GENETICS			English	Article							RECEPTOR; PATHWAY; CANCER; TUMORS; MICE	Chondrosarcoma is a heterogeneous collection of malignant bone tumors and is the second most common primary malignancy of bone after osteosarcoma. Recent work has identified frequent, recurrent mutations in IDH1 or IDH2 in nearly half of central chondrosarcomas. However, there has been little systematic genomic analysis of this tumor type, and, thus, the contribution of other genes is unclear. Here we report comprehensive genomic analyses of 49 individuals with chondrosarcoma (cases). We identified hypermutability of the major cartilage collagen gene COL2A1, with insertions, deletions and rearrangements identified in 37% of cases. The patterns of mutation were consistent with selection for variants likely to impair normal collagen biosynthesis. In addition, we identified mutations in IDH1 or IDH2 (59%), TP53 (20%), the RB1 pathway (33%) and Hedgehog signaling (18%).	[Tarpey, Patrick S.; Behjati, Sam; Cooke, Susanna L.; Van Loo, Peter; Wedge, David C.; Marshall, John; O'Meara, Sarah; Davies, Helen; Nik-Zainal, Serena; Beare, David; Butler, Adam; Gamble, John; Hardy, Claire; Hinton, Jonathon; Jia, Ming Ming; Jayakumar, Alagu; Jones, David; Latimer, Calli; Maddison, Mark; Martin, Sancha; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Raine, Keiran; Teague, Jon W.; Tubio, Jose M. C.; Campbell, Peter J.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Louvain, Belgium; [Pillay, Nischalan; Halai, Dina; Tirabosco, Roberto; Amary, Fernanda; Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp Natl Hlth Serv NHS Trus, Stanmore, Middx, England; [Pillay, Nischalan; Flanagan, Adrienne M.] UCL, Inst Canc, London, England; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Flanders Institute for Biotechnology (VIB); KU Leuven; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge, England.	afutreal@mdanderson.org	Amary, Fernanda/AAI-7339-2020; Nik-Zainal, Serena/ABD-4437-2020; Tubio, Jose M.C./H-5076-2015; Tubio, Jose/AAG-7345-2019	Tubio, Jose M.C./0000-0003-3540-2459; Tubio, Jose/0000-0003-3540-2459; Wedge, David/0000-0002-7572-3196; Behjati, Sam/0000-0002-6600-7665; Raine, Keiran/0000-0002-5634-1539; Van Loo, Peter/0000-0003-0292-1949; Martin, Sancha/0000-0001-6213-5259; Pillay, Nischalan/0000-0003-0579-4105; Flanagan, Adrienne/0000-0002-2832-1303	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Skeletal Cancer Action Trust (SCAT), UK; National Institute for Health Research; University College London Hospital Biomedical Research Centre; UCL Experimental Cancer Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Skeletal Cancer Action Trust (SCAT), UK; National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospital Biomedical Research Centre; UCL Experimental Cancer Centre	We are grateful to the patients for participating in the research and to the clinicians and support staff of the London Sarcoma Service involved in their care. This work was supported by funding from the Wellcome Trust (grant 077012/Z/05/Z) and the Skeletal Cancer Action Trust (SCAT), UK. Material was obtained from the Royal National Orthopaedic Hospital Musculoskeletal Research Program and Biobank. Support was provided to A.M.F. by the National Institute for Health Research, the University College London Hospital Biomedical Research Centre and the UCL Experimental Cancer Centre. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant WT088340MA). P.V.L. is a postdoctoral researcher of the Research Foundation-Flanders (FWO). S.B. is funded through the Wellcome Trust PhD Programme for Clinicians.	Aceto Gitana, 2005, Hum Mutat, V26, P394, DOI 10.1002/humu.9370; AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Barbieri O, 2003, AM J PHYSIOL-CELL PH, V285, pC1504, DOI 10.1152/ajpcell.00579.2002; Bruce SJ, 2010, J BIOL CHEM, V285, P27967, DOI 10.1074/jbc.M109.091785; Chiu LH, 2011, J CELL PHYSIOL, V226, P1981, DOI 10.1002/jcp.22530; Fathi AT, 2012, BLOOD, V120, P4649, DOI 10.1182/blood-2012-06-438267; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Schrage YM, 2009, J CELL MOL MED, V13, P2843, DOI 10.1111/j.1582-4934.2008.00406.x; Shalaby A, 2011, J PATHOL, V223, P336, DOI 10.1002/path.2818; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Yang G, 2008, DEVELOPMENT, V135, P3587, DOI 10.1242/dev.028118; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	25	124	126	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					923	U293		10.1038/ng.2668	http://dx.doi.org/10.1038/ng.2668			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23770606	Green Accepted			2022-12-17	WOS:000322374900017
J	Sun, Y; Bak, B; Schoenmakers, N; van Trotsenburg, ASP; Oostdijk, W; Voshol, P; Cambridge, E; White, JK; le Tissier, P; Gharavy, SNM; Martinez-Barbera, JP; Stokvis-Brantsma, WH; Vulsma, T; Kempers, MJ; Persani, L; Campi, I; Bonomi, M; Beck-Peccoz, P; Zhu, HD; Davis, TME; Hokken-Koelega, ACS; Del Blanco, DG; Rangasami, JJ; Ruivenkamp, CAL; Laros, JFJ; Kriek, M; Kant, SG; Bosch, CAJ; Biermasz, NR; Appelman-Dijkstra, NM; Corssmit, EP; Hovens, GCJ; Pereira, AM; den Dunnen, JT; Wade, MG; Breuning, MH; Hennekam, RC; Chatterjee, K; Dattani, MT; Wit, JM; Bernard, DJ				Sun, Yu; Bak, Beata; Schoenmakers, Nadia; van Trotsenburg, A. S. Paul; Oostdijk, Wilma; Voshol, Peter; Cambridge, Emma; White, Jacqueline K.; le Tissier, Paul; Gharavy, S. Neda Mousavy; Martinez-Barbera, Juan P.; Stokvis-Brantsma, Wilhelmina H.; Vulsma, Thomas; Kempers, Marlies J.; Persani, Luca; Campi, Irene; Bonomi, Marco; Beck-Peccoz, Paolo; Zhu, Hongdong; Davis, Timothy M. E.; Hokken-Koelega, Anita C. S.; Del Blanco, Dania Gorbenko; Rangasami, Jayanti J.; Ruivenkamp, Claudia A. L.; Laros, Jeroen F. J.; Kriek, Marjolein; Kant, Sarina G.; Bosch, Cathy A. J.; Biermasz, Nienke R.; Appelman-Dijkstra, Natasha M.; Corssmit, Eleonora P.; Hovens, Guido C. J.; Pereira, Alberto M.; den Dunnen, Johan T.; Wade, Michael G.; Breuning, Martijn H.; Hennekam, Raoul C.; Chatterjee, Krishna; Dattani, Mehul T.; Wit, Jan M.; Bernard, Daniel J.			Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement	NATURE GENETICS			English	Article							THYROTROPIN-RELEASING-HORMONE; INHIBIN-BINDING-PROTEIN; STIMULATION TEST; DIAGNOSIS; PITUITARY; BIOACTIVITY; EXPRESSION; THYROXINE; DISEASE	Congenital central hypothyroidism occurs either in isolation or in conjunction with other pituitary hormone deficits. Using exome and candidate gene sequencing, we identified 8 distinct mutations and 2 deletions in IGSF1 in males from 11 unrelated families with central hypothyroidism, testicular enlargement and variably low prolactin concentrations. IGSF1 is a membrane glycoprotein that is highly expressed in the anterior pituitary gland, and the identified mutations impair its trafficking to the cell surface in heterologous cells. Igsf1-deficient male mice show diminished pituitary and serum thyroid-stimulating hormone (TSH) concentrations, reduced pituitary thyrotropin-releasing hormone (TRH) receptor expression, decreased triiodothyronine concentrations and increased body mass. Collectively, our observations delineate a new X-linked disorder in which loss-of-function mutations in IGSF1 cause central hypothyroidism, likely secondary to an associated impairment in pituitary TRH signaling.	[Oostdijk, Wilma; Stokvis-Brantsma, Wilhelmina H.; Wit, Jan M.] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Sun, Yu; Ruivenkamp, Claudia A. L.; Laros, Jeroen F. J.; Kriek, Marjolein; Kant, Sarina G.; Bosch, Cathy A. J.; den Dunnen, Johan T.; Breuning, Martijn H.] Leiden Univ, Ctr Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Bak, Beata; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Schoenmakers, Nadia; Voshol, Peter; Chatterjee, Krishna] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [van Trotsenburg, A. S. Paul; Vulsma, Thomas; Kempers, Marlies J.; Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [Cambridge, Emma; White, Jacqueline K.] Wellcome Trust Sanger Inst, Sanger Inst Mouse Genet Project, Cambridge, England; [le Tissier, Paul; Gharavy, S. Neda Mousavy; Martinez-Barbera, Juan P.] UCL, Inst Child Hlth, Neural Dev Unit, London, England; [le Tissier, Paul] Natl Inst Med Res, Div Mol Neuroendocrinol, London NW7 1AA, England; [Kempers, Marlies J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Persani, Luca; Campi, Irene; Beck-Peccoz, Paolo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Persani, Luca; Bonomi, Marco] Ist Auxol Italiano, IRCCS, Div Endocrine & Metab Disorders, Milan, Italy; [Campi, Irene; Beck-Peccoz, Paolo] Fdn IRCCS Ca Granda, Endocrine Unit, Milan, Italy; [Zhu, Hongdong; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp Unit, Perth, WA 6009, Australia; [Hokken-Koelega, Anita C. S.; Del Blanco, Dania Gorbenko] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands; [Rangasami, Jayanti J.] W Middlesex Univ Hosp, Dept Paediat, Isleworth, England; [Biermasz, Nienke R.; Appelman-Dijkstra, Natasha M.; Corssmit, Eleonora P.; Hovens, Guido C. J.; Pereira, Alberto M.] Leiden Univ, Dept Endocrinol & Metab Disorders, Med Ctr, Leiden, Netherlands; [den Dunnen, Johan T.] Leiden Univ, Leiden Genome Technol Ctr, Med Ctr, Leiden, Netherlands; [Wade, Michael G.] Hlth Canada, Hazard Identificat Div, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Dattani, Mehul T.] UCL Inst Child Hlth, Dev Endocrinol Res Grp, Clin & Mol Genet Unit, London, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; McGill University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Wellcome Trust Sanger Institute; University of London; University College London; MRC National Institute for Medical Research; Radboud University Nijmegen; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Western Australia; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Health Canada; University of London; University College London	Wit, JM (corresponding author), Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands.	kkc1@medschl.cam.ac.uk; m.dattani@ucl.ac.uk; j.m.wit@lumc.nl; daniel.bernard@mcgill.ca	dunnen, johan den/ABH-4228-2020; Appelman-Dijkstra, Natasha/CAE-9054-2022; Campi, Irene/AAB-1335-2019; Pereira, Alberto M./Q-7175-2017; Biermasz, Nienke/ABE-9436-2021; Appelman-Dijkstra, Natasha/V-7322-2018; van Trotsenburg, Paul/ABC-2379-2020; Kant, Sarina/F-8596-2010; Martinez-Barbera, Juan Pedro/AAE-9284-2020; Davis, Timothy ME/M-5144-2014; Persani, Luca/B-6543-2008; del Blanco, Darya Gorbenko/N-6069-2018; Bonomi, Marco/T-6487-2019	dunnen, johan den/0000-0002-6304-1710; Appelman-Dijkstra, Natasha/0000-0001-5035-127X; Pereira, Alberto M./0000-0002-1194-9866; Biermasz, Nienke/0000-0001-5817-3594; Appelman-Dijkstra, Natasha/0000-0001-5035-127X; van Trotsenburg, Paul/0000-0002-9677-7441; Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Persani, Luca/0000-0003-2068-9581; del Blanco, Darya Gorbenko/0000-0002-9674-2388; Schoenmakers, Nadia/0000-0002-0847-2884; Davis, Timothy/0000-0003-0749-7411; Bonomi, Marco/0000-0001-5454-6074; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Wade, Michael/0000-0002-7331-3839; CAMPI, IRENE/0000-0002-0340-9923; Le Tissier, Paul/0000-0002-7220-5705; Bernard, Daniel/0000-0001-5365-5586; Laros, Jeroen F.J./0000-0002-8715-7371; Sun, Yu/0000-0002-2938-0233	US National Institutes of Health (NIH) [DK15700]; China Scholarship Council; National Sciences and Engineering Research Council (NSERC); NSERC [341801-07]; Fonds de la Recherche en Sante du Quebec (FRSQ) Chercheur Boursier Senior Award; Wellcome Trust [095564, WT077157/Z/05/Z, 084361, 078432, 086545]; National Institutes of Health Research Cambridge Biomedical Research Centre; UK Medical Research Council (MRE) [U117570590]; National Health and Medical Research Council of Australia; Dutch Growth Research Foundation; Istituto Auxologico Italian IRCCS [GR-2008-1137632]; Great Ormond Street Children's Hospital Charity; Italian Ministry of Health; MRC [MC_U117570590] Funding Source: UKRI; Medical Research Council [MC_U117570590] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10198] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1255] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015700] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ) Chercheur Boursier Senior Award; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Research Cambridge Biomedical Research Centre; UK Medical Research Council (MRE)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dutch Growth Research Foundation; Istituto Auxologico Italian IRCCS; Great Ormond Street Children's Hospital Charity; Italian Ministry of Health(Ministry of Health, Italy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank X.-H. Liao from the Refetoff laboratory (The University of Chicago, supported by US National Institutes of Health (NIH) grant DK15700) for measuring T4, T3, FT4I and TSH in mice, P. Scheiffele for the antibody to IGSF1 CTD and S. Kimmins (McGill University) and P. Bisschop (Academic Medical Center, University of Amsterdam) for human testis and pituitary RNA, respectively. We also thank H. Bikker, J.C. Moreno, A. Escudero, E. Aten, M. Losekoot, E. Endert, J.W.A. Smit, R.van Rijn and E.L. van Persijn-van Meerten for technical support and advice. We thank F.J. de Jong and Y. de Rijke for measuring serum inhibin B and AMH and for providing age references. We thank S. Iran and X. Zhou for assistance with collection of mouse serum samples. We acknowledge the help of N. Zwaveling, J. Gosen, E.J. Schroor, L.C.G. de Graaff and G. Radetti in providing clinical data. We acknowledge The Eastern Region Sequencing and Informatics Hub (see URLs), who undertook sequencing and preliminary bioinformatics analyses of data from the UK families. We thank the subjects and their families for participating. Our work was supported in part by a grant from the China Scholarship Council (to Y.S.); a National Sciences and Engineering Research Council (NSERC) Doctoral Research Award (to B.B.), NSERC Discovery Grant 341801-07 and a Fonds de la Recherche en Sante du Quebec (FRSQ) Chercheur Boursier Senior Award (to D.J.B.); grants from the Wellcome Trust (095564 to N.S. and K.C.; WT077157/Z/05/Z to E.C. and J.K.W.; 084361, 078432 and 086545 to J.P.M.-B.), the National Institutes of Health Research Cambridge Biomedical Research Centre (to N.S. and K.C.) and the UK Medical Research Council (MRE; U117570590 to P.I.T.); a National Health and Medical Research Council of Australia Practitioner Fellowship (to T.M.E.D.); the Dutch Growth Research Foundation (D.G.D.B.); the Young Investigator grant of the Italian Ministry of Health and Istituto Auxologico Italian IRCCS (GR-2008-1137632 to M.B.); and the Great Ormond Street Children's Hospital Charity (to M.T.D.).	Bernard DJ, 2003, MOL CELL BIOL, V23, P4882, DOI 10.1128/MCB.23.14.4882-4891.2003; Bernard DJ, 2001, MOL ENDOCRINOL, V15, P654, DOI 10.1210/me.15.4.654; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; Chapman SC, 2001, MOL ENDOCRINOL, V15, P668, DOI 10.1210/me.15.4.668; Chong HR, 2000, ENDOCRINOLOGY, V141, P2600, DOI 10.1210/en.141.7.2600; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; Crofton PM, 2008, HORM RES, V69, P53, DOI 10.1159/000111796; Doin FC, 2012, EUR J ENDOCRINOL, V166, P631, DOI 10.1530/EJE-11-0907; Elmlinger MW, 2001, CLIN CHEM LAB MED, V39, P973, DOI 10.1515/CCLM.2001.158; FAGLIA G, 1973, J CLIN ENDOCR METAB, V37, P595, DOI 10.1210/jcem-37-4-595; Frattini A, 1998, GENE, V214, P1, DOI 10.1016/S0378-1119(98)00253-4; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Goede J, 2011, HORM RES PAEDIAT, V76, P56, DOI 10.1159/000326057; Hindmarsh P.C., 2009, BROOKS CLIN PEDIAT E, P213; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156; Mehta A, 2003, J CLIN ENDOCR METAB, V88, P5696, DOI 10.1210/jc.2003-030943; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; PERSANI L, 1994, J CLIN ENDOCR METAB, V78, P1034, DOI 10.1210/jc.78.5.1034; Persani L, 2000, J CLIN ENDOCR METAB, V85, P3631, DOI 10.1210/jc.85.10.3631; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; SCHNAKENBURG KV, 1980, EUR J PEDIATR, V133, P259, DOI 10.1007/BF00496086; Singh S, 2008, INT J CARDIOL, V125, P41, DOI 10.1016/j.ijcard.2007.02.027; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Van Tijn DA, 2008, J CLIN ENDOCR METAB, V93, P410, DOI 10.1210/jc.2006-2656	27	124	128	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1375	1381		10.1038/ng.2453	http://dx.doi.org/10.1038/ng.2453			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143598	Green Accepted, Green Published			2022-12-17	WOS:000311713200019
J	Guernsey, DL; Matsuoka, M; Jiang, HY; Evans, S; Macgillivray, C; Nightingale, M; Perry, S; Ferguson, M; LeBlanc, M; Paquette, J; Patry, L; Rideout, AL; Thomas, A; Orr, A; McMaster, CR; Michaud, JL; Deal, C; Langlois, S; Superneau, DW; Parkash, S; Ludman, M; Skidmore, DL; Samuels, ME				Guernsey, Duane L.; Matsuoka, Makoto; Jiang, Haiyan; Evans, Susan; Macgillivray, Christine; Nightingale, Mathew; Perry, Scott; Ferguson, Meghan; LeBlanc, Marissa; Paquette, Jean; Patry, Lysanne; Rideout, Andrea L.; Thomas, Aidan; Orr, Andrew; McMaster, Chris R.; Michaud, Jacques L.; Deal, Cheri; Langlois, Sylvie; Superneau, Duane W.; Parkash, Sandhya; Ludman, Mark; Skidmore, David L.; Samuels, Mark E.			Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin syndrome	NATURE GENETICS			English	Article							SHORT STATURE SYNDROME; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; S-PHASE; DNA-REPLICATION; PATELLA; PROTEIN; EAR; HISTORY; ADULT	Meier-Gorlin syndrome is a rare autosomal recessive genetic condition whose primary clinical hallmarks include small stature, small external ears and small or absent patellae. Using marker-assisted mapping in multiple families from a founder population and traditional coding exon sequencing of positional candidate genes, we identified three different mutations in the gene encoding ORC4, a component of the eukaryotic origin recognition complex, in five individuals with Meier-Gorlin syndrome. In two such individuals that were negative for mutations in ORC4, we found potential mutations in ORC1 and CDT1, two other genes involved in origin recognition. ORC4 is well conserved in eukaryotes, and the yeast equivalent of the human ORC4 missense mutation was shown to be pathogenic in functional assays of cell growth. This is the first report, to our knowledge, of a germline mutation in any gene of the origin recognition complex in a vertebrate organism.	[Guernsey, Duane L.; Matsuoka, Makoto; Jiang, Haiyan; Evans, Susan; Nightingale, Mathew; Perry, Scott; Samuels, Mark E.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Macgillivray, Christine; Orr, Andrew] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Ferguson, Meghan; Rideout, Andrea L.; Thomas, Aidan; Parkash, Sandhya; Ludman, Mark; Skidmore, David L.] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS, Canada; [LeBlanc, Marissa; McMaster, Chris R.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Paquette, Jean; Patry, Lysanne; Michaud, Jacques L.; Deal, Cheri; Samuels, Mark E.] Univ Montreal, Ctr Rech, CHU Ste Justine, Montreal, PQ, Canada; [Langlois, Sylvie] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Superneau, Duane W.] Our Lady Lakes Genet Serv, Baton Rouge, LA USA; [Parkash, Sandhya; Ludman, Mark; Skidmore, David L.] Dalhousie Univ, Dept Pediat, Div Med Genet, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Universite de Montreal; University of British Columbia; Dalhousie University	Samuels, ME (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	mark.e.samuels@umontreal.ca	Langlois, Sylvie/AAR-7978-2021	Nightingale, Mat/0000-0003-1465-7911; McMaster, Christopher/0000-0003-0822-5776; Orr, Andrew/0000-0002-9388-9034; Ludman, Mark/0000-0002-9658-6784	Genome Canada; Genome Atlantic; Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; IWK Health Centre Foundation; Dalhousie Medical Research Fund; Capital Health Research Fund; Centre de Recherche du CHU Ste-Justine; Canadian Institutes of Health Research; Canada Research Chairs fund	Genome Canada(Genome Canada); Genome Atlantic; Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; IWK Health Centre Foundation; Dalhousie Medical Research Fund; Capital Health Research Fund; Centre de Recherche du CHU Ste-Justine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs fund(Canada Research Chairs)	Foremost we thank the families who generously contributed their time and material to this research study. Thanks to B. McConkey for suggestions regarding the ORC4 structure. D.L.G. and M.E.S. were supported by Genome Canada, Genome Atlantic, Nova Scotia Health Research Foundation, Nova Scotia Research and Innovation Trust, IWK Health Centre Foundation, Dalhousie Medical Research Fund and Capital Health Research Fund. M.E.S. was supported by the Centre de Recherche du CHU Ste-Justine. J.L.M. is a senior scientist of the Fonds pour la Recherche en Sante du Quebec and was supported by an operating grant from the Canadian Institutes of Health Research. C.R.M. is supported by an operating grant from the Canadian Institutes of Health Research and the Canada Research Chairs fund. M.A.L. is supported by the Nova Scotia Health Research Foundation.	Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Boles R G, 1994, Clin Dysmorphol, V3, P207; Bongers EMHF, 2005, CLIN GENET, V68, P302, DOI 10.1111/j.1399-0004.2005.00508.x; Bongers EMHF, 2001, AM J MED GENET, V102, P115, DOI 10.1002/ajmg.1452; Brachmann CB, 1998, YEAST, V14, P115; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Cohen A, 2002, AM J MED GENET, V107, P48, DOI 10.1002/ajmg.10083; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Dudkievvicz M, 2004, J ARTHROPLASTY, V19, P931, DOI 10.1016/j.arth.2004.03.016; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Faqeih E, 2005, AM J MED GENET A, V137A, P339, DOI 10.1002/ajmg.a.30899; Feingold M, 2002, AM J MED GENET, V109, P338, DOI 10.1002/ajmg.10315; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fryns JP, 1998, CLIN DYSMORPHOL, V7, P231, DOI 10.1097/00019605-199807000-00016; Gorlin R J, 1975, Birth Defects Orig Artic Ser, V11, P39; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Loeys BL, 1999, AM J MED GENET, V84, P61, DOI 10.1002/(SICI)1096-8628(19990507)84:1<61::AID-AJMG12>3.0.CO;2-6; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radojkovic M, 2009, AM J MED SCI, V338, P527, DOI 10.1097/MAJ.0b013e3181b7f17c; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Shalev SA, 2003, CLIN DYSMORPHOL, V12, P167, DOI 10.1097/01.mcd.0000065052.36236.32; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Thomer M, 2004, DEVELOPMENT, V131, P4807, DOI 10.1242/dev.01348; TONOKI H, 2001, RYOIKIBETSU SHOKOGUN, V164; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	33	124	129	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2011	43	4					360	U157		10.1038/ng.777	http://dx.doi.org/10.1038/ng.777			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21358631				2022-12-17	WOS:000288903700018
J	Nakashima, M; Chung, S; Takahashi, A; Kamatani, N; Kawaguchi, T; Tsunoda, T; Hosono, N; Kubo, M; Nakamura, Y; Zembutsu, H				Nakashima, Mitsuko; Chung, Suyoun; Takahashi, Atsushi; Kamatani, Naoyuki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Hosono, Naoya; Kubo, Michiaki; Nakamura, Yusuke; Zembutsu, Hitoshi			A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population	NATURE GENETICS			English	Article							GENETIC SUSCEPTIBILITY; TGF-BETA; DISEASE; GROWTH; POLYMORPHISMS; DEGRADATION; TAMOXIFEN; RECEPTOR; PROTEIN	Keloid is a dermal fibroproliferative growth that results from dysfunction of the wound healing processes. Through a multistage genome-wide association study using 824 individuals with keloid (cases) and 3,205 unaffected controls in the Japanese population, we identified significant associations of keloid with four SNP loci in three chromosomal regions: 1q41, 3q22.3-23 and 15q21.3. The most significant association with keloid was observed at rs873549 (combined P = 5.89 x 10(-23), odds ratio (OR) = 1.77) on chromosome 1. Associations on chromosome 3 were observed at two separate linkage disequilibrium (LD) blocks: rs1511412 in the LD block including FOXL2 with P = 2.31 x 10(-13) (OR = 1.87) and rs940187 in another LD block with P = 1.80 x 10(-13) (OR = 1.98). Association of rs8032158 located in NEDD4 on chromosome 15 yielded P = 5.96 x 10(-13) (OR = 1.51). Our findings provide new insights into the pathophysiology of keloid formation.	[Nakashima, Mitsuko; Chung, Suyoun; Nakamura, Yusuke; Zembutsu, Hitoshi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Wako, Kanagawa, Japan; [Kawaguchi, Takahisa; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Wako, Kanagawa, Japan; [Hosono, Naoya; Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Wako, Kanagawa, Japan	University of Tokyo; RIKEN; RIKEN; RIKEN	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918	Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We express our heartfelt gratitude to all the subjects who participated in this study and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We would like to thank S.-K. Low for her assistance in the statistical analysis. We also thank the technical staff of the Laboratory for Genotyping Development in RIKEN. We would like to express our gratefulness to T. Tamamoto and K. Matsuda for their outstanding technical assistance. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayat A, 2005, BRIT J PLAST SURG, V58, P914, DOI 10.1016/j.bjps.2005.04.009; Bayat A, 2003, PLAST RECONSTR SURG, V111, P535, DOI 10.1097/01.PRS.0000041536.02524.A3; Bayat A, 2002, BRIT J PLAST SURG, V55, P283, DOI 10.1054/bjps.2002.3853; Bayat A, 2003, PLAST RECONSTR SURG, V111, P544; Bettinger DA, 1996, PLAST RECONSTR SURG, V98, P827, DOI 10.1097/00006534-199610000-00012; Brown JJ, 2008, EXP DERMATOL, V17, P610, DOI 10.1111/j.1600-0625.2007.00654.x; Chau D, 1998, ANN PLAS SURG, V40, P490, DOI 10.1097/00000637-199805000-00008; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Hu D, 1998, BRIT J PLAST SURG, V51, P462, DOI 10.1054/bjps.1997.0100; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Kelly AP, 2009, SEMIN CUTAN MED SURG, V28, P71, DOI 10.1016/j.sder.2009.04.002; KELLY AP, 1988, DERMATOL CLIN, V6, P413, DOI 10.1016/S0733-8635(18)30653-3; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; LEONID L, 1999, NAT GENET, V22, P139; Marneros AG, 2001, ARCH DERMATOL, V137, P1429; Marneros AG, 2004, J INVEST DERMATOL, V122, P1126, DOI 10.1111/j.0022-202X.2004.22327.x; Marneros Alexander G, 2004, J Dtsch Dermatol Ges, V2, P905, DOI 10.1046/j.1439-0353.2004.04077.x; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; MOUSTAFA MFH, 1975, PLAST RECONSTR SURG, V56, P450, DOI 10.1097/00006534-197510000-00019; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robles DT, 2007, CLIN DERMATOL, V25, P26, DOI 10.1016/j.clindermatol.2006.09.009; Saito A, 2002, J HUM GENET, V47, P360, DOI 10.1007/s100380200050; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	33	124	130	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					768	U56		10.1038/ng.645	http://dx.doi.org/10.1038/ng.645			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20711176				2022-12-17	WOS:000281388400012
J	Bezzina, CR; Pazoki, R; Bardai, A; Marsman, RF; de Jong, JSSG; Blom, MT; Scicluna, BP; Jukema, JW; Bindraban, NR; Lichtner, P; Pfeufer, A; Bishopric, NH; Roden, DM; Meitinger, T; Chugh, SS; Myerburg, RJ; Jouven, X; Kaab, S; Dekker, LRC; Tan, HL; Tanck, MWT; Wilde, AAM				Bezzina, Connie R.; Pazoki, Raha; Bardai, Abdennasser; Marsman, Roos F.; de Jong, Jonas S. S. G.; Blom, Marieke T.; Scicluna, Brendon P.; Jukema, J. Wouter; Bindraban, Navin R.; Lichtner, Peter; Pfeufer, Arne; Bishopric, Nanette H.; Roden, Dan M.; Meitinger, Thomas; Chugh, Sumeet S.; Myerburg, Robert J.; Jouven, Xavier; Kaab, Stefan; Dekker, Lukas R. C.; Tan, Hanno L.; Tanck, Michael W. T.; Wilde, Arthur A. M.			Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction	NATURE GENETICS			English	Article							SUDDEN CARDIAC DEATH; QT INTERVAL DURATION; COMMON VARIANTS; RISK-FACTOR; CARDIOMYOPATHY; ADENOVIRUSES; NETHERLANDS; DISRUPTION; SEQUENCES; GENETICS	Sudden cardiac death from ventricular fibrillation during acute myocardial infarction is a leading cause of total and cardiovascular mortality. To our knowledge, we here report the first genome-wide association study for this trait, conducted in a set of 972 individuals with a first acute myocardial infarction, 515 of whom had ventricular fibrillation and 457 of whom did not, from the Arrhythmia Genetics in The Netherlands (AGNES) study. The most significant association to ventricular fibrillation was found at 21q21 (rs2824292, odds ratio = 1.78, 95% CI 1.47-2.13, P = 3.3 x 10(-10)). The association of rs2824292 with ventricular fibrillation was replicated in an independent case-control set consisting of 146 out-of-hospital cardiac arrest individuals with myocardial infarction complicated by ventricular fibrillation and 391 individuals who survived a myocardial infarction (controls) (odds ratio = 1.49, 95% CI 1.14-1.95, P = 0.004). The closest gene to this SNP is CXADR, which encodes a viral receptor previously implicated in myocarditis and dilated cardiomyopathy and which has recently been identified as a modulator of cardiac conduction. This locus has not previously been implicated in arrhythmia susceptibility.	[Bezzina, Connie R.; Pazoki, Raha; Bardai, Abdennasser; Marsman, Roos F.; Blom, Marieke T.; Scicluna, Brendon P.; Tan, Hanno L.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pazoki, Raha; Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Jonas S. S. G.; Bindraban, Navin R.; Dekker, Lukas R. C.; Tan, Hanno L.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Bindraban, Navin R.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands; [Lichtner, Peter; Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Pfeufer, Arne; Meitinger, Thomas] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Bishopric, Nanette H.; Myerburg, Robert J.] Univ Miami, Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Jouven, Xavier] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kaab, Stefan] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Dekker, Lukas R. C.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Miami; University of Miami; University of Miami; Vanderbilt University; Cedars Sinai Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Catharina Hospital	Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl	Roden, Dan/ABD-5412-2021; Jukema, J. Wouter/ABD-6503-2021; Meitinger, Thomas/O-1318-2015; Pfeufer, Arne/B-6634-2013; Scicluna, Brendon/T-8112-2018; Kaab, Stefan/H-3915-2012; , Bardai/AAL-2340-2020	Jukema, J. Wouter/0000-0002-3246-8359; Scicluna, Brendon/0000-0003-2826-0341; Pazoki, Raha/0000-0002-5142-2348; Blom, Marieke Tabo/0000-0002-8088-1105; Meitinger, Thomas/0000-0002-8838-8403; Tanck, Michael/0000-0001-9828-4459; Bezzina, Connie/0000-0002-0633-3514	Netherlands Heart Foundation [2001D019, 2003T302, 2007B202, 2005T024]; Leducq Foundation [05-CVD]; Center for Translational Molecular Medicine (CTMM COHFAR); Interuniversity Cardiology Institute of The Netherlands; Netherlands Organization for Scientific Research (NWO) [918.86.616, 017.003.084]; Medicines Evaluation Board Netherlands (CBG); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL065962, R01HL071094] Funding Source: NIH RePORTER	Netherlands Heart Foundation(Netherlands Heart Foundation); Leducq Foundation(Leducq Foundation); Center for Translational Molecular Medicine (CTMM COHFAR); Interuniversity Cardiology Institute of The Netherlands; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medicines Evaluation Board Netherlands (CBG); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research grants from The Netherlands Heart Foundation (grants 2001D019, 2003T302 and 2007B202), the Leducq Foundation (grant 05-CVD), the Center for Translational Molecular Medicine (CTMM COHFAR) and the Interuniversity Cardiology Institute of The Netherlands (project 27). C. R. B. is an Established Investigator of The Netherlands Heart Foundation (grant 2005T024). H. L. T. is supported by The Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616) and the Medicines Evaluation Board Netherlands (CBG). A. B. was supported by The Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). A. H. Zwinderman and E. P. A. van Iperen provided the genotype data from the GENDER study. We thank L. Beekman for technical support and N. Bruinsma for assistance in collection of subject data.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Andreoletti L, 2007, J AM COLL CARDIOL, V50, P2207, DOI 10.1016/j.jacc.2007.07.080; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BOWLES NE, 1986, LANCET, V1, P1120; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Eijgelsheim M, 2009, HUM MOL GENET, V18, P4213, DOI 10.1093/hmg/ddp356; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Godbout R, 2003, DEV DYNAM, V227, P409, DOI 10.1002/dvdy.10310; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Myerburg RJ, 2006, HEART RHYTHM, V3, P235, DOI 10.1016/j.hrthm.2005.09.023; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Myerburg RJ., 2007, BRAUNWALDS HEART DIS, P933; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Noseworthy PA, 2008, CIRCULATION, V118, P1854, DOI 10.1161/CIRCULATIONAHA.108.783654; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Sampietro ML, 2009, NETH HEART J, V17, P262, DOI 10.1007/BF03086261; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Watkins H, 2008, HEART, V94, P1264, DOI 10.1136/hrt.2008.154104; Wilde AAM, 2005, HEART, V91, P1352, DOI 10.1136/hrt.2004.046334; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	36	124	126	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					688	U64		10.1038/ng.623	http://dx.doi.org/10.1038/ng.623			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20622880	Green Accepted			2022-12-17	WOS:000280524000013
J	Koshiba-Takeuchi, K; Takeuchi, JK; Arruda, EP; Kathiriya, IS; Mo, R; Hui, CC; Srivastava, D; Bruneau, BG				Koshiba-Takeuchi, K; Takeuchi, JK; Arruda, EP; Kathiriya, IS; Mo, R; Hui, CC; Srivastava, D; Bruneau, BG			Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart	NATURE GENETICS			English	Article							HOLT-ORAM-SYNDROME; ULNAR-MAMMARY SYNDROME; OKIHIRO-SYNDROME; TRANSCRIPTIONAL REGULATION; DIGIT IDENTITY; MUTATIONS; HINDLIMB; GENE; SHH; MORPHOGENESIS	Human mutations in TBX5, a gene encoding a T-box transcription factor, and SALL4, a gene encoding a zinc-finger transcription factor, cause similar upper limb and heart defects. Here we show that Tbx5 regulates Sall4 expression in the developing mouse forelimb and heart; mice heterozygous for a gene trap allele of Sall4 show limb and heart defects that model human disease. Tbx5 and Sall4 interact both positively and negatively to finely regulate patterning and morphogenesis of the anterior forelimb and heart. Thus, a positive and negative feed-forward circuit between Tbx5 and Sall4 ensures precise patterning of embryonic limb and heart and provides a unifying mechanism for heart/hand syndromes.	Hosp Sick Children, Program Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bruneau, BG (corresponding author), Hosp Sick Children, Program Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bbruneau@sickkids.ca		Bruneau, Benoit/0000-0002-0804-7597				Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brassington AME, 2003, AM J HUM GENET, V73, P74, DOI 10.1086/376436; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 2003, DEVELOPMENT, V130, P6401, DOI 10.1242/dev.00956; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Pizard A, 2005, MOL CELL BIOL, V25, P5073, DOI 10.1128/MCB.25.12.5073-5083.2005; POZNANSK AK, 1970, RADIOLOGY, V94, P45, DOI 10.1148/94.1.45; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620	48	124	125	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					175	183		10.1038/ng1707	http://dx.doi.org/10.1038/ng1707			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380715				2022-12-17	WOS:000234953200011
J	Glaser, S; Anastassiadis, K; Stewart, AF				Glaser, S; Anastassiadis, K; Stewart, AF			Current issues in mouse genome engineering	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; ES CELLS; FUNCTIONAL-ANALYSIS; RNA INTERFERENCE; CRE RECOMBINASE; LARGE-SCALE; WILD-TYPE; DNA; MICE; MULTIPURPOSE	The mouse is the foremost vertebrate experimental model because its genome can be precisely and variously engineered. Now that the mouse genome has been sequenced and annotated, the task of mutating each gene is feasible, and an international cooperation is providing mutated embryonic stem cells and mice as readily available resources. Because these resources will change biomedical research, decisions about their nature will have far-reaching effects. It is therefore timely to consider topical issues for mouse genome engineering, such as the background genotype; homologous, site-specific and transpositional recombination; conditional mutagenesis; RNA-mediated interference; and functional genomics with embryonic stem cells.	Tech Univ Dresden, Bioinnovat Zentrum, D-01307 Dresden, Germany	Technische Universitat Dresden	Stewart, AF (corresponding author), Tech Univ Dresden, Bioinnovat Zentrum, Tatzberg 47, D-01307 Dresden, Germany.	stewart@biotec.tu-dresden.de	Anastassiadis, Konstantinos/A-8944-2010; Stewart, A. Francis/E-7789-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559; 				Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bestor TH, 2005, CELL, V122, P322, DOI 10.1016/j.cell.2005.07.024; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Corcoran LM, 1999, J IMMUNOL, V163, P5836; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Drabek D, 2003, GENOMICS, V81, P108, DOI 10.1016/S0888-7543(02)00030-7; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Eggan K, 2003, METHOD ENZYMOL, V365, P25; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Greber B, 2005, GENOMICS, V85, P557, DOI 10.1016/j.ygeno.2005.01.011; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Largaespada David A, 2003, Reprod Biol Endocrinol, V1, P80, DOI 10.1186/1477-7827-1-80; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; ORAM M, 1995, CURR BIOL, V5, P1106, DOI 10.1016/S0960-9822(95)00222-3; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tanaka M, 2000, METH MOL B, V158, P135; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; THOMAS KR, 1992, MOL CELL BIOL, V12, P2919, DOI 10.1128/MCB.12.7.2919; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; VONMELCHNER H, 2004, HDB STEM CELLS, V1, P609; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	75	124	149	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1187	1193		10.1038/ng1668	http://dx.doi.org/10.1038/ng1668			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254565				2022-12-17	WOS:000233045200015
J	Kopelman, NM; Lancet, D; Yanai, I				Kopelman, NM; Lancet, D; Yanai, I			Alternative splicing and gene duplication are inversely correlated evolutionary mechanisms	NATURE GENETICS			English	Article							EXON DUPLICATION; COMPLEMENTARY; EXPRESSION; ORIGIN	Gene duplication and alternative splicing are distinct evolutionary mechanisms that provide the raw material for new biological functions. We explored their relationships in human and mouse and found an inverse correlation between the size of a gene's family and its use of alternatively spliced isoforms. A cross-organism analysis suggests that selection for genome-wide genic proliferation might be interchangeably met by either evolutionary mechanism.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yanai, I (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	yanai@mcb.harvard.edu		Yanai, Itai/0000-0002-8438-2741				Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Force A, 1999, GENETICS, V151, P1531; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Ohno S., 1970, EVOLUTION GENE DUPLI; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030	15	124	126	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					588	589		10.1038/ng1575	http://dx.doi.org/10.1038/ng1575			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895079				2022-12-17	WOS:000229495300010
J	Mazeyrat, S; Saut, N; Grigoriev, V; Mahadevaiah, SK; Ojarikre, OA; Rattigan, A; Bishop, C; Eicher, EM; Mitchell, MJ; Burgoyne, PS				Mazeyrat, S; Saut, N; Grigoriev, V; Mahadevaiah, SK; Ojarikre, OA; Rattigan, A; Bishop, C; Eicher, EM; Mitchell, MJ; Burgoyne, PS			A Y-encoded subunit of the translation initiation factor Eif2 is essential for mouse spermatogenesis	NATURE GENETICS			English	Article							UBIQUITIN-ACTIVATING ENZYME-E1; EXPRESSION ANALYSIS; MALE-INFERTILITY; CHROMOSOME GENE; INTERVAL; REGION; MICE; SPERMATOCYTES; SPERMATOGONIA; TRANSCRIPT	In mouse and man, deletions of specific regions of the Y chromosome have been linked to early failure of spermatogenesis and consequent sterility; the Y chromosomal gene(s) with this essential early role in spermatogenesis have not been identified. The partial deletion of the mouse Y short arm (the Sxr(b) deletion) that occurred when Tp(Y)1Ct(Sxr-b) (hereafter Sxr(b)) arose from Tp(Y)1CT(Sxr-b) (hereafter Sxr(a)) defines Spy, a Y chromosomal factor essential for normal spermatogonial proliferation(1-3). Molecular analysis has identified six genes that lie within the deletion: Ube1y1 (refs. 4,5), Smcy(6), Uty(7), Usp9y (also known as Dffry)(8), Eif2s3y (also known as Eif-2 gammaY)(9) and Dby(10); all have closely similar X-encoded homologs. of the Y-encoded genes, Ube1y1 and Dby have been considered strong candidates for mouse Spy function(4,5,10,11), whereas Smcy has been effectively ruled out as a candidate(12). There is no Ube1y1 homolog in man, and DBY, either alone or in conjunction with USP9Y, is the favored candidate for an early spermatogenic role(10,13-15). Here we show that introduction of Ube1y1 and Dby as transgenes. into Sxr(b)-deletion mice fails to overcome the spermatogenic block. However, the introduction of Eif2s3y restores normal spermatogonial proliferation and progression through meiotic prophase. Therefore, Eif2s3y, which encodes a subunit of the eukaryotic translation initiation factor Eif2, is Spy.	Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; Fac Med Marseille, INSERM, U491, F-13385 Marseille 5, France; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA	MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Baylor College of Medicine; Jackson Laboratory	Burgoyne, PS (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, Mill Hill, London NW7 1AA, England.		Mitchell, Michael/I-3987-2016	Mitchell, Michael/0000-0003-2052-7347	NCI NIH HHS [CA34196] Funding Source: Medline; NIGMS NIH HHS [GM20919] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020919, R01GM020919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agulnik AI, 1999, MAMM GENOME, V10, P926, DOI 10.1007/s003359901116; AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Agulnik AI, 2001, MAMM GENOME, V12, P112, DOI 10.1007/s003350010249; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; BURGOYNE PS, 1986, NATURE, V320, P170, DOI 10.1038/320170a0; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; DRESSER DW, 1995, HUM MOL GENET, V4, P1613, DOI 10.1093/hmg/4.9.1613; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LEVY ER, 1986, CYTOGENET CELL GENET, V42, P208, DOI 10.1159/000132280; Levy N, 2000, MAMM GENOME, V11, P164, DOI 10.1007/s003350010031; Mahaffey CL, 1997, GENOMICS, V41, P123, DOI 10.1006/geno.1997.4611; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; MITCHELL MJ, 2000, GENETIC BASIS MALE I, P233; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Sargent CA, 1999, J MED GENET, V36, P670; SIMPSON EM, 1991, GENOMICS, V11, P601, DOI 10.1016/0888-7543(91)90067-O; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; SUTCLIFFE MJ, 1991, MOL REPROD DEV, V30, P81, DOI 10.1002/mrd.1080300202; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; VOGT PH, 1996, ADV DEV BIO, V4, P191	30	124	128	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2001	29	1					49	53		10.1038/ng717	http://dx.doi.org/10.1038/ng717			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528390				2022-12-17	WOS:000170781300015
J	Shifman, S; Darvasi, A				Shifman, S; Darvasi, A			The value of isolated populations	NATURE GENETICS			English	Letter							COMMON DISEASE GENES; LINKAGE DISEQUILIBRIUM		Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel; IDgene Pharmaceut Ltd, IL-91344 Jerusalem, Israel	Hebrew University of Jerusalem	Darvasi, A (corresponding author), Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel.		Shifman, Sagiv/D-8749-2017	Shifman, Sagiv/0000-0003-4071-5361				Abbott A, 2000, NATURE, V406, P340, DOI 10.1038/35019167; Boehnke M, 2000, NAT GENET, V25, P246, DOI 10.1038/76980; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Eaves IA, 2000, NAT GENET, V25, P320; FRANKEL WN, 1995, TRENDS GENET, V11, P471, DOI 10.1016/S0168-9525(00)89155-6; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100	11	124	129	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2001	28	4					309	310		10.1038/91060	http://dx.doi.org/10.1038/91060			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11479587				2022-12-17	WOS:000170174800006
J	Avela, K; Lipsanen-Nyman, M; Idanheimo, N; Seemanova, E; Rosengren, S; Makela, TP; Perheentupa, J; de la Chapelle, A; Lehesjoki, AE				Avela, K; Lipsanen-Nyman, M; Idanheimo, N; Seemanova, E; Rosengren, S; Makela, TP; Perheentupa, J; de la Chapelle, A; Lehesjoki, AE			Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism	NATURE GENETICS			English	Article							NUCLEAR RECEPTORS; WILMS-TUMOR; IN-VIVO; FINGER; EXPRESSION; DOMAIN; IDENTIFICATION; MUTATIONS; PRODUCT; DISEASE	Mulibrey nanism (for muscle-liver-brain-eye nanism, MUL; MIM 253250) is an autosomal recessive disorder that involves several tissues of mesodermal origin, implying a defect in a highly pleiotropic gene(1). Characteristic features include severe growth failure of prenatal onset and constrictive pericardium with consequent hepatomegaly(1-3). In addition, muscle hypotonia, J-shaped sella turcica, yellowish dots in the ocular fundi, typical dysmorphic features and hypoplasia of various endocrine glands causing hormonal deficiency are (1-3). About 4% of RAUL patients develop Wilms' common tumour(2,4,5). MUL is enriched in the Finnish population, but is rare elsewhere(1-3). We previously assigned MUL to chromosome 17q22-q23 and constructed a physical contig over the critical MUL region(6,7). The region has now been further refined by haplotype analysis and new positional candidate genes have been localized. We identified a gene with four independent MUL-associated mutations that all cause a frameshift and predict a truncated protein. MUL is ubiquitously expressed and encodes a new member of the RINC-B-box-Coiled-coil (RBCC) family of zinc-finger proteins(8-10), whose members are involved in diverse cellular functions such as developmental patterning and oncogenesis.	Folkhalsan Inst Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Haartman Inst, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Charles Univ, Sch Med 2, Inst Biol & Med Genet, Prague, Czech Republic; Univ Connecticut, Sch Med, Farmington, CT USA; Univ Helsinki, Bioctr, FIN-00014 Helsinki, Finland; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Helsinki; University of Helsinki; Charles University Prague; University of Connecticut; University of Helsinki; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Avela, K (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.		makela, tomi/B-3734-2009	makela, tomi/0000-0002-4869-8044; Lipsanen-Nyman, Marita/0000-0003-4959-2310	NCI NIH HHS [P30CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avela K, 1997, AM J HUM GENET, V60, P896; Bernot A, 1997, NAT GENET, V17, P25; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; Cainarca S, 1999, HUM MOL GENET, V8, P1387, DOI 10.1093/hmg/8.8.1387; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; COOPER DN, 1991, HUM GENET, V87, P409; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dow MR, 1998, GENETICS, V150, P119; LAPUNZINA P, 1995, AM J MED GENET, V55, P349, DOI 10.1002/ajmg.1320550320; Le Douarin B, 1998, J STEROID BIOCHEM, V65, P43, DOI 10.1016/S0960-0760(97)00175-1; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LIPSANENNYMAN M, 1986, THESIS U HELSINKI; Nagai Y, 1997, FEBS LETT, V418, P23, DOI 10.1016/S0014-5793(97)01340-9; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Paavola P, 1999, GENOME RES, V9, P267; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; PERHEENTUPA J, 1973, LANCET, V2, P351, DOI 10.1016/S0140-6736(73)93193-0; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rahman N, 1996, NAT GENET, V13, P461, DOI 10.1038/ng0896-461; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Seemanova E, 1999, AM J MED GENET, V85, P76, DOI 10.1002/(SICI)1096-8628(19990702)85:1<76::AID-AJMG12>3.0.CO;2-Z; SIMILA S, 1980, CLIN GENET, V17, P29; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430	31	124	127	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					298	301		10.1038/77053	http://dx.doi.org/10.1038/77053			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888877				2022-12-17	WOS:000087920900017
J	Bielinska, B; Blaydes, SM; Buiting, K; Yang, T; Krajewska-Walasek, M; Horsthemke, B; Brannan, CI				Bielinska, B; Blaydes, SM; Buiting, K; Yang, T; Krajewska-Walasek, M; Horsthemke, B; Brannan, CI			De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; SYNDROME CRITICAL REGION; ANGELMAN-SYNDROMES; TARGETED MUTATION; DNA METHYLATION; EXPRESSED GENE; NECDIN GENE; TRANSCRIPT; LETHALITY; 15Q11-13	Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity(1). PWS is due to a lack of paternal genetic information at 15q11-q13 (ref. 2). Five imprinted, paternally expressed genes map to the PWS region, MKRN3 (ref. 3), NDN (ref. 4), NDNL1 (ref. 5), SNRPN (refs 6-8) and IPW (ref. 9), as well as two poorly characterized framents designated PAR-1 and PAR-5 (ref. 10). Imprinting of this region involves a bipartite 'imprinting centre' (IC), which overlaps SNRPN (refs 10,11). Deletion of the SNRPN promoter/exon 1 region (the PWS IC element) appears to impair the establishment of the paternal imprint in the male germ line and leads to PWS. Here we report a PWS family in which the father is mosaic for an IC deletion on his paternal chromosome. The deletion chromosome has acquired a maternal methylation imprint in his somatic cells. We have made identical findings in chimaeric mice generated from two independent embryonic stem (ES) cell lines harbouring a similar deletion. Our studies demonstrate that the PWS IC element is not only required for the establishment of the paternal imprint, but also for its postzygotic maintenance.	Univ Essen Gesamthsch, Inst Human Genet, Essen, Germany; Childrens Mem Hlth Inst, Dept Genet, Warsaw, Poland; Univ Florida, Coll Med, Inst Brain, Gainesville, FL USA; Univ Florida, Coll Med, Ctr Mammalian Genet, Dept Mol Genet & Microbiol, Gainesville, FL USA	University of Duisburg Essen; Children's Memorial Health Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Horsthemke, B (corresponding author), Univ Essen Gesamthsch, Inst Human Genet, Essen, Germany.			Krajewska-Walasek, Malgorzata/0000-0001-8721-210X	NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09126] Funding Source: Medline; NIGMS NIH HHS [GM55272] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; BUITING K, 1994, HUM MOL GENET, V3, P893, DOI 10.1093/hmg/3.6.893; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; DITTRICH B, 1992, HUM GENET, V90, P313; DITTRICH B, 1994, HUM GENET, V94, P583; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; HOGAN B, 1994, MANIPULATING MOUSE E; HOLM VA, 1993, PEDIATRICS, V91, P398; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Schumacher A, 1998, NAT GENET, V19, P324, DOI 10.1038/1211; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Wevrick R, 1997, HUM MOL GENET, V6, P325, DOI 10.1093/hmg/6.2.325; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; ZECHNIGK M, 1997, EUR J HUM GENET, V5, P94	29	124	124	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					74	78		10.1038/75629	http://dx.doi.org/10.1038/75629			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802660				2022-12-17	WOS:000086884000020
J	Persons, DA; Paulson, RF; Loyd, MR; Herley, MT; Bodner, SM; Bernstein, A; Correll, PH; Ney, PA				Persons, DA; Paulson, RF; Loyd, MR; Herley, MT; Bodner, SM; Bernstein, A; Correll, PH; Ney, PA			Fv2 encodes a truncated form of the Stk receptor tyrosine kinase	NATURE GENETICS			English	Article							FRIEND-LEUKEMIA VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; FV-2 GENE-ACTION; PROGENITOR CELLS; CELLULAR SITE; ERYTHROLEUKEMIA; GLYCOPROTEIN; GP55; MICE; ONCOGENE	The Friend virus susceptibility 2 (Fv2) locus encodes a dominant host factor that confers susceptibility to Friend virus-induced erythroleukaemia in mice. We mapped Fv2 to a 1.0-Mb interval that also contained the gene (Ron) encoding the stem cell kinase receptor (Stk). A truncated form of Stk (Sf-stk), which was the most abundant form of Stk in Fv2-sensitive (Fv2(ss)) erythroid cells, was not expressed in Fv2 resistant (Fv2(rr)) cells. Enforced expression of Sf-stk conferred susceptibility to Friend disease, whereas targeted disruption of Ron caused resistance. We conclude that the Fv2 locus encodes Ron, and that a naturally expressed, truncated form of Stk confers susceptibility to Friend virus-induced erythroleukaemia.	St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Expt Hematol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Ney, PA (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	paul.ney@stjude.org			NATIONAL CANCER INSTITUTE [R01CA084214, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084214-01, R01 CA084214-03, R01 CA084214-05, P30 CA21765, R01 CA084214-02, R01 CA084214-04, R01 CA084214] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AIZAWA S, 1990, EMBO J, V9, P2107, DOI 10.1002/j.1460-2075.1990.tb07379.x; AMANUMA H, 1983, P NATL ACAD SCI-BIOL, V80, P3913, DOI 10.1073/pnas.80.13.3913; AXELRAD A, 1969, CAN CANC C, V8, P313; AXELRAD AA, 1964, VIROLOGY, V24, P513, DOI 10.1016/0042-6822(64)90199-0; BEHRINGER RR, 1989, EXP HEMATOL, V17, P330; BEHRINGER RR, 1985, CELL, V40, P441, DOI 10.1016/0092-8674(85)90158-8; BENDAVID Y, 1991, CELL, V66, P831, DOI 10.1016/0092-8674(91)90428-2; BENNETT M, 1968, SCIENCE, V162, P564, DOI 10.1126/science.162.3853.564; BERGER SA, 1985, P NATL ACAD SCI USA, V82, P6913, DOI 10.1073/pnas.82.20.6913; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Blake JA, 1998, NUCLEIC ACIDS RES, V26, P130, DOI 10.1093/nar/26.1.130; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHESEBRO B, 1978, J IMMUNOL, V120, P1081; CLARK SP, 1983, P NATL ACAD SCI-BIOL, V80, P5037, DOI 10.1073/pnas.80.16.5037; Constantinescu SN, 1998, BLOOD, V91, P1163, DOI 10.1182/blood.V91.4.1163; Correll Pamela H., 1997, Genes and Function, V1, P69; DIETRICH W, 1992, GENETICS, V131, P423; ELIOTT RW, 1978, ELECTROPHORESIS, P261; FRIEND C, 1957, J EXP MED, V105, P307, DOI 10.1084/jem.105.4.307; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; GEIB RW, 1987, VIRUS RES, V8, P327, DOI 10.1016/0168-1702(87)90005-0; Hoatlin Maureen E., 1995, Trends in Microbiology, V3, P51, DOI 10.1016/S0966-842X(00)88875-7; HOATLIN ME, 1995, J VIROL, V69, P856, DOI 10.1128/JVI.69.2.856-863.1995; IWAMA A, 1994, BLOOD, V83, P3160, DOI 10.1182/blood.V83.11.3160.bloodjournal83113160; KABAT D, 1989, CURR TOP MICROBIOL, V148, P1; KAI K, 1986, VIROLOGY, V150, P509, DOI 10.1016/0042-6822(86)90315-6; KOZAK CA, 1985, J VIROL, V55, P281, DOI 10.1128/JVI.55.2.281-285.1985; KUMAR V, 1978, J NATL CANCER I, V61, P1117; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; LILLY F, 1970, J NATL CANCER I, V45, P163; MAGER D, 1981, MOL CELL BIOL, V1, P721, DOI 10.1128/MCB.1.8.721; Mera A, 1999, J BIOL CHEM, V274, P15766, DOI 10.1074/jbc.274.22.15766; METCALF D, 1959, CANCER RES, V19, P52; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Paulson RF, 1998, MAMM GENOME, V9, P381, DOI 10.1007/s003359900774; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Riberdy JM, 1999, J VIROL, V73, P1453, DOI 10.1128/JVI.73.2.1453-1459.1999; Santoro MM, 1997, MOL CELL BIOL, V17, P1758; SHIBUYA T, 1982, NATURE, V296, P577, DOI 10.1038/296577a0; SMITH DR, 1989, P NATL ACAD SCI USA, V86, P5291, DOI 10.1073/pnas.86.14.5291; STEEVES RA, 1975, J NATL CANCER I, V54, P289, DOI 10.1093/jnci/54.2.289; STEEVES RA, 1968, NATURE, V218, P372, DOI 10.1038/218372a0; SUZUKI S, 1980, CELL, V19, P225, DOI 10.1016/0092-8674(80)90404-3; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; VANDERGAAG HC, 1990, VIROLOGY, V177, P837, DOI 10.1016/0042-6822(90)90561-5; Waltz SE, 1998, ONCOGENE, V16, P27, DOI 10.1038/sj.onc.1201508; Wei MH, 1996, CANCER RES, V56, P1487; WOLFF L, 1985, SCIENCE, V228, P1549, DOI 10.1126/science.2990034	50	124	128	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1999	23	2					159	165		10.1038/13787	http://dx.doi.org/10.1038/13787			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508511				2022-12-17	WOS:000082827500014
J	Mayer, J; Sauter, M; Racz, A; Scherer, D; Mueller-Lantzsch, N; Meese, E				Mayer, J; Sauter, M; Racz, A; Scherer, D; Mueller-Lantzsch, N; Meese, E			An almost-intact human endogenous retrovirus K on human chromosome 7	NATURE GENETICS			English	Letter							SEQUENCE; ENCODES; PROTEIN; REGION; GENOME		Univ Saarlandes Kliniken, Inst Humangenet, Haus 60, D-66421 Homburg, Germany; Univ Saarlandes Kliniken, Inst Med Mikrobiol & Hyg, Abt Virol, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Mayer, J (corresponding author), Univ Saarlandes Kliniken, Inst Humangenet, Haus 60, Haus 60, D-66421 Homburg, Germany.		Mayer, Jens/P-4777-2019; Mayer, Jens/B-8506-2013; Meese, Eckart Ulrich/ABD-1983-2021	Mayer, Jens/0000-0002-1090-5765; Mayer, Jens/0000-0002-1090-5765; 				DANGEL AW, 1995, IMMUNOGENETICS, V42, P41, DOI 10.1007/BF00164986; Kitamura Y, 1996, J VIROL, V70, P3302, DOI 10.1128/JVI.70.5.3302-3306.1996; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lavrentieva I, 1998, HUM GENET, V102, P107, DOI 10.1007/s004390050662; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; LOWER R, 1995, J VIROL, V69, P141; Mayer J, 1998, J VIROL, V72, P1870, DOI 10.1128/JVI.72.3.1870-1875.1998; Mayer J, 1997, CYTOGENET CELL GENET, V78, P1, DOI 10.1159/000134614; Mayer J, 1997, CYTOGENET CELL GENET, V79, P157, DOI 10.1159/000134709; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; MUELLERLANTZSCH N, 1993, AIDS RES HUM RETROV, V9, P343, DOI 10.1089/aid.1993.9.343; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; RAO JKM, 1991, BIOCHEMISTRY-US, V30, P4663, DOI 10.1021/bi00233a005; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989	14	124	131	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1999	21	3					257	258		10.1038/6766	http://dx.doi.org/10.1038/6766			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080172				2022-12-17	WOS:000078977900013
J	BROUGHTON, BC; STEINGRIMSDOTTIR, H; WEBER, CA; LEHMANN, AR				BROUGHTON, BC; STEINGRIMSDOTTIR, H; WEBER, CA; LEHMANN, AR			MUTATIONS IN THE XERODERMA-PIGMENTOSUM GROUP-D DNA REPAIR/TRANSCRIPTION GENE IN PATIENTS WITH TRICHOTHIODYSTROPHY	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; RAD3 PROTEIN; YEAST RAD3; HELICASE; CLONING; ERCC2; HETEROGENEITY; RECOMBINATION; DISORDER	DNA repair defects in the xeroderma pigmentosum (XP) group D complementation group can be associated with the clinical features of two quite different disorders; XP, a sun-sensitive and cancer-prone disorder, or trichothiodystrophy (TTD) which is characterized by sulphur-deficient brittle hair and a variety of other associated abnormalities, but no skin cancer. The XPD gene product, a DNA helicase, is required for nucleotide excision repair and recent evidence has demonstrated a role in transcription. We have now identified causative mutations in XPD in four TTD patients. The patients are all compound heterozygotes and the locations of the mutations enable us to suggest relationships between different domains in the gene and its roles in excision repair and transcription.	UNIV SUSSEX, MRC, CELL MUTAT UNIT, BRIGHTON BN1 9RR, ENGLAND; LAWRENCE LIVERMORE NATL LAB, DIV BIOMED SCI, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94551 USA	University of Sussex; United States Department of Energy (DOE); Lawrence Livermore National Laboratory								BAILLY V, 1991, P NATL ACAD SCI USA, V88, P9712, DOI 10.1073/pnas.88.21.9712; BROUGHTON BC, 1990, MUTAT RES, V235, P33, DOI 10.1016/0921-8777(90)90020-6; COOPER DN, 1990, HUM GENET, V85, P55; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; HAROSH I, 1991, NUCLEIC ACIDS RES, V19, P6331, DOI 10.1093/nar/19.22.6331; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; KING MD, 1984, J MED GENET, V21, P286, DOI 10.1136/jmg.21.4.286; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; LEHMANN AR, 1988, CANCER RES, V48, P6090; LEHMANN AR, 1989, CARCINOGENESIS, V10, P1353, DOI 10.1093/carcin/10.8.1353; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; MURRAY JM, 1992, NUCLEIC ACIDS RES, V20, P2673, DOI 10.1093/nar/20.11.2673; NAEGELI H, 1992, J BIOL CHEM, V267, P7839; NAUMOVSKI L, 1986, MOL CELL BIOL, V6, P1218, DOI 10.1128/MCB.6.4.1218; REYNOLDS PR, 1992, NUCLEIC ACIDS RES, V20, P2327, DOI 10.1093/nar/20.9.2327; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SONG JM, 1990, J BACTERIOL, V172, P6620, DOI 10.1128/jb.172.12.6620-6630.1990; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Tolmie J L, 1994, Clin Dysmorphol, V3, P1; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x	33	124	126	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1994	7	2					189	194		10.1038/ng0694-189	http://dx.doi.org/10.1038/ng0694-189			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920640				2022-12-17	WOS:A1994NQ03700021
J	STRATTON, MR; FORD, D; NEUHASEN, S; SEAL, S; WOOSTER, R; FRIEDMAN, LS; KING, MC; EGILSSON, V; DEVILEE, P; MCMANUS, R; DALY, PA; SMYTH, E; PONDER, BAJ; PETO, J; CANNONALBRIGHT, L; EASTON, DF; GOLDGAR, DE				STRATTON, MR; FORD, D; NEUHASEN, S; SEAL, S; WOOSTER, R; FRIEDMAN, LS; KING, MC; EGILSSON, V; DEVILEE, P; MCMANUS, R; DALY, PA; SMYTH, E; PONDER, BAJ; PETO, J; CANNONALBRIGHT, L; EASTON, DF; GOLDGAR, DE			FAMILIAL MALE BREAST-CANCER IS NOT LINKED TO THE BRCA1 LOCUS ON CHROMOSOME 17Q	NATURE GENETICS			English	Article							RISK-FACTORS; LINKAGE; ONSET; GENE; MEN	Breast cancer in men is about a hundredfold less common than in women and this has hindered research into its genetic basis. We have examined 22 families with at least one case of male breast cancer for linkage to the hereditary breast and ovarian cancer locus, BRCA1, on chromosome 17q. We found strong evidence against linkage to BRCA1 (led score - 16.63) and the best estimate of the proportion of linked families was 0% (95% Cl 0-18%). Our results indicate that there is a gene(s) other than BRCA1 which predisposes to early-onset breast cancer in women and which confers a higher risk of male breast cancer. Identification of additional pedigrees that include cases of male breast cancer may therefore facilitate the mapping and isolation of this gene.	INST CANC RES, CRC, EPIDEMIOL SECT, SUTTON SM2 5NG, SURREY, ENGLAND; UNIV UTAH, DEPT MED INFORMAT, SALT LAKE CITY, UT 84108 USA; UNIV UTAH, DEPT INTERNAL MED, SALT LAKE CITY, UT 84108 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, BERKELEY, CA 94720 USA; UNIV HOSP ICELAND, CELL BIOL LAB, IS-121 REYKJAVIK, ICELAND; LEIDEN STATE UNIV, DEPT PATHOL, 2333 AL LEIDEN, NETHERLANDS; UNIV DUBLIN TRINITY COLL, ST JAMES HOSP, SCH MED, DEPT MED, DUBLIN 8, IRELAND; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV CAMBRIDGE, DEPT PATHOL, CRC, HUMAN CANC GENET GRP, CAMBRIDGE CB2 1QP, ENGLAND	University of London; Institute of Cancer Research - UK; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Landspitali National University Hospital; Leiden University; Leiden University - Excl LUMC; Trinity College Dublin; University of Edinburgh; University of Cambridge	STRATTON, MR (corresponding author), INST CANC RES, MOLEC CARCINOGENESIS SECT, SUTTON SM2 5NG, SURREY, ENGLAND.		DEVILEE, PETER/ABR-2140-2022; McManus, Ross/AAE-9236-2020	albright, lisa/0000-0003-2602-3668; McManus, Ross/0000-0002-0529-9617; King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [P01CA048711, R03CA054936] Funding Source: NIH RePORTER; NCI NIH HHS [CA-48711, CA-54936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; ANDERSON DE, 1992, J NATL CANCER I, V84, P1114, DOI 10.1093/jnci/84.14.1114; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; ARASON A, 1993, AM J HUM GENET, V52, P711; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; COHEN BB, 1993, AM J HUM GENET, V52, P723; DEMETER JG, 1990, CANCER, V65, P2342, DOI 10.1002/1097-0142(19900515)65:10<2342::AID-CNCR2820651029>3.0.CO;2-Y; EASTON DF, 1993, AM J HUM GENET, V52, P678; EASTON DF, IN PRESS CANCER SURV; EVERSON RB, 1976, LANCET, V1, P9; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KOZAK FK, 1986, CANCER, V58, P2736, DOI 10.1002/1097-0142(19861215)58:12<2736::AID-CNCR2820581230>3.0.CO;2-A; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAURENCE DJ, 1991, OXFORD REV REPROD B, V13, P149; LENFANTPEJOVIC MH, 1990, INT J CANCER, V45, P661, DOI 10.1002/ijc.2910450415; LOBACCARO JM, 1993, NAT GENET, V5, P109, DOI 10.1038/ng1093-109; MARGER D, 1975, CANCER-AM CANCER SOC, V36, P458, DOI 10.1002/1097-0142(197508)36:2<458::AID-CNCR2820360222>3.0.CO;2-V; NAROD SA, 1991, LANCET, V338, P82; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; ROSENBLATT KA, 1991, JNCI-J NATL CANCER I, V83, P849, DOI 10.1093/jnci/83.12.849; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SMITH SA, 1993, AM J HUM GENET, V52, P767; TEASDALE C, 1976, LANCET, V1, P360; THOMAS DB, 1993, EPIDEMIOL REV, V15, P220, DOI 10.1093/oxfordjournals.epirev.a036108; THOMAS DB, 1992, AM J EPIDEMIOL, V135, P734, DOI 10.1093/oxfordjournals.aje.a116360; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WILSON JD, 1987, HARRISONS PRINCIPLES, P1387; WOOSTER R, 1992, NAT GENET, V2, P132, DOI 10.1038/ng1092-132	32	124	125	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					103	107		10.1038/ng0594-103	http://dx.doi.org/10.1038/ng0594-103			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075631				2022-12-17	WOS:A1994NJ84200022
J	BODMER, W; BISHOP, T; KARRAN, P				BODMER, W; BISHOP, T; KARRAN, P			GENETIC STEPS IN COLORECTAL-CANCER	NATURE GENETICS			English	Editorial Material							FAMILIAL ADENOMATOUS POLYPOSIS; IDENTIFICATION		ST JAMES UNIV HOSP, ICRF, GENET EPIDEMIOL LAB, LEEDS LS2 9LY, YORKS, ENGLAND; ICRF, CLARE HALL LABS, ENFIELD EN6 3LD, MIDDX, ENGLAND	Saint James's University Hospital	BODMER, W (corresponding author), IMPERIAL CANC RES FUND, 44 LINCOLNS INN FIELDS, LONDON WC2A 3PX, ENGLAND.			Bishop, Tim/0000-0002-8752-8785; Bodmer, Walter/0000-0001-6244-9792				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; AQUILINA G, IN PRESS P NATN ACAD; BICKNELL DC, IN PRESS P NATN ACAD; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BODMER WF, 1993, ANN NY ACAD SCI, V690, P42; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HALL NR, IN PRESS EUR J CANCE; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LOTHE RA, 1993, CANCER RES, V53, P5849; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; PALOMBO F, 1994, NATURE, V367, P417, DOI 10.1038/367417a0; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, CANCER RES, V53, P5853; PIGNATELLI M, 1990, J PATHOL, V162, P95, DOI 10.1002/path.1711620202; PIGNATELLI M, 1988, P NATL ACAD SCI USA, V85, P5561, DOI 10.1073/pnas.85.15.5561; PIGNATELLI M, 1993, CANCER SURV, V16, P3; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; SHIBATA O, 1994, NAT GENET, V6, P273; STJOHN DJB, 1992, MTG AM GASTRO ASS; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; VASEN HFA, 1991, LANCET, V338, P877, DOI 10.1016/0140-6736(91)91520-5	27	124	129	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1994	6	3					217	219		10.1038/ng0394-217	http://dx.doi.org/10.1038/ng0394-217			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012377				2022-12-17	WOS:A1994MZ56200002
J	GEORGES, M; DRINKWATER, R; KING, T; MISHRA, A; MOORE, SS; NIELSEN, D; SARGEANT, LS; SORENSEN, A; STEELE, MR; ZHAO, XY; WOMACK, JE; HETZEL, J				GEORGES, M; DRINKWATER, R; KING, T; MISHRA, A; MOORE, SS; NIELSEN, D; SARGEANT, LS; SORENSEN, A; STEELE, MR; ZHAO, XY; WOMACK, JE; HETZEL, J			MICROSATELLITE MAPPING OF A GENE AFFECTING HORN DEVELOPMENT IN BOS-TAURUS	NATURE GENETICS			English	Article							MARKERS	The presence or absence of horns in Bos taurus is thought to be under the genetic control of the autosomal polled locus, characterized by two alleles: P dominant over p, and causing the polled or hornless phenotype. We have demonstrated genetic linkage between the polled locus and two microsatellite markers, GMPOLL-1 and GMPOLL-2, and have assigned the corresponding linkage group to bovine chromosome 1. This confirms the existence of the postulated polled locus and the hypothesized inheritance pattern. It will allow marker assisted selection for the polledness trait in breeding programs and is a first step towards positional cloning and molecular study of a gene that has been subjected to both natural and artificial selection.	UNIV QUEENSLAND,CSIRO,CTR MOLEC ANIM GENET,DIV TROP ANIM PRODUCT,BRISBANE,QLD 4072,AUSTRALIA; TEXAS A&M UNIV SYST,COLL VET MED,DEPT PATHOBIOL,COLL STN,TX 77843	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Texas A&M University System; Texas A&M University College Station	GEORGES, M (corresponding author), GENMARK INC,421 WAKARA WAY,SALT LAKE CITY,UT 84108, USA.		Moore, Stephen S/F-5285-2013	Moore, Stephen/0000-0002-9758-166X; Georges, Michel/0000-0003-4124-2375; Nielsen, Dahlia/0000-0003-0123-6085				BATESON W, 1902, REPORTS EVOLUTIONARY, V1; BRICKER RA, 1991, 36TH ANN M GEN SOC C; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CHEVALET C, 1986, CYTOGENET CELL GENET, V43, P132, DOI 10.1159/000132311; DIETZ AB, 1992, MAMM GENOME, V3, P106, DOI 10.1007/BF00431254; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; FRISCH JE, 1980, ANIM PROD, V31, P119, DOI 10.1017/S000335610002434X; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; GEORGES M, 1991, GENOMICS, V11, P24, DOI 10.1016/0888-7543(91)90098-Y; GEORGES M, 1992, Patent No. 13102; JOHANSSON I, 1968, GENETICS ANIMAL BREE, P180; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; MEISCHKE HR, 1974, AUST VET J, V50, P432, DOI 10.1111/j.1751-0813.1974.tb06864.x; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1991, CYTOGENET CELL GENET, V58, P1124, DOI 10.1159/000133725; Smith ADB, 1927, J GENET, V18, P365, DOI 10.1007/BF02983113; SOLLER M, 1969, CYTOGENETICS, V8, P51, DOI 10.1159/000130022; STEELE MR, 1991, GENOMICS, V10, P889, DOI 10.1016/0888-7543(91)90177-G; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; WOMACK JE, 1986, J HERED, V77, P2, DOI 10.1093/oxfordjournals.jhered.a110160; [No title captured]	23	124	133	1	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					206	210		10.1038/ng0693-206	http://dx.doi.org/10.1038/ng0693-206			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348158				2022-12-17	WOS:A1993LF81600025
J	BAIN, SC; PRINS, JB; HEARNE, CM; RODRIGUES, NR; ROWE, BR; PRITCHARD, LE; RITCHIE, RJ; HALL, JRS; UNDLIEN, DE; RONNINGEN, KS; DUNGER, DB; BARNETT, AH; TODD, JA				BAIN, SC; PRINS, JB; HEARNE, CM; RODRIGUES, NR; ROWE, BR; PRITCHARD, LE; RITCHIE, RJ; HALL, JRS; UNDLIEN, DE; RONNINGEN, KS; DUNGER, DB; BARNETT, AH; TODD, JA			INSULIN GENE REGION-ENCODED SUSCEPTIBILITY TO TYPE-1 DIABETES IS NOT RESTRICTED TO HLA-DR4-POSITIVE INDIVIDUALS	NATURE GENETICS			English	Article							HLA-DR; MELLITUS; ASSOCIATION; LINKAGE; DISEASE; HETEROGENEITY; POLYMORPHISM; HLA-DR3; FAMILY; MICE	Type 1 or insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease of the insulin-producing pancreatic beta-cells which is determined by both genetic and environmental factors. The major histocompatibility complex and the insulin gene region (INS) on human chromosomes 6p and 11p, respectively, contain susceptibility genes. Using a mostly French data set, evidence for linkage of INS to IDDM was recently obtained but only in male meioses (suggesting involvement of maternal imprinting) and only in HLA-DR4-positive diabetics. In contrast, we find evidence for linkage in both male and female meioses and that the effect of the susceptibility gene(s) in the INS region is not dependent on the presence of HLA-DR4.	UNIV OXFORD, JOHN RADCLIFFE HOSP, NUFFIELD DEPT SURG, OXFORD OX3 9DU, ENGLAND; E BIRMINGHAM DIST GEN HOSP, BIRMINGHAM B9 5ST, W MIDLANDS, ENGLAND; UNIV OXFORD, JOHN RADCLIFFE HOSP, DEPT PAEDIAT, OXFORD OX3 9DU, ENGLAND; UNIV BIRMINGHAM, DEPT MED, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND; NATL HOSP, INST TRANSPLANTAT IMMUNOL, N-0027 OSLO, NORWAY	University of Oxford; University of Oxford; University of Birmingham; University of Oslo; National Hospital Norway			Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Prins, Jan-Bas/0000-0002-1831-8522	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AWAD J, 1987, TISSUE ANTIGENS, V29, P55; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BAIN SC, IN PRESS METHODS MOL; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CAILLATZUCMAN S, 1992, IN PRESS J CLIN INVE; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; COX NJ, 1988, AM J HUM GENET, V43, P495; DCCT Res Grp, 1987, J CLIN ENDOCR METAB, V65, P30; DESCHAMPS I, 1988, DIABETOLOGIA, V31, P896; DONALD JA, 1989, GENET EPIDEMIOL, V6, P77, DOI 10.1002/gepi.1370060115; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; HYER RN, 1991, AM J HUM GENET, V48, P243; JENKINS D, 1990, DIABETOLOGIA, V33, P387, DOI 10.1007/BF00404086; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; MCGINNIS RE, 1991, AM J HUM GENET S, V49, pA476; OKOYE RC, 1989, TISSUE ANTIGENS, V33, P445, DOI 10.1111/j.1399-0039.1989.tb01693.x; OWERBACH D, 1990, DIABETES, V39, P1504, DOI 10.2337/diabetes.39.12.1504; RAFFEL LJ, 1991, METABOLISM, V40, P1244, DOI 10.1016/0026-0495(91)90023-P; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; TARN AC, 1988, LANCET, V1, P845; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; TODD JA, 1990, DIABETIC MED, V164, P17; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; WOLF E, 1983, DIABETOLOGIA, V24, P224; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	34	124	124	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					212	215		10.1038/ng1192-212	http://dx.doi.org/10.1038/ng1192-212			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345171				2022-12-17	WOS:A1992JW16500011
J	Huang, G; Wu, ZG; Percy, RG; Bai, MZ; Li, Y; Frelichowski, JE; Hu, J; Wang, K; Yu, JZ; Zhu, YX				Huang, Gai; Wu, Zhiguo; Percy, Richard G.; Bai, Mingzhou; Li, Yang; Frelichowski, James E.; Hu, Jiang; Wang, Kun; Yu, John Z.; Zhu, Yuxian			Genome sequence of Gossypium herbaceum and genome updates of Gossypium arboreum and Gossypium hirsutum provide insights into cotton A-genome evolution	NATURE GENETICS			English	Article							PHYLOGENETIC ANALYSIS; DRAFT GENOME; FIBER; PREDICTION; TOOL; RECONSTRUCTION; SELECTION; ALIGNMENT; PROGRAM; FINDER	Upon assembling the first Gossypium herbaceum (A(1)) genome and substantially improving the existing Gossypium arboreum (A(2)) and Gossypium hirsutum ((AD)(1)) genomes, we showed that all existing A-genomes may have originated from a common ancestor, referred to here as A(0), which was more phylogenetically related to A(1) than A(2). Further, allotetraploid formation was shown to have preceded the speciation of A(1) and A(2). Both A-genomes evolved independently, with no ancestor-progeny relationship. Gaussian probability density function analysis indicates that several long-terminal-repeat bursts that occurred from 5.7 million years ago to less than 0.61 million years ago contributed compellingly to A-genome size expansion, speciation and evolution. Abundant species-specific structural variations in genic regions changed the expression of many important genes, which may have led to fiber cell improvement in (AD)(1). Our findings resolve existing controversial concepts surrounding A-genome origins and provide valuable genomic resources for cotton genetic improvement. Assembly of the first Gossypium herbaceum genome and improved Gossypium arboreum and Gossypium hirsutum genomes provide insights into the phylogenetic relationships and origin history of cotton A-genomes.	[Huang, Gai; Zhu, Yuxian] Wuhan Univ, Inst Adv Studies, Wuhan, Peoples R China; [Huang, Gai] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Wu, Zhiguo; Li, Yang; Wang, Kun] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Percy, Richard G.; Frelichowski, James E.; Yu, John Z.] USDA ARS, Crop Germplasm Res Unit, Southern Plains Agr Res Ctr, College Stn, TX 77840 USA; [Bai, Mingzhou] BGI Shenzhen, BGI Genom, Shenzhen, Peoples R China; [Hu, Jiang] Next Biosci Inst, Wuhan, Peoples R China	Wuhan University; Peking University; Wuhan University; United States Department of Agriculture (USDA); Beijing Genomics Institute (BGI)	Zhu, YX (corresponding author), Wuhan Univ, Inst Adv Studies, Wuhan, Peoples R China.; Yu, JZ (corresponding author), USDA ARS, Crop Germplasm Res Unit, Southern Plains Agr Res Ctr, College Stn, TX 77840 USA.	john.yu@usda.gov; zhuyx@whu.edu.cn		Wang, Kun/0000-0001-5910-1568; Huang, Gai/0000-0003-0426-9691; Yu, John/0000-0002-7417-3102	Natural Science Foundation of China [31690090, 31690091]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS) [3091-21000-044-00D]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States Department of Agriculture, Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA))	This work was supported by grants from the Natural Science Foundation of China (grant nos. 31690090 and 31690091 to Y.Z.) and the United States Department of Agriculture, Agricultural Research Service (USDA-ARS project grant no. 3091-21000-044-00D to J.Z.Y.).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Du XM, 2018, NAT GENET, V50, P796, DOI 10.1038/s41588-018-0116-x; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Fang L, 2017, NAT GENET, V49, P1089, DOI 10.1038/ng.3887; Gao Y, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy051; GERSTEL DU, 1953, EVOLUTION, V7, P234, DOI 10.2307/2405734; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hu Y, 2019, NAT GENET, V51, P739, DOI 10.1038/s41588-019-0371-5; HUTCHINSON JB, 1954, HEREDITY, V8, P225, DOI 10.1038/hdy.1954.20; HUTCHINSON JB, 1947, EVOLUTION GOSSYPIUM; Islam MS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.223; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keilwagen J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw092; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kulkarni Venkatesh N., 2009, V3, P69, DOI 10.1007/978-0-387-70810-2_4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2018, NATURE, V557, P424, DOI 10.1038/s41586-018-0108-0; Ma ZY, 2018, NAT GENET, V50, P803, DOI 10.1038/s41588-018-0119-7; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Martin SH, 2017, GENETICS, V206, P429, DOI 10.1534/genetics.116.194720; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MENZEL MY, 1954, GENETICS, V39, P546; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Palmer SA, 2012, MOL BIOL EVOL, V29, P2031, DOI 10.1093/molbev/mss070; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pease JB, 2013, EVOLUTION, V67, P2376, DOI 10.1111/evo.12118; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Renny-Byfield S, 2016, GENOME BIOL EVOL, V8, P1940, DOI 10.1093/gbe/evw129; Schumer M, 2016, MOL ECOL, V25, P2661, DOI 10.1111/mec.13602; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stephens SG, 1944, NATURE, V153, P53, DOI 10.1038/153053a0; Sun SL, 2018, NAT GENET, V50, P1289, DOI 10.1038/s41588-018-0182-0; Teh BT, 2017, NAT GENET, V49, P1633, DOI 10.1038/ng.3972; Van Belleghem SM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0052; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang MJ, 2019, NAT GENET, V51, P224, DOI 10.1038/s41588-018-0282-x; Wang MJ, 2017, NAT GENET, V49, P579, DOI 10.1038/ng.3807; Wang S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0678-1; Watt G., 1907, WILD CULTIVATED COTT; Webber JM, 1936, SCIENCE, V84, P378, DOI 10.1126/science.84.2182.378; Wendel J. F., 2009, GENETICS GENOMICS CO, V3; Wendel J. F., 2012, POLYPLOIDY GENOME EV; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wu ZG, 2017, J GENET GENOMICS, V44, P511, DOI 10.1016/j.jgg.2017.09.009; Xiao GH, 2016, J INTEGR PLANT BIOL, V58, P577, DOI 10.1111/jipb.12429; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zahn LM, 2012, SCIENCE, V335, P1148, DOI DOI 10.1126/SCIENCE.335.6073.1148-A; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	76	123	134	10	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2020	52	5					516	+		10.1038/s41588-020-0607-4	http://dx.doi.org/10.1038/s41588-020-0607-4		APR 2020	22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LX9BG	32284579	Green Published, hybrid			2022-12-17	WOS:000526266000001
J	Despang, A; Schopflin, R; Franke, M; Ali, S; Jerkovic, I; Paliou, C; Chan, WL; Timmermann, B; Wittler, L; Vingron, M; Mundlos, S; Ibrahim, DM				Despang, Alexandra; Schoepflin, Robert; Franke, Martin; Ali, Salaheddine; Jerkovic, Ivana; Paliou, Christina; Chan, Wing-Lee; Timmermann, Bernd; Wittler, Lars; Vingron, Martin; Mundlos, Stefan; Ibrahim, Daniel M.			Functional dissection of the Sox9-Kcnj2 locus identifies nonessential and instructive roles of TAD architecture	NATURE GENETICS			English	Article							MAMMALIAN GENOMES; CHROMATIN; DOMAINS; COHESIN; CTCF; REVEALS; INACTIVATION; ORGANIZATION; INSULATION; GENERATION	The genome is organized in three-dimensional units called topologically associating domains (TADs), through a process dependent on the cooperative action of cohesin and the DNA-binding factor CTCF. Genomic rearrangements of TADs have been shown to cause gene misexpression and disease, but genome-wide depletion of CTCF has no drastic effects on transcription. Here, we investigate TAD function in vivo in mouse limb buds at the Sox9-Kcnj2 locus. We show that the removal of all major CTCF sites at the boundary and within the TAD resulted in a fusion of neighboring TADs, without major effects on gene expression. Gene misexpression and disease phenotypes, however, were achieved by redirecting regulatory activity through inversions and/or the repositioning of boundaries. Thus, TAD structures provide robustness and precision but are not essential for developmental gene regulation. Aberrant disease-related gene activation is not induced by a mere loss of insulation but requires CTCF-dependent redirection of enhancer-promoter contacts.	[Despang, Alexandra; Schoepflin, Robert; Franke, Martin; Ali, Salaheddine; Jerkovic, Ivana; Paliou, Christina; Mundlos, Stefan; Ibrahim, Daniel M.] Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany; [Despang, Alexandra; Schoepflin, Robert; Ali, Salaheddine; Jerkovic, Ivana; Paliou, Christina; Chan, Wing-Lee; Mundlos, Stefan; Ibrahim, Daniel M.] Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany; [Despang, Alexandra; Schoepflin, Robert; Ali, Salaheddine; Mundlos, Stefan; Ibrahim, Daniel M.] Charite, BCRT Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany; [Timmermann, Bernd] Max Planck Inst Mol Genet, Sequencing Core Facil, Berlin, Germany; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [Franke, Martin] Univ Pablo de Olavide, Junta de Andalucia, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Jerkovic, Ivana] CNRS, Inst Human Genet, Montpellier, France	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Max Planck Society; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mundlos, S; Ibrahim, DM (corresponding author), Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany.; Mundlos, S; Ibrahim, DM (corresponding author), Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany.; Mundlos, S; Ibrahim, DM (corresponding author), Charite, BCRT Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany.	mundlos@molgen.mpg.de; ibrahim@molgen.mpg.de	Franke, Martin/AAX-6027-2021; Mundlos, Stefan/ABH-9585-2020; Franke, Martin/O-8986-2017	Franke, Martin/0000-0002-4626-3290; Franke, Martin/0000-0002-4626-3290; Ibrahim, Daniel Murad/0000-0002-0019-3354; Jerkovic, Ivana/0000-0001-9707-8303; Paliou, Christina/0000-0003-3383-2527; Ali, Salaheddine/0000-0002-0351-1645; Mundlos, Stefan/0000-0002-9788-3166	Deutsche Forschungsgemeinschaft [KR3985/7-3, MU 880/16-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (KR3985/7-3 and MU 880/16-1 to S.M.). We thank J. Fiedler and K. Macura (transgenic unit) and M. Hochradel (sequencing core facility) of the MPIMG, A. Stiege and U. Fischer for help with cloning and cell culture, and N. Brieske for in situ hybridizations. We also thank M. Robson, F. Martinez-Real and all members of the Mundlos laboratory for input and discussions.	Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Kraft K, 2019, NAT CELL BIOL, V21, P305, DOI 10.1038/s41556-019-0273-x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Narendra V, 2016, GENE DEV, V30, P2657, DOI 10.1101/gad.288324.116; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rodriguez-Carballo E, 2017, GENE DEV, V31, P2264, DOI 10.1101/gad.307769.117; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	35	123	126	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2019	51	8					1263	+		10.1038/s41588-019-0466-z	http://dx.doi.org/10.1038/s41588-019-0466-z			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM4EE	31358994	Green Submitted			2022-12-17	WOS:000477946700013
J	He, F; Pasam, R; Shi, F; Kant, S; Keeble-Gagnere, G; Kay, P; Forrest, K; Fritz, A; Hucl, P; Wiebe, K; Knox, R; Cuthbert, R; Pozniak, C; Akhunova, A; Morrell, PL; Davies, JP; Webb, SR; Spangenberg, G; Hayes, B; Daetwyler, H; Tibbits, J; Hayden, M; Akhunov, E				He, Fei; Pasam, Raj; Shi, Fan; Kant, Surya; Keeble-Gagnere, Gabriel; Kay, Pippa; Forrest, Kerrie; Fritz, Allan; Hucl, Pierre; Wiebe, Krystalee; Knox, Ron; Cuthbert, Richard; Pozniak, Curtis; Akhunova, Alina; Morrell, Peter L.; Davies, John P.; Webb, Steve R.; Spangenberg, German; Hayes, Ben; Daetwyler, Hans; Tibbits, Josquin; Hayden, Matthew; Akhunov, Eduard			Exome sequencing highlights the role of wild-relative introgression in shaping the adaptive landscape of the wheat genome	NATURE GENETICS			English	Article							GENE FLOW; MOLECULAR CHARACTERIZATION; DELETERIOUS MUTATIONS; DOMESTICATION; DIVERSITY; PROGENITOR; SELECTION; POPULATIONS; IMPROVEMENT; EVOLUTION	Introgression is a potential source of beneficial genetic diversity. The contribution of introgression to adaptive evolution and improvement of wheat as it was disseminated worldwide remains unknown. We used targeted re-sequencing of 890 diverse accessions of hexaploid and tetraploid wheat to identify wild-relative introgression. Introgression, and selection for improvement and environmental adaptation, each reduced deleterious allele burden. Introgression increased diversity genome wide and in regions harboring major agronomic genes, and contributed alleles explaining a substantial proportion of phenotypic variation. These results suggest that historic gene flow from wild relatives made a substantial contribution to the adaptive diversity of modern bread wheat.	[He, Fei; Akhunova, Alina; Akhunov, Eduard] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Pasam, Raj; Shi, Fan; Kant, Surya; Keeble-Gagnere, Gabriel; Kay, Pippa; Forrest, Kerrie; Spangenberg, German; Hayes, Ben; Daetwyler, Hans; Tibbits, Josquin; Hayden, Matthew] Ctr AgriBiosci, AgriBio, Agr Victoria, Bundoora, Vic, Australia; [Fritz, Allan] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Hucl, Pierre; Wiebe, Krystalee; Pozniak, Curtis] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada; [Knox, Ron; Cuthbert, Richard] Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Akhunova, Alina] Kansas State Univ, Integrated Genom Facil, Manhattan, KS 66506 USA; [Morrell, Peter L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Davies, John P.; Webb, Steve R.] DowDuPont, Div Agr, Corteva Agrisci, Indianapolis, IN USA; [Spangenberg, German; Daetwyler, Hans; Tibbits, Josquin; Hayden, Matthew] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [Hayes, Ben] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	Kansas State University; La Trobe University; Kansas State University; University of Saskatchewan; Kansas State University; University of Minnesota System; University of Minnesota Twin Cities; La Trobe University; University of Queensland	Akhunov, E (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.; Hayden, M (corresponding author), Ctr AgriBiosci, AgriBio, Agr Victoria, Bundoora, Vic, Australia.; Hayden, M (corresponding author), La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia.	matthew.hayden@ecodev.vic.gov.au; eakhunov@ksu.edu	Morrell, Peter/E-2059-2011; Daetwyler, Hans D/H-9775-2019; Hayes, Ben J/L-3308-2016; FEI, HE/C-5912-2015	Morrell, Peter/0000-0001-6282-1582; Hayes, Ben J/0000-0002-5606-3970; FEI, HE/0000-0002-1165-3248; Akhunov, Eduard/0000-0002-0416-5211; Keeble-Gagnere, Gabriel/0000-0002-9165-0724; Kant, Surya/0000-0001-6178-7036; Daetwyler, Hans D/0000-0002-3018-3640; Hayden, Matthew/0000-0003-3117-5500; Pasam, Raj/0000-0003-0908-1882	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2017-67007-25939, 2016-67013-24473]; Bill and Melinda Gates Foundation; Kansas Wheat Commission; Canadian Triticum Applied Genomics grant - Genome Canada; Genome Prairie; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; US National Science Foundation [IOS-1339393]; Corteva Agriscience, Agriculture Division of DowDuPont; NSF [ACI-144054]	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Kansas Wheat Commission; Canadian Triticum Applied Genomics grant - Genome Canada; Genome Prairie; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; US National Science Foundation(National Science Foundation (NSF)); Corteva Agriscience, Agriculture Division of DowDuPont; NSF(National Science Foundation (NSF))	This project was supported by the Agriculture and Food Research Initiative Competitive Grants 2017-67007-25939 (Wheat-CAP) and 2016-67013-24473 from the USDA National Institute of Food and Agriculture, and grants from the Bill and Melinda Gates Foundation and Kansas Wheat Commission. Exome sequencing of Canadian wheat cultivars was supported through the Canadian Triticum Applied Genomics grant funded by Genome Canada, Genome Prairie, Saskatchewan Ministry of Agriculture, and the Western Grains Research Foundation. P.L.M. was supported by grant IOS-1339393 from the US National Science Foundation. Corteva Agriscience, Agriculture Division of DowDuPont provided financial support through collaboration with Agriculture Victoria Services enabling the development of the SNP dataset and technologies used in this manuscript. The authors would like to thank International Wheat Genome Sequencing Consortium for providing access to wheat genome sequence under Toronto agreement, D. Andresen for assistance with the computing resources of the KSU Beocat cluster funded by NSF grant ACI-144054 and K. Jordan for valuable suggestions and editing the manuscript.	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Dvorak J, 2011, CZECH J GENET PLANT, V47, pS20, DOI 10.17221/3249-CJGPB; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hao Y, 2018, GENOME BIOL EVOL, V10, P999, DOI 10.1093/gbe/evy061; Hardigan MA, 2017, P NATL ACAD SCI USA, V114, pE9999, DOI 10.1073/pnas.1714380114; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hubner S, 2012, MOL ECOL, V21, P1115, DOI 10.1111/j.1365-294X.2011.05434.x; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jordan KW, 2018, PLANT J, V95, P1039, DOI 10.1111/tpj.14009; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Keightley PD, 2018, GENETICS, V209, P897, DOI 10.1534/genetics.118.301120; KERBER ER, 1964, SCIENCE, V143, P253, DOI 10.1126/science.143.3603.253; Kiba T, 2016, PLANT CELL PHYSIOL, V57, P707, DOI 10.1093/pcp/pcw052; Kihara H., 1944, AGR HORTIC, V19, P13; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kono TJY, 2016, MOL BIOL EVOL, V33, P2307, DOI 10.1093/molbev/msw102; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu QP, 2017, MOL BIOL EVOL, V34, P908, DOI 10.1093/molbev/msw296; Long TW, 2018, NAT PLANTS, V4, P272, DOI 10.1038/s41477-018-0141-x; Lu GH, 2014, PLANT CELL REP, V33, P617, DOI 10.1007/s00299-014-1586-7; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; Martin SH, 2015, MOL BIOL EVOL, V32, P244, DOI 10.1093/molbev/msu269; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mezmouk S, 2014, G3-GENES GENOM GENET, V4, P163, DOI 10.1534/g3.113.008870; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Nave M, 2016, THEOR APPL GENET, V129, P1303, DOI 10.1007/s00122-016-2704-4; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nesbitt M., 1996, Hulled wheats. Proceedings of the First International Workshop on Hulled Wheats, held at Castelvecchio Pascoli, Tuscany, Italy, 21-22 July 1995., P41; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Poets AM, 2016, G3-GENES GENOM GENET, V6, P609, DOI 10.1534/g3.115.024349; Ramu P, 2017, NAT GENET, V49, P959, DOI 10.1038/ng.3845; Rendon-Anaya M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1190-6; Salojarvi J, 2017, NAT GENET, V49, P904, DOI 10.1038/ng.3862; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Smith Joel, 2013, Biol Lett, V9, P20130503, DOI 10.1098/rsbl.2013.0503; Smith O., 2014, SCIENCE, V347, P998; Stitzer MC, 2018, NEW PHYTOL, V220, P395, DOI 10.1111/nph.15350; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tanno K, 2006, SCIENCE, V311, P1886, DOI [10.1126/science.1124635, 10.1126/science.311.5769.1866a]; Thuillet AC, 2005, GENETICS, V169, P1589, DOI 10.1534/genetics.104.029553; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Wang L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1346-4; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yu XJ, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-46; Zhao YS, 2015, P NATL ACAD SCI USA, V112, P15624, DOI 10.1073/pnas.1514547112	68	123	127	5	69	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2019	51	5					896	+		10.1038/s41588-019-0382-2	http://dx.doi.org/10.1038/s41588-019-0382-2			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW7AK	31043759				2022-12-17	WOS:000466842000017
J	Klarin, D; Zhu, QM; Emdin, CA; Chaffin, M; Horner, S; McMillan, BJ; Leed, A; Weale, ME; Spencer, CCA; Aguet, F; Segre, AV; Ardlie, KG; Khera, AV; Kaushik, VK; Natarajan, P; Kathiresan, S				Klarin, Derek; Zhu, Qiuyu Martin; Emdin, Connor A.; Chaffin, Mark; Horner, Steven; McMillan, Brian J.; Leed, Alison; Weale, Michael E.; Spencer, Chris C. A.; Aguet, Francois; Segre, Ayellet V.; Ardlie, Kristin G.; Khera, Amit V.; Kaushik, Virendar K.; Natarajan, Pradeep; Kathiresan, Sekar		CARDIoGRAMplusc4d Consortium	Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NUCLEOTIDE EXCHANGE FACTOR; SUSCEPTIBILITY LOCI; PROVIDES INSIGHTS; ARCHITECTURE; RISK; METAANALYSIS; VARIANT; TRAITS	UK Biobank is among the world's largest repositories for phenotypic and genotypic information in individuals of European ancestry1. We performed a genome-wide association study in UK Biobank testing similar to 9 million DNA sequence variants for association with coronary artery disease (4,831 cases and 115,455 controls) and carried out meta-analysis with previously published results. We identified 15 new loci, bringing the total number of loci associated with coronary artery disease to 95 at the time of analysis. Phenome-wide association scanning showed that CCDC92 likely affects coronary artery disease through insulin resistance pathways, whereas experimental analysis suggests that ARHGEF26 influences the transendothelial migration of leukocytes.	[Klarin, Derek; Zhu, Qiuyu Martin; Emdin, Connor A.; Chaffin, Mark; Khera, Amit V.; Natarajan, Pradeep; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02115 USA; [Klarin, Derek; Zhu, Qiuyu Martin; Emdin, Connor A.; Chaffin, Mark; Ardlie, Kristin G.; Khera, Amit V.; Natarajan, Pradeep; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Klarin, Derek] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Horner, Steven; McMillan, Brian J.; Leed, Alison; Kaushik, Virendar K.] Broad Inst, Ctr Dev Therapeut, Cambridge, MA USA; [Weale, Michael E.; Spencer, Chris C. A.] Genom Plc, Oxford, England; [Aguet, Francois; Segre, Ayellet V.] Broad Inst, Canc Program, Cambridge, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kathiresan, S (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02115 USA.; Kathiresan, S (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	skathiresan1@mgh.harvard.edu	Weale, Michael E/F-2587-2010; Natarajan, Pradeep/H-9764-2019; Zhu, Qiuyu/M-7578-2017	Weale, Michael E/0000-0003-4593-1186; Natarajan, Pradeep/0000-0001-8402-7435; Chaffin, Mark/0000-0002-1234-5562; Aguet, Francois/0000-0001-9414-300X; Klarin, Derek/0000-0002-4636-5780; Zhu, Qiuyu/0000-0003-2751-7985	National Heart, Lung, and Blood Institute of the US National Institutes of Health [T32 HL007734]; John S. LaDue Memorial Fellowship in Cardiology at Harvard Medical School; KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst - US National Institutes of Health [TR001100]; Ofer and Shelly Nemirovsky Research Scholar award from Massachusetts General Hospital (MGH); Donovan Family Foundation; US National Institutes of Health [R01 HL127564]; Medical Research Council [MC_qA137853] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734, R01HL127564] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); John S. LaDue Memorial Fellowship in Cardiology at Harvard Medical School; KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst - US National Institutes of Health; Ofer and Shelly Nemirovsky Research Scholar award from Massachusetts General Hospital (MGH); Donovan Family Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research has been conducted using the UK Biobank resource, application 7089. The PheWAS carried out by Genomics plc was also conducted using the UK Biobank resource under a separate agreement. The authors thank K. Burridge and E. Wittchen for technical advice on the leukocyte transendothelial migration assay. This analysis was supported by the National Heart, Lung, and Blood Institute of the US National Institutes of Health under award number T32 HL007734 (D.K.), the John S. LaDue Memorial Fellowship in Cardiology at Harvard Medical School (P.N.), the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst funded by the US National Institutes of Health (TR001100) (A.V.K.), the Ofer and Shelly Nemirovsky Research Scholar award from Massachusetts General Hospital (MGH), the Donovan Family Foundation, and US National Institutes of Health grant R01 HL127564 (S. K.). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Aguet F., 2016, LOCAL GENETIC EFFECT; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Howson JMM, 2017, NAT GENET; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Khera AV, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2016.160; Lee VS, 2016, P NATL ACAD SCI USA, V113, P8759, DOI 10.1073/pnas.1601442113; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Maass PG, 2015, NAT GENET, V47, P647, DOI 10.1038/ng.3302; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nioi P, 2016, NEW ENGL J MED, V374, P2131, DOI 10.1056/NEJMoa1508419; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055202; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Stitziel NO., 2016, NEW ENGL J MED, V374, P1134; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zahedi F, 2017, CELL MOL LIFE SCI, V74, P359, DOI 10.1007/s00018-016-2349-0	45	123	124	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2017	49	9					1392	+		10.1038/ng.3914	http://dx.doi.org/10.1038/ng.3914			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FF1PS	28714974	Green Accepted, Green Submitted			2022-12-17	WOS:000408672000018
J	Malmstrom, M; Matschiner, M; Torresen, OK; Star, B; Snipen, LG; Hansen, TF; Baalsrud, HT; Nederbragt, AJ; Hanel, R; Salzburger, W; Stenseth, NC; Jakobsen, KS; Jentoft, S				Malmstrom, Martin; Matschiner, Michael; Torresen, Ole K.; Star, Bastiaan; Snipen, Lars G.; Hansen, Thomas F.; Baalsrud, Helle T.; Nederbragt, Alexander J.; Hanel, Reinhold; Salzburger, Walter; Stenseth, Nils C.; Jakobsen, Kjetill S.; Jentoft, Sissel			Evolution of the immune system influences speciation rates in teleost fishes	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; SEXUAL SELECTION; ANTIGEN PRESENTATION; ADAPTIVE IMMUNITY; MATE CHOICE; ADAPTATION; GENOME; POLYMORPHISM; GENES	Teleost fishes constitute the most species-rich vertebrate clade and exhibit extensive genetic and phenotypic variation, including diverse immune defense strategies. The genomic basis of a particularly aberrant strategy is exemplified by Atlantic cod, in which a loss of major histocompatibility complex (MHC) II functionality coincides with a marked expansion of MHC I genes. Through low-coverage genome sequencing (9-39x), assembly and comparative analyses for 66 teleost species, we show here that MHC II is missing in the entire Gadiformes lineage and thus was lost once in their common ancestor. In contrast, we find that MHC I gene expansions have occurred multiple times, both inside and outside this clade. Moreover, we identify an association between high MHC I copy number and elevated speciation rates using trait-dependent diversification models. Our results extend current understanding of the plasticity of the adaptive immune system and suggest an important role for immune-related genes in animal diversification.	[Malmstrom, Martin; Matschiner, Michael; Torresen, Ole K.; Star, Bastiaan; Hansen, Thomas F.; Baalsrud, Helle T.; Nederbragt, Alexander J.; Salzburger, Walter; Stenseth, Nils C.; Jakobsen, Kjetill S.; Jentoft, Sissel] Univ Oslo, Dept Biosci, Oslo, Norway; [Snipen, Lars G.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Hanel, Reinhold] Fed Res Inst Rural Areas Forestry & Fisheries, Inst Fisheries Ecol, Hamburg, Germany; [Salzburger, Walter] Univ Basel, Inst Zool, Basel, Switzerland; [Stenseth, Nils C.] Flodevigen Marine Res Stn, Inst Marine Res, His, Norway; [Stenseth, Nils C.; Jentoft, Sissel] Univ Agder, Dept Nat Sci, Kristiansand, Norway	University of Oslo; Norwegian University of Life Sciences; University of Basel; Institute of Marine Research - Norway; University of Agder	Jakobsen, KS; Jentoft, S (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.; Jentoft, S (corresponding author), Univ Agder, Dept Nat Sci, Kristiansand, Norway.	k.s.jakobsen@ibv.uio.no; sissel.jentoft@ibv.uio.no	Hansen, Thomas/GWZ-2858-2022; Hanel, Reinhold/AAO-4887-2021	Jentoft, Sissel/0000-0001-8707-531X; Matschiner, Michael/0000-0003-4741-3884; Baalsrud, Helle Tessand/0000-0002-4161-3247; Torresen, Ole Kristian/0000-0002-1932-8212; Star, Bastiaan/0000-0003-0235-9810; Nederbragt, Lex/0000-0001-5539-0999	Research Council of Norway (RCN grant) [199806, 222378]; Swiss National Science Foundation (SNF grant) [PBBSP3-138680]; German Federal Ministry of Food and Agriculture (grant AutoMAT) [2819100712]; European Research Council (ERC)	Research Council of Norway (RCN grant); Swiss National Science Foundation (SNF grant); German Federal Ministry of Food and Agriculture (grant AutoMAT); European Research Council (ERC)(European Research Council (ERC))	All computational work was performed on the Abel Supercomputing Cluster (Norwegian Metacenter for High-Performance Computing (NOTUR) and the University of Oslo), operated by the Research Computing Services group at USIT, the University of Oslo IT Department. Sequencing library creation and high-throughput sequencing were carried out at the Norwegian Sequencing Centre (NSC), University of Oslo, Norway, and the McGill University and Genome Queeec Innovation Centre, Canada. We are grateful for the kindness of the following researchers for providing tissue samples for this study: K. Ostbye (University of Oslo), F. Cortesi (University of Queensland), J.Y. Poulsen (Greenland Institute of Natural Resources), M. Miya (Natural History Museum and Institute, Chiba University), A. Bentley (University of Kansas Biodiversity Institute), I. Kilde (Norwegian University of Science and Technology, Trondheim), I.R. Bradbury (Memorial University), C. Pampoulie (Marine Research Institute of Iceland) and L. Ruber (Natural History Museum, Bern). This work was funded by grants from the Research Council of Norway (RCN grants 199806 and 222378) to K.S.J. M. Matschiner acknowledges funding from the Swiss National Science Foundation (SNF grant PBBSP3-138680), R.H. acknowledges funding from the German Federal Ministry of Food and Agriculture (grant AutoMAT, 2819100712) and W.S. acknowledges funding from the European Research Council (ERC). We thank G. Holm (University of Oslo) for the teleost illustrations, and B. Walenz and J.R. Miller for assistance with the Celera Assembler.	Aeschlimann PB, 2003, BEHAV ECOL SOCIOBIOL, V54, P119, DOI 10.1007/s00265-003-0611-6; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Buonocore F, 2016, MOL IMMUNOL, V69, P157, DOI 10.1016/j.molimm.2015.09.003; Chen W.-J., 2014, FRONT MATER SCI, V1, pe215; Dijkstra JM, 2007, IMMUNOGENETICS, V59, P305, DOI 10.1007/s00251-007-0198-6; Eizaguirre C, 2010, J FISH BIOL, V77, P2023, DOI 10.1111/j.1095-8649.2010.02819.x; Eizaguirre C, 2012, ECOL LETT, V15, P723, DOI 10.1111/j.1461-0248.2012.01791.x; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Eschmeyer WN, 2016, CATALOG OF FISHES; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Grimholt U, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0309-1; Haase D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0044; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kalbe M, 2009, P ROY SOC B-BIOL SCI, V276, P925, DOI 10.1098/rspb.2008.1466; Karvonen Anssi, 2012, International Journal of Ecology, P1; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kruiswijk CP, 2002, J IMMUNOL, V169, P1936, DOI 10.4049/jimmunol.169.4.1936; Labra A, 2009, AM NAT, V174, P204, DOI 10.1086/600088; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Malmstrom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074004; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Miya M, 2007, ICHTHYOL RES, V54, P323, DOI 10.1007/s10228-007-0408-0; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Ohta Y, 2015, IMMUNOL REV, V267, P6, DOI 10.1111/imr.12324; Parham P, 2015, IMMUNOL REV, V267, P1, DOI 10.1111/imr.12338; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pascual-Anaya J, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-26; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Star B, 2012, BIOESSAYS, V34, P648, DOI 10.1002/bies.201200005; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stet RJM, 2003, CRIT REV IMMUNOL, V23, P441; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174	45	123	125	3	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2016	48	10					1204	1210		10.1038/ng.3645	http://dx.doi.org/10.1038/ng.3645			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX5AG	27548311	Green Accepted, Green Published, hybrid			2022-12-17	WOS:000384391600015
J	Pradeepa, MM; Grimes, GR; Kumar, Y; Olley, G; Taylor, GCA; Schneider, R; Bickmore, WA				Pradeepa, Madapura M.; Grimes, Graeme R.; Kumar, Yatendra; Olley, Gabrielle; Taylor, Gillian C. A.; Schneider, Robert; Bickmore, Wendy A.			Histone H3 globular domain acetylation identifies a new class of enhancers	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; LATERAL SURFACE; GENES; SIGNATURES; TRITHORAX; DISTINCT; H3K27	Histone acetylation is generally associated with active chromatin, but most studies have focused on the acetylation of histone tails. Various histone H3 and H4 tail acetylations mark the promoters of active genes(1). These modifications include acetylation of histone H3 at lysine 27 (H3K27ac), which blocks Polycomb-mediated trimethylation of H3K27 (H3K27me3)(2). H3K27ac is also widely used to identify active enhancers(3,4), and the assumption has been that profiling H3K27ac is a comprehensive way of cataloguing the set of active enhancers in mammalian cell types. Here we show that acetylation of lysine residues in the globular domain of histone H3 (lysine 64 (H3K64ac) and lysine 122 (H3K122ac)) marks active gene promoters and also a subset of active enhancers. Moreover, we find a new class of active functional enhancers that is marked by H3K122ac but lacks H3K27ac. This work suggests that, to identify enhancers, a more comprehensive analysis of histone acetylation is required than has previously been considered.	[Pradeepa, Madapura M.; Grimes, Graeme R.; Kumar, Yatendra; Olley, Gabrielle; Taylor, Gillian C. A.; Bickmore, Wendy A.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Pradeepa, Madapura M.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Schneider, Robert] Univ Strasbourg, INSERM U964, CNRS UMR 7104, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Schneider, Robert] Helmholtz Zentrum Munchen, Inst Funct Epigenet, Neuherberg, Germany	University of Edinburgh; University of Essex; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pradeepa, MM; Bickmore, WA (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Pradeepa, MM (corresponding author), Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England.	pmadap@essex.ac.uk; wendy.bickmore@igmm.ed.ac.uk	madapura, Pradeepa/AAS-1288-2020	madapura, Pradeepa/0000-0001-9095-9247	Medical Research Council UK; European Research Council advanced grant [249956]; Fondation pour la Recherche Medicale (FRM); Agence Nationale de Recherche (ANR); La Ligue National Contre La Cancer (Equipe Labellise); INSERM Plan Cancer (Epigenetique et Cancer); Agence Nationale de Recherche (CoreAc); MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202, 1584120] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council advanced grant(European Research Council (ERC)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); La Ligue National Contre La Cancer (Equipe Labellise); INSERM Plan Cancer (Epigenetique et Cancer); Agence Nationale de Recherche (CoreAc)(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Illingworth, R. Young and P. Tropberger for discussions, U. Basu (Albert Einstein College of Medicine) for sharing mapped RNA-seq data from Exosc3<SUP>-/-</SUP> mESCs and S. Qi (Stanford University) for sharing a CRISPR gRNA plasmid backbone. This work was supported by the Medical Research Council UK and by European Research Council advanced grant 249956 (W.A.B.). Work in the laboratory of R.S. is supported by the Fondation pour la Recherche Medicale (FRM), the Agence Nationale de Recherche (ANR, CoreAc), La Ligue National Contre La Cancer (Equipe Labellise) and INSERM Plan Cancer (Epigenetique et Cancer).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bogu GK, 2016, MOL CELL BIOL, V36, P809, DOI 10.1128/MCB.00955-15; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim TW, 2015, STEM CELLS, V33, P2442, DOI 10.1002/stem.2046; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pradeepa MM, 2014, NUCLEIC ACIDS RES, V42, P9021, DOI 10.1093/nar/gku647; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravens S, 2014, ELIFE, V3, DOI 10.7554/eLife.02104; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Tie F, 2014, DEVELOPMENT, V141, P1129, DOI 10.1242/dev.102392; Tropberger P, 2013, NAT STRUCT MOL BIOL, V20, P657, DOI 10.1038/nsmb.2581; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	123	130	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					681	+		10.1038/ng.3550	http://dx.doi.org/10.1038/ng.3550			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27089178	Green Accepted			2022-12-17	WOS:000376744200017
J	Lim, WK; Ong, CK; Tan, J; Thike, AA; Young Ng, CC; Rajasegaran, V; Myint, SS; Nagarajan, S; Md Nasir, ND; McPherson, JR; Cutcutache, I; Poore, G; Tay, ST; Ooi, WS; Tan, VKM; Hartman, M; Ong, KW; Tan, BKT; Rozen, SG; Tan, PH; Tan, P; Teh, BT				Lim, Weng Khong; Ong, Choon Kiat; Tan, Jing; Thike, Aye Aye; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Nasir, Nur Diyana Md; McPherson, John R.; Cutcutache, Ioana; Poore, Gregory; Tay, Su Ting; Ooi, Wei Siong; Tan, Veronique Kiak Mien; Hartman, Mikael; Ong, Kong Wee; Tan, Benita K. T.; Rozen, Steven G.; Tan, Puay Hoon; Tan, Patrick; Teh, Bin Tean			Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma	NATURE GENETICS			English	Article							PHYLLODES TUMOR; CANCER; RISK; GENE; LANDSCAPE	Fibroadenomas are the most common breast tumors in women under 30 (refs. 1,2). Exome sequencing of eight fibroadenomas with matching whole-blood samples revealed recurrent somatic mutations solely in MED12, which encodes a Mediator complex subunit. Targeted sequencing of an additional 90 fibroadenomas confirmed highly frequent MED12 exon 2 mutations (58/98, 59%) that are probably somatic, with 71% of mutations occurring in codon 44. Using laser capture microdissection, we show that MED12 fibroadenoma mutations are present in stromal but not epithelial mammary cells. Expression profiling of MED12-mutated and wild-type fibroadenomas revealed that MED12 mutations are associated with dysregulated estrogen signaling and extracellular matrix organization. The fibroadenoma MED12 mutation spectrum is nearly identical to that of previously reported MED12 lesions in uterine leiomyoma but not those of other tumors. Benign tumors of the breast and uterus, both of which are key target tissues of estrogen, may thus share a common genetic basis underpinned by highly frequent and specific MED12 mutations.	[Lim, Weng Khong; Ong, Choon Kiat; Tan, Jing; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Teh, Bin Tean] Natl Canc Ctr, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Lim, Weng Khong; Ong, Choon Kiat; Tan, Jing; Ng, Cedric Chuan Young; Rajasegaran, Vikneswari; Myint, Swe Swe; Nagarajan, Sanjanaa; Tay, Su Ting; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore, Grad Sch Med, Div Canc & Stem Cell Biol, Singapore, Singapore; [Thike, Aye Aye; Nasir, Nur Diyana Md; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [McPherson, John R.; Cutcutache, Ioana; Rozen, Steven G.] Duke NUS Grad Med Sch, Div Neurosci & Behav Disorders, Singapore, Singapore; [Poore, Gregory] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Ooi, Wei Siong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Tan, Veronique Kiak Mien; Ong, Kong Wee] Natl Canc Ctr, Div Surg Oncol, Singapore, Singapore; [Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Tan, Benita K. T.] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick; Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; National University of Singapore; Duke University; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Teh, BT (corresponding author), Natl Canc Ctr, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.	steve.rozen@duke-nus.edu.sg; tan.puay.hoon@sgh.com.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Lim, Weng Khong/Q-8661-2019; Rozen, Steven G./J-5939-2013; Hartman, Mikael/B-4324-2011	Lim, Weng Khong/0000-0003-4391-1130; Ong, Choon Kiat/0000-0001-6402-4288; Myint, Swe Swe/0000-0002-2430-088X; Tan, Jing/0000-0002-4605-4624; Rozen, Steven G./0000-0002-4288-0056; Hartman, Mikael/0000-0001-5726-9965; Teh, Bin Tean/0000-0003-1514-1124	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore Millennium Foundation; Lee Foundation; Tanoto Foundation; Singapore National Cancer Centre Research Fund; Duke-NUS Graduate Medical School; Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); Lee Foundation; Tanoto Foundation; Singapore National Cancer Centre Research Fund; Duke-NUS Graduate Medical School(National University of Singapore); Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong	This work was supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), the Singapore Millennium Foundation, the Lee Foundation, the Tanoto Foundation, the Singapore National Cancer Centre Research Fund, the Duke-NUS Graduate Medical School, the Cancer Science Institute, Singapore and the Verdant Foundation, Hong Kong. We thank the Duke-NUS Genome Biology Facility for sequencing services rendered, as well as the Advanced Molecular Pathology Laboratory, Institute of Molecular and Cell Biology, A*STAR, Singapore for providing LCM resources. We also thank the SingHealth Tissue Repository for frozen tissue samples.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardes J R M Jr, 2003, Breast J, V9, P302, DOI 10.1046/j.1524-4741.2003.09410.x; DUPONT WD, 1994, NEW ENGL J MED, V331, P10, DOI 10.1056/NEJM199407073310103; Fine RE, 2003, AM J SURG, V186, P362, DOI 10.1016/S0002-9610(03)00263-0; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco N, 2001, CANCER RES, V61, P7955; Harper PS, 2011, HUM GENET, V130, P169, DOI 10.1007/s00439-011-1013-x; Je EM, 2012, INT J CANCER, V131, pE1044, DOI 10.1002/ijc.27610; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krishnamurthy S, 2000, CANCER CYTOPATHOL, V90, P342, DOI 10.1002/1097-0142(20001225)90:6<342::AID-CNCR4>3.3.CO;2-9; Liu XF, 2011, SCAND J SURG, V100, P147, DOI 10.1177/145749691110000302; Makinen N, 2014, INT J CANCER, V134, P1008, DOI 10.1002/ijc.28410; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; MILLIKAN R, 1995, J CLIN ONCOL, V13, P2293, DOI 10.1200/JCO.1995.13.9.2293; Nelson ZC, 2002, AM J EPIDEMIOL, V156, P599, DOI 10.1093/aje/kwf094; NOGUCHI S, 1993, CANCER RES, V53, P4071; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vorkas PA, 2010, J MOL DIAGN, V12, P697, DOI 10.2353/jmoldx.2010.100008; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	27	123	125	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					877	880		10.1038/ng.3037	http://dx.doi.org/10.1038/ng.3037			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038752				2022-12-17	WOS:000339704400017
J	Lin, ZM; Bei, JX; Shen, MX; Li, QX; Liao, ZT; Zhang, YL; Lv, Q; Wei, QJ; Low, HQ; Guo, YM; Cao, SY; Yang, MC; Hu, ZY; Xu, ML; Wang, XW; Wei, YL; Li, L; Li, C; Li, TW; Huang, JL; Pan, YF; Jin, O; Wu, YQ; Wu, J; Guo, ZS; He, PG; Hu, SX; Wu, HS; Song, H; Zhan, F; Liu, SY; Gao, GM; Liu, ZS; Li, YN; Xiao, CH; Li, J; Ye, ZZ; He, WZ; Liu, DZ; Shen, LX; Huang, AB; Wu, HL; Tao, Y; Pan, XP; Yu, BY; Tai, ES; Zeng, YX; Ren, EC; Shen, Y; Liu, JJ; Gu, JR				Lin, Zhiming; Bei, Jin-Xin; Shen, Meixin; Li, Qiuxia; Liao, Zetao; Zhang, Yanli; Lv, Qing; Wei, Qiujing; Low, Hui-Qi; Guo, Yun-Miao; Cao, Shuangyan; Yang, Mingcan; Hu, Zaiying; Xu, Manlong; Wang, Xinwei; Wei, Yanlin; Li, Li; Li, Chao; Li, Tianwang; Huang, Jianlin; Pan, Yunfeng; Jin, Ou; Wu, Yuqiong; Wu, Jing; Guo, Zishi; He, Peigen; Hu, Shaoxian; Wu, Husheng; Song, Hui; Zhan, Feng; Liu, Shengyun; Gao, Guanmin; Liu, Zhangsuo; Li, Yinong; Xiao, Changhong; Li, Juan; Ye, Zhizhong; He, Weizhen; Liu, Dongzhou; Shen, Lingxun; Huang, Anbin; Wu, Henglian; Tao, Yi; Pan, Xieping; Yu, Buyun; Tai, E. Shyong; Zeng, Yi-Xin; Ren, Ee Chee; Shen, Yan; Liu, Jianjun; Gu, Jieruo			A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis	NATURE GENETICS			English	Article							HLA-B27; POPULATION; MATURATION; VARIANTS; SUBTYPES; PROTEIN; ERAP1	To identify susceptibility loci for ankylosing spondylitis, we performed a two-stage genome-wide association study in Han Chinese. In the discovery stage, we analyzed 1,356,350 autosomal SNPs in 1,837 individuals with ankylosing spondylitis and 4,231 controls; in the validation stage, we analyzed 30 suggestive SNPs in an additional 2,100 affected individuals and 3,496 controls. We identified two new susceptibility loci between EDIL3 and HAPLN1 at 5q14.3 (rs4552569; P = 8.77 x 10(-10)) and within ANO6 at 12q12 (rs17095830; P = 1.63 x 10(-8)). We also confirmed previously reported associations in Europeans within the major histocompatibility complex (MHC) region (top SNP, rs13202464; P < 5 x 10(-324)) and at 2p15 (rs10865331; P = 1.98 x 10(-8)). We show that rs13202464 within the MHC region mainly represents the risk effect of HLA-B*27 variants (including HLA-B*2704, HLA-B*2705 and HLA-B*2715) in Chinese. The two newly discovered loci implicate genes related to bone formation and cartilage development, suggesting their potential involvement in the etiology of ankylosing spondylitis.	[Lin, Zhiming; Li, Qiuxia; Liao, Zetao; Zhang, Yanli; Lv, Qing; Wei, Qiujing; Cao, Shuangyan; Yang, Mingcan; Hu, Zaiying; Xu, Manlong; Wang, Xinwei; Wei, Yanlin; Li, Li; Li, Chao; Li, Tianwang; Huang, Jianlin; Pan, Yunfeng; Jin, Ou; Wu, Yuqiong; Wu, Jing; Guo, Zishi; Yu, Buyun; Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China; [Bei, Jin-Xin; Guo, Yun-Miao; Zeng, Yi-Xin] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Meixin] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Low, Hui-Qi; Liu, Jianjun] ASTAR, Agcy Sci, Genome Inst Singapore, Singapore, Singapore; [He, Peigen; Hu, Shaoxian] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol & Rheumatol, Tongji Hosp, Wuhan, Hubei, Peoples R China; [Wu, Husheng; Song, Hui] Beijing Jishuitan Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Zhan, Feng] Hainan Prov Peoples Hosp, Dept Rheumatol, Hainan, Peoples R China; [Liu, Shengyun; Gao, Guanmin; Liu, Zhangsuo] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol & Rheumatol, Zhengzhou, Henan, Peoples R China; [Li, Yinong] Fuzhou Gen Hosp Nanjing Mil Command, Dept Rheumatol, Fuzhou, Peoples R China; [Xiao, Changhong] Hosp Integrated Tradit Chinese Med, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China; [Xiao, Changhong] Western Med So Med Univ, Guangzhou, Guangdong, Peoples R China; [Li, Juan] So Med Univ, Nanfang Hosp, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China; [Ye, Zhizhong; He, Weizhen] Guangdong Med Coll, Shenzhen Rheumatol Inst, Peoples Hosp Shenzhen 4, Xiangmihu Rheumatol Branch, Shenzhen, Peoples R China; [Liu, Dongzhou] Jinan Univ, Clin Med Coll 2, Dept Rheumatol & Immunol, Shenzhen Peoples Hosp, Shenzhen, Peoples R China; [Shen, Lingxun; Huang, Anbin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Immunol & Rheumatol, Wuhan, Hubei, Peoples R China; [Tao, Yi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China; [Pan, Xieping] Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Rheumatol & Immunol, Suzhou, Jiangsu, Peoples R China; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Ren, Ee Chee] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Ren, Ee Chee] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Shen, Yan] Tsinghua Univ, Peking Union Med Coll, Beijing 100084, Peoples R China; [Shen, Yan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Liu, Jianjun] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Huazhong University of Science & Technology; Zhengzhou University; Southern Medical University - China; Guangdong Medical University; Jinan University; Huazhong University of Science & Technology; Guangzhou Medical University; Soochow University - China; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Anhui Medical University	Gu, JR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510275, Guangdong, Peoples R China.	liuj3@gis.a-star.edu.sg; gujieruo@163.com	Tai, E Shyong/J-9831-2013; Liu, Jianjun/AAK-4989-2020; Bei, Jin-Xin/AAO-1259-2020; gao, guanmin/S-6403-2019	Liu, Jianjun/0000-0002-3255-3019; gao, guanmin/0000-0001-7458-8378; Shen, Meixin/0000-0003-1757-2753; gu, jieruo/0000-0002-8785-0600; Li, Tian-wang/0000-0001-6438-2691; Tai, E Shyong/0000-0003-2929-8966	China National Funds for Distinguished Young Scientists [30325019]; National Natural Science Foundation of China [30571735]; Clinical Subject of the Ministry of Public Health of China; Foundation of Guangdong Province of China [2005A30801005, 2009B080701086]; Foundation of Guangzhou of China [2006Z2-E0221]; Sun Yat-sen University; Agency of Science, Technology and Research (A<SUP>star</SUP>STAR) of Singapore	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Subject of the Ministry of Public Health of China; Foundation of Guangdong Province of China; Foundation of Guangzhou of China; Sun Yat-sen University; Agency of Science, Technology and Research (A<SUP>star</SUP>STAR) of Singapore	We thank all participants recruited for this study. We also thank Y. Xie, X. Guo, Q. Li, L. Zhao, S. Zhang, Z. Huang and Z. Guo for providing suggestions and for their help in the recruitment of subjects. This work was funded by China National Funds for Distinguished Young Scientists (30325019), The National Natural Science Foundation of China (30571735), Clinical Subject of the Ministry of Public Health of China (2007, 2010), the Foundation of Guangdong Province of China (2005A30801005, 2009B080701086), the Foundation of Guangzhou of China (2006Z2-E0221), 5010 Subject of Sun Yat-sen University (2009-2010) and the Agency of Science, Technology and Research (A<SUP>star</SUP>STAR) of Singapore.	Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Boonen A, 2006, NAT CLIN PRACT RHEUM, V2, P546, DOI 10.1038/ncprheum0297; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Chen C, 2012, RHEUMATOL INT, V32, P15, DOI 10.1007/s00296-010-1566-3; Cheng S, 2007, SEMIN ARTHRITIS RHEU, V37, P39, DOI 10.1016/j.semarthrit.2007.01.003; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Glantschnig H, 2010, J BIOL CHEM, V285, P40135, DOI 10.1074/jbc.M110.166892; GonzalezRoces S, 1997, TISSUE ANTIGENS, V49, P116, DOI 10.1111/j.1399-0039.1997.tb02724.x; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hou TY, 2007, INTERN MED J, V37, P749, DOI 10.1111/j.1445-5994.2007.01450.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Liu X, 2010, RHEUMATOL INT, V30, P587, DOI 10.1007/s00296-009-1018-0; Liu Y, 2010, TISSUE ANTIGENS, V75, P61, DOI 10.1111/j.1399-0039.2009.01379.x; Montserrat V, 2006, J IMMUNOL, V177, P7015, DOI 10.4049/jimmunol.177.10.7015; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pozzi S, 1999, TISSUE ANTIGENS, V53, P275, DOI 10.1034/j.1399-0039.1999.530308.x; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Saleki K, 2006, ANTIOXID REDOX SIGN, V8, P292, DOI 10.1089/ars.2006.8.292; Sieper J, 2008, ARTHRITIS RHEUM-US, V58, P649, DOI 10.1002/art.23260; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takai A, 2010, DEVELOPMENT, V137, P3293, DOI 10.1242/dev.051136; Tew SR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2311; Uderhardt S, 2010, ANN RHEUM DIS, V69, P592, DOI 10.1136/ard.2008.102046; Urano T, 2011, EUR SPINE J, V20, P572, DOI 10.1007/s00586-010-1598-0; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P3063, DOI 10.1002/art.23901; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	39	123	130	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					73	U104		10.1038/ng.1005	http://dx.doi.org/10.1038/ng.1005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22138694				2022-12-17	WOS:000298664000017
J	Barton, A; Thomson, W; Ke, X; Eyre, S; Hinks, A; Bowes, J; Plant, D; Gibbons, LJ; Wilson, AG; Bax, DE; Morgan, AW; Emery, P; Steer, S; Hocking, L; Reid, DM; Wordsworth, P; Harrison, P; Worthington, J				Barton, Anne; Thomson, Wendy; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Plant, Darren; Gibbons, Laura J.; Wilson, Anthony G.; Bax, Deborah E.; Morgan, Ann W.; Emery, Paul; Steer, Sophia; Hocking, Lynne; Reid, David M.; Wordsworth, Paul; Harrison, Pille; Worthington, Jane		Wellcome Trust Case Control Consor; Year Consortium; BIRAC Consortium	Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; PATHWAY; 6Q23; RISK	The WTCCC study identified 49 SNPs putatively associated with rheumatoid arthritis at P = 1 x 10(-4) - 1 x 10(-5) (tier 3). Here we show that three of these SNPs, mapping to chromosome 10p15 (rs4750316), 12q13 (rs1678542) and 22q13 (rs3218253), are also associated (trend P = 4 x 10(-5), P = 4 x 10(-4) and P = 4 x 10(-4), respectively) in a validation study of 4,106 individuals with rheumatoid arthritis and an expanded reference group of 11,238 subjects, confirming them as true susceptibility loci in individuals of European ancestry.	[Barton, Anne; Thomson, Wendy; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Plant, Darren; Gibbons, Laura J.; Worthington, Jane] Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Wilson, Anthony G.; Bax, Deborah E.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; [Morgan, Ann W.; Emery, Paul] Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Steer, Sophia] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London SE5 9RS, England; [Hocking, Lynne; Reid, David M.] Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland; [Wordsworth, Paul; Harrison, Pille] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford OX3 7LD, England	University of Manchester; University of Sheffield; Chapel Allerton Hospital; University of Leeds; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Aberdeen; University of Oxford	Barton, A (corresponding author), Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Stopford Bldg, Manchester, Lancs, England.	anne.barton@manchester.ac.uk	Breen, Gerome/Y-2706-2019; Worthington, Jane/M-9770-2014; Ke, Xiayi/C-7674-2009; eyre, stephen/K-3776-2017; Dominiczak, Anna F/P-9390-2017; Barton, Anne/N-2053-2014; Bowes, John/B-3472-2015; Breen, Gerome D/A-5540-2010; emery, paul/B-3560-2013; Hinks, Anne/E-1853-2015; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Breen, Gerome/0000-0003-2053-1792; Worthington, Jane/0000-0003-0544-042X; eyre, stephen/0000-0002-1251-6974; Dominiczak, Anna F/0000-0003-4913-3608; Barton, Anne/0000-0003-3316-2527; Bowes, John/0000-0003-4659-031X; Breen, Gerome D/0000-0003-2053-1792; Hinks, Anne/0000-0001-8843-3967; Packham, Jon/0000-0001-5531-1680; Weedon, Michael/0000-0002-6174-6135; Hensor, Elizabeth/0000-0002-5245-4755; Hattersley, Andrew/0000-0001-5620-473X; Lango Allen, Hana/0000-0002-7803-8688; Young-Min, Steven/0000-0001-8270-6207; Parkes, Miles/0000-0002-6467-0631; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Dunger, Professor David/0000-0002-2566-9304; Hyrich, Kimme/0000-0001-8242-9262; Munroe, Patricia/0000-0002-4176-2947; Harrison, Pille/0000-0003-4117-6910; Potter, Simon/0000-0003-4208-4102; Lindgren, Cecilia/0000-0002-4903-9374; Hocking, Lynne J/0000-0002-2414-2826; McInnes, Iain/0000-0002-6462-4280; Zeggini, Eleftheria/0000-0003-4238-659X; Thomson, Wendy/0000-0002-9022-5179; Lees, Charlie/0000-0002-0732-8215; Gaffney, Karl/0000-0002-7863-9176; Morgan, Ann/0000-0003-1109-624X; Conaghan, Philip/0000-0002-3478-5665; Wilson, Anthony Gerard/0000-0003-4855-3926	Arthritis Research Campaign [17552]; National Health Service (NHS) Research and Development; Guy's and St Thomas' and Lewisham NHS Trusts; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; European Community's Sixth Framework Programme Autocure; Medical Research Council [G0600329] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish; MRC [G0000934, G0600329] Funding Source: UKRI	Arthritis Research Campaign(Versus Arthritis); National Health Service (NHS) Research and Development; Guy's and St Thomas' and Lewisham NHS Trusts; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community's Sixth Framework Programme Autocure(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Arthritis Research Campaign for their support (arc grant reference no. 17552). We would also like to acknowledge the National Health Service (NHS) Research and Development Support Fund for Guy's and St Thomas' and Lewisham NHS Trusts. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. We thank the YEAR consortium for allowing us access to their DNA collection. D. P. is supported by the European Community's Sixth Framework Programme Autocure funding. Information-technology support was provided by P. Steer and technical support by P. Gilbert, B. Lad and S. G. Martin. Nursing support was provided by J. Grumley, J. Shotton and C. Farrar.	Barton A, 2008, HUM MOL GENET, V17, P2274, DOI 10.1093/hmg/ddn128; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Niiro H, 2003, IMMUNITY, V19, P637, DOI 10.1016/S1074-7613(03)00303-0; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200	12	123	127	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1156	1159		10.1038/ng.218	http://dx.doi.org/10.1038/ng.218			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794857	Green Accepted			2022-12-17	WOS:000259651000012
J	Todd, JA				Todd, JA			Statistical false positive or true disease pathway?	NATURE GENETICS			English	Editorial Material							GENOME-WIDE ASSOCIATION; TYPE-1 DIABETES LOCUS; PARKINSON-DISEASE; GENE; VARIANT; RISK; SUSCEPTIBILITY; POLYMORPHISM; PROBABILITY; HAPLOTYPE		Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab,Addenbrooke, Cambridge Inst Med Res,Wellcome Trust Med Res Cou, Cambridge CB2 2XY, England	University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab,Addenbrooke, Cambridge Inst Med Res,Wellcome Trust Med Res Cou, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; BRASSAT D, 2006, GENES IMMUN; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GROVES CJ, IN PRESS DIABETES; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Manly KF, 2004, GENOME RES, V14, P997, DOI 10.1101/gr.2156804; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Raymond CK, 2005, GENOMICS, V86, P759, DOI 10.1016/j.ygeno.2005.08.013; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; 1999, NAT GENET, V22, P1; 2005, NAT GENET, V37, P1153	26	123	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2006	38	7					731	733		10.1038/ng0706-731	http://dx.doi.org/10.1038/ng0706-731			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804532				2022-12-17	WOS:000238669300002
J	Slotkin, RK; Freeling, M; Lisch, D				Slotkin, RK; Freeling, M; Lisch, D			Heritable transposon silencing initiated by a naturally occurring transposon inverted duplication	NATURE GENETICS			English	Article							RNA INTERFERENCE; DELETION DERIVATIVES; CYTOSINE METHYLATION; MUTATOR TRANSPOSONS; DNA METHYLATION; TANDEM REPEATS; C-ELEGANS; ARABIDOPSIS; GENE; ELEMENTS	It has been suggested that gene silencing evolved as a defense against genomic parasites such as transposons(1). This idea is based on analysis of mutations that reactivate transposons that are stably silenced(2-9): they affect maintenance rather than initiation of silencing. Here we describe the cloning and characterization of a naturally occurring locus able to heritably silence the otherwise highly active MuDR transposon in maize. This locus, Mu killer (Muk), results from the inverted duplication of a partially deleted autonomous MuDR element located at the breakpoint of a genomic deletion. Muk produces a hybrid hairpin transcript that is processed into small RNAs, which are amplified when the target MuDR transcript is present. Muk provides the first example of a naturally occurring transposon derivative capable of initiating the heritable silencing of an active transposon family. Further, transposon-generated inverted duplications may be important for the generation of double-stranded RNAs used in gene silencing.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lisch, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	dlisch@uclink.berkeley.edu	Slotkin, R. Keith/H-6965-2013; Lisch, Damon/A-9414-2010	Slotkin, R. Keith/0000-0001-9582-3533; Lisch, Damon/0000-0002-8693-8651				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; Kim SH, 2003, PLANT CELL, V15, P2430, DOI 10.1105/tpc.014605; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Lisch D, 1999, GENETICS, V151, P331; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; Rudenko GN, 2001, PLANT CELL, V13, P553, DOI 10.1105/tpc.13.3.553; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2003, GENETICS, V165, P781; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249	28	123	132	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					641	644		10.1038/ng1576	http://dx.doi.org/10.1038/ng1576			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15908951				2022-12-17	WOS:000229495300020
J	Kuroiwa, Y; Kasinathan, P; Matsushita, H; Sathiyaselan, J; Sullivan, EJ; Kakitani, M; Tomizuka, K; Ishida, I; Robl, JM				Kuroiwa, Y; Kasinathan, P; Matsushita, H; Sathiyaselan, J; Sullivan, EJ; Kakitani, M; Tomizuka, K; Ishida, I; Robl, JM			Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle	NATURE GENETICS			English	Article							NUCLEAR TRANSFER; STEM-CELLS; CALVES; RECOMBINATION; EXPRESSION; GENOME; FETAL; PIGS	Gene targeting is accomplished using embryonic stem cells in the mouse but has been successful, only using primary somatic cells followed by embryonic cloning, in other species. Gene targeting in somatic cells versus embryonic stem cells is a challenge; consequently, there are few reported successes and none include the targeting of transcriptionally silent genes or double targeting to produce homozygotes. Here, we report a sequential gene targeting system for primary fibroblast cells that we used to knock out both alleles of a silent gene, the bovine gene encoding immunoglobulin-mu (IGHM), and produce both heterozygous and homozygous knockout calves. We also carried out sequential knockout targeting of both alleles of a gene that is active in fibroblasts, encoding the bovine prion protein ( PRNP), in the same genetic line to produce doubly homozygous knockout fetuses. The sequential gene targeting system we used alleviates the need for germline transmission for complex genetic modifications and should be broadly applicable to gene functional analysis and to biomedical and agricultural applications.	Hematech, Sioux Falls, SD 57106 USA; Gemini Sci, San Diego, CA 92109 USA; Kirin Brewery Co Ltd, Div Pharmaceut, Shibuya Ku, Tokyo, Japan	Kirin Brewery Company Limited	Robl, JM (corresponding author), Hematech, 4401 S Technol Dr, Sioux Falls, SD 57106 USA.	i-ishida@kirin.co.jp; jrobl@hematech.com		Sullivan, Eddie/0000-0001-7468-2006				Abuin A, 1996, MOL CELL BIOL, V16, P1851; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Denning C, 2003, REPRODUCTION, V126, P1, DOI 10.1530/rep.0.1260001; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Piedrahita JA, 2000, THERIOGENOLOGY, V53, P105, DOI 10.1016/S0093-691X(99)00244-7; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Sharma A, 2003, TRANSPLANTATION, V75, P430, DOI 10.1097/01.TP.0000053615.98201.77; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; Thomson AJ, 2003, REPRODUCTION, P495; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang Bin, 2003, Reprod Biol Endocrinol, V1, P103, DOI 10.1186/1477-7827-1-103; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	26	123	196	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					775	780		10.1038/ng1373	http://dx.doi.org/10.1038/ng1373			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15184897	Bronze			2022-12-17	WOS:000222354100031
J	Cook, PR				Cook, PR			Predicting three-dimensional genome structure from transcriptional activity	NATURE GENETICS			English	Editorial Material							RNA-POLYMERASE; INTERPHASE CHROMOSOMES; BACILLUS-SUBTILIS; SELF-ORGANIZATION; NUCLEAR MATRIX; LIVING CELLS; MODEL; GENES; DNA; SITES	We would like to be able to predict how genomes are folded in the cell from the primary DNA sequence. A model for the three-dimensional structure of all genomes is presented; it is based on the structure of the bacterial nucleoid, where RNA polymerases cluster and loop the DNA. Loops appear and disappear as polymerases initiate and terminate, but the microscopic structure is 'self-organizing' and, to some extent, predictable. At the macroscopic level, transcriptional activity drives pairing between homologous sequences, inactivity allows genome compaction, and the segregation machinery orients whole chromosomes.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Cook, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	peter.cook@path.ox.ac.uk		Cook, Peter/0000-0002-6639-188X				Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Bremer H, 1996, ESCHERICHIA COLI SAL, P1553; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 1997, J CELL SCI, V110, P1033; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1995, J CELL SCI, V108, P2927; Cook PR, 2001, PRINCIPLES NUCL STRU; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Gustafsson MGL, 1999, CURR OPIN STRUC BIOL, V9, P627, DOI 10.1016/S0959-440X(99)00016-0; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; Ishihama A, 1981, Adv Biophys, V14, P1; Jackson DA, 1996, NUCLEIC ACIDS RES, V24, P1212, DOI 10.1093/nar/24.7.1212; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1984, J CELL SCI, P59; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MCKEE BD, 1992, GENETICS, V132, P529; MCMANUS J, 1994, J CELL SCI, V107, P469; Minsky A, 2002, NAT REV MOL CELL BIO, V3, P50, DOI 10.1038/nrm700; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nickerson JA, 2001, J CELL SCI, V114, P463; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; Pombo A, 1998, EMBO J, V17, P1768, DOI 10.1093/emboj/17.6.1768; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; SAITOH Y, 1978, COLD SPRING HARB SYM, V58, P755; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sudbrak R, 2001, HUM MOL GENET, V10, P77, DOI 10.1093/hmg/10.1.77; Sugaya K, 2000, J CELL SCI, V113, P2679	52	123	128	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					347	352		10.1038/ng1102-347	http://dx.doi.org/10.1038/ng1102-347			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410231				2022-12-17	WOS:000179034800007
J	Miller, DG; Rutledge, EA; Russell, DW				Miller, DG; Rutledge, EA; Russell, DW			Chromosomal effects of adeno-associated virus vector integration	NATURE GENETICS			English	Article							SITE-SPECIFIC INTEGRATION; ADENOASSOCIATED VIRUS; DNA; RECOMBINATION; JUNCTIONS; TRANSDUCTION; INCREASE	Adeno-associated virus (AAV) vectors are currently being used in several clinical gene-therapy trials (see the NIH OBA Human Gene Transfer Clinical Trials Database); however, little is known about the chromosomal effects of vector integration. Here we report that integrated vector proviruses are associated with chromosomal deletions and other rearrangements and are frequently located on chromosome 19 (although not at the wildtype AAV integration site).	Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.			Miller, Daniel/0000-0002-5700-3048	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062100] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK062100] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; GIRAUD C, 1995, J VIROL, V69, P6917, DOI 10.1128/JVI.69.11.6917-6924.1995; Hirata RK, 2000, J VIROL, V74, P4612, DOI 10.1128/JVI.74.10.4612-4620.2000; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; RUSSELL DW, 1995, P NATL ACAD SCI USA, V92, P5719, DOI 10.1073/pnas.92.12.5719; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000	10	123	127	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					147	148		10.1038/ng824	http://dx.doi.org/10.1038/ng824			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11799395				2022-12-17	WOS:000173708700012
J	Tian, XC; Xu, J; Yang, XZ				Tian, XC; Xu, J; Yang, XZ			Normal telomere lengths found in cloned cattle	NATURE GENETICS			English	Article							CELLS; ADULT; MICE		Univ Connecticut, Dept Anim Sci, Storrs, CT 06268 USA; Univ Connecticut, Ctr Biotechnol, Storrs, CT USA	University of Connecticut; University of Connecticut	Yang, XZ (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06268 USA.		Pillay, Nischalan/F-9536-2012					Betts DH, 1999, DEV GENET, V25, P397, DOI 10.1002/(SICI)1520-6408(1999)25:4&lt;397::AID-DVG13&gt;3.0.CO;2-J; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kozik A, 1998, MOL REPROD DEV, V51, P98, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;98::AID-MRD12&gt;3.0.CO;2-Q; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xu J, 2000, BIOL REPROD, V63, P1124, DOI 10.1095/biolreprod63.4.1124; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	16	123	140	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					272	273		10.1038/81559	http://dx.doi.org/10.1038/81559			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062462				2022-12-17	WOS:000165176500011
J	Liu, XY; Dangel, AW; Kelley, RI; Zhao, W; Denny, P; Botcherby, M; Cattanach, B; Peters, J; Hunsicker, PR; Mallon, AM; Strivens, MA; Bate, R; Miller, W; Rhodes, M; Brown, SDM; Herman, GE				Liu, XY; Dangel, AW; Kelley, RI; Zhao, W; Denny, P; Botcherby, M; Cattanach, B; Peters, J; Hunsicker, PR; Mallon, AM; Strivens, MA; Bate, R; Miller, W; Rhodes, M; Brown, SDM; Herman, GE			The gene mutated in bare patches and striated mice encodes a novel 3 beta-hydroxysteroid dehydrogenase	NATURE GENETICS			English	Article							LEMLI-OPITZ-SYNDROME; STR CRITICAL REGIONS; CHOLESTEROL-BIOSYNTHESIS; STEROL BIOSYNTHESIS; REDUCTASE GENE; HUMAN XQ28; MUTATIONS; MOUSE; 7-DEHYDROCHOLESTEROL; TRANSCRIPTS	X-linked dominant disorders that are exclusively lethal prenatally in hemizygous males have been described in human and (1). None of the genes responsible has been isolated in mouse either species; The bare patches (Bpa):and striated (Str) mouse mutations were originally identified in female offspring of X-irradiated males(2) (3). Subsequently, additional independent alleles were described. We have previously mapped these X-linked dominant, male-lethal mutations to an overlapping region:of 600 kb that is homologous to human Xq28 (ref. 4) and identified several candidate genes in this: interval(5). Here we report mutations in one of these genes, Nsdhl, encoding an NAD(P)H steroid dehydrogenase-like protein, in two independent Bpa and three independent Str alleles. Quantitative analysis of sterols from tissues of affected Bpa mice support a role for Nsdhl in cholesterol biosynthesis. Our results demonstrate that Bpa and Sfr are allelic mutations and identify the first mammalian locus associated with an X-linked dominant, male-lethal phenotype. They also expand the spectrum of phenotypes associated with abnormalities of cholesterol metabolism.	Ohio State Univ, Childrens Hosp Res Fdn, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21205 USA; MRC, Mouse Genome Ctr, Didcot OX11 ORD, Oxon, England; MRC, Mammalian Genet Lab, Didcot OX11 ORD, Oxon, England; MRC, Human Genome Mapping Project Resource Ctr, Cambridge, England; Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN 37831 USA; Penn State Univ, Dept Comp Sci, University Pk, PA 16802 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Herman, GE (corresponding author), Ohio State Univ, Childrens Hosp Res Fdn, Columbus, OH 43205 USA.			Denny, Paul/0000-0003-4659-6893	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034953] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005110] Funding Source: NIH RePORTER; MRC [MC_U142684171] Funding Source: UKRI; Medical Research Council [MC_U142684171] Funding Source: Medline; NINDS NIH HHS [R01 NS34953] Funding Source: Medline; NLM NIH HHS [R01 LM05110] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ANGEL T, 1993, GENOME, V4, P171; AnsariLari MA, 1996, BIOTECHNIQUES, V21, P34; Antoine JP, 1996, REV MATH PHYS, V8, P1, DOI 10.1142/S0129055X96000020; BJORCK S, 1987, QUATERNARY RES, V28, P1, DOI 10.1016/0033-5894(87)90030-5; CHATTERJEE A, 1995, MAMM GENOME, V6, P802, DOI 10.1007/BF00539008; Clayton PT, 1998, ARCH DIS CHILD, V78, P185, DOI 10.1136/adc.78.2.185; Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.3.CO;2-5; DAVISSON M T, 1987, Genomics, V1, P213, DOI 10.1016/0888-7543(87)90047-4; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; GIBSON KM, 1990, J LIPID RES, V31, P515; HAPPLE R, 1983, HUM GENET, V63, P24, DOI 10.1007/BF00285392; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Heiss NS, 1996, GENOME RES, V6, P478, DOI 10.1101/gr.6.6.478; Johnson RL, 1998, CURR OPIN GENET DEV, V8, P450, DOI 10.1016/S0959-437X(98)80117-2; Kelley RI, 1998, AM J HUM GENET, V63, P322, DOI 10.1086/301987; Kelley RI, 1999, AM J MED GENET, V83, P213, DOI 10.1002/(SICI)1096-8628(19990319)83:3<213::AID-AJMG15>3.0.CO;2-C; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Levin ML, 1996, GENOME RES, V6, P465, DOI 10.1101/gr.6.6.465; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; PHILLIPS RJ, 1963, GENET RES, V4, P151, DOI 10.1017/S0016672300003499; PHILLIPS RJ, 1973, GENET RES, V22, P91, DOI 10.1017/S0016672300012866; PUCK JM, 1989, AM J HUM GENET, V44, P724; REED V, 1994, NAT GENET, V8, P11, DOI 10.1038/ng0994-11; SCHROEPFER GJ, 1982, ANNU REV BIOCHEM, V51, P555, DOI 10.1146/annurev.bi.51.070182.003011; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982	30	123	126	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					182	187		10.1038/9700	http://dx.doi.org/10.1038/9700			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369263				2022-12-17	WOS:000080680900026
J	Aparicio, S; Hawker, K; Cottage, A; Mikawa, Y; Zuo, L; Venkatesh, B; Chen, E; Krumlauf, R; Brenner, S				Aparicio, S; Hawker, K; Cottage, A; Mikawa, Y; Zuo, L; Venkatesh, B; Chen, E; Krumlauf, R; Brenner, S			Organization of the Fugu rubripes Hox clusters: Evidence for continuing evolution of vertebrate Hox complexes	NATURE GENETICS			English	Article							HOMEOTIC TRANSFORMATIONS; GENE FAMILY; EXPRESSION; DROSOPHILA; GENOME; ACID	The clustered organization of. Hox genes provides a powerful opportunity to examine gene gain and loss in evolution because physical linkage is a key diagnostic feature which allows homology to be established unambiguously. Furthermore, Hox genes play a key role in determination of axial and appendicular skeletal morphology(1,2) and may be a key component of the evolution of diverse metazoan body forms. Despite suggestions that changes in Hox gene number played a role in evolution of metazoan body plans(3,4), there has been a general lack of evidence for such variation amongst gnathostomes (or indeed any vertebrate) and it has therefore been widely assumed that differential regulation may be the key element in all vertebrate Hox evolution. We have studied the Hox gene clusters of a teleost fish, Fugu rubripes, to test the possibility that Hox organization may have varied since the origin of jawed vertebrates. We have identified four Hox complexes in Fugu and found an unprecedented degree of variation when compared with tetrapod clusters. Our data show that: fugu clusters are widely variant with respect to length; at least nine genes have been lost; there is a new group-2 paralogue; and pseudo-gene remnants of group-1 and group-3 paralogues were found in the Hoxc complex, when compared with the present mammalian clusters. We show that gene loss after duplication of the prototypical vertebrate Hox clusters is a key feature of both tetrapod and fish evolution.	MRC CTR,IMPERIAL CANC RES FUND,CELL INTERACT UNIT,CAMBRIDGE CB2 2QH,ENGLAND; INST MOL SCI,LA JOLLA,CA 92037; SEQUANA THERAPEUT,LA JOLLA,CA 92037; IMCB,SINGAPORE 119260,SINGAPORE; PERKIN ELMER CORP,APPL BIOSYST DIV,ADV CTR GENET TECHNOL,FOSTER CITY,CA 94404; NATL INST MED RES,MRC,DEV NEUROBIOL LAB,LONDON NW7 1AA,ENGLAND; MRC HGMP RESOURCE CTR,CAMBRIDGE CB10 1SB,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Thermo Fisher Scientific; Applied Biosystems; MRC National Institute for Medical Research	Aparicio, S (corresponding author), WELLCOME CRC INST DEV BIOL & CANC RES,TENNIS COURT RD,CAMBRIDGE CB2 1QR,ENGLAND.		Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927; Aparicio, Samuel/0000-0002-0487-9599; Venkatesh, Byrappa/0000-0003-3620-0277	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; AKAM M, 1995, PHILOS T R SOC B, V349, P313, DOI 10.1098/rstb.1995.0119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; BURKE AC, 1995, DEVELOPMENT, V121, P333; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G, P284; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Misof BY, 1996, MOL PHYLOGENET EVOL, V5, P309, DOI 10.1006/mpev.1996.0026; Misof BY, 1996, J EXP ZOOL, V274, P193, DOI 10.1002/(SICI)1097-010X(19960215)274:3&lt;193::AID-JEZ6&gt;3.0.CO;2-J; Nelson J.S., 1994, FISHES WORLD, Vthird, P1; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; POLLOCK RA, 1995, P NATL ACAD SCI USA, V92, P4492, DOI 10.1073/pnas.92.10.4492; POLLOCK RA, 1992, CELL, V71, P911, DOI 10.1016/0092-8674(92)90388-S; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P2951, DOI 10.1093/nar/10.9.2951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYLER J C, 1980, NOAA (National Oceanic and Atmospheric Administration) Technical Report NMFS (National Marine Fisheries Service) Circular, P1; vanderHoeven F, 1996, MECH DEVELOP, V54, P9, DOI 10.1016/0925-4773(95)00455-6; Zeltser L, 1996, DEVELOPMENT, V122, P2475	29	123	134	2	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					79	83		10.1038/ng0597-79	http://dx.doi.org/10.1038/ng0597-79			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140399				2022-12-17	WOS:A1997WX02400026
J	Sawada, S; Florell, S; Purandare, SM; Ota, M; Stephens, K; Viskochil, D				Sawada, S; Florell, S; Purandare, SM; Ota, M; Stephens, K; Viskochil, D			Identification of NF1 mutations in both alleles of a dermal neurofibroma	NATURE GENETICS			English	Letter							TYPE-1 NEUROFIBROMATOSIS; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; GENE-PRODUCT; DELETIONS; TUMORS; HETEROZYGOSITY; CHROMOSOME-17; PROTEINS; DOMAIN; ORIGIN		UNIV UTAH,DEPT PEDIAT,DIV MED GENET,SALT LAKE CITY,UT 84112; JIKEI UNIV,SCH MED,DEPT DERMATOL,MINATO KU,TOKYO 105,JAPAN; UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84112; UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195	Utah System of Higher Education; University of Utah; Jikei University; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle								ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; ENZINGER F, 1988, SOFT TISSUE TUMORS, P821; FIALKOW PJ, 1971, NEW ENGL J MED, V284, P298, DOI 10.1056/NEJM197102112840604; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; KAYES LM, 1994, AM J HUM GENET, V54, P424; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Leppig KA, 1996, CYTOGENET CELL GENET, V72, P95, DOI 10.1159/000134171; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; LOTHE RA, 1995, J NEUROPATH EXP NEUR, V54, P65, DOI 10.1097/00005072-199501000-00008; MARCHUK DA, 1992, GENOMICS, V13, P672, DOI 10.1016/0888-7543(92)90140-N; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; REYNOLDS JE, 1992, HUM GENET, V90, P450; Sambrook J, 1989, MOL CLONING LAB MANU; SARNOWITZ W, 1995, GASTROENTEROLOGY, V109, P1765; SAWADA S, 1995, JAP J DERMATOL, V105, P1187; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; SHIMIZU E, 1993, CANCER, V71, P725, DOI 10.1002/1097-0142(19930201)71:3<725::AID-CNCR2820710312>3.0.CO;2-F; SKUSE GR, 1991, AM J HUM GENET, V49, P600; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	29	123	125	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1996	14	1					110	112		10.1038/ng0996-110	http://dx.doi.org/10.1038/ng0996-110			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VF611	8782831				2022-12-17	WOS:A1996VF61100032
J	PARK, S; BERNARD, A; BOVE, KE; SENS, DA; HAZENMARTIN, DJ; GARVIN, AJ; HABER, DA				PARK, S; BERNARD, A; BOVE, KE; SENS, DA; HAZENMARTIN, DJ; GARVIN, AJ; HABER, DA			INACTIVATION OF WT1 IN NEPHROGENIC RESTS, GENETIC PRECURSORS TO WILMS-TUMOR	NATURE GENETICS			English	Article							ZINC-FINGER GENE; DELETION; KIDNEY; MUTATIONS; ASSOCIATION; DISEASE; CANCER; MODEL; LOCUS; CELLS	Nephrogenic rests consist of foci of primitive renal cells, typically microscopic, that are found within the normal kidney tissue of children with Wilms' tumour. To study the relationship between nephrogenic rests and the associated tumours, we screened these lesions for mutations in the 11p13 Wilms' tumour suppressor gene, WT1. In two cases in which the Wilms' tumour contained a somatic WT1 mutation, the nephrogenic rest had the identical mutation. Nephrogenic rests and Wilms' tumours are therefore topographically distinct lesions that are clonally derived from an early renal stem cell. Inactivation of WT1 appears to be an early genetic event which can lead to the formation of nephrogenic rests, enhancing the probability that additional genetic hits will lead to Wilms' tumour.	MASSACHUSETTS GEN HOSP,CTR CANC,MOLEC GENET LAB,BOSTON,MA 02129; HARVARD UNIV,SCH MED,BOSTON,MA 02129; CHILDRENS HOSP MED CTR,DEPT PATHOL,CINCINNATI,OH 45229; MED UNIV S CAROLINA,DEPT PATHOL & LAB MED,CHARLESTON,SC 29425	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Medical University of South Carolina				Bernard, Amy/0000-0003-2540-1153	NCI NIH HHS [CA58596, CA37887] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058596, R01CA037887, R37CA058596, R23CA037887] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALMER A, 1991, OPHTHALMIC PAED GEN, V12, P131, DOI 10.3109/13816819109029394; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; BECKWITH J B, 1969, Birth Defects Original Article Series, V5, P188; Bove K E, 1976, Perspect Pediatr Pathol, V3, P185; BOVE KE, 1978, J NATL CANCER I, V61, P285; BOVE KE, 1991, LAB INVEST, V64, pA2; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; COSTANZI E, 1989, GENET, V10, P157; COWELL JK, 1991, ONCOGENE, V6, P595; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HABER DA, 1992, ADV CANCER RES, V59, P41, DOI 10.1016/S0065-230X(08)60302-4; HABER DA, 1992, P NATL ACAD SCI USA, V89, P6010, DOI 10.1073/pnas.89.13.6010; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HABER DA, 1991, CELL, V64, P5, DOI 10.1016/0092-8674(91)90200-I; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HUFF V, 1991, AM J HUM GENET, V48, P997; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; MULVIHILL DM, 1989, PEDIATR NEPHROL, V3, P286, DOI 10.1007/BF00858531; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PRITCHARDJONES K, 1991, ONCOGENE, V6, P2211; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SIDRANSKY D, 1992, NEW ENGL J MED, V326, P737, DOI 10.1056/NEJM199203123261104; TON CCT, 1991, GENOMICS, V10, P293, DOI 10.1016/0888-7543(91)90516-H; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223	31	123	125	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					363	367		10.1038/ng1293-363	http://dx.doi.org/10.1038/ng1293-363			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298644				2022-12-17	WOS:A1993ML14500012
J	TREZISE, AEO; LINDER, CC; GRIEGER, D; THOMPSON, EW; MEUNIER, H; GRISWOLD, MD; BUCHWALD, M				TREZISE, AEO; LINDER, CC; GRIEGER, D; THOMPSON, EW; MEUNIER, H; GRISWOLD, MD; BUCHWALD, M			CFTR EXPRESSION IS REGULATED DURING BOTH THE CYCLE OF THE SEMINIFEROUS EPITHELIUM AND THE ESTROUS-CYCLE OF RODENTS	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; MESSENGER-RNAS; IDENTIFICATION; CELLS; SPERMATOGENESIS; LOCALIZATION; CONDUCTANCE; SPERMATIDS; TRANSPORT; TESTES	Severely reduced, fertility is a common finding in cystic fibrosis (CF). We used in situ hybridization to examine the cell-specific expression of CFTR in the reproductive organs of rodents. In males CFTR mRNA is found in the round spermatids (spermatogenic stages V-X) and in the principal cells that line the initial segment of the epididymis. In both the testis and the epididymis, CFTR expression is developmentally regulated suggesting that the defect in the genital tract of male CF patients is of developmental origin. CFTR expression in the luminal and glandular epithelium of the uterus is regulated during the oestrous cycle and is maximal at pro-oestrus. Our results provide a biological rationale for the reduced fertility of CF patients, and suggest a possible cause for the comparatively poorer prognosis for women with CF.	HOSP SICK CHILDREN, RES INST, DEPT GENET, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, RES INST, DIV ENDOCRINOL, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT CLIN BIOCHEM, TORONTO M5G 1X8, ON, CANADA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO M5G 1X8, ON, CANADA; WASHINGTON STATE UNIV, BIOCHEM & BIOPHYS PROGRAM, PULLMAN, WA 99164 USA; GEORGETOWN UNIV, MED CTR, VINCENT T LOMBARDI CANC RES CTR, WASHINGTON, DC 20007 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Washington State University; Georgetown University			Thompson, Erik W/A-1425-2009; Thompson, Erik/GPK-2067-2022	Thompson, Erik W/0000-0002-9723-4924; Thompson, Erik/0000-0002-9723-4924				ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; BRUGMAN SM, 1987, CYSTIC FIBROSIS, P323; CALDWELL KA, 1991, P NATL ACAD SCI USA, V88, P2407, DOI 10.1073/pnas.88.6.2407; CHALON J, 1971, J AMER MED ASSOC, V218, P1928, DOI 10.1001/jama.218.13.1928; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; COLLEDGE WH, 1992, LANCET, V340, P680, DOI 10.1016/0140-6736(92)92223-3; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOTTLIEB C, 1991, INT J ANDROL, V14, P437, DOI 10.1111/j.1365-2605.1991.tb01272.x; Harper M.J.K., 1988, P103; HARRIS A, 1991, DEVELOPMENT, V113, P305; HEATON ND, 1990, BRIT J UROL, V66, P538, DOI 10.1111/j.1464-410X.1990.tb15006.x; HESS RA, 1990, BIOL REPROD, V43, P525, DOI 10.1095/biolreprod43.3.525; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; MORALES CR, 1989, MOL ENDOCRINOL, V3, P725, DOI 10.1210/mend-3-4-725; MURTI JR, 1992, MOL CELL BIOL, V12, P2545, DOI 10.1128/MCB.12.6.2545; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; PHILLIPS DM, 1970, J CELL BIOL, V44, P243, DOI 10.1083/jcb.44.2.243; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robaire B., 1988, P999; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUSSELL LD, 1987, ENDOCRINOLOGY, V120, P1615, DOI 10.1210/endo-120-4-1615; SCHIMENTI J, 1988, CELL, V55, P71, DOI 10.1016/0092-8674(88)90010-4; Setchell B.P., 1988, P753; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; SPRANDO RL, 1987, AM J ANAT, V178, P72, DOI 10.1002/aja.1001780109; STALLARD BJ, 1991, MOL CELL BIOL, V11, P1448, DOI 10.1128/MCB.11.3.1448; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; TREZISE AEO, 1992, GENOMICS, V14, P869, DOI 10.1016/S0888-7543(05)80107-7; TREZISE AEO, 1992, EMBO J, V11, P4291, DOI 10.1002/j.1460-2075.1992.tb05528.x; Tsui L C, 1991, Adv Hum Genet, V20, P153; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; WONG PYD, 1978, INT J ANDROL, P608, DOI 10.1111/j.1365-2605.1978.tb00512.x; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174	49	123	126	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1993	3	2					157	164		10.1038/ng0293-157	http://dx.doi.org/10.1038/ng0293-157			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	7684647				2022-12-17	WOS:A1993KL01000014
J	Li, GQ; Zhou, JY; Jia, HY; Gao, ZX; Fan, M; Luo, YJ; Zhao, PT; Xue, SL; Li, N; Yuan, Y; Ma, SW; Kong, ZX; Jia, L; An, X; Jiang, G; Liu, WX; Cao, WJ; Zhang, RR; Fan, JC; Xu, XW; Liu, YF; Kong, QQ; Zheng, SH; Wang, Y; Qin, B; Cao, SY; Ding, YX; Shi, JX; Yan, HS; Wang, X; Ran, CF; Ma, ZQ				Li, Guoqiang; Zhou, Jiyang; Jia, Haiyan; Gao, Zhongxia; Fan, Min; Luo, Yanjun; Zhao, Panting; Xue, Shulin; Li, Na; Yuan, Yang; Ma, Shengwei; Kong, Zhongxin; Jia, Li; An, Xia; Jiang, Ge; Liu, Wenxing; Cao, Wenjin; Zhang, Rongrong; Fan, Jicai; Xu, Xiaowu; Liu, Yanfang; Kong, Qianqian; Zheng, Shouhang; Wang, Yao; Qin, Bin; Cao, Shouyang; Ding, Yunxiao; Shi, Jinxing; Yan, Haisheng; Wang, Xin; Ran, Congfu; Ma, Zhengqiang			Mutation of a histidine-rich calcium-binding-protein gene in wheat confers resistance to Fusarium head blight	NATURE GENETICS			English	Article							DISEASE RESISTANCE; SUBCELLULAR-LOCALIZATION; IDENTIFICATION; BARLEY; FHB1; PATHOGENS; GERMPLASM; BLAST; QTL	Head or ear blight, mainly caused by Fusarium species, can devastate almost all staple cereal crops (particularly wheat), resulting in great economic loss and imposing health threats on both human beings and livestock(1-3). However, achievement in breeding for highly resistant cultivars is still not satisfactory. Here, we isolated the major-effect wheat quantitative trait locus, Qfhs.njau-3B, which confers head blight resistance, and showed that it is the same as the previously designated Fhb1. Fhb1 results from a rare deletion involving the 3' exon of the histidine-rich calcium-binding-protein gene on chromosome 3BS. Both wheat and Arabidopsis transformed with the Fhb1 sequence showed enhanced resistance to Fusarium graminearum spread. The translation products of this gene's homologs among plants are well conserved and might be essential for plant growth and development. Fhb1 could be useful not only for curbing Fusarium head blight in grain crops but also for improving other plants vulnerable to Fusarium species.	[Li, Guoqiang; Zhou, Jiyang; Jia, Haiyan; Gao, Zhongxia; Fan, Min; Luo, Yanjun; Zhao, Panting; Xue, Shulin; Li, Na; Yuan, Yang; Ma, Shengwei; Kong, Zhongxin; Jia, Li; An, Xia; Jiang, Ge; Liu, Wenxing; Cao, Wenjin; Zhang, Rongrong; Fan, Jicai; Xu, Xiaowu; Liu, Yanfang; Kong, Qianqian; Zheng, Shouhang; Wang, Yao; Qin, Bin; Cao, Shouyang; Ding, Yunxiao; Shi, Jinxing; Yan, Haisheng; Wang, Xin; Ran, Congfu; Ma, Zhengqiang] Nanjing Agr Univ, Appl Plant Genom Lab, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Xue, Shulin] Henan Univ, Sch Life Sci, Kaifeng, Peoples R China; [An, Xia] Zibo Acad Agr Sci, Zibo, Peoples R China; [Zheng, Shouhang] Mianyang Acad Agr Sci, Mianyang, Sichuan, Peoples R China	Nanjing Agricultural University; Henan University	Ma, ZQ (corresponding author), Nanjing Agr Univ, Appl Plant Genom Lab, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China.	zqm2@njau.edu.cn	Ma, Zhengqiang/AAQ-9160-2021; Ma, Zhengqiang/AAI-9876-2020; liu, yan/HCI-5542-2022; 马, 省伟/GXN-3981-2022; liu, yan/HGV-1365-2022	Ma, Zhengqiang/0000-0003-4950-5387; 马, 省伟/0000-0001-6196-811X; 	Ministry of Science and Technology of China [2016YFD0101004, 2016YFD0101802, 2012ZX08009003, 2012CB125902, 2009ZX08009-049B, 2004CB117205, 2002AA224161]; innovation team program for Jiangsu universities (2014); '111' project [B08025]; Priority Academic Program Development of Jiangsu; National Natural Science Foundation of China [30025030, 30430440, 30721140555, 31030054, 30671295, 31501306]; Fundamental Research Funds for the Central Universities; Jiangsu collaborative innovation initiative for modern crop production	Ministry of Science and Technology of China(Ministry of Science and Technology, China); innovation team program for Jiangsu universities (2014); '111' project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu collaborative innovation initiative for modern crop production	We thank S. Cai and H. Chen of the Jiangsu Academy of Agricultural Sciences, L. Li of the Chinese Academy of Agricultural Sciences, Y. Zhou, D. Liu and J. Wang of Sichuan Agricultural University, H. Wang and J. Tian of Shandong Agricultural University, B. Gill of Kansas State University, C. Chu of the Chinese Academy of Sciences, and many other colleagues, for providing materials for this study. We also thank L. Yan of Oklahoma State University for inspiring discussions and support, and all of the laboratory members not listed as authors for planting and phenotyping. This work was partially supported by grants from the Ministry of Science and Technology of China (2016YFD0101004, 2016YFD0101802, 2012ZX08009003, 2012CB125902, 2009ZX08009-049B, 2004CB117205 and 2002AA224161), innovation team program for Jiangsu universities (2014), '111' project (B08025), Priority Academic Program Development of Jiangsu, Fundamental Research Funds for the Central Universities and Jiangsu collaborative innovation initiative for modern crop production. Special thanks to the National Natural Science Foundation of China for long-term funding support (30025030, 30430440, 30721140555, 31030054, 30671295 and 31501306).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; [Anonymous], 2000, P INT S WHEAT IMPROV; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chen XW, 2006, MOL PLANT PATHOL, V7, P391, DOI 10.1111/j.1364-3703.2006.00349.x; Cheng NH, 2004, FEBS LETT, V559, P99, DOI 10.1016/S0014-5793(04)00036-5; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Ding L., 2012, PLOS ONE, V6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; He XY, 2014, EUPHYTICA, V195, P383, DOI 10.1007/s10681-013-1002-3; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jeger MJ, 2001, THEOR APPL GENET, V102, P32, DOI 10.1007/s001220051615; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Li WT, 2017, CELL, V170, P114, DOI 10.1016/j.cell.2017.06.008; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin F, 2004, THEOR APPL GENET, V109, P1504, DOI 10.1007/s00122-004-1772-z; Liu Sixin, 2006, Functional & Integrative Genomics, V6, P83, DOI 10.1007/s10142-005-0007-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo AD, 2005, J INTEGR PLANT BIOL, V47, P745, DOI 10.1111/j.1744-7909.2005.00071.x; Ma YM, 2009, J GENET GENOMICS, V36, P267, DOI 10.1016/S1673-8527(08)60114-9; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Moore JW, 2015, NAT GENET, V47, P1494, DOI 10.1038/ng.3439; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Rawat N, 2016, NAT GENET, V48, P1576, DOI 10.1038/ng.3706; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Schweiger W, 2016, THEOR APPL GENET, V129, P1607, DOI 10.1007/s00122-016-2727-x; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; Singh RP, 2016, ANNU REV PHYTOPATHOL, V54, P303, DOI 10.1146/annurev-phyto-080615-095835; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Xiao J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5572; Xu P, 2009, PLANT PHYSIOL, V149, P760, DOI 10.1104/pp.108.132217; Xue SL, 2010, MOL BREEDING, V25, P397, DOI 10.1007/s11032-009-9339-y; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zhang JX, 2008, CROP SCI, V48, P223, DOI 10.2135/cropsci2007.02.0116; Zhang L, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.973818; Zhou XG, 2018, P NATL ACAD SCI USA, V115, P3174, DOI 10.1073/pnas.1705927115	49	122	144	11	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2019	51	7					1106	+		10.1038/s41588-019-0426-7	http://dx.doi.org/10.1038/s41588-019-0426-7			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG0PF	31182810				2022-12-17	WOS:000473491900009
J	Xiao, J; Jin, R; Yu, X; Shen, M; Wagner, JD; Pai, A; Song, C; Zhuang, M; Klasfeld, S; He, CS; Santos, AM; Helliwell, C; Pruneda-Paz, JL; Kay, SA; Lin, XW; Cui, SJ; Garcia, MF; Clarenz, O; Goodrich, J; Zhang, XY; Austin, RS; Bonasio, R; Wagner, D				Xiao, Jun; Jin, Run; Yu, Xiang; Shen, Max; Wagner, John D.; Pai, Armaan; Song, Claire; Zhuang, Michael; Klasfeld, Samantha; He, Chongsheng; Santos, Alexandre M.; Helliwell, Chris; Pruneda-Paz, Jose L.; Kay, Steve A.; Lin, Xiaowei; Cui, Sujuan; Garcia, Meilin Fernandez; Clarenz, Oliver; Goodrich, Justin; Zhang, Xiaoyu; Austin, Ryan S.; Bonasio, Roberto; Wagner, Doris			Cis and trans determinants of epigenetic silencing by Polycomb repressive complex 2 in Arabidopsis	NATURE GENETICS			English	Article							GENE-EXPRESSION; HISTONE H3; ELEMENTS; PROTEIN; TRIMETHYLATION; TRANSCRIPTION; VERNALIZATION; RECRUITMENT; REQUIRES; VECTORS	Disruption of gene silencing by Polycomb protein complexes leads to homeotic transformations and altered developmental-phase identity in plants(1-5). Here we define short genomic fragments, known as Polycomb response elements (PREs), that direct Polycomb repressive complex 2 (PRC2) placement at developmental genes regulated by silencing in Arabidopsis thaliana. We identify transcription factor families that bind to these PREs, colocalize with PRC2 on chromatin, physically interact with and recruit PRC2, and are required for PRC2-mediated gene silencing in vivo. Two of the cis sequence motifs enriched in the PREs are cognate binding sites for the identified transcription factors and are necessary and sufficient for PRE activity. Thus PRC2 recruitment in Arabidopsis relies in large part on binding of trans-acting factors to cis-localized DNA sequence motifs.	[Xiao, Jun; Jin, Run; Yu, Xiang; Shen, Max; Wagner, John D.; Pai, Armaan; Song, Claire; Zhuang, Michael; Klasfeld, Samantha; Wagner, Doris] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [He, Chongsheng; Bonasio, Roberto] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Santos, Alexandre M.; Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Helliwell, Chris] CSIRO, Agr & Food, Canberra, ACT, Australia; [Pruneda-Paz, Jose L.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Kay, Steve A.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA USA; [Lin, Xiaowei; Cui, Sujuan] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China; [Garcia, Meilin Fernandez] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Clarenz, Oliver; Goodrich, Justin] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Austin, Ryan S.] Agr & Agri Food Canada, London, ON, Canada; [Austin, Ryan S.] Western Univ, Dept Biol, London, ON, Canada	University of Pennsylvania; University of Pennsylvania; University System of Georgia; University of Georgia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California San Diego; University of Southern California; Hebei Normal University; University of Pennsylvania; University of Edinburgh; Agriculture & Agri Food Canada; Western University (University of Western Ontario)	Wagner, D (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	wagnerdo@sas.upenn.edu	Yu, Xiang/H-9666-2019; Helliwell, Chris/A-1469-2008; He, Cshe1985!/AAV-1903-2021; Kay, Steve A/F-6025-2011; Zhang, xiaoyu/GXA-3206-2022	Yu, Xiang/0000-0002-5730-8802; Helliwell, Chris/0000-0001-5943-897X; Kay, Steve A/0000-0002-0402-2878; Fernandez Garcia, Meilin/0000-0002-8745-9775; He, Chongsheng/0000-0003-1719-6794; Wagner, Doris/0000-0003-4656-2490	NSF [MCB-1243757, MCB-1614355, IOS-1238142]; AAFC [GRDI-130]; BBSRC [G20266]; DFG [CL 393/1-1]; NIH [NRSA 1F31GM112417-01, R01GM056006, R01GM067837, RC2GM092412, DP2MH107055]; MoD [1-FY-15-344]; Searle Scholar Program award; BBSRC [BB/P008569/1, BB/H004319/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P008569/1, BB/H004319/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); AAFC(Agriculture & Agri Food Canada); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MoD; Searle Scholar Program award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank U.-S. Lee for help with manuscript preparation, students of the BIOL425 lab course at the University of Pennsylvania (Spring 2015 and Fall 2015) for the telobox interactome screen, J. He for help with the fluorometric assay of GUS activity, and W. Li (Chinese Academy of Sciences) for statistical analyses. Support for the study comes from NSF MCB-1243757 and MCB-1614355 to D.W., NSF IOS-1238142 to X.Z., AAFC GRDI-130 to R.S.A., BBSRC award G20266 to J.G., BBSRC award G20266 and DFG fellowship CL 393/1-1 to O.C., NIH NRSA 1F31GM112417-01 to M.F.G., NIH R01GM056006 to S.A.K. and J.L.P.-P. NIH R01GM067837 and RC2GM092412 to S.A.K., and NIH DP2MH107055, MoD 1-FY-15-344, and a Searle Scholar Program award to R.B.	Aichinger E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000605; Alexandre C, 2009, MOL PLANT, V2, P675, DOI 10.1093/mp/ssp012; Austin RS, 2016, PLANT J, V88, P490, DOI 10.1111/tpj.13261; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Berger N, 2011, PLANT CELL, V23, P4065, DOI 10.1105/tpc.111.087866; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Blazquez M., 2007, CSH PROTOC; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Castrillo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021524; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-593; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Forderer A, 2016, CURR OPIN PLANT BIOL, V29, P169, DOI 10.1016/j.pbi.2015.11.010; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Hecker A, 2015, PLANT PHYSIOL, V168, P130, DOI 10.1104/pp.15.00409; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/nar/gki791; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Kim SY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002512; Kim SY, 2010, PLANT PHYSIOL, V152, P516, DOI 10.1104/pp.109.143495; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kooiker M, 2005, PLANT CELL, V17, P722, DOI 10.1105/tpc.104.030130; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11868; Lodha M, 2013, GENE DEV, V27, P596, DOI 10.1101/gad.211425.112; Lopez-Vernaza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030715; Maghuly F, 2008, J BIOTECHNOL, V135, P105, DOI 10.1016/j.jbiotec.2008.02.021; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Meister RJ, 2004, PLANT J, V37, P426, DOI 10.1046/j.1365-313X.2003.01971.x; Molitor AM, 2016, PLANT CELL, V28, P2197, DOI 10.1105/tpc.16.00244; Monfared MM, 2011, PLANT J, V66, P1020, DOI 10.1111/j.1365-313X.2011.04562.x; Mozgova I, 2015, ANNU REV PLANT BIOL, V66, P269, DOI 10.1146/annurev-arplant-043014-115627; Mu Y, 2017, PLANT CELL PHYSIOL, V58, P607, DOI 10.1093/pcp/pcx006; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Pu L, 2015, TRENDS GENET, V31, P252, DOI 10.1016/j.tig.2015.03.004; Questa JI, 2016, SCIENCE, V353, P485, DOI 10.1126/science.aaf7354; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; WANG H, 1995, J BIOL CHEM, V270, P23322, DOI 10.1074/jbc.270.40.23322; Wang H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005771; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wu MF, 2015, ELIFE, V4, DOI 10.7554/eLife.09269; Xiao J, 2015, CURR OPIN PLANT BIOL, V23, P15, DOI 10.1016/j.pbi.2014.10.003; Xiao J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5572; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yamaguchi N, 2014, SCIENCE, V344, P638, DOI 10.1126/science.1250498; Yamaguchi Nobutoshi, 2014, Arabidopsis Book, V12, pe0170, DOI 10.1199/tab.0170; Yamaguchi N, 2013, DEV CELL, V24, P271, DOI 10.1016/j.devcel.2012.12.017; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan WY, 2016, NAT GENET, V48, P1527, DOI 10.1038/ng.3712; Zerbino DR, 2014, BIOINFORMATICS, V30, P1008, DOI 10.1093/bioinformatics/btt737; Zhang BL, 2015, GENE DEV, V29, P975, DOI 10.1101/gad.251520.114; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou Y, 2016, PLANT CELL, V28, P87, DOI 10.1105/tpc.15.00787	77	122	124	5	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2017	49	10					1546	+		10.1038/ng.3937	http://dx.doi.org/10.1038/ng.3937			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI3JD	28825728	Green Accepted			2022-12-17	WOS:000411855800020
J	Yang, Q; He, YJ; Kabahuma, M; Chaya, T; Kelly, A; Borrego, E; Bian, Y; El Kasmi, F; Yang, L; Teixeira, P; Kolkman, J; Nelson, R; Kolomiets, M; Dangl, JL; Wisser, R; Caplan, J; Li, X; Lauter, N; Balint-Kurti, P				Yang, Qin; He, Yijian; Kabahuma, Mercy; Chaya, Timothy; Kelly, Amy; Borrego, Eli; Bian, Yang; El Kasmi, Farid; Yang, Li; Teixeira, Paulo; Kolkman, Judith; Nelson, Rebecca; Kolomiets, Michael; Dangl, Jeffery L.; Wisser, Randall; Caplan, Jeffrey; Li, Xu; Lauter, Nick; Balint-Kurti, Peter			A gene encoding maize caffeoyl-CoA O-methyltransferase confers quantitative resistance to multiple pathogens	NATURE GENETICS			English	Article							SOUTHERN LEAF-BLIGHT; DISEASE RESISTANCE; BROAD-SPECTRUM; TRAIT LOCI; FUSARIUM-VERTICILLIOIDES; LIGNIN BIOSYNTHESIS; FUNGAL PATHOGENS; PAN-GENOME; CELL-DEATH; ARABIDOPSIS	Alleles that confer multiple disease resistance (MDR) are valuable in crop improvement, although the molecular mechanisms underlying their functions remain largely unknown. A quantitative trait locus, qMdr9.02, associated with resistance to three important foliar maize diseases-southern leaf blight, gray leaf spot and northern leaf blight-has been identified on maize chromosome 9. Through fine-mapping, association analysis, expression analysis, insertional mutagenesis and transgenic validation, we demonstrate that ZmCCoAOMT2, which encodes a caffeoyl-CoA O-methyltransferase associated with the phenylpropanoid pathway and lignin production, is the gene within qMdr9.02 conferring quantitative resistance to both southern leaf blight and gray leaf spot. We suggest that resistance might be caused by allelic variation at the level of both gene expression and amino acid sequence, thus resulting in differences in levels of lignin and other metabolites of the phenylpropanoid pathway and regulation of programmed cell death.	[Yang, Qin; He, Yijian; Kelly, Amy; Balint-Kurti, Peter] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Kabahuma, Mercy; Lauter, Nick] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Chaya, Timothy; Wisser, Randall; Caplan, Jeffrey] Univ Delaware, Dept Plant & Soil Sci, Newark, DE USA; [Borrego, Eli; Kolomiets, Michael] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Bian, Yang] North Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [El Kasmi, Farid; Yang, Li; Teixeira, Paulo; Dangl, Jeffery L.; Caplan, Jeffrey] Univ N Carolina, Howard Hughes Med Inst, Dept Biol, Chapel Hill, NC USA; [Kolkman, Judith; Nelson, Rebecca] Cornell Univ, Sch Integrat Plant Sci, Ithaca, NY USA; [Caplan, Jeffrey] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Li, Xu] North Carolina State Univ, Dept Plant & Microbial Biol, Plants Human Hlth Inst, Kannapolis, NC USA; [Lauter, Nick] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Balint-Kurti, Peter] USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Iowa State University; University of Delaware; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; University of Delaware; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Yang, Q; Balint-Kurti, P (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Balint-Kurti, P (corresponding author), USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA.	qyang6@ncsu.edu; peter.balint-kurti@ars.usda.gov	Balint-kurti, Peter/AES-0111-2022; El Kasmi, Farid/AHC-5099-2022; Borrego, Eli/G-9867-2011; Teixeira, Paulo/C-1546-2013	Borrego, Eli/0000-0002-3538-3203; Teixeira, Paulo/0000-0002-0776-5044; Balint-Kurti, Peter/0000-0002-3916-194X; Chaya, Timothy/0000-0003-4821-0317; Caplan, Jeffrey/0000-0002-3991-0912; El Kasmi, Farid/0000-0002-4634-7689; Bian, Yang/0000-0001-7172-3976	USDA; United States National Science Foundation [IOS-1127076, 1444503]; NIH [S10 OD016361]; NIH-NIGMS [P20 GM103446]; Division Of Integrative Organismal Systems [1127076] Funding Source: National Science Foundation	USDA(United States Department of Agriculture (USDA)); United States National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Holland and J. Dunne for help with association analysis and providing the filtered hapmap3 marker set in the qMdr<INF>9.02</INF> region in NAM founder lines. We thank W. Boerjan (Ghent University), K. Wang (Iowa State University), D. McCarty (University of Florida), K. Koch (University of Florida) and J. Brumos (North Carolina State University) for providing materials. We thank R. Franks, E. Johannes and S. Sermons for technical assistance. We thank C. Herring, G. Marshall and the staff at Central Crops Research Station for help with field work. We thank C. Saravitz and the staff at the NCSU Phytotron for growth-chamber-trial support. We thank D. Jackson, S. Kamoun, S. Christensen, B. Olukolu and T. Jamann for helpful discussions. We acknowledge the MaizeGDB database (URLs), which was essential to this work. Research was supported by the USDA and United States National Science Foundation grants IOS-1127076 to R. W. and 1444503 to P.B.-K. Purchase of and access to microscopes was made possible by NIH shared instrumentation grant S10 OD016361 and NIH-NIGMS grant P20 GM103446, both to J.C.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asai S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004443; Belcher AR, 2012, THEOR APPL GENET, V124, P433, DOI 10.1007/s00122-011-1718-1; Benson JM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005045; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Bian Y, 2015, G3-GENES GENOM GENET, V5, P2073, DOI 10.1534/g3.115.021121; Bian Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1068; Blount JW, 2000, PLANT PHYSIOL, V122, P107, DOI 10.1104/pp.122.1.107; Borrego EJ, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5040041; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Broglie K., 2006, US patent, Patent No. [20080016595 A1, 20080016595]; BUBECK DM, 1993, CROP SCI, V33, P838, DOI 10.2135/cropsci1993.0011183X003300040041x; Bukowski R., 2015, PREPRINT; Carson ML, 2004, PHYTOPATHOLOGY, V94, P862, DOI 10.1094/PHYTO.2004.94.8.862; Christensen SA, 2014, MOL PLANT MICROBE IN, V27, P1263, DOI 10.1094/MPMI-06-13-0184-R; Coletta VC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-43; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Davis GL, 1999, GENETICS, V152, P1137; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Farre G, 2015, CURR OPIN BIOTECH, V32, P54, DOI 10.1016/j.copbio.2014.11.004; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Hirsch CN, 2016, PLANT CELL, V28, P2700, DOI 10.1105/tpc.16.00353; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Hubert DA, 2009, P NATL ACAD SCI USA, V106, P9556, DOI 10.1073/pnas.0904877106; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Jamann TM, 2014, GENETICS, V198, P333, DOI 10.1534/genetics.114.167486; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Konig S, 2014, NEW PHYTOL, V202, P823, DOI 10.1111/nph.12709; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lennon JR, 2016, CROP SCI, V56, P209, DOI 10.2135/cropsci2014.07.0468; Li L, 2015, PLANT J, V81, P493, DOI 10.1111/tpj.12745; Liu QQ, 2017, MOL PLANT, V10, P483, DOI 10.1016/j.molp.2017.02.002; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; Ludovici M, 2014, FOOD ADDIT CONTAM A, V31, P2026, DOI 10.1080/19440049.2014.968810; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Miedaner T, 2012, PHYTOPATHOLOGY, V102, P560, DOI 10.1094/PHYTO-05-11-0157; Moore JW, 2015, NAT GENET, V47, P1494, DOI 10.1038/ng.3439; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; NEWMAN TC, 1993, PLANT CELL, V5, P701, DOI 10.1105/tpc.5.6.701; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Olukolu BA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004562; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Pataky J.K., 2011, MIDWEST VEGETABLE VA, P115; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rocha S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00102; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Settles AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-116; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Strauch RC, 2015, P NATL ACAD SCI USA, V112, P11726, DOI 10.1073/pnas.1503272112; Teran H, 2013, EUPHYTICA, V189, P283, DOI 10.1007/s10681-012-0803-0; Tonnessen BW, 2015, PLANT MOL BIOL, V87, P273, DOI 10.1007/s11103-014-0275-9; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Unterseer S., 2017, PREPRINT; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang GF, 2016, PLANT PHYSIOL, V171, P2166, DOI 10.1104/pp.16.00224; Wiesner-Hanks T, 2016, ANNU REV PHYTOPATHOL, V54, P229, DOI 10.1146/annurev-phyto-080615-100037; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120; Wisser RJ, 2005, GENETICS, V169, P2277, DOI 10.1534/genetics.104.036327; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yang L, 2017, CELL HOST MICROBE, V21, P156, DOI 10.1016/j.chom.2017.01.003; Yang Q, 2017, MOL PLANT, V10, P402, DOI 10.1016/j.molp.2017.02.004; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170; Zwonitzer JC, 2010, PHYTOPATHOLOGY, V100, P72, DOI 10.1094/PHYTO-100-1-0072; Zwonitzer JC, 2009, THEOR APPL GENET, V118, P911, DOI 10.1007/s00122-008-0949-2	84	122	132	21	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2017	49	9					1364	+		10.1038/ng.3919	http://dx.doi.org/10.1038/ng.3919			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FF1PS	28740263	Green Submitted			2022-12-17	WOS:000408672000015
J	Varshney, RK; Saxena, RK; Upadhyaya, HD; Khan, AW; Yu, Y; Kim, C; Rathore, A; Kim, D; Kim, J; An, S; Kumar, V; Anuradha, G; Yamini, KN; Zhang, W; Muniswamy, S; Kim, JS; Penmetsa, RV; von Wettberg, E; Datta, SK				Varshney, Rajeev K.; Saxena, Rachit K.; Upadhyaya, Hari D.; Khan, Aamir W.; Yu, Yue; Kim, Changhoon; Rathore, Abhishek; Kim, Dongseon; Kim, Jihun; An, Shaun; Kumar, Vinay; Anuradha, Ghanta; Yamini, Kalinati Narasimhan; Zhang, Wei; Muniswamy, Sonnappa; Kim, Jong-So; Penmetsa, R. Varma; von Wettberg, Eric; Datta, Swapan K.			Whole-genome resequencing of 292 pigeonpea accessions identifies genomic regions associated with domestication and agronomic traits	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; ARABIDOPSIS-THALIANA; POPULATION-STRUCTURE; GENETIC DIVERSITY; WIDE ASSOCIATION; WILD; CROP; SCHIZOPHRENIA; IMPROVEMENT; ADAPTATION	Pigeonpea (Cajanus cajan), a tropical grain legume with low input requirements, is expected to continue to have an important role in supplying food and nutritional security in developing countries in Asia, Africa and the tropical Americas. From wholegenome resequencing of 292 Cajanus accessions encompassing breeding lines, landraces and wild species, we characterize genome-wide variation. On the basis of a scan for selective sweeps, we find several genomic regions that were likely targets of domestication and breeding. Using genome-wide association analysis, we identify associations between several candidate genes and agronomically important traits. Candidate genes for these traits in pigeonpea have sequence similarity to genes functionally characterized in other plants for flowering time control, seed development and pod dehiscence. Our findings will allow acceleration of genetic gains for key traits to improve yield and sustainability in pigeonpea.	[Varshney, Rajeev K.; Saxena, Rachit K.; Upadhyaya, Hari D.; Khan, Aamir W.; Rathore, Abhishek; Kumar, Vinay] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Varshney, Rajeev K.] Univ Western Australia, Sch Agr & Environm, Crawley, WA, Australia; [Varshney, Rajeev K.] Univ Western Australia, Inst Agr, Crawley, WA, Australia; [Yu, Yue; An, Shaun; Zhang, Wei] Shenzhen Millennium Genom Inc, Shenzhen, Peoples R China; [Kim, Changhoon; Kim, Dongseon; Kim, Jihun; Kim, Jong-So] MACROGEN Inc, Seoul, South Korea; [Anuradha, Ghanta; Yamini, Kalinati Narasimhan] PJTSAU, Inst Biotechnol, Hyderabad, Andhra Pradesh, India; [Muniswamy, Sonnappa] UAS, Agr Res Stn ARS Gulbarga, Bengaluru, Karnataka, India; [Penmetsa, R. Varma] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [von Wettberg, Eric] Florida Int Univ, Biol Sci & Int Ctr Trop Bot, Miami, FL 33199 USA; [Datta, Swapan K.] Visva Bharati, Santini Ketan, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Western Australia; University of Western Australia; Macrogen, Inc.; University of Agricultural Sciences Bangalore; University of California System; University of California Davis; State University System of Florida; Florida International University; Visva Bharati University	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.; Varshney, RK (corresponding author), Univ Western Australia, Sch Agr & Environm, Crawley, WA, Australia.; Varshney, RK (corresponding author), Univ Western Australia, Inst Agr, Crawley, WA, Australia.	r.k.varshney@cgiar.org	Khan, Mohammad Aamir Waseem/AAP-1262-2021; von Wettberg, Eric/C-1115-2016; Varshney, Rajeev K/C-5295-2014; Yu, Hongli/ABA-8855-2021	Khan, Mohammad Aamir Waseem/0000-0001-9734-8123; von Wettberg, Eric/0000-0002-2724-0317; Varshney, Rajeev K/0000-0002-4562-9131; 	US Agency for International Development (USAID)	US Agency for International Development (USAID)(United States Agency for International Development (USAID))	The authors are thankful to the US Agency for International Development (USAID) for providing financial support to R.K.V. The authors would like to thank A. Gafoor, B. Poornima and P. Bajaj for their support in this work. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of the CGIAR Consortium.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Horiguchi G, 2009, PLANT J, V60, P122, DOI 10.1111/j.1365-313X.2009.03940.x; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Saxena RK, 2014, BRIEF FUNCT GENOMICS, V13, P296, DOI 10.1093/bfgp/elu016; Saxena RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088568; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Upadhyaya HD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00179; Upadhyaya HD, 2011, PLANT GENET RESOUR-C, V9, P97, DOI 10.1017/S1479262110000419; Upadhyaya H.D., 2009, MANAGING ENHANCING U; Van der Maesen L.G.J., 1990, PIGEONPEA, P15; Van der Maesen L.J.G., 1986, L J G CAJANUS DC ATY; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2010, PLANT BREEDING REV, V33, P257; Vavilov N.I., 1951, CHRONICA BOTONICA, V13, P1, DOI [DOI 10.1097/00010694-195112000-00018, 10.2134/agronj1952.00021962004400020016x]; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094829; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weller JL, 2012, P NATL ACAD SCI USA, V109, P21158, DOI 10.1073/pnas.1207943110; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	36	122	128	7	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2017	49	7					1082	+		10.1038/ng.3872	http://dx.doi.org/10.1038/ng.3872			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EY8OB	28530677	Green Accepted			2022-12-17	WOS:000404253300017
J	Novikova, PY; Hohmann, N; Nizhynska, V; Tsuchimatsu, T; Ali, J; Muir, G; Guggisberg, A; Paape, T; Schmid, K; Fedorenko, OM; Holm, S; Sall, T; Schlotterer, C; Marhold, K; Widmer, A; Sese, J; Shimizu, KK; Weigel, D; Kramer, U; Koch, MA; Nordborg, M				Novikova, Polina Yu; Hohmann, Nora; Nizhynska, Viktoria; Tsuchimatsu, Takashi; Ali, Jamshaid; Muir, Graham; Guggisberg, Alessia; Paape, Tim; Schmid, Karl; Fedorenko, Olga M.; Holm, Svante; Sall, Torbjorn; Schlotterer, Christian; Marhold, Karol; Widmer, Alex; Sese, Jun; Shimizu, Kentaro K.; Weigel, Detlef; Kramer, Ute; Koch, Marcus A.; Nordborg, Magnus			Sequencing of the genus Arabidopsis identifies a complex history of nonbifurcating speciation and abundant trans-specific polymorphism	NATURE GENETICS			English	Article							ALLOPOLYPLOID ARABIDOPSIS; METAL HYPERACCUMULATION; PHYLOGENETIC ANALYSIS; PARTITIONING SCHEMES; GENOME; EVOLUTION; POPULATION; SELECTION; THALIANA; PLANTS	The notion of species as reproductively isolated units related through a bifurcating tree implies that gene trees should generally agree with the species tree and that sister taxa should not share polymorphisms unless they diverged recently and should be equally closely related to outgroups. It is now possible to evaluate this model systematically. We sequenced multiple individuals from 27 described taxa representing the entire Arabidopsis genus. Cluster analysis identified seven groups, corresponding to described species that capture the structure of the genus. However, at the level of gene trees, only the separation of Arabidopsis thaliana from the remaining species was universally supported, and, overall, the amount of shared polymorphism demonstrated that reproductive isolation was considerably more recent than the estimated divergence times. We uncovered multiple cases of past gene flow that contradict a bifurcating species tree. Finally, we showed that the pattern of divergence differs between gene ontologies, suggesting a role for selection.	[Novikova, Polina Yu; Nizhynska, Viktoria; Tsuchimatsu, Takashi; Nordborg, Magnus] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, Vienna, Austria; [Novikova, Polina Yu; Muir, Graham] Vetmeduni, Inst Populat Genet, Vienna Grad Sch Populat Genet, Vienna, Austria; [Hohmann, Nora; Koch, Marcus A.] Heidelberg Univ, Ctr Organismal Studies Heidelberg, Heidelberg, Germany; [Ali, Jamshaid; Widmer, Alex; Kramer, Ute] Ruhr Univ Bochum, Dept Plant Physiol, Bochum, Germany; [Guggisberg, Alessia] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Paape, Tim; Shimizu, Kentaro K.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Karl] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, Stuttgart, Germany; [Fedorenko, Olga M.] Russian Acad Sci, Karelian Res Ctr, Inst Biol, Petrozavodsk, Russia; [Holm, Svante] Mid Sweden Univ, Dept Nat Sci, Fac Sci Technol & Media, Sundsvall, Sweden; [Sall, Torbjorn] Lund Univ, Dept Biol, Lund, Sweden; [Schlotterer, Christian] Vetmeduni, Inst Populat Genet, Vienna, Austria; [Marhold, Karol] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Marhold, Karol] Slovak Acad Sci, Inst Bot, Bratislava, Slovakia; [Sese, Jun] Natl Inst Adv Ind Sci & Technol, Artificial Intelligence Res Ctr, Tokyo, Japan; [Weigel, Detlef] Max Planck Inst Dev Biol, Tubingen, Germany; [Tsuchimatsu, Takashi] Chiba Univ, Dept Biol, Chiba, Japan	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Ruprecht Karls University Heidelberg; Ruhr University Bochum; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Hohenheim; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; Mid-Sweden University; Lund University; Charles University Prague; Slovak Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); Max Planck Society; Chiba University	Nordborg, M (corresponding author), Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst, Vienna, Austria.	magnus.nordborg@gmi.oeaw.ac.at	Walden, Nora/AAV-4074-2020; Schlötterer, Christian/Q-5264-2019; Novikova, Polina Yu./AAZ-9233-2020; Guggisberg, Alessia/ABD-9839-2021; Kraemer, Ute/C-5025-2008; Sese, Jun/A-5651-2017; Koch, Marcus A/A-4924-2011; Tsuchimatsu, Takashi/A-9218-2017; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Marhold, Karol/B-4699-2011; Weigel, Detlef/C-1418-2008; Tsuchimatsu, Takashi/T-7402-2019; Widmer, Alex/B-6841-2009	Walden, Nora/0000-0002-3078-6791; Schlötterer, Christian/0000-0003-4710-6526; Novikova, Polina Yu./0000-0002-4552-4575; Guggisberg, Alessia/0000-0001-8258-0472; Kraemer, Ute/0000-0001-7870-4508; Sese, Jun/0000-0003-3495-4382; Koch, Marcus A/0000-0002-1693-6829; Tsuchimatsu, Takashi/0000-0003-1241-9338; Weigel, Detlef/0000-0002-2114-7963; Marhold, Karol/0000-0002-7658-0844; Weigel, Detlef/0000-0002-2114-7963; Tsuchimatsu, Takashi/0000-0003-1241-9338; Widmer, Alex/0000-0001-8253-5137; Paape, Timothy/0000-0002-3595-2875; Ali, Jamshaid/0000-0001-5732-1444; Nordborg, Magnus/0000-0001-7178-9748; Shimizu, Kentaro K./0000-0002-6483-1781	German Research Foundation [DFG SPP 1529, KO 2302/13-2, KO 2302/14-1]; Swiss National Science Foundation; URPP Evolution in Action; HFSP; EU; Czech Science Foundation [P506/12/0668]; Austrian Science Funds [FWF DK W1225]; Grants-in-Aid for Scientific Research [15K18583] Funding Source: KAKEN	German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); URPP Evolution in Action; HFSP(Human Frontier Science Program); EU(European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); Austrian Science Funds(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Belkhadir, K. Bomblies and J. de Meaux for discussions and comments on the manuscript; R. Schmickl, L. Paule, C. Tremblay, J. Cayouette, G. Mitrow, H. Tsukaya and O. Savolainen for help with collections; and P. Forai, M. Hatakeyama and M. Kiefer for IT support. This work was supported by the German Research Foundation (DFG SPP 1529 to M.A.K., U.K., M.N., C.S., D.W. and A.W., and KO 2302/13-2, KO 2302/14-1 to M. A. K.), by the Swiss National Science Foundation and URPP Evolution in Action (to K.K.S.), by HFSP (to J.S. and K.K.S.), by the EU Plant Fellows Program (to T.P.), by the Czech Science Foundation (P506/12/0668 to K.M.), and by the Austrian Science Funds (FWF DK W1225 to C.S.).	Akama S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1376; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Brandvain Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003754; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cui XF, 2007, PLANT CELL, V19, P1388, DOI 10.1105/tpc.107.051375; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doyle JJ., 1987, PHYTOCHEM B, V19, P11, DOI [10.1007/s001220100710, DOI 10.2307/4119796]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; Hohmann N, 2015, PLANT CELL, V27, P2770, DOI 10.1105/tpc.15.00482; Hohmann N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0224-x; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; HYLANDER NILS, 1957, BULL JARD BOT ETAT BRUXELLES, V27, P591, DOI 10.2307/3666887; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jonsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KLEIN J, 1993, J MED PRIMATOL, V22, P57; Kofler R, 2012, BIOINFORMATICS, V28, P2084, DOI 10.1093/bioinformatics/bts315; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Mailund T., 2014, ELS; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nagylaki T, 1998, GENETICS, V148, P1325; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2000, GENETICS, V154, P923; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavlidis P, 2010, MOL ECOL RESOUR, V10, P723, DOI 10.1111/j.1755-0998.2010.02832.x; Pease JB, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002379; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Schmickl R, 2011, P NATL ACAD SCI USA, V108, P14192, DOI 10.1073/pnas.1104212108; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; Shimizu Kentaro K., 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P163; Shimizu KK, 2015, ANNU REV ECOL EVOL S, V46, P593, DOI 10.1146/annurev-ecolsys-112414-054249; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Shimizu-Inatsugi R, 2009, MOL ECOL, V18, P4024, DOI 10.1111/j.1365-294X.2009.04329.x; Slatkin M, 2008, MOL BIOL EVOL, V25, P2241, DOI 10.1093/molbev/msn172; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suh A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002224; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; TAJIMA F, 1989, GENETICS, V123, P585; The 1001 Genomes Consortium, 2016, CELL; Toivainen T, 2014, MOL ECOL, V23, P1040, DOI 10.1111/mec.12682; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Willems G, 2007, GENETICS, V176, P659, DOI 10.1534/genetics.106.064485; Wiuf C, 2004, GENETICS, V168, P2363, DOI 10.1534/genetics.104.029488	73	122	125	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1077	+		10.1038/ng.3617	http://dx.doi.org/10.1038/ng.3617			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27428747	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-17	WOS:000382398800021
J	Kleinman, CL; Gerges, N; Papillon-Cavanagh, S; Sin-Chan, P; Pramatarova, A; Quang, DAK; Adoue, V; Busche, S; Caron, M; Djambazian, H; Bemmo, A; Fontebasso, AM; Spence, T; Schwartzentruber, J; Albrecht, S; Hauser, P; Garami, M; Klekner, A; Bognar, L; Montes, JL; Staffa, A; Montpetit, A; Berube, P; Zakrzewska, M; Zakrzewski, K; Liberski, PP; Dong, ZF; Siegel, PM; Duchaine, T; Perotti, C; Fleming, A; Faury, D; Remke, M; Gallo, M; Dirks, P; Taylor, MD; Sladek, R; Pastinen, T; Chan, JA; Huang, A; Majewski, J; Jabado, N				Kleinman, Claudia L.; Gerges, Noha; Papillon-Cavanagh, Simon; Sin-Chan, Patrick; Pramatarova, Albena; Quang, Dong-Anh Khuong; Adoue, Veronique; Busche, Stephan; Caron, Maxime; Djambazian, Haig; Bemmo, Amandine; Fontebasso, Adam M.; Spence, Tara; Schwartzentruber, Jeremy; Albrecht, Steffen; Hauser, Peter; Garami, Miklos; Klekner, Almos; Bognar, Laszlo; Montes, Jose-Luis; Staffa, Alfredo; Montpetit, Alexandre; Berube, Pierre; Zakrzewska, Magdalena; Zakrzewski, Krzysztof; Liberski, Pawel P.; Dong, Zhifeng; Siegel, Peter M.; Duchaine, Thomas; Perotti, Christian; Fleming, Adam; Faury, Damien; Remke, Marc; Gallo, Marco; Dirks, Peter; Taylor, Michael D.; Sladek, Robert; Pastinen, Tomi; Chan, Jennifer A.; Huang, Annie; Majewski, Jacek; Jabado, Nada			Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASES DNMT3A; RNA-SEQ; CANCER-CELLS; HUMAN GENOME; METHYLATION; GENES; IDENTIFICATION; MUTATIONS; ULTRAFAST; ALIGNMENT	Embryonal tumors with multilayered rosettes (ETMRs) are rare, deadly pediatric brain tumors characterized by high-level amplification of the microRNA cluster C19MC(1,2). We performed integrated genetic and epigenetic analyses of 12 ETMR samples and identified, in all cases, C19MC fusions to TTYH1 driving expression of the microRNAs. ETMR tumors, cell lines and xenografts showed a specific DNA methylation pattern distinct from those of other tumors and normal tissues. We detected extreme overexpression of a previously uncharacterized isoform of DNMT3B originating at an alternative promoter(3) that is active only in the first weeks of neural tube development. Transcriptional and immunohistochemical analyses suggest that C19MC-dependent DNMT3B deregulation is mediated by RBL2, a known repressor of DNMT3B(4,5). Transfection with individual C19MC microRNAs resulted in DNMT3B upregulation and RBL2 downregulation in cultured cells. Our data suggest a potential oncogenic re-engagement of an early developmental program in ETMR via epigenetic alteration mediated by an embryonic, brain-specific DNMT3B isoform.	[Kleinman, Claudia L.; Papillon-Cavanagh, Simon; Pramatarova, Albena; Adoue, Veronique; Busche, Stephan; Caron, Maxime; Djambazian, Haig; Bemmo, Amandine; Schwartzentruber, Jeremy; Staffa, Alfredo; Montpetit, Alexandre; Berube, Pierre; Sladek, Robert; Pastinen, Tomi] McGill Univ, Montreal, PQ, Canada; [Kleinman, Claudia L.; Papillon-Cavanagh, Simon; Pramatarova, Albena; Adoue, Veronique; Busche, Stephan; Caron, Maxime; Djambazian, Haig; Bemmo, Amandine; Schwartzentruber, Jeremy; Staffa, Alfredo; Montpetit, Alexandre; Berube, Pierre; Sladek, Robert; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Kleinman, Claudia L.; Gerges, Noha; Quang, Dong-Anh Khuong; Sladek, Robert; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sin-Chan, Patrick; Spence, Tara; Huang, Annie] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Fontebasso, Adam M.; Jabado, Nada] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Ctr Hlth, Montreal, PQ, Canada; [Hauser, Peter; Garami, Miklos] Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, H-4012 Debrecen, Hungary; [Montes, Jose-Luis] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Neurosurg,,Dept Surg, Montreal, PQ, Canada; [Zakrzewska, Magdalena; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland; [Zakrzewski, Krzysztof] Polish Mothers Mem Hosp, Res Inst, Dept Neurosurg, Lodz, Poland; [Dong, Zhifeng; Siegel, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Duchaine, Thomas] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Perotti, Christian; Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Fleming, Adam; Faury, Damien] McGill Univ, Dept Pediat, Div Pediat Hematol Oncol, Montreal, PQ, Canada; [Fleming, Adam; Faury, Damien] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Remke, Marc; Gallo, Marco; Dirks, Peter; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Huang, Annie] Univ Toronto, Hosp Sick Children, Dept Pediat, Arthur & Sonia Labatt Brain Tumour Res Ctr,Progra, Toronto, ON M5G 1X8, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; Semmelweis University; University of Debrecen; McGill University; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; McGill University; McGill University; University of Calgary; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Jabado, N (corresponding author), McGill Univ, Montreal, PQ, Canada.	annie.huang@sickkids.ca; jacek.majewski@mcgill.ca; nada.jabado@mcgill.ca	Fleming, Adam J/ABB-2202-2021; Garami, Miklós/AAK-5680-2021; Khuong Quang, Dong Anh/GPT-2523-2022; Zakrzewski, Krzysztof/M-5985-2014; Papillon-Cavanagh, Simon/AAS-8749-2020; Duchaine, Thomas/U-2399-2019; Sladek, Robert/R-2391-2019; Zakrzewska, Magdalena/S-9308-2016; Jabado, Nada/AAN-4026-2020	Fleming, Adam J/0000-0002-7194-3220; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Sladek, Robert/0000-0002-2730-1204; Zakrzewska, Magdalena/0000-0001-5826-7726; Kleinman, Claudia/0000-0002-5158-7126; Berube, Pierre/0000-0002-1008-192X; Gallo, Marco/0000-0002-8451-8207; Remke, Marc/0000-0002-9404-9993; Adoue, Veronique/0000-0003-3548-7456; Taylor, Michael/0000-0001-7009-3466; Duchaine, Thomas/0000-0002-3454-1839; Schwartzentruber, Jeremy/0000-0002-6183-2092; Zakrzewski, Krzysztof/0000-0001-5454-1783	Cancer Research Society; National Research and Development Fund (NKFP) [1A/002/2004, TAMOP-4.2.2A-11/1/KONV-2012-0025]; Canadian Institutes of Health Research [102684]; Chercheur Clinicien Senior Award; RMGA (Reseau Medical de Genetique Apliquee; Network of Applied Genetic Medicine) fellowship; Fonds de Recherche du Quebec-Sante; Cedars; Canadian Institutes of Health Research; McGill-Canadian Institutes of Health Research Training Program in Systems Biology; Hungarian Scientific Research Fund (OTKA) [T-04639]	Cancer Research Society; National Research and Development Fund (NKFP); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Chercheur Clinicien Senior Award; RMGA (Reseau Medical de Genetique Apliquee; Network of Applied Genetic Medicine) fellowship; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Cedars; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill-Canadian Institutes of Health Research Training Program in Systems Biology; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Cancer Research Society and was funded in part by Hungarian Scientific Research Fund (OTKA) contract T-04639, by National Research and Development Fund (NKFP) contracts 1A/002/2004 (P. H., M. Garami and L. B.) and TAMOP-4.2.2A-11/1/KONV-2012-0025 (A. K. and L. B.), and by Canadian Institutes of Health Research grant 102684 (A. H.). N.J. is a member of the Penny Cole laboratory and is the recipient of a Chercheur Clinicien Senior Award. S. B. is supported by an RMGA (Reseau Medical de Genetique Apliquee; Network of Applied Genetic Medicine) fellowship. T. P. and J.M. hold Canada Research Chairs (tier 2). C. L. K. is the recipient of a fellowship award from the Fonds de Recherche du Quebec-Sante, N.G. is the recipient of a studentship award from Cedars, and A. M. F. is the recipient of a studentship from the Canadian Institutes of Health Research and the McGill-Canadian Institutes of Health Research Training Program in Systems Biology. R. S. is supported by the Canadian Institutes of Health Research.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flor I, 2012, J PATHOL, V227, P270, DOI 10.1002/path.4014; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Gessi M, 2009, AM J SURG PATHOL, V33, P211, DOI 10.1097/PAS.0b013e318186235b; Hayette S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051527; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korshunov A, 2012, ACTA NEUROPATHOL, V124, P875, DOI 10.1007/s00401-012-1068-3; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Pfister S, 2009, ACTA NEUROPATHOL, V117, P457, DOI 10.1007/s00401-008-0467-y; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shi YH, 2013, BIOINFORMATICS, V29, P1461, DOI 10.1093/bioinformatics/btt151; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; Tan MH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.65; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Yanagisawa Y, 2002, BBA-GENE STRUCT EXPR, V1577, P457, DOI 10.1016/S0167-4781(02)00482-7; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008	43	122	125	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2014	46	1					39	+		10.1038/ng.2849	http://dx.doi.org/10.1038/ng.2849			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	281PM	24316981				2022-12-17	WOS:000329113500010
J	Ruark, E; Seal, S; McDonald, H; Zhang, F; Elliot, A; Lau, K; Perdeaux, E; Rapley, E; Eeles, R; Peto, J; Kote-Jarai, Z; Muir, K; Nsengimana, J; Shipley, J; Bishop, DT; Stratton, MR; Easton, DF; Huddart, RA; Rahman, N; Turnbull, C				Ruark, Elise; Seal, Sheila; McDonald, Heather; Zhang, Feng; Elliot, Anna; Lau, KingWai; Perdeaux, Elizabeth; Rapley, Elizabeth; Eeles, Rosalind; Peto, Julian; Kote-Jarai, Zsofia; Muir, Kenneth; Nsengimana, Jeremie; Shipley, Janet; Bishop, D. Timothy; Stratton, Michael R.; Easton, Douglas F.; Huddart, Robert A.; Rahman, Nazneen; Turnbull, Clare		UKTCC	Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GERM-CELL LINEAGE; TERT-CLPTM1L LOCUS; AUTOSOMAL GENE; BREAST-CANCER; MICE; PROTEIN; TESTIS; TUMOR; TEX14	Testicular germ cell tumor (TGCT) is the most common cancer in young men and is notable for its high familial risks(1,2). So far, six loci associated with TGCT have been reported(3-7). From genome-wide association study (GWAS) analysis of 307,291 SNPs in 986 TGCT cases and 4,946 controls, we selected for follow-up 694 SNPs, which we genotyped in a further 1,064 TGCT cases and 10,082 controls from the UK. We identified SNPs at nine new loci (1q22, 1q24.1, 3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1, 17q22 and 21q22.3) showing association with TGCT (P < 5 x 10(-8)), which together account for an additional 4-6% of the familial risk of TGCT. The loci include genes plausibly related to TGCT development. PRDM14, at 8q13.3, is essential for early germ cell specification(8), and DAZL, at 3p24.3, is required for the regulation of germ cell development(9). Furthermore, PITX1, at 5q31.1, regulates TERT expression and is the third TGCT-associated locus implicated in telomerase regulation(10).	[Ruark, Elise; Seal, Sheila; McDonald, Heather; Zhang, Feng; Elliot, Anna; Lau, KingWai; Perdeaux, Elizabeth; Rapley, Elizabeth; Eeles, Rosalind; Kote-Jarai, Zsofia; Rahman, Nazneen; Turnbull, Clare] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Ruark, Elise; Seal, Sheila; McDonald, Heather; Zhang, Feng; Elliot, Anna; Lau, KingWai; Perdeaux, Elizabeth; Rapley, Elizabeth; Eeles, Rosalind; Kote-Jarai, Zsofia; Rahman, Nazneen; Turnbull, Clare] Royal Marsden Natl Hlth Serv NHS Fdn, Fulham, SA, Australia; [Eeles, Rosalind] Royal Marsden Natl Hlth Serv NHS Fdn, Sutton, Surrey, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Muir, Kenneth] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Nsengimana, Jeremie; Bishop, D. Timothy] Leeds Inst Mol Med, Sect Epidemiol & Biostat, Leeds, W Yorkshire, England; [Shipley, Janet] Inst Canc Res, Sutton, Surrey, England; [Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge, England; [Easton, Douglas F.] Canc Res UK, Strangeways Res Lab, Genet Epidemiol Unit, Cambridge, England; [Huddart, Robert A.] Inst Canc Res, Acad Radiotherapy Unit, Sutton, Surrey, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of Leeds; University of London; Institute of Cancer Research - UK; Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; Institute of Cancer Research - UK	Turnbull, C (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	clare.turnbull@icr.ac.uk	Turnbull, Clare/AAA-6596-2019; Nsengimana, Jeremie/AAP-3185-2020; Nsengimana, Jeremie/AGK-5625-2022; Rahman, Nazneen/D-2802-2013	huddart, robert/0000-0003-3604-1990; Bishop, Tim/0000-0002-8752-8785; Perdeaux, Elizabeth/0000-0001-7042-830X; Rahman, Nazneen/0000-0003-4376-0440; Turnbull, Clare/0000-0002-1734-5772; Eeles, Rosalind/0000-0002-3698-6241; Shipley, Janet/0000-0001-6748-8678	National Health Service; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]; Cancer Research UK [C1287/A10710, C5047/A7357]; Prostate Action; Institute of Cancer Research; Wellcome Trust; Movember; Cancer Research UK [15007, 10118, 11022, 10589] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish	National Health Service; European Community's Seventh Framework Programme(European Commission); Cancer Research UK(Cancer Research UK); Prostate Action; Institute of Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Movember; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the subjects with TGCT and the clinicians involved in their care for participation in this study. We also thank M. Warren Perry, D. Dudakia, J. Pugh, R. Linger, J. Marke, D. Hughes and D. Pernet for recruitment of subjects and database entry for the TGCT collections, and we thank the UK Genetics of Prostate Cancer Study (UKGPCS) study teams for the recruitment of the UKGPCS controls. This study would not have been possible without the contributions of the following: P. Hall (COGS); D. F. Easton (BCAC), A. Berchuck (OCAC), R. Eeles (PRACTICAL), G. Chenevix-Trench (CIMBA), J. Dennis, A. M. Dunning, A. Lee, E. Dicks and D. F. Easton (Cambridge); J. Benitez, A. Gonzalez-Neira and the staff of the CNIO genotyping unit; J. Simard and D.C. Tessier, F. Bacot, D. Vincent, S. LaBoissiere and F. Robidoux and the staff of the McGill University and Genome Quebec Innovation Centre; S.E. Bojesen, S.F. Nielsen, B.G. Nordestgaard and the staff of the Copenhagen DNA laboratory; and J.M. Cunningham, S.A. Windebank, C.A. Hilker, J. Meyer and the staff of Mayo Clinic Genotyping Core Facility. We acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. The COGS (Collaborative Oncological Gene-environment Study) research initiative leading to these results has received support from the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175), Cancer Research UK (grants C1287/A10710 and C5047/A7357) and Prostate Action. This study makes use of data generated by the Wellcome Trust Case Control Consortium 2 (WTCCC2). A full list of the investigators who contributed to the generation of the data is available from the WTCCC website. D.F.E. is a Principal Research Fellow of Cancer Research UK. The initial GWAS study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust. This study was supported by the Institute of Cancer Research and Movember.	Bray F, 2006, NAT CLIN PRACT UROL, V3, P532, DOI 10.1038/ncpuro0606; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Dettman EJ, 2011, ONCOGENE, V30, P2859, DOI 10.1038/onc.2011.12; Dettman EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003823; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Jin JL, 2005, BIOL REPROD, V73, P1235, DOI 10.1095/biolreprod.105.045468; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kurimoto K, 2008, CELL CYCLE, V7, P3514, DOI 10.4161/cc.7.22.6979; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; Liu Bingbing, 2010, Zhongguo Fei Ai Za Zhi, V13, P867, DOI 10.3779/j.issn.1009-3419.2010.09.06; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Monda G, 2012, MOL CELL, V45, P680, DOI 10.1016/j.molcel.2012.01.013; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Shan ZH, 1996, HUM MOL GENET, V5, P2005, DOI 10.1093/hmg/5.12.2005; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Turnbull C, 2011, INT J ANDROL, V34, pE86, DOI 10.1111/j.1365-2605.2011.01162.x; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wu MH, 2003, GENE EXPR PATTERNS, V3, P231, DOI 10.1016/S1567-133X(03)00036-X; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013	47	122	125	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					686	+		10.1038/ng.2635	http://dx.doi.org/10.1038/ng.2635			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23666240	Green Accepted			2022-12-17	WOS:000319563900018
J	Svishcheva, GR; Axenovich, TI; Belonogova, NM; van Duijn, CM; Aulchenko, YS				Svishcheva, Gulnara R.; Axenovich, Tatiana I.; Belonogova, Nadezhda M.; van Duijn, Cornelia M.; Aulchenko, Yurii S.			Rapid variance components-based method for whole-genome association analysis	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; WIDE ASSOCIATION; MIXED-MODEL	The variance component tests used in genome-wide association studies (GWAS) including large sample sizes become computationally exhaustive when the number of genetic markers is over a few hundred thousand. We present an extremely fast variance components-based two-step method, GRAMMAR-Gamma, developed as an analytical approximation within a framework of the score test approach. Using simulated and real human GWAS data sets, we show that this method provides unbiased estimates of the SNP effect and has a power close to that of the likelihood ratio test-based method. The computational complexity of our method is close to its theoretical minimum, that is, to the complexity of the analysis that ignores genetic structure. The running time of our method linearly depends on sample size, whereas this dependency is quadratic for other existing methods. Simulations suggest that GRAMMAR-Gamma may be used for association testing in whole-genome resequencing studies of large human cohorts.	[Svishcheva, Gulnara R.; Axenovich, Tatiana I.; Belonogova, Nadezhda M.; Aulchenko, Yurii S.] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk, Russia; [van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Erasmus University Rotterdam; Erasmus MC	Aulchenko, YS (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk, Russia.	yurii@bionet.nsc.ru	Svishcheva, Gulnara/AAD-2881-2022; Axenovich, Tatiana I/AAD-2595-2022; Aulchenko, Yurii/M-8270-2013	Svishcheva, Gulnara/0000-0001-9478-267X; Axenovich, Tatiana I/0000-0002-4318-4458; Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204	Russian Foundation for Basic Research (RFBR) Programs of the Russian Academy of Sciences; RFBR-Helmholtz Joint Research Groups program [12-04-91322-CNT_a]	Russian Foundation for Basic Research (RFBR) Programs of the Russian Academy of Sciences; RFBR-Helmholtz Joint Research Groups program	We thank A. Kirichenko, D. Fabregat Traver and P. Bientinesi for technical support and advice and M. Axenovich, D. Balding, P. Borodin and W. Astle for discussion. This work was supported by grants from the Russian Foundation for Basic Research (RFBR) Programs of the Russian Academy of Sciences and the RFBR-Helmholtz Joint Research Groups program (research project 12-04-91322-CNT_a).	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Astle W., 2009, THESIS U LONDON; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; HENDERSON CR, 1953, BIOMETRICS, V9, P226, DOI 10.2307/3001853; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	19	122	130	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1166	+		10.1038/ng.2410	http://dx.doi.org/10.1038/ng.2410			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22983301				2022-12-17	WOS:000309550200021
J	Harakalova, M; van Harssel, JJT; Terhal, PA; van Lieshout, S; Duran, K; Renkens, I; Amor, DJ; Wilson, LC; Kirk, EP; Turner, CLS; Shears, D; Garcia-Minaur, S; Lees, MM; Ross, A; Venselaar, H; Vriend, G; Takanari, H; Rook, MB; van der Heyden, MAG; Asselbergs, FW; Breur, HM; Swinkels, ME; Scurr, IJ; Smithson, SF; Knoers, NV; van der Smagt, JJ; Nijman, IJ; Kloosterman, WP; van Haelst, MM; van Haaften, G; Cuppen, E				Harakalova, Magdalena; van Harssel, Jeske J. T.; Terhal, Paulien A.; van Lieshout, Stef; Duran, Karen; Renkens, Ivo; Amor, David J.; Wilson, Louise C.; Kirk, Edwin P.; Turner, Claire L. S.; Shears, Debbie; Garcia-Minaur, Sixto; Lees, Melissa M.; Ross, Alison; Venselaar, Hanka; Vriend, Gert; Takanari, Hiroki; Rook, Martin B.; van der Heyden, Marcel A. G.; Asselbergs, Folkert W.; Breur, Hans M.; Swinkels, Marielle E.; Scurr, Ingrid J.; Smithson, Sarah F.; Knoers, Nine V.; van der Smagt, Jasper J.; Nijman, Isaac J.; Kloosterman, Wigard P.; van Haelst, Mieke M.; van Haaften, Gijs; Cuppen, Edwin			Dominant missense mutations in ABCC9 cause Cantu syndrome	NATURE GENETICS			English	Article							K-ATP CHANNELS; CONGENITAL HYPERTRICHOSIS; GENOMIC ENRICHMENT; OSTEOCHONDRODYSPLASIA; SUR; INHERITANCE; PATIENT; OPENERS	Cantu syndrome is characterized by congenital hypertrichosis, distinctive facial features, osteochondrodysplasia and cardiac defects. By using family-based exome sequencing, we identified a de novo mutation in ABCC9. Subsequently, we discovered novel dominant missense mutations in ABCC9 in 14 of the 16 individuals with Cantu syndrome examined. The ABCC9 protein is part of an ATP-dependent potassium (K-ATP) channel that couples the metabolic state of a cell with its electrical activity. All mutations altered amino acids in or close to the transmembrane domains of ABCC9. Using electrophysiological measurements, we show that mutations in ABCC9 reduce the ATP-mediated potassium channel inhibition, resulting in channel opening. Moreover, similarities between the phenotype of individuals with Cantu syndrome and side effects from the K-ATP channel agonist minoxidil indicate that the mutations in ABCC9 result in channel opening. Given the availability of ABCC9 antagonists, our findings may have direct implications for the treatment of individuals with Cantu syndrome.	[Harakalova, Magdalena; van Harssel, Jeske J. T.; Terhal, Paulien A.; van Lieshout, Stef; Duran, Karen; Renkens, Ivo; Swinkels, Marielle E.; Knoers, Nine V.; van der Smagt, Jasper J.; Nijman, Isaac J.; Kloosterman, Wigard P.; van Haelst, Mieke M.; van Haaften, Gijs; Cuppen, Edwin] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Amor, David J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Amor, David J.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Wilson, Louise C.; Lees, Melissa M.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London, England; [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Turner, Claire L. S.] Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England; [Shears, Debbie] Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; [Garcia-Minaur, Sixto] La Paz Univ Hosp, Inst Med & Mol Genet, Madrid, Spain; [Ross, Alison] Dept Clin Genet, Aberdeen, Scotland; [Venselaar, Hanka; Vriend, Gert] CMBI, Nijmegen, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Med Ctr, NCMLS, NL-6525 ED Nijmegen, Netherlands; [Takanari, Hiroki; Rook, Martin B.; van der Heyden, Marcel A. G.] Univ Med Ctr Utrecht, Dept Med Physiol, Utrecht, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Breur, Hans M.] Univ Med Ctr Utrecht, Dept Pediat Cardiol, Utrecht, Netherlands; [Scurr, Ingrid J.; Smithson, Sarah F.] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [van Haelst, Mieke M.] Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London, England; [Cuppen, Edwin] Univ Med Ctr Utrecht, Royal Dutch Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Sydney; University of Exeter; University of Oxford; Hospital Universitario La Paz; University of Aberdeen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Imperial College London; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Cuppen, E (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	g.vanhaaften@umcutrecht.nl; e.cuppen@hubrecht.eu	Cuppen, Edwin/F-5696-2011; Venselaar, Hanka/D-2009-2016; Amor, David J/A-6478-2018; breur, hans/AAY-2340-2020; Cuppen, Edwin/H-2389-2016; Vriend, G./H-8112-2014; van Haaften, Gijs/G-7832-2012; Asselbergs, Folkert W./ABD-6752-2021	Cuppen, Edwin/0000-0002-0400-9542; Venselaar, Hanka/0000-0001-9824-6559; Amor, David J/0000-0001-7191-8511; Cuppen, Edwin/0000-0002-0400-9542; van Haaften, Gijs/0000-0003-3033-0329; Asselbergs, Folkert W./0000-0002-1692-8669; van der Heyden, Marcel/0000-0002-4225-7942; Kirk, Edwin/0000-0002-4662-0024; Nijman, Isaac/0000-0002-1840-1158	Netherlands Organisation for Health Research and Development (ZonMw) [90700342]; Veni Grant from the Netherlands Organisation for Health Research and Development; University Medical Center Utrecht	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Veni Grant from the Netherlands Organisation for Health Research and Development; University Medical Center Utrecht	We thank the families of our subjects for participating in this study. We thank J.A. Sanchez-Chapula (Centro Universitario de Investigaciones Biomedicas de la Universidad de Colima) for providing wild-type KCNJ11 and ABCC9 expression constructs and N. Lansu and E. de Bruijn for technical support. F.W.A. is supported by a clinical fellowship from the Netherlands Organisation for Health Research and Development (ZonMw; 90700342). G.v.H. is supported by a Veni Grant from the Netherlands Organisation for Health Research and Development. This study was financially supported by the Child Health Priority Program of the University Medical Center Utrecht.	Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; CANTU JM, 1982, HUM GENET, V60, P36, DOI 10.1007/BF00281261; Concolino D, 2000, AM J MED GENET, V92, P191, DOI 10.1002/(SICI)1096-8628(20000529)92:3<191::AID-AJMG6>3.0.CO;2-K; Engels H, 2002, AM J MED GENET, V111, P205, DOI 10.1002/ajmg.10560; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; GarciaCruz D, 1997, AM J MED GENET, V69, P138, DOI 10.1002/(SICI)1096-8628(19970317)69:2<138::AID-AJMG5>3.0.CO;2-L; Grange DK, 2006, AM J MED GENET A, V140A, P1673, DOI 10.1002/ajmg.a.31348; Graziadio C, 2011, AM J MED GENET A, V155A, P1184, DOI 10.1002/ajmg.a.33904; Harakalova M, 2011, NAT PROTOC, V6, P1870, DOI 10.1038/nprot.2011.396; Ishihara K, 2004, J PHYSIOL-LONDON, V556, P61, DOI 10.1113/jphysiol.2003.055434; Lazalde B, 2000, AM J MED GENET, V94, P421, DOI 10.1002/1096-8628(20001023)94:5<421::AID-AJMG15>3.0.CO;2-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Nevin NC, 1996, AM J MED GENET, V66, P33, DOI 10.1002/(SICI)1096-8628(19961202)66:1<33::AID-AJMG8>3.3.CO;2-3; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nijman IJ, 2010, NAT METHODS, V7, P913, DOI 10.1038/nmeth.1516; Olson TM, 2007, NAT CLIN PRACT CARD, V4, P110, DOI 10.1038/ncpcardio0792; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Robertson SP, 1999, AM J MED GENET, V85, P395, DOI 10.1002/(SICI)1096-8628(19990806)85:4<395::AID-AJMG17>3.3.CO;2-9; Rosser EM, 1998, CLIN DYSMORPHOL, V7, P79, DOI 10.1097/00019605-199804000-00001; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Scurr I, 2011, AM J MED GENET A, V155A, P508, DOI 10.1002/ajmg.a.33885; Shi NQ, 2005, J MOL CELL CARDIOL, V39, P51, DOI 10.1016/j.yjmcc.2004.11.024; Shorter K, 2008, FASEB J, V22, P1725, DOI 10.1096/fj.07-099424; Tan TY, 2005, AM J MED GENET A, V139A, P216, DOI 10.1002/ajmg.a.31013	28	122	127	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2012	44	7					793	U223		10.1038/ng.2324	http://dx.doi.org/10.1038/ng.2324			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967DP	22610116				2022-12-17	WOS:000305886900014
J	Houlden, H; Johnson, J; Gardner-Thorpe, C; Lashley, T; Hernandez, D; Worth, P; Singleton, AB; Hilton, DA; Holton, J; Revesz, T; Davis, MB; Giunti, P; Wood, NW				Houlden, Henry; Johnson, Janel; Gardner-Thorpe, Christopher; Lashley, Tammaryn; Hernandez, Dena; Worth, Paul; Singleton, Andrew B.; Hilton, David A.; Holton, Janice; Revesz, Tamas; Davis, Mary B.; Giunti, Paolo; Wood, Nicholas W.			Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR ATAXIAS; ALZHEIMERS-DISEASE; CLINICAL-FEATURES; DISORDERS; PROTEIN; FAMILY	The microtubule-associated protein tau ( encoded by MAPT) and several tau kinases have been implicated in neurodegeneration, but only MAPT has a proven role in disease. We identified mutations in the gene encoding tau tubulin kinase 2 ( TTBK2) as the cause of spinocerebellar ataxia type 11. Affected brain tissue showed substantial cerebellar degeneration and tau deposition. These data suggest that TTBK2 is important in the tau cascade and in spinocerebellar degeneration.	UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; NIA, NIH, Neurogenet Lab, Mol Genet Unit, Bethesda, MD 20892 USA; Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; Norwich Univ Hosp, Dept Neurol, Natl Hlth Serv, Norwich NR4 7UY, Norfolk, England; Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Exeter; NHS Blood & Transplant (NHSBT); Derriford Hospital	Houlden, H (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Neurosci, Queen Square, London WC1N 3BG, England.	h.houlden@ion.ucl.ac.uk; n.wood@ion.ucl.ac.uk	Holton, Janice L/F-6831-2011; Houlden, Henry J/C-1532-2008; Revesz, Tamas/A-8732-2010; Lashley, Tammaryn/D-2583-2009; Giunti, Paola/E-5526-2012; Johnson, Janel/A-7136-2010; Wood, Nicholas W/C-2505-2009; Singleton, Andrew B/C-3010-2009	Holton, Janice L/0000-0002-3882-5249; Houlden, Henry J/0000-0002-2866-7777; Revesz, Tamas/0000-0003-2501-0259; Giunti, Paola/0000-0003-3508-4788; Wood, Nicholas W/0000-0002-9500-3348; 	MRC [G108/638] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [Z01AG000958, ZIAAG000958] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G108/638] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Kitano-Takahashi M, 2007, ACTA CRYSTALLOGR F, V63, P602, DOI 10.1107/S1744309107028783; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; MANN DMA, 1990, NEUROPATH APPL NEURO, V16, P17, DOI 10.1111/j.1365-2990.1990.tb00928.x; MUKAETOVALADINSKA EB, 1993, AM J PATHOL, V143, P565; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Riudavets MA, 2006, J NEUROPATH EXP NEUR, V65, P1143, DOI 10.1097/01.jnen.0000248548.20799.a3; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Worth PF, 1999, AM J HUM GENET, V65, P420, DOI 10.1086/302495	15	122	129	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1434	1436		10.1038/ng.2007.43	http://dx.doi.org/10.1038/ng.2007.43			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18037885				2022-12-17	WOS:000251267400008
J	Khetchoumian, K; Teletin, M; Tisserand, J; Mark, M; Herquel, B; Ignat, M; Zucman-Rossi, J; Cammas, F; Lerouge, T; Thibault, C; Metzger, D; Chambon, P; Losson, R				Khetchoumian, Konstantin; Teletin, Marius; Tisserand, Johan; Mark, Manuel; Herquel, Benjamin; Ignat, Mihaela; Zucman-Rossi, Jessica; Cammas, Florence; Lerouge, Thierry; Thibault, Christelle; Metzger, Daniel; Chambon, Pierre; Losson, Regine			Loss of Trim24 (Tif1 alpha) gene function confers oncogenic activity to retinoic acid receptor alpha	NATURE GENETICS			English	Article							NUCLEAR RECEPTORS; HEPATOCELLULAR-CARCINOMA; RAR-ALPHA; LIVER; CHEMOPREVENTION; EXPRESSION; PROTEIN; FAMILY; MEMBER; TIF1	Hepatocellular carcinoma ( HCC) is a major cause of death worldwide. Here, we provide evidence that the ligand-dependent nuclear receptor co-regulator Trim24 ( also known as Tif1 alpha) functions in mice as a liver-specific tumor suppressor. In Trim24-null mice, hepatocytes fail to execute proper cell cycle withdrawal during the neonatal-to-adult transition and continue to cycle in adult livers, becoming prone to a continuum of cellular alterations that progress toward metastatic HCC. Using pharmacological approaches, we show that inhibition of retinoic acid signaling markedly reduces hepatocyte proliferation in Trim24(-/-) mice. We further show that deletion of a single retinoic acid receptor alpha ( Rara) allele in a Trim24-null background suppresses HCC development and restores wild-type expression of retinoic acid-responsive genes in the liver, thus demonstrating that in this genetic background Rara expresses an oncogenic activity correlating with a dysregulation of the retinoic acid signaling pathway. Our results not only provide genetic evidence that Trim24 and Rara co-regulate hepatocarcinogenesis in an antagonistic manner but also suggest that aberrant activation of Rara is deleterious to liver homeostasis.	Univ Strasbourg 1, Coll France, Inst Genet Biol Mol & Cellulaire, Dept Funct Genom,Ctr Natl Rech Sci,Inst Natl Sant, F-67070 Illkirch Graffenstaden, France; Inst Univ Hematol, INSERM, U674, Ctr Polymorphisme Human, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Losson, R (corresponding author), Univ Strasbourg 1, Coll France, Inst Genet Biol Mol & Cellulaire, Dept Funct Genom,Ctr Natl Rech Sci,Inst Natl Sant, BP 10142, F-67070 Illkirch Graffenstaden, France.	losson@igbmc.u-strasbg.fr	zucman-rossi, Jessica/B-5098-2009; TELETIN, Marius/P-6460-2016; TELETIN, Marius/AAS-2241-2020; Cammas, florence m/D-1823-2017; j, zucman-rossi/AAV-3594-2021	zucman-rossi, Jessica/0000-0002-5687-0334; TELETIN, Marius/0000-0002-3286-8125; TELETIN, Marius/0000-0002-3286-8125; Cammas, florence m/0000-0003-4117-8182; j, zucman-rossi/0000-0002-5687-0334; Thibault-Carpentier, Christelle/0000-0003-1562-1451; Metzger, Daniel/0000-0002-5555-046X; Ignat, Mihaela/0000-0002-0250-3280				Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Chapellier B, 2002, GENESIS, V32, P87, DOI 10.1002/gene.10071; Di Bisceglie AM, 2005, J LAB CLIN MED, V145, P134, DOI 10.1016/j.lab.2005.01.003; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; FRITH CH, 1994, PATHOLOGY TUMORS LAB, V2, P223; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; LE DB, 1996, EMBO J, V15, P6701; Ledda-Columbano GM, 2004, CARCINOGENESIS, V25, P2061, DOI 10.1093/carcin/bgh221; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sano K, 2003, CLIN CANCER RES, V9, P3679; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	22	122	124	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1500	1506		10.1038/ng.2007.15	http://dx.doi.org/10.1038/ng.2007.15			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026104				2022-12-17	WOS:000251267400019
J	Cartolano, M; Castillo, R; Efremova, N; Kuckenberg, M; Zethof, J; Gerats, T; Schwarz-Sommer, Z; Vandenbussche, M				Cartolano, Maria; Castillo, Rosa; Efremova, Nadia; Kuckenberg, Markus; Zethof, Jan; Gerats, Tom; Schwarz-Sommer, Zsuzsanna; Vandenbussche, Michiel			A conserved microRNA module exerts homeotic control over Petunia hybrida and Antirrhinum majus floral organ identity	NATURE GENETICS			English	Article							ARABIDOPSIS; FLOWER; GENES; EXPRESSION; MORPHOGENESIS; FIMBRIATA; ELEMENTS; STYLOSA	It is commonly thought that deep phylogenetic conservation of plant microRNAs ( miRNAs) and their targets(1,2) indicates conserved regulatory functions. We show that the blind ( bl) mutant of Petunia hybrida(3) and the fistulata ( fis) mutant of Antirrhinum majus(4,5), which have similar homeotic phenotypes, are recessive alleles of two homologous miRNA- encoding genes. The BL and FIS genes control the spatial restriction of homeotic class C genes(6,7) to the inner floral whorls, but their ubiquitous early floral expression patterns are in contradiction with a potential role in patterning C gene expression. We provide genetic evidence for the unexpected function of the MIRFIS and MIRBL genes in the center of the flower and propose a dynamic mechanism underlying their regulatory role. Notably, Arabidopsis thaliana, a more distantly related species, also contains this miRNA module but does not seem to use it to confine early C gene expression to the center of the flower.	Max Planck Inst Zuchtungsforsch, Plant Mol Genet Dept, D-50829 Cologne, Germany; Radboud Univ Nijmegen, Inst Wetlands & Water Res, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Schwarz-Sommer, Z (corresponding author), Max Planck Inst Zuchtungsforsch, Plant Mol Genet Dept, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schwarzs@mpiz-koeln.mpg.de	Gerats, Tom/A-3528-2012	Cartolano, Maria/0000-0001-9830-988X; VANDENBUSSCHE, Michiel/0000-0002-4192-7369				Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Davies B, 2006, ADV BOT RES, V44, P279, DOI 10.1016/S0065-2296(06)44007-6; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Ingram GC, 1997, EMBO J, V16, P6521, DOI 10.1093/emboj/16.21.6521; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kater MM, 1998, PLANT CELL, V10, P171, DOI 10.1105/tpc.10.2.171; Keck E, 2003, EMBO J, V22, P1058, DOI 10.1093/emboj/cdg097; Maes T, 2001, PLANT CELL, V13, P229, DOI 10.1105/tpc.13.2.229; McSteen PCM, 1998, DEVELOPMENT, V125, P2359; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Motte P, 1998, DEVELOPMENT, V125, P71; Navarro C, 2004, DEVELOPMENT, V131, P3649, DOI 10.1242/dev.01205; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; VALLADE J, 1987, CAN J BOT, V65, P761, DOI 10.1139/b87-101; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943	28	122	146	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					901	905		10.1038/ng2056	http://dx.doi.org/10.1038/ng2056			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17589508	Green Published			2022-12-17	WOS:000247619800022
J	Shi, S; Calhoun, HC; Xia, F; Li, JH; Le, L; Li, WX				Shi, Song; Calhoun, Healani C.; Xia, Fan; Li, Jinghong; Le, Long; Li, Willis X.			JAK signaling globally counteracts heterochromatic gene silencing	NATURE GENETICS			English	Article							HEMATOPOIETIC ONCOGENE; JAK/STAT PATHWAY; DROSOPHILA; GENOME; ACTIVATION; COMPONENTS; KINASE; CANCER; STATS; IDENTIFICATION	The JAK/STAT pathway has pleiotropic roles in animal development, and its aberrant activation is implicated in multiple human cancers(1-3). JAK/ STAT signaling effects have been attributed largely to direct transcriptional regulation by STAT of specific target genes that promote tumor cell proliferation or survival. We show here in a Drosophila melanogaster hematopoietic tumor model, however, that JAK overactivation globally disrupts heterochromatic gene silencing, an epigenetic tumor suppressive mechanism(4). This disruption allows derepression of genes that are not direct targets of STAT, as evidenced by suppression of heterochromatin-mediated position effect variegation. Moreover, mutations in the genes encoding heterochromatin components heterochromatin protein 1 (HP1) and Su(var)3-9 enhance tumorigenesis induced by an oncogenic JAK kinase without affecting JAK/ STAT signaling. Consistently, JAK loss of function enhances heterochromatic gene silencing, whereas overexpressing HP1 suppresses oncogenic JAK-induced tumors. These results demonstrate that the JAK/ STAT pathway regulates cellular epigenetic status and that globally disrupting heterochromatin-mediated tumor suppression is essential for tumorigenesis induced by JAK overactivation.	Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Li, WX (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	willis_li@urmc.rochester.edu	Li, Willis/ABC-5695-2020; Li, Willis X/AAL-7212-2020	Li, Willis/0000-0001-9041-7341; Li, Willis X/0000-0001-9041-7341; Li, Jinghong/0000-0003-2497-9295	NCI NIH HHS [R01 CA131326-01A2, R01 CA131326] Funding Source: Medline; NIGMS NIH HHS [R01 GM065774, R01GM077046, R01 GM065774-04, R01 GM077046, R01 GM077046-03, R01GM65774] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA131326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077046, R01GM065774] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Bach EA, 2003, GENETICS, V165, P1149; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gilbert MM, 2005, MECH DEVELOP, V122, P939, DOI 10.1016/j.mod.2005.03.004; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Ronsseray S, 2001, GENETICS, V159, P1631; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; ZINYK DL, 1993, NAT GENET, V4, P195, DOI 10.1038/ng0693-195	28	122	127	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1071	1076		10.1038/ng1860	http://dx.doi.org/10.1038/ng1860			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16892059	Green Accepted			2022-12-17	WOS:000240112100027
J	Jadeja, S; Smyth, I; Pitera, JE; Taylor, MS; van Haelst, M; Bentley, E; McGregor, L; Hopkins, J; Chalepakis, G; Philip, N; Aytes, AP; Watt, FM; Darling, SM; Jackson, I; Woolf, AS; Scambler, PJ				Jadeja, S; Smyth, I; Pitera, JE; Taylor, MS; van Haelst, M; Bentley, E; McGregor, L; Hopkins, J; Chalepakis, G; Philip, N; Aytes, AP; Watt, FM; Darling, SM; Jackson, I; Woolf, AS; Scambler, PJ			Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs	NATURE GENETICS			English	Article							CRYPTOPHTHALMOS; PHENOTYPE; ADHESION; MOLECULE; CADHERIN; PROTEIN; DOMAIN; MICE	Fraser syndrome is a recessive, multisystem disorder presenting with cryptophthalmos, syndactyly and renal defects(1,2) and associated with loss-of-function mutations of the extracellular matrix protein FRAS1. Fras1 mutant mice have a blebbed phenotype characterized by intrauterine epithelial fragility generating serous and, later, hemorrhagic blisters. The myelencephalic blebs ( my) strain has a similar phenotype. We mapped my to Frem2, a gene related to Fras1 and Frem1, and showed that a Frem2 gene-trap mutation was allelic to my. Expression of Frem2 in adult kidneys correlated with cyst formation in my homozygotes, indicating that the gene is required for maintaining the differentiated state of renal epithelia. Two individuals with Fraser syndrome were homozygous with respect to the same missense mutation of FREM2, confirming genetic heterogeneity. This is the only missense mutation reported in any blebbing mutant or individual with Fraser syndrome, suggesting that calcium binding in the CALX beta-cadherin motif is important for normal functioning of FREM2.	UCL, Mol Med Unit, Inst Child Hlth, London WC1N 1EH, England; CR UK London Res Inst, London WC2A 3PX, England; UCL, Nephrourol Unit, Inst Child Hlth, London WC1N 1EH, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Univ Crete, Dept Biol, Iraklion 71409, Greece; Hosp Enfants Timone, Marseille, France; Hosp Infantil La Fe, Valencia, Spain; Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; University College London; University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of Crete; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Edinburgh	Scambler, PJ (corresponding author), UCL, Mol Med Unit, Inst Child Hlth, London WC1N 1EH, England.	p.scambler@ich.ucl.ac.uk	Scambler, Peter J/C-4998-2008; Woolf, Adrian S./AAZ-1075-2020; Scambler, Peter/AAZ-6026-2020; Watt, Fiona/AHB-0226-2022; Taylor, Martin S/C-3825-2009; Philip, Nicole/I-2881-2016	Scambler, Peter J/0000-0002-1487-4628; Woolf, Adrian S./0000-0001-5541-1358; Scambler, Peter/0000-0002-1487-4628; Watt, Fiona/0000-0001-9151-5154; Taylor, Martin S/0000-0001-7656-330X; Jackson, Ian/0000-0001-6526-0688; Perez-Aytes, Antonio/0000-0003-3401-6943; Smyth, Ian/0000-0002-1727-7829				Darling S, 1994, Clin Dysmorphol, V3, P91; FRASER GR, 1962, ANN HUM GENET, V25, P387, DOI 10.1111/j.1469-1809.1962.tb01774.x; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Little CC, 1923, AM J ROENTGENOL RADI, V10, P975; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	15	122	127	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					520	525		10.1038/ng1549	http://dx.doi.org/10.1038/ng1549			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838507				2022-12-17	WOS:000228862300022
J	Sun, XD; Frierson, HF; Chen, C; Li, CL; Ran, QM; Otto, KB; Cantarel, BM; Vessella, RL; Gao, AC; Petros, J; Miura, Y; Simons, JW; Dong, JT				Sun, XD; Frierson, HF; Chen, C; Li, CL; Ran, QM; Otto, KB; Cantarel, BM; Vessella, RL; Gao, AC; Petros, J; Miura, Y; Simons, JW; Dong, JT			Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENES; NEURONAL DIFFERENTIATION; CARCINOMA-CELLS; PROTEIN; ACTIVATION; DELETIONS; IDENTIFICATION; BINDING; REGION; 16Q	Cancer often results from the accumulation of multiple genetic alterations. Although most malignancies are sporadic, only a small number of genes have been shown to undergo frequent mutations in sporadic cancers. The long arm of chromosome 16 is frequently deleted in human cancers, but the target gene for this deletion has not been identified(1-4). Here we report that ATBF1, which encodes a transcription factor that negatively regulates AFP and MYB5,6 but transactivates CDKN1A(7), is a good candidate for the 16q22 tumor-suppressor gene. We narrowed the region of deletion at 16q22 to 861 kb containing ATBF1. ATBF1 mRNA was abundant in normal prostates but more scarce in approximately half of prostate cancers tested. In 24 of 66 (36%) cancers examined, we identified 22 unique somatic mutations, many of which impair ATBF1 function. Furthermore, ATBF1 inhibited cell proliferation. Hence, loss of ATBF1 is one mechanism that defines the absence of growth control in prostate cancer.	Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA; Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA 22901 USA; Chinese Acad Med Sci, Canc Inst Hosp, Dept Urol Oncol, Beijing 100021, Peoples R China; Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA; Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA; Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Nagoya, Aichi 4678601, Japan; Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Program Genet & Mol Biol, Atlanta, GA 30322 USA	Emory University; University of Virginia; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; University of Virginia; University of Washington; University of Washington Seattle; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Emory University; Emory University; Nagoya City University; Emory University; Emory University	Dong, JT (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA.	jdong2@emory.edu		Dong, Jin-Tang/0000-0003-2349-5782				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Chen CS, 2001, GENOMICS, V77, P135, DOI 10.1006/geno.2001.6631; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dong JT, 2000, CANCER RES, V60, P3880; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Goldberg EK, 2000, AM J HUM GENET, V67, P417, DOI 10.1086/302999; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Kaspar P, 1999, J BIOL CHEM, V274, P14422, DOI 10.1074/jbc.274.20.14422; Kataoka H, 2003, CANCER RES, V63, P5785; Kataoka H, 2001, ONCOGENE, V20, P869, DOI 10.1038/sj.onc.1204160; Kawaguchi M, 2001, BBA-PROTEIN STRUCT M, V1550, P164, DOI 10.1016/S0167-4838(01)00284-9; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; Latil A, 1997, CANCER RES, V57, P1058; Matsuyama H, 2003, PROSTATE, V54, P103, DOI 10.1002/pros.10173; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ninomiya T, 2002, HEPATOLOGY, V35, P82, DOI 10.1053/jhep.2002.30420; Remacle JE, 1997, EMBO J, V16, P5722, DOI 10.1093/emboj/16.18.5722; Strup SE, 1999, J UROLOGY, V162, P590, DOI 10.1016/S0022-5347(05)68631-4; Sun SY, 1997, CANCER RES, V57, P4931; Takada N, 1999, CANCER RES, V59, P2810	29	122	132	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2005	37	4					407	412		10.1038/ng1528	http://dx.doi.org/10.1038/ng1528			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15750593				2022-12-17	WOS:000228040000024
J	Kalscheuer, VM; Freude, K; Musante, L; Jensen, LR; Yntema, HG; Gecz, J; Sefiani, A; Hoffmann, K; Moser, B; Haas, S; Gurok, U; Haesler, S; Aranda, B; Nshedjan, A; Tzschach, A; Hartmann, N; Roloff, TC; Shoichet, S; Hagens, O; Tao, J; van Bokhoven, H; Turner, G; Chelly, J; Moraine, C; Fryns, JP; Nuber, U; Hoeltzenbein, M; Scharff, C; Scherthan, H; Lenzner, S; Hamel, BCJ; Schweiger, S; Ropers, HH				Kalscheuer, VM; Freude, K; Musante, L; Jensen, LR; Yntema, HG; Gecz, J; Sefiani, A; Hoffmann, K; Moser, B; Haas, S; Gurok, U; Haesler, S; Aranda, B; Nshedjan, A; Tzschach, A; Hartmann, N; Roloff, TC; Shoichet, S; Hagens, O; Tao, J; van Bokhoven, H; Turner, G; Chelly, J; Moraine, C; Fryns, JP; Nuber, U; Hoeltzenbein, M; Scharff, C; Scherthan, H; Lenzner, S; Hamel, BCJ; Schweiger, S; Ropers, HH			Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation	NATURE GENETICS			English	Article							BINDING PROTEIN; TRACT-BINDING; WW DOMAIN; TRANSCRIPTION; PQBP-1; NPW38	We found mutations in the gene PQBP1 in 5 of 29 families with nonsyndromic (MRX) and syndromic (MRXS) forms of X-linked mental retardation (XLMR). Clinical features in affected males include mental retardation, microcephaly, short stature, spastic paraplegia and midline defects. PQBP1 has previously been implicated in the pathogenesis of polyglutamine expansion diseases. Our findings link this gene to XLMR and shed more light on the pathogenesis of this common disorder.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia; Dept Genet & Biol Mol INH, Rabat, Morocco; Hunter Genet, Waratah, NSW 2298, Australia; Univ Newcastle, Waratah, NSW 2298, Australia; CHU Cochin Port Royal, INSERM, CNRS, Inst Cochin Genet Mol, F-75014 Paris, France; CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours, France; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium	Max Planck Society; Radboud University Nijmegen; Womens & Childrens Hospital Australia; University of Adelaide; University of Newcastle; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Catholique Louvain	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.		van Bokhoven, Hans/D-8764-2012; Gecz, Jozef/X-3469-2019; Chelly, Jamel/J-7528-2015; Scharff, Constance/HHN-0673-2022; Yntema, H.G./L-4771-2015; Haesler, Sebastian/A-8755-2012; Hoeltzenbein, Maria/AAP-4145-2020; Musante, Luciana/AAA-5726-2021; Bokhoven, J.H.L.M. van van/H-8015-2014; Tzschach, Andreas/I-2648-2019	Gecz, Jozef/0000-0002-7884-6861; Chelly, Jamel/0000-0002-0939-8719; Hoeltzenbein, Maria/0000-0002-2451-4247; Musante, Luciana/0000-0002-2742-1484; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Tzschach, Andreas/0000-0002-6840-965X; Freude, Kristine/0000-0001-9480-2386; Haas, Stefan/0000-0003-3418-3688; Haesler, Sebastian/0000-0003-4924-7381; Kalscheuer, Vera/0000-0001-6898-3259				Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Craggs G, 2001, J BIOL CHEM, V276, P30552, DOI 10.1074/jbc.M103142200; Deqaqi SC, 1998, ANN GENET-PARIS, V41, P11; HAMEL BCJ, 1994, AM J MED GENET, V51, P591, DOI 10.1002/ajmg.1320510459; Iwamoto K, 2000, GENE, V259, P69, DOI 10.1016/S0378-1119(00)00437-6; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; SHOICHET S, IN PRESS AM J HUM GE; SUTHERLAND GR, 1988, AM J MED GENET, V30, P493, DOI 10.1002/ajmg.1320300152; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992	15	122	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					313	315		10.1038/ng1264	http://dx.doi.org/10.1038/ng1264			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14634649	Green Published			2022-12-17	WOS:000186791000010
J	Kanehisa, M; Bork, P				Kanehisa, M; Bork, P			Bioinformatics in the post-sequence era	NATURE GENETICS			English	Review							GENE-EXPRESSION; RESEARCH TOOL; DATABASE; IDENTIFICATION; ALIGNMENT; BIOLOGY; CLASSIFICATION; PREDICTION; ALGORITHM; PROTEINS	In the past decade, bioinformatics has become an integral part of research and development in the biomedical sciences. Bioinformatics now has an essential role both in deciphering genomic, transcriptomic and proteomic data generated by high-throughput experimental technologies and in organizing information gathered from traditional biology. Sequence-based methods of analyzing individual genes or proteins have been elaborated and expanded, and methods have been developed for analyzing large numbers of genes or proteins simultaneously, such as in the identification of clusters of related genes and networks of interacting proteins. With the complete genome sequences for an increasing number of organisms at hand, bioinformatics is beginning to provide both conceptual bases and practical methods for detecting systemic functional behaviors of the cell and the organism.	Kyoto Univ, Bioinformat Ctr, Kyoto 6110011, Japan; European Mol Biol Lab, D-69012 Heidelberg, Germany	Kyoto University; European Molecular Biology Laboratory (EMBL)	Kanehisa, M (corresponding author), Kyoto Univ, Bioinformat Ctr, Kyoto 6110011, Japan.	kanehisa@kuicr.kyoto-u.ac.jp	Bork, Peer/F-1813-2013; Kanehisa, Minoru/R-3081-2018	Bork, Peer/0000-0002-2627-833X; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2002, NUCLEIC ACIDS RES, V30, P239, DOI 10.1093/nar/30.1.239; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baxevanis AD, 2002, NUCLEIC ACIDS RES, V30, P1, DOI 10.1093/nar/30.1.1; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, POSTGENOME INFORMATI; Karp PD, 1996, NUCLEIC ACIDS RES, V24, P32, DOI 10.1093/nar/24.1.32; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Ogata H, 2000, NUCLEIC ACIDS RES, V28, P4021, DOI 10.1093/nar/28.20.4021; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	56	122	133	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			305	310		10.1038/ng1109	http://dx.doi.org/10.1038/ng1109			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610540				2022-12-17	WOS:000181390900011
J	Pal, C; Hurst, LD				Pal, C; Hurst, LD			Evidence for co-evolution of gene order and recombination rate	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; LINKAGE INTENSITY; NATURAL-SELECTION; GENOME; EVOLUTION; YEAST; EXPRESSION; PROVIDES	There is increasing evidence in eukaryotic genomes that gene order is not random, even allowing for tandem duplication. Notably, in numerous genomes(1-6), genes of similar expression tend to be clustered. Are there other reasons for clustering of functionally similar genes? If genes are linked to enable genetic, rather than physical clustering, then we also expect that clusters of certain genes might be associated with blocks of reduced recombination rates. Here we show that, in yeast, essential genes are highly clustered and this clustering is independent of clustering of co-expressed genes and of tandem duplications. Adjacent pairs of essential genes are preferentially conserved through evolution. Notably, we also find that clusters of essential genes are in regions of low recombination and that larger clusters have lower recombination rates. These results suggest that selection acts to modify both the fine-scale intragenomic variation in the recombination rate and the distribution of genes and provide evidence for co-evolution of gene order and recombination rate.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Somerset, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary	University of Bath; Eotvos Lorand University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Somerset, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball CA, 2001, NUCLEIC ACIDS RES, V29, P80, DOI 10.1093/nar/29.1.80; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COOPER DN, 1999, HUMAN GENE EVOLUTION; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; COX EC, 1972, NATURE-NEW BIOL, V92, P133; Dickinson J. R., 1999, METABOLISM MOL PHYSL; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gessler DDG, 1999, GENET RES, V73, P119, DOI 10.1017/S001667239800367X; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; LERCHER MJ, IN PRESS GENOME RES; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; NEI M, 1968, NATURE, V218, P1160, DOI 10.1038/2181160a0; NEI M, 1967, GENETICS, V57, P625; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Strathern J. N., 1981, MOL BIOL YEAST SACCH; STRATHERN JN, 1995, GENETICS, V140, P965; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	28	122	124	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					392	395		10.1038/ng1111	http://dx.doi.org/10.1038/ng1111			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577060				2022-12-17	WOS:000181312700017
J	Yan, H; Chen, CY; Kobayashi, R; Newport, J				Yan, H; Chen, CY; Kobayashi, R; Newport, J			Replication focus-forming activity 1 and the Werner syndrome gene product	NATURE GENETICS			English	Article							DNA-SYNTHESIS; CENTERS; PROTEIN; ORIGINS; YEAST	The initiation of DNA replication involves a minimum of four factors: a specific DNA sequence (origin), an initiator protein which binds to the origin, a helicase that unwinds the origin and a protein that binds single-stranded DNA that stabilizes the unwound origin(1). In eukaryotic cells, the origin recognition complex(2) (ORC) is the initiator protein and replication protein A (RPA; ref. 3) is the single-stranded DNA-binding protein. However, the helicase has not been identified and the nature of origins remains elusive, except in the case of Saccharomyces cerevisiae. A unique feature of eukaryotic DNA replication is that it occurs at a few-hundred discrete foci(4). It has thus been proposed that a real origin must contain a specific DNA sequence and must be attached to replication foci. Using Xenopus laevis egg extracts, we have identified and purified a 170-kD protein, focus-forming activity 1 (FFA-1), which is required for the formation of replication foci(5). Here we report that FFA-1 has DNA-helicase activity. Moreover, it is a homologue of the human Werner syndrome gene product WRN, a protein associated with premature ageing in humans(6).	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Fox Chase Cancer Center; Cold Spring Harbor Laboratory; University of California System; University of California San Diego	Yan, H (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave,W450, Philadelphia, PA 19111 USA.	hong_yan@fccc.edu						ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; FUKIWARA Y, 1985, WERNERS SYNDROME HUM, P459; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GOBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713; Imamura O, 1997, GENOMICS, V41, P298, DOI 10.1006/geno.1997.4661; Kornberg A., 1992, DNA REPLICATION; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; TAKEUCHI F, 1982, HUM GENET, V60, P365, DOI 10.1007/BF00569220; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; YAN H, 1995, J CELL BIOL, V129, P1, DOI 10.1083/jcb.129.1.1; YAN H, 1995, SCIENCE, V269, P1883, DOI 10.1126/science.7569932; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Yu CE, 1997, AM J HUM GENET, V60, P330; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	25	122	125	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					375	378		10.1038/1263	http://dx.doi.org/10.1038/1263			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697700				2022-12-17	WOS:000075107600022
J	Brennan, TJ; Seeley, WW; Kilgard, M; Schreiner, CE; Tecott, LH				Brennan, TJ; Seeley, WW; Kilgard, M; Schreiner, CE; Tecott, LH			Sound-induced seizures in serotonin 5-HT2C receptor mutant mice	NATURE GENETICS			English	Article							INFERIOR COLLICULUS NEURONS; CENTRAL-NERVOUS-SYSTEM; EPILEPSY-PRONE RATS; AUDIOGENIC-SEIZURES; C-FOS; HEARING-LOSS; SUSCEPTIBILITY; MOUSE; 5-HYDROXYTRYPTAMINE; RESOLUTION	The epilepsies are a heterogeneous collection of seizure disorders with a lifetime expectancy risk rate of 2-4%(1). A convergence of evidence indicates that heritable factors contribute significantly to seizure susceptibility(2,3). Genetically epilepsy-prone rodent strains have been frequently used to examine the effect of genetic factors on seizure susceptibility. The most extensively studied of these have been strains that are susceptible to sound-induced convulsions (audiogenic seizures, or AGSs). Early observations of the ACS phenomenon were made in the laboratory of Dr. Ivan Pavlov; in the course of appetite-conditioning experiments in mice, the loud bell used to signal food presentation unexpectedly produced seizures in some animals(4). In 1947, DBA/2 (D2) mice were found to exhibit a genetic susceptibility to AGSs stimulated by a doorbell mounted in an iron tub(5). Since this discovery, AGSs have been among the most intensively studied phenotypes in behavioural genetics(6,7). Although several genetic loci confer susceptibility to AGSs, the corresponding genes have not been cloned. We report that null mutant mice lacking serotonin 5-HT2C receptors are extremely susceptible to AGSs. The onset of susceptibility is between two and three months of age, with complete penetrance in adult animals. ACS-induced immediate early gene expression indicates that AGSs are subcortical phenomena in auditory circuits. This AGS syndrome is the first produced by a known genetic defect; it provides a robust model for the examination of serotoninergic mechanisms in epilepsy.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT OTOLARYNGOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Schreiner, Christoph/0000-0002-4571-4328; Kilgard, Michael/0000-0002-6699-1818	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002260] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERMANN E, 1982, GENETIC BASIS EPILEP, P355; ANDERSON VE, 1982, GENETIC BASIS EPILEP, P103; BEVAN W, 1955, PSYCHOL BULL, V52, P473, DOI 10.1037/h0044568; Browning R A, 1978, Ann N Y Acad Sci, V305, P437, DOI 10.1111/j.1749-6632.1978.tb31540.x; BUTERBAUGH GG, 1978, LIFE SCI, V23, P2393, DOI 10.1016/0024-3205(78)90297-7; COLLINS RL, 1968, SCIENCE, V162, P1137, DOI 10.1126/science.162.3858.1137; COLLINS RL, 1972, EXPT MODELS EPILEPSY, P347; DAILEY JW, 1992, LIFE SCI, V50, P319, DOI 10.1016/0024-3205(92)90340-U; DAILEY JW, 1992, J PHARMACOL EXP THER, V260, P533; DECKARD BS, 1976, DEV PSYCHOBIOL, V9, P17, DOI 10.1002/dev.420090104; DELGADOESCUETA AV, 1986, ADV NEUROL, P3; FULLER JL, 1967, J HERED, V58, P135, DOI 10.1093/oxfordjournals.jhered.a107565; Hall Calvin S., 1947, JOUR HEREDITY, V38, P3; HENRY KR, 1980, AUDIOLOGY, V19, P369; HENRY KR, 1967, SCIENCE, V158, P938, DOI 10.1126/science.158.3803.938-a; HIRAMATSU M, 1987, EPILEPSY RES, V1, P40, DOI 10.1016/0920-1211(87)90049-0; JOBE PC, 1973, LIFE SCI, V13, P1, DOI 10.1016/0024-3205(73)90271-3; Krushinsky L., 1970, PHYSIOLOGICAL EFFECT, P159; LANGNER G, 1987, HEARING RES, V31, P197, DOI 10.1016/0378-5955(87)90127-4; LASALLE GL, 1990, BRAIN RES, V518, P308, DOI 10.1016/0006-8993(90)90988-N; LAZAROVA M, 1983, N-S ARCH PHARMACOL, V322, P147, DOI 10.1007/BF00512388; Milatovich Athena, 1992, Human Molecular Genetics, V1, P681, DOI 10.1093/hmg/1.9.681; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; PIERSON M, 1992, EPILEPSY RES, V13, P35, DOI 10.1016/0920-1211(92)90005-E; RIGEL CE, 1989, EPILEPSY RES, V4, P63; SCHLESINGER K, 1968, LIFE SCI PT 1 PHYSI, V7, P437, DOI 10.1016/0024-3205(68)90015-5; SCHREIBER RA, 1971, PHYSIOL BEHAV, V6, P635, DOI 10.1016/0031-9384(71)90247-2; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SEYFRIED TN, 1983, BRAIN RES, V271, P325, DOI 10.1016/0006-8993(83)90294-9; SEYFRIED TN, 1981, GENETICS, V99, P117; SHARP FR, 1993, CRIT REV NEUROBIOL, V7, P205; SNYDERKELLER AM, 1992, NEUROSCI LETT, V135, P108, DOI 10.1016/0304-3940(92)90147-Y; SPARKS DL, 1985, PHARMACOL BIOCHEM BE, V23, P753, DOI 10.1016/0091-3057(85)90067-X; SPROTT RL, 1975, BEHV STUDIES USING G, P27; Statnick M. A., 1992, Society for Neuroscience Abstracts, V18, P907; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vicari EM, 1951, J PSYCHOL, V32, P79, DOI 10.1080/00223980.1951.9916086; WADA JA, 1972, ELECTROEN CLIN NEURO, V33, P520, DOI 10.1016/0013-4694(72)90216-7; WILLOTT JF, 1981, J NEUROPHYSIOL, V45, P35, DOI 10.1152/jn.1981.45.1.35; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391	41	122	124	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					387	390		10.1038/ng0897-387	http://dx.doi.org/10.1038/ng0897-387			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241279				2022-12-17	WOS:A1997XM90900024
J	EIBERG, H; BERENDT, I; MOHR, J				EIBERG, H; BERENDT, I; MOHR, J			ASSIGNMENT OF DOMINANT INHERITED NOCTURNAL ENURESIS (ENUR1) TO CHROMOSOME 13Q	NATURE GENETICS			English	Letter							LINKAGE MAP; DESMOPRESSIN; GENE				EIBERG, H (corresponding author), UNIV COPENHAGEN,INST MED BIOCHEM & GENET,DEPT MED GENET,GENOME GRP,DANISH CTR GENOME RES,COPENHAGEN,DENMARK.							ARAI H, 1993, J BIOL CHEM, V268, P3463; BAKWIN H, 1973, BLADDER CONTROL ENUR, P73; Bartolozzi G, 1991, Pediatr Med Chir, V13, P389; BIRKASOVA M, 1978, PEDIATRICS, V62, P970; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; BOWCOCK A, 1991, CYTOGENET CELL GENET, V58, P580, DOI 10.1159/000133173; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; EIBERG H, 1989, CLIN GENET, V35, P313; ELBERG H, 1994, EUR J HUM GENET, V2, P132; FERGUSSON DM, 1986, PEDIATRICS, V78, P884; HOGG RJ, 1993, J UROLOGY, V150, P444, DOI 10.1016/S0022-5347(17)35506-4; HSIEH CL, 1990, SOMAT CELL MOLEC GEN, V16, P567, DOI 10.1007/BF01233097; JARVELIN MR, 1988, ACTA PAEDIATR SCAND, V77, P148, DOI 10.1111/j.1651-2227.1988.tb10614.x; Kaushansky A, 1972, Harefuah, V83, P245; Kolvin I, 1973, BLADDER CONTROL ENUR, P156; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEONARD BE, 1994, INT CLIN PSYCHOPHARM, V9, P7, DOI 10.1097/00004850-199403001-00003; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; Norgaard J P, 1991, Scand J Urol Nephrol Suppl, V140, P1; OTT J, 1973, AM J HUM GENET, V28, P528; RETTIG WJ, 1987, SOMAT CELL MOLEC GEN, V11, P189; RITTIG S, 1989, AM J PHYSIOL, V25, P664; SUMMAR ML, 1990, MOL ENDOCRINOL, V4, P947, DOI 10.1210/mend-4-6-947; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIEMSPERGER NF, 1994, J CARDIOVASC PHARM, V23, P37	25	122	127	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					354	356		10.1038/ng0795-354	http://dx.doi.org/10.1038/ng0795-354			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670476				2022-12-17	WOS:A1995RG38600022
J	ROTHNAGEL, JA; TRAUPE, H; WOJCIK, S; HUBER, M; HOHL, D; PITTELKOW, MR; SAEKI, H; ISHIBASHI, Y; ROOP, DR				ROTHNAGEL, JA; TRAUPE, H; WOJCIK, S; HUBER, M; HOHL, D; PITTELKOW, MR; SAEKI, H; ISHIBASHI, Y; ROOP, DR			MUTATIONS IN THE ROD DOMAIN OF KERATIN 2E IN PATIENTS WITH ICHTHYOSIS BULLOSA OF SIEMENS	NATURE GENETICS			English	Article							INTERMEDIATE FILAMENT STRUCTURE; EPIDERMOLYTIC HYPERKERATOSIS; EPIDERMAL DIFFERENTIATION; CYTOKERATIN-2; EXPRESSION; DIAGNOSIS; EPITHELIA; PATTERNS; SEQUENCE; SIMPLEX	Ichthyosis bullosa of Siemens (IBS) is an autosomal dominant skin disorder that resembles epidermolytic hyperkeratosis (EHK). We have indentified mutations in two families originally diagnosed with EHK and in four families diagnosed with IBS at the same codon in the highly conserved carboxy terminal of the rod domain of keratin 2e, thus revealing a mutational hot spot. Our results allow a differential diagnosis to be made between IBS and EHK at the genetic level and we suggest that patients diagnosed with EHK, but lacking keratin K1 or K10 mutations, should be re-examined for mutations in their K2e genes.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT DERMATOL,HOUSTON,TX 77030; UNIV MUNSTER,DEPT DERMATOL,W-4400 MUNSTER,GERMANY; UNIV LAUSANNE,MED CTR,DEPT DERMATOL,LAUSANNE,SWITZERLAND; MAYO CLIN & MAYO FDN,DEPT DERMATOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905; UNIV TOKYO,DEPT DERMATOL,TOKYO 113,JAPAN	Baylor College of Medicine; Baylor College of Medicine; University of Munster; University of Lausanne; Mayo Clinic; Mayo Clinic; University of Tokyo			Hohl, Daniel M/N-7554-2016; Huber, Marcel/M-8822-2016; Rothnagel, Joe/A-4874-2010	Huber, Marcel/0000-0003-3821-2378; Rothnagel, Joe/0000-0002-6710-3165	NICHD NIH HHS [HD25479] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025479] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANTONLAMPRECHT I, 1983, J INVEST DERMATOL, V81, pS149, DOI 10.1111/1523-1747.ep12540961; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2; COLLIN C, 1992, DIFFERENTIATION, V51, P137, DOI 10.1111/j.1432-0436.1992.tb00690.x; COMPTON JG, 1994, NAT GENET, V6, P6, DOI 10.1038/ng0194-6; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; HATZFELD M, 1991, J CELL SCI, V99, P351; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANGBEIN L, 1993, DIFFERENTIATION, V55, P57, DOI 10.1111/j.1432-0436.1993.tb00033.x; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; McKusick V.A., 1992, MENDELIAN INHERITANC; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; REQUENA L, 1991, CLIN EXP DERMATOL, V16, P383, DOI 10.1111/j.1365-2230.1991.tb00407.x; ROTHNAGEL JA, 1993, HUM MOL GENET, V2, P2147, DOI 10.1093/hmg/2.12.2147; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; ROTHNAGEL JA, 1994, J INVEST DERMATOL, V102, P13, DOI 10.1111/1523-1747.ep12371723; Rothnagel JA, 1995, CURR OPIN DERMATOL, V2, P211; Siemens HW, 1937, ARCH DERMATOL SYPH-G, V175, P590, DOI 10.1007/BF02058387; STEIJLEN PM, 1990, ARCH DERMATOL RES, V282, P1, DOI 10.1007/BF00505636; STEINERT PM, 1993, J INVEST DERMATOL, V100, P729, DOI 10.1111/1523-1747.ep12475665; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEPHENS K, 1993, J INVEST DERMATOL, V101, P240, DOI 10.1111/1523-1747.ep12365079; SYDER AJ, 1994, J CLIN INVEST, V93, P1533, DOI 10.1172/JCI117132; TRAUPE H, 1986, J AM ACAD DERMATOL, V14, P1000, DOI 10.1016/S0190-9622(86)70123-0; TRAUPE H, 1989, ICHTHYOSES GUIDE CLI, P139; WILSON AK, 1992, J CELL BIOL, V119, P401, DOI 10.1083/jcb.119.2.401	32	122	129	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					485	490		10.1038/ng0894-485	http://dx.doi.org/10.1038/ng0894-485			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7524919				2022-12-17	WOS:A1994PA83200014
J	RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; RAMESAR, RS; OLD, J; BONTROP, R; MCMAHON, R; BARTON, DE; FERGUSONSMITH, MA				RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; RAMESAR, RS; OLD, J; BONTROP, R; MCMAHON, R; BARTON, DE; FERGUSONSMITH, MA			MUTATIONAL BIAS PROVIDES A MODEL FOR THE EVOLUTION OF HUNTINGTONS-DISEASE AND PREDICTS A GENERAL INCREASE IN DISEASE PREVALENCE	NATURE GENETICS			English	Article							AGE-OF-ONSET; TRINUCLEOTIDE REPEAT; POLYMORPHISM; LENGTH; EXPANSION	Huntington's disease (HD) correlates with abnormal expansion in a block of GAG repeats in the Huntington's disease gene. We have investigated HD evolution by typing GAG alleles in several human populations and in a variety of primates. We find that human alleles have expanded from a shorter ancestral state and exhibit unusual asymmetric length distributions. Computer simulations are used to show that the human state can be derived readily from a primate ancestor, without the need to invoke natural selection. The key element is a simple length-dependent mutational bias towards longer alleles. Our model can explain a number of empirical observations, and predicts an ever-increasing incidence of HD.	ADDENBROOKES NHS TRUST, DEPT CLIN GENET, CAMBRIDGE CB2 2QQ, CAMBS, ENGLAND; UNIV CAMBRIDGE, DEPT GENET, CAMBRIDGE CB2 3EH, CAMBS, ENGLAND; UNIV CAPE TOWN, DEPT HUMAN GENET, CAPE TOWN, SOUTH AFRICA; JOHN RADCLIFFE HOSP, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND; TNO, MED BIOL LAB, 2280 RIJSWIJK, NETHERLANDS; UNIV CAMBRIDGE, DEPT PATHOL, CAMBRIDGE CB2 1QP, CAMBS, ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cape Town; University of Oxford; Netherlands Organization Applied Science Research; University of Cambridge	RUBINSZTEIN, DC (corresponding author), ADDENBROOKES NHS TRUST, E ANGLIAN REG GENET SERV, GENET MOLEC LAB, BOX 158, CAMBRIDGE CB2 2QQ, CAMBS, ENGLAND.		Barton, David E/B-9460-2008; Rubinsztein, David C/C-3472-2011; Bontrop, Ronald/J-3628-2012; Ramesar, Rajkumar/I-6941-2015	Bontrop, Ronald/0000-0003-0874-6467; Barton, David E/0000-0002-2031-9719; Ramesar, Rajkumar/0000-0001-5688-1634				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; HARPER PS, 1991, HUNTINGTONS DISEASE, P251; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MADDOX J, 1994, NATURE, V368, P685, DOI 10.1038/368685a0; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; ROUSE I, 1986, MIGRATIONS PREHISTOR, P67; RUBINSZTEIN DC, 1993, NAT GENET, V5, P214, DOI 10.1038/ng1193-214; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; SLIERENDREGT BL, 1993, TISSUE ANTIGENS, V42, P55, DOI 10.1111/j.1399-0039.1993.tb02167.x; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063	19	122	122	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					525	530		10.1038/ng0894-525	http://dx.doi.org/10.1038/ng0894-525			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951324				2022-12-17	WOS:A1994PA83200021
J	HARDY, J				HARDY, J			FRAMING BETA-AMYLOID	NATURE GENETICS			English	Editorial Material							HEREDITARY CEREBRAL-HEMORRHAGE; FAMILIAL ALZHEIMERS-DISEASE; PROTEIN-PRECURSOR GENE; DUTCH TYPE; DOMAIN; CHROMOSOME-21; LINKAGE		UNIV S FLORIDA,DEPT PSYCHIAT,SUNCOAST ALZHEIMERS DIS LABS,TAMPA,FL 33612	State University System of Florida; University of South Florida	HARDY, J (corresponding author), ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND.		Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423				ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FIDANI L, IN PRESS HUM MOL GEN; George Hyslop P. St., 1990, NATURE, V347, P194; GLENNER GG, 1989, J NEUROL SCI, V94, P1, DOI 10.1016/0022-510X(89)90214-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAAN J, 1990, BRAIN, V113, P1251, DOI 10.1093/brain/113.5.1251; HARDY J, 1992, AM J HUM GENET, V50, P648; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY J, 1991, LANCET, V337, P1342; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARLIN MCC, 1991, NATURE, V353, P844; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; JONES CT, 1992, NAT GENET, V1, P306, DOI 10.1038/ng0792-306; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; LANTOS PL, 1992, NEUROSCI LETT, V137, P221, DOI 10.1016/0304-3940(92)90408-Y; LEMAIRE HG, 1989, NUCLEIC ACIDS RES, V17, P517, DOI 10.1093/nar/17.2.517; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MANN DMA, 1992, NEUROSCI LETT, V137, P225, DOI 10.1016/0304-3940(92)90409-Z; MULLAN M, IN PRESS NATURE GENE; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; VANNOSTRAND WE, 1991, P NATL ACAD SCI USA, V88, P10302, DOI 10.1073/pnas.88.22.10302; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	38	122	168	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					233	234		10.1038/ng0792-233	http://dx.doi.org/10.1038/ng0792-233			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1363811				2022-12-17	WOS:A1992JC98400002
J	Kurilshikov, A; Medina-Gomez, C; Bacigalupe, R; Radjabzadeh, D; Wang, J; Demirkan, A; Le Roy, CI; Garay, JAR; Finnicum, CT; Liu, XR; Zhernakova, DV; Bonder, MJ; Hansen, TH; Frost, F; Ruhlemann, MC; Turpin, W; Moon, JY; Kim, HN; Lull, K; Barkan, E; Shah, SA; Fornage, M; Szopinska-Tokov, J; Wallen, ZD; Borisevich, D; Agreus, L; Andreasson, A; Bang, C; Bedrani, L; Bell, JT; Bisgaard, H; Boehnke, M; Boomsma, DI; Burk, RD; Claringbould, A; Croitoru, K; Davies, GE; van Duijn, CM; Duijts, L; Falony, G; Fu, JY; van der Graaf, A; Hansen, T; Homuth, G; Hughes, DA; Ijzerman, RG; Jackson, MA; Jaddoe, VWV; Joossens, M; Jorgensen, T; Keszthelyi, D; Knight, R; Laakso, M; Laudes, M; Launer, LJ; Lieb, W; Lusis, AJ; Masclee, AAM; Moll, HA; Mujagic, Z; Qibin, Q; Rothschild, D; Shin, H; Sorensen, SJ; Steves, CJ; Thorsen, J; Timpson, NJ; Tito, RY; Vieira-Silva, S; Volker, U; Volzke, H; Vosa, U; Wade, KH; Walter, S; Watanabe, K; Weiss, S; Weiss, FU; Weissbrod, O; Westra, HJ; Willemsen, G; Payami, H; Jonkers, DMAE; Vasquez, AA; de Geus, EJC; Meyer, KA; Stokholm, J; Segal, E; Org, E; Wijmenga, C; Kim, HL; Kaplan, RC; Spector, TD; Uitterlinden, AG; Rivadeneira, F; Franke, A; Lerch, MM; Franke, L; Sanna, S; D'Amato, M; Pedersen, O; Paterson, AD; Kraaij, R; Raes, J; Zhernakova, A				Kurilshikov, Alexander; Medina-Gomez, Carolina; Bacigalupe, Rodrigo; Radjabzadeh, Djawad; Wang, Jun; Demirkan, Ayse; Le Roy, Caroline, I; Garay, Juan Antonio Raygoza; Finnicum, Casey T.; Liu, Xingrong; Zhernakova, Daria, V; Bonder, Marc Jan; Hansen, Tue H.; Frost, Fabian; Ruhlemann, Malte C.; Turpin, Williams; Moon, Jee-Young; Kim, Han-Na; Lull, Kreete; Barkan, Elad; Shah, Shiraz A.; Fornage, Myriam; Szopinska-Tokov, Joanna; Wallen, Zachary D.; Borisevich, Dmitrii; Agreus, Lars; Andreasson, Anna; Bang, Corinna; Bedrani, Larbi; Bell, Jordana T.; Bisgaard, Hans; Boehnke, Michael; Boomsma, Dorret, I; Burk, Robert D.; Claringbould, Annique; Croitoru, Kenneth; Davies, Gareth E.; van Duijn, Cornelia M.; Duijts, Liesbeth; Falony, Gwen; Fu, Jingyuan; van der Graaf, Adriaan; Hansen, Torben; Homuth, Georg; Hughes, David A.; Ijzerman, Richard G.; Jackson, Matthew A.; Jaddoe, Vincent W. V.; Joossens, Marie; Jorgensen, Torben; Keszthelyi, Daniel; Knight, Rob; Laakso, Markku; Laudes, Matthias; Launer, Lenore J.; Lieb, Wolfgang; Lusis, Aldons J.; Masclee, Ad A. M.; Moll, Henriette A.; Mujagic, Zlatan; Qibin, Qi; Rothschild, Daphna; Shin, Hocheol; Sorensen, Soren J.; Steves, Claire J.; Thorsen, Jonathan; Timpson, Nicholas J.; Tito, Raul Y.; Vieira-Silva, Sara; Volker, Uwe; Volzke, Henry; Vosa, Urmo; Wade, Kaitlin H.; Walter, Susanna; Watanabe, Kyoko; Weiss, Stefan; Weiss, Frank U.; Weissbrod, Omer; Westra, Harm-Jan; Willemsen, Gonneke; Payami, Haydeh; Jonkers, Daisy M. A. E.; Vasquez, Alejandro Arias; de Geus, Eco J. C.; Meyer, Katie A.; Stokholm, Jakob; Segal, Eran; Org, Elin; Wijmenga, Cisca; Kim, Hyung-Lae; Kaplan, Robert C.; Spector, Tim D.; Uitterlinden, Andre G.; Rivadeneira, Fernando; Franke, Andre; Lerch, Markus M.; Franke, Lude; Sanna, Serena; D'Amato, Mauro; Pedersen, Oluf; Paterson, Andrew D.; Kraaij, Robert; Raes, Jeroen; Zhernakova, Alexandra			Large-scale association analyses identify host factors influencing human gut microbiome composition	NATURE GENETICS			English	Article								To study the effect of host genetics on gut microbiome composition, the MiBioGen consortium curated and analyzed genome-wide genotypes and 16S fecal microbiome data from 18,340 individuals (24 cohorts). Microbial composition showed high variability across cohorts: only 9 of 410 genera were detected in more than 95% of samples. A genome-wide association study of host genetic variation regarding microbial taxa identified 31 loci affecting the microbiome at a genome-wide significant (P < 5 x 10(-8)) threshold. One locus, the lactase (LCT) gene locus, reached study-wide significance (genome-wide association study signal: P = 1.28 x 10(-20)), and it showed an age-dependent association with Bifidobacterium abundance. Other associations were suggestive (1.95 x 10(-10) < P < 5 x 10(-8)) but enriched for taxa showing high heritability and for genes expressed in the intestine and brain. A phenome-wide association study and Mendelian randomization identified enrichment of microbiome trait loci in the metabolic, nutrition and environment domains and suggested the microbiome might have causal effects in ulcerative colitis and rheumatoid arthritis.	[Kurilshikov, Alexander; Demirkan, Ayse; Zhernakova, Daria, V; Bonder, Marc Jan; Claringbould, Annique; Fu, Jingyuan; van der Graaf, Adriaan; Vosa, Urmo; Westra, Harm-Jan; Wijmenga, Cisca; Franke, Lude; Sanna, Serena; Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Medina-Gomez, Carolina; Radjabzadeh, Djawad; Uitterlinden, Andre G.; Rivadeneira, Fernando; Kraaij, Robert] Erasmus MC Univ Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Medina-Gomez, Carolina; Duijts, Liesbeth; Jaddoe, Vincent W. V.; Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC Univ Med Ctr, Generat R Study, Rotterdam, Netherlands; [Bacigalupe, Rodrigo; Wang, Jun; Falony, Gwen; Joossens, Marie; Tito, Raul Y.; Vieira-Silva, Sara; Raes, Jeroen] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium; [Bacigalupe, Rodrigo; Wang, Jun; Falony, Gwen; Joossens, Marie; Tito, Raul Y.; Vieira-Silva, Sara; Raes, Jeroen] VIB, Ctr Microbiol, Leuven, Belgium; [Wang, Jun] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Demirkan, Ayse] Univ Surrey, Sch Biosci & Med, Dept Clin & Expt Med, Sect Stat Multiomics, Guildford, Surrey, England; [Le Roy, Caroline, I; Bell, Jordana T.; Jackson, Matthew A.; Steves, Claire J.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Garay, Juan Antonio Raygoza; Turpin, Williams; Bedrani, Larbi; Croitoru, Kenneth] Univ Toronto, Dept Med, Toronto, ON, Canada; [Garay, Juan Antonio Raygoza; Turpin, Williams; Croitoru, Kenneth] Mt Sinai Hosp, Div Gastroenterol, Toronto, ON, Canada; [Finnicum, Casey T.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD USA; [Finnicum, Casey T.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Liu, Xingrong; D'Amato, Mauro] Karolinska Inst, Ctr Mol Med, Dept Med Solna, Stockholm, Sweden; [Liu, Xingrong; D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, Stockholm, Sweden; [Zhernakova, Daria, V] ITMO Univ, Ctr Comp Technol, Lab Genom Divers, St Petersburg, Russia; [Hansen, Tue H.; Borisevich, Dmitrii; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Frost, Fabian; Weiss, Stefan; Weiss, Frank U.; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, Greifswald, Germany; [Ruhlemann, Malte C.; Bang, Corinna; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Moon, Jee-Young; Qibin, Qi] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Kim, Han-Na] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Med Res Inst, Sch Med, Seoul, South Korea; [Kim, Han-Na] Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul, South Korea; [Lull, Kreete; Org, Elin] Univ Tartu, Estonian Genome Ctr, Inst Genom, Tartu, Estonia; [Barkan, Elad; Rothschild, Daphna; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Cell Biol, Rehovot, Israel; [Shah, Shiraz A.; Bisgaard, Hans; Thorsen, Jonathan; Stokholm, Jakob] Copenhagen Univ Hosp, COPSAC, Copenhagen, Denmark; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med McGovern Med Sch, Houston, TX 77030 USA; [Szopinska-Tokov, Joanna; Vasquez, Alejandro Arias] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr Sch Publ Hlth, Houston, TX USA; [Szopinska-Tokov, Joanna; Vasquez, Alejandro Arias] Radboudumc, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Wallen, Zachary D.; Payami, Haydeh] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Agreus, Lars] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Stockholm, Sweden; [Andreasson, Anna] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Boomsma, Dorret, I; Davies, Gareth E.; Willemsen, Gonneke; de Geus, Eco J. C.] Vrije Univ, Biol Psychol, Amsterdam, Netherlands; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [van Duijn, Cornelia M.; Jaddoe, Vincent W. V.; Uitterlinden, Andre G.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [van Duijn, Cornelia M.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Duijts, Liesbeth; Moll, Henriette A.] Erasmus MC Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Homuth, Georg; Volker, Uwe; Weiss, Stefan] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Hughes, David A.; Timpson, Nicholas J.; Wade, Kaitlin H.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Hughes, David A.; Timpson, Nicholas J.; Wade, Kaitlin H.] Univ Bristol Sch Med, Populat Hlth Sci, Bristol, Avon, England; [Ijzerman, Richard G.] Amsterdam Univ Med Ctr, Dept Endocrinol, Locat VUMC, Amsterdam, Netherlands; [Jackson, Matthew A.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Jorgensen, Torben] Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Capital Reg Copenhagen, Ctr Clin Res & Prevent, Copenhagen, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Keszthelyi, Daniel; Masclee, Ad A. M.; Mujagic, Zlatan; Jonkers, Daisy M. A. E.] Maastricht Univ Med Ctr, Div Gastroenterol Hepatol, Maastricht, Netherlands; [Keszthelyi, Daniel; Masclee, Ad A. M.; Mujagic, Zlatan; Jonkers, Daisy M. A. E.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laudes, Matthias] Univ Hosp Schleswig Holstein, Dept Med 1, Campus Kiel, Kiel, Germany; [Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Shin, Hocheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Family Med, Sch Med, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Ctr Cohort Studies, Total Healthcare Ctr,Sch Med, Seoul, South Korea; [Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Volzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Walter, Susanna] Univ Linkoping, Dept Biomed & Clin Sci, Linkoping, Sweden; [Walter, Susanna] Cty Council Ostergotland, Dept Gastroenterol, Linkoping, Sweden; [Watanabe, Kyoko] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Weissbrod, Omer] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Vasquez, Alejandro Arias] Radboudumc, Dept Human Genet, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [de Geus, Eco J. C.] Amsterdam UMC, Amsterdam Publ Hlth, Amsterdam, Netherlands; [Meyer, Katie A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Meyer, Katie A.] Univ North Carolina Chapel Hill, Nutr Res Inst, Kannapolis, NC USA; [Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Kaplan, Robert C.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Sanna, Serena] CNR, Ist Ric Genet & Biomed, Monserrato, Italy; [D'Amato, Mauro] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [D'Amato, Mauro] Biodonostia Hlth Res Inst, Dept Gastrointestinal & Liver Dis, San Sebastian, Spain; [D'Amato, Mauro] Basque Sci Fdn, Ikerbasque, Bilbao, Spain; [Paterson, Andrew D.] Hosp Sick Children Res Inst, Genet & Genome Biol, Toronto, ON, Canada	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; KU Leuven; Flanders Institute for Biotechnology (VIB); Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Surrey; University of London; King's College London; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Karolinska Institutet; Karolinska Institutet; ITMO University; Novo Nordisk Foundation; University of Copenhagen; Greifswald Medical School; University of Kiel; Yeshiva University; Albert Einstein College of Medicine; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); University of Tartu; Weizmann Institute of Science; University of Copenhagen; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Radboud University Nijmegen; University of Alabama System; University of Alabama Birmingham; Karolinska Institutet; Stockholm University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vrije Universiteit Amsterdam; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Greifswald Medical School; University of Bristol; University of Bristol; University of Oxford; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Eastern Finland; University of Kiel; Schleswig Holstein University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Kiel; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Copenhagen; Greifswald Medical School; Linkoping University; City Council Ostergotland; Vrije Universiteit Amsterdam; Harvard University; Harvard T.H. Chan School of Public Health; Radboud University Nijmegen; University of Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Ewha Womans University; Fred Hutchinson Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Monash University; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kurilshikov, A; Zhernakova, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	alexa.kur@gmail.com; sasha.zhernakova@gmail.com	Garay, Juan Antonio Raygoza/AAM-9568-2021; D'Amato, Mauro/F-2450-2010; Hansen, Tue Haldor/S-7724-2016; Lerch, Markus M./E-2206-2016; sanna, serena/H-3009-2019; Fu, Jingyuan/ABE-6868-2020; Lieb, Wolfgang/AAC-7650-2022; Tito, Raul/CAG-3546-2022; Franke, Andre/B-2151-2010; Pedersen, Oluf/Z-1731-2019; Hughes, David/E-7190-2015; Võsa, Urmo/AAJ-5928-2020; Keszthelyi, Daniel/H-7746-2019; Thorsen, Jonathan/AAQ-9269-2021; Zhernakova, Alexandra/ABA-9372-2020; Rühlemann, Malte Christoph/AAA-6528-2019; Org, Elin/AAJ-9631-2021; Claringbould, Annique/AAI-7711-2021; Timpson, Nicholas John/O-7548-2015; Falony, Gwen/AAN-5011-2020; Williams, Turpin/H-3255-2019; Kurilshikov, Alexander/GWC-1519-2022; Keszthelyi, Daniel/ABD-9496-2021; Vieira-Silva, Sara/ABE-1247-2021; Bisgaard, Hans/N-4761-2016; Paterson, Andrew/A-4088-2011; de Geus, Eco/M-9318-2015; Raes, Jeroen/D-7835-2018	D'Amato, Mauro/0000-0003-2743-5197; Hansen, Tue Haldor/0000-0001-5948-8993; Lerch, Markus M./0000-0002-9643-8263; sanna, serena/0000-0002-3768-1749; Fu, Jingyuan/0000-0001-5578-1236; Franke, Andre/0000-0003-1530-5811; Pedersen, Oluf/0000-0002-3321-3972; Hughes, David/0000-0002-9644-8998; Võsa, Urmo/0000-0003-3476-1652; Keszthelyi, Daniel/0000-0001-9856-9980; Thorsen, Jonathan/0000-0003-0200-0461; Rühlemann, Malte Christoph/0000-0002-0685-0052; Claringbould, Annique/0000-0002-9201-6557; Timpson, Nicholas John/0000-0002-7141-9189; Falony, Gwen/0000-0003-2450-0782; Williams, Turpin/0000-0001-9364-5868; Kurilshikov, Alexander/0000-0003-2541-5627; Vieira-Silva, Sara/0000-0002-4616-7602; Bisgaard, Hans/0000-0003-4131-7592; Wallen, Zachary/0000-0002-2278-7348; Org, Elin/0000-0001-8688-9717; LIU, XINGRONG/0000-0003-0199-0221; Paterson, Andrew/0000-0002-9169-118X; Steves, Claire/0000-0002-4910-0489; Raygoza Garay, Juan Antonio/0000-0003-4296-4118; Borisevich, Dmitrii/0000-0002-1686-3578; Van Duijn, Cornelia/0000-0002-2374-9204; de Geus, Eco/0000-0001-6022-2666; Bonder, Marc Jan/0000-0002-8431-3180; Raes, Jeroen/0000-0002-1337-041X; Hansen, Torben/0000-0001-8748-3831; Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Medina-Gomez, Carolina/0000-0001-7999-5538; Willemsen, Gonneke/0000-0003-3755-0236; Weiss, Stefan/0000-0002-3553-4315; Bacigalupe, Rodrigo/0000-0001-7310-997X; Stokholm, Jakob/0000-0003-4989-9769; Le Roy, Caroline/0000-0002-0341-751X; Knight, Rob/0000-0002-0975-9019	MRC [MR/N01183X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		A. A.Andrew, 2018, bioRxiv, DOI 10.1101/447367; [Anonymous], 2019, NUTRIENTS, DOI DOI 10.3390/nu11061383; [Anonymous], 2019, NAT GENET, DOI DOI 10.1038/s41588-019-0481-0; [Anonymous], 2012, NAT GENET, DOI DOI 10.1038/ng.2354; [Anonymous], 2017, FEMS MICROBIOL RE S1, DOI DOI 10.1093/femsre/fux027; [Anonymous], 2018, NAT MED, DOI DOI 10.1038/nm.4517; [Anonymous], 2011, G3 GENES GENOM GENET, DOI DOI 10.1534/g3.111.001198; [Anonymous], 2009, DIABETOLOGIA, DOI DOI 10.1007/s00125-009-1514-5; [Anonymous], 2017, TRENDS IMMUNOL, DOI DOI 10.1016/J.IT.2017.06.003; [Anonymous], 2017, NAT COMMUN, DOI DOI 10.1038/s41467-017-01261-5; [Anonymous], 2010, AM J GASTROENTEROL, DOI DOI 10.1038/ajg.2010.218; [Anonymous], 2016, NAT GENET, DOI DOI 10.1038/ng.3695; [Anonymous], 2018, AM J EPIDEMIOL, DOI DOI 10.1093/aje/kwy096; [Anonymous], 2015, GENOME BIOL, DOI DOI 10.1186/s13059-015-0841-8; [Anonymous], 2010, BMC BIOINFORMATI S12, DOI DOI 10.1186/1471-2105-11-S12-S12; [Anonymous], 2010, PLOS ONE; [Anonymous], 2015, INT J EPIDEMIOL, DOI DOI 10.1093/ije/dyv080; [Anonymous], 2018, J CLIN ENDOCR METAB, DOI DOI 10.1210/jc.2017-02114; [Anonymous], 2015, NAT GENET, DOI DOI 10.1038/ng.3406; [Anonymous], 2019, CELL, DOI DOI 10.1016/j.cell.2019.07.045; [Anonymous], 2013, NAT GENET, DOI DOI 10.1038/ng.2756; [Anonymous], 2019, FRONT NUTR, DOI DOI 10.3389/FNUT.2019.00048; [Anonymous], 2014, CELL, DOI DOI 10.1016/j.cell.2014.09.053; [Anonymous], 2016, CELL, DOI DOI 10.1016/j.cell.2016.04.007; [Anonymous], 2012, AM J HUM GENET, DOI DOI 10.1016/j.ajhg.2012.03.007; [Anonymous], 2016, NAT GENET, DOI DOI 10.1038/ng.3663; [Anonymous], 2016, NAT GENET, DOI DOI 10.1038/ng.3693; [Anonymous], 2015, BIOINFORMATICS, DOI DOI 10.1093/bioinformatics/btv402; [Anonymous], 2017, NAT BIOTECHNOL, DOI DOI 10.1038/nbt.3981; [Anonymous], 2018, AM J HUM GENET, DOI DOI 10.1016/j.ajhg.2018.08.004; [Anonymous], 2007, P NATL ACAD SCI USA, DOI DOI 10.1073/pnas.0706625104; [Anonymous], 2017, STAT MED, DOI DOI 10.1002/sim.7221; [Anonymous], 2011, AM J CLIN NUTR, DOI DOI 10.3945/ajcn.110.009860; [Anonymous], 2019, PLOS PATHOG; [Anonymous], 2014, PLOS GENET; [Anonymous], 2010, BIOINFORMATICS, DOI DOI 10.1093/bioinformatics/btq340; [Anonymous], 2018, MICROBIOME, DOI DOI 10.1186/s40168-018-0479-3; [Anonymous], 2018, TWIN RES HUM GENET, DOI DOI 10.1017/thg.2018.26; [Anonymous], 2013, P NATL ACAD SCI USA, DOI DOI 10.1073/pnas.1306070110; [Anonymous], 2019, NAT GENET, DOI DOI 10.1038/s41588-019-0350-x; [Anonymous], 2015, BIOINFORMATICS, DOI DOI 10.1093/bioinformatics/btu655; [Anonymous], 2016, SCIENCE, DOI DOI 10.1126/science.aad3503; [Anonymous], 2015, BMC MICROBIOL, DOI DOI 10.1186/s12866-015-0351-6; [Anonymous], 2018, FRONT MICROBIOL, DOI DOI 10.3389/FMICB.2018.02780; [Anonymous], 2016, SCIENCE, DOI DOI 10.1126/SCIENCE.AAD3369; [Anonymous], 2013, GENET EPIDEMIOL, DOI DOI 10.1002/gepi.21758; [Anonymous], 2012, GENOME BIOL, DOI DOI 10.1186/gb-2012-13-9-r79; [Anonymous], 2016, NAT GENET, DOI DOI 10.1038/ng.3643; [Anonymous], 2018, NAT GENET, DOI DOI 10.1038/s41588-018-0224-7; [Anonymous], 2014, NAT COMMUN, DOI DOI 10.1038/ncomms5835; [Anonymous], 2018, NATURE, DOI DOI 10.1038/nature25973; [Anonymous], 2014, NAT GENET, DOI DOI 10.1038/ng.2982; [Anonymous], 2016, NAT GENET; [Anonymous], 2015, BEHAV BRAIN RES, DOI DOI 10.1016/j.bbr.2014.07.027; [Anonymous], 2019, NATURE, DOI DOI 10.1038/s41586-019-1237-9; [Anonymous], 2015, GENOME BIOL, DOI DOI 10.1186/s13059-015-0759-1; [Anonymous], 2018, FRONT MICROBIOL, DOI DOI 10.3389/fmicb.2018.02558; [Anonymous], 2018, SCI TRANSL MED; [Anonymous], 2016, CELL HOST MICROBE, DOI DOI 10.1016/j.chom.2016.04.017; [Anonymous], 2012, NATURE, DOI DOI 10.1038/nature11450; [Anonymous], 2018, NUTRIENTS, DOI DOI 10.3390/NU10121956; [Anonymous], 2013, NATURE, DOI DOI 10.1038/nature12198; [Anonymous], 2018, NAT GENET, DOI DOI 10.1038/s41588-018-0099-7; [Anonymous], 2018, JAMA PEDIATR, DOI DOI 10.1001/jamapediatrics.2017.5535; [Anonymous], 2016, CLIN IMMUNOL, DOI DOI 10.1016/j.clim.2016.07.026; [Anonymous], 2017, INT J EPIDEMIOL, DOI DOI 10.1093/ije/dyx102; [Anonymous], 2013, NAT MED, DOI DOI 10.1038/nm.3145; [Anonymous], 2019, NAT MICROBIOL, DOI DOI 10.1038/S41564-018-0337-X; [Anonymous], 2019, MICROORGANISMS, DOI DOI 10.3390/microorganisms7010014; [Anonymous], 2015, PLOS ONE; [Anonymous], 2018, ELIFE; [Anonymous], 2009, NUCLEIC ACIDS RES, DOI DOI 10.1093/nar/gkn879; [Anonymous], 2019, DIABETES, DOI DOI 10.2337/db19-0153; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Deelen Patrick, 2014, BMC Res Notes, V7, P901, DOI 10.1186/1756-0500-7-901; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Scher JU, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0206-x; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Wade Kaitlin H, 2019, Wellcome Open Res, V4, P199, DOI 10.12688/wellcomeopenres.15628.1	80	121	126	28	131	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2021	53	2					156	+		10.1038/s41588-020-00763-1	http://dx.doi.org/10.1038/s41588-020-00763-1		JAN 2021	19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QD3KE	33462485	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000608658900003
J	Cortes-Ciriano, I; Lee, JJK; Xi, RB; Jain, D; Jung, YL; Yang, LX; Gordenin, D; Klimczak, LJ; Zhang, CZ; Pellman, DS; Park, PJ; Akdemir, KC; Alvarez, EG; Baez-Ortega, A; Beroukhim, R; Boutros, PC; Bowtell, DDL; Brors, B; Burns, KH; Campbell, PJ; Chan, K; Chen, K; Dueso-Barroso, A; Dunford, AJ; Edwards, PA; Estivill, X; Etemadmoghadam, D; Feuerbach, L; Fink, JL; Frenkel-Morgenstern, M; Garsed, DW; Gerstein, M; Gordenin, DA; Haan, D; Haber, JE; Hess, JM; Hutter, B; Imielinski, M; Jones, DTW; Ju, YS; Kazanov, MD; Koh, Y; Korbel, JO; Kumar, K; Lee, EA; Li, YL; Lynch, AG; Macintyre, G; Markowetz, F; Martincorena, I; Martinez-Fundichely, A; Miyano, S; Nakagawa, H; Navarro, FCP; Ossowski, S; Pearson, JV; Puiggros, M; Rippe, K; Roberts, ND; Roberts, SA; Rodriguez-Martin, B; Schumacher, SE; Scully, R; Shackleton, M; Sidiropoulos, N; Sieverling, L; Stewart, C; Torrents, D; Tubio, JMC; Villasante, I; Waddell, N; Wala, JA; Weischenfeldt, J; Yao, XT; Yoon, SS; Zamora, J				Cortes-Ciriano, Isidro; Lee, Jake June-Koo; Xi, Ruibin; Jain, Dhawal; Jung, Youngsook L.; Yang, Lixing; Gordenin, Dmitry; Klimczak, Leszek J.; Zhang, Cheng-Zhong; Pellman, David S.; Park, Peter J.; Akdemir, Kadir C.; Alvarez, Eva G.; Baez-Ortega, Adrian; Beroukhim, Rameen; Boutros, Paul C.; Bowtell, David D. L.; Brors, Benedikt; Burns, Kathleen H.; Campbell, Peter J.; Chan, Kin; Chen, Ken; Dueso-Barroso, Ana; Dunford, Andrew J.; Edwards, Paul A.; Estivill, Xavier; Etemadmoghadam, Dariush; Feuerbach, Lars; Fink, J. Lynn; Frenkel-Morgenstern, Milana; Garsed, Dale W.; Gerstein, Mark; Gordenin, Dmitry A.; Haan, David; Haber, James E.; Hess, Julian M.; Hutter, Barbara; Imielinski, Marcin; Jones, David T. W.; Ju, Young Seok; Kazanov, Marat D.; Koh, Youngil; Korbel, Jan O.; Kumar, Kiran; Lee, Eunjung Alice; Li, Yilong; Lynch, Andy G.; Macintyre, Geoff; Markowetz, Florian; Martincorena, Inigo; Martinez-Fundichely, Alexander; Miyano, Satoru; Nakagawa, Hidewaki; Navarro, Fabio C. P.; Ossowski, Stephan; Pearson, John, V; Puiggros, Montserrat; Rippe, Karsten; Roberts, Nicola D.; Roberts, Steven A.; Rodriguez-Martin, Bernardo; Schumacher, Steven E.; Scully, Ralph; Shackleton, Mark; Sidiropoulos, Nikos; Sieverling, Lina; Stewart, Chip; Torrents, David; Tubio, Jose M. C.; Villasante, Izar; Waddell, Nicola; Wala, Jeremiah A.; Weischenfeldt, Joachim; Yao, Xiaotong; Yoon, Sung-Soo; Zamora, Jorge		PCAWG Struct Variation Working Grp; PCAWG Consortium	Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing	NATURE GENETICS			English	Article							DNA BREAKS; REARRANGEMENTS; MECHANISMS; REPAIR; REPLICATION; LANDSCAPE; EVOLUTION; PATTERNS	Analysis of whole-genome sequencing data across 2,658 tumors spanning 38 cancer types shows that chromothripsis is pervasive, with a frequency of more than 50% in several cancer types, contributing to oncogene amplification, gene inactivation and cancer genome evolution. Chromothripsis is a mutational phenomenon characterized by massive, clustered genomic rearrangements that occurs in cancer and other diseases. Recent studies in selected cancer types have suggested that chromothripsis may be more common than initially inferred from low-resolution copy-number data. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA), we analyze patterns of chromothripsis across 2,658 tumors from 38 cancer types using whole-genome sequencing data. We find that chromothripsis events are pervasive across cancers, with a frequency of more than 50% in several cancer types. Whereas canonical chromothripsis profiles display oscillations between two copy-number states, a considerable fraction of events involve multiple chromosomes and additional structural alterations. In addition to non-homologous end joining, we detect signatures of replication-associated processes and templated insertions. Chromothripsis contributes to oncogene amplification and to inactivation of genes such as mismatch-repair-related genes. These findings show that chromothripsis is a major process that drives genome evolution in human cancer.	[Cortes-Ciriano, Isidro; Lee, Jake June-Koo; Jain, Dhawal; Jung, Youngsook L.; Zhang, Cheng-Zhong] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Cortes-Ciriano, Isidro; Lee, Jake June-Koo; Park, Peter J.] Ludwig Ctr Harvard, Boston, MA 02215 USA; [Cortes-Ciriano, Isidro; Park, Peter J.] Univ Cambridge, Ctr Mol Sci Informat, Dept Chem, Cambridge, England; [Xi, Ruibin] Peking Univ, Sch Math Sci, Beijing, Peoples R China; [Xi, Ruibin] Peking Univ, Ctr Stat Sci, Beijing, Peoples R China; [Yang, Lixing] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yang, Lixing] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gordenin, Dmitry; Gordenin, Dmitry A.] NIEHS, Genome Integr & Struct Biol, NIH, Durham, NC USA; [Klimczak, Leszek J.] NIEHS, Integrat Bioinformat Grp, NIH, Durham, NC USA; [Zhang, Cheng-Zhong] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA; [Pellman, David S.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Pellman, David S.] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA; [Pellman, David S.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Cortes-Ciriano, Isidro; Korbel, Jan O.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Akdemir, Kadir C.; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Alvarez, Eva G.; Rodriguez-Martin, Bernardo; Tubio, Jose M. C.; Zamora, Jorge] Univ Santiago de Compostela, Dept Zool Genet & Phys Anthropol, Santiago De Compostela, Spain; [Alvarez, Eva G.; Rodriguez-Martin, Bernardo; Tubio, Jose M. C.; Zamora, Jorge] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Alvarez, Eva G.; Rodriguez-Martin, Bernardo; Tubio, Jose M. C.; Zamora, Jorge] Univ Vigo, Biomed Res Ctr CINBIO, Vigo, Spain; [Baez-Ortega, Adrian] Univ Cambridge, Dept Vet Med, Transmissible Canc Grp, Cambridge, England; [Beroukhim, Rameen; Dunford, Andrew J.; Hess, Julian M.; Kumar, Kiran; Schumacher, Steven E.; Stewart, Chip; Wala, Jeremiah A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Lee, Eunjung Alice; Wala, Jeremiah A.] Harvard Med Sch, Boston, MA 02115 USA; [Boutros, Paul C.] Ontario Inst Canc Res, Computat Biol Program, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Bowtell, David D. L.; Etemadmoghadam, Dariush; Garsed, Dale W.] Peter MacCallum Canc Ctr, Victoria, Australia; [Bowtell, David D. L.; Etemadmoghadam, Dariush; Garsed, Dale W.; Shackleton, Mark; Sidiropoulos, Nikos; Weischenfeldt, Joachim] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Brors, Benedikt; Feuerbach, Lars; Sieverling, Lina] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Brors, Benedikt; Hutter, Barbara] Natl Ctr Tumor Dis NCT Heidelberg, Heidelberg, Germany; [Burns, Kathleen H.] Johns Hopkins Sch Med, Baltimore, MD USA; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Campbell, Peter J.; Ju, Young Seok; Li, Yilong; Martincorena, Inigo; Roberts, Nicola D.; Zamora, Jorge] Wellcome Sanger Inst, Hinxton, England; [Chan, Kin] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Dueso-Barroso, Ana; Fink, J. Lynn; Puiggros, Montserrat; Torrents, David; Villasante, Izar] Barcelona Supercomp Ctr, Barcelona, Spain; [Edwards, Paul A.; Lynch, Andy G.; Macintyre, Geoff; Markowetz, Florian] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Edwards, Paul A.; Lynch, Andy G.; Markowetz, Florian] Univ Cambridge, Cambridge, England; [Estivill, Xavier] Sidra Med, Doha, Qatar; [Fink, J. Lynn] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld, Australia; [Frenkel-Morgenstern, Milana] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Gerstein, Mark] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA; [Gerstein, Mark; Navarro, Fabio C. P.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Haan, David] Univ Calif Santa Cruz, Biomol Engn Dept, Santa Cruz, CA 95064 USA; [Haber, James E.] Brandeis Univ, Waltham, MA USA; [Hess, Julian M.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Hutter, Barbara] German Canc Consortium DKTK, Heidelberg, Germany; [Hutter, Barbara] German Canc Res Ctr, Heidelberg Ctr Personalized Oncol DKFZ HIPO, Heidelberg, Germany; [Imielinski, Marcin; Yao, Xiaotong] New York Genome Ctr, New York, NY USA; [Imielinski, Marcin] Weill Cornell Med, New York, NY USA; [Jones, David T. W.] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany; [Jones, David T. W.] German Canc Res Ctr, Pediat Glioma Res Grp, Heidelberg, Germany; [Ju, Young Seok] Korea Adv Inst Sci & Technol, Daejeon, South Korea; [Kazanov, Marat D.] Skolkovo Inst Sci & Technol, Moscow, Russia; [Kazanov, Marat D.] AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Kazanov, Marat D.] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia; [Koh, Youngil] Seoul Natl Univ Hosp, Ctr Med Innovat, Seoul, South Korea; [Koh, Youngil; Yoon, Sung-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Korbel, Jan O.; Weischenfeldt, Joachim] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Lee, Eunjung Alice] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Lynch, Andy G.] Univ St Andrews, Sch Med, Sch Math & Stat, St Andrews, Fife, Scotland; [Martinez-Fundichely, Alexander] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Martinez-Fundichely, Alexander] Weill Cornell Med, Englander Inst Precis Med, New York, NY USA; [Martinez-Fundichely, Alexander] Weill Cornell Med, Inst Computat Biomed, New York, NY USA; [Miyano, Satoru] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nakagawa, Hidewaki] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Ossowski, Stephan] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Ossowski, Stephan] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain; [Ossowski, Stephan] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Pearson, John, V] Univ Pompeu Fabra, Barcelona, Spain; [Pearson, John, V] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Rippe, Karsten] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Roberts, Steven A.; Waddell, Nicola] German Canc Res Ctr, Heidelberg, Germany; [Schumacher, Steven E.; Waddell, Nicola] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Schumacher, Steven E.; Waddell, Nicola] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Scully, Ralph] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Shackleton, Mark] Righosp, Finsen Lab, Copenhagen, Denmark; [Sidiropoulos, Nikos; Weischenfeldt, Joachim] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Sieverling, Lina] Univ Copenhagen, Fac Hlth & Med Sci, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Torrents, David] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Wala, Jeremiah A.] ICREA, Barcelona, Spain; [Weischenfeldt, Joachim] Charit Univ Med Berlin, Dept Urol, Berlin, Germany; [Yao, Xiaotong] Weill Cornell Med, Triinst PhD Program Computat Biol & Med, New York, NY USA	Harvard University; Harvard Medical School; University of Cambridge; Peking University; Peking University; University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); University of Texas System; UTMD Anderson Cancer Center; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Vigo; CINBIO; University of Cambridge; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johns Hopkins University; Johns Hopkins Medicine; University of Cambridge; Wellcome Trust Sanger Institute; University of Ottawa; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Sidra Medical & Research Center; University of Queensland; Bar Ilan University; Princeton University; Yale University; Yale University; Yale University; University of California System; University of California Santa Cruz; Brandeis University; Harvard University; Massachusetts General Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Cornell University; Helmholtz Association; German Cancer Research Center (DKFZ); Korea Advanced Institute of Science & Technology (KAIST); Skolkovo Institute of Science & Technology; Kharkevich Institute for Information Transmission Problems of the RAS; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; European Molecular Biology Laboratory (EMBL); Harvard University; Boston Children's Hospital; University of St Andrews; Cornell University; Cornell University; Cornell University; Harvard University; Dana-Farber Cancer Institute; University of Tokyo; RIKEN; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Eberhard Karls University of Tubingen; Pompeu Fabra University; QIMR Berghofer Medical Research Institute; University of Queensland; Helmholtz Association; German Cancer Research Center (DKFZ); Washington State University; Washington State University; Harvard University; Dana-Farber Cancer Institute; University of Copenhagen; Harvard University; Beth Israel Deaconess Medical Center; University of Copenhagen; Ruprecht Karls University Heidelberg; ICREA; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cornell University	Park, PJ (corresponding author), Ludwig Ctr Harvard, Boston, MA 02215 USA.; Park, PJ (corresponding author), Univ Cambridge, Ctr Mol Sci Informat, Dept Chem, Cambridge, England.	peter_park@hms.harvard.edu	Kazanov, Marat D/D-6381-2013; Brors, Benedikt/E-5620-2013; Yakneen, Sergei/O-8928-2017; Bowtell, David/H-1007-2016; Ciriano, Isidro Cortes/ABE-1794-2021; Chen, Ken/AAU-1432-2021; Fink, Lynn/C-2031-2008; Scully, Ralph/F-5008-2013; Waddell, Nicola/H-4929-2015; Martinez-Fundichely, Alexander/AAR-7309-2020; Weischenfeldt, Joachim/O-3681-2015; Rippe, Karsten/A-3562-2012; Tsunoda, Tatsuhiko/K-2061-2014	Kazanov, Marat D/0000-0002-2314-5507; Brors, Benedikt/0000-0001-5940-3101; Yakneen, Sergei/0000-0001-7827-9839; Bowtell, David/0000-0001-9089-7525; Ciriano, Isidro Cortes/0000-0002-2036-494X; Chen, Ken/0000-0003-4013-5279; Fink, Lynn/0000-0003-2912-6048; Waddell, Nicola/0000-0002-3950-2476; Martinez-Fundichely, Alexander/0000-0002-7660-5511; Weischenfeldt, Joachim/0000-0002-3917-5524; Rippe, Karsten/0000-0001-9951-9395; Tsunoda, Tatsuhiko/0000-0002-5439-7918	European Union [703543]; Ludwig Center at Harvard; US National Institutes of Health Intramural Research Program Project [Z1AES103266];  [K22CA193848];  [R01CA213404]	European Union(European Commission); Ludwig Center at Harvard; US National Institutes of Health Intramural Research Program Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported by the European Union's Framework Programme For Research and Innovation Horizon 2020 under the Marie Sklodowska-Curie grant agreement no. 703543 (I.C.-C.), the Ludwig Center at Harvard (I.C.-C., J.J.-K.L. and P.J.P.), K22CA193848 (L.Y.), R01CA213404 (D.S.P.) and the US National Institutes of Health Intramural Research Program Project Z1AES103266 (D.G. and L.J.K.). We thank the Research Information Technology Group at Harvard Medical School for providing computational resources and S. Ouellette in the Park laboratory for help in deploying the companion website. We acknowledge the contributions of the many clinical networks across ICGC and TCGA, who provided samples and data to the PCAWG Consortium, and the contributions of the Technical Working Group and the Germline Working Group of the PCAWG Consortium for collation, realignment and harmonized variant calling of the cancer genomes used in this study. We thank the patients and their families for their participation in the individual ICGC and TCGA projects.	Akbani R., 2015, CELL, V161, P1681, DOI [10.1016/j.cell.2015.05.044, DOI 10.1016/J.CELL.2015.05.044]; Behjati S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15936; Cai H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-82; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Chudasama P, 2018, CANCER RES, V78, DOI [10.1158/1538-7445.AM2018-4336, 10.1038/s41467-017-02602-0]; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Garsed DW, 2014, CANCER CELL, V26, P653, DOI 10.1016/j.ccell.2014.09.010; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Govind SK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-78; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Ho SVS, 2020, NAT REV GENET, V21, P171, DOI 10.1038/s41576-019-0180-9; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lawson ARJ, 2011, GENOME RES, V21, P505, DOI 10.1101/gr.115782.110; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li YL, 2020, NATURE, V578, P112, DOI 10.1038/s41586-019-1913-9; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; McClintock B, 1941, GENETICS, V26, P234; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Sanborn JZ, 2013, CANCER RES, V73, P6036, DOI 10.1158/0008-5472.CAN-13-0186; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tan EH, 2015, ELIFE, V4, DOI 10.7554/eLife.06516; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Whalley J. P., 2017, FRAMEWORK QUALITY AS, DOI [10.1101/140921, DOI 10.1101/140921]; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	64	121	124	8	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2020	52	3					331	+		10.1038/s41588-019-0576-7	http://dx.doi.org/10.1038/s41588-019-0576-7		FEB 2020	12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KS5DL		Green Submitted, hybrid, Green Published			2022-12-17	WOS:000511282900004
J	deCarvalho, AC; Kim, H; Poisson, LM; Winn, ME; Mueller, C; Cherba, D; Koeman, J; Seth, S; Protopopov, A; Felicella, M; Zheng, SY; Multani, A; Jiang, YY; Zhang, JH; Nam, DH; Petricoin, EF; Chin, L; Mikkelsen, T; Verhaak, RGW				deCarvalho, Ana C.; Kim, Hoon; Poisson, Laila M.; Winn, Mary E.; Mueller, Claudius; Cherba, David; Koeman, Julie; Seth, Sahil; Protopopov, Alexei; Felicella, Michelle; Zheng, Siyuan; Multani, Asha; Jiang, Yongying; Zhang, Jianhua; Nam, Do-Hyun; Petricoin, Emanuel F.; Chin, Lynda; Mikkelsen, Tom; Verhaak, Roel G. W.			Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma	NATURE GENETICS			English	Article							FACTOR RECEPTOR GENE; GENOME ANALYSIS; WHOLE-GENOME; COPY NUMBER; AMPLIFICATION; EGFR; ALIGNMENT; TUMORS; PDGFRA; SUBPOPULATIONS	To understand how genomic heterogeneity of glioblastoma (GBM) contributes to poor therapy response, we performed DNA and RNA sequencing on GBM samples and the neurospheres and orthotopic xenograft models derived from them. We used the resulting dataset to show that somatic driver alterations including single-nucleotide variants, focal DNA alterations and oncogene amplification on extrachromosomal DNA (ecDNA) elements were in majority propagated from tumor to model systems. In several instances, ecDNAs and chromosomal alterations demonstrated divergent inheritance patterns and clonal selection dynamics during cell culture and xenografting. We infer that ecDNA was unevenly inherited by offspring cells, a characteristic that affects the oncogenic potential of cells with more or fewer ecDNAs. Longitudinal patient tumor profiling found that oncogenic ecDNAs are frequently retained throughout the course of disease. Our analysis shows that extrachromosomal elements allow rapid increase of genomic heterogeneity during GBM evolution, independently of chromosomal DNA alterations.	[deCarvalho, Ana C.; Mikkelsen, Tom] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Kim, Hoon; Verhaak, Roel G. W.] Jackson Lab Genom Med, Farmington, CT USA; [Poisson, Laila M.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Winn, Mary E.; Cherba, David] Van Andel Res Inst, Bioinformat & Biostat Core, Grand Rapids, MI USA; [Mueller, Claudius] George Mason Univ, Ctr Appl Prot & Mol Med, Manassas, VA USA; [Koeman, Julie] Van Andel Res Inst, Genom Core, Grand Rapids, MI USA; [Seth, Sahil; Protopopov, Alexei; Jiang, Yongying; Zhang, Jianhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Felicella, Michelle] Henry Ford Hosp, Dept Pathol, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Zheng, Siyuan; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Multani, Asha] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Nam, Do-Hyun] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea; [Nam, Do-Hyun] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Nam, Do-Hyun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea; [Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Jackson Laboratory; Henry Ford Health System; Henry Ford Hospital; Van Andel Institute; George Mason University; Van Andel Institute; University of Texas System; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Henry Ford Health System; Henry Ford Hospital	deCarvalho, AC; Mikkelsen, T (corresponding author), Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA.; Verhaak, RGW (corresponding author), Jackson Lab Genom Med, Farmington, CT USA.; Mikkelsen, T (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	adecarv1@hfhs.org; tmikkel1@hfhs.org; roel.verhaak@jax.org	Winn, Mary/AAN-6495-2021; Kim, Hoon/AAL-9283-2020; Verhaak, Roel/ABE-7058-2020; Seth, Sahil/I-5809-2019; Zheng, sy/GRS-3136-2022	Kim, Hoon/0000-0003-4244-6126; Seth, Sahil/0000-0003-4579-3959; deCarvalho, Ana C/0000-0003-1183-4548	LIGHT Research Program at the Hermelin Brain Tumor Center; US National Institutes of Health [R01 CA190121]; Cancer Center Support Grant [P30CA034196]; Cancer Prevention and Research Institute of Texas (CPRIT) [R140606]; National Brain Tumor Society; Korea Health Technology R&D project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI14C3418]; NATIONAL CANCER INSTITUTE [P30CA034196, R01CA190121] Funding Source: NIH RePORTER	LIGHT Research Program at the Hermelin Brain Tumor Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Cancer Prevention and Research Institute of Texas (CPRIT); National Brain Tumor Society; Korea Health Technology R&D project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank our colleagues at Henry Ford Hospital: N. Lehman and C. Hao for contributions to pathology reviews; L. Scarpace for clinical information; S. Irtenkauf, L. Hasselbach, K. Nelson, K. Bergman and S. Sobiechowski for cell culture and animal work; and A. Transou, Y. Meng and E. Carlton for histology. We are indebted to M. Wimsatt (JAX) for the creative design in Fig. 6. We thank G. Geneau, S. Roland and PacBio platform personnel of the Genome Quebec/Genome Canada-funded Innovation Centre for providing Pacific Biosciences sequencing. AmpliconArchitect analysis of TCGA was made possible through the Cancer Genomics Cloud of the Institute for Systems Biology (ISB-CGC). This work was supported by the LIGHT Research Program at the Hermelin Brain Tumor Center (A.C.d., T.M.); grants from the US National Institutes of Health R01 CA190121 (R.G.W.V.); Cancer Center Support Grant P30CA034196; the Cancer Prevention and Research Institute of Texas (CPRIT) R140606 (R.G.W.V.); and the National Brain Tumor Society (R.G.W.V.). This work was also supported by grant HI14C3418 of the Korea Health Technology R&D project through the Korea Health Industry Development Institute funded by the Ministry of Health & Welfare, Republic of Korea (D.N.). We are hugely indebted to the patients who provided biospecimens for the purpose of this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Annibali D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5632; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Arena S, 2007, P NATL ACAD SCI USA, V104, P11412, DOI 10.1073/pnas.0703205104; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; BIGNER SH, 1990, CANCER GENET CYTOGEN, V47, P141, DOI 10.1016/0165-4608(90)90024-5; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chi AS, 2012, J CLIN ONCOL, V30, pE30, DOI 10.1200/JCO.2011.38.4586; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/NMETH.3505, 10.1038/nmeth.3505]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; COX D, 1965, LANCET, V2, P55; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Graveel C, 2004, P NATL ACAD SCI USA, V101, P17198, DOI 10.1073/pnas.0407651101; Hasselbach LA, 2014, JOVE-J VIS EXP, DOI 10.3791/51088; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Irtenkauf SM, 2017, COMPARATIVE MED, V67, P300; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Lundberg G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003099; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Sanborn JZ, 2013, CANCER RES, V73, P6036, DOI 10.1158/0008-5472.CAN-13-0186; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tesfay L, 2016, MOL BIOL CELL, V27, P2493, DOI 10.1091/mbc.E15-09-0649; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113	58	121	127	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					708	+		10.1038/s41588-018-0105-0	http://dx.doi.org/10.1038/s41588-018-0105-0			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	29686388	Green Submitted, Green Accepted			2022-12-17	WOS:000431394900014
J	Park, SJ; Jiang, K; Tal, L; Yichie, Y; Gar, O; Zamir, D; Eshed, Y; Lippman, ZB				Park, Soon Ju; Jiang, Ke; Tal, Lior; Yichie, Yoav; Gar, Oron; Zamir, Dani; Eshed, Yuval; Lippman, Zachary B.			Optimization of crop productivity in tomato using induced mutations in the florigen pathway	NATURE GENETICS			English	Article							GROWTH HABIT; DETERMINATE GROWTH; FLOWERING TIME; GENE; ARABIDOPSIS; FT; TFL1; DOMESTICATION; ARCHITECTURE; EVOLUTION	Naturally occurring genetic variation in the universal florigen flowering pathway has produced major advancements in crop domestication(1-10). However, variants that can maximize crop yields may not exist in natural populations. Here we show that tomato productivity can be fine-tuned and optimized by exploiting combinations of selected mutations in multiple florigen pathway components. By screening for chemically induced mutations that suppress the bushy, determinate growth habit of field tomatoes, we isolated a new weak allele of the florigen gene SINGLE FLOWER TRUSS (SFT) and two mutations affecting a bZIP transcription factor component of the 'florigen activation complex' (ref. 11). By combining heterozygous mutations, we pinpointed an optimal balance of flowering signals, resulting in a new partially determinate architecture that translated to maximum yields. We propose that harnessing mutations in the florigen pathway to customize plant architecture and flower production offers a broad toolkit to boost crop productivity.	[Park, Soon Ju; Jiang, Ke; Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tal, Lior; Eshed, Yuval] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Yichie, Yoav; Gar, Oron; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel	Cold Spring Harbor Laboratory; Weizmann Institute of Science; Hebrew University of Jerusalem	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lippman@cshl.edu		Lippman, Zachary/0000-0001-7668-9025; Tal, Lior/0000-0002-1119-3392; Eshed, Yuval/0000-0001-8290-0018	European Research Council (ERC)-Advanced grant entitled YIELD; Israel Science Foundation (ISF) [1294-10]; Binational Agricultural Research and Development Fund (BARD) [IS4536-12C]; National Science Foundation (NSF) Plant Genome Research Program [1237880]	European Research Council (ERC)-Advanced grant entitled YIELD; Israel Science Foundation (ISF)(Israel Science Foundation); Binational Agricultural Research and Development Fund (BARD); National Science Foundation (NSF) Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank members of the Lippman laboratory for discussions, C. Brooks for technical assistance, T. Mulligan and P. Hanlon for plant care, and staff from Cornell University's Long Island Horticultural Research and Extension Center in Riverhead, New York, and the Western Galilee Experimental Station in Akko, Israel, for assistance with the yield trials. We also thank M. Lodha and D. Jackson (Cold Spring Harbor Laboratory) for providing vectors, F. Yang and Y.K. Lee for guidance on in situ hybridization and Agrobacterium infiltration in tobacco, and S. Hearn for assistance with confocal microscopy. This research was supported by a European Research Council (ERC)-Advanced grant entitled YIELD to D.Z., by Israel Science Foundation (ISF; 1294-10) and Binational Agricultural Research and Development Fund (BARD; IS4536-12C) grants to YE. and by a grant from the National Science Foundation (NSF) Plant Genome Research Program (1237880) to Z.B.L.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Fernandez L, 2010, PLANT J, V61, P545, DOI 10.1111/j.1365-313X.2009.04090.x; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Guo Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00282; Ho WWH, 2014, PLANT CELL, V26, P552, DOI 10.1105/tpc.113.115220; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jiang K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004043; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00465; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; RICK CM, 1978, SCI AM, V239, P77; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yeager AF, 1927, J HERED, V18, P263, DOI 10.1093/oxfordjournals.jhered.a102869	34	121	125	13	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1337	1342		10.1038/ng.3131	http://dx.doi.org/10.1038/ng.3131			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	25362485				2022-12-17	WOS:000345547300016
J	Ellinghaus, D; Baurecht, H; Esparza-Gordillo, J; Rodriguez, E; Matanovic, A; Marenholz, I; Hubner, N; Schaarschmidt, H; Novak, N; Michel, S; Maintz, L; Werfel, T; Meyer-Hoffert, U; Hotze, M; Prokisch, H; Heim, K; Herder, C; Hirota, O; Tamari, M; Kubo, M; Takahashi, A; Nakamura, Y; Tsoi, LC; Stuart, P; Elder, JT; Sun, LD; Zuo, XB; Yang, S; Zhang, XJ; Hoffmann, P; Nothen, MM; Folster-Holst, R; Winkelmann, J; Illig, T; Boehm, BO; Duerr, RH; Buning, C; Brand, S; Glas, J; McAleer, MA; Fahy, CM; Kabesch, M; Brown, S; McLean, WHI; Irvine, AD; Schreiber, S; Lee, YA; Franke, A; Weidinger, S				Ellinghaus, David; Baurecht, Hansjoerg; Esparza-Gordillo, Jorge; Rodriguez, Elke; Matanovic, Anja; Marenholz, Ingo; Huebner, Norbert; Schaarschmidt, Heidi; Novak, Natalija; Michel, Sven; Maintz, Laura; Werfel, Thomas; Meyer-Hoffert, Ulf; Hotze, Melanie; Prokisch, Holger; Heim, Katharina; Herder, Christian; Hirota, Omomitsu; Tamari, Mayumi; Kubo, Michiaki; Takahashi, Atsushi; Nakamura, Yusuke; Tsoi, Lam C.; Stuart, Philip; Elder, James T.; Sun, Liangdan; Zuo, Xianbo; Yang, Sen; Zhang, Xuejun; Hoffmann, Per; Noethen, Markus M.; Foelster-Holst, Regina; Winkelmann, Juliane; Illig, Thomas; Boehm, Bernhard O.; Duerr, Richard H.; Buening, Carsten; Brand, Stephan; Glas, Juergen; McAleer, Maeve A.; Fahy, Caoimhe M.; Kabesch, Michael; Brown, Sara; McLean, W. H. Irwin; Irvine, Alan D.; Schreiber, Stefan; Lee, Young-Ae; Franke, Andre; Weidinger, Stephan			High-density genotyping study identifies four new susceptibility loci for atopic dermatitis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; MYOCARDIAL-INFARCTION; CHROMOSOME 11Q13; COMMON VARIANT; CELIAC-DISEASE; PSORIATIC SKIN; POPULATION; ASTHMA; GENE	Atopic dermatitis is a common inflammatory skin disease with a strong heritable component. Pathogenetic models consider keratinocyte differentiation defects and immune alterations as scaffolds(1), and recent data indicate a role for autoreactivity in at least a subgroup of patients(2). FLG (encoding filaggrin) has been identified as a major locus causing skin barrier deficiency(3). To better define risk variants and identify additional susceptibility loci, we densely genotyped 2,425 German individuals with atopic dermatitis (cases) and 5,449 controls using the Immunochip array followed by replication in 7,196 cases and 15,480 controls from Germany, Ireland, Japan and China. We identified four new susceptibility loci for atopic dermatitis and replicated previous associations. This brings the number of atopic dermatitis risk loci reported in individuals of European ancestry to 11. We estimate that these susceptibility loci together account for 14.4% of the heritability for atopic dermatitis.	[Ellinghaus, David; Schaarschmidt, Heidi; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Baurecht, Hansjoerg; Rodriguez, Elke; Meyer-Hoffert, Ulf; Hotze, Melanie; Foelster-Holst, Regina; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venerol, Kiel, Germany; [Baurecht, Hansjoerg] Tech Univ Munich, GSISH, D-80290 Munich, Germany; [Esparza-Gordillo, Jorge; Matanovic, Anja; Marenholz, Ingo; Huebner, Norbert; Lee, Young-Ae] Max Delbruck Ctr MDC Mol Med, Berlin, Germany; [Esparza-Gordillo, Jorge; Matanovic, Anja; Marenholz, Ingo; Lee, Young-Ae] Charite, Pediat Allergol Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Novak, Natalija; Maintz, Laura] Univ Bonn, Med Ctr, Dept Dermatol & Allergy, Bonn, Germany; [Michel, Sven; Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Regensburg, Germany; [Werfel, Thomas] Hannover Med Sch, Div Immunodermatol & Allergy Res, Dept Dermatol & Allergy, Hannover, Germany; [Prokisch, Holger; Heim, Katharina; Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Human Genet, Neuherberg, Germany; [Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Hirota, Omomitsu; Tamari, Mayumi] RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Resp Dis, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Takahashi, Atsushi] RIKEN, Ctr Genom Med, Lab Stat Anal, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Lab Mol Med, Tokyo, Japan; [Tsoi, Lam C.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Stuart, Philip; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Sun, Liangdan; Zuo, Xianbo; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hefei, Anhui, Peoples R China; [Sun, Liangdan; Zuo, Xianbo; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Inst Dermatol Hosp 1, Hefei, Anhui, Peoples R China; [Sun, Liangdan; Zuo, Xianbo; Yang, Sen; Zhang, Xuejun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Hoffmann, Per] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Hoffmann, Per] Univ Basel, Dept Biomed, Basel, Switzerland; [Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar MRI, Inst Human Genet, D-80290 Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, MRI, Dept Neurol, D-80290 Munich, Germany; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Boehm, Bernhard O.] Univ Med Ctr Ulm, Div Endocrinol & Diabet, Dept Internal Med 1, Ulm, Germany; [Boehm, Bernhard O.] Ctr Excellence Metab Disorders, Ulm, Germany; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Buening, Carsten] Charite, Dept Gastroenterol Hepatol & Endocrinol, Berlin, Germany; [Brand, Stephan; Glas, Juergen] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [McAleer, Maeve A.; Fahy, Caoimhe M.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Brown, Sara; McLean, W. H. Irwin] Univ Dundee, Colleges Life Sci & Med Dent & Nursing, Ctr Dermatol & Genet Med, Dundee, Scotland; [Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin, Ireland; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med, Kiel, Germany; [Schreiber, Stefan; Weidinger, Stephan] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Technical University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; RIKEN; RIKEN; RIKEN; University of Tokyo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Anhui Medical University; Anhui Medical University; University of Bonn; University of Bonn; University of Basel; University of Basel; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Ulm University; Ulm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Munich; RWTH Aachen University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	a.franke@mucosa.de	Kubo, Michiaki/N-7947-2015; Werfel, Thomas/B-6921-2012; Ellinghaus, David/G-4467-2012; Hoffmann, Per/A-5149-2010; Ellinghaus, David/ABC-3610-2020; Kabesch, Michael/GZM-1583-2022; Boehm, Bernhard Otto/F-8750-2015; Rodríguez, Elke/C-4259-2013; Tamari, Mayumi/N-5378-2015; Kabesch, Michael/AAB-5701-2020; Prokisch, Holger/N-8964-2013; Franke, Andre/B-2151-2010; Brown, Sara J/AAF-7095-2019; Duerr, Richard H/B-4188-2009; Irvine, Alan D/A-3982-2008; Meyer-Hoffert, Ulf/F-4623-2012; Weidinger, Stephan/C-8461-2011; Chen, Gang/G-2722-2010; Baurecht, Hansjorg/C-4035-2013	Hoffmann, Per/0000-0002-6573-983X; Ellinghaus, David/0000-0002-4332-6110; Rodríguez, Elke/0000-0003-3692-3950; Franke, Andre/0000-0003-1530-5811; Brown, Sara J/0000-0002-3232-5251; Duerr, Richard H/0000-0001-6586-3905; Irvine, Alan D/0000-0002-9048-2044; Meyer-Hoffert, Ulf/0000-0003-2305-1428; Weidinger, Stephan/0000-0003-3944-252X; Baurecht, Hansjorg/0000-0002-9265-5594; Michel, Sven/0000-0003-3604-3187; Nothen, Markus/0000-0002-8770-2464; Tsoi, Lam Cheung/0000-0003-1627-5722; Winkelmann, Juliane/0000-0003-2667-9691; McLean, William Henry Irwin/0000-0001-5539-5757; Prokisch, Holger/0000-0003-2379-6286	Deutsche Forschungsgemeinschaft (DFG) [FR 2821/2-1]; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) [01GS 0818, 01GS 0812]; PopGen biobank; Heisenberg fellowship of the DFG [WE 2678/7-1]; National Children's Research Centre, Dublin; Wellcome Trust [090066/B/09/Z, 092530/Z/10/Z]; DFG [BR1912/6-1]; Else-Kroner-Fresenius-Stiftung [2010_EKES.32]; US National Institutes of Health [1R01CA141743-01]; University of Pittsburgh Genomics and Proteomics Core Laboratories for the Immunochip genotyping services; Wellcome Trust Strategic Award [098439/Z/12/Z]; General Program of National Natural Science Foundation of China [31171224]; Program for New Century Excellent Talents in University [NCET-11-0889]; Science and Technological Foundation of Anhui Province for Outstanding Youth [1108085J10]; State Key Basic Research Program 973 of China [2012CB722404]; MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063611, RC1AR058315, R01AR050511] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); PopGen biobank; Heisenberg fellowship of the DFG(German Research Foundation (DFG)); National Children's Research Centre, Dublin; Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Genomics and Proteomics Core Laboratories for the Immunochip genotyping services; Wellcome Trust Strategic Award(Wellcome Trust); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technological Foundation of Anhui Province for Outstanding Youth; State Key Basic Research Program 973 of China; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank all individuals with atopic dermatitis, their families, control individuals and clinicians for their participation. We thank T. Wesse, T. Henke, S. S. Sabet, S. Greve, I. Urbach, G. Patone, C. Flachmeier, S. Kolberg and G. Born for expert technical help. This study was supported by the Deutsche Forschungsgemeinschaft (DFG) grant FR 2821/2-1, the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN; 01GS 0818 and 01GS 0812 to Y.-A.L.) and the PopGen biobank. S. W. is supported by a Heisenberg fellowship of the DFG (WE 2678/7-1). The project received infrastructure support through the DFG Clusters of Excellence 'Inflammation at Interfaces'. A. D. I. is supported by the National Children's Research Centre, Dublin. A. D. I. and I. M. are supported by the Wellcome Trust (reference 090066/B/09/Z and 092530/Z/10/Z).; S. Brand is supported by DFG grant BR1912/6-1 and the Else-Kroner-Fresenius-Stiftung (stipend 2010_EKES.32). We acknowledge US National Institutes of Health grant 1R01CA141743-01 (R. H. D., principal investigator) and the University of Pittsburgh Genomics and Proteomics Core Laboratories for the Immunochip genotyping services. This work was supported by Wellcome Trust Programme and Bioresources grants (090066/B/09/Z and 092530/Z/10/Z) to W. H. I. M. and A. D. I. and a Wellcome Trust Strategic Award (098439/Z/12/Z) to W. H. I. M. Parts of this study were funded by the General Program of National Natural Science Foundation of China (31171224), the Program for New Century Excellent Talents in University (NCET-11-0889), the Science and Technological Foundation of Anhui Province for Outstanding Youth (1108085J10) and a pre-project of State Key Basic Research Program 973 of China (2012CB722404).	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; de Koning HD, 2012, BRIT J DERMATOL, V166, P1245, DOI 10.1111/j.1365-2133.2012.10885.x; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Haenle MM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-233; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hsu TL, 2002, J IMMUNOL, V168, P4846, DOI 10.4049/jimmunol.168.10.4846; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jagielska D, 2012, J INVEST DERMATOL, V132, P2192, DOI 10.1038/jid.2012.129; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Li YH, 2008, HUM MOL GENET, V17, P2978, DOI 10.1093/hmg/ddn196; Marenholz I, 2011, HUM MOL GENET, V20, P2443, DOI 10.1093/hmg/ddr117; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tang TS, 2012, J ALLERGY CLIN IMMUN, V129, P1209, DOI 10.1016/j.jaci.2012.02.002; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zeilinger S, 2009, ALLERGY, V64, P1790, DOI 10.1111/j.1398-9995.2009.02131.x; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	44	121	124	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2013	45	7					808	+		10.1038/ng.2642	http://dx.doi.org/10.1038/ng.2642			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	172LQ	23727859	Green Accepted			2022-12-17	WOS:000321005200017
J	Dumas, ME; Wilder, SP; Bihoreau, MT; Barton, RH; Fearnside, JF; Argoud, K; D'Amato, L; Wallis, RH; Blancher, C; Keun, HC; Baunsgaard, D; Scott, J; Sidelmann, UG; Nicholson, JK; Gauguier, D				Dumas, Marc-Emmanuel; Wilder, Steven P.; Bihoreau, Marie-Therese; Barton, Richard H.; Fearnside, Jane F.; Argoud, Karene; D'Amato, Lisa; Wallis, Robert H.; Blancher, Christine; Keun, Hector C.; Baunsgaard, Dorrit; Scott, James; Sidelmann, Ulla Grove; Nicholson, Jeremy K.; Gauguier, Dominique			Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models	NATURE GENETICS			English	Article							GOTO-KAKIZAKI RATS; BROWN-NORWAY; METABONOMICS; GENOME; EXPRESSION; ASSOCIATION; GENETICS; DISEASE; CROSSES; SYSTEMS	Characterizing the relationships between genomic and phenotypic variation is essential to understanding disease etiology. Information-dense data sets derived from pathophysiological(1), proteomic(2,3) and transcriptomic(4) profiling have been applied to map quantitative trait loci (QTLs). Metabolic traits, already used in QTL studies in plants(5), are essential phenotypes in mammalian genetics to define disease biomarkers. Using a complex mammalian system, here we show chromosomal mapping of untargeted plasma metabolic fingerprints derived from NMR spectroscopic analysis(6) in a cross between diabetic and control rats. We propose candidate metabolites for the most significant QTLs. Metabolite profiling in congenic strains provided evidence of QTL replication. Linkage to a gut microbial metabolite ( benzoate) can be explained by deletion of a uridine diphosphate glucuronosyltransferase. Mapping metabotypic QTLs provides a practical approach to understanding genome-phenotype relationships in mammals and may uncover deeper biological complexity, as extended genome(7) (microbiome) perturbations that affect disease processes through transgenomic effects(8) may influence QTL detection.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biomol Med, Div Surg Oncol Reprod Biol & Anaesthet, London SW7 2AZ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; NovoNordisk AS, DK-2760 Malov, Denmark; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, London SW7 2AZ, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; Novo Nordisk; Imperial College London	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biomol Med, Div Surg Oncol Reprod Biol & Anaesthet, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk; gdomi@well.ox.ac.uk	Nicholson, Jeremy K/B-3395-2012; Dumas, Marc-Emmanuel/C-1736-2008; Gauguier, Dominique/G-2190-2016	Nicholson, Jeremy K/0000-0002-8123-8349; Dumas, Marc-Emmanuel/0000-0001-9523-7024; Gauguier, Dominique/0000-0001-6156-9530; Wilder, Steven/0000-0001-8049-2559; Barton, Richard H./0000-0001-7469-2845				Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Collins SC, 2006, MAMM GENOME, V17, P538, DOI 10.1007/s00335-005-0168-y; DAMERVAL C, 1994, GENETICS, V137, P289; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, V3, P1154; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Watanabe TK, 2005, CLIN EXP PHARMACOL P, V32, P355, DOI 10.1111/j.1440-1681.2005.04196.x; Wilder SP, 2004, GENOME RES, V14, P758, DOI 10.1101/gr.2001604	30	121	125	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					666	672		10.1038/ng2026	http://dx.doi.org/10.1038/ng2026			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17435758				2022-12-17	WOS:000245971300024
J	Gutierrez-Marcos, JF; Costa, LM; Dal Pra, M; Scholten, S; Kranz, E; Perez, P; Dickinson, HG				Gutierrez-Marcos, Jose F.; Costa, Liliana M.; Dal Pra, Mauro; Scholten, Stefan; Kranz, Erhard; Perez, Pascual; Dickinson, Hugh G.			Epigenetic asymmetry of imprinted genes in plant gametes	NATURE GENETICS			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; POLYCOMB GENE; GLYCOSYLASE; ENDOSPERM; MEDEA; EXPRESSION; DEMETER; PROTEIN; GENOME	Plant imprinted genes show parent-of-origin expression in seed endosperm, but little is known about the nature of parental imprints in gametes before fertilization. We show here that single differentially methylated regions (DMRs) correlate with allele-specific expression of two maternally expressed genes in the seed and that one DMR is differentially methylated between gametes. Thus, plants seem to have developed similar strategies as mammals to epigenetically mark imprinted genes.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Hamburg, Biozentrum Klein Flottbek, D-22609 Hamburg, Germany; Univ Hamburg, Bot Garten, D-22609 Hamburg, Germany; Biogemma, F-63170 Clermont Ferrand, France	University of Oxford; University of Hamburg; University of Hamburg	Gutierrez-Marcos, JF (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	jose.gutierrez@plants.ox.ac.uk	Gutierrez-Marcos, Jose/AAE-2229-2020	Gutierrez-Marcos, Jose/0000-0002-5441-9080				Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gutierrez-Marcos JF, 2003, PHILOS T ROY SOC B, V358, P1105, DOI 10.1098/rstb.2003.1292; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; JULLIEN PE, 2006, PLANT CELL; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367	15	121	133	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					876	878		10.1038/ng1828	http://dx.doi.org/10.1038/ng1828			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16823380				2022-12-17	WOS:000239325700015
J	Wang, YX; Putnam, CD; Kane, MF; Zhang, WJ; Edelmann, L; Russell, R; Carrion, DV; Chin, L; Kucherlapati, R; Kolodner, RD; Edelmann, W				Wang, YX; Putnam, CD; Kane, MF; Zhang, WJ; Edelmann, L; Russell, R; Carrion, DV; Chin, L; Kucherlapati, R; Kolodner, RD; Edelmann, W			Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice	NATURE GENETICS			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; GENOME INSTABILITY; HOMOLOGOUS RECOMBINATION; SHORT ARM; REARRANGEMENTS; SUPPRESSION; DAMAGE; GENES; HETEROZYGOSITY	Most cancers have multiple chromosomal rearrangements; the molecular mechanisms that generate them remain largely unknown. Mice carrying a heterozygous missense change in one of the DNA- binding domains of Rpa1 develop lymphoid tumors, and their homozygous littermates succumb to early embryonic lethality. Array comparative genomic hybridization of the tumors identified large- scale chromosomal changes as well as segmental gains and losses. The Rpa1 mutation resulted in defects in DNA double- strand break repair and precipitated chromosomal breaks as well as aneuploidy in primary heterozygous mutant mouse embryonic fibroblasts. The equivalent mutation in yeast is hypomorphic and semidominant and enhanced the formation of gross chromosomal rearrangements in multiple genetic backgrounds. These results indicate that Rpa1 functions in DNA metabolism are essential for the maintenance of chromosomal stability and tumor suppression.	Univ Calif San Diego, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Harvard Univ, Sch Med, Ctr Genet & Genom, Harvard Med Sch Partners Healthcare Ctr Genet & G, Boston, MA 02115 USA; NYU, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; New York University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute	Kolodner, RD (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu; edelmann@aecom.yu.edu	Kucherlapati, Raju/ABC-8807-2021	Wang, Yuxun/0000-0002-4252-6102; Putnam, Christopher/0000-0002-6145-1265				BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3847, DOI 10.1073/pnas.88.9.3847; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; Cory S, 1999, CANCER RES, V59, p1685S; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Klein HL, 2001, GENETICS, V159, P1501; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lim DS, 1996, MOL CELL BIOL, V16, P7133; MACKAY J, 1988, LANCET, V2, P1384; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Pennaneach V, 2004, NAT GENET, V36, P612, DOI 10.1038/ng1359; Soustelle C, 2002, GENETICS, V161, P535; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tharapel SA, 2002, AM J MED GENET, V107, P123, DOI 10.1002/ajmg.10105; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; UMBRICHT CB, 1994, GENOMICS, V20, P249, DOI 10.1006/geno.1994.1161; Umezu K, 1998, GENETICS, V148, P989; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	30	121	122	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					750	755		10.1038/ng1587	http://dx.doi.org/10.1038/ng1587			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15965476				2022-12-17	WOS:000230196400023
J	Passegue, E; Jochum, W; Behrens, A; Ricci, R; Wagner, EF				Passegue, E; Jochum, W; Behrens, A; Ricci, R; Wagner, EF			JunB can substitute for Jun in mouse development and cell proliferation	NATURE GENETICS			English	Article							D1 MESSENGER-RNA; C-JUN; TRANSCRIPTIONAL ACTIVATION; CYCLE PROGRESSION; EXPRESSION; FOS; APOPTOSIS; GROWTH; AP-1; PHOSPHORYLATION	The Jun and JunB components of the AP-1 transcription factor are known to have antagonistic functions. Here we show, by a knock-in strategy and a transgenic complementation approach, that Junb can substitute for absence of Jun during mouse development. Junb can rescue both liver and cardiac defects in Jun-null mice in a manner dependent on gene dosage. JunB restores the expression of genes regulated by Jun/Fos, but not those regulated by Jun/ATF, thereby rescuing Jun-dependent defects in vivo as well as in primary fibroblasts and fetal hepatoblasts in vitro. Thus, the transcriptionally less active JunB has the potential to substitute for Jun, indicating that the spatial and temporal regulation of expression of the transcription factor AP-1 may be more important than the coding sequence of its components.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	wagner@nt.imp.univie.ac.at	Ricci, Romeo/K-3009-2013	Ricci, Romeo/0000-0002-9766-4369; Wagner, Erwin F/0000-0001-7872-0196; Behrens, Axel/0000-0002-1557-1143; Passegue, Emmanuelle/0000-0002-3516-297X				Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BENBROOK DM, 1990, ONCOGENE, V5, P295; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Cirillo G, 1999, MOL CELL BIOL, V19, P6240; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HSU JC, 1993, CANCER RES, V53, P3789; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; KITABAYASHI I, 1993, J BIOL CHEM, V268, P14482; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; van Dam H, 1998, GENE DEV, V12, P1227, DOI 10.1101/gad.12.8.1227; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	41	121	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					158	166		10.1038/ng790	http://dx.doi.org/10.1038/ng790			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11818961				2022-12-17	WOS:000173708700015
J	O'Hagan, RC; Schreiber-Agus, N; Chen, K; David, G; Engelman, JA; Schwab, R; Alland, L; Thomson, C; Ronning, DR; Sacchettini, JC; Meltzer, P; DePinho, RA				O'Hagan, RC; Schreiber-Agus, N; Chen, K; David, G; Engelman, JA; Schwab, R; Alland, L; Thomson, C; Ronning, DR; Sacchettini, JC; Meltzer, P; DePinho, RA			Gene-target recognition among members of the Myc superfamily and implications for oncogenesis	NATURE GENETICS			English	Article							C-MYC; DNA-BINDING; REPRESSES TRANSCRIPTION; CELL-GROWTH; IN-VIVO; MAX; PROTEIN; DOMAIN; DIFFERENTIATION; NETWORK	Myc and Mad family proteins regulate multiple biological processes through their capacity to influence gene expression directly. Here we show that the basic regions of Myc and Mad proteins are not functionally equivalent in oncogenesis, have separable E-box-binding activities and engage both common and distinct gene targets. Our data support the view that the opposing biological actions of Myc and Mxi1 extend beyond reciprocal regulation of common gene targets. Identification of differentially regulated gene targets provides a framework for understanding the mechanism through which the Myc superfamily governs the growth, proliferation and survival of normal and neoplastic cells.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Natl Human Genome Res Inst, NIH, Bethesda, MD USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.			DePinho, Ronald/0000-0002-5625-577X; Ronning, Donald/0000-0003-2583-8849; , gregory/0000-0002-3371-4558	NEI NIH HHS [R01EY09300] Funding Source: Medline; NICHD NIH HHS [R01HD28317] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028317] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009300] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chiorini JA, 1999, J BIOL CHEM, V274, P4195, DOI 10.1074/jbc.274.7.4195; Dang CV, 1999, MOL CELL BIOL, V19, P1; DeRisi J, 1996, NAT GENET, V14, P457; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Ferre d'Amare AR, 1993, NATURE, V363, P38; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; HALAZONETIS TD, 1991, P NATL ACAD SCI USA, V88, P6162, DOI 10.1073/pnas.88.14.6162; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khan J, 1998, CANCER RES, V58, P5009; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee LA, 1997, CURR TOP MICROBIOL, V224, P131; Lee TC, 1997, P NATL ACAD SCI USA, V94, P12886, DOI 10.1073/pnas.94.24.12886; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; SOLOMON DLC, 1993, NUCLEIC ACIDS RES, V21, P5372, DOI 10.1093/nar/21.23.5372; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; [No title captured]	37	121	125	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					113	119		10.1038/72761	http://dx.doi.org/10.1038/72761			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655054				2022-12-17	WOS:000085104600009
J	Wang, H; Long, QM; Marty, SD; Sassa, S; Lin, S				Wang, H; Long, QM; Marty, SD; Sassa, S; Lin, S			A zebrafish model for hepatoerythropoietic porphyria	NATURE GENETICS			English	Article							HUMAN UROPORPHYRINOGEN DECARBOXYLASE; NUCLEOTIDE-SEQUENCE; POINT MUTATION; GENE SEQUENCE; CUTANEA-TARDA; IDENTIFICATION; DEFECTS; CLONING; CDNA; DNA	Defects in the enzymes involved in the haem biosynthetic pathway can lead to a group of human diseases known as the porphyrias. yquem (yqe(tp61)) is a zebrafish mutant with a photosensitive porphyria syndrome. Here we show that the porphyric phenotype is due to an inherited homozygous mutation in the gene encoding uroporphyrinogen decarboxylase (UROD); a homozygous deficiency of this enzyme causes hepatoerythropoietic porphyria (HEP) in humans. The zebrafish mutant represents the first genetically 'accurate' animal model of HEP, and should be useful for studying the pathogenesis of UROD deficiency and evaluating gene therapy vectors.. We rescued the mutant phenotype by transient and germline expression of the wild-type allele.	Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; Rockefeller Univ, New York, NY 10021 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Rockefeller University	Lin, S (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.		Long, Qiaoming/L-5074-2017; Wang, Han/A-9774-2008	Long, Qiaoming/0000-0001-8243-589X; Wang, Han/0000-0003-2420-3147	NIDDK NIH HHS [DK-32890, R01 DK54508-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054508, R01DK032890] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; CHELSTOWSKA A, 1992, BIOCHEM J, V288, P753, DOI 10.1042/bj2880753; CULP P, 1991, P NATL ACAD SCI USA, V88, P7953, DOI 10.1073/pnas.88.18.7953; de Verneuil H, 1978, Hum Genet, V44, P145; DEVERNEUIL H, 1983, BIOCHEM J, V214, P145, DOI 10.1042/bj2140145; DEVERNEUIL H, 1992, HUM GENET, V89, P548; DEVERNEUIL H, 1986, SCIENCE, V234, P732, DOI 10.1126/science.3775362; ELDER GH, 1989, CLIN BIOCHEM, V22, P163, DOI 10.1016/S0009-9120(89)80072-4; Elder GH, 1998, SEMIN LIVER DIS, V18, P67, DOI 10.1055/s-2007-1007142; GAREY JR, 1992, EUR J BIOCHEM, V205, P1011, DOI 10.1111/j.1432-1033.1992.tb16868.x; GAREY JR, 1989, BLOOD, V73, P892; Haffter P, 1996, DEVELOPMENT, V123, P1; Kappas A, 1995, METABOLIC MOL BASES, P2103; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; Long QM, 1997, DEVELOPMENT, V124, P4105; McManus JF, 1996, BLOOD, V88, P3589, DOI 10.1182/blood.V88.9.3589.bloodjournal8893589; MEGURO K, 1994, J INVEST DERMATOL, V102, P681, DOI 10.1111/1523-1747.ep12374134; MoranJimenez MJ, 1996, AM J HUM GENET, V58, P712; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NISHIMURA K, 1993, GENE, V133, P109; NUSSLEINVOLHARD C, 1994, SCIENCE, V266, P572, DOI 10.1126/science.7939708; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Ransom DG, 1996, DEVELOPMENT, V123, P311; ROBERTS AG, 1995, J INVEST DERMATOL, V104, P500, DOI 10.1111/1523-1747.ep12605953; ROMANA M, 1991, EUR J CLIN INVEST, V21, P225, DOI 10.1111/j.1365-2362.1991.tb01814.x; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7343, DOI 10.1093/nar/15.18.7343; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7211, DOI 10.1093/nar/15.17.7211; ROMEO PH, 1986, J BIOL CHEM, V261, P9825; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Westerfield M, 1995, ZEBRAFISH BOOK; Wu C, 1996, MAMM GENOME, V7, P349, DOI 10.1007/s003359900101; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	33	121	131	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					239	243		10.1038/3041	http://dx.doi.org/10.1038/3041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806541				2022-12-17	WOS:000076698100016
J	Liu, WG; Qian, CP; Francke, U				Liu, WG; Qian, CP; Francke, U			Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome	NATURE GENETICS			English	Letter							MESSENGER-RNA; SPLICE-SITE; SEQUENCES; SELECTION; NONSENSE; PROTEIN; FBN1		STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University; Stanford University								BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; Berg Mary Anne, 1992, Human Mutation, V1, P24, DOI 10.1002/humu.1380010105; CHEN BW, 1994, BIOTECHNIQUES, V17, P657; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KRAWCZAK M, 1992, HUM GENET, V90, P41; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; Liu WG, 1996, HUM MOL GENET, V5, P1581, DOI 10.1093/hmg/5.10.1581; Milland J, 1996, EUR J BIOCHEM, V238, P221, DOI 10.1111/j.1432-1033.1996.0221q.x; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; TIAN HC, 1995, MOL CELL BIOL, V15, P6291	17	121	124	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					328	329		10.1038/ng0897-328	http://dx.doi.org/10.1038/ng0897-328			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241263				2022-12-17	WOS:A1997XM90900008
J	Chang, CC; Lee, WH; Moser, H; Valle, D; Gould, SJ				Chang, CC; Lee, WH; Moser, H; Valle, D; Gould, SJ			Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TARGETING SIGNAL; PROTEIN; MUTATIONS; THIOLASE; MEMBER; IMPORT	The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous diseases lethal in early infancy(1). Although the clinical features of PBD patients may vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins. This cellular phenotype is shared by yeast per mutants, and human orthologues of yeast PEX genes have been shown to be defective in some groups of PBD patients(2,3). We identified a putative human orthologue of ScPEX12 by screening the database of expressed sequence tags for cDNAs capable of encoding a protein similar to yeast Pex12p(4). Although its sequence similarity to yeast Pex12 proteins was limited. PEX12 shared the same subcellular distribution as yeast Pex12p and localized to the peroxisome membrane. PEX12 expression restored peroxisomal protein import in fibroblasts from PBD patients of complement group 3 (CG3) and frameshift mutations in PEX12 were detected in two unrelated CG3 patients. These data demonstrate that mutations in PEX12 are responsible for CG3 of the PBD and that PEX12 plays an essential role in peroxisomal matrix protein import.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ANAT & CELL BIOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University				Chang, Chia-Che/0000-0003-3509-3713	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10981] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Kalish JE, 1996, EMBO J, V15, P3275, DOI 10.1002/j.1460-2075.1996.tb00692.x; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MOTLEY A, 1994, J CELL BIOL, V125, P735; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	19	121	123	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					385	388		10.1038/ng0497-385	http://dx.doi.org/10.1038/ng0497-385			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090384				2022-12-17	WOS:A1997WQ38900017
